data_2k6z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k6z _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 CA--C 1.544 0.729 0 CA-C-O 121.237 0.541 . . . . 4.6500000000000004 112.038 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.68 179.32 35.33 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.65 1.119 . . . . 1.5 114.869 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -146.25 146.33 30.72 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.134 1.374 . . . . 2.7999999999999998 112.721 162.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -86.57 149.76 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.711 1.204 . . . . 2.3700000000000001 108.236 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -84.49 149.95 25.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.852 1.31 . . . . 4.5300000000000002 113.162 -176.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.416 ' H ' ' HD3' ' A' ' 9' ' ' ARG . 64.7 t80 -76.36 134.05 39.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.56 2.744 . . . . 3.1699999999999999 110.823 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.1 t 175.62 135.59 0.18 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.912 1.685 . . . . 2.79 112.058 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.58 -24.85 21.61 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.441 2.094 . . . . 1.6399999999999999 112.506 170.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.2 171.59 12.27 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 127.074 2.273 . . . . 0.85999999999999999 111.375 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.65 -8.21 39.71 Favored 'Cis proline' 0 CA--C 1.538 0.692 0 CA-C-N 118.886 1.343 . . . . 1.04 113.307 0.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -144.2 157.81 44.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.968 1.307 . . . . 2.0499999999999998 113.44 -172.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.02 -175.74 4.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.023 3.329 . . . . 1.55 108.473 -176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.34 176.81 8.37 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.155 1.382 . . . . 1.46 109.173 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.8 138.17 19.49 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.685 1.13 . . . . 1.5800000000000001 112.327 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 17.7 m-85 -119.02 137.51 53.48 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.256 2.222 . . . . 3.3300000000000001 108.262 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -168.35 148.37 4.67 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.324 1.05 . . . . 2.5899999999999999 111.707 -172.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -89.53 122.21 32.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.923 0.889 . . . . 2.4900000000000002 111.172 -176.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.58 120.3 40.3 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.077 1.351 . . . . 3.7000000000000002 108.765 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -122.13 141.75 51.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.527 1.131 . . . . 3.8999999999999999 111.3 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -117.05 108.94 43.31 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.393 1.077 . . . . 1.46 110.659 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.78 -10.99 10.4 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.939 2.426 . . . . 1.3200000000000001 113.848 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.25 175.88 49.93 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-O 122.787 1.215 . . . . 1.1699999999999999 113.224 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.403 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 6.5 m-20 -99.41 -3.83 32.87 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.327 2.651 . . . . 3.0 111.43 -175.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -122.37 157.27 59.23 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 128.336 2.654 . . . . 3.3199999999999998 109.883 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.0 145.8 31.86 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.788 2.325 . . . . 1.0600000000000001 111.137 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.1 mt -105.83 157.08 17.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 122.716 1.246 . . . . 2.8199999999999998 109.959 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -147.99 110.71 4.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.789 -2.005 . . . . 2.98 112.724 -170.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.99 107.37 19.16 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.447 1.899 . . . . 2.75 109.297 -173.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 m -103.71 -24.55 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.209 1.003 . . . . 1.8300000000000001 112.949 -168.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.34 -177.61 32.58 Favored Glycine 0 N--CA 1.466 0.686 0 C-N-CA 125.387 1.47 . . . . 0.48999999999999999 112.095 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.06 -178.84 5.27 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.057 -0.672 . . . . 1.48 111.648 169.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.8 mtp-105 -144.32 177.07 8.89 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.237 1.815 . . . . 4.6100000000000003 108.273 158.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 t -172.92 152.31 2.36 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.158 1.783 . . . . 1.8200000000000001 109.517 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.39 -7.52 15.98 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.134 1.889 . . . . 0.81000000000000005 114.172 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.8 m -113.63 24.29 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 115.969 1.84 . . . . 1.6499999999999999 115.969 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.06 143.18 19.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.677 1.591 . . . . 1.6499999999999999 110.977 169.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -68.87 -33.23 73.44 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.661 1.584 . . . . 3.1200000000000001 112.862 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -137.91 159.89 40.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.965 2.106 . . . . 5.2699999999999996 108.843 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.69 143.49 30.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.026 1.33 . . . . 1.6799999999999999 108.407 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -123.21 149.77 44.25 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.665 1.986 . . . . 2.6699999999999999 109.055 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.8 tp -102.3 121.75 42.89 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.573 0.749 . . . . 1.8200000000000001 110.389 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -125.06 159.6 31.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 123.603 1.668 . . . . 0.48999999999999999 113.921 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' CD ' HH21 ' A' ' 62' ' ' ARG . 15.9 pt-20 -104.61 159.51 15.7 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.831 2.452 . . . . 2.1299999999999999 110.976 158.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.3 m -128.49 148.36 50.74 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 105.906 -1.887 . . . . 1.78 105.906 165.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -159.97 175.89 12.49 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.992 0.917 . . . . 3.5099999999999998 112.857 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.8 ttp -111.65 136.36 50.98 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.342 1.457 . . . . 4.0499999999999998 111.282 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -120.54 159.92 24.24 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.346 1.858 . . . . 5.4299999999999997 110.611 171.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.481 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 4.1 tp10 -90.68 147.99 22.91 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.451 0.7 . . . . 2.27 109.503 151.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.8 t -138.79 118.78 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.579 1.552 . . . . 3.2599999999999998 106.915 157.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 61.09 25.68 15.67 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.758 1.392 . . . . 3.3300000000000001 114.758 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.34 4.68 90.09 Favored Glycine 0 N--CA 1.481 1.647 0 O-C-N 120.044 -1.66 . . . . 1.79 113.984 -171.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -105.54 120.14 40.89 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.587 2.355 . . . . 3.1499999999999999 107.885 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.481 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 34.1 mmtm -71.54 113.83 8.98 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.693 1.597 . . . . 3.3399999999999999 109.778 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.1 t -140.46 133.72 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.402 1.481 . . . . 3.0899999999999999 109.518 -172.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.7 mtt -79.5 171.88 14.56 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.347 1.24 . . . . 3.3700000000000001 114.347 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.82 168.18 29.94 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.364 1.935 . . . . 0.79000000000000004 112.226 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.0 ttm -149.08 145.37 27.21 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.697 1.599 . . . . 1.8600000000000001 108.95 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.432 HH21 ' CD ' ' A' ' 47' ' ' GLU . 25.8 mtm180 -148.06 152.9 40.93 Favored Pre-proline 0 N--CA 1.467 0.4 0 C-N-CA 125.121 1.368 . . . . 5.2400000000000002 109.853 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.24 154.28 41.28 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.103 1.869 . . . . 0.52000000000000002 110.742 163.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.05 157.95 70.45 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 125.768 1.627 . . . . 1.77 110.309 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.22 -26.74 2.66 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.024 2.483 . . . . 0.64000000000000001 113.32 -167.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -177.43 164.54 2.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.662 1.585 . . . . 3.2799999999999998 111.763 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.2 mt -110.86 153.09 25.91 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.094 1.358 . . . . 1.8 110.404 164.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -110.96 147.05 35.52 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.049 1.339 . . . . 2.0499999999999998 109.895 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.62 121.44 17.24 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 123.363 0.665 . . . . 2.4700000000000002 111.195 163.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.14 159.05 54.47 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.222 2.614 . . . . 1.3200000000000001 111.424 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.5 138.98 83.84 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.605 2.87 . . . . 1.02 112.319 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 69.8 mmtt 65.63 -3.64 0.68 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.484 1.914 . . . . 2.46 114.032 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.08 -176.64 34.82 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 126.971 2.224 . . . . 1.1599999999999999 113.2 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -147.83 152.85 38.36 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.246 1.019 . . . . 4.25 112.406 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.81 134.24 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.805 1.642 . . . . 4.1799999999999997 107.735 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 143.82 31.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.305 1.042 . . . . 3.29 112.199 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -74.33 130.1 39.05 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.481 -1.303 . . . . 2.4399999999999999 107.481 151.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 155.2 73.92 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.445 1.498 . . . . 3.3500000000000001 113.392 -170.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 38.4 Cg_endo -58.83 -36.72 96.53 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.507 2.805 . . . . 2.3700000000000001 113.731 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.26 12.89 36.03 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.592 -1.116 . . . . 1.79 115.001 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.35 -122.38 0.62 Allowed Glycine 0 C--N 1.343 0.937 0 CA-C-N 119.562 1.681 . . . . 1.76 114.778 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -71.34 140.9 50.4 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.049 -0.677 . . . . 3.02 111.585 -168.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -161.88 153.97 19.35 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.288 1.035 . . . . 0.58999999999999997 112.137 -174.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -79.04 143.0 36.06 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.416 -0.587 . . . . 2.9300000000000002 109.416 161.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -100.06 123.13 43.95 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.438 1.495 . . . . 1.78 108.168 163.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -98.77 130.27 45.22 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.273 -1.01 . . . . 2.1099999999999999 108.273 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mp -129.32 139.05 51.88 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.672 0.789 . . . . 3.0299999999999998 111.326 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.33 47.03 8.49 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 123.588 0.613 . . . . 1.5800000000000001 112.223 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -51.88 158.36 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 115.9 1.815 . . . . 1.78 115.9 -174.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -119.33 -32.83 4.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.035 -1.439 . . . . 2.2999999999999998 113.097 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -96.28 142.69 24.92 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.067 1.347 . . . . 5.7199999999999998 107.711 161.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 117.71 5.29 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 N-CA-C 106.33 -2.219 . . . . 1.4299999999999999 106.33 150.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.6 105.34 7.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.139 1.775 . . . . 2.8799999999999999 108.827 -175.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -98.56 171.91 7.84 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.746 1.219 . . . . 4.1200000000000001 111.452 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.9 131.77 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.216 -0.928 . . . . 1.77 108.687 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.74 58.81 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.751 -1.027 . . . . 1.3400000000000001 114.576 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.83 -176.26 4.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.509 1.154 . . . . 2.3900000000000001 110.076 161.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -139.65 145.98 39.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 127.996 2.518 . . . . 2.79 105.851 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -146.42 149.28 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 127.537 2.335 . . . . 2.0 108.871 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.496 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 18.9 pt-20 -111.87 150.13 30.85 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.066 0.946 . . . . 2.3999999999999999 113.091 175.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.4 mp -129.51 140.88 51.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.1 2.16 . . . . 2.6499999999999999 109.552 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -85.31 131.15 34.45 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.208 -1.034 . . . . 2.2000000000000002 108.208 160.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.88 109.8 21.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 121.239 1.836 . . . . 2.2599999999999998 107.602 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.49 113.96 18.04 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.508 -0.923 . . . . 1.6200000000000001 108.508 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -105.35 140.76 37.99 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.792 1.237 . . . . 3.4700000000000002 110.566 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.03 126.73 28.67 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.49 -1.381 . . . . 2.3900000000000001 113.823 -173.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.34 75.84 0.85 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.785 1.183 . . . . 4.0099999999999998 112.739 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.8 72.62 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 115.473 0.949 . . . . 2.0 115.473 166.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -130.87 149.79 52.34 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.103 1.452 . . . . 4.1600000000000001 112.236 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.8 t -149.01 147.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.175 1.39 . . . . 3.2799999999999998 108.421 167.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.4 tp -126.2 113.74 17.4 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.869 1.267 . . . . 3.2799999999999998 108.985 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 32.0 ttpt -83.3 133.44 34.97 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.731 -1.231 . . . . 2.8199999999999998 110.393 172.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -126.89 160.78 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.041 1.337 . . . . 2.7200000000000002 109.167 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 t -133.15 137.71 52.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 127.125 2.17 . . . . 2.98 107.591 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.22 150.85 20.33 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.752 1.221 . . . . 3.1299999999999999 111.763 -169.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.36 163.88 30.46 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.258 2.639 . . . . 0.96999999999999997 112.387 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 t -100.48 124.37 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.393 -0.821 . . . . 1.9199999999999999 109.001 163.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 122.631 1.205 . . . . 3.7200000000000002 111.603 172.48 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.798 0.809 . . . . 4.6399999999999997 110.011 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.43 153.87 22.7 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 125.086 1.326 . . . . 1.3300000000000001 110.885 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -126.14 134.97 51.16 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.346 1.059 . . . . 3.0499999999999998 111.367 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 t -84.26 56.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.065 1.346 . . . . 3.3999999999999999 109.166 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 32.08 -116.56 0.05 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.052 2.541 . . . . 5.6399999999999997 112.658 -171.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.0 t80 171.48 134.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.455 2.702 . . . . 3.6699999999999999 108.154 -173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.5 t -178.31 144.54 0.49 Allowed Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.215 1.806 . . . . 2.54 110.745 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.76 -24.19 18.42 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.749 2.3 . . . . 1.46 112.513 164.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.22 -173.95 15.07 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.658 1.599 . . . . 0.93999999999999995 112.591 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.38 -12.66 19.68 Favored 'Cis proline' 0 CA--C 1.539 0.745 0 CA-C-N 118.55 1.175 . . . . 1.25 113.475 1.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -125.05 169.83 11.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.803 1.641 . . . . 2.1400000000000001 111.718 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.67 -175.63 5.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.014 2.526 . . . . 1.6499999999999999 110.96 -173.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.27 169.83 16.61 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.219 1.808 . . . . 1.72 108.571 170.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.01 127.46 15.97 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.711 1.204 . . . . 1.8700000000000001 110.99 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -107.27 66.58 0.67 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.861 2.064 . . . . 3.4399999999999999 110.122 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.27 153.06 42.69 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.183 -0.948 . . . . 2.6600000000000001 111.942 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.5 m -130.83 132.33 45.15 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.737 1.215 . . . . 3.1800000000000002 108.785 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.26 178.02 10.47 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.998 2.119 . . . . 6.29 109.382 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -139.67 160.24 40.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.385 1.474 . . . . 4.7999999999999998 110.772 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -103.66 96.78 9.42 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.367 1.867 . . . . 1.4399999999999999 109.335 171.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.8 -1.39 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.103 2.535 . . . . 1.5600000000000001 114.675 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.05 156.26 25.14 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.418 1.008 . . . . 1.3100000000000001 111.331 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.86 5.61 9.26 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.097 2.559 . . . . 4.0099999999999998 112.339 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.28 151.57 49.55 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 127.92 2.488 . . . . 4.2599999999999998 110.616 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.75 161.44 27.48 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.759 2.306 . . . . 1.1699999999999999 111.58 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.1 mt -120.67 152.57 38.05 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 122.525 1.155 . . . . 2.9399999999999999 110.985 169.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -132.64 118.22 18.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 112.558 -2.11 . . . . 2.6800000000000002 109.176 169.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.92 113.61 26.97 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.317 1.847 . . . . 2.96 107.724 -172.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 m -110.64 -24.6 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.54 0.736 . . . . 1.6299999999999999 112.83 -167.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.22 -174.85 28.45 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 125.053 1.311 . . . . 0.34999999999999998 112.884 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.4 -178.13 5.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.836 1.254 . . . . 1.8200000000000001 110.92 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.71 170.07 20.08 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.504 1.922 . . . . 7.04 109.131 164.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -175.98 151.41 1.17 Allowed Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 127.12 2.168 . . . . 1.8 109.117 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.0 -2.82 11.99 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.753 2.302 . . . . 0.90000000000000002 114.111 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.05 28.72 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.578 1.551 . . . . 2.1499999999999999 114.545 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.29 138.56 11.3 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.202 1.001 . . . . 1.6399999999999999 111.76 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -65.55 -31.62 72.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.848 1.659 . . . . 2.8999999999999999 113.742 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -146.3 154.59 41.86 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.66 1.584 . . . . 5.4500000000000002 109.339 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -141.26 140.94 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.238 1.415 . . . . 1.77 110.133 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -139.78 139.54 36.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.088 1.755 . . . . 2.8399999999999999 109.447 -166.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.6 tp -89.89 128.81 36.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.869 1.213 . . . . 2.6099999999999999 110.656 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -118.58 160.85 21.03 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.262 1.825 . . . . 1.0600000000000001 113.854 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -122.45 152.92 39.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.55 2.34 . . . . 2.27 109.991 167.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 m -129.84 135.47 48.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.524 1.53 . . . . 1.78 107.7 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -150.5 171.24 17.38 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.542 1.163 . . . . 3.4100000000000001 113.673 -167.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.2 ttp -101.87 143.8 31.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.942 1.697 . . . . 4.5999999999999996 110.652 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -155.7 152.86 29.1 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.121 1.768 . . . . 9.2799999999999994 112.596 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 139.13 37.09 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.274 1.03 . . . . 2.6400000000000001 111.508 170.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.9 t -141.09 129.04 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 106.521 -1.659 . . . . 3.9700000000000002 106.521 164.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.59 29.99 17.0 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.195 0.998 . . . . 4.5300000000000002 112.392 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.37 16.56 78.79 Favored Glycine 0 N--CA 1.472 1.087 0 O-C-N 121.031 -1.043 . . . . 2.29 114.167 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -133.48 133.6 42.45 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.405 1.482 . . . . 4.2599999999999998 110.758 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.32 122.86 22.7 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.078 1.351 . . . . 6.1799999999999997 110.493 -177.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -135.0 -175.78 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 129.492 3.117 . . . . 4.1699999999999999 108.951 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -111.99 169.24 8.98 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.085 0.945 . . . . 3.77 113.401 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.24 171.93 33.45 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.636 2.065 . . . . 0.75 112.446 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.9 ttm -150.24 142.89 24.58 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.896 1.678 . . . . 2.4300000000000002 109.364 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -144.01 155.58 58.76 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 125.483 1.513 . . . . 5.2999999999999998 110.174 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -75.36 161.18 38.11 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.319 2.013 . . . . 0.81999999999999995 111.061 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.31 156.65 39.76 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.8 1.64 . . . . 2.6299999999999999 110.536 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.03 -25.68 1.71 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.366 2.711 . . . . 0.69999999999999996 113.813 -165.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -176.74 171.58 2.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.614 1.966 . . . . 3.8799999999999999 110.962 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.4 mt -116.07 153.04 32.42 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.346 1.858 . . . . 1.79 109.942 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.1 145.02 42.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.803 1.241 . . . . 1.8700000000000001 108.029 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.9 133.96 12.66 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 118.664 0.665 . . . . 2.29 112.759 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.41 170.83 12.74 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.56 2.84 . . . . 1.1100000000000001 112.704 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.36 147.32 87.31 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.105 2.537 . . . . 1.04 113.297 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.306 22.0 mtmt 54.75 44.95 27.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.636 1.574 . . . . 3.96 113.548 171.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.02 175.54 21.05 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.827 2.632 . . . . 1.3300000000000001 113.761 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -79.44 154.07 29.2 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.884 -0.774 . . . . 5.96 112.406 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.47 66.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 127.259 2.224 . . . . 6.9500000000000002 107.253 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -127.1 137.89 53.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.652 0.982 . . . . 2.7599999999999998 113.652 -172.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.45 71.88 0.89 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.29 2.236 . . . . 2.1800000000000002 109.922 -170.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 140.02 17.46 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 125.754 1.622 . . . . 3.8199999999999998 113.674 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.01 -17.9 51.51 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.91 3.073 . . . . 2.1099999999999999 114.826 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.14 10.14 61.68 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.086 -1.396 . . . . 1.8600000000000001 114.435 175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.57 -111.2 0.26 Allowed Glycine 0 N--CA 1.473 1.13 0 CA-C-N 119.251 1.525 . . . . 1.4299999999999999 114.369 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -74.18 136.1 42.82 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.889 -0.771 . . . . 3.0600000000000001 112.318 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -160.79 164.96 31.09 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.793 1.237 . . . . 0.97999999999999998 111.796 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -92.84 140.7 29.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.544 0.611 . . . . 3.5699999999999998 111.141 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -93.98 135.96 34.77 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.902 1.681 . . . . 1.98 109.478 163.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -114.54 135.71 53.83 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.863 1.665 . . . . 2.4199999999999999 108.755 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.91 138.28 48.32 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.78 0.832 . . . . 3.27 111.348 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.19 51.19 6.96 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.036 0.827 . . . . 1.6100000000000001 112.788 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.33 153.6 3.82 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 115.66 1.726 . . . . 1.8700000000000001 115.66 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -102.89 -16.13 15.98 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.939 1.459 . . . . 2.3700000000000001 114.939 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.2 mmt-85 -137.42 145.78 50.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 128.23 2.612 . . . . 7.7300000000000004 110.03 166.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.25 124.97 13.73 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 N-CA-C 106.649 -2.096 . . . . 1.6000000000000001 106.649 148.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.36 101.99 11.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.088 0.947 . . . . 3.4399999999999999 108.801 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.57 13.69 6.61 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.248 2.314 . . . . 5.4400000000000004 117.248 -152.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 74.92 151.0 0.12 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 129.493 3.117 . . . . 2.9199999999999999 112.498 -171.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.84 39.82 98.01 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.628 -0.989 . . . . 1.53 110.628 -165.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.58 171.27 7.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.96 1.704 . . . . 2.48 107.539 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -142.18 129.71 21.37 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.705 2.002 . . . . 3.7799999999999998 106.922 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.0 t -153.28 141.13 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.166 1.787 . . . . 2.6800000000000002 109.326 -162.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -86.42 147.47 26.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.657 1.354 . . . . 2.8900000000000001 114.657 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mp -121.29 146.48 46.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.832 1.653 . . . . 2.71 110.5 164.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.58 134.67 38.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.04 2.536 . . . . 2.3100000000000001 108.245 161.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.84 130.96 46.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.849 1.26 . . . . 1.95 108.072 164.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.4 mt -110.85 108.42 18.22 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.658 1.183 . . . . 1.8999999999999999 110.082 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -104.32 155.12 19.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.851 1.66 . . . . 3.48 111.285 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.45 145.03 45.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.556 0.742 . . . . 2.6099999999999999 112.036 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.95 20.88 41.24 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.961 -0.911 . . . . 3.8199999999999998 114.598 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.46 9.22 86.98 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 118.521 1.16 . . . . 2.0499999999999998 113.901 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -79.32 106.83 11.63 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.357 -1.084 . . . . 3.8300000000000001 111.229 -174.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.5 p -115.89 115.84 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.199 1.4 . . . . 3.3300000000000001 110.848 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.9 mp -120.83 117.45 27.44 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.799 1.239 . . . . 4.1200000000000001 109.562 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -105.87 134.63 48.7 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.807 0.443 . . . . 3.6400000000000001 112.143 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.4 t -144.47 159.92 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.58 1.552 . . . . 4.1200000000000001 109.221 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -107.01 134.4 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.659 1.584 . . . . 3.3700000000000001 110.31 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.82 148.37 57.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.034 1.734 . . . . 4.3200000000000003 110.12 -169.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.05 170.33 19.22 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.516 2.811 . . . . 1.0700000000000001 113.374 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.68 121.19 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 127.291 2.236 . . . . 2.1200000000000001 109.589 169.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 122.788 1.28 . . . . 4.0999999999999996 114.1 176.198 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 120.987 0.422 . . . . 7.0599999999999996 110.325 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.47 -175.03 44.72 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.429 1.014 . . . . 1.8300000000000001 111.633 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.2 p90 -142.59 -173.7 3.94 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.819 -0.812 . . . . 2.9500000000000002 112.988 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.4 t -122.61 129.23 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.029 -1.044 . . . . 2.71 110.426 -169.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -48.88 -27.42 3.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.367 1.867 . . . . 7.6799999999999997 115.227 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 89.2 t80 69.42 116.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.452 2.701 . . . . 4.5199999999999996 111.437 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.1 m -170.12 150.48 3.62 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.13 1.372 . . . . 3.3300000000000001 110.231 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.17 -29.93 1.41 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.284 2.656 . . . . 1.6299999999999999 113.029 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.1 173.56 20.52 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.557 2.503 . . . . 1.01 110.538 -170.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -81.02 4.74 41.43 Favored 'Cis proline' 0 CA--C 1.541 0.827 0 CA-C-N 120.193 1.996 . . . . 1.8300000000000001 113.18 -3.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -148.26 164.86 32.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.159 0.98 . . . . 2.54 112.839 168.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.65 -178.14 4.93 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.049 2.139 . . . . 1.52 109.771 165.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.49 154.82 49.82 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.949 2.1 . . . . 2.0600000000000001 107.183 168.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.82 142.67 49.09 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.073 0.949 . . . . 1.72 110.434 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -124.03 19.98 9.14 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.608 1.336 . . . . 3.5600000000000001 114.608 -160.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -51.48 161.46 0.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.753 1.76 . . . . 3.73 115.753 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -82.18 144.77 30.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.406 -0.815 . . . . 2.7599999999999998 111.845 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.47 118.04 22.39 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.642 1.177 . . . . 4.7400000000000002 110.031 168.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -113.85 132.7 55.8 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.414 -1.328 . . . . 4.29 107.414 167.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -92.04 110.85 46.87 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.933 0.893 . . . . 1.5 109.321 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -85.07 -9.58 8.5 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.296 2.664 . . . . 1.52 115.04 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.48 166.06 29.06 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 119.503 1.047 . . . . 1.3200000000000001 112.067 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.84 4.87 27.33 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.511 2.324 . . . . 3.5600000000000001 112.14 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.61 154.5 52.53 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 128.159 2.584 . . . . 3.8700000000000001 110.425 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.56 145.24 20.57 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.925 2.417 . . . . 0.96999999999999997 110.566 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 mt -105.04 148.55 26.65 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 122.319 1.057 . . . . 3.1699999999999999 111.649 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -130.22 112.08 13.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.283 -2.235 . . . . 2.6200000000000001 111.265 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -100.16 111.12 23.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.242 2.217 . . . . 3.4100000000000001 109.265 -172.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -104.11 -25.62 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.415 1.086 . . . . 1.9199999999999999 111.697 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.92 -175.89 32.43 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 125.022 1.296 . . . . 0.35999999999999999 113.432 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.94 -179.9 6.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.631 1.572 . . . . 1.7 110.045 169.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -156.72 157.29 34.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.266 2.227 . . . . 5.5999999999999996 108.024 174.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -164.8 150.08 8.53 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.984 1.313 . . . . 1.8300000000000001 109.858 175.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.56 -12.14 33.7 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.96 2.44 . . . . 1.0700000000000001 115.061 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.7 m -109.64 16.56 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 116.732 2.123 . . . . 1.8999999999999999 116.732 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.39 162.08 34.02 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.826 -1.171 . . . . 1.6000000000000001 114.144 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -100.07 -63.03 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.228 1.411 . . . . 2.6600000000000001 109.505 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -107.43 98.5 8.11 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.924 -1.11 . . . . 7.6799999999999997 110.382 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -79.01 141.62 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.223 -0.899 . . . . 2.7000000000000002 110.189 164.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -153.26 138.37 17.34 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.5 1.52 . . . . 2.7799999999999998 109.4 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.0 tp -96.65 122.31 39.44 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.731 0.777 . . . . 1.8700000000000001 112.023 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -121.97 161.56 22.69 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.911 1.685 . . . . 0.98999999999999999 113.779 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.13 -178.42 3.66 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.934 2.094 . . . . 3.1000000000000001 111.642 158.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.6 m -154.14 145.82 23.31 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.984 1.713 . . . . 1.8999999999999999 107.111 169.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -157.17 179.8 8.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.629 1.204 . . . . 3.8100000000000001 112.999 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.7 mtm -121.37 142.14 50.28 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.591 1.556 . . . . 6.1799999999999997 110.006 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -149.54 162.76 39.52 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.986 0.914 . . . . 6.1399999999999997 112.896 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.18 145.5 30.97 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.633 0.773 . . . . 3.0699999999999998 110.51 162.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.25 1.77 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 114.576 1.325 . . . . 4.3099999999999996 114.576 164.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -177.62 22.22 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.689 1.996 . . . . 4.6200000000000001 112.381 -168.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.41 -10.44 4.89 Favored Glycine 0 CA--C 1.543 1.798 0 O-C-N 119.148 -2.22 . . . . 2.1299999999999999 113.242 -160.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -95.13 130.49 41.82 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 129.346 3.059 . . . . 4.1699999999999999 108.213 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -77.1 117.37 18.59 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 128.04 2.536 . . . . 3.3199999999999998 109.149 -173.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -139.39 135.65 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.823 1.649 . . . . 3.2400000000000002 109.132 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.83 159.42 20.41 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 122.442 1.115 . . . . 4.1799999999999997 113.618 -175.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.02 164.98 24.99 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 125.103 1.335 . . . . 0.81000000000000005 112.451 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -149.38 132.96 16.74 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.271 1.428 . . . . 2.8900000000000001 109.891 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -141.89 149.9 54.56 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.485 1.914 . . . . 10.83 109.773 -170.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.43 153.66 39.94 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.228 1.952 . . . . 0.81000000000000005 110.012 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.18 148.95 64.48 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.157 0.983 . . . . 1.97 110.37 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.71 -23.08 13.0 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.525 2.816 . . . . 0.67000000000000004 112.725 -170.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -173.93 172.51 3.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.296 1.838 . . . . 2.9300000000000002 111.278 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -117.06 154.09 31.59 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.128 2.171 . . . . 1.72 109.863 161.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -110.03 144.01 39.21 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.387 -0.968 . . . . 1.55 108.387 172.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.07 126.02 18.38 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.999 -0.524 . . . . 1.9199999999999999 111.285 163.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -68.2 164.22 33.09 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.788 2.992 . . . . 1.1499999999999999 111.239 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.24 135.95 57.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.915 2.41 . . . . 1.1299999999999999 112.414 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.285 17.5 mtmt 59.27 40.18 21.66 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.018 1.39 . . . . 3.3700000000000001 113.193 171.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.37 164.72 26.9 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 127.926 2.679 . . . . 1.4099999999999999 113.699 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -113.82 146.52 39.83 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.18 1.792 . . . . 4.3799999999999999 111.732 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -139.82 116.45 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.5 1.12 . . . . 4.0800000000000001 108.481 152.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -79.92 148.31 31.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.961 0.905 . . . . 3.04 110.685 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mp -85.69 52.09 2.37 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.167 0.987 . . . . 2.52 112.707 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.94 146.21 8.2 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 115.424 1.638 . . . . 3.6699999999999999 115.424 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.24 -32.92 95.01 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.072 3.181 . . . . 3.6400000000000001 114.076 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.32 31.24 1.38 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.475 1.036 . . . . 2.0299999999999998 113.433 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.72 -122.65 0.94 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.681 1.61 . . . . 1.6000000000000001 113.382 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -73.31 134.93 44.32 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 121.934 -0.745 . . . . 3.5499999999999998 112.761 -170.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -160.15 164.45 32.92 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.838 1.051 . . . . 1.0800000000000001 113.838 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -92.67 131.7 37.54 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 109.887 -0.412 . . . . 3.4700000000000002 109.887 165.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 tpt -85.26 138.37 32.37 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.222 2.209 . . . . 1.76 108.648 164.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.9 mt -132.24 91.39 2.94 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.44 1.496 . . . . 4.3399999999999999 109.221 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.0 mp -88.98 157.5 18.36 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.522 1.129 . . . . 3.6200000000000001 111.869 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.99 -52.67 4.77 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.322 1.915 . . . . 3.0499999999999998 112.577 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.5 mt 55.86 169.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 128.281 2.632 . . . . 1.73 113.707 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -118.73 -25.88 6.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.937 -1.483 . . . . 2.4500000000000002 112.717 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -143.23 157.79 59.44 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 126.611 1.964 . . . . 7.3600000000000003 111.678 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.33 151.2 48.12 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.0 2.466 . . . . 1.53 110.467 158.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.93 148.0 22.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.83 1.252 . . . . 3.0099999999999998 111.524 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -95.73 -166.9 1.51 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.332 1.063 . . . . 5.54 111.122 164.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.49 152.05 24.17 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.737 1.215 . . . . 2.3999999999999999 108.579 157.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.58 29.81 59.12 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.583 -0.565 . . . . 2.1499999999999999 114.287 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -109.63 -179.99 3.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.227 1.411 . . . . 2.9100000000000001 109.431 168.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -129.98 146.15 51.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 104.735 -2.32 . . . . 5.1500000000000004 104.735 164.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.3 t -138.76 139.49 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.861 1.665 . . . . 2.3799999999999999 109.628 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 8.0 pt-20 -92.1 144.96 24.91 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 122.831 1.3 . . . . 2.3399999999999999 112.787 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -135.98 140.71 44.14 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.71 2.404 . . . . 3.9300000000000002 109.207 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -88.74 140.58 29.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.218 1.807 . . . . 2.2000000000000002 109.064 164.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.5 mt -110.07 130.47 55.53 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.289 1.436 . . . . 3.4300000000000002 108.813 166.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.0 mt -110.06 125.15 52.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.097 1.359 . . . . 1.5900000000000001 111.184 -174.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.06 153.28 37.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.457 1.503 . . . . 3.3100000000000001 112.549 -168.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.56 127.37 29.45 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.944 1.091 . . . . 2.0899999999999999 113.944 -174.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.19 59.39 3.63 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.734 1.159 . . . . 3.6800000000000002 113.46 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.71 28.65 66.8 Favored Glycine 0 N--CA 1.474 1.17 0 CA-C-N 117.802 0.801 . . . . 1.72 115.074 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -113.7 145.01 41.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.937 1.369 . . . . 5.0999999999999996 112.242 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.1 150.63 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.212 1.405 . . . . 3.3500000000000001 111.969 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.4 tp -149.28 114.36 5.45 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.235 1.414 . . . . 3.2400000000000002 109.885 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 31.7 ttpt -92.6 134.72 34.72 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.345 -0.847 . . . . 2.7200000000000002 111.472 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.7 173.94 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.839 2.056 . . . . 3.1299999999999999 108.322 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.0 p -149.98 127.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.919 1.288 . . . . 3.8199999999999998 110.431 -172.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.17 150.11 73.05 Favored Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 126.127 1.771 . . . . 3.6000000000000001 112.221 -171.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.36 148.3 43.12 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.772 2.981 . . . . 1.6899999999999999 111.631 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 t -94.5 81.68 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.083 -1.08 . . . . 2.4399999999999999 108.083 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 CA--C 1.538 0.486 0 C-N-CA 125.834 1.654 . . . . 4.3399999999999999 109.93 166.586 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 123.464 1.602 . . . . 4.7599999999999998 111.541 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.78 -179.93 20.69 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.67 1.605 . . . . 1.3600000000000001 110.195 168.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.3 p90 -142.13 160.36 40.39 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.339 1.055 . . . . 3.6200000000000001 112.035 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.28 136.39 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.514 -1.291 . . . . 2.1899999999999999 107.514 164.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -51.82 -55.03 22.33 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.848 1.796 . . . . 5.0099999999999998 115.848 -155.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.4 t80 107.54 123.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 130.52 3.528 . . . . 3.5899999999999999 108.451 -154.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.4 m 175.52 131.33 0.15 Allowed Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 127.711 2.404 . . . . 3.2999999999999998 109.255 -176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.71 -32.82 1.9 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.655 2.236 . . . . 1.48 112.577 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.13 176.14 22.15 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.77 1.652 . . . . 0.89000000000000001 111.678 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.05 -10.24 21.39 Favored 'Cis proline' 0 CA--C 1.537 0.647 0 CA-C-N 119.021 1.41 . . . . 1.0900000000000001 112.572 -3.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -143.52 162.87 34.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.497 1.519 . . . . 2.8399999999999999 112.315 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.14 -177.67 4.23 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.255 1.822 . . . . 1.8300000000000001 111.623 -176.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -120.7 167.03 12.89 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.486 1.114 . . . . 1.75 110.453 161.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.01 146.46 33.88 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.756 1.223 . . . . 1.8500000000000001 111.477 168.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -127.84 81.37 2.02 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.601 2.361 . . . . 4.8499999999999996 109.247 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.51 159.54 14.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.61 1.337 . . . . 2.6200000000000001 114.61 -170.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.3 m -131.02 150.84 51.96 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.366 1.867 . . . . 2.25 109.311 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.68 175.54 11.86 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.314 3.045 . . . . 5.8399999999999999 107.882 172.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -115.03 147.28 40.33 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 123.107 0.563 . . . . 4.6799999999999997 110.538 164.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -100.64 90.81 1.58 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.641 0.776 . . . . 1.5 109.868 163.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.5 -5.07 16.39 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.756 2.304 . . . . 2.0600000000000001 113.96 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.25 178.55 53.89 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 122.831 1.24 . . . . 1.6399999999999999 113.793 -174.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.465 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 6.8 m-20 -109.76 -1.28 18.04 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.405 2.282 . . . . 3.4900000000000002 112.132 -170.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -116.7 159.62 39.75 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 127.667 2.387 . . . . 3.5899999999999999 110.65 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.11 139.88 17.38 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.56 2.174 . . . . 1.1399999999999999 111.004 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.37 159.29 15.84 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 125.829 1.652 . . . . 3.7599999999999998 110.965 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -155.27 111.0 3.09 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.724 -1.58 . . . . 2.5099999999999998 111.155 -168.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.97 107.42 19.7 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.81 1.644 . . . . 3.4300000000000002 109.176 -171.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 m -104.59 -21.75 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.834 0.853 . . . . 1.96 112.426 -169.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.38 -176.61 32.66 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 124.996 1.284 . . . . 0.47999999999999998 113.495 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.54 -178.74 6.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.55 1.54 . . . . 1.6000000000000001 111.594 170.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -158.36 155.04 28.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.903 1.681 . . . . 4.9299999999999997 108.177 167.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.8 t -157.59 153.74 23.65 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.302 1.441 . . . . 1.8999999999999999 108.755 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.38 -12.19 14.17 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.127 1.885 . . . . 0.87 113.492 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 24.8 m -98.74 23.21 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.197 1.184 . . . . 2.0899999999999999 114.197 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.37 165.47 31.94 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.357 1.863 . . . . 1.47 107.978 167.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.9 -35.76 9.29 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.687 1.195 . . . . 2.8199999999999998 112.617 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.54 177.68 7.43 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.673 1.589 . . . . 7.0099999999999998 107.71 171.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.62 150.67 10.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 125.468 1.507 . . . . 2.0 108.254 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -131.11 156.88 44.49 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.166 2.186 . . . . 2.8100000000000001 109.11 174.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 tp -110.78 117.25 32.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.759 1.224 . . . . 1.8799999999999999 110.513 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -121.0 154.89 35.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.391 1.476 . . . . 0.81999999999999995 113.192 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -95.23 154.32 17.24 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.335 -1.302 . . . . 1.95 110.267 155.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -103.48 146.0 29.17 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.642 -1.614 . . . . 2.0299999999999998 106.642 154.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -134.61 176.79 8.31 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.414 1.102 . . . . 3.3100000000000001 112.855 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.6 ttp -122.22 140.87 52.08 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.732 1.613 . . . . 4.0599999999999996 109.823 170.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.74 145.89 48.89 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.878 1.271 . . . . 7.0499999999999998 110.836 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -113.38 143.7 44.03 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.757 1.623 . . . . 2.8500000000000001 108.611 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.3 139.64 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.832 1.653 . . . . 5.46 108.079 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 64.41 18.7 11.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.527 1.131 . . . . 5.5599999999999996 112.558 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.29 21.02 79.49 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.329 -1.482 . . . . 2.04 113.057 -171.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -120.9 119.7 33.37 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.23 1.812 . . . . 5.1799999999999997 108.33 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.52 121.62 38.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.255 1.422 . . . . 3.29 111.675 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.1 t -137.05 141.36 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.389 1.876 . . . . 3.3199999999999998 108.266 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.62 167.39 13.95 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.077 0.769 . . . . 4.4000000000000004 113.077 -176.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.92 -177.95 28.73 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 125.356 1.455 . . . . 0.80000000000000004 112.281 -172.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.3 ttm -158.76 149.68 20.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.903 1.281 . . . . 2.5600000000000001 109.552 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.7 ptt85 -160.89 151.96 15.66 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 123.921 0.888 . . . . 5.46 111.707 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.48 150.98 52.68 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.156 1.904 . . . . 0.65000000000000002 111.204 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.58 150.8 73.12 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 125.246 1.418 . . . . 1.71 109.827 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.85 -22.47 7.54 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.367 2.711 . . . . 0.65000000000000002 113.201 -166.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -177.99 166.59 2.03 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 3.6200000000000001 110.617 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.0 mt -109.44 154.45 22.6 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.478 1.111 . . . . 1.8999999999999999 110.077 161.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -113.65 144.69 42.5 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.346 1.458 . . . . 2.0600000000000001 109.289 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.0 130.58 10.23 Favored Pre-proline 0 N--CA 1.473 0.693 0 N-CA-C 112.541 0.571 . . . . 2.4199999999999999 112.541 169.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.86 168.46 18.62 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.286 2.658 . . . . 1.1000000000000001 112.65 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.12 141.53 98.23 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.347 2.698 . . . . 1.3600000000000001 111.598 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.465 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 63.4 mmtt 65.61 8.13 4.93 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.516 1.526 . . . . 2.5699999999999998 113.053 -175.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.58 150.66 24.6 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.714 2.102 . . . . 1.47 114.367 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -78.96 115.81 18.87 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.629 1.971 . . . . 4.4000000000000004 111.141 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.47 55.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 122.484 1.135 . . . . 6.6699999999999999 108.946 -174.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.6 123.78 46.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.928 1.691 . . . . 3.0 108.794 177.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mp -58.28 -56.19 25.31 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.469 1.107 . . . . 4.3099999999999996 112.439 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HE3' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 139.59 140.94 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 131.618 3.967 . . . . 3.8999999999999999 111.176 178.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.21 131.94 26.42 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 N-CA-C 107.782 -1.661 . . . . 4.4199999999999999 107.782 159.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.89 -38.03 1.94 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.393 -1.226 . . . . 3.3399999999999999 114.794 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.8 -110.63 0.39 Allowed Glycine 0 N--CA 1.475 1.28 0 CA-C-N 119.165 1.483 . . . . 1.8200000000000001 113.692 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.76 141.3 49.74 Favored 'General case' 0 C--O 1.223 -0.319 0 O-C-N 121.617 -0.931 . . . . 3.1600000000000001 111.007 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -158.3 143.19 16.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.716 -0.675 . . . . 0.78000000000000003 110.997 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -78.89 133.69 36.95 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.063 -0.717 . . . . 3.0699999999999998 109.063 167.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.2 tpt -92.74 119.44 32.12 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.697 1.599 . . . . 2.1699999999999999 108.086 168.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -103.88 105.69 15.97 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.475 1.51 . . . . 2.3300000000000001 110.161 -168.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.01 132.99 40.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.823 0.849 . . . . 3.6200000000000001 111.696 -166.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.08 47.47 7.56 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 123.954 0.788 . . . . 1.71 113.73 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.7 mt -49.02 154.89 0.69 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 116.345 1.98 . . . . 1.8 116.345 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 50.8 mmtt -119.22 -30.54 4.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 113.302 -1.772 . . . . 3.1299999999999999 113.29 -176.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.471 HH21 ' CD ' ' A' ' 97' ' ' GLU . 9.9 mmm180 -106.74 144.89 29.96 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 126.444 1.897 . . . . 6.1500000000000004 108.173 160.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.92 128.06 13.65 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 N-CA-C 107.225 -1.875 . . . . 1.95 107.225 153.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.29 115.72 22.62 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.741 -0.837 . . . . 3.1499999999999999 108.741 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.25 162.21 32.79 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.04 1.336 . . . . 5.46 113.874 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 132.59 54.47 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.504 1.522 . . . . 2.46 110.934 -172.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.23 44.86 16.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.023 -0.99 . . . . 1.3600000000000001 112.85 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.471 ' CD ' HH21 ' A' ' 91' ' ' ARG . 0.9 OUTLIER -103.67 167.06 10.03 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 117.787 0.793 . . . . 2.6200000000000001 109.044 148.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.43 128.34 46.85 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 102.625 -3.102 . . . . 4.9000000000000004 102.625 154.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.7 t -137.28 137.67 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.829 1.251 . . . . 2.6099999999999999 109.999 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -84.54 155.97 21.87 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.061 1.504 . . . . 2.4100000000000001 115.061 -174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tt -155.31 140.3 17.34 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.127 2.171 . . . . 4.1699999999999999 110.902 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -84.38 127.87 34.25 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.899 2.08 . . . . 2.0699999999999998 109.29 165.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.16 127.0 35.15 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.563 -0.903 . . . . 2.4700000000000002 108.563 161.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.5 mt -103.55 105.75 16.08 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 122.497 1.142 . . . . 2.0600000000000001 109.869 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -96.16 152.76 18.26 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.146 1.379 . . . . 3.5800000000000001 111.354 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.45 127.51 20.18 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.55 1.14 . . . . 2.1800000000000002 113.643 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.22 66.1 2.25 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.573 1.082 . . . . 3.3700000000000001 112.793 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.5 11.81 80.18 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 115.792 1.077 . . . . 1.8300000000000001 115.792 167.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -96.15 104.14 16.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.779 1.79 . . . . 4.3300000000000001 110.983 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.82 143.23 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 123.863 0.865 . . . . 3.6699999999999999 110.685 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -145.07 108.02 4.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.209 1.004 . . . . 3.52 108.776 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -93.65 131.91 38.49 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.046 0.387 . . . . 2.75 112.046 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.2 t -138.85 163.2 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.602 1.561 . . . . 3.6600000000000001 110.204 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.32 126.84 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.849 2.06 . . . . 3.02 109.808 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.27 145.3 38.16 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 126.548 1.939 . . . . 4.21 109.737 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.05 162.7 41.03 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.183 3.256 . . . . 1.3899999999999999 113.008 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.24 110.75 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 114.576 -1.193 . . . . 2.5099999999999998 110.994 165.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 127.19 2.196 . . . . 3.6800000000000002 109.324 156.768 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 108.287 -1.005 . . . . 6.0 108.287 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.83 167.58 29.92 Favored Glycine 0 N--CA 1.473 1.115 0 O-C-N 120.858 -1.151 . . . . 1.24 114.334 -167.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -152.76 169.27 23.18 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.852 1.427 . . . . 2.5800000000000001 114.852 -172.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.2 t -106.67 144.8 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.177 1.791 . . . . 2.3199999999999998 107.13 168.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.426 ' CG ' ' H ' ' A' ' 10' ' ' PHE 0.26 0.6 OUTLIER -73.18 -100.11 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.388 0.884 . . . . 4.8600000000000003 113.388 175.543 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.426 ' H ' ' CG ' ' A' ' 9' ' ' ARG . 73.1 t80 -161.21 143.46 12.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.242 1.817 . . . . 3.5899999999999999 109.5 -167.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t 171.81 136.17 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 126.93 2.092 . . . . 2.7000000000000002 111.676 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.08 -27.47 6.78 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.745 2.297 . . . . 1.8300000000000001 111.901 166.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.39 171.91 17.01 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 126.696 2.093 . . . . 1.0700000000000001 111.195 -175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -78.46 -9.0 35.88 Favored 'Cis proline' 0 CA--C 1.537 0.631 0 CA-C-N 118.508 1.154 . . . . 1.0800000000000001 113.045 -0.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -151.36 167.89 26.5 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.734 1.214 . . . . 1.8999999999999999 113.374 -168.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.87 -177.51 6.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.485 2.314 . . . . 1.9099999999999999 111.72 -173.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.42 39.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.402 1.481 . . . . 1.8 108.576 169.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.14 141.78 47.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.656 1.582 . . . . 1.8799999999999999 110.544 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.513 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 51.3 m-85 -121.42 70.78 0.94 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.724 2.01 . . . . 3.25 110.835 -171.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -90.85 164.47 14.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.089 0.955 . . . . 2.9300000000000002 113.21 -170.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.88 124.61 39.97 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.457 -0.777 . . . . 2.6099999999999999 110.299 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.2 tp -96.23 104.08 16.02 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.198 -1.038 . . . . 5.96 108.198 167.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -82.46 171.24 14.36 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.663 0.744 . . . . 5.8700000000000001 111.929 165.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -134.58 101.12 12.07 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.566 0.747 . . . . 1.4299999999999999 109.417 155.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.78 -11.86 11.24 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.158 2.572 . . . . 1.74 112.992 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.23 178.92 49.45 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-O 122.749 1.194 . . . . 1.1899999999999999 112.55 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -104.29 -1.73 26.6 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.076 2.15 . . . . 3.1299999999999999 112.3 -173.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.9 mt -124.8 162.98 39.99 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 127.782 2.433 . . . . 4.8399999999999999 109.323 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.59 158.44 28.63 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.354 2.036 . . . . 1.1899999999999999 111.503 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mp -118.28 154.69 31.87 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.161 1.784 . . . . 3.3799999999999999 110.019 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -138.51 110.29 7.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 113.494 -1.685 . . . . 2.5899999999999999 109.511 173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.7 118.41 30.63 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.727 1.611 . . . . 2.9700000000000002 107.727 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 m -113.53 -22.43 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.181 0.993 . . . . 1.79 112.691 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.32 -176.91 31.91 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 124.359 0.98 . . . . 0.42999999999999999 113.31 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.5 178.12 6.7 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.718 -0.872 . . . . 1.4199999999999999 112.17 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.42 HH21 ' CG ' ' A' ' 102' ' ' ASP . 32.6 ttp180 -150.2 148.87 29.44 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.635 2.374 . . . . 8.6199999999999992 107.957 173.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 t -164.82 148.81 7.73 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 117.934 -1.031 . . . . 1.8500000000000001 110.158 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.78 -12.11 21.97 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.174 1.916 . . . . 0.79000000000000004 114.78 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.63 20.82 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.125 1.528 . . . . 1.98 115.125 -170.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.36 150.25 25.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.486 1.514 . . . . 1.8799999999999999 109.075 169.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.85 -47.67 7.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.532 1.133 . . . . 3.3500000000000001 112.832 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -122.33 98.7 6.05 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.453 -1.314 . . . . 7.1399999999999997 107.453 -171.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.26 125.89 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.697 -0.683 . . . . 1.8600000000000001 109.802 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -116.82 150.46 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.71 2.004 . . . . 2.7000000000000002 109.069 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.4 tp -105.12 118.64 37.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.043 0.937 . . . . 1.8300000000000001 110.356 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.1 m170 -124.64 155.29 39.41 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.046 1.338 . . . . 0.55000000000000004 114.123 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -100.43 162.54 12.87 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.867 1.667 . . . . 2.21 112.484 158.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.0 m -132.33 144.41 50.54 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.876 2.07 . . . . 2.02 105.661 167.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -152.76 170.14 21.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.908 0.883 . . . . 3.2999999999999998 112.491 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.9 ttp -98.83 140.1 33.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.92 1.288 . . . . 4.2699999999999996 110.812 173.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.3 148.18 32.15 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.018 1.727 . . . . 6.1799999999999997 111.314 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.92 144.49 26.15 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.298 1.039 . . . . 2.4199999999999999 108.572 166.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -141.83 138.05 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 107.806 -1.183 . . . . 3.7000000000000002 107.806 155.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 59.11 22.85 11.02 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.847 1.425 . . . . 4.3200000000000003 114.847 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.31 17.83 79.75 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 120.717 -1.24 . . . . 1.6699999999999999 113.956 -170.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -109.45 122.57 47.69 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.626 1.971 . . . . 3.2999999999999998 107.558 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -79.81 117.99 21.19 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.767 1.227 . . . . 3.6600000000000001 108.642 172.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 m -141.68 -175.76 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.709 2.404 . . . . 3.5 109.858 -171.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.76 175.74 5.39 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.807 0.843 . . . . 3.8300000000000001 112.974 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.9 170.2 33.12 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.62 2.057 . . . . 0.80000000000000004 111.94 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -149.31 137.96 21.02 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.441 1.496 . . . . 1.9399999999999999 109.817 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -143.73 151.63 53.91 Favored Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 125.618 1.567 . . . . 10.44 110.605 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.99 151.9 45.49 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.132 1.888 . . . . 0.64000000000000001 109.98 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.9 m -137.5 153.51 74.46 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.013 1.325 . . . . 1.6899999999999999 109.994 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.59 -28.12 2.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.719 2.279 . . . . 0.48999999999999999 112.805 -165.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -177.2 165.75 2.31 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.047 1.339 . . . . 3.5299999999999998 112.483 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.2 mt -109.91 152.0 26.37 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.673 1.589 . . . . 1.96 111.051 162.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -121.89 136.76 54.94 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.584 1.553 . . . . 2.1600000000000001 108.407 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.8 t -143.69 129.4 9.97 Favored Pre-proline 0 N--CA 1.475 0.808 0 N-CA-C 113.665 0.987 . . . . 2.1299999999999999 113.665 174.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.81 161.66 43.18 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.161 3.241 . . . . 1.4199999999999999 111.693 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.63 141.07 96.5 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.557 2.838 . . . . 1.25 113.172 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 69.15 0.23 2.74 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.919 2.088 . . . . 3.1000000000000001 114.572 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.53 175.73 47.63 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.928 1.728 . . . . 1.0800000000000001 113.223 171.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.08 132.87 11.39 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.21 1.004 . . . . 6.4299999999999997 112.725 173.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.5 t -125.18 108.4 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.381 2.272 . . . . 4.1699999999999999 109.524 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.5 126.92 31.66 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 127.879 2.471 . . . . 3.6299999999999999 112.21 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -74.12 75.46 1.76 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.986 1.714 . . . . 2.1299999999999999 109.811 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 155.11 92.76 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 114.819 1.415 . . . . 3.1600000000000001 114.819 -173.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.513 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 37.0 Cg_endo -59.34 -15.81 31.46 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.323 3.349 . . . . 2.3700000000000001 116.628 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -97.92 -1.04 58.62 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.265 -1.297 . . . . 1.95 115.292 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.86 -115.66 0.9 Allowed Glycine 0 N--CA 1.473 1.136 0 CA-C-N 119.908 1.854 . . . . 1.54 113.958 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -70.79 141.55 51.4 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.17 -0.606 . . . . 2.98 110.386 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -161.45 160.25 29.08 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.758 1.223 . . . . 0.68999999999999995 111.582 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -92.7 130.8 38.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.546 -0.539 . . . . 3.1000000000000001 109.546 166.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 tpt -84.96 128.8 34.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.072 1.349 . . . . 2.0 108.89 166.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -114.74 107.53 15.58 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.36 1.064 . . . . 2.3300000000000001 108.614 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mp -107.45 148.91 28.54 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.045 0.839 . . . . 3.3399999999999999 111.036 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.82 43.39 28.26 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.993 -0.893 . . . . 1.71 113.353 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 mt -46.62 150.88 0.63 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.999 1.481 . . . . 2.1699999999999999 114.999 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -108.01 -21.31 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 112.986 -1.916 . . . . 2.9700000000000002 114.248 -172.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.92 145.83 58.75 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 126.699 1.999 . . . . 6.46 110.548 162.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -66.69 154.31 74.91 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.085 1.857 . . . . 1.47 108.777 162.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.85 159.76 43.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.466 1.127 . . . . 3.9100000000000001 112.547 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.55 173.9 6.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.923 2.089 . . . . 5.6900000000000004 111.301 -165.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.14 135.72 56.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.231 1.012 . . . . 2.2799999999999998 112.857 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.69 40.37 31.88 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 114.828 -1.078 . . . . 1.5800000000000001 113.428 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -113.89 176.33 5.08 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.497 1.119 . . . . 2.7599999999999998 108.992 157.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -121.96 164.3 17.84 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.662 1.585 . . . . 2.9399999999999999 107.161 159.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.0 t -148.94 154.77 9.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 130.588 3.555 . . . . 2.8300000000000001 109.053 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.469 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 29.8 tt0 -121.95 138.53 54.38 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.366 1.466 . . . . 3.4399999999999999 111.252 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.62 137.2 54.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.863 1.265 . . . . 2.75 110.962 165.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.42 ' CG ' HH21 ' A' ' 36' ' ' ARG . 12.3 m-20 -87.8 138.51 31.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.264 1.826 . . . . 2.4300000000000002 110.044 155.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.3 136.61 34.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.509 1.924 . . . . 2.2200000000000002 109.45 167.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt -107.16 118.5 36.87 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.7 1.6 . . . . 1.8200000000000001 109.519 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -109.49 156.25 20.34 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.647 1.179 . . . . 3.2799999999999998 111.041 -175.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.05 141.66 58.67 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.465 -0.772 . . . . 2.3500000000000001 110.748 164.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.54 35.68 11.55 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 119.066 -0.852 . . . . 4.1799999999999997 114.951 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.97 7.47 84.08 Favored Glycine 0 N--CA 1.476 1.317 0 CA-C-N 118.234 1.017 . . . . 1.8799999999999999 115.553 167.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -89.53 137.28 32.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.063 0.932 . . . . 3.8799999999999999 111.261 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.31 131.53 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.56 1.544 . . . . 3.0299999999999998 108.079 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.27 143.56 27.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.763 1.625 . . . . 4.46 109.189 -174.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.469 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 14.8 ptpt -120.3 151.84 38.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.291 1.589 . . . . 3.5099999999999998 115.291 -172.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.0 m -122.98 153.04 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 128.062 2.545 . . . . 4.1100000000000003 110.825 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.2 138.72 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.106 1.762 . . . . 4.1299999999999999 109.609 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -141.29 125.4 10.28 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.401 1.08 . . . . 3.6600000000000001 111.547 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.78 167.11 24.4 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.788 2.325 . . . . 1.27 110.776 162.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.25 149.33 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.909 1.284 . . . . 1.9399999999999999 110.508 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 126.514 1.925 . . . . 4.9299999999999997 112.817 -176.593 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.52 0 CA-C-O 123.482 1.61 . . . . 6.2199999999999998 112.161 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.54 157.54 15.78 Favored Glycine 0 C--N 1.329 0.155 0 CA-C-N 114.082 -1.417 . . . . 2.2400000000000002 110.039 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -92.42 162.55 14.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.611 1.196 . . . . 3.1299999999999999 112.268 -160.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -80.34 132.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.49 -1.3 . . . . 2.02 107.49 157.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -21.24 59.01 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.116 1.895 . . . . 7.4100000000000001 116.116 -163.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 t80 85.75 144.01 0.06 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.972 2.909 . . . . 3.79 111.201 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 t -171.28 150.9 2.93 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.672 1.189 . . . . 2.6200000000000001 112.233 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -81.37 -18.5 8.36 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.344 2.696 . . . . 1.6200000000000001 112.109 158.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.81 -170.17 13.73 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 126.754 2.121 . . . . 1.3400000000000001 111.631 -170.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.64 -3.54 22.15 Favored 'Cis proline' 0 CA--C 1.54 0.817 0 CA-C-N 119.196 1.498 . . . . 1.8100000000000001 112.477 -9.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -136.02 176.91 8.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.778 1.231 . . . . 5.4699999999999998 110.843 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.59 -174.54 4.98 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.611 2.365 . . . . 1.9099999999999999 112.133 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.47 149.25 28.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.957 2.503 . . . . 1.78 108.452 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -135.52 136.5 41.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.857 1.208 . . . . 1.53 113.417 -175.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 28.8 m-85 -106.5 41.12 1.49 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.715 1.606 . . . . 3.5800000000000001 114.09 -170.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.38 155.89 33.94 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.336 1.606 . . . . 2.75 115.336 -167.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 54.8 m -99.71 143.29 30.11 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.438 1.095 . . . . 2.5099999999999998 112.128 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.47 123.62 47.93 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.83 2.452 . . . . 4.2199999999999998 111.804 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -102.97 141.05 36.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.589 0.756 . . . . 3.7200000000000002 109.537 158.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -108.34 84.31 2.26 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.756 -0.59 . . . . 1.6399999999999999 109.928 159.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.8 -10.05 24.46 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.424 2.083 . . . . 1.3999999999999999 113.181 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.73 176.43 47.75 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-O 122.861 1.256 . . . . 1.3899999999999999 113.1 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.433 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 4.8 m-20 -102.02 -8.62 21.32 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.759 2.424 . . . . 3.3700000000000001 112.179 -170.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.0 mt -132.01 152.56 80.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.523 1.929 . . . . 5.1699999999999999 109.264 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.83 167.74 24.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.093 2.528 . . . . 1.6399999999999999 113.698 -152.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mp -115.05 147.98 39.47 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.29 1.836 . . . . 3.4300000000000002 108.683 168.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.23 98.92 3.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 112.855 -1.975 . . . . 3.0099999999999998 108.737 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.3 tp -83.67 102.37 12.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.878 2.071 . . . . 3.3799999999999999 109.387 -168.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -94.7 -25.3 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.917 1.287 . . . . 2.4199999999999999 111.711 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.06 -176.85 31.57 Favored Glycine 0 C--N 1.343 0.922 0 C-N-CA 123.792 0.711 . . . . 0.56999999999999995 114.092 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.24 -177.88 5.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.935 1.694 . . . . 1.6899999999999999 110.382 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -156.51 175.25 14.28 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 127.434 2.293 . . . . 6.9900000000000002 107.948 161.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t -162.7 152.2 13.12 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 128.755 2.822 . . . . 2.0800000000000001 106.796 166.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.07 -29.65 39.74 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 120.894 1.355 . . . . 2.1499999999999999 111.918 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.6 m -86.78 14.63 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 115.299 1.592 . . . . 2.9399999999999999 115.299 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.09 138.48 25.37 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.586 1.539 . . . . 1.97 113.89 168.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.54 -26.84 41.35 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.837 1.421 . . . . 4.0099999999999998 114.837 -165.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -146.63 165.7 28.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.908 2.083 . . . . 6.21 108.341 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.88 143.89 15.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 124.972 1.309 . . . . 1.97 109.383 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -118.57 158.04 26.18 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.654 1.982 . . . . 3.2799999999999998 109.512 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 tp -106.88 117.56 34.39 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.538 0.735 . . . . 1.9399999999999999 110.307 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -119.86 165.08 15.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 123.516 1.627 . . . . 0.68000000000000005 113.897 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -121.57 162.6 20.32 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.18 -1.827 . . . . 3.5899999999999999 111.501 156.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.4 m -118.01 139.56 51.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.19 2.196 . . . . 1.8799999999999999 106.158 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -136.48 169.31 17.9 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.578 1.18 . . . . 3.21 113.736 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.2 ttp -111.55 147.27 35.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.281 1.833 . . . . 4.0599999999999996 109.102 170.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 153.53 38.3 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.802 1.241 . . . . 6.2699999999999996 110.505 -174.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -105.23 138.58 41.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.351 1.46 . . . . 3.4900000000000002 110.267 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.25 113.98 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.625 -1.25 . . . . 3.5899999999999999 107.625 169.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.537 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 16.4 mt-10 66.66 14.25 9.69 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.238 1.815 . . . . 3.8599999999999999 114.33 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.5 20.43 58.5 Favored Glycine 0 N--CA 1.477 1.376 0 O-C-N 121.249 -0.907 . . . . 2.6499999999999999 113.467 -167.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.537 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 45.3 mtmt -119.3 125.95 50.3 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.956 1.703 . . . . 3.1699999999999999 109.305 172.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -88.08 123.06 32.37 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.764 1.226 . . . . 5.8200000000000003 111.249 -170.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.0 t -141.68 141.06 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.2 1.8 . . . . 3.29 109.601 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -93.56 168.45 11.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.339 1.056 . . . . 4.0800000000000001 113.051 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.04 -178.73 31.39 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.94 1.257 . . . . 0.68000000000000005 113.634 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ttm -152.66 150.1 29.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.963 1.705 . . . . 2.2599999999999998 108.816 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -158.22 154.26 23.56 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 118.23 -0.89 . . . . 5.5800000000000001 111.776 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.93 154.98 62.87 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.23 1.954 . . . . 0.60999999999999999 111.155 169.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.66 151.66 63.94 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.014 1.326 . . . . 1.8899999999999999 110.241 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.63 -27.85 8.68 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.382 2.721 . . . . 0.65000000000000002 112.573 -167.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -176.16 163.16 2.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.112 1.765 . . . . 2.9100000000000001 111.472 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.8 mt -105.31 153.51 21.52 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.235 1.014 . . . . 1.8300000000000001 110.592 160.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.18 144.02 34.54 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.405 1.082 . . . . 1.8100000000000001 110.271 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.4 t -140.48 121.99 9.39 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 118.552 0.615 . . . . 2.0299999999999998 111.714 163.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -71.36 159.6 51.17 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.465 2.777 . . . . 1.2 111.095 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.85 142.99 99.26 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.384 2.723 . . . . 1.52 111.816 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 70.1 mmtt 67.28 -5.48 0.72 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.178 2.191 . . . . 2.9500000000000002 114.374 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.12 165.31 48.79 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.016 1.293 . . . . 1.3200000000000001 112.118 172.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 145.53 35.87 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.701 1.201 . . . . 5.4000000000000004 109.298 171.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.0 t -148.96 158.86 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 126.562 1.945 . . . . 3.7200000000000002 107.809 -169.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -135.03 142.6 46.42 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.007 1.276 . . . . 4.46 111.706 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.21 79.05 1.79 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 122.121 0.962 . . . . 2.27 109.117 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -62.98 150.55 87.91 Favored Pre-proline 0 CA--C 1.558 1.281 0 N-CA-C 114.319 1.229 . . . . 4.2300000000000004 114.319 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.484 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 38.2 Cg_endo -58.32 -49.68 11.69 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.396 2.731 . . . . 2.27 113.055 174.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.53 58.3 4.45 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.869 0.747 . . . . 2.1200000000000001 111.474 171.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.32 -125.44 1.5 Allowed Glycine 0 N--CA 1.469 0.86 0 C-N-CA 124.819 1.2 . . . . 1.74 114.167 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -73.04 138.89 46.21 Favored 'General case' 0 C--O 1.219 -0.518 0 O-C-N 122.191 -0.593 . . . . 3.77 112.279 -168.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -162.58 152.01 15.6 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.02 0.928 . . . . 0.71999999999999997 110.971 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.56 143.68 33.03 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.724 -0.473 . . . . 3.1299999999999999 109.724 162.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -96.33 123.99 40.17 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.726 1.61 . . . . 1.8100000000000001 108.428 166.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.17 120.37 42.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.397 0.999 . . . . 2.2000000000000002 108.906 -174.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -106.47 154.7 20.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.335 1.054 . . . . 3.5899999999999999 110.985 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.12 -51.4 3.21 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 127.269 2.366 . . . . 2.5600000000000001 114.747 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.7 mt 54.57 168.3 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.577 2.751 . . . . 1.9299999999999999 114.568 -171.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -116.82 -23.61 8.02 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.465 1.506 . . . . 3.5800000000000001 114.015 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.4 ptt-85 -137.31 149.85 67.01 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.569 1.548 . . . . 7.6500000000000004 111.414 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -68.19 142.65 56.27 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.982 1.788 . . . . 1.53 107.89 154.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.96 176.95 8.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.71 0.804 . . . . 3.0 110.479 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -120.66 176.28 5.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.194 1.798 . . . . 4.2300000000000004 108.618 155.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.18 126.96 33.62 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.399 -1.334 . . . . 2.0499999999999998 107.399 154.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.69 6.24 54.76 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.195 -1.336 . . . . 1.99 116.155 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -77.54 -176.53 4.31 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.392 1.596 . . . . 2.8500000000000001 110.444 159.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.15 170.44 9.56 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 130.607 3.563 . . . . 4.8099999999999996 107.124 165.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.0 t -150.37 141.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 127.089 2.156 . . . . 2.3700000000000001 108.975 166.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.24 126.29 52.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.158 1.383 . . . . 3.9700000000000002 110.62 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.1 mp -115.33 140.78 48.82 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.15 0.98 . . . . 2.98 111.52 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.93 139.27 31.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 128.576 2.75 . . . . 2.9100000000000001 108.994 167.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -118.83 131.12 56.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.548 1.139 . . . . 2.1000000000000001 109.503 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.4 mt -112.44 116.9 31.03 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.48 1.512 . . . . 1.8899999999999999 110.061 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -116.78 132.82 56.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.477 1.111 . . . . 3.4300000000000002 110.771 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.9 -24.05 66.71 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.976 0.732 . . . . 3.25 112.976 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.83 41.88 2.22 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.591 1.567 . . . . 5.5300000000000002 114.223 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.49 23.64 77.59 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.346 1.45 . . . . 3.4300000000000002 115.601 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -135.66 145.41 46.75 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.085 1.442 . . . . 4.7300000000000004 112.981 -166.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.19 141.89 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.591 1.556 . . . . 3.75 107.496 162.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.45 172.1 13.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.841 1.656 . . . . 3.3100000000000001 109.658 -174.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.78 150.94 52.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.843 0.857 . . . . 5.5 111.033 167.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.7 t -136.75 157.69 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.28 1.032 . . . . 2.8500000000000001 109.0 168.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.6 t -120.22 120.81 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.746 1.618 . . . . 3.6600000000000001 108.262 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -122.93 145.31 45.33 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 126.744 2.018 . . . . 3.7799999999999998 109.321 -170.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.48 164.08 33.12 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.192 2.595 . . . . 1.6200000000000001 110.807 171.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.6 t -100.89 119.66 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.465 -0.939 . . . . 1.8999999999999999 108.465 160.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 106.22 -1.77 . . . . 4.7400000000000002 106.22 178.698 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 122.375 1.083 . . . . 5.2300000000000004 109.834 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.78 -178.75 30.29 Favored Glycine 0 C--N 1.34 0.805 0 O-C-N 121.306 -0.871 . . . . 1.1899999999999999 111.634 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -131.77 160.38 35.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.024 1.12 . . . . 2.7799999999999998 114.024 -170.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.18 145.25 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.199 1.4 . . . . 2.5800000000000001 108.552 159.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -93.3 150.05 20.77 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.75 0.82 . . . . 5.79 111.908 -175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -70.6 139.7 51.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.605 2.362 . . . . 4.0599999999999996 113.227 -172.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -179.99 142.4 0.35 Allowed Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.187 1.395 . . . . 2.54 112.827 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.01 -20.88 18.88 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.727 2.285 . . . . 1.6000000000000001 112.492 162.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.58 175.67 13.96 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.809 2.147 . . . . 1.01 111.698 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.82 -15.6 29.07 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 118.893 1.346 . . . . 1.3899999999999999 112.946 -3.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -128.44 159.89 33.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.031 0.919 . . . . 2.8100000000000001 113.125 174.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -131.22 -178.69 4.95 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.652 3.581 . . . . 1.95 107.841 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.95 171.74 12.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.846 1.658 . . . . 1.73 108.295 169.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.34 118.74 19.8 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.488 -0.757 . . . . 2.1400000000000001 109.894 164.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -102.32 63.05 0.87 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.55 1.54 . . . . 4.0499999999999998 108.583 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -89.68 160.02 16.81 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.975 -1.011 . . . . 2.6200000000000001 112.092 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -130.18 127.74 40.32 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.849 1.26 . . . . 2.8199999999999998 108.443 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.74 179.72 4.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.03 1.332 . . . . 6.0199999999999996 109.826 162.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -127.05 164.14 22.21 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.654 0.781 . . . . 4.8399999999999999 109.886 165.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.15 81.46 0.42 Allowed Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.585 1.954 . . . . 3.1600000000000001 109.314 -174.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.52 -17.41 34.15 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.78 2.32 . . . . 1.45 114.809 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.7 157.95 51.0 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.367 0.985 . . . . 1.5 110.975 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.76 4.27 37.6 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 127.59 2.356 . . . . 3.77 112.408 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mp -122.88 158.0 58.48 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 127.291 2.236 . . . . 5.0099999999999998 108.72 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -83.01 141.63 10.62 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.72 2.28 . . . . 1.55 111.381 -166.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -89.74 150.04 22.47 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 123.41 1.576 . . . . 3.2200000000000002 112.626 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttm-85 -130.82 97.68 4.41 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.099 -1.864 . . . . 3.8999999999999999 110.227 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -78.79 110.66 14.17 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 125.236 1.414 . . . . 3.8900000000000001 107.695 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -100.12 -27.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 122.827 0.451 . . . . 1.5600000000000001 111.697 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 -173.76 29.51 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.094 1.33 . . . . 0.42999999999999999 113.396 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.31 177.99 8.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.11 1.764 . . . . 1.4199999999999999 112.295 171.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -143.26 169.22 18.04 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.402 1.481 . . . . 6.4800000000000004 109.319 158.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -168.85 150.44 4.57 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.757 1.623 . . . . 1.6399999999999999 108.313 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.07 -14.56 12.14 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.524 1.483 . . . . 0.85999999999999999 113.266 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 17.1 m -101.25 24.45 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.687 1.195 . . . . 1.8400000000000001 113.621 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.9 161.82 39.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.482 1.513 . . . . 1.47 109.46 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -93.58 -44.04 8.4 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.074 2.15 . . . . 3.96 112.363 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -131.83 159.56 38.19 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.07 0.948 . . . . 7.8499999999999996 109.013 160.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.84 143.6 30.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 125.277 1.431 . . . . 2.0499999999999998 108.887 166.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -117.47 149.25 40.89 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.858 1.663 . . . . 2.6400000000000001 109.272 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.5 tp -100.88 120.77 40.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.35 0.66 . . . . 1.8400000000000001 110.022 175.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -122.62 157.94 31.08 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.16 1.384 . . . . 0.65000000000000002 113.903 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -98.2 176.85 5.58 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.885 2.074 . . . . 2.4100000000000001 111.878 161.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.3 m -151.76 147.36 26.58 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.024 1.73 . . . . 1.9199999999999999 106.762 166.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -161.71 -179.73 7.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.635 1.174 . . . . 3.77 111.976 -164.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.0 ptt? -110.09 146.9 34.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.656 1.182 . . . . 5.0800000000000001 113.538 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -132.05 148.46 52.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.412 1.885 . . . . 6.7000000000000002 111.675 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.39 142.91 35.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.166 1.786 . . . . 3.5299999999999998 112.298 173.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.4 m -145.56 5.47 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 127.058 2.143 . . . . 4.2300000000000004 115.561 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -174.67 18.11 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.288 1.588 . . . . 3.8999999999999999 115.288 -161.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.27 -5.82 32.74 Favored Glycine 0 CA--C 1.54 1.606 0 O-C-N 119.914 -1.741 . . . . 2.2000000000000002 113.471 -163.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -97.39 69.93 2.27 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 129.12 2.968 . . . . 3.48 109.64 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -55.33 120.08 6.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.884 1.274 . . . . 3.71 109.953 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -145.37 144.56 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.32 1.848 . . . . 3.6800000000000002 109.122 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.5 mtp -82.28 169.13 16.89 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.293 1.22 . . . . 4.9900000000000002 114.293 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.2 176.83 32.72 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.911 1.719 . . . . 0.62 113.078 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.2 ttm -156.3 149.17 24.0 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.109 1.764 . . . . 2.5499999999999998 109.916 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -150.94 155.43 35.2 Favored Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 125.835 1.654 . . . . 5.1500000000000004 109.361 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.5 155.89 50.13 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.941 1.76 . . . . 0.55000000000000004 110.847 165.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.43 153.89 66.3 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.731 1.613 . . . . 1.79 110.09 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.27 -23.41 5.19 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.649 2.899 . . . . 0.63 113.631 -167.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -176.54 160.47 2.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.05 1.74 . . . . 3.4399999999999999 111.011 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -106.28 159.04 16.42 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.486 1.115 . . . . 1.9399999999999999 109.182 159.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -132.95 149.97 52.2 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.256 1.022 . . . . 2.2799999999999998 110.157 173.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.65 138.62 15.46 Favored Pre-proline 0 CA--C 1.537 0.464 0 O-C-N 124.056 0.847 . . . . 2.0699999999999998 112.237 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.62 156.54 35.9 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.743 2.962 . . . . 1.4299999999999999 112.264 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.35 140.41 91.64 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.874 3.049 . . . . 1.52 112.995 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.45 2.78 1.67 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.25 2.22 . . . . 3.79 113.96 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.52 179.7 51.92 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.227 2.346 . . . . 1.53 113.523 171.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.06 124.67 49.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.672 1.989 . . . . 5.5499999999999998 110.926 -173.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.8 t -94.67 72.92 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.807 2.043 . . . . 6.6799999999999997 108.27 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -117.52 115.27 24.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.806 1.288 . . . . 3.2400000000000002 111.794 -158.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -87.19 74.68 9.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.551 1.94 . . . . 2.0299999999999998 107.836 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 146.95 99.04 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 120.834 -1.166 . . . . 3.3100000000000001 113.514 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -61.02 147.13 96.63 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.335 2.023 . . . . 3.3500000000000001 109.485 164.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.07 -5.75 74.81 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.447 -1.196 . . . . 2.7400000000000002 113.703 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -147.33 -121.23 1.25 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 119.156 1.478 . . . . 1.48 113.674 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -73.94 138.47 44.26 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.482 -1.011 . . . . 3.21 111.319 -167.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -160.24 153.09 21.36 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.824 0.849 . . . . 0.81999999999999995 111.453 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -80.29 139.45 36.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.865 -0.791 . . . . 3.04 108.865 164.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 tpt -100.73 120.49 40.16 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.381 1.873 . . . . 2.4199999999999999 108.045 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -103.89 117.27 33.94 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.467 1.507 . . . . 2.0600000000000001 108.152 -175.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.88 148.13 41.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.222 0.919 . . . . 3.1800000000000002 112.163 -174.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.61 36.78 36.85 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 124.154 0.883 . . . . 1.51 113.12 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.1 mt -46.0 151.93 0.43 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 117.194 2.294 . . . . 1.8799999999999999 117.194 -170.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 60.6 mmtt -114.27 -31.36 6.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 113.088 -1.869 . . . . 3.4500000000000002 113.423 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -100.47 125.54 38.87 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 117.109 -1.424 . . . . 5.6799999999999997 107.776 156.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.96 112.36 2.0 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 N-CA-C 105.501 -2.538 . . . . 1.3999999999999999 105.501 152.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.01 137.88 51.12 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.472 1.129 . . . . 3.3599999999999999 112.995 -159.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -132.99 164.78 26.23 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 126.058 1.743 . . . . 4.21 113.67 -157.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.54 116.93 15.79 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.185 -0.916 . . . . 2.0299999999999998 109.778 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.2 15.13 36.63 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.736 -1.036 . . . . 1.26 114.527 -171.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -97.67 178.82 5.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.8 1.3 . . . . 2.21 110.411 159.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -137.32 150.83 48.03 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.391 2.276 . . . . 3.2799999999999998 105.873 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.1 t -145.06 144.83 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 127.177 2.191 . . . . 2.1099999999999999 109.329 -172.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -92.87 134.27 35.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.871 -0.604 . . . . 3.4900000000000002 111.429 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -114.3 146.01 41.02 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.271 1.828 . . . . 3.77 109.774 164.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -101.35 139.82 36.5 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.473 1.509 . . . . 2.0099999999999998 108.757 157.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.82 122.6 46.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.248 1.419 . . . . 1.98 108.932 167.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.8 mt -94.76 114.38 26.27 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.279 1.032 . . . . 1.8700000000000001 110.232 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -109.93 112.92 25.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.039 1.336 . . . . 3.4199999999999999 111.326 -172.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 51.51 29.77 5.72 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.837 1.655 . . . . 2.6800000000000002 113.023 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.97 -71.21 1.71 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.182 1.373 . . . . 4.6600000000000001 111.98 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.9 13.45 18.71 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 116.999 1.56 . . . . 1.6799999999999999 116.999 -163.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -132.05 143.75 50.26 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.634 1.574 . . . . 4.1600000000000001 110.048 168.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.63 144.79 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.39 1.076 . . . . 3.2799999999999998 109.106 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.9 tp -136.27 123.39 21.64 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.26 1.024 . . . . 3.4199999999999999 110.188 170.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -99.99 140.78 33.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.765 1.226 . . . . 4.0099999999999998 111.993 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.18 138.53 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.028 1.331 . . . . 3.3999999999999999 112.102 -173.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.3 p -83.07 136.53 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.814 0.846 . . . . 3.6800000000000002 109.862 165.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 mt -134.96 142.37 41.88 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.338 2.255 . . . . 3.4399999999999999 107.472 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 154.93 66.46 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.7 2.266 . . . . 0.88 111.571 168.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 64.9 t -91.1 126.41 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.936 0.494 . . . . 2.0299999999999998 110.141 165.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 125.358 1.463 . . . . 4.6600000000000001 112.638 175.307 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.411 ' CD ' HH22 ' A' ' 74' ' ' ARG . 7.9 tt0 . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 107.151 -1.426 . . . . 4.8799999999999999 107.151 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.77 172.03 37.01 Favored Glycine 0 N--CA 1.464 0.536 0 O-C-N 121.341 -0.849 . . . . 1.73 112.775 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.9 p90 -157.92 151.46 23.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.722 1.609 . . . . 2.8300000000000001 110.974 167.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.35 145.96 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 106.964 -1.495 . . . . 2.6299999999999999 106.964 162.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -80.29 -88.98 0.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.056 1.298 . . . . 6.5099999999999998 111.786 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -164.09 141.55 6.95 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.723 0.809 . . . . 4.21 112.118 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.1 t -176.43 140.2 0.51 Allowed Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.795 1.638 . . . . 2.8399999999999999 111.489 165.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.32 -29.59 7.59 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.507 2.138 . . . . 1.7 112.53 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.64 171.91 12.35 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.309 1.909 . . . . 1.1100000000000001 111.629 -170.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.55 -6.02 31.53 Favored 'Cis proline' 0 CA--C 1.536 0.613 0 CA-C-N 119.305 1.552 . . . . 1.4099999999999999 113.528 0.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -148.64 164.75 33.35 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.457 1.28 . . . . 2.54 114.457 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.35 -179.02 5.64 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.975 2.51 . . . . 1.8400000000000001 110.443 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.39 138.97 33.38 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.148 1.379 . . . . 1.5900000000000001 109.305 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.21 154.73 47.26 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.059 1.744 . . . . 1.95 112.597 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.419 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 9.8 m-85 -136.89 143.91 43.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.51 2.324 . . . . 3.8100000000000001 110.187 -167.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -171.35 153.48 3.6 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.13 1.159 . . . . 3.5099999999999998 114.13 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.7 p -90.45 144.3 25.93 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.522 1.929 . . . . 3.8500000000000001 110.456 173.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.5 142.86 51.28 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.733 1.613 . . . . 4.9500000000000002 107.929 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -127.9 140.59 51.91 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.949 -0.76 . . . . 4.3399999999999999 108.949 157.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -86.15 112.51 46.24 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.326 1.05 . . . . 1.4399999999999999 108.958 170.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.39 -12.89 11.29 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.615 2.21 . . . . 1.3200000000000001 113.788 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 171.74 46.85 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 122.964 1.313 . . . . 1.22 112.456 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.406 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 6.1 m-20 -97.32 -5.38 36.72 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.346 2.659 . . . . 2.9300000000000002 112.274 -176.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.5 mt -121.16 162.62 34.61 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 127.896 2.478 . . . . 4.7599999999999998 109.3 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.72 150.51 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.359 2.04 . . . . 1.02 111.849 -168.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.8 mt -103.45 148.83 25.45 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.26 1.024 . . . . 2.79 109.951 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -134.0 101.92 5.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 112.886 -1.961 . . . . 2.48 110.471 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.15 104.63 16.87 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.631 1.572 . . . . 2.7999999999999998 108.318 -172.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -97.91 -30.3 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.616 0.766 . . . . 1.8899999999999999 112.443 -168.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.33 -175.7 29.56 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.468 1.032 . . . . 0.44 112.423 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.01 174.21 10.42 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.658 0.742 . . . . 1.7 111.98 166.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -127.65 164.03 22.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.481 1.912 . . . . 6.8099999999999996 107.8 156.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -171.8 151.02 2.69 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 127.186 2.195 . . . . 1.77 108.801 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.13 -24.39 5.71 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.223 1.949 . . . . 1.1299999999999999 114.013 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.445 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 25.5 m -103.97 22.58 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.502 1.121 . . . . 2.0 113.817 -172.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.95 152.22 24.49 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 126.37 1.868 . . . . 1.5800000000000001 108.221 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -90.93 -66.77 0.9 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 126.039 1.735 . . . . 3.5 109.394 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -86.79 140.7 29.45 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.951 -1.87 . . . . 7.71 105.951 164.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.18 127.57 65.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 106.769 -1.567 . . . . 2.4700000000000002 106.769 162.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -124.75 125.79 44.63 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.563 1.145 . . . . 2.6299999999999999 109.275 -163.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.2 tp -79.89 122.78 27.1 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.053 -0.404 . . . . 2.0899999999999999 110.796 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -120.33 161.6 20.87 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.323 1.449 . . . . 0.57999999999999996 112.804 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -112.13 159.3 18.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.027 2.131 . . . . 2.8799999999999999 110.742 161.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.3 m -124.43 143.25 50.73 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.435 2.294 . . . . 1.97 105.654 168.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -152.03 170.62 19.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.711 0.804 . . . . 3.3700000000000001 112.51 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.8 ptm -99.34 143.35 29.69 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.992 0.917 . . . . 5.3300000000000001 111.867 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -156.65 154.39 30.06 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.667 1.187 . . . . 9.3100000000000005 113.02 -177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.47 160.12 26.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.954 0.901 . . . . 5.1100000000000003 110.589 158.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.5 m -146.87 -12.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 117.083 2.253 . . . . 4.79 117.083 170.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.504 ' CD ' ' HZ2' ' A' ' 56' ' ' LYS . 1.1 tt0 178.38 32.35 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.493 2.035 . . . . 4.54 116.493 -158.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.56 15.45 70.79 Favored Glycine 0 N--CA 1.476 1.359 0 O-C-N 119.288 -2.133 . . . . 2.3799999999999999 112.685 -167.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.504 ' HZ2' ' CD ' ' A' ' 54' ' ' GLU . 36.4 mtmm -142.87 88.63 2.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.987 2.515 . . . . 4.1500000000000004 110.002 -166.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.13 122.63 12.87 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.023 -1.048 . . . . 4.8899999999999997 113.022 174.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.4 m -135.76 -176.08 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 129.376 3.071 . . . . 3.75 110.043 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.5 mtp -98.51 166.21 11.46 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.803 1.287 . . . . 5.3300000000000001 113.953 167.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.77 -179.91 17.51 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 127.142 2.306 . . . . 0.78000000000000003 111.079 170.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -149.47 145.69 27.03 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.366 1.866 . . . . 2.1899999999999999 108.344 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.35 147.47 33.96 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.646 1.578 . . . . 8.7200000000000006 109.533 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.82 150.01 23.57 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.522 2.148 . . . . 0.68999999999999995 110.254 167.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -139.09 156.2 72.4 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.802 1.241 . . . . 1.9099999999999999 111.185 -172.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -84.87 -23.22 2.63 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.128 2.552 . . . . 0.59999999999999998 113.712 -165.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -179.13 162.82 1.25 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.413 1.885 . . . . 3.0 111.415 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -107.71 150.39 27.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.573 1.149 . . . . 1.6000000000000001 110.244 162.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -109.5 142.76 40.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.018 -1.105 . . . . 2.1000000000000001 108.018 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.5 t -134.79 122.47 15.47 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.18 -0.438 . . . . 1.8 111.131 165.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -69.23 161.5 45.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.539 2.826 . . . . 1.02 111.153 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -58.99 138.5 86.03 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.412 2.742 . . . . 1.02 112.41 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 64.6 mmtt 67.24 -7.68 0.5 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.134 1.774 . . . . 2.3599999999999999 114.092 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.55 142.97 25.32 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.751 1.167 . . . . 1.21 113.025 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.411 HH22 ' CD ' ' A' ' 5' ' ' GLU . 1.1 ttt180 -101.69 133.03 47.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.406 1.482 . . . . 4.75 108.913 168.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -148.59 141.51 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.765 2.026 . . . . 4.0499999999999998 108.542 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.04 137.67 54.56 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.259 1.024 . . . . 3.5099999999999998 113.294 -168.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -70.63 74.03 0.56 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.126 1.77 . . . . 2.1000000000000001 109.372 158.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -68.65 138.92 91.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.244 2.218 . . . . 3.02 111.99 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.419 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 55.9 Cg_endo -63.65 -34.46 62.99 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.643 2.229 . . . . 2.2599999999999998 114.12 -173.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.89 6.78 46.49 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.26 -0.745 . . . . 1.8500000000000001 114.178 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.89 -121.07 1.27 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.307 1.908 . . . . 1.5600000000000001 111.907 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -73.71 138.14 44.48 Favored 'General case' 0 C--O 1.223 -0.312 0 O-C-N 121.567 -0.961 . . . . 3.4700000000000002 112.341 -171.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -159.89 150.67 19.11 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 124.209 1.003 . . . . 0.79000000000000004 111.1 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -87.8 128.01 35.33 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.755 -0.591 . . . . 3.1499999999999999 109.481 171.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.2 tpt -85.57 110.87 19.54 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.752 1.621 . . . . 1.8600000000000001 109.655 168.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.7 mp -90.28 116.42 28.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.852 1.261 . . . . 2.2400000000000002 108.574 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tt -127.17 143.36 51.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.995 0.902 . . . . 3.8599999999999999 112.54 -164.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.78 38.6 41.93 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 121.418 -0.801 . . . . 1.72 112.445 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt -45.52 153.88 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 117.865 2.543 . . . . 1.8999999999999999 117.865 -170.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 51.5 mmtt -119.26 -24.74 6.32 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.673 -1.603 . . . . 3.3500000000000001 113.759 -176.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -125.87 147.83 60.3 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.168 2.187 . . . . 7.2800000000000002 107.992 157.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -66.89 144.67 71.63 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.948 1.765 . . . . 2.0800000000000001 108.28 165.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.16 75.73 8.13 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.919 -1.141 . . . . 3.54 107.919 170.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -88.8 165.1 14.91 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.609 1.164 . . . . 3.9399999999999999 111.662 170.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.47 132.14 51.5 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.454 -0.779 . . . . 3.52 111.372 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.6 1.41 58.94 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 117.231 -1.872 . . . . 1.8999999999999999 115.745 169.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -76.6 167.59 21.58 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.82 1.81 . . . . 3.0800000000000001 110.342 169.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.23 133.02 47.34 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 130.455 3.502 . . . . 3.8999999999999999 104.362 173.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.1 t -136.98 132.62 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.828 1.251 . . . . 2.3199999999999998 111.196 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -79.37 142.78 35.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.279 -1.328 . . . . 2.3900000000000001 112.067 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -122.47 154.82 37.3 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.138 -0.937 . . . . 2.8799999999999999 109.922 152.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -125.76 112.65 16.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.175 2.19 . . . . 2.6099999999999999 108.809 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mp -84.98 116.71 23.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.599 1.16 . . . . 1.73 111.194 -171.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.9 mt -85.69 106.71 17.15 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.705 1.202 . . . . 1.8500000000000001 109.937 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -103.24 107.71 18.63 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.279 1.432 . . . . 3.3999999999999999 111.74 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 55.17 27.43 9.59 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.975 1.71 . . . . 2.7000000000000002 112.906 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.85 -59.23 3.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.52 1.533 . . . . 4.6799999999999997 113.163 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.68 -1.23 70.96 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.58 1.392 . . . . 1.6100000000000001 116.58 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -133.32 146.74 51.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.218 1.509 . . . . 3.6200000000000001 111.372 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.89 149.75 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.352 1.461 . . . . 3.3700000000000001 110.779 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.7 tt -145.01 130.08 18.44 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.621 1.168 . . . . 3.1899999999999999 111.259 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 140.55 38.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.642 1.177 . . . . 3.2000000000000002 113.425 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.77 165.82 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.881 1.672 . . . . 4.0300000000000002 110.749 163.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.24 151.3 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.813 1.245 . . . . 3.8100000000000001 109.493 168.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.38 137.77 9.6 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 126.188 1.795 . . . . 3.5299999999999998 112.796 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.45 163.62 31.89 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.264 3.309 . . . . 1.5800000000000001 113.364 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.6 t -103.87 109.58 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 122.326 1.06 . . . . 2.4300000000000002 110.624 174.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 127.689 2.396 . . . . 4.1699999999999999 109.635 -170.383 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 121.457 0.646 . . . . 4.8300000000000001 111.631 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.09 -178.42 15.5 Favored Glycine 0 N--CA 1.469 0.849 0 O-C-N 120.774 -1.204 . . . . 1.26 111.583 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -144.83 166.87 24.02 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.296 0.85 . . . . 2.8399999999999999 113.296 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.5 t -115.99 143.46 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.846 1.259 . . . . 2.3100000000000001 109.185 176.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -26.29 60.9 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 117.268 2.322 . . . . 5.3399999999999999 117.268 -151.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.505 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER 79.78 114.79 0.06 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.232 2.213 . . . . 4.1900000000000004 108.159 -167.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.5 m -160.88 138.59 6.98 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.645 1.978 . . . . 3.2200000000000002 108.286 166.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.03 -33.13 10.08 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.39 2.06 . . . . 1.71 111.76 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.57 179.87 22.14 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.18 1.372 . . . . 0.95999999999999996 112.331 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.22 -5.64 16.38 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 CA-C-N 118.48 1.14 . . . . 1.3500000000000001 113.013 -2.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.414 ' ND2' ' H ' ' A' ' 88' ' ' GLY . 2.8 m120 -135.74 175.14 9.87 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.759 1.623 . . . . 5.29 111.903 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.27 -175.46 5.42 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.947 2.899 . . . . 1.5 111.585 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.37 154.93 45.92 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.365 2.266 . . . . 1.6699999999999999 107.84 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.2 130.53 39.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.83 0.741 . . . . 1.78 110.391 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -110.64 54.12 0.68 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.175 2.19 . . . . 3.52 111.366 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.97 150.75 37.39 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.136 -0.978 . . . . 2.5800000000000001 113.309 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -91.79 134.67 34.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.304 0.642 . . . . 2.0600000000000001 109.78 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.56 134.54 51.79 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.143 2.177 . . . . 3.9199999999999999 110.234 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -119.17 151.98 37.38 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.889 1.676 . . . . 5.3399999999999999 110.445 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -114.65 103.68 54.75 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.196 0.998 . . . . 1.46 109.083 160.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -83.62 -8.54 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.244 2.629 . . . . 1.8700000000000001 114.455 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.57 175.9 30.73 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 119.441 1.019 . . . . 1.3500000000000001 112.066 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -92.18 1.21 57.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.069 2.148 . . . . 3.5099999999999998 112.984 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -112.16 157.21 40.5 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 127.425 2.29 . . . . 4.8700000000000001 110.402 175.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.25 158.01 41.42 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.802 2.335 . . . . 1.24 111.067 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.3 mt -134.0 130.3 37.4 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 124.239 1.971 . . . . 3.04 112.785 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -108.89 106.12 15.97 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 110.704 -2.953 . . . . 2.7599999999999998 111.331 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.29 114.74 26.85 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.361 1.464 . . . . 3.6000000000000001 108.358 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.2 -25.56 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.646 0.778 . . . . 1.6200000000000001 112.685 -170.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.28 -174.55 27.13 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.319 0.961 . . . . 0.54000000000000004 112.9 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.94 -177.55 5.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.248 1.019 . . . . 2.04 111.056 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.54 -175.58 5.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.849 2.459 . . . . 6.0999999999999996 109.441 164.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t 178.71 150.37 0.44 Allowed Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 129.528 3.131 . . . . 1.6899999999999999 106.192 -167.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.24 -12.82 14.11 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.925 1.75 . . . . 0.89000000000000001 113.472 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.93 23.54 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.717 1.377 . . . . 2.0499999999999998 114.717 -170.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.78 134.15 16.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.874 1.67 . . . . 1.54 109.764 168.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -59.51 -48.88 79.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.35 1.06 . . . . 2.7799999999999998 111.569 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.39 165.29 16.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.7 2.4 . . . . 6.1600000000000001 109.568 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -148.17 145.89 18.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 126.072 1.749 . . . . 1.97 108.323 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -130.12 146.09 51.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.499 1.92 . . . . 2.6699999999999999 109.435 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -99.37 117.01 32.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.014 0.925 . . . . 1.97 109.588 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -118.66 149.95 40.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 123.089 1.423 . . . . 0.60999999999999999 113.844 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.419 ' CD ' HH21 ' A' ' 62' ' ' ARG . 11.8 pt-20 -95.84 172.44 8.02 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.915 1.686 . . . . 2.3599999999999999 111.348 164.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.4 m -148.29 144.56 27.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.525 1.53 . . . . 1.9399999999999999 107.165 170.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -157.17 166.81 32.19 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.939 0.718 . . . . 3.3700000000000001 112.939 -166.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.2 mtp -93.73 144.36 25.48 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.068 0.947 . . . . 4.96 111.473 170.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -157.88 163.0 38.36 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.708 1.603 . . . . 9.3200000000000003 111.906 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.27 152.65 32.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.904 1.282 . . . . 3.4100000000000001 110.534 165.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.65 120.46 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 106.714 -1.587 . . . . 4.8899999999999997 106.714 142.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 55.34 44.28 27.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.4 1.48 . . . . 5.7400000000000002 113.113 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.48 0.74 63.43 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.051 -1.031 . . . . 2.4900000000000002 114.128 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -109.35 114.78 28.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.077 1.351 . . . . 4.4800000000000004 109.753 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -67.65 127.07 31.39 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.094 1.358 . . . . 4.6900000000000004 111.171 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.65 -177.17 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 129.763 3.225 . . . . 3.3700000000000001 109.75 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 59.2 mtt -110.08 167.27 10.3 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.109 -0.994 . . . . 3.6600000000000001 113.602 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.53 172.15 29.56 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 126.034 1.778 . . . . 0.69999999999999996 112.262 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -149.68 147.5 28.15 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.294 1.838 . . . . 1.99 108.952 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.419 HH21 ' CD ' ' A' ' 47' ' ' GLU . 32.0 mtm180 -151.16 156.88 35.37 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 127.034 2.134 . . . . 5.9000000000000004 108.866 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.15 149.72 28.63 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.13 1.887 . . . . 0.5 110.508 167.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.7 m -137.64 152.42 72.7 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 125.399 1.48 . . . . 2.2200000000000002 110.362 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.59 -24.29 2.98 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.09 2.526 . . . . 0.59999999999999998 113.504 -160.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -177.11 160.85 1.81 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.255 1.422 . . . . 3.6400000000000001 112.25 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.63 154.77 20.43 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.704 1.601 . . . . 1.79 109.89 162.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -115.77 149.86 37.83 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.7 1.2 . . . . 3.0699999999999998 108.71 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.19 127.86 10.64 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 112.776 0.658 . . . . 2.0499999999999998 112.776 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.62 155.42 44.77 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.416 2.744 . . . . 1.5 112.098 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.33 139.59 83.69 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.228 3.285 . . . . 1.53 113.388 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.45 1.34 0.97 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.968 2.107 . . . . 3.9399999999999999 114.347 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.84 167.13 51.14 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.201 1.858 . . . . 1.3999999999999999 113.037 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.21 150.73 45.88 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.541 1.536 . . . . 4.8399999999999999 109.174 169.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.3 t -149.79 135.97 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.866 1.667 . . . . 4.2999999999999998 107.216 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.99 132.55 54.12 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 119.071 0.85 . . . . 2.6499999999999999 111.741 -177.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -71.25 80.7 0.73 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.933 1.349 . . . . 2.3700000000000001 109.694 168.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.53 146.85 66.52 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.529 1.532 . . . . 3.8799999999999999 112.838 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -53.56 -41.94 69.69 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.403 2.735 . . . . 3.46 112.431 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.94 54.0 4.66 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 118.612 -1.104 . . . . 2.29 113.202 170.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.48 -29.64 0.51 Allowed Glycine 0 N--CA 1.472 1.084 0 N-CA-C 119.953 2.741 . . . . 2.46 119.953 155.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -147.26 137.12 23.05 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.924 2.362 . . . . 3.4399999999999999 111.528 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -161.32 156.7 24.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.599 0.592 . . . . 0.71999999999999997 112.599 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -84.43 145.3 28.24 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.409 -0.589 . . . . 2.9900000000000002 109.409 163.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -99.23 132.19 44.72 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.073 1.749 . . . . 1.8100000000000001 108.838 161.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -110.21 115.38 29.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.17 1.388 . . . . 1.98 108.257 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.62 142.22 42.78 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.96 0.904 . . . . 3.4399999999999999 109.809 -171.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.414 ' H ' ' ND2' ' A' ' 15' ' ' ASN . . . 64.03 55.83 21.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.413 1.006 . . . . 1.77 113.877 174.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 mt -48.56 154.26 0.68 Allowed 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 115.153 1.538 . . . . 1.8999999999999999 115.153 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -98.88 -26.69 14.2 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 113.016 -1.902 . . . . 2.5299999999999998 113.276 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.83 152.0 29.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.734 2.414 . . . . 6.8600000000000003 110.741 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.39 135.4 24.43 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.422 2.748 . . . . 1.52 110.534 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -124.36 125.61 44.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.744 1.217 . . . . 2.98 111.913 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.505 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 4.1 ptpp? -114.87 168.57 9.78 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.639 1.175 . . . . 3.9100000000000001 113.699 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.33 140.46 48.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.252 0.621 . . . . 2.8599999999999999 109.845 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.31 12.63 62.9 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.651 1.119 . . . . 1.8700000000000001 113.993 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -99.77 179.64 4.46 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.29 1.036 . . . . 2.3300000000000001 110.161 162.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -124.86 152.57 43.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.538 2.335 . . . . 3.3900000000000001 104.761 163.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.5 t -147.39 144.79 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.385 1.874 . . . . 2.1099999999999999 109.809 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.46 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 6.5 pt-20 -94.12 142.26 27.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.115 0.966 . . . . 2.3900000000000001 113.3 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 54.2 mt -130.19 160.89 32.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.303 2.241 . . . . 3.9399999999999999 110.596 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -121.29 126.13 48.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.65 2.38 . . . . 2.7999999999999998 109.05 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.95 123.56 45.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.233 1.413 . . . . 2.4500000000000002 110.653 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.8 mt -104.23 110.59 22.86 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.314 1.045 . . . . 1.8 110.829 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.65 144.06 35.26 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.416 1.486 . . . . 3.25 111.044 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.51 134.39 56.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.569 0.748 . . . . 2.4199999999999999 112.152 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.67 42.2 5.81 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.865 -0.964 . . . . 3.6600000000000001 113.909 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.14 6.47 86.18 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 115.846 1.098 . . . . 1.8200000000000001 115.846 166.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -90.99 121.64 32.98 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.43 1.115 . . . . 4.0199999999999996 111.496 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.38 137.0 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.583 1.553 . . . . 3.1899999999999999 108.828 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.6 tp -137.15 113.58 10.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.049 0.94 . . . . 3.7599999999999998 110.329 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 27.1 ttpt -83.43 141.53 31.63 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.936 -0.478 . . . . 3.23 111.803 171.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.8 171.13 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 127.437 2.295 . . . . 3.9700000000000002 110.683 -171.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.87 138.22 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.484 1.113 . . . . 3.5699999999999998 110.394 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mp -142.94 153.2 60.39 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.106 1.762 . . . . 4.3600000000000003 109.951 -175.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.46 154.32 69.09 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.016 3.144 . . . . 1.28 112.999 171.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.5 t -93.98 125.75 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.237 -1.023 . . . . 2.02 108.237 165.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.466 0.345 0 C-N-CA 125.195 1.398 . . . . 4.3200000000000003 108.421 179.159 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 108.774 -0.825 . . . . 6.1399999999999997 108.774 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.25 169.33 13.76 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 114.927 0.731 . . . . 1.55 114.927 -169.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -151.61 168.64 24.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.16 1.384 . . . . 2.6899999999999999 113.036 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.44 148.07 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.688 1.595 . . . . 1.9199999999999999 107.784 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -70.98 -132.79 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.26 1.024 . . . . 7.29 111.34 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -145.27 134.93 23.4 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.447 -1.408 . . . . 3.0600000000000001 109.831 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.1 p -176.53 117.13 0.28 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.883 1.068 . . . . 4.2199999999999998 113.883 -163.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.4 -28.01 10.72 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.432 2.088 . . . . 1.5900000000000001 112.263 169.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.24 -176.52 18.11 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.815 1.674 . . . . 0.96999999999999997 111.936 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.42 -8.26 21.81 Favored 'Cis proline' 0 CA--C 1.536 0.581 0 CA-C-N 118.924 1.362 . . . . 1.29 113.43 1.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -128.23 165.01 21.31 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 126.41 1.884 . . . . 1.97 112.552 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.57 -178.54 6.75 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.936 2.494 . . . . 1.8500000000000001 110.707 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.31 141.76 26.43 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.992 1.317 . . . . 1.5 110.042 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.48 150.48 50.14 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.262 1.425 . . . . 1.78 111.561 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -133.36 66.46 1.56 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.828 2.051 . . . . 3.54 109.564 -166.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -72.4 165.57 24.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.631 1.572 . . . . 3.04 114.666 -173.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -93.63 151.45 19.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.321 1.048 . . . . 5.4299999999999997 110.4 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.9 tp -135.99 117.42 14.73 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.271 1.428 . . . . 5.2800000000000002 110.074 -167.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -114.11 135.18 54.31 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.306 1.442 . . . . 6.3499999999999996 111.001 -173.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.35 67.16 3.44 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.071 -1.018 . . . . 3.1000000000000001 110.965 171.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.75 -22.72 56.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.42 2.746 . . . . 1.78 114.64 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.56 -171.94 42.48 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-O 122.534 1.074 . . . . 1.6799999999999999 113.338 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.424 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.9 m-20 -110.85 -0.42 16.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.746 2.018 . . . . 2.98 112.929 -167.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.9 mt -122.29 160.25 48.73 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 127.001 2.12 . . . . 5.21 109.243 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -81.96 144.29 13.46 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.711 2.274 . . . . 1.0 111.349 -168.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 mp -101.55 154.61 18.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 123.031 1.396 . . . . 3.9399999999999999 111.271 171.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -136.69 103.66 5.28 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 113.583 -1.644 . . . . 2.4300000000000002 109.627 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.15 108.07 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.571 1.549 . . . . 2.9700000000000002 108.263 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.5 m -102.57 -25.53 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.519 0.933 . . . . 1.6799999999999999 113.519 -169.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.23 -176.98 30.89 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 124.862 1.22 . . . . 0.53000000000000003 112.055 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.83 -179.72 5.47 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.555 0.693 . . . . 1.79 112.582 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 172.91 14.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.371 2.269 . . . . 7.04 108.862 161.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t 175.12 150.14 0.27 Allowed Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 129.509 3.123 . . . . 1.74 106.977 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.2 -15.73 25.42 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.128 1.885 . . . . 1.26 114.311 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.57 23.07 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 116.059 1.874 . . . . 2.1800000000000002 116.059 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.21 136.63 14.11 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.42 1.488 . . . . 1.8300000000000001 110.761 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.431 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 4.2 tp10 -60.34 -46.55 89.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.251 1.02 . . . . 2.7599999999999998 112.338 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -127.52 160.22 32.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.894 2.078 . . . . 5.4400000000000004 108.993 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.0 152.96 24.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 126.851 2.06 . . . . 1.5900000000000001 108.545 170.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.5 147.41 26.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.232 1.813 . . . . 4.2599999999999998 108.313 -166.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.2 tp -111.05 110.12 20.51 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.445 1.02 . . . . 1.8 110.711 -164.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -117.65 153.72 32.83 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 123.019 1.39 . . . . 0.69999999999999996 113.654 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.406 ' C ' ' HG1' ' A' ' 48' ' ' THR . 4.1 pt-20 -109.92 177.26 4.77 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 113.392 -1.731 . . . . 2.48 111.671 163.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.406 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 63.8 m -152.93 103.14 2.72 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.156 1.382 . . . . 2.0499999999999998 107.342 -169.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -107.28 165.25 11.52 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.276 1.031 . . . . 3.6499999999999999 113.59 -166.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.4 mtm -101.55 150.58 22.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.048 1.339 . . . . 5.8399999999999999 110.57 166.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.28 156.48 32.51 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.238 1.015 . . . . 6.0599999999999996 110.934 -169.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.489 ' CD ' ' HZ1' ' A' ' 57' ' ' LYS . 2.5 tp10 -108.89 145.7 34.93 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.606 1.563 . . . . 2.6400000000000001 108.665 169.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -153.13 136.62 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.545 -0.909 . . . . 3.96 108.545 160.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 67.45 16.94 10.06 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.747 1.219 . . . . 3.8900000000000001 112.863 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.12 17.43 78.24 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.73 -1.231 . . . . 1.52 113.357 -169.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -120.82 126.72 50.81 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.985 2.114 . . . . 3.8900000000000001 109.109 -172.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 3.8 mmtt -73.15 121.27 19.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.253 1.821 . . . . 3.6699999999999999 108.974 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.26 179.8 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.418 1.887 . . . . 3.8199999999999998 110.543 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.7 mtt -130.31 170.27 14.35 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.178 1.391 . . . . 3.29 111.091 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.49 -178.22 29.51 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.382 0.991 . . . . 0.56000000000000005 112.916 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.9 ttm -143.91 150.2 38.02 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.98 1.712 . . . . 2.2000000000000002 108.149 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -159.22 153.84 20.81 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.377 1.071 . . . . 5.71 109.994 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.72 159.82 38.36 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.368 2.045 . . . . 0.56999999999999995 110.986 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.94 152.66 40.86 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 125.875 1.67 . . . . 2.4100000000000001 109.88 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -83.51 -26.53 2.09 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.992 2.461 . . . . 0.78000000000000003 113.557 -160.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -177.61 166.33 2.17 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.835 1.654 . . . . 3.6000000000000001 111.819 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.3 mt -109.83 153.35 24.53 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.405 1.482 . . . . 1.8400000000000001 110.277 161.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -117.97 147.55 43.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.888 1.675 . . . . 1.6899999999999999 108.504 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 t -140.41 139.06 19.74 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 112.606 0.595 . . . . 2.3700000000000001 112.606 171.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.77 157.11 15.91 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.887 3.058 . . . . 1.23 112.232 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.35 146.75 96.93 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.926 3.084 . . . . 1.3700000000000001 114.597 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.424 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 33.2 mmtm 70.37 -5.65 1.32 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.153 2.581 . . . . 3.2400000000000002 114.189 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.81 167.09 52.54 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.947 1.26 . . . . 2.0 113.987 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.18 135.19 20.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.223 2.609 . . . . 7.5899999999999999 106.457 168.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.2 t -152.87 96.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.715 1.206 . . . . 4.6500000000000004 111.848 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -74.04 160.39 31.35 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.31 -1.494 . . . . 4.2400000000000002 112.149 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mp -67.34 90.15 0.22 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.878 1.323 . . . . 2.3999999999999999 108.611 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -42.23 135.34 2.43 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 127.428 2.291 . . . . 5.0599999999999996 112.865 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.9 -31.79 91.92 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.389 2.06 . . . . 2.5 112.513 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.65 96.37 1.72 Allowed Glycine 0 C--N 1.343 0.933 0 C-N-CA 123.97 0.795 . . . . 3.1099999999999999 111.374 166.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.56 -15.67 4.92 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 117.548 1.779 . . . . 1.8799999999999999 117.548 149.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -140.95 146.28 37.15 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.442 2.121 . . . . 3.5299999999999998 112.175 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -160.59 148.29 16.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.588 1.155 . . . . 0.84999999999999998 111.78 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -79.54 120.89 24.53 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.501 -0.925 . . . . 3.0600000000000001 108.501 161.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 tpt -78.88 127.6 32.23 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.061 2.545 . . . . 1.95 108.756 167.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.1 mt -113.93 134.59 54.73 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.952 1.701 . . . . 3.6800000000000002 109.338 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.3 131.04 36.0 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.198 0.908 . . . . 3.27 111.797 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.66 49.28 4.92 Favored Glycine 0 N--CA 1.468 0.819 0 C-N-CA 123.747 0.689 . . . . 1.8999999999999999 112.201 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.4 mt -52.66 155.83 2.11 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 115.078 1.51 . . . . 2.02 115.078 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.431 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 66.3 mmtt -110.01 -13.17 14.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.869 -1.514 . . . . 2.4900000000000002 114.849 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.1 mmt-85 -140.38 138.11 18.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 130.136 3.374 . . . . 8.2599999999999998 108.697 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.52 137.89 18.91 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.34 2.027 . . . . 1.4099999999999999 108.583 161.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -91.65 143.64 26.35 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.785 0.802 . . . . 3.27 112.525 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.466 ' HZ3' ' CD ' ' A' ' 97' ' ' GLU . 2.1 mmtm -91.71 -162.96 0.97 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.911 1.338 . . . . 4.5999999999999996 109.203 163.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.11 142.96 37.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.132 -1.395 . . . . 2.1000000000000001 107.811 155.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.84 33.83 12.09 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.877 -0.957 . . . . 1.3200000000000001 114.309 -173.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.466 ' CD ' ' HZ3' ' A' ' 94' ' ' LYS . 47.7 mt-10 -112.62 -176.38 2.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.162 1.385 . . . . 2.1699999999999999 110.473 168.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -146.51 134.99 22.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 128.274 2.63 . . . . 3.1000000000000001 105.153 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.4 t -143.72 144.51 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.118 1.367 . . . . 2.1899999999999999 107.929 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.79 146.21 28.1 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.514 0.673 . . . . 3.29 111.027 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.81 140.11 53.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.335 1.054 . . . . 2.6800000000000002 109.894 169.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -79.78 135.17 36.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.595 2.758 . . . . 2.23 109.708 162.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.32 123.65 46.51 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.992 1.717 . . . . 2.6600000000000001 106.946 170.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.67 104.67 16.68 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.926 -1.139 . . . . 2.02 107.926 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -96.19 128.84 43.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.456 1.102 . . . . 3.48 111.237 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 45.13 40.64 4.99 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.438 1.895 . . . . 2.9399999999999999 112.831 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.52 -94.38 1.97 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.539 1.066 . . . . 5.9000000000000004 111.506 -170.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.1 -6.78 62.91 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 117.121 1.609 . . . . 3.1200000000000001 117.121 -160.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -80.8 104.85 11.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.819 2.309 . . . . 3.4300000000000002 110.765 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.02 135.07 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.252 1.021 . . . . 3.4700000000000002 111.402 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 tt -155.19 129.92 9.25 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.549 1.54 . . . . 3.1200000000000001 109.26 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.64 153.14 20.4 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.856 1.428 . . . . 4.8200000000000003 114.856 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 t -130.14 161.35 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.602 2.361 . . . . 3.1200000000000001 108.9 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.83 147.03 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.0 1.72 . . . . 3.2000000000000002 109.051 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.61 138.19 11.75 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.237 1.015 . . . . 3.1299999999999999 111.598 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.18 160.82 46.3 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.901 3.067 . . . . 1.1200000000000001 112.962 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.3 t -106.6 128.38 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.407 1.883 . . . . 2.1000000000000001 109.548 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 CA--C 1.542 0.666 0 C-N-CA 124.509 1.124 . . . . 3.46 110.956 -174.385 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 121.515 0.674 . . . . 4.5999999999999996 111.952 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.04 177.35 39.79 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 116.079 1.192 . . . . 1.55 116.079 -163.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -150.24 149.46 30.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.337 1.855 . . . . 2.6000000000000001 110.483 166.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.0 t -93.22 148.61 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 121.004 -1.06 . . . . 2.2200000000000002 108.174 172.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -143.26 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.304 0.573 . . . . 6.2599999999999998 110.957 170.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -152.76 121.12 6.3 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 119.78 -1.825 . . . . 3.3700000000000001 111.044 -160.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -165.14 146.95 6.47 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 127.704 2.402 . . . . 2.5699999999999998 109.796 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.46 -34.11 4.8 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.413 2.075 . . . . 1.96 111.538 164.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.05 176.74 23.41 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.139 1.828 . . . . 1.23 111.24 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.25 -4.62 33.85 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 CA-C-N 119.395 1.597 . . . . 1.1699999999999999 113.319 -1.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -138.27 164.04 30.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 122.265 1.031 . . . . 2.5 113.337 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.31 -177.48 4.86 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.349 2.26 . . . . 1.9299999999999999 110.701 169.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.38 153.33 51.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.935 1.694 . . . . 1.9199999999999999 109.227 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.21 153.07 42.46 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.991 0.916 . . . . 2.02 113.025 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -126.82 134.94 50.44 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.568 1.947 . . . . 4.0700000000000003 108.811 -174.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.48 171.58 11.71 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.458 1.026 . . . . 4.3099999999999996 112.587 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.1 m -111.01 147.3 35.05 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.241 1.416 . . . . 3.0899999999999999 111.128 -171.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.96 138.55 49.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.266 2.226 . . . . 5.3600000000000003 109.356 167.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.53 175.04 5.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.574 1.55 . . . . 6.9699999999999998 110.749 165.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -146.71 103.7 3.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 121.214 -0.929 . . . . 1.8400000000000001 109.728 166.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.03 -13.65 12.65 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.885 2.39 . . . . 2.21 113.247 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.63 179.59 53.04 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 122.748 1.194 . . . . 1.5600000000000001 112.795 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 13.4 m-20 -105.18 -2.49 24.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.866 2.466 . . . . 3.1099999999999999 111.87 -173.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -123.07 159.36 54.47 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.391 2.676 . . . . 3.52 109.866 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.73 151.29 28.19 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.439 2.093 . . . . 1.1499999999999999 112.171 -171.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.8 mt -100.15 155.9 17.49 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 125.278 1.431 . . . . 3.27 110.498 168.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -139.55 120.69 14.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 113.716 -1.584 . . . . 2.8900000000000001 110.289 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.3 116.1 31.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.602 1.961 . . . . 2.8100000000000001 107.951 -171.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.32 -21.79 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.142 0.977 . . . . 1.79 112.819 -166.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.4 -175.72 31.71 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 124.716 1.15 . . . . 0.55000000000000004 113.224 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.61 176.65 9.05 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.525 0.73 . . . . 1.46 112.017 170.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.26 153.5 38.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.525 3.13 . . . . 6.5700000000000003 107.96 176.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -167.93 153.49 6.89 Favored Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 127.122 2.169 . . . . 1.6499999999999999 109.548 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -74.41 -18.54 20.25 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.834 2.356 . . . . 0.91000000000000003 114.246 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 34.6 m -108.72 20.15 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.739 1.385 . . . . 2.1899999999999999 114.739 -172.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.07 150.61 31.97 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.469 1.907 . . . . 1.4199999999999999 107.813 166.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -79.79 -62.4 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.588 0.755 . . . . 3.6299999999999999 109.709 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.85 172.08 7.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.45 1.9 . . . . 6.21 107.452 170.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.57 135.85 9.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 107.347 -1.353 . . . . 2.0 107.347 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -105.97 149.84 26.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.476 1.51 . . . . 3.0299999999999998 109.496 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.3 tp -103.25 120.19 40.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.677 0.791 . . . . 2.0600000000000001 109.62 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -123.65 149.61 45.21 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.239 1.416 . . . . 0.53000000000000003 113.966 -174.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CD ' HH21 ' A' ' 62' ' ' ARG . 16.3 pt-20 -92.36 157.11 16.8 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.466 1.506 . . . . 2.0299999999999998 111.144 162.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.1 m -120.04 146.09 46.22 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 105.736 -1.949 . . . . 2.3799999999999999 105.736 165.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -160.18 -171.87 3.37 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.202 0.91 . . . . 3.3999999999999999 112.796 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.2 mtt -127.78 148.0 50.43 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.25 1.42 . . . . 5.9400000000000004 113.131 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.28 146.86 52.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.882 1.673 . . . . 6.6299999999999999 112.992 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -87.51 140.0 29.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.652 1.181 . . . . 2.4399999999999999 109.103 151.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.4 t -142.82 122.59 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.275 1.83 . . . . 3.1299999999999999 106.974 168.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.527 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 29.5 mt-10 63.76 12.76 6.92 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.155 1.782 . . . . 3.3300000000000001 114.777 -175.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.31 24.23 59.51 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 120.918 -1.114 . . . . 1.5600000000000001 113.174 -167.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.527 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 50.5 mtmt -127.65 137.42 52.52 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.059 2.144 . . . . 3.04 108.296 176.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -98.31 123.98 42.7 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.678 1.191 . . . . 4.1600000000000001 111.92 -166.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.6 t -143.09 139.89 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.51 1.924 . . . . 3.1699999999999999 108.411 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.1 mtm -82.2 168.2 17.9 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.533 0.938 . . . . 4.7000000000000002 113.533 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.77 166.96 26.08 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.635 1.588 . . . . 0.78000000000000003 112.815 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.7 ttm -155.8 144.27 20.18 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.12 1.768 . . . . 1.8300000000000001 108.634 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.415 HH21 ' CD ' ' A' ' 47' ' ' GLU . 32.7 mtm180 -146.36 155.75 49.88 Favored Pre-proline 0 N--CA 1.468 0.458 0 C-N-CA 125.244 1.418 . . . . 5.0199999999999996 109.813 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.85 154.85 38.86 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.663 1.575 . . . . 0.58999999999999997 110.589 164.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.52 155.39 73.72 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 125.503 1.521 . . . . 1.8899999999999999 110.462 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.93 -28.41 3.26 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.738 2.292 . . . . 0.5 112.867 -168.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -176.03 165.97 2.94 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.223 1.409 . . . . 2.9900000000000002 112.294 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.7 153.21 24.61 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.694 1.598 . . . . 1.74 110.284 164.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -110.76 146.45 36.33 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.937 1.295 . . . . 1.72 109.833 174.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.6 t -140.16 131.16 14.15 Favored Pre-proline 0 N--CA 1.477 0.891 0 N-CA-C 114.452 1.278 . . . . 2.52 114.452 168.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.58 160.61 34.83 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.36 3.373 . . . . 1.23 113.124 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.12 145.31 89.14 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.428 3.418 . . . . 1.1299999999999999 113.792 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 69.6 mmtt 67.93 -4.25 1.04 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.077 2.151 . . . . 3.1499999999999999 114.384 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.87 -179.98 47.35 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.694 1.616 . . . . 1.76 113.189 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.66 139.67 21.02 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.146 1.379 . . . . 5.25 109.26 167.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -144.93 146.47 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.739 1.615 . . . . 4.0599999999999996 109.284 -168.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.33 150.97 46.66 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.882 1.068 . . . . 2.6299999999999999 113.882 -173.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -72.5 66.54 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.024 1.73 . . . . 2.0800000000000001 109.435 163.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.27 127.9 84.82 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.578 1.151 . . . . 3.8599999999999999 110.17 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -54.8 -38.61 91.98 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.338 3.359 . . . . 2.4900000000000002 113.916 -166.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.44 -1.08 56.84 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 117.53 -1.706 . . . . 1.8500000000000001 115.338 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -143.56 -23.15 0.17 Allowed Glycine 0 N--CA 1.474 1.199 0 CA-C-N 120.047 1.923 . . . . 2.2799999999999998 117.793 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -149.04 146.64 27.85 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.443 2.121 . . . . 3.7000000000000002 112.425 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -161.87 156.05 22.06 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.267 1.027 . . . . 0.72999999999999998 110.748 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -83.45 145.56 28.89 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.653 -0.499 . . . . 3.4100000000000001 109.653 164.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -103.72 111.03 23.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.521 1.928 . . . . 1.98 108.542 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.65 120.22 29.84 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.485 1.114 . . . . 2.3399999999999999 108.697 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -121.12 144.39 48.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.458 1.123 . . . . 3.0899999999999999 112.881 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.01 38.42 40.66 Favored Glycine 0 N--CA 1.468 0.768 0 CA-C-N 115.163 -0.926 . . . . 1.75 111.867 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.4 mt -45.02 154.36 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 127.213 2.205 . . . . 1.7 116.217 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 55.2 mmtt -116.35 -21.98 9.02 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 113.544 -1.662 . . . . 3.23 114.723 -175.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -136.2 141.23 35.38 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 127.659 2.384 . . . . 8.3399999999999999 108.806 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.16 144.57 23.62 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.982 3.122 . . . . 1.3799999999999999 109.835 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.69 119.35 30.86 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.56 0.744 . . . . 2.9399999999999999 110.369 -172.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -102.51 163.25 12.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.982 0.913 . . . . 4.5300000000000002 111.397 165.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.7 132.98 45.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.794 -0.817 . . . . 1.8500000000000001 108.794 166.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.6 1.09 71.67 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.16 -1.356 . . . . 1.3 115.641 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -75.0 179.87 4.71 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.571 1.686 . . . . 2.73 109.291 162.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -147.42 153.47 39.64 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.195 1.798 . . . . 3.04 108.03 165.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.9 t -142.79 143.3 25.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 127.718 2.407 . . . . 2.04 109.589 -169.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.404 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -100.96 144.96 29.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.977 1.311 . . . . 3.5299999999999998 112.33 176.004 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 mp -130.5 138.72 50.37 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.124 1.77 . . . . 2.7400000000000002 109.861 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.409 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 28.5 m-20 -93.62 130.45 39.53 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.826 1.65 . . . . 2.3300000000000001 109.47 156.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.76 140.4 29.7 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.462 1.505 . . . . 2.1299999999999999 108.93 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.3 mt -111.75 131.3 55.41 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.506 1.522 . . . . 1.6200000000000001 110.547 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -126.7 153.22 45.73 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.499 0.72 . . . . 4.04 112.675 -167.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.34 134.26 55.48 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.987 0.899 . . . . 2.52 112.036 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.68 42.93 45.24 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.667 -1.074 . . . . 4.1399999999999997 113.703 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.65 46.2 6.48 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 116.235 1.254 . . . . 1.99 116.235 161.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -128.99 154.74 46.31 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.098 1.449 . . . . 4.3799999999999999 112.182 167.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.5 t -143.69 144.71 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.593 1.957 . . . . 3.1099999999999999 107.034 171.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 tt -152.19 127.08 9.63 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.644 0.778 . . . . 3.5899999999999999 110.803 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.409 ' HE3' ' OD1' ' A' ' 102' ' ' ASP . 2.7 ttmt -93.89 134.57 36.13 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.172 0.804 . . . . 3.7599999999999998 113.172 -177.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.62 153.2 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.026 1.33 . . . . 2.8999999999999999 108.272 162.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 t -128.81 139.79 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.886 1.275 . . . . 3.0899999999999999 107.611 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.17 142.23 15.18 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 113.152 0.797 . . . . 3.4700000000000002 113.152 -165.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.84 170.39 14.21 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.282 3.321 . . . . 1.0900000000000001 112.863 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.34 145.74 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.982 1.313 . . . . 1.99 110.632 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 125.015 1.326 . . . . 4.7300000000000004 112.805 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 . . . . . 0 CA--C 1.545 0.787 0 CA-C-O 121.078 0.466 . . . . 4.9400000000000004 110.54 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.16 159.95 15.39 Favored Glycine 0 N--CA 1.469 0.844 0 O-C-N 120.907 -1.121 . . . . 1.1799999999999999 111.575 175.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.2 p90 -156.66 157.55 35.4 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.947 0.899 . . . . 2.8599999999999999 112.187 166.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.45 145.47 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.589 1.156 . . . . 2.1000000000000001 108.446 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -69.75 -159.76 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.266 1.026 . . . . 6.4400000000000004 110.668 164.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -128.63 150.61 50.15 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.328 1.451 . . . . 4.0499999999999998 110.684 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -170.72 145.22 2.03 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.958 1.703 . . . . 2.9300000000000002 109.294 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.03 -22.06 15.15 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.98 2.453 . . . . 2.23 112.683 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.09 173.21 13.26 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 126.158 1.837 . . . . 1.1499999999999999 111.745 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.98 -0.49 39.01 Favored 'Cis proline' 0 CA--C 1.541 0.834 0 CA-C-N 119.122 1.461 . . . . 1.27 113.474 0.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -147.52 162.42 39.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.317 1.047 . . . . 2.4199999999999999 113.62 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.27 -179.05 5.33 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 129.606 3.163 . . . . 1.5700000000000001 109.634 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.81 146.78 49.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.399 1.48 . . . . 1.79 108.728 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.23 148.67 45.01 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.327 1.051 . . . . 1.78 112.333 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -115.66 136.17 53.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.932 2.093 . . . . 3.6200000000000001 111.197 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.93 145.65 43.48 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.757 0.823 . . . . 4.0599999999999996 110.807 173.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.0 m -124.96 113.65 18.1 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.827 0.851 . . . . 2.4100000000000001 109.983 166.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.28 174.12 7.92 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.666 1.986 . . . . 6.3399999999999999 107.72 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' CD ' HH11 ' A' ' 74' ' ' ARG . 46.0 mt-10 -145.21 155.91 43.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.557 -1.275 . . . . 5.5499999999999998 107.557 173.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -101.16 100.26 12.86 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.167 0.587 . . . . 1.6100000000000001 111.036 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.81 -15.39 13.43 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.177 1.918 . . . . 2.52 113.514 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.98 -178.07 52.22 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 119.137 0.88 . . . . 1.48 112.471 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.425 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 16.0 m-20 -114.86 3.27 14.56 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.43 1.892 . . . . 4.0 112.232 -167.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -106.36 154.01 40.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 127.096 2.158 . . . . 4.2300000000000004 110.254 166.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.21 147.08 20.38 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.869 2.379 . . . . 1.3500000000000001 110.877 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.7 mt -99.35 138.73 36.04 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 123.633 1.682 . . . . 3.4500000000000002 111.003 170.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.478 ' HE ' ' CD ' ' A' ' 68' ' ' GLU . 14.6 tpp85 -134.68 105.85 6.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 111.716 -2.493 . . . . 2.7999999999999998 108.248 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.74 105.41 17.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.128 1.371 . . . . 3.2799999999999998 108.6 -171.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -101.78 -22.67 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.617 0.767 . . . . 1.6200000000000001 112.235 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.24 -177.07 30.99 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.199 1.381 . . . . 0.40999999999999998 112.553 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.0 -176.58 4.55 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.573 1.549 . . . . 1.4399999999999999 109.277 166.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.41 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -157.16 166.44 33.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.669 1.587 . . . . 5.0099999999999998 108.118 177.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 t -177.77 153.93 0.98 Allowed Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.865 1.266 . . . . 1.9299999999999999 110.382 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.31 -0.28 9.82 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.271 2.647 . . . . 1.05 114.763 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.7 m -116.78 26.96 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 115.508 1.67 . . . . 1.8700000000000001 115.508 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.75 157.44 33.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.277 1.431 . . . . 1.55 110.503 167.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.4 -26.99 41.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.021 1.728 . . . . 2.8900000000000001 112.087 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -155.56 149.35 25.31 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 127.498 2.319 . . . . 6.8600000000000003 108.621 -156.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.7 p -161.4 59.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 123.79 1.757 . . . . 2.5800000000000001 113.028 -158.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -91.4 134.86 34.26 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.096 -1.865 . . . . 5.46 112.236 -167.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.3 tp -83.06 122.9 28.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.496 1.518 . . . . 1.96 112.159 -167.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -121.91 150.29 42.19 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.843 1.657 . . . . 0.56999999999999995 112.415 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -88.93 173.57 8.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.113 0.965 . . . . 2.02 111.067 162.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.7 m -139.99 129.99 24.86 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.589 -1.634 . . . . 2.1800000000000002 106.589 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -134.79 173.31 11.83 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.417 1.103 . . . . 3.6200000000000001 112.951 -165.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.8 ttp -120.43 141.74 49.87 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.97 1.308 . . . . 4.1600000000000001 111.004 165.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -135.44 157.29 47.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.212 1.405 . . . . 6.3399999999999999 111.55 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -97.1 144.13 27.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.312 1.445 . . . . 2.3700000000000001 109.962 165.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 m -142.68 130.55 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.574 1.549 . . . . 4.0099999999999998 108.584 163.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 62.21 11.2 4.26 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.599 2.074 . . . . 3.54 116.599 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.9 25.68 40.4 Favored Glycine 0 CA--C 1.539 1.533 0 O-C-N 120.909 -1.119 . . . . 1.74 113.537 -165.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -127.15 120.17 28.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.052 1.741 . . . . 3.1099999999999999 109.453 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.34 118.98 28.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.57 0.748 . . . . 8.4000000000000004 110.619 -175.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.52 139.85 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.024 1.73 . . . . 3.4300000000000002 109.5 -172.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 58.0 mtm -83.71 167.47 17.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.885 1.069 . . . . 4.1900000000000004 113.885 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.5 -176.49 30.61 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.028 1.299 . . . . 0.91000000000000003 113.3 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ttm -155.85 150.06 25.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.783 2.033 . . . . 2.25 107.65 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.96 158.49 30.17 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 124.495 1.118 . . . . 5.6399999999999997 110.509 174.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.44 154.94 40.82 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.152 1.901 . . . . 0.57999999999999996 111.907 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -143.08 152.61 58.71 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.419 1.487 . . . . 1.6499999999999999 109.808 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -84.13 -23.44 3.0 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.187 2.592 . . . . 0.73999999999999999 113.547 -165.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.43 ' CD1' ' HD2' ' A' ' 31' ' ' ARG . 54.0 p90 -177.14 166.93 2.41 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.593 1.957 . . . . 3.25 110.678 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.2 mt -110.66 154.31 24.01 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.457 1.103 . . . . 1.5800000000000001 110.059 164.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.478 ' CD ' ' HE ' ' A' ' 31' ' ' ARG . 3.9 tp10 -127.06 138.09 53.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.126 1.37 . . . . 1.74 109.612 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 t -143.48 136.79 14.02 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.998 0.919 . . . . 2.6600000000000001 110.654 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.99 170.4 15.74 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.776 2.318 . . . . 1.48 112.334 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.56 143.96 97.69 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.969 2.446 . . . . 1.6499999999999999 110.783 161.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.425 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 33.6 mmtm 67.47 0.13 2.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.403 1.481 . . . . 3.5899999999999999 114.157 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.56 162.77 41.89 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.753 1.644 . . . . 1.8999999999999999 113.635 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.447 HH11 ' CD ' ' A' ' 23' ' ' GLU . 59.5 mtt-85 -91.48 129.42 37.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.563 0.745 . . . . 6.2599999999999998 111.412 176.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -103.24 61.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.764 2.025 . . . . 6.5899999999999999 109.478 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.76 127.26 56.1 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.229 1.411 . . . . 3.1899999999999999 109.755 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mp -70.98 -38.59 72.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.604 1.562 . . . . 3.2000000000000002 114.003 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptt 91.13 138.07 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 129.416 3.086 . . . . 4.21 109.93 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.7 11.74 0.47 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.589 2.86 . . . . 2.8500000000000001 114.731 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.61 17.27 0.09 OUTLIER Glycine 0 CA--C 1.535 1.32 0 CA-C-O 116.621 -2.211 . . . . 2.1000000000000001 116.42 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.27 -29.31 0.45 Allowed Glycine 0 N--CA 1.487 2.044 0 CA-C-N 121.233 2.516 . . . . 2.1000000000000001 117.626 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.06 146.89 43.51 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.249 2.025 . . . . 3.5899999999999999 111.197 163.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -158.46 149.02 20.19 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.572 0.582 . . . . 0.75 112.572 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -79.96 131.8 35.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.345 -0.613 . . . . 3.1899999999999999 109.345 161.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -91.81 103.42 15.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.038 1.735 . . . . 1.6399999999999999 108.459 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -85.73 116.88 24.26 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.659 -1.238 . . . . 2.1600000000000001 107.659 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 tt -130.19 134.85 47.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.562 1.145 . . . . 4.3300000000000001 111.165 -162.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.53 48.69 7.83 Favored Glycine 0 N--CA 1.473 1.11 0 O-C-N 121.751 -0.593 . . . . 1.8500000000000001 111.969 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -48.26 154.34 0.61 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 126.253 1.821 . . . . 1.8100000000000001 114.99 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -119.34 -29.95 5.03 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.681 -1.6 . . . . 2.46 114.585 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -107.38 147.5 35.37 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.902 1.681 . . . . 6.7000000000000002 109.552 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.39 162.68 37.84 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.66 2.24 . . . . 3.04 109.132 157.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.8 155.87 35.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.48 1.512 . . . . 3.7599999999999998 109.759 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 24.24 1.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.326 1.973 . . . . 4.9699999999999998 116.326 -174.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 66.87 164.76 0.2 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.12 2.168 . . . . 2.3900000000000001 110.943 -161.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.04 -5.99 30.02 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.947 -0.918 . . . . 1.3400000000000001 114.676 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -76.99 166.06 23.83 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.422 1.089 . . . . 2.9100000000000001 110.099 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -118.14 126.19 51.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 129.146 2.978 . . . . 3.8500000000000001 104.625 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.7 t -126.2 140.6 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.66 1.184 . . . . 2.3700000000000001 110.065 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -106.83 134.69 49.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.42 1.088 . . . . 3.7599999999999998 112.786 -170.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.5 133.57 43.96 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.25 1.42 . . . . 3.0099999999999998 111.887 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.41 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 27.4 m-20 -77.84 136.45 38.08 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.777 2.031 . . . . 1.8300000000000001 108.61 159.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.99 126.86 50.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.338 1.055 . . . . 1.9299999999999999 108.785 165.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.0 mt -104.19 106.54 17.08 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.353 1.061 . . . . 2.02 110.069 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -105.8 151.81 24.02 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.612 1.565 . . . . 3.3799999999999999 112.35 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.83 131.39 46.79 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.87 1.063 . . . . 2.79 113.87 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 58.13 3.13 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.924 1.25 . . . . 3.8700000000000001 113.347 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.37 11.09 79.72 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 124.421 1.01 . . . . 2.1899999999999999 115.609 169.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -93.49 113.1 25.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.917 1.359 . . . . 3.7400000000000002 111.217 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.68 136.12 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.936 1.294 . . . . 3.0 109.887 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.1 tt -143.12 112.61 6.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.471 0.708 . . . . 4.0300000000000002 111.544 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -87.73 98.35 11.4 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.961 0.726 . . . . 4.6799999999999997 112.961 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.9 t -80.01 172.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 126.444 1.898 . . . . 3.4500000000000002 110.869 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.34 143.01 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.057 2.143 . . . . 3.8399999999999999 108.378 166.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.48 144.55 15.01 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.883 1.673 . . . . 3.27 111.677 -167.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.95 155.5 26.44 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.179 2.586 . . . . 1.0800000000000001 113.705 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.1 t -93.93 121.7 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.44 1.496 . . . . 2.0600000000000001 109.472 173.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 126.317 1.847 . . . . 4.1299999999999999 110.582 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 CA--C 1.542 0.652 0 CA-C-O 121.584 0.707 . . . . 4.5999999999999996 111.59 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.49 168.75 33.77 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.02 -1.05 . . . . 1.23 114.296 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -152.16 172.6 16.12 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.254 1.022 . . . . 2.5499999999999998 112.945 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 t -109.36 138.85 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.098 -1.001 . . . . 2.1499999999999999 109.03 172.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -51.68 -81.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.965 1.306 . . . . 5.75 113.093 -173.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.1 t80 158.22 153.0 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 130.118 3.367 . . . . 4.4199999999999999 107.282 -157.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.0 t 150.22 128.8 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 129.34 3.056 . . . . 2.6499999999999999 110.879 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.88 -35.85 14.62 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.855 1.703 . . . . 1.52 111.793 173.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.25 173.13 21.52 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.483 1.992 . . . . 0.97999999999999998 112.035 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.75 5.16 56.05 Favored 'Cis proline' 0 CA--C 1.541 0.865 0 CA-C-N 119.33 1.565 . . . . 1.24 113.654 3.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -154.68 160.24 41.25 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.412 1.085 . . . . 2.04 113.673 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.87 -177.44 5.33 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.935 2.094 . . . . 1.6000000000000001 111.623 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.27 147.92 28.24 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.791 1.236 . . . . 1.8500000000000001 110.756 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.03 145.52 48.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.092 1.757 . . . . 1.74 111.539 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 83' ' ' HIS . 96.2 m-85 -144.19 121.52 11.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.884 2.073 . . . . 4.0300000000000002 109.961 -164.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -166.0 148.59 7.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.442 -1.411 . . . . 3.3100000000000001 114.318 -155.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.5 m -81.99 135.17 35.39 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.759 0.79 . . . . 2.8799999999999999 110.434 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.51 137.0 47.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.881 2.072 . . . . 4.25 108.791 170.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -114.67 166.41 11.76 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.129 0.572 . . . . 4.29 111.64 166.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -119.97 111.71 35.46 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 123.031 0.532 . . . . 1.48 110.246 164.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.21 -15.62 10.12 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.759 2.306 . . . . 1.3799999999999999 113.919 175.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.23 -175.27 49.76 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.496 1.046 . . . . 1.3 113.149 -173.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.91 -10.12 27.07 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.066 1.747 . . . . 3.3500000000000001 111.613 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -130.45 161.24 61.8 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 127.572 2.349 . . . . 4.9900000000000002 108.913 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.65 155.94 49.35 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.65 2.233 . . . . 1.6100000000000001 111.541 -170.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.9 mt -110.55 152.22 26.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 125.103 1.361 . . . . 2.79 110.429 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -128.5 105.07 8.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.507 -1.679 . . . . 2.8199999999999998 111.264 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.54 104.57 16.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.133 1.373 . . . . 2.98 108.118 -172.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.4 m -98.21 -28.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.401 0.681 . . . . 1.8400000000000001 112.182 -166.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.93 -178.61 33.1 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.521 1.534 . . . . 0.55000000000000004 111.336 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.24 -178.48 4.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.868 0.867 . . . . 2.0099999999999998 109.375 161.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -144.75 169.73 17.46 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 129.539 3.136 . . . . 6.7699999999999996 106.348 165.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -172.35 149.74 2.15 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 126.938 2.095 . . . . 1.6799999999999999 108.006 -172.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -71.51 -30.9 14.48 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.065 1.177 . . . . 1.01 112.478 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -89.16 19.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 115.856 1.799 . . . . 1.8100000000000001 115.856 -168.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.99 154.0 34.07 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.718 1.007 . . . . 1.55 113.718 174.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -79.98 -65.17 1.04 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.611 1.564 . . . . 3.1000000000000001 109.819 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.3 mtp-105 -110.71 107.96 17.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.655 0.74 . . . . 7.4199999999999999 110.683 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -77.58 146.9 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 126.054 1.741 . . . . 2.2799999999999998 108.689 162.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -155.5 146.62 22.57 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.852 1.261 . . . . 2.6400000000000001 109.417 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.0 tp -105.83 120.27 41.28 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.358 0.981 . . . . 1.97 111.099 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -127.79 159.56 34.46 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.929 1.347 . . . . 0.83999999999999997 113.981 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.86 161.32 14.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.909 2.084 . . . . 2.1000000000000001 112.351 159.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.9 m -137.23 145.68 43.91 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.985 2.114 . . . . 2.3599999999999999 107.089 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.81 165.61 36.0 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.762 1.267 . . . . 3.4700000000000002 114.24 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.62 146.88 24.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.718 1.207 . . . . 6.96 111.278 166.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.13 161.85 42.0 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.588 1.555 . . . . 6.25 110.061 -171.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -112.79 142.36 45.52 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.347 1.059 . . . . 2.4300000000000002 112.296 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.8 t -136.28 115.96 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.264 1.425 . . . . 3.3300000000000001 108.433 164.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 66.37 7.48 4.99 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 127.291 2.236 . . . . 3.29 115.211 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.18 7.59 59.41 Favored Glycine 0 CA--C 1.54 1.624 0 O-C-N 121.123 -0.986 . . . . 1.6699999999999999 114.189 -165.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -109.09 129.43 55.47 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 127.416 2.286 . . . . 3.5800000000000001 108.292 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -79.7 120.54 24.15 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.938 -1.483 . . . . 3.4700000000000002 109.251 -166.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.2 t -134.38 131.52 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.231 1.812 . . . . 3.4900000000000002 108.846 -173.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.1 mtt -83.35 165.3 19.4 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.506 -0.746 . . . . 3.5499999999999998 112.632 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.24 173.88 32.73 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 124.25 0.929 . . . . 0.82999999999999996 112.943 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.5 ttm -157.09 137.39 12.86 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.889 1.676 . . . . 2.1000000000000001 109.395 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -143.01 149.28 48.63 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 125.529 1.532 . . . . 10.44 110.643 -174.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.63 153.18 43.58 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.066 1.844 . . . . 0.62 109.962 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.07 156.0 77.26 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.735 1.214 . . . . 1.8700000000000001 110.111 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.72 -27.82 2.44 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.851 2.367 . . . . 0.64000000000000001 113.242 -169.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -177.84 165.94 2.05 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.344 1.858 . . . . 3.6899999999999999 111.297 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.7 mt -110.7 155.85 21.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.031 1.332 . . . . 1.6699999999999999 109.884 163.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -113.24 146.77 38.77 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.725 1.21 . . . . 2.0800000000000001 109.105 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.88 128.0 14.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 113.647 0.98 . . . . 2.0699999999999998 113.647 168.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.59 156.57 28.26 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.332 3.355 . . . . 1.4299999999999999 113.05 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.11 141.89 78.34 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.758 3.639 . . . . 1.4199999999999999 114.005 -172.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 71.39 -15.95 0.4 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 129.122 2.969 . . . . 2.3599999999999999 114.161 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.83 -177.12 50.21 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.597 1.57 . . . . 1.71 113.561 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -146.72 150.7 35.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.086 0.954 . . . . 5.4900000000000002 111.389 163.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -149.67 139.44 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.965 2.106 . . . . 4.6299999999999999 107.079 -175.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.1 147.43 34.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.304 1.049 . . . . 3.5600000000000001 113.499 -174.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.07 74.94 0.49 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.668 1.587 . . . . 2.1400000000000001 107.438 157.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 142.48 78.91 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.625 1.17 . . . . 3.0899999999999999 114.08 -170.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.455 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 29.8 Cg_endo -58.86 -10.41 9.64 Favored 'Trans proline' 0 C--N 1.357 1.014 1 C-N-CA 125.606 4.204 . . . . 2.7400000000000002 117.736 -170.049 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.88 2.45 22.93 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.728 1.156 . . . . 2.7599999999999998 115.43 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.84 -112.07 1.46 Allowed Glycine 0 N--CA 1.472 1.084 0 CA-C-N 119.148 1.474 . . . . 1.97 113.136 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -72.5 143.09 48.5 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.988 -0.713 . . . . 3.1200000000000001 111.662 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.469 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 51.4 p-80 -160.39 157.17 27.35 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.568 1.147 . . . . 0.77000000000000002 111.843 -174.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.2 135.33 35.74 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.834 -0.802 . . . . 3.8199999999999998 108.834 155.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.1 126.09 47.77 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.272 2.229 . . . . 1.6799999999999999 108.444 169.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.14 113.09 23.53 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.16 0.984 . . . . 4.0199999999999996 109.847 -176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.07 152.13 19.63 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.082 1.753 . . . . 3.0899999999999999 110.63 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.94 -50.65 4.44 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 127.799 2.619 . . . . 3.0299999999999998 113.551 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.1 mt 57.94 169.09 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.864 2.865 . . . . 2.23 115.675 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -128.48 -23.8 3.15 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.518 2.327 . . . . 2.6600000000000001 114.256 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 97' ' ' GLU . 26.0 mmm180 -130.61 150.76 77.26 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.512 2.325 . . . . 6.3300000000000001 109.903 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.21 123.94 8.13 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.585 2.19 . . . . 2.1000000000000001 108.538 163.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.04 113.47 17.19 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.186 0.994 . . . . 3.4700000000000002 108.609 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.86 166.01 26.48 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.371 1.469 . . . . 4.4299999999999997 111.055 172.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.11 123.61 16.54 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.011 0.924 . . . . 2.6000000000000001 110.98 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.93 25.86 59.32 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.678 -0.692 . . . . 2.6400000000000001 113.82 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 91' ' ' ARG . 16.2 mm-40 -86.69 172.71 9.99 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.893 1.347 . . . . 2.96 108.757 133.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -144.37 158.56 43.68 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.045 2.938 . . . . 3.1299999999999999 105.257 171.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.7 t -150.56 146.59 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.385 1.874 . . . . 2.5899999999999999 110.112 -169.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.522 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 38.0 mt-10 -95.83 138.01 34.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.234 0.614 . . . . 2.6400000000000001 110.442 165.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.36 137.43 52.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.734 0.778 . . . . 2.52 110.262 159.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.62 113.17 26.58 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 128.316 2.646 . . . . 2.5600000000000001 108.92 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -94.75 132.9 39.01 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.513 -1.367 . . . . 2.1299999999999999 111.339 -168.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.9 mt -104.65 106.24 16.66 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.392 1.477 . . . . 1.76 109.994 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.0 115.27 30.14 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.76 1.224 . . . . 3.6899999999999999 110.76 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.11 23.74 2.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.863 2.065 . . . . 2.8199999999999998 113.845 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.0 -56.73 4.33 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.328 1.442 . . . . 4.4500000000000002 112.914 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.15 -6.68 69.48 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 117.054 1.582 . . . . 1.5700000000000001 117.054 -165.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -128.38 121.51 29.26 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.485 1.643 . . . . 5.4699999999999998 113.015 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -102.35 136.3 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.157 1.383 . . . . 3.0600000000000001 109.429 166.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.9 tp -155.39 128.19 8.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.011 1.325 . . . . 4.0999999999999996 109.688 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.522 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 52.0 pttt -109.23 160.87 15.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.374 1.62 . . . . 3.0800000000000001 115.374 -174.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -140.07 161.6 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 126.838 2.055 . . . . 2.8900000000000001 109.439 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.5 t -106.89 142.18 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.53 1.532 . . . . 2.71 109.152 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -144.41 128.5 9.03 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.004 1.722 . . . . 4.0199999999999996 110.2 -171.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.53 164.92 32.83 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.07 2.514 . . . . 1.27 111.921 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.1 t -109.91 151.76 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.183 0.593 . . . . 1.8799999999999999 110.782 171.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 CA--C 1.547 0.847 0 C-N-CA 126.756 2.022 . . . . 4.1600000000000001 112.54 -169.474 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 106.369 -1.715 . . . . 4.79 106.369 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.2 -178.17 32.96 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.637 1.589 . . . . 1.52 113.426 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -156.18 157.71 36.38 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.422 1.889 . . . . 2.9199999999999999 112.345 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.9 132.7 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.283 1.433 . . . . 2.9399999999999999 108.481 169.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.466 ' HG2' ' H ' ' A' ' 10' ' ' PHE . 12.1 ttt180 -67.93 162.13 24.96 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.996 0.903 . . . . 5.1100000000000003 112.445 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.466 ' H ' ' HG2' ' A' ' 9' ' ' ARG . 49.0 t80 -98.65 130.12 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.22 -1.4 . . . . 3.29 107.22 171.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -167.73 147.43 4.38 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 127.057 2.143 . . . . 3.3100000000000001 107.083 174.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.99 -22.91 9.69 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.929 2.419 . . . . 2.0800000000000001 113.218 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.25 173.63 13.47 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 126.462 1.982 . . . . 1.6200000000000001 110.354 -166.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -70.67 -9.14 12.66 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 CA-C-N 119.681 1.741 . . . . 2.3999999999999999 112.412 -4.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -137.62 161.35 36.69 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.625 1.343 . . . . 2.79 114.625 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.93 -173.87 3.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 131.654 3.981 . . . . 1.6599999999999999 107.492 174.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.9 166.75 23.27 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.635 -1.291 . . . . 2.27 110.676 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.04 148.51 32.76 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 122.109 0.957 . . . . 1.78 111.929 171.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -145.15 129.83 18.08 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.873 2.069 . . . . 3.9199999999999999 107.919 -165.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.11 150.79 9.68 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.571 1.078 . . . . 3.52 113.892 -174.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.2 m -79.87 112.73 17.44 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.62 1.568 . . . . 2.77 110.74 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.77 127.69 36.01 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.214 1.005 . . . . 3.5800000000000001 108.571 169.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -116.63 134.42 54.85 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.905 1.282 . . . . 4.3700000000000001 108.801 168.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -99.46 117.68 63.45 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.506 1.122 . . . . 1.3700000000000001 109.882 173.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -88.4 -8.9 5.25 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.252 2.635 . . . . 1.52 114.825 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.34 160.06 26.64 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 119.789 1.177 . . . . 1.4099999999999999 111.928 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.09 3.05 21.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.947 2.499 . . . . 3.75 112.127 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -123.87 152.12 65.75 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 128.333 2.653 . . . . 3.6899999999999999 109.248 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.74 146.35 23.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.125 2.55 . . . . 1.3100000000000001 111.205 -171.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.4 mt -98.88 145.28 27.15 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.428 1.109 . . . . 2.7799999999999998 111.481 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HD2' ' CD2' ' A' ' 66' ' ' PHE . 5.1 tpp180 -130.45 104.91 7.52 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.271 -1.786 . . . . 3.2799999999999998 109.796 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -98.17 115.01 27.43 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.234 2.214 . . . . 3.2400000000000002 108.991 -169.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.98 -28.34 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.208 0.913 . . . . 2.2599999999999998 112.363 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.01 -175.09 30.6 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 115.26 0.864 . . . . 0.41999999999999998 115.26 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.42 -176.85 4.78 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.977 1.711 . . . . 1.48 112.049 171.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttt-85 -159.56 153.39 23.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.871 2.069 . . . . 6.1399999999999997 108.149 172.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -163.55 150.9 10.73 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-N 120.109 1.322 . . . . 1.8 110.473 -170.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.29 -15.29 11.47 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.818 2.345 . . . . 1.1399999999999999 115.135 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -105.45 26.68 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.158 1.383 . . . . 2.3900000000000001 113.634 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.38 174.03 10.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.242 1.417 . . . . 1.6899999999999999 109.215 162.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -99.91 -48.44 4.67 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.966 1.706 . . . . 3.96 109.505 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -126.15 171.61 10.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.883 2.473 . . . . 6.0800000000000001 107.596 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.8 p -154.78 142.75 12.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 125.596 1.558 . . . . 2.2599999999999998 108.532 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -115.59 158.11 23.15 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.67 1.588 . . . . 3.48 109.524 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -111.22 117.01 32.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.076 1.35 . . . . 1.8799999999999999 109.099 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -120.14 149.86 41.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.206 1.402 . . . . 0.68000000000000005 114.223 -174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 62' ' ' ARG . 14.4 pt-20 -93.3 161.12 14.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.265 1.826 . . . . 2.4199999999999999 111.134 160.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.6 m -129.4 146.14 51.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.52 1.928 . . . . 2.2599999999999998 106.301 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -160.15 -179.05 7.41 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.727 1.01 . . . . 3.5800000000000001 113.727 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.7 mtm -116.46 148.28 40.91 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.792 1.637 . . . . 5.25 111.882 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.62 154.34 45.34 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.444 1.497 . . . . 8.1199999999999992 111.977 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.49 ' CD ' ' HZ1' ' A' ' 57' ' ' LYS . 2.2 tp10 -91.54 137.43 32.37 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.738 -1.208 . . . . 3.1200000000000001 107.738 148.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -144.03 139.7 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.491 -1.67 . . . . 3.6400000000000001 106.491 160.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 64.18 19.92 11.97 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.141 1.376 . . . . 4.5700000000000003 113.931 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.76 17.12 72.88 Favored Glycine 0 CA--C 1.538 1.5 0 O-C-N 120.354 -1.466 . . . . 2.2599999999999998 113.354 -169.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -122.01 135.18 54.82 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.039 2.535 . . . . 3.6600000000000001 109.526 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.49 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 2.2 mmtt -74.49 118.7 17.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.861 2.064 . . . . 4.7199999999999998 108.564 -176.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.44 -179.55 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.74 2.016 . . . . 3.7799999999999998 110.673 -174.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.97 174.31 6.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.507 1.123 . . . . 3.9100000000000001 111.955 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.73 173.54 33.79 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.862 1.22 . . . . 0.89000000000000001 112.922 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -157.7 146.06 19.14 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.436 1.894 . . . . 1.97 107.841 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.418 HH21 ' CD ' ' A' ' 47' ' ' GLU . 34.5 mtm180 -150.39 157.74 36.58 Favored Pre-proline 0 N--CA 1.468 0.458 0 C-N-CA 125.255 1.422 . . . . 5.0499999999999998 109.6 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.82 153.87 43.01 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.724 1.616 . . . . 0.56999999999999995 111.07 164.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.5 m -134.6 152.18 77.29 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.531 1.532 . . . . 1.76 110.966 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -81.76 -21.61 5.87 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.301 2.667 . . . . 0.64000000000000001 113.208 -169.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.498 ' CD2' ' HD2' ' A' ' 31' ' ' ARG . 47.3 p90 -175.87 164.05 2.85 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.206 1.402 . . . . 3.5099999999999998 112.07 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.3 mt -109.98 156.64 20.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.877 1.671 . . . . 1.71 110.145 163.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -114.35 146.6 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.182 0.593 . . . . 2.75 109.797 163.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.71 126.77 26.0 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.408 1.483 . . . . 2.5600000000000001 109.219 164.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -67.56 165.63 26.69 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.441 2.761 . . . . 1.6299999999999999 110.687 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.33 138.31 55.04 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.016 2.477 . . . . 1.3600000000000001 113.411 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.282 14.4 mtmt 60.14 29.75 19.28 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.684 1.594 . . . . 3.79 114.89 168.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.77 -179.85 18.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.727 2.584 . . . . 1.5900000000000001 113.816 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.24 156.74 22.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.751 0.82 . . . . 5.1900000000000004 112.963 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.5 t -148.65 117.06 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.093 1.757 . . . . 4.0899999999999999 107.797 163.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.19 158.3 23.64 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.346 0.869 . . . . 2.8799999999999999 113.346 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -80.8 62.39 4.81 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.671 1.224 . . . . 2.04 109.704 151.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.433 ' H ' ' CD ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -56.54 126.69 70.8 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-O 118.066 -0.969 . . . . 4.4400000000000004 111.152 171.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -56.96 -39.17 93.43 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.256 3.304 . . . . 2.5499999999999998 114.018 -167.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.11 -3.21 51.52 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.025 -1.431 . . . . 1.96 115.051 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.59 -24.32 0.22 Allowed Glycine 0 N--CA 1.473 1.131 0 N-CA-C 118.155 2.022 . . . . 2.4100000000000001 118.155 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -148.89 143.47 26.26 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 120.67 2.235 . . . . 3.7599999999999998 112.796 175.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -160.48 154.61 23.13 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.745 1.218 . . . . 0.90000000000000002 110.961 174.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -77.8 150.06 34.34 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.673 -0.862 . . . . 3.8599999999999999 108.673 161.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 tpt -106.71 115.18 29.75 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.34 1.856 . . . . 2.3100000000000001 106.783 166.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.58 120.68 37.35 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.402 1.081 . . . . 2.4199999999999999 108.741 -174.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.7 mp -116.82 138.15 51.7 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.008 0.923 . . . . 2.9300000000000002 112.611 -167.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.16 49.58 8.36 Favored Glycine 0 N--CA 1.473 1.158 0 O-C-N 121.928 -0.482 . . . . 1.5600000000000001 112.023 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -48.61 154.99 0.6 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 126.969 2.108 . . . . 1.9399999999999999 115.318 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -118.13 -31.38 5.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 113.511 -1.677 . . . . 3.3599999999999999 113.759 -173.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 -118.99 134.5 23.62 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 125.505 1.522 . . . . 6.4000000000000004 107.69 170.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -69.99 113.52 3.44 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 N-CA-C 107.144 -1.906 . . . . 1.75 107.144 163.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.61 153.72 12.71 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.969 1.308 . . . . 3.0 113.262 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -131.49 147.05 52.51 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 123.512 1.625 . . . . 5.8899999999999997 113.592 163.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.96 112.51 10.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.602 -1.636 . . . . 2.0699999999999998 110.237 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.67 -0.55 20.09 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 117.97 -1.461 . . . . 1.6399999999999999 115.376 -173.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -86.51 -176.32 5.8 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.48 1.64 . . . . 2.3900000000000001 110.372 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -142.76 146.15 33.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.641 2.376 . . . . 4.3399999999999999 108.084 171.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -145.22 142.15 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.64 1.576 . . . . 2.71 111.56 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -88.85 164.39 15.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.664 1.357 . . . . 2.5099999999999998 114.664 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 tt -154.97 134.1 12.36 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.347 1.459 . . . . 3.77 110.872 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.37 153.34 29.83 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 127.479 2.312 . . . . 1.97 110.503 169.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.18 124.98 35.99 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.708 2.003 . . . . 2.1400000000000001 108.989 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.8 mt -106.21 116.32 31.74 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.725 1.21 . . . . 1.8700000000000001 109.754 -170.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -112.14 130.31 55.94 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.772 1.229 . . . . 3.4100000000000001 111.394 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.07 -19.13 62.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.982 1.313 . . . . 3.2200000000000002 113.367 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.64 32.63 1.01 Allowed Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.728 1.156 . . . . 4.8499999999999996 114.272 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.7 35.35 85.55 Favored Glycine 0 N--CA 1.471 1.003 0 C-N-CA 125.619 1.581 . . . . 2.71 114.342 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -142.06 145.39 34.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.942 1.371 . . . . 3.8199999999999998 114.026 -167.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -127.32 146.87 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.513 1.925 . . . . 3.48 109.326 167.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -156.7 147.78 22.05 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.045 2.138 . . . . 3.4900000000000002 107.932 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -122.73 155.91 35.5 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.591 1.541 . . . . 3.0099999999999998 114.044 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.404 ' CG1' ' H ' ' A' ' 114' ' ' VAL . 55.8 t -130.52 173.24 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.373 2.269 . . . . 2.9100000000000001 108.886 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.404 ' H ' ' CG1' ' A' ' 113' ' ' VAL . 13.5 p -136.1 136.81 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.443 1.497 . . . . 3.2799999999999998 110.618 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 mt -137.89 136.76 20.18 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.303 1.441 . . . . 3.2000000000000002 111.127 -166.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.94 159.39 53.13 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.625 2.883 . . . . 0.97999999999999998 112.128 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.7 t -103.76 131.12 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.747 1.219 . . . . 2.71 109.761 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 CA--C 1.541 0.629 0 C-N-CA 126.227 1.811 . . . . 4.0599999999999996 110.838 -179.582 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 123.545 1.64 . . . . 4.4800000000000004 112.528 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.32 -178.66 15.72 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.188 1.851 . . . . 1.3999999999999999 111.935 175.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -148.95 149.0 30.45 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.071 1.138 . . . . 2.5899999999999999 114.071 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -79.08 133.39 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 106.64 -1.615 . . . . 2.2799999999999998 106.64 163.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -68.05 -18.64 64.74 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.575 1.695 . . . . 5.1200000000000001 115.575 -158.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.4 t80 76.67 151.32 0.12 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.746 2.418 . . . . 4.0199999999999996 112.534 -174.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 t 174.88 161.31 0.38 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 129.667 3.187 . . . . 2.5499999999999998 108.639 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.63 -24.94 5.8 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.809 2.339 . . . . 1.4299999999999999 112.761 159.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.47 -178.43 17.02 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.265 1.888 . . . . 1.0 112.447 -169.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.26 -0.49 21.9 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.023 1.412 . . . . 1.6000000000000001 113.273 -2.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -135.34 166.79 22.32 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.378 1.471 . . . . 2.2400000000000002 113.205 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.47 -174.12 4.8 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 129.191 2.996 . . . . 1.5600000000000001 111.413 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.26 175.6 9.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.401 1.88 . . . . 1.4199999999999999 108.83 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.59 17.81 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.339 -0.851 . . . . 1.8100000000000001 111.641 170.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.416 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 53.7 m-85 -109.21 69.64 0.71 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.386 1.874 . . . . 3.75 109.268 176.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -79.28 158.65 27.51 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.617 0.767 . . . . 2.8700000000000001 112.795 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.4 m -119.07 140.34 50.24 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.193 1.797 . . . . 2.9399999999999999 109.087 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.0 tp -155.33 178.95 9.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.037 1.735 . . . . 5.46 108.811 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -158.27 149.61 21.09 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.222 1.809 . . . . 4.6399999999999997 107.889 -171.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -106.51 87.17 2.53 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 124.919 1.288 . . . . 1.6899999999999999 110.252 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.56 -11.55 28.28 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.512 2.142 . . . . 2.48 114.136 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.28 174.45 53.48 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-O 123.075 1.375 . . . . 1.47 113.049 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.448 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.1 m-20 -101.6 -1.76 32.07 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.205 2.202 . . . . 3.27 112.768 -167.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.27 156.87 57.13 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.698 1.999 . . . . 4.2800000000000002 109.683 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.12 170.4 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.908 2.406 . . . . 1.54 112.203 -162.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.21 146.55 44.15 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 122.851 1.31 . . . . 3.79 111.354 167.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -135.53 110.94 9.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 111.73 -2.486 . . . . 2.71 109.333 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.1 tp -94.37 112.14 23.92 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.945 1.698 . . . . 3.3700000000000001 110.042 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.64 -22.96 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.847 0.859 . . . . 1.9199999999999999 111.602 -170.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.57 -174.79 30.84 Favored Glycine 0 C--N 1.345 1.072 0 C-N-CA 125.117 1.341 . . . . 0.44 113.838 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.22 -178.44 6.39 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.401 1.881 . . . . 1.8700000000000001 110.913 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -156.58 175.36 14.14 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.41 2.284 . . . . 7.0 108.022 161.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -170.5 158.61 5.89 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 127.037 2.135 . . . . 1.74 109.448 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.41 -5.94 9.16 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.452 2.101 . . . . 1.1399999999999999 114.861 169.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.88 16.45 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.017 1.488 . . . . 2.4300000000000002 115.017 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.77 159.47 24.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.945 2.098 . . . . 2.1200000000000001 109.181 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.446 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 4.7 tp10 -108.33 -42.24 4.65 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.306 0.854 . . . . 3.8500000000000001 113.306 -170.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -113.98 147.82 37.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 122.48 1.133 . . . . 7.5800000000000001 108.442 164.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -135.47 134.31 52.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 125.186 1.395 . . . . 1.6200000000000001 107.582 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -130.92 125.86 34.6 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.508 1.523 . . . . 3.2999999999999998 109.525 -166.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.54 119.06 24.74 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.832 -0.543 . . . . 1.8 111.925 -175.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -121.55 161.06 23.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.822 1.649 . . . . 0.54000000000000004 113.523 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.6 159.96 15.56 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.858 1.663 . . . . 2.1099999999999999 111.009 158.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.1 m -114.77 137.54 51.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 105.757 -1.942 . . . . 1.7 105.757 161.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -133.75 174.57 10.31 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.667 1.222 . . . . 3.4300000000000002 113.203 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.4 mtm -119.24 141.03 49.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.244 1.417 . . . . 5.6799999999999997 110.554 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -133.99 144.77 48.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.317 1.047 . . . . 6.6900000000000004 110.738 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -78.86 114.53 17.87 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 106.479 -1.675 . . . . 2.29 106.479 137.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.9 t -94.03 97.86 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 104.449 -2.426 . . . . 3.7000000000000002 104.449 171.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.31 37.26 11.1 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.903 1.335 . . . . 8.8300000000000001 111.246 166.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.17 75.65 Favored Glycine 0 CA--C 1.527 0.824 0 O-C-N 121.018 -1.051 . . . . 2.2599999999999998 112.387 -175.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -120.93 108.96 14.52 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.725 1.61 . . . . 5.1299999999999999 110.525 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.505 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -57.41 127.54 32.49 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.008 -1.683 . . . . 4.6500000000000004 111.706 171.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.3 p -158.33 174.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.398 1.879 . . . . 3.3399999999999999 110.711 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.9 mtt -105.97 172.38 6.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.572 1.149 . . . . 3.7000000000000002 112.414 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.87 -178.62 31.13 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.821 1.201 . . . . 0.69999999999999996 112.898 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.8 ttm -154.75 150.73 27.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.814 1.646 . . . . 2.1600000000000001 108.397 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -158.53 158.56 29.6 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 123.92 0.888 . . . . 5.6299999999999999 111.49 173.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.89 154.84 58.36 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.438 2.092 . . . . 0.62 111.287 171.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.47 153.39 65.62 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.533 1.533 . . . . 1.76 110.117 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.84 -26.7 4.38 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.27 2.647 . . . . 0.64000000000000001 113.116 -167.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -178.24 164.06 1.72 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.961 1.704 . . . . 3.5299999999999998 111.172 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.5 mt -109.44 154.39 22.69 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.696 1.198 . . . . 1.9199999999999999 109.762 166.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -124.93 137.01 54.28 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.052 1.341 . . . . 1.74 110.389 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.2 t -143.94 135.03 12.48 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 118.35 0.523 . . . . 2.5099999999999998 112.275 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.93 172.19 11.17 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.693 2.929 . . . . 1.02 113.047 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -59.93 145.33 98.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.881 2.387 . . . . 1.1299999999999999 111.588 164.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.448 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 66.0 mmtt 67.58 -2.2 1.4 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.783 2.033 . . . . 2.6699999999999999 114.059 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.85 159.8 46.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.673 1.606 . . . . 1.3899999999999999 114.247 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 134.7 34.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.99 1.316 . . . . 4.4299999999999997 110.848 172.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 t -114.9 64.21 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 127.365 2.266 . . . . 6.3300000000000001 107.617 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -98.32 137.07 37.58 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.275 -0.891 . . . . 3.02 110.069 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 mp -73.62 -63.79 1.13 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 118.011 -0.995 . . . . 3.1899999999999999 111.034 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm 107.99 128.89 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 128.928 2.891 . . . . 4.4400000000000004 114.248 161.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.416 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 14.9 Cg_endo -53.48 -56.7 2.46 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 124.283 3.322 . . . . 2.1200000000000001 113.599 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.01 28.62 1.91 Allowed Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.555 -1.136 . . . . 1.8600000000000001 113.861 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.25 -128.88 0.99 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.709 1.147 . . . . 1.6299999999999999 115.554 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -74.76 144.21 43.7 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.052 -1.264 . . . . 3.0499999999999998 111.54 -165.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -160.75 151.06 17.94 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.348 -0.845 . . . . 0.64000000000000001 112.246 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -78.06 128.5 33.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.738 -0.838 . . . . 3.3399999999999999 108.738 161.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 tpt -79.78 128.91 34.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.768 -1.197 . . . . 1.9099999999999999 107.768 160.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.48 115.36 29.5 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.3 1.04 . . . . 2.0899999999999999 108.303 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.05 149.78 42.19 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.666 1.186 . . . . 3.1699999999999999 111.137 -175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.72 49.18 11.05 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.169 0.89 . . . . 1.8 111.277 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mt -52.03 153.28 2.72 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 123.479 1.609 . . . . 1.6200000000000001 114.395 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.446 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 63.6 mttm -121.13 -16.27 8.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 112.547 -2.115 . . . . 3.3100000000000001 115.435 -168.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -134.3 144.59 51.84 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.816 1.246 . . . . 6.2800000000000002 111.084 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.6 91.98 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.458 2.105 . . . . 3.4900000000000002 107.55 161.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.476 HD21 ' H ' ' A' ' 93' ' ' LEU . 1.7 pt? -81.07 155.92 26.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.198 1.799 . . . . 3.98 111.662 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.446 ' HZ3' ' CD ' ' A' ' 97' ' ' GLU . 4.0 mmtm -113.46 165.52 12.4 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 122.384 1.088 . . . . 4.3799999999999999 111.468 166.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.49 129.66 37.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.318 -1.31 . . . . 2.6899999999999999 107.665 153.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.14 20.7 37.97 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.311 -1.272 . . . . 1.5 114.76 -172.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.446 ' CD ' ' HZ3' ' A' ' 94' ' ' LYS . 48.4 mt-10 -100.31 179.09 4.57 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.56 1.68 . . . . 2.48 109.543 159.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -132.97 126.47 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.309 2.244 . . . . 3.6699999999999999 105.738 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.7 t -148.23 145.4 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 126.801 2.041 . . . . 2.77 108.194 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.3 151.49 22.65 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 123.407 1.575 . . . . 3.6499999999999999 114.079 -171.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.62 134.61 54.98 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.476 1.511 . . . . 2.75 110.07 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.409 ' OD1' ' HE2' ' A' ' 112' ' ' LYS . 11.6 m-20 -81.65 130.67 35.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.003 1.721 . . . . 2.9500000000000002 108.273 164.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.64 135.58 48.84 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.035 1.289 . . . . 2.71 111.086 168.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -110.38 113.84 26.8 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.719 1.607 . . . . 1.49 109.259 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.83 158.09 19.81 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.825 1.25 . . . . 3.6099999999999999 110.506 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.39 148.5 41.37 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.554 -0.716 . . . . 2.6800000000000002 112.079 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.7 23.14 43.68 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 119.056 -0.858 . . . . 4.1200000000000001 115.053 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.18 7.52 88.45 Favored Glycine 0 N--CA 1.474 1.225 0 CA-C-N 118.827 1.314 . . . . 1.8100000000000001 114.023 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -78.33 121.06 23.97 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.326 -1.103 . . . . 5.4199999999999999 111.381 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.66 142.0 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.7 1.2 . . . . 2.98 108.686 167.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.3 tt -151.19 112.58 4.38 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.934 0.893 . . . . 3.6800000000000002 109.997 -176.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.409 ' HE2' ' OD1' ' A' ' 102' ' ' ASP . 23.7 ttmm -84.46 125.8 32.69 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.734 -0.604 . . . . 4.3099999999999996 111.881 175.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 m -98.0 145.98 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.277 1.431 . . . . 3.8500000000000001 110.329 170.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.19 135.37 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.082 1.753 . . . . 3.2200000000000002 107.726 168.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -158.09 155.14 25.62 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.619 1.567 . . . . 3.1000000000000001 111.409 -171.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -65.91 145.74 80.94 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.774 2.316 . . . . 1.1200000000000001 112.227 169.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.9 t -82.35 124.24 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 105.896 -1.89 . . . . 2.1699999999999999 105.896 151.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 124.039 0.936 . . . . 3.9900000000000002 110.694 -172.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 10.0 tt0 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 110.096 -0.335 . . . . 9.3000000000000007 110.096 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.491 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -95.26 173.55 31.56 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.184 1.373 . . . . 2.7000000000000002 113.337 -174.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -154.87 167.67 29.5 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.458 1.103 . . . . 3.54 112.3 173.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.94 148.6 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.73 1.212 . . . . 2.29 108.391 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -77.88 -135.96 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.105 -0.702 . . . . 6.5999999999999996 109.105 158.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -140.52 152.64 45.73 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.882 1.273 . . . . 3.9399999999999999 111.489 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 m -161.35 142.02 8.32 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 127.771 2.428 . . . . 3.02 108.983 161.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.22 -23.74 20.73 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.424 2.083 . . . . 2.3799999999999999 112.261 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.04 171.81 13.69 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 127.145 2.307 . . . . 1.3200000000000001 110.8 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -79.55 4.14 33.51 Favored 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 119.667 1.733 . . . . 1.28 112.403 -9.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.3 139.47 16.54 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.239 1.57 . . . . 2.8999999999999999 115.239 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.33 -176.78 3.17 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.024 2.53 . . . . 1.8200000000000001 111.282 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.77 135.08 18.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.807 1.643 . . . . 1.6100000000000001 108.805 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.7 137.32 54.8 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.758 1.223 . . . . 1.6699999999999999 111.237 -175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -105.62 86.34 2.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.242 1.817 . . . . 3.8999999999999999 109.068 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -90.41 158.08 17.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.403 0.681 . . . . 2.9100000000000001 112.708 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 m -131.53 134.02 45.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.016 1.327 . . . . 2.1800000000000002 109.535 -172.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.35 169.95 23.58 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.003 1.721 . . . . 6.0599999999999996 108.865 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -142.86 145.52 33.22 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.287 1.435 . . . . 4.6500000000000004 108.4 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -93.58 108.15 31.97 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.772 1.229 . . . . 1.5700000000000001 110.87 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.58 -10.27 12.05 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.949 2.433 . . . . 1.8999999999999999 114.91 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.44 169.62 54.05 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 120.085 1.311 . . . . 1.8799999999999999 113.616 -171.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.65 -6.47 58.24 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.414 2.286 . . . . 4.3099999999999996 111.537 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mp -124.5 162.11 44.32 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 127.057 2.143 . . . . 5.1900000000000004 109.587 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.34 155.66 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.854 2.369 . . . . 1.45 111.478 -171.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.79 162.11 18.62 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.625 1.97 . . . . 4.0899999999999999 111.016 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -155.12 120.66 5.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.193 -1.367 . . . . 3.02 111.266 -173.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.5 tp -103.49 114.1 28.11 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.608 1.963 . . . . 3.3700000000000001 109.757 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.3 m -112.86 -20.28 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.749 0.819 . . . . 1.6799999999999999 112.634 -167.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.15 -174.71 29.22 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 124.674 1.13 . . . . 0.52000000000000002 112.251 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.64 -178.43 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.1 1.36 . . . . 1.8700000000000001 110.878 168.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -152.62 164.86 36.85 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.139 2.176 . . . . 6.0199999999999996 108.417 172.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -169.2 146.06 2.95 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 124.849 1.259 . . . . 1.8400000000000001 108.919 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -77.32 -10.22 17.58 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.381 2.054 . . . . 1.24 113.367 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.97 21.47 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.747 1.388 . . . . 2.3900000000000001 114.747 -174.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.3 38.97 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.172 -0.955 . . . . 1.8100000000000001 113.067 167.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -72.98 -30.62 63.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.433 1.493 . . . . 3.5099999999999998 113.168 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -155.16 168.44 27.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.156 2.582 . . . . 5.4800000000000004 107.743 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.97 154.87 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.173 1.389 . . . . 1.8100000000000001 108.876 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.61 146.34 28.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.975 1.71 . . . . 4.0599999999999996 108.676 -166.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.8 tp -113.03 110.13 19.97 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.48 1.036 . . . . 2.0299999999999998 111.298 -164.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -116.71 150.04 38.85 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 122.663 1.221 . . . . 0.53000000000000003 113.927 -173.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.409 ' C ' ' HG1' ' A' ' 48' ' ' THR . 7.8 pt-20 -91.94 -178.28 4.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.957 -1.474 . . . . 2.1499999999999999 111.136 158.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.409 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 87.1 m -149.24 127.41 12.06 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.085 -1.82 . . . . 2.0699999999999998 106.085 174.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -128.41 170.17 13.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.967 0.889 . . . . 3.4300000000000002 113.267 -167.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.93 144.72 32.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.152 1.781 . . . . 6.2699999999999996 110.68 170.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.37 147.2 21.94 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.512 -0.742 . . . . 6.2800000000000002 112.849 -172.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -91.76 132.62 36.27 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.479 1.512 . . . . 2.2999999999999998 109.835 165.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.33 130.33 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.496 -1.668 . . . . 3.9399999999999999 106.496 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 62.88 28.05 16.22 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.761 0.824 . . . . 4.9500000000000002 112.254 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.21 16.05 79.85 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 120.967 -1.083 . . . . 2.4300000000000002 113.904 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -135.21 134.42 40.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.986 1.714 . . . . 4.8799999999999999 109.883 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.07 126.31 34.68 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.466 1.506 . . . . 3.1499999999999999 111.976 -173.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.25 -178.97 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 129.558 3.143 . . . . 4.0 109.603 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.3 mtm -110.76 170.01 8.38 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.817 0.847 . . . . 4.3799999999999999 112.033 168.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.89 -176.55 27.24 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.047 1.784 . . . . 1.04 112.206 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ttm -154.67 149.53 26.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.611 1.565 . . . . 1.8899999999999999 108.596 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.9 ptt85 -158.57 156.8 27.93 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 124.891 1.276 . . . . 5.5700000000000003 110.314 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.2 158.06 45.54 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.0 1.8 . . . . 0.56999999999999995 111.644 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.84 149.85 65.74 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.908 1.683 . . . . 1.8200000000000001 109.087 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.31 -20.28 11.25 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.256 2.637 . . . . 0.77000000000000002 113.02 -167.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 p90 178.96 167.62 0.93 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.666 2.386 . . . . 3.5099999999999998 110.114 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.75 150.84 32.8 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.124 1.369 . . . . 1.9099999999999999 110.137 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -117.81 141.79 48.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.034 1.334 . . . . 2.3199999999999998 109.3 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 t -143.93 132.05 10.93 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 113.276 0.843 . . . . 2.73 113.276 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.85 170.32 14.38 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.256 2.637 . . . . 1.7 112.488 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -56.63 139.82 88.89 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.699 2.266 . . . . 1.72 110.658 164.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt 69.13 1.84 3.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.489 1.516 . . . . 2.9399999999999999 113.743 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.77 158.09 36.58 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.676 1.608 . . . . 2.1299999999999999 113.449 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -79.92 145.63 32.55 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.926 0.89 . . . . 4.29 111.925 173.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.57 61.29 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.015 2.126 . . . . 7.0599999999999996 107.92 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -116.57 136.21 53.17 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.845 0.831 . . . . 3.1299999999999999 111.192 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.97 85.55 7.47 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.099 -1.445 . . . . 2.1600000000000001 107.099 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -55.95 139.7 70.35 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 113.672 0.99 . . . . 5.8499999999999996 113.672 -167.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -56.54 130.02 37.82 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.08 1.853 . . . . 4.4699999999999998 109.289 165.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.64 28.98 66.29 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.655 -1.081 . . . . 2.1499999999999999 114.813 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.68 -17.56 0.02 OUTLIER Glycine 0 N--CA 1.472 1.087 0 N-CA-C 118.966 2.347 . . . . 2.3799999999999999 118.966 158.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -143.24 150.03 38.73 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.222 2.011 . . . . 2.9900000000000002 112.406 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -162.44 153.69 17.83 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.287 1.035 . . . . 0.69999999999999996 111.192 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -86.47 127.68 34.88 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.193 -0.669 . . . . 3.9500000000000002 109.193 165.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.4 tpt -82.64 119.41 24.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.394 2.278 . . . . 1.8400000000000001 109.396 170.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -100.33 120.82 40.52 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.345 -0.983 . . . . 2.1099999999999999 108.345 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.56 146.02 30.18 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.626 1.17 . . . . 3.6499999999999999 112.415 -169.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.89 -48.77 3.04 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 126.919 2.199 . . . . 3.0099999999999998 114.126 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.0 mt 56.49 165.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.066 3.346 . . . . 1.8200000000000001 115.388 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -119.36 -7.41 10.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.385 1.874 . . . . 2.9199999999999999 113.292 174.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -127.96 131.51 23.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 128.366 2.666 . . . . 5.6299999999999999 109.385 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.35 76.28 3.97 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.755 2.303 . . . . 2.9500000000000002 106.454 153.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.34 140.3 55.89 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.585 1.154 . . . . 4.3499999999999996 113.669 -156.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -93.31 156.92 16.51 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.381 1.086 . . . . 6.46 111.65 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.62 118.15 7.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 113.847 -1.524 . . . . 2.77 107.545 159.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.62 -2.36 36.54 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-O 117.853 -1.526 . . . . 1.77 115.869 -168.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.42 -178.6 5.28 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.586 1.693 . . . . 3.3199999999999998 111.467 160.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -152.62 141.77 21.38 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.753 2.821 . . . . 4.6100000000000003 106.636 -171.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 82.5 t -144.15 146.09 21.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 126.601 1.96 . . . . 2.5699999999999998 109.561 -168.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -97.76 136.29 38.31 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.953 0.901 . . . . 2.8399999999999999 110.094 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.63 140.12 50.42 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.262 1.025 . . . . 3.73 109.888 165.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -94.44 134.12 37.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.149 2.579 . . . . 1.8700000000000001 108.351 160.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.44 130.18 42.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.634 1.574 . . . . 2.0 108.848 164.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.4 111.43 23.33 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.049 0.939 . . . . 1.9199999999999999 110.678 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -103.66 163.68 12.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.142 1.377 . . . . 3.46 111.582 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.57 154.86 13.39 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.679 -0.691 . . . . 2.6000000000000001 112.122 166.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.36 24.95 62.22 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.138 -0.812 . . . . 3.9500000000000002 114.977 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.91 13.69 82.29 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 118.436 1.118 . . . . 1.8999999999999999 114.171 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -90.52 117.51 29.26 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.448 -1.03 . . . . 4.3799999999999999 112.128 -172.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.27 140.86 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.61 1.564 . . . . 3.6099999999999999 110.431 169.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 mt -140.01 129.2 23.78 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.035 1.334 . . . . 3.6600000000000001 110.846 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -106.21 143.41 34.39 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.797 0.666 . . . . 3.1499999999999999 112.797 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.96 160.01 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 127.49 2.316 . . . . 3.3900000000000001 111.704 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.47 137.23 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.542 1.937 . . . . 2.73 110.57 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.4 mp -134.76 114.57 12.08 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 126.525 1.93 . . . . 3.6699999999999999 110.741 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -75.5 150.02 35.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.265 2.644 . . . . 1.4299999999999999 110.665 169.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.8 t -91.25 132.88 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.848 0.859 . . . . 2.0800000000000001 111.195 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 N--CA 1.477 0.882 0 C-N-CA 125.901 1.68 . . . . 4.5199999999999996 113.089 -176.26 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 122.925 1.345 . . . . 4.8499999999999996 110.359 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.31 172.35 20.38 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.883 1.23 . . . . 1.3 113.897 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -156.23 160.15 39.55 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.499 1.92 . . . . 2.7799999999999998 110.96 172.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -103.61 147.94 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.356 -1.35 . . . . 2.79 107.356 170.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HG2' ' H ' ' A' ' 10' ' ' PHE . 18.7 ttm180 -72.08 -119.77 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 CA-C-O 121.542 0.687 . . . . 5.8700000000000001 109.432 164.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.451 ' H ' ' HG2' ' A' ' 9' ' ' ARG . 47.1 t80 -151.41 143.03 23.64 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 119.383 -2.073 . . . . 4.4000000000000004 110.92 -172.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.0 t -171.68 143.31 1.44 Allowed Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.703 1.601 . . . . 2.8100000000000001 110.572 167.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.9 -26.32 4.58 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.733 2.289 . . . . 1.6599999999999999 112.26 166.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.31 170.42 12.03 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.643 2.068 . . . . 1.0700000000000001 111.419 -171.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.69 -16.12 22.83 Favored 'Cis proline' 0 C--N 1.349 0.596 0 CA-C-N 119.328 1.564 . . . . 1.4399999999999999 112.761 0.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -142.09 160.43 40.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.805 1.288 . . . . 2.7799999999999998 114.421 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.88 -179.06 4.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.433 2.693 . . . . 1.72 110.486 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.06 133.39 26.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.162 1.385 . . . . 1.5800000000000001 109.208 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.32 150.95 50.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.562 1.145 . . . . 1.99 113.481 -171.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.462 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 50.8 m-85 -131.55 127.15 36.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.19 2.196 . . . . 3.4199999999999999 109.548 -163.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.262 0.0 OUTLIER -162.5 161.7 27.13 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.822 1.415 . . . . 4.0099999999999998 114.822 -172.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.5 m -93.26 127.75 38.96 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.896 1.678 . . . . 2.5699999999999998 111.735 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.9 tp -112.34 122.0 46.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.809 1.243 . . . . 5.2000000000000002 110.302 166.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -122.07 142.29 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.577 1.151 . . . . 4.5099999999999998 109.211 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -105.87 97.73 16.06 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.561 0.744 . . . . 1.46 111.322 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.31 -5.59 14.36 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.857 2.371 . . . . 1.3200000000000001 114.044 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.93 163.65 34.95 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 119.624 1.102 . . . . 1.3400000000000001 111.347 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.9 4.29 50.42 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.848 2.059 . . . . 3.5099999999999998 112.374 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -118.79 152.81 52.01 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.248 2.219 . . . . 3.9199999999999999 110.346 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.35 142.36 21.12 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.216 1.944 . . . . 1.0800000000000001 110.7 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.1 mt -96.57 149.46 21.74 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 122.258 1.027 . . . . 2.8700000000000001 110.841 172.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 68' ' ' GLU . 38.5 ttm105 -135.98 100.14 4.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 113.866 -1.515 . . . . 3.04 110.946 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.46 97.39 9.5 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.999 2.12 . . . . 2.9399999999999999 108.066 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 m -94.13 -25.42 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.875 0.87 . . . . 1.72 112.801 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.46 -177.09 32.23 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 123.974 0.797 . . . . 0.40000000000000002 113.208 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.3 178.94 6.33 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.462 0.705 . . . . 1.4399999999999999 111.18 172.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.75 170.97 17.01 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.512 2.725 . . . . 6.5300000000000002 106.591 165.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t -177.36 148.42 0.72 Allowed Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 127.187 2.195 . . . . 1.8400000000000001 108.703 -172.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -77.14 -24.73 9.32 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.031 1.821 . . . . 1.3999999999999999 113.958 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.5 m -112.57 23.42 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 114.221 1.193 . . . . 2.23 114.221 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.39 35.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.142 1.377 . . . . 2.0899999999999999 107.822 160.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -83.3 -54.41 5.02 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.237 1.015 . . . . 3.0 111.075 -171.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -115.97 166.75 11.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.582 2.753 . . . . 6.3099999999999996 106.392 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.95 134.36 2.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 125.533 1.533 . . . . 1.99 108.267 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -113.97 135.99 53.39 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.21 1.404 . . . . 2.9399999999999999 109.455 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -83.48 124.45 30.73 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.542 -0.54 . . . . 2.4100000000000001 109.542 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -122.61 158.33 30.19 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.19 1.796 . . . . 0.70999999999999996 112.896 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -179.89 4.07 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.626 1.571 . . . . 3.3199999999999998 110.701 165.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.5 m -154.77 141.82 19.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.785 1.634 . . . . 1.8100000000000001 106.988 170.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -155.58 175.0 14.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.54 1.162 . . . . 3.3900000000000001 113.387 -167.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.7 ttp -117.2 146.16 43.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.71 1.604 . . . . 4.1399999999999997 110.137 171.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -148.11 161.05 42.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.716 2.406 . . . . 8.7200000000000006 110.272 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -91.03 144.81 25.27 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.832 0.853 . . . . 2.46 109.5 166.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.7 t -137.22 115.48 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.095 -1.817 . . . . 3.3799999999999999 106.095 163.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 58.08 34.85 24.63 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.992 1.479 . . . . 5.4100000000000001 114.992 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.18 4.63 68.89 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.253 -1.529 . . . . 1.6200000000000001 113.553 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -103.52 115.31 30.29 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.122 1.769 . . . . 3.5899999999999999 107.673 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 117.06 17.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.903 0.881 . . . . 3.7200000000000002 110.221 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 t -138.88 153.73 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 128.609 2.764 . . . . 3.1899999999999999 107.705 -161.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.23 173.43 6.46 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.615 -1.303 . . . . 4.8600000000000003 113.531 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.09 166.84 33.19 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.703 1.144 . . . . 0.57999999999999996 112.451 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 ttm -150.43 139.74 21.31 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.143 2.177 . . . . 2.4500000000000002 107.286 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -150.56 154.23 35.16 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.681 1.992 . . . . 5.1600000000000001 108.672 -171.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.71 159.71 31.52 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.323 2.016 . . . . 0.56000000000000005 111.194 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.76 155.99 52.21 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 125.767 1.627 . . . . 2.3599999999999999 110.931 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -84.88 -26.43 1.54 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.407 2.738 . . . . 0.52000000000000002 114.089 -164.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -174.8 164.81 3.58 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.991 1.716 . . . . 2.9300000000000002 111.477 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 mt -111.7 160.57 17.15 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.924 1.29 . . . . 1.6000000000000001 109.296 157.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 31' ' ' ARG . 29.5 tt0 -138.0 148.79 45.51 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.61 1.164 . . . . 1.9399999999999999 110.11 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 t -139.82 129.09 13.69 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 123.836 0.71 . . . . 2.2400000000000002 111.755 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -68.39 162.81 39.03 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.189 2.593 . . . . 1.3100000000000001 110.967 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.05 138.66 79.83 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.097 2.532 . . . . 1.25 112.17 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.14 3.43 2.69 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 127.27 2.228 . . . . 3.0699999999999998 115.036 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.67 169.71 34.35 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.136 1.827 . . . . 1.47 113.263 169.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -132.17 157.21 44.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.334 1.054 . . . . 5.3899999999999997 112.305 168.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.3 t -145.08 140.93 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 128.026 2.53 . . . . 4.2300000000000004 107.505 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -134.32 130.06 36.45 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.186 0.517 . . . . 3.9700000000000002 110.822 -170.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -75.69 80.51 2.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.224 1.41 . . . . 2.1099999999999999 109.709 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.84 155.58 91.31 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 126.604 1.962 . . . . 4.79 114.323 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.462 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 55.9 Cg_endo -61.8 -44.46 21.0 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.126 2.551 . . . . 2.25 112.329 171.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.48 60.33 4.88 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.106 -0.83 . . . . 2.2200000000000002 112.426 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.25 -126.44 2.03 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 125.428 1.49 . . . . 1.51 114.191 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -72.63 136.62 45.74 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.674 -0.898 . . . . 3.0299999999999998 112.11 -167.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -160.09 163.88 33.49 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.61 1.164 . . . . 0.92000000000000004 111.439 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -97.18 132.68 42.71 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.914 -0.491 . . . . 3.0299999999999998 109.921 170.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -88.35 115.69 26.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.822 2.049 . . . . 1.78 108.983 166.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.12 119.19 37.43 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.185 0.994 . . . . 2.27 109.013 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.56 141.04 52.11 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.263 1.208 . . . . 4.3399999999999999 114.263 -164.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.24 38.34 25.97 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.539 1.066 . . . . 1.8799999999999999 113.142 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mt -43.86 152.75 0.15 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 116.386 1.995 . . . . 1.8899999999999999 116.386 -174.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -112.84 -16.9 12.64 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.718 -1.583 . . . . 2.7000000000000002 114.939 -173.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -138.25 142.31 34.85 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.698 2.799 . . . . 7.6900000000000004 108.599 165.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.24 135.65 27.45 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.965 1.776 . . . . 1.45 107.753 158.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.56 105.9 16.15 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.318 0.508 . . . . 4.0199999999999996 109.851 -176.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -86.91 20.54 2.58 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.587 2.069 . . . . 4.8700000000000001 116.587 -163.022 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 67.01 157.25 0.12 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 128.541 2.737 . . . . 2.5299999999999998 111.845 -161.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.25 0.26 85.89 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 118.95 -0.917 . . . . 1.29 114.536 -172.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.89 175.69 8.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.921 1.688 . . . . 2.6899999999999999 110.259 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -128.48 153.4 47.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.932 2.093 . . . . 4.0899999999999999 105.423 163.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.1 t -136.72 138.04 46.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 126.407 1.883 . . . . 2.7999999999999998 109.077 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.51 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 38.9 tt0 -89.81 136.08 33.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.08 1.352 . . . . 3.6099999999999999 109.853 173.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.63 139.89 52.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.914 1.286 . . . . 3.6499999999999999 109.62 170.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -99.06 143.45 29.32 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.84 2.056 . . . . 2.6299999999999999 109.669 167.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -114.74 118.79 34.6 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.844 1.657 . . . . 2.04 109.292 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.1 mt -92.39 112.31 24.21 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.883 1.273 . . . . 1.8600000000000001 109.408 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -104.66 106.5 17.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.567 1.147 . . . . 3.4199999999999999 110.564 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.8 21.8 2.08 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.766 1.626 . . . . 2.6400000000000001 114.78 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.68 -55.48 4.46 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.12 1.343 . . . . 4.2400000000000002 112.976 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.65 1.12 54.09 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 116.126 1.21 . . . . 2.0499999999999998 116.126 -172.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -140.68 149.15 41.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.077 1.439 . . . . 4.8300000000000001 112.326 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.71 153.14 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.407 1.483 . . . . 3.29 110.919 170.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.0 tp -155.19 164.02 39.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.953 2.101 . . . . 3.0499999999999998 107.973 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.51 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 41.2 pttt -146.58 156.16 43.02 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.16 1.541 . . . . 2.6899999999999999 115.16 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.15 160.16 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.951 2.5 . . . . 3.9100000000000001 109.929 -167.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.0 142.97 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.959 0.904 . . . . 3.7200000000000002 110.028 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.21 144.57 15.21 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 124.631 1.172 . . . . 3.6400000000000001 113.664 -168.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.49 158.86 25.65 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.984 3.79 . . . . 1.3200000000000001 114.478 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.99 124.5 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.152 1.381 . . . . 2.02 110.227 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 N--CA 1.47 0.55 0 C-N-CA 124.345 1.058 . . . . 3.7200000000000002 111.149 174.956 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 113.362 0.875 . . . . 5.29 113.362 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.16 172.38 34.04 Favored Glycine 0 C--N 1.34 0.78 0 O-C-N 120.797 -1.189 . . . . 1.3100000000000001 114.809 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -157.35 159.55 37.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.198 1.399 . . . . 2.7000000000000002 113.358 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.1 t -107.99 143.31 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.905 1.282 . . . . 2.3500000000000001 109.707 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -73.12 -15.77 61.47 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 117.263 2.32 . . . . 6.6900000000000004 117.263 -159.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 1.1 t80 71.83 115.76 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.863 2.065 . . . . 4.3499999999999996 110.778 -174.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.5 m -162.06 145.4 9.14 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.887 1.675 . . . . 3.3599999999999999 108.806 169.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.12 -33.29 6.03 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.7 2.267 . . . . 2.1600000000000001 112.551 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.71 172.2 18.29 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.437 1.494 . . . . 1.25 111.503 -175.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.94 -1.26 25.14 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 CA-C-N 119.194 1.497 . . . . 1.24 112.891 -1.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -144.0 169.38 17.93 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.256 1.023 . . . . 2.1899999999999999 113.45 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.26 178.27 9.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.966 2.506 . . . . 1.8300000000000001 110.941 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.64 166.3 22.93 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.989 2.116 . . . . 2.0600000000000001 108.823 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.24 154.4 34.58 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.863 0.865 . . . . 1.8600000000000001 111.863 174.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.25 131.86 28.84 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.537 1.535 . . . . 3.8900000000000001 109.818 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.26 162.47 39.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.083 0.856 . . . . 3.9900000000000002 112.841 175.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.4 m -89.03 127.08 35.67 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.346 1.458 . . . . 2.7000000000000002 110.221 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.7 tp -104.47 127.47 52.18 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.115 1.366 . . . . 4.9199999999999999 108.534 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -135.86 132.83 37.09 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.815 1.246 . . . . 4.6900000000000004 109.106 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -103.71 101.21 23.0 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.538 1.135 . . . . 1.53 110.41 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.82 -10.17 19.84 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.297 1.998 . . . . 1.24 113.535 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 177.3 50.84 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-O 122.764 1.202 . . . . 1.1499999999999999 113.102 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.424 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 13.6 m-20 -104.46 -5.25 21.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.496 2.318 . . . . 2.8799999999999999 112.368 -172.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -120.34 161.2 40.31 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 127.359 2.264 . . . . 4.8099999999999996 109.033 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.74 151.99 14.83 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.711 2.274 . . . . 1.1599999999999999 111.911 -167.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp -104.93 149.88 25.35 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.81 1.291 . . . . 3.2200000000000002 109.387 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -139.87 116.65 10.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.726 -1.579 . . . . 2.9199999999999999 108.594 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -93.31 114.85 27.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.3 2.24 . . . . 3.27 108.193 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.5 -25.34 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.708 0.803 . . . . 1.9099999999999999 111.984 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.04 -175.8 33.45 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 123.808 0.718 . . . . 0.55000000000000004 114.573 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -123.51 178.29 5.25 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.64 1.176 . . . . 1.71 112.1 166.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -157.06 147.66 21.41 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.708 1.603 . . . . 6.8499999999999996 107.094 162.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 t -159.59 151.6 17.1 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-O 117.538 -1.22 . . . . 1.73 108.317 -169.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.93 0.59 9.1 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 121.805 1.67 . . . . 0.91000000000000003 114.047 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.07 28.3 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.809 2.044 . . . . 2.1000000000000001 114.791 -171.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.26 143.14 16.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.786 1.175 . . . . 2.23 111.013 168.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.96 -38.51 91.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.174 1.39 . . . . 3.02 111.697 173.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -149.95 144.39 25.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.085 1.754 . . . . 8.0299999999999994 107.856 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.66 132.67 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.329 1.452 . . . . 2.1800000000000002 109.394 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -97.63 167.98 10.63 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.714 1.206 . . . . 3.21 110.02 166.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -119.61 137.25 53.98 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.986 1.374 . . . . 3.6800000000000002 112.441 154.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -121.5 153.72 37.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.661 1.984 . . . . 0.79000000000000004 110.808 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -90.35 157.28 17.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.896 -1.047 . . . . 1.98 109.945 153.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.4 m -108.89 140.13 42.79 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 105.033 -2.21 . . . . 1.73 105.033 157.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -136.15 167.99 20.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.869 1.318 . . . . 3.3399999999999999 113.701 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.4 mtm -113.12 142.87 45.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.532 1.533 . . . . 5.5 110.843 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -134.88 143.27 46.87 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.129 1.372 . . . . 7.1799999999999997 110.047 170.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -91.25 142.31 27.85 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.214 -1.032 . . . . 3.3900000000000001 108.214 154.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.3 t -138.85 118.71 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 106.599 -1.63 . . . . 4.5700000000000003 106.599 164.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 64.59 19.89 11.97 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.411 1.484 . . . . 4.9199999999999999 114.264 -177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.54 4.81 87.41 Favored Glycine 0 N--CA 1.481 1.646 0 O-C-N 120.477 -1.39 . . . . 3.2799999999999998 113.64 -169.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -103.68 111.43 23.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.672 1.989 . . . . 4.5599999999999996 107.87 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.64 117.71 26.64 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.336 1.454 . . . . 3.5299999999999998 111.085 -173.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.17 139.85 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.396 1.878 . . . . 3.6600000000000001 109.329 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -101.13 166.98 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.902 1.281 . . . . 4.4900000000000002 112.77 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.1 -178.0 29.84 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.44 1.019 . . . . 0.58999999999999997 113.166 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.2 ttm -152.41 143.37 23.04 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.666 1.586 . . . . 2.02 108.759 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -162.96 153.75 14.23 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 123.569 0.748 . . . . 5.8399999999999999 112.065 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.33 146.22 35.33 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.644 2.229 . . . . 0.72999999999999998 112.852 -174.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.66 155.15 63.38 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 118.347 -0.835 . . . . 2.0699999999999998 110.905 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.38 -23.66 5.98 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.133 2.555 . . . . 0.64000000000000001 112.89 -171.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -178.37 167.41 1.88 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.089 1.756 . . . . 3.4700000000000002 111.113 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.6 mt -115.08 155.13 27.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.191 1.796 . . . . 1.99 109.952 163.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -116.13 145.81 42.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.387 1.475 . . . . 2.23 110.531 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.5 t -142.23 126.6 10.03 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 118.878 0.763 . . . . 1.97 112.588 163.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.58 165.57 32.33 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.089 3.193 . . . . 1.0900000000000001 112.39 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.99 137.63 80.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.342 2.694 . . . . 1.0900000000000001 112.218 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.424 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 64.9 mmtt 67.59 1.21 2.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.362 1.865 . . . . 2.4500000000000002 114.396 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.12 167.43 27.83 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 126.007 1.765 . . . . 1.1899999999999999 113.406 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -137.03 156.16 48.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.576 1.15 . . . . 6.75 111.826 169.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.0 t -146.84 130.71 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.888 2.075 . . . . 4.1699999999999999 108.145 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.492 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -96.33 140.47 30.96 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.622 1.101 . . . . 3.1200000000000001 111.392 164.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -41.2 -52.37 3.36 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.364 1.865 . . . . 3.0600000000000001 111.959 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HZ1' ' CD ' ' A' ' 76' ' ' GLU . 0.3 OUTLIER 104.11 127.89 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 128.575 2.75 . . . . 3.8199999999999998 111.217 164.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.18 -11.27 30.53 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.238 2.625 . . . . 2.5 114.83 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.67 20.26 8.82 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.108 1.337 . . . . 1.8300000000000001 113.753 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -144.54 -119.32 1.3 Allowed Glycine 0 N--CA 1.471 1.0 0 CA-C-N 119.204 1.502 . . . . 1.8100000000000001 113.31 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -72.74 144.68 47.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.275 1.038 . . . . 3.5899999999999999 110.518 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -161.48 151.14 16.69 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.532 -0.73 . . . . 0.71999999999999997 110.728 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -77.76 143.01 38.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.477 -0.935 . . . . 3.9500000000000002 108.477 166.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 tpt -115.88 114.52 24.8 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.391 2.276 . . . . 2.4199999999999999 107.902 172.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -98.04 118.85 35.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.938 1.695 . . . . 2.3300000000000001 108.73 -173.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.85 135.13 54.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.685 1.194 . . . . 3.3300000000000001 110.336 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.51 50.84 10.66 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.718 -0.614 . . . . 1.6299999999999999 112.689 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -47.76 156.38 0.33 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 115.932 1.827 . . . . 1.96 115.932 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -112.08 -30.77 7.11 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 113.43 -1.714 . . . . 2.3500000000000001 113.772 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -112.66 134.79 21.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.465 1.506 . . . . 5.1500000000000004 108.959 166.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.62 82.89 1.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.785 2.324 . . . . 1.55 107.265 160.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -87.6 124.75 33.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.562 0.745 . . . . 3.6000000000000001 112.952 -163.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 24.4 mtmm -110.38 167.23 10.36 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 115.268 1.581 . . . . 4.5499999999999998 115.268 -165.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.86 124.82 21.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.353 -1.294 . . . . 1.9399999999999999 109.123 172.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.13 5.25 62.44 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 117.959 -1.467 . . . . 1.6899999999999999 115.639 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.01 178.26 6.71 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.193 1.997 . . . . 2.77 111.246 163.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -149.12 125.76 11.05 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 129.497 3.119 . . . . 3.4900000000000002 104.607 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.4 t -146.52 139.96 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.809 0.844 . . . . 2.96 110.783 -168.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -80.13 152.12 29.43 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.524 1.13 . . . . 3.1499999999999999 113.982 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.2 tt -144.47 130.74 19.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.426 1.49 . . . . 4.4100000000000001 110.639 168.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.8 117.88 21.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.644 2.778 . . . . 2.3500000000000001 109.095 165.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -87.87 121.08 29.85 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.124 -1.065 . . . . 2.0899999999999999 108.124 171.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.1 mt -97.61 118.56 34.41 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.002 0.921 . . . . 1.8300000000000001 109.979 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -116.2 144.51 44.09 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.308 1.043 . . . . 3.5099999999999998 112.852 -171.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.58 137.0 57.94 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.279 -0.888 . . . . 2.4500000000000002 113.271 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.17 46.38 5.6 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.746 -1.03 . . . . 3.9199999999999999 113.627 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.3 32.79 46.54 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 123.959 0.79 . . . . 1.72 114.728 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -125.77 144.81 50.48 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.675 1.237 . . . . 4.4699999999999998 112.201 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.04 149.02 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.376 1.47 . . . . 3.2200000000000002 110.644 176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -149.3 119.29 7.16 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.143 0.977 . . . . 3.5099999999999998 108.699 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -96.08 133.71 40.01 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.635 -0.665 . . . . 3.04 111.757 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.28 170.47 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.934 1.693 . . . . 3.3300000000000001 108.469 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -124.75 136.77 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.752 1.621 . . . . 3.3500000000000001 108.726 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -127.73 139.12 34.4 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.305 1.442 . . . . 3.7999999999999998 109.131 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.26 150.41 76.5 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.231 2.621 . . . . 1.47 111.311 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.1 t -99.39 137.73 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.491 1.116 . . . . 2.3999999999999999 108.384 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 126.525 1.93 . . . . 4.79 112.271 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 . . . . . 0 C--O 1.237 0.441 0 N-CA-C 107.602 -1.259 . . . . 5.4699999999999998 107.602 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.17 137.14 9.19 Favored Glycine 0 N--CA 1.467 0.701 0 N-CA-C 110.95 -0.86 . . . . 2.2000000000000002 110.95 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -96.87 173.12 7.46 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.521 1.304 . . . . 2.75 114.521 -168.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.43 148.36 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.214 1.806 . . . . 1.98 108.6 168.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -69.46 -103.02 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.407 1.083 . . . . 5.3700000000000001 112.613 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.2 t80 169.96 126.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.705 2.402 . . . . 3.0499999999999998 108.419 -166.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 m -173.34 145.47 1.22 Allowed Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 126.015 1.726 . . . . 2.73 109.389 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.78 -33.74 0.6 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.915 2.41 . . . . 1.8200000000000001 112.589 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.29 166.8 11.95 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.949 1.738 . . . . 1.54 111.314 -170.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.76 -2.04 25.17 Favored 'Cis proline' 0 CA--C 1.54 0.777 0 CA-C-N 119.192 1.496 . . . . 1.72 113.092 -0.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -147.6 163.66 35.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.796 1.638 . . . . 2.2000000000000002 112.994 -172.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.58 -175.43 4.92 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.259 2.224 . . . . 1.6599999999999999 111.773 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.11 148.0 33.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.532 1.133 . . . . 1.8600000000000001 110.989 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.23 137.75 39.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 1.6299999999999999 113.096 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -105.93 23.36 14.09 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.252 2.621 . . . . 4.0700000000000003 113.818 -168.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -58.47 160.72 5.09 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 117.263 2.319 . . . . 3.3599999999999999 117.263 -163.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -79.46 150.13 31.34 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.119 2.168 . . . . 2.9300000000000002 112.046 174.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.67 132.7 33.31 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.058 2.143 . . . . 4.2599999999999998 110.334 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -135.6 162.78 31.73 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.125 1.37 . . . . 4.6399999999999997 111.456 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -130.31 98.94 19.92 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.909 0.883 . . . . 1.76 109.662 168.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.16 -11.15 16.32 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.779 2.319 . . . . 1.3300000000000001 113.007 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.85 -172.66 47.54 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.994 1.283 . . . . 1.26 113.155 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -113.73 -2.64 13.67 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.438 1.895 . . . . 3.3199999999999998 112.239 -165.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -124.54 153.86 69.65 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.363 2.265 . . . . 4.2199999999999998 110.231 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.99 158.5 38.29 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.643 2.229 . . . . 1.48 112.709 -168.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.3 mt -119.04 152.5 36.33 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.083 1.753 . . . . 3.0899999999999999 110.196 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.3 ttp-105 -138.01 102.39 4.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.281 -1.781 . . . . 4.2300000000000004 110.722 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.82 106.88 16.68 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.318 1.847 . . . . 2.79 108.671 -174.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.25 -26.08 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.698 0.999 . . . . 1.8400000000000001 113.698 -170.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.09 -174.23 31.71 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 125.615 1.579 . . . . 0.48999999999999999 111.805 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.71 -175.14 4.54 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.643 0.735 . . . . 1.6200000000000001 112.443 173.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -145.23 178.1 8.32 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.808 2.843 . . . . 6.4500000000000002 107.598 160.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t 179.41 150.7 0.5 Allowed Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 127.089 2.156 . . . . 1.5900000000000001 109.115 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.77 -9.68 22.69 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.014 2.476 . . . . 1.1200000000000001 113.746 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.466 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 30.1 m -114.04 23.34 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 115.248 1.573 . . . . 1.79 115.248 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.75 173.24 14.97 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.408 1.483 . . . . 1.75 109.252 166.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -101.21 -58.02 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.612 1.565 . . . . 4.5999999999999996 110.795 165.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -98.14 152.61 19.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.615 2.366 . . . . 6.8300000000000001 108.536 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.5 p -160.55 108.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 127.04 2.136 . . . . 2.23 110.224 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -127.58 140.94 51.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.16 -1.382 . . . . 5.4900000000000002 111.469 -168.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 tp -82.03 125.27 30.61 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.666 0.746 . . . . 2.7400000000000002 111.59 -170.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -119.09 159.5 23.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.288 1.835 . . . . 0.56000000000000005 112.161 171.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -114.31 165.43 12.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.906 -1.497 . . . . 2.25 110.863 166.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -124.3 126.76 46.57 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.16 -1.793 . . . . 1.9199999999999999 106.16 169.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -127.14 171.35 11.49 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.23 0.826 . . . . 3.4700000000000002 113.23 -172.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 ttp -105.38 145.28 31.0 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.779 1.632 . . . . 4.4900000000000002 110.823 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -152.25 153.42 33.71 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.467 1.507 . . . . 9.4199999999999999 112.122 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -155.66 142.16 18.65 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.197 1.799 . . . . 2.79 108.802 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -164.78 145.41 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 129.54 3.136 . . . . 6.8600000000000003 105.797 171.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 61.64 9.18 2.66 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.767 1.627 . . . . 3.5899999999999999 115.063 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.48 8.52 73.99 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.416 1.008 . . . . 2.23 114.95 -168.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -85.55 66.66 9.78 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.948 -1.325 . . . . 3.6099999999999999 111.938 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 111.93 1.7 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.331 -1.481 . . . . 3.3199999999999998 111.315 171.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -155.23 159.81 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.203 1.401 . . . . 4.2699999999999996 110.082 -170.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 65.1 mtm -91.84 172.69 8.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.71 1.004 . . . . 4.0700000000000003 113.71 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.59 -179.17 24.3 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.472 1.987 . . . . 0.78000000000000003 111.211 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ttm -144.38 147.21 33.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.248 1.419 . . . . 2.0299999999999998 107.856 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -158.97 155.44 24.47 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 5.5599999999999996 110.84 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.87 156.85 24.02 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.782 2.322 . . . . 0.75 111.635 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.49 155.58 63.92 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.44 1.496 . . . . 2.21 110.756 -176.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -84.81 -27.23 1.32 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.071 2.514 . . . . 0.68000000000000005 113.493 -165.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -178.39 166.56 1.85 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.228 1.811 . . . . 2.9300000000000002 112.003 -178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.2 mt -108.35 157.24 18.56 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.021 1.328 . . . . 2.1000000000000001 110.319 157.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -106.35 153.74 21.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.427 1.091 . . . . 1.8799999999999999 109.341 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.3 t -140.59 122.79 9.63 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 118.722 0.692 . . . . 2.3799999999999999 112.157 160.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.29 159.16 44.11 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.549 2.833 . . . . 1.3400000000000001 111.296 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.6 140.89 89.22 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.423 2.748 . . . . 1.3899999999999999 112.586 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt 66.21 -2.07 1.06 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.877 2.071 . . . . 2.6499999999999999 113.948 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.6 172.75 41.27 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.262 1.887 . . . . 1.26 113.577 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.51 144.0 23.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.137 1.375 . . . . 6.75 111.348 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.9 t -149.48 137.35 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 126.814 2.046 . . . . 4.0199999999999996 107.16 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -133.45 127.33 33.09 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.446 -1.316 . . . . 4.3600000000000003 107.446 -162.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.6 -51.41 68.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.37 0.668 . . . . 2.6899999999999999 111.616 -162.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 82.74 158.63 0.12 Allowed Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 126.708 2.003 . . . . 6.4500000000000002 114.98 159.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -60.53 127.14 21.82 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.218 1.945 . . . . 2.8399999999999999 110.22 168.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.88 54.7 34.77 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.975 -0.557 . . . . 3.0899999999999999 113.709 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.36 -44.74 0.03 OUTLIER Glycine 0 N--CA 1.473 1.117 0 N-CA-C 116.489 1.356 . . . . 1.9099999999999999 116.489 160.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -135.24 147.62 49.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.991 1.395 . . . . 3.54 109.871 163.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -161.24 149.01 15.33 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.678 0.791 . . . . 0.70999999999999996 109.693 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -79.07 136.43 37.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.426 -0.953 . . . . 3.5699999999999998 108.426 160.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.0 tpt -88.8 116.85 27.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.848 1.659 . . . . 1.9299999999999999 107.569 163.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -89.37 129.77 35.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.003 1.321 . . . . 2.0099999999999998 107.971 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.15 140.12 51.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.165 0.986 . . . . 3.2799999999999998 111.073 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.57 48.88 7.64 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.923 0.773 . . . . 2.4100000000000001 111.259 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.0 mt -51.99 156.11 1.64 Allowed 'General case' 0 N--CA 1.46 0.046 0 N-CA-C 115.254 1.576 . . . . 1.8700000000000001 115.254 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 29.9 mmtp -120.92 -22.12 6.31 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 113.551 -1.659 . . . . 4.46 113.513 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -132.89 142.83 46.16 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 128.436 2.695 . . . . 7.5499999999999998 109.122 165.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -68.93 137.57 38.26 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.369 2.046 . . . . 1.52 107.951 157.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.24 140.68 29.9 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.704 0.802 . . . . 3.0499999999999998 111.265 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.513 ' HZ1' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -113.24 165.12 12.72 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 123.559 1.647 . . . . 4.5999999999999996 111.329 165.478 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.81 134.1 41.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 112.88 -1.963 . . . . 2.0099999999999998 109.249 170.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.99 12.43 59.01 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.073 1.32 . . . . 1.97 115.051 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.513 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 43.8 mt-10 -94.07 -176.71 4.08 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.68 1.192 . . . . 2.6299999999999999 111.522 171.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.77 136.6 17.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 128.369 2.668 . . . . 3.04 106.183 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.3 t -147.86 146.2 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.979 1.312 . . . . 2.46 110.738 -168.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.542 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 14.6 mt-10 -76.4 142.77 40.99 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.56 0.744 . . . . 2.5699999999999998 112.162 -178.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mp -120.69 145.26 47.64 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.512 1.149 . . . . 2.9199999999999999 110.774 150.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -112.07 103.61 11.81 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.665 2.786 . . . . 2.4100000000000001 108.527 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.91 130.17 34.57 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.67 -1.268 . . . . 2.6099999999999999 110.762 -166.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.74 116.01 31.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.497 1.119 . . . . 2.3399999999999999 111.446 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -111.04 104.05 12.57 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.339 1.455 . . . . 3.3300000000000001 111.829 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 55.52 25.48 7.93 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.393 1.877 . . . . 3.2200000000000002 113.411 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.88 -58.22 4.27 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.229 1.395 . . . . 4.8099999999999996 112.697 -173.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.4 0.09 56.01 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.868 1.507 . . . . 2.1000000000000001 116.868 -167.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -137.04 143.09 42.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.535 1.668 . . . . 3.6000000000000001 111.649 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.35 148.82 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.121 1.768 . . . . 3.3199999999999998 110.711 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.5 tt -155.66 131.61 9.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.102 1.361 . . . . 3.1000000000000001 110.599 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.542 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 20.7 ttmm -92.36 144.75 25.06 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.265 -0.897 . . . . 3.3900000000000001 112.288 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.02 161.9 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.675 1.59 . . . . 2.9399999999999999 108.381 167.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.62 130.64 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.18 0.992 . . . . 2.9300000000000002 108.88 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.92 136.7 29.41 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.944 1.698 . . . . 4.0899999999999999 109.501 -165.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.47 160.2 41.99 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.385 2.723 . . . . 1.6599999999999999 111.911 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 t -109.51 120.61 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.255 1.022 . . . . 2.1400000000000001 110.478 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 . . . . . 0 N--CA 1.466 0.374 0 C-N-CA 126.169 1.788 . . . . 3.77 108.732 173.071 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 120.69 0.281 . . . . 4.9299999999999997 111.162 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.15 167.75 21.7 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 121.212 -0.93 . . . . 1.45 112.889 -169.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -151.96 165.5 34.44 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.619 0.768 . . . . 2.6600000000000001 112.893 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -105.88 139.58 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 106.471 -1.677 . . . . 2.1299999999999999 106.471 168.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ttt-85 -79.8 -126.63 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.102 0.865 . . . . 5.3600000000000003 109.001 170.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -154.45 154.43 33.19 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 119.695 -1.878 . . . . 4.4500000000000002 113.342 -173.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.7 t -176.36 140.36 0.52 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 129.757 3.223 . . . . 2.7799999999999998 107.037 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.2 -32.52 5.09 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.467 2.112 . . . . 1.49 112.067 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.88 171.95 23.58 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.807 1.194 . . . . 0.90000000000000002 112.657 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.95 1.21 19.5 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 119.026 1.413 . . . . 0.98999999999999999 112.6 -6.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.86 144.83 24.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.463 1.653 . . . . 3.25 115.463 -173.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.23 -176.11 3.14 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.898 2.479 . . . . 1.6299999999999999 112.58 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.5 133.25 25.45 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.089 1.356 . . . . 1.4099999999999999 110.987 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.0 141.69 40.76 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.699 1.2 . . . . 1.6899999999999999 112.67 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -115.64 58.69 0.73 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.143 2.577 . . . . 3.7799999999999998 109.978 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -64.31 162.05 15.57 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.054 -1.029 . . . . 2.8599999999999999 111.836 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 m -108.32 139.76 42.57 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.403 0.681 . . . . 2.3100000000000001 110.941 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.64 127.38 52.37 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.904 -1.044 . . . . 3.8399999999999999 110.242 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.3 145.71 39.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.4 1.48 . . . . 5.5 110.178 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.46 60.42 48.13 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.614 0.766 . . . . 3.04 111.897 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -60.66 -20.3 64.49 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.678 2.919 . . . . 1.6699999999999999 114.573 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.41 -171.84 36.73 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 122.638 1.132 . . . . 1.3799999999999999 113.677 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.414 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 10.3 m-20 -111.74 -3.02 15.11 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.17 1.788 . . . . 3.0899999999999999 112.45 -163.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.58 154.69 69.9 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 127.528 2.331 . . . . 3.9700000000000002 110.021 175.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.66 138.59 19.32 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.731 2.287 . . . . 1.6299999999999999 111.219 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.9 mt -94.89 137.84 33.44 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 123.602 1.667 . . . . 3.1899999999999999 112.341 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 ttp-105 -123.97 95.97 4.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.471 -2.149 . . . . 4.5300000000000002 111.508 -173.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.0 tp -79.62 107.71 12.6 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.413 1.885 . . . . 3.3900000000000001 109.909 -176.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -98.01 -25.41 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 112.724 0.639 . . . . 1.79 112.724 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.47 -173.96 27.56 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 124.657 1.122 . . . . 0.42999999999999999 112.388 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.23 174.19 10.06 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.667 -0.767 . . . . 1.4299999999999999 111.88 163.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.4 mtp-105 -138.97 170.95 15.05 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 128.992 2.917 . . . . 5.9199999999999999 107.056 158.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t 179.92 153.46 0.63 Allowed Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 125.459 1.504 . . . . 1.9199999999999999 110.022 -168.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.02 -1.7 9.45 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.8 2.333 . . . . 1.03 115.236 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -118.63 18.56 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 115.706 1.743 . . . . 1.97 115.706 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.04 162.63 18.04 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.194 2.197 . . . . 1.5800000000000001 109.105 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -120.84 -69.26 0.85 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.069 1.748 . . . . 4.0499999999999998 108.345 -172.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -84.1 75.05 10.2 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.528 -1.358 . . . . 6.6900000000000004 108.009 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.45 148.75 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.512 -0.767 . . . . 1.78 109.577 166.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.35 154.28 30.33 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.332 1.853 . . . . 4.0899999999999999 108.414 -164.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.9 tp -121.38 107.95 13.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.47 1.032 . . . . 1.8700000000000001 110.864 -167.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -115.94 150.13 37.63 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 114.99 1.478 . . . . 0.67000000000000004 114.99 -171.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -106.93 153.62 22.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.662 1.985 . . . . 2.1200000000000001 110.684 163.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.411 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 3.5 m -131.27 133.17 45.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.651 1.981 . . . . 2.2799999999999998 106.973 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -144.33 172.3 13.13 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.649 0.981 . . . . 3.3999999999999999 113.649 -167.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.5 ttp -99.25 147.05 25.56 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.627 1.571 . . . . 4.5899999999999999 109.889 167.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.91 158.35 43.05 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.876 1.67 . . . . 6.2699999999999996 109.822 -174.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -110.11 143.2 40.51 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.808 1.643 . . . . 2.8999999999999999 109.818 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.6 p -157.84 138.32 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.935 -1.135 . . . . 4.5300000000000002 107.935 163.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 64.25 25.11 13.51 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.864 0.865 . . . . 4.0099999999999998 111.587 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.03 10.6 78.09 Favored Glycine 0 N--CA 1.48 1.584 0 O-C-N 120.428 -1.42 . . . . 2.3700000000000001 113.865 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -123.18 121.61 36.37 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.791 2.036 . . . . 3.4500000000000002 109.565 -166.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 mtmm -72.38 131.92 43.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.165 1.386 . . . . 4.29 110.957 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.29 -179.5 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 129.095 2.958 . . . . 3.6600000000000001 109.367 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.73 162.39 22.11 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.787 0.835 . . . . 5.0700000000000003 112.289 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.57 31.12 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.54 1.067 . . . . 0.72999999999999998 113.319 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.0 ttm -154.75 144.3 21.4 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.226 1.41 . . . . 1.8600000000000001 110.567 -174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -148.79 161.72 31.94 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 126.105 1.762 . . . . 5.2599999999999998 109.897 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.07 161.4 26.54 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.247 1.964 . . . . 0.59999999999999998 111.956 168.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.92 154.9 68.99 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 126.683 1.993 . . . . 2.3100000000000001 110.612 175.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.91 -20.41 7.63 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.799 2.999 . . . . 0.52000000000000002 113.561 -165.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -178.33 163.69 1.65 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.431 1.892 . . . . 3.2200000000000002 111.166 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -110.98 157.76 19.54 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.946 1.299 . . . . 1.8100000000000001 109.822 159.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -133.17 152.33 51.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.519 0.728 . . . . 2.3199999999999998 111.359 172.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.2 t -136.15 141.09 34.95 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.536 1.934 . . . . 2.0299999999999998 112.398 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.83 156.13 13.57 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.282 3.321 . . . . 1.55 112.708 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -65.91 148.21 85.81 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.599 2.866 . . . . 1.3600000000000001 114.064 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 71.9 mmtt 70.24 -13.4 0.44 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 129.133 2.973 . . . . 2.3999999999999999 114.934 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.7 164.23 48.61 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.289 0.947 . . . . 1.96 113.454 173.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -98.41 159.06 15.19 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.519 -0.919 . . . . 4.8899999999999997 108.519 145.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.9 t -148.57 118.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.268 1.427 . . . . 4.4199999999999999 107.48 163.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -78.85 156.26 28.76 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.719 -0.613 . . . . 2.9700000000000002 112.376 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.89 144.43 57.28 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.099 -1.074 . . . . 2.6000000000000001 108.099 155.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.408 ' H ' ' HB2' ' A' ' 82' ' ' TYR . 7.9 mptt -84.45 126.98 67.77 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 120.153 -1.592 . . . . 4.25 109.751 -170.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -60.78 -14.82 34.07 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.814 3.009 . . . . 2.8399999999999999 115.071 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.56 -58.24 0.77 Allowed Glycine 0 CA--C 1.531 1.069 0 CA-C-N 118.752 0.706 . . . . 3.4700000000000002 111.867 155.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -75.15 -17.12 80.28 Favored Glycine 0 N--CA 1.476 1.338 0 N-CA-C 119.307 2.483 . . . . 2.0 119.307 -158.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.408 ' HB2' ' H ' ' A' ' 78' ' ' LYS . 80.5 m-85 -147.63 141.32 25.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.698 2.249 . . . . 3.46 111.643 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -158.2 150.32 21.88 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.606 0.763 . . . . 0.93000000000000005 111.392 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -79.71 117.03 20.24 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 108.912 -0.773 . . . . 3.02 108.912 162.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 tpt -77.81 124.49 28.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.726 2.01 . . . . 1.9099999999999999 108.278 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.5 mt -117.05 97.32 5.87 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.343 1.457 . . . . 3.2799999999999998 108.946 -167.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.51 149.39 26.26 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.775 0.798 . . . . 3.4700000000000002 111.839 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.41 51.98 6.35 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 110.879 -0.888 . . . . 2.0800000000000001 110.879 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -50.77 151.44 2.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.682 1.23 . . . . 2.0600000000000001 113.864 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -114.45 -20.49 10.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.031 -1.895 . . . . 3.9900000000000002 114.648 -173.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -126.51 154.55 75.2 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.294 2.238 . . . . 7.1200000000000001 108.184 166.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -64.7 139.92 65.56 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 N-CA-C 107.867 -1.628 . . . . 2.98 107.867 151.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.26 163.34 29.52 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.192 1.397 . . . . 3.5499999999999998 109.225 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.07 170.47 20.41 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.236 0.828 . . . . 4.9500000000000002 113.236 174.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.19 134.44 57.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.932 0.893 . . . . 2.54 110.339 170.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.11 -7.52 35.32 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.683 1.611 . . . . 1.6899999999999999 115.323 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.69 -179.69 6.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.447 1.123 . . . . 3.7999999999999998 110.676 174.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -138.51 141.7 39.36 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.648 1.979 . . . . 3.3999999999999999 106.937 160.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.9 t -148.53 145.25 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.784 1.634 . . . . 2.4399999999999999 110.181 -165.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.51 145.62 26.72 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.263 1.579 . . . . 3.4700000000000002 115.263 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -118.31 144.29 45.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.79 1.636 . . . . 3.6800000000000002 109.526 161.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -95.62 113.24 24.87 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 128.568 2.747 . . . . 1.9399999999999999 108.171 167.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.9 mp -86.5 112.16 21.26 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.617 1.167 . . . . 2.9700000000000002 107.954 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.9 mt -95.61 106.33 18.41 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.79 0.805 . . . . 2.02 110.705 -174.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -98.25 126.84 43.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.882 1.273 . . . . 3.25 111.929 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.81 41.27 4.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.088 2.155 . . . . 2.9100000000000001 112.822 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.85 -93.17 1.73 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 125.338 1.447 . . . . 5.9900000000000002 111.458 -171.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.08 -6.68 61.55 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 116.969 1.548 . . . . 3.0800000000000001 116.969 -160.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -81.94 100.37 9.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.111 2.456 . . . . 5.0499999999999998 110.632 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -94.91 137.0 24.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.235 1.014 . . . . 3.3799999999999999 112.554 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.4 tp -133.71 113.97 12.92 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.711 1.604 . . . . 3.6400000000000001 109.703 170.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -89.73 125.59 35.34 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.616 -0.677 . . . . 3.1699999999999999 111.482 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.04 157.9 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.745 0.818 . . . . 3.71 110.765 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.0 t -104.13 143.76 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.715 1.606 . . . . 2.77 108.706 -173.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.13 141.11 14.56 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.571 1.549 . . . . 2.9900000000000002 109.399 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.16 157.88 59.91 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.221 3.281 . . . . 0.98999999999999999 113.743 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.7 t -110.23 139.59 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.852 2.061 . . . . 2.1800000000000002 108.928 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? . . . . . 0 N--CA 1.479 1.02 0 CA-C-N 119.741 1.155 . . . . 5.3499999999999996 114.025 -170.518 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 106.454 -1.684 . . . . 4.0800000000000001 106.454 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.93 164.69 32.38 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 127.159 2.314 . . . . 1.55 111.091 -178.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -157.75 156.3 31.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.125 1.37 . . . . 2.5899999999999999 111.213 177.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.3 t -80.27 158.54 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.441 0.696 . . . . 2.52 109.42 175.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.72 -26.39 44.76 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.805 1.78 . . . . 6.3399999999999999 115.805 -176.144 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 85.0 t80 72.36 115.32 0.05 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.69 2.796 . . . . 3.5299999999999998 111.756 -168.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.1 m -164.24 143.16 5.97 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 126.239 1.815 . . . . 3.27 108.047 169.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.35 -25.77 11.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.828 2.352 . . . . 1.53 112.374 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.4 175.2 16.27 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 126.814 2.15 . . . . 0.80000000000000004 110.189 -172.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.42 -7.71 15.84 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 CA-C-N 119.473 1.637 . . . . 1.0600000000000001 112.747 -5.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -140.44 169.63 17.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.083 0.953 . . . . 2.02 113.393 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.65 -177.62 5.39 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.644 2.378 . . . . 1.8700000000000001 109.966 175.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.59 170.35 14.86 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.76 1.224 . . . . 1.9299999999999999 110.071 169.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.98 144.22 21.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.727 1.211 . . . . 1.8300000000000001 111.254 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.94 152.52 40.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.681 1.992 . . . . 4.4900000000000002 109.315 -178.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -165.45 157.44 14.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.954 1.094 . . . . 3.1600000000000001 113.954 -177.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.8 m -84.4 124.15 30.99 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.789 1.635 . . . . 2.4300000000000002 109.928 169.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.38 132.17 44.89 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.399 1.479 . . . . 4.3300000000000001 108.988 170.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -123.53 145.03 49.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.691 0.797 . . . . 3.5800000000000001 112.01 177.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.53 72.59 7.63 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.264 -0.88 . . . . 3.2200000000000002 110.47 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.31 -19.84 55.69 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.707 2.271 . . . . 1.3899999999999999 113.607 -178.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.29 169.7 54.86 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-O 123.034 1.352 . . . . 1.3400000000000001 113.01 174.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.451 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 11.5 m-20 -95.82 -4.33 43.98 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 128.199 2.6 . . . . 3.1499999999999999 112.843 -170.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -122.24 160.31 48.33 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.353 2.261 . . . . 5.4000000000000004 108.717 172.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.97 143.25 14.29 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.859 2.373 . . . . 1.53 110.844 -169.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.8 mt -94.3 153.49 17.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 122.72 1.247 . . . . 2.8500000000000001 112.435 172.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -136.41 113.12 10.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.131 -1.849 . . . . 2.5299999999999998 110.65 178.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.87 112.02 24.36 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.78 2.032 . . . . 3.04 108.539 -172.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.3 m -102.54 -29.07 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.886 0.875 . . . . 1.8799999999999999 113.011 -169.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.07 -174.44 30.94 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.969 1.271 . . . . 0.54000000000000004 113.047 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.76 -178.75 5.15 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.79 0.805 . . . . 1.99 110.924 167.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -139.73 179.39 6.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.667 2.787 . . . . 7.04 107.393 161.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t 176.6 151.19 0.35 Allowed Pre-proline 0 N--CA 1.469 0.484 0 C-N-CA 127.769 2.427 . . . . 1.7 106.796 -170.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.68 -7.74 14.65 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.716 2.277 . . . . 0.87 113.902 174.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.74 31.94 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.725 1.38 . . . . 2.04 114.725 -170.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.92 138.28 13.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.662 1.585 . . . . 1.75 110.977 168.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -61.2 -39.94 92.08 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.259 1.023 . . . . 2.8799999999999999 111.498 173.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -144.15 143.38 31.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 128.567 2.747 . . . . 6.9800000000000004 106.308 -168.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.07 137.02 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.018 -1.105 . . . . 2.2200000000000002 108.018 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -144.12 138.29 28.1 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.813 1.245 . . . . 2.98 109.638 -171.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -87.06 135.61 33.22 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 123.076 1.417 . . . . 3.29 113.335 173.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -116.89 154.67 30.39 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 127.576 2.35 . . . . 1.1399999999999999 110.914 176.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -103.31 155.93 18.1 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.388 1.875 . . . . 2.9100000000000001 110.453 161.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.432 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 24.6 m -127.73 132.44 49.59 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.007 -1.479 . . . . 2.0699999999999998 107.007 172.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -144.81 176.44 9.45 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.729 1.381 . . . . 3.3700000000000001 114.729 -166.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.6 ttp -113.36 142.47 45.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.823 2.049 . . . . 4.75 111.399 176.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -128.29 163.28 25.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.227 1.811 . . . . 6.9000000000000004 111.753 166.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -94.6 145.32 24.91 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.008 -1.849 . . . . 3.52 106.008 152.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.8 p -153.09 124.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.324 0.65 . . . . 4.46 109.367 164.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.495 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 0.7 OUTLIER 64.02 22.03 12.8 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.925 1.69 . . . . 4.54 113.163 -172.655 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.23 11.55 83.35 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 120.547 -1.346 . . . . 2.4300000000000002 113.622 -171.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 8.8 mtmp? -109.57 118.8 37.54 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.55 1.54 . . . . 4.8499999999999996 110.265 177.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.63 127.28 31.21 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.986 1.314 . . . . 4.5300000000000002 109.251 164.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -145.52 176.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 128.294 2.637 . . . . 4.4800000000000004 109.759 -176.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -130.5 166.25 20.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.313 1.045 . . . . 4.6600000000000001 112.459 178.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.92 -179.84 31.29 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.395 1.474 . . . . 0.90000000000000002 112.954 177.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -153.91 137.38 15.89 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.006 1.322 . . . . 2.0099999999999998 110.305 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -144.73 156.29 56.06 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.785 1.634 . . . . 11.279999999999999 111.302 -174.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.95 154.71 53.22 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.705 2.27 . . . . 0.68999999999999995 110.488 172.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.83 158.39 73.87 Favored Pre-proline 0 N--CA 1.484 1.275 0 CA-C-O 118.299 -0.858 . . . . 1.8700000000000001 111.063 169.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -84.26 -18.78 4.88 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.313 2.675 . . . . 0.91000000000000003 113.969 -170.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -178.09 169.04 1.96 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.284 1.833 . . . . 2.9900000000000002 111.771 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.8 mt -115.27 154.99 28.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.79 2.036 . . . . 1.79 110.089 162.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.84 146.67 42.74 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.196 1.399 . . . . 1.6499999999999999 108.577 173.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.3 t -137.35 138.69 25.61 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.948 -0.548 . . . . 2.0 111.991 169.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -83.72 156.23 13.79 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 124.237 3.291 . . . . 1.29 112.479 178.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.57 140.31 80.73 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.765 2.977 . . . . 1.28 113.668 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 69.1 mmtt 69.55 -8.34 0.76 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.369 2.668 . . . . 2.1699999999999999 114.345 -177.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.96 149.84 35.03 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.671 1.129 . . . . 1.3200000000000001 112.266 175.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -108.71 132.03 54.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.924 1.689 . . . . 5.4699999999999998 106.88 163.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.8 122.93 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.075 1.35 . . . . 4.3499999999999996 107.916 177.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -101.95 135.56 43.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.87 1.268 . . . . 5.0599999999999996 110.116 -176.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.84 -48.5 66.98 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.877 1.671 . . . . 3.3199999999999998 113.216 -171.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HB2' ' HZ3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 103.25 118.38 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 131.047 3.739 . . . . 4.1200000000000001 111.307 176.213 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.66 -1.01 6.8 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.513 2.808 . . . . 2.8100000000000001 115.036 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.13 2.31 12.99 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.434 1.492 . . . . 2.4900000000000002 114.774 170.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -132.9 -106.66 1.0 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.355 1.455 . . . . 1.8999999999999999 112.248 -174.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -77.47 138.19 39.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.147 0.975 . . . . 3.4900000000000002 111.489 -175.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -160.17 146.01 15.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.827 -0.624 . . . . 0.84999999999999998 111.057 -175.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.8 136.49 38.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.093 -1.077 . . . . 3.1600000000000001 108.093 165.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.7 mtp -99.79 135.66 40.88 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 118.717 0.689 . . . . 3.1899999999999999 110.001 157.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.8 109.03 20.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.691 -1.596 . . . . 2.5 106.691 -179.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -102.61 130.9 49.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.88 1.672 . . . . 3.6800000000000002 108.489 -173.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.81 53.51 8.12 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.824 0.726 . . . . 1.73 112.836 174.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.0 mt -48.23 156.54 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 115.938 1.829 . . . . 1.6100000000000001 115.938 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -110.96 -25.73 9.66 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 113.733 -1.576 . . . . 2.3799999999999999 113.973 178.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -124.53 142.07 39.48 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.412 2.285 . . . . 5.8799999999999999 109.068 169.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.27 156.18 55.3 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.7 2.267 . . . . 1.45 109.73 160.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.21 161.77 13.81 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.249 1.02 . . . . 2.8500000000000001 112.025 -169.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -132.74 -176.42 4.1 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.952 2.101 . . . . 5.3200000000000003 110.641 175.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.5 150.49 24.54 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.259 -1.015 . . . . 2.73 108.259 156.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.39 36.77 43.49 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.429 0.537 . . . . 1.77 114.386 176.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -122.63 -178.03 3.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.609 1.164 . . . . 3.3399999999999999 110.009 161.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -139.56 135.57 33.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.873 2.469 . . . . 3.6299999999999999 105.214 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.3 t -142.85 148.94 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.488 1.915 . . . . 2.6800000000000002 109.898 -171.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.56 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 4.0 pt-20 -100.83 148.67 24.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.165 1.386 . . . . 2.5499999999999998 114.071 -173.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mp -127.16 158.91 35.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.189 2.195 . . . . 2.6299999999999999 110.125 167.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -132.14 94.3 3.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.983 1.713 . . . . 2.79 110.762 -172.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.2 mp -78.48 135.93 37.48 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.375 1.07 . . . . 2.5699999999999998 111.264 -168.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.2 mt -106.83 119.5 39.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.069 1.747 . . . . 1.95 110.072 -176.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -118.58 145.44 45.39 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.235 1.414 . . . . 3.25 111.016 -172.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.81 126.35 27.3 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.912 1.079 . . . . 2.25 113.912 -169.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.82 68.47 1.49 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.907 1.241 . . . . 3.5899999999999999 112.502 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 20.44 79.83 Favored Glycine 0 N--CA 1.472 1.099 0 N-CA-C 116.278 1.271 . . . . 1.54 116.278 163.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -112.99 138.59 49.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.552 1.676 . . . . 4.4800000000000004 111.72 -173.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.4 t -139.82 145.87 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.347 1.059 . . . . 3.04 109.675 178.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 tp -145.66 120.38 9.86 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.794 1.237 . . . . 3.1400000000000001 111.23 178.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.56 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 23.0 ttmm -79.01 137.92 37.79 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.529 -0.732 . . . . 3.3700000000000001 111.155 173.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.05 161.58 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.946 2.098 . . . . 4.0199999999999996 110.026 173.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.2 t -136.09 136.02 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.377 1.471 . . . . 2.79 109.084 177.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.84 148.29 35.52 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.925 1.69 . . . . 3.54 111.354 -173.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.81 151.97 81.39 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.403 2.735 . . . . 1.01 113.243 175.24 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.0 t -95.32 118.86 42.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.839 -1.073 . . . . 2.5 108.376 172.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 . . . . . 0 CA--C 1.535 0.382 0 C-N-CA 125.4 1.48 . . . . 5.5899999999999999 109.302 178.069 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.432 ' C ' ' HB ' ' A' ' 21' ' ' THR . 8.6 pm0 . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 114.769 1.396 . . . . 5.4000000000000004 114.769 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.8 179.41 53.18 Favored Glycine 0 N--CA 1.47 0.908 0 O-C-N 121.285 -0.884 . . . . 2.73 114.078 173.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -153.01 146.07 24.62 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.999 1.319 . . . . 3.23 112.929 167.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.8 t -93.67 146.82 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.268 1.427 . . . . 1.99 107.277 177.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.401 ' HG3' ' H ' ' A' ' 10' ' ' PHE 0.33 0.3 OUTLIER -74.88 -106.1 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.419 1.009 . . . . 5.5800000000000001 113.528 176.117 . . . . . . . . 4 4 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.401 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 50.9 t80 -171.19 148.75 2.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.667 1.987 . . . . 3.1800000000000002 110.349 -178.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.8 t -179.6 143.43 0.38 Allowed Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 128.114 2.566 . . . . 2.7000000000000002 109.268 174.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.07 -23.75 10.25 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.843 2.362 . . . . 1.3899999999999999 112.12 169.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.81 176.81 14.56 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 126.676 2.084 . . . . 0.83999999999999997 111.573 -171.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.11 -6.37 16.7 Favored 'Cis proline' 0 CA--C 1.537 0.653 0 CA-C-N 118.571 1.185 . . . . 1.02 112.337 -9.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -147.61 148.53 31.2 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.578 1.325 . . . . 2.8599999999999999 114.578 -177.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.08 -174.58 2.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.588 2.755 . . . . 1.54 111.313 -179.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.81 164.33 30.52 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.066 1.746 . . . . 1.4199999999999999 108.825 170.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.96 153.16 32.4 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.323 0.965 . . . . 1.76 112.595 -177.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -122.6 87.71 2.8 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.631 1.972 . . . . 4.1100000000000003 110.802 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.45 158.68 35.6 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 119.41 -2.056 . . . . 3.3799999999999999 113.374 177.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.432 ' HB ' ' C ' ' A' ' 5' ' ' GLU . 20.8 m -135.47 141.27 45.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.459 1.904 . . . . 2.7000000000000002 106.62 167.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.9 tp -162.46 156.27 20.88 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.9 2.48 . . . . 5.7599999999999998 109.556 177.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -102.04 154.35 19.06 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.224 -1.548 . . . . 4.25 113.427 166.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -97.74 92.68 1.4 Allowed Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 121.036 -1.04 . . . . 1.52 109.13 162.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.05 -15.65 18.37 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.566 2.177 . . . . 1.6499999999999999 113.436 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.52 -173.75 47.06 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-O 122.421 1.011 . . . . 1.1399999999999999 112.882 -178.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.4 m-20 -115.66 2.23 13.69 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.16 1.784 . . . . 3.2000000000000002 112.306 -167.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -112.41 155.58 43.49 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.985 2.114 . . . . 4.0199999999999996 111.017 173.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.55 158.83 25.44 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.615 2.21 . . . . 1.01 110.979 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.6 mt -115.52 148.66 39.24 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.198 1.399 . . . . 3.0699999999999998 110.469 174.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -131.61 110.63 11.07 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 112.608 -2.087 . . . . 2.9100000000000001 110.655 171.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -98.12 110.39 22.98 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.959 2.103 . . . . 3.23 108.348 -170.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.78 -21.61 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.303 1.041 . . . . 1.8999999999999999 111.938 -165.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.85 -175.97 33.45 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 125.586 1.565 . . . . 0.44 112.617 -178.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.42 -174.92 4.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.079 1.351 . . . . 1.3600000000000001 111.372 172.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -155.73 154.58 31.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.398 1.479 . . . . 5.2000000000000002 108.11 163.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -167.51 149.33 5.27 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 117.597 -1.192 . . . . 2.1499999999999999 109.215 -176.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.43 -19.1 10.49 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.884 1.723 . . . . 1.1499999999999999 113.207 -174.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -87.13 18.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 113.874 1.064 . . . . 2.8700000000000001 113.874 -178.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.45 175.15 13.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.531 1.933 . . . . 1.79 109.599 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -111.56 -32.24 6.74 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.403 1.481 . . . . 2.73 113.155 177.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -139.59 159.59 41.81 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.014 2.926 . . . . 6.8300000000000001 106.11 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 p -157.05 106.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 125.219 1.408 . . . . 2.27 111.005 -173.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.22 132.74 54.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.663 -1.608 . . . . 5.3899999999999997 111.622 -159.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.0 tp -84.69 124.08 31.09 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.012 -0.995 . . . . 2.0899999999999999 111.994 -163.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -121.39 161.97 21.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.355 1.462 . . . . 0.62 113.088 179.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.88 -174.09 2.44 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.477 1.911 . . . . 3.29 110.73 163.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 m -146.03 138.78 25.64 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.056 -1.091 . . . . 1.8700000000000001 108.056 167.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -135.42 173.3 11.87 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 122.984 1.373 . . . . 3.6699999999999999 114.112 -172.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -122.06 142.17 50.62 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.709 2.004 . . . . 6.0899999999999999 111.897 170.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.15 158.84 41.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.627 1.971 . . . . 7.5899999999999999 110.739 172.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -129.01 133.29 47.69 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.955 2.102 . . . . 2.75 106.421 166.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -150.42 9.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.236 1.014 . . . . 4.4100000000000001 113.532 -169.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -168.95 18.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.161 0.8 . . . . 4.2599999999999998 113.161 -156.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.28 13.44 58.03 Favored Glycine 0 N--CA 1.478 1.497 0 O-C-N 120.882 -1.136 . . . . 2.04 113.346 -168.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -143.96 145.76 32.47 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.461 2.704 . . . . 3.9500000000000002 107.661 -174.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -105.54 133.61 50.02 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.009 2.124 . . . . 3.6499999999999999 109.331 -171.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -155.15 149.13 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.108 1.363 . . . . 3.4500000000000002 110.488 -171.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -102.42 167.01 10.23 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.546 0.943 . . . . 4.1200000000000001 113.546 -169.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.62 -179.19 30.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.996 1.76 . . . . 0.78000000000000003 112.851 178.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -151.56 141.79 22.32 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.104 1.762 . . . . 1.98 108.082 -177.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -150.73 157.14 36.21 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.198 0.999 . . . . 5.7599999999999998 110.217 -177.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.06 158.01 34.13 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.6 2.2 . . . . 0.55000000000000004 111.497 -179.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.68 152.75 71.37 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.647 1.179 . . . . 1.6299999999999999 110.154 177.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.7 -24.12 6.41 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.14 2.56 . . . . 0.67000000000000004 113.187 -167.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -178.3 166.72 1.9 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.444 1.898 . . . . 3.3100000000000001 111.15 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 mt -109.91 154.27 23.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.953 1.301 . . . . 1.72 110.091 163.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -114.24 143.06 45.46 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.581 1.152 . . . . 1.8 109.28 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.8 t -144.5 136.19 12.86 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.136 0.791 . . . . 2.0899999999999999 113.136 172.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.24 167.34 26.03 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.648 2.898 . . . . 0.93000000000000005 113.061 177.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.54 145.67 97.62 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.742 2.961 . . . . 1.01 111.632 167.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 57.4 mmtt 66.94 -3.69 0.9 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.813 1.645 . . . . 2.2400000000000002 113.634 -178.005 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.48 174.73 55.05 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.748 1.642 . . . . 1.23 112.05 171.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 mtt85 -102.64 137.82 40.36 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.426 1.09 . . . . 5.9000000000000004 109.255 175.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.05 104.07 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.535 1.934 . . . . 7.2199999999999998 106.447 176.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.21 130.08 12.47 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.443 1.116 . . . . 3.6800000000000002 112.394 -163.173 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.32 131.13 40.25 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.156 1.382 . . . . 2.52 107.716 166.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.53 149.78 37.4 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.547 1.139 . . . . 4.3700000000000001 112.525 -166.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.26 -38.45 90.88 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.991 3.127 . . . . 2.6099999999999999 112.6 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.34 115.68 4.34 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.714 -1.354 . . . . 2.8700000000000001 109.714 164.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.51 -122.49 5.45 Favored Glycine 0 N--CA 1.467 0.704 0 C-N-CA 126.716 2.103 . . . . 1.55 110.896 176.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -71.34 134.56 46.81 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.709 0.755 . . . . 3.02 112.313 -167.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -157.81 151.86 24.31 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.536 1.134 . . . . 0.72999999999999998 110.893 -177.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -84.47 135.24 34.33 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.064 -1.022 . . . . 3.3999999999999999 108.414 168.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -86.31 127.16 34.75 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 126.207 1.803 . . . . 1.8400000000000001 108.285 162.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.73 112.16 25.12 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.839 1.255 . . . . 2.5 108.387 -175.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.87 135.17 47.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.33 1.052 . . . . 3.6899999999999999 110.57 -169.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.62 48.51 7.91 Favored Glycine 0 N--CA 1.472 1.045 0 O-C-N 121.415 -0.803 . . . . 1.72 113.803 172.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.96 153.11 1.92 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 123.369 1.557 . . . . 1.71 114.768 178.036 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -124.18 -23.49 4.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 112.174 -2.285 . . . . 2.5299999999999998 114.472 -165.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -118.06 145.82 37.77 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 117.927 -1.035 . . . . 7.2199999999999998 108.727 152.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.11 98.08 0.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 106.675 -2.086 . . . . 1.8100000000000001 106.675 164.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.88 164.31 26.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.339 1.056 . . . . 3.7000000000000002 113.211 -169.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -139.4 150.22 45.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.362 1.865 . . . . 6.6100000000000003 113.412 -173.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.01 137.37 56.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 113.879 -1.509 . . . . 2.6899999999999999 108.159 171.03 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.02 -6.2 81.75 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.137 1.351 . . . . 1.5600000000000001 114.601 -173.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -76.61 -176.89 3.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.047 1.424 . . . . 2.6400000000000001 111.707 167.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -135.44 155.55 50.35 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 128.619 2.768 . . . . 3.9500000000000002 107.127 171.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.6 t -147.85 156.08 9.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 129.538 3.135 . . . . 2.1400000000000001 107.667 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -117.81 154.16 32.26 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.62 -0.675 . . . . 2.2799999999999998 111.26 167.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 tt -145.71 132.65 20.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.764 0.793 . . . . 4.04 111.327 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -77.14 134.21 38.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 129.152 2.981 . . . . 2.1800000000000002 109.332 166.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -97.58 127.61 43.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.183 0.993 . . . . 2.4100000000000001 108.763 162.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.21 115.75 30.6 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.01 0.924 . . . . 1.73 109.337 175.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -111.2 151.86 27.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.579 1.552 . . . . 3.4199999999999999 111.414 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.59 151.74 32.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.126 0.571 . . . . 2.3300000000000001 111.448 170.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.58 23.33 47.31 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 119.003 -0.887 . . . . 3.8700000000000001 114.364 -177.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.52 35.49 46.85 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.246 0.927 . . . . 1.54 113.376 173.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -120.6 122.08 39.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 117.871 0.836 . . . . 4.1299999999999999 111.582 -167.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.23 142.86 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.801 1.64 . . . . 3.1800000000000002 109.96 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.92 113.91 5.45 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.759 0.824 . . . . 3.0699999999999998 110.829 -177.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -94.75 121.0 35.88 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.647 0.779 . . . . 2.79 112.397 -176.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.4 t -109.39 163.34 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.653 1.981 . . . . 2.8900000000000001 109.888 178.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.7 t -119.3 140.78 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.552 1.941 . . . . 3.2799999999999998 109.616 178.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.24 142.65 13.21 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.867 1.267 . . . . 3.4900000000000002 114.047 -165.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.32 163.84 36.77 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.438 2.759 . . . . 1.03 112.582 172.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.26 131.18 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.996 1.318 . . . . 1.8999999999999999 109.107 165.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 126.874 2.07 . . . . 3.48 108.69 179.238 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.008 0.433 . . . . 4.6100000000000003 111.163 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.08 163.48 30.16 Favored Glycine 0 C--N 1.333 0.402 0 O-C-N 121.406 -0.809 . . . . 1.53 111.207 170.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.0 p90 -140.4 177.91 7.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.737 0.643 . . . . 2.8599999999999999 112.737 178.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.9 t -111.72 143.75 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.707 1.203 . . . . 2.2599999999999998 111.301 -178.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -27.06 64.38 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 129.328 3.051 . . . . 9.0500000000000007 116.445 -173.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.5 t80 66.73 129.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.611 2.765 . . . . 3.2599999999999998 113.634 -168.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -174.34 146.64 1.12 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.185 1.794 . . . . 2.5099999999999998 110.896 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.13 -20.21 11.57 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.961 2.441 . . . . 1.52 112.73 168.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.28 -174.49 19.23 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.781 1.658 . . . . 0.93999999999999995 111.663 -172.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.74 -10.64 9.77 Favored 'Cis proline' 0 CA--C 1.537 0.674 0 CA-C-N 119.133 1.467 . . . . 1.24 112.493 -8.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -132.25 157.74 43.59 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 123.295 1.521 . . . . 2.4900000000000002 114.879 173.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.05 -176.39 4.05 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.448 2.699 . . . . 1.55 109.781 171.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.9 152.58 36.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.153 1.781 . . . . 1.7 107.617 176.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.01 140.1 41.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.32 0.964 . . . . 1.5600000000000001 111.322 -177.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -114.18 34.22 4.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.51 1.524 . . . . 3.9500000000000002 112.763 -165.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 tt -48.43 143.82 4.56 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.737 2.015 . . . . 3.6899999999999999 112.862 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 15.1 t -82.74 149.75 27.09 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.457 0.91 . . . . 3.48 113.457 170.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.83 116.47 27.51 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.77 0.828 . . . . 4.5700000000000003 110.278 170.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -121.71 142.69 49.91 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.288 1.435 . . . . 4.5199999999999996 109.53 171.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -106.38 101.4 35.1 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.595 1.158 . . . . 1.5600000000000001 109.875 175.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.03 -10.95 15.13 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.951 2.434 . . . . 1.3700000000000001 113.597 175.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.23 -177.61 50.75 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-O 122.502 1.057 . . . . 1.1100000000000001 112.86 -176.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -108.81 -1.71 19.05 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.383 2.273 . . . . 2.9100000000000001 111.774 -173.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.6 160.85 42.49 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 128.502 2.721 . . . . 3.6200000000000001 109.67 173.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.63 146.69 21.54 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.674 2.249 . . . . 1.01 111.525 -175.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mp -107.77 150.09 27.41 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.78 1.232 . . . . 3.52 110.383 174.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -135.91 108.15 7.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.436 -2.165 . . . . 4.3099999999999996 110.257 178.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 tt -86.44 124.11 32.4 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.011 0.925 . . . . 3.2200000000000002 109.013 176.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.3 -23.61 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.53 0.732 . . . . 2.1600000000000001 111.531 -179.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.85 -173.16 27.99 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 124.73 1.157 . . . . 0.48999999999999999 114.299 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.93 -179.07 5.39 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.925 1.29 . . . . 1.8 111.216 165.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -139.16 160.38 39.94 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.658 1.983 . . . . 6.7000000000000002 107.252 155.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -161.0 149.26 12.85 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 125.651 1.58 . . . . 1.6499999999999999 108.248 -178.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.02 -2.25 12.37 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.129 1.886 . . . . 1.1100000000000001 114.25 -177.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.99 31.38 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.336 1.454 . . . . 1.8600000000000001 114.524 -170.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.39 159.51 44.41 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.835 1.654 . . . . 1.8999999999999999 110.419 165.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -83.4 -57.37 3.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.76 1.624 . . . . 2.77 110.094 169.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -106.68 130.47 54.41 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.47 1.508 . . . . 6.4400000000000004 107.351 166.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.78 144.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.137 -0.69 . . . . 2.0 109.137 152.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -138.6 152.49 48.19 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.966 1.707 . . . . 2.75 109.374 -173.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.2 tp -108.6 117.61 34.63 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.498 0.719 . . . . 2.1800000000000002 110.916 -173.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -121.73 152.76 39.06 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.569 1.548 . . . . 0.54000000000000004 113.283 -176.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -96.7 167.87 10.85 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.842 1.257 . . . . 2.1899999999999999 111.476 159.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.9 m -129.42 138.95 51.76 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.284 1.834 . . . . 1.8700000000000001 107.096 170.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -140.69 171.27 14.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.403 1.096 . . . . 3.29 113.649 -173.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -115.31 142.51 46.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.543 1.937 . . . . 6.6200000000000001 111.407 173.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -137.59 139.45 40.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.155 0.982 . . . . 6.75 111.658 169.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -91.11 139.07 31.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.886 1.275 . . . . 2.9199999999999999 107.788 161.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.9 t -141.76 128.56 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 106.033 -1.839 . . . . 3.4399999999999999 106.033 168.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 58.68 24.42 12.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.11 1.364 . . . . 5.6699999999999999 114.408 -176.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.56 29.15 73.73 Favored Glycine 0 N--CA 1.472 1.095 0 O-C-N 120.488 -1.382 . . . . 1.98 112.453 -170.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mmtm -121.4 120.62 35.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.009 2.124 . . . . 5.7999999999999998 108.427 169.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 126.47 40.97 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.119 1.367 . . . . 3.5099999999999998 112.12 -176.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.3 t -144.33 144.98 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.976 2.11 . . . . 3.4700000000000002 108.277 -171.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 73.4 mtm -90.63 172.9 8.35 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.361 0.874 . . . . 4.1900000000000004 113.361 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.4 30.99 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.748 1.166 . . . . 1.1299999999999999 111.783 166.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.07 162.32 35.23 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.484 0.713 . . . . 4.4500000000000002 110.771 161.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -157.19 154.47 26.04 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.871 1.268 . . . . 5.4199999999999999 110.062 -177.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.86 154.65 43.34 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.134 1.89 . . . . 0.62 112.001 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.0 155.05 74.74 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.669 1.588 . . . . 1.8500000000000001 110.182 179.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.78 -26.34 2.53 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.096 2.531 . . . . 0.65000000000000002 113.333 -167.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -176.42 166.73 2.77 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.989 1.716 . . . . 3.71 111.231 -177.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.6 mt -114.63 151.76 33.0 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.002 1.721 . . . . 2.1600000000000001 110.517 166.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -120.79 138.94 53.77 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.767 1.227 . . . . 1.8100000000000001 109.024 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -140.81 126.67 11.41 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.192 0.442 . . . . 2.1899999999999999 112.192 170.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.53 161.71 41.65 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.392 3.394 . . . . 1.3200000000000001 111.958 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -59.9 140.37 92.65 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.673 2.916 . . . . 0.94999999999999996 113.051 -175.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 68.65 -3.02 1.49 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.179 2.192 . . . . 2.3799999999999999 114.484 178.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.4 169.15 28.74 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.565 1.555 . . . . 1.21 113.183 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -143.47 158.64 43.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.853 0.861 . . . . 6.0599999999999996 112.536 172.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.1 t -156.14 113.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 127.642 2.377 . . . . 4.6900000000000004 108.475 174.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -77.34 151.33 34.98 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.03 0.832 . . . . 3.5600000000000001 111.813 -179.693 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.4 65.21 1.21 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.53 1.157 . . . . 2.3500000000000001 109.414 162.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -58.52 145.89 74.84 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.55 1.14 . . . . 5.1699999999999999 113.201 -174.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.85 81.39 0.84 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.342 2.695 . . . . 2.73 109.391 169.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.64 34.0 0.1 OUTLIER Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.372 0.987 . . . . 2.3999999999999999 113.495 -162.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.04 -25.75 0.24 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 117.418 1.727 . . . . 2.4199999999999999 117.418 160.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -145.48 146.91 31.66 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.742 1.271 . . . . 3.0899999999999999 111.196 169.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -159.48 154.61 25.12 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.992 0.917 . . . . 0.60999999999999999 110.005 174.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -77.67 141.31 39.47 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.39 -0.967 . . . . 3.0299999999999998 108.39 159.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -94.25 131.96 39.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.218 1.407 . . . . 1.8600000000000001 108.354 164.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -109.2 109.92 21.0 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.012 -1.107 . . . . 2.3999999999999999 108.012 178.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.71 134.07 51.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.182 1.393 . . . . 3.3100000000000001 109.489 -175.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.18 53.49 14.0 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.854 -0.529 . . . . 1.6499999999999999 112.48 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.4 mt -44.66 155.41 0.1 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.088 1.755 . . . . 1.6699999999999999 115.067 178.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -108.6 -32.99 7.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 113.281 -1.782 . . . . 2.3399999999999999 112.847 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -120.99 137.57 26.75 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.55 1.54 . . . . 7.79 108.634 163.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -66.88 130.95 24.29 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 N-CA-C 106.654 -2.094 . . . . 1.4099999999999999 106.654 160.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.16 171.61 14.21 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.245 0.545 . . . . 2.8100000000000001 111.166 -174.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.83 157.91 24.83 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.267 -0.895 . . . . 4.8099999999999996 109.827 150.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.45 123.61 21.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.001 -1.481 . . . . 2.4500000000000002 107.001 159.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.76 53.96 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.166 -1.352 . . . . 2.0299999999999998 115.813 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -81.91 -174.39 5.02 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.816 1.808 . . . . 3.0099999999999998 111.12 165.001 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.29 135.7 48.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.829 2.452 . . . . 3.6800000000000002 106.284 166.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -119.24 144.78 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.829 2.052 . . . . 2.6699999999999999 109.439 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.485 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 13.3 mt-10 -89.15 134.16 34.13 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.051 0.54 . . . . 2.6200000000000001 110.493 171.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp -116.51 132.4 56.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.301 1.048 . . . . 2.8700000000000001 110.14 154.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -83.32 145.08 29.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.446 1.899 . . . . 2.1000000000000001 109.109 158.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.3 123.29 46.17 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.399 1.48 . . . . 2.73 109.943 -175.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.53 115.13 29.95 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.493 1.117 . . . . 3.6099999999999999 109.816 -176.168 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -112.66 145.89 39.64 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.263 1.425 . . . . 3.3700000000000001 111.76 -177.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.22 151.81 39.37 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.583 0.753 . . . . 2.4100000000000001 112.253 176.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.59 33.63 37.88 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.031 -0.872 . . . . 4.3399999999999999 113.56 177.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.66 47.49 15.24 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 124.618 1.104 . . . . 2.0699999999999998 113.852 171.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -133.88 131.82 39.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.195 0.998 . . . . 4.29 111.755 -171.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.1 t -140.87 150.56 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.594 1.158 . . . . 3.5 109.121 178.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.4 tp -149.57 170.97 17.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.601 2.36 . . . . 3.27 108.551 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.485 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 45.7 pttt -145.53 156.72 43.88 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.779 1.172 . . . . 3.0 113.072 162.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.1 160.98 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.309 1.443 . . . . 3.2799999999999998 109.351 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.9 t -112.44 136.66 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.614 1.566 . . . . 2.8900000000000001 108.788 -179.378 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.61 142.44 41.0 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.63 1.572 . . . . 3.2200000000000002 110.145 -175.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.0 154.42 73.47 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.737 2.291 . . . . 1.3 112.143 175.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.4 t -93.47 139.49 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.704 -1.221 . . . . 2.1699999999999999 107.704 157.286 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 . . . . . 0 N--CA 1.468 0.465 0 C-N-CA 125.008 1.323 . . . . 4.29 109.937 174.822 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 121.704 0.764 . . . . 5.1200000000000001 111.138 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.06 172.33 23.21 Favored Glycine 0 N--CA 1.471 0.998 0 O-C-N 120.47 -1.394 . . . . 1.3100000000000001 115.546 -176.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -154.24 -179.34 7.83 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.33 1.452 . . . . 3.3999999999999999 112.475 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 t -121.24 144.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.226 1.011 . . . . 2.3399999999999999 109.986 168.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -26.27 62.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.794 2.038 . . . . 7.2599999999999998 115.641 -175.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 73.2 t80 90.64 146.99 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 129.875 3.27 . . . . 4.46 111.994 -168.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.8 m -176.77 144.79 0.63 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 130.159 3.383 . . . . 3.23 108.793 160.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.51 -36.32 0.93 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.678 2.252 . . . . 1.49 111.917 177.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.06 169.91 27.18 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.577 1.084 . . . . 0.90000000000000002 111.949 -179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.7 -4.42 19.6 Favored 'Cis proline' 0 CA--C 1.539 0.748 0 CA-C-N 118.797 1.299 . . . . 1.3 112.767 -5.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.1 153.72 34.49 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.99 1.107 . . . . 3.1600000000000001 113.99 -172.287 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.91 -178.99 3.88 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.524 1.93 . . . . 1.8799999999999999 111.837 174.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.25 140.78 48.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.794 1.237 . . . . 1.52 108.872 167.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.15 143.08 46.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.319 1.448 . . . . 1.6200000000000001 110.458 -178.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -131.11 105.66 7.85 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.866 2.066 . . . . 4.1799999999999997 108.994 -170.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.59 162.27 37.05 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.788 1.033 . . . . 3.4500000000000002 113.788 -168.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.4 ' CG2' ' HD2' ' A' ' 74' ' ' ARG . 2.9 m -79.86 155.6 27.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.031 -1.441 . . . . 2.3999999999999999 112.125 177.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.21 116.79 18.91 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 113.312 -1.767 . . . . 4.3899999999999997 109.447 170.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.8 mp0 -101.26 133.85 45.21 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.666 1.986 . . . . 5.1600000000000001 110.923 175.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.27 76.67 1.09 Allowed Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 120.545 -1.347 . . . . 3.04 110.888 176.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.64 -19.3 42.11 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.667 2.245 . . . . 1.3700000000000001 114.288 -176.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.43 176.6 54.2 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 122.733 1.185 . . . . 1.1599999999999999 112.956 176.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.419 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.0 m-20 -100.52 -3.37 30.86 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.688 2.395 . . . . 2.8900000000000001 112.176 -170.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mp -126.01 160.35 57.39 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 128.122 2.569 . . . . 4.71 108.534 174.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.55 139.51 11.39 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.462 2.108 . . . . 1.22 111.455 -167.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.22 146.91 23.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 123.212 1.482 . . . . 3.3700000000000001 110.314 169.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.4 ttp-105 -134.53 102.78 5.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.536 -1.665 . . . . 4.5999999999999996 110.221 -176.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.7 tp -84.04 103.87 13.64 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.302 1.841 . . . . 3.6099999999999999 110.249 -174.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 m -97.35 -24.46 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.611 0.764 . . . . 1.72 112.565 -174.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.64 -174.42 29.37 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.839 1.209 . . . . 0.46999999999999997 113.052 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.69 -176.73 4.99 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.898 1.679 . . . . 1.8899999999999999 111.101 171.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -155.87 166.33 33.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 130.353 3.461 . . . . 5.4000000000000004 107.261 174.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t 179.75 153.19 0.6 Allowed Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 127.921 2.488 . . . . 1.76 108.279 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.84 -27.69 10.13 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 CA-C-N 121.263 1.487 . . . . 0.87 113.014 176.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.72 22.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.193 1.553 . . . . 1.9399999999999999 115.193 -170.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.18 162.16 34.97 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.206 1.803 . . . . 1.76 108.075 164.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -77.32 -56.0 4.93 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.033 1.333 . . . . 4.2699999999999996 109.996 168.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -133.76 177.61 7.58 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.872 2.069 . . . . 6.7300000000000004 109.337 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.9 p -153.36 147.14 14.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.354 1.462 . . . . 1.9099999999999999 109.079 -174.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -133.17 147.74 52.06 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.783 1.633 . . . . 2.6699999999999999 110.381 -179.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.7 tp -96.76 121.06 38.2 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.322 0.649 . . . . 2.2400000000000002 110.702 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -122.76 157.93 31.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 123.148 1.452 . . . . 0.67000000000000004 113.118 -175.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.32 154.37 21.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.873 -1.512 . . . . 2.0299999999999998 110.055 158.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -114.78 135.87 53.71 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.831 -1.915 . . . . 3.04 105.831 159.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -126.12 165.46 18.82 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.41 1.084 . . . . 3.3199999999999998 112.398 -177.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.7 ttp -105.05 144.85 31.29 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.685 1.594 . . . . 3.9399999999999999 109.614 168.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.26 150.48 30.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.195 0.998 . . . . 6.9199999999999999 111.698 -175.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -95.42 142.83 27.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.786 1.634 . . . . 2.8399999999999999 110.131 169.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 t -116.0 -110.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.053 1.341 . . . . 3.6499999999999999 107.781 170.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.59 44.94 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 131.319 3.848 . . . . 4.3200000000000003 112.851 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.34 17.62 62.02 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 120.16 -1.587 . . . . 1.6399999999999999 112.746 -166.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -133.18 134.82 44.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.707 2.403 . . . . 3.2400000000000002 107.605 -168.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -91.53 132.41 36.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.47 1.908 . . . . 3.5299999999999998 110.819 -167.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -143.5 143.95 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.334 1.854 . . . . 3.1600000000000001 108.282 -176.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.4 mtm -88.49 165.42 14.89 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.633 0.605 . . . . 4.1299999999999999 112.633 173.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.76 -179.51 23.83 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.725 1.155 . . . . 0.89000000000000001 112.29 174.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.2 ttm -147.68 147.14 29.65 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.166 1.387 . . . . 2.2599999999999998 109.032 175.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -155.81 154.07 27.16 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.265 1.026 . . . . 5.4100000000000001 110.394 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.4 156.2 50.41 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.172 1.915 . . . . 0.64000000000000001 110.834 173.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.08 155.0 76.33 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.389 1.476 . . . . 1.77 110.19 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.47 -23.79 3.97 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.781 2.32 . . . . 0.5 113.468 -166.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -178.38 165.96 1.82 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.611 1.964 . . . . 2.8999999999999999 111.219 179.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 mt -110.13 159.1 17.64 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.863 1.265 . . . . 1.9199999999999999 109.785 157.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -127.09 152.62 47.05 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.949 0.9 . . . . 1.8999999999999999 110.12 169.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.4 t -136.7 141.65 36.07 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 123.894 0.877 . . . . 2.23 110.784 172.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.39 155.9 14.35 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.992 3.128 . . . . 1.1100000000000001 112.685 178.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.58 140.07 84.86 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.21 3.274 . . . . 0.98999999999999999 114.438 -174.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.419 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 68.0 mmtt 69.14 -8.53 0.68 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.719 2.408 . . . . 2.27 113.792 -176.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.18 166.76 52.93 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.126 1.346 . . . . 1.21 112.636 174.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 11.8 ttp-105 -136.29 136.26 39.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.172 2.189 . . . . 5.5800000000000001 106.994 172.065 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.6 t -149.65 139.27 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.231 1.412 . . . . 4.9000000000000004 108.782 177.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.463 ' CD ' ' HZ2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -103.32 149.48 24.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.325 1.059 . . . . 3.6000000000000001 113.383 179.89 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -59.78 108.02 0.69 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.197 -1.409 . . . . 1.95 107.197 158.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.463 ' HZ2' ' CD ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -60.04 139.38 90.92 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.902 -1.523 . . . . 3.2400000000000002 112.647 -160.783 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.51 -28.94 17.31 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.734 3.623 . . . . 3.5 115.791 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.59 4.11 13.35 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 117.559 -1.69 . . . . 2.8300000000000001 116.198 173.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.75 -98.58 1.42 Allowed Glycine 0 N--CA 1.472 1.057 0 CA-C-N 120.874 2.337 . . . . 1.8500000000000001 113.0 -176.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -71.86 140.87 49.53 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.158 -1.201 . . . . 3.5600000000000001 111.28 -176.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -161.57 153.71 19.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.624 1.17 . . . . 0.71999999999999997 111.076 -174.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -88.01 129.78 35.16 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.556 -0.715 . . . . 2.96 109.305 166.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -82.83 119.52 24.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.836 1.654 . . . . 2.0 109.407 165.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -102.02 110.9 22.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.785 1.234 . . . . 2.3900000000000001 109.296 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -104.24 139.87 38.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.071 1.348 . . . . 3.6699999999999999 111.079 -168.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.39 45.77 45.31 Favored Glycine 0 N--CA 1.473 1.156 0 O-C-N 121.328 -0.858 . . . . 1.8500000000000001 112.83 174.581 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.2 mt -47.8 155.19 0.43 Allowed 'General case' 0 CA--C 1.523 -0.09 0 CA-C-O 123.563 1.649 . . . . 2.1099999999999999 115.28 -177.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -116.09 -29.69 6.22 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 112.862 -1.972 . . . . 4.1900000000000004 112.55 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.8 mmt-85 -105.03 134.73 19.49 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.681 2.392 . . . . 5.29 109.509 163.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.17 74.84 3.45 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 N-CA-C 106.572 -2.126 . . . . 1.8999999999999999 106.572 147.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -63.5 127.34 30.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.887 0.851 . . . . 3.1000000000000001 112.717 -159.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -84.96 138.79 32.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.762 1.267 . . . . 7.0099999999999998 112.185 -170.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.64 118.91 5.74 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.928 -1.487 . . . . 1.98 108.194 167.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.16 -9.99 39.63 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 117.788 -1.562 . . . . 1.95 115.572 -169.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -78.59 173.27 12.59 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.13 1.965 . . . . 3.02 110.653 161.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -138.47 144.1 39.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.032 -1.84 . . . . 3.6400000000000001 106.032 160.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.0 148.69 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.824 1.249 . . . . 3.1699999999999999 109.411 -171.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.88 149.44 21.54 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 123.401 1.572 . . . . 3.3300000000000001 114.578 -170.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.56 151.75 39.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.72 -1.582 . . . . 2.6299999999999999 110.083 170.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -118.02 103.51 9.98 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.78 2.432 . . . . 2.8599999999999999 109.483 174.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.7 mp -83.6 134.96 34.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.679 1.192 . . . . 2.2400000000000002 110.786 -172.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.98 110.56 23.0 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 122.341 1.067 . . . . 2.0699999999999998 110.406 -174.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -103.77 123.72 47.59 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.847 1.659 . . . . 3.27 111.309 -176.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 46.57 35.82 3.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.934 2.094 . . . . 2.4900000000000002 112.892 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.44 -102.54 2.73 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.989 1.281 . . . . 5.6200000000000001 111.05 -169.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.24 -6.76 83.96 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 117.026 1.57 . . . . 2.8599999999999999 117.026 -160.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -80.97 102.52 10.2 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.138 2.469 . . . . 4.0300000000000002 110.848 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.1 p -87.08 142.32 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 124.253 0.97 . . . . 3.3700000000000001 112.242 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.14 125.57 19.0 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.822 0.849 . . . . 3.7599999999999998 112.134 173.097 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.42 117.27 21.72 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.243 1.017 . . . . 3.7000000000000002 111.472 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.13 166.76 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 126.31 1.844 . . . . 3.8999999999999999 110.66 169.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -144.6 117.76 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 119.171 0.896 . . . . 3.5299999999999998 110.51 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -124.06 142.18 39.08 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.219 1.008 . . . . 4.2000000000000002 112.374 -172.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -70.04 151.35 67.44 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.316 3.344 . . . . 0.96999999999999997 113.398 169.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.8 t -84.59 128.94 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.51 -0.768 . . . . 2.1800000000000002 109.702 168.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 127.118 2.167 . . . . 3.8700000000000001 107.88 172.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 108.958 -0.756 . . . . 7.2000000000000002 108.958 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.99 177.15 39.75 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 122.296 0.942 . . . . 1.3500000000000001 113.093 -177.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -157.23 155.12 30.3 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.492 0.717 . . . . 8.6699999999999999 111.1 168.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.0 t -128.96 137.02 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 106.68 -1.6 . . . . 2.6800000000000002 106.68 163.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -75.56 -62.4 1.59 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.484 0.584 . . . . 7.0099999999999998 110.362 -176.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -171.99 150.22 2.52 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.374 1.07 . . . . 4.1100000000000003 110.982 178.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 m -135.86 112.75 10.62 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.878 0.871 . . . . 5.3300000000000001 112.37 -178.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -82.92 -34.66 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.896 2.398 . . . . 2.98 112.115 170.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.12 151.62 27.99 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 110.904 -0.878 . . . . 1.54 110.904 -158.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.94 0.65 32.86 Favored 'Cis proline' 0 CA--C 1.539 0.742 0 CA-C-N 119.636 1.718 . . . . 1.6100000000000001 113.297 1.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -144.75 172.58 12.81 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.514 1.302 . . . . 2.0299999999999998 114.514 -177.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.02 -175.65 5.4 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 129.786 3.234 . . . . 1.6399999999999999 112.335 -176.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.68 136.97 23.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.897 2.079 . . . . 1.99 108.72 174.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.89 144.15 50.48 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.841 1.657 . . . . 1.73 112.543 -174.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.416 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 73.1 m-85 -126.97 59.34 1.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.668 1.987 . . . . 3.8799999999999999 111.999 -163.158 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -73.18 152.04 41.26 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.963 1.468 . . . . 2.6899999999999999 114.963 -173.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 m -84.97 144.16 28.5 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 121.34 -0.85 . . . . 2.7999999999999998 110.443 161.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.2 129.63 25.66 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.281 1.832 . . . . 5.0 111.318 -170.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -127.46 143.71 51.16 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.631 1.172 . . . . 3.8599999999999999 111.356 -176.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -105.73 95.22 10.05 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.815 0.846 . . . . 1.77 108.917 160.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.04 -4.99 15.85 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.097 2.532 . . . . 1.49 113.873 175.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.94 174.39 47.73 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 122.805 1.225 . . . . 1.27 113.099 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 15.4 m-20 -99.85 -1.86 36.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.246 2.618 . . . . 3.4100000000000001 111.887 -174.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -122.21 157.95 56.89 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 128.473 2.709 . . . . 4.0700000000000003 110.021 176.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.33 143.44 22.16 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.587 2.191 . . . . 1.6799999999999999 111.302 -173.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.61 156.13 22.28 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.7 1.6 . . . . 4.2000000000000002 109.839 173.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.1 ttp-105 -140.57 104.91 4.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.518 1.527 . . . . 4.1500000000000004 109.178 -177.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.8 113.72 21.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.453 1.501 . . . . 3.4900000000000002 108.144 -176.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 m -103.88 -27.03 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.674 0.789 . . . . 1.9299999999999999 112.361 -174.233 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.25 -177.78 31.66 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 124.55 1.072 . . . . 0.40999999999999998 113.555 177.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.68 -174.72 3.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.947 1.299 . . . . 1.8799999999999999 109.642 168.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -155.59 168.75 26.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 128.029 2.532 . . . . 6.2800000000000002 106.82 173.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -173.51 151.08 1.89 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 125.504 1.522 . . . . 1.8700000000000001 108.431 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.72 -10.51 21.73 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.869 1.713 . . . . 1.21 113.832 176.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.13 18.94 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.96 1.467 . . . . 2.3900000000000001 114.96 -170.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.83 128.44 7.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.396 1.479 . . . . 1.71 111.683 172.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.69 -36.64 81.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.667 1.587 . . . . 3.4500000000000002 114.09 -176.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -140.66 88.02 2.16 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.515 1.526 . . . . 7.5800000000000001 108.683 -167.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 p -82.48 138.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.251 -0.886 . . . . 1.71 110.905 169.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -124.06 152.43 42.67 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.203 2.201 . . . . 2.5499999999999998 110.026 177.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.7 tp -106.04 119.07 38.26 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.29 1.036 . . . . 1.8200000000000001 110.621 177.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -122.97 155.28 37.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.014 1.726 . . . . 0.57999999999999996 113.592 -175.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -100.89 159.88 14.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.876 -1.511 . . . . 2.3199999999999998 110.949 156.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.0 m -117.2 134.7 54.47 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 104.99 -2.226 . . . . 1.8300000000000001 104.99 158.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -122.42 166.98 13.87 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.944 1.298 . . . . 3.3799999999999999 112.637 -174.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.7 ptm -91.1 149.56 21.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.464 0.706 . . . . 5.04 111.707 169.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.29 151.04 27.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.596 1.158 . . . . 7.8399999999999999 112.929 -177.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.447 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 2.2 tp10 -109.19 139.85 43.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.906 1.682 . . . . 2.4100000000000001 106.474 161.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.6 m -138.17 126.67 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.168 -1.049 . . . . 4.3200000000000003 108.168 166.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.68 19.29 10.37 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.804 1.242 . . . . 4.2300000000000004 114.209 -178.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.96 14.74 76.69 Favored Glycine 0 N--CA 1.478 1.448 0 O-C-N 120.609 -1.307 . . . . 1.79 113.914 -170.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -112.24 118.62 35.8 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.796 2.438 . . . . 4.04 108.575 -179.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.447 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -78.91 131.89 36.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.277 1.831 . . . . 3.4700000000000002 109.925 -176.863 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.3 p -155.83 175.72 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.497 1.519 . . . . 4.79 111.132 -173.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.7 mtm -108.69 163.97 12.79 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.332 1.053 . . . . 4.6900000000000004 112.021 164.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.1 -176.65 17.35 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.422 1.487 . . . . 1.0800000000000001 111.624 169.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.0 ttm -146.35 152.59 39.35 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.115 1.366 . . . . 1.8600000000000001 109.992 -173.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -162.18 156.17 18.34 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 124.796 1.238 . . . . 5.6200000000000001 111.328 173.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.09 153.68 57.34 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.331 2.021 . . . . 0.56000000000000005 111.423 171.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.86 154.82 73.15 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 125.777 1.631 . . . . 1.9199999999999999 109.902 -177.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.61 -25.73 3.54 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.434 2.089 . . . . 0.54000000000000004 113.178 -165.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -179.38 165.24 1.4 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.045 1.738 . . . . 2.9399999999999999 111.797 -177.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.5 mt -111.7 153.41 26.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.958 1.703 . . . . 1.99 109.651 163.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -107.1 149.38 27.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.175 0.99 . . . . 2.1200000000000001 108.934 175.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.48 121.28 9.93 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 118.253 0.479 . . . . 2.4700000000000002 111.273 164.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -67.49 164.66 30.04 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.966 2.444 . . . . 1.3799999999999999 110.58 175.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -58.4 138.79 87.72 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.594 2.196 . . . . 1.3600000000000001 112.04 177.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.416 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 68.3 mmtt 65.25 5.75 3.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.496 1.918 . . . . 2.9399999999999999 113.675 -175.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.07 163.98 49.63 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.341 1.924 . . . . 1.8200000000000001 114.473 -174.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -127.75 142.23 51.37 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.51 2.324 . . . . 6.6100000000000003 109.877 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.3 t -143.27 135.7 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 107.166 -1.42 . . . . 4.0099999999999998 107.166 163.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -129.11 117.97 21.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.574 -0.899 . . . . 4.5999999999999996 108.574 -175.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -76.48 78.5 3.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.085 1.354 . . . . 2.3500000000000001 110.602 -168.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -66.96 151.01 97.54 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.083 1.353 . . . . 4.5099999999999998 114.058 -174.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.416 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 56.2 Cg_endo -64.2 -31.09 64.57 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.563 2.176 . . . . 2.6800000000000002 113.32 173.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.15 53.85 4.48 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.177 0.899 . . . . 2.2400000000000002 111.929 168.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.09 -132.9 3.01 Favored Glycine 0 N--CA 1.471 1.024 0 C-N-CA 124.494 1.045 . . . . 1.6200000000000001 114.062 -179.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -72.49 140.42 48.21 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 122.866 0.467 . . . . 2.9900000000000002 112.019 -170.024 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -162.64 160.56 25.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.625 1.17 . . . . 0.72999999999999998 111.351 -175.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -90.54 135.47 33.68 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.802 -0.561 . . . . 3.5099999999999998 109.877 167.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 tpt -86.55 127.52 34.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.14 -1.059 . . . . 1.8200000000000001 108.14 163.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.55 106.84 17.46 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.879 -1.156 . . . . 2.2200000000000002 107.879 177.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.88 151.28 26.49 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.756 0.788 . . . . 3.98 111.307 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.94 41.76 39.8 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.887 0.755 . . . . 2.1299999999999999 112.636 176.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.9 mt -50.2 154.02 1.3 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 123.401 1.572 . . . . 2.0 114.229 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -99.83 -28.21 13.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 112.884 -1.962 . . . . 2.8900000000000001 112.501 173.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -146.39 148.52 34.63 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 127.409 2.283 . . . . 9.5899999999999999 111.171 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.7 146.87 55.57 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.939 2.426 . . . . 1.6699999999999999 109.866 165.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.1 mt -126.45 130.59 50.96 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.772 1.629 . . . . 4.2800000000000002 109.43 -174.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.61 -178.84 4.64 Favored 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 126.52 1.928 . . . . 4.5800000000000001 111.984 -156.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.97 133.05 34.03 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.38 -0.825 . . . . 2.0600000000000001 111.473 -175.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.82 46.81 8.22 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.834 1.207 . . . . 1.3200000000000001 112.06 -169.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -131.65 176.95 7.89 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.353 1.061 . . . . 2.3999999999999999 111.197 174.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -149.12 125.79 11.07 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.599 2.36 . . . . 3.4399999999999999 106.199 -165.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.0 t -140.77 140.25 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.329 1.052 . . . . 2.2000000000000002 111.282 -170.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.483 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 33.2 mt-10 -94.99 134.48 37.61 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.861 0.865 . . . . 3.54 112.881 177.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.8 mp -113.11 138.82 49.36 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.035 0.934 . . . . 2.7400000000000002 110.678 158.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.07 142.76 36.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.616 1.566 . . . . 2.48 108.447 159.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mp -110.7 123.82 50.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.782 2.433 . . . . 2.04 109.659 176.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -106.45 115.12 29.67 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.343 1.057 . . . . 1.46 110.73 -175.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.19 120.17 41.72 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.923 1.689 . . . . 3.2400000000000002 111.538 -177.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.35 25.38 0.87 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.258 2.223 . . . . 3.0699999999999998 115.055 173.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.21 -60.75 3.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.23 1.395 . . . . 4.71 112.461 -168.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.49 -2.15 59.33 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 117.49 1.756 . . . . 1.8799999999999999 117.49 -164.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -135.45 130.66 35.09 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 120.057 1.929 . . . . 5.6799999999999997 113.248 173.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -96.96 151.75 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.41 1.484 . . . . 3.3100000000000001 110.563 161.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.9 tp -146.2 179.61 7.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.822 2.449 . . . . 3.4500000000000002 107.848 164.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.483 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 30.2 ttpt -147.29 145.55 29.42 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.078 1.308 . . . . 3.3700000000000001 111.401 -177.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 t -142.86 157.24 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.561 1.145 . . . . 2.8399999999999999 109.435 176.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.23 154.79 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.072 2.149 . . . . 3.2799999999999998 109.732 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.96 120.48 9.24 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.336 1.854 . . . . 3.9199999999999999 110.305 176.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.52 145.29 16.92 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 124.562 3.508 . . . . 2.04 113.549 156.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.57 127.95 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.828 -0.804 . . . . 2.1200000000000001 108.828 161.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 . . . . . 0 N--CA 1.44 -0.974 0 C-N-CA 126.173 1.789 . . . . 4.7000000000000002 109.344 169.643 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.818 0 CA-C-O 121.064 0.459 . . . . 4.6399999999999997 111.483 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.02 156.44 27.2 Favored Glycine 0 N--CA 1.474 1.183 0 O-C-N 120.485 -1.384 . . . . 1.5800000000000001 115.604 -176.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -155.87 170.87 21.11 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.358 1.063 . . . . 2.54 113.29 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -114.14 130.95 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.728 -1.212 . . . . 2.2400000000000002 107.728 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -78.69 -29.81 45.74 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.779 1.77 . . . . 6.6200000000000001 115.779 -157.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.9 t80 146.43 137.26 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 130.653 3.581 . . . . 3.3799999999999999 109.721 174.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 t 179.54 133.78 0.25 Allowed Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 126.683 1.993 . . . . 2.4199999999999999 110.801 166.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.38 -25.66 15.2 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.419 2.079 . . . . 1.4099999999999999 112.481 171.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.11 -176.96 17.07 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.82 1.676 . . . . 0.93000000000000005 112.256 -174.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.69 -11.43 20.54 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 118.445 1.122 . . . . 1.03 113.449 3.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -128.02 155.79 43.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.586 1.954 . . . . 2.2400000000000002 112.87 179.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.43 173.42 11.62 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.07 2.148 . . . . 1.48 110.867 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.09 125.09 30.53 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.056 1.343 . . . . 1.5700000000000001 108.355 172.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.3 151.2 22.98 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.421 1.488 . . . . 1.7 110.751 177.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -141.79 70.39 1.34 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.593 1.557 . . . . 3.3799999999999999 110.053 -166.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -90.69 161.01 15.55 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.356 -0.84 . . . . 2.9399999999999999 112.941 175.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.1 m -79.59 157.61 27.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.125 -0.943 . . . . 2.29 109.985 160.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.68 136.44 54.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.227 1.011 . . . . 4.3700000000000001 110.156 175.882 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.84 131.35 47.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.698 1.199 . . . . 5.96 111.297 -173.234 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -107.05 111.17 63.7 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.387 -0.598 . . . . 1.46 109.387 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -86.83 -11.72 5.48 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.283 2.655 . . . . 2.0499999999999998 113.586 173.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.0 -179.84 47.19 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 124.992 1.282 . . . . 1.26 112.933 -175.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -104.21 -5.35 22.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.996 2.518 . . . . 3.3700000000000001 111.679 -171.268 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -121.18 159.61 48.91 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.817 2.447 . . . . 3.54 109.702 175.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.03 137.5 19.57 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.124 1.882 . . . . 1.21 110.463 -175.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.61 155.54 16.73 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.651 1.18 . . . . 3.5899999999999999 109.614 171.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 ttp-105 -143.93 102.96 3.97 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.423 1.489 . . . . 3.77 110.567 -170.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -86.4 109.57 19.11 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.158 2.183 . . . . 3.21 109.891 -173.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -103.14 -20.88 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.553 1.141 . . . . 1.6899999999999999 111.851 -172.385 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.85 -174.66 30.96 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 124.897 1.237 . . . . 0.44 113.507 177.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.99 -179.72 5.83 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.047 0.939 . . . . 1.47 112.119 166.263 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.08 170.27 16.15 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.161 2.184 . . . . 6.25 107.97 160.335 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -171.64 149.18 2.37 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 125.63 1.572 . . . . 1.71 108.768 176.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.28 -14.47 16.47 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.405 2.07 . . . . 0.83999999999999997 113.706 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.424 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 34.6 m -107.46 26.76 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.045 1.338 . . . . 1.8500000000000001 113.615 -177.045 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.67 161.2 42.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.437 1.495 . . . . 1.8400000000000001 109.039 163.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -95.46 -36.51 11.29 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.348 1.059 . . . . 3.1000000000000001 112.858 177.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.7 160.86 33.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.024 1.729 . . . . 6.6100000000000003 107.38 170.448 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.81 155.06 17.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.387 1.475 . . . . 1.72 109.014 173.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.59 152.57 34.27 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.636 1.974 . . . . 4.1900000000000004 108.324 -167.757 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.2 tp -121.07 107.44 12.63 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.224 -0.923 . . . . 1.79 110.926 -162.076 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.6 m170 -117.64 145.05 44.62 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.473 1.286 . . . . 0.71999999999999997 114.473 -169.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.402 ' C ' ' HG1' ' A' ' 48' ' ' THR . 10.6 pt-20 -84.72 169.99 13.72 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.241 1.816 . . . . 2.1600000000000001 111.329 163.463 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 88.2 m -145.99 142.27 28.49 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.538 -1.352 . . . . 1.8999999999999999 107.444 174.06 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -162.21 178.84 8.39 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.743 1.386 . . . . 3.2200000000000002 114.743 -167.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.8 ptm -118.36 150.99 38.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.048 1.739 . . . . 4.6699999999999999 112.541 176.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -156.07 146.37 21.6 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.834 1.254 . . . . 8.7200000000000006 112.64 -174.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -100.96 142.17 32.8 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.395 1.478 . . . . 2.6800000000000002 109.848 171.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.6 t -141.33 121.06 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.611 1.564 . . . . 3.48 107.717 174.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 64.58 12.45 7.49 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.989 1.716 . . . . 4.6100000000000003 115.049 -179.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.24 22.99 53.19 Favored Glycine 0 N--CA 1.477 1.425 0 O-C-N 121.07 -1.019 . . . . 2.5600000000000001 113.243 -167.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -118.28 120.31 37.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.861 2.064 . . . . 5.1799999999999997 107.6 175.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -73.07 127.94 34.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.613 1.565 . . . . 5.1900000000000004 111.673 174.447 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -138.72 160.83 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 128.786 2.834 . . . . 3.6299999999999999 108.477 -173.084 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.9 mtt -111.5 170.12 8.34 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.823 -1.173 . . . . 3.3799999999999999 112.704 174.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.28 166.29 32.09 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.449 0.94 . . . . 0.70999999999999996 115.449 -167.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -161.05 146.19 14.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 128.439 2.696 . . . . 2.1899999999999999 107.107 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -153.2 157.4 32.93 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.637 1.975 . . . . 5.2300000000000004 108.073 -177.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -78.27 159.93 29.55 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.631 1.554 . . . . 0.78000000000000003 110.692 167.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.26 152.86 74.26 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.126 1.371 . . . . 1.8700000000000001 110.532 177.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.26 -24.11 11.18 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.851 2.367 . . . . 0.71999999999999997 112.68 -170.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -176.95 166.91 2.5 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.569 1.948 . . . . 3.2200000000000002 111.55 178.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -112.81 152.09 29.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.186 1.794 . . . . 2.02 110.989 162.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -103.54 151.58 22.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.205 1.002 . . . . 1.8 109.874 176.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.57 126.68 13.83 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.154 0.582 . . . . 2.6899999999999999 111.71 161.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.21 158.85 44.78 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.984 3.122 . . . . 1.7 112.013 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.76 140.65 87.05 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 124.074 3.183 . . . . 1.4199999999999999 113.871 -174.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 66.72 -10.08 0.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.163 2.185 . . . . 3.2799999999999998 114.358 -178.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.01 136.23 13.49 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.993 1.282 . . . . 1.72 113.209 -176.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.44 135.44 33.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.032 2.133 . . . . 4.5199999999999996 109.783 159.082 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -149.2 124.15 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.718 1.607 . . . . 4.71 108.807 178.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 2.2 mp0 -89.06 157.13 18.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.435 0.694 . . . . 3.25 111.637 -170.673 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mp -66.23 -32.87 74.55 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.218 0.917 . . . . 3.1899999999999999 113.372 174.051 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 93.5 140.95 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 130.518 3.527 . . . . 3.7599999999999998 110.426 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.71 -1.24 7.25 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.394 2.729 . . . . 2.5499999999999998 114.643 178.442 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.86 19.85 0.25 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-O 117.439 -1.756 . . . . 2.02 116.207 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.87 -27.46 0.86 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 120.243 2.022 . . . . 2.0699999999999998 116.987 172.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -137.87 151.54 48.15 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.3 2.05 . . . . 3.4900000000000002 111.435 160.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -156.84 148.46 22.49 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.333 0.653 . . . . 0.83999999999999997 110.65 175.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -81.84 116.84 21.7 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.792 -0.818 . . . . 3.4900000000000002 108.792 165.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 tpt -78.25 107.8 11.11 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 126.705 2.002 . . . . 1.9399999999999999 108.609 170.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.3 mp -87.49 139.73 30.25 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.446 1.498 . . . . 2.5099999999999998 109.12 176.23 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.38 138.03 46.1 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.259 1.024 . . . . 3.0800000000000001 112.263 178.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.25 42.45 10.58 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 124.997 1.284 . . . . 1.5900000000000001 113.118 173.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.7 mt -47.36 151.28 0.77 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.938 1.829 . . . . 1.73 115.938 -172.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 61.3 mmtt -111.42 -26.29 9.18 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 113.721 -1.581 . . . . 3.1499999999999999 113.85 -176.246 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -120.63 136.36 25.32 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.302 1.441 . . . . 5.5499999999999998 109.218 159.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.07 116.24 4.64 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.022 2.481 . . . . 1.45 107.767 170.14 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.357 4.1 pp -98.43 105.24 17.36 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 124.279 1.99 . . . . 4.25 112.708 -162.506 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.26 171.01 7.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.03 2.132 . . . . 4.4199999999999999 112.256 176.68 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.31 129.46 41.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.106 0.962 . . . . 2.4300000000000002 110.804 175.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.66 31.78 48.62 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.702 -0.681 . . . . 2.9100000000000001 112.939 -173.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -100.02 179.38 4.52 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.382 -0.97 . . . . 2.7400000000000002 108.382 143.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.22 160.51 43.31 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.279 1.831 . . . . 3.3999999999999999 106.725 165.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.0 t -151.96 157.91 4.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 128.734 2.813 . . . . 2.6800000000000002 107.73 -158.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -126.61 154.13 44.38 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.678 0.791 . . . . 2.73 110.226 165.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.16 134.88 54.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.056 1.343 . . . . 2.8500000000000001 109.96 166.351 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -78.18 134.79 37.57 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.334 2.254 . . . . 2.5899999999999999 108.432 161.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.99 109.6 21.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.437 1.895 . . . . 2.4900000000000002 108.815 178.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.5 mt -93.88 116.3 28.75 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.201 0.6 . . . . 1.8200000000000001 110.1 -176.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -109.23 148.71 30.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.614 1.166 . . . . 3.27 111.806 -177.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.75 150.18 33.26 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.775 -0.578 . . . . 2.5699999999999998 112.012 169.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.23 34.39 41.34 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.142 -0.81 . . . . 4.1399999999999997 114.029 177.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.72 44.3 39.64 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 118.048 0.924 . . . . 1.9399999999999999 114.235 166.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -134.07 140.96 46.99 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.241 1.02 . . . . 4.0700000000000003 111.713 -177.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.2 t -142.67 134.39 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.83 1.252 . . . . 3.2999999999999998 109.283 172.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -116.62 174.74 5.91 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.319 1.847 . . . . 4.1600000000000001 107.598 163.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -139.21 154.14 47.98 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.011 -1.056 . . . . 2.75 112.373 161.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.0 t -132.3 160.86 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.197 1.399 . . . . 2.8500000000000001 109.734 -176.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.53 143.27 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 127.358 2.263 . . . . 4.1399999999999997 111.592 -173.288 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -143.76 105.2 4.93 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.742 1.617 . . . . 3.8900000000000001 109.84 -175.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -61.3 157.36 40.81 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.394 2.063 . . . . 1.6299999999999999 111.396 158.455 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.8 t -107.4 141.92 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.593 0.711 . . . . 1.77 110.139 173.155 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 128.577 2.751 . . . . 3.9199999999999999 110.496 -165.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 121.453 0.644 . . . . 4.5800000000000001 110.651 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.67 -177.79 32.09 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 125.581 1.563 . . . . 1.4199999999999999 113.642 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.1 p90 -152.96 143.21 22.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.558 1.543 . . . . 2.8599999999999999 110.567 170.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.3 156.61 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 121.048 -1.033 . . . . 2.6400000000000001 108.404 167.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.8 ttt85 -86.3 149.75 24.83 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.865 1.317 . . . . 5.3700000000000001 112.974 -176.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -72.11 132.43 44.18 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 129.236 3.014 . . . . 3.8199999999999998 109.84 170.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.3 t 178.84 141.27 0.28 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 126.565 1.946 . . . . 2.7400000000000002 111.229 176.307 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.74 -28.96 13.26 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.562 2.174 . . . . 1.6100000000000001 112.683 169.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.03 171.14 12.5 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.407 1.956 . . . . 0.94999999999999996 112.36 -172.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -82.98 -0.14 54.34 Favored 'Cis proline' 0 CA--C 1.539 0.74 0 CA-C-N 119.27 1.535 . . . . 1.22 113.923 2.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -143.33 157.39 44.51 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.772 1.397 . . . . 2.5 114.772 174.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.13 -175.34 3.59 Favored 'General case' 0 CA--C 1.549 0.924 1 C-N-CA 131.838 4.055 . . . . 1.5600000000000001 108.804 175.349 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.64 171.02 13.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.793 2.037 . . . . 1.6499999999999999 108.259 173.01 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.62 135.96 22.79 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.107 0.956 . . . . 1.8899999999999999 112.576 170.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -123.44 141.06 52.37 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.574 2.35 . . . . 3.5699999999999998 108.957 -174.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -174.05 143.16 0.9 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.869 1.433 . . . . 3.1099999999999999 114.869 -171.379 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.0 m -79.52 120.86 24.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.594 1.157 . . . . 2.5800000000000001 110.98 178.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 135.23 39.72 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.329 1.852 . . . . 4.0300000000000002 109.361 175.036 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -139.12 146.89 41.22 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.066 1.747 . . . . 5.1500000000000004 109.137 -171.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -131.98 99.56 16.46 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.508 0.723 . . . . 1.6499999999999999 109.934 177.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -70.38 -14.37 34.05 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.368 2.045 . . . . 2.0299999999999998 113.069 176.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.35 140.69 11.58 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 128.188 2.804 . . . . 3.5099999999999998 112.666 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t0 174.23 -55.89 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.562 2.745 . . . . 8.3900000000000006 103.86 -158.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp 178.06 173.55 0.38 Allowed Pre-proline 0 CA--C 1.552 1.021 1 C-N-CA 132.898 4.479 . . . . 5.5199999999999996 110.848 -177.148 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.37 134.94 10.38 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.345 2.03 . . . . 1.5800000000000001 111.227 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.3 mt -93.84 145.23 24.76 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.646 1.178 . . . . 3.1899999999999999 111.108 -175.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 ttp-105 -137.31 91.88 2.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 112.62 -2.082 . . . . 4.2199999999999998 111.628 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 98.02 7.37 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.098 1.759 . . . . 2.7999999999999998 108.418 -170.485 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.9 m -94.36 -30.65 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.25 1.42 . . . . 1.5600000000000001 112.21 -169.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.64 -176.78 32.09 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 123.87 0.747 . . . . 0.59999999999999998 113.765 178.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.26 177.45 8.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.322 1.049 . . . . 1.5600000000000001 112.253 172.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -153.36 157.64 40.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.051 2.54 . . . . 6.9400000000000004 108.236 168.444 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -167.32 152.45 6.98 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 123.798 0.839 . . . . 2.04 111.894 -176.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.2 -8.75 23.35 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.794 2.329 . . . . 1.52 115.599 178.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.64 0.55 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 115.829 1.789 . . . . 2.5499999999999998 115.829 178.166 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.04 164.13 37.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.135 1.374 . . . . 2.2400000000000002 112.186 -178.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -124.77 -65.04 1.06 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 123.103 1.43 . . . . 4.3899999999999997 111.399 -167.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -79.01 147.59 32.82 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.426 -2.065 . . . . 5.5999999999999996 105.426 164.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -156.66 135.05 2.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 C-N-CA 125.141 1.376 . . . . 2.3599999999999999 108.034 -177.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -127.54 156.6 41.94 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.757 2.023 . . . . 2.8300000000000001 109.323 178.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.1 tp -105.46 126.58 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.799 0.84 . . . . 2.0899999999999999 109.231 169.032 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -124.24 160.63 27.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.0 2.12 . . . . 0.78000000000000003 113.984 -175.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -107.64 163.61 12.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.751 1.62 . . . . 2.0600000000000001 111.091 156.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.5 m -116.05 140.93 48.78 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.463 1.905 . . . . 2.27 106.602 165.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -145.31 -178.15 5.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.547 1.139 . . . . 3.3799999999999999 113.42 -177.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.1 mtm -126.79 144.28 51.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.364 1.466 . . . . 4.4500000000000002 112.749 -177.586 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.12 135.82 39.59 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.699 1.6 . . . . 7.0 111.764 178.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -104.49 127.69 52.26 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.844 1.658 . . . . 3.1600000000000001 111.34 168.35 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.9 t -134.82 123.97 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 107.651 -1.24 . . . . 3.7599999999999998 107.651 176.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 62.67 10.63 4.28 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.169 2.188 . . . . 3.98 115.146 -169.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.82 30.19 52.81 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 120.965 -1.085 . . . . 1.74 112.885 -164.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -118.52 129.28 55.27 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.955 1.702 . . . . 3.3700000000000001 108.261 169.08 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -86.84 126.61 34.75 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.029 1.732 . . . . 7.1600000000000001 112.294 -177.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.89 142.98 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.542 1.937 . . . . 3.7000000000000002 109.423 175.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 52.2 mtt -88.45 163.42 15.96 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.892 1.071 . . . . 3.5 113.892 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.98 175.15 22.35 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.549 1.547 . . . . 0.59999999999999998 112.457 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.3 ttm -157.04 148.11 21.86 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.46 1.904 . . . . 2.1899999999999999 108.245 -179.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -161.08 153.68 17.3 Favored Pre-proline 0 N--CA 1.476 0.862 0 CA-C-O 118.051 -0.976 . . . . 5.4400000000000004 111.639 -178.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.91 155.29 43.37 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.197 1.931 . . . . 0.66000000000000003 111.875 178.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.99 151.03 61.23 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.038 1.735 . . . . 1.71 109.999 -177.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.8 -21.03 8.68 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.465 2.777 . . . . 0.56000000000000005 113.493 -164.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -178.09 165.83 1.94 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.568 1.947 . . . . 2.9399999999999999 110.746 177.548 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 mt -106.95 146.26 31.26 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.082 0.953 . . . . 1.77 110.529 158.347 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -105.86 140.2 39.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.391 1.076 . . . . 1.8700000000000001 108.929 175.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.9 t -141.01 113.14 6.88 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 122.902 0.481 . . . . 1.71 110.725 165.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.9 162.44 37.32 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 124.095 3.197 . . . . 2.1200000000000001 111.75 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.64 136.89 56.3 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.931 2.42 . . . . 1.6299999999999999 111.784 -177.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt 74.68 -4.81 2.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 128.118 2.567 . . . . 4.7000000000000002 114.402 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.38 155.3 23.35 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.411 1.481 . . . . 1.8300000000000001 112.12 170.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -135.67 153.47 51.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.39 1.476 . . . . 5.0800000000000001 110.366 172.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.7 t -154.04 129.76 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.353 1.461 . . . . 4.5499999999999998 108.781 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.8 136.24 33.15 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.938 -1.101 . . . . 3.2200000000000002 112.265 176.52 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.82 84.17 0.66 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.077 -1.083 . . . . 2.2599999999999998 108.077 157.22 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -92.21 150.29 40.02 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.418 2.287 . . . . 3.25 113.377 -178.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -64.66 -39.69 26.03 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.004 2.469 . . . . 2.52 113.102 -174.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.33 45.84 2.66 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.689 1.137 . . . . 2.3300000000000001 112.511 170.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.08 -129.08 1.96 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 126.371 1.939 . . . . 1.48 111.65 177.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -73.57 138.33 44.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.714 1.257 . . . . 3.2000000000000002 113.239 -166.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -161.32 161.5 30.56 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.59 1.156 . . . . 1.03 111.503 -178.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -85.99 150.83 24.21 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.502 -0.749 . . . . 2.9100000000000001 110.915 165.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -105.96 126.13 51.82 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.415 1.486 . . . . 2.0499999999999998 108.706 163.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.01 118.31 36.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.734 1.214 . . . . 2.1600000000000001 108.75 -175.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.08 155.26 31.82 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 123.409 1.576 . . . . 3.0299999999999998 112.212 -170.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.09 -43.75 3.25 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 128.024 2.726 . . . . 2.4399999999999999 112.139 -178.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.2 mt 47.97 167.55 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.602 3.161 . . . . 1.8 115.891 -168.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -135.33 -21.2 1.59 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.342 1.457 . . . . 3.7599999999999998 113.781 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -122.27 149.86 55.71 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.148 2.179 . . . . 5.8200000000000003 107.619 161.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.71 112.37 2.63 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 106.23 -2.258 . . . . 1.49 106.23 153.209 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.35 108.16 5.33 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.048 -0.723 . . . . 3.1400000000000001 109.048 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -65.02 174.43 1.95 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.382 1.087 . . . . 4.8499999999999996 112.083 158.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.97 159.68 24.83 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.673 -1.149 . . . . 2.3700000000000001 108.439 149.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.16 49.74 75.31 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 121.575 -0.703 . . . . 2.1800000000000002 112.524 -172.317 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.53 -179.6 4.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.96 1.304 . . . . 2.3599999999999999 108.483 163.23 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -148.04 151.48 35.79 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.154 1.781 . . . . 3.4199999999999999 107.346 169.167 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.7 t -154.35 145.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 128.006 2.522 . . . . 2.4700000000000002 109.357 -160.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -101.11 154.37 18.79 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.276 0.63 . . . . 4.6900000000000004 111.385 171.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mt -139.56 134.14 31.75 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.594 1.557 . . . . 3.3500000000000001 110.26 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -83.69 131.41 34.94 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.709 2.004 . . . . 1.98 108.823 165.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.29 111.35 22.6 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.918 1.287 . . . . 1.8200000000000001 109.585 172.486 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.72 110.85 19.61 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.669 1.187 . . . . 1.8799999999999999 109.806 -178.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -106.28 105.3 15.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.923 1.289 . . . . 3.23 110.751 -177.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 57.43 11.12 1.09 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.013 1.725 . . . . 2.5899999999999999 115.22 174.209 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.36 -43.08 2.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.498 1.523 . . . . 3.8300000000000001 113.186 -169.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.96 -11.11 78.56 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.339 0.971 . . . . 2.6200000000000001 115.514 -175.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -137.49 157.15 47.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.818 1.309 . . . . 5.0499999999999998 111.867 170.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.78 153.97 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 125.708 1.603 . . . . 3.2599999999999998 109.93 169.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.5 tp -144.44 121.78 11.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.593 1.157 . . . . 3.02 109.654 174.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.77 114.33 28.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.53 0.732 . . . . 4.6699999999999999 110.587 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.55 167.72 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 126.748 2.019 . . . . 3.1400000000000001 110.548 -170.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.29 141.56 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.734 2.013 . . . . 3.75 110.655 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.4 mt -150.85 149.1 24.6 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 126.279 1.832 . . . . 4.04 111.625 -174.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -70.01 174.34 9.87 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.734 2.956 . . . . 1.1799999999999999 112.048 166.027 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.5 t -121.82 134.48 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.572 1.549 . . . . 2.5499999999999998 109.507 166.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 C--O 1.235 0.34 0 N-CA-C 114.377 1.251 . . . . 5.0199999999999996 114.377 177.073 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 121.897 0.856 . . . . 4.9500000000000002 110.916 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.33 -177.15 33.18 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.95 1.262 . . . . 1.3999999999999999 114.129 -175.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -153.81 160.02 42.08 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.606 1.562 . . . . 2.77 111.381 167.754 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 t -97.04 146.78 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 106.897 -1.52 . . . . 2.23 106.897 165.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -75.67 -102.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.367 0.985 . . . . 6.2000000000000002 112.032 -178.209 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -170.67 127.29 0.76 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.869 1.268 . . . . 4.1500000000000004 108.198 -168.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 p 179.6 111.22 0.19 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.565 -0.731 . . . . 3.3500000000000001 111.588 -167.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.29 -31.97 8.72 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.38 2.053 . . . . 1.4399999999999999 112.671 174.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.68 178.0 28.58 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.475 1.512 . . . . 1.0600000000000001 111.772 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.6 2.77 35.18 Favored 'Cis proline' 0 CA--C 1.539 0.77 0 CA-C-N 119.245 1.523 . . . . 1.55 112.952 -3.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -151.9 167.45 28.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.109 0.963 . . . . 2.5699999999999998 112.085 176.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.48 173.73 12.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.537 2.335 . . . . 1.6399999999999999 110.842 -171.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.55 139.28 24.04 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.51 1.124 . . . . 1.6000000000000001 110.281 179.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.09 140.35 50.83 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.295 1.438 . . . . 1.8799999999999999 111.549 -173.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -115.08 142.07 47.14 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.972 2.109 . . . . 4.7699999999999996 111.332 -176.176 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -162.94 147.43 11.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.869 1.433 . . . . 3.0099999999999998 114.869 178.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.7 m -79.82 116.12 19.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.205 1.402 . . . . 2.8100000000000001 110.477 176.07 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.75 126.45 40.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.582 1.153 . . . . 4.2400000000000002 110.08 174.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -124.24 142.89 50.88 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.561 1.544 . . . . 4.1900000000000004 110.959 175.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -103.84 94.95 6.93 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.838 1.255 . . . . 1.6000000000000001 109.985 171.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.12 -8.24 18.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.717 2.278 . . . . 1.48 113.796 177.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.72 177.96 51.27 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 122.425 1.014 . . . . 1.3300000000000001 112.36 -178.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -103.02 -2.44 27.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.17 2.188 . . . . 3.23 111.295 -176.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.61 162.12 21.92 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 129.333 3.053 . . . . 5.2300000000000004 108.873 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.29 146.86 20.03 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.453 2.102 . . . . 1.1599999999999999 110.784 178.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mp -112.11 151.28 29.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.792 1.237 . . . . 3.4199999999999999 110.731 174.047 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.422 HH21 ' CD ' ' A' ' 68' ' ' GLU . 25.3 ttm180 -141.14 109.8 6.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.037 -1.892 . . . . 2.6000000000000001 110.076 179.265 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.52 123.78 32.78 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 125.282 1.433 . . . . 3.0899999999999999 108.607 178.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -106.57 -28.58 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.201 0.91 . . . . 1.9099999999999999 111.927 -175.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.24 -173.34 27.55 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 124.536 1.065 . . . . 0.52000000000000002 113.704 177.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.21 -176.77 3.82 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.339 1.056 . . . . 1.79 111.014 161.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -144.98 156.33 43.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 131.357 3.863 . . . . 7.0 105.178 166.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -167.18 137.24 2.37 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 124.256 1.022 . . . . 1.6899999999999999 109.991 171.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.57 -17.56 38.37 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.362 2.042 . . . . 1.05 113.321 -171.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.2 m -93.8 17.5 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 114.747 1.388 . . . . 1.8500000000000001 114.747 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.12 164.15 28.3 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.582 1.083 . . . . 1.6399999999999999 113.609 170.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -92.62 -35.86 13.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.546 1.138 . . . . 4.0700000000000003 111.149 175.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -135.36 156.72 48.47 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.179 2.192 . . . . 5.7599999999999998 108.011 169.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.24 149.47 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.701 1.601 . . . . 2.1099999999999999 108.764 168.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -152.04 150.41 29.92 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.692 1.997 . . . . 2.8399999999999999 108.524 -172.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -105.83 134.15 49.41 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 123.068 1.414 . . . . 3.1800000000000002 113.105 172.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -116.76 154.74 30.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.514 -1.676 . . . . 0.73999999999999999 111.321 177.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -175.48 5.32 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.566 1.546 . . . . 3.3500000000000001 110.889 159.112 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.0 m -151.15 147.7 27.37 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.585 1.154 . . . . 1.6899999999999999 108.489 164.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -159.2 177.01 11.51 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 123.467 1.604 . . . . 3.4100000000000001 113.724 -171.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.6 ttp -129.42 128.02 42.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.071 1.748 . . . . 4.1200000000000001 110.597 -179.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.49 148.76 22.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.343 1.457 . . . . 6.9100000000000001 110.623 164.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.65 138.05 33.51 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.468 -0.938 . . . . 2.6400000000000001 108.468 147.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.96 125.17 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 106.238 -1.764 . . . . 3.2000000000000002 106.238 166.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 60.31 33.62 20.86 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.621 0.768 . . . . 4.3300000000000001 112.044 178.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.74 9.62 79.15 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.834 -1.166 . . . . 1.6200000000000001 114.454 -176.353 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -126.02 134.92 51.31 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.11 1.764 . . . . 2.9700000000000002 109.241 -172.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -84.61 123.75 30.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.634 1.574 . . . . 3.9300000000000002 111.124 -171.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.1 t -141.36 131.0 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.657 1.983 . . . . 3.1200000000000001 108.403 -173.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.73 161.63 13.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.768 1.227 . . . . 4.1600000000000001 113.626 -171.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.27 -179.66 32.36 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.046 1.308 . . . . 1.0800000000000001 113.086 172.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.91 153.75 43.41 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.291 1.036 . . . . 4.71 111.164 170.412 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -141.06 152.52 65.22 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.778 2.031 . . . . 5.2199999999999998 109.417 -174.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.69 153.61 59.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.119 1.879 . . . . 0.78000000000000003 111.273 172.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.53 154.92 77.53 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-O 118.452 -0.785 . . . . 2.1800000000000002 110.828 171.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.35 -22.9 10.58 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.114 2.543 . . . . 0.56999999999999995 112.602 -172.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -174.15 171.9 3.43 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.94 1.696 . . . . 3.5099999999999998 110.894 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.7 mt -117.54 158.27 24.86 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.225 1.81 . . . . 1.97 109.915 160.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' A' ' 31' ' ' ARG . 28.0 tt0 -137.34 146.34 44.45 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.69 0.796 . . . . 2.1899999999999999 110.673 178.06 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.9 t -144.04 130.12 9.99 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 123.961 0.788 . . . . 2.1299999999999999 110.854 175.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.82 165.45 29.71 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.73 2.953 . . . . 1.3600000000000001 111.316 175.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.61 141.66 97.7 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.281 2.654 . . . . 1.0600000000000001 113.16 -179.1 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt 69.62 -4.43 1.4 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 127.53 2.332 . . . . 2.46 114.681 177.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.58 169.39 47.06 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.137 1.351 . . . . 1.28 113.974 179.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 -133.35 156.86 46.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.401 1.08 . . . . 5.54 111.691 164.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -149.0 133.53 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.92 2.088 . . . . 4.4400000000000004 106.922 171.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -98.03 133.71 42.12 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.947 -1.095 . . . . 2.8399999999999999 111.393 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mp -68.47 78.9 0.27 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.394 -0.965 . . . . 2.5 108.394 154.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -94.09 154.38 40.61 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.717 2.007 . . . . 3.5099999999999998 112.051 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.43 -34.55 94.86 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.997 2.465 . . . . 2.7200000000000002 113.211 175.358 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.75 66.39 3.85 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.18 -0.768 . . . . 2.77 111.18 171.203 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.84 -123.59 3.72 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.178 1.371 . . . . 1.6200000000000001 112.966 -178.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -74.65 141.64 44.6 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.938 0.718 . . . . 3.6000000000000001 112.938 -162.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -159.97 154.97 24.69 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.587 -0.696 . . . . 0.77000000000000002 112.044 -176.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -90.3 118.66 29.98 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.558 0.343 . . . . 4.04 110.208 171.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -85.62 125.18 32.93 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.009 1.324 . . . . 1.74 109.257 170.16 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.96 127.82 52.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.476 1.51 . . . . 2.46 107.537 177.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.82 150.14 39.66 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.824 0.821 . . . . 2.9500000000000002 112.237 -176.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.43 -41.26 1.83 Allowed Glycine 0 CA--C 1.531 1.094 0 C-N-CA 126.48 1.991 . . . . 2.8900000000000001 113.57 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.8 mt 57.04 170.52 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 129.916 3.286 . . . . 1.9199999999999999 114.29 -177.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -129.82 -28.51 2.21 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.002 2.121 . . . . 2.27 112.857 172.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -110.99 132.58 21.6 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.43 1.492 . . . . 5.5800000000000001 108.065 166.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.95 101.19 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 N-CA-C 106.362 -2.207 . . . . 1.9099999999999999 106.362 158.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.11 128.0 41.6 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.419 1.104 . . . . 3.8900000000000001 112.674 -159.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -132.87 172.31 12.76 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.259 1.823 . . . . 4.3899999999999997 113.335 -167.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.69 124.61 23.36 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.574 -0.739 . . . . 2.04 110.083 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.36 7.36 51.97 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.554 1.55 . . . . 1.8799999999999999 115.497 -176.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.28 -175.16 3.74 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.421 1.111 . . . . 2.9199999999999999 111.519 161.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -149.29 154.53 39.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.305 3.042 . . . . 3.1499999999999999 105.733 178.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.9 t -147.83 139.05 17.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 127.238 2.215 . . . . 2.54 109.035 -176.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.491 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -105.15 149.76 25.63 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.795 1.238 . . . . 3.1600000000000001 110.998 176.852 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mp -132.16 134.24 45.17 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.192 1.397 . . . . 2.71 111.066 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -87.56 125.1 34.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.259 1.824 . . . . 2.1299999999999999 107.459 159.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 mp -98.29 131.51 44.55 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.102 1.361 . . . . 2.3399999999999999 109.421 172.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.6 mt -107.19 120.04 41.03 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.0 1.32 . . . . 1.8200000000000001 109.589 -175.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -113.69 160.41 18.66 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.525 1.53 . . . . 3.2200000000000002 110.601 178.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.62 143.04 10.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.242 -0.89 . . . . 2.4900000000000002 111.605 170.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.88 -3.72 86.81 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 118.759 -1.023 . . . . 3.6299999999999999 114.37 -169.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.14 16.13 56.35 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.814 1.307 . . . . 2.8999999999999999 114.114 175.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -78.4 134.8 37.36 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.143 -1.21 . . . . 6.4199999999999999 112.557 -173.049 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.9 t -107.15 136.66 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.228 1.811 . . . . 3.0499999999999998 109.423 175.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.4 tp -141.17 133.62 28.37 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.115 0.966 . . . . 2.8100000000000001 111.502 174.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.491 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 1.9 tpmt? -79.93 126.41 30.98 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.669 0.618 . . . . 3.4700000000000002 112.669 177.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.3 t -114.74 164.48 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.334 1.854 . . . . 3.77 108.355 157.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.6 t -146.61 140.36 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.893 1.677 . . . . 3.02 109.958 -176.027 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.3 mt -143.24 135.68 13.43 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 126.666 1.986 . . . . 3.4700000000000002 111.114 -167.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -73.97 159.1 45.3 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.113 2.542 . . . . 1.29 110.76 163.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.34 131.13 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.734 -0.839 . . . . 1.97 108.734 167.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 124.461 1.105 . . . . 3.8100000000000001 113.359 -165.098 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 CA--C 1.545 0.763 0 CA-C-O 122.183 0.992 . . . . 4.96 112.718 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.18 179.69 19.21 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.331 1.443 . . . . 1.1899999999999999 113.09 176.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 23.2 p90 -155.46 169.58 23.92 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.845 1.424 . . . . 2.8399999999999999 114.845 -172.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.39 140.52 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 126.502 1.921 . . . . 2.1899999999999999 109.407 170.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -17.79 61.73 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.938 2.095 . . . . 7.1100000000000003 115.513 -174.203 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.3 t80 79.87 129.55 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.91 2.484 . . . . 3.8799999999999999 111.631 -177.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 t -175.77 142.85 0.65 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 129.378 3.071 . . . . 2.73 107.774 174.358 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.08 -27.56 4.43 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.89 2.394 . . . . 1.6599999999999999 112.465 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.92 175.32 20.53 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.664 1.126 . . . . 0.82999999999999996 112.314 -174.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.57 -5.61 12.26 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 118.848 1.324 . . . . 1.02 112.775 -4.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -147.26 160.98 41.86 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 123.435 1.588 . . . . 2.1899999999999999 114.358 -176.68 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.27 -176.93 4.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.74 2.816 . . . . 1.6100000000000001 110.454 -176.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.06 152.38 34.73 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.019 1.727 . . . . 1.79 108.207 175.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.14 141.91 40.13 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.943 0.897 . . . . 1.73 112.508 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.516 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 88.0 m-85 -105.87 74.33 1.05 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.129 2.172 . . . . 4.5199999999999996 108.776 174.026 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -76.43 159.0 30.85 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.268 -0.895 . . . . 2.9399999999999999 111.43 -177.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.5 m -140.25 147.25 39.7 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.431 1.092 . . . . 2.4300000000000002 110.479 175.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.82 -178.11 5.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.346 2.258 . . . . 6.5300000000000002 108.69 169.907 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -140.45 123.93 16.97 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.807 -1.183 . . . . 4.5700000000000003 109.958 173.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -76.91 119.01 75.71 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.255 1.422 . . . . 1.6000000000000001 108.87 178.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.48 -17.99 33.9 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 121.974 1.783 . . . . 2.0600000000000001 113.459 176.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.4 126.05 0.64 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 124.469 1.033 . . . . 2.8300000000000001 110.522 -163.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -178.66 -47.86 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.257 -2.497 . . . . 8.2699999999999996 104.257 -146.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -164.92 -171.21 0.25 Allowed Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 131.418 3.887 . . . . 5.8300000000000001 107.477 164.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.28 130.36 9.12 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 108.043 -1.56 . . . . 1.3100000000000001 108.043 159.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.86 156.52 17.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.691 1.234 . . . . 3.6499999999999999 110.516 -175.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -153.47 107.04 2.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 113.736 -1.575 . . . . 2.46 111.571 -173.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.64 108.42 19.96 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.422 1.489 . . . . 3.6200000000000001 109.162 -171.395 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -106.66 -20.37 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 113.146 0.795 . . . . 1.8700000000000001 113.146 -169.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.49 -177.95 33.04 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 124.854 1.216 . . . . 0.42999999999999999 111.822 176.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.83 -179.51 5.44 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.819 0.848 . . . . 1.71 111.18 171.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -147.92 169.37 20.0 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.935 2.094 . . . . 4.5199999999999996 108.833 169.129 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.8 t 178.41 154.24 0.52 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.096 1.759 . . . . 1.8999999999999999 109.574 -171.105 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -89.39 -7.1 5.07 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.622 2.881 . . . . 0.81000000000000005 113.997 171.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.5 m -113.27 24.95 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 114.191 1.182 . . . . 1.79 114.191 -173.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.43 163.86 38.03 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.163 1.385 . . . . 1.8799999999999999 108.893 166.153 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -96.58 -30.84 13.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.141 1.776 . . . . 3.25 112.879 175.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 mtt85 -137.86 157.96 45.34 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.193 2.197 . . . . 6.5099999999999998 107.274 175.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 p -153.88 131.09 2.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 125.339 1.455 . . . . 1.8500000000000001 108.568 -176.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -140.16 133.14 29.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.199 0.999 . . . . 3.75 110.189 -160.066 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.3 tp -85.23 117.49 24.21 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.921 0.867 . . . . 2.5099999999999998 111.436 -177.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.8 m170 -117.38 162.48 17.85 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.592 1.557 . . . . 0.67000000000000004 112.859 176.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -113.11 -178.71 3.45 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.546 -1.661 . . . . 3.1800000000000002 110.801 163.885 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -148.67 135.65 20.0 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 106.594 -1.632 . . . . 2.0699999999999998 106.594 172.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -131.71 169.03 16.75 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.275 1.43 . . . . 3.6000000000000001 113.138 -169.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.1 139.33 45.34 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.817 1.247 . . . . 6.8099999999999996 110.909 168.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -129.05 141.99 51.05 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.316 1.446 . . . . 6.3300000000000001 110.362 166.341 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -89.81 138.63 31.32 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.847 -1.168 . . . . 2.9399999999999999 107.847 154.317 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.0 t -133.94 116.14 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 106.43 -1.693 . . . . 3.46 106.43 168.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.89 31.42 13.92 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.445 1.098 . . . . 5.0899999999999999 113.261 175.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.31 10.19 85.69 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 121.072 -1.018 . . . . 1.9399999999999999 114.112 -174.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -125.88 119.71 28.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.457 1.503 . . . . 3.8100000000000001 110.384 -173.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.453 ' H ' ' HD3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -81.38 135.16 35.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.265 1.426 . . . . 4.1799999999999997 111.472 -171.243 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.1 p -149.83 133.23 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 125.435 1.494 . . . . 3.6800000000000002 109.313 -178.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.7 mtp -83.8 165.43 18.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.532 0.682 . . . . 4.5800000000000001 111.657 177.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.59 178.65 27.89 Favored Glycine 0 C--O 1.224 -0.48 0 CA-C-N 115.357 -0.838 . . . . 0.87 111.717 170.086 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 ttm -147.07 143.15 28.13 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.833 1.653 . . . . 1.8999999999999999 107.4 -178.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -151.82 157.43 34.41 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.403 0.681 . . . . 5.6500000000000004 110.112 178.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.01 159.34 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.422 2.081 . . . . 0.62 111.462 178.451 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.39 156.01 64.1 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.878 1.671 . . . . 1.78 109.905 177.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.72 -24.83 2.14 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.855 2.37 . . . . 0.48999999999999999 113.562 -167.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -176.34 169.87 2.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.497 1.919 . . . . 2.9399999999999999 111.157 -178.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.99 154.37 26.57 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.068 1.347 . . . . 1.98 110.554 159.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.19 142.09 46.2 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.614 1.565 . . . . 2.0800000000000001 108.003 173.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 t -143.65 128.9 9.78 Favored Pre-proline 0 N--CA 1.474 0.74 0 N-CA-C 112.458 0.54 . . . . 1.95 112.458 169.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.34 167.32 24.22 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.324 2.683 . . . . 1.01 112.294 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.29 145.87 14.55 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.33 3.353 . . . . 1.79 112.281 171.013 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt 73.49 -14.36 0.64 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.574 1.95 . . . . 4.1100000000000003 114.635 178.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.56 158.8 45.69 Favored Glycine 0 N--CA 1.472 1.088 0 CA-C-N 119.017 0.826 . . . . 1.3300000000000001 114.144 -168.149 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 mmt-85 -76.87 136.94 38.89 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.995 0.918 . . . . 5.0899999999999999 108.811 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.67 63.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.246 2.218 . . . . 6.9900000000000002 107.098 -174.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.39 134.84 41.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.496 1.518 . . . . 3.6200000000000001 110.924 -177.756 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.32 94.15 8.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.185 -1.413 . . . . 2.3700000000000001 107.185 164.416 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.12 115.83 3.2 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 117.638 -1.172 . . . . 3.4900000000000002 113.954 -168.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.516 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 30.0 Cg_endo -57.43 140.63 93.73 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.29 2.66 . . . . 3.71 112.536 176.734 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.56 -19.95 10.1 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.846 1.212 . . . . 2.73 114.343 -168.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.98 -98.7 1.73 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.003 1.402 . . . . 1.8300000000000001 113.331 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 77.6 m-85 -75.13 137.88 41.66 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 121.616 -0.932 . . . . 3.0299999999999998 111.756 -173.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -160.35 147.2 15.8 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.098 0.959 . . . . 0.64000000000000001 111.059 -174.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -82.39 127.24 33.06 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.089 -1.078 . . . . 3.4199999999999999 108.089 166.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -77.09 143.44 39.23 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.531 1.532 . . . . 2.2799999999999998 108.667 164.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.9 mt -128.3 112.14 14.14 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.983 1.313 . . . . 3.23 108.782 -173.45 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.5 132.21 56.37 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.494 1.117 . . . . 3.4399999999999999 109.954 -166.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.24 47.08 7.72 Favored Glycine 0 N--CA 1.472 1.095 0 C-N-CA 124.022 0.82 . . . . 1.8 113.965 173.191 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.5 mt -49.86 153.48 1.28 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 117.119 2.266 . . . . 1.8500000000000001 117.119 -173.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -117.3 -33.35 4.67 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.354 -1.748 . . . . 3.0299999999999998 113.399 -174.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -105.32 133.4 20.18 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 106.786 -1.561 . . . . 7.3899999999999997 106.786 156.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.15 135.01 28.48 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 N-CA-C 107.148 -1.904 . . . . 1.45 107.148 156.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.23 157.99 16.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.347 0.594 . . . . 3.4900000000000002 111.05 -177.015 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.85 162.71 37.0 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.182 2.193 . . . . 5.2199999999999998 111.531 170.089 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.77 140.46 58.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.798 1.239 . . . . 1.97 110.232 -175.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.79 48.41 28.14 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.416 -1.265 . . . . 1.9299999999999999 111.777 -170.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.26 176.49 7.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.762 1.225 . . . . 2.5600000000000001 108.524 153.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -137.38 162.1 34.51 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 127.657 2.383 . . . . 4.25 107.59 161.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 t -153.83 154.1 7.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 127.773 2.429 . . . . 2.7599999999999998 110.088 -175.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -83.22 140.1 32.73 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 123.13 1.443 . . . . 3.6400000000000001 113.931 161.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mp -109.97 167.93 9.81 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.143 -1.39 . . . . 2.9700000000000002 108.526 148.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -130.22 140.8 50.69 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.689 2.396 . . . . 2.5499999999999998 108.406 176.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 mp -103.26 127.37 50.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.252 1.421 . . . . 2.4900000000000002 109.735 175.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 mt -100.3 106.75 18.42 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.495 1.118 . . . . 2.04 108.693 175.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -97.86 125.23 42.63 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.036 0.934 . . . . 3.4700000000000002 111.629 177.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.56 15.06 0.45 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.894 2.077 . . . . 2.8999999999999999 115.36 176.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.59 -7.5 79.71 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.661 1.6 . . . . 4.9500000000000002 115.773 -178.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -134.53 -37.72 0.21 Allowed Glycine 0 N--CA 1.477 1.39 0 CA-C-N 119.438 1.619 . . . . 2.1800000000000002 116.483 -172.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -85.63 107.74 17.67 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.486 -1.596 . . . . 5.1600000000000001 110.851 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.0 t -99.73 132.86 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.94 0.896 . . . . 2.9399999999999999 110.731 178.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.02 127.28 30.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 3.7200000000000002 111.868 172.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -79.88 141.67 35.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.711 1.604 . . . . 3.3999999999999999 114.174 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.61 164.18 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 127.989 2.516 . . . . 3.7599999999999998 109.91 170.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.4 t -135.16 132.66 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 106.647 -1.612 . . . . 2.6400000000000001 106.647 156.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.81 145.83 20.62 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.684 1.194 . . . . 3.3500000000000001 111.115 -167.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.61 161.69 39.23 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.552 2.835 . . . . 1.1799999999999999 112.51 176.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.9 t -95.53 128.9 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.636 1.174 . . . . 2.1600000000000001 110.025 164.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 128.283 2.633 . . . . 3.0499999999999998 109.031 -173.309 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 122.761 1.267 . . . . 4.6100000000000003 109.361 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.64 154.17 25.15 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.221 1.391 . . . . 1.45 113.612 171.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . 0.443 ' CD2' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -83.66 156.92 22.41 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.953 1.701 . . . . 9.9299999999999997 114.458 173.092 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -84.62 55.63 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 122.794 1.283 . . . . 3.27 110.19 165.431 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.443 ' HA ' ' CD2' ' A' ' 7' ' ' TRP 0.286 0.2 OUTLIER 27.58 -121.32 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 128.438 2.695 . . . . 6.5300000000000002 115.043 -169.15 . . . . . . . . 4 4 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -166.35 131.3 2.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.346 1.458 . . . . 4.0899999999999999 109.182 -179.115 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -175.84 138.56 0.53 Allowed Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.96 1.304 . . . . 2.3700000000000001 110.306 -176.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.34 -38.85 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.666 2.244 . . . . 1.8300000000000001 111.519 164.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.23 173.32 23.83 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.426 1.965 . . . . 1.1899999999999999 111.049 -173.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -77.76 2.44 25.93 Favored 'Cis proline' 0 CA--C 1.542 0.885 0 CA-C-N 119.559 1.679 . . . . 1.51 112.722 -4.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -151.14 160.94 43.58 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 123.14 1.448 . . . . 2.1000000000000001 113.561 -175.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.69 -175.99 4.49 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.183 2.193 . . . . 1.6299999999999999 111.765 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.8 148.06 30.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.443 1.897 . . . . 1.8200000000000001 108.243 176.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.82 127.58 52.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.558 1.072 . . . . 2.0699999999999998 109.968 179.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.433 ' CE2' ' HA ' ' A' ' 79' ' ' PRO . 56.6 m-85 -116.2 78.93 1.24 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.054 1.341 . . . . 3.8799999999999999 109.59 -176.089 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -82.14 152.69 26.39 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.53 0.732 . . . . 3.5499999999999998 112.374 -179.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.1 m -84.1 130.71 34.84 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.675 -1.231 . . . . 2.71 107.675 157.633 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.4 tp -96.7 133.3 41.41 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.071 -0.344 . . . . 5.4800000000000004 110.071 -179.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -124.69 129.29 50.24 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.629 1.172 . . . . 6.2000000000000002 112.215 -175.195 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -107.14 99.61 27.92 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.351 -0.843 . . . . 1.6399999999999999 110.506 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -81.16 -12.87 11.56 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.075 2.517 . . . . 1.78 113.564 175.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.74 179.68 51.3 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.567 1.08 . . . . 1.6799999999999999 112.226 -175.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -105.05 0.45 27.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.115 2.166 . . . . 3.23 112.124 -174.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.12 161.08 51.6 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 128.363 2.665 . . . . 3.6299999999999999 109.665 176.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.32 143.29 27.91 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.168 1.912 . . . . 1.55 110.995 -175.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.33 150.1 24.77 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.801 1.241 . . . . 3.5 109.558 171.142 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -136.56 97.18 3.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.316 -1.766 . . . . 3.1099999999999999 110.24 -174.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 tt -80.29 115.42 19.83 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.092 -1.077 . . . . 2.8700000000000001 108.092 -175.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.81 -31.38 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.605 1.162 . . . . 2.1299999999999999 112.58 -176.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.3 177.26 35.06 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 124.716 1.15 . . . . 0.67000000000000004 113.939 175.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -124.38 160.13 28.83 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.821 -0.811 . . . . 1.6799999999999999 110.549 169.147 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -130.52 157.36 42.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.458 1.903 . . . . 5.2000000000000002 108.432 167.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.5 t -165.71 148.31 6.56 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.152 1.781 . . . . 2.1600000000000001 108.683 175.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -73.05 -19.71 22.65 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.521 1.481 . . . . 0.89000000000000001 113.609 -176.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 m -90.86 12.57 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 115.799 1.777 . . . . 1.8999999999999999 115.799 -176.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.28 155.39 38.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.518 1.303 . . . . 1.98 114.518 173.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -92.1 -43.92 9.11 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.988 -1.005 . . . . 3.3799999999999999 113.695 -167.11 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -138.69 123.47 18.72 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.884 1.274 . . . . 6.7999999999999998 107.751 -167.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 p -126.15 132.8 70.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.209 1.404 . . . . 2.6200000000000001 109.479 -166.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.417 ' CD ' ' HE2' ' A' ' 46' ' ' HIS . 36.5 mt-10 -120.47 157.87 28.45 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.148 1.379 . . . . 3.1000000000000001 109.441 169.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.2 tp -105.58 117.69 34.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.798 1.239 . . . . 2.0299999999999998 108.686 169.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . 0.417 ' HE2' ' CD ' ' A' ' 44' ' ' GLU . 54.3 m170 -118.89 147.61 43.8 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.122 1.369 . . . . 0.83999999999999997 113.533 -175.33 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.423 ' C ' ' HG1' ' A' ' 48' ' ' THR . 10.0 pt-20 -89.11 177.23 6.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.185 1.794 . . . . 2.3700000000000001 110.608 161.057 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.423 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 86.5 m -153.39 140.95 19.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.992 -1.855 . . . . 2.0499999999999998 105.992 174.434 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -153.43 173.18 16.01 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.243 1.201 . . . . 3.4700000000000002 114.243 -165.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.47 134.83 50.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.659 1.584 . . . . 6.7699999999999996 111.534 170.79 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.45 155.46 44.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.232 1.413 . . . . 6.8899999999999997 110.653 171.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -86.91 141.17 28.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.97 -0.752 . . . . 2.8700000000000001 108.97 157.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.9 t -135.69 115.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.165 1.786 . . . . 3.4500000000000002 106.277 165.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 56.09 41.09 30.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.632 1.173 . . . . 4.7699999999999996 113.737 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.47 6.18 65.28 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.723 -1.236 . . . . 1.9299999999999999 114.281 -177.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -118.08 126.48 52.35 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.978 2.111 . . . . 3.6899999999999999 108.117 -178.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -76.86 121.93 24.1 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.921 1.289 . . . . 4.3200000000000003 109.533 -173.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.45 132.88 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.317 1.847 . . . . 3.3199999999999998 109.129 -174.295 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtt -80.55 166.66 20.94 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.154 0.798 . . . . 3.0 113.154 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.97 177.07 32.43 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.1 0.857 . . . . 0.92000000000000004 113.426 179.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.5 ttm -155.93 140.56 16.96 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.524 1.529 . . . . 2.21 109.707 -176.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -145.02 156.8 54.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.622 1.969 . . . . 10.19 109.218 -176.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.46 151.97 15.44 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.761 2.308 . . . . 0.93999999999999995 110.629 170.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.25 155.51 79.84 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.477 1.511 . . . . 1.8200000000000001 110.449 -179.04 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.29 -27.59 3.47 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.945 2.43 . . . . 0.91000000000000003 113.094 -166.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -175.68 167.09 3.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.566 1.546 . . . . 3.4100000000000001 111.752 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.0 mt -113.27 153.31 28.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.469 1.908 . . . . 1.6100000000000001 110.355 166.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -117.14 142.77 46.59 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.879 1.272 . . . . 1.9099999999999999 109.434 176.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.3 t -140.97 128.49 12.09 Favored Pre-proline 0 N--CA 1.472 0.657 0 N-CA-C 112.436 0.532 . . . . 2.0800000000000001 112.436 168.004 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.84 159.89 44.37 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.979 3.12 . . . . 1.4399999999999999 112.159 178.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.1 144.13 99.5 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.945 3.097 . . . . 1.6799999999999999 113.34 -176.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mptt 67.3 -9.56 0.39 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.589 2.356 . . . . 3.8500000000000001 114.483 -177.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.51 134.92 14.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.41 1.005 . . . . 1.6599999999999999 112.656 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.22 135.67 41.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.77 -0.826 . . . . 5.0199999999999996 108.77 155.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -147.07 129.53 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.031 1.732 . . . . 5.0099999999999998 107.65 -174.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 4.5 mp0 -94.54 150.55 20.13 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.348 -0.845 . . . . 2.8599999999999999 112.565 -167.2 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.24 84.83 2.42 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.081 -1.451 . . . . 2.4900000000000002 107.081 156.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.434 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -64.08 145.5 97.94 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 120.949 -1.094 . . . . 3.46 113.261 -171.482 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.433 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 20.8 Cg_endo -55.36 -38.73 93.61 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.459 3.439 . . . . 2.29 113.582 -174.421 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.14 24.3 19.54 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.199 -1.89 . . . . 2.2599999999999998 115.503 175.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.47 -15.11 0.02 OUTLIER Glycine 0 N--CA 1.476 1.315 0 N-CA-C 121.342 3.297 . . . . 2.2999999999999998 121.342 171.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -149.11 145.92 27.45 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 122.118 2.959 . . . . 3.3300000000000001 114.336 174.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -162.05 158.3 24.72 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.894 1.278 . . . . 0.79000000000000004 112.709 172.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -79.09 142.03 36.82 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.391 -0.818 . . . . 3.75 109.597 157.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 tpt -99.35 125.79 45.09 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.107 2.163 . . . . 2.1400000000000001 108.471 169.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mp -120.3 112.57 19.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.909 1.283 . . . . 2.7200000000000002 109.051 -173.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.15 155.33 18.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.242 1.417 . . . . 3.1600000000000001 110.928 -174.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.24 -48.82 3.99 Favored Glycine 0 N--CA 1.469 0.852 0 C-N-CA 126.822 2.153 . . . . 2.9900000000000002 113.05 173.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.9 mt 51.34 172.67 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.903 2.881 . . . . 1.8700000000000001 115.198 -172.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -137.9 -22.56 1.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.544 2.338 . . . . 3.5299999999999998 113.467 -176.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -137.63 143.99 42.91 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 128.566 2.747 . . . . 5.96 109.178 175.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.43 145.38 37.96 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.31 2.007 . . . . 1.72 108.351 155.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.64 119.6 39.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.851 0.86 . . . . 2.8700000000000001 111.203 -177.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -85.29 170.06 13.17 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.88 0.848 . . . . 4.6900000000000004 112.197 169.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.67 136.81 58.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.819 -0.628 . . . . 2.7799999999999998 109.32 157.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.79 9.51 87.01 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.291 -1.283 . . . . 1.75 114.954 174.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.63 173.06 10.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.982 1.391 . . . . 3.1400000000000001 108.792 160.359 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -145.47 151.68 38.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.64 2.376 . . . . 3.3599999999999999 106.869 169.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.4 t -153.08 139.87 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 127.105 2.162 . . . . 2.5899999999999999 109.664 -176.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.21 144.29 34.53 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.489 0.922 . . . . 2.4700000000000002 113.489 173.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.1 mp -120.38 148.01 44.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.555 1.542 . . . . 3.04 110.874 165.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.99 117.28 34.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.706 2.003 . . . . 2.8399999999999999 110.616 164.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -85.73 114.8 22.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.633 1.173 . . . . 2.6000000000000001 108.745 176.102 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.8 mt -90.91 114.03 26.39 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.646 1.178 . . . . 2.2999999999999998 108.91 -175.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -113.07 117.22 31.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.613 1.565 . . . . 3.2200000000000002 112.495 -171.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 54.04 26.62 6.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.512 1.525 . . . . 2.7799999999999998 113.736 171.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.5 -68.93 2.64 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.144 1.354 . . . . 4.3799999999999999 112.351 -172.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.25 2.28 62.15 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 116.571 1.388 . . . . 1.8100000000000001 116.571 -166.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -129.44 139.04 51.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.445 1.623 . . . . 3.5699999999999998 111.078 173.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -137.74 142.47 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.425 1.49 . . . . 3.3199999999999998 108.196 176.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.3 tp -154.43 110.97 3.29 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.252 0.549 . . . . 3.54 112.279 -166.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -82.76 152.29 25.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.851 1.056 . . . . 3.1299999999999999 113.851 -170.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.14 167.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.128 1.771 . . . . 3.5 110.291 178.3 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.26 138.58 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.307 1.043 . . . . 2.8399999999999999 109.744 -177.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.7 mp -130.17 134.16 25.78 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.038 1.735 . . . . 3.9500000000000002 110.744 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.63 177.71 7.68 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.298 2.665 . . . . 1.1799999999999999 111.562 170.317 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 t -118.28 95.84 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.033 0.933 . . . . 2.2599999999999998 108.65 164.321 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.404 ' H ' ' CB ' ' A' ' 7' ' ' TRP . 41.8 mt-10 . . . . . 0 N--CA 1.481 1.103 0 O-C-N 121.21 -0.931 . . . . 5.5999999999999996 113.282 -169.252 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 120.809 0.338 . . . . 9.2599999999999998 110.457 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.97 -171.98 13.6 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.087 2.28 . . . . 2.1099999999999999 110.78 177.358 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -121.81 178.27 4.93 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.004 1.483 . . . . 2.5699999999999998 115.004 -179.718 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.06 142.09 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.124 2.17 . . . . 2.6299999999999999 107.106 172.217 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -79.36 -93.59 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.17 0.588 . . . . 8.4000000000000004 110.852 -178.697 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -161.59 150.56 15.94 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.92 -1.113 . . . . 4.7400000000000002 111.738 -170.941 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.16 127.73 25.8 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.523 1.129 . . . . 4.8300000000000001 111.444 176.215 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.49 -49.52 0.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 N-CA-C 109.126 -1.144 . . . . 4.8600000000000003 109.126 154.143 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.04 141.3 9.33 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 108.872 -1.691 . . . . 1.4199999999999999 108.872 -155.171 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -86.91 14.93 44.17 Favored 'Cis proline' 0 CA--C 1.54 0.814 0 CA-C-N 120.308 2.054 . . . . 1.27 112.63 5.166 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -144.22 171.54 14.15 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.343 1.238 . . . . 2.3799999999999999 114.343 -172.12 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.99 -177.03 6.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.03 2.532 . . . . 1.6599999999999999 112.897 -176.443 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.0 141.46 22.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.657 1.583 . . . . 1.5900000000000001 110.122 177.537 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.24 153.61 36.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 1.6499999999999999 111.325 178.797 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -139.26 59.3 1.61 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.445 1.898 . . . . 3.2999999999999998 111.636 -168.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.86 167.37 17.46 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.612 1.338 . . . . 2.8999999999999999 114.612 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.3 m -101.41 146.46 27.58 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.84 1.656 . . . . 2.2599999999999998 110.628 -177.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.2 117.66 30.19 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.506 1.122 . . . . 5.1699999999999999 110.012 172.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -123.23 128.35 49.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.961 -1.496 . . . . 4.2800000000000002 106.961 163.64 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -97.41 106.21 30.91 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.528 0.731 . . . . 1.4199999999999999 110.575 -179.473 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -84.58 -11.68 8.0 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.602 2.201 . . . . 1.21 114.431 178.132 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.55 166.74 34.73 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 119.406 1.003 . . . . 1.2 111.422 -176.819 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.04 2.85 53.42 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.757 2.023 . . . . 3.3399999999999999 112.308 175.401 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -113.15 155.53 44.25 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.814 2.046 . . . . 4.4500000000000002 110.799 174.536 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -79.47 142.47 16.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.427 2.085 . . . . 1.0 110.69 -178.08 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.91 142.61 30.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.903 0.859 . . . . 3.7599999999999998 109.575 172.513 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -138.02 106.15 5.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.608 1.963 . . . . 3.52 108.724 178.135 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.47 106.16 18.2 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 128.31 2.644 . . . . 2.9700000000000002 107.863 -170.27 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.3 m -104.35 -21.55 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.912 0.708 . . . . 1.71 112.912 -167.434 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.41 -174.89 28.7 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.839 1.209 . . . . 0.62 112.395 175.398 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.36 179.7 6.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.639 0.733 . . . . 1.6100000000000001 112.974 170.678 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -144.81 158.57 43.74 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.823 2.049 . . . . 6.25 107.873 161.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 t -164.6 145.2 6.34 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 125.717 1.607 . . . . 1.73 108.542 175.324 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.24 -2.84 12.89 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.695 1.597 . . . . 1.26 113.982 -175.914 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.6 m -107.03 11.98 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 116.174 1.916 . . . . 2.5699999999999998 116.174 -174.163 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.05 156.43 46.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.423 1.465 . . . . 2.0600000000000001 113.283 177.377 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -86.41 -31.07 21.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.683 1.193 . . . . 3.1800000000000002 111.598 173.408 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -140.61 147.4 39.32 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.004 1.322 . . . . 5.4199999999999999 109.332 166.801 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.38 141.99 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.858 1.663 . . . . 1.77 108.392 161.629 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -140.37 137.68 34.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.317 1.447 . . . . 2.9399999999999999 108.293 -171.449 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.3 tp -99.5 111.98 24.25 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.371 -0.831 . . . . 2.1099999999999999 111.922 -170.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -118.92 155.64 30.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.962 1.305 . . . . 0.76000000000000001 113.236 -176.614 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -100.25 176.51 5.35 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.579 1.552 . . . . 1.9099999999999999 112.187 159.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.3 m -143.64 136.27 27.26 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.1 -1.815 . . . . 1.8500000000000001 106.1 165.085 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -138.77 164.65 29.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.97 1.308 . . . . 3.3399999999999999 112.675 -165.672 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.5 ttp -99.42 142.64 30.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.929 1.292 . . . . 4.6500000000000004 109.943 170.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -142.75 145.16 33.04 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.903 1.681 . . . . 9.0700000000000003 111.278 173.22 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.93 141.39 34.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.466 1.106 . . . . 3.6699999999999999 109.903 158.768 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.3 t -138.44 121.19 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.159 1.783 . . . . 3.4399999999999999 106.4 170.699 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 62.39 15.98 8.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.506 1.522 . . . . 3.3700000000000001 114.011 -173.292 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.67 16.36 66.08 Favored Glycine 0 N--CA 1.477 1.402 0 O-C-N 120.979 -1.076 . . . . 2.1899999999999999 113.871 -170.356 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -121.37 121.11 36.91 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.686 2.395 . . . . 3.1400000000000001 108.394 -179.097 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.87 139.65 48.94 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.379 -1.45 . . . . 4.54 113.178 178.028 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.7 p -155.26 169.7 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 128.246 2.618 . . . . 3.4700000000000002 108.347 176.762 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.0 mtm -100.29 172.1 7.37 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.787 -1.195 . . . . 4.9299999999999997 113.31 176.795 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.49 174.04 31.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.688 2.09 . . . . 0.60999999999999999 111.355 166.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ttm -136.43 153.73 50.99 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.33 1.852 . . . . 2.3300000000000001 108.08 175.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -159.13 156.06 25.41 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-O 118.076 -0.964 . . . . 5.5899999999999999 111.082 175.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.96 155.5 52.95 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.432 2.088 . . . . 0.59999999999999998 110.849 170.446 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -141.1 159.5 61.4 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 125.637 1.575 . . . . 2.1000000000000001 110.38 -175.199 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -82.19 -27.12 2.5 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.432 2.088 . . . . 0.78000000000000003 113.134 -168.412 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -177.59 164.82 2.08 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.378 1.471 . . . . 3.8900000000000001 112.171 -177.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.1 mt -107.94 160.21 15.94 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.93 1.292 . . . . 2.0 110.376 160.272 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -145.15 147.58 32.65 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.235 -0.916 . . . . 2.04 111.521 -179.567 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.3 t -143.25 131.0 10.99 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.086 0.954 . . . . 2.1899999999999999 111.736 176.018 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.42 162.15 42.29 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 124.175 3.25 . . . . 1.01 112.457 179.122 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -59.49 135.47 64.99 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.215 3.277 . . . . 0.97999999999999998 113.08 -177.419 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.55 -5.36 0.62 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.927 2.091 . . . . 3.1000000000000001 114.508 -179.51 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.84 167.92 51.86 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.917 1.722 . . . . 1.28 112.589 171.518 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.86 151.74 40.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.53 0.732 . . . . 6.9400000000000004 112.22 174.623 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 t -146.83 -178.81 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 128.021 2.529 . . . . 4.3899999999999997 107.784 -178.498 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.83 154.52 41.44 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.347 1.859 . . . . 3.6200000000000001 108.206 171.191 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.7 mp -51.19 -38.88 54.81 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 123.048 0.539 . . . . 3.0600000000000001 111.899 175.788 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm 101.14 118.19 0.01 OUTLIER Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 127.773 2.429 . . . . 3.23 109.906 161.605 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.24 -16.36 54.57 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.114 2.543 . . . . 2.7599999999999998 116.181 -161.06 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -115.34 7.16 20.89 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.655 1.121 . . . . 2.75 114.946 169.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.62 -110.09 1.93 Allowed Glycine 0 N--CA 1.47 0.915 0 C-N-CA 125.839 1.685 . . . . 2.1499999999999999 113.263 -171.123 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -73.1 147.95 44.45 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 123.378 1.561 . . . . 3.3100000000000001 111.773 -175.873 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -159.68 142.39 13.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.579 -1.646 . . . . 1.04 111.045 -178.24 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -79.88 111.24 16.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.972 -1.122 . . . . 3.4900000000000002 107.972 165.424 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.7 tpt -77.03 120.9 22.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.343 2.257 . . . . 2.23 107.908 175.111 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.3 mt -109.74 122.22 47.0 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.272 1.429 . . . . 3.6200000000000001 109.035 -173.206 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.98 143.76 46.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.691 1.196 . . . . 3.3999999999999999 111.415 -170.093 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.33 -43.22 2.85 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 127.248 2.356 . . . . 2.9300000000000002 113.955 175.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.8 mt 56.77 168.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 129.698 3.199 . . . . 1.97 115.637 -176.284 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -123.97 -30.83 3.46 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.97 1.708 . . . . 2.73 112.427 173.658 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -127.66 140.22 37.46 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 128.932 2.893 . . . . 6.9000000000000004 107.612 166.219 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.81 59.19 0.9 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.376 2.717 . . . . 2.79 112.717 -165.341 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -33.73 106.2 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 116.566 2.061 . . . . 3.96 116.566 -157.704 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -100.95 168.63 9.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.265 1.826 . . . . 9.0199999999999996 111.043 169.047 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.69 134.2 50.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.93 0.892 . . . . 2.2000000000000002 110.724 -176.555 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.72 -6.33 52.05 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.26 1.886 . . . . 1.52 114.376 -175.331 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.59 -175.1 5.58 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.985 1.314 . . . . 2.9300000000000002 112.106 170.769 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.7 142.02 23.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 128.543 2.737 . . . . 6.5 107.247 -173.415 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 t -142.79 124.4 12.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 124.004 0.921 . . . . 2.9900000000000002 110.68 -168.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -98.64 129.53 45.14 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.903 -1.044 . . . . 2.7400000000000002 110.707 -178.573 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.11 137.9 53.27 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.193 1.797 . . . . 3.6299999999999999 110.3 179.091 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -97.92 124.2 42.25 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.324 2.25 . . . . 1.8 108.889 170.402 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.15 115.66 27.98 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.797 1.239 . . . . 2.0499999999999998 109.756 178.407 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.89 101.5 13.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.222 -0.658 . . . . 1.98 109.222 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -94.29 136.9 34.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.161 0.984 . . . . 3.3500000000000001 111.097 176.669 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.97 125.88 13.03 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.706 1.202 . . . . 2.2799999999999998 113.449 -174.566 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.68 70.51 1.28 Allowed Glycine 0 N--CA 1.47 0.951 0 C-N-CA 124.259 0.933 . . . . 3.71 112.897 177.54 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.72 5.99 58.1 Favored Glycine 0 N--CA 1.474 1.224 0 N-CA-C 116.485 1.354 . . . . 1.6100000000000001 116.485 164.498 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -98.51 127.12 44.31 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.395 1.598 . . . . 4.3799999999999999 109.878 -179.794 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.24 142.92 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.3 1.04 . . . . 3.3900000000000001 109.01 179.865 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.0 tt -152.5 135.98 15.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.336 1.455 . . . . 3.02 109.208 -177.841 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -102.1 140.42 36.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.354 0.662 . . . . 4.0300000000000002 112.433 -179.485 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.8 t -127.84 162.7 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 127.109 2.164 . . . . 2.5699999999999998 108.311 175.575 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.9 t -128.33 141.25 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.397 1.479 . . . . 3.0600000000000001 110.436 -178.662 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.3 mt -136.45 124.66 15.0 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.693 1.197 . . . . 3.29 109.848 -164.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.67 149.36 48.72 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.048 1.832 . . . . 1.01 110.244 173.767 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.0 t -90.94 117.35 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.861 -0.792 . . . . 1.9199999999999999 108.861 167.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 108.12 -1.067 . . . . 4.04 108.12 175.25 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.088 0 N-CA-C 106.213 -2.755 . . . . 9.1899999999999995 106.213 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.68 147.35 3.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.109 0.455 . . . . 9.0299999999999994 111.662 127.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -161.33 138.9 9.06 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.132 2.173 . . . . 9.0600000000000005 109.659 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.8 p -80.08 57.06 2.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.353 1.061 . . . . 5.6900000000000004 111.123 167.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -85.56 123.79 31.38 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.699 1.199 . . . . 4.6500000000000004 112.038 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.68 179.32 35.33 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.65 1.119 . . . . 1.5 114.869 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -146.25 146.33 30.72 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.134 1.374 . . . . 2.7999999999999998 112.721 162.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -86.57 149.76 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.711 1.204 . . . . 2.3700000000000001 108.236 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -84.49 149.95 25.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.852 1.31 . . . . 4.5300000000000002 113.162 -176.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.416 ' H ' ' HD3' ' A' ' 9' ' ' ARG . 64.7 t80 -76.36 134.05 39.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.56 2.744 . . . . 3.1699999999999999 110.823 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.1 t 175.62 135.59 0.18 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.912 1.685 . . . . 2.79 112.058 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.58 -24.85 21.61 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.441 2.094 . . . . 1.6399999999999999 112.506 170.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.2 171.59 12.27 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 127.074 2.273 . . . . 0.85999999999999999 111.375 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.65 -8.21 39.71 Favored 'Cis proline' 0 CA--C 1.538 0.692 0 CA-C-N 118.886 1.343 . . . . 1.04 113.307 0.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -144.2 157.81 44.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.968 1.307 . . . . 2.0499999999999998 113.44 -172.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.02 -175.74 4.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.023 3.329 . . . . 1.55 108.473 -176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.34 176.81 8.37 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.155 1.382 . . . . 1.46 109.173 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.8 138.17 19.49 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.685 1.13 . . . . 1.5800000000000001 112.327 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 17.7 m-85 -119.02 137.51 53.48 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.256 2.222 . . . . 3.3300000000000001 108.262 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -168.35 148.37 4.67 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.324 1.05 . . . . 2.5899999999999999 111.707 -172.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -89.53 122.21 32.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.923 0.889 . . . . 2.4900000000000002 111.172 -176.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.58 120.3 40.3 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.077 1.351 . . . . 3.7000000000000002 108.765 -177.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -122.13 141.75 51.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.527 1.131 . . . . 3.8999999999999999 111.3 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -117.05 108.94 43.31 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.393 1.077 . . . . 1.46 110.659 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.78 -10.99 10.4 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.939 2.426 . . . . 1.3200000000000001 113.848 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.25 175.88 49.93 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-O 122.787 1.215 . . . . 1.1699999999999999 113.224 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.403 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 6.5 m-20 -99.41 -3.83 32.87 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.327 2.651 . . . . 3.0 111.43 -175.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -122.37 157.27 59.23 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 128.336 2.654 . . . . 3.3199999999999998 109.883 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.0 145.8 31.86 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.788 2.325 . . . . 1.0600000000000001 111.137 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.1 mt -105.83 157.08 17.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 122.716 1.246 . . . . 2.8199999999999998 109.959 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -147.99 110.71 4.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.789 -2.005 . . . . 2.98 112.724 -170.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.99 107.37 19.16 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.447 1.899 . . . . 2.75 109.297 -173.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 m -103.71 -24.55 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.209 1.003 . . . . 1.8300000000000001 112.949 -168.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.34 -177.61 32.58 Favored Glycine 0 N--CA 1.466 0.686 0 C-N-CA 125.387 1.47 . . . . 0.48999999999999999 112.095 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.06 -178.84 5.27 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.057 -0.672 . . . . 1.48 111.648 169.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.8 mtp-105 -144.32 177.07 8.89 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.237 1.815 . . . . 4.6100000000000003 108.273 158.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 t -172.92 152.31 2.36 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.158 1.783 . . . . 1.8200000000000001 109.517 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.39 -7.52 15.98 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.134 1.889 . . . . 0.81000000000000005 114.172 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.8 m -113.63 24.29 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 115.969 1.84 . . . . 1.6499999999999999 115.969 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.06 143.18 19.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.677 1.591 . . . . 1.6499999999999999 110.977 169.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -68.87 -33.23 73.44 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.661 1.584 . . . . 3.1200000000000001 112.862 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -137.91 159.89 40.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.965 2.106 . . . . 5.2699999999999996 108.843 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.69 143.49 30.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.026 1.33 . . . . 1.6799999999999999 108.407 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -123.21 149.77 44.25 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.665 1.986 . . . . 2.6699999999999999 109.055 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.8 tp -102.3 121.75 42.89 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.573 0.749 . . . . 1.8200000000000001 110.389 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -125.06 159.6 31.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 123.603 1.668 . . . . 0.48999999999999999 113.921 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' CD ' HH21 ' A' ' 62' ' ' ARG . 15.9 pt-20 -104.61 159.51 15.7 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.831 2.452 . . . . 2.1299999999999999 110.976 158.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.3 m -128.49 148.36 50.74 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 105.906 -1.887 . . . . 1.78 105.906 165.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -159.97 175.89 12.49 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.992 0.917 . . . . 3.5099999999999998 112.857 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.8 ttp -111.65 136.36 50.98 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.342 1.457 . . . . 4.0499999999999998 111.282 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -120.54 159.92 24.24 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.346 1.858 . . . . 5.4299999999999997 110.611 171.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.481 ' CD ' ' HZ3' ' A' ' 57' ' ' LYS . 4.1 tp10 -90.68 147.99 22.91 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.451 0.7 . . . . 2.27 109.503 151.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.8 t -138.79 118.78 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.579 1.552 . . . . 3.2599999999999998 106.915 157.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 61.09 25.68 15.67 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.758 1.392 . . . . 3.3300000000000001 114.758 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.34 4.68 90.09 Favored Glycine 0 N--CA 1.481 1.647 0 O-C-N 120.044 -1.66 . . . . 1.79 113.984 -171.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -105.54 120.14 40.89 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.587 2.355 . . . . 3.1499999999999999 107.885 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.481 ' HZ3' ' CD ' ' A' ' 52' ' ' GLU . 34.1 mmtm -71.54 113.83 8.98 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.693 1.597 . . . . 3.3399999999999999 109.778 -178.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.1 t -140.46 133.72 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.402 1.481 . . . . 3.0899999999999999 109.518 -172.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.7 mtt -79.5 171.88 14.56 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.347 1.24 . . . . 3.3700000000000001 114.347 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.82 168.18 29.94 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.364 1.935 . . . . 0.79000000000000004 112.226 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.0 ttm -149.08 145.37 27.21 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.697 1.599 . . . . 1.8600000000000001 108.95 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.432 HH21 ' CD ' ' A' ' 47' ' ' GLU . 25.8 mtm180 -148.06 152.9 40.93 Favored Pre-proline 0 N--CA 1.467 0.4 0 C-N-CA 125.121 1.368 . . . . 5.2400000000000002 109.853 -177.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.24 154.28 41.28 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.103 1.869 . . . . 0.52000000000000002 110.742 163.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.05 157.95 70.45 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 125.768 1.627 . . . . 1.77 110.309 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.22 -26.74 2.66 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.024 2.483 . . . . 0.64000000000000001 113.32 -167.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -177.43 164.54 2.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.662 1.585 . . . . 3.2799999999999998 111.763 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.2 mt -110.86 153.09 25.91 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.094 1.358 . . . . 1.8 110.404 164.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -110.96 147.05 35.52 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.049 1.339 . . . . 2.0499999999999998 109.895 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.62 121.44 17.24 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 123.363 0.665 . . . . 2.4700000000000002 111.195 163.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.14 159.05 54.47 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.222 2.614 . . . . 1.3200000000000001 111.424 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.5 138.98 83.84 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.605 2.87 . . . . 1.02 112.319 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.403 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 69.8 mmtt 65.63 -3.64 0.68 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.484 1.914 . . . . 2.46 114.032 -177.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.08 -176.64 34.82 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 126.971 2.224 . . . . 1.1599999999999999 113.2 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -147.83 152.85 38.36 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.246 1.019 . . . . 4.25 112.406 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.81 134.24 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.805 1.642 . . . . 4.1799999999999997 107.735 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 143.82 31.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.305 1.042 . . . . 3.29 112.199 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -74.33 130.1 39.05 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.481 -1.303 . . . . 2.4399999999999999 107.481 151.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 155.2 73.92 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.445 1.498 . . . . 3.3500000000000001 113.392 -170.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 38.4 Cg_endo -58.83 -36.72 96.53 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.507 2.805 . . . . 2.3700000000000001 113.731 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.26 12.89 36.03 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.592 -1.116 . . . . 1.79 115.001 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.35 -122.38 0.62 Allowed Glycine 0 C--N 1.343 0.937 0 CA-C-N 119.562 1.681 . . . . 1.76 114.778 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -71.34 140.9 50.4 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.049 -0.677 . . . . 3.02 111.585 -168.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -161.88 153.97 19.35 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.288 1.035 . . . . 0.58999999999999997 112.137 -174.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -79.04 143.0 36.06 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.416 -0.587 . . . . 2.9300000000000002 109.416 161.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -100.06 123.13 43.95 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.438 1.495 . . . . 1.78 108.168 163.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -98.77 130.27 45.22 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.273 -1.01 . . . . 2.1099999999999999 108.273 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mp -129.32 139.05 51.88 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.672 0.789 . . . . 3.0299999999999998 111.326 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.33 47.03 8.49 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 123.588 0.613 . . . . 1.5800000000000001 112.223 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -51.88 158.36 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 115.9 1.815 . . . . 1.78 115.9 -174.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -119.33 -32.83 4.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.035 -1.439 . . . . 2.2999999999999998 113.097 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -96.28 142.69 24.92 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.067 1.347 . . . . 5.7199999999999998 107.711 161.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 117.71 5.29 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 N-CA-C 106.33 -2.219 . . . . 1.4299999999999999 106.33 150.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -76.6 105.34 7.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.139 1.775 . . . . 2.8799999999999999 108.827 -175.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -98.56 171.91 7.84 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.746 1.219 . . . . 4.1200000000000001 111.452 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.9 131.77 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.216 -0.928 . . . . 1.77 108.687 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.74 58.81 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.751 -1.027 . . . . 1.3400000000000001 114.576 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.83 -176.26 4.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.509 1.154 . . . . 2.3900000000000001 110.076 161.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -139.65 145.98 39.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 127.996 2.518 . . . . 2.79 105.851 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -146.42 149.28 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 127.537 2.335 . . . . 2.0 108.871 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.496 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 18.9 pt-20 -111.87 150.13 30.85 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.066 0.946 . . . . 2.3999999999999999 113.091 175.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.4 mp -129.51 140.88 51.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.1 2.16 . . . . 2.6499999999999999 109.552 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -85.31 131.15 34.45 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.208 -1.034 . . . . 2.2000000000000002 108.208 160.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.88 109.8 21.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 121.239 1.836 . . . . 2.2599999999999998 107.602 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.49 113.96 18.04 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.508 -0.923 . . . . 1.6200000000000001 108.508 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -105.35 140.76 37.99 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.792 1.237 . . . . 3.4700000000000002 110.566 -175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.03 126.73 28.67 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.49 -1.381 . . . . 2.3900000000000001 113.823 -173.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.34 75.84 0.85 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.785 1.183 . . . . 4.0099999999999998 112.739 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.8 72.62 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 115.473 0.949 . . . . 2.0 115.473 166.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -130.87 149.79 52.34 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.103 1.452 . . . . 4.1600000000000001 112.236 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.8 t -149.01 147.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.175 1.39 . . . . 3.2799999999999998 108.421 167.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.4 tp -126.2 113.74 17.4 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.869 1.267 . . . . 3.2799999999999998 108.985 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 32.0 ttpt -83.3 133.44 34.97 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.731 -1.231 . . . . 2.8199999999999998 110.393 172.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -126.89 160.78 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.041 1.337 . . . . 2.7200000000000002 109.167 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 t -133.15 137.71 52.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 127.125 2.17 . . . . 2.98 107.591 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.22 150.85 20.33 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.752 1.221 . . . . 3.1299999999999999 111.763 -169.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.36 163.88 30.46 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.258 2.639 . . . . 0.96999999999999997 112.387 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 t -100.48 124.37 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.393 -0.821 . . . . 1.9199999999999999 109.001 163.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.414 ' CD ' HH21 ' A' ' 120' ' ' ARG . 62.2 mt-10 -120.03 145.35 46.92 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.631 1.205 . . . . 3.7200000000000002 111.603 172.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.76 58.7 4.77 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.499 1.12 . . . . 2.3199999999999998 110.671 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.414 HH21 ' CD ' ' A' ' 118' ' ' GLU . 30.5 ttm-85 . . . . . 0 C--O 1.246 0.906 0 C-N-CA 125.757 1.623 . . . . 7.2199999999999998 110.144 177.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.309 0 N-CA-C 108.213 -1.955 . . . . 8.8200000000000003 108.213 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m 70.62 -162.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.116 -1.809 . . . . 7.6399999999999997 106.116 -114.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -135.04 101.25 4.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.965 1.711 . . . . 10.789999999999999 110.402 167.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -139.07 -6.7 1.41 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.414 1.886 . . . . 5.2699999999999996 111.254 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -75.19 95.19 3.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.157 1.783 . . . . 4.6399999999999997 110.011 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.43 153.87 22.7 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 125.086 1.326 . . . . 1.3300000000000001 110.885 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -126.14 134.97 51.16 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.346 1.059 . . . . 3.0499999999999998 111.367 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 t -84.26 56.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.065 1.346 . . . . 3.3999999999999999 109.166 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 32.08 -116.56 0.05 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.052 2.541 . . . . 5.6399999999999997 112.658 -171.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.0 t80 171.48 134.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.455 2.702 . . . . 3.6699999999999999 108.154 -173.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.5 t -178.31 144.54 0.49 Allowed Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.215 1.806 . . . . 2.54 110.745 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.76 -24.19 18.42 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.749 2.3 . . . . 1.46 112.513 164.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.22 -173.95 15.07 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.658 1.599 . . . . 0.93999999999999995 112.591 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.38 -12.66 19.68 Favored 'Cis proline' 0 CA--C 1.539 0.745 0 CA-C-N 118.55 1.175 . . . . 1.25 113.475 1.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -125.05 169.83 11.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.803 1.641 . . . . 2.1400000000000001 111.718 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.67 -175.63 5.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.014 2.526 . . . . 1.6499999999999999 110.96 -173.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.27 169.83 16.61 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.219 1.808 . . . . 1.72 108.571 170.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.01 127.46 15.97 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.711 1.204 . . . . 1.8700000000000001 110.99 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -107.27 66.58 0.67 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.861 2.064 . . . . 3.4399999999999999 110.122 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.27 153.06 42.69 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.183 -0.948 . . . . 2.6600000000000001 111.942 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.5 m -130.83 132.33 45.15 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.737 1.215 . . . . 3.1800000000000002 108.785 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.26 178.02 10.47 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.998 2.119 . . . . 6.29 109.382 -178.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -139.67 160.24 40.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.385 1.474 . . . . 4.7999999999999998 110.772 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -103.66 96.78 9.42 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.367 1.867 . . . . 1.4399999999999999 109.335 171.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.8 -1.39 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.103 2.535 . . . . 1.5600000000000001 114.675 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.05 156.26 25.14 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.418 1.008 . . . . 1.3100000000000001 111.331 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.86 5.61 9.26 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.097 2.559 . . . . 4.0099999999999998 112.339 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.28 151.57 49.55 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 127.92 2.488 . . . . 4.2599999999999998 110.616 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.75 161.44 27.48 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.759 2.306 . . . . 1.1699999999999999 111.58 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.1 mt -120.67 152.57 38.05 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 122.525 1.155 . . . . 2.9399999999999999 110.985 169.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -132.64 118.22 18.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 112.558 -2.11 . . . . 2.6800000000000002 109.176 169.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.92 113.61 26.97 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.317 1.847 . . . . 2.96 107.724 -172.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 m -110.64 -24.6 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.54 0.736 . . . . 1.6299999999999999 112.83 -167.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.22 -174.85 28.45 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 125.053 1.311 . . . . 0.34999999999999998 112.884 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.4 -178.13 5.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.836 1.254 . . . . 1.8200000000000001 110.92 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.71 170.07 20.08 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.504 1.922 . . . . 7.04 109.131 164.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -175.98 151.41 1.17 Allowed Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 127.12 2.168 . . . . 1.8 109.117 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.0 -2.82 11.99 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.753 2.302 . . . . 0.90000000000000002 114.111 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.05 28.72 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.578 1.551 . . . . 2.1499999999999999 114.545 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.29 138.56 11.3 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.202 1.001 . . . . 1.6399999999999999 111.76 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -65.55 -31.62 72.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.848 1.659 . . . . 2.8999999999999999 113.742 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -146.3 154.59 41.86 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.66 1.584 . . . . 5.4500000000000002 109.339 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -141.26 140.94 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.238 1.415 . . . . 1.77 110.133 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -139.78 139.54 36.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.088 1.755 . . . . 2.8399999999999999 109.447 -166.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.6 tp -89.89 128.81 36.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.869 1.213 . . . . 2.6099999999999999 110.656 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -118.58 160.85 21.03 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.262 1.825 . . . . 1.0600000000000001 113.854 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -122.45 152.92 39.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.55 2.34 . . . . 2.27 109.991 167.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 m -129.84 135.47 48.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.524 1.53 . . . . 1.78 107.7 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -150.5 171.24 17.38 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.542 1.163 . . . . 3.4100000000000001 113.673 -167.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.2 ttp -101.87 143.8 31.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.942 1.697 . . . . 4.5999999999999996 110.652 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -155.7 152.86 29.1 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.121 1.768 . . . . 9.2799999999999994 112.596 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 139.13 37.09 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.274 1.03 . . . . 2.6400000000000001 111.508 170.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.9 t -141.09 129.04 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 106.521 -1.659 . . . . 3.9700000000000002 106.521 164.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.59 29.99 17.0 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.195 0.998 . . . . 4.5300000000000002 112.392 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.37 16.56 78.79 Favored Glycine 0 N--CA 1.472 1.087 0 O-C-N 121.031 -1.043 . . . . 2.29 114.167 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -133.48 133.6 42.45 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.405 1.482 . . . . 4.2599999999999998 110.758 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.32 122.86 22.7 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.078 1.351 . . . . 6.1799999999999997 110.493 -177.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -135.0 -175.78 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 129.492 3.117 . . . . 4.1699999999999999 108.951 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -111.99 169.24 8.98 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.085 0.945 . . . . 3.77 113.401 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.24 171.93 33.45 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.636 2.065 . . . . 0.75 112.446 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.9 ttm -150.24 142.89 24.58 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.896 1.678 . . . . 2.4300000000000002 109.364 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -144.01 155.58 58.76 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 125.483 1.513 . . . . 5.2999999999999998 110.174 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -75.36 161.18 38.11 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.319 2.013 . . . . 0.81999999999999995 111.061 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.31 156.65 39.76 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.8 1.64 . . . . 2.6299999999999999 110.536 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.03 -25.68 1.71 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.366 2.711 . . . . 0.69999999999999996 113.813 -165.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -176.74 171.58 2.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.614 1.966 . . . . 3.8799999999999999 110.962 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.4 mt -116.07 153.04 32.42 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.346 1.858 . . . . 1.79 109.942 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.1 145.02 42.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.803 1.241 . . . . 1.8700000000000001 108.029 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.9 133.96 12.66 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 118.664 0.665 . . . . 2.29 112.759 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.41 170.83 12.74 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.56 2.84 . . . . 1.1100000000000001 112.704 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.36 147.32 87.31 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.105 2.537 . . . . 1.04 113.297 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.306 22.0 mtmt 54.75 44.95 27.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.636 1.574 . . . . 3.96 113.548 171.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.02 175.54 21.05 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.827 2.632 . . . . 1.3300000000000001 113.761 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -79.44 154.07 29.2 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.884 -0.774 . . . . 5.96 112.406 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.47 66.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 127.259 2.224 . . . . 6.9500000000000002 107.253 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -127.1 137.89 53.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.652 0.982 . . . . 2.7599999999999998 113.652 -172.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.45 71.88 0.89 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.29 2.236 . . . . 2.1800000000000002 109.922 -170.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 140.02 17.46 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 125.754 1.622 . . . . 3.8199999999999998 113.674 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.01 -17.9 51.51 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.91 3.073 . . . . 2.1099999999999999 114.826 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.14 10.14 61.68 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.086 -1.396 . . . . 1.8600000000000001 114.435 175.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.57 -111.2 0.26 Allowed Glycine 0 N--CA 1.473 1.13 0 CA-C-N 119.251 1.525 . . . . 1.4299999999999999 114.369 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -74.18 136.1 42.82 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.889 -0.771 . . . . 3.0600000000000001 112.318 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -160.79 164.96 31.09 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.793 1.237 . . . . 0.97999999999999998 111.796 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -92.84 140.7 29.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.544 0.611 . . . . 3.5699999999999998 111.141 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -93.98 135.96 34.77 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.902 1.681 . . . . 1.98 109.478 163.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -114.54 135.71 53.83 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.863 1.665 . . . . 2.4199999999999999 108.755 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.91 138.28 48.32 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.78 0.832 . . . . 3.27 111.348 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.19 51.19 6.96 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.036 0.827 . . . . 1.6100000000000001 112.788 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.33 153.6 3.82 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 115.66 1.726 . . . . 1.8700000000000001 115.66 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -102.89 -16.13 15.98 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.939 1.459 . . . . 2.3700000000000001 114.939 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.2 mmt-85 -137.42 145.78 50.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 128.23 2.612 . . . . 7.7300000000000004 110.03 166.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.25 124.97 13.73 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 N-CA-C 106.649 -2.096 . . . . 1.6000000000000001 106.649 148.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.36 101.99 11.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.088 0.947 . . . . 3.4399999999999999 108.801 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.57 13.69 6.61 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.248 2.314 . . . . 5.4400000000000004 117.248 -152.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 74.92 151.0 0.12 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 129.493 3.117 . . . . 2.9199999999999999 112.498 -171.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.84 39.82 98.01 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.628 -0.989 . . . . 1.53 110.628 -165.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.58 171.27 7.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.96 1.704 . . . . 2.48 107.539 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -142.18 129.71 21.37 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.705 2.002 . . . . 3.7799999999999998 106.922 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.0 t -153.28 141.13 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.166 1.787 . . . . 2.6800000000000002 109.326 -162.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -86.42 147.47 26.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.657 1.354 . . . . 2.8900000000000001 114.657 -178.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mp -121.29 146.48 46.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.832 1.653 . . . . 2.71 110.5 164.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.58 134.67 38.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.04 2.536 . . . . 2.3100000000000001 108.245 161.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.84 130.96 46.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.849 1.26 . . . . 1.95 108.072 164.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.4 mt -110.85 108.42 18.22 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.658 1.183 . . . . 1.8999999999999999 110.082 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -104.32 155.12 19.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.851 1.66 . . . . 3.48 111.285 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.45 145.03 45.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.556 0.742 . . . . 2.6099999999999999 112.036 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.95 20.88 41.24 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.961 -0.911 . . . . 3.8199999999999998 114.598 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.46 9.22 86.98 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 118.521 1.16 . . . . 2.0499999999999998 113.901 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -79.32 106.83 11.63 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.357 -1.084 . . . . 3.8300000000000001 111.229 -174.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.5 p -115.89 115.84 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.199 1.4 . . . . 3.3300000000000001 110.848 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.9 mp -120.83 117.45 27.44 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.799 1.239 . . . . 4.1200000000000001 109.562 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.4 ttpm? -105.87 134.63 48.7 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.807 0.443 . . . . 3.6400000000000001 112.143 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 8.4 t -144.47 159.92 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.58 1.552 . . . . 4.1200000000000001 109.221 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -107.01 134.4 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.659 1.584 . . . . 3.3700000000000001 110.31 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.82 148.37 57.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.034 1.734 . . . . 4.3200000000000003 110.12 -169.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.05 170.33 19.22 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.516 2.811 . . . . 1.0700000000000001 113.374 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.68 121.19 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 127.291 2.236 . . . . 2.1200000000000001 109.589 169.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -158.85 150.78 21.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.788 1.28 . . . . 4.0999999999999996 114.1 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.53 53.65 2.74 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.58 1.326 . . . . 3.27 114.58 -162.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.419 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 3.1 tpm_? . . . . . 0 C--O 1.25 1.125 0 CA-C-O 116.871 -1.537 . . . . 8.9299999999999997 111.653 173.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.91 0 N-CA-C 107.868 -2.093 . . . . 12.630000000000001 107.868 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.9 150.12 18.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.467 0.634 . . . . 9.4700000000000006 109.707 -148.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -68.57 130.17 42.07 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.375 -0.828 . . . . 10.59 109.079 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 p 48.77 47.59 20.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.902 1.281 . . . . 9.9199999999999999 111.742 -171.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -77.86 164.81 24.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.061 0.944 . . . . 7.0599999999999996 110.325 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.47 -175.03 44.72 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.429 1.014 . . . . 1.8300000000000001 111.633 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.2 p90 -142.59 -173.7 3.94 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.819 -0.812 . . . . 2.9500000000000002 112.988 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.4 t -122.61 129.23 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.029 -1.044 . . . . 2.71 110.426 -169.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -48.88 -27.42 3.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.367 1.867 . . . . 7.6799999999999997 115.227 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 89.2 t80 69.42 116.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.452 2.701 . . . . 4.5199999999999996 111.437 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.1 m -170.12 150.48 3.62 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.13 1.372 . . . . 3.3300000000000001 110.231 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.17 -29.93 1.41 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.284 2.656 . . . . 1.6299999999999999 113.029 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.1 173.56 20.52 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.557 2.503 . . . . 1.01 110.538 -170.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -81.02 4.74 41.43 Favored 'Cis proline' 0 CA--C 1.541 0.827 0 CA-C-N 120.193 1.996 . . . . 1.8300000000000001 113.18 -3.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -148.26 164.86 32.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.159 0.98 . . . . 2.54 112.839 168.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.65 -178.14 4.93 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.049 2.139 . . . . 1.52 109.771 165.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.49 154.82 49.82 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.949 2.1 . . . . 2.0600000000000001 107.183 168.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.82 142.67 49.09 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.073 0.949 . . . . 1.72 110.434 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -124.03 19.98 9.14 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.608 1.336 . . . . 3.5600000000000001 114.608 -160.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -51.48 161.46 0.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.753 1.76 . . . . 3.73 115.753 -171.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -82.18 144.77 30.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.406 -0.815 . . . . 2.7599999999999998 111.845 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.47 118.04 22.39 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.642 1.177 . . . . 4.7400000000000002 110.031 168.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -113.85 132.7 55.8 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.414 -1.328 . . . . 4.29 107.414 167.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -92.04 110.85 46.87 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.933 0.893 . . . . 1.5 109.321 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -85.07 -9.58 8.5 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.296 2.664 . . . . 1.52 115.04 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.48 166.06 29.06 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 119.503 1.047 . . . . 1.3200000000000001 112.067 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.84 4.87 27.33 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.511 2.324 . . . . 3.5600000000000001 112.14 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.61 154.5 52.53 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 128.159 2.584 . . . . 3.8700000000000001 110.425 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.56 145.24 20.57 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.925 2.417 . . . . 0.96999999999999997 110.566 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 mt -105.04 148.55 26.65 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 122.319 1.057 . . . . 3.1699999999999999 111.649 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -130.22 112.08 13.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.283 -2.235 . . . . 2.6200000000000001 111.265 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -100.16 111.12 23.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.242 2.217 . . . . 3.4100000000000001 109.265 -172.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -104.11 -25.62 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.415 1.086 . . . . 1.9199999999999999 111.697 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.92 -175.89 32.43 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 125.022 1.296 . . . . 0.35999999999999999 113.432 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.94 -179.9 6.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.631 1.572 . . . . 1.7 110.045 169.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -156.72 157.29 34.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.266 2.227 . . . . 5.5999999999999996 108.024 174.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -164.8 150.08 8.53 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.984 1.313 . . . . 1.8300000000000001 109.858 175.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.56 -12.14 33.7 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.96 2.44 . . . . 1.0700000000000001 115.061 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.7 m -109.64 16.56 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 116.732 2.123 . . . . 1.8999999999999999 116.732 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.39 162.08 34.02 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.826 -1.171 . . . . 1.6000000000000001 114.144 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -100.07 -63.03 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.228 1.411 . . . . 2.6600000000000001 109.505 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -107.43 98.5 8.11 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.924 -1.11 . . . . 7.6799999999999997 110.382 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -79.01 141.62 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.223 -0.899 . . . . 2.7000000000000002 110.189 164.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -153.26 138.37 17.34 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.5 1.52 . . . . 2.7799999999999998 109.4 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.0 tp -96.65 122.31 39.44 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.731 0.777 . . . . 1.8700000000000001 112.023 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -121.97 161.56 22.69 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.911 1.685 . . . . 0.98999999999999999 113.779 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.13 -178.42 3.66 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.934 2.094 . . . . 3.1000000000000001 111.642 158.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.6 m -154.14 145.82 23.31 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.984 1.713 . . . . 1.8999999999999999 107.111 169.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -157.17 179.8 8.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.629 1.204 . . . . 3.8100000000000001 112.999 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.7 mtm -121.37 142.14 50.28 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.591 1.556 . . . . 6.1799999999999997 110.006 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -149.54 162.76 39.52 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.986 0.914 . . . . 6.1399999999999997 112.896 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.18 145.5 30.97 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.633 0.773 . . . . 3.0699999999999998 110.51 162.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.25 1.77 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 114.576 1.325 . . . . 4.3099999999999996 114.576 164.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -177.62 22.22 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.689 1.996 . . . . 4.6200000000000001 112.381 -168.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.41 -10.44 4.89 Favored Glycine 0 CA--C 1.543 1.798 0 O-C-N 119.148 -2.22 . . . . 2.1299999999999999 113.242 -160.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -95.13 130.49 41.82 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 129.346 3.059 . . . . 4.1699999999999999 108.213 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -77.1 117.37 18.59 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 128.04 2.536 . . . . 3.3199999999999998 109.149 -173.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -139.39 135.65 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.823 1.649 . . . . 3.2400000000000002 109.132 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.83 159.42 20.41 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 122.442 1.115 . . . . 4.1799999999999997 113.618 -175.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.02 164.98 24.99 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 125.103 1.335 . . . . 0.81000000000000005 112.451 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -149.38 132.96 16.74 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.271 1.428 . . . . 2.8900000000000001 109.891 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -141.89 149.9 54.56 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.485 1.914 . . . . 10.83 109.773 -170.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.43 153.66 39.94 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.228 1.952 . . . . 0.81000000000000005 110.012 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.18 148.95 64.48 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.157 0.983 . . . . 1.97 110.37 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.71 -23.08 13.0 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.525 2.816 . . . . 0.67000000000000004 112.725 -170.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -173.93 172.51 3.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.296 1.838 . . . . 2.9300000000000002 111.278 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -117.06 154.09 31.59 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.128 2.171 . . . . 1.72 109.863 161.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -110.03 144.01 39.21 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.387 -0.968 . . . . 1.55 108.387 172.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.07 126.02 18.38 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.999 -0.524 . . . . 1.9199999999999999 111.285 163.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -68.2 164.22 33.09 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.788 2.992 . . . . 1.1499999999999999 111.239 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.24 135.95 57.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.915 2.41 . . . . 1.1299999999999999 112.414 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.285 17.5 mtmt 59.27 40.18 21.66 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.018 1.39 . . . . 3.3700000000000001 113.193 171.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.37 164.72 26.9 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 127.926 2.679 . . . . 1.4099999999999999 113.699 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -113.82 146.52 39.83 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.18 1.792 . . . . 4.3799999999999999 111.732 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -139.82 116.45 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.5 1.12 . . . . 4.0800000000000001 108.481 152.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -79.92 148.31 31.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.961 0.905 . . . . 3.04 110.685 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mp -85.69 52.09 2.37 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.167 0.987 . . . . 2.52 112.707 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.94 146.21 8.2 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 115.424 1.638 . . . . 3.6699999999999999 115.424 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.24 -32.92 95.01 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.072 3.181 . . . . 3.6400000000000001 114.076 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.32 31.24 1.38 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.475 1.036 . . . . 2.0299999999999998 113.433 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.72 -122.65 0.94 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.681 1.61 . . . . 1.6000000000000001 113.382 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -73.31 134.93 44.32 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 121.934 -0.745 . . . . 3.5499999999999998 112.761 -170.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -160.15 164.45 32.92 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.838 1.051 . . . . 1.0800000000000001 113.838 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -92.67 131.7 37.54 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 109.887 -0.412 . . . . 3.4700000000000002 109.887 165.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 tpt -85.26 138.37 32.37 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.222 2.209 . . . . 1.76 108.648 164.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.9 mt -132.24 91.39 2.94 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.44 1.496 . . . . 4.3399999999999999 109.221 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.0 mp -88.98 157.5 18.36 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.522 1.129 . . . . 3.6200000000000001 111.869 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.99 -52.67 4.77 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.322 1.915 . . . . 3.0499999999999998 112.577 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.5 mt 55.86 169.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 128.281 2.632 . . . . 1.73 113.707 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -118.73 -25.88 6.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.937 -1.483 . . . . 2.4500000000000002 112.717 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -143.23 157.79 59.44 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 126.611 1.964 . . . . 7.3600000000000003 111.678 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.33 151.2 48.12 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.0 2.466 . . . . 1.53 110.467 158.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.93 148.0 22.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.83 1.252 . . . . 3.0099999999999998 111.524 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -95.73 -166.9 1.51 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.332 1.063 . . . . 5.54 111.122 164.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.49 152.05 24.17 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.737 1.215 . . . . 2.3999999999999999 108.579 157.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.58 29.81 59.12 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.583 -0.565 . . . . 2.1499999999999999 114.287 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -109.63 -179.99 3.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.227 1.411 . . . . 2.9100000000000001 109.431 168.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -129.98 146.15 51.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 104.735 -2.32 . . . . 5.1500000000000004 104.735 164.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.3 t -138.76 139.49 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.861 1.665 . . . . 2.3799999999999999 109.628 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 8.0 pt-20 -92.1 144.96 24.91 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 122.831 1.3 . . . . 2.3399999999999999 112.787 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -135.98 140.71 44.14 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.71 2.404 . . . . 3.9300000000000002 109.207 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -88.74 140.58 29.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.218 1.807 . . . . 2.2000000000000002 109.064 164.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.5 mt -110.07 130.47 55.53 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.289 1.436 . . . . 3.4300000000000002 108.813 166.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.0 mt -110.06 125.15 52.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.097 1.359 . . . . 1.5900000000000001 111.184 -174.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.06 153.28 37.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.457 1.503 . . . . 3.3100000000000001 112.549 -168.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.56 127.37 29.45 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.944 1.091 . . . . 2.0899999999999999 113.944 -174.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.19 59.39 3.63 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.734 1.159 . . . . 3.6800000000000002 113.46 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.71 28.65 66.8 Favored Glycine 0 N--CA 1.474 1.17 0 CA-C-N 117.802 0.801 . . . . 1.72 115.074 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -113.7 145.01 41.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.937 1.369 . . . . 5.0999999999999996 112.242 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.1 150.63 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.212 1.405 . . . . 3.3500000000000001 111.969 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.4 tp -149.28 114.36 5.45 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.235 1.414 . . . . 3.2400000000000002 109.885 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.448 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 31.7 ttpt -92.6 134.72 34.72 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.345 -0.847 . . . . 2.7200000000000002 111.472 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.4 t -133.7 173.94 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.839 2.056 . . . . 3.1299999999999999 108.322 -176.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.0 p -149.98 127.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.919 1.288 . . . . 3.8199999999999998 110.431 -172.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.17 150.11 73.05 Favored Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 126.127 1.771 . . . . 3.6000000000000001 112.221 -171.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.36 148.3 43.12 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.772 2.981 . . . . 1.6899999999999999 111.631 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 t -94.5 81.68 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.083 -1.08 . . . . 2.4399999999999999 108.083 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -126.34 151.67 47.28 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.834 1.654 . . . . 4.3399999999999999 109.93 166.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.75 81.48 1.53 Allowed 'General case' 0 C--O 1.243 0.759 0 N-CA-C 113.777 1.029 . . . . 2.8700000000000001 113.777 -145.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.584 ' CZ ' ' HA ' ' A' ' 120' ' ' ARG 0.304 1.5 mmp_? . . . . . 0 C--O 1.252 1.211 0 CA-C-O 114.662 -2.59 . . . . 8.6500000000000004 117.61 172.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.713 0 CA-C-O 118.047 -1.418 . . . . 12.76 110.519 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m -147.8 -16.0 0.37 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 117.045 2.239 . . . . 11.23 117.045 -161.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -175.0 37.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.602 2.761 . . . . 12.58 109.116 -176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 p -170.7 38.87 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.07 1.748 . . . . 5.6399999999999997 109.363 -135.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -77.49 87.18 3.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.464 1.602 . . . . 4.7599999999999998 111.541 -167.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.78 -179.93 20.69 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.67 1.605 . . . . 1.3600000000000001 110.195 168.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.3 p90 -142.13 160.36 40.39 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.339 1.055 . . . . 3.6200000000000001 112.035 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.28 136.39 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.514 -1.291 . . . . 2.1899999999999999 107.514 164.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.407 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 8.6 tpt180 -51.82 -55.03 22.33 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.848 1.796 . . . . 5.0099999999999998 115.848 -155.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.4 t80 107.54 123.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 130.52 3.528 . . . . 3.5899999999999999 108.451 -154.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.4 m 175.52 131.33 0.15 Allowed Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 127.711 2.404 . . . . 3.2999999999999998 109.255 -176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.71 -32.82 1.9 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.655 2.236 . . . . 1.48 112.577 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.13 176.14 22.15 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.77 1.652 . . . . 0.89000000000000001 111.678 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.05 -10.24 21.39 Favored 'Cis proline' 0 CA--C 1.537 0.647 0 CA-C-N 119.021 1.41 . . . . 1.0900000000000001 112.572 -3.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -143.52 162.87 34.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.497 1.519 . . . . 2.8399999999999999 112.315 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.14 -177.67 4.23 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.255 1.822 . . . . 1.8300000000000001 111.623 -176.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -120.7 167.03 12.89 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.486 1.114 . . . . 1.75 110.453 161.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.01 146.46 33.88 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.756 1.223 . . . . 1.8500000000000001 111.477 168.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -127.84 81.37 2.02 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.601 2.361 . . . . 4.8499999999999996 109.247 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.51 159.54 14.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.61 1.337 . . . . 2.6200000000000001 114.61 -170.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.3 m -131.02 150.84 51.96 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.366 1.867 . . . . 2.25 109.311 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.68 175.54 11.86 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.314 3.045 . . . . 5.8399999999999999 107.882 172.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -115.03 147.28 40.33 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 123.107 0.563 . . . . 4.6799999999999997 110.538 164.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -100.64 90.81 1.58 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.641 0.776 . . . . 1.5 109.868 163.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.5 -5.07 16.39 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.756 2.304 . . . . 2.0600000000000001 113.96 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.25 178.55 53.89 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 122.831 1.24 . . . . 1.6399999999999999 113.793 -174.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.465 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 6.8 m-20 -109.76 -1.28 18.04 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.405 2.282 . . . . 3.4900000000000002 112.132 -170.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -116.7 159.62 39.75 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 127.667 2.387 . . . . 3.5899999999999999 110.65 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.11 139.88 17.38 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.56 2.174 . . . . 1.1399999999999999 111.004 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -104.37 159.29 15.84 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 125.829 1.652 . . . . 3.7599999999999998 110.965 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -155.27 111.0 3.09 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.724 -1.58 . . . . 2.5099999999999998 111.155 -168.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.97 107.42 19.7 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.81 1.644 . . . . 3.4300000000000002 109.176 -171.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 m -104.59 -21.75 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.834 0.853 . . . . 1.96 112.426 -169.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.38 -176.61 32.66 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 124.996 1.284 . . . . 0.47999999999999998 113.495 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.54 -178.74 6.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.55 1.54 . . . . 1.6000000000000001 111.594 170.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -158.36 155.04 28.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.903 1.681 . . . . 4.9299999999999997 108.177 167.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.8 t -157.59 153.74 23.65 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.302 1.441 . . . . 1.8999999999999999 108.755 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.38 -12.19 14.17 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.127 1.885 . . . . 0.87 113.492 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.459 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 24.8 m -98.74 23.21 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.197 1.184 . . . . 2.0899999999999999 114.197 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.37 165.47 31.94 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.357 1.863 . . . . 1.47 107.978 167.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.9 -35.76 9.29 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.687 1.195 . . . . 2.8199999999999998 112.617 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.54 177.68 7.43 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.673 1.589 . . . . 7.0099999999999998 107.71 171.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.62 150.67 10.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 125.468 1.507 . . . . 2.0 108.254 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -131.11 156.88 44.49 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.166 2.186 . . . . 2.8100000000000001 109.11 174.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 tp -110.78 117.25 32.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.759 1.224 . . . . 1.8799999999999999 110.513 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -121.0 154.89 35.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.391 1.476 . . . . 0.81999999999999995 113.192 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -95.23 154.32 17.24 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.335 -1.302 . . . . 1.95 110.267 155.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -103.48 146.0 29.17 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.642 -1.614 . . . . 2.0299999999999998 106.642 154.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -134.61 176.79 8.31 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.414 1.102 . . . . 3.3100000000000001 112.855 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.6 ttp -122.22 140.87 52.08 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.732 1.613 . . . . 4.0599999999999996 109.823 170.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.74 145.89 48.89 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.878 1.271 . . . . 7.0499999999999998 110.836 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -113.38 143.7 44.03 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.757 1.623 . . . . 2.8500000000000001 108.611 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.3 139.64 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.832 1.653 . . . . 5.46 108.079 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 64.41 18.7 11.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.527 1.131 . . . . 5.5599999999999996 112.558 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.29 21.02 79.49 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.329 -1.482 . . . . 2.04 113.057 -171.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -120.9 119.7 33.37 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.23 1.812 . . . . 5.1799999999999997 108.33 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.52 121.62 38.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.255 1.422 . . . . 3.29 111.675 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.1 t -137.05 141.36 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.389 1.876 . . . . 3.3199999999999998 108.266 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.62 167.39 13.95 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.077 0.769 . . . . 4.4000000000000004 113.077 -176.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.92 -177.95 28.73 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 125.356 1.455 . . . . 0.80000000000000004 112.281 -172.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.3 ttm -158.76 149.68 20.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.903 1.281 . . . . 2.5600000000000001 109.552 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.7 ptt85 -160.89 151.96 15.66 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 123.921 0.888 . . . . 5.46 111.707 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.48 150.98 52.68 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.156 1.904 . . . . 0.65000000000000002 111.204 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.58 150.8 73.12 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 125.246 1.418 . . . . 1.71 109.827 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.85 -22.47 7.54 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.367 2.711 . . . . 0.65000000000000002 113.201 -166.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -177.99 166.59 2.03 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 3.6200000000000001 110.617 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.0 mt -109.44 154.45 22.6 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.478 1.111 . . . . 1.8999999999999999 110.077 161.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -113.65 144.69 42.5 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.346 1.458 . . . . 2.0600000000000001 109.289 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.0 130.58 10.23 Favored Pre-proline 0 N--CA 1.473 0.693 0 N-CA-C 112.541 0.571 . . . . 2.4199999999999999 112.541 169.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.86 168.46 18.62 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.286 2.658 . . . . 1.1000000000000001 112.65 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.12 141.53 98.23 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.347 2.698 . . . . 1.3600000000000001 111.598 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.465 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 63.4 mmtt 65.61 8.13 4.93 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.516 1.526 . . . . 2.5699999999999998 113.053 -175.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.58 150.66 24.6 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.714 2.102 . . . . 1.47 114.367 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -78.96 115.81 18.87 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.629 1.971 . . . . 4.4000000000000004 111.141 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.47 55.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 122.484 1.135 . . . . 6.6699999999999999 108.946 -174.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.6 123.78 46.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.928 1.691 . . . . 3.0 108.794 177.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mp -58.28 -56.19 25.31 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.469 1.107 . . . . 4.3099999999999996 112.439 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.455 ' HE3' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 139.59 140.94 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 131.618 3.967 . . . . 3.8999999999999999 111.176 178.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.21 131.94 26.42 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 N-CA-C 107.782 -1.661 . . . . 4.4199999999999999 107.782 159.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.89 -38.03 1.94 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.393 -1.226 . . . . 3.3399999999999999 114.794 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.8 -110.63 0.39 Allowed Glycine 0 N--CA 1.475 1.28 0 CA-C-N 119.165 1.483 . . . . 1.8200000000000001 113.692 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.76 141.3 49.74 Favored 'General case' 0 C--O 1.223 -0.319 0 O-C-N 121.617 -0.931 . . . . 3.1600000000000001 111.007 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -158.3 143.19 16.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.716 -0.675 . . . . 0.78000000000000003 110.997 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -78.89 133.69 36.95 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.063 -0.717 . . . . 3.0699999999999998 109.063 167.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.2 tpt -92.74 119.44 32.12 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.697 1.599 . . . . 2.1699999999999999 108.086 168.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -103.88 105.69 15.97 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.475 1.51 . . . . 2.3300000000000001 110.161 -168.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.01 132.99 40.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.823 0.849 . . . . 3.6200000000000001 111.696 -166.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.08 47.47 7.56 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 123.954 0.788 . . . . 1.71 113.73 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.7 mt -49.02 154.89 0.69 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 116.345 1.98 . . . . 1.8 116.345 -174.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 50.8 mmtt -119.22 -30.54 4.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 113.302 -1.772 . . . . 3.1299999999999999 113.29 -176.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.471 HH21 ' CD ' ' A' ' 97' ' ' GLU . 9.9 mmm180 -106.74 144.89 29.96 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 126.444 1.897 . . . . 6.1500000000000004 108.173 160.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.92 128.06 13.65 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 N-CA-C 107.225 -1.875 . . . . 1.95 107.225 153.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.29 115.72 22.62 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.741 -0.837 . . . . 3.1499999999999999 108.741 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.25 162.21 32.79 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.04 1.336 . . . . 5.46 113.874 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 132.59 54.47 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.504 1.522 . . . . 2.46 110.934 -172.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.23 44.86 16.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.023 -0.99 . . . . 1.3600000000000001 112.85 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.471 ' CD ' HH21 ' A' ' 91' ' ' ARG . 0.9 OUTLIER -103.67 167.06 10.03 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 117.787 0.793 . . . . 2.6200000000000001 109.044 148.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.43 128.34 46.85 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 102.625 -3.102 . . . . 4.9000000000000004 102.625 154.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.7 t -137.28 137.67 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.829 1.251 . . . . 2.6099999999999999 109.999 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -84.54 155.97 21.87 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.061 1.504 . . . . 2.4100000000000001 115.061 -174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tt -155.31 140.3 17.34 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.127 2.171 . . . . 4.1699999999999999 110.902 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -84.38 127.87 34.25 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.899 2.08 . . . . 2.0699999999999998 109.29 165.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.16 127.0 35.15 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.563 -0.903 . . . . 2.4700000000000002 108.563 161.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.5 mt -103.55 105.75 16.08 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 122.497 1.142 . . . . 2.0600000000000001 109.869 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -96.16 152.76 18.26 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.146 1.379 . . . . 3.5800000000000001 111.354 174.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.45 127.51 20.18 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.55 1.14 . . . . 2.1800000000000002 113.643 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.22 66.1 2.25 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.573 1.082 . . . . 3.3700000000000001 112.793 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.5 11.81 80.18 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 115.792 1.077 . . . . 1.8300000000000001 115.792 167.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -96.15 104.14 16.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.779 1.79 . . . . 4.3300000000000001 110.983 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.82 143.23 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 123.863 0.865 . . . . 3.6699999999999999 110.685 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -145.07 108.02 4.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.209 1.004 . . . . 3.52 108.776 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -93.65 131.91 38.49 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.046 0.387 . . . . 2.75 112.046 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 54.2 t -138.85 163.2 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.602 1.561 . . . . 3.6600000000000001 110.204 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.32 126.84 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.849 2.06 . . . . 3.02 109.808 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.27 145.3 38.16 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 126.548 1.939 . . . . 4.21 109.737 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.05 162.7 41.03 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.183 3.256 . . . . 1.3899999999999999 113.008 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.24 110.75 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 114.576 -1.193 . . . . 2.5099999999999998 110.994 165.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -102.06 -175.64 2.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.19 2.196 . . . . 3.6800000000000002 109.324 156.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.12 94.38 4.86 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.476 -0.765 . . . . 2.6699999999999999 110.733 165.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.407 ' C ' ' HE ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.188 0 C-N-CA 126.411 1.885 . . . . 7.3300000000000001 110.313 -176.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 108.883 -1.687 . . . . 10.19 108.883 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m -142.26 161.04 39.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.661 1.184 . . . . 8.7400000000000002 109.316 -172.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -88.33 7.62 31.45 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.632 1.573 . . . . 12.779999999999999 112.549 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.1 t -165.48 148.06 7.75 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.261 1.424 . . . . 5.71 110.317 -163.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -159.75 59.06 0.38 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.419 2.288 . . . . 6.0 108.287 -155.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.83 167.58 29.92 Favored Glycine 0 N--CA 1.473 1.115 0 O-C-N 120.858 -1.151 . . . . 1.24 114.334 -167.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -152.76 169.27 23.18 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.852 1.427 . . . . 2.5800000000000001 114.852 -172.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.2 t -106.67 144.8 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.177 1.791 . . . . 2.3199999999999998 107.13 168.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.426 ' CG ' ' H ' ' A' ' 10' ' ' PHE 0.26 0.6 OUTLIER -73.18 -100.11 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.388 0.884 . . . . 4.8600000000000003 113.388 175.543 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.426 ' H ' ' CG ' ' A' ' 9' ' ' ARG . 73.1 t80 -161.21 143.46 12.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.242 1.817 . . . . 3.5899999999999999 109.5 -167.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t 171.81 136.17 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 126.93 2.092 . . . . 2.7000000000000002 111.676 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.08 -27.47 6.78 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.745 2.297 . . . . 1.8300000000000001 111.901 166.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.39 171.91 17.01 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 126.696 2.093 . . . . 1.0700000000000001 111.195 -175.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -78.46 -9.0 35.88 Favored 'Cis proline' 0 CA--C 1.537 0.631 0 CA-C-N 118.508 1.154 . . . . 1.0800000000000001 113.045 -0.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -151.36 167.89 26.5 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.734 1.214 . . . . 1.8999999999999999 113.374 -168.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.87 -177.51 6.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.485 2.314 . . . . 1.9099999999999999 111.72 -173.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.42 39.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.402 1.481 . . . . 1.8 108.576 169.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.14 141.78 47.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.656 1.582 . . . . 1.8799999999999999 110.544 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.513 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 51.3 m-85 -121.42 70.78 0.94 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.724 2.01 . . . . 3.25 110.835 -171.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -90.85 164.47 14.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.089 0.955 . . . . 2.9300000000000002 113.21 -170.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.88 124.61 39.97 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.457 -0.777 . . . . 2.6099999999999999 110.299 175.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.2 tp -96.23 104.08 16.02 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.198 -1.038 . . . . 5.96 108.198 167.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -82.46 171.24 14.36 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.663 0.744 . . . . 5.8700000000000001 111.929 165.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -134.58 101.12 12.07 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.566 0.747 . . . . 1.4299999999999999 109.417 155.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.78 -11.86 11.24 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.158 2.572 . . . . 1.74 112.992 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.23 178.92 49.45 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-O 122.749 1.194 . . . . 1.1899999999999999 112.55 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -104.29 -1.73 26.6 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.076 2.15 . . . . 3.1299999999999999 112.3 -173.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.9 mt -124.8 162.98 39.99 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 127.782 2.433 . . . . 4.8399999999999999 109.323 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.59 158.44 28.63 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.354 2.036 . . . . 1.1899999999999999 111.503 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mp -118.28 154.69 31.87 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.161 1.784 . . . . 3.3799999999999999 110.019 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -138.51 110.29 7.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 113.494 -1.685 . . . . 2.5899999999999999 109.511 173.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.7 118.41 30.63 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.727 1.611 . . . . 2.9700000000000002 107.727 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 m -113.53 -22.43 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.181 0.993 . . . . 1.79 112.691 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.32 -176.91 31.91 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 124.359 0.98 . . . . 0.42999999999999999 113.31 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.5 178.12 6.7 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.718 -0.872 . . . . 1.4199999999999999 112.17 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.42 HH21 ' CG ' ' A' ' 102' ' ' ASP . 32.6 ttp180 -150.2 148.87 29.44 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.635 2.374 . . . . 8.6199999999999992 107.957 173.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 t -164.82 148.81 7.73 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 117.934 -1.031 . . . . 1.8500000000000001 110.158 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.78 -12.11 21.97 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.174 1.916 . . . . 0.79000000000000004 114.78 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.63 20.82 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.125 1.528 . . . . 1.98 115.125 -170.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.36 150.25 25.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.486 1.514 . . . . 1.8799999999999999 109.075 169.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.85 -47.67 7.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.532 1.133 . . . . 3.3500000000000001 112.832 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -122.33 98.7 6.05 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.453 -1.314 . . . . 7.1399999999999997 107.453 -171.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.26 125.89 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.697 -0.683 . . . . 1.8600000000000001 109.802 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -116.82 150.46 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.71 2.004 . . . . 2.7000000000000002 109.069 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.4 tp -105.12 118.64 37.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.043 0.937 . . . . 1.8300000000000001 110.356 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.1 m170 -124.64 155.29 39.41 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.046 1.338 . . . . 0.55000000000000004 114.123 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -100.43 162.54 12.87 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.867 1.667 . . . . 2.21 112.484 158.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.0 m -132.33 144.41 50.54 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.876 2.07 . . . . 2.02 105.661 167.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -152.76 170.14 21.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.908 0.883 . . . . 3.2999999999999998 112.491 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.9 ttp -98.83 140.1 33.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.92 1.288 . . . . 4.2699999999999996 110.812 173.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.3 148.18 32.15 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.018 1.727 . . . . 6.1799999999999997 111.314 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.92 144.49 26.15 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.298 1.039 . . . . 2.4199999999999999 108.572 166.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -141.83 138.05 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 107.806 -1.183 . . . . 3.7000000000000002 107.806 155.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 59.11 22.85 11.02 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.847 1.425 . . . . 4.3200000000000003 114.847 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.31 17.83 79.75 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 120.717 -1.24 . . . . 1.6699999999999999 113.956 -170.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -109.45 122.57 47.69 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.626 1.971 . . . . 3.2999999999999998 107.558 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -79.81 117.99 21.19 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.767 1.227 . . . . 3.6600000000000001 108.642 172.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 m -141.68 -175.76 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.709 2.404 . . . . 3.5 109.858 -171.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.76 175.74 5.39 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.807 0.843 . . . . 3.8300000000000001 112.974 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.9 170.2 33.12 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.62 2.057 . . . . 0.80000000000000004 111.94 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -149.31 137.96 21.02 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.441 1.496 . . . . 1.9399999999999999 109.817 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -143.73 151.63 53.91 Favored Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 125.618 1.567 . . . . 10.44 110.605 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.99 151.9 45.49 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.132 1.888 . . . . 0.64000000000000001 109.98 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.9 m -137.5 153.51 74.46 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.013 1.325 . . . . 1.6899999999999999 109.994 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.59 -28.12 2.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.719 2.279 . . . . 0.48999999999999999 112.805 -165.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -177.2 165.75 2.31 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.047 1.339 . . . . 3.5299999999999998 112.483 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.2 mt -109.91 152.0 26.37 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.673 1.589 . . . . 1.96 111.051 162.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -121.89 136.76 54.94 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.584 1.553 . . . . 2.1600000000000001 108.407 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.8 t -143.69 129.4 9.97 Favored Pre-proline 0 N--CA 1.475 0.808 0 N-CA-C 113.665 0.987 . . . . 2.1299999999999999 113.665 174.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.81 161.66 43.18 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.161 3.241 . . . . 1.4199999999999999 111.693 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.63 141.07 96.5 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.557 2.838 . . . . 1.25 113.172 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 69.15 0.23 2.74 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.919 2.088 . . . . 3.1000000000000001 114.572 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.53 175.73 47.63 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.928 1.728 . . . . 1.0800000000000001 113.223 171.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.08 132.87 11.39 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.21 1.004 . . . . 6.4299999999999997 112.725 173.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.5 t -125.18 108.4 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.381 2.272 . . . . 4.1699999999999999 109.524 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.5 126.92 31.66 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 127.879 2.471 . . . . 3.6299999999999999 112.21 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -74.12 75.46 1.76 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.986 1.714 . . . . 2.1299999999999999 109.811 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.07 155.11 92.76 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 114.819 1.415 . . . . 3.1600000000000001 114.819 -173.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.513 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 37.0 Cg_endo -59.34 -15.81 31.46 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.323 3.349 . . . . 2.3700000000000001 116.628 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -97.92 -1.04 58.62 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.265 -1.297 . . . . 1.95 115.292 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.86 -115.66 0.9 Allowed Glycine 0 N--CA 1.473 1.136 0 CA-C-N 119.908 1.854 . . . . 1.54 113.958 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -70.79 141.55 51.4 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.17 -0.606 . . . . 2.98 110.386 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -161.45 160.25 29.08 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.758 1.223 . . . . 0.68999999999999995 111.582 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -92.7 130.8 38.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.546 -0.539 . . . . 3.1000000000000001 109.546 166.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 tpt -84.96 128.8 34.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.072 1.349 . . . . 2.0 108.89 166.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -114.74 107.53 15.58 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.36 1.064 . . . . 2.3300000000000001 108.614 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mp -107.45 148.91 28.54 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.045 0.839 . . . . 3.3399999999999999 111.036 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.82 43.39 28.26 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.993 -0.893 . . . . 1.71 113.353 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 mt -46.62 150.88 0.63 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.999 1.481 . . . . 2.1699999999999999 114.999 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -108.01 -21.31 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 112.986 -1.916 . . . . 2.9700000000000002 114.248 -172.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.92 145.83 58.75 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 126.699 1.999 . . . . 6.46 110.548 162.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -66.69 154.31 74.91 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.085 1.857 . . . . 1.47 108.777 162.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.85 159.76 43.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.466 1.127 . . . . 3.9100000000000001 112.547 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.55 173.9 6.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.923 2.089 . . . . 5.6900000000000004 111.301 -165.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.14 135.72 56.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.231 1.012 . . . . 2.2799999999999998 112.857 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.69 40.37 31.88 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 114.828 -1.078 . . . . 1.5800000000000001 113.428 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -113.89 176.33 5.08 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.497 1.119 . . . . 2.7599999999999998 108.992 157.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -121.96 164.3 17.84 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.662 1.585 . . . . 2.9399999999999999 107.161 159.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.0 t -148.94 154.77 9.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 130.588 3.555 . . . . 2.8300000000000001 109.053 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.469 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 29.8 tt0 -121.95 138.53 54.38 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.366 1.466 . . . . 3.4399999999999999 111.252 179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.62 137.2 54.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.863 1.265 . . . . 2.75 110.962 165.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.42 ' CG ' HH21 ' A' ' 36' ' ' ARG . 12.3 m-20 -87.8 138.51 31.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.264 1.826 . . . . 2.4300000000000002 110.044 155.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.3 136.61 34.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.509 1.924 . . . . 2.2200000000000002 109.45 167.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt -107.16 118.5 36.87 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.7 1.6 . . . . 1.8200000000000001 109.519 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -109.49 156.25 20.34 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.647 1.179 . . . . 3.2799999999999998 111.041 -175.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.05 141.66 58.67 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.465 -0.772 . . . . 2.3500000000000001 110.748 164.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.54 35.68 11.55 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 119.066 -0.852 . . . . 4.1799999999999997 114.951 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.97 7.47 84.08 Favored Glycine 0 N--CA 1.476 1.317 0 CA-C-N 118.234 1.017 . . . . 1.8799999999999999 115.553 167.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -89.53 137.28 32.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.063 0.932 . . . . 3.8799999999999999 111.261 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.31 131.53 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.56 1.544 . . . . 3.0299999999999998 108.079 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.27 143.56 27.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.763 1.625 . . . . 4.46 109.189 -174.405 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.469 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 14.8 ptpt -120.3 151.84 38.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.291 1.589 . . . . 3.5099999999999998 115.291 -172.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.0 m -122.98 153.04 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 128.062 2.545 . . . . 4.1100000000000003 110.825 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.2 138.72 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.106 1.762 . . . . 4.1299999999999999 109.609 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -141.29 125.4 10.28 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.401 1.08 . . . . 3.6600000000000001 111.547 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.78 167.11 24.4 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.788 2.325 . . . . 1.27 110.776 162.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.25 149.33 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.909 1.284 . . . . 1.9399999999999999 110.508 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -135.56 -172.49 3.1 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.514 1.925 . . . . 4.9299999999999997 112.817 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.11 66.97 1.28 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.258 1.823 . . . . 3.0899999999999999 112.156 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.183 0 C-N-CA 124.318 1.047 . . . . 10.09 113.384 -172.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 CA-C-O 118.98 -0.9 . . . . 13.42 113.86 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 t -170.67 168.25 7.55 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.088 1.444 . . . . 11.109999999999999 109.469 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -75.06 78.07 2.24 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.404 1.002 . . . . 12.25 109.492 172.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 175.89 -42.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 1 C-N-CA 131.784 4.034 . . . . 8.1799999999999997 109.203 -160.634 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.33 134.93 5.75 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 123.482 1.61 . . . . 6.2199999999999998 112.161 177.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.54 157.54 15.78 Favored Glycine 0 C--N 1.329 0.155 0 CA-C-N 114.082 -1.417 . . . . 2.2400000000000002 110.039 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -92.42 162.55 14.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.611 1.196 . . . . 3.1299999999999999 112.268 -160.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -80.34 132.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.49 -1.3 . . . . 2.02 107.49 157.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -21.24 59.01 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.116 1.895 . . . . 7.4100000000000001 116.116 -163.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 t80 85.75 144.01 0.06 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.972 2.909 . . . . 3.79 111.201 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 t -171.28 150.9 2.93 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.672 1.189 . . . . 2.6200000000000001 112.233 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -81.37 -18.5 8.36 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.344 2.696 . . . . 1.6200000000000001 112.109 158.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.81 -170.17 13.73 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 126.754 2.121 . . . . 1.3400000000000001 111.631 -170.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.64 -3.54 22.15 Favored 'Cis proline' 0 CA--C 1.54 0.817 0 CA-C-N 119.196 1.498 . . . . 1.8100000000000001 112.477 -9.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -136.02 176.91 8.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.778 1.231 . . . . 5.4699999999999998 110.843 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.59 -174.54 4.98 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.611 2.365 . . . . 1.9099999999999999 112.133 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.47 149.25 28.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.957 2.503 . . . . 1.78 108.452 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -135.52 136.5 41.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.857 1.208 . . . . 1.53 113.417 -175.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.484 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 28.8 m-85 -106.5 41.12 1.49 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.715 1.606 . . . . 3.5800000000000001 114.09 -170.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.38 155.89 33.94 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.336 1.606 . . . . 2.75 115.336 -167.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 54.8 m -99.71 143.29 30.11 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.438 1.095 . . . . 2.5099999999999998 112.128 -178.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.47 123.62 47.93 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.83 2.452 . . . . 4.2199999999999998 111.804 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -102.97 141.05 36.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.589 0.756 . . . . 3.7200000000000002 109.537 158.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -108.34 84.31 2.26 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.756 -0.59 . . . . 1.6399999999999999 109.928 159.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.8 -10.05 24.46 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.424 2.083 . . . . 1.3999999999999999 113.181 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.73 176.43 47.75 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-O 122.861 1.256 . . . . 1.3899999999999999 113.1 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.433 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 4.8 m-20 -102.02 -8.62 21.32 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.759 2.424 . . . . 3.3700000000000001 112.179 -170.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.0 mt -132.01 152.56 80.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.523 1.929 . . . . 5.1699999999999999 109.264 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.83 167.74 24.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.093 2.528 . . . . 1.6399999999999999 113.698 -152.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mp -115.05 147.98 39.47 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.29 1.836 . . . . 3.4300000000000002 108.683 168.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.23 98.92 3.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 112.855 -1.975 . . . . 3.0099999999999998 108.737 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.3 tp -83.67 102.37 12.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.878 2.071 . . . . 3.3799999999999999 109.387 -168.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -94.7 -25.3 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.917 1.287 . . . . 2.4199999999999999 111.711 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.06 -176.85 31.57 Favored Glycine 0 C--N 1.343 0.922 0 C-N-CA 123.792 0.711 . . . . 0.56999999999999995 114.092 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.24 -177.88 5.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.935 1.694 . . . . 1.6899999999999999 110.382 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -156.51 175.25 14.28 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 127.434 2.293 . . . . 6.9900000000000002 107.948 161.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t -162.7 152.2 13.12 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 128.755 2.822 . . . . 2.0800000000000001 106.796 166.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.07 -29.65 39.74 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 120.894 1.355 . . . . 2.1499999999999999 111.918 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.6 m -86.78 14.63 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 115.299 1.592 . . . . 2.9399999999999999 115.299 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.09 138.48 25.37 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.586 1.539 . . . . 1.97 113.89 168.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.54 -26.84 41.35 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.837 1.421 . . . . 4.0099999999999998 114.837 -165.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -146.63 165.7 28.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.908 2.083 . . . . 6.21 108.341 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.88 143.89 15.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 124.972 1.309 . . . . 1.97 109.383 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -118.57 158.04 26.18 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.654 1.982 . . . . 3.2799999999999998 109.512 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 tp -106.88 117.56 34.39 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.538 0.735 . . . . 1.9399999999999999 110.307 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -119.86 165.08 15.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 123.516 1.627 . . . . 0.68000000000000005 113.897 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -121.57 162.6 20.32 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.18 -1.827 . . . . 3.5899999999999999 111.501 156.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.4 m -118.01 139.56 51.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.19 2.196 . . . . 1.8799999999999999 106.158 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -136.48 169.31 17.9 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.578 1.18 . . . . 3.21 113.736 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.2 ttp -111.55 147.27 35.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.281 1.833 . . . . 4.0599999999999996 109.102 170.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 153.53 38.3 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.802 1.241 . . . . 6.2699999999999996 110.505 -174.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -105.23 138.58 41.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.351 1.46 . . . . 3.4900000000000002 110.267 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.25 113.98 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.625 -1.25 . . . . 3.5899999999999999 107.625 169.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.537 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 16.4 mt-10 66.66 14.25 9.69 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.238 1.815 . . . . 3.8599999999999999 114.33 -178.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.5 20.43 58.5 Favored Glycine 0 N--CA 1.477 1.376 0 O-C-N 121.249 -0.907 . . . . 2.6499999999999999 113.467 -167.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.537 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 45.3 mtmt -119.3 125.95 50.3 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.956 1.703 . . . . 3.1699999999999999 109.305 172.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -88.08 123.06 32.37 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.764 1.226 . . . . 5.8200000000000003 111.249 -170.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.0 t -141.68 141.06 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.2 1.8 . . . . 3.29 109.601 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -93.56 168.45 11.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.339 1.056 . . . . 4.0800000000000001 113.051 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.04 -178.73 31.39 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.94 1.257 . . . . 0.68000000000000005 113.634 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ttm -152.66 150.1 29.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.963 1.705 . . . . 2.2599999999999998 108.816 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -158.22 154.26 23.56 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 118.23 -0.89 . . . . 5.5800000000000001 111.776 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.93 154.98 62.87 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.23 1.954 . . . . 0.60999999999999999 111.155 169.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.66 151.66 63.94 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.014 1.326 . . . . 1.8899999999999999 110.241 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.63 -27.85 8.68 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.382 2.721 . . . . 0.65000000000000002 112.573 -167.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -176.16 163.16 2.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.112 1.765 . . . . 2.9100000000000001 111.472 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.8 mt -105.31 153.51 21.52 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.235 1.014 . . . . 1.8300000000000001 110.592 160.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.18 144.02 34.54 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.405 1.082 . . . . 1.8100000000000001 110.271 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.4 t -140.48 121.99 9.39 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 118.552 0.615 . . . . 2.0299999999999998 111.714 163.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -71.36 159.6 51.17 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.465 2.777 . . . . 1.2 111.095 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.85 142.99 99.26 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.384 2.723 . . . . 1.52 111.816 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.433 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 70.1 mmtt 67.28 -5.48 0.72 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.178 2.191 . . . . 2.9500000000000002 114.374 -178.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.12 165.31 48.79 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.016 1.293 . . . . 1.3200000000000001 112.118 172.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 145.53 35.87 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.701 1.201 . . . . 5.4000000000000004 109.298 171.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.0 t -148.96 158.86 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 126.562 1.945 . . . . 3.7200000000000002 107.809 -169.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -135.03 142.6 46.42 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.007 1.276 . . . . 4.46 111.706 -178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.21 79.05 1.79 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 122.121 0.962 . . . . 2.27 109.117 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -62.98 150.55 87.91 Favored Pre-proline 0 CA--C 1.558 1.281 0 N-CA-C 114.319 1.229 . . . . 4.2300000000000004 114.319 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.484 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 38.2 Cg_endo -58.32 -49.68 11.69 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.396 2.731 . . . . 2.27 113.055 174.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.53 58.3 4.45 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.869 0.747 . . . . 2.1200000000000001 111.474 171.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.32 -125.44 1.5 Allowed Glycine 0 N--CA 1.469 0.86 0 C-N-CA 124.819 1.2 . . . . 1.74 114.167 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -73.04 138.89 46.21 Favored 'General case' 0 C--O 1.219 -0.518 0 O-C-N 122.191 -0.593 . . . . 3.77 112.279 -168.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -162.58 152.01 15.6 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.02 0.928 . . . . 0.71999999999999997 110.971 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.56 143.68 33.03 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.724 -0.473 . . . . 3.1299999999999999 109.724 162.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -96.33 123.99 40.17 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.726 1.61 . . . . 1.8100000000000001 108.428 166.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.17 120.37 42.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.397 0.999 . . . . 2.2000000000000002 108.906 -174.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -106.47 154.7 20.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.335 1.054 . . . . 3.5899999999999999 110.985 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.12 -51.4 3.21 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 127.269 2.366 . . . . 2.5600000000000001 114.747 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.7 mt 54.57 168.3 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.577 2.751 . . . . 1.9299999999999999 114.568 -171.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -116.82 -23.61 8.02 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.465 1.506 . . . . 3.5800000000000001 114.015 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.4 ptt-85 -137.31 149.85 67.01 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.569 1.548 . . . . 7.6500000000000004 111.414 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -68.19 142.65 56.27 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.982 1.788 . . . . 1.53 107.89 154.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.96 176.95 8.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.71 0.804 . . . . 3.0 110.479 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -120.66 176.28 5.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.194 1.798 . . . . 4.2300000000000004 108.618 155.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.18 126.96 33.62 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.399 -1.334 . . . . 2.0499999999999998 107.399 154.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.69 6.24 54.76 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.195 -1.336 . . . . 1.99 116.155 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -77.54 -176.53 4.31 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.392 1.596 . . . . 2.8500000000000001 110.444 159.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.15 170.44 9.56 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 130.607 3.563 . . . . 4.8099999999999996 107.124 165.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.0 t -150.37 141.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 127.089 2.156 . . . . 2.3700000000000001 108.975 166.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.24 126.29 52.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.158 1.383 . . . . 3.9700000000000002 110.62 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.1 mp -115.33 140.78 48.82 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.15 0.98 . . . . 2.98 111.52 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.93 139.27 31.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 128.576 2.75 . . . . 2.9100000000000001 108.994 167.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -118.83 131.12 56.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.548 1.139 . . . . 2.1000000000000001 109.503 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.4 mt -112.44 116.9 31.03 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.48 1.512 . . . . 1.8899999999999999 110.061 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -116.78 132.82 56.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.477 1.111 . . . . 3.4300000000000002 110.771 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.9 -24.05 66.71 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.976 0.732 . . . . 3.25 112.976 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.83 41.88 2.22 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.591 1.567 . . . . 5.5300000000000002 114.223 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.49 23.64 77.59 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.346 1.45 . . . . 3.4300000000000002 115.601 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -135.66 145.41 46.75 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.085 1.442 . . . . 4.7300000000000004 112.981 -166.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.19 141.89 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.591 1.556 . . . . 3.75 107.496 162.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.45 172.1 13.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.841 1.656 . . . . 3.3100000000000001 109.658 -174.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.78 150.94 52.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.843 0.857 . . . . 5.5 111.033 167.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.7 t -136.75 157.69 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.28 1.032 . . . . 2.8500000000000001 109.0 168.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.6 t -120.22 120.81 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.746 1.618 . . . . 3.6600000000000001 108.262 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -122.93 145.31 45.33 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 126.744 2.018 . . . . 3.7799999999999998 109.321 -170.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.48 164.08 33.12 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.192 2.595 . . . . 1.6200000000000001 110.807 171.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.6 t -100.89 119.66 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.465 -0.939 . . . . 1.8999999999999999 108.465 160.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -129.56 138.34 51.25 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.22 -1.77 . . . . 4.7400000000000002 106.22 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.51 68.74 9.7 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.851 -1.155 . . . . 2.1499999999999999 110.903 -172.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.928 0 N-CA-C 115.927 1.825 . . . . 8.6500000000000004 115.927 -171.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.905 0 N-CA-C 107.213 -2.355 . . . . 10.050000000000001 107.213 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -153.29 -81.11 0.09 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.983 0.735 . . . . 7.1699999999999999 112.983 -142.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 171.88 -153.51 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.886 0.874 . . . . 11.789999999999999 109.431 -137.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.5 t -97.03 148.13 23.3 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.356 -0.979 . . . . 6.2199999999999998 108.356 147.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.22 57.59 0.89 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.375 1.083 . . . . 5.2300000000000004 109.834 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.78 -178.75 30.29 Favored Glycine 0 C--N 1.34 0.805 0 O-C-N 121.306 -0.871 . . . . 1.1899999999999999 111.634 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -131.77 160.38 35.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.024 1.12 . . . . 2.7799999999999998 114.024 -170.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.18 145.25 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.199 1.4 . . . . 2.5800000000000001 108.552 159.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -93.3 150.05 20.77 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.75 0.82 . . . . 5.79 111.908 -175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -70.6 139.7 51.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.605 2.362 . . . . 4.0599999999999996 113.227 -172.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -179.99 142.4 0.35 Allowed Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.187 1.395 . . . . 2.54 112.827 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.01 -20.88 18.88 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.727 2.285 . . . . 1.6000000000000001 112.492 162.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.58 175.67 13.96 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.809 2.147 . . . . 1.01 111.698 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.82 -15.6 29.07 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 118.893 1.346 . . . . 1.3899999999999999 112.946 -3.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -128.44 159.89 33.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.031 0.919 . . . . 2.8100000000000001 113.125 174.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -131.22 -178.69 4.95 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.652 3.581 . . . . 1.95 107.841 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.95 171.74 12.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.846 1.658 . . . . 1.73 108.295 169.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.34 118.74 19.8 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.488 -0.757 . . . . 2.1400000000000001 109.894 164.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -102.32 63.05 0.87 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.55 1.54 . . . . 4.0499999999999998 108.583 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -89.68 160.02 16.81 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.975 -1.011 . . . . 2.6200000000000001 112.092 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -130.18 127.74 40.32 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.849 1.26 . . . . 2.8199999999999998 108.443 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -119.74 179.72 4.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.03 1.332 . . . . 6.0199999999999996 109.826 162.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -127.05 164.14 22.21 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.654 0.781 . . . . 4.8399999999999999 109.886 165.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.15 81.46 0.42 Allowed Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.585 1.954 . . . . 3.1600000000000001 109.314 -174.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.52 -17.41 34.15 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.78 2.32 . . . . 1.45 114.809 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.7 157.95 51.0 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.367 0.985 . . . . 1.5 110.975 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.76 4.27 37.6 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 127.59 2.356 . . . . 3.77 112.408 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mp -122.88 158.0 58.48 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 127.291 2.236 . . . . 5.0099999999999998 108.72 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -83.01 141.63 10.62 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.72 2.28 . . . . 1.55 111.381 -166.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -89.74 150.04 22.47 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 123.41 1.576 . . . . 3.2200000000000002 112.626 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttm-85 -130.82 97.68 4.41 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.099 -1.864 . . . . 3.8999999999999999 110.227 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.7 tt -78.79 110.66 14.17 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 125.236 1.414 . . . . 3.8900000000000001 107.695 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -100.12 -27.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 122.827 0.451 . . . . 1.5600000000000001 111.697 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 -173.76 29.51 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.094 1.33 . . . . 0.42999999999999999 113.396 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.31 177.99 8.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.11 1.764 . . . . 1.4199999999999999 112.295 171.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -143.26 169.22 18.04 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.402 1.481 . . . . 6.4800000000000004 109.319 158.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -168.85 150.44 4.57 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.757 1.623 . . . . 1.6399999999999999 108.313 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.07 -14.56 12.14 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.524 1.483 . . . . 0.85999999999999999 113.266 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 17.1 m -101.25 24.45 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.687 1.195 . . . . 1.8400000000000001 113.621 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.9 161.82 39.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.482 1.513 . . . . 1.47 109.46 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -93.58 -44.04 8.4 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.074 2.15 . . . . 3.96 112.363 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -131.83 159.56 38.19 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.07 0.948 . . . . 7.8499999999999996 109.013 160.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.84 143.6 30.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 125.277 1.431 . . . . 2.0499999999999998 108.887 166.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -117.47 149.25 40.89 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.858 1.663 . . . . 2.6400000000000001 109.272 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.5 tp -100.88 120.77 40.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.35 0.66 . . . . 1.8400000000000001 110.022 175.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -122.62 157.94 31.08 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.16 1.384 . . . . 0.65000000000000002 113.903 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -98.2 176.85 5.58 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.885 2.074 . . . . 2.4100000000000001 111.878 161.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.3 m -151.76 147.36 26.58 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.024 1.73 . . . . 1.9199999999999999 106.762 166.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -161.71 -179.73 7.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.635 1.174 . . . . 3.77 111.976 -164.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.0 ptt? -110.09 146.9 34.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.656 1.182 . . . . 5.0800000000000001 113.538 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -132.05 148.46 52.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.412 1.885 . . . . 6.7000000000000002 111.675 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.39 142.91 35.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.166 1.786 . . . . 3.5299999999999998 112.298 173.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.4 m -145.56 5.47 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 127.058 2.143 . . . . 4.2300000000000004 115.561 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -174.67 18.11 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.288 1.588 . . . . 3.8999999999999999 115.288 -161.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.27 -5.82 32.74 Favored Glycine 0 CA--C 1.54 1.606 0 O-C-N 119.914 -1.741 . . . . 2.2000000000000002 113.471 -163.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -97.39 69.93 2.27 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 129.12 2.968 . . . . 3.48 109.64 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -55.33 120.08 6.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.884 1.274 . . . . 3.71 109.953 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -145.37 144.56 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.32 1.848 . . . . 3.6800000000000002 109.122 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.5 mtp -82.28 169.13 16.89 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.293 1.22 . . . . 4.9900000000000002 114.293 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.2 176.83 32.72 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.911 1.719 . . . . 0.62 113.078 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.2 ttm -156.3 149.17 24.0 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.109 1.764 . . . . 2.5499999999999998 109.916 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -150.94 155.43 35.2 Favored Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 125.835 1.654 . . . . 5.1500000000000004 109.361 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.5 155.89 50.13 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.941 1.76 . . . . 0.55000000000000004 110.847 165.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.43 153.89 66.3 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.731 1.613 . . . . 1.79 110.09 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.27 -23.41 5.19 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.649 2.899 . . . . 0.63 113.631 -167.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -176.54 160.47 2.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.05 1.74 . . . . 3.4399999999999999 111.011 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -106.28 159.04 16.42 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.486 1.115 . . . . 1.9399999999999999 109.182 159.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -132.95 149.97 52.2 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.256 1.022 . . . . 2.2799999999999998 110.157 173.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.65 138.62 15.46 Favored Pre-proline 0 CA--C 1.537 0.464 0 O-C-N 124.056 0.847 . . . . 2.0699999999999998 112.237 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.62 156.54 35.9 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.743 2.962 . . . . 1.4299999999999999 112.264 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.35 140.41 91.64 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.874 3.049 . . . . 1.52 112.995 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.45 2.78 1.67 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.25 2.22 . . . . 3.79 113.96 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.52 179.7 51.92 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.227 2.346 . . . . 1.53 113.523 171.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.06 124.67 49.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.672 1.989 . . . . 5.5499999999999998 110.926 -173.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.8 t -94.67 72.92 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.807 2.043 . . . . 6.6799999999999997 108.27 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -117.52 115.27 24.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.806 1.288 . . . . 3.2400000000000002 111.794 -158.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -87.19 74.68 9.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.551 1.94 . . . . 2.0299999999999998 107.836 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 146.95 99.04 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 120.834 -1.166 . . . . 3.3100000000000001 113.514 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -61.02 147.13 96.63 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.335 2.023 . . . . 3.3500000000000001 109.485 164.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.07 -5.75 74.81 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.447 -1.196 . . . . 2.7400000000000002 113.703 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -147.33 -121.23 1.25 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 119.156 1.478 . . . . 1.48 113.674 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -73.94 138.47 44.26 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.482 -1.011 . . . . 3.21 111.319 -167.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -160.24 153.09 21.36 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.824 0.849 . . . . 0.81999999999999995 111.453 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -80.29 139.45 36.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.865 -0.791 . . . . 3.04 108.865 164.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 tpt -100.73 120.49 40.16 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.381 1.873 . . . . 2.4199999999999999 108.045 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -103.89 117.27 33.94 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.467 1.507 . . . . 2.0600000000000001 108.152 -175.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.88 148.13 41.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.222 0.919 . . . . 3.1800000000000002 112.163 -174.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.61 36.78 36.85 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 124.154 0.883 . . . . 1.51 113.12 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.1 mt -46.0 151.93 0.43 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 117.194 2.294 . . . . 1.8799999999999999 117.194 -170.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 60.6 mmtt -114.27 -31.36 6.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 113.088 -1.869 . . . . 3.4500000000000002 113.423 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -100.47 125.54 38.87 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 117.109 -1.424 . . . . 5.6799999999999997 107.776 156.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.96 112.36 2.0 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 N-CA-C 105.501 -2.538 . . . . 1.3999999999999999 105.501 152.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.01 137.88 51.12 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.472 1.129 . . . . 3.3599999999999999 112.995 -159.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -132.99 164.78 26.23 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 126.058 1.743 . . . . 4.21 113.67 -157.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.54 116.93 15.79 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.185 -0.916 . . . . 2.0299999999999998 109.778 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.2 15.13 36.63 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.736 -1.036 . . . . 1.26 114.527 -171.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -97.67 178.82 5.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.8 1.3 . . . . 2.21 110.411 159.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -137.32 150.83 48.03 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.391 2.276 . . . . 3.2799999999999998 105.873 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.1 t -145.06 144.83 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 127.177 2.191 . . . . 2.1099999999999999 109.329 -172.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -92.87 134.27 35.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.871 -0.604 . . . . 3.4900000000000002 111.429 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -114.3 146.01 41.02 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.271 1.828 . . . . 3.77 109.774 164.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -101.35 139.82 36.5 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.473 1.509 . . . . 2.0099999999999998 108.757 157.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.82 122.6 46.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.248 1.419 . . . . 1.98 108.932 167.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.8 mt -94.76 114.38 26.27 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.279 1.032 . . . . 1.8700000000000001 110.232 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -109.93 112.92 25.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.039 1.336 . . . . 3.4199999999999999 111.326 -172.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 51.51 29.77 5.72 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.837 1.655 . . . . 2.6800000000000002 113.023 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.97 -71.21 1.71 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.182 1.373 . . . . 4.6600000000000001 111.98 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.9 13.45 18.71 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 116.999 1.56 . . . . 1.6799999999999999 116.999 -163.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -132.05 143.75 50.26 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.634 1.574 . . . . 4.1600000000000001 110.048 168.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.63 144.79 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.39 1.076 . . . . 3.2799999999999998 109.106 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.9 tp -136.27 123.39 21.64 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.26 1.024 . . . . 3.4199999999999999 110.188 170.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -99.99 140.78 33.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.765 1.226 . . . . 4.0099999999999998 111.993 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.18 138.53 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.028 1.331 . . . . 3.3999999999999999 112.102 -173.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.3 p -83.07 136.53 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.814 0.846 . . . . 3.6800000000000002 109.862 165.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 mt -134.96 142.37 41.88 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.338 2.255 . . . . 3.4399999999999999 107.472 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 154.93 66.46 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.7 2.266 . . . . 0.88 111.571 168.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 64.9 t -91.1 126.41 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.936 0.494 . . . . 2.0299999999999998 110.141 165.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -117.72 146.89 43.45 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.358 1.463 . . . . 4.6600000000000001 112.638 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.61 63.22 6.86 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.23 1.412 . . . . 2.27 112.529 171.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 124.595 1.158 . . . . 8.1899999999999995 109.658 161.923 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.033 0 N-CA-C 107.24 -2.344 . . . . 10.91 107.24 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.4 p -71.53 -144.73 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 120.523 -0.471 . . . . 8.0 110.487 137.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -162.15 173.93 13.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.081 1.352 . . . . 8.4800000000000004 110.961 -166.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.6 m -64.5 128.29 35.16 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.719 -0.845 . . . . 6.3200000000000003 108.719 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.411 ' CD ' HH22 ' A' ' 74' ' ' ARG . 7.9 tt0 -158.87 108.98 2.0 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 107.151 -1.426 . . . . 4.8799999999999999 107.151 -169.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.77 172.03 37.01 Favored Glycine 0 N--CA 1.464 0.536 0 O-C-N 121.341 -0.849 . . . . 1.73 112.775 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.9 p90 -157.92 151.46 23.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.722 1.609 . . . . 2.8300000000000001 110.974 167.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.35 145.96 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 106.964 -1.495 . . . . 2.6299999999999999 106.964 162.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -80.29 -88.98 0.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.056 1.298 . . . . 6.5099999999999998 111.786 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -164.09 141.55 6.95 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.723 0.809 . . . . 4.21 112.118 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.1 t -176.43 140.2 0.51 Allowed Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.795 1.638 . . . . 2.8399999999999999 111.489 165.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.32 -29.59 7.59 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.507 2.138 . . . . 1.7 112.53 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.64 171.91 12.35 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.309 1.909 . . . . 1.1100000000000001 111.629 -170.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.55 -6.02 31.53 Favored 'Cis proline' 0 CA--C 1.536 0.613 0 CA-C-N 119.305 1.552 . . . . 1.4099999999999999 113.528 0.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -148.64 164.75 33.35 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.457 1.28 . . . . 2.54 114.457 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.35 -179.02 5.64 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.975 2.51 . . . . 1.8400000000000001 110.443 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.39 138.97 33.38 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.148 1.379 . . . . 1.5900000000000001 109.305 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.21 154.73 47.26 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.059 1.744 . . . . 1.95 112.597 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.419 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 9.8 m-85 -136.89 143.91 43.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.51 2.324 . . . . 3.8100000000000001 110.187 -167.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -171.35 153.48 3.6 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.13 1.159 . . . . 3.5099999999999998 114.13 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.7 p -90.45 144.3 25.93 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.522 1.929 . . . . 3.8500000000000001 110.456 173.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.5 142.86 51.28 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.733 1.613 . . . . 4.9500000000000002 107.929 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -127.9 140.59 51.91 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.949 -0.76 . . . . 4.3399999999999999 108.949 157.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -86.15 112.51 46.24 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.326 1.05 . . . . 1.4399999999999999 108.958 170.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.39 -12.89 11.29 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.615 2.21 . . . . 1.3200000000000001 113.788 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 171.74 46.85 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 122.964 1.313 . . . . 1.22 112.456 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.406 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 6.1 m-20 -97.32 -5.38 36.72 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.346 2.659 . . . . 2.9300000000000002 112.274 -176.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.5 mt -121.16 162.62 34.61 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 127.896 2.478 . . . . 4.7599999999999998 109.3 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.72 150.51 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.359 2.04 . . . . 1.02 111.849 -168.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.8 mt -103.45 148.83 25.45 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.26 1.024 . . . . 2.79 109.951 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -134.0 101.92 5.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 112.886 -1.961 . . . . 2.48 110.471 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.15 104.63 16.87 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.631 1.572 . . . . 2.7999999999999998 108.318 -172.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -97.91 -30.3 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.616 0.766 . . . . 1.8899999999999999 112.443 -168.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.33 -175.7 29.56 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.468 1.032 . . . . 0.44 112.423 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.01 174.21 10.42 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.658 0.742 . . . . 1.7 111.98 166.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -127.65 164.03 22.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.481 1.912 . . . . 6.8099999999999996 107.8 156.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -171.8 151.02 2.69 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 127.186 2.195 . . . . 1.77 108.801 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.13 -24.39 5.71 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.223 1.949 . . . . 1.1299999999999999 114.013 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.445 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 25.5 m -103.97 22.58 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.502 1.121 . . . . 2.0 113.817 -172.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.95 152.22 24.49 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 126.37 1.868 . . . . 1.5800000000000001 108.221 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -90.93 -66.77 0.9 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 126.039 1.735 . . . . 3.5 109.394 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -86.79 140.7 29.45 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.951 -1.87 . . . . 7.71 105.951 164.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.18 127.57 65.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 106.769 -1.567 . . . . 2.4700000000000002 106.769 162.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -124.75 125.79 44.63 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.563 1.145 . . . . 2.6299999999999999 109.275 -163.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.2 tp -79.89 122.78 27.1 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.053 -0.404 . . . . 2.0899999999999999 110.796 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -120.33 161.6 20.87 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.323 1.449 . . . . 0.57999999999999996 112.804 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -112.13 159.3 18.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.027 2.131 . . . . 2.8799999999999999 110.742 161.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.3 m -124.43 143.25 50.73 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.435 2.294 . . . . 1.97 105.654 168.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -152.03 170.62 19.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.711 0.804 . . . . 3.3700000000000001 112.51 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.8 ptm -99.34 143.35 29.69 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.992 0.917 . . . . 5.3300000000000001 111.867 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -156.65 154.39 30.06 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.667 1.187 . . . . 9.3100000000000005 113.02 -177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.47 160.12 26.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.954 0.901 . . . . 5.1100000000000003 110.589 158.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.5 m -146.87 -12.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 117.083 2.253 . . . . 4.79 117.083 170.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.504 ' CD ' ' HZ2' ' A' ' 56' ' ' LYS . 1.1 tt0 178.38 32.35 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.493 2.035 . . . . 4.54 116.493 -158.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.56 15.45 70.79 Favored Glycine 0 N--CA 1.476 1.359 0 O-C-N 119.288 -2.133 . . . . 2.3799999999999999 112.685 -167.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.504 ' HZ2' ' CD ' ' A' ' 54' ' ' GLU . 36.4 mtmm -142.87 88.63 2.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.987 2.515 . . . . 4.1500000000000004 110.002 -166.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.13 122.63 12.87 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.023 -1.048 . . . . 4.8899999999999997 113.022 174.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.4 m -135.76 -176.08 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 129.376 3.071 . . . . 3.75 110.043 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.5 mtp -98.51 166.21 11.46 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.803 1.287 . . . . 5.3300000000000001 113.953 167.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.77 -179.91 17.51 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 127.142 2.306 . . . . 0.78000000000000003 111.079 170.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -149.47 145.69 27.03 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.366 1.866 . . . . 2.1899999999999999 108.344 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.35 147.47 33.96 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.646 1.578 . . . . 8.7200000000000006 109.533 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.82 150.01 23.57 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.522 2.148 . . . . 0.68999999999999995 110.254 167.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -139.09 156.2 72.4 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.802 1.241 . . . . 1.9099999999999999 111.185 -172.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -84.87 -23.22 2.63 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.128 2.552 . . . . 0.59999999999999998 113.712 -165.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -179.13 162.82 1.25 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.413 1.885 . . . . 3.0 111.415 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -107.71 150.39 27.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.573 1.149 . . . . 1.6000000000000001 110.244 162.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -109.5 142.76 40.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.018 -1.105 . . . . 2.1000000000000001 108.018 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.5 t -134.79 122.47 15.47 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.18 -0.438 . . . . 1.8 111.131 165.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -69.23 161.5 45.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.539 2.826 . . . . 1.02 111.153 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -58.99 138.5 86.03 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.412 2.742 . . . . 1.02 112.41 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 64.6 mmtt 67.24 -7.68 0.5 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.134 1.774 . . . . 2.3599999999999999 114.092 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.55 142.97 25.32 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.751 1.167 . . . . 1.21 113.025 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.411 HH22 ' CD ' ' A' ' 5' ' ' GLU . 1.1 ttt180 -101.69 133.03 47.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.406 1.482 . . . . 4.75 108.913 168.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -148.59 141.51 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.765 2.026 . . . . 4.0499999999999998 108.542 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.04 137.67 54.56 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.259 1.024 . . . . 3.5099999999999998 113.294 -168.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -70.63 74.03 0.56 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.126 1.77 . . . . 2.1000000000000001 109.372 158.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -68.65 138.92 91.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.244 2.218 . . . . 3.02 111.99 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.419 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 55.9 Cg_endo -63.65 -34.46 62.99 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.643 2.229 . . . . 2.2599999999999998 114.12 -173.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.89 6.78 46.49 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.26 -0.745 . . . . 1.8500000000000001 114.178 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.89 -121.07 1.27 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.307 1.908 . . . . 1.5600000000000001 111.907 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -73.71 138.14 44.48 Favored 'General case' 0 C--O 1.223 -0.312 0 O-C-N 121.567 -0.961 . . . . 3.4700000000000002 112.341 -171.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -159.89 150.67 19.11 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 124.209 1.003 . . . . 0.79000000000000004 111.1 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -87.8 128.01 35.33 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.755 -0.591 . . . . 3.1499999999999999 109.481 171.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.2 tpt -85.57 110.87 19.54 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.752 1.621 . . . . 1.8600000000000001 109.655 168.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.7 mp -90.28 116.42 28.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.852 1.261 . . . . 2.2400000000000002 108.574 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tt -127.17 143.36 51.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.995 0.902 . . . . 3.8599999999999999 112.54 -164.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.78 38.6 41.93 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 121.418 -0.801 . . . . 1.72 112.445 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt -45.52 153.88 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 117.865 2.543 . . . . 1.8999999999999999 117.865 -170.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.445 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 51.5 mmtt -119.26 -24.74 6.32 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.673 -1.603 . . . . 3.3500000000000001 113.759 -176.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -125.87 147.83 60.3 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.168 2.187 . . . . 7.2800000000000002 107.992 157.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -66.89 144.67 71.63 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.948 1.765 . . . . 2.0800000000000001 108.28 165.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.16 75.73 8.13 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.919 -1.141 . . . . 3.54 107.919 170.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -88.8 165.1 14.91 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.609 1.164 . . . . 3.9399999999999999 111.662 170.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.47 132.14 51.5 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.454 -0.779 . . . . 3.52 111.372 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.6 1.41 58.94 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 117.231 -1.872 . . . . 1.8999999999999999 115.745 169.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -76.6 167.59 21.58 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.82 1.81 . . . . 3.0800000000000001 110.342 169.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.23 133.02 47.34 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 130.455 3.502 . . . . 3.8999999999999999 104.362 173.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.1 t -136.98 132.62 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.828 1.251 . . . . 2.3199999999999998 111.196 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -79.37 142.78 35.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.279 -1.328 . . . . 2.3900000000000001 112.067 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -122.47 154.82 37.3 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.138 -0.937 . . . . 2.8799999999999999 109.922 152.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -125.76 112.65 16.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.175 2.19 . . . . 2.6099999999999999 108.809 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mp -84.98 116.71 23.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.599 1.16 . . . . 1.73 111.194 -171.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.9 mt -85.69 106.71 17.15 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.705 1.202 . . . . 1.8500000000000001 109.937 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -103.24 107.71 18.63 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.279 1.432 . . . . 3.3999999999999999 111.74 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 55.17 27.43 9.59 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.975 1.71 . . . . 2.7000000000000002 112.906 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.85 -59.23 3.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.52 1.533 . . . . 4.6799999999999997 113.163 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.68 -1.23 70.96 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.58 1.392 . . . . 1.6100000000000001 116.58 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -133.32 146.74 51.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.218 1.509 . . . . 3.6200000000000001 111.372 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.89 149.75 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.352 1.461 . . . . 3.3700000000000001 110.779 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.7 tt -145.01 130.08 18.44 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.621 1.168 . . . . 3.1899999999999999 111.259 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 140.55 38.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.642 1.177 . . . . 3.2000000000000002 113.425 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.77 165.82 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.881 1.672 . . . . 4.0300000000000002 110.749 163.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.24 151.3 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.813 1.245 . . . . 3.8100000000000001 109.493 168.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.38 137.77 9.6 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 126.188 1.795 . . . . 3.5299999999999998 112.796 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.45 163.62 31.89 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.264 3.309 . . . . 1.5800000000000001 113.364 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.6 t -103.87 109.58 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 122.326 1.06 . . . . 2.4300000000000002 110.624 174.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -110.67 88.92 2.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.689 2.396 . . . . 4.1699999999999999 109.635 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.75 82.12 5.0 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.378 -0.826 . . . . 3.6699999999999999 110.457 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 126.084 1.754 . . . . 10.74 109.642 -174.064 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.254 0 N-CA-C 105.274 -3.13 . . . . 13.48 105.274 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.3 m -152.55 150.5 29.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.098 -1.041 . . . . 10.74 113.61 -123.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.68 67.34 0.96 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.094 1.758 . . . . 10.130000000000001 110.232 -172.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.0 p -77.47 66.89 3.29 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.573 1.149 . . . . 5.9900000000000002 110.963 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -76.42 59.69 1.48 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.011 1.724 . . . . 4.8300000000000001 111.631 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.09 -178.42 15.5 Favored Glycine 0 N--CA 1.469 0.849 0 O-C-N 120.774 -1.204 . . . . 1.26 111.583 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -144.83 166.87 24.02 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.296 0.85 . . . . 2.8399999999999999 113.296 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.5 t -115.99 143.46 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.846 1.259 . . . . 2.3100000000000001 109.185 176.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -26.29 60.9 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 117.268 2.322 . . . . 5.3399999999999999 117.268 -151.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.505 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER 79.78 114.79 0.06 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.232 2.213 . . . . 4.1900000000000004 108.159 -167.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.5 m -160.88 138.59 6.98 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.645 1.978 . . . . 3.2200000000000002 108.286 166.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.03 -33.13 10.08 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.39 2.06 . . . . 1.71 111.76 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.57 179.87 22.14 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.18 1.372 . . . . 0.95999999999999996 112.331 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.22 -5.64 16.38 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 CA-C-N 118.48 1.14 . . . . 1.3500000000000001 113.013 -2.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.414 ' ND2' ' H ' ' A' ' 88' ' ' GLY . 2.8 m120 -135.74 175.14 9.87 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.759 1.623 . . . . 5.29 111.903 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.27 -175.46 5.42 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.947 2.899 . . . . 1.5 111.585 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.37 154.93 45.92 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.365 2.266 . . . . 1.6699999999999999 107.84 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.2 130.53 39.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.83 0.741 . . . . 1.78 110.391 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -110.64 54.12 0.68 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.175 2.19 . . . . 3.52 111.366 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.97 150.75 37.39 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.136 -0.978 . . . . 2.5800000000000001 113.309 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -91.79 134.67 34.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.304 0.642 . . . . 2.0600000000000001 109.78 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.56 134.54 51.79 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.143 2.177 . . . . 3.9199999999999999 110.234 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -119.17 151.98 37.38 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.889 1.676 . . . . 5.3399999999999999 110.445 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -114.65 103.68 54.75 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.196 0.998 . . . . 1.46 109.083 160.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -83.62 -8.54 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.244 2.629 . . . . 1.8700000000000001 114.455 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.57 175.9 30.73 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 119.441 1.019 . . . . 1.3500000000000001 112.066 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -92.18 1.21 57.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.069 2.148 . . . . 3.5099999999999998 112.984 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -112.16 157.21 40.5 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 127.425 2.29 . . . . 4.8700000000000001 110.402 175.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.25 158.01 41.42 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.802 2.335 . . . . 1.24 111.067 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.3 mt -134.0 130.3 37.4 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 124.239 1.971 . . . . 3.04 112.785 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -108.89 106.12 15.97 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 110.704 -2.953 . . . . 2.7599999999999998 111.331 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.29 114.74 26.85 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.361 1.464 . . . . 3.6000000000000001 108.358 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.2 -25.56 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.646 0.778 . . . . 1.6200000000000001 112.685 -170.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.28 -174.55 27.13 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.319 0.961 . . . . 0.54000000000000004 112.9 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.94 -177.55 5.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.248 1.019 . . . . 2.04 111.056 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.54 -175.58 5.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.849 2.459 . . . . 6.0999999999999996 109.441 164.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t 178.71 150.37 0.44 Allowed Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 129.528 3.131 . . . . 1.6899999999999999 106.192 -167.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.24 -12.82 14.11 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.925 1.75 . . . . 0.89000000000000001 113.472 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.93 23.54 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.717 1.377 . . . . 2.0499999999999998 114.717 -170.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.78 134.15 16.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.874 1.67 . . . . 1.54 109.764 168.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -59.51 -48.88 79.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.35 1.06 . . . . 2.7799999999999998 111.569 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.39 165.29 16.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.7 2.4 . . . . 6.1600000000000001 109.568 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -148.17 145.89 18.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 126.072 1.749 . . . . 1.97 108.323 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -130.12 146.09 51.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.499 1.92 . . . . 2.6699999999999999 109.435 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -99.37 117.01 32.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.014 0.925 . . . . 1.97 109.588 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -118.66 149.95 40.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 123.089 1.423 . . . . 0.60999999999999999 113.844 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.419 ' CD ' HH21 ' A' ' 62' ' ' ARG . 11.8 pt-20 -95.84 172.44 8.02 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.915 1.686 . . . . 2.3599999999999999 111.348 164.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.4 m -148.29 144.56 27.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.525 1.53 . . . . 1.9399999999999999 107.165 170.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -157.17 166.81 32.19 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.939 0.718 . . . . 3.3700000000000001 112.939 -166.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.2 mtp -93.73 144.36 25.48 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.068 0.947 . . . . 4.96 111.473 170.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -157.88 163.0 38.36 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.708 1.603 . . . . 9.3200000000000003 111.906 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.27 152.65 32.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.904 1.282 . . . . 3.4100000000000001 110.534 165.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.65 120.46 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 106.714 -1.587 . . . . 4.8899999999999997 106.714 142.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 55.34 44.28 27.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.4 1.48 . . . . 5.7400000000000002 113.113 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.48 0.74 63.43 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.051 -1.031 . . . . 2.4900000000000002 114.128 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -109.35 114.78 28.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.077 1.351 . . . . 4.4800000000000004 109.753 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -67.65 127.07 31.39 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.094 1.358 . . . . 4.6900000000000004 111.171 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.65 -177.17 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 129.763 3.225 . . . . 3.3700000000000001 109.75 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 59.2 mtt -110.08 167.27 10.3 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.109 -0.994 . . . . 3.6600000000000001 113.602 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.53 172.15 29.56 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 126.034 1.778 . . . . 0.69999999999999996 112.262 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -149.68 147.5 28.15 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.294 1.838 . . . . 1.99 108.952 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.419 HH21 ' CD ' ' A' ' 47' ' ' GLU . 32.0 mtm180 -151.16 156.88 35.37 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 127.034 2.134 . . . . 5.9000000000000004 108.866 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.15 149.72 28.63 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.13 1.887 . . . . 0.5 110.508 167.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.7 m -137.64 152.42 72.7 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 125.399 1.48 . . . . 2.2200000000000002 110.362 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.59 -24.29 2.98 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.09 2.526 . . . . 0.59999999999999998 113.504 -160.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -177.11 160.85 1.81 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.255 1.422 . . . . 3.6400000000000001 112.25 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.63 154.77 20.43 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.704 1.601 . . . . 1.79 109.89 162.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -115.77 149.86 37.83 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.7 1.2 . . . . 3.0699999999999998 108.71 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.19 127.86 10.64 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 112.776 0.658 . . . . 2.0499999999999998 112.776 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.62 155.42 44.77 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.416 2.744 . . . . 1.5 112.098 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.33 139.59 83.69 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.228 3.285 . . . . 1.53 113.388 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.45 1.34 0.97 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.968 2.107 . . . . 3.9399999999999999 114.347 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.84 167.13 51.14 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.201 1.858 . . . . 1.3999999999999999 113.037 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.21 150.73 45.88 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.541 1.536 . . . . 4.8399999999999999 109.174 169.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.3 t -149.79 135.97 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.866 1.667 . . . . 4.2999999999999998 107.216 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.99 132.55 54.12 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 119.071 0.85 . . . . 2.6499999999999999 111.741 -177.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -71.25 80.7 0.73 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.933 1.349 . . . . 2.3700000000000001 109.694 168.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.53 146.85 66.52 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.529 1.532 . . . . 3.8799999999999999 112.838 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -53.56 -41.94 69.69 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.403 2.735 . . . . 3.46 112.431 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.94 54.0 4.66 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 118.612 -1.104 . . . . 2.29 113.202 170.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.48 -29.64 0.51 Allowed Glycine 0 N--CA 1.472 1.084 0 N-CA-C 119.953 2.741 . . . . 2.46 119.953 155.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -147.26 137.12 23.05 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.924 2.362 . . . . 3.4399999999999999 111.528 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -161.32 156.7 24.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.599 0.592 . . . . 0.71999999999999997 112.599 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -84.43 145.3 28.24 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.409 -0.589 . . . . 2.9900000000000002 109.409 163.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -99.23 132.19 44.72 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.073 1.749 . . . . 1.8100000000000001 108.838 161.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -110.21 115.38 29.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.17 1.388 . . . . 1.98 108.257 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.62 142.22 42.78 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.96 0.904 . . . . 3.4399999999999999 109.809 -171.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.414 ' H ' ' ND2' ' A' ' 15' ' ' ASN . . . 64.03 55.83 21.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.413 1.006 . . . . 1.77 113.877 174.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 17.7 mt -48.56 154.26 0.68 Allowed 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 115.153 1.538 . . . . 1.8999999999999999 115.153 176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -98.88 -26.69 14.2 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 113.016 -1.902 . . . . 2.5299999999999998 113.276 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.83 152.0 29.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.734 2.414 . . . . 6.8600000000000003 110.741 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.39 135.4 24.43 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.422 2.748 . . . . 1.52 110.534 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -124.36 125.61 44.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.744 1.217 . . . . 2.98 111.913 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.505 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 4.1 ptpp? -114.87 168.57 9.78 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.639 1.175 . . . . 3.9100000000000001 113.699 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.33 140.46 48.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.252 0.621 . . . . 2.8599999999999999 109.845 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.31 12.63 62.9 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.651 1.119 . . . . 1.8700000000000001 113.993 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -99.77 179.64 4.46 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.29 1.036 . . . . 2.3300000000000001 110.161 162.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -124.86 152.57 43.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.538 2.335 . . . . 3.3900000000000001 104.761 163.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.5 t -147.39 144.79 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.385 1.874 . . . . 2.1099999999999999 109.809 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.46 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 6.5 pt-20 -94.12 142.26 27.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.115 0.966 . . . . 2.3900000000000001 113.3 178.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 54.2 mt -130.19 160.89 32.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.303 2.241 . . . . 3.9399999999999999 110.596 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -121.29 126.13 48.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.65 2.38 . . . . 2.7999999999999998 109.05 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.95 123.56 45.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.233 1.413 . . . . 2.4500000000000002 110.653 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.8 mt -104.23 110.59 22.86 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.314 1.045 . . . . 1.8 110.829 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.65 144.06 35.26 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.416 1.486 . . . . 3.25 111.044 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.51 134.39 56.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.569 0.748 . . . . 2.4199999999999999 112.152 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.67 42.2 5.81 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.865 -0.964 . . . . 3.6600000000000001 113.909 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.14 6.47 86.18 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 115.846 1.098 . . . . 1.8200000000000001 115.846 166.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -90.99 121.64 32.98 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.43 1.115 . . . . 4.0199999999999996 111.496 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.38 137.0 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.583 1.553 . . . . 3.1899999999999999 108.828 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.6 tp -137.15 113.58 10.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.049 0.94 . . . . 3.7599999999999998 110.329 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 27.1 ttpt -83.43 141.53 31.63 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.936 -0.478 . . . . 3.23 111.803 171.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.8 171.13 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 127.437 2.295 . . . . 3.9700000000000002 110.683 -171.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.87 138.22 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.484 1.113 . . . . 3.5699999999999998 110.394 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mp -142.94 153.2 60.39 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.106 1.762 . . . . 4.3600000000000003 109.951 -175.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.46 154.32 69.09 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.016 3.144 . . . . 1.28 112.999 171.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.5 t -93.98 125.75 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.237 -1.023 . . . . 2.02 108.237 165.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -144.27 141.94 30.14 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.195 1.398 . . . . 4.3200000000000003 108.421 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.24 53.88 2.62 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.411 -0.806 . . . . 3.0299999999999998 112.679 -171.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 . . . . . 0 C--O 1.251 1.169 0 N-CA-C 114.381 1.252 . . . . 8.9299999999999997 114.381 -167.917 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 108.764 -1.734 . . . . 16.440000000000001 108.764 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -145.95 167.56 23.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.526 1.13 . . . . 12.94 109.812 -173.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -69.85 156.15 39.49 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.411 0.685 . . . . 14.65 110.868 166.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.5 p -147.35 18.22 1.2 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.889 2.076 . . . . 9.4299999999999997 110.339 163.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -157.17 160.83 39.15 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.39 1.876 . . . . 6.1399999999999997 108.774 -166.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.25 169.33 13.76 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 114.927 0.731 . . . . 1.55 114.927 -169.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -151.61 168.64 24.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.16 1.384 . . . . 2.6899999999999999 113.036 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.44 148.07 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.688 1.595 . . . . 1.9199999999999999 107.784 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -70.98 -132.79 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.26 1.024 . . . . 7.29 111.34 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -145.27 134.93 23.4 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.447 -1.408 . . . . 3.0600000000000001 109.831 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.1 p -176.53 117.13 0.28 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.883 1.068 . . . . 4.2199999999999998 113.883 -163.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.4 -28.01 10.72 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.432 2.088 . . . . 1.5900000000000001 112.263 169.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.24 -176.52 18.11 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.815 1.674 . . . . 0.96999999999999997 111.936 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.42 -8.26 21.81 Favored 'Cis proline' 0 CA--C 1.536 0.581 0 CA-C-N 118.924 1.362 . . . . 1.29 113.43 1.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -128.23 165.01 21.31 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 126.41 1.884 . . . . 1.97 112.552 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.57 -178.54 6.75 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.936 2.494 . . . . 1.8500000000000001 110.707 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.31 141.76 26.43 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.992 1.317 . . . . 1.5 110.042 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.48 150.48 50.14 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.262 1.425 . . . . 1.78 111.561 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -133.36 66.46 1.56 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.828 2.051 . . . . 3.54 109.564 -166.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -72.4 165.57 24.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.631 1.572 . . . . 3.04 114.666 -173.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -93.63 151.45 19.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.321 1.048 . . . . 5.4299999999999997 110.4 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.9 tp -135.99 117.42 14.73 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.271 1.428 . . . . 5.2800000000000002 110.074 -167.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -114.11 135.18 54.31 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.306 1.442 . . . . 6.3499999999999996 111.001 -173.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.35 67.16 3.44 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.071 -1.018 . . . . 3.1000000000000001 110.965 171.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.75 -22.72 56.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.42 2.746 . . . . 1.78 114.64 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.56 -171.94 42.48 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-O 122.534 1.074 . . . . 1.6799999999999999 113.338 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.424 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.9 m-20 -110.85 -0.42 16.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.746 2.018 . . . . 2.98 112.929 -167.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.9 mt -122.29 160.25 48.73 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 127.001 2.12 . . . . 5.21 109.243 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -81.96 144.29 13.46 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.711 2.274 . . . . 1.0 111.349 -168.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 mp -101.55 154.61 18.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 123.031 1.396 . . . . 3.9399999999999999 111.271 171.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -136.69 103.66 5.28 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 113.583 -1.644 . . . . 2.4300000000000002 109.627 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.15 108.07 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.571 1.549 . . . . 2.9700000000000002 108.263 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.5 m -102.57 -25.53 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.519 0.933 . . . . 1.6799999999999999 113.519 -169.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.23 -176.98 30.89 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 124.862 1.22 . . . . 0.53000000000000003 112.055 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.83 -179.72 5.47 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.555 0.693 . . . . 1.79 112.582 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 172.91 14.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.371 2.269 . . . . 7.04 108.862 161.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t 175.12 150.14 0.27 Allowed Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 129.509 3.123 . . . . 1.74 106.977 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.2 -15.73 25.42 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.128 1.885 . . . . 1.26 114.311 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.57 23.07 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 116.059 1.874 . . . . 2.1800000000000002 116.059 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.21 136.63 14.11 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.42 1.488 . . . . 1.8300000000000001 110.761 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.431 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 4.2 tp10 -60.34 -46.55 89.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.251 1.02 . . . . 2.7599999999999998 112.338 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -127.52 160.22 32.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.894 2.078 . . . . 5.4400000000000004 108.993 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.0 152.96 24.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 126.851 2.06 . . . . 1.5900000000000001 108.545 170.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.5 147.41 26.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.232 1.813 . . . . 4.2599999999999998 108.313 -166.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.2 tp -111.05 110.12 20.51 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.445 1.02 . . . . 1.8 110.711 -164.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -117.65 153.72 32.83 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 123.019 1.39 . . . . 0.69999999999999996 113.654 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.406 ' C ' ' HG1' ' A' ' 48' ' ' THR . 4.1 pt-20 -109.92 177.26 4.77 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 113.392 -1.731 . . . . 2.48 111.671 163.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.406 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 63.8 m -152.93 103.14 2.72 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.156 1.382 . . . . 2.0499999999999998 107.342 -169.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -107.28 165.25 11.52 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.276 1.031 . . . . 3.6499999999999999 113.59 -166.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.4 mtm -101.55 150.58 22.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.048 1.339 . . . . 5.8399999999999999 110.57 166.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.28 156.48 32.51 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.238 1.015 . . . . 6.0599999999999996 110.934 -169.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.489 ' CD ' ' HZ1' ' A' ' 57' ' ' LYS . 2.5 tp10 -108.89 145.7 34.93 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.606 1.563 . . . . 2.6400000000000001 108.665 169.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -153.13 136.62 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.545 -0.909 . . . . 3.96 108.545 160.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 67.45 16.94 10.06 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.747 1.219 . . . . 3.8900000000000001 112.863 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.12 17.43 78.24 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.73 -1.231 . . . . 1.52 113.357 -169.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -120.82 126.72 50.81 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.985 2.114 . . . . 3.8900000000000001 109.109 -172.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 3.8 mmtt -73.15 121.27 19.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.253 1.821 . . . . 3.6699999999999999 108.974 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.26 179.8 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.418 1.887 . . . . 3.8199999999999998 110.543 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.7 mtt -130.31 170.27 14.35 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.178 1.391 . . . . 3.29 111.091 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.49 -178.22 29.51 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.382 0.991 . . . . 0.56000000000000005 112.916 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.9 ttm -143.91 150.2 38.02 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.98 1.712 . . . . 2.2000000000000002 108.149 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -159.22 153.84 20.81 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.377 1.071 . . . . 5.71 109.994 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.72 159.82 38.36 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.368 2.045 . . . . 0.56999999999999995 110.986 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.94 152.66 40.86 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 125.875 1.67 . . . . 2.4100000000000001 109.88 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -83.51 -26.53 2.09 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.992 2.461 . . . . 0.78000000000000003 113.557 -160.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -177.61 166.33 2.17 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.835 1.654 . . . . 3.6000000000000001 111.819 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.3 mt -109.83 153.35 24.53 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.405 1.482 . . . . 1.8400000000000001 110.277 161.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -117.97 147.55 43.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.888 1.675 . . . . 1.6899999999999999 108.504 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 t -140.41 139.06 19.74 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 112.606 0.595 . . . . 2.3700000000000001 112.606 171.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.77 157.11 15.91 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.887 3.058 . . . . 1.23 112.232 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.35 146.75 96.93 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.926 3.084 . . . . 1.3700000000000001 114.597 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.424 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 33.2 mmtm 70.37 -5.65 1.32 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.153 2.581 . . . . 3.2400000000000002 114.189 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.81 167.09 52.54 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.947 1.26 . . . . 2.0 113.987 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.18 135.19 20.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.223 2.609 . . . . 7.5899999999999999 106.457 168.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.2 t -152.87 96.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.715 1.206 . . . . 4.6500000000000004 111.848 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -74.04 160.39 31.35 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.31 -1.494 . . . . 4.2400000000000002 112.149 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mp -67.34 90.15 0.22 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.878 1.323 . . . . 2.3999999999999999 108.611 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.471 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -42.23 135.34 2.43 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 127.428 2.291 . . . . 5.0599999999999996 112.865 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.9 -31.79 91.92 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.389 2.06 . . . . 2.5 112.513 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.65 96.37 1.72 Allowed Glycine 0 C--N 1.343 0.933 0 C-N-CA 123.97 0.795 . . . . 3.1099999999999999 111.374 166.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.56 -15.67 4.92 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 117.548 1.779 . . . . 1.8799999999999999 117.548 149.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -140.95 146.28 37.15 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.442 2.121 . . . . 3.5299999999999998 112.175 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -160.59 148.29 16.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.588 1.155 . . . . 0.84999999999999998 111.78 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -79.54 120.89 24.53 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.501 -0.925 . . . . 3.0600000000000001 108.501 161.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 tpt -78.88 127.6 32.23 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.061 2.545 . . . . 1.95 108.756 167.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.1 mt -113.93 134.59 54.73 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.952 1.701 . . . . 3.6800000000000002 109.338 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.3 131.04 36.0 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.198 0.908 . . . . 3.27 111.797 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.66 49.28 4.92 Favored Glycine 0 N--CA 1.468 0.819 0 C-N-CA 123.747 0.689 . . . . 1.8999999999999999 112.201 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.4 mt -52.66 155.83 2.11 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 115.078 1.51 . . . . 2.02 115.078 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.431 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 66.3 mmtt -110.01 -13.17 14.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.869 -1.514 . . . . 2.4900000000000002 114.849 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.1 mmt-85 -140.38 138.11 18.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 130.136 3.374 . . . . 8.2599999999999998 108.697 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.52 137.89 18.91 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.34 2.027 . . . . 1.4099999999999999 108.583 161.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -91.65 143.64 26.35 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.785 0.802 . . . . 3.27 112.525 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.466 ' HZ3' ' CD ' ' A' ' 97' ' ' GLU . 2.1 mmtm -91.71 -162.96 0.97 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.911 1.338 . . . . 4.5999999999999996 109.203 163.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.11 142.96 37.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.132 -1.395 . . . . 2.1000000000000001 107.811 155.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.84 33.83 12.09 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.877 -0.957 . . . . 1.3200000000000001 114.309 -173.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.466 ' CD ' ' HZ3' ' A' ' 94' ' ' LYS . 47.7 mt-10 -112.62 -176.38 2.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.162 1.385 . . . . 2.1699999999999999 110.473 168.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -146.51 134.99 22.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 128.274 2.63 . . . . 3.1000000000000001 105.153 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.4 t -143.72 144.51 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.118 1.367 . . . . 2.1899999999999999 107.929 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.79 146.21 28.1 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.514 0.673 . . . . 3.29 111.027 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.81 140.11 53.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.335 1.054 . . . . 2.6800000000000002 109.894 169.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -79.78 135.17 36.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.595 2.758 . . . . 2.23 109.708 162.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.32 123.65 46.51 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.992 1.717 . . . . 2.6600000000000001 106.946 170.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.67 104.67 16.68 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.926 -1.139 . . . . 2.02 107.926 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -96.19 128.84 43.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.456 1.102 . . . . 3.48 111.237 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 45.13 40.64 4.99 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.438 1.895 . . . . 2.9399999999999999 112.831 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.52 -94.38 1.97 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.539 1.066 . . . . 5.9000000000000004 111.506 -170.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.1 -6.78 62.91 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 117.121 1.609 . . . . 3.1200000000000001 117.121 -160.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -80.8 104.85 11.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.819 2.309 . . . . 3.4300000000000002 110.765 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.02 135.07 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.252 1.021 . . . . 3.4700000000000002 111.402 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 tt -155.19 129.92 9.25 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.549 1.54 . . . . 3.1200000000000001 109.26 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.64 153.14 20.4 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.856 1.428 . . . . 4.8200000000000003 114.856 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 t -130.14 161.35 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.602 2.361 . . . . 3.1200000000000001 108.9 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.83 147.03 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.0 1.72 . . . . 3.2000000000000002 109.051 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.61 138.19 11.75 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.237 1.015 . . . . 3.1299999999999999 111.598 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.18 160.82 46.3 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.901 3.067 . . . . 1.1200000000000001 112.962 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.3 t -106.6 128.38 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.407 1.883 . . . . 2.1000000000000001 109.548 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -152.62 148.43 27.31 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.509 1.124 . . . . 3.46 110.956 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.38 91.96 3.32 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.965 0.888 . . . . 2.8199999999999998 111.208 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.4 mmp_? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 128.614 2.766 . . . . 7.6399999999999997 109.759 164.55 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.383 0 N-CA-C 108.765 -1.734 . . . . 13.33 108.765 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 m -150.5 158.52 44.24 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.614 1.207 . . . . 10.380000000000001 109.941 -167.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -71.01 164.79 24.84 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.875 1.27 . . . . 9.9700000000000006 111.529 170.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.3 m -167.87 101.89 0.47 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.365 1.866 . . . . 9.1099999999999994 107.575 172.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -123.74 -178.33 4.01 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.27 1.028 . . . . 4.5999999999999996 111.952 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.04 177.35 39.79 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 116.079 1.192 . . . . 1.55 116.079 -163.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -150.24 149.46 30.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.337 1.855 . . . . 2.6000000000000001 110.483 166.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.0 t -93.22 148.61 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 121.004 -1.06 . . . . 2.2200000000000002 108.174 172.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -143.26 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.304 0.573 . . . . 6.2599999999999998 110.957 170.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -152.76 121.12 6.3 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 119.78 -1.825 . . . . 3.3700000000000001 111.044 -160.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -165.14 146.95 6.47 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 127.704 2.402 . . . . 2.5699999999999998 109.796 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.46 -34.11 4.8 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.413 2.075 . . . . 1.96 111.538 164.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.05 176.74 23.41 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.139 1.828 . . . . 1.23 111.24 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.25 -4.62 33.85 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 CA-C-N 119.395 1.597 . . . . 1.1699999999999999 113.319 -1.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -138.27 164.04 30.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 122.265 1.031 . . . . 2.5 113.337 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.31 -177.48 4.86 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.349 2.26 . . . . 1.9299999999999999 110.701 169.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.38 153.33 51.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.935 1.694 . . . . 1.9199999999999999 109.227 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.21 153.07 42.46 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.991 0.916 . . . . 2.02 113.025 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -126.82 134.94 50.44 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.568 1.947 . . . . 4.0700000000000003 108.811 -174.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.48 171.58 11.71 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.458 1.026 . . . . 4.3099999999999996 112.587 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.1 m -111.01 147.3 35.05 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.241 1.416 . . . . 3.0899999999999999 111.128 -171.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.96 138.55 49.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.266 2.226 . . . . 5.3600000000000003 109.356 167.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.53 175.04 5.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.574 1.55 . . . . 6.9699999999999998 110.749 165.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -146.71 103.7 3.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 121.214 -0.929 . . . . 1.8400000000000001 109.728 166.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.03 -13.65 12.65 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.885 2.39 . . . . 2.21 113.247 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.63 179.59 53.04 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 122.748 1.194 . . . . 1.5600000000000001 112.795 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 13.4 m-20 -105.18 -2.49 24.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.866 2.466 . . . . 3.1099999999999999 111.87 -173.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -123.07 159.36 54.47 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.391 2.676 . . . . 3.52 109.866 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.73 151.29 28.19 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.439 2.093 . . . . 1.1499999999999999 112.171 -171.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.8 mt -100.15 155.9 17.49 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 125.278 1.431 . . . . 3.27 110.498 168.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -139.55 120.69 14.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 113.716 -1.584 . . . . 2.8900000000000001 110.289 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.3 116.1 31.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.602 1.961 . . . . 2.8100000000000001 107.951 -171.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.32 -21.79 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.142 0.977 . . . . 1.79 112.819 -166.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.4 -175.72 31.71 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 124.716 1.15 . . . . 0.55000000000000004 113.224 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.61 176.65 9.05 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.525 0.73 . . . . 1.46 112.017 170.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.26 153.5 38.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.525 3.13 . . . . 6.5700000000000003 107.96 176.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -167.93 153.49 6.89 Favored Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 127.122 2.169 . . . . 1.6499999999999999 109.548 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -74.41 -18.54 20.25 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.834 2.356 . . . . 0.91000000000000003 114.246 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.431 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 34.6 m -108.72 20.15 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.739 1.385 . . . . 2.1899999999999999 114.739 -172.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.07 150.61 31.97 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.469 1.907 . . . . 1.4199999999999999 107.813 166.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -79.79 -62.4 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.588 0.755 . . . . 3.6299999999999999 109.709 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.85 172.08 7.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.45 1.9 . . . . 6.21 107.452 170.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.57 135.85 9.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 107.347 -1.353 . . . . 2.0 107.347 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -105.97 149.84 26.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.476 1.51 . . . . 3.0299999999999998 109.496 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.3 tp -103.25 120.19 40.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.677 0.791 . . . . 2.0600000000000001 109.62 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -123.65 149.61 45.21 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.239 1.416 . . . . 0.53000000000000003 113.966 -174.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' CD ' HH21 ' A' ' 62' ' ' ARG . 16.3 pt-20 -92.36 157.11 16.8 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.466 1.506 . . . . 2.0299999999999998 111.144 162.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.1 m -120.04 146.09 46.22 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 105.736 -1.949 . . . . 2.3799999999999999 105.736 165.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -160.18 -171.87 3.37 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.202 0.91 . . . . 3.3999999999999999 112.796 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.2 mtt -127.78 148.0 50.43 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.25 1.42 . . . . 5.9400000000000004 113.131 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.28 146.86 52.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.882 1.673 . . . . 6.6299999999999999 112.992 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -87.51 140.0 29.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.652 1.181 . . . . 2.4399999999999999 109.103 151.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.4 t -142.82 122.59 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.275 1.83 . . . . 3.1299999999999999 106.974 168.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.527 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 29.5 mt-10 63.76 12.76 6.92 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.155 1.782 . . . . 3.3300000000000001 114.777 -175.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.31 24.23 59.51 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 120.918 -1.114 . . . . 1.5600000000000001 113.174 -167.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 50.5 mtmt -127.65 137.42 52.52 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.059 2.144 . . . . 3.04 108.296 176.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -98.31 123.98 42.7 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.678 1.191 . . . . 4.1600000000000001 111.92 -166.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.6 t -143.09 139.89 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.51 1.924 . . . . 3.1699999999999999 108.411 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.1 mtm -82.2 168.2 17.9 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.533 0.938 . . . . 4.7000000000000002 113.533 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.77 166.96 26.08 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.635 1.588 . . . . 0.78000000000000003 112.815 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.7 ttm -155.8 144.27 20.18 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.12 1.768 . . . . 1.8300000000000001 108.634 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.415 HH21 ' CD ' ' A' ' 47' ' ' GLU . 32.7 mtm180 -146.36 155.75 49.88 Favored Pre-proline 0 N--CA 1.468 0.458 0 C-N-CA 125.244 1.418 . . . . 5.0199999999999996 109.813 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.85 154.85 38.86 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.663 1.575 . . . . 0.58999999999999997 110.589 164.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.52 155.39 73.72 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 125.503 1.521 . . . . 1.8899999999999999 110.462 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.93 -28.41 3.26 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.738 2.292 . . . . 0.5 112.867 -168.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -176.03 165.97 2.94 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.223 1.409 . . . . 2.9900000000000002 112.294 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.7 153.21 24.61 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.694 1.598 . . . . 1.74 110.284 164.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -110.76 146.45 36.33 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.937 1.295 . . . . 1.72 109.833 174.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.6 t -140.16 131.16 14.15 Favored Pre-proline 0 N--CA 1.477 0.891 0 N-CA-C 114.452 1.278 . . . . 2.52 114.452 168.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.58 160.61 34.83 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.36 3.373 . . . . 1.23 113.124 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.12 145.31 89.14 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.428 3.418 . . . . 1.1299999999999999 113.792 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.405 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 69.6 mmtt 67.93 -4.25 1.04 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.077 2.151 . . . . 3.1499999999999999 114.384 179.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.87 -179.98 47.35 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.694 1.616 . . . . 1.76 113.189 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.66 139.67 21.02 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.146 1.379 . . . . 5.25 109.26 167.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -144.93 146.47 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.739 1.615 . . . . 4.0599999999999996 109.284 -168.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.33 150.97 46.66 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.882 1.068 . . . . 2.6299999999999999 113.882 -173.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -72.5 66.54 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.024 1.73 . . . . 2.0800000000000001 109.435 163.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.27 127.9 84.82 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.578 1.151 . . . . 3.8599999999999999 110.17 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -54.8 -38.61 91.98 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.338 3.359 . . . . 2.4900000000000002 113.916 -166.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.44 -1.08 56.84 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 117.53 -1.706 . . . . 1.8500000000000001 115.338 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -143.56 -23.15 0.17 Allowed Glycine 0 N--CA 1.474 1.199 0 CA-C-N 120.047 1.923 . . . . 2.2799999999999998 117.793 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -149.04 146.64 27.85 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.443 2.121 . . . . 3.7000000000000002 112.425 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -161.87 156.05 22.06 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.267 1.027 . . . . 0.72999999999999998 110.748 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -83.45 145.56 28.89 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.653 -0.499 . . . . 3.4100000000000001 109.653 164.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -103.72 111.03 23.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.521 1.928 . . . . 1.98 108.542 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.65 120.22 29.84 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.485 1.114 . . . . 2.3399999999999999 108.697 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -121.12 144.39 48.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.458 1.123 . . . . 3.0899999999999999 112.881 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.01 38.42 40.66 Favored Glycine 0 N--CA 1.468 0.768 0 CA-C-N 115.163 -0.926 . . . . 1.75 111.867 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.4 mt -45.02 154.36 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 127.213 2.205 . . . . 1.7 116.217 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 55.2 mmtt -116.35 -21.98 9.02 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 113.544 -1.662 . . . . 3.23 114.723 -175.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -136.2 141.23 35.38 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 127.659 2.384 . . . . 8.3399999999999999 108.806 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.16 144.57 23.62 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.982 3.122 . . . . 1.3799999999999999 109.835 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.69 119.35 30.86 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.56 0.744 . . . . 2.9399999999999999 110.369 -172.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -102.51 163.25 12.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.982 0.913 . . . . 4.5300000000000002 111.397 165.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.7 132.98 45.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.794 -0.817 . . . . 1.8500000000000001 108.794 166.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.6 1.09 71.67 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.16 -1.356 . . . . 1.3 115.641 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -75.0 179.87 4.71 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.571 1.686 . . . . 2.73 109.291 162.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -147.42 153.47 39.64 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.195 1.798 . . . . 3.04 108.03 165.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.9 t -142.79 143.3 25.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 127.718 2.407 . . . . 2.04 109.589 -169.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.404 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -100.96 144.96 29.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.977 1.311 . . . . 3.5299999999999998 112.33 176.004 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 mp -130.5 138.72 50.37 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.124 1.77 . . . . 2.7400000000000002 109.861 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.409 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 28.5 m-20 -93.62 130.45 39.53 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.826 1.65 . . . . 2.3300000000000001 109.47 156.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.76 140.4 29.7 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.462 1.505 . . . . 2.1299999999999999 108.93 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.3 mt -111.75 131.3 55.41 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.506 1.522 . . . . 1.6200000000000001 110.547 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -126.7 153.22 45.73 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.499 0.72 . . . . 4.04 112.675 -167.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.34 134.26 55.48 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.987 0.899 . . . . 2.52 112.036 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.68 42.93 45.24 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.667 -1.074 . . . . 4.1399999999999997 113.703 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.65 46.2 6.48 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 116.235 1.254 . . . . 1.99 116.235 161.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -128.99 154.74 46.31 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.098 1.449 . . . . 4.3799999999999999 112.182 167.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.5 t -143.69 144.71 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.593 1.957 . . . . 3.1099999999999999 107.034 171.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 tt -152.19 127.08 9.63 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.644 0.778 . . . . 3.5899999999999999 110.803 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.409 ' HE3' ' OD1' ' A' ' 102' ' ' ASP . 2.7 ttmt -93.89 134.57 36.13 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.172 0.804 . . . . 3.7599999999999998 113.172 -177.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.62 153.2 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.026 1.33 . . . . 2.8999999999999999 108.272 162.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 t -128.81 139.79 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.886 1.275 . . . . 3.0899999999999999 107.611 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.17 142.23 15.18 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 113.152 0.797 . . . . 3.4700000000000002 113.152 -165.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.84 170.39 14.21 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.282 3.321 . . . . 1.0900000000000001 112.863 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.34 145.74 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.982 1.313 . . . . 1.99 110.632 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.48 144.77 32.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.015 1.326 . . . . 4.7300000000000004 112.805 -174.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.03 55.07 1.53 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.153 0.981 . . . . 2.9900000000000002 111.198 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 . . . . . 0 C--O 1.244 0.777 0 CA-C-O 115.783 -2.055 . . . . 8.4199999999999999 113.012 -152.633 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.082 0 N-CA-C 109.578 -1.409 . . . . 11.130000000000001 109.578 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.524 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -94.68 -173.87 3.14 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.205 1.402 . . . . 7.6299999999999999 109.709 146.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -80.82 150.17 29.28 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.578 -1.327 . . . . 12.119999999999999 112.04 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.297 20.0 p 61.06 24.85 14.92 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.196 2.199 . . . . 6.1399999999999997 114.798 168.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 2' ' ' SER . 62.5 mt-10 -78.32 61.86 2.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.444 1.498 . . . . 4.9400000000000004 110.54 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.16 159.95 15.39 Favored Glycine 0 N--CA 1.469 0.844 0 O-C-N 120.907 -1.121 . . . . 1.1799999999999999 111.575 175.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.2 p90 -156.66 157.55 35.4 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.947 0.899 . . . . 2.8599999999999999 112.187 166.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.45 145.47 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.589 1.156 . . . . 2.1000000000000001 108.446 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -69.75 -159.76 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.266 1.026 . . . . 6.4400000000000004 110.668 164.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -128.63 150.61 50.15 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.328 1.451 . . . . 4.0499999999999998 110.684 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -170.72 145.22 2.03 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.958 1.703 . . . . 2.9300000000000002 109.294 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.03 -22.06 15.15 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.98 2.453 . . . . 2.23 112.683 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.09 173.21 13.26 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 126.158 1.837 . . . . 1.1499999999999999 111.745 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.98 -0.49 39.01 Favored 'Cis proline' 0 CA--C 1.541 0.834 0 CA-C-N 119.122 1.461 . . . . 1.27 113.474 0.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -147.52 162.42 39.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.317 1.047 . . . . 2.4199999999999999 113.62 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.27 -179.05 5.33 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 129.606 3.163 . . . . 1.5700000000000001 109.634 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.81 146.78 49.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.399 1.48 . . . . 1.79 108.728 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.23 148.67 45.01 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.327 1.051 . . . . 1.78 112.333 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -115.66 136.17 53.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.932 2.093 . . . . 3.6200000000000001 111.197 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.93 145.65 43.48 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.757 0.823 . . . . 4.0599999999999996 110.807 173.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.0 m -124.96 113.65 18.1 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.827 0.851 . . . . 2.4100000000000001 109.983 166.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.28 174.12 7.92 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.666 1.986 . . . . 6.3399999999999999 107.72 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' CD ' HH11 ' A' ' 74' ' ' ARG . 46.0 mt-10 -145.21 155.91 43.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.557 -1.275 . . . . 5.5499999999999998 107.557 173.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -101.16 100.26 12.86 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.167 0.587 . . . . 1.6100000000000001 111.036 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.81 -15.39 13.43 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.177 1.918 . . . . 2.52 113.514 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.98 -178.07 52.22 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 119.137 0.88 . . . . 1.48 112.471 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.425 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 16.0 m-20 -114.86 3.27 14.56 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.43 1.892 . . . . 4.0 112.232 -167.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -106.36 154.01 40.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 127.096 2.158 . . . . 4.2300000000000004 110.254 166.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.21 147.08 20.38 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.869 2.379 . . . . 1.3500000000000001 110.877 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.7 mt -99.35 138.73 36.04 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 123.633 1.682 . . . . 3.4500000000000002 111.003 170.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.478 ' HE ' ' CD ' ' A' ' 68' ' ' GLU . 14.6 tpp85 -134.68 105.85 6.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 111.716 -2.493 . . . . 2.7999999999999998 108.248 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.74 105.41 17.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.128 1.371 . . . . 3.2799999999999998 108.6 -171.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -101.78 -22.67 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.617 0.767 . . . . 1.6200000000000001 112.235 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.24 -177.07 30.99 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.199 1.381 . . . . 0.40999999999999998 112.553 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.0 -176.58 4.55 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.573 1.549 . . . . 1.4399999999999999 109.277 166.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.41 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -157.16 166.44 33.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.669 1.587 . . . . 5.0099999999999998 108.118 177.375 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 t -177.77 153.93 0.98 Allowed Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.865 1.266 . . . . 1.9299999999999999 110.382 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.31 -0.28 9.82 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.271 2.647 . . . . 1.05 114.763 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.7 m -116.78 26.96 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 115.508 1.67 . . . . 1.8700000000000001 115.508 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.75 157.44 33.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.277 1.431 . . . . 1.55 110.503 167.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.4 -26.99 41.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.021 1.728 . . . . 2.8900000000000001 112.087 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -155.56 149.35 25.31 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 127.498 2.319 . . . . 6.8600000000000003 108.621 -156.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.7 p -161.4 59.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 123.79 1.757 . . . . 2.5800000000000001 113.028 -158.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -91.4 134.86 34.26 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.096 -1.865 . . . . 5.46 112.236 -167.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.3 tp -83.06 122.9 28.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.496 1.518 . . . . 1.96 112.159 -167.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -121.91 150.29 42.19 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.843 1.657 . . . . 0.56999999999999995 112.415 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -88.93 173.57 8.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.113 0.965 . . . . 2.02 111.067 162.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.7 m -139.99 129.99 24.86 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.589 -1.634 . . . . 2.1800000000000002 106.589 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -134.79 173.31 11.83 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.417 1.103 . . . . 3.6200000000000001 112.951 -165.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.8 ttp -120.43 141.74 49.87 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.97 1.308 . . . . 4.1600000000000001 111.004 165.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -135.44 157.29 47.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.212 1.405 . . . . 6.3399999999999999 111.55 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -97.1 144.13 27.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.312 1.445 . . . . 2.3700000000000001 109.962 165.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 m -142.68 130.55 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.574 1.549 . . . . 4.0099999999999998 108.584 163.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 62.21 11.2 4.26 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.599 2.074 . . . . 3.54 116.599 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.9 25.68 40.4 Favored Glycine 0 CA--C 1.539 1.533 0 O-C-N 120.909 -1.119 . . . . 1.74 113.537 -165.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -127.15 120.17 28.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.052 1.741 . . . . 3.1099999999999999 109.453 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.34 118.98 28.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.57 0.748 . . . . 8.4000000000000004 110.619 -175.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.52 139.85 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.024 1.73 . . . . 3.4300000000000002 109.5 -172.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 58.0 mtm -83.71 167.47 17.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.885 1.069 . . . . 4.1900000000000004 113.885 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.5 -176.49 30.61 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.028 1.299 . . . . 0.91000000000000003 113.3 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ttm -155.85 150.06 25.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.783 2.033 . . . . 2.25 107.65 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.96 158.49 30.17 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 124.495 1.118 . . . . 5.6399999999999997 110.509 174.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.44 154.94 40.82 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.152 1.901 . . . . 0.57999999999999996 111.907 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -143.08 152.61 58.71 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.419 1.487 . . . . 1.6499999999999999 109.808 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -84.13 -23.44 3.0 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.187 2.592 . . . . 0.73999999999999999 113.547 -165.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.43 ' CD1' ' HD2' ' A' ' 31' ' ' ARG . 54.0 p90 -177.14 166.93 2.41 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.593 1.957 . . . . 3.25 110.678 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.2 mt -110.66 154.31 24.01 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.457 1.103 . . . . 1.5800000000000001 110.059 164.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.478 ' CD ' ' HE ' ' A' ' 31' ' ' ARG . 3.9 tp10 -127.06 138.09 53.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.126 1.37 . . . . 1.74 109.612 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 t -143.48 136.79 14.02 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.998 0.919 . . . . 2.6600000000000001 110.654 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.99 170.4 15.74 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.776 2.318 . . . . 1.48 112.334 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.56 143.96 97.69 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.969 2.446 . . . . 1.6499999999999999 110.783 161.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.425 ' HZ3' ' CG ' ' A' ' 27' ' ' ASP . 33.6 mmtm 67.47 0.13 2.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.403 1.481 . . . . 3.5899999999999999 114.157 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.56 162.77 41.89 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.753 1.644 . . . . 1.8999999999999999 113.635 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.447 HH11 ' CD ' ' A' ' 23' ' ' GLU . 59.5 mtt-85 -91.48 129.42 37.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.563 0.745 . . . . 6.2599999999999998 111.412 176.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -103.24 61.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.764 2.025 . . . . 6.5899999999999999 109.478 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.76 127.26 56.1 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.229 1.411 . . . . 3.1899999999999999 109.755 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mp -70.98 -38.59 72.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.604 1.562 . . . . 3.2000000000000002 114.003 -176.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptt 91.13 138.07 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 129.416 3.086 . . . . 4.21 109.93 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.7 11.74 0.47 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.589 2.86 . . . . 2.8500000000000001 114.731 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.61 17.27 0.09 OUTLIER Glycine 0 CA--C 1.535 1.32 0 CA-C-O 116.621 -2.211 . . . . 2.1000000000000001 116.42 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.27 -29.31 0.45 Allowed Glycine 0 N--CA 1.487 2.044 0 CA-C-N 121.233 2.516 . . . . 2.1000000000000001 117.626 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.06 146.89 43.51 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.249 2.025 . . . . 3.5899999999999999 111.197 163.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -158.46 149.02 20.19 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.572 0.582 . . . . 0.75 112.572 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -79.96 131.8 35.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.345 -0.613 . . . . 3.1899999999999999 109.345 161.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -91.81 103.42 15.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.038 1.735 . . . . 1.6399999999999999 108.459 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -85.73 116.88 24.26 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.659 -1.238 . . . . 2.1600000000000001 107.659 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 tt -130.19 134.85 47.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.562 1.145 . . . . 4.3300000000000001 111.165 -162.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.53 48.69 7.83 Favored Glycine 0 N--CA 1.473 1.11 0 O-C-N 121.751 -0.593 . . . . 1.8500000000000001 111.969 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -48.26 154.34 0.61 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 126.253 1.821 . . . . 1.8100000000000001 114.99 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -119.34 -29.95 5.03 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.681 -1.6 . . . . 2.46 114.585 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -107.38 147.5 35.37 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.902 1.681 . . . . 6.7000000000000002 109.552 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.39 162.68 37.84 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.66 2.24 . . . . 3.04 109.132 157.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.8 155.87 35.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.48 1.512 . . . . 3.7599999999999998 109.759 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 24.24 1.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.326 1.973 . . . . 4.9699999999999998 116.326 -174.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 66.87 164.76 0.2 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.12 2.168 . . . . 2.3900000000000001 110.943 -161.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.04 -5.99 30.02 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.947 -0.918 . . . . 1.3400000000000001 114.676 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -76.99 166.06 23.83 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.422 1.089 . . . . 2.9100000000000001 110.099 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -118.14 126.19 51.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 129.146 2.978 . . . . 3.8500000000000001 104.625 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.7 t -126.2 140.6 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.66 1.184 . . . . 2.3700000000000001 110.065 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -106.83 134.69 49.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.42 1.088 . . . . 3.7599999999999998 112.786 -170.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.5 133.57 43.96 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.25 1.42 . . . . 3.0099999999999998 111.887 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.41 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 27.4 m-20 -77.84 136.45 38.08 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.777 2.031 . . . . 1.8300000000000001 108.61 159.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.99 126.86 50.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.338 1.055 . . . . 1.9299999999999999 108.785 165.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.0 mt -104.19 106.54 17.08 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.353 1.061 . . . . 2.02 110.069 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -105.8 151.81 24.02 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.612 1.565 . . . . 3.3799999999999999 112.35 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.83 131.39 46.79 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.87 1.063 . . . . 2.79 113.87 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 58.13 3.13 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.924 1.25 . . . . 3.8700000000000001 113.347 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.37 11.09 79.72 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 124.421 1.01 . . . . 2.1899999999999999 115.609 169.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -93.49 113.1 25.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.917 1.359 . . . . 3.7400000000000002 111.217 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.68 136.12 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.936 1.294 . . . . 3.0 109.887 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.1 tt -143.12 112.61 6.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.471 0.708 . . . . 4.0300000000000002 111.544 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -87.73 98.35 11.4 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.961 0.726 . . . . 4.6799999999999997 112.961 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.9 t -80.01 172.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 126.444 1.898 . . . . 3.4500000000000002 110.869 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.7 p -139.34 143.01 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.057 2.143 . . . . 3.8399999999999999 108.378 166.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.48 144.55 15.01 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.883 1.673 . . . . 3.27 111.677 -167.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.95 155.5 26.44 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.179 2.586 . . . . 1.0800000000000001 113.705 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.1 t -93.93 121.7 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.44 1.496 . . . . 2.0600000000000001 109.472 173.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.0 159.49 15.29 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.317 1.847 . . . . 4.1299999999999999 110.582 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -93.03 55.66 2.4 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.216 -0.928 . . . . 2.8900000000000001 110.794 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 . . . . . 0 C--O 1.248 1.017 0 N-CA-C 115.107 1.521 . . . . 7.1799999999999997 115.107 -144.201 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.416 ' H1 ' ' CD ' ' A' ' 23' ' ' GLU . . . . . . . . 0 N--CA 1.477 1.384 0 N-CA-C 108.952 -1.659 . . . . 10.98 108.952 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -77.27 -123.02 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 117.339 -1.315 . . . . 10.57 107.959 132.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.01 167.34 30.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 121.108 1.776 . . . . 9.3399999999999999 112.083 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.4 p -128.13 61.63 1.44 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.744 1.618 . . . . 6.2400000000000002 111.853 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -79.51 118.2 21.16 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.094 -1.004 . . . . 4.5999999999999996 111.59 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.49 168.75 33.77 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.02 -1.05 . . . . 1.23 114.296 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -152.16 172.6 16.12 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.254 1.022 . . . . 2.5499999999999998 112.945 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 t -109.36 138.85 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.098 -1.001 . . . . 2.1499999999999999 109.03 172.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -51.68 -81.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.965 1.306 . . . . 5.75 113.093 -173.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.1 t80 158.22 153.0 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 130.118 3.367 . . . . 4.4199999999999999 107.282 -157.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.0 t 150.22 128.8 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 129.34 3.056 . . . . 2.6499999999999999 110.879 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.88 -35.85 14.62 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.855 1.703 . . . . 1.52 111.793 173.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.25 173.13 21.52 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.483 1.992 . . . . 0.97999999999999998 112.035 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.75 5.16 56.05 Favored 'Cis proline' 0 CA--C 1.541 0.865 0 CA-C-N 119.33 1.565 . . . . 1.24 113.654 3.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -154.68 160.24 41.25 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.412 1.085 . . . . 2.04 113.673 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.87 -177.44 5.33 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.935 2.094 . . . . 1.6000000000000001 111.623 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.27 147.92 28.24 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.791 1.236 . . . . 1.8500000000000001 110.756 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.03 145.52 48.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.092 1.757 . . . . 1.74 111.539 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.469 ' CE2' ' HB3' ' A' ' 83' ' ' HIS . 96.2 m-85 -144.19 121.52 11.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.884 2.073 . . . . 4.0300000000000002 109.961 -164.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -166.0 148.59 7.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.442 -1.411 . . . . 3.3100000000000001 114.318 -155.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.5 m -81.99 135.17 35.39 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.759 0.79 . . . . 2.8799999999999999 110.434 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.51 137.0 47.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.881 2.072 . . . . 4.25 108.791 170.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' CD ' ' H1 ' ' A' ' 1' ' ' GLY . 7.9 pt-20 -114.67 166.41 11.76 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.129 0.572 . . . . 4.29 111.64 166.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -119.97 111.71 35.46 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 123.031 0.532 . . . . 1.48 110.246 164.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.21 -15.62 10.12 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.759 2.306 . . . . 1.3799999999999999 113.919 175.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.23 -175.27 49.76 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.496 1.046 . . . . 1.3 113.149 -173.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.91 -10.12 27.07 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.066 1.747 . . . . 3.3500000000000001 111.613 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -130.45 161.24 61.8 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 127.572 2.349 . . . . 4.9900000000000002 108.913 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.65 155.94 49.35 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.65 2.233 . . . . 1.6100000000000001 111.541 -170.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.9 mt -110.55 152.22 26.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 125.103 1.361 . . . . 2.79 110.429 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -128.5 105.07 8.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.507 -1.679 . . . . 2.8199999999999998 111.264 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.54 104.57 16.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.133 1.373 . . . . 2.98 108.118 -172.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.4 m -98.21 -28.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.401 0.681 . . . . 1.8400000000000001 112.182 -166.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.93 -178.61 33.1 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.521 1.534 . . . . 0.55000000000000004 111.336 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.24 -178.48 4.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.868 0.867 . . . . 2.0099999999999998 109.375 161.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -144.75 169.73 17.46 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 129.539 3.136 . . . . 6.7699999999999996 106.348 165.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -172.35 149.74 2.15 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 126.938 2.095 . . . . 1.6799999999999999 108.006 -172.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -71.51 -30.9 14.48 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.065 1.177 . . . . 1.01 112.478 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -89.16 19.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 115.856 1.799 . . . . 1.8100000000000001 115.856 -168.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.99 154.0 34.07 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.718 1.007 . . . . 1.55 113.718 174.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -79.98 -65.17 1.04 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.611 1.564 . . . . 3.1000000000000001 109.819 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.3 mtp-105 -110.71 107.96 17.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.655 0.74 . . . . 7.4199999999999999 110.683 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.4 p -77.58 146.9 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 126.054 1.741 . . . . 2.2799999999999998 108.689 162.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -155.5 146.62 22.57 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.852 1.261 . . . . 2.6400000000000001 109.417 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.0 tp -105.83 120.27 41.28 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.358 0.981 . . . . 1.97 111.099 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -127.79 159.56 34.46 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.929 1.347 . . . . 0.83999999999999997 113.981 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.86 161.32 14.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.909 2.084 . . . . 2.1000000000000001 112.351 159.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.9 m -137.23 145.68 43.91 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.985 2.114 . . . . 2.3599999999999999 107.089 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.81 165.61 36.0 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.762 1.267 . . . . 3.4700000000000002 114.24 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.62 146.88 24.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.718 1.207 . . . . 6.96 111.278 166.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.13 161.85 42.0 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.588 1.555 . . . . 6.25 110.061 -171.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -112.79 142.36 45.52 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.347 1.059 . . . . 2.4300000000000002 112.296 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.8 t -136.28 115.96 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.264 1.425 . . . . 3.3300000000000001 108.433 164.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 66.37 7.48 4.99 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 127.291 2.236 . . . . 3.29 115.211 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.18 7.59 59.41 Favored Glycine 0 CA--C 1.54 1.624 0 O-C-N 121.123 -0.986 . . . . 1.6699999999999999 114.189 -165.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -109.09 129.43 55.47 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 127.416 2.286 . . . . 3.5800000000000001 108.292 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -79.7 120.54 24.15 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.938 -1.483 . . . . 3.4700000000000002 109.251 -166.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.2 t -134.38 131.52 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.231 1.812 . . . . 3.4900000000000002 108.846 -173.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.1 mtt -83.35 165.3 19.4 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.506 -0.746 . . . . 3.5499999999999998 112.632 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.24 173.88 32.73 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 124.25 0.929 . . . . 0.82999999999999996 112.943 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.5 ttm -157.09 137.39 12.86 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.889 1.676 . . . . 2.1000000000000001 109.395 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -143.01 149.28 48.63 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 125.529 1.532 . . . . 10.44 110.643 -174.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.63 153.18 43.58 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.066 1.844 . . . . 0.62 109.962 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.07 156.0 77.26 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.735 1.214 . . . . 1.8700000000000001 110.111 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.72 -27.82 2.44 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.851 2.367 . . . . 0.64000000000000001 113.242 -169.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -177.84 165.94 2.05 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.344 1.858 . . . . 3.6899999999999999 111.297 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.7 mt -110.7 155.85 21.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.031 1.332 . . . . 1.6699999999999999 109.884 163.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -113.24 146.77 38.77 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.725 1.21 . . . . 2.0800000000000001 109.105 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.88 128.0 14.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 113.647 0.98 . . . . 2.0699999999999998 113.647 168.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.59 156.57 28.26 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.332 3.355 . . . . 1.4299999999999999 113.05 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.11 141.89 78.34 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.758 3.639 . . . . 1.4199999999999999 114.005 -172.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 71.39 -15.95 0.4 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 129.122 2.969 . . . . 2.3599999999999999 114.161 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.83 -177.12 50.21 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.597 1.57 . . . . 1.71 113.561 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -146.72 150.7 35.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.086 0.954 . . . . 5.4900000000000002 111.389 163.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -149.67 139.44 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.965 2.106 . . . . 4.6299999999999999 107.079 -175.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.1 147.43 34.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.304 1.049 . . . . 3.5600000000000001 113.499 -174.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.07 74.94 0.49 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.668 1.587 . . . . 2.1400000000000001 107.438 157.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 142.48 78.91 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.625 1.17 . . . . 3.0899999999999999 114.08 -170.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.455 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 29.8 Cg_endo -58.86 -10.41 9.64 Favored 'Trans proline' 0 C--N 1.357 1.014 1 C-N-CA 125.606 4.204 . . . . 2.7400000000000002 117.736 -170.049 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.88 2.45 22.93 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.728 1.156 . . . . 2.7599999999999998 115.43 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.84 -112.07 1.46 Allowed Glycine 0 N--CA 1.472 1.084 0 CA-C-N 119.148 1.474 . . . . 1.97 113.136 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -72.5 143.09 48.5 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.988 -0.713 . . . . 3.1200000000000001 111.662 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.469 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 51.4 p-80 -160.39 157.17 27.35 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.568 1.147 . . . . 0.77000000000000002 111.843 -174.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.2 135.33 35.74 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.834 -0.802 . . . . 3.8199999999999998 108.834 155.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.1 126.09 47.77 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.272 2.229 . . . . 1.6799999999999999 108.444 169.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.14 113.09 23.53 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.16 0.984 . . . . 4.0199999999999996 109.847 -176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.07 152.13 19.63 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.082 1.753 . . . . 3.0899999999999999 110.63 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.94 -50.65 4.44 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 127.799 2.619 . . . . 3.0299999999999998 113.551 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.1 mt 57.94 169.09 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.864 2.865 . . . . 2.23 115.675 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -128.48 -23.8 3.15 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.518 2.327 . . . . 2.6600000000000001 114.256 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.407 HH21 ' CD ' ' A' ' 97' ' ' GLU . 26.0 mmm180 -130.61 150.76 77.26 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.512 2.325 . . . . 6.3300000000000001 109.903 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.21 123.94 8.13 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.585 2.19 . . . . 2.1000000000000001 108.538 163.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.04 113.47 17.19 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.186 0.994 . . . . 3.4700000000000002 108.609 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.86 166.01 26.48 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.371 1.469 . . . . 4.4299999999999997 111.055 172.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.11 123.61 16.54 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.011 0.924 . . . . 2.6000000000000001 110.98 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.93 25.86 59.32 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.678 -0.692 . . . . 2.6400000000000001 113.82 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.407 ' CD ' HH21 ' A' ' 91' ' ' ARG . 16.2 mm-40 -86.69 172.71 9.99 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.893 1.347 . . . . 2.96 108.757 133.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -144.37 158.56 43.68 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.045 2.938 . . . . 3.1299999999999999 105.257 171.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.7 t -150.56 146.59 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.385 1.874 . . . . 2.5899999999999999 110.112 -169.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.522 ' CD ' ' HZ3' ' A' ' 112' ' ' LYS . 38.0 mt-10 -95.83 138.01 34.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.234 0.614 . . . . 2.6400000000000001 110.442 165.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.36 137.43 52.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.734 0.778 . . . . 2.52 110.262 159.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.62 113.17 26.58 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 128.316 2.646 . . . . 2.5600000000000001 108.92 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -94.75 132.9 39.01 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.513 -1.367 . . . . 2.1299999999999999 111.339 -168.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.9 mt -104.65 106.24 16.66 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.392 1.477 . . . . 1.76 109.994 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.0 115.27 30.14 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.76 1.224 . . . . 3.6899999999999999 110.76 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.11 23.74 2.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.863 2.065 . . . . 2.8199999999999998 113.845 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.0 -56.73 4.33 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.328 1.442 . . . . 4.4500000000000002 112.914 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.15 -6.68 69.48 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 117.054 1.582 . . . . 1.5700000000000001 117.054 -165.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -128.38 121.51 29.26 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.485 1.643 . . . . 5.4699999999999998 113.015 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -102.35 136.3 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.157 1.383 . . . . 3.0600000000000001 109.429 166.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.9 tp -155.39 128.19 8.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.011 1.325 . . . . 4.0999999999999996 109.688 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.522 ' HZ3' ' CD ' ' A' ' 100' ' ' GLU . 52.0 pttt -109.23 160.87 15.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.374 1.62 . . . . 3.0800000000000001 115.374 -174.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -140.07 161.6 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 126.838 2.055 . . . . 2.8900000000000001 109.439 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.5 t -106.89 142.18 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.53 1.532 . . . . 2.71 109.152 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -144.41 128.5 9.03 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.004 1.722 . . . . 4.0199999999999996 110.2 -171.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.53 164.92 32.83 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.07 2.514 . . . . 1.27 111.921 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.1 t -109.91 151.76 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.183 0.593 . . . . 1.8799999999999999 110.782 171.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -124.28 -171.09 2.26 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.756 2.022 . . . . 4.1600000000000001 112.54 -169.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.17 103.06 8.94 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.859 -1.15 . . . . 2.7599999999999998 109.359 167.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 . . . . . 0 N--CA 1.477 0.879 0 C-N-CA 128.127 2.571 . . . . 7.0800000000000001 110.36 -167.237 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.42 ' H1 ' ' CD ' ' A' ' 23' ' ' GLU . . . . . . . . 0 N--CA 1.468 0.783 0 N-CA-C 109.668 -1.373 . . . . 10.77 109.668 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.3 t -132.01 104.99 7.13 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.22 1.408 . . . . 7.8099999999999996 110.401 -175.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -159.39 171.6 19.48 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.573 2.349 . . . . 11.140000000000001 109.578 -168.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.253 6.4 t 58.38 2.7 0.22 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 126.536 1.935 . . . . 5.7199999999999998 115.372 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -73.37 90.21 1.66 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.369 -1.715 . . . . 4.79 106.369 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.2 -178.17 32.96 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.637 1.589 . . . . 1.52 113.426 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -156.18 157.71 36.38 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.422 1.889 . . . . 2.9199999999999999 112.345 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.9 132.7 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.283 1.433 . . . . 2.9399999999999999 108.481 169.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.466 ' HG2' ' H ' ' A' ' 10' ' ' PHE . 12.1 ttt180 -67.93 162.13 24.96 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.996 0.903 . . . . 5.1100000000000003 112.445 -178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.466 ' H ' ' HG2' ' A' ' 9' ' ' ARG . 49.0 t80 -98.65 130.12 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.22 -1.4 . . . . 3.29 107.22 171.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -167.73 147.43 4.38 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 127.057 2.143 . . . . 3.3100000000000001 107.083 174.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.99 -22.91 9.69 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.929 2.419 . . . . 2.0800000000000001 113.218 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.25 173.63 13.47 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 126.462 1.982 . . . . 1.6200000000000001 110.354 -166.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -70.67 -9.14 12.66 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 CA-C-N 119.681 1.741 . . . . 2.3999999999999999 112.412 -4.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -137.62 161.35 36.69 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.625 1.343 . . . . 2.79 114.625 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.93 -173.87 3.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 131.654 3.981 . . . . 1.6599999999999999 107.492 174.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.9 166.75 23.27 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.635 -1.291 . . . . 2.27 110.676 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.04 148.51 32.76 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 122.109 0.957 . . . . 1.78 111.929 171.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -145.15 129.83 18.08 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.873 2.069 . . . . 3.9199999999999999 107.919 -165.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.11 150.79 9.68 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.571 1.078 . . . . 3.52 113.892 -174.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.2 m -79.87 112.73 17.44 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.62 1.568 . . . . 2.77 110.74 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.77 127.69 36.01 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.214 1.005 . . . . 3.5800000000000001 108.571 169.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.42 ' CD ' ' H1 ' ' A' ' 1' ' ' GLY . 48.3 tt0 -116.63 134.42 54.85 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.905 1.282 . . . . 4.3700000000000001 108.801 168.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -99.46 117.68 63.45 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.506 1.122 . . . . 1.3700000000000001 109.882 173.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -88.4 -8.9 5.25 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.252 2.635 . . . . 1.52 114.825 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.34 160.06 26.64 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 119.789 1.177 . . . . 1.4099999999999999 111.928 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.09 3.05 21.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.947 2.499 . . . . 3.75 112.127 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -123.87 152.12 65.75 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 128.333 2.653 . . . . 3.6899999999999999 109.248 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.74 146.35 23.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.125 2.55 . . . . 1.3100000000000001 111.205 -171.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.4 mt -98.88 145.28 27.15 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.428 1.109 . . . . 2.7799999999999998 111.481 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.498 ' HD2' ' CD2' ' A' ' 66' ' ' PHE . 5.1 tpp180 -130.45 104.91 7.52 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.271 -1.786 . . . . 3.2799999999999998 109.796 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -98.17 115.01 27.43 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.234 2.214 . . . . 3.2400000000000002 108.991 -169.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.98 -28.34 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.208 0.913 . . . . 2.2599999999999998 112.363 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.01 -175.09 30.6 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 115.26 0.864 . . . . 0.41999999999999998 115.26 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.42 -176.85 4.78 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.977 1.711 . . . . 1.48 112.049 171.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttt-85 -159.56 153.39 23.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.871 2.069 . . . . 6.1399999999999997 108.149 172.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -163.55 150.9 10.73 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-N 120.109 1.322 . . . . 1.8 110.473 -170.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.29 -15.29 11.47 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.818 2.345 . . . . 1.1399999999999999 115.135 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -105.45 26.68 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.158 1.383 . . . . 2.3900000000000001 113.634 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.38 174.03 10.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.242 1.417 . . . . 1.6899999999999999 109.215 162.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -99.91 -48.44 4.67 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.966 1.706 . . . . 3.96 109.505 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -126.15 171.61 10.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.883 2.473 . . . . 6.0800000000000001 107.596 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.8 p -154.78 142.75 12.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 125.596 1.558 . . . . 2.2599999999999998 108.532 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -115.59 158.11 23.15 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.67 1.588 . . . . 3.48 109.524 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -111.22 117.01 32.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.076 1.35 . . . . 1.8799999999999999 109.099 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -120.14 149.86 41.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.206 1.402 . . . . 0.68000000000000005 114.223 -174.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' CD ' HH21 ' A' ' 62' ' ' ARG . 14.4 pt-20 -93.3 161.12 14.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.265 1.826 . . . . 2.4199999999999999 111.134 160.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.6 m -129.4 146.14 51.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.52 1.928 . . . . 2.2599999999999998 106.301 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -160.15 -179.05 7.41 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.727 1.01 . . . . 3.5800000000000001 113.727 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.7 mtm -116.46 148.28 40.91 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.792 1.637 . . . . 5.25 111.882 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.62 154.34 45.34 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.444 1.497 . . . . 8.1199999999999992 111.977 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.49 ' CD ' ' HZ1' ' A' ' 57' ' ' LYS . 2.2 tp10 -91.54 137.43 32.37 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.738 -1.208 . . . . 3.1200000000000001 107.738 148.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -144.03 139.7 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.491 -1.67 . . . . 3.6400000000000001 106.491 160.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 64.18 19.92 11.97 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.141 1.376 . . . . 4.5700000000000003 113.931 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.76 17.12 72.88 Favored Glycine 0 CA--C 1.538 1.5 0 O-C-N 120.354 -1.466 . . . . 2.2599999999999998 113.354 -169.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -122.01 135.18 54.82 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.039 2.535 . . . . 3.6600000000000001 109.526 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.49 ' HZ1' ' CD ' ' A' ' 52' ' ' GLU . 2.2 mmtt -74.49 118.7 17.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.861 2.064 . . . . 4.7199999999999998 108.564 -176.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.44 -179.55 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.74 2.016 . . . . 3.7799999999999998 110.673 -174.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.97 174.31 6.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.507 1.123 . . . . 3.9100000000000001 111.955 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.73 173.54 33.79 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.862 1.22 . . . . 0.89000000000000001 112.922 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -157.7 146.06 19.14 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.436 1.894 . . . . 1.97 107.841 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.418 HH21 ' CD ' ' A' ' 47' ' ' GLU . 34.5 mtm180 -150.39 157.74 36.58 Favored Pre-proline 0 N--CA 1.468 0.458 0 C-N-CA 125.255 1.422 . . . . 5.0499999999999998 109.6 -179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.82 153.87 43.01 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.724 1.616 . . . . 0.56999999999999995 111.07 164.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.5 m -134.6 152.18 77.29 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.531 1.532 . . . . 1.76 110.966 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -81.76 -21.61 5.87 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.301 2.667 . . . . 0.64000000000000001 113.208 -169.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.498 ' CD2' ' HD2' ' A' ' 31' ' ' ARG . 47.3 p90 -175.87 164.05 2.85 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.206 1.402 . . . . 3.5099999999999998 112.07 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.3 mt -109.98 156.64 20.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.877 1.671 . . . . 1.71 110.145 163.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -114.35 146.6 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.182 0.593 . . . . 2.75 109.797 163.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.71 126.77 26.0 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.408 1.483 . . . . 2.5600000000000001 109.219 164.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -67.56 165.63 26.69 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.441 2.761 . . . . 1.6299999999999999 110.687 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.33 138.31 55.04 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.016 2.477 . . . . 1.3600000000000001 113.411 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.282 14.4 mtmt 60.14 29.75 19.28 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.684 1.594 . . . . 3.79 114.89 168.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.77 -179.85 18.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.727 2.584 . . . . 1.5900000000000001 113.816 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.24 156.74 22.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.751 0.82 . . . . 5.1900000000000004 112.963 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.5 t -148.65 117.06 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.093 1.757 . . . . 4.0899999999999999 107.797 163.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.19 158.3 23.64 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.346 0.869 . . . . 2.8799999999999999 113.346 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -80.8 62.39 4.81 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.671 1.224 . . . . 2.04 109.704 151.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' H ' ' CD ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -56.54 126.69 70.8 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-O 118.066 -0.969 . . . . 4.4400000000000004 111.152 171.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -56.96 -39.17 93.43 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.256 3.304 . . . . 2.5499999999999998 114.018 -167.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.11 -3.21 51.52 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.025 -1.431 . . . . 1.96 115.051 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.59 -24.32 0.22 Allowed Glycine 0 N--CA 1.473 1.131 0 N-CA-C 118.155 2.022 . . . . 2.4100000000000001 118.155 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -148.89 143.47 26.26 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 120.67 2.235 . . . . 3.7599999999999998 112.796 175.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -160.48 154.61 23.13 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.745 1.218 . . . . 0.90000000000000002 110.961 174.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -77.8 150.06 34.34 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.673 -0.862 . . . . 3.8599999999999999 108.673 161.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 tpt -106.71 115.18 29.75 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.34 1.856 . . . . 2.3100000000000001 106.783 166.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.58 120.68 37.35 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.402 1.081 . . . . 2.4199999999999999 108.741 -174.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.7 mp -116.82 138.15 51.7 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.008 0.923 . . . . 2.9300000000000002 112.611 -167.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.16 49.58 8.36 Favored Glycine 0 N--CA 1.473 1.158 0 O-C-N 121.928 -0.482 . . . . 1.5600000000000001 112.023 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -48.61 154.99 0.6 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 126.969 2.108 . . . . 1.9399999999999999 115.318 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -118.13 -31.38 5.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 113.511 -1.677 . . . . 3.3599999999999999 113.759 -173.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 -118.99 134.5 23.62 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 125.505 1.522 . . . . 6.4000000000000004 107.69 170.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -69.99 113.52 3.44 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 N-CA-C 107.144 -1.906 . . . . 1.75 107.144 163.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.61 153.72 12.71 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.969 1.308 . . . . 3.0 113.262 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -131.49 147.05 52.51 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 123.512 1.625 . . . . 5.8899999999999997 113.592 163.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.96 112.51 10.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.602 -1.636 . . . . 2.0699999999999998 110.237 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.67 -0.55 20.09 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 117.97 -1.461 . . . . 1.6399999999999999 115.376 -173.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -86.51 -176.32 5.8 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.48 1.64 . . . . 2.3900000000000001 110.372 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -142.76 146.15 33.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.641 2.376 . . . . 4.3399999999999999 108.084 171.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -145.22 142.15 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.64 1.576 . . . . 2.71 111.56 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -88.85 164.39 15.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.664 1.357 . . . . 2.5099999999999998 114.664 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 tt -154.97 134.1 12.36 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.347 1.459 . . . . 3.77 110.872 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.37 153.34 29.83 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 127.479 2.312 . . . . 1.97 110.503 169.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.18 124.98 35.99 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.708 2.003 . . . . 2.1400000000000001 108.989 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.8 mt -106.21 116.32 31.74 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.725 1.21 . . . . 1.8700000000000001 109.754 -170.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -112.14 130.31 55.94 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.772 1.229 . . . . 3.4100000000000001 111.394 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.07 -19.13 62.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.982 1.313 . . . . 3.2200000000000002 113.367 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.64 32.63 1.01 Allowed Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.728 1.156 . . . . 4.8499999999999996 114.272 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.7 35.35 85.55 Favored Glycine 0 N--CA 1.471 1.003 0 C-N-CA 125.619 1.581 . . . . 2.71 114.342 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -142.06 145.39 34.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.942 1.371 . . . . 3.8199999999999998 114.026 -167.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -127.32 146.87 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.513 1.925 . . . . 3.48 109.326 167.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -156.7 147.78 22.05 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.045 2.138 . . . . 3.4900000000000002 107.932 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -122.73 155.91 35.5 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.591 1.541 . . . . 3.0099999999999998 114.044 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.404 ' CG1' ' H ' ' A' ' 114' ' ' VAL . 55.8 t -130.52 173.24 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.373 2.269 . . . . 2.9100000000000001 108.886 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.404 ' H ' ' CG1' ' A' ' 113' ' ' VAL . 13.5 p -136.1 136.81 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.443 1.497 . . . . 3.2799999999999998 110.618 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 mt -137.89 136.76 20.18 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.303 1.441 . . . . 3.2000000000000002 111.127 -166.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.94 159.39 53.13 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.625 2.883 . . . . 0.97999999999999998 112.128 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.7 t -103.76 131.12 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.747 1.219 . . . . 2.71 109.761 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.54 170.56 16.18 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.227 1.811 . . . . 4.0599999999999996 110.838 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.32 118.1 31.82 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.218 1.007 . . . . 2.52 110.647 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 . . . . . 0 C--O 1.248 0.974 0 C-N-CA 126.422 1.889 . . . . 7.8899999999999997 109.086 -160.403 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.352 0 N-CA-C 107.835 -2.106 . . . . 10.550000000000001 107.835 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 p -56.8 -103.42 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 118.965 -1.094 . . . . 9.0099999999999998 108.804 114.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -67.69 157.01 35.59 Favored 'General case' 0 CA--C 1.552 1.051 0 O-C-N 120.423 -1.423 . . . . 9.4499999999999993 112.73 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.17 17.55 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.046 2.138 . . . . 5.7000000000000002 114.989 -167.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -76.43 73.81 3.18 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 123.545 1.64 . . . . 4.4800000000000004 112.528 -175.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.32 -178.66 15.72 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.188 1.851 . . . . 1.3999999999999999 111.935 175.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -148.95 149.0 30.45 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.071 1.138 . . . . 2.5899999999999999 114.071 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -79.08 133.39 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 106.64 -1.615 . . . . 2.2799999999999998 106.64 163.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -68.05 -18.64 64.74 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.575 1.695 . . . . 5.1200000000000001 115.575 -158.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.4 t80 76.67 151.32 0.12 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.746 2.418 . . . . 4.0199999999999996 112.534 -174.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 t 174.88 161.31 0.38 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 129.667 3.187 . . . . 2.5499999999999998 108.639 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.63 -24.94 5.8 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.809 2.339 . . . . 1.4299999999999999 112.761 159.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.47 -178.43 17.02 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.265 1.888 . . . . 1.0 112.447 -169.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.26 -0.49 21.9 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.023 1.412 . . . . 1.6000000000000001 113.273 -2.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -135.34 166.79 22.32 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.378 1.471 . . . . 2.2400000000000002 113.205 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.47 -174.12 4.8 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 129.191 2.996 . . . . 1.5600000000000001 111.413 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.26 175.6 9.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.401 1.88 . . . . 1.4199999999999999 108.83 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.59 17.81 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.339 -0.851 . . . . 1.8100000000000001 111.641 170.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.416 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 53.7 m-85 -109.21 69.64 0.71 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.386 1.874 . . . . 3.75 109.268 176.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -79.28 158.65 27.51 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.617 0.767 . . . . 2.8700000000000001 112.795 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.4 m -119.07 140.34 50.24 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.193 1.797 . . . . 2.9399999999999999 109.087 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.0 tp -155.33 178.95 9.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.037 1.735 . . . . 5.46 108.811 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -158.27 149.61 21.09 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.222 1.809 . . . . 4.6399999999999997 107.889 -171.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -106.51 87.17 2.53 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 124.919 1.288 . . . . 1.6899999999999999 110.252 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.56 -11.55 28.28 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.512 2.142 . . . . 2.48 114.136 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.28 174.45 53.48 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-O 123.075 1.375 . . . . 1.47 113.049 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.448 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.1 m-20 -101.6 -1.76 32.07 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.205 2.202 . . . . 3.27 112.768 -167.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.27 156.87 57.13 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.698 1.999 . . . . 4.2800000000000002 109.683 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.12 170.4 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.908 2.406 . . . . 1.54 112.203 -162.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.21 146.55 44.15 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 122.851 1.31 . . . . 3.79 111.354 167.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -135.53 110.94 9.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 111.73 -2.486 . . . . 2.71 109.333 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.1 tp -94.37 112.14 23.92 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.945 1.698 . . . . 3.3700000000000001 110.042 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.64 -22.96 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.847 0.859 . . . . 1.9199999999999999 111.602 -170.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.57 -174.79 30.84 Favored Glycine 0 C--N 1.345 1.072 0 C-N-CA 125.117 1.341 . . . . 0.44 113.838 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.22 -178.44 6.39 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.401 1.881 . . . . 1.8700000000000001 110.913 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -156.58 175.36 14.14 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.41 2.284 . . . . 7.0 108.022 161.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -170.5 158.61 5.89 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 127.037 2.135 . . . . 1.74 109.448 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.41 -5.94 9.16 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.452 2.101 . . . . 1.1399999999999999 114.861 169.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.88 16.45 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.017 1.488 . . . . 2.4300000000000002 115.017 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.77 159.47 24.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.945 2.098 . . . . 2.1200000000000001 109.181 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.446 ' CD ' ' HZ3' ' A' ' 90' ' ' LYS . 4.7 tp10 -108.33 -42.24 4.65 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.306 0.854 . . . . 3.8500000000000001 113.306 -170.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -113.98 147.82 37.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 122.48 1.133 . . . . 7.5800000000000001 108.442 164.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -135.47 134.31 52.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 125.186 1.395 . . . . 1.6200000000000001 107.582 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -130.92 125.86 34.6 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.508 1.523 . . . . 3.2999999999999998 109.525 -166.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.54 119.06 24.74 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.832 -0.543 . . . . 1.8 111.925 -175.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -121.55 161.06 23.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.822 1.649 . . . . 0.54000000000000004 113.523 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.6 159.96 15.56 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.858 1.663 . . . . 2.1099999999999999 111.009 158.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.1 m -114.77 137.54 51.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 105.757 -1.942 . . . . 1.7 105.757 161.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -133.75 174.57 10.31 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.667 1.222 . . . . 3.4300000000000002 113.203 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.4 mtm -119.24 141.03 49.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.244 1.417 . . . . 5.6799999999999997 110.554 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -133.99 144.77 48.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.317 1.047 . . . . 6.6900000000000004 110.738 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -78.86 114.53 17.87 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 106.479 -1.675 . . . . 2.29 106.479 137.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.9 t -94.03 97.86 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 104.449 -2.426 . . . . 3.7000000000000002 104.449 171.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.31 37.26 11.1 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.903 1.335 . . . . 8.8300000000000001 111.246 166.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.17 75.65 Favored Glycine 0 CA--C 1.527 0.824 0 O-C-N 121.018 -1.051 . . . . 2.2599999999999998 112.387 -175.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -120.93 108.96 14.52 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.725 1.61 . . . . 5.1299999999999999 110.525 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.505 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -57.41 127.54 32.49 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.008 -1.683 . . . . 4.6500000000000004 111.706 171.818 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.3 p -158.33 174.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.398 1.879 . . . . 3.3399999999999999 110.711 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.9 mtt -105.97 172.38 6.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.572 1.149 . . . . 3.7000000000000002 112.414 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.87 -178.62 31.13 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.821 1.201 . . . . 0.69999999999999996 112.898 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.8 ttm -154.75 150.73 27.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.814 1.646 . . . . 2.1600000000000001 108.397 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -158.53 158.56 29.6 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 123.92 0.888 . . . . 5.6299999999999999 111.49 173.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.89 154.84 58.36 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.438 2.092 . . . . 0.62 111.287 171.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.47 153.39 65.62 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.533 1.533 . . . . 1.76 110.117 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.84 -26.7 4.38 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.27 2.647 . . . . 0.64000000000000001 113.116 -167.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -178.24 164.06 1.72 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.961 1.704 . . . . 3.5299999999999998 111.172 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.5 mt -109.44 154.39 22.69 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.696 1.198 . . . . 1.9199999999999999 109.762 166.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -124.93 137.01 54.28 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.052 1.341 . . . . 1.74 110.389 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.2 t -143.94 135.03 12.48 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 118.35 0.523 . . . . 2.5099999999999998 112.275 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.93 172.19 11.17 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.693 2.929 . . . . 1.02 113.047 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -59.93 145.33 98.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.881 2.387 . . . . 1.1299999999999999 111.588 164.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.448 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 66.0 mmtt 67.58 -2.2 1.4 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.783 2.033 . . . . 2.6699999999999999 114.059 -178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.85 159.8 46.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.673 1.606 . . . . 1.3899999999999999 114.247 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 134.7 34.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.99 1.316 . . . . 4.4299999999999997 110.848 172.162 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 t -114.9 64.21 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 127.365 2.266 . . . . 6.3300000000000001 107.617 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -98.32 137.07 37.58 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.275 -0.891 . . . . 3.02 110.069 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.9 mp -73.62 -63.79 1.13 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 118.011 -0.995 . . . . 3.1899999999999999 111.034 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm 107.99 128.89 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 128.928 2.891 . . . . 4.4400000000000004 114.248 161.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.416 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 14.9 Cg_endo -53.48 -56.7 2.46 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 124.283 3.322 . . . . 2.1200000000000001 113.599 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.01 28.62 1.91 Allowed Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.555 -1.136 . . . . 1.8600000000000001 113.861 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.25 -128.88 0.99 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.709 1.147 . . . . 1.6299999999999999 115.554 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -74.76 144.21 43.7 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.052 -1.264 . . . . 3.0499999999999998 111.54 -165.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.3 p-80 -160.75 151.06 17.94 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.348 -0.845 . . . . 0.64000000000000001 112.246 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -78.06 128.5 33.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.738 -0.838 . . . . 3.3399999999999999 108.738 161.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 tpt -79.78 128.91 34.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.768 -1.197 . . . . 1.9099999999999999 107.768 160.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.48 115.36 29.5 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.3 1.04 . . . . 2.0899999999999999 108.303 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.05 149.78 42.19 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.666 1.186 . . . . 3.1699999999999999 111.137 -175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.72 49.18 11.05 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.169 0.89 . . . . 1.8 111.277 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mt -52.03 153.28 2.72 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 123.479 1.609 . . . . 1.6200000000000001 114.395 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.446 ' HZ3' ' CD ' ' A' ' 41' ' ' GLU . 63.6 mttm -121.13 -16.27 8.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 112.547 -2.115 . . . . 3.3100000000000001 115.435 -168.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -134.3 144.59 51.84 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.816 1.246 . . . . 6.2800000000000002 111.084 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.6 91.98 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.458 2.105 . . . . 3.4900000000000002 107.55 161.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.476 HD21 ' H ' ' A' ' 93' ' ' LEU . 1.7 pt? -81.07 155.92 26.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.198 1.799 . . . . 3.98 111.662 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.446 ' HZ3' ' CD ' ' A' ' 97' ' ' GLU . 4.0 mmtm -113.46 165.52 12.4 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 122.384 1.088 . . . . 4.3799999999999999 111.468 166.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.49 129.66 37.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.318 -1.31 . . . . 2.6899999999999999 107.665 153.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.14 20.7 37.97 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.311 -1.272 . . . . 1.5 114.76 -172.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.446 ' CD ' ' HZ3' ' A' ' 94' ' ' LYS . 48.4 mt-10 -100.31 179.09 4.57 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.56 1.68 . . . . 2.48 109.543 159.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -132.97 126.47 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.309 2.244 . . . . 3.6699999999999999 105.738 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.7 t -148.23 145.4 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 126.801 2.041 . . . . 2.77 108.194 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.3 151.49 22.65 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 123.407 1.575 . . . . 3.6499999999999999 114.079 -171.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.62 134.61 54.98 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.476 1.511 . . . . 2.75 110.07 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.409 ' OD1' ' HE2' ' A' ' 112' ' ' LYS . 11.6 m-20 -81.65 130.67 35.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.003 1.721 . . . . 2.9500000000000002 108.273 164.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.64 135.58 48.84 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.035 1.289 . . . . 2.71 111.086 168.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -110.38 113.84 26.8 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.719 1.607 . . . . 1.49 109.259 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.83 158.09 19.81 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.825 1.25 . . . . 3.6099999999999999 110.506 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.39 148.5 41.37 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.554 -0.716 . . . . 2.6800000000000002 112.079 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.7 23.14 43.68 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 119.056 -0.858 . . . . 4.1200000000000001 115.053 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.18 7.52 88.45 Favored Glycine 0 N--CA 1.474 1.225 0 CA-C-N 118.827 1.314 . . . . 1.8100000000000001 114.023 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -78.33 121.06 23.97 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.326 -1.103 . . . . 5.4199999999999999 111.381 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.66 142.0 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.7 1.2 . . . . 2.98 108.686 167.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.3 tt -151.19 112.58 4.38 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.934 0.893 . . . . 3.6800000000000002 109.997 -176.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.409 ' HE2' ' OD1' ' A' ' 102' ' ' ASP . 23.7 ttmm -84.46 125.8 32.69 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.734 -0.604 . . . . 4.3099999999999996 111.881 175.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 m -98.0 145.98 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.277 1.431 . . . . 3.8500000000000001 110.329 170.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.19 135.37 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.082 1.753 . . . . 3.2200000000000002 107.726 168.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -158.09 155.14 25.62 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.619 1.567 . . . . 3.1000000000000001 111.409 -171.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -65.91 145.74 80.94 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.774 2.316 . . . . 1.1200000000000001 112.227 169.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.9 t -82.35 124.24 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 105.896 -1.89 . . . . 2.1699999999999999 105.896 151.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.93 151.05 28.99 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.039 0.936 . . . . 3.9900000000000002 110.694 -172.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.3 73.85 5.33 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.544 0.737 . . . . 2.4100000000000001 112.758 -170.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 C-N-CA 124.876 1.27 . . . . 7.6699999999999999 108.684 156.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.403 0 N-CA-C 109.476 -1.45 . . . . 10.69 109.476 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -71.24 -29.18 64.8 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.258 1.577 . . . . 12.07 115.258 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -176.57 154.75 1.28 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.961 2.104 . . . . 11.67 109.727 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.0 p -149.62 55.13 0.96 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.409 1.484 . . . . 7.4900000000000002 110.473 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 10.0 tt0 -156.23 -179.99 8.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.444 1.098 . . . . 9.3000000000000007 110.096 -177.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.491 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -95.26 173.55 31.56 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.184 1.373 . . . . 2.7000000000000002 113.337 -174.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -154.87 167.67 29.5 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.458 1.103 . . . . 3.54 112.3 173.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.94 148.6 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.73 1.212 . . . . 2.29 108.391 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -77.88 -135.96 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.105 -0.702 . . . . 6.5999999999999996 109.105 158.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -140.52 152.64 45.73 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.882 1.273 . . . . 3.9399999999999999 111.489 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 m -161.35 142.02 8.32 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 127.771 2.428 . . . . 3.02 108.983 161.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.22 -23.74 20.73 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.424 2.083 . . . . 2.3799999999999999 112.261 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.04 171.81 13.69 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 127.145 2.307 . . . . 1.3200000000000001 110.8 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -79.55 4.14 33.51 Favored 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 119.667 1.733 . . . . 1.28 112.403 -9.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.3 139.47 16.54 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.239 1.57 . . . . 2.8999999999999999 115.239 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.33 -176.78 3.17 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.024 2.53 . . . . 1.8200000000000001 111.282 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.77 135.08 18.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.807 1.643 . . . . 1.6100000000000001 108.805 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.7 137.32 54.8 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.758 1.223 . . . . 1.6699999999999999 111.237 -175.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -105.62 86.34 2.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.242 1.817 . . . . 3.8999999999999999 109.068 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -90.41 158.08 17.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.403 0.681 . . . . 2.9100000000000001 112.708 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 m -131.53 134.02 45.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.016 1.327 . . . . 2.1800000000000002 109.535 -172.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.35 169.95 23.58 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.003 1.721 . . . . 6.0599999999999996 108.865 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -142.86 145.52 33.22 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.287 1.435 . . . . 4.6500000000000004 108.4 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -93.58 108.15 31.97 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.772 1.229 . . . . 1.5700000000000001 110.87 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.58 -10.27 12.05 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.949 2.433 . . . . 1.8999999999999999 114.91 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.44 169.62 54.05 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 120.085 1.311 . . . . 1.8799999999999999 113.616 -171.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.65 -6.47 58.24 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.414 2.286 . . . . 4.3099999999999996 111.537 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mp -124.5 162.11 44.32 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 127.057 2.143 . . . . 5.1900000000000004 109.587 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.34 155.66 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.854 2.369 . . . . 1.45 111.478 -171.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -117.79 162.11 18.62 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.625 1.97 . . . . 4.0899999999999999 111.016 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -155.12 120.66 5.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.193 -1.367 . . . . 3.02 111.266 -173.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.5 tp -103.49 114.1 28.11 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.608 1.963 . . . . 3.3700000000000001 109.757 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.3 m -112.86 -20.28 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.749 0.819 . . . . 1.6799999999999999 112.634 -167.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.15 -174.71 29.22 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 124.674 1.13 . . . . 0.52000000000000002 112.251 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.64 -178.43 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.1 1.36 . . . . 1.8700000000000001 110.878 168.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -152.62 164.86 36.85 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.139 2.176 . . . . 6.0199999999999996 108.417 172.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -169.2 146.06 2.95 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 124.849 1.259 . . . . 1.8400000000000001 108.919 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -77.32 -10.22 17.58 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.381 2.054 . . . . 1.24 113.367 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.97 21.47 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.747 1.388 . . . . 2.3900000000000001 114.747 -174.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.3 38.97 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.172 -0.955 . . . . 1.8100000000000001 113.067 167.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -72.98 -30.62 63.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.433 1.493 . . . . 3.5099999999999998 113.168 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -155.16 168.44 27.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.156 2.582 . . . . 5.4800000000000004 107.743 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.97 154.87 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.173 1.389 . . . . 1.8100000000000001 108.876 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.61 146.34 28.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.975 1.71 . . . . 4.0599999999999996 108.676 -166.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.8 tp -113.03 110.13 19.97 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.48 1.036 . . . . 2.0299999999999998 111.298 -164.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -116.71 150.04 38.85 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 122.663 1.221 . . . . 0.53000000000000003 113.927 -173.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.409 ' C ' ' HG1' ' A' ' 48' ' ' THR . 7.8 pt-20 -91.94 -178.28 4.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.957 -1.474 . . . . 2.1499999999999999 111.136 158.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.409 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 87.1 m -149.24 127.41 12.06 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.085 -1.82 . . . . 2.0699999999999998 106.085 174.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -128.41 170.17 13.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.967 0.889 . . . . 3.4300000000000002 113.267 -167.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.93 144.72 32.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.152 1.781 . . . . 6.2699999999999996 110.68 170.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.37 147.2 21.94 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.512 -0.742 . . . . 6.2800000000000002 112.849 -172.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -91.76 132.62 36.27 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.479 1.512 . . . . 2.2999999999999998 109.835 165.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.33 130.33 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.496 -1.668 . . . . 3.9399999999999999 106.496 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 62.88 28.05 16.22 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.761 0.824 . . . . 4.9500000000000002 112.254 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.21 16.05 79.85 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 120.967 -1.083 . . . . 2.4300000000000002 113.904 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -135.21 134.42 40.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.986 1.714 . . . . 4.8799999999999999 109.883 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.07 126.31 34.68 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.466 1.506 . . . . 3.1499999999999999 111.976 -173.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.25 -178.97 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 129.558 3.143 . . . . 4.0 109.603 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.3 mtm -110.76 170.01 8.38 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.817 0.847 . . . . 4.3799999999999999 112.033 168.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.89 -176.55 27.24 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.047 1.784 . . . . 1.04 112.206 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ttm -154.67 149.53 26.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.611 1.565 . . . . 1.8899999999999999 108.596 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.9 ptt85 -158.57 156.8 27.93 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 124.891 1.276 . . . . 5.5700000000000003 110.314 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.2 158.06 45.54 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.0 1.8 . . . . 0.56999999999999995 111.644 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.84 149.85 65.74 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.908 1.683 . . . . 1.8200000000000001 109.087 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.31 -20.28 11.25 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.256 2.637 . . . . 0.77000000000000002 113.02 -167.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 p90 178.96 167.62 0.93 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.666 2.386 . . . . 3.5099999999999998 110.114 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.75 150.84 32.8 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.124 1.369 . . . . 1.9099999999999999 110.137 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -117.81 141.79 48.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.034 1.334 . . . . 2.3199999999999998 109.3 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 t -143.93 132.05 10.93 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 113.276 0.843 . . . . 2.73 113.276 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.85 170.32 14.38 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.256 2.637 . . . . 1.7 112.488 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -56.63 139.82 88.89 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.699 2.266 . . . . 1.72 110.658 164.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt 69.13 1.84 3.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.489 1.516 . . . . 2.9399999999999999 113.743 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.77 158.09 36.58 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.676 1.608 . . . . 2.1299999999999999 113.449 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -79.92 145.63 32.55 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.926 0.89 . . . . 4.29 111.925 173.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.57 61.29 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.015 2.126 . . . . 7.0599999999999996 107.92 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -116.57 136.21 53.17 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.845 0.831 . . . . 3.1299999999999999 111.192 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.97 85.55 7.47 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.099 -1.445 . . . . 2.1600000000000001 107.099 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -55.95 139.7 70.35 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 113.672 0.99 . . . . 5.8499999999999996 113.672 -167.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -56.54 130.02 37.82 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.08 1.853 . . . . 4.4699999999999998 109.289 165.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.64 28.98 66.29 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.655 -1.081 . . . . 2.1499999999999999 114.813 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.68 -17.56 0.02 OUTLIER Glycine 0 N--CA 1.472 1.087 0 N-CA-C 118.966 2.347 . . . . 2.3799999999999999 118.966 158.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -143.24 150.03 38.73 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.222 2.011 . . . . 2.9900000000000002 112.406 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -162.44 153.69 17.83 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.287 1.035 . . . . 0.69999999999999996 111.192 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -86.47 127.68 34.88 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.193 -0.669 . . . . 3.9500000000000002 109.193 165.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.4 tpt -82.64 119.41 24.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.394 2.278 . . . . 1.8400000000000001 109.396 170.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -100.33 120.82 40.52 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.345 -0.983 . . . . 2.1099999999999999 108.345 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.56 146.02 30.18 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.626 1.17 . . . . 3.6499999999999999 112.415 -169.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.89 -48.77 3.04 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 126.919 2.199 . . . . 3.0099999999999998 114.126 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.0 mt 56.49 165.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.066 3.346 . . . . 1.8200000000000001 115.388 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -119.36 -7.41 10.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.385 1.874 . . . . 2.9199999999999999 113.292 174.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -127.96 131.51 23.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 128.366 2.666 . . . . 5.6299999999999999 109.385 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.35 76.28 3.97 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.755 2.303 . . . . 2.9500000000000002 106.454 153.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.34 140.3 55.89 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.585 1.154 . . . . 4.3499999999999996 113.669 -156.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -93.31 156.92 16.51 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.381 1.086 . . . . 6.46 111.65 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.62 118.15 7.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 113.847 -1.524 . . . . 2.77 107.545 159.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.62 -2.36 36.54 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-O 117.853 -1.526 . . . . 1.77 115.869 -168.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.42 -178.6 5.28 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.586 1.693 . . . . 3.3199999999999998 111.467 160.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -152.62 141.77 21.38 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.753 2.821 . . . . 4.6100000000000003 106.636 -171.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 82.5 t -144.15 146.09 21.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 126.601 1.96 . . . . 2.5699999999999998 109.561 -168.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -97.76 136.29 38.31 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.953 0.901 . . . . 2.8399999999999999 110.094 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.63 140.12 50.42 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.262 1.025 . . . . 3.73 109.888 165.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -94.44 134.12 37.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.149 2.579 . . . . 1.8700000000000001 108.351 160.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.44 130.18 42.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.634 1.574 . . . . 2.0 108.848 164.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.4 111.43 23.33 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.049 0.939 . . . . 1.9199999999999999 110.678 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -103.66 163.68 12.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.142 1.377 . . . . 3.46 111.582 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.57 154.86 13.39 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.679 -0.691 . . . . 2.6000000000000001 112.122 166.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.36 24.95 62.22 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.138 -0.812 . . . . 3.9500000000000002 114.977 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.91 13.69 82.29 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 118.436 1.118 . . . . 1.8999999999999999 114.171 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -90.52 117.51 29.26 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.448 -1.03 . . . . 4.3799999999999999 112.128 -172.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.27 140.86 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.61 1.564 . . . . 3.6099999999999999 110.431 169.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 mt -140.01 129.2 23.78 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.035 1.334 . . . . 3.6600000000000001 110.846 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -106.21 143.41 34.39 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.797 0.666 . . . . 3.1499999999999999 112.797 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.96 160.01 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 127.49 2.316 . . . . 3.3900000000000001 111.704 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.47 137.23 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.542 1.937 . . . . 2.73 110.57 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.4 mp -134.76 114.57 12.08 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 126.525 1.93 . . . . 3.6699999999999999 110.741 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -75.5 150.02 35.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.265 2.644 . . . . 1.4299999999999999 110.665 169.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.8 t -91.25 132.88 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.848 0.859 . . . . 2.0800000000000001 111.195 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.9 149.31 44.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.901 1.68 . . . . 4.5199999999999996 113.089 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.63 96.13 5.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.675 0.79 . . . . 2.5299999999999998 109.645 159.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.241 0 C-N-CA 128.559 2.744 . . . . 7.2000000000000002 110.413 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 107.284 -2.327 . . . . 11.66 107.284 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -57.7 -176.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 117.194 0.497 . . . . 11.199999999999999 111.108 134.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -74.38 155.54 38.02 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.027 -0.421 . . . . 9.5600000000000005 110.274 151.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.2 t 138.65 114.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 1 C-N-CA 132.301 4.24 . . . . 5.6200000000000001 104.371 -164.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.48 65.06 0.95 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.925 1.345 . . . . 4.8499999999999996 110.359 -160.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.31 172.35 20.38 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.883 1.23 . . . . 1.3 113.897 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -156.23 160.15 39.55 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.499 1.92 . . . . 2.7799999999999998 110.96 172.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -103.61 147.94 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.356 -1.35 . . . . 2.79 107.356 170.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.451 ' HG2' ' H ' ' A' ' 10' ' ' PHE . 18.7 ttm180 -72.08 -119.77 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 CA-C-O 121.542 0.687 . . . . 5.8700000000000001 109.432 164.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.451 ' H ' ' HG2' ' A' ' 9' ' ' ARG . 47.1 t80 -151.41 143.03 23.64 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 119.383 -2.073 . . . . 4.4000000000000004 110.92 -172.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.0 t -171.68 143.31 1.44 Allowed Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.703 1.601 . . . . 2.8100000000000001 110.572 167.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.9 -26.32 4.58 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.733 2.289 . . . . 1.6599999999999999 112.26 166.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.31 170.42 12.03 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.643 2.068 . . . . 1.0700000000000001 111.419 -171.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.69 -16.12 22.83 Favored 'Cis proline' 0 C--N 1.349 0.596 0 CA-C-N 119.328 1.564 . . . . 1.4399999999999999 112.761 0.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -142.09 160.43 40.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.805 1.288 . . . . 2.7799999999999998 114.421 178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.88 -179.06 4.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.433 2.693 . . . . 1.72 110.486 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.06 133.39 26.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.162 1.385 . . . . 1.5800000000000001 109.208 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.32 150.95 50.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.562 1.145 . . . . 1.99 113.481 -171.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.462 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 50.8 m-85 -131.55 127.15 36.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.19 2.196 . . . . 3.4199999999999999 109.548 -163.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.262 0.0 OUTLIER -162.5 161.7 27.13 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.822 1.415 . . . . 4.0099999999999998 114.822 -172.334 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.5 m -93.26 127.75 38.96 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.896 1.678 . . . . 2.5699999999999998 111.735 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.9 tp -112.34 122.0 46.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.809 1.243 . . . . 5.2000000000000002 110.302 166.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -122.07 142.29 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.577 1.151 . . . . 4.5099999999999998 109.211 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -105.87 97.73 16.06 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.561 0.744 . . . . 1.46 111.322 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.31 -5.59 14.36 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.857 2.371 . . . . 1.3200000000000001 114.044 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.93 163.65 34.95 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 119.624 1.102 . . . . 1.3400000000000001 111.347 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.9 4.29 50.42 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.848 2.059 . . . . 3.5099999999999998 112.374 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -118.79 152.81 52.01 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.248 2.219 . . . . 3.9199999999999999 110.346 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.35 142.36 21.12 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.216 1.944 . . . . 1.0800000000000001 110.7 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.1 mt -96.57 149.46 21.74 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 122.258 1.027 . . . . 2.8700000000000001 110.841 172.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.424 HH21 ' CD ' ' A' ' 68' ' ' GLU . 38.5 ttm105 -135.98 100.14 4.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 113.866 -1.515 . . . . 3.04 110.946 176.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.46 97.39 9.5 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.999 2.12 . . . . 2.9399999999999999 108.066 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 m -94.13 -25.42 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.875 0.87 . . . . 1.72 112.801 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.46 -177.09 32.23 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 123.974 0.797 . . . . 0.40000000000000002 113.208 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.3 178.94 6.33 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.462 0.705 . . . . 1.4399999999999999 111.18 172.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -148.75 170.97 17.01 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.512 2.725 . . . . 6.5300000000000002 106.591 165.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t -177.36 148.42 0.72 Allowed Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 127.187 2.195 . . . . 1.8400000000000001 108.703 -172.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -77.14 -24.73 9.32 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.031 1.821 . . . . 1.3999999999999999 113.958 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.5 m -112.57 23.42 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 114.221 1.193 . . . . 2.23 114.221 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.39 35.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.142 1.377 . . . . 2.0899999999999999 107.822 160.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -83.3 -54.41 5.02 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.237 1.015 . . . . 3.0 111.075 -171.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -115.97 166.75 11.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.582 2.753 . . . . 6.3099999999999996 106.392 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.95 134.36 2.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 125.533 1.533 . . . . 1.99 108.267 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -113.97 135.99 53.39 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.21 1.404 . . . . 2.9399999999999999 109.455 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -83.48 124.45 30.73 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.542 -0.54 . . . . 2.4100000000000001 109.542 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -122.61 158.33 30.19 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.19 1.796 . . . . 0.70999999999999996 112.896 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -179.89 4.07 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.626 1.571 . . . . 3.3199999999999998 110.701 165.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.5 m -154.77 141.82 19.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.785 1.634 . . . . 1.8100000000000001 106.988 170.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -155.58 175.0 14.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.54 1.162 . . . . 3.3900000000000001 113.387 -167.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.7 ttp -117.2 146.16 43.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.71 1.604 . . . . 4.1399999999999997 110.137 171.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -148.11 161.05 42.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.716 2.406 . . . . 8.7200000000000006 110.272 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -91.03 144.81 25.27 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.832 0.853 . . . . 2.46 109.5 166.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.7 t -137.22 115.48 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.095 -1.817 . . . . 3.3799999999999999 106.095 163.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 58.08 34.85 24.63 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.992 1.479 . . . . 5.4100000000000001 114.992 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.18 4.63 68.89 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.253 -1.529 . . . . 1.6200000000000001 113.553 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -103.52 115.31 30.29 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.122 1.769 . . . . 3.5899999999999999 107.673 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 117.06 17.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.903 0.881 . . . . 3.7200000000000002 110.221 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 t -138.88 153.73 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 128.609 2.764 . . . . 3.1899999999999999 107.705 -161.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.23 173.43 6.46 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.615 -1.303 . . . . 4.8600000000000003 113.531 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.09 166.84 33.19 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.703 1.144 . . . . 0.57999999999999996 112.451 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 ttm -150.43 139.74 21.31 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.143 2.177 . . . . 2.4500000000000002 107.286 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -150.56 154.23 35.16 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.681 1.992 . . . . 5.1600000000000001 108.672 -171.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.71 159.71 31.52 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.323 2.016 . . . . 0.56000000000000005 111.194 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.76 155.99 52.21 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 125.767 1.627 . . . . 2.3599999999999999 110.931 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -84.88 -26.43 1.54 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.407 2.738 . . . . 0.52000000000000002 114.089 -164.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -174.8 164.81 3.58 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.991 1.716 . . . . 2.9300000000000002 111.477 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 mt -111.7 160.57 17.15 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.924 1.29 . . . . 1.6000000000000001 109.296 157.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.424 ' CD ' HH21 ' A' ' 31' ' ' ARG . 29.5 tt0 -138.0 148.79 45.51 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.61 1.164 . . . . 1.9399999999999999 110.11 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 t -139.82 129.09 13.69 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 123.836 0.71 . . . . 2.2400000000000002 111.755 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -68.39 162.81 39.03 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.189 2.593 . . . . 1.3100000000000001 110.967 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.05 138.66 79.83 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.097 2.532 . . . . 1.25 112.17 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.14 3.43 2.69 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 127.27 2.228 . . . . 3.0699999999999998 115.036 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.67 169.71 34.35 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.136 1.827 . . . . 1.47 113.263 169.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -132.17 157.21 44.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.334 1.054 . . . . 5.3899999999999997 112.305 168.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.3 t -145.08 140.93 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 128.026 2.53 . . . . 4.2300000000000004 107.505 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -134.32 130.06 36.45 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.186 0.517 . . . . 3.9700000000000002 110.822 -170.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -75.69 80.51 2.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.224 1.41 . . . . 2.1099999999999999 109.709 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.84 155.58 91.31 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 126.604 1.962 . . . . 4.79 114.323 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.462 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 55.9 Cg_endo -61.8 -44.46 21.0 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.126 2.551 . . . . 2.25 112.329 171.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.48 60.33 4.88 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.106 -0.83 . . . . 2.2200000000000002 112.426 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.25 -126.44 2.03 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 125.428 1.49 . . . . 1.51 114.191 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -72.63 136.62 45.74 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.674 -0.898 . . . . 3.0299999999999998 112.11 -167.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -160.09 163.88 33.49 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.61 1.164 . . . . 0.92000000000000004 111.439 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -97.18 132.68 42.71 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.914 -0.491 . . . . 3.0299999999999998 109.921 170.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -88.35 115.69 26.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.822 2.049 . . . . 1.78 108.983 166.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.12 119.19 37.43 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.185 0.994 . . . . 2.27 109.013 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.56 141.04 52.11 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.263 1.208 . . . . 4.3399999999999999 114.263 -164.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.24 38.34 25.97 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.539 1.066 . . . . 1.8799999999999999 113.142 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mt -43.86 152.75 0.15 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 116.386 1.995 . . . . 1.8899999999999999 116.386 -174.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -112.84 -16.9 12.64 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.718 -1.583 . . . . 2.7000000000000002 114.939 -173.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -138.25 142.31 34.85 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.698 2.799 . . . . 7.6900000000000004 108.599 165.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.24 135.65 27.45 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.965 1.776 . . . . 1.45 107.753 158.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.56 105.9 16.15 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.318 0.508 . . . . 4.0199999999999996 109.851 -176.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -86.91 20.54 2.58 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.587 2.069 . . . . 4.8700000000000001 116.587 -163.022 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 67.01 157.25 0.12 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 128.541 2.737 . . . . 2.5299999999999998 111.845 -161.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.25 0.26 85.89 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 118.95 -0.917 . . . . 1.29 114.536 -172.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.89 175.69 8.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.921 1.688 . . . . 2.6899999999999999 110.259 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -128.48 153.4 47.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.932 2.093 . . . . 4.0899999999999999 105.423 163.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.1 t -136.72 138.04 46.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 126.407 1.883 . . . . 2.7999999999999998 109.077 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.51 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 38.9 tt0 -89.81 136.08 33.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.08 1.352 . . . . 3.6099999999999999 109.853 173.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.63 139.89 52.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.914 1.286 . . . . 3.6499999999999999 109.62 170.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -99.06 143.45 29.32 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.84 2.056 . . . . 2.6299999999999999 109.669 167.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -114.74 118.79 34.6 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.844 1.657 . . . . 2.04 109.292 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.1 mt -92.39 112.31 24.21 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.883 1.273 . . . . 1.8600000000000001 109.408 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -104.66 106.5 17.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.567 1.147 . . . . 3.4199999999999999 110.564 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.8 21.8 2.08 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.766 1.626 . . . . 2.6400000000000001 114.78 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.68 -55.48 4.46 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.12 1.343 . . . . 4.2400000000000002 112.976 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.65 1.12 54.09 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 116.126 1.21 . . . . 2.0499999999999998 116.126 -172.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -140.68 149.15 41.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.077 1.439 . . . . 4.8300000000000001 112.326 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.71 153.14 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.407 1.483 . . . . 3.29 110.919 170.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.0 tp -155.19 164.02 39.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.953 2.101 . . . . 3.0499999999999998 107.973 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.51 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 41.2 pttt -146.58 156.16 43.02 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.16 1.541 . . . . 2.6899999999999999 115.16 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.15 160.16 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.951 2.5 . . . . 3.9100000000000001 109.929 -167.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.0 142.97 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.959 0.904 . . . . 3.7200000000000002 110.028 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.21 144.57 15.21 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 124.631 1.172 . . . . 3.6400000000000001 113.664 -168.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.49 158.86 25.65 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.984 3.79 . . . . 1.3200000000000001 114.478 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.99 124.5 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.152 1.381 . . . . 2.02 110.227 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -135.57 143.48 45.68 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.345 1.058 . . . . 3.7200000000000002 111.149 174.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.48 59.42 4.62 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.104 -0.998 . . . . 2.7999999999999998 111.368 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 125.138 1.375 . . . . 7.0499999999999998 113.991 -173.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.353 0 N-CA-C 108.723 -1.751 . . . . 15.279999999999999 108.723 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p 176.94 159.84 0.37 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.981 1.712 . . . . 10.75 108.717 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.66 161.63 42.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.153 0.981 . . . . 12.529999999999999 112.211 -171.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.2 m -135.58 70.57 1.43 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.128 1.771 . . . . 6.9500000000000002 108.172 176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -144.43 169.98 16.9 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.337 1.055 . . . . 5.29 113.362 -162.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.16 172.38 34.04 Favored Glycine 0 C--N 1.34 0.78 0 O-C-N 120.797 -1.189 . . . . 1.3100000000000001 114.809 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -157.35 159.55 37.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.198 1.399 . . . . 2.7000000000000002 113.358 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.1 t -107.99 143.31 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.905 1.282 . . . . 2.3500000000000001 109.707 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.4 ' HE ' ' C ' ' A' ' 120' ' ' ARG . 2.4 tmt_? -73.12 -15.77 61.47 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 117.263 2.32 . . . . 6.6900000000000004 117.263 -159.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.487 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 1.1 t80 71.83 115.76 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.863 2.065 . . . . 4.3499999999999996 110.778 -174.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.5 m -162.06 145.4 9.14 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.887 1.675 . . . . 3.3599999999999999 108.806 169.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.12 -33.29 6.03 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.7 2.267 . . . . 2.1600000000000001 112.551 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.71 172.2 18.29 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.437 1.494 . . . . 1.25 111.503 -175.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.94 -1.26 25.14 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 CA-C-N 119.194 1.497 . . . . 1.24 112.891 -1.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -144.0 169.38 17.93 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.256 1.023 . . . . 2.1899999999999999 113.45 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.26 178.27 9.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.966 2.506 . . . . 1.8300000000000001 110.941 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.64 166.3 22.93 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.989 2.116 . . . . 2.0600000000000001 108.823 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.24 154.4 34.58 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.863 0.865 . . . . 1.8600000000000001 111.863 174.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.25 131.86 28.84 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.537 1.535 . . . . 3.8900000000000001 109.818 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.26 162.47 39.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.083 0.856 . . . . 3.9900000000000002 112.841 175.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.4 m -89.03 127.08 35.67 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.346 1.458 . . . . 2.7000000000000002 110.221 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.7 tp -104.47 127.47 52.18 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.115 1.366 . . . . 4.9199999999999999 108.534 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -135.86 132.83 37.09 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.815 1.246 . . . . 4.6900000000000004 109.106 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -103.71 101.21 23.0 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.538 1.135 . . . . 1.53 110.41 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.82 -10.17 19.84 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.297 1.998 . . . . 1.24 113.535 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 177.3 50.84 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-O 122.764 1.202 . . . . 1.1499999999999999 113.102 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.424 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 13.6 m-20 -104.46 -5.25 21.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.496 2.318 . . . . 2.8799999999999999 112.368 -172.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -120.34 161.2 40.31 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 127.359 2.264 . . . . 4.8099999999999996 109.033 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.74 151.99 14.83 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.711 2.274 . . . . 1.1599999999999999 111.911 -167.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp -104.93 149.88 25.35 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.81 1.291 . . . . 3.2200000000000002 109.387 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -139.87 116.65 10.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.726 -1.579 . . . . 2.9199999999999999 108.594 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -93.31 114.85 27.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.3 2.24 . . . . 3.27 108.193 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.5 -25.34 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.708 0.803 . . . . 1.9099999999999999 111.984 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.04 -175.8 33.45 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 123.808 0.718 . . . . 0.55000000000000004 114.573 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -123.51 178.29 5.25 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.64 1.176 . . . . 1.71 112.1 166.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -157.06 147.66 21.41 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.708 1.603 . . . . 6.8499999999999996 107.094 162.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 t -159.59 151.6 17.1 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-O 117.538 -1.22 . . . . 1.73 108.317 -169.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.93 0.59 9.1 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 121.805 1.67 . . . . 0.91000000000000003 114.047 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.07 28.3 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.809 2.044 . . . . 2.1000000000000001 114.791 -171.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.26 143.14 16.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.786 1.175 . . . . 2.23 111.013 168.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.96 -38.51 91.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.174 1.39 . . . . 3.02 111.697 173.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -149.95 144.39 25.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.085 1.754 . . . . 8.0299999999999994 107.856 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.66 132.67 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.329 1.452 . . . . 2.1800000000000002 109.394 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -97.63 167.98 10.63 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.714 1.206 . . . . 3.21 110.02 166.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -119.61 137.25 53.98 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.986 1.374 . . . . 3.6800000000000002 112.441 154.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -121.5 153.72 37.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.661 1.984 . . . . 0.79000000000000004 110.808 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -90.35 157.28 17.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.896 -1.047 . . . . 1.98 109.945 153.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.4 m -108.89 140.13 42.79 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 105.033 -2.21 . . . . 1.73 105.033 157.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -136.15 167.99 20.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.869 1.318 . . . . 3.3399999999999999 113.701 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.4 mtm -113.12 142.87 45.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.532 1.533 . . . . 5.5 110.843 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -134.88 143.27 46.87 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.129 1.372 . . . . 7.1799999999999997 110.047 170.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -91.25 142.31 27.85 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.214 -1.032 . . . . 3.3900000000000001 108.214 154.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.3 t -138.85 118.71 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 106.599 -1.63 . . . . 4.5700000000000003 106.599 164.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 64.59 19.89 11.97 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.411 1.484 . . . . 4.9199999999999999 114.264 -177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.54 4.81 87.41 Favored Glycine 0 N--CA 1.481 1.646 0 O-C-N 120.477 -1.39 . . . . 3.2799999999999998 113.64 -169.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -103.68 111.43 23.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.672 1.989 . . . . 4.5599999999999996 107.87 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.64 117.71 26.64 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.336 1.454 . . . . 3.5299999999999998 111.085 -173.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.17 139.85 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.396 1.878 . . . . 3.6600000000000001 109.329 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -101.13 166.98 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.902 1.281 . . . . 4.4900000000000002 112.77 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.1 -178.0 29.84 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.44 1.019 . . . . 0.58999999999999997 113.166 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.2 ttm -152.41 143.37 23.04 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.666 1.586 . . . . 2.02 108.759 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -162.96 153.75 14.23 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 123.569 0.748 . . . . 5.8399999999999999 112.065 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.33 146.22 35.33 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.644 2.229 . . . . 0.72999999999999998 112.852 -174.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.66 155.15 63.38 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 118.347 -0.835 . . . . 2.0699999999999998 110.905 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.38 -23.66 5.98 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.133 2.555 . . . . 0.64000000000000001 112.89 -171.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -178.37 167.41 1.88 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.089 1.756 . . . . 3.4700000000000002 111.113 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.6 mt -115.08 155.13 27.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.191 1.796 . . . . 1.99 109.952 163.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -116.13 145.81 42.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.387 1.475 . . . . 2.23 110.531 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.5 t -142.23 126.6 10.03 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 118.878 0.763 . . . . 1.97 112.588 163.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.58 165.57 32.33 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.089 3.193 . . . . 1.0900000000000001 112.39 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.99 137.63 80.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.342 2.694 . . . . 1.0900000000000001 112.218 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.424 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 64.9 mmtt 67.59 1.21 2.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.362 1.865 . . . . 2.4500000000000002 114.396 179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.12 167.43 27.83 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 126.007 1.765 . . . . 1.1899999999999999 113.406 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -137.03 156.16 48.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.576 1.15 . . . . 6.75 111.826 169.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.0 t -146.84 130.71 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.888 2.075 . . . . 4.1699999999999999 108.145 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.492 ' CD ' ' HZ1' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -96.33 140.47 30.96 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.622 1.101 . . . . 3.1200000000000001 111.392 164.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -41.2 -52.37 3.36 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.364 1.865 . . . . 3.0600000000000001 111.959 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HZ1' ' CD ' ' A' ' 76' ' ' GLU . 0.3 OUTLIER 104.11 127.89 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 128.575 2.75 . . . . 3.8199999999999998 111.217 164.434 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.18 -11.27 30.53 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.238 2.625 . . . . 2.5 114.83 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.67 20.26 8.82 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.108 1.337 . . . . 1.8300000000000001 113.753 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -144.54 -119.32 1.3 Allowed Glycine 0 N--CA 1.471 1.0 0 CA-C-N 119.204 1.502 . . . . 1.8100000000000001 113.31 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -72.74 144.68 47.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.275 1.038 . . . . 3.5899999999999999 110.518 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -161.48 151.14 16.69 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.532 -0.73 . . . . 0.71999999999999997 110.728 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -77.76 143.01 38.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.477 -0.935 . . . . 3.9500000000000002 108.477 166.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 tpt -115.88 114.52 24.8 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.391 2.276 . . . . 2.4199999999999999 107.902 172.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -98.04 118.85 35.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.938 1.695 . . . . 2.3300000000000001 108.73 -173.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.85 135.13 54.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.685 1.194 . . . . 3.3300000000000001 110.336 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.51 50.84 10.66 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.718 -0.614 . . . . 1.6299999999999999 112.689 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -47.76 156.38 0.33 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 115.932 1.827 . . . . 1.96 115.932 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -112.08 -30.77 7.11 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 113.43 -1.714 . . . . 2.3500000000000001 113.772 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -112.66 134.79 21.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.465 1.506 . . . . 5.1500000000000004 108.959 166.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.62 82.89 1.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.785 2.324 . . . . 1.55 107.265 160.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -87.6 124.75 33.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.562 0.745 . . . . 3.6000000000000001 112.952 -163.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 24.4 mtmm -110.38 167.23 10.36 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 115.268 1.581 . . . . 4.5499999999999998 115.268 -165.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.86 124.82 21.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.353 -1.294 . . . . 1.9399999999999999 109.123 172.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.13 5.25 62.44 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 117.959 -1.467 . . . . 1.6899999999999999 115.639 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.01 178.26 6.71 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.193 1.997 . . . . 2.77 111.246 163.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -149.12 125.76 11.05 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 129.497 3.119 . . . . 3.4900000000000002 104.607 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.4 t -146.52 139.96 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.809 0.844 . . . . 2.96 110.783 -168.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -80.13 152.12 29.43 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.524 1.13 . . . . 3.1499999999999999 113.982 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.2 tt -144.47 130.74 19.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.426 1.49 . . . . 4.4100000000000001 110.639 168.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.8 117.88 21.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.644 2.778 . . . . 2.3500000000000001 109.095 165.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -87.87 121.08 29.85 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.124 -1.065 . . . . 2.0899999999999999 108.124 171.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.1 mt -97.61 118.56 34.41 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.002 0.921 . . . . 1.8300000000000001 109.979 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -116.2 144.51 44.09 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.308 1.043 . . . . 3.5099999999999998 112.852 -171.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.58 137.0 57.94 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.279 -0.888 . . . . 2.4500000000000002 113.271 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.17 46.38 5.6 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.746 -1.03 . . . . 3.9199999999999999 113.627 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.3 32.79 46.54 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 123.959 0.79 . . . . 1.72 114.728 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -125.77 144.81 50.48 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.675 1.237 . . . . 4.4699999999999998 112.201 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.04 149.02 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.376 1.47 . . . . 3.2200000000000002 110.644 176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -149.3 119.29 7.16 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.143 0.977 . . . . 3.5099999999999998 108.699 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -96.08 133.71 40.01 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.635 -0.665 . . . . 3.04 111.757 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.28 170.47 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.934 1.693 . . . . 3.3300000000000001 108.469 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -124.75 136.77 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.752 1.621 . . . . 3.3500000000000001 108.726 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -127.73 139.12 34.4 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.305 1.442 . . . . 3.7999999999999998 109.131 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.26 150.41 76.5 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.231 2.621 . . . . 1.47 111.311 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.1 t -99.39 137.73 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.491 1.116 . . . . 2.3999999999999999 108.384 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 160.21 42.33 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.525 1.93 . . . . 4.79 112.271 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.45 142.71 37.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.074 1.349 . . . . 2.6099999999999999 113.384 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.4 ' C ' ' HE ' ' A' ' 9' ' ' ARG 0.26 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 130.04 3.336 . . . . 10.130000000000001 110.193 169.404 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.148 0 N-CA-C 107.427 -2.269 . . . . 11.949999999999999 107.427 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -61.66 159.11 13.95 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.359 1.08 . . . . 9.1899999999999995 110.21 146.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -82.57 41.02 0.69 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.273 -0.892 . . . . 13.57 112.27 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.4 p -149.05 29.62 0.8 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 129.71 3.204 . . . . 8.8000000000000007 108.835 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -157.06 139.99 15.27 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 128.559 2.743 . . . . 5.4699999999999998 107.602 -172.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.17 137.14 9.19 Favored Glycine 0 N--CA 1.467 0.701 0 N-CA-C 110.95 -0.86 . . . . 2.2000000000000002 110.95 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -96.87 173.12 7.46 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.521 1.304 . . . . 2.75 114.521 -168.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.43 148.36 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.214 1.806 . . . . 1.98 108.6 168.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -69.46 -103.02 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.407 1.083 . . . . 5.3700000000000001 112.613 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.2 t80 169.96 126.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.705 2.402 . . . . 3.0499999999999998 108.419 -166.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 m -173.34 145.47 1.22 Allowed Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 126.015 1.726 . . . . 2.73 109.389 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.78 -33.74 0.6 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.915 2.41 . . . . 1.8200000000000001 112.589 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.29 166.8 11.95 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.949 1.738 . . . . 1.54 111.314 -170.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.76 -2.04 25.17 Favored 'Cis proline' 0 CA--C 1.54 0.777 0 CA-C-N 119.192 1.496 . . . . 1.72 113.092 -0.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -147.6 163.66 35.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.796 1.638 . . . . 2.2000000000000002 112.994 -172.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.58 -175.43 4.92 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.259 2.224 . . . . 1.6599999999999999 111.773 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.11 148.0 33.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.532 1.133 . . . . 1.8600000000000001 110.989 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.23 137.75 39.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 1.6299999999999999 113.096 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -105.93 23.36 14.09 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.252 2.621 . . . . 4.0700000000000003 113.818 -168.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -58.47 160.72 5.09 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 117.263 2.319 . . . . 3.3599999999999999 117.263 -163.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -79.46 150.13 31.34 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.119 2.168 . . . . 2.9300000000000002 112.046 174.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.67 132.7 33.31 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.058 2.143 . . . . 4.2599999999999998 110.334 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -135.6 162.78 31.73 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.125 1.37 . . . . 4.6399999999999997 111.456 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -130.31 98.94 19.92 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.909 0.883 . . . . 1.76 109.662 168.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.16 -11.15 16.32 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.779 2.319 . . . . 1.3300000000000001 113.007 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.85 -172.66 47.54 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.994 1.283 . . . . 1.26 113.155 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -113.73 -2.64 13.67 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.438 1.895 . . . . 3.3199999999999998 112.239 -165.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -124.54 153.86 69.65 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.363 2.265 . . . . 4.2199999999999998 110.231 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.99 158.5 38.29 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.643 2.229 . . . . 1.48 112.709 -168.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.3 mt -119.04 152.5 36.33 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.083 1.753 . . . . 3.0899999999999999 110.196 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.3 ttp-105 -138.01 102.39 4.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.281 -1.781 . . . . 4.2300000000000004 110.722 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.82 106.88 16.68 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.318 1.847 . . . . 2.79 108.671 -174.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.25 -26.08 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.698 0.999 . . . . 1.8400000000000001 113.698 -170.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.09 -174.23 31.71 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 125.615 1.579 . . . . 0.48999999999999999 111.805 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.71 -175.14 4.54 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.643 0.735 . . . . 1.6200000000000001 112.443 173.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -145.23 178.1 8.32 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.808 2.843 . . . . 6.4500000000000002 107.598 160.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t 179.41 150.7 0.5 Allowed Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 127.089 2.156 . . . . 1.5900000000000001 109.115 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.77 -9.68 22.69 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.014 2.476 . . . . 1.1200000000000001 113.746 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.466 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 30.1 m -114.04 23.34 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 115.248 1.573 . . . . 1.79 115.248 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.75 173.24 14.97 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.408 1.483 . . . . 1.75 109.252 166.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -101.21 -58.02 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.612 1.565 . . . . 4.5999999999999996 110.795 165.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -98.14 152.61 19.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.615 2.366 . . . . 6.8300000000000001 108.536 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.5 p -160.55 108.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 127.04 2.136 . . . . 2.23 110.224 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -127.58 140.94 51.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.16 -1.382 . . . . 5.4900000000000002 111.469 -168.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 tp -82.03 125.27 30.61 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.666 0.746 . . . . 2.7400000000000002 111.59 -170.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -119.09 159.5 23.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.288 1.835 . . . . 0.56000000000000005 112.161 171.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -114.31 165.43 12.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.906 -1.497 . . . . 2.25 110.863 166.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -124.3 126.76 46.57 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.16 -1.793 . . . . 1.9199999999999999 106.16 169.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -127.14 171.35 11.49 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.23 0.826 . . . . 3.4700000000000002 113.23 -172.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 ttp -105.38 145.28 31.0 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.779 1.632 . . . . 4.4900000000000002 110.823 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -152.25 153.42 33.71 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.467 1.507 . . . . 9.4199999999999999 112.122 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -155.66 142.16 18.65 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.197 1.799 . . . . 2.79 108.802 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -164.78 145.41 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 129.54 3.136 . . . . 6.8600000000000003 105.797 171.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 61.64 9.18 2.66 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.767 1.627 . . . . 3.5899999999999999 115.063 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.48 8.52 73.99 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.416 1.008 . . . . 2.23 114.95 -168.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -85.55 66.66 9.78 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.948 -1.325 . . . . 3.6099999999999999 111.938 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 111.93 1.7 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.331 -1.481 . . . . 3.3199999999999998 111.315 171.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -155.23 159.81 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.203 1.401 . . . . 4.2699999999999996 110.082 -170.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 65.1 mtm -91.84 172.69 8.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.71 1.004 . . . . 4.0700000000000003 113.71 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.59 -179.17 24.3 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.472 1.987 . . . . 0.78000000000000003 111.211 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ttm -144.38 147.21 33.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.248 1.419 . . . . 2.0299999999999998 107.856 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -158.97 155.44 24.47 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 5.5599999999999996 110.84 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.87 156.85 24.02 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.782 2.322 . . . . 0.75 111.635 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.49 155.58 63.92 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.44 1.496 . . . . 2.21 110.756 -176.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -84.81 -27.23 1.32 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.071 2.514 . . . . 0.68000000000000005 113.493 -165.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -178.39 166.56 1.85 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.228 1.811 . . . . 2.9300000000000002 112.003 -178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.2 mt -108.35 157.24 18.56 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.021 1.328 . . . . 2.1000000000000001 110.319 157.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -106.35 153.74 21.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.427 1.091 . . . . 1.8799999999999999 109.341 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.3 t -140.59 122.79 9.63 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 118.722 0.692 . . . . 2.3799999999999999 112.157 160.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.29 159.16 44.11 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.549 2.833 . . . . 1.3400000000000001 111.296 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.6 140.89 89.22 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.423 2.748 . . . . 1.3899999999999999 112.586 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt 66.21 -2.07 1.06 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.877 2.071 . . . . 2.6499999999999999 113.948 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.6 172.75 41.27 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.262 1.887 . . . . 1.26 113.577 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.51 144.0 23.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.137 1.375 . . . . 6.75 111.348 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.9 t -149.48 137.35 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 126.814 2.046 . . . . 4.0199999999999996 107.16 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -133.45 127.33 33.09 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.446 -1.316 . . . . 4.3600000000000003 107.446 -162.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.6 -51.41 68.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.37 0.668 . . . . 2.6899999999999999 111.616 -162.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 82.74 158.63 0.12 Allowed Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 126.708 2.003 . . . . 6.4500000000000002 114.98 159.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -60.53 127.14 21.82 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.218 1.945 . . . . 2.8399999999999999 110.22 168.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.88 54.7 34.77 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.975 -0.557 . . . . 3.0899999999999999 113.709 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.36 -44.74 0.03 OUTLIER Glycine 0 N--CA 1.473 1.117 0 N-CA-C 116.489 1.356 . . . . 1.9099999999999999 116.489 160.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -135.24 147.62 49.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.991 1.395 . . . . 3.54 109.871 163.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -161.24 149.01 15.33 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.678 0.791 . . . . 0.70999999999999996 109.693 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -79.07 136.43 37.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.426 -0.953 . . . . 3.5699999999999998 108.426 160.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.0 tpt -88.8 116.85 27.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.848 1.659 . . . . 1.9299999999999999 107.569 163.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -89.37 129.77 35.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.003 1.321 . . . . 2.0099999999999998 107.971 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.15 140.12 51.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.165 0.986 . . . . 3.2799999999999998 111.073 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.57 48.88 7.64 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.923 0.773 . . . . 2.4100000000000001 111.259 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.0 mt -51.99 156.11 1.64 Allowed 'General case' 0 N--CA 1.46 0.046 0 N-CA-C 115.254 1.576 . . . . 1.8700000000000001 115.254 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.466 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 29.9 mmtp -120.92 -22.12 6.31 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 113.551 -1.659 . . . . 4.46 113.513 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -132.89 142.83 46.16 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 128.436 2.695 . . . . 7.5499999999999998 109.122 165.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -68.93 137.57 38.26 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.369 2.046 . . . . 1.52 107.951 157.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.24 140.68 29.9 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.704 0.802 . . . . 3.0499999999999998 111.265 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.513 ' HZ1' ' CD ' ' A' ' 97' ' ' GLU . 0.0 OUTLIER -113.24 165.12 12.72 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 123.559 1.647 . . . . 4.5999999999999996 111.329 165.478 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.81 134.1 41.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 112.88 -1.963 . . . . 2.0099999999999998 109.249 170.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.99 12.43 59.01 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.073 1.32 . . . . 1.97 115.051 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.513 ' CD ' ' HZ1' ' A' ' 94' ' ' LYS . 43.8 mt-10 -94.07 -176.71 4.08 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.68 1.192 . . . . 2.6299999999999999 111.522 171.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.77 136.6 17.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 128.369 2.668 . . . . 3.04 106.183 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.3 t -147.86 146.2 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.979 1.312 . . . . 2.46 110.738 -168.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.542 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 14.6 mt-10 -76.4 142.77 40.99 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.56 0.744 . . . . 2.5699999999999998 112.162 -178.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mp -120.69 145.26 47.64 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.512 1.149 . . . . 2.9199999999999999 110.774 150.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -112.07 103.61 11.81 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.665 2.786 . . . . 2.4100000000000001 108.527 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.91 130.17 34.57 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.67 -1.268 . . . . 2.6099999999999999 110.762 -166.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.74 116.01 31.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.497 1.119 . . . . 2.3399999999999999 111.446 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -111.04 104.05 12.57 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.339 1.455 . . . . 3.3300000000000001 111.829 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 55.52 25.48 7.93 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.393 1.877 . . . . 3.2200000000000002 113.411 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.88 -58.22 4.27 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.229 1.395 . . . . 4.8099999999999996 112.697 -173.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.4 0.09 56.01 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.868 1.507 . . . . 2.1000000000000001 116.868 -167.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -137.04 143.09 42.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.535 1.668 . . . . 3.6000000000000001 111.649 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.35 148.82 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.121 1.768 . . . . 3.3199999999999998 110.711 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.5 tt -155.66 131.61 9.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.102 1.361 . . . . 3.1000000000000001 110.599 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.542 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 20.7 ttmm -92.36 144.75 25.06 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.265 -0.897 . . . . 3.3900000000000001 112.288 179.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.02 161.9 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.675 1.59 . . . . 2.9399999999999999 108.381 167.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.62 130.64 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.18 0.992 . . . . 2.9300000000000002 108.88 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.92 136.7 29.41 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.944 1.698 . . . . 4.0899999999999999 109.501 -165.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.47 160.2 41.99 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.385 2.723 . . . . 1.6599999999999999 111.911 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 t -109.51 120.61 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.255 1.022 . . . . 2.1400000000000001 110.478 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -132.35 128.83 38.5 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.169 1.788 . . . . 3.77 108.732 173.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.89 55.04 1.99 Allowed 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.475 -0.766 . . . . 2.6800000000000002 113.0 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 . . . . . 0 C--O 1.248 1.025 0 C-N-CA 125.251 1.42 . . . . 7.1500000000000004 111.045 -173.379 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.407 0 N-CA-C 106.538 -2.625 . . . . 9.7300000000000004 106.538 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -62.27 158.87 16.2 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 116.853 -1.939 . . . . 10.31 109.645 125.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -136.73 36.06 2.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.971 1.708 . . . . 11.15 111.011 -171.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.42 56.01 2.43 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.135 1.774 . . . . 6.3200000000000003 111.457 -175.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.22 60.59 1.96 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.491 2.317 . . . . 4.9299999999999997 111.162 -172.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.15 167.75 21.7 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 121.212 -0.93 . . . . 1.45 112.889 -169.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -151.96 165.5 34.44 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.619 0.768 . . . . 2.6600000000000001 112.893 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -105.88 139.58 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 106.471 -1.677 . . . . 2.1299999999999999 106.471 168.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ttt-85 -79.8 -126.63 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.102 0.865 . . . . 5.3600000000000003 109.001 170.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -154.45 154.43 33.19 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 119.695 -1.878 . . . . 4.4500000000000002 113.342 -173.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.7 t -176.36 140.36 0.52 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 129.757 3.223 . . . . 2.7799999999999998 107.037 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.2 -32.52 5.09 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.467 2.112 . . . . 1.49 112.067 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.88 171.95 23.58 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.807 1.194 . . . . 0.90000000000000002 112.657 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.95 1.21 19.5 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 119.026 1.413 . . . . 0.98999999999999999 112.6 -6.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.86 144.83 24.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.463 1.653 . . . . 3.25 115.463 -173.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.23 -176.11 3.14 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.898 2.479 . . . . 1.6299999999999999 112.58 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.5 133.25 25.45 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.089 1.356 . . . . 1.4099999999999999 110.987 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.0 141.69 40.76 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.699 1.2 . . . . 1.6899999999999999 112.67 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -115.64 58.69 0.73 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.143 2.577 . . . . 3.7799999999999998 109.978 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -64.31 162.05 15.57 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.054 -1.029 . . . . 2.8599999999999999 111.836 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 m -108.32 139.76 42.57 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.403 0.681 . . . . 2.3100000000000001 110.941 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.64 127.38 52.37 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.904 -1.044 . . . . 3.8399999999999999 110.242 -178.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.3 145.71 39.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.4 1.48 . . . . 5.5 110.178 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.46 60.42 48.13 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.614 0.766 . . . . 3.04 111.897 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -60.66 -20.3 64.49 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.678 2.919 . . . . 1.6699999999999999 114.573 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.41 -171.84 36.73 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 122.638 1.132 . . . . 1.3799999999999999 113.677 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.414 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 10.3 m-20 -111.74 -3.02 15.11 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.17 1.788 . . . . 3.0899999999999999 112.45 -163.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.58 154.69 69.9 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 127.528 2.331 . . . . 3.9700000000000002 110.021 175.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.66 138.59 19.32 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.731 2.287 . . . . 1.6299999999999999 111.219 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.9 mt -94.89 137.84 33.44 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 123.602 1.667 . . . . 3.1899999999999999 112.341 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 ttp-105 -123.97 95.97 4.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.471 -2.149 . . . . 4.5300000000000002 111.508 -173.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 44.0 tp -79.62 107.71 12.6 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.413 1.885 . . . . 3.3900000000000001 109.909 -176.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -98.01 -25.41 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 112.724 0.639 . . . . 1.79 112.724 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.47 -173.96 27.56 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 124.657 1.122 . . . . 0.42999999999999999 112.388 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.23 174.19 10.06 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.667 -0.767 . . . . 1.4299999999999999 111.88 163.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.4 mtp-105 -138.97 170.95 15.05 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 128.992 2.917 . . . . 5.9199999999999999 107.056 158.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t 179.92 153.46 0.63 Allowed Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 125.459 1.504 . . . . 1.9199999999999999 110.022 -168.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.02 -1.7 9.45 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.8 2.333 . . . . 1.03 115.236 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -118.63 18.56 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 115.706 1.743 . . . . 1.97 115.706 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -166.04 162.63 18.04 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.194 2.197 . . . . 1.5800000000000001 109.105 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -120.84 -69.26 0.85 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.069 1.748 . . . . 4.0499999999999998 108.345 -172.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -84.1 75.05 10.2 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.528 -1.358 . . . . 6.6900000000000004 108.009 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.45 148.75 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.512 -0.767 . . . . 1.78 109.577 166.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.35 154.28 30.33 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.332 1.853 . . . . 4.0899999999999999 108.414 -164.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.9 tp -121.38 107.95 13.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.47 1.032 . . . . 1.8700000000000001 110.864 -167.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -115.94 150.13 37.63 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 114.99 1.478 . . . . 0.67000000000000004 114.99 -171.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -106.93 153.62 22.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.662 1.985 . . . . 2.1200000000000001 110.684 163.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.411 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 3.5 m -131.27 133.17 45.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.651 1.981 . . . . 2.2799999999999998 106.973 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -144.33 172.3 13.13 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.649 0.981 . . . . 3.3999999999999999 113.649 -167.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.5 ttp -99.25 147.05 25.56 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.627 1.571 . . . . 4.5899999999999999 109.889 167.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.91 158.35 43.05 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.876 1.67 . . . . 6.2699999999999996 109.822 -174.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -110.11 143.2 40.51 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.808 1.643 . . . . 2.8999999999999999 109.818 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.6 p -157.84 138.32 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.935 -1.135 . . . . 4.5300000000000002 107.935 163.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 64.25 25.11 13.51 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.864 0.865 . . . . 4.0099999999999998 111.587 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.03 10.6 78.09 Favored Glycine 0 N--CA 1.48 1.584 0 O-C-N 120.428 -1.42 . . . . 2.3700000000000001 113.865 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -123.18 121.61 36.37 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.791 2.036 . . . . 3.4500000000000002 109.565 -166.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 mtmm -72.38 131.92 43.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.165 1.386 . . . . 4.29 110.957 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.29 -179.5 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 129.095 2.958 . . . . 3.6600000000000001 109.367 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.73 162.39 22.11 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.787 0.835 . . . . 5.0700000000000003 112.289 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.57 31.12 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.54 1.067 . . . . 0.72999999999999998 113.319 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.0 ttm -154.75 144.3 21.4 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.226 1.41 . . . . 1.8600000000000001 110.567 -174.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -148.79 161.72 31.94 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 126.105 1.762 . . . . 5.2599999999999998 109.897 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.07 161.4 26.54 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.247 1.964 . . . . 0.59999999999999998 111.956 168.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.92 154.9 68.99 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 126.683 1.993 . . . . 2.3100000000000001 110.612 175.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.91 -20.41 7.63 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.799 2.999 . . . . 0.52000000000000002 113.561 -165.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -178.33 163.69 1.65 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.431 1.892 . . . . 3.2200000000000002 111.166 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -110.98 157.76 19.54 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.946 1.299 . . . . 1.8100000000000001 109.822 159.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -133.17 152.33 51.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.519 0.728 . . . . 2.3199999999999998 111.359 172.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.2 t -136.15 141.09 34.95 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.536 1.934 . . . . 2.0299999999999998 112.398 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.83 156.13 13.57 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.282 3.321 . . . . 1.55 112.708 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -65.91 148.21 85.81 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.599 2.866 . . . . 1.3600000000000001 114.064 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 71.9 mmtt 70.24 -13.4 0.44 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 129.133 2.973 . . . . 2.3999999999999999 114.934 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.7 164.23 48.61 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.289 0.947 . . . . 1.96 113.454 173.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -98.41 159.06 15.19 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.519 -0.919 . . . . 4.8899999999999997 108.519 145.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.9 t -148.57 118.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.268 1.427 . . . . 4.4199999999999999 107.48 163.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -78.85 156.26 28.76 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.719 -0.613 . . . . 2.9700000000000002 112.376 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.89 144.43 57.28 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.099 -1.074 . . . . 2.6000000000000001 108.099 155.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.408 ' H ' ' HB2' ' A' ' 82' ' ' TYR . 7.9 mptt -84.45 126.98 67.77 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 120.153 -1.592 . . . . 4.25 109.751 -170.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -60.78 -14.82 34.07 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.814 3.009 . . . . 2.8399999999999999 115.071 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.56 -58.24 0.77 Allowed Glycine 0 CA--C 1.531 1.069 0 CA-C-N 118.752 0.706 . . . . 3.4700000000000002 111.867 155.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -75.15 -17.12 80.28 Favored Glycine 0 N--CA 1.476 1.338 0 N-CA-C 119.307 2.483 . . . . 2.0 119.307 -158.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.408 ' HB2' ' H ' ' A' ' 78' ' ' LYS . 80.5 m-85 -147.63 141.32 25.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.698 2.249 . . . . 3.46 111.643 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -158.2 150.32 21.88 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.606 0.763 . . . . 0.93000000000000005 111.392 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -79.71 117.03 20.24 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 108.912 -0.773 . . . . 3.02 108.912 162.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 tpt -77.81 124.49 28.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.726 2.01 . . . . 1.9099999999999999 108.278 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.5 mt -117.05 97.32 5.87 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.343 1.457 . . . . 3.2799999999999998 108.946 -167.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.51 149.39 26.26 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.775 0.798 . . . . 3.4700000000000002 111.839 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.41 51.98 6.35 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 110.879 -0.888 . . . . 2.0800000000000001 110.879 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -50.77 151.44 2.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.682 1.23 . . . . 2.0600000000000001 113.864 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -114.45 -20.49 10.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.031 -1.895 . . . . 3.9900000000000002 114.648 -173.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -126.51 154.55 75.2 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.294 2.238 . . . . 7.1200000000000001 108.184 166.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -64.7 139.92 65.56 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 N-CA-C 107.867 -1.628 . . . . 2.98 107.867 151.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.26 163.34 29.52 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.192 1.397 . . . . 3.5499999999999998 109.225 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.07 170.47 20.41 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.236 0.828 . . . . 4.9500000000000002 113.236 174.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.19 134.44 57.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.932 0.893 . . . . 2.54 110.339 170.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.11 -7.52 35.32 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.683 1.611 . . . . 1.6899999999999999 115.323 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.69 -179.69 6.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.447 1.123 . . . . 3.7999999999999998 110.676 174.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -138.51 141.7 39.36 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.648 1.979 . . . . 3.3999999999999999 106.937 160.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.9 t -148.53 145.25 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.784 1.634 . . . . 2.4399999999999999 110.181 -165.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.51 145.62 26.72 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.263 1.579 . . . . 3.4700000000000002 115.263 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -118.31 144.29 45.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.79 1.636 . . . . 3.6800000000000002 109.526 161.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -95.62 113.24 24.87 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 128.568 2.747 . . . . 1.9399999999999999 108.171 167.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.9 mp -86.5 112.16 21.26 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.617 1.167 . . . . 2.9700000000000002 107.954 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.9 mt -95.61 106.33 18.41 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.79 0.805 . . . . 2.02 110.705 -174.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -98.25 126.84 43.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.882 1.273 . . . . 3.25 111.929 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.81 41.27 4.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.088 2.155 . . . . 2.9100000000000001 112.822 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.85 -93.17 1.73 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 125.338 1.447 . . . . 5.9900000000000002 111.458 -171.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.08 -6.68 61.55 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 116.969 1.548 . . . . 3.0800000000000001 116.969 -160.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -81.94 100.37 9.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.111 2.456 . . . . 5.0499999999999998 110.632 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -94.91 137.0 24.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.235 1.014 . . . . 3.3799999999999999 112.554 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.4 tp -133.71 113.97 12.92 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.711 1.604 . . . . 3.6400000000000001 109.703 170.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -89.73 125.59 35.34 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.616 -0.677 . . . . 3.1699999999999999 111.482 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.04 157.9 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.745 0.818 . . . . 3.71 110.765 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.0 t -104.13 143.76 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.715 1.606 . . . . 2.77 108.706 -173.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.13 141.11 14.56 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.571 1.549 . . . . 2.9900000000000002 109.399 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.16 157.88 59.91 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.221 3.281 . . . . 0.98999999999999999 113.743 177.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.7 t -110.23 139.59 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.852 2.061 . . . . 2.1800000000000002 108.928 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -150.21 164.32 35.98 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.741 1.155 . . . . 5.3499999999999996 114.025 -170.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.18 151.78 36.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.339 -0.85 . . . . 2.8599999999999999 112.361 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 1 C-N-CA 132.769 4.428 . . . . 6.2400000000000002 105.36 -160.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.313 0 N-CA-C 106.024 -2.83 . . . . 11.01 106.024 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.6 p -59.38 166.86 2.1 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 117.971 -1.492 . . . . 10.039999999999999 109.559 133.856 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -63.45 167.03 5.85 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.751 0.82 . . . . 9.4100000000000001 110.039 154.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -156.81 48.38 0.45 Allowed 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.105 -0.997 . . . . 6.4199999999999999 109.752 -177.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.8 91.3 2.41 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.454 -1.684 . . . . 4.0800000000000001 106.454 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.93 164.69 32.38 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 127.159 2.314 . . . . 1.55 111.091 -178.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -157.75 156.3 31.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.125 1.37 . . . . 2.5899999999999999 111.213 177.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.3 t -80.27 158.54 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.441 0.696 . . . . 2.52 109.42 175.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.72 -26.39 44.76 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.805 1.78 . . . . 6.3399999999999999 115.805 -176.144 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 85.0 t80 72.36 115.32 0.05 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.69 2.796 . . . . 3.5299999999999998 111.756 -168.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.1 m -164.24 143.16 5.97 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 126.239 1.815 . . . . 3.27 108.047 169.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.35 -25.77 11.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.828 2.352 . . . . 1.53 112.374 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.4 175.2 16.27 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 126.814 2.15 . . . . 0.80000000000000004 110.189 -172.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.42 -7.71 15.84 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 CA-C-N 119.473 1.637 . . . . 1.0600000000000001 112.747 -5.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -140.44 169.63 17.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.083 0.953 . . . . 2.02 113.393 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.65 -177.62 5.39 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.644 2.378 . . . . 1.8700000000000001 109.966 175.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.59 170.35 14.86 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.76 1.224 . . . . 1.9299999999999999 110.071 169.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.98 144.22 21.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.727 1.211 . . . . 1.8300000000000001 111.254 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.94 152.52 40.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.681 1.992 . . . . 4.4900000000000002 109.315 -178.274 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -165.45 157.44 14.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.954 1.094 . . . . 3.1600000000000001 113.954 -177.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.8 m -84.4 124.15 30.99 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.789 1.635 . . . . 2.4300000000000002 109.928 169.154 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.38 132.17 44.89 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.399 1.479 . . . . 4.3300000000000001 108.988 170.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -123.53 145.03 49.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.691 0.797 . . . . 3.5800000000000001 112.01 177.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.53 72.59 7.63 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.264 -0.88 . . . . 3.2200000000000002 110.47 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.31 -19.84 55.69 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.707 2.271 . . . . 1.3899999999999999 113.607 -178.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.29 169.7 54.86 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-O 123.034 1.352 . . . . 1.3400000000000001 113.01 174.639 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 11.5 m-20 -95.82 -4.33 43.98 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 128.199 2.6 . . . . 3.1499999999999999 112.843 -170.245 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -122.24 160.31 48.33 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.353 2.261 . . . . 5.4000000000000004 108.717 172.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.97 143.25 14.29 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.859 2.373 . . . . 1.53 110.844 -169.073 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.8 mt -94.3 153.49 17.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 122.72 1.247 . . . . 2.8500000000000001 112.435 172.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -136.41 113.12 10.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.131 -1.849 . . . . 2.5299999999999998 110.65 178.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.87 112.02 24.36 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.78 2.032 . . . . 3.04 108.539 -172.326 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.3 m -102.54 -29.07 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.886 0.875 . . . . 1.8799999999999999 113.011 -169.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.07 -174.44 30.94 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.969 1.271 . . . . 0.54000000000000004 113.047 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.76 -178.75 5.15 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.79 0.805 . . . . 1.99 110.924 167.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -139.73 179.39 6.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.667 2.787 . . . . 7.04 107.393 161.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t 176.6 151.19 0.35 Allowed Pre-proline 0 N--CA 1.469 0.484 0 C-N-CA 127.769 2.427 . . . . 1.7 106.796 -170.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.68 -7.74 14.65 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.716 2.277 . . . . 0.87 113.902 174.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.74 31.94 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.725 1.38 . . . . 2.04 114.725 -170.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.92 138.28 13.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.662 1.585 . . . . 1.75 110.977 168.284 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -61.2 -39.94 92.08 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.259 1.023 . . . . 2.8799999999999999 111.498 173.32 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -144.15 143.38 31.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 128.567 2.747 . . . . 6.9800000000000004 106.308 -168.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.07 137.02 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.018 -1.105 . . . . 2.2200000000000002 108.018 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -144.12 138.29 28.1 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.813 1.245 . . . . 2.98 109.638 -171.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -87.06 135.61 33.22 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 123.076 1.417 . . . . 3.29 113.335 173.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -116.89 154.67 30.39 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 127.576 2.35 . . . . 1.1399999999999999 110.914 176.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -103.31 155.93 18.1 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.388 1.875 . . . . 2.9100000000000001 110.453 161.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.432 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 24.6 m -127.73 132.44 49.59 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.007 -1.479 . . . . 2.0699999999999998 107.007 172.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -144.81 176.44 9.45 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.729 1.381 . . . . 3.3700000000000001 114.729 -166.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.6 ttp -113.36 142.47 45.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.823 2.049 . . . . 4.75 111.399 176.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -128.29 163.28 25.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.227 1.811 . . . . 6.9000000000000004 111.753 166.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -94.6 145.32 24.91 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.008 -1.849 . . . . 3.52 106.008 152.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.8 p -153.09 124.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.324 0.65 . . . . 4.46 109.367 164.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.495 ' CD ' ' HZ1' ' A' ' 56' ' ' LYS . 0.7 OUTLIER 64.02 22.03 12.8 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.925 1.69 . . . . 4.54 113.163 -172.655 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.23 11.55 83.35 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 120.547 -1.346 . . . . 2.4300000000000002 113.622 -171.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.495 ' HZ1' ' CD ' ' A' ' 54' ' ' GLU . 8.8 mtmp? -109.57 118.8 37.54 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.55 1.54 . . . . 4.8499999999999996 110.265 177.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.63 127.28 31.21 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.986 1.314 . . . . 4.5300000000000002 109.251 164.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -145.52 176.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 128.294 2.637 . . . . 4.4800000000000004 109.759 -176.116 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -130.5 166.25 20.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.313 1.045 . . . . 4.6600000000000001 112.459 178.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.92 -179.84 31.29 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.395 1.474 . . . . 0.90000000000000002 112.954 177.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -153.91 137.38 15.89 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.006 1.322 . . . . 2.0099999999999998 110.305 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -144.73 156.29 56.06 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.785 1.634 . . . . 11.279999999999999 111.302 -174.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.95 154.71 53.22 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.705 2.27 . . . . 0.68999999999999995 110.488 172.581 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.83 158.39 73.87 Favored Pre-proline 0 N--CA 1.484 1.275 0 CA-C-O 118.299 -0.858 . . . . 1.8700000000000001 111.063 169.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -84.26 -18.78 4.88 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.313 2.675 . . . . 0.91000000000000003 113.969 -170.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -178.09 169.04 1.96 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.284 1.833 . . . . 2.9900000000000002 111.771 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.8 mt -115.27 154.99 28.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.79 2.036 . . . . 1.79 110.089 162.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.84 146.67 42.74 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.196 1.399 . . . . 1.6499999999999999 108.577 173.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.3 t -137.35 138.69 25.61 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.948 -0.548 . . . . 2.0 111.991 169.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -83.72 156.23 13.79 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 124.237 3.291 . . . . 1.29 112.479 178.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.57 140.31 80.73 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.765 2.977 . . . . 1.28 113.668 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.451 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 69.1 mmtt 69.55 -8.34 0.76 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.369 2.668 . . . . 2.1699999999999999 114.345 -177.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.96 149.84 35.03 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.671 1.129 . . . . 1.3200000000000001 112.266 175.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -108.71 132.03 54.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.924 1.689 . . . . 5.4699999999999998 106.88 163.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.8 122.93 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.075 1.35 . . . . 4.3499999999999996 107.916 177.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -101.95 135.56 43.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.87 1.268 . . . . 5.0599999999999996 110.116 -176.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.84 -48.5 66.98 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.877 1.671 . . . . 3.3199999999999998 113.216 -171.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HB2' ' HZ3' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 103.25 118.38 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 131.047 3.739 . . . . 4.1200000000000001 111.307 176.213 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.66 -1.01 6.8 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.513 2.808 . . . . 2.8100000000000001 115.036 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.13 2.31 12.99 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.434 1.492 . . . . 2.4900000000000002 114.774 170.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -132.9 -106.66 1.0 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.355 1.455 . . . . 1.8999999999999999 112.248 -174.521 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -77.47 138.19 39.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.147 0.975 . . . . 3.4900000000000002 111.489 -175.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -160.17 146.01 15.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.827 -0.624 . . . . 0.84999999999999998 111.057 -175.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.8 136.49 38.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.093 -1.077 . . . . 3.1600000000000001 108.093 165.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.7 mtp -99.79 135.66 40.88 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 118.717 0.689 . . . . 3.1899999999999999 110.001 157.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.8 109.03 20.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.691 -1.596 . . . . 2.5 106.691 -179.211 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -102.61 130.9 49.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.88 1.672 . . . . 3.6800000000000002 108.489 -173.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.81 53.51 8.12 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.824 0.726 . . . . 1.73 112.836 174.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.0 mt -48.23 156.54 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 115.938 1.829 . . . . 1.6100000000000001 115.938 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -110.96 -25.73 9.66 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 113.733 -1.576 . . . . 2.3799999999999999 113.973 178.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -124.53 142.07 39.48 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.412 2.285 . . . . 5.8799999999999999 109.068 169.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.27 156.18 55.3 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.7 2.267 . . . . 1.45 109.73 160.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.21 161.77 13.81 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.249 1.02 . . . . 2.8500000000000001 112.025 -169.527 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -132.74 -176.42 4.1 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.952 2.101 . . . . 5.3200000000000003 110.641 175.316 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.5 150.49 24.54 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.259 -1.015 . . . . 2.73 108.259 156.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.39 36.77 43.49 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.429 0.537 . . . . 1.77 114.386 176.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -122.63 -178.03 3.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.609 1.164 . . . . 3.3399999999999999 110.009 161.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -139.56 135.57 33.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.873 2.469 . . . . 3.6299999999999999 105.214 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.3 t -142.85 148.94 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.488 1.915 . . . . 2.6800000000000002 109.898 -171.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.56 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 4.0 pt-20 -100.83 148.67 24.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.165 1.386 . . . . 2.5499999999999998 114.071 -173.588 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mp -127.16 158.91 35.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.189 2.195 . . . . 2.6299999999999999 110.125 167.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -132.14 94.3 3.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.983 1.713 . . . . 2.79 110.762 -172.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.2 mp -78.48 135.93 37.48 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.375 1.07 . . . . 2.5699999999999998 111.264 -168.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.2 mt -106.83 119.5 39.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.069 1.747 . . . . 1.95 110.072 -176.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -118.58 145.44 45.39 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.235 1.414 . . . . 3.25 111.016 -172.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.81 126.35 27.3 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.912 1.079 . . . . 2.25 113.912 -169.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.82 68.47 1.49 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.907 1.241 . . . . 3.5899999999999999 112.502 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 20.44 79.83 Favored Glycine 0 N--CA 1.472 1.099 0 N-CA-C 116.278 1.271 . . . . 1.54 116.278 163.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -112.99 138.59 49.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.552 1.676 . . . . 4.4800000000000004 111.72 -173.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.4 t -139.82 145.87 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.347 1.059 . . . . 3.04 109.675 178.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 tp -145.66 120.38 9.86 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.794 1.237 . . . . 3.1400000000000001 111.23 178.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.56 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 23.0 ttmm -79.01 137.92 37.79 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.529 -0.732 . . . . 3.3700000000000001 111.155 173.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.05 161.58 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.946 2.098 . . . . 4.0199999999999996 110.026 173.599 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.2 t -136.09 136.02 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.377 1.471 . . . . 2.79 109.084 177.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.84 148.29 35.52 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.925 1.69 . . . . 3.54 111.354 -173.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.81 151.97 81.39 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.403 2.735 . . . . 1.01 113.243 175.24 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.0 t -95.32 118.86 42.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.839 -1.073 . . . . 2.5 108.376 172.228 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -147.67 179.99 7.29 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.4 1.48 . . . . 5.5899999999999999 109.302 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.33 136.18 55.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.762 1.393 . . . . 2.3799999999999999 114.762 -168.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 127.872 2.469 . . . . 10.550000000000001 109.809 166.046 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.982 0 N-CA-C 109.078 -1.609 . . . . 10.779999999999999 109.078 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.1 m -88.2 -23.92 23.44 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.635 1.346 . . . . 10.949999999999999 114.635 176.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -134.13 25.52 3.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.159 1.784 . . . . 10.77 112.327 -161.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.94 22.22 7.17 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.523 2.329 . . . . 6.5099999999999998 113.82 -175.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.432 ' C ' ' HB ' ' A' ' 21' ' ' THR . 8.6 pm0 -91.04 146.64 23.68 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.741 2.016 . . . . 5.4000000000000004 114.769 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.8 179.41 53.18 Favored Glycine 0 N--CA 1.47 0.908 0 O-C-N 121.285 -0.884 . . . . 2.73 114.078 173.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -153.01 146.07 24.62 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.999 1.319 . . . . 3.23 112.929 167.333 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.8 t -93.67 146.82 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.268 1.427 . . . . 1.99 107.277 177.232 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.401 ' HG3' ' H ' ' A' ' 10' ' ' PHE 0.33 0.3 OUTLIER -74.88 -106.1 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.419 1.009 . . . . 5.5800000000000001 113.528 176.117 . . . . . . . . 4 4 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.401 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 50.9 t80 -171.19 148.75 2.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.667 1.987 . . . . 3.1800000000000002 110.349 -178.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.8 t -179.6 143.43 0.38 Allowed Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 128.114 2.566 . . . . 2.7000000000000002 109.268 174.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.07 -23.75 10.25 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.843 2.362 . . . . 1.3899999999999999 112.12 169.085 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.81 176.81 14.56 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 126.676 2.084 . . . . 0.83999999999999997 111.573 -171.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.11 -6.37 16.7 Favored 'Cis proline' 0 CA--C 1.537 0.653 0 CA-C-N 118.571 1.185 . . . . 1.02 112.337 -9.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -147.61 148.53 31.2 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.578 1.325 . . . . 2.8599999999999999 114.578 -177.131 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.08 -174.58 2.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.588 2.755 . . . . 1.54 111.313 -179.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.81 164.33 30.52 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.066 1.746 . . . . 1.4199999999999999 108.825 170.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.96 153.16 32.4 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.323 0.965 . . . . 1.76 112.595 -177.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -122.6 87.71 2.8 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.631 1.972 . . . . 4.1100000000000003 110.802 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.6 pp -70.45 158.68 35.6 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 119.41 -2.056 . . . . 3.3799999999999999 113.374 177.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.432 ' HB ' ' C ' ' A' ' 5' ' ' GLU . 20.8 m -135.47 141.27 45.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.459 1.904 . . . . 2.7000000000000002 106.62 167.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.9 tp -162.46 156.27 20.88 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.9 2.48 . . . . 5.7599999999999998 109.556 177.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -102.04 154.35 19.06 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.224 -1.548 . . . . 4.25 113.427 166.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -97.74 92.68 1.4 Allowed Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 121.036 -1.04 . . . . 1.52 109.13 162.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.05 -15.65 18.37 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.566 2.177 . . . . 1.6499999999999999 113.436 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.52 -173.75 47.06 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-O 122.421 1.011 . . . . 1.1399999999999999 112.882 -178.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.452 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 5.4 m-20 -115.66 2.23 13.69 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.16 1.784 . . . . 3.2000000000000002 112.306 -167.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -112.41 155.58 43.49 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.985 2.114 . . . . 4.0199999999999996 111.017 173.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.55 158.83 25.44 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.615 2.21 . . . . 1.01 110.979 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.6 mt -115.52 148.66 39.24 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.198 1.399 . . . . 3.0699999999999998 110.469 174.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -131.61 110.63 11.07 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 112.608 -2.087 . . . . 2.9100000000000001 110.655 171.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -98.12 110.39 22.98 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.959 2.103 . . . . 3.23 108.348 -170.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.78 -21.61 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.303 1.041 . . . . 1.8999999999999999 111.938 -165.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.85 -175.97 33.45 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 125.586 1.565 . . . . 0.44 112.617 -178.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.42 -174.92 4.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.079 1.351 . . . . 1.3600000000000001 111.372 172.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -155.73 154.58 31.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.398 1.479 . . . . 5.2000000000000002 108.11 163.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -167.51 149.33 5.27 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 117.597 -1.192 . . . . 2.1499999999999999 109.215 -176.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.43 -19.1 10.49 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.884 1.723 . . . . 1.1499999999999999 113.207 -174.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -87.13 18.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 113.874 1.064 . . . . 2.8700000000000001 113.874 -178.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.45 175.15 13.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.531 1.933 . . . . 1.79 109.599 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -111.56 -32.24 6.74 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.403 1.481 . . . . 2.73 113.155 177.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -139.59 159.59 41.81 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.014 2.926 . . . . 6.8300000000000001 106.11 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 p -157.05 106.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 125.219 1.408 . . . . 2.27 111.005 -173.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.22 132.74 54.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.663 -1.608 . . . . 5.3899999999999997 111.622 -159.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.0 tp -84.69 124.08 31.09 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.012 -0.995 . . . . 2.0899999999999999 111.994 -163.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -121.39 161.97 21.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.355 1.462 . . . . 0.62 113.088 179.081 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.88 -174.09 2.44 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.477 1.911 . . . . 3.29 110.73 163.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 m -146.03 138.78 25.64 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.056 -1.091 . . . . 1.8700000000000001 108.056 167.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -135.42 173.3 11.87 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 122.984 1.373 . . . . 3.6699999999999999 114.112 -172.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -122.06 142.17 50.62 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.709 2.004 . . . . 6.0899999999999999 111.897 170.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.15 158.84 41.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.627 1.971 . . . . 7.5899999999999999 110.739 172.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -129.01 133.29 47.69 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.955 2.102 . . . . 2.75 106.421 166.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -150.42 9.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.236 1.014 . . . . 4.4100000000000001 113.532 -169.326 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -168.95 18.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.161 0.8 . . . . 4.2599999999999998 113.161 -156.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.28 13.44 58.03 Favored Glycine 0 N--CA 1.478 1.497 0 O-C-N 120.882 -1.136 . . . . 2.04 113.346 -168.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -143.96 145.76 32.47 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.461 2.704 . . . . 3.9500000000000002 107.661 -174.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -105.54 133.61 50.02 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.009 2.124 . . . . 3.6499999999999999 109.331 -171.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -155.15 149.13 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.108 1.363 . . . . 3.4500000000000002 110.488 -171.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -102.42 167.01 10.23 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.546 0.943 . . . . 4.1200000000000001 113.546 -169.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.62 -179.19 30.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.996 1.76 . . . . 0.78000000000000003 112.851 178.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -151.56 141.79 22.32 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.104 1.762 . . . . 1.98 108.082 -177.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -150.73 157.14 36.21 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.198 0.999 . . . . 5.7599999999999998 110.217 -177.48 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.06 158.01 34.13 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.6 2.2 . . . . 0.55000000000000004 111.497 -179.099 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.68 152.75 71.37 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.647 1.179 . . . . 1.6299999999999999 110.154 177.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.7 -24.12 6.41 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.14 2.56 . . . . 0.67000000000000004 113.187 -167.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -178.3 166.72 1.9 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.444 1.898 . . . . 3.3100000000000001 111.15 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 mt -109.91 154.27 23.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.953 1.301 . . . . 1.72 110.091 163.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -114.24 143.06 45.46 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.581 1.152 . . . . 1.8 109.28 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.8 t -144.5 136.19 12.86 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.136 0.791 . . . . 2.0899999999999999 113.136 172.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.24 167.34 26.03 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.648 2.898 . . . . 0.93000000000000005 113.061 177.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.54 145.67 97.62 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.742 2.961 . . . . 1.01 111.632 167.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.452 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 57.4 mmtt 66.94 -3.69 0.9 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.813 1.645 . . . . 2.2400000000000002 113.634 -178.005 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.48 174.73 55.05 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.748 1.642 . . . . 1.23 112.05 171.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 mtt85 -102.64 137.82 40.36 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.426 1.09 . . . . 5.9000000000000004 109.255 175.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.05 104.07 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.535 1.934 . . . . 7.2199999999999998 106.447 176.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.21 130.08 12.47 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.443 1.116 . . . . 3.6800000000000002 112.394 -163.173 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.32 131.13 40.25 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.156 1.382 . . . . 2.52 107.716 166.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.53 149.78 37.4 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.547 1.139 . . . . 4.3700000000000001 112.525 -166.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.26 -38.45 90.88 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.991 3.127 . . . . 2.6099999999999999 112.6 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.34 115.68 4.34 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.714 -1.354 . . . . 2.8700000000000001 109.714 164.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.51 -122.49 5.45 Favored Glycine 0 N--CA 1.467 0.704 0 C-N-CA 126.716 2.103 . . . . 1.55 110.896 176.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -71.34 134.56 46.81 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.709 0.755 . . . . 3.02 112.313 -167.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -157.81 151.86 24.31 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.536 1.134 . . . . 0.72999999999999998 110.893 -177.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -84.47 135.24 34.33 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.064 -1.022 . . . . 3.3999999999999999 108.414 168.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -86.31 127.16 34.75 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 126.207 1.803 . . . . 1.8400000000000001 108.285 162.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.73 112.16 25.12 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.839 1.255 . . . . 2.5 108.387 -175.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.87 135.17 47.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.33 1.052 . . . . 3.6899999999999999 110.57 -169.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.62 48.51 7.91 Favored Glycine 0 N--CA 1.472 1.045 0 O-C-N 121.415 -0.803 . . . . 1.72 113.803 172.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.96 153.11 1.92 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 123.369 1.557 . . . . 1.71 114.768 178.036 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -124.18 -23.49 4.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 112.174 -2.285 . . . . 2.5299999999999998 114.472 -165.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -118.06 145.82 37.77 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 117.927 -1.035 . . . . 7.2199999999999998 108.727 152.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.11 98.08 0.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 106.675 -2.086 . . . . 1.8100000000000001 106.675 164.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.88 164.31 26.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.339 1.056 . . . . 3.7000000000000002 113.211 -169.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -139.4 150.22 45.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.362 1.865 . . . . 6.6100000000000003 113.412 -173.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.01 137.37 56.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 113.879 -1.509 . . . . 2.6899999999999999 108.159 171.03 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.02 -6.2 81.75 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.137 1.351 . . . . 1.5600000000000001 114.601 -173.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -76.61 -176.89 3.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.047 1.424 . . . . 2.6400000000000001 111.707 167.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -135.44 155.55 50.35 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 128.619 2.768 . . . . 3.9500000000000002 107.127 171.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.6 t -147.85 156.08 9.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 129.538 3.135 . . . . 2.1400000000000001 107.667 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -117.81 154.16 32.26 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.62 -0.675 . . . . 2.2799999999999998 111.26 167.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 tt -145.71 132.65 20.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.764 0.793 . . . . 4.04 111.327 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -77.14 134.21 38.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 129.152 2.981 . . . . 2.1800000000000002 109.332 166.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -97.58 127.61 43.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.183 0.993 . . . . 2.4100000000000001 108.763 162.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.21 115.75 30.6 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.01 0.924 . . . . 1.73 109.337 175.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -111.2 151.86 27.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.579 1.552 . . . . 3.4199999999999999 111.414 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.59 151.74 32.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.126 0.571 . . . . 2.3300000000000001 111.448 170.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.58 23.33 47.31 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 119.003 -0.887 . . . . 3.8700000000000001 114.364 -177.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.52 35.49 46.85 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.246 0.927 . . . . 1.54 113.376 173.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -120.6 122.08 39.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 117.871 0.836 . . . . 4.1299999999999999 111.582 -167.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.23 142.86 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.801 1.64 . . . . 3.1800000000000002 109.96 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.92 113.91 5.45 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.759 0.824 . . . . 3.0699999999999998 110.829 -177.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -94.75 121.0 35.88 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.647 0.779 . . . . 2.79 112.397 -176.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.4 t -109.39 163.34 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.653 1.981 . . . . 2.8900000000000001 109.888 178.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.7 t -119.3 140.78 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.552 1.941 . . . . 3.2799999999999998 109.616 178.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.24 142.65 13.21 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.867 1.267 . . . . 3.4900000000000002 114.047 -165.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.32 163.84 36.77 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.438 2.759 . . . . 1.03 112.582 172.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.26 131.18 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.996 1.318 . . . . 1.8999999999999999 109.107 165.398 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.32 126.95 7.4 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.874 2.07 . . . . 3.48 108.69 179.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.67 57.53 1.64 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.552 2.056 . . . . 3.0099999999999998 116.552 -154.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.299 0 C-N-CA 124.909 1.283 . . . . 10.24 113.958 -172.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 N-CA-C 104.973 -3.251 . . . . 10.81 104.973 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -161.42 166.95 26.54 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.339 -0.615 . . . . 8.75 109.339 -143.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -166.43 18.12 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.307 2.243 . . . . 11.57 111.506 -170.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.1 t -175.32 61.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.018 2.127 . . . . 6.6100000000000003 110.233 -159.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -80.17 58.83 3.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.342 1.457 . . . . 4.6100000000000003 111.163 -172.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.08 163.48 30.16 Favored Glycine 0 C--N 1.333 0.402 0 O-C-N 121.406 -0.809 . . . . 1.53 111.207 170.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.0 p90 -140.4 177.91 7.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.737 0.643 . . . . 2.8599999999999999 112.737 178.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.9 t -111.72 143.75 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.707 1.203 . . . . 2.2599999999999998 111.301 -178.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -27.06 64.38 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 129.328 3.051 . . . . 9.0500000000000007 116.445 -173.367 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.5 t80 66.73 129.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.611 2.765 . . . . 3.2599999999999998 113.634 -168.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -174.34 146.64 1.12 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.185 1.794 . . . . 2.5099999999999998 110.896 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.13 -20.21 11.57 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.961 2.441 . . . . 1.52 112.73 168.202 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.28 -174.49 19.23 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.781 1.658 . . . . 0.93999999999999995 111.663 -172.741 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.74 -10.64 9.77 Favored 'Cis proline' 0 CA--C 1.537 0.674 0 CA-C-N 119.133 1.467 . . . . 1.24 112.493 -8.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -132.25 157.74 43.59 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 123.295 1.521 . . . . 2.4900000000000002 114.879 173.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.05 -176.39 4.05 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.448 2.699 . . . . 1.55 109.781 171.391 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.9 152.58 36.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.153 1.781 . . . . 1.7 107.617 176.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.01 140.1 41.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.32 0.964 . . . . 1.5600000000000001 111.322 -177.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -114.18 34.22 4.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.51 1.524 . . . . 3.9500000000000002 112.763 -165.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 tt -48.43 143.82 4.56 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.737 2.015 . . . . 3.6899999999999999 112.862 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 15.1 t -82.74 149.75 27.09 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.457 0.91 . . . . 3.48 113.457 170.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.83 116.47 27.51 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.77 0.828 . . . . 4.5700000000000003 110.278 170.15 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -121.71 142.69 49.91 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.288 1.435 . . . . 4.5199999999999996 109.53 171.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -106.38 101.4 35.1 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.595 1.158 . . . . 1.5600000000000001 109.875 175.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.03 -10.95 15.13 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.951 2.434 . . . . 1.3700000000000001 113.597 175.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.23 -177.61 50.75 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-O 122.502 1.057 . . . . 1.1100000000000001 112.86 -176.778 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -108.81 -1.71 19.05 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.383 2.273 . . . . 2.9100000000000001 111.774 -173.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.6 160.85 42.49 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 128.502 2.721 . . . . 3.6200000000000001 109.67 173.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.63 146.69 21.54 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.674 2.249 . . . . 1.01 111.525 -175.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mp -107.77 150.09 27.41 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.78 1.232 . . . . 3.52 110.383 174.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -135.91 108.15 7.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.436 -2.165 . . . . 4.3099999999999996 110.257 178.5 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 tt -86.44 124.11 32.4 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.011 0.925 . . . . 3.2200000000000002 109.013 176.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.3 -23.61 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.53 0.732 . . . . 2.1600000000000001 111.531 -179.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.85 -173.16 27.99 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 124.73 1.157 . . . . 0.48999999999999999 114.299 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.93 -179.07 5.39 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.925 1.29 . . . . 1.8 111.216 165.466 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -139.16 160.38 39.94 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.658 1.983 . . . . 6.7000000000000002 107.252 155.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -161.0 149.26 12.85 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 125.651 1.58 . . . . 1.6499999999999999 108.248 -178.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.02 -2.25 12.37 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.129 1.886 . . . . 1.1100000000000001 114.25 -177.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.99 31.38 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.336 1.454 . . . . 1.8600000000000001 114.524 -170.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.39 159.51 44.41 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.835 1.654 . . . . 1.8999999999999999 110.419 165.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -83.4 -57.37 3.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.76 1.624 . . . . 2.77 110.094 169.371 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -106.68 130.47 54.41 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.47 1.508 . . . . 6.4400000000000004 107.351 166.558 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.78 144.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.137 -0.69 . . . . 2.0 109.137 152.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -138.6 152.49 48.19 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.966 1.707 . . . . 2.75 109.374 -173.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.2 tp -108.6 117.61 34.63 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.498 0.719 . . . . 2.1800000000000002 110.916 -173.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -121.73 152.76 39.06 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.569 1.548 . . . . 0.54000000000000004 113.283 -176.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -96.7 167.87 10.85 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.842 1.257 . . . . 2.1899999999999999 111.476 159.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.9 m -129.42 138.95 51.76 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.284 1.834 . . . . 1.8700000000000001 107.096 170.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -140.69 171.27 14.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.403 1.096 . . . . 3.29 113.649 -173.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -115.31 142.51 46.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.543 1.937 . . . . 6.6200000000000001 111.407 173.445 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -137.59 139.45 40.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.155 0.982 . . . . 6.75 111.658 169.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -91.11 139.07 31.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.886 1.275 . . . . 2.9199999999999999 107.788 161.018 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.9 t -141.76 128.56 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 106.033 -1.839 . . . . 3.4399999999999999 106.033 168.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 58.68 24.42 12.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.11 1.364 . . . . 5.6699999999999999 114.408 -176.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.56 29.15 73.73 Favored Glycine 0 N--CA 1.472 1.095 0 O-C-N 120.488 -1.382 . . . . 1.98 112.453 -170.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mmtm -121.4 120.62 35.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.009 2.124 . . . . 5.7999999999999998 108.427 169.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 126.47 40.97 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.119 1.367 . . . . 3.5099999999999998 112.12 -176.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.3 t -144.33 144.98 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.976 2.11 . . . . 3.4700000000000002 108.277 -171.196 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 73.4 mtm -90.63 172.9 8.35 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.361 0.874 . . . . 4.1900000000000004 113.361 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.4 30.99 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.748 1.166 . . . . 1.1299999999999999 111.783 166.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.07 162.32 35.23 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.484 0.713 . . . . 4.4500000000000002 110.771 161.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -157.19 154.47 26.04 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.871 1.268 . . . . 5.4199999999999999 110.062 -177.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.86 154.65 43.34 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.134 1.89 . . . . 0.62 112.001 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.0 155.05 74.74 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.669 1.588 . . . . 1.8500000000000001 110.182 179.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.78 -26.34 2.53 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.096 2.531 . . . . 0.65000000000000002 113.333 -167.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -176.42 166.73 2.77 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.989 1.716 . . . . 3.71 111.231 -177.315 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.6 mt -114.63 151.76 33.0 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.002 1.721 . . . . 2.1600000000000001 110.517 166.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -120.79 138.94 53.77 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.767 1.227 . . . . 1.8100000000000001 109.024 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -140.81 126.67 11.41 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.192 0.442 . . . . 2.1899999999999999 112.192 170.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.53 161.71 41.65 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.392 3.394 . . . . 1.3200000000000001 111.958 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -59.9 140.37 92.65 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.673 2.916 . . . . 0.94999999999999996 113.051 -175.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 68.65 -3.02 1.49 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.179 2.192 . . . . 2.3799999999999999 114.484 178.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.4 169.15 28.74 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.565 1.555 . . . . 1.21 113.183 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -143.47 158.64 43.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.853 0.861 . . . . 6.0599999999999996 112.536 172.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.1 t -156.14 113.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 127.642 2.377 . . . . 4.6900000000000004 108.475 174.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -77.34 151.33 34.98 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.03 0.832 . . . . 3.5600000000000001 111.813 -179.693 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.4 65.21 1.21 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.53 1.157 . . . . 2.3500000000000001 109.414 162.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -58.52 145.89 74.84 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.55 1.14 . . . . 5.1699999999999999 113.201 -174.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.85 81.39 0.84 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.342 2.695 . . . . 2.73 109.391 169.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.64 34.0 0.1 OUTLIER Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.372 0.987 . . . . 2.3999999999999999 113.495 -162.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.04 -25.75 0.24 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 117.418 1.727 . . . . 2.4199999999999999 117.418 160.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -145.48 146.91 31.66 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.742 1.271 . . . . 3.0899999999999999 111.196 169.087 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -159.48 154.61 25.12 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.992 0.917 . . . . 0.60999999999999999 110.005 174.407 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -77.67 141.31 39.47 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.39 -0.967 . . . . 3.0299999999999998 108.39 159.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -94.25 131.96 39.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.218 1.407 . . . . 1.8600000000000001 108.354 164.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -109.2 109.92 21.0 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.012 -1.107 . . . . 2.3999999999999999 108.012 178.459 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.71 134.07 51.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.182 1.393 . . . . 3.3100000000000001 109.489 -175.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.18 53.49 14.0 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.854 -0.529 . . . . 1.6499999999999999 112.48 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.4 mt -44.66 155.41 0.1 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.088 1.755 . . . . 1.6699999999999999 115.067 178.132 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -108.6 -32.99 7.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 113.281 -1.782 . . . . 2.3399999999999999 112.847 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -120.99 137.57 26.75 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.55 1.54 . . . . 7.79 108.634 163.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -66.88 130.95 24.29 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 N-CA-C 106.654 -2.094 . . . . 1.4099999999999999 106.654 160.028 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.16 171.61 14.21 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.245 0.545 . . . . 2.8100000000000001 111.166 -174.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -116.83 157.91 24.83 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.267 -0.895 . . . . 4.8099999999999996 109.827 150.547 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.45 123.61 21.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.001 -1.481 . . . . 2.4500000000000002 107.001 159.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.76 53.96 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.166 -1.352 . . . . 2.0299999999999998 115.813 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -81.91 -174.39 5.02 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.816 1.808 . . . . 3.0099999999999998 111.12 165.001 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.29 135.7 48.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.829 2.452 . . . . 3.6800000000000002 106.284 166.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -119.24 144.78 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.829 2.052 . . . . 2.6699999999999999 109.439 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.485 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 13.3 mt-10 -89.15 134.16 34.13 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.051 0.54 . . . . 2.6200000000000001 110.493 171.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp -116.51 132.4 56.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.301 1.048 . . . . 2.8700000000000001 110.14 154.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -83.32 145.08 29.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.446 1.899 . . . . 2.1000000000000001 109.109 158.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.3 123.29 46.17 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.399 1.48 . . . . 2.73 109.943 -175.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.53 115.13 29.95 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.493 1.117 . . . . 3.6099999999999999 109.816 -176.168 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -112.66 145.89 39.64 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.263 1.425 . . . . 3.3700000000000001 111.76 -177.023 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.22 151.81 39.37 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.583 0.753 . . . . 2.4100000000000001 112.253 176.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.59 33.63 37.88 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.031 -0.872 . . . . 4.3399999999999999 113.56 177.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.66 47.49 15.24 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 124.618 1.104 . . . . 2.0699999999999998 113.852 171.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -133.88 131.82 39.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.195 0.998 . . . . 4.29 111.755 -171.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.1 t -140.87 150.56 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.594 1.158 . . . . 3.5 109.121 178.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.4 tp -149.57 170.97 17.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.601 2.36 . . . . 3.27 108.551 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.485 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 45.7 pttt -145.53 156.72 43.88 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.779 1.172 . . . . 3.0 113.072 162.845 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.1 160.98 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.309 1.443 . . . . 3.2799999999999998 109.351 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.9 t -112.44 136.66 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.614 1.566 . . . . 2.8900000000000001 108.788 -179.378 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.61 142.44 41.0 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.63 1.572 . . . . 3.2200000000000002 110.145 -175.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.0 154.42 73.47 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.737 2.291 . . . . 1.3 112.143 175.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.4 t -93.47 139.49 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.704 -1.221 . . . . 2.1699999999999999 107.704 157.286 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -123.68 -179.71 4.47 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.008 1.323 . . . . 4.29 109.937 174.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.37 174.48 7.55 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.152 0.981 . . . . 3.3700000000000001 112.445 177.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 126.882 2.073 . . . . 11.890000000000001 109.75 166.956 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.546 ' H3 ' ' CD ' ' A' ' 98' ' ' GLU . . . . . . . . 0 N--CA 1.471 0.985 0 N-CA-C 110.194 -1.163 . . . . 14.42 110.194 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.0 p -176.91 -152.43 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.677 1.991 . . . . 11.220000000000001 108.618 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -79.15 -11.47 59.98 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.521 1.129 . . . . 12.359999999999999 113.331 168.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.9 p -73.88 111.34 8.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.491 1.041 . . . . 6.0800000000000001 111.675 -162.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -78.49 65.7 3.85 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.616 1.566 . . . . 5.1200000000000001 111.138 -169.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.06 172.33 23.21 Favored Glycine 0 N--CA 1.471 0.998 0 O-C-N 120.47 -1.394 . . . . 1.3100000000000001 115.546 -176.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -154.24 -179.34 7.83 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.33 1.452 . . . . 3.3999999999999999 112.475 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 t -121.24 144.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.226 1.011 . . . . 2.3399999999999999 109.986 168.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -26.27 62.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.794 2.038 . . . . 7.2599999999999998 115.641 -175.389 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 73.2 t80 90.64 146.99 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 129.875 3.27 . . . . 4.46 111.994 -168.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.8 m -176.77 144.79 0.63 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 130.159 3.383 . . . . 3.23 108.793 160.706 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.51 -36.32 0.93 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.678 2.252 . . . . 1.49 111.917 177.717 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.06 169.91 27.18 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.577 1.084 . . . . 0.90000000000000002 111.949 -179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.7 -4.42 19.6 Favored 'Cis proline' 0 CA--C 1.539 0.748 0 CA-C-N 118.797 1.299 . . . . 1.3 112.767 -5.126 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.1 153.72 34.49 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.99 1.107 . . . . 3.1600000000000001 113.99 -172.287 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.91 -178.99 3.88 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.524 1.93 . . . . 1.8799999999999999 111.837 174.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.25 140.78 48.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.794 1.237 . . . . 1.52 108.872 167.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.15 143.08 46.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.319 1.448 . . . . 1.6200000000000001 110.458 -178.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -131.11 105.66 7.85 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.866 2.066 . . . . 4.1799999999999997 108.994 -170.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.59 162.27 37.05 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.788 1.033 . . . . 3.4500000000000002 113.788 -168.366 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.4 ' CG2' ' HD2' ' A' ' 74' ' ' ARG . 2.9 m -79.86 155.6 27.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.031 -1.441 . . . . 2.3999999999999999 112.125 177.853 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.21 116.79 18.91 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 113.312 -1.767 . . . . 4.3899999999999997 109.447 170.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.8 mp0 -101.26 133.85 45.21 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.666 1.986 . . . . 5.1600000000000001 110.923 175.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.27 76.67 1.09 Allowed Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 120.545 -1.347 . . . . 3.04 110.888 176.0 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.64 -19.3 42.11 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.667 2.245 . . . . 1.3700000000000001 114.288 -176.277 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.43 176.6 54.2 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 122.733 1.185 . . . . 1.1599999999999999 112.956 176.403 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.419 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 5.0 m-20 -100.52 -3.37 30.86 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.688 2.395 . . . . 2.8900000000000001 112.176 -170.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mp -126.01 160.35 57.39 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 128.122 2.569 . . . . 4.71 108.534 174.401 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.55 139.51 11.39 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.462 2.108 . . . . 1.22 111.455 -167.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.22 146.91 23.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 123.212 1.482 . . . . 3.3700000000000001 110.314 169.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.4 ttp-105 -134.53 102.78 5.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.536 -1.665 . . . . 4.5999999999999996 110.221 -176.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 52.7 tp -84.04 103.87 13.64 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.302 1.841 . . . . 3.6099999999999999 110.249 -174.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 m -97.35 -24.46 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.611 0.764 . . . . 1.72 112.565 -174.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.64 -174.42 29.37 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.839 1.209 . . . . 0.46999999999999997 113.052 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.69 -176.73 4.99 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.898 1.679 . . . . 1.8899999999999999 111.101 171.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -155.87 166.33 33.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 130.353 3.461 . . . . 5.4000000000000004 107.261 174.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t 179.75 153.19 0.6 Allowed Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 127.921 2.488 . . . . 1.76 108.279 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.84 -27.69 10.13 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 CA-C-N 121.263 1.487 . . . . 0.87 113.014 176.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.72 22.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.193 1.553 . . . . 1.9399999999999999 115.193 -170.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.18 162.16 34.97 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.206 1.803 . . . . 1.76 108.075 164.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -77.32 -56.0 4.93 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.033 1.333 . . . . 4.2699999999999996 109.996 168.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -133.76 177.61 7.58 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.872 2.069 . . . . 6.7300000000000004 109.337 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.9 p -153.36 147.14 14.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.354 1.462 . . . . 1.9099999999999999 109.079 -174.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -133.17 147.74 52.06 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.783 1.633 . . . . 2.6699999999999999 110.381 -179.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.7 tp -96.76 121.06 38.2 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.322 0.649 . . . . 2.2400000000000002 110.702 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -122.76 157.93 31.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 123.148 1.452 . . . . 0.67000000000000004 113.118 -175.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.32 154.37 21.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.873 -1.512 . . . . 2.0299999999999998 110.055 158.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -114.78 135.87 53.71 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.831 -1.915 . . . . 3.04 105.831 159.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -126.12 165.46 18.82 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.41 1.084 . . . . 3.3199999999999998 112.398 -177.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.7 ttp -105.05 144.85 31.29 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.685 1.594 . . . . 3.9399999999999999 109.614 168.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.26 150.48 30.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.195 0.998 . . . . 6.9199999999999999 111.698 -175.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -95.42 142.83 27.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.786 1.634 . . . . 2.8399999999999999 110.131 169.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 t -116.0 -110.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.053 1.341 . . . . 3.6499999999999999 107.781 170.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.59 44.94 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 131.319 3.848 . . . . 4.3200000000000003 112.851 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.34 17.62 62.02 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 120.16 -1.587 . . . . 1.6399999999999999 112.746 -166.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -133.18 134.82 44.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.707 2.403 . . . . 3.2400000000000002 107.605 -168.337 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -91.53 132.41 36.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.47 1.908 . . . . 3.5299999999999998 110.819 -167.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -143.5 143.95 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.334 1.854 . . . . 3.1600000000000001 108.282 -176.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.4 mtm -88.49 165.42 14.89 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.633 0.605 . . . . 4.1299999999999999 112.633 173.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.76 -179.51 23.83 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.725 1.155 . . . . 0.89000000000000001 112.29 174.498 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.2 ttm -147.68 147.14 29.65 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.166 1.387 . . . . 2.2599999999999998 109.032 175.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -155.81 154.07 27.16 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.265 1.026 . . . . 5.4100000000000001 110.394 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.4 156.2 50.41 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.172 1.915 . . . . 0.64000000000000001 110.834 173.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.08 155.0 76.33 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.389 1.476 . . . . 1.77 110.19 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.47 -23.79 3.97 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.781 2.32 . . . . 0.5 113.468 -166.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -178.38 165.96 1.82 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.611 1.964 . . . . 2.8999999999999999 111.219 179.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 mt -110.13 159.1 17.64 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.863 1.265 . . . . 1.9199999999999999 109.785 157.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -127.09 152.62 47.05 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.949 0.9 . . . . 1.8999999999999999 110.12 169.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.4 t -136.7 141.65 36.07 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 123.894 0.877 . . . . 2.23 110.784 172.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.39 155.9 14.35 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.992 3.128 . . . . 1.1100000000000001 112.685 178.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.58 140.07 84.86 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.21 3.274 . . . . 0.98999999999999999 114.438 -174.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.419 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 68.0 mmtt 69.14 -8.53 0.68 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.719 2.408 . . . . 2.27 113.792 -176.518 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.18 166.76 52.93 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.126 1.346 . . . . 1.21 112.636 174.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.4 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 11.8 ttp-105 -136.29 136.26 39.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.172 2.189 . . . . 5.5800000000000001 106.994 172.065 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.6 t -149.65 139.27 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.231 1.412 . . . . 4.9000000000000004 108.782 177.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.463 ' CD ' ' HZ2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -103.32 149.48 24.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.325 1.059 . . . . 3.6000000000000001 113.383 179.89 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -59.78 108.02 0.69 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.197 -1.409 . . . . 1.95 107.197 158.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.463 ' HZ2' ' CD ' ' A' ' 76' ' ' GLU . 0.0 OUTLIER -60.04 139.38 90.92 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.902 -1.523 . . . . 3.2400000000000002 112.647 -160.783 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.51 -28.94 17.31 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.734 3.623 . . . . 3.5 115.791 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.59 4.11 13.35 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 117.559 -1.69 . . . . 2.8300000000000001 116.198 173.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.75 -98.58 1.42 Allowed Glycine 0 N--CA 1.472 1.057 0 CA-C-N 120.874 2.337 . . . . 1.8500000000000001 113.0 -176.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -71.86 140.87 49.53 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.158 -1.201 . . . . 3.5600000000000001 111.28 -176.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -161.57 153.71 19.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.624 1.17 . . . . 0.71999999999999997 111.076 -174.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -88.01 129.78 35.16 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.556 -0.715 . . . . 2.96 109.305 166.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -82.83 119.52 24.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.836 1.654 . . . . 2.0 109.407 165.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -102.02 110.9 22.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.785 1.234 . . . . 2.3900000000000001 109.296 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -104.24 139.87 38.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.071 1.348 . . . . 3.6699999999999999 111.079 -168.103 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.39 45.77 45.31 Favored Glycine 0 N--CA 1.473 1.156 0 O-C-N 121.328 -0.858 . . . . 1.8500000000000001 112.83 174.581 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.2 mt -47.8 155.19 0.43 Allowed 'General case' 0 CA--C 1.523 -0.09 0 CA-C-O 123.563 1.649 . . . . 2.1099999999999999 115.28 -177.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -116.09 -29.69 6.22 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 112.862 -1.972 . . . . 4.1900000000000004 112.55 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.8 mmt-85 -105.03 134.73 19.49 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.681 2.392 . . . . 5.29 109.509 163.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.17 74.84 3.45 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 N-CA-C 106.572 -2.126 . . . . 1.8999999999999999 106.572 147.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -63.5 127.34 30.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.887 0.851 . . . . 3.1000000000000001 112.717 -159.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -84.96 138.79 32.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.762 1.267 . . . . 7.0099999999999998 112.185 -170.273 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.64 118.91 5.74 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.928 -1.487 . . . . 1.98 108.194 167.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.16 -9.99 39.63 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 117.788 -1.562 . . . . 1.95 115.572 -169.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -78.59 173.27 12.59 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.13 1.965 . . . . 3.02 110.653 161.18 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.546 ' CD ' ' H3 ' ' A' ' 1' ' ' GLY . 13.1 pt-20 -138.47 144.1 39.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.032 -1.84 . . . . 3.6400000000000001 106.032 160.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.0 148.69 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.824 1.249 . . . . 3.1699999999999999 109.411 -171.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.88 149.44 21.54 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 123.401 1.572 . . . . 3.3300000000000001 114.578 -170.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.56 151.75 39.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.72 -1.582 . . . . 2.6299999999999999 110.083 170.671 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -118.02 103.51 9.98 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.78 2.432 . . . . 2.8599999999999999 109.483 174.419 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.7 mp -83.6 134.96 34.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.679 1.192 . . . . 2.2400000000000002 110.786 -172.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.98 110.56 23.0 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 122.341 1.067 . . . . 2.0699999999999998 110.406 -174.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -103.77 123.72 47.59 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.847 1.659 . . . . 3.27 111.309 -176.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 46.57 35.82 3.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.934 2.094 . . . . 2.4900000000000002 112.892 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.44 -102.54 2.73 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.989 1.281 . . . . 5.6200000000000001 111.05 -169.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.24 -6.76 83.96 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 117.026 1.57 . . . . 2.8599999999999999 117.026 -160.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -80.97 102.52 10.2 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.138 2.469 . . . . 4.0300000000000002 110.848 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.1 p -87.08 142.32 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 124.253 0.97 . . . . 3.3700000000000001 112.242 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.14 125.57 19.0 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.822 0.849 . . . . 3.7599999999999998 112.134 173.097 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.42 117.27 21.72 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.243 1.017 . . . . 3.7000000000000002 111.472 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.13 166.76 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 126.31 1.844 . . . . 3.8999999999999999 110.66 169.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -144.6 117.76 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 119.171 0.896 . . . . 3.5299999999999998 110.51 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -124.06 142.18 39.08 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.219 1.008 . . . . 4.2000000000000002 112.374 -172.116 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -70.04 151.35 67.44 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.316 3.344 . . . . 0.96999999999999997 113.398 169.268 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.8 t -84.59 128.94 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.51 -0.768 . . . . 2.1800000000000002 109.702 168.676 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.24 169.38 9.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.118 2.167 . . . . 3.8700000000000001 107.88 172.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.16 53.68 0.81 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.419 -0.8 . . . . 2.25 110.167 174.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.0 ttt-85 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 117.22 -1.371 . . . . 7.5999999999999996 114.348 -155.306 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.237 0 N-CA-C 108.591 -1.804 . . . . 13.039999999999999 108.591 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 p 172.11 -174.8 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.026 1.73 . . . . 11.59 107.79 -159.143 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -68.34 169.47 10.54 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.727 0.694 . . . . 15.31 109.835 151.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.9 t 149.09 -5.44 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 129.601 3.16 . . . . 8.0800000000000001 112.762 -164.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.11 -179.94 6.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.047 1.339 . . . . 7.2000000000000002 108.958 175.42 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.99 177.15 39.75 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 122.296 0.942 . . . . 1.3500000000000001 113.093 -177.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -157.23 155.12 30.3 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.492 0.717 . . . . 8.6699999999999999 111.1 168.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.0 t -128.96 137.02 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 106.68 -1.6 . . . . 2.6800000000000002 106.68 163.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.407 HH21 ' C ' ' A' ' 120' ' ' ARG . 25.5 mmm-85 -75.56 -62.4 1.59 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.484 0.584 . . . . 7.0099999999999998 110.362 -176.519 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -171.99 150.22 2.52 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.374 1.07 . . . . 4.1100000000000003 110.982 178.175 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 m -135.86 112.75 10.62 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.878 0.871 . . . . 5.3300000000000001 112.37 -178.234 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -82.92 -34.66 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.896 2.398 . . . . 2.98 112.115 170.066 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.12 151.62 27.99 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 110.904 -0.878 . . . . 1.54 110.904 -158.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.94 0.65 32.86 Favored 'Cis proline' 0 CA--C 1.539 0.742 0 CA-C-N 119.636 1.718 . . . . 1.6100000000000001 113.297 1.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -144.75 172.58 12.81 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.514 1.302 . . . . 2.0299999999999998 114.514 -177.06 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.02 -175.65 5.4 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 129.786 3.234 . . . . 1.6399999999999999 112.335 -176.277 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.68 136.97 23.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.897 2.079 . . . . 1.99 108.72 174.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.89 144.15 50.48 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.841 1.657 . . . . 1.73 112.543 -174.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.416 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 73.1 m-85 -126.97 59.34 1.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.668 1.987 . . . . 3.8799999999999999 111.999 -163.158 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -73.18 152.04 41.26 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.963 1.468 . . . . 2.6899999999999999 114.963 -173.404 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 m -84.97 144.16 28.5 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 121.34 -0.85 . . . . 2.7999999999999998 110.443 161.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.2 129.63 25.66 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.281 1.832 . . . . 5.0 111.318 -170.451 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -127.46 143.71 51.16 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.631 1.172 . . . . 3.8599999999999999 111.356 -176.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -105.73 95.22 10.05 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.815 0.846 . . . . 1.77 108.917 160.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.04 -4.99 15.85 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.097 2.532 . . . . 1.49 113.873 175.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.94 174.39 47.73 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 122.805 1.225 . . . . 1.27 113.099 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' CG ' ' HZ2' ' A' ' 72' ' ' LYS . 15.4 m-20 -99.85 -1.86 36.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.246 2.618 . . . . 3.4100000000000001 111.887 -174.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -122.21 157.95 56.89 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 128.473 2.709 . . . . 4.0700000000000003 110.021 176.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.33 143.44 22.16 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.587 2.191 . . . . 1.6799999999999999 111.302 -173.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.61 156.13 22.28 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.7 1.6 . . . . 4.2000000000000002 109.839 173.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.1 ttp-105 -140.57 104.91 4.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.518 1.527 . . . . 4.1500000000000004 109.178 -177.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.8 113.72 21.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.453 1.501 . . . . 3.4900000000000002 108.144 -176.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 m -103.88 -27.03 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.674 0.789 . . . . 1.9299999999999999 112.361 -174.233 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.25 -177.78 31.66 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 124.55 1.072 . . . . 0.40999999999999998 113.555 177.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.68 -174.72 3.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.947 1.299 . . . . 1.8799999999999999 109.642 168.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -155.59 168.75 26.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 128.029 2.532 . . . . 6.2800000000000002 106.82 173.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -173.51 151.08 1.89 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 125.504 1.522 . . . . 1.8700000000000001 108.431 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.72 -10.51 21.73 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.869 1.713 . . . . 1.21 113.832 176.432 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.13 18.94 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.96 1.467 . . . . 2.3900000000000001 114.96 -170.734 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.83 128.44 7.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.396 1.479 . . . . 1.71 111.683 172.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.69 -36.64 81.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.667 1.587 . . . . 3.4500000000000002 114.09 -176.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -140.66 88.02 2.16 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.515 1.526 . . . . 7.5800000000000001 108.683 -167.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 p -82.48 138.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.251 -0.886 . . . . 1.71 110.905 169.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -124.06 152.43 42.67 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.203 2.201 . . . . 2.5499999999999998 110.026 177.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.7 tp -106.04 119.07 38.26 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.29 1.036 . . . . 1.8200000000000001 110.621 177.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -122.97 155.28 37.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.014 1.726 . . . . 0.57999999999999996 113.592 -175.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -100.89 159.88 14.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.876 -1.511 . . . . 2.3199999999999998 110.949 156.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.0 m -117.2 134.7 54.47 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 104.99 -2.226 . . . . 1.8300000000000001 104.99 158.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -122.42 166.98 13.87 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.944 1.298 . . . . 3.3799999999999999 112.637 -174.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.7 ptm -91.1 149.56 21.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.464 0.706 . . . . 5.04 111.707 169.193 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.29 151.04 27.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.596 1.158 . . . . 7.8399999999999999 112.929 -177.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.447 ' CD ' ' HZ2' ' A' ' 57' ' ' LYS . 2.2 tp10 -109.19 139.85 43.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.906 1.682 . . . . 2.4100000000000001 106.474 161.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.6 m -138.17 126.67 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.168 -1.049 . . . . 4.3200000000000003 108.168 166.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.68 19.29 10.37 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.804 1.242 . . . . 4.2300000000000004 114.209 -178.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.96 14.74 76.69 Favored Glycine 0 N--CA 1.478 1.448 0 O-C-N 120.609 -1.307 . . . . 1.79 113.914 -170.477 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -112.24 118.62 35.8 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.796 2.438 . . . . 4.04 108.575 -179.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.447 ' HZ2' ' CD ' ' A' ' 52' ' ' GLU . 0.9 OUTLIER -78.91 131.89 36.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.277 1.831 . . . . 3.4700000000000002 109.925 -176.863 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.3 p -155.83 175.72 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.497 1.519 . . . . 4.79 111.132 -173.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.7 mtm -108.69 163.97 12.79 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.332 1.053 . . . . 4.6900000000000004 112.021 164.194 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.1 -176.65 17.35 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.422 1.487 . . . . 1.0800000000000001 111.624 169.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.0 ttm -146.35 152.59 39.35 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.115 1.366 . . . . 1.8600000000000001 109.992 -173.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -162.18 156.17 18.34 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 124.796 1.238 . . . . 5.6200000000000001 111.328 173.876 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.09 153.68 57.34 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.331 2.021 . . . . 0.56000000000000005 111.423 171.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.86 154.82 73.15 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 125.777 1.631 . . . . 1.9199999999999999 109.902 -177.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.61 -25.73 3.54 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.434 2.089 . . . . 0.54000000000000004 113.178 -165.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -179.38 165.24 1.4 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.045 1.738 . . . . 2.9399999999999999 111.797 -177.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.5 mt -111.7 153.41 26.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.958 1.703 . . . . 1.99 109.651 163.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -107.1 149.38 27.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.175 0.99 . . . . 2.1200000000000001 108.934 175.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.48 121.28 9.93 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 118.253 0.479 . . . . 2.4700000000000002 111.273 164.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -67.49 164.66 30.04 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.966 2.444 . . . . 1.3799999999999999 110.58 175.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -58.4 138.79 87.72 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.594 2.196 . . . . 1.3600000000000001 112.04 177.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.416 ' HZ2' ' CG ' ' A' ' 27' ' ' ASP . 68.3 mmtt 65.25 5.75 3.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.496 1.918 . . . . 2.9399999999999999 113.675 -175.249 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.07 163.98 49.63 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.341 1.924 . . . . 1.8200000000000001 114.473 -174.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -127.75 142.23 51.37 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.51 2.324 . . . . 6.6100000000000003 109.877 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.3 t -143.27 135.7 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 107.166 -1.42 . . . . 4.0099999999999998 107.166 163.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -129.11 117.97 21.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.574 -0.899 . . . . 4.5999999999999996 108.574 -175.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -76.48 78.5 3.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.085 1.354 . . . . 2.3500000000000001 110.602 -168.431 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -66.96 151.01 97.54 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.083 1.353 . . . . 4.5099999999999998 114.058 -174.306 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.416 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 56.2 Cg_endo -64.2 -31.09 64.57 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.563 2.176 . . . . 2.6800000000000002 113.32 173.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.15 53.85 4.48 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.177 0.899 . . . . 2.2400000000000002 111.929 168.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.09 -132.9 3.01 Favored Glycine 0 N--CA 1.471 1.024 0 C-N-CA 124.494 1.045 . . . . 1.6200000000000001 114.062 -179.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -72.49 140.42 48.21 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 122.866 0.467 . . . . 2.9900000000000002 112.019 -170.024 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -162.64 160.56 25.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.625 1.17 . . . . 0.72999999999999998 111.351 -175.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -90.54 135.47 33.68 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.802 -0.561 . . . . 3.5099999999999998 109.877 167.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 tpt -86.55 127.52 34.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.14 -1.059 . . . . 1.8200000000000001 108.14 163.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.55 106.84 17.46 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.879 -1.156 . . . . 2.2200000000000002 107.879 177.732 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.88 151.28 26.49 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.756 0.788 . . . . 3.98 111.307 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.94 41.76 39.8 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.887 0.755 . . . . 2.1299999999999999 112.636 176.225 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.9 mt -50.2 154.02 1.3 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 123.401 1.572 . . . . 2.0 114.229 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -99.83 -28.21 13.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 112.884 -1.962 . . . . 2.8900000000000001 112.501 173.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -146.39 148.52 34.63 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 127.409 2.283 . . . . 9.5899999999999999 111.171 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.7 146.87 55.57 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.939 2.426 . . . . 1.6699999999999999 109.866 165.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.1 mt -126.45 130.59 50.96 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.772 1.629 . . . . 4.2800000000000002 109.43 -174.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.61 -178.84 4.64 Favored 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 126.52 1.928 . . . . 4.5800000000000001 111.984 -156.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.97 133.05 34.03 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.38 -0.825 . . . . 2.0600000000000001 111.473 -175.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.82 46.81 8.22 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.834 1.207 . . . . 1.3200000000000001 112.06 -169.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -131.65 176.95 7.89 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.353 1.061 . . . . 2.3999999999999999 111.197 174.067 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -149.12 125.79 11.07 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.599 2.36 . . . . 3.4399999999999999 106.199 -165.195 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.0 t -140.77 140.25 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.329 1.052 . . . . 2.2000000000000002 111.282 -170.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.483 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 33.2 mt-10 -94.99 134.48 37.61 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.861 0.865 . . . . 3.54 112.881 177.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.8 mp -113.11 138.82 49.36 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.035 0.934 . . . . 2.7400000000000002 110.678 158.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -79.07 142.76 36.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.616 1.566 . . . . 2.48 108.447 159.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mp -110.7 123.82 50.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.782 2.433 . . . . 2.04 109.659 176.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -106.45 115.12 29.67 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.343 1.057 . . . . 1.46 110.73 -175.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.19 120.17 41.72 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.923 1.689 . . . . 3.2400000000000002 111.538 -177.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.35 25.38 0.87 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.258 2.223 . . . . 3.0699999999999998 115.055 173.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.21 -60.75 3.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.23 1.395 . . . . 4.71 112.461 -168.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.49 -2.15 59.33 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 117.49 1.756 . . . . 1.8799999999999999 117.49 -164.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -135.45 130.66 35.09 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 120.057 1.929 . . . . 5.6799999999999997 113.248 173.029 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -96.96 151.75 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.41 1.484 . . . . 3.3100000000000001 110.563 161.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.9 tp -146.2 179.61 7.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.822 2.449 . . . . 3.4500000000000002 107.848 164.487 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.483 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 30.2 ttpt -147.29 145.55 29.42 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.078 1.308 . . . . 3.3700000000000001 111.401 -177.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 t -142.86 157.24 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.561 1.145 . . . . 2.8399999999999999 109.435 176.065 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.23 154.79 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.072 2.149 . . . . 3.2799999999999998 109.732 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.96 120.48 9.24 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.336 1.854 . . . . 3.9199999999999999 110.305 176.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.52 145.29 16.92 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 124.562 3.508 . . . . 2.04 113.549 156.382 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.57 127.95 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.828 -0.804 . . . . 2.1200000000000001 108.828 161.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.464 ' CD ' HH21 ' A' ' 120' ' ' ARG . 12.1 tt0 -153.91 129.86 10.24 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.173 1.789 . . . . 4.7000000000000002 109.344 169.643 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.12 110.23 11.62 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.647 1.179 . . . . 3.1699999999999999 108.826 174.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.464 HH21 ' CD ' ' A' ' 118' ' ' GLU . 19.0 ttm180 . . . . . 0 C--O 1.25 1.107 0 C-N-CA 129.114 2.966 . . . . 8.9399999999999995 107.817 -172.206 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.364 0 N-CA-C 105.365 -3.094 . . . . 10.619999999999999 105.365 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 m -58.86 169.98 0.9 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 119.38 -0.928 . . . . 9.9499999999999993 110.959 135.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -177.75 -168.19 0.17 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 129.827 3.251 . . . . 9.0199999999999996 107.793 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.1 t -150.32 162.3 40.79 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.532 1.133 . . . . 5.25 110.718 177.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.47 111.58 2.11 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.769 1.228 . . . . 4.6399999999999997 111.483 -156.662 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.02 156.44 27.2 Favored Glycine 0 N--CA 1.474 1.183 0 O-C-N 120.485 -1.384 . . . . 1.5800000000000001 115.604 -176.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -155.87 170.87 21.11 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.358 1.063 . . . . 2.54 113.29 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -114.14 130.95 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.728 -1.212 . . . . 2.2400000000000002 107.728 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -78.69 -29.81 45.74 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.779 1.77 . . . . 6.6200000000000001 115.779 -157.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.9 t80 146.43 137.26 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 130.653 3.581 . . . . 3.3799999999999999 109.721 174.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 t 179.54 133.78 0.25 Allowed Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 126.683 1.993 . . . . 2.4199999999999999 110.801 166.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.38 -25.66 15.2 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.419 2.079 . . . . 1.4099999999999999 112.481 171.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.11 -176.96 17.07 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.82 1.676 . . . . 0.93000000000000005 112.256 -174.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.69 -11.43 20.54 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 118.445 1.122 . . . . 1.03 113.449 3.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -128.02 155.79 43.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.586 1.954 . . . . 2.2400000000000002 112.87 179.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.43 173.42 11.62 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.07 2.148 . . . . 1.48 110.867 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.09 125.09 30.53 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.056 1.343 . . . . 1.5700000000000001 108.355 172.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.3 151.2 22.98 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.421 1.488 . . . . 1.7 110.751 177.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -141.79 70.39 1.34 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.593 1.557 . . . . 3.3799999999999999 110.053 -166.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -90.69 161.01 15.55 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.356 -0.84 . . . . 2.9399999999999999 112.941 175.105 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.1 m -79.59 157.61 27.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.125 -0.943 . . . . 2.29 109.985 160.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.68 136.44 54.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.227 1.011 . . . . 4.3700000000000001 110.156 175.882 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.84 131.35 47.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.698 1.199 . . . . 5.96 111.297 -173.234 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -107.05 111.17 63.7 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.387 -0.598 . . . . 1.46 109.387 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -86.83 -11.72 5.48 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.283 2.655 . . . . 2.0499999999999998 113.586 173.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.0 -179.84 47.19 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 124.992 1.282 . . . . 1.26 112.933 -175.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -104.21 -5.35 22.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.996 2.518 . . . . 3.3700000000000001 111.679 -171.268 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -121.18 159.61 48.91 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.817 2.447 . . . . 3.54 109.702 175.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.03 137.5 19.57 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.124 1.882 . . . . 1.21 110.463 -175.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.61 155.54 16.73 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.651 1.18 . . . . 3.5899999999999999 109.614 171.521 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 ttp-105 -143.93 102.96 3.97 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.423 1.489 . . . . 3.77 110.567 -170.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -86.4 109.57 19.11 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.158 2.183 . . . . 3.21 109.891 -173.159 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -103.14 -20.88 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.553 1.141 . . . . 1.6899999999999999 111.851 -172.385 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.85 -174.66 30.96 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 124.897 1.237 . . . . 0.44 113.507 177.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.99 -179.72 5.83 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.047 0.939 . . . . 1.47 112.119 166.263 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.08 170.27 16.15 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.161 2.184 . . . . 6.25 107.97 160.335 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -171.64 149.18 2.37 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 125.63 1.572 . . . . 1.71 108.768 176.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.28 -14.47 16.47 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.405 2.07 . . . . 0.83999999999999997 113.706 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.424 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 34.6 m -107.46 26.76 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.045 1.338 . . . . 1.8500000000000001 113.615 -177.045 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.67 161.2 42.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.437 1.495 . . . . 1.8400000000000001 109.039 163.748 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -95.46 -36.51 11.29 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.348 1.059 . . . . 3.1000000000000001 112.858 177.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.7 160.86 33.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.024 1.729 . . . . 6.6100000000000003 107.38 170.448 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.81 155.06 17.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.387 1.475 . . . . 1.72 109.014 173.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.59 152.57 34.27 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.636 1.974 . . . . 4.1900000000000004 108.324 -167.757 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.2 tp -121.07 107.44 12.63 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.224 -0.923 . . . . 1.79 110.926 -162.076 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.6 m170 -117.64 145.05 44.62 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.473 1.286 . . . . 0.71999999999999997 114.473 -169.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' C ' ' HG1' ' A' ' 48' ' ' THR . 10.6 pt-20 -84.72 169.99 13.72 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.241 1.816 . . . . 2.1600000000000001 111.329 163.463 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.402 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 88.2 m -145.99 142.27 28.49 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.538 -1.352 . . . . 1.8999999999999999 107.444 174.06 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -162.21 178.84 8.39 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.743 1.386 . . . . 3.2200000000000002 114.743 -167.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.8 ptm -118.36 150.99 38.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.048 1.739 . . . . 4.6699999999999999 112.541 176.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -156.07 146.37 21.6 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.834 1.254 . . . . 8.7200000000000006 112.64 -174.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -100.96 142.17 32.8 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.395 1.478 . . . . 2.6800000000000002 109.848 171.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.6 t -141.33 121.06 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.611 1.564 . . . . 3.48 107.717 174.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 64.58 12.45 7.49 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.989 1.716 . . . . 4.6100000000000003 115.049 -179.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.24 22.99 53.19 Favored Glycine 0 N--CA 1.477 1.425 0 O-C-N 121.07 -1.019 . . . . 2.5600000000000001 113.243 -167.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -118.28 120.31 37.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.861 2.064 . . . . 5.1799999999999997 107.6 175.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.556 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -73.07 127.94 34.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.613 1.565 . . . . 5.1900000000000004 111.673 174.447 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -138.72 160.83 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 128.786 2.834 . . . . 3.6299999999999999 108.477 -173.084 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.9 mtt -111.5 170.12 8.34 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.823 -1.173 . . . . 3.3799999999999999 112.704 174.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.28 166.29 32.09 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.449 0.94 . . . . 0.70999999999999996 115.449 -167.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -161.05 146.19 14.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 128.439 2.696 . . . . 2.1899999999999999 107.107 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -153.2 157.4 32.93 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.637 1.975 . . . . 5.2300000000000004 108.073 -177.763 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -78.27 159.93 29.55 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.631 1.554 . . . . 0.78000000000000003 110.692 167.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.26 152.86 74.26 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.126 1.371 . . . . 1.8700000000000001 110.532 177.754 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.26 -24.11 11.18 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.851 2.367 . . . . 0.71999999999999997 112.68 -170.951 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -176.95 166.91 2.5 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.569 1.948 . . . . 3.2200000000000002 111.55 178.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -112.81 152.09 29.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.186 1.794 . . . . 2.02 110.989 162.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -103.54 151.58 22.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.205 1.002 . . . . 1.8 109.874 176.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.57 126.68 13.83 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.154 0.582 . . . . 2.6899999999999999 111.71 161.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.21 158.85 44.78 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.984 3.122 . . . . 1.7 112.013 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.76 140.65 87.05 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 124.074 3.183 . . . . 1.4199999999999999 113.871 -174.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 66.72 -10.08 0.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.163 2.185 . . . . 3.2799999999999998 114.358 -178.383 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.01 136.23 13.49 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.993 1.282 . . . . 1.72 113.209 -176.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.44 135.44 33.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.032 2.133 . . . . 4.5199999999999996 109.783 159.082 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -149.2 124.15 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.718 1.607 . . . . 4.71 108.807 178.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 2.2 mp0 -89.06 157.13 18.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.435 0.694 . . . . 3.25 111.637 -170.673 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mp -66.23 -32.87 74.55 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.218 0.917 . . . . 3.1899999999999999 113.372 174.051 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 93.5 140.95 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 130.518 3.527 . . . . 3.7599999999999998 110.426 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.71 -1.24 7.25 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.394 2.729 . . . . 2.5499999999999998 114.643 178.442 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.86 19.85 0.25 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-O 117.439 -1.756 . . . . 2.02 116.207 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.87 -27.46 0.86 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 120.243 2.022 . . . . 2.0699999999999998 116.987 172.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -137.87 151.54 48.15 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.3 2.05 . . . . 3.4900000000000002 111.435 160.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -156.84 148.46 22.49 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.333 0.653 . . . . 0.83999999999999997 110.65 175.673 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -81.84 116.84 21.7 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.792 -0.818 . . . . 3.4900000000000002 108.792 165.472 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 tpt -78.25 107.8 11.11 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 126.705 2.002 . . . . 1.9399999999999999 108.609 170.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.3 mp -87.49 139.73 30.25 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.446 1.498 . . . . 2.5099999999999998 109.12 176.23 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.38 138.03 46.1 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.259 1.024 . . . . 3.0800000000000001 112.263 178.293 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.25 42.45 10.58 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 124.997 1.284 . . . . 1.5900000000000001 113.118 173.601 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.7 mt -47.36 151.28 0.77 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.938 1.829 . . . . 1.73 115.938 -172.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.424 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 61.3 mmtt -111.42 -26.29 9.18 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 113.721 -1.581 . . . . 3.1499999999999999 113.85 -176.246 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -120.63 136.36 25.32 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.302 1.441 . . . . 5.5499999999999998 109.218 159.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.07 116.24 4.64 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.022 2.481 . . . . 1.45 107.767 170.14 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.357 4.1 pp -98.43 105.24 17.36 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 124.279 1.99 . . . . 4.25 112.708 -162.506 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.26 171.01 7.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.03 2.132 . . . . 4.4199999999999999 112.256 176.68 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.31 129.46 41.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.106 0.962 . . . . 2.4300000000000002 110.804 175.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.66 31.78 48.62 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.702 -0.681 . . . . 2.9100000000000001 112.939 -173.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -100.02 179.38 4.52 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.382 -0.97 . . . . 2.7400000000000002 108.382 143.642 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.22 160.51 43.31 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.279 1.831 . . . . 3.3999999999999999 106.725 165.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.0 t -151.96 157.91 4.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 128.734 2.813 . . . . 2.6800000000000002 107.73 -158.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -126.61 154.13 44.38 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.678 0.791 . . . . 2.73 110.226 165.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.16 134.88 54.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.056 1.343 . . . . 2.8500000000000001 109.96 166.351 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -78.18 134.79 37.57 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.334 2.254 . . . . 2.5899999999999999 108.432 161.587 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.99 109.6 21.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.437 1.895 . . . . 2.4900000000000002 108.815 178.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.5 mt -93.88 116.3 28.75 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.201 0.6 . . . . 1.8200000000000001 110.1 -176.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -109.23 148.71 30.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.614 1.166 . . . . 3.27 111.806 -177.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.75 150.18 33.26 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.775 -0.578 . . . . 2.5699999999999998 112.012 169.562 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.23 34.39 41.34 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.142 -0.81 . . . . 4.1399999999999997 114.029 177.166 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.72 44.3 39.64 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 118.048 0.924 . . . . 1.9399999999999999 114.235 166.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -134.07 140.96 46.99 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.241 1.02 . . . . 4.0700000000000003 111.713 -177.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.2 t -142.67 134.39 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.83 1.252 . . . . 3.2999999999999998 109.283 172.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -116.62 174.74 5.91 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.319 1.847 . . . . 4.1600000000000001 107.598 163.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -139.21 154.14 47.98 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.011 -1.056 . . . . 2.75 112.373 161.177 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.0 t -132.3 160.86 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.197 1.399 . . . . 2.8500000000000001 109.734 -176.645 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.53 143.27 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 127.358 2.263 . . . . 4.1399999999999997 111.592 -173.288 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -143.76 105.2 4.93 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.742 1.617 . . . . 3.8900000000000001 109.84 -175.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -61.3 157.36 40.81 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.394 2.063 . . . . 1.6299999999999999 111.396 158.455 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.8 t -107.4 141.92 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.593 0.711 . . . . 1.77 110.139 173.155 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -174.03 3.18 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.577 2.751 . . . . 3.9199999999999999 110.496 -165.389 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -131.56 93.73 3.39 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.414 1.086 . . . . 2.9700000000000002 110.855 162.271 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 . . . . . 0 N--CA 1.484 1.262 0 C-N-CA 125.996 1.718 . . . . 8.9100000000000001 113.299 -170.922 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.179 0 N-CA-C 108.406 -1.878 . . . . 8.8699999999999992 108.406 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t 71.78 -176.37 0.19 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.059 -1.089 . . . . 8.3300000000000001 108.059 -126.365 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -107.85 -13.38 15.0 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.17 0.988 . . . . 12.27 111.846 158.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.6 p -78.58 52.9 1.24 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.993 2.117 . . . . 5.8700000000000001 112.517 -165.379 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -102.63 105.61 16.13 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.453 0.644 . . . . 4.5800000000000001 110.651 -163.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.67 -177.79 32.09 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 125.581 1.563 . . . . 1.4199999999999999 113.642 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.1 p90 -152.96 143.21 22.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.558 1.543 . . . . 2.8599999999999999 110.567 170.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.3 156.61 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 121.048 -1.033 . . . . 2.6400000000000001 108.404 167.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.8 ttt85 -86.3 149.75 24.83 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.865 1.317 . . . . 5.3700000000000001 112.974 -176.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -72.11 132.43 44.18 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 129.236 3.014 . . . . 3.8199999999999998 109.84 170.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.3 t 178.84 141.27 0.28 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 126.565 1.946 . . . . 2.7400000000000002 111.229 176.307 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.74 -28.96 13.26 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.562 2.174 . . . . 1.6100000000000001 112.683 169.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.03 171.14 12.5 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.407 1.956 . . . . 0.94999999999999996 112.36 -172.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -82.98 -0.14 54.34 Favored 'Cis proline' 0 CA--C 1.539 0.74 0 CA-C-N 119.27 1.535 . . . . 1.22 113.923 2.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -143.33 157.39 44.51 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.772 1.397 . . . . 2.5 114.772 174.331 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.13 -175.34 3.59 Favored 'General case' 0 CA--C 1.549 0.924 1 C-N-CA 131.838 4.055 . . . . 1.5600000000000001 108.804 175.349 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.64 171.02 13.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.793 2.037 . . . . 1.6499999999999999 108.259 173.01 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.62 135.96 22.79 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.107 0.956 . . . . 1.8899999999999999 112.576 170.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -123.44 141.06 52.37 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.574 2.35 . . . . 3.5699999999999998 108.957 -174.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -174.05 143.16 0.9 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.869 1.433 . . . . 3.1099999999999999 114.869 -171.379 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.0 m -79.52 120.86 24.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.594 1.157 . . . . 2.5800000000000001 110.98 178.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 135.23 39.72 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.329 1.852 . . . . 4.0300000000000002 109.361 175.036 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -139.12 146.89 41.22 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.066 1.747 . . . . 5.1500000000000004 109.137 -171.351 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -131.98 99.56 16.46 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.508 0.723 . . . . 1.6499999999999999 109.934 177.499 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -70.38 -14.37 34.05 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.368 2.045 . . . . 2.0299999999999998 113.069 176.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.35 140.69 11.58 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 128.188 2.804 . . . . 3.5099999999999998 112.666 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t0 174.23 -55.89 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.562 2.745 . . . . 8.3900000000000006 103.86 -158.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp 178.06 173.55 0.38 Allowed Pre-proline 0 CA--C 1.552 1.021 1 C-N-CA 132.898 4.479 . . . . 5.5199999999999996 110.848 -177.148 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.37 134.94 10.38 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.345 2.03 . . . . 1.5800000000000001 111.227 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.3 mt -93.84 145.23 24.76 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.646 1.178 . . . . 3.1899999999999999 111.108 -175.55 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 ttp-105 -137.31 91.88 2.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 112.62 -2.082 . . . . 4.2199999999999998 111.628 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 98.02 7.37 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.098 1.759 . . . . 2.7999999999999998 108.418 -170.485 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.9 m -94.36 -30.65 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.25 1.42 . . . . 1.5600000000000001 112.21 -169.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.64 -176.78 32.09 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 123.87 0.747 . . . . 0.59999999999999998 113.765 178.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.26 177.45 8.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.322 1.049 . . . . 1.5600000000000001 112.253 172.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -153.36 157.64 40.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.051 2.54 . . . . 6.9400000000000004 108.236 168.444 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -167.32 152.45 6.98 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 123.798 0.839 . . . . 2.04 111.894 -176.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.2 -8.75 23.35 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.794 2.329 . . . . 1.52 115.599 178.817 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.64 0.55 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 115.829 1.789 . . . . 2.5499999999999998 115.829 178.166 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.04 164.13 37.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.135 1.374 . . . . 2.2400000000000002 112.186 -178.978 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -124.77 -65.04 1.06 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 123.103 1.43 . . . . 4.3899999999999997 111.399 -167.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -79.01 147.59 32.82 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.426 -2.065 . . . . 5.5999999999999996 105.426 164.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -156.66 135.05 2.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 C-N-CA 125.141 1.376 . . . . 2.3599999999999999 108.034 -177.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -127.54 156.6 41.94 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.757 2.023 . . . . 2.8300000000000001 109.323 178.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.1 tp -105.46 126.58 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.799 0.84 . . . . 2.0899999999999999 109.231 169.032 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -124.24 160.63 27.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.0 2.12 . . . . 0.78000000000000003 113.984 -175.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -107.64 163.61 12.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.751 1.62 . . . . 2.0600000000000001 111.091 156.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.5 m -116.05 140.93 48.78 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.463 1.905 . . . . 2.27 106.602 165.189 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -145.31 -178.15 5.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.547 1.139 . . . . 3.3799999999999999 113.42 -177.114 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.1 mtm -126.79 144.28 51.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.364 1.466 . . . . 4.4500000000000002 112.749 -177.586 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.12 135.82 39.59 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.699 1.6 . . . . 7.0 111.764 178.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -104.49 127.69 52.26 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.844 1.658 . . . . 3.1600000000000001 111.34 168.35 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.9 t -134.82 123.97 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 107.651 -1.24 . . . . 3.7599999999999998 107.651 176.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 62.67 10.63 4.28 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.169 2.188 . . . . 3.98 115.146 -169.228 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.82 30.19 52.81 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 120.965 -1.085 . . . . 1.74 112.885 -164.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -118.52 129.28 55.27 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.955 1.702 . . . . 3.3700000000000001 108.261 169.08 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -86.84 126.61 34.75 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.029 1.732 . . . . 7.1600000000000001 112.294 -177.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.89 142.98 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.542 1.937 . . . . 3.7000000000000002 109.423 175.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 52.2 mtt -88.45 163.42 15.96 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.892 1.071 . . . . 3.5 113.892 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.98 175.15 22.35 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.549 1.547 . . . . 0.59999999999999998 112.457 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.3 ttm -157.04 148.11 21.86 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.46 1.904 . . . . 2.1899999999999999 108.245 -179.423 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -161.08 153.68 17.3 Favored Pre-proline 0 N--CA 1.476 0.862 0 CA-C-O 118.051 -0.976 . . . . 5.4400000000000004 111.639 -178.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.91 155.29 43.37 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.197 1.931 . . . . 0.66000000000000003 111.875 178.53 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.99 151.03 61.23 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.038 1.735 . . . . 1.71 109.999 -177.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.8 -21.03 8.68 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.465 2.777 . . . . 0.56000000000000005 113.493 -164.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -178.09 165.83 1.94 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.568 1.947 . . . . 2.9399999999999999 110.746 177.548 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 mt -106.95 146.26 31.26 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.082 0.953 . . . . 1.77 110.529 158.347 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -105.86 140.2 39.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.391 1.076 . . . . 1.8700000000000001 108.929 175.078 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.9 t -141.01 113.14 6.88 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 122.902 0.481 . . . . 1.71 110.725 165.314 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.9 162.44 37.32 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 124.095 3.197 . . . . 2.1200000000000001 111.75 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.64 136.89 56.3 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.931 2.42 . . . . 1.6299999999999999 111.784 -177.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt 74.68 -4.81 2.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 128.118 2.567 . . . . 4.7000000000000002 114.402 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.38 155.3 23.35 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.411 1.481 . . . . 1.8300000000000001 112.12 170.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -135.67 153.47 51.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.39 1.476 . . . . 5.0800000000000001 110.366 172.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.7 t -154.04 129.76 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.353 1.461 . . . . 4.5499999999999998 108.781 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.8 136.24 33.15 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.938 -1.101 . . . . 3.2200000000000002 112.265 176.52 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.82 84.17 0.66 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.077 -1.083 . . . . 2.2599999999999998 108.077 157.22 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -92.21 150.29 40.02 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.418 2.287 . . . . 3.25 113.377 -178.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -64.66 -39.69 26.03 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.004 2.469 . . . . 2.52 113.102 -174.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.33 45.84 2.66 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.689 1.137 . . . . 2.3300000000000001 112.511 170.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.08 -129.08 1.96 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 126.371 1.939 . . . . 1.48 111.65 177.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -73.57 138.33 44.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.714 1.257 . . . . 3.2000000000000002 113.239 -166.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -161.32 161.5 30.56 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.59 1.156 . . . . 1.03 111.503 -178.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -85.99 150.83 24.21 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.502 -0.749 . . . . 2.9100000000000001 110.915 165.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -105.96 126.13 51.82 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.415 1.486 . . . . 2.0499999999999998 108.706 163.008 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.01 118.31 36.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.734 1.214 . . . . 2.1600000000000001 108.75 -175.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.08 155.26 31.82 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 123.409 1.576 . . . . 3.0299999999999998 112.212 -170.48 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.09 -43.75 3.25 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 128.024 2.726 . . . . 2.4399999999999999 112.139 -178.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.2 mt 47.97 167.55 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.602 3.161 . . . . 1.8 115.891 -168.474 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -135.33 -21.2 1.59 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.342 1.457 . . . . 3.7599999999999998 113.781 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -122.27 149.86 55.71 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.148 2.179 . . . . 5.8200000000000003 107.619 161.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.71 112.37 2.63 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 106.23 -2.258 . . . . 1.49 106.23 153.209 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.35 108.16 5.33 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.048 -0.723 . . . . 3.1400000000000001 109.048 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -65.02 174.43 1.95 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.382 1.087 . . . . 4.8499999999999996 112.083 158.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.97 159.68 24.83 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.673 -1.149 . . . . 2.3700000000000001 108.439 149.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.16 49.74 75.31 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 121.575 -0.703 . . . . 2.1800000000000002 112.524 -172.317 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.53 -179.6 4.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.96 1.304 . . . . 2.3599999999999999 108.483 163.23 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -148.04 151.48 35.79 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.154 1.781 . . . . 3.4199999999999999 107.346 169.167 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.7 t -154.35 145.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 128.006 2.522 . . . . 2.4700000000000002 109.357 -160.496 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -101.11 154.37 18.79 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.276 0.63 . . . . 4.6900000000000004 111.385 171.79 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mt -139.56 134.14 31.75 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.594 1.557 . . . . 3.3500000000000001 110.26 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -83.69 131.41 34.94 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.709 2.004 . . . . 1.98 108.823 165.774 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.29 111.35 22.6 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.918 1.287 . . . . 1.8200000000000001 109.585 172.486 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.72 110.85 19.61 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.669 1.187 . . . . 1.8799999999999999 109.806 -178.191 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -106.28 105.3 15.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.923 1.289 . . . . 3.23 110.751 -177.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 57.43 11.12 1.09 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.013 1.725 . . . . 2.5899999999999999 115.22 174.209 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.36 -43.08 2.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.498 1.523 . . . . 3.8300000000000001 113.186 -169.12 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.96 -11.11 78.56 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.339 0.971 . . . . 2.6200000000000001 115.514 -175.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -137.49 157.15 47.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.818 1.309 . . . . 5.0499999999999998 111.867 170.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.78 153.97 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 125.708 1.603 . . . . 3.2599999999999998 109.93 169.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.5 tp -144.44 121.78 11.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.593 1.157 . . . . 3.02 109.654 174.373 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.77 114.33 28.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.53 0.732 . . . . 4.6699999999999999 110.587 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.55 167.72 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 126.748 2.019 . . . . 3.1400000000000001 110.548 -170.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.29 141.56 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.734 2.013 . . . . 3.75 110.655 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.4 mt -150.85 149.1 24.6 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 126.279 1.832 . . . . 4.04 111.625 -174.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -70.01 174.34 9.87 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.734 2.956 . . . . 1.1799999999999999 112.048 166.027 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.5 t -121.82 134.48 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.572 1.549 . . . . 2.5499999999999998 109.507 166.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -150.0 159.25 44.54 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.377 1.251 . . . . 5.0199999999999996 114.377 177.073 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.08 50.72 2.0 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.347 -0.842 . . . . 2.9700000000000002 111.635 178.369 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? . . . . . 0 C--O 1.245 0.842 0 C-N-CA 124.31 1.044 . . . . 8.1099999999999994 110.477 175.19 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' HA3' ' OE2' ' A' ' 23' ' ' GLU . . . . . . . . 0 CA--C 1.503 -0.663 0 CA-C-O 119.678 -0.512 . . . . 10.550000000000001 112.371 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -87.85 -38.01 16.03 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.997 1.319 . . . . 7.3600000000000003 110.312 163.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 71.18 -42.77 0.54 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.02 2.528 . . . . 12.0 116.874 161.236 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.0 t -144.62 2.09 1.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.349 1.459 . . . . 5.9000000000000004 113.55 -163.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -77.31 104.23 7.7 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.847 0.859 . . . . 4.9500000000000002 110.916 -159.102 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.33 -177.15 33.18 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.95 1.262 . . . . 1.3999999999999999 114.129 -175.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -153.81 160.02 42.08 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.606 1.562 . . . . 2.77 111.381 167.754 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 t -97.04 146.78 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 106.897 -1.52 . . . . 2.23 106.897 165.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -75.67 -102.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.367 0.985 . . . . 6.2000000000000002 112.032 -178.209 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -170.67 127.29 0.76 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.869 1.268 . . . . 4.1500000000000004 108.198 -168.788 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 p 179.6 111.22 0.19 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.565 -0.731 . . . . 3.3500000000000001 111.588 -167.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.29 -31.97 8.72 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.38 2.053 . . . . 1.4399999999999999 112.671 174.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.68 178.0 28.58 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.475 1.512 . . . . 1.0600000000000001 111.772 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.6 2.77 35.18 Favored 'Cis proline' 0 CA--C 1.539 0.77 0 CA-C-N 119.245 1.523 . . . . 1.55 112.952 -3.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -151.9 167.45 28.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.109 0.963 . . . . 2.5699999999999998 112.085 176.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.48 173.73 12.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.537 2.335 . . . . 1.6399999999999999 110.842 -171.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.55 139.28 24.04 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.51 1.124 . . . . 1.6000000000000001 110.281 179.206 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.09 140.35 50.83 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.295 1.438 . . . . 1.8799999999999999 111.549 -173.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -115.08 142.07 47.14 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.972 2.109 . . . . 4.7699999999999996 111.332 -176.176 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -162.94 147.43 11.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.869 1.433 . . . . 3.0099999999999998 114.869 178.12 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.7 m -79.82 116.12 19.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.205 1.402 . . . . 2.8100000000000001 110.477 176.07 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.75 126.45 40.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.582 1.153 . . . . 4.2400000000000002 110.08 174.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' OE2' ' HA3' ' A' ' 1' ' ' GLY . 47.5 tt0 -124.24 142.89 50.88 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.561 1.544 . . . . 4.1900000000000004 110.959 175.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -103.84 94.95 6.93 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.838 1.255 . . . . 1.6000000000000001 109.985 171.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.12 -8.24 18.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.717 2.278 . . . . 1.48 113.796 177.354 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.72 177.96 51.27 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 122.425 1.014 . . . . 1.3300000000000001 112.36 -178.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -103.02 -2.44 27.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.17 2.188 . . . . 3.23 111.295 -176.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.61 162.12 21.92 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 129.333 3.053 . . . . 5.2300000000000004 108.873 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.29 146.86 20.03 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.453 2.102 . . . . 1.1599999999999999 110.784 178.15 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mp -112.11 151.28 29.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.792 1.237 . . . . 3.4199999999999999 110.731 174.047 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.422 HH21 ' CD ' ' A' ' 68' ' ' GLU . 25.3 ttm180 -141.14 109.8 6.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.037 -1.892 . . . . 2.6000000000000001 110.076 179.265 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.52 123.78 32.78 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 125.282 1.433 . . . . 3.0899999999999999 108.607 178.124 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -106.57 -28.58 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.201 0.91 . . . . 1.9099999999999999 111.927 -175.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.24 -173.34 27.55 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 124.536 1.065 . . . . 0.52000000000000002 113.704 177.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.21 -176.77 3.82 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.339 1.056 . . . . 1.79 111.014 161.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -144.98 156.33 43.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 131.357 3.863 . . . . 7.0 105.178 166.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -167.18 137.24 2.37 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 124.256 1.022 . . . . 1.6899999999999999 109.991 171.807 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.57 -17.56 38.37 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.362 2.042 . . . . 1.05 113.321 -171.694 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.2 m -93.8 17.5 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 114.747 1.388 . . . . 1.8500000000000001 114.747 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.12 164.15 28.3 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.582 1.083 . . . . 1.6399999999999999 113.609 170.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -92.62 -35.86 13.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.546 1.138 . . . . 4.0700000000000003 111.149 175.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -135.36 156.72 48.47 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.179 2.192 . . . . 5.7599999999999998 108.011 169.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.24 149.47 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.701 1.601 . . . . 2.1099999999999999 108.764 168.334 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -152.04 150.41 29.92 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.692 1.997 . . . . 2.8399999999999999 108.524 -172.373 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -105.83 134.15 49.41 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 123.068 1.414 . . . . 3.1800000000000002 113.105 172.641 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -116.76 154.74 30.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.514 -1.676 . . . . 0.73999999999999999 111.321 177.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -175.48 5.32 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.566 1.546 . . . . 3.3500000000000001 110.889 159.112 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.0 m -151.15 147.7 27.37 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.585 1.154 . . . . 1.6899999999999999 108.489 164.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -159.2 177.01 11.51 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 123.467 1.604 . . . . 3.4100000000000001 113.724 -171.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.6 ttp -129.42 128.02 42.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.071 1.748 . . . . 4.1200000000000001 110.597 -179.433 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.49 148.76 22.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.343 1.457 . . . . 6.9100000000000001 110.623 164.655 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.65 138.05 33.51 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.468 -0.938 . . . . 2.6400000000000001 108.468 147.135 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.96 125.17 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 106.238 -1.764 . . . . 3.2000000000000002 106.238 166.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 60.31 33.62 20.86 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.621 0.768 . . . . 4.3300000000000001 112.044 178.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.74 9.62 79.15 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.834 -1.166 . . . . 1.6200000000000001 114.454 -176.353 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -126.02 134.92 51.31 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.11 1.764 . . . . 2.9700000000000002 109.241 -172.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -84.61 123.75 30.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.634 1.574 . . . . 3.9300000000000002 111.124 -171.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.1 t -141.36 131.0 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.657 1.983 . . . . 3.1200000000000001 108.403 -173.171 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.73 161.63 13.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.768 1.227 . . . . 4.1600000000000001 113.626 -171.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.27 -179.66 32.36 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.046 1.308 . . . . 1.0800000000000001 113.086 172.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.91 153.75 43.41 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.291 1.036 . . . . 4.71 111.164 170.412 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -141.06 152.52 65.22 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.778 2.031 . . . . 5.2199999999999998 109.417 -174.408 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.69 153.61 59.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.119 1.879 . . . . 0.78000000000000003 111.273 172.399 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.53 154.92 77.53 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-O 118.452 -0.785 . . . . 2.1800000000000002 110.828 171.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.35 -22.9 10.58 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.114 2.543 . . . . 0.56999999999999995 112.602 -172.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -174.15 171.9 3.43 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.94 1.696 . . . . 3.5099999999999998 110.894 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.7 mt -117.54 158.27 24.86 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.225 1.81 . . . . 1.97 109.915 160.318 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.422 ' CD ' HH21 ' A' ' 31' ' ' ARG . 28.0 tt0 -137.34 146.34 44.45 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.69 0.796 . . . . 2.1899999999999999 110.673 178.06 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.9 t -144.04 130.12 9.99 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 123.961 0.788 . . . . 2.1299999999999999 110.854 175.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.82 165.45 29.71 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.73 2.953 . . . . 1.3600000000000001 111.316 175.664 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.61 141.66 97.7 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.281 2.654 . . . . 1.0600000000000001 113.16 -179.1 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt 69.62 -4.43 1.4 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 127.53 2.332 . . . . 2.46 114.681 177.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.58 169.39 47.06 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.137 1.351 . . . . 1.28 113.974 179.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 -133.35 156.86 46.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.401 1.08 . . . . 5.54 111.691 164.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -149.0 133.53 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.92 2.088 . . . . 4.4400000000000004 106.922 171.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -98.03 133.71 42.12 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.947 -1.095 . . . . 2.8399999999999999 111.393 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mp -68.47 78.9 0.27 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.394 -0.965 . . . . 2.5 108.394 154.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -94.09 154.38 40.61 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.717 2.007 . . . . 3.5099999999999998 112.051 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.43 -34.55 94.86 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.997 2.465 . . . . 2.7200000000000002 113.211 175.358 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.75 66.39 3.85 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.18 -0.768 . . . . 2.77 111.18 171.203 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.84 -123.59 3.72 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.178 1.371 . . . . 1.6200000000000001 112.966 -178.46 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -74.65 141.64 44.6 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.938 0.718 . . . . 3.6000000000000001 112.938 -162.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -159.97 154.97 24.69 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.587 -0.696 . . . . 0.77000000000000002 112.044 -176.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -90.3 118.66 29.98 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.558 0.343 . . . . 4.04 110.208 171.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -85.62 125.18 32.93 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.009 1.324 . . . . 1.74 109.257 170.16 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.96 127.82 52.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.476 1.51 . . . . 2.46 107.537 177.384 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.82 150.14 39.66 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.824 0.821 . . . . 2.9500000000000002 112.237 -176.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.43 -41.26 1.83 Allowed Glycine 0 CA--C 1.531 1.094 0 C-N-CA 126.48 1.991 . . . . 2.8900000000000001 113.57 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.8 mt 57.04 170.52 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 129.916 3.286 . . . . 1.9199999999999999 114.29 -177.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -129.82 -28.51 2.21 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.002 2.121 . . . . 2.27 112.857 172.583 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -110.99 132.58 21.6 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.43 1.492 . . . . 5.5800000000000001 108.065 166.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.95 101.19 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 N-CA-C 106.362 -2.207 . . . . 1.9099999999999999 106.362 158.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.11 128.0 41.6 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.419 1.104 . . . . 3.8900000000000001 112.674 -159.703 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -132.87 172.31 12.76 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.259 1.823 . . . . 4.3899999999999997 113.335 -167.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.69 124.61 23.36 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.574 -0.739 . . . . 2.04 110.083 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.36 7.36 51.97 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.554 1.55 . . . . 1.8799999999999999 115.497 -176.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.28 -175.16 3.74 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.421 1.111 . . . . 2.9199999999999999 111.519 161.493 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -149.29 154.53 39.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.305 3.042 . . . . 3.1499999999999999 105.733 178.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.9 t -147.83 139.05 17.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 127.238 2.215 . . . . 2.54 109.035 -176.233 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.491 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -105.15 149.76 25.63 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.795 1.238 . . . . 3.1600000000000001 110.998 176.852 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mp -132.16 134.24 45.17 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.192 1.397 . . . . 2.71 111.066 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -87.56 125.1 34.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.259 1.824 . . . . 2.1299999999999999 107.459 159.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 mp -98.29 131.51 44.55 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.102 1.361 . . . . 2.3399999999999999 109.421 172.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.6 mt -107.19 120.04 41.03 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.0 1.32 . . . . 1.8200000000000001 109.589 -175.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -113.69 160.41 18.66 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.525 1.53 . . . . 3.2200000000000002 110.601 178.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.62 143.04 10.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.242 -0.89 . . . . 2.4900000000000002 111.605 170.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.88 -3.72 86.81 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 118.759 -1.023 . . . . 3.6299999999999999 114.37 -169.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.14 16.13 56.35 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.814 1.307 . . . . 2.8999999999999999 114.114 175.456 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -78.4 134.8 37.36 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.143 -1.21 . . . . 6.4199999999999999 112.557 -173.049 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.9 t -107.15 136.66 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.228 1.811 . . . . 3.0499999999999998 109.423 175.617 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.4 tp -141.17 133.62 28.37 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.115 0.966 . . . . 2.8100000000000001 111.502 174.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.491 ' HZ1' ' CD ' ' A' ' 100' ' ' GLU . 1.9 tpmt? -79.93 126.41 30.98 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.669 0.618 . . . . 3.4700000000000002 112.669 177.763 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.3 t -114.74 164.48 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.334 1.854 . . . . 3.77 108.355 157.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.6 t -146.61 140.36 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.893 1.677 . . . . 3.02 109.958 -176.027 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.3 mt -143.24 135.68 13.43 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 126.666 1.986 . . . . 3.4700000000000002 111.114 -167.584 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -73.97 159.1 45.3 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.113 2.542 . . . . 1.29 110.76 163.229 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.34 131.13 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.734 -0.839 . . . . 1.97 108.734 167.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -153.12 146.94 25.25 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.461 1.105 . . . . 3.8100000000000001 113.359 -165.098 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.04 59.87 2.8 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 120.621 -1.299 . . . . 3.2799999999999998 111.697 171.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.8 mtm105 . . . . . 0 N--CA 1.478 0.959 0 C-N-CA 125.754 1.621 . . . . 8.6500000000000004 113.704 -179.963 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.992 0 N-CA-C 108.156 -1.978 . . . . 11.19 108.156 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m 52.74 -129.11 2.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 117.967 -1.016 . . . . 7.8300000000000001 111.452 -179.223 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -148.6 -173.96 4.48 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.409 1.459 . . . . 9.2300000000000004 112.329 167.529 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.3 p -78.45 62.95 3.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.074 1.35 . . . . 6.5300000000000002 110.353 175.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -78.99 60.54 2.94 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.353 1.861 . . . . 4.96 112.718 -172.044 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.18 179.69 19.21 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.331 1.443 . . . . 1.1899999999999999 113.09 176.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 23.2 p90 -155.46 169.58 23.92 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.845 1.424 . . . . 2.8399999999999999 114.845 -172.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.39 140.52 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 126.502 1.921 . . . . 2.1899999999999999 109.407 170.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -17.79 61.73 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.938 2.095 . . . . 7.1100000000000003 115.513 -174.203 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.3 t80 79.87 129.55 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.91 2.484 . . . . 3.8799999999999999 111.631 -177.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 t -175.77 142.85 0.65 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 129.378 3.071 . . . . 2.73 107.774 174.358 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.08 -27.56 4.43 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.89 2.394 . . . . 1.6599999999999999 112.465 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.92 175.32 20.53 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.664 1.126 . . . . 0.82999999999999996 112.314 -174.545 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.57 -5.61 12.26 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 118.848 1.324 . . . . 1.02 112.775 -4.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -147.26 160.98 41.86 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 123.435 1.588 . . . . 2.1899999999999999 114.358 -176.68 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.27 -176.93 4.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.74 2.816 . . . . 1.6100000000000001 110.454 -176.57 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.06 152.38 34.73 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.019 1.727 . . . . 1.79 108.207 175.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.14 141.91 40.13 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.943 0.897 . . . . 1.73 112.508 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.516 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 88.0 m-85 -105.87 74.33 1.05 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.129 2.172 . . . . 4.5199999999999996 108.776 174.026 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -76.43 159.0 30.85 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.268 -0.895 . . . . 2.9399999999999999 111.43 -177.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.5 m -140.25 147.25 39.7 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.431 1.092 . . . . 2.4300000000000002 110.479 175.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.82 -178.11 5.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.346 2.258 . . . . 6.5300000000000002 108.69 169.907 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -140.45 123.93 16.97 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.807 -1.183 . . . . 4.5700000000000003 109.958 173.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -76.91 119.01 75.71 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.255 1.422 . . . . 1.6000000000000001 108.87 178.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.48 -17.99 33.9 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 121.974 1.783 . . . . 2.0600000000000001 113.459 176.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.4 126.05 0.64 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 124.469 1.033 . . . . 2.8300000000000001 110.522 -163.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -178.66 -47.86 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.257 -2.497 . . . . 8.2699999999999996 104.257 -146.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -164.92 -171.21 0.25 Allowed Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 131.418 3.887 . . . . 5.8300000000000001 107.477 164.789 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.28 130.36 9.12 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 108.043 -1.56 . . . . 1.3100000000000001 108.043 159.592 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.86 156.52 17.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.691 1.234 . . . . 3.6499999999999999 110.516 -175.835 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -153.47 107.04 2.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 113.736 -1.575 . . . . 2.46 111.571 -173.196 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.64 108.42 19.96 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.422 1.489 . . . . 3.6200000000000001 109.162 -171.395 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -106.66 -20.37 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 113.146 0.795 . . . . 1.8700000000000001 113.146 -169.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.49 -177.95 33.04 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 124.854 1.216 . . . . 0.42999999999999999 111.822 176.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.83 -179.51 5.44 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.819 0.848 . . . . 1.71 111.18 171.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -147.92 169.37 20.0 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.935 2.094 . . . . 4.5199999999999996 108.833 169.129 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.8 t 178.41 154.24 0.52 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.096 1.759 . . . . 1.8999999999999999 109.574 -171.105 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -89.39 -7.1 5.07 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.622 2.881 . . . . 0.81000000000000005 113.997 171.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.5 m -113.27 24.95 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 114.191 1.182 . . . . 1.79 114.191 -173.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.43 163.86 38.03 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.163 1.385 . . . . 1.8799999999999999 108.893 166.153 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -96.58 -30.84 13.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.141 1.776 . . . . 3.25 112.879 175.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 mtt85 -137.86 157.96 45.34 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.193 2.197 . . . . 6.5099999999999998 107.274 175.423 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 p -153.88 131.09 2.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 125.339 1.455 . . . . 1.8500000000000001 108.568 -176.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -140.16 133.14 29.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.199 0.999 . . . . 3.75 110.189 -160.066 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.3 tp -85.23 117.49 24.21 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.921 0.867 . . . . 2.5099999999999998 111.436 -177.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.8 m170 -117.38 162.48 17.85 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.592 1.557 . . . . 0.67000000000000004 112.859 176.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -113.11 -178.71 3.45 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.546 -1.661 . . . . 3.1800000000000002 110.801 163.885 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -148.67 135.65 20.0 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 106.594 -1.632 . . . . 2.0699999999999998 106.594 172.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -131.71 169.03 16.75 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.275 1.43 . . . . 3.6000000000000001 113.138 -169.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.1 139.33 45.34 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.817 1.247 . . . . 6.8099999999999996 110.909 168.777 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -129.05 141.99 51.05 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.316 1.446 . . . . 6.3300000000000001 110.362 166.341 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -89.81 138.63 31.32 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.847 -1.168 . . . . 2.9399999999999999 107.847 154.317 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.0 t -133.94 116.14 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 106.43 -1.693 . . . . 3.46 106.43 168.969 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.89 31.42 13.92 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.445 1.098 . . . . 5.0899999999999999 113.261 175.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.31 10.19 85.69 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 121.072 -1.018 . . . . 1.9399999999999999 114.112 -174.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -125.88 119.71 28.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.457 1.503 . . . . 3.8100000000000001 110.384 -173.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.453 ' H ' ' HD3' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -81.38 135.16 35.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.265 1.426 . . . . 4.1799999999999997 111.472 -171.243 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.1 p -149.83 133.23 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 125.435 1.494 . . . . 3.6800000000000002 109.313 -178.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.7 mtp -83.8 165.43 18.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.532 0.682 . . . . 4.5800000000000001 111.657 177.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.59 178.65 27.89 Favored Glycine 0 C--O 1.224 -0.48 0 CA-C-N 115.357 -0.838 . . . . 0.87 111.717 170.086 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 ttm -147.07 143.15 28.13 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.833 1.653 . . . . 1.8999999999999999 107.4 -178.05 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -151.82 157.43 34.41 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.403 0.681 . . . . 5.6500000000000004 110.112 178.886 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.01 159.34 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.422 2.081 . . . . 0.62 111.462 178.451 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.39 156.01 64.1 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.878 1.671 . . . . 1.78 109.905 177.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.72 -24.83 2.14 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.855 2.37 . . . . 0.48999999999999999 113.562 -167.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -176.34 169.87 2.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.497 1.919 . . . . 2.9399999999999999 111.157 -178.667 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.99 154.37 26.57 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.068 1.347 . . . . 1.98 110.554 159.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.19 142.09 46.2 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.614 1.565 . . . . 2.0800000000000001 108.003 173.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 t -143.65 128.9 9.78 Favored Pre-proline 0 N--CA 1.474 0.74 0 N-CA-C 112.458 0.54 . . . . 1.95 112.458 169.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.34 167.32 24.22 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.324 2.683 . . . . 1.01 112.294 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.29 145.87 14.55 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.33 3.353 . . . . 1.79 112.281 171.013 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt 73.49 -14.36 0.64 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.574 1.95 . . . . 4.1100000000000003 114.635 178.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.56 158.8 45.69 Favored Glycine 0 N--CA 1.472 1.088 0 CA-C-N 119.017 0.826 . . . . 1.3300000000000001 114.144 -168.149 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 mmt-85 -76.87 136.94 38.89 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.995 0.918 . . . . 5.0899999999999999 108.811 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.67 63.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.246 2.218 . . . . 6.9900000000000002 107.098 -174.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.39 134.84 41.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.496 1.518 . . . . 3.6200000000000001 110.924 -177.756 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.32 94.15 8.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.185 -1.413 . . . . 2.3700000000000001 107.185 164.416 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -46.12 115.83 3.2 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 117.638 -1.172 . . . . 3.4900000000000002 113.954 -168.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.516 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 30.0 Cg_endo -57.43 140.63 93.73 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.29 2.66 . . . . 3.71 112.536 176.734 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.56 -19.95 10.1 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.846 1.212 . . . . 2.73 114.343 -168.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.98 -98.7 1.73 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.003 1.402 . . . . 1.8300000000000001 113.331 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 77.6 m-85 -75.13 137.88 41.66 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 121.616 -0.932 . . . . 3.0299999999999998 111.756 -173.677 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -160.35 147.2 15.8 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.098 0.959 . . . . 0.64000000000000001 111.059 -174.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -82.39 127.24 33.06 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.089 -1.078 . . . . 3.4199999999999999 108.089 166.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -77.09 143.44 39.23 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.531 1.532 . . . . 2.2799999999999998 108.667 164.945 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.9 mt -128.3 112.14 14.14 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.983 1.313 . . . . 3.23 108.782 -173.45 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.5 132.21 56.37 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.494 1.117 . . . . 3.4399999999999999 109.954 -166.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.24 47.08 7.72 Favored Glycine 0 N--CA 1.472 1.095 0 C-N-CA 124.022 0.82 . . . . 1.8 113.965 173.191 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.5 mt -49.86 153.48 1.28 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 117.119 2.266 . . . . 1.8500000000000001 117.119 -173.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -117.3 -33.35 4.67 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.354 -1.748 . . . . 3.0299999999999998 113.399 -174.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -105.32 133.4 20.18 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 106.786 -1.561 . . . . 7.3899999999999997 106.786 156.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.15 135.01 28.48 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 N-CA-C 107.148 -1.904 . . . . 1.45 107.148 156.623 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.23 157.99 16.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.347 0.594 . . . . 3.4900000000000002 111.05 -177.015 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.85 162.71 37.0 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.182 2.193 . . . . 5.2199999999999998 111.531 170.089 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.77 140.46 58.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.798 1.239 . . . . 1.97 110.232 -175.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.79 48.41 28.14 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.416 -1.265 . . . . 1.9299999999999999 111.777 -170.158 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.26 176.49 7.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.762 1.225 . . . . 2.5600000000000001 108.524 153.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -137.38 162.1 34.51 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 127.657 2.383 . . . . 4.25 107.59 161.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 t -153.83 154.1 7.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 127.773 2.429 . . . . 2.7599999999999998 110.088 -175.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -83.22 140.1 32.73 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 123.13 1.443 . . . . 3.6400000000000001 113.931 161.049 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mp -109.97 167.93 9.81 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.143 -1.39 . . . . 2.9700000000000002 108.526 148.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 62.3 m-20 -130.22 140.8 50.69 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.689 2.396 . . . . 2.5499999999999998 108.406 176.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.5 mp -103.26 127.37 50.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.252 1.421 . . . . 2.4900000000000002 109.735 175.528 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 mt -100.3 106.75 18.42 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.495 1.118 . . . . 2.04 108.693 175.291 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -97.86 125.23 42.63 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.036 0.934 . . . . 3.4700000000000002 111.629 177.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.56 15.06 0.45 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.894 2.077 . . . . 2.8999999999999999 115.36 176.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.59 -7.5 79.71 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.661 1.6 . . . . 4.9500000000000002 115.773 -178.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -134.53 -37.72 0.21 Allowed Glycine 0 N--CA 1.477 1.39 0 CA-C-N 119.438 1.619 . . . . 2.1800000000000002 116.483 -172.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -85.63 107.74 17.67 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.486 -1.596 . . . . 5.1600000000000001 110.851 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.0 t -99.73 132.86 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.94 0.896 . . . . 2.9399999999999999 110.731 178.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.02 127.28 30.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 3.7200000000000002 111.868 172.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -79.88 141.67 35.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.711 1.604 . . . . 3.3999999999999999 114.174 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.61 164.18 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 127.989 2.516 . . . . 3.7599999999999998 109.91 170.81 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.4 t -135.16 132.66 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 106.647 -1.612 . . . . 2.6400000000000001 106.647 156.56 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.81 145.83 20.62 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.684 1.194 . . . . 3.3500000000000001 111.115 -167.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.61 161.69 39.23 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.552 2.835 . . . . 1.1799999999999999 112.51 176.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.9 t -95.53 128.9 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.636 1.174 . . . . 2.1600000000000001 110.025 164.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -142.79 -179.05 6.1 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.283 2.633 . . . . 3.0499999999999998 109.031 -173.309 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.22 109.58 12.48 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.041 -1.037 . . . . 4.3099999999999996 109.953 162.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 129.165 2.986 . . . . 8.0399999999999991 108.519 -161.413 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.408 ' H2 ' ' HG ' ' A' ' 111' ' ' LEU . . . . . . . . 0 N--CA 1.469 0.872 0 N-CA-C 107.9 -2.08 . . . . 14.48 107.9 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.3 p -159.46 -15.87 0.06 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.119 2.168 . . . . 10.199999999999999 113.413 174.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.88 33.84 0.3 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.705 1.139 . . . . 8.4600000000000009 113.71 -159.106 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.9 p -71.37 70.03 0.59 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.761 1.224 . . . . 7.1900000000000004 112.076 170.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -76.4 76.79 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.047 1.339 . . . . 4.6100000000000003 109.361 173.408 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.64 154.17 25.15 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.221 1.391 . . . . 1.45 113.612 171.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.443 ' CD2' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -83.66 156.92 22.41 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.953 1.701 . . . . 9.9299999999999997 114.458 173.092 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -84.62 55.63 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 122.794 1.283 . . . . 3.27 110.19 165.431 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.443 ' HA ' ' CD2' ' A' ' 7' ' ' TRP 0.286 0.2 OUTLIER 27.58 -121.32 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 128.438 2.695 . . . . 6.5300000000000002 115.043 -169.15 . . . . . . . . 4 4 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -166.35 131.3 2.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.346 1.458 . . . . 4.0899999999999999 109.182 -179.115 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -175.84 138.56 0.53 Allowed Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.96 1.304 . . . . 2.3700000000000001 110.306 -176.243 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.34 -38.85 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.666 2.244 . . . . 1.8300000000000001 111.519 164.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.23 173.32 23.83 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.426 1.965 . . . . 1.1899999999999999 111.049 -173.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -77.76 2.44 25.93 Favored 'Cis proline' 0 CA--C 1.542 0.885 0 CA-C-N 119.559 1.679 . . . . 1.51 112.722 -4.685 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -151.14 160.94 43.58 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 123.14 1.448 . . . . 2.1000000000000001 113.561 -175.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.69 -175.99 4.49 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.183 2.193 . . . . 1.6299999999999999 111.765 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.8 148.06 30.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.443 1.897 . . . . 1.8200000000000001 108.243 176.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.82 127.58 52.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.558 1.072 . . . . 2.0699999999999998 109.968 179.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.433 ' CE2' ' HA ' ' A' ' 79' ' ' PRO . 56.6 m-85 -116.2 78.93 1.24 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.054 1.341 . . . . 3.8799999999999999 109.59 -176.089 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -82.14 152.69 26.39 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.53 0.732 . . . . 3.5499999999999998 112.374 -179.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.1 m -84.1 130.71 34.84 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.675 -1.231 . . . . 2.71 107.675 157.633 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.4 tp -96.7 133.3 41.41 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.071 -0.344 . . . . 5.4800000000000004 110.071 -179.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -124.69 129.29 50.24 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.629 1.172 . . . . 6.2000000000000002 112.215 -175.195 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -107.14 99.61 27.92 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.351 -0.843 . . . . 1.6399999999999999 110.506 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -81.16 -12.87 11.56 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.075 2.517 . . . . 1.78 113.564 175.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.74 179.68 51.3 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.567 1.08 . . . . 1.6799999999999999 112.226 -175.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -105.05 0.45 27.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.115 2.166 . . . . 3.23 112.124 -174.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.12 161.08 51.6 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 128.363 2.665 . . . . 3.6299999999999999 109.665 176.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.32 143.29 27.91 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.168 1.912 . . . . 1.55 110.995 -175.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.33 150.1 24.77 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.801 1.241 . . . . 3.5 109.558 171.142 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -136.56 97.18 3.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.316 -1.766 . . . . 3.1099999999999999 110.24 -174.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 tt -80.29 115.42 19.83 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.092 -1.077 . . . . 2.8700000000000001 108.092 -175.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.81 -31.38 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.605 1.162 . . . . 2.1299999999999999 112.58 -176.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.3 177.26 35.06 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 124.716 1.15 . . . . 0.67000000000000004 113.939 175.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -124.38 160.13 28.83 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.821 -0.811 . . . . 1.6799999999999999 110.549 169.147 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -130.52 157.36 42.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.458 1.903 . . . . 5.2000000000000002 108.432 167.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.5 t -165.71 148.31 6.56 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.152 1.781 . . . . 2.1600000000000001 108.683 175.092 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -73.05 -19.71 22.65 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.521 1.481 . . . . 0.89000000000000001 113.609 -176.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 m -90.86 12.57 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 115.799 1.777 . . . . 1.8999999999999999 115.799 -176.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.28 155.39 38.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.518 1.303 . . . . 1.98 114.518 173.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -92.1 -43.92 9.11 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.988 -1.005 . . . . 3.3799999999999999 113.695 -167.11 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -138.69 123.47 18.72 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.884 1.274 . . . . 6.7999999999999998 107.751 -167.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.3 p -126.15 132.8 70.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.209 1.404 . . . . 2.6200000000000001 109.479 -166.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.417 ' CD ' ' HE2' ' A' ' 46' ' ' HIS . 36.5 mt-10 -120.47 157.87 28.45 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.148 1.379 . . . . 3.1000000000000001 109.441 169.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.2 tp -105.58 117.69 34.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.798 1.239 . . . . 2.0299999999999998 108.686 169.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . 0.417 ' HE2' ' CD ' ' A' ' 44' ' ' GLU . 54.3 m170 -118.89 147.61 43.8 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.122 1.369 . . . . 0.83999999999999997 113.533 -175.33 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.423 ' C ' ' HG1' ' A' ' 48' ' ' THR . 10.0 pt-20 -89.11 177.23 6.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.185 1.794 . . . . 2.3700000000000001 110.608 161.057 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.423 ' HG1' ' C ' ' A' ' 47' ' ' GLU . 86.5 m -153.39 140.95 19.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.992 -1.855 . . . . 2.0499999999999998 105.992 174.434 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -153.43 173.18 16.01 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.243 1.201 . . . . 3.4700000000000002 114.243 -165.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.47 134.83 50.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.659 1.584 . . . . 6.7699999999999996 111.534 170.79 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.45 155.46 44.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.232 1.413 . . . . 6.8899999999999997 110.653 171.64 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -86.91 141.17 28.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.97 -0.752 . . . . 2.8700000000000001 108.97 157.864 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.9 t -135.69 115.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.165 1.786 . . . . 3.4500000000000002 106.277 165.482 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 56.09 41.09 30.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.632 1.173 . . . . 4.7699999999999996 113.737 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.47 6.18 65.28 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.723 -1.236 . . . . 1.9299999999999999 114.281 -177.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -118.08 126.48 52.35 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.978 2.111 . . . . 3.6899999999999999 108.117 -178.017 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -76.86 121.93 24.1 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.921 1.289 . . . . 4.3200000000000003 109.533 -173.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.45 132.88 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.317 1.847 . . . . 3.3199999999999998 109.129 -174.295 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtt -80.55 166.66 20.94 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.154 0.798 . . . . 3.0 113.154 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.97 177.07 32.43 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.1 0.857 . . . . 0.92000000000000004 113.426 179.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.5 ttm -155.93 140.56 16.96 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.524 1.529 . . . . 2.21 109.707 -176.059 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -145.02 156.8 54.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.622 1.969 . . . . 10.19 109.218 -176.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.46 151.97 15.44 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.761 2.308 . . . . 0.93999999999999995 110.629 170.677 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.25 155.51 79.84 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.477 1.511 . . . . 1.8200000000000001 110.449 -179.04 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.29 -27.59 3.47 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.945 2.43 . . . . 0.91000000000000003 113.094 -166.585 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -175.68 167.09 3.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.566 1.546 . . . . 3.4100000000000001 111.752 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.0 mt -113.27 153.31 28.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.469 1.908 . . . . 1.6100000000000001 110.355 166.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -117.14 142.77 46.59 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.879 1.272 . . . . 1.9099999999999999 109.434 176.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.3 t -140.97 128.49 12.09 Favored Pre-proline 0 N--CA 1.472 0.657 0 N-CA-C 112.436 0.532 . . . . 2.0800000000000001 112.436 168.004 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.84 159.89 44.37 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.979 3.12 . . . . 1.4399999999999999 112.159 178.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.1 144.13 99.5 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.945 3.097 . . . . 1.6799999999999999 113.34 -176.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mptt 67.3 -9.56 0.39 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.589 2.356 . . . . 3.8500000000000001 114.483 -177.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.51 134.92 14.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.41 1.005 . . . . 1.6599999999999999 112.656 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.22 135.67 41.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.77 -0.826 . . . . 5.0199999999999996 108.77 155.948 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -147.07 129.53 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.031 1.732 . . . . 5.0099999999999998 107.65 -174.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 4.5 mp0 -94.54 150.55 20.13 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.348 -0.845 . . . . 2.8599999999999999 112.565 -167.2 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.24 84.83 2.42 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.081 -1.451 . . . . 2.4900000000000002 107.081 156.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.434 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -64.08 145.5 97.94 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 120.949 -1.094 . . . . 3.46 113.261 -171.482 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.433 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 20.8 Cg_endo -55.36 -38.73 93.61 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.459 3.439 . . . . 2.29 113.582 -174.421 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.14 24.3 19.54 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.199 -1.89 . . . . 2.2599999999999998 115.503 175.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.47 -15.11 0.02 OUTLIER Glycine 0 N--CA 1.476 1.315 0 N-CA-C 121.342 3.297 . . . . 2.2999999999999998 121.342 171.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -149.11 145.92 27.45 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 122.118 2.959 . . . . 3.3300000000000001 114.336 174.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -162.05 158.3 24.72 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.894 1.278 . . . . 0.79000000000000004 112.709 172.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -79.09 142.03 36.82 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.391 -0.818 . . . . 3.75 109.597 157.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 tpt -99.35 125.79 45.09 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.107 2.163 . . . . 2.1400000000000001 108.471 169.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mp -120.3 112.57 19.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.909 1.283 . . . . 2.7200000000000002 109.051 -173.08 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.15 155.33 18.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.242 1.417 . . . . 3.1600000000000001 110.928 -174.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.24 -48.82 3.99 Favored Glycine 0 N--CA 1.469 0.852 0 C-N-CA 126.822 2.153 . . . . 2.9900000000000002 113.05 173.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.9 mt 51.34 172.67 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.903 2.881 . . . . 1.8700000000000001 115.198 -172.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -137.9 -22.56 1.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.544 2.338 . . . . 3.5299999999999998 113.467 -176.75 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -137.63 143.99 42.91 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 128.566 2.747 . . . . 5.96 109.178 175.892 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.43 145.38 37.96 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.31 2.007 . . . . 1.72 108.351 155.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.64 119.6 39.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.851 0.86 . . . . 2.8700000000000001 111.203 -177.724 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -85.29 170.06 13.17 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.88 0.848 . . . . 4.6900000000000004 112.197 169.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.67 136.81 58.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.819 -0.628 . . . . 2.7799999999999998 109.32 157.715 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.79 9.51 87.01 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.291 -1.283 . . . . 1.75 114.954 174.247 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.63 173.06 10.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.982 1.391 . . . . 3.1400000000000001 108.792 160.359 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -145.47 151.68 38.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.64 2.376 . . . . 3.3599999999999999 106.869 169.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.4 t -153.08 139.87 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 127.105 2.162 . . . . 2.5899999999999999 109.664 -176.166 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.21 144.29 34.53 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.489 0.922 . . . . 2.4700000000000002 113.489 173.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.1 mp -120.38 148.01 44.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.555 1.542 . . . . 3.04 110.874 165.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.99 117.28 34.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.706 2.003 . . . . 2.8399999999999999 110.616 164.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -85.73 114.8 22.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.633 1.173 . . . . 2.6000000000000001 108.745 176.102 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.8 mt -90.91 114.03 26.39 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.646 1.178 . . . . 2.2999999999999998 108.91 -175.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -113.07 117.22 31.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.613 1.565 . . . . 3.2200000000000002 112.495 -171.806 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 54.04 26.62 6.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.512 1.525 . . . . 2.7799999999999998 113.736 171.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.5 -68.93 2.64 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.144 1.354 . . . . 4.3799999999999999 112.351 -172.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.25 2.28 62.15 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 116.571 1.388 . . . . 1.8100000000000001 116.571 -166.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -129.44 139.04 51.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.445 1.623 . . . . 3.5699999999999998 111.078 173.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -137.74 142.47 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.425 1.49 . . . . 3.3199999999999998 108.196 176.73 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.408 ' HG ' ' H2 ' ' A' ' 1' ' ' GLY . 50.3 tp -154.43 110.97 3.29 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.252 0.549 . . . . 3.54 112.279 -166.832 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -82.76 152.29 25.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.851 1.056 . . . . 3.1299999999999999 113.851 -170.7 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.14 167.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.128 1.771 . . . . 3.5 110.291 178.3 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.26 138.58 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.307 1.043 . . . . 2.8399999999999999 109.744 -177.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.7 mp -130.17 134.16 25.78 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.038 1.735 . . . . 3.9500000000000002 110.744 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.63 177.71 7.68 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.298 2.665 . . . . 1.1799999999999999 111.562 170.317 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 t -118.28 95.84 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.033 0.933 . . . . 2.2599999999999998 108.65 164.321 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.404 ' H ' ' CB ' ' A' ' 7' ' ' TRP . 41.8 mt-10 -95.44 60.21 2.22 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 121.21 -0.931 . . . . 5.5999999999999996 113.282 -169.252 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.43 117.32 19.53 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.659 -0.651 . . . . 4.9199999999999999 112.3 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.438 ' C ' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 126.591 1.956 . . . . 8.5899999999999999 111.028 -173.034 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.779 0 N-CA-C 107.715 -2.154 . . . . 9.0299999999999994 107.715 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 m -65.45 103.18 0.79 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.94 -1.133 . . . . 10.15 107.94 157.91 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 70.46 123.95 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.089 2.156 . . . . 11.359999999999999 110.6 -154.577 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -119.68 -29.96 4.92 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.363 1.865 . . . . 5.9299999999999997 110.307 168.283 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -95.92 174.84 6.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.326 1.45 . . . . 9.2599999999999998 110.457 164.706 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.97 -171.98 13.6 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.087 2.28 . . . . 2.1099999999999999 110.78 177.358 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -121.81 178.27 4.93 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.004 1.483 . . . . 2.5699999999999998 115.004 -179.718 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.06 142.09 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.124 2.17 . . . . 2.6299999999999999 107.106 172.217 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -79.36 -93.59 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.17 0.588 . . . . 8.4000000000000004 110.852 -178.697 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -161.59 150.56 15.94 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.92 -1.113 . . . . 4.7400000000000002 111.738 -170.941 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.16 127.73 25.8 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.523 1.129 . . . . 4.8300000000000001 111.444 176.215 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.49 -49.52 0.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 N-CA-C 109.126 -1.144 . . . . 4.8600000000000003 109.126 154.143 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.04 141.3 9.33 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 108.872 -1.691 . . . . 1.4199999999999999 108.872 -155.171 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -86.91 14.93 44.17 Favored 'Cis proline' 0 CA--C 1.54 0.814 0 CA-C-N 120.308 2.054 . . . . 1.27 112.63 5.166 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -144.22 171.54 14.15 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.343 1.238 . . . . 2.3799999999999999 114.343 -172.12 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.99 -177.03 6.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.03 2.532 . . . . 1.6599999999999999 112.897 -176.443 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.0 141.46 22.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.657 1.583 . . . . 1.5900000000000001 110.122 177.537 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.24 153.61 36.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 1.6499999999999999 111.325 178.797 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -139.26 59.3 1.61 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.445 1.898 . . . . 3.2999999999999998 111.636 -168.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.86 167.37 17.46 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.612 1.338 . . . . 2.8999999999999999 114.612 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.3 m -101.41 146.46 27.58 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.84 1.656 . . . . 2.2599999999999998 110.628 -177.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.2 117.66 30.19 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.506 1.122 . . . . 5.1699999999999999 110.012 172.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -123.23 128.35 49.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.961 -1.496 . . . . 4.2800000000000002 106.961 163.64 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -97.41 106.21 30.91 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.528 0.731 . . . . 1.4199999999999999 110.575 -179.473 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -84.58 -11.68 8.0 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.602 2.201 . . . . 1.21 114.431 178.132 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.55 166.74 34.73 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 119.406 1.003 . . . . 1.2 111.422 -176.819 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.04 2.85 53.42 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.757 2.023 . . . . 3.3399999999999999 112.308 175.401 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -113.15 155.53 44.25 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.814 2.046 . . . . 4.4500000000000002 110.799 174.536 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -79.47 142.47 16.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.427 2.085 . . . . 1.0 110.69 -178.08 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.91 142.61 30.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.903 0.859 . . . . 3.7599999999999998 109.575 172.513 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -138.02 106.15 5.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.608 1.963 . . . . 3.52 108.724 178.135 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.47 106.16 18.2 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 128.31 2.644 . . . . 2.9700000000000002 107.863 -170.27 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.3 m -104.35 -21.55 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.912 0.708 . . . . 1.71 112.912 -167.434 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.41 -174.89 28.7 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.839 1.209 . . . . 0.62 112.395 175.398 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.36 179.7 6.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.639 0.733 . . . . 1.6100000000000001 112.974 170.678 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -144.81 158.57 43.74 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.823 2.049 . . . . 6.25 107.873 161.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 t -164.6 145.2 6.34 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 125.717 1.607 . . . . 1.73 108.542 175.324 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.24 -2.84 12.89 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.695 1.597 . . . . 1.26 113.982 -175.914 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.6 m -107.03 11.98 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 116.174 1.916 . . . . 2.5699999999999998 116.174 -174.163 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.05 156.43 46.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.423 1.465 . . . . 2.0600000000000001 113.283 177.377 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -86.41 -31.07 21.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.683 1.193 . . . . 3.1800000000000002 111.598 173.408 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -140.61 147.4 39.32 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.004 1.322 . . . . 5.4199999999999999 109.332 166.801 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.38 141.99 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.858 1.663 . . . . 1.77 108.392 161.629 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -140.37 137.68 34.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.317 1.447 . . . . 2.9399999999999999 108.293 -171.449 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.3 tp -99.5 111.98 24.25 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.371 -0.831 . . . . 2.1099999999999999 111.922 -170.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -118.92 155.64 30.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.962 1.305 . . . . 0.76000000000000001 113.236 -176.614 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -100.25 176.51 5.35 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.579 1.552 . . . . 1.9099999999999999 112.187 159.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.3 m -143.64 136.27 27.26 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.1 -1.815 . . . . 1.8500000000000001 106.1 165.085 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -138.77 164.65 29.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.97 1.308 . . . . 3.3399999999999999 112.675 -165.672 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.5 ttp -99.42 142.64 30.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.929 1.292 . . . . 4.6500000000000004 109.943 170.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -142.75 145.16 33.04 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.903 1.681 . . . . 9.0700000000000003 111.278 173.22 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.93 141.39 34.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.466 1.106 . . . . 3.6699999999999999 109.903 158.768 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.3 t -138.44 121.19 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.159 1.783 . . . . 3.4399999999999999 106.4 170.699 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 62.39 15.98 8.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.506 1.522 . . . . 3.3700000000000001 114.011 -173.292 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.67 16.36 66.08 Favored Glycine 0 N--CA 1.477 1.402 0 O-C-N 120.979 -1.076 . . . . 2.1899999999999999 113.871 -170.356 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -121.37 121.11 36.91 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.686 2.395 . . . . 3.1400000000000001 108.394 -179.097 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.87 139.65 48.94 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.379 -1.45 . . . . 4.54 113.178 178.028 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.7 p -155.26 169.7 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 128.246 2.618 . . . . 3.4700000000000002 108.347 176.762 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.0 mtm -100.29 172.1 7.37 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.787 -1.195 . . . . 4.9299999999999997 113.31 176.795 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.49 174.04 31.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.688 2.09 . . . . 0.60999999999999999 111.355 166.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ttm -136.43 153.73 50.99 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.33 1.852 . . . . 2.3300000000000001 108.08 175.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -159.13 156.06 25.41 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-O 118.076 -0.964 . . . . 5.5899999999999999 111.082 175.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.96 155.5 52.95 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.432 2.088 . . . . 0.59999999999999998 110.849 170.446 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -141.1 159.5 61.4 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 125.637 1.575 . . . . 2.1000000000000001 110.38 -175.199 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -82.19 -27.12 2.5 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.432 2.088 . . . . 0.78000000000000003 113.134 -168.412 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -177.59 164.82 2.08 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.378 1.471 . . . . 3.8900000000000001 112.171 -177.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.1 mt -107.94 160.21 15.94 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.93 1.292 . . . . 2.0 110.376 160.272 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -145.15 147.58 32.65 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.235 -0.916 . . . . 2.04 111.521 -179.567 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.3 t -143.25 131.0 10.99 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.086 0.954 . . . . 2.1899999999999999 111.736 176.018 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.42 162.15 42.29 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 124.175 3.25 . . . . 1.01 112.457 179.122 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -59.49 135.47 64.99 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.215 3.277 . . . . 0.97999999999999998 113.08 -177.419 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.55 -5.36 0.62 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.927 2.091 . . . . 3.1000000000000001 114.508 -179.51 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.84 167.92 51.86 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.917 1.722 . . . . 1.28 112.589 171.518 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.86 151.74 40.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.53 0.732 . . . . 6.9400000000000004 112.22 174.623 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.7 t -146.83 -178.81 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 128.021 2.529 . . . . 4.3899999999999997 107.784 -178.498 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.83 154.52 41.44 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.347 1.859 . . . . 3.6200000000000001 108.206 171.191 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.7 mp -51.19 -38.88 54.81 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 123.048 0.539 . . . . 3.0600000000000001 111.899 175.788 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm 101.14 118.19 0.01 OUTLIER Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 127.773 2.429 . . . . 3.23 109.906 161.605 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.24 -16.36 54.57 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.114 2.543 . . . . 2.7599999999999998 116.181 -161.06 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -115.34 7.16 20.89 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.655 1.121 . . . . 2.75 114.946 169.884 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.62 -110.09 1.93 Allowed Glycine 0 N--CA 1.47 0.915 0 C-N-CA 125.839 1.685 . . . . 2.1499999999999999 113.263 -171.123 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -73.1 147.95 44.45 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 123.378 1.561 . . . . 3.3100000000000001 111.773 -175.873 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -159.68 142.39 13.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.579 -1.646 . . . . 1.04 111.045 -178.24 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -79.88 111.24 16.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.972 -1.122 . . . . 3.4900000000000002 107.972 165.424 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.7 tpt -77.03 120.9 22.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.343 2.257 . . . . 2.23 107.908 175.111 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.3 mt -109.74 122.22 47.0 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.272 1.429 . . . . 3.6200000000000001 109.035 -173.206 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.98 143.76 46.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.691 1.196 . . . . 3.3999999999999999 111.415 -170.093 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.33 -43.22 2.85 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 127.248 2.356 . . . . 2.9300000000000002 113.955 175.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.8 mt 56.77 168.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 129.698 3.199 . . . . 1.97 115.637 -176.284 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -123.97 -30.83 3.46 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.97 1.708 . . . . 2.73 112.427 173.658 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -127.66 140.22 37.46 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 128.932 2.893 . . . . 6.9000000000000004 107.612 166.219 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.81 59.19 0.9 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.376 2.717 . . . . 2.79 112.717 -165.341 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -33.73 106.2 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 116.566 2.061 . . . . 3.96 116.566 -157.704 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -100.95 168.63 9.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.265 1.826 . . . . 9.0199999999999996 111.043 169.047 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.69 134.2 50.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.93 0.892 . . . . 2.2000000000000002 110.724 -176.555 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.72 -6.33 52.05 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.26 1.886 . . . . 1.52 114.376 -175.331 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.59 -175.1 5.58 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.985 1.314 . . . . 2.9300000000000002 112.106 170.769 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.7 142.02 23.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 128.543 2.737 . . . . 6.5 107.247 -173.415 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 t -142.79 124.4 12.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 124.004 0.921 . . . . 2.9900000000000002 110.68 -168.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -98.64 129.53 45.14 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.903 -1.044 . . . . 2.7400000000000002 110.707 -178.573 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.11 137.9 53.27 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.193 1.797 . . . . 3.6299999999999999 110.3 179.091 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -97.92 124.2 42.25 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.324 2.25 . . . . 1.8 108.889 170.402 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.15 115.66 27.98 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.797 1.239 . . . . 2.0499999999999998 109.756 178.407 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.89 101.5 13.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.222 -0.658 . . . . 1.98 109.222 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -94.29 136.9 34.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.161 0.984 . . . . 3.3500000000000001 111.097 176.669 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.97 125.88 13.03 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.706 1.202 . . . . 2.2799999999999998 113.449 -174.566 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.68 70.51 1.28 Allowed Glycine 0 N--CA 1.47 0.951 0 C-N-CA 124.259 0.933 . . . . 3.71 112.897 177.54 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.72 5.99 58.1 Favored Glycine 0 N--CA 1.474 1.224 0 N-CA-C 116.485 1.354 . . . . 1.6100000000000001 116.485 164.498 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -98.51 127.12 44.31 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.395 1.598 . . . . 4.3799999999999999 109.878 -179.794 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.24 142.92 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.3 1.04 . . . . 3.3900000000000001 109.01 179.865 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.0 tt -152.5 135.98 15.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.336 1.455 . . . . 3.02 109.208 -177.841 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -102.1 140.42 36.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.354 0.662 . . . . 4.0300000000000002 112.433 -179.485 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.8 t -127.84 162.7 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 127.109 2.164 . . . . 2.5699999999999998 108.311 175.575 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.9 t -128.33 141.25 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.397 1.479 . . . . 3.0600000000000001 110.436 -178.662 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.3 mt -136.45 124.66 15.0 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.693 1.197 . . . . 3.29 109.848 -164.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.67 149.36 48.72 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.048 1.832 . . . . 1.01 110.244 173.767 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.0 t -90.94 117.35 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.861 -0.792 . . . . 1.9199999999999999 108.861 167.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -137.8 123.71 20.11 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.12 -1.067 . . . . 4.04 108.12 175.25 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.18 58.23 2.46 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.093 0.557 . . . . 2.3799999999999999 111.781 -179.278 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.907 0 C-N-CA 126.263 1.825 . . . . 9.1199999999999992 112.107 -179.224 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 CA--C 1.544 0.729 0 CA-C-O 121.237 0.541 . . . . 4.6500000000000004 112.038 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.68 179.32 35.33 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.65 1.119 . . . . 1.28 114.869 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -146.25 146.33 30.72 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.134 1.374 . . . . 2.4100000000000001 112.721 162.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -86.57 149.76 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.711 1.204 . . . . 1.4399999999999999 108.236 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -84.49 149.95 25.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.852 1.31 . . . . 3.8199999999999998 113.162 -176.035 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.416 ' H ' ' HD3' ' A' ' 9' ' ' ARG . 64.7 t80 -76.36 134.05 39.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.56 2.744 . . . . 2.1099999999999999 110.823 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.1 t 175.62 135.59 0.18 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.912 1.685 . . . . 2.3700000000000001 112.058 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.58 -24.85 21.61 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.441 2.094 . . . . 1.3899999999999999 112.506 170.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.2 171.59 12.27 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 127.074 2.273 . . . . 0.84999999999999998 111.375 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.65 -8.21 39.71 Favored 'Cis proline' 0 CA--C 1.538 0.692 0 CA-C-N 118.886 1.343 . . . . 0.92000000000000004 113.307 0.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -144.2 157.81 44.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.968 1.307 . . . . 1.8600000000000001 113.44 -172.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.02 -175.74 4.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.023 3.329 . . . . 0.42999999999999999 108.473 -176.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.34 176.81 8.37 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.155 1.382 . . . . 1.0600000000000001 109.173 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.8 138.17 19.49 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.685 1.13 . . . . 0.53000000000000003 112.327 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 17.7 m-85 -119.02 137.51 53.48 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.256 2.222 . . . . 2.0699999999999998 108.262 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -168.35 148.37 4.67 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.324 1.05 . . . . 1.6699999999999999 111.707 -172.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -89.53 122.21 32.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.923 0.889 . . . . 1.76 111.172 -176.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.401 HD11 ' CZ ' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -102.58 120.3 40.3 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.077 1.351 . . . . 3.1000000000000001 108.765 -177.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -122.13 141.75 51.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.527 1.131 . . . . 3.8999999999999999 111.3 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -117.05 108.94 43.31 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.393 1.077 . . . . 1.46 110.659 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.78 -10.99 10.4 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.939 2.426 . . . . 1.1599999999999999 113.848 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.25 175.88 49.93 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-O 122.787 1.215 . . . . 1.1699999999999999 113.224 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -99.41 -3.83 32.87 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.327 2.651 . . . . 3.0 111.43 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -122.37 157.27 59.23 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 128.336 2.654 . . . . 2.6699999999999999 109.883 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.0 145.8 31.86 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.788 2.325 . . . . 0.93000000000000005 111.137 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.1 mt -105.83 157.08 17.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 122.716 1.246 . . . . 1.9299999999999999 109.959 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -147.99 110.71 4.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.789 -2.005 . . . . 2.2400000000000002 112.724 -170.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.99 107.37 19.16 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.447 1.899 . . . . 1.8700000000000001 109.297 -173.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 m -103.71 -24.55 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.209 1.003 . . . . 0.67000000000000004 112.949 -168.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.34 -177.61 32.58 Favored Glycine 0 N--CA 1.466 0.686 0 C-N-CA 125.387 1.47 . . . . 0.48999999999999999 112.095 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.06 -178.84 5.27 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.057 -0.672 . . . . 0.56000000000000005 111.648 169.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.8 mtp-105 -144.32 177.07 8.89 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.237 1.815 . . . . 3.8199999999999998 108.273 158.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 t -172.92 152.31 2.36 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.158 1.783 . . . . 0.71999999999999997 109.517 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.39 -7.52 15.98 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.134 1.889 . . . . 0.81000000000000005 114.172 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.8 m -113.63 24.29 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 115.969 1.84 . . . . 0.78000000000000003 115.969 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.06 143.18 19.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.677 1.591 . . . . 0.88 110.977 169.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -68.87 -33.23 73.44 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.661 1.584 . . . . 3.1200000000000001 112.862 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -137.91 159.89 40.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.965 2.106 . . . . 4.4699999999999998 108.843 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.69 143.49 30.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.026 1.33 . . . . 0.93000000000000005 108.407 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -123.21 149.77 44.25 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.665 1.986 . . . . 2.6699999999999999 109.055 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.8 tp -102.3 121.75 42.89 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.573 0.749 . . . . 0.88 110.389 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -125.06 159.6 31.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 123.603 1.668 . . . . 0.48999999999999999 113.921 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -104.61 159.51 15.7 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.831 2.452 . . . . 2.1299999999999999 110.976 158.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.3 m -128.49 148.36 50.74 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 105.906 -1.887 . . . . 0.72999999999999998 105.906 165.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -159.97 175.89 12.49 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.992 0.917 . . . . 2.23 112.857 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.8 ttp -111.65 136.36 50.98 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.342 1.457 . . . . 3.2999999999999998 111.282 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -120.54 159.92 24.24 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.346 1.858 . . . . 4.75 110.611 171.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -90.68 147.99 22.91 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.451 0.7 . . . . 2.27 109.503 151.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.8 t -138.79 118.78 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.579 1.552 . . . . 2.2799999999999998 106.915 157.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 61.09 25.68 15.67 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.758 1.392 . . . . 3.3300000000000001 114.758 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.34 4.68 90.09 Favored Glycine 0 N--CA 1.481 1.647 0 O-C-N 120.044 -1.66 . . . . 1.79 113.984 -171.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -105.54 120.14 40.89 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.587 2.355 . . . . 2.5099999999999998 107.885 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -71.54 113.83 8.98 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.693 1.597 . . . . 2.6400000000000001 109.778 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.1 t -140.46 133.72 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.402 1.481 . . . . 2.1499999999999999 109.518 -172.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.7 mtt -79.5 171.88 14.56 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.347 1.24 . . . . 2.54 114.347 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.82 168.18 29.94 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.364 1.935 . . . . 0.79000000000000004 112.226 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.0 ttm -149.08 145.37 27.21 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.697 1.599 . . . . 1.0900000000000001 108.95 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -148.06 152.9 40.93 Favored Pre-proline 0 N--CA 1.467 0.4 0 C-N-CA 125.121 1.368 . . . . 4.4199999999999999 109.853 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.24 154.28 41.28 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.103 1.869 . . . . 0.5 110.742 163.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.05 157.95 70.45 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 125.768 1.627 . . . . 0.60999999999999999 110.309 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.22 -26.74 2.66 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.024 2.483 . . . . 0.58999999999999997 113.32 -167.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -177.43 164.54 2.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.662 1.585 . . . . 2.0499999999999998 111.763 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.2 mt -110.86 153.09 25.91 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.094 1.358 . . . . 0.72999999999999998 110.404 164.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -110.96 147.05 35.52 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.049 1.339 . . . . 2.0499999999999998 109.895 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.62 121.44 17.24 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 123.363 0.665 . . . . 1.4099999999999999 111.195 163.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.14 159.05 54.47 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.222 2.614 . . . . 1.1899999999999999 111.424 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.5 138.98 83.84 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.605 2.87 . . . . 0.93999999999999995 112.319 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt 65.63 -3.64 0.68 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.484 1.914 . . . . 1.7 114.032 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.08 -176.64 34.82 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 126.971 2.224 . . . . 1.1599999999999999 113.2 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -147.83 152.85 38.36 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.246 1.019 . . . . 3.5 112.406 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.81 134.24 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.805 1.642 . . . . 3.4900000000000002 107.735 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 143.82 31.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.305 1.042 . . . . 3.29 112.199 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -74.33 130.1 39.05 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.481 -1.303 . . . . 2.4399999999999999 107.481 151.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 155.2 73.92 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.445 1.498 . . . . 2.48 113.392 -170.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 38.4 Cg_endo -58.83 -36.72 96.53 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.507 2.805 . . . . 2.3199999999999998 113.731 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.26 12.89 36.03 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.592 -1.116 . . . . 1.79 115.001 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.35 -122.38 0.62 Allowed Glycine 0 C--N 1.343 0.937 0 CA-C-N 119.562 1.681 . . . . 1.76 114.778 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -71.34 140.9 50.4 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.049 -0.677 . . . . 1.8100000000000001 111.585 -168.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -161.88 153.97 19.35 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.288 1.035 . . . . 0.55000000000000004 112.137 -174.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -79.04 143.0 36.06 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.416 -0.587 . . . . 1.73 109.416 161.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -100.06 123.13 43.95 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.438 1.495 . . . . 0.70999999999999996 108.168 163.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -98.77 130.27 45.22 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.273 -1.01 . . . . 1.3300000000000001 108.273 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mp -129.32 139.05 51.88 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.672 0.789 . . . . 2.0099999999999998 111.326 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.33 47.03 8.49 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 123.588 0.613 . . . . 1.5800000000000001 112.223 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.413 HD13 HD23 ' A' ' 93' ' ' LEU . 10.5 mt -51.88 158.36 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 115.9 1.815 . . . . 0.87 115.9 -174.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -119.33 -32.83 4.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.035 -1.439 . . . . 1.6699999999999999 113.097 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -96.28 142.69 24.92 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.067 1.347 . . . . 4.8799999999999999 107.711 161.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 117.71 5.29 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 N-CA-C 106.33 -2.219 . . . . 1.4299999999999999 106.33 150.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.413 HD23 HD13 ' A' ' 89' ' ' LEU . 2.0 mm? -76.6 105.34 7.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.139 1.775 . . . . 1.9299999999999999 108.827 -175.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -98.56 171.91 7.84 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.746 1.219 . . . . 3.5699999999999998 111.452 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.9 131.77 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.216 -0.928 . . . . 1.0900000000000001 108.687 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.74 58.81 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.751 -1.027 . . . . 1.3400000000000001 114.576 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.83 -176.26 4.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.509 1.154 . . . . 2.3900000000000001 110.076 161.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -139.65 145.98 39.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 127.996 2.518 . . . . 2.79 105.851 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -146.42 149.28 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 127.537 2.335 . . . . 1.1299999999999999 108.871 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -111.87 150.13 30.85 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.066 0.946 . . . . 2.1400000000000001 113.091 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.4 mp -129.51 140.88 51.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.1 2.16 . . . . 1.6899999999999999 109.552 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -85.31 131.15 34.45 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.208 -1.034 . . . . 2.2000000000000002 108.208 160.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.88 109.8 21.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 121.239 1.836 . . . . 1.3 107.602 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.49 113.96 18.04 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.508 -0.923 . . . . 0.68999999999999995 108.508 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.401 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 9.2 m-30 -105.35 140.76 37.99 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.792 1.237 . . . . 2.1899999999999999 110.566 -175.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.03 126.73 28.67 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.49 -1.381 . . . . 2.3900000000000001 113.823 -173.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.34 75.84 0.85 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.785 1.183 . . . . 4.0099999999999998 112.739 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.8 72.62 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 115.473 0.949 . . . . 2.0 115.473 166.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -130.87 149.79 52.34 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.103 1.452 . . . . 3.46 112.236 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.8 t -149.01 147.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.175 1.39 . . . . 2.23 108.421 167.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.4 tp -126.2 113.74 17.4 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.869 1.267 . . . . 2.3999999999999999 108.985 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -83.3 133.44 34.97 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.731 -1.231 . . . . 2.0499999999999998 110.393 172.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -126.89 160.78 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.041 1.337 . . . . 1.72 109.167 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 t -133.15 137.71 52.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 127.125 2.17 . . . . 2.1000000000000001 107.591 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.22 150.85 20.33 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.752 1.221 . . . . 2.04 111.763 -169.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.36 163.88 30.46 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.258 2.639 . . . . 0.84999999999999998 112.387 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 t -100.48 124.37 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.393 -0.821 . . . . 0.92000000000000004 109.001 163.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 122.631 1.205 . . . . 3.7200000000000002 111.603 172.48 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.798 0.809 . . . . 4.6399999999999997 110.011 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.43 153.87 22.7 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 125.086 1.326 . . . . 1.1799999999999999 110.885 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -126.14 134.97 51.16 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.346 1.059 . . . . 2.52 111.367 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 t -84.26 56.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.065 1.346 . . . . 3.2000000000000002 109.166 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 32.08 -116.56 0.05 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.052 2.541 . . . . 4.4800000000000004 112.658 -171.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.0 t80 171.48 134.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.455 2.702 . . . . 2.5499999999999998 108.154 -173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.5 t -178.31 144.54 0.49 Allowed Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.215 1.806 . . . . 1.97 110.745 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.76 -24.19 18.42 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.749 2.3 . . . . 1.24 112.513 164.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.22 -173.95 15.07 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.658 1.599 . . . . 0.84999999999999998 112.591 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.38 -12.66 19.68 Favored 'Cis proline' 0 CA--C 1.539 0.745 0 CA-C-N 118.55 1.175 . . . . 1.0700000000000001 113.475 1.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -125.05 169.83 11.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.803 1.641 . . . . 1.8500000000000001 111.718 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.67 -175.63 5.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.014 2.526 . . . . 0.62 110.96 -173.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.27 169.83 16.61 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.219 1.808 . . . . 1.1000000000000001 108.571 170.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.01 127.46 15.97 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.711 1.204 . . . . 0.75 110.99 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -107.27 66.58 0.67 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.861 2.064 . . . . 2.1299999999999999 110.122 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.27 153.06 42.69 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.183 -0.948 . . . . 1.74 111.942 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.439 HG23 ' HB3' ' A' ' 76' ' ' GLU . 88.5 m -130.83 132.33 45.15 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.737 1.215 . . . . 2.2200000000000002 108.785 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD21 HG21 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -154.26 178.02 10.47 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.998 2.119 . . . . 5.5499999999999998 109.382 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -139.67 160.24 40.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.385 1.474 . . . . 4.7999999999999998 110.772 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -103.66 96.78 9.42 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.367 1.867 . . . . 1.4399999999999999 109.335 171.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.8 -1.39 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.103 2.535 . . . . 1.3700000000000001 114.675 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.05 156.26 25.14 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.418 1.008 . . . . 1.3100000000000001 111.331 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.86 5.61 9.26 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.097 2.559 . . . . 4.0099999999999998 112.339 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.28 151.57 49.55 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 127.92 2.488 . . . . 3.2599999999999998 110.616 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.75 161.44 27.48 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.759 2.306 . . . . 1.02 111.58 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.1 mt -120.67 152.57 38.05 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 122.525 1.155 . . . . 1.96 110.985 169.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -132.64 118.22 18.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 112.558 -2.11 . . . . 2.1200000000000001 109.176 169.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.92 113.61 26.97 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.317 1.847 . . . . 1.77 107.724 -172.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 m -110.64 -24.6 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.54 0.736 . . . . 0.45000000000000001 112.83 -167.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.22 -174.85 28.45 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 125.053 1.311 . . . . 0.34999999999999998 112.884 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.4 -178.13 5.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.836 1.254 . . . . 0.45000000000000001 110.92 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.71 170.07 20.08 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.504 1.922 . . . . 5.9400000000000004 109.131 164.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -175.98 151.41 1.17 Allowed Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 127.12 2.168 . . . . 0.68999999999999995 109.117 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.0 -2.82 11.99 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.753 2.302 . . . . 0.88 114.111 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.05 28.72 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.578 1.551 . . . . 1.02 114.545 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.29 138.56 11.3 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.202 1.001 . . . . 1.0 111.76 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -65.55 -31.62 72.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.848 1.659 . . . . 2.8999999999999999 113.742 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -146.3 154.59 41.86 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.66 1.584 . . . . 4.6900000000000004 109.339 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -141.26 140.94 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.238 1.415 . . . . 0.83999999999999997 110.133 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -139.78 139.54 36.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.088 1.755 . . . . 2.8399999999999999 109.447 -166.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.6 tp -89.89 128.81 36.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.869 1.213 . . . . 1.4399999999999999 110.656 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -118.58 160.85 21.03 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.262 1.825 . . . . 0.93000000000000005 113.854 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -122.45 152.92 39.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.55 2.34 . . . . 2.27 109.991 167.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 m -129.84 135.47 48.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.524 1.53 . . . . 0.92000000000000004 107.7 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -150.5 171.24 17.38 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.542 1.163 . . . . 2.0600000000000001 113.673 -167.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.2 ttp -101.87 143.8 31.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.942 1.697 . . . . 3.8799999999999999 110.652 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -155.7 152.86 29.1 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.121 1.768 . . . . 8.2100000000000009 112.596 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 139.13 37.09 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.274 1.03 . . . . 2.6400000000000001 111.508 170.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.9 t -141.09 129.04 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 106.521 -1.659 . . . . 3.1299999999999999 106.521 164.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.59 29.99 17.0 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.195 0.998 . . . . 4.5300000000000002 112.392 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.37 16.56 78.79 Favored Glycine 0 N--CA 1.472 1.087 0 O-C-N 121.031 -1.043 . . . . 2.1400000000000001 114.167 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -133.48 133.6 42.45 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.405 1.482 . . . . 3.0600000000000001 110.758 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.32 122.86 22.7 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.078 1.351 . . . . 5.0499999999999998 110.493 -177.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -135.0 -175.78 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 129.492 3.117 . . . . 3.0 108.951 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -111.99 169.24 8.98 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.085 0.945 . . . . 2.79 113.401 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.24 171.93 33.45 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.636 2.065 . . . . 0.75 112.446 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.9 ttm -150.24 142.89 24.58 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.896 1.678 . . . . 1.76 109.364 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -144.01 155.58 58.76 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 125.483 1.513 . . . . 4.46 110.174 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -75.36 161.18 38.11 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.319 2.013 . . . . 0.73999999999999999 111.061 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.31 156.65 39.76 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.8 1.64 . . . . 1.1599999999999999 110.536 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.03 -25.68 1.71 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.366 2.711 . . . . 0.66000000000000003 113.813 -165.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -176.74 171.58 2.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.614 1.966 . . . . 2.4300000000000002 110.962 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.4 mt -116.07 153.04 32.42 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.346 1.858 . . . . 0.67000000000000004 109.942 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.1 145.02 42.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.803 1.241 . . . . 1.8700000000000001 108.029 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.9 133.96 12.66 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 118.664 0.665 . . . . 1.1299999999999999 112.759 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.41 170.83 12.74 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.56 2.84 . . . . 1.0600000000000001 112.704 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.36 147.32 87.31 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.105 2.537 . . . . 1.04 113.297 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.306 22.0 mtmt 54.75 44.95 27.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.636 1.574 . . . . 3.0 113.548 171.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.02 175.54 21.05 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.827 2.632 . . . . 1.1100000000000001 113.761 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -79.44 154.07 29.2 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.884 -0.774 . . . . 4.9400000000000004 112.406 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.47 66.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 127.259 2.224 . . . . 5.7599999999999998 107.253 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HB3' HG23 ' A' ' 21' ' ' THR . 2.1 pp20? -127.1 137.89 53.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.652 0.982 . . . . 2.7599999999999998 113.652 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.45 71.88 0.89 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.29 2.236 . . . . 2.1200000000000001 109.922 -170.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 140.02 17.46 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 125.754 1.622 . . . . 3.0499999999999998 113.674 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.01 -17.9 51.51 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.91 3.073 . . . . 1.99 114.826 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.14 10.14 61.68 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.086 -1.396 . . . . 1.8600000000000001 114.435 175.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.57 -111.2 0.26 Allowed Glycine 0 N--CA 1.473 1.13 0 CA-C-N 119.251 1.525 . . . . 1.4299999999999999 114.369 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -74.18 136.1 42.82 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.889 -0.771 . . . . 1.8799999999999999 112.318 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -160.79 164.96 31.09 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.793 1.237 . . . . 0.85999999999999999 111.796 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -92.84 140.7 29.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.544 0.611 . . . . 2.1400000000000001 111.141 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -93.98 135.96 34.77 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.902 1.681 . . . . 0.85999999999999999 109.478 163.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -114.54 135.71 53.83 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.863 1.665 . . . . 1.23 108.755 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.91 138.28 48.32 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.78 0.832 . . . . 2.1000000000000001 111.348 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.19 51.19 6.96 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.036 0.827 . . . . 1.6100000000000001 112.788 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.33 153.6 3.82 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 115.66 1.726 . . . . 0.81999999999999995 115.66 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -102.89 -16.13 15.98 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.939 1.459 . . . . 1.5700000000000001 114.939 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.2 mmt-85 -137.42 145.78 50.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 128.23 2.612 . . . . 6.5999999999999996 110.03 166.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.25 124.97 13.73 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 N-CA-C 106.649 -2.096 . . . . 1.4099999999999999 106.649 148.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.36 101.99 11.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.088 0.947 . . . . 2.3999999999999999 108.801 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.57 13.69 6.61 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.248 2.314 . . . . 4.8300000000000001 117.248 -152.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 74.92 151.0 0.12 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 129.493 3.117 . . . . 1.6899999999999999 112.498 -171.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.84 39.82 98.01 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.628 -0.989 . . . . 1.53 110.628 -165.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.58 171.27 7.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.96 1.704 . . . . 2.48 107.539 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -142.18 129.71 21.37 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.705 2.002 . . . . 3.7799999999999998 106.922 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.0 t -153.28 141.13 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.166 1.787 . . . . 1.6499999999999999 109.326 -162.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.41 ' OE1' ' HE2' ' A' ' 112' ' ' LYS . 9.6 pt-20 -86.42 147.47 26.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.657 1.354 . . . . 2.8900000000000001 114.657 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mp -121.29 146.48 46.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.832 1.653 . . . . 1.6499999999999999 110.5 164.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.58 134.67 38.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.04 2.536 . . . . 2.3100000000000001 108.245 161.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.84 130.96 46.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.849 1.26 . . . . 0.92000000000000004 108.072 164.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.4 mt -110.85 108.42 18.22 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.658 1.183 . . . . 0.66000000000000003 110.082 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -104.32 155.12 19.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.851 1.66 . . . . 2.1800000000000002 111.285 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.45 145.03 45.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.556 0.742 . . . . 2.6099999999999999 112.036 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.95 20.88 41.24 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.961 -0.911 . . . . 3.8199999999999998 114.598 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.46 9.22 86.98 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 118.521 1.16 . . . . 2.0499999999999998 113.901 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -79.32 106.83 11.63 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.357 -1.084 . . . . 3.0899999999999999 111.229 -174.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.5 p -115.89 115.84 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.199 1.4 . . . . 2.0800000000000001 110.848 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.9 mp -120.83 117.45 27.44 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.799 1.239 . . . . 3.1400000000000001 109.562 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.41 ' HE2' ' OE1' ' A' ' 100' ' ' GLU . 2.4 ttpm? -105.87 134.63 48.7 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.807 0.443 . . . . 2.6099999999999999 112.143 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.402 HG21 HD21 ' A' ' 22' ' ' LEU . 8.4 t -144.47 159.92 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.58 1.552 . . . . 2.8100000000000001 109.221 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -107.01 134.4 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.659 1.584 . . . . 2.6099999999999999 110.31 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.82 148.37 57.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.034 1.734 . . . . 3.1200000000000001 110.12 -169.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.05 170.33 19.22 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.516 2.811 . . . . 1.0700000000000001 113.374 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.68 121.19 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 127.291 2.236 . . . . 0.98999999999999999 109.589 169.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 122.788 1.28 . . . . 4.0999999999999996 114.1 176.198 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 120.987 0.422 . . . . 7.0599999999999996 110.325 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.47 -175.03 44.72 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.429 1.014 . . . . 1.51 111.633 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.2 p90 -142.59 -173.7 3.94 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.819 -0.812 . . . . 2.5800000000000001 112.988 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.4 t -122.61 129.23 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.029 -1.044 . . . . 1.9299999999999999 110.426 -169.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -48.88 -27.42 3.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.367 1.867 . . . . 6.6699999999999999 115.227 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 89.2 t80 69.42 116.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.452 2.701 . . . . 3.0899999999999999 111.437 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.1 m -170.12 150.48 3.62 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.13 1.372 . . . . 2.3799999999999999 110.231 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.17 -29.93 1.41 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.284 2.656 . . . . 1.3500000000000001 113.029 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.1 173.56 20.52 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.557 2.503 . . . . 1.01 110.538 -170.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -81.02 4.74 41.43 Favored 'Cis proline' 0 CA--C 1.541 0.827 0 CA-C-N 120.193 1.996 . . . . 1.6000000000000001 113.18 -3.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -148.26 164.86 32.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.159 0.98 . . . . 2.54 112.839 168.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.65 -178.14 4.93 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.049 2.139 . . . . 0.40999999999999998 109.771 165.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.49 154.82 49.82 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.949 2.1 . . . . 0.73999999999999999 107.183 168.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.82 142.67 49.09 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.073 0.949 . . . . 0.78000000000000003 110.434 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -124.03 19.98 9.14 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.608 1.336 . . . . 2.29 114.608 -160.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.402 ' HB3' HD22 ' A' ' 115' ' ' LEU . 2.4 pt? -51.48 161.46 0.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.753 1.76 . . . . 2.7200000000000002 115.753 -171.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -82.18 144.77 30.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.406 -0.815 . . . . 1.73 111.845 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.47 118.04 22.39 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.642 1.177 . . . . 3.8500000000000001 110.031 168.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -113.85 132.7 55.8 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.414 -1.328 . . . . 4.29 107.414 167.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -92.04 110.85 46.87 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.933 0.893 . . . . 1.3 109.321 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -85.07 -9.58 8.5 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.296 2.664 . . . . 1.3100000000000001 115.04 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.48 166.06 29.06 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 119.503 1.047 . . . . 1.3200000000000001 112.067 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.84 4.87 27.33 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.511 2.324 . . . . 3.5600000000000001 112.14 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.61 154.5 52.53 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 128.159 2.584 . . . . 2.9100000000000001 110.425 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.56 145.24 20.57 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.925 2.417 . . . . 0.89000000000000001 110.566 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 mt -105.04 148.55 26.65 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 122.319 1.057 . . . . 1.9099999999999999 111.649 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -130.22 112.08 13.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.283 -2.235 . . . . 1.8500000000000001 111.265 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.483 HD11 ' CZ ' ' A' ' 84' ' ' PHE . 2.4 tm? -100.16 111.12 23.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.242 2.217 . . . . 2.25 109.265 -172.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -104.11 -25.62 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.415 1.086 . . . . 0.51000000000000001 111.697 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.92 -175.89 32.43 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 125.022 1.296 . . . . 0.35999999999999999 113.432 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -140.94 -179.9 6.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.631 1.572 . . . . 0.45000000000000001 110.045 169.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -156.72 157.29 34.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.266 2.227 . . . . 4.4800000000000004 108.024 174.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -164.8 150.08 8.53 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.984 1.313 . . . . 0.81000000000000005 109.858 175.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.56 -12.14 33.7 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.96 2.44 . . . . 0.93999999999999995 115.061 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.7 m -109.64 16.56 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 116.732 2.123 . . . . 0.88 116.732 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.39 162.08 34.02 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.826 -1.171 . . . . 0.90000000000000002 114.144 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -100.07 -63.03 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.228 1.411 . . . . 2.6600000000000001 109.505 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -107.43 98.5 8.11 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.924 -1.11 . . . . 6.3700000000000001 110.382 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -79.01 141.62 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.223 -0.899 . . . . 1.54 110.189 164.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -153.26 138.37 17.34 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.5 1.52 . . . . 2.7799999999999998 109.4 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.0 tp -96.65 122.31 39.44 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.731 0.777 . . . . 1.01 112.023 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -121.97 161.56 22.69 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.911 1.685 . . . . 0.98999999999999999 113.779 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.13 -178.42 3.66 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.934 2.094 . . . . 3.1000000000000001 111.642 158.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.6 m -154.14 145.82 23.31 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.984 1.713 . . . . 0.97999999999999998 107.111 169.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -157.17 179.8 8.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.629 1.204 . . . . 2.4500000000000002 112.999 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.7 mtm -121.37 142.14 50.28 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.591 1.556 . . . . 5.2800000000000002 110.006 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -149.54 162.76 39.52 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.986 0.914 . . . . 5.2999999999999998 112.896 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.18 145.5 30.97 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.633 0.773 . . . . 3.0699999999999998 110.51 162.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.25 1.77 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 114.576 1.325 . . . . 3.3500000000000001 114.576 164.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -177.62 22.22 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.689 1.996 . . . . 4.6200000000000001 112.381 -168.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.41 -10.44 4.89 Favored Glycine 0 CA--C 1.543 1.798 0 O-C-N 119.148 -2.22 . . . . 2.1299999999999999 113.242 -160.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -95.13 130.49 41.82 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 129.346 3.059 . . . . 3.3900000000000001 108.213 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -77.1 117.37 18.59 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 128.04 2.536 . . . . 2.6899999999999999 109.149 -173.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -139.39 135.65 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.823 1.649 . . . . 2.2200000000000002 109.132 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.83 159.42 20.41 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 122.442 1.115 . . . . 3.2799999999999998 113.618 -175.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.02 164.98 24.99 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 125.103 1.335 . . . . 0.81000000000000005 112.451 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -149.38 132.96 16.74 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.271 1.428 . . . . 1.5 109.891 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -141.89 149.9 54.56 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.485 1.914 . . . . 9.1799999999999997 109.773 -170.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.43 153.66 39.94 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.228 1.952 . . . . 0.73999999999999999 110.012 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.18 148.95 64.48 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.157 0.983 . . . . 0.75 110.37 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.71 -23.08 13.0 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.525 2.816 . . . . 0.62 112.725 -170.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -173.93 172.51 3.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.296 1.838 . . . . 1.71 111.278 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -117.06 154.09 31.59 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.128 2.171 . . . . 0.59999999999999998 109.863 161.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -110.03 144.01 39.21 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.387 -0.968 . . . . 1.55 108.387 172.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.07 126.02 18.38 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.999 -0.524 . . . . 0.85999999999999999 111.285 163.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -68.2 164.22 33.09 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.788 2.992 . . . . 1.02 111.239 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.24 135.95 57.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.915 2.41 . . . . 0.98999999999999999 112.414 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.285 17.5 mtmt 59.27 40.18 21.66 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.018 1.39 . . . . 2.3300000000000001 113.193 171.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.37 164.72 26.9 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 127.926 2.679 . . . . 1.1299999999999999 113.699 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -113.82 146.52 39.83 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.18 1.792 . . . . 3.5899999999999999 111.732 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -139.82 116.45 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.5 1.12 . . . . 3.4199999999999999 108.481 152.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -79.92 148.31 31.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.961 0.905 . . . . 3.04 110.685 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mp -85.69 52.09 2.37 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.167 0.987 . . . . 2.52 112.707 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.94 146.21 8.2 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 115.424 1.638 . . . . 2.8900000000000001 115.424 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.24 -32.92 95.01 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.072 3.181 . . . . 3.0 114.076 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.32 31.24 1.38 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.475 1.036 . . . . 2.0299999999999998 113.433 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.72 -122.65 0.94 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.681 1.61 . . . . 1.6000000000000001 113.382 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -73.31 134.93 44.32 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 121.934 -0.745 . . . . 2.1699999999999999 112.761 -170.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -160.15 164.45 32.92 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.838 1.051 . . . . 1.01 113.838 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 73.8 m-85 -92.67 131.7 37.54 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 109.887 -0.412 . . . . 2.02 109.887 165.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 tpt -85.26 138.37 32.37 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.222 2.209 . . . . 0.81999999999999995 108.648 164.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.9 mt -132.24 91.39 2.94 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.44 1.496 . . . . 2.8300000000000001 109.221 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.0 mp -88.98 157.5 18.36 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.522 1.129 . . . . 2.5899999999999999 111.869 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.99 -52.67 4.77 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.322 1.915 . . . . 3.0499999999999998 112.577 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.5 mt 55.86 169.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 128.281 2.632 . . . . 1.0900000000000001 113.707 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -118.73 -25.88 6.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.937 -1.483 . . . . 1.6200000000000001 112.717 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -143.23 157.79 59.44 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 126.611 1.964 . . . . 6.2800000000000002 111.678 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.33 151.2 48.12 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.0 2.466 . . . . 1.5 110.467 158.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.93 148.0 22.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.83 1.252 . . . . 2.1299999999999999 111.524 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -95.73 -166.9 1.51 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.332 1.063 . . . . 4.75 111.122 164.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.49 152.05 24.17 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.737 1.215 . . . . 1.77 108.579 157.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.58 29.81 59.12 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.583 -0.565 . . . . 2.1499999999999999 114.287 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -109.63 -179.99 3.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.227 1.411 . . . . 2.5299999999999998 109.431 168.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -129.98 146.15 51.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 104.735 -2.32 . . . . 5.1500000000000004 104.735 164.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.3 t -138.76 139.49 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.861 1.665 . . . . 1.3799999999999999 109.628 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -92.1 144.96 24.91 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 122.831 1.3 . . . . 2.3399999999999999 112.787 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -135.98 140.71 44.14 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.71 2.404 . . . . 2.9300000000000002 109.207 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -88.74 140.58 29.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.218 1.807 . . . . 2.2000000000000002 109.064 164.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.5 mt -110.07 130.47 55.53 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.289 1.436 . . . . 2.1800000000000002 108.813 166.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.0 mt -110.06 125.15 52.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.097 1.359 . . . . 0.63 111.184 -174.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.06 153.28 37.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.457 1.503 . . . . 2.0299999999999998 112.549 -168.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.56 127.37 29.45 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.944 1.091 . . . . 1.95 113.944 -174.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.19 59.39 3.63 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.734 1.159 . . . . 3.6800000000000002 113.46 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.71 28.65 66.8 Favored Glycine 0 N--CA 1.474 1.17 0 CA-C-N 117.802 0.801 . . . . 1.72 115.074 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -113.7 145.01 41.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.937 1.369 . . . . 4.2999999999999998 112.242 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.1 150.63 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.212 1.405 . . . . 2.1600000000000001 111.969 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.4 tp -149.28 114.36 5.45 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.235 1.414 . . . . 2.3199999999999998 109.885 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -92.6 134.72 34.72 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.345 -0.847 . . . . 1.98 111.472 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 114' ' ' VAL . 40.4 t -133.7 173.94 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.839 2.056 . . . . 2.1600000000000001 108.322 -176.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.494 ' H ' HG12 ' A' ' 113' ' ' VAL . 11.0 p -149.98 127.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.919 1.288 . . . . 2.5299999999999998 110.431 -172.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -128.17 150.11 73.05 Favored Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 126.127 1.771 . . . . 2.5499999999999998 112.221 -171.241 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.36 148.3 43.12 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.772 2.981 . . . . 1.5 111.631 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 t -94.5 81.68 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.083 -1.08 . . . . 1.52 108.083 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 CA--C 1.538 0.486 0 C-N-CA 125.834 1.654 . . . . 4.3399999999999999 109.93 166.586 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 123.464 1.602 . . . . 4.7599999999999998 111.541 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.78 -179.93 20.69 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.67 1.605 . . . . 1.27 110.195 168.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.3 p90 -142.13 160.36 40.39 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.339 1.055 . . . . 3.1099999999999999 112.035 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.28 136.39 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.514 -1.291 . . . . 1.22 107.514 164.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -51.82 -55.03 22.33 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.848 1.796 . . . . 4.2699999999999996 115.848 -155.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.4 t80 107.54 123.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 130.52 3.528 . . . . 2.5600000000000001 108.451 -154.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.4 m 175.52 131.33 0.15 Allowed Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 127.711 2.404 . . . . 2.5800000000000001 109.255 -176.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.71 -32.82 1.9 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.655 2.236 . . . . 1.29 112.577 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.13 176.14 22.15 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.77 1.652 . . . . 0.89000000000000001 111.678 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.05 -10.24 21.39 Favored 'Cis proline' 0 CA--C 1.537 0.647 0 CA-C-N 119.021 1.41 . . . . 0.98999999999999999 112.572 -3.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -143.52 162.87 34.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.497 1.519 . . . . 2.3900000000000001 112.315 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.14 -177.67 4.23 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.255 1.822 . . . . 0.62 111.623 -176.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -120.7 167.03 12.89 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.486 1.114 . . . . 0.92000000000000004 110.453 161.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.01 146.46 33.88 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.756 1.223 . . . . 0.71999999999999997 111.477 168.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -127.84 81.37 2.02 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.601 2.361 . . . . 3.3900000000000001 109.247 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.51 159.54 14.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.61 1.337 . . . . 1.71 114.61 -170.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.3 m -131.02 150.84 51.96 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.366 1.867 . . . . 1.79 109.311 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.602 HD21 HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -150.68 175.54 11.86 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.314 3.045 . . . . 5.0899999999999999 107.882 172.281 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -115.03 147.28 40.33 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 123.107 0.563 . . . . 4.6799999999999997 110.538 164.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -100.64 90.81 1.58 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.641 0.776 . . . . 1.3600000000000001 109.868 163.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.5 -5.07 16.39 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.756 2.304 . . . . 1.8500000000000001 113.96 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.25 178.55 53.89 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 122.831 1.24 . . . . 1.6399999999999999 113.793 -174.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -109.76 -1.28 18.04 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.405 2.282 . . . . 3.4900000000000002 112.132 -170.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -116.7 159.62 39.75 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 127.667 2.387 . . . . 2.9100000000000001 110.65 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.11 139.88 17.38 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.56 2.174 . . . . 1.04 111.004 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.44 HD12 ' CD1' ' A' ' 105' ' ' PHE . 1.4 mm? -104.37 159.29 15.84 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 125.829 1.652 . . . . 2.6099999999999999 110.965 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -155.27 111.0 3.09 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.724 -1.58 . . . . 1.73 111.155 -168.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.97 107.42 19.7 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.81 1.644 . . . . 2.5299999999999998 109.176 -171.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 m -104.59 -21.75 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.834 0.853 . . . . 0.64000000000000001 112.426 -169.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.38 -176.61 32.66 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 124.996 1.284 . . . . 0.47999999999999998 113.495 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.54 -178.74 6.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.55 1.54 . . . . 0.5 111.594 170.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -158.36 155.04 28.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.903 1.681 . . . . 3.9900000000000002 108.177 167.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.8 t -157.59 153.74 23.65 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.302 1.441 . . . . 0.77000000000000002 108.755 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.38 -12.19 14.17 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.127 1.885 . . . . 0.87 113.492 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.429 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 24.8 m -98.74 23.21 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.197 1.184 . . . . 0.97999999999999998 114.197 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -149.37 165.47 31.94 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.357 1.863 . . . . 1.1799999999999999 107.978 167.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.9 -35.76 9.29 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.687 1.195 . . . . 2.8199999999999998 112.617 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.54 177.68 7.43 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.673 1.589 . . . . 6.2599999999999998 107.71 171.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.62 150.67 10.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 125.468 1.507 . . . . 1.0800000000000001 108.254 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -131.11 156.88 44.49 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.166 2.186 . . . . 2.8100000000000001 109.11 174.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 tp -110.78 117.25 32.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.759 1.224 . . . . 0.83999999999999997 110.513 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -121.0 154.89 35.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.391 1.476 . . . . 0.75 113.192 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -95.23 154.32 17.24 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.335 -1.302 . . . . 1.95 110.267 155.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -103.48 146.0 29.17 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.642 -1.614 . . . . 0.98999999999999999 106.642 154.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -134.61 176.79 8.31 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.414 1.102 . . . . 2.0699999999999998 112.855 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.6 ttp -122.22 140.87 52.08 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.732 1.613 . . . . 3.23 109.823 170.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.74 145.89 48.89 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.878 1.271 . . . . 6.25 110.836 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -113.38 143.7 44.03 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.757 1.623 . . . . 2.8500000000000001 108.611 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.3 139.64 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.832 1.653 . . . . 4.3499999999999996 108.079 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 64.41 18.7 11.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.527 1.131 . . . . 5.5599999999999996 112.558 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.29 21.02 79.49 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.329 -1.482 . . . . 2.0299999999999998 113.057 -171.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -120.9 119.7 33.37 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.23 1.812 . . . . 4.0099999999999998 108.33 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.52 121.62 38.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.255 1.422 . . . . 2.8399999999999999 111.675 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.1 t -137.05 141.36 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.389 1.876 . . . . 2.2599999999999998 108.266 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.62 167.39 13.95 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.077 0.769 . . . . 3.5600000000000001 113.077 -176.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.92 -177.95 28.73 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 125.356 1.455 . . . . 0.80000000000000004 112.281 -172.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.3 ttm -158.76 149.68 20.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.903 1.281 . . . . 1.4299999999999999 109.552 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.7 ptt85 -160.89 151.96 15.66 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 123.921 0.888 . . . . 4.6799999999999997 111.707 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.48 150.98 52.68 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.156 1.904 . . . . 0.65000000000000002 111.204 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.58 150.8 73.12 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 125.246 1.418 . . . . 0.58999999999999997 109.827 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.85 -22.47 7.54 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.367 2.711 . . . . 0.57999999999999996 113.201 -166.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -177.99 166.59 2.03 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 2.1499999999999999 110.617 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.0 mt -109.44 154.45 22.6 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.478 1.111 . . . . 0.69999999999999996 110.077 161.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -113.65 144.69 42.5 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.346 1.458 . . . . 2.0600000000000001 109.289 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.0 130.58 10.23 Favored Pre-proline 0 N--CA 1.473 0.693 0 N-CA-C 112.541 0.571 . . . . 1.1200000000000001 112.541 169.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.86 168.46 18.62 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.286 2.658 . . . . 1.03 112.65 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.12 141.53 98.23 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.347 2.698 . . . . 1.26 111.598 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt 65.61 8.13 4.93 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.516 1.526 . . . . 1.95 113.053 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.58 150.66 24.6 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.714 2.102 . . . . 1.47 114.367 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -78.96 115.81 18.87 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.629 1.971 . . . . 3.71 111.141 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.47 55.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 122.484 1.135 . . . . 5.4500000000000002 108.946 -174.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.6 123.78 46.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.928 1.691 . . . . 2.9900000000000002 108.794 177.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mp -58.28 -56.19 25.31 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.469 1.107 . . . . 4.3099999999999996 112.439 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.595 ' HE3' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 139.59 140.94 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 131.618 3.967 . . . . 3.1600000000000001 111.176 178.578 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.21 131.94 26.42 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 N-CA-C 107.782 -1.661 . . . . 3.7999999999999998 107.782 159.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.89 -38.03 1.94 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.393 -1.226 . . . . 3.3399999999999999 114.794 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.8 -110.63 0.39 Allowed Glycine 0 N--CA 1.475 1.28 0 CA-C-N 119.165 1.483 . . . . 1.8200000000000001 113.692 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.76 141.3 49.74 Favored 'General case' 0 C--O 1.223 -0.319 0 O-C-N 121.617 -0.931 . . . . 1.97 111.007 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -158.3 143.19 16.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.716 -0.675 . . . . 0.76000000000000001 110.997 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -78.89 133.69 36.95 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.063 -0.717 . . . . 1.8700000000000001 109.063 167.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.2 tpt -92.74 119.44 32.12 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.697 1.599 . . . . 1.0600000000000001 108.086 168.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -103.88 105.69 15.97 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.475 1.51 . . . . 1.1499999999999999 110.161 -168.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.01 132.99 40.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.823 0.849 . . . . 2.4500000000000002 111.696 -166.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.08 47.47 7.56 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 123.954 0.788 . . . . 1.71 113.73 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 18.7 mt -49.02 154.89 0.69 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 116.345 1.98 . . . . 0.95999999999999996 116.345 -174.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 50.8 mmtt -119.22 -30.54 4.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 113.302 -1.772 . . . . 2.27 113.29 -176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.455 HH21 ' CD ' ' A' ' 97' ' ' GLU . 9.9 mmm180 -106.74 144.89 29.96 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 126.444 1.897 . . . . 5.2699999999999996 108.173 160.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.92 128.06 13.65 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 N-CA-C 107.225 -1.875 . . . . 1.8799999999999999 107.225 153.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.29 115.72 22.62 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.741 -0.837 . . . . 2.2599999999999998 108.741 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.25 162.21 32.79 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.04 1.336 . . . . 4.7000000000000002 113.874 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 132.59 54.47 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.504 1.522 . . . . 1.3999999999999999 110.934 -172.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.23 44.86 16.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.023 -0.99 . . . . 1.3600000000000001 112.85 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.455 ' CD ' HH21 ' A' ' 91' ' ' ARG . 0.9 OUTLIER -103.67 167.06 10.03 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 117.787 0.793 . . . . 2.3999999999999999 109.044 148.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.43 128.34 46.85 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 102.625 -3.102 . . . . 4.9000000000000004 102.625 154.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.7 t -137.28 137.67 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.829 1.251 . . . . 1.55 109.999 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -84.54 155.97 21.87 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.061 1.504 . . . . 2.4100000000000001 115.061 -174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tt -155.31 140.3 17.34 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.127 2.171 . . . . 3.1000000000000001 110.902 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -84.38 127.87 34.25 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.899 2.08 . . . . 2.0699999999999998 109.29 165.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.16 127.0 35.15 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.563 -0.903 . . . . 1.22 108.563 161.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.5 mt -103.55 105.75 16.08 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 122.497 1.142 . . . . 0.73999999999999999 109.869 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.44 ' CD1' HD12 ' A' ' 30' ' ' LEU . 98.0 m-85 -96.16 152.76 18.26 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.146 1.379 . . . . 2.2799999999999998 111.354 174.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.45 127.51 20.18 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.55 1.14 . . . . 2.1299999999999999 113.643 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.22 66.1 2.25 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.573 1.082 . . . . 3.3700000000000001 112.793 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.5 11.81 80.18 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 115.792 1.077 . . . . 1.8300000000000001 115.792 167.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -96.15 104.14 16.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.779 1.79 . . . . 3.5600000000000001 110.983 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.82 143.23 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 123.863 0.865 . . . . 2.3799999999999999 110.685 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -145.07 108.02 4.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.209 1.004 . . . . 2.46 108.776 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -93.65 131.91 38.49 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.046 0.387 . . . . 2.1600000000000001 112.046 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.602 HG21 HD21 ' A' ' 22' ' ' LEU . 54.2 t -138.85 163.2 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.602 1.561 . . . . 2.3900000000000001 110.204 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.32 126.84 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.849 2.06 . . . . 2.0699999999999998 109.808 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.27 145.3 38.16 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 126.548 1.939 . . . . 3.1200000000000001 109.737 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.05 162.7 41.03 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.183 3.256 . . . . 1.1599999999999999 113.008 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.24 110.75 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 114.576 -1.193 . . . . 1.23 110.994 165.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 127.19 2.196 . . . . 3.6800000000000002 109.324 156.768 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.59 ' N ' ' HG1' ' A' ' 21' ' ' THR . 10.3 pt-20 . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 108.287 -1.005 . . . . 6.0 108.287 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.83 167.58 29.92 Favored Glycine 0 N--CA 1.473 1.115 0 O-C-N 120.858 -1.151 . . . . 1.05 114.334 -167.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -152.76 169.27 23.18 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.852 1.427 . . . . 2.1800000000000002 114.852 -172.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.2 t -106.67 144.8 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.177 1.791 . . . . 1.23 107.13 168.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.26 0.6 OUTLIER -73.18 -100.11 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.388 0.884 . . . . 3.9100000000000001 113.388 175.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -161.21 143.46 12.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.242 1.817 . . . . 2.4900000000000002 109.5 -167.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t 171.81 136.17 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 126.93 2.092 . . . . 2.3100000000000001 111.676 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.08 -27.47 6.78 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.745 2.297 . . . . 1.6000000000000001 111.901 166.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.39 171.91 17.01 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 126.696 2.093 . . . . 1.05 111.195 -175.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -78.46 -9.0 35.88 Favored 'Cis proline' 0 CA--C 1.537 0.631 0 CA-C-N 118.508 1.154 . . . . 1.01 113.045 -0.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -151.36 167.89 26.5 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.734 1.214 . . . . 1.8899999999999999 113.374 -168.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.87 -177.51 6.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.485 2.314 . . . . 0.54000000000000004 111.72 -173.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.42 39.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.402 1.481 . . . . 0.96999999999999997 108.576 169.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.14 141.78 47.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.656 1.582 . . . . 0.59999999999999998 110.544 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.522 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 51.3 m-85 -121.42 70.78 0.94 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.724 2.01 . . . . 2.0499999999999998 110.835 -171.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -90.85 164.47 14.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.089 0.955 . . . . 1.98 113.21 -170.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.59 ' HG1' ' N ' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -95.88 124.61 39.97 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.457 -0.777 . . . . 1.8899999999999999 110.299 175.046 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.2 tp -96.23 104.08 16.02 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.198 -1.038 . . . . 5.1699999999999999 108.198 167.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -82.46 171.24 14.36 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.663 0.744 . . . . 5.8700000000000001 111.929 165.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -134.58 101.12 12.07 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.566 0.747 . . . . 1.3400000000000001 109.417 155.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.78 -11.86 11.24 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.158 2.572 . . . . 1.55 112.992 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.23 178.92 49.45 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-O 122.749 1.194 . . . . 1.1899999999999999 112.55 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -104.29 -1.73 26.6 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.076 2.15 . . . . 3.1299999999999999 112.3 -173.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.9 mt -124.8 162.98 39.99 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 127.782 2.433 . . . . 3.6299999999999999 109.323 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.59 158.44 28.63 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.354 2.036 . . . . 1.0800000000000001 111.503 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mp -118.28 154.69 31.87 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.161 1.784 . . . . 2.1899999999999999 110.019 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -138.51 110.29 7.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 113.494 -1.685 . . . . 2.04 109.511 173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.7 118.41 30.63 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.727 1.611 . . . . 1.8999999999999999 107.727 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 m -113.53 -22.43 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.181 0.993 . . . . 0.48999999999999999 112.691 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.32 -176.91 31.91 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 124.359 0.98 . . . . 0.42999999999999999 113.31 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.5 178.12 6.7 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.718 -0.872 . . . . 0.44 112.17 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -150.2 148.87 29.44 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.635 2.374 . . . . 7.5300000000000002 107.957 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 t -164.82 148.81 7.73 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 117.934 -1.031 . . . . 0.62 110.158 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.78 -12.11 21.97 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.174 1.916 . . . . 0.72999999999999998 114.78 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.63 20.82 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.125 1.528 . . . . 0.88 115.125 -170.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.36 150.25 25.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.486 1.514 . . . . 0.98999999999999999 109.075 169.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.85 -47.67 7.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.532 1.133 . . . . 3.3500000000000001 112.832 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -122.33 98.7 6.05 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.453 -1.314 . . . . 6.2599999999999998 107.453 -171.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.26 125.89 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.697 -0.683 . . . . 0.81999999999999995 109.802 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -116.82 150.46 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.71 2.004 . . . . 2.7000000000000002 109.069 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.4 tp -105.12 118.64 37.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.043 0.937 . . . . 0.88 110.356 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.1 m170 -124.64 155.29 39.41 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.046 1.338 . . . . 0.51000000000000001 114.123 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -100.43 162.54 12.87 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.867 1.667 . . . . 2.21 112.484 158.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.0 m -132.33 144.41 50.54 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.876 2.07 . . . . 0.73999999999999999 105.661 167.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -152.76 170.14 21.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.908 0.883 . . . . 2.02 112.491 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.9 ttp -98.83 140.1 33.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.92 1.288 . . . . 3.4500000000000002 110.812 173.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.3 148.18 32.15 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.018 1.727 . . . . 5.2800000000000002 111.314 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.92 144.49 26.15 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.298 1.039 . . . . 2.4199999999999999 108.572 166.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -141.83 138.05 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 107.806 -1.183 . . . . 2.79 107.806 155.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 59.11 22.85 11.02 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.847 1.425 . . . . 4.3200000000000003 114.847 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.31 17.83 79.75 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 120.717 -1.24 . . . . 1.6699999999999999 113.956 -170.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -109.45 122.57 47.69 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.626 1.971 . . . . 2.25 107.558 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -79.81 117.99 21.19 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.767 1.227 . . . . 3.0699999999999998 108.642 172.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 m -141.68 -175.76 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.709 2.404 . . . . 2.5 109.858 -171.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.76 175.74 5.39 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.807 0.843 . . . . 3.0 112.974 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.9 170.2 33.12 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.62 2.057 . . . . 0.80000000000000004 111.94 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -149.31 137.96 21.02 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.441 1.496 . . . . 1.1299999999999999 109.817 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -143.73 151.63 53.91 Favored Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 125.618 1.567 . . . . 8.8499999999999996 110.605 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.99 151.9 45.49 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.132 1.888 . . . . 0.57999999999999996 109.98 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.9 m -137.5 153.51 74.46 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.013 1.325 . . . . 0.56000000000000005 109.994 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.59 -28.12 2.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.719 2.279 . . . . 0.45000000000000001 112.805 -165.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -177.2 165.75 2.31 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.047 1.339 . . . . 2.0800000000000001 112.483 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.2 mt -109.91 152.0 26.37 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.673 1.589 . . . . 0.79000000000000004 111.051 162.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -121.89 136.76 54.94 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.584 1.553 . . . . 2.1600000000000001 108.407 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.8 t -143.69 129.4 9.97 Favored Pre-proline 0 N--CA 1.475 0.808 0 N-CA-C 113.665 0.987 . . . . 1.1599999999999999 113.665 174.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.81 161.66 43.18 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.161 3.241 . . . . 1.23 111.693 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.63 141.07 96.5 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.557 2.838 . . . . 1.1000000000000001 113.172 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 69.15 0.23 2.74 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.919 2.088 . . . . 2.1000000000000001 114.572 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.53 175.73 47.63 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.928 1.728 . . . . 1.0800000000000001 113.223 171.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.08 132.87 11.39 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.21 1.004 . . . . 5.6600000000000001 112.725 173.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.5 t -125.18 108.4 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.381 2.272 . . . . 3.5499999999999998 109.524 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.5 126.92 31.66 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 127.879 2.471 . . . . 3.6299999999999999 112.21 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -74.12 75.46 1.76 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.986 1.714 . . . . 2.1299999999999999 109.811 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -68.07 155.11 92.76 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 114.819 1.415 . . . . 2.4100000000000001 114.819 -173.354 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.522 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 37.0 Cg_endo -59.34 -15.81 31.46 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.323 3.349 . . . . 2.3700000000000001 116.628 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -97.92 -1.04 58.62 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.265 -1.297 . . . . 1.95 115.292 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.86 -115.66 0.9 Allowed Glycine 0 N--CA 1.473 1.136 0 CA-C-N 119.908 1.854 . . . . 1.54 113.958 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -70.79 141.55 51.4 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.17 -0.606 . . . . 1.8100000000000001 110.386 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -161.45 160.25 29.08 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.758 1.223 . . . . 0.64000000000000001 111.582 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -92.7 130.8 38.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.546 -0.539 . . . . 1.9099999999999999 109.546 166.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 tpt -84.96 128.8 34.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.072 1.349 . . . . 0.76000000000000001 108.89 166.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -114.74 107.53 15.58 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.36 1.064 . . . . 1.1000000000000001 108.614 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mp -107.45 148.91 28.54 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.045 0.839 . . . . 2.29 111.036 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.82 43.39 28.26 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.993 -0.893 . . . . 1.71 113.353 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 mt -46.62 150.88 0.63 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.999 1.481 . . . . 0.87 114.999 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -108.01 -21.31 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 112.986 -1.916 . . . . 2.0899999999999999 114.248 -172.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.92 145.83 58.75 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 126.699 1.999 . . . . 5.75 110.548 162.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -66.69 154.31 74.91 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.085 1.857 . . . . 1.47 108.777 162.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.85 159.76 43.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.466 1.127 . . . . 2.7200000000000002 112.547 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.55 173.9 6.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.923 2.089 . . . . 4.7400000000000002 111.301 -165.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.14 135.72 56.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.231 1.012 . . . . 1.45 112.857 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.69 40.37 31.88 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 114.828 -1.078 . . . . 1.5800000000000001 113.428 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -113.89 176.33 5.08 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.497 1.119 . . . . 2.7599999999999998 108.992 157.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -121.96 164.3 17.84 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.662 1.585 . . . . 2.9399999999999999 107.161 159.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.0 t -148.94 154.77 9.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 130.588 3.555 . . . . 1.6499999999999999 109.053 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.95 138.53 54.38 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.366 1.466 . . . . 2.9399999999999999 111.252 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.62 137.2 54.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.863 1.265 . . . . 1.8500000000000001 110.962 165.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.8 138.51 31.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.264 1.826 . . . . 2.4300000000000002 110.044 155.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.3 136.61 34.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.509 1.924 . . . . 1.27 109.45 167.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt -107.16 118.5 36.87 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.7 1.6 . . . . 0.64000000000000001 109.519 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -109.49 156.25 20.34 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.647 1.179 . . . . 1.99 111.041 -175.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.05 141.66 58.67 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.465 -0.772 . . . . 2.3500000000000001 110.748 164.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.54 35.68 11.55 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 119.066 -0.852 . . . . 4.1799999999999997 114.951 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.97 7.47 84.08 Favored Glycine 0 N--CA 1.476 1.317 0 CA-C-N 118.234 1.017 . . . . 1.8799999999999999 115.553 167.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -89.53 137.28 32.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.063 0.932 . . . . 3.2000000000000002 111.261 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.31 131.53 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.56 1.544 . . . . 1.8700000000000001 108.079 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.27 143.56 27.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.763 1.625 . . . . 3.52 109.189 -174.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -120.3 151.84 38.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.291 1.589 . . . . 2.3100000000000001 115.291 -172.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.0 m -122.98 153.04 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 128.062 2.545 . . . . 3.0299999999999998 110.825 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.2 138.72 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.106 1.762 . . . . 3.02 109.609 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -141.29 125.4 10.28 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.401 1.08 . . . . 2.6699999999999999 111.547 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.78 167.11 24.4 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.788 2.325 . . . . 1.1299999999999999 110.776 162.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.25 149.33 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.909 1.284 . . . . 1.0600000000000001 110.508 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 126.514 1.925 . . . . 4.9299999999999997 112.817 -176.593 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.52 0 CA-C-O 123.482 1.61 . . . . 6.2199999999999998 112.161 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.54 157.54 15.78 Favored Glycine 0 C--N 1.329 0.155 0 CA-C-N 114.082 -1.417 . . . . 2.1299999999999999 110.039 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -92.42 162.55 14.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.611 1.196 . . . . 2.71 112.268 -160.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -80.34 132.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.49 -1.3 . . . . 1.1699999999999999 107.49 157.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -21.24 59.01 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.116 1.895 . . . . 6.2800000000000002 116.116 -163.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 t80 85.75 144.01 0.06 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.972 2.909 . . . . 2.77 111.201 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 t -171.28 150.9 2.93 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.672 1.189 . . . . 2.1499999999999999 112.233 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -81.37 -18.5 8.36 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.344 2.696 . . . . 1.5 112.109 158.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.81 -170.17 13.73 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 126.754 2.121 . . . . 1.28 111.631 -170.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.64 -3.54 22.15 Favored 'Cis proline' 0 CA--C 1.54 0.817 0 CA-C-N 119.196 1.498 . . . . 1.6499999999999999 112.477 -9.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -136.02 176.91 8.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.778 1.231 . . . . 4.3899999999999997 110.843 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.59 -174.54 4.98 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.611 2.365 . . . . 0.60999999999999999 112.133 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.47 149.25 28.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.957 2.503 . . . . 0.70999999999999996 108.452 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -135.52 136.5 41.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.857 1.208 . . . . 0.66000000000000003 113.417 -175.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 28.8 m-85 -106.5 41.12 1.49 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.715 1.606 . . . . 2.3199999999999998 114.09 -170.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.38 155.89 33.94 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.336 1.606 . . . . 1.75 115.336 -167.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 76' ' ' GLU . 54.8 m -99.71 143.29 30.11 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.438 1.095 . . . . 1.6000000000000001 112.128 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.47 123.62 47.93 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.83 2.452 . . . . 3.29 111.804 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -102.97 141.05 36.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.589 0.756 . . . . 3.7200000000000002 109.537 158.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -108.34 84.31 2.26 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.756 -0.59 . . . . 1.53 109.928 159.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.8 -10.05 24.46 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.424 2.083 . . . . 1.3999999999999999 113.181 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.73 176.43 47.75 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-O 122.861 1.256 . . . . 1.3899999999999999 113.1 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -102.02 -8.62 21.32 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.759 2.424 . . . . 3.3700000000000001 112.179 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.0 mt -132.01 152.56 80.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.523 1.929 . . . . 3.96 109.264 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.83 167.74 24.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.093 2.528 . . . . 1.5800000000000001 113.698 -152.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mp -115.05 147.98 39.47 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.29 1.836 . . . . 2.3700000000000001 108.683 168.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.23 98.92 3.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 112.855 -1.975 . . . . 2.52 108.737 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.3 tp -83.67 102.37 12.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.878 2.071 . . . . 2.1200000000000001 109.387 -168.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -94.7 -25.3 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.917 1.287 . . . . 1.21 111.711 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.06 -176.85 31.57 Favored Glycine 0 C--N 1.343 0.922 0 C-N-CA 123.792 0.711 . . . . 0.53000000000000003 114.092 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.24 -177.88 5.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.935 1.694 . . . . 0.56999999999999995 110.382 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -156.51 175.25 14.28 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 127.434 2.293 . . . . 5.8700000000000001 107.948 161.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t -162.7 152.2 13.12 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 128.755 2.822 . . . . 1.4099999999999999 106.796 166.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.07 -29.65 39.74 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 120.894 1.355 . . . . 1.9099999999999999 111.918 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.6 m -86.78 14.63 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 115.299 1.592 . . . . 1.9299999999999999 115.299 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.09 138.48 25.37 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.586 1.539 . . . . 1.1599999999999999 113.89 168.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.54 -26.84 41.35 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.837 1.421 . . . . 4.0099999999999998 114.837 -165.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -146.63 165.7 28.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.908 2.083 . . . . 5.0599999999999996 108.341 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.88 143.89 15.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 124.972 1.309 . . . . 1.1000000000000001 109.383 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -118.57 158.04 26.18 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.654 1.982 . . . . 3.2799999999999998 109.512 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 tp -106.88 117.56 34.39 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.538 0.735 . . . . 0.87 110.307 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -119.86 165.08 15.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 123.516 1.627 . . . . 0.68000000000000005 113.897 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -121.57 162.6 20.32 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.18 -1.827 . . . . 3.5899999999999999 111.501 156.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.4 m -118.01 139.56 51.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.19 2.196 . . . . 0.93000000000000005 106.158 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -136.48 169.31 17.9 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.578 1.18 . . . . 1.8999999999999999 113.736 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.2 ttp -111.55 147.27 35.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.281 1.833 . . . . 3.3599999999999999 109.102 170.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 153.53 38.3 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.802 1.241 . . . . 5.4400000000000004 110.505 -174.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -105.23 138.58 41.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.351 1.46 . . . . 3.4900000000000002 110.267 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.25 113.98 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.625 -1.25 . . . . 2.4700000000000002 107.625 169.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 66.66 14.25 9.69 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.238 1.815 . . . . 3.8599999999999999 114.33 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.5 20.43 58.5 Favored Glycine 0 N--CA 1.477 1.376 0 O-C-N 121.249 -0.907 . . . . 2.6499999999999999 113.467 -167.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -119.3 125.95 50.3 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.956 1.703 . . . . 2.4700000000000002 109.305 172.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -88.08 123.06 32.37 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.764 1.226 . . . . 4.8600000000000003 111.249 -170.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.0 t -141.68 141.06 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.2 1.8 . . . . 2.3100000000000001 109.601 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -93.56 168.45 11.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.339 1.056 . . . . 3.1699999999999999 113.051 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.04 -178.73 31.39 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.94 1.257 . . . . 0.68000000000000005 113.634 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ttm -152.66 150.1 29.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.963 1.705 . . . . 1.1499999999999999 108.816 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -158.22 154.26 23.56 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 118.23 -0.89 . . . . 4.8300000000000001 111.776 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.93 154.98 62.87 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.23 1.954 . . . . 0.52000000000000002 111.155 169.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.66 151.66 63.94 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.014 1.326 . . . . 0.56000000000000005 110.241 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.63 -27.85 8.68 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.382 2.721 . . . . 0.59999999999999998 112.573 -167.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -176.16 163.16 2.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.112 1.765 . . . . 1.7 111.472 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.8 mt -105.31 153.51 21.52 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.235 1.014 . . . . 0.56999999999999995 110.592 160.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.18 144.02 34.54 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.405 1.082 . . . . 1.8100000000000001 110.271 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.4 t -140.48 121.99 9.39 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 118.552 0.615 . . . . 1.0900000000000001 111.714 163.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -71.36 159.6 51.17 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.465 2.777 . . . . 1.1699999999999999 111.095 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.85 142.99 99.26 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.384 2.723 . . . . 1.46 111.816 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt 67.28 -5.48 0.72 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.178 2.191 . . . . 2.3300000000000001 114.374 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.12 165.31 48.79 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.016 1.293 . . . . 1.3200000000000001 112.118 172.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 145.53 35.87 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.701 1.201 . . . . 4.3099999999999996 109.298 171.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.0 t -148.96 158.86 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 126.562 1.945 . . . . 3.0600000000000001 107.809 -169.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 21' ' ' THR . 10.2 mt-10 -135.03 142.6 46.42 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.007 1.276 . . . . 4.46 111.706 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.21 79.05 1.79 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 122.121 0.962 . . . . 2.27 109.117 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -62.98 150.55 87.91 Favored Pre-proline 0 CA--C 1.558 1.281 0 N-CA-C 114.319 1.229 . . . . 3.2200000000000002 114.319 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.49 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 38.2 Cg_endo -58.32 -49.68 11.69 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.396 2.731 . . . . 2.27 113.055 174.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.53 58.3 4.45 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.869 0.747 . . . . 2.1200000000000001 111.474 171.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.32 -125.44 1.5 Allowed Glycine 0 N--CA 1.469 0.86 0 C-N-CA 124.819 1.2 . . . . 1.74 114.167 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -73.04 138.89 46.21 Favored 'General case' 0 C--O 1.219 -0.518 0 O-C-N 122.191 -0.593 . . . . 2.3399999999999999 112.279 -168.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -162.58 152.01 15.6 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.02 0.928 . . . . 0.65000000000000002 110.971 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.56 143.68 33.03 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.724 -0.473 . . . . 1.9299999999999999 109.724 162.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -96.33 123.99 40.17 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.726 1.61 . . . . 0.81999999999999995 108.428 166.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.17 120.37 42.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.397 0.999 . . . . 1.1799999999999999 108.906 -174.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -106.47 154.7 20.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.335 1.054 . . . . 2.4700000000000002 110.985 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.12 -51.4 3.21 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 127.269 2.366 . . . . 2.5600000000000001 114.747 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.7 mt 54.57 168.3 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.577 2.751 . . . . 1.1399999999999999 114.568 -171.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -116.82 -23.61 8.02 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.465 1.506 . . . . 2.5299999999999998 114.015 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.4 ptt-85 -137.31 149.85 67.01 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.569 1.548 . . . . 6.5199999999999996 111.414 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -68.19 142.65 56.27 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.982 1.788 . . . . 1.53 107.89 154.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.96 176.95 8.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.71 0.804 . . . . 3.0 110.479 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -120.66 176.28 5.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.194 1.798 . . . . 3.4700000000000002 108.618 155.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.18 126.96 33.62 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.399 -1.334 . . . . 1.49 107.399 154.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.69 6.24 54.76 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.195 -1.336 . . . . 1.99 116.155 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -77.54 -176.53 4.31 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.392 1.596 . . . . 2.8500000000000001 110.444 159.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.15 170.44 9.56 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 130.607 3.563 . . . . 4.8099999999999996 107.124 165.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.0 t -150.37 141.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 127.089 2.156 . . . . 1.3899999999999999 108.975 166.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.24 126.29 52.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.158 1.383 . . . . 3.9700000000000002 110.62 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.1 mp -115.33 140.78 48.82 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.15 0.98 . . . . 1.78 111.52 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.93 139.27 31.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 128.576 2.75 . . . . 2.9100000000000001 108.994 167.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -118.83 131.12 56.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.548 1.139 . . . . 1.1399999999999999 109.503 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.4 mt -112.44 116.9 31.03 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.48 1.512 . . . . 0.88 110.061 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -116.78 132.82 56.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.477 1.111 . . . . 2.1299999999999999 110.771 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.9 -24.05 66.71 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.976 0.732 . . . . 2.46 112.976 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.83 41.88 2.22 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.591 1.567 . . . . 5.5300000000000002 114.223 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.49 23.64 77.59 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.346 1.45 . . . . 3.4300000000000002 115.601 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -135.66 145.41 46.75 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.085 1.442 . . . . 3.9399999999999999 112.981 -166.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.19 141.89 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.591 1.556 . . . . 2.6499999999999999 107.496 162.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.45 172.1 13.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.841 1.656 . . . . 2.0899999999999999 109.658 -174.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.78 150.94 52.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.843 0.857 . . . . 4.3899999999999997 111.033 167.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.7 t -136.75 157.69 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.28 1.032 . . . . 2.1000000000000001 109.0 168.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.6 t -120.22 120.81 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.746 1.618 . . . . 2.3399999999999999 108.262 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -122.93 145.31 45.33 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 126.744 2.018 . . . . 2.9100000000000001 109.321 -170.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.48 164.08 33.12 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.192 2.595 . . . . 1.3100000000000001 110.807 171.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.6 t -100.89 119.66 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.465 -0.939 . . . . 0.93000000000000005 108.465 160.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 106.22 -1.77 . . . . 4.7400000000000002 106.22 178.698 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 122.375 1.083 . . . . 5.2300000000000004 109.834 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.78 -178.75 30.29 Favored Glycine 0 C--N 1.34 0.805 0 O-C-N 121.306 -0.871 . . . . 1.1399999999999999 111.634 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -131.77 160.38 35.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.024 1.12 . . . . 2.3500000000000001 114.024 -170.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.18 145.25 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.199 1.4 . . . . 1.55 108.552 159.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -93.3 150.05 20.77 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.75 0.82 . . . . 4.8399999999999999 111.908 -175.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -70.6 139.7 51.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.605 2.362 . . . . 2.6200000000000001 113.227 -172.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -179.99 142.4 0.35 Allowed Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.187 1.395 . . . . 2.1099999999999999 112.827 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.01 -20.88 18.88 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.727 2.285 . . . . 1.3600000000000001 112.492 162.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.58 175.67 13.96 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.809 2.147 . . . . 1.01 111.698 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.82 -15.6 29.07 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 118.893 1.346 . . . . 1.24 112.946 -3.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -128.44 159.89 33.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.031 0.919 . . . . 2.8100000000000001 113.125 174.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -131.22 -178.69 4.95 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.652 3.581 . . . . 0.58999999999999997 107.841 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.95 171.74 12.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.846 1.658 . . . . 1.1200000000000001 108.295 169.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.34 118.74 19.8 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.488 -0.757 . . . . 0.90000000000000002 109.894 164.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -102.32 63.05 0.87 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.55 1.54 . . . . 2.6699999999999999 108.583 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -89.68 160.02 16.81 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.975 -1.011 . . . . 1.6100000000000001 112.092 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -130.18 127.74 40.32 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.849 1.26 . . . . 2.21 108.443 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.498 HD21 HG11 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -119.74 179.72 4.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.03 1.332 . . . . 5.25 109.826 162.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -127.05 164.14 22.21 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.654 0.781 . . . . 4.8399999999999999 109.886 165.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.15 81.46 0.42 Allowed Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.585 1.954 . . . . 3.1600000000000001 109.314 -174.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.52 -17.41 34.15 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.78 2.32 . . . . 1.3300000000000001 114.809 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.7 157.95 51.0 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.367 0.985 . . . . 1.5 110.975 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.76 4.27 37.6 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 127.59 2.356 . . . . 3.77 112.408 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mp -122.88 158.0 58.48 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 127.291 2.236 . . . . 3.9100000000000001 108.72 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -83.01 141.63 10.62 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.72 2.28 . . . . 1.3999999999999999 111.381 -166.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -89.74 150.04 22.47 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 123.41 1.576 . . . . 2.25 112.626 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttm-85 -130.82 97.68 4.41 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.099 -1.864 . . . . 2.77 110.227 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.525 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 6.7 tt -78.79 110.66 14.17 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 125.236 1.414 . . . . 2.6000000000000001 107.695 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -100.12 -27.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 122.827 0.451 . . . . 0.5 111.697 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 -173.76 29.51 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.094 1.33 . . . . 0.42999999999999999 113.396 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -143.31 177.99 8.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.11 1.764 . . . . 0.42999999999999999 112.295 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -143.26 169.22 18.04 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.402 1.481 . . . . 5.5199999999999996 109.319 158.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -168.85 150.44 4.57 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.757 1.623 . . . . 0.62 108.313 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.07 -14.56 12.14 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.524 1.483 . . . . 0.85999999999999999 113.266 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 17.1 m -101.25 24.45 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.687 1.195 . . . . 0.81999999999999995 113.621 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.9 161.82 39.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.482 1.513 . . . . 0.87 109.46 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -93.58 -44.04 8.4 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.074 2.15 . . . . 3.96 112.363 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -131.83 159.56 38.19 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.07 0.948 . . . . 6.9100000000000001 109.013 160.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.84 143.6 30.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 125.277 1.431 . . . . 0.85999999999999999 108.887 166.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -117.47 149.25 40.89 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.858 1.663 . . . . 2.6400000000000001 109.272 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.5 tp -100.88 120.77 40.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.35 0.66 . . . . 0.90000000000000002 110.022 175.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -122.62 157.94 31.08 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.16 1.384 . . . . 0.65000000000000002 113.903 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -98.2 176.85 5.58 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.885 2.074 . . . . 2.4100000000000001 111.878 161.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.3 m -151.76 147.36 26.58 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.024 1.73 . . . . 1.02 106.762 166.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -161.71 -179.73 7.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.635 1.174 . . . . 2.4100000000000001 111.976 -164.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.0 ptt? -110.09 146.9 34.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.656 1.182 . . . . 4.3300000000000001 113.538 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -132.05 148.46 52.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.412 1.885 . . . . 5.7800000000000002 111.675 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.39 142.91 35.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.166 1.786 . . . . 3.5299999999999998 112.298 173.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.4 m -145.56 5.47 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 127.058 2.143 . . . . 3.8599999999999999 115.561 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -174.67 18.11 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.288 1.588 . . . . 3.8999999999999999 115.288 -161.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.27 -5.82 32.74 Favored Glycine 0 CA--C 1.54 1.606 0 O-C-N 119.914 -1.741 . . . . 2.2000000000000002 113.471 -163.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -97.39 69.93 2.27 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 129.12 2.968 . . . . 2.7400000000000002 109.64 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -55.33 120.08 6.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.884 1.274 . . . . 2.9500000000000002 109.953 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -145.37 144.56 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.32 1.848 . . . . 2.8300000000000001 109.122 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.5 mtp -82.28 169.13 16.89 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.293 1.22 . . . . 4.1500000000000004 114.293 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.2 176.83 32.72 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.911 1.719 . . . . 0.62 113.078 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.2 ttm -156.3 149.17 24.0 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.109 1.764 . . . . 1.26 109.916 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -150.94 155.43 35.2 Favored Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 125.835 1.654 . . . . 4.3499999999999996 109.361 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.5 155.89 50.13 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.941 1.76 . . . . 0.53000000000000003 110.847 165.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.43 153.89 66.3 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.731 1.613 . . . . 0.65000000000000002 110.09 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.27 -23.41 5.19 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.649 2.899 . . . . 0.57999999999999996 113.631 -167.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -176.54 160.47 2.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.05 1.74 . . . . 2.0099999999999998 111.011 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -106.28 159.04 16.42 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.486 1.115 . . . . 0.66000000000000003 109.182 159.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -132.95 149.97 52.2 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.256 1.022 . . . . 2.2799999999999998 110.157 173.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.65 138.62 15.46 Favored Pre-proline 0 CA--C 1.537 0.464 0 O-C-N 124.056 0.847 . . . . 1.1299999999999999 112.237 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.62 156.54 35.9 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.743 2.962 . . . . 1.3899999999999999 112.264 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.35 140.41 91.64 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.874 3.049 . . . . 1.52 112.995 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.45 2.78 1.67 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.25 2.22 . . . . 2.4100000000000001 113.96 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.52 179.7 51.92 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.227 2.346 . . . . 1.53 113.523 171.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.06 124.67 49.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.672 1.989 . . . . 4.5099999999999998 110.926 -173.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.8 t -94.67 72.92 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.807 2.043 . . . . 5.5700000000000003 108.27 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -117.52 115.27 24.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.806 1.288 . . . . 2.9700000000000002 111.794 -158.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -87.19 74.68 9.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.551 1.94 . . . . 2.0299999999999998 107.836 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 146.95 99.04 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 120.834 -1.166 . . . . 2.3100000000000001 113.514 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -61.02 147.13 96.63 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.335 2.023 . . . . 3.3500000000000001 109.485 164.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.07 -5.75 74.81 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.447 -1.196 . . . . 2.1499999999999999 113.703 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -147.33 -121.23 1.25 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 119.156 1.478 . . . . 1.48 113.674 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -73.94 138.47 44.26 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.482 -1.011 . . . . 2.0299999999999998 111.319 -167.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -160.24 153.09 21.36 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.824 0.849 . . . . 0.70999999999999996 111.453 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.528 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 43.8 m-85 -80.29 139.45 36.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.865 -0.791 . . . . 1.8 108.865 164.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 tpt -100.73 120.49 40.16 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.381 1.873 . . . . 1.1499999999999999 108.045 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -103.89 117.27 33.94 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.467 1.507 . . . . 1.21 108.152 -175.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.88 148.13 41.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.222 0.919 . . . . 2.0299999999999998 112.163 -174.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.61 36.78 36.85 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 124.154 0.883 . . . . 1.51 113.12 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.1 mt -46.0 151.93 0.43 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 117.194 2.294 . . . . 1.0700000000000001 117.194 -170.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 60.6 mmtt -114.27 -31.36 6.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 113.088 -1.869 . . . . 2.5699999999999998 113.423 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -100.47 125.54 38.87 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 117.109 -1.424 . . . . 4.8200000000000003 107.776 156.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.96 112.36 2.0 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 N-CA-C 105.501 -2.538 . . . . 1.3200000000000001 105.501 152.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.01 137.88 51.12 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.472 1.129 . . . . 2.4300000000000002 112.995 -159.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -132.99 164.78 26.23 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 126.058 1.743 . . . . 3.4500000000000002 113.67 -157.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.54 116.93 15.79 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.185 -0.916 . . . . 1.3400000000000001 109.778 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.2 15.13 36.63 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.736 -1.036 . . . . 1.26 114.527 -171.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -97.67 178.82 5.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.8 1.3 . . . . 2.21 110.411 159.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -137.32 150.83 48.03 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.391 2.276 . . . . 3.2799999999999998 105.873 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.1 t -145.06 144.83 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 127.177 2.191 . . . . 1.1399999999999999 109.329 -172.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -92.87 134.27 35.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.871 -0.604 . . . . 3.4900000000000002 111.429 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -114.3 146.01 41.02 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.271 1.828 . . . . 2.7200000000000002 109.774 164.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -101.35 139.82 36.5 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.473 1.509 . . . . 2.0099999999999998 108.757 157.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.82 122.6 46.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.248 1.419 . . . . 1.0900000000000001 108.932 167.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.8 mt -94.76 114.38 26.27 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.279 1.032 . . . . 0.63 110.232 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -109.93 112.92 25.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.039 1.336 . . . . 2.1099999999999999 111.326 -172.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 51.51 29.77 5.72 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.837 1.655 . . . . 2.3500000000000001 113.023 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.97 -71.21 1.71 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.182 1.373 . . . . 4.6600000000000001 111.98 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.9 13.45 18.71 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 116.999 1.56 . . . . 1.6799999999999999 116.999 -163.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -132.05 143.75 50.26 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.634 1.574 . . . . 3.29 110.048 168.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.63 144.79 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.39 1.076 . . . . 2.0600000000000001 109.106 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.9 tp -136.27 123.39 21.64 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.26 1.024 . . . . 2.2599999999999998 110.188 170.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -99.99 140.78 33.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.765 1.226 . . . . 3.0099999999999998 111.993 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.498 HG11 HD21 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -149.18 138.53 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.028 1.331 . . . . 2.0699999999999998 112.102 -173.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.3 p -83.07 136.53 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.814 0.846 . . . . 2.71 109.862 165.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 mt -134.96 142.37 41.88 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.338 2.255 . . . . 2.5 107.472 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 154.93 66.46 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.7 2.266 . . . . 0.79000000000000004 111.571 168.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 64.9 t -91.1 126.41 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.936 0.494 . . . . 0.93999999999999995 110.141 165.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 125.358 1.463 . . . . 4.6600000000000001 112.638 175.307 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 107.151 -1.426 . . . . 4.8799999999999999 107.151 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.77 172.03 37.01 Favored Glycine 0 N--CA 1.464 0.536 0 O-C-N 121.341 -0.849 . . . . 1.3999999999999999 112.775 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.9 p90 -157.92 151.46 23.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.722 1.609 . . . . 2.3500000000000001 110.974 167.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.35 145.96 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 106.964 -1.495 . . . . 1.55 106.964 162.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -80.29 -88.98 0.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.056 1.298 . . . . 5.9100000000000001 111.786 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -164.09 141.55 6.95 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.723 0.809 . . . . 3.1099999999999999 112.118 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.1 t -176.43 140.2 0.51 Allowed Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.795 1.638 . . . . 2.25 111.489 165.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.32 -29.59 7.59 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.507 2.138 . . . . 1.46 112.53 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.64 171.91 12.35 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.309 1.909 . . . . 1.1100000000000001 111.629 -170.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.55 -6.02 31.53 Favored 'Cis proline' 0 CA--C 1.536 0.613 0 CA-C-N 119.305 1.552 . . . . 1.28 113.528 0.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -148.64 164.75 33.35 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.457 1.28 . . . . 2.0099999999999998 114.457 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.35 -179.02 5.64 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.975 2.51 . . . . 0.68999999999999995 110.443 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.39 138.97 33.38 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.148 1.379 . . . . 1.26 109.305 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.21 154.73 47.26 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.059 1.744 . . . . 0.88 112.597 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -136.89 143.91 43.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.51 2.324 . . . . 2.5099999999999998 110.187 -167.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -171.35 153.48 3.6 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.13 1.159 . . . . 2.2000000000000002 114.13 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.7 p -90.45 144.3 25.93 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.522 1.929 . . . . 2.96 110.456 173.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.5 142.86 51.28 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.733 1.613 . . . . 3.8900000000000001 107.929 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -127.9 140.59 51.91 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.949 -0.76 . . . . 4.3399999999999999 108.949 157.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -86.15 112.51 46.24 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.326 1.05 . . . . 1.3600000000000001 108.958 170.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.39 -12.89 11.29 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.615 2.21 . . . . 1.1699999999999999 113.788 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 171.74 46.85 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 122.964 1.313 . . . . 1.22 112.456 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.32 -5.38 36.72 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.346 2.659 . . . . 2.9300000000000002 112.274 -176.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.5 mt -121.16 162.62 34.61 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 127.896 2.478 . . . . 3.9300000000000002 109.3 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.72 150.51 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.359 2.04 . . . . 0.92000000000000004 111.849 -168.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.8 mt -103.45 148.83 25.45 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.26 1.024 . . . . 1.8500000000000001 109.951 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -134.0 101.92 5.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 112.886 -1.961 . . . . 1.6899999999999999 110.471 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.15 104.63 16.87 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.631 1.572 . . . . 1.77 108.318 -172.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -97.91 -30.3 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.616 0.766 . . . . 0.63 112.443 -168.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.33 -175.7 29.56 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.468 1.032 . . . . 0.44 112.423 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.01 174.21 10.42 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.658 0.742 . . . . 0.59999999999999998 111.98 166.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -127.65 164.03 22.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.481 1.912 . . . . 5.7800000000000002 107.8 156.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -171.8 151.02 2.69 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 127.186 2.195 . . . . 0.76000000000000001 108.801 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.13 -24.39 5.71 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.223 1.949 . . . . 1.02 114.013 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 25.5 m -103.97 22.58 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.502 1.121 . . . . 0.94999999999999996 113.817 -172.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.95 152.22 24.49 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 126.37 1.868 . . . . 1.03 108.221 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -90.93 -66.77 0.9 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 126.039 1.735 . . . . 3.5 109.394 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -86.79 140.7 29.45 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.951 -1.87 . . . . 6.4000000000000004 105.951 164.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.18 127.57 65.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 106.769 -1.567 . . . . 1.3400000000000001 106.769 162.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -124.75 125.79 44.63 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.563 1.145 . . . . 2.6299999999999999 109.275 -163.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.2 tp -79.89 122.78 27.1 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.053 -0.404 . . . . 0.97999999999999998 110.796 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -120.33 161.6 20.87 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.323 1.449 . . . . 0.54000000000000004 112.804 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.465 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 19.6 pt-20 -112.13 159.3 18.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.027 2.131 . . . . 2.8799999999999999 110.742 161.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.3 m -124.43 143.25 50.73 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.435 2.294 . . . . 0.77000000000000002 105.654 168.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -152.03 170.62 19.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.711 0.804 . . . . 2.1000000000000001 112.51 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.8 ptm -99.34 143.35 29.69 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.992 0.917 . . . . 4.3399999999999999 111.867 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -156.65 154.39 30.06 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.667 1.187 . . . . 8.1899999999999995 113.02 -177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.47 160.12 26.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.954 0.901 . . . . 5.1100000000000003 110.589 158.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.5 m -146.87 -12.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 117.083 2.253 . . . . 4.1699999999999999 117.083 170.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 178.38 32.35 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.493 2.035 . . . . 4.54 116.493 -158.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.56 15.45 70.79 Favored Glycine 0 N--CA 1.476 1.359 0 O-C-N 119.288 -2.133 . . . . 2.3799999999999999 112.685 -167.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -142.87 88.63 2.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.987 2.515 . . . . 2.8599999999999999 110.002 -166.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.13 122.63 12.87 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.023 -1.048 . . . . 3.7200000000000002 113.022 174.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.4 m -135.76 -176.08 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 129.376 3.071 . . . . 2.6400000000000001 110.043 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.5 mtp -98.51 166.21 11.46 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.803 1.287 . . . . 4.46 113.953 167.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.77 -179.91 17.51 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 127.142 2.306 . . . . 0.78000000000000003 111.079 170.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -149.47 145.69 27.03 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.366 1.866 . . . . 1.1599999999999999 108.344 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.35 147.47 33.96 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.646 1.578 . . . . 7.5800000000000001 109.533 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.82 150.01 23.57 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.522 2.148 . . . . 0.57999999999999996 110.254 167.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -139.09 156.2 72.4 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.802 1.241 . . . . 0.59999999999999998 111.185 -172.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -84.87 -23.22 2.63 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.128 2.552 . . . . 0.56000000000000005 113.712 -165.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -179.13 162.82 1.25 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.413 1.885 . . . . 1.77 111.415 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -107.71 150.39 27.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.573 1.149 . . . . 0.51000000000000001 110.244 162.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -109.5 142.76 40.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.018 -1.105 . . . . 2.1000000000000001 108.018 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.5 t -134.79 122.47 15.47 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.18 -0.438 . . . . 0.84999999999999998 111.131 165.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -69.23 161.5 45.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.539 2.826 . . . . 0.93999999999999995 111.153 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -58.99 138.5 86.03 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.412 2.742 . . . . 0.97999999999999998 112.41 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt 67.24 -7.68 0.5 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.134 1.774 . . . . 1.6799999999999999 114.092 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.55 142.97 25.32 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.751 1.167 . . . . 1.21 113.025 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -101.69 133.03 47.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.406 1.482 . . . . 3.8999999999999999 108.913 168.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -148.59 141.51 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.765 2.026 . . . . 3.3300000000000001 108.542 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.04 137.67 54.56 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.259 1.024 . . . . 3.5099999999999998 113.294 -168.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -70.63 74.03 0.56 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.126 1.77 . . . . 2.1000000000000001 109.372 158.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -68.65 138.92 91.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.244 2.218 . . . . 2.3999999999999999 111.99 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.65 -34.46 62.99 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.643 2.229 . . . . 2.2599999999999998 114.12 -173.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.89 6.78 46.49 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.26 -0.745 . . . . 1.8500000000000001 114.178 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.89 -121.07 1.27 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.307 1.908 . . . . 1.5600000000000001 111.907 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 96.8 m-85 -73.71 138.14 44.48 Favored 'General case' 0 C--O 1.223 -0.312 0 O-C-N 121.567 -0.961 . . . . 2.04 112.341 -171.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -159.89 150.67 19.11 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 124.209 1.003 . . . . 0.70999999999999996 111.1 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -87.8 128.01 35.33 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.755 -0.591 . . . . 1.95 109.481 171.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.2 tpt -85.57 110.87 19.54 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.752 1.621 . . . . 0.81999999999999995 109.655 168.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.7 mp -90.28 116.42 28.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.852 1.261 . . . . 1.48 108.574 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tt -127.17 143.36 51.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.995 0.902 . . . . 2.7799999999999998 112.54 -164.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.78 38.6 41.93 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 121.418 -0.801 . . . . 1.72 112.445 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt -45.52 153.88 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 117.865 2.543 . . . . 0.76000000000000001 117.865 -170.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 51.5 mmtt -119.26 -24.74 6.32 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.673 -1.603 . . . . 2.2400000000000002 113.759 -176.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -125.87 147.83 60.3 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.168 2.187 . . . . 6.1100000000000003 107.992 157.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -66.89 144.67 71.63 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.948 1.765 . . . . 2.0800000000000001 108.28 165.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.16 75.73 8.13 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.919 -1.141 . . . . 2.7400000000000002 107.919 170.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -88.8 165.1 14.91 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.609 1.164 . . . . 3.2999999999999998 111.662 170.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.47 132.14 51.5 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.454 -0.779 . . . . 2.1000000000000001 111.372 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.6 1.41 58.94 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 117.231 -1.872 . . . . 1.8999999999999999 115.745 169.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -76.6 167.59 21.58 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.82 1.81 . . . . 2.3900000000000001 110.342 169.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.23 133.02 47.34 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 130.455 3.502 . . . . 3.8999999999999999 104.362 173.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.1 t -136.98 132.62 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.828 1.251 . . . . 1.3 111.196 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -79.37 142.78 35.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.279 -1.328 . . . . 2.3900000000000001 112.067 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -122.47 154.82 37.3 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.138 -0.937 . . . . 1.95 109.922 152.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -125.76 112.65 16.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.175 2.19 . . . . 2.6099999999999999 108.809 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mp -84.98 116.71 23.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.599 1.16 . . . . 0.91000000000000003 111.194 -171.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.9 mt -85.69 106.71 17.15 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.705 1.202 . . . . 0.60999999999999999 109.937 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -103.24 107.71 18.63 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.279 1.432 . . . . 2.04 111.74 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 55.17 27.43 9.59 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.975 1.71 . . . . 2.5099999999999998 112.906 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.85 -59.23 3.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.52 1.533 . . . . 4.6799999999999997 113.163 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.68 -1.23 70.96 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.58 1.392 . . . . 1.6100000000000001 116.58 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -133.32 146.74 51.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.218 1.509 . . . . 2.8300000000000001 111.372 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.89 149.75 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.352 1.461 . . . . 2.2400000000000002 110.779 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.7 tt -145.01 130.08 18.44 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.621 1.168 . . . . 2.1600000000000001 111.259 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 140.55 38.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.642 1.177 . . . . 2.2200000000000002 113.425 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.77 165.82 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.881 1.672 . . . . 2.71 110.749 163.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.24 151.3 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.813 1.245 . . . . 2.6699999999999999 109.493 168.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.38 137.77 9.6 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 126.188 1.795 . . . . 2.4500000000000002 112.796 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.45 163.62 31.89 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.264 3.309 . . . . 1.4199999999999999 113.364 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.6 t -103.87 109.58 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 122.326 1.06 . . . . 1.52 110.624 174.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 127.689 2.396 . . . . 4.1699999999999999 109.635 -170.383 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 121.457 0.646 . . . . 4.8300000000000001 111.631 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.09 -178.42 15.5 Favored Glycine 0 N--CA 1.469 0.849 0 O-C-N 120.774 -1.204 . . . . 1.21 111.583 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -144.83 166.87 24.02 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.296 0.85 . . . . 2.4100000000000001 113.296 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.5 t -115.99 143.46 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.846 1.259 . . . . 1.24 109.185 176.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -26.29 60.9 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 117.268 2.322 . . . . 4.6500000000000004 117.268 -151.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER 79.78 114.79 0.06 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.232 2.213 . . . . 2.9399999999999999 108.159 -167.258 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.5 m -160.88 138.59 6.98 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.645 1.978 . . . . 2.29 108.286 166.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.03 -33.13 10.08 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.39 2.06 . . . . 1.46 111.76 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.57 179.87 22.14 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.18 1.372 . . . . 0.95999999999999996 112.331 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.22 -5.64 16.38 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 CA-C-N 118.48 1.14 . . . . 1.22 113.013 -2.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -135.74 175.14 9.87 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.759 1.623 . . . . 4.1399999999999997 111.903 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.27 -175.46 5.42 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.947 2.899 . . . . 0.44 111.585 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.37 154.93 45.92 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.365 2.266 . . . . 0.73999999999999999 107.84 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.2 130.53 39.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.83 0.741 . . . . 0.52000000000000002 110.391 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -110.64 54.12 0.68 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.175 2.19 . . . . 2.3300000000000001 111.366 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.97 150.75 37.39 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.136 -0.978 . . . . 1.6299999999999999 113.309 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -91.79 134.67 34.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.304 0.642 . . . . 1.6299999999999999 109.78 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.56 134.54 51.79 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.143 2.177 . . . . 3.29 110.234 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -119.17 151.98 37.38 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.889 1.676 . . . . 5.3399999999999999 110.445 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -114.65 103.68 54.75 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.196 0.998 . . . . 1.3899999999999999 109.083 160.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -83.62 -8.54 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.244 2.629 . . . . 1.6699999999999999 114.455 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.57 175.9 30.73 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 119.441 1.019 . . . . 1.3500000000000001 112.066 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -92.18 1.21 57.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.069 2.148 . . . . 3.5099999999999998 112.984 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.0 pt? -112.16 157.21 40.5 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 127.425 2.29 . . . . 3.8799999999999999 110.402 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.25 158.01 41.42 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.802 2.335 . . . . 1.1499999999999999 111.067 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.3 mt -134.0 130.3 37.4 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 124.239 1.971 . . . . 1.8300000000000001 112.785 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -108.89 106.12 15.97 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 110.704 -2.953 . . . . 2.0 111.331 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.29 114.74 26.85 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.361 1.464 . . . . 2.3999999999999999 108.358 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.2 -25.56 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.646 0.778 . . . . 0.69999999999999996 112.685 -170.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.28 -174.55 27.13 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.319 0.961 . . . . 0.54000000000000004 112.9 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.94 -177.55 5.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.248 1.019 . . . . 0.67000000000000004 111.056 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.54 -175.58 5.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.849 2.459 . . . . 5.4500000000000002 109.441 164.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t 178.71 150.37 0.44 Allowed Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 129.528 3.131 . . . . 0.94999999999999996 106.192 -167.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.24 -12.82 14.11 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.925 1.75 . . . . 0.89000000000000001 113.472 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.93 23.54 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.717 1.377 . . . . 1.01 114.717 -170.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -150.78 134.15 16.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.874 1.67 . . . . 1.1200000000000001 109.764 168.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -59.51 -48.88 79.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.35 1.06 . . . . 2.7799999999999998 111.569 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.39 165.29 16.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.7 2.4 . . . . 5.4199999999999999 109.568 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -148.17 145.89 18.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 126.072 1.749 . . . . 0.90000000000000002 108.323 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -130.12 146.09 51.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.499 1.92 . . . . 2.6699999999999999 109.435 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -99.37 117.01 32.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.014 0.925 . . . . 0.89000000000000001 109.588 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -118.66 149.95 40.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 123.089 1.423 . . . . 0.56000000000000005 113.844 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -95.84 172.44 8.02 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.915 1.686 . . . . 2.3599999999999999 111.348 164.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.4 m -148.29 144.56 27.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.525 1.53 . . . . 0.94999999999999996 107.165 170.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -157.17 166.81 32.19 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.939 0.718 . . . . 2.0099999999999998 112.939 -166.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.2 mtp -93.73 144.36 25.48 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.068 0.947 . . . . 4.0199999999999996 111.473 170.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -157.88 163.0 38.36 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.708 1.603 . . . . 8.1899999999999995 111.906 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.27 152.65 32.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.904 1.282 . . . . 3.4100000000000001 110.534 165.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.65 120.46 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 106.714 -1.587 . . . . 3.8599999999999999 106.714 142.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 55.34 44.28 27.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.4 1.48 . . . . 5.7400000000000002 113.113 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.48 0.74 63.43 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.051 -1.031 . . . . 2.4700000000000002 114.128 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -109.35 114.78 28.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.077 1.351 . . . . 3.54 109.753 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -67.65 127.07 31.39 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.094 1.358 . . . . 4.25 111.171 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.65 -177.17 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 129.763 3.225 . . . . 2.3900000000000001 109.75 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 59.2 mtt -110.08 167.27 10.3 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.109 -0.994 . . . . 2.8799999999999999 113.602 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.53 172.15 29.56 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 126.034 1.778 . . . . 0.69999999999999996 112.262 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -149.68 147.5 28.15 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.294 1.838 . . . . 1.28 108.952 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -151.16 156.88 35.37 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 127.034 2.134 . . . . 4.6799999999999997 108.866 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.15 149.72 28.63 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.13 1.887 . . . . 0.45000000000000001 110.508 167.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.7 m -137.64 152.42 72.7 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 125.399 1.48 . . . . 0.88 110.362 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.59 -24.29 2.98 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.09 2.526 . . . . 0.57999999999999996 113.504 -160.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -177.11 160.85 1.81 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.255 1.422 . . . . 2.2000000000000002 112.25 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.63 154.77 20.43 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.704 1.601 . . . . 0.67000000000000004 109.89 162.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -115.77 149.86 37.83 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.7 1.2 . . . . 3.0699999999999998 108.71 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.19 127.86 10.64 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 112.776 0.658 . . . . 0.95999999999999996 112.776 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.62 155.42 44.77 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.416 2.744 . . . . 1.4399999999999999 112.098 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.33 139.59 83.69 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.228 3.285 . . . . 1.53 113.388 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.45 1.34 0.97 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.968 2.107 . . . . 2.54 114.347 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.84 167.13 51.14 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.201 1.858 . . . . 1.3999999999999999 113.037 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.21 150.73 45.88 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.541 1.536 . . . . 4.0499999999999998 109.174 169.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.3 t -149.79 135.97 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.866 1.667 . . . . 3.5 107.216 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.99 132.55 54.12 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 119.071 0.85 . . . . 2.6499999999999999 111.741 -177.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -71.25 80.7 0.73 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.933 1.349 . . . . 2.3700000000000001 109.694 168.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.53 146.85 66.52 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.529 1.532 . . . . 2.8799999999999999 112.838 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -53.56 -41.94 69.69 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.403 2.735 . . . . 2.9399999999999999 112.431 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.94 54.0 4.66 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 118.612 -1.104 . . . . 2.29 113.202 170.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.48 -29.64 0.51 Allowed Glycine 0 N--CA 1.472 1.084 0 N-CA-C 119.953 2.741 . . . . 2.46 119.953 155.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -147.26 137.12 23.05 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.924 2.362 . . . . 2.21 111.528 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -161.32 156.7 24.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.599 0.592 . . . . 0.66000000000000003 112.599 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -84.43 145.3 28.24 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.409 -0.589 . . . . 1.8200000000000001 109.409 163.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -99.23 132.19 44.72 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.073 1.749 . . . . 0.78000000000000003 108.838 161.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -110.21 115.38 29.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.17 1.388 . . . . 1.1499999999999999 108.257 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.62 142.22 42.78 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.96 0.904 . . . . 2.5 109.809 -171.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.03 55.83 21.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.413 1.006 . . . . 1.77 113.877 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 17.7 mt -48.56 154.26 0.68 Allowed 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 115.153 1.538 . . . . 0.72999999999999998 115.153 176.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -98.88 -26.69 14.2 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 113.016 -1.902 . . . . 1.75 113.276 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.83 152.0 29.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.734 2.414 . . . . 5.6200000000000001 110.741 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.39 135.4 24.43 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.422 2.748 . . . . 1.52 110.534 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -124.36 125.61 44.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.744 1.217 . . . . 2.2400000000000002 111.913 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 4.1 ptpp? -114.87 168.57 9.78 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.639 1.175 . . . . 3.1200000000000001 113.699 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.33 140.46 48.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.252 0.621 . . . . 1.9399999999999999 109.845 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.31 12.63 62.9 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.651 1.119 . . . . 1.8700000000000001 113.993 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -99.77 179.64 4.46 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.29 1.036 . . . . 2.3300000000000001 110.161 162.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 39.2 mt-10 -124.86 152.57 43.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.538 2.335 . . . . 3.3900000000000001 104.761 163.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.5 t -147.39 144.79 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.385 1.874 . . . . 1.2 109.809 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -94.12 142.26 27.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.115 0.966 . . . . 2.3799999999999999 113.3 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 54.2 mt -130.19 160.89 32.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.303 2.241 . . . . 2.73 110.596 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -121.29 126.13 48.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.65 2.38 . . . . 2.7999999999999998 109.05 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.95 123.56 45.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.233 1.413 . . . . 1.1499999999999999 110.653 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.8 mt -104.23 110.59 22.86 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.314 1.045 . . . . 0.79000000000000004 110.829 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.65 144.06 35.26 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.416 1.486 . . . . 1.95 111.044 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.51 134.39 56.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.569 0.748 . . . . 2.4199999999999999 112.152 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.67 42.2 5.81 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.865 -0.964 . . . . 3.6600000000000001 113.909 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.14 6.47 86.18 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 115.846 1.098 . . . . 1.8200000000000001 115.846 166.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -90.99 121.64 32.98 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.43 1.115 . . . . 3.2000000000000002 111.496 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.38 137.0 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.583 1.553 . . . . 2.0699999999999998 108.828 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.6 tp -137.15 113.58 10.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.049 0.94 . . . . 2.5800000000000001 110.329 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -83.43 141.53 31.63 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.936 -0.478 . . . . 2.5699999999999998 111.803 171.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.8 171.13 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 127.437 2.295 . . . . 2.6299999999999999 110.683 -171.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.87 138.22 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.484 1.113 . . . . 2.4300000000000002 110.394 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mp -142.94 153.2 60.39 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.106 1.762 . . . . 3.0600000000000001 109.951 -175.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 72.1 Cg_endo -69.46 154.32 69.09 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.016 3.144 . . . . 1.1699999999999999 112.999 171.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.5 t -93.98 125.75 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.237 -1.023 . . . . 1.29 108.237 165.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.466 0.345 0 C-N-CA 125.195 1.398 . . . . 4.3200000000000003 108.421 179.159 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 108.774 -0.825 . . . . 6.1399999999999997 108.774 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.25 169.33 13.76 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 114.927 0.731 . . . . 1.1699999999999999 114.927 -169.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -151.61 168.64 24.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.16 1.384 . . . . 2.3100000000000001 113.036 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.44 148.07 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.688 1.595 . . . . 1.26 107.784 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -70.98 -132.79 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.26 1.024 . . . . 6.6200000000000001 111.34 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -145.27 134.93 23.4 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.447 -1.408 . . . . 2.0099999999999998 109.831 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.1 p -176.53 117.13 0.28 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.883 1.068 . . . . 3.5600000000000001 113.883 -163.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.4 -28.01 10.72 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.432 2.088 . . . . 1.3899999999999999 112.263 169.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.24 -176.52 18.11 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.815 1.674 . . . . 0.96999999999999997 111.936 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.42 -8.26 21.81 Favored 'Cis proline' 0 CA--C 1.536 0.581 0 CA-C-N 118.924 1.362 . . . . 1.1399999999999999 113.43 1.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -128.23 165.01 21.31 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 126.41 1.884 . . . . 1.8700000000000001 112.552 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.57 -178.54 6.75 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.936 2.494 . . . . 0.71999999999999997 110.707 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.31 141.76 26.43 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.992 1.317 . . . . 0.67000000000000004 110.042 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.48 150.48 50.14 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.262 1.425 . . . . 0.81000000000000005 111.561 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -133.36 66.46 1.56 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.828 2.051 . . . . 2.29 109.564 -166.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -72.4 165.57 24.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.631 1.572 . . . . 2.0299999999999998 114.666 -173.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -93.63 151.45 19.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.321 1.048 . . . . 4.3799999999999999 110.4 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.9 tp -135.99 117.42 14.73 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.271 1.428 . . . . 4.3200000000000003 110.074 -167.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -114.11 135.18 54.31 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.306 1.442 . . . . 6.3499999999999996 111.001 -173.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.35 67.16 3.44 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.071 -1.018 . . . . 2.6299999999999999 110.965 171.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.75 -22.72 56.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.42 2.746 . . . . 1.7 114.64 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.56 -171.94 42.48 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-O 122.534 1.074 . . . . 1.54 113.338 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.85 -0.42 16.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.746 2.018 . . . . 2.98 112.929 -167.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.9 mt -122.29 160.25 48.73 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 127.001 2.12 . . . . 3.8999999999999999 109.243 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -81.96 144.29 13.46 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.711 2.274 . . . . 0.96999999999999997 111.349 -168.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 mp -101.55 154.61 18.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 123.031 1.396 . . . . 2.79 111.271 171.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -136.69 103.66 5.28 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 113.583 -1.644 . . . . 1.8100000000000001 109.627 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.15 108.07 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.571 1.549 . . . . 1.9099999999999999 108.263 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.5 m -102.57 -25.53 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.519 0.933 . . . . 0.60999999999999999 113.519 -169.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.23 -176.98 30.89 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 124.862 1.22 . . . . 0.53000000000000003 112.055 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.83 -179.72 5.47 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.555 0.693 . . . . 0.54000000000000004 112.582 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 172.91 14.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.371 2.269 . . . . 5.7199999999999998 108.862 161.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t 175.12 150.14 0.27 Allowed Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 129.509 3.123 . . . . 0.88 106.977 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.2 -15.73 25.42 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.128 1.885 . . . . 1.26 114.311 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.57 23.07 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 116.059 1.874 . . . . 1.1499999999999999 116.059 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.21 136.63 14.11 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.42 1.488 . . . . 1.1299999999999999 110.761 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.34 -46.55 89.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.251 1.02 . . . . 2.7599999999999998 112.338 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -127.52 160.22 32.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.894 2.078 . . . . 4.6600000000000001 108.993 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.0 152.96 24.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 126.851 2.06 . . . . 0.91000000000000003 108.545 170.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.5 147.41 26.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.232 1.813 . . . . 4.2599999999999998 108.313 -166.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.2 tp -111.05 110.12 20.51 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.445 1.02 . . . . 0.81999999999999995 110.711 -164.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -117.65 153.72 32.83 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 123.019 1.39 . . . . 0.57999999999999996 113.654 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -109.92 177.26 4.77 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 113.392 -1.731 . . . . 2.48 111.671 163.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.8 m -152.93 103.14 2.72 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.156 1.382 . . . . 1.2 107.342 -169.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -107.28 165.25 11.52 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.276 1.031 . . . . 2.27 113.59 -166.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.4 mtm -101.55 150.58 22.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.048 1.339 . . . . 4.8200000000000003 110.57 166.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.28 156.48 32.51 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.238 1.015 . . . . 5.2999999999999998 110.934 -169.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -108.89 145.7 34.93 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.606 1.563 . . . . 2.6400000000000001 108.665 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -153.13 136.62 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.545 -0.909 . . . . 2.9900000000000002 108.545 160.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 67.45 16.94 10.06 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.747 1.219 . . . . 3.8900000000000001 112.863 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.12 17.43 78.24 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.73 -1.231 . . . . 1.52 113.357 -169.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -120.82 126.72 50.81 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.985 2.114 . . . . 3.2200000000000002 109.109 -172.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -73.15 121.27 19.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.253 1.821 . . . . 3.04 108.974 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.26 179.8 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.418 1.887 . . . . 2.8500000000000001 110.543 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.7 mtt -130.31 170.27 14.35 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.178 1.391 . . . . 2.5699999999999998 111.091 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.49 -178.22 29.51 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.382 0.991 . . . . 0.56000000000000005 112.916 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.9 ttm -143.91 150.2 38.02 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.98 1.712 . . . . 1.1599999999999999 108.149 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -159.22 153.84 20.81 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.377 1.071 . . . . 4.9500000000000002 109.994 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.72 159.82 38.36 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.368 2.045 . . . . 0.55000000000000004 110.986 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.94 152.66 40.86 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 125.875 1.67 . . . . 1.0600000000000001 109.88 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -83.51 -26.53 2.09 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.992 2.461 . . . . 0.68999999999999995 113.557 -160.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -177.61 166.33 2.17 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.835 1.654 . . . . 2.1499999999999999 111.819 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.3 mt -109.83 153.35 24.53 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.405 1.482 . . . . 0.71999999999999997 110.277 161.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -117.97 147.55 43.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.888 1.675 . . . . 1.6899999999999999 108.504 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 t -140.41 139.06 19.74 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 112.606 0.595 . . . . 1.28 112.606 171.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.77 157.11 15.91 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.887 3.058 . . . . 1.1699999999999999 112.232 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.35 146.75 96.93 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.926 3.084 . . . . 1.3700000000000001 114.597 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm 70.37 -5.65 1.32 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.153 2.581 . . . . 2.2000000000000002 114.189 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.81 167.09 52.54 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.947 1.26 . . . . 2.0 113.987 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.18 135.19 20.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.223 2.609 . . . . 6.6600000000000001 106.457 168.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.2 t -152.87 96.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.715 1.206 . . . . 3.6600000000000001 111.848 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -74.04 160.39 31.35 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.31 -1.494 . . . . 4.2400000000000002 112.149 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mp -67.34 90.15 0.22 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.878 1.323 . . . . 2.3300000000000001 108.611 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.628 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -42.23 135.34 2.43 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 127.428 2.291 . . . . 4.0499999999999998 112.865 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.9 -31.79 91.92 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.389 2.06 . . . . 2.1499999999999999 112.513 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.65 96.37 1.72 Allowed Glycine 0 C--N 1.343 0.933 0 C-N-CA 123.97 0.795 . . . . 3.1099999999999999 111.374 166.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.56 -15.67 4.92 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 117.548 1.779 . . . . 1.8799999999999999 117.548 149.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -140.95 146.28 37.15 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.442 2.121 . . . . 2.1499999999999999 112.175 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -160.59 148.29 16.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.588 1.155 . . . . 0.78000000000000003 111.78 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -79.54 120.89 24.53 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.501 -0.925 . . . . 1.8500000000000001 108.501 161.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 tpt -78.88 127.6 32.23 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.061 2.545 . . . . 1.1599999999999999 108.756 167.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.1 mt -113.93 134.59 54.73 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.952 1.701 . . . . 2.3599999999999999 109.338 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.3 131.04 36.0 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.198 0.908 . . . . 2.1699999999999999 111.797 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.66 49.28 4.92 Favored Glycine 0 N--CA 1.468 0.819 0 C-N-CA 123.747 0.689 . . . . 1.8999999999999999 112.201 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.4 mt -52.66 155.83 2.11 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 115.078 1.51 . . . . 0.72999999999999998 115.078 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -110.01 -13.17 14.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.869 -1.514 . . . . 1.71 114.849 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.1 mmt-85 -140.38 138.11 18.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 130.136 3.374 . . . . 7.0499999999999998 108.697 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.52 137.89 18.91 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.34 2.027 . . . . 1.4099999999999999 108.583 161.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -91.65 143.64 26.35 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.785 0.802 . . . . 2.48 112.525 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -91.71 -162.96 0.97 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.911 1.338 . . . . 3.8100000000000001 109.203 163.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.11 142.96 37.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.132 -1.395 . . . . 1.0800000000000001 107.811 155.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.84 33.83 12.09 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.877 -0.957 . . . . 1.3200000000000001 114.309 -173.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -112.62 -176.38 2.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.162 1.385 . . . . 2.1699999999999999 110.473 168.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -146.51 134.99 22.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 128.274 2.63 . . . . 3.1000000000000001 105.153 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.4 t -143.72 144.51 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.118 1.367 . . . . 1.1899999999999999 107.929 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.79 146.21 28.1 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.514 0.673 . . . . 3.29 111.027 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.81 140.11 53.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.335 1.054 . . . . 1.75 109.894 169.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -79.78 135.17 36.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.595 2.758 . . . . 2.23 109.708 162.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.32 123.65 46.51 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.992 1.717 . . . . 1.29 106.946 170.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.67 104.67 16.68 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.926 -1.139 . . . . 0.84999999999999998 107.926 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -96.19 128.84 43.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.456 1.102 . . . . 2.1800000000000002 111.237 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 45.13 40.64 4.99 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.438 1.895 . . . . 2.9399999999999999 112.831 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.52 -94.38 1.97 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.539 1.066 . . . . 5.9000000000000004 111.506 -170.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.1 -6.78 62.91 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 117.121 1.609 . . . . 3.1200000000000001 117.121 -160.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -80.8 104.85 11.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.819 2.309 . . . . 2.6099999999999999 110.765 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.02 135.07 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.252 1.021 . . . . 2.46 111.402 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 tt -155.19 129.92 9.25 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.549 1.54 . . . . 2.2400000000000002 109.26 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.64 153.14 20.4 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.856 1.428 . . . . 3.7400000000000002 114.856 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 t -130.14 161.35 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.602 2.361 . . . . 2.1400000000000001 108.9 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.83 147.03 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.0 1.72 . . . . 2.0899999999999999 109.051 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.61 138.19 11.75 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.237 1.015 . . . . 2.0600000000000001 111.598 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.18 160.82 46.3 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.901 3.067 . . . . 0.98999999999999999 112.962 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.3 t -106.6 128.38 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.407 1.883 . . . . 0.94999999999999996 109.548 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 CA--C 1.542 0.666 0 C-N-CA 124.509 1.124 . . . . 3.46 110.956 -174.385 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 121.515 0.674 . . . . 4.5800000000000001 111.952 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.04 177.35 39.79 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 116.079 1.192 . . . . 1.21 116.079 -163.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -150.24 149.46 30.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.337 1.855 . . . . 2.1800000000000002 110.483 166.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.0 t -93.22 148.61 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 121.004 -1.06 . . . . 1.1799999999999999 108.174 172.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -143.26 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.304 0.573 . . . . 5.2800000000000002 110.957 170.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -152.76 121.12 6.3 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 119.78 -1.825 . . . . 2.3100000000000001 111.044 -160.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -165.14 146.95 6.47 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 127.704 2.402 . . . . 1.95 109.796 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.46 -34.11 4.8 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.413 2.075 . . . . 1.6799999999999999 111.538 164.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.05 176.74 23.41 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.139 1.828 . . . . 1.0800000000000001 111.24 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.25 -4.62 33.85 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 CA-C-N 119.395 1.597 . . . . 1.0600000000000001 113.319 -1.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -138.27 164.04 30.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 122.265 1.031 . . . . 2.0299999999999998 113.337 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.31 -177.48 4.86 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.349 2.26 . . . . 0.56000000000000005 110.701 169.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.38 153.33 51.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.935 1.694 . . . . 0.87 109.227 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.21 153.07 42.46 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.991 0.916 . . . . 0.82999999999999996 113.025 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -126.82 134.94 50.44 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.568 1.947 . . . . 2.7599999999999998 108.811 -174.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.48 171.58 11.71 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.458 1.026 . . . . 3.0800000000000001 112.587 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.1 m -111.01 147.3 35.05 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.241 1.416 . . . . 1.97 111.128 -171.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.96 138.55 49.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.266 2.226 . . . . 4.2800000000000002 109.356 167.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.53 175.04 5.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.574 1.55 . . . . 6.9699999999999998 110.749 165.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -146.71 103.7 3.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 121.214 -0.929 . . . . 1.8300000000000001 109.728 166.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.03 -13.65 12.65 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.885 2.39 . . . . 2.0699999999999998 113.247 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.63 179.59 53.04 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 122.748 1.194 . . . . 1.5600000000000001 112.795 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.18 -2.49 24.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.866 2.466 . . . . 3.1099999999999999 111.87 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -123.07 159.36 54.47 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.391 2.676 . . . . 2.6800000000000002 109.866 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.73 151.29 28.19 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.439 2.093 . . . . 1.03 112.171 -171.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.8 mt -100.15 155.9 17.49 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 125.278 1.431 . . . . 2.1299999999999999 110.498 168.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -139.55 120.69 14.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 113.716 -1.584 . . . . 2.23 110.289 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.3 116.1 31.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.602 1.961 . . . . 1.8500000000000001 107.951 -171.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.32 -21.79 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.142 0.977 . . . . 0.51000000000000001 112.819 -166.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.4 -175.72 31.71 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 124.716 1.15 . . . . 0.55000000000000004 113.224 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.61 176.65 9.05 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.525 0.73 . . . . 0.69999999999999996 112.017 170.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.26 153.5 38.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.525 3.13 . . . . 5.5599999999999996 107.96 176.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -167.93 153.49 6.89 Favored Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 127.122 2.169 . . . . 0.67000000000000004 109.548 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -74.41 -18.54 20.25 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.834 2.356 . . . . 0.85999999999999999 114.246 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -108.72 20.15 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.739 1.385 . . . . 0.95999999999999996 114.739 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.07 150.61 31.97 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.469 1.907 . . . . 0.79000000000000004 107.813 166.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -79.79 -62.4 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.588 0.755 . . . . 3.6299999999999999 109.709 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.85 172.08 7.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.45 1.9 . . . . 4.8899999999999997 107.452 170.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.57 135.85 9.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 107.347 -1.353 . . . . 0.94999999999999996 107.347 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -105.97 149.84 26.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.476 1.51 . . . . 3.0299999999999998 109.496 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.3 tp -103.25 120.19 40.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.677 0.791 . . . . 0.88 109.62 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -123.65 149.61 45.21 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.239 1.416 . . . . 0.51000000000000001 113.966 -174.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -92.36 157.11 16.8 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.466 1.506 . . . . 2.0299999999999998 111.144 162.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.1 m -120.04 146.09 46.22 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 105.736 -1.949 . . . . 1.22 105.736 165.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -160.18 -171.87 3.37 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.202 0.91 . . . . 2.0899999999999999 112.796 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.2 mtt -127.78 148.0 50.43 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.25 1.42 . . . . 5.0999999999999996 113.131 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.28 146.86 52.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.882 1.673 . . . . 5.8499999999999996 112.992 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -87.51 140.0 29.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.652 1.181 . . . . 2.4399999999999999 109.103 151.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.4 t -142.82 122.59 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.275 1.83 . . . . 2.2599999999999998 106.974 168.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 63.76 12.76 6.92 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.155 1.782 . . . . 3.3300000000000001 114.777 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.31 24.23 59.51 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 120.918 -1.114 . . . . 1.5600000000000001 113.174 -167.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -127.65 137.42 52.52 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.059 2.144 . . . . 2.4700000000000002 108.296 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -98.31 123.98 42.7 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.678 1.191 . . . . 3.2400000000000002 111.92 -166.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.6 t -143.09 139.89 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.51 1.924 . . . . 2.2200000000000002 108.411 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.1 mtm -82.2 168.2 17.9 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.533 0.938 . . . . 3.7400000000000002 113.533 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.77 166.96 26.08 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.635 1.588 . . . . 0.78000000000000003 112.815 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.7 ttm -155.8 144.27 20.18 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.12 1.768 . . . . 1.1499999999999999 108.634 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 -146.36 155.75 49.88 Favored Pre-proline 0 N--CA 1.468 0.458 0 C-N-CA 125.244 1.418 . . . . 4.25 109.813 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.85 154.85 38.86 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.663 1.575 . . . . 0.53000000000000003 110.589 164.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.52 155.39 73.72 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 125.503 1.521 . . . . 0.56999999999999995 110.462 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.93 -28.41 3.26 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.738 2.292 . . . . 0.46999999999999997 112.867 -168.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -176.03 165.97 2.94 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.223 1.409 . . . . 1.77 112.294 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.7 153.21 24.61 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.694 1.598 . . . . 0.56999999999999995 110.284 164.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -110.76 146.45 36.33 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.937 1.295 . . . . 1.72 109.833 174.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.6 t -140.16 131.16 14.15 Favored Pre-proline 0 N--CA 1.477 0.891 0 N-CA-C 114.452 1.278 . . . . 1.3700000000000001 114.452 168.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.58 160.61 34.83 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.36 3.373 . . . . 1.1200000000000001 113.124 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.12 145.31 89.14 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.428 3.418 . . . . 1.1299999999999999 113.792 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt 67.93 -4.25 1.04 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.077 2.151 . . . . 2.2400000000000002 114.384 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.87 -179.98 47.35 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.694 1.616 . . . . 1.76 113.189 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.66 139.67 21.02 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.146 1.379 . . . . 3.9399999999999999 109.26 167.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -144.93 146.47 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.739 1.615 . . . . 3.1699999999999999 109.284 -168.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.33 150.97 46.66 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.882 1.068 . . . . 2.6299999999999999 113.882 -173.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -72.5 66.54 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.024 1.73 . . . . 2.0800000000000001 109.435 163.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.27 127.9 84.82 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.578 1.151 . . . . 3.0499999999999998 110.17 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -54.8 -38.61 91.98 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.338 3.359 . . . . 2.4900000000000002 113.916 -166.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.44 -1.08 56.84 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 117.53 -1.706 . . . . 1.8500000000000001 115.338 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -143.56 -23.15 0.17 Allowed Glycine 0 N--CA 1.474 1.199 0 CA-C-N 120.047 1.923 . . . . 2.2799999999999998 117.793 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -149.04 146.64 27.85 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.443 2.121 . . . . 2.2799999999999998 112.425 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -161.87 156.05 22.06 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.267 1.027 . . . . 0.66000000000000003 110.748 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -83.45 145.56 28.89 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.653 -0.499 . . . . 1.99 109.653 164.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -103.72 111.03 23.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.521 1.928 . . . . 0.79000000000000004 108.542 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.65 120.22 29.84 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.485 1.114 . . . . 1.28 108.697 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -121.12 144.39 48.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.458 1.123 . . . . 2.0600000000000001 112.881 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.01 38.42 40.66 Favored Glycine 0 N--CA 1.468 0.768 0 CA-C-N 115.163 -0.926 . . . . 1.75 111.867 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.4 mt -45.02 154.36 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 127.213 2.205 . . . . 0.71999999999999997 116.217 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -116.35 -21.98 9.02 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 113.544 -1.662 . . . . 2.1800000000000002 114.723 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -136.2 141.23 35.38 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 127.659 2.384 . . . . 7.1200000000000001 108.806 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.16 144.57 23.62 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.982 3.122 . . . . 1.3799999999999999 109.835 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.69 119.35 30.86 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.56 0.744 . . . . 2.0 110.369 -172.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -102.51 163.25 12.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.982 0.913 . . . . 3.5499999999999998 111.397 165.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.7 132.98 45.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.794 -0.817 . . . . 1.0800000000000001 108.794 166.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.6 1.09 71.67 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.16 -1.356 . . . . 1.3 115.641 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -75.0 179.87 4.71 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.571 1.686 . . . . 2.73 109.291 162.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -147.42 153.47 39.64 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.195 1.798 . . . . 3.04 108.03 165.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.9 t -142.79 143.3 25.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 127.718 2.407 . . . . 1.1499999999999999 109.589 -169.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.96 144.96 29.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.977 1.311 . . . . 3.5299999999999998 112.33 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 mp -130.5 138.72 50.37 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.124 1.77 . . . . 1.6799999999999999 109.861 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.407 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 28.5 m-20 -93.62 130.45 39.53 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.826 1.65 . . . . 2.3300000000000001 109.47 156.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.76 140.4 29.7 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.462 1.505 . . . . 1.02 108.93 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.3 mt -111.75 131.3 55.41 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.506 1.522 . . . . 0.73999999999999999 110.547 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -126.7 153.22 45.73 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.499 0.72 . . . . 2.71 112.675 -167.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.34 134.26 55.48 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.987 0.899 . . . . 2.1299999999999999 112.036 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.68 42.93 45.24 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.667 -1.074 . . . . 4.1399999999999997 113.703 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.65 46.2 6.48 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 116.235 1.254 . . . . 1.99 116.235 161.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -128.99 154.74 46.31 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.098 1.449 . . . . 3.46 112.182 167.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.5 t -143.69 144.71 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.593 1.957 . . . . 1.8899999999999999 107.034 171.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 tt -152.19 127.08 9.63 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.644 0.778 . . . . 2.6099999999999999 110.803 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.407 ' HE3' ' OD1' ' A' ' 102' ' ' ASP . 2.7 ttmt -93.89 134.57 36.13 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.172 0.804 . . . . 2.7599999999999998 113.172 -177.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.62 153.2 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.026 1.33 . . . . 1.8700000000000001 108.272 162.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 t -128.81 139.79 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.886 1.275 . . . . 2.0800000000000001 107.611 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.17 142.23 15.18 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 113.152 0.797 . . . . 2.3599999999999999 113.152 -165.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.84 170.39 14.21 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.282 3.321 . . . . 0.96999999999999997 112.863 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.34 145.74 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.982 1.313 . . . . 0.90000000000000002 110.632 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 125.015 1.326 . . . . 4.7300000000000004 112.805 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 . . . . . 0 CA--C 1.545 0.787 0 CA-C-O 121.078 0.466 . . . . 4.9400000000000004 110.54 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.16 159.95 15.39 Favored Glycine 0 N--CA 1.469 0.844 0 O-C-N 120.907 -1.121 . . . . 1.1599999999999999 111.575 175.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.2 p90 -156.66 157.55 35.4 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.947 0.899 . . . . 2.4100000000000001 112.187 166.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.45 145.47 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.589 1.156 . . . . 1.3500000000000001 108.446 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -69.75 -159.76 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.266 1.026 . . . . 5.79 110.668 164.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -128.63 150.61 50.15 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.328 1.451 . . . . 2.6099999999999999 110.684 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -170.72 145.22 2.03 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.958 1.703 . . . . 2.4199999999999999 109.294 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.03 -22.06 15.15 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.98 2.453 . . . . 1.97 112.683 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.09 173.21 13.26 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 126.158 1.837 . . . . 1.1499999999999999 111.745 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.98 -0.49 39.01 Favored 'Cis proline' 0 CA--C 1.541 0.834 0 CA-C-N 119.122 1.461 . . . . 1.0900000000000001 113.474 0.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -147.52 162.42 39.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.317 1.047 . . . . 1.8500000000000001 113.62 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.27 -179.05 5.33 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 129.606 3.163 . . . . 0.41999999999999998 109.634 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.81 146.78 49.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.399 1.48 . . . . 0.72999999999999998 108.728 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.23 148.67 45.01 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.327 1.051 . . . . 0.65000000000000002 112.333 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -115.66 136.17 53.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.932 2.093 . . . . 2.4300000000000002 111.197 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.93 145.65 43.48 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.757 0.823 . . . . 2.8399999999999999 110.807 173.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.0 m -124.96 113.65 18.1 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.827 0.851 . . . . 2.21 109.983 166.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.28 174.12 7.92 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.666 1.986 . . . . 5.4100000000000001 107.72 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.431 ' CD ' HH11 ' A' ' 74' ' ' ARG . 46.0 mt-10 -145.21 155.91 43.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.557 -1.275 . . . . 5.5499999999999998 107.557 173.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -101.16 100.26 12.86 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.167 0.587 . . . . 1.6100000000000001 111.036 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.81 -15.39 13.43 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.177 1.918 . . . . 2.2999999999999998 113.514 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.98 -178.07 52.22 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 119.137 0.88 . . . . 1.48 112.471 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 16.0 m-20 -114.86 3.27 14.56 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.43 1.892 . . . . 4.0 112.232 -167.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -106.36 154.01 40.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 127.096 2.158 . . . . 3.3100000000000001 110.254 166.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.21 147.08 20.38 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.869 2.379 . . . . 1.1399999999999999 110.877 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.7 mt -99.35 138.73 36.04 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 123.633 1.682 . . . . 2.3500000000000001 111.003 170.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 68' ' ' GLU . 14.6 tpp85 -134.68 105.85 6.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 111.716 -2.493 . . . . 2.0899999999999999 108.248 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.74 105.41 17.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.128 1.371 . . . . 2.3799999999999999 108.6 -171.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -101.78 -22.67 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.617 0.767 . . . . 0.47999999999999998 112.235 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.24 -177.07 30.99 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.199 1.381 . . . . 0.40999999999999998 112.553 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.0 -176.58 4.55 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.573 1.549 . . . . 0.51000000000000001 109.277 166.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.439 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -157.16 166.44 33.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.669 1.587 . . . . 4.2599999999999998 108.118 177.375 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 t -177.77 153.93 0.98 Allowed Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.865 1.266 . . . . 0.80000000000000004 110.382 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.31 -0.28 9.82 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.271 2.647 . . . . 0.93999999999999995 114.763 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.7 m -116.78 26.96 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 115.508 1.67 . . . . 0.85999999999999999 115.508 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.75 157.44 33.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.277 1.431 . . . . 0.85999999999999999 110.503 167.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.4 -26.99 41.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.021 1.728 . . . . 2.8900000000000001 112.087 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -155.56 149.35 25.31 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 127.498 2.319 . . . . 5.5599999999999996 108.621 -156.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.7 p -161.4 59.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 123.79 1.757 . . . . 2.2200000000000002 113.028 -158.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -91.4 134.86 34.26 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.096 -1.865 . . . . 5.46 112.236 -167.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.3 tp -83.06 122.9 28.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.496 1.518 . . . . 0.88 112.159 -167.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -121.91 150.29 42.19 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.843 1.657 . . . . 0.5 112.415 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -88.93 173.57 8.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.113 0.965 . . . . 2.02 111.067 162.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.7 m -139.99 129.99 24.86 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.589 -1.634 . . . . 0.97999999999999998 106.589 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -134.79 173.31 11.83 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.417 1.103 . . . . 2.23 112.951 -165.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.8 ttp -120.43 141.74 49.87 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.97 1.308 . . . . 3.3399999999999999 111.004 165.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -135.44 157.29 47.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.212 1.405 . . . . 5.4299999999999997 111.55 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -97.1 144.13 27.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.312 1.445 . . . . 2.3700000000000001 109.962 165.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 m -142.68 130.55 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.574 1.549 . . . . 2.77 108.584 163.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 62.21 11.2 4.26 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.599 2.074 . . . . 3.54 116.599 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.9 25.68 40.4 Favored Glycine 0 CA--C 1.539 1.533 0 O-C-N 120.909 -1.119 . . . . 1.74 113.537 -165.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -127.15 120.17 28.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.052 1.741 . . . . 2.4900000000000002 109.453 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.34 118.98 28.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.57 0.748 . . . . 7.0800000000000001 110.619 -175.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.52 139.85 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.024 1.73 . . . . 2.3300000000000001 109.5 -172.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 58.0 mtm -83.71 167.47 17.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.885 1.069 . . . . 3.25 113.885 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.5 -176.49 30.61 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.028 1.299 . . . . 0.91000000000000003 113.3 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ttm -155.85 150.06 25.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.783 2.033 . . . . 1.1200000000000001 107.65 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.96 158.49 30.17 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 124.495 1.118 . . . . 5.0 110.509 174.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.44 154.94 40.82 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.152 1.901 . . . . 0.54000000000000004 111.907 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -143.08 152.61 58.71 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.419 1.487 . . . . 0.54000000000000004 109.808 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -84.13 -23.44 3.0 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.187 2.592 . . . . 0.68000000000000005 113.547 -165.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.443 ' CD1' ' HD2' ' A' ' 31' ' ' ARG . 54.0 p90 -177.14 166.93 2.41 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.593 1.957 . . . . 2.02 110.678 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.2 mt -110.66 154.31 24.01 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.457 1.103 . . . . 0.56000000000000005 110.059 164.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 31' ' ' ARG . 3.9 tp10 -127.06 138.09 53.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.126 1.37 . . . . 1.74 109.612 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 t -143.48 136.79 14.02 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.998 0.919 . . . . 1.52 110.654 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.99 170.4 15.74 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.776 2.318 . . . . 1.3899999999999999 112.334 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.56 143.96 97.69 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.969 2.446 . . . . 1.6499999999999999 110.783 161.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.434 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 33.6 mmtm 67.47 0.13 2.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.403 1.481 . . . . 2.5299999999999998 114.157 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.56 162.77 41.89 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.753 1.644 . . . . 1.8999999999999999 113.635 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.431 HH11 ' CD ' ' A' ' 23' ' ' GLU . 59.5 mtt-85 -91.48 129.42 37.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.563 0.745 . . . . 5.5700000000000003 111.412 176.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -103.24 61.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.764 2.025 . . . . 5.4100000000000001 109.478 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.76 127.26 56.1 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.229 1.411 . . . . 3.1899999999999999 109.755 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 83' ' ' HIS . 3.3 mp -70.98 -38.59 72.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.604 1.562 . . . . 3.2000000000000002 114.003 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptt 91.13 138.07 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 129.416 3.086 . . . . 3.5499999999999998 109.93 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.7 11.74 0.47 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.589 2.86 . . . . 2.75 114.731 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.61 17.27 0.09 OUTLIER Glycine 0 CA--C 1.535 1.32 0 CA-C-O 116.621 -2.211 . . . . 1.8799999999999999 116.42 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.27 -29.31 0.45 Allowed Glycine 0 N--CA 1.487 2.044 0 CA-C-N 121.233 2.516 . . . . 2.1000000000000001 117.626 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.06 146.89 43.51 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.249 2.025 . . . . 2.1600000000000001 111.197 163.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.49 ' HA ' HD23 ' A' ' 77' ' ' LEU . 57.1 p-80 -158.46 149.02 20.19 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.572 0.582 . . . . 0.68000000000000005 112.572 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -79.96 131.8 35.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.345 -0.613 . . . . 1.97 109.345 161.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -91.81 103.42 15.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.038 1.735 . . . . 0.81000000000000005 108.459 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -85.73 116.88 24.26 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.659 -1.238 . . . . 1.25 107.659 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 tt -130.19 134.85 47.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.562 1.145 . . . . 3.1200000000000001 111.165 -162.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.53 48.69 7.83 Favored Glycine 0 N--CA 1.473 1.11 0 O-C-N 121.751 -0.593 . . . . 1.8500000000000001 111.969 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -48.26 154.34 0.61 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 126.253 1.821 . . . . 0.70999999999999996 114.99 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -119.34 -29.95 5.03 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.681 -1.6 . . . . 1.6899999999999999 114.585 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -107.38 147.5 35.37 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.902 1.681 . . . . 5.8300000000000001 109.552 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.39 162.68 37.84 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.66 2.24 . . . . 2.6600000000000001 109.132 157.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.8 155.87 35.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.48 1.512 . . . . 2.7799999999999998 109.759 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 24.24 1.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.326 1.973 . . . . 4.1399999999999997 116.326 -174.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 66.87 164.76 0.2 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.12 2.168 . . . . 1.49 110.943 -161.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.04 -5.99 30.02 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.947 -0.918 . . . . 1.3400000000000001 114.676 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -76.99 166.06 23.83 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.422 1.089 . . . . 2.9100000000000001 110.099 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -118.14 126.19 51.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 129.146 2.978 . . . . 3.8500000000000001 104.625 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.7 t -126.2 140.6 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.66 1.184 . . . . 1.3899999999999999 110.065 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -106.83 134.69 49.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.42 1.088 . . . . 3.7599999999999998 112.786 -170.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.5 133.57 43.96 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.25 1.42 . . . . 1.9099999999999999 111.887 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 27.4 m-20 -77.84 136.45 38.08 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.777 2.031 . . . . 1.8300000000000001 108.61 159.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.99 126.86 50.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.338 1.055 . . . . 0.97999999999999998 108.785 165.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.0 mt -104.19 106.54 17.08 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.353 1.061 . . . . 0.71999999999999997 110.069 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -105.8 151.81 24.02 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.612 1.565 . . . . 2.0699999999999998 112.35 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.83 131.39 46.79 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.87 1.063 . . . . 2.79 113.87 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 58.13 3.13 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.924 1.25 . . . . 3.8700000000000001 113.347 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.37 11.09 79.72 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 124.421 1.01 . . . . 2.1899999999999999 115.609 169.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -93.49 113.1 25.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.917 1.359 . . . . 2.8599999999999999 111.217 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.68 136.12 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.936 1.294 . . . . 1.8899999999999999 109.887 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.1 tt -143.12 112.61 6.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.471 0.708 . . . . 2.9700000000000002 111.544 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -87.73 98.35 11.4 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.961 0.726 . . . . 3.7000000000000002 112.961 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 114' ' ' VAL . 26.9 t -80.01 172.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 126.444 1.898 . . . . 2.1299999999999999 110.869 171.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.409 ' N ' HG12 ' A' ' 113' ' ' VAL . 10.7 p -139.34 143.01 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.057 2.143 . . . . 2.9199999999999999 108.378 166.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.48 144.55 15.01 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.883 1.673 . . . . 2.1800000000000002 111.677 -167.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.95 155.5 26.44 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.179 2.586 . . . . 0.96999999999999997 113.705 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.1 t -93.93 121.7 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.44 1.496 . . . . 1.04 109.472 173.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 126.317 1.847 . . . . 4.1299999999999999 110.582 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 CA--C 1.542 0.652 0 CA-C-O 121.584 0.707 . . . . 4.5999999999999996 111.59 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.49 168.75 33.77 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.02 -1.05 . . . . 1.1699999999999999 114.296 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -152.16 172.6 16.12 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.254 1.022 . . . . 2.1600000000000001 112.945 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 t -109.36 138.85 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.098 -1.001 . . . . 1.1399999999999999 109.03 172.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -51.68 -81.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.965 1.306 . . . . 5.0599999999999996 113.093 -173.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.1 t80 158.22 153.0 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 130.118 3.367 . . . . 3.0600000000000001 107.282 -157.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.0 t 150.22 128.8 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 129.34 3.056 . . . . 2.1400000000000001 110.879 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.88 -35.85 14.62 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.855 1.703 . . . . 1.29 111.793 173.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.25 173.13 21.52 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.483 1.992 . . . . 0.96999999999999997 112.035 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.75 5.16 56.05 Favored 'Cis proline' 0 CA--C 1.541 0.865 0 CA-C-N 119.33 1.565 . . . . 1.1200000000000001 113.654 3.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -154.68 160.24 41.25 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.412 1.085 . . . . 1.76 113.673 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.87 -177.44 5.33 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.935 2.094 . . . . 0.41999999999999998 111.623 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.27 147.92 28.24 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.791 1.236 . . . . 0.72999999999999998 110.756 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.03 145.52 48.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.092 1.757 . . . . 0.5 111.539 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' A' ' 79' ' ' PRO . 96.2 m-85 -144.19 121.52 11.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.884 2.073 . . . . 2.6899999999999999 109.961 -164.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -166.0 148.59 7.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.442 -1.411 . . . . 1.99 114.318 -155.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.5 m -81.99 135.17 35.39 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.759 0.79 . . . . 1.8899999999999999 110.434 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.51 137.0 47.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.881 2.072 . . . . 3.3500000000000001 108.791 170.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -114.67 166.41 11.76 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.129 0.572 . . . . 4.29 111.64 166.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -119.97 111.71 35.46 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 123.031 0.532 . . . . 1.48 110.246 164.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.21 -15.62 10.12 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.759 2.306 . . . . 1.1899999999999999 113.919 175.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.23 -175.27 49.76 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.496 1.046 . . . . 1.3 113.149 -173.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.91 -10.12 27.07 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.066 1.747 . . . . 3.3500000000000001 111.613 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -130.45 161.24 61.8 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 127.572 2.349 . . . . 3.8399999999999999 108.913 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.65 155.94 49.35 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.65 2.233 . . . . 1.4299999999999999 111.541 -170.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.9 mt -110.55 152.22 26.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 125.103 1.361 . . . . 1.8700000000000001 110.429 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -128.5 105.07 8.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.507 -1.679 . . . . 2.0099999999999998 111.264 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.54 104.57 16.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.133 1.373 . . . . 1.8400000000000001 108.118 -172.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.4 m -98.21 -28.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.401 0.681 . . . . 0.69999999999999996 112.182 -166.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.93 -178.61 33.1 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.521 1.534 . . . . 0.55000000000000004 111.336 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.55 ' O ' HG11 ' A' ' 43' ' ' VAL . . . -131.24 -178.48 4.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.868 0.867 . . . . 0.77000000000000002 109.375 161.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -144.75 169.73 17.46 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 129.539 3.136 . . . . 5.54 106.348 165.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -172.35 149.74 2.15 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 126.938 2.095 . . . . 0.56000000000000005 108.006 -172.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -71.51 -30.9 14.48 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.065 1.177 . . . . 1.01 112.478 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -89.16 19.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 115.856 1.799 . . . . 0.78000000000000003 115.856 -168.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.99 154.0 34.07 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.718 1.007 . . . . 0.79000000000000004 113.718 174.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -79.98 -65.17 1.04 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.611 1.564 . . . . 3.1000000000000001 109.819 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.3 mtp-105 -110.71 107.96 17.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.655 0.74 . . . . 6.1600000000000001 110.683 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 35' ' ' ALA . 7.4 p -77.58 146.9 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 126.054 1.741 . . . . 1.4299999999999999 108.689 162.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -155.5 146.62 22.57 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.852 1.261 . . . . 2.6400000000000001 109.417 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.0 tp -105.83 120.27 41.28 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.358 0.981 . . . . 0.92000000000000004 111.099 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -127.79 159.56 34.46 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.929 1.347 . . . . 0.76000000000000001 113.981 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.86 161.32 14.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.909 2.084 . . . . 2.1000000000000001 112.351 159.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.9 m -137.23 145.68 43.91 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.985 2.114 . . . . 1.3100000000000001 107.089 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.81 165.61 36.0 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.762 1.267 . . . . 2.1299999999999999 114.24 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.62 146.88 24.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.718 1.207 . . . . 5.8600000000000003 111.278 166.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.13 161.85 42.0 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.588 1.555 . . . . 5.4299999999999997 110.061 -171.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -112.79 142.36 45.52 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.347 1.059 . . . . 2.4300000000000002 112.296 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.8 t -136.28 115.96 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.264 1.425 . . . . 2.3500000000000001 108.433 164.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 66.37 7.48 4.99 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 127.291 2.236 . . . . 3.29 115.211 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.18 7.59 59.41 Favored Glycine 0 CA--C 1.54 1.624 0 O-C-N 121.123 -0.986 . . . . 1.6699999999999999 114.189 -165.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -109.09 129.43 55.47 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 127.416 2.286 . . . . 2.8100000000000001 108.292 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -79.7 120.54 24.15 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.938 -1.483 . . . . 2.75 109.251 -166.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.2 t -134.38 131.52 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.231 1.812 . . . . 2.5699999999999998 108.846 -173.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.1 mtt -83.35 165.3 19.4 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.506 -0.746 . . . . 2.79 112.632 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.24 173.88 32.73 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 124.25 0.929 . . . . 0.82999999999999996 112.943 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.5 ttm -157.09 137.39 12.86 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.889 1.676 . . . . 1.3300000000000001 109.395 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -143.01 149.28 48.63 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 125.529 1.532 . . . . 8.8499999999999996 110.643 -174.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.63 153.18 43.58 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.066 1.844 . . . . 0.57999999999999996 109.962 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.07 156.0 77.26 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.735 1.214 . . . . 0.68000000000000005 110.111 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.72 -27.82 2.44 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.851 2.367 . . . . 0.58999999999999997 113.242 -169.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -177.84 165.94 2.05 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.344 1.858 . . . . 2.2400000000000002 111.297 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.7 mt -110.7 155.85 21.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.031 1.332 . . . . 0.53000000000000003 109.884 163.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -113.24 146.77 38.77 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.725 1.21 . . . . 2.0800000000000001 109.105 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.88 128.0 14.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 113.647 0.98 . . . . 1.1100000000000001 113.647 168.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.59 156.57 28.26 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.332 3.355 . . . . 1.3700000000000001 113.05 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.11 141.89 78.34 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.758 3.639 . . . . 1.4199999999999999 114.005 -172.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 71.39 -15.95 0.4 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 129.122 2.969 . . . . 1.8799999999999999 114.161 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.83 -177.12 50.21 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.597 1.57 . . . . 1.71 113.561 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -146.72 150.7 35.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.086 0.954 . . . . 4.8799999999999999 111.389 163.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -149.67 139.44 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.965 2.106 . . . . 3.6400000000000001 107.079 -175.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.1 147.43 34.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.304 1.049 . . . . 3.5600000000000001 113.499 -174.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.07 74.94 0.49 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.668 1.587 . . . . 2.0600000000000001 107.438 157.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.47 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -57.87 142.48 78.91 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.625 1.17 . . . . 2.3199999999999998 114.08 -170.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.544 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 29.8 Cg_endo -58.86 -10.41 9.64 Favored 'Trans proline' 0 C--N 1.357 1.014 1 C-N-CA 125.606 4.204 . . . . 2.7400000000000002 117.736 -170.049 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.88 2.45 22.93 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.728 1.156 . . . . 2.7599999999999998 115.43 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.84 -112.07 1.46 Allowed Glycine 0 N--CA 1.472 1.084 0 CA-C-N 119.148 1.474 . . . . 1.97 113.136 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -72.5 143.09 48.5 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.988 -0.713 . . . . 1.8999999999999999 111.662 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 51.4 p-80 -160.39 157.17 27.35 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.568 1.147 . . . . 0.76000000000000001 111.843 -174.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.2 135.33 35.74 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.834 -0.802 . . . . 2.3500000000000001 108.834 155.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.1 126.09 47.77 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.272 2.229 . . . . 1.0600000000000001 108.444 169.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.14 113.09 23.53 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.16 0.984 . . . . 2.6099999999999999 109.847 -176.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.07 152.13 19.63 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.082 1.753 . . . . 2.0899999999999999 110.63 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.94 -50.65 4.44 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 127.799 2.619 . . . . 3.0299999999999998 113.551 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.1 mt 57.94 169.09 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.864 2.865 . . . . 1.0 115.675 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -128.48 -23.8 3.15 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.518 2.327 . . . . 1.7 114.256 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -130.61 150.76 77.26 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.512 2.325 . . . . 5.3200000000000003 109.903 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.21 123.94 8.13 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.585 2.19 . . . . 1.99 108.538 163.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.04 113.47 17.19 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.186 0.994 . . . . 2.5099999999999998 108.609 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.86 166.01 26.48 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.371 1.469 . . . . 3.6800000000000002 111.055 172.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.11 123.61 16.54 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.011 0.924 . . . . 1.4399999999999999 110.98 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.93 25.86 59.32 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.678 -0.692 . . . . 2.6400000000000001 113.82 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -86.69 172.71 9.99 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.893 1.347 . . . . 2.5299999999999998 108.757 133.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -144.37 158.56 43.68 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.045 2.938 . . . . 3.1299999999999999 105.257 171.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.7 t -150.56 146.59 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.385 1.874 . . . . 1.3100000000000001 110.112 -169.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.46 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 38.0 mt-10 -95.83 138.01 34.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.234 0.614 . . . . 2.6400000000000001 110.442 165.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.36 137.43 52.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.734 0.778 . . . . 1.71 110.262 159.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.62 113.17 26.58 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 128.316 2.646 . . . . 2.5600000000000001 108.92 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -94.75 132.9 39.01 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.513 -1.367 . . . . 1.0 111.339 -168.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.9 mt -104.65 106.24 16.66 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.392 1.477 . . . . 0.68999999999999995 109.994 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.0 115.27 30.14 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.76 1.224 . . . . 2.3700000000000001 110.76 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.11 23.74 2.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.863 2.065 . . . . 2.3199999999999998 113.845 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.0 -56.73 4.33 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.328 1.442 . . . . 4.4500000000000002 112.914 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.15 -6.68 69.48 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 117.054 1.582 . . . . 1.5700000000000001 117.054 -165.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -128.38 121.51 29.26 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.485 1.643 . . . . 4.5199999999999996 113.015 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -102.35 136.3 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.157 1.383 . . . . 1.96 109.429 166.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.9 tp -155.39 128.19 8.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.011 1.325 . . . . 2.8700000000000001 109.688 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 52.0 pttt -109.23 160.87 15.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.374 1.62 . . . . 2.1899999999999999 115.374 -174.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -140.07 161.6 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 126.838 2.055 . . . . 1.95 109.439 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.5 t -106.89 142.18 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.53 1.532 . . . . 1.8500000000000001 109.152 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -144.41 128.5 9.03 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.004 1.722 . . . . 2.77 110.2 -171.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.53 164.92 32.83 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.07 2.514 . . . . 1.1399999999999999 111.921 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.1 t -109.91 151.76 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.183 0.593 . . . . 0.82999999999999996 110.782 171.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 CA--C 1.547 0.847 0 C-N-CA 126.756 2.022 . . . . 4.1600000000000001 112.54 -169.474 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 106.369 -1.715 . . . . 4.79 106.369 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.2 -178.17 32.96 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.637 1.589 . . . . 1.24 113.426 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -156.18 157.71 36.38 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.422 1.889 . . . . 2.4700000000000002 112.345 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.9 132.7 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.283 1.433 . . . . 1.73 108.481 169.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -67.93 162.13 24.96 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.996 0.903 . . . . 4.3099999999999996 112.445 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -98.65 130.12 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.22 -1.4 . . . . 2.3199999999999998 107.22 171.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -167.73 147.43 4.38 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 127.057 2.143 . . . . 2.6000000000000001 107.083 174.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.99 -22.91 9.69 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.929 2.419 . . . . 1.9399999999999999 113.218 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.25 173.63 13.47 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 126.462 1.982 . . . . 1.6200000000000001 110.354 -166.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -70.67 -9.14 12.66 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 CA-C-N 119.681 1.741 . . . . 2.1899999999999999 112.412 -4.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -137.62 161.35 36.69 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.625 1.343 . . . . 2.3500000000000001 114.625 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.93 -173.87 3.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 131.654 3.981 . . . . 0.59999999999999998 107.492 174.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.9 166.75 23.27 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.635 -1.291 . . . . 1.1000000000000001 110.676 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.04 148.51 32.76 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 122.109 0.957 . . . . 0.56000000000000005 111.929 171.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -145.15 129.83 18.08 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.873 2.069 . . . . 2.6200000000000001 107.919 -165.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.11 150.79 9.68 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.571 1.078 . . . . 2.27 113.892 -174.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.2 m -79.87 112.73 17.44 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.62 1.568 . . . . 1.8400000000000001 110.74 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.77 127.69 36.01 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.214 1.005 . . . . 2.9199999999999999 108.571 169.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -116.63 134.42 54.85 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.905 1.282 . . . . 4.3700000000000001 108.801 168.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -99.46 117.68 63.45 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.506 1.122 . . . . 1.3700000000000001 109.882 173.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -88.4 -8.9 5.25 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.252 2.635 . . . . 1.3200000000000001 114.825 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.34 160.06 26.64 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 119.789 1.177 . . . . 1.4099999999999999 111.928 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.09 3.05 21.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.947 2.499 . . . . 3.75 112.127 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -123.87 152.12 65.75 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 128.333 2.653 . . . . 2.75 109.248 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.74 146.35 23.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.125 2.55 . . . . 1.1599999999999999 111.205 -171.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.4 mt -98.88 145.28 27.15 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.428 1.109 . . . . 1.8400000000000001 111.481 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.531 ' HD2' ' CD2' ' A' ' 66' ' ' PHE . 5.1 tpp180 -130.45 104.91 7.52 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.271 -1.786 . . . . 2.6400000000000001 109.796 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.407 HD13 ' C ' ' A' ' 32' ' ' LEU . 1.8 tm? -98.17 115.01 27.43 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.234 2.214 . . . . 2.0800000000000001 108.991 -169.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.98 -28.34 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.208 0.913 . . . . 0.88 112.363 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.01 -175.09 30.6 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 115.26 0.864 . . . . 0.41999999999999998 115.26 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -140.42 -176.85 4.78 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.977 1.711 . . . . 0.53000000000000003 112.049 171.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttt-85 -159.56 153.39 23.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.871 2.069 . . . . 5.1200000000000001 108.149 172.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -163.55 150.9 10.73 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-N 120.109 1.322 . . . . 0.91000000000000003 110.473 -170.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.29 -15.29 11.47 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.818 2.345 . . . . 1.1399999999999999 115.135 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -105.45 26.68 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.158 1.383 . . . . 1.2 113.634 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.38 174.03 10.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.242 1.417 . . . . 1.6000000000000001 109.215 162.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -99.91 -48.44 4.67 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.966 1.706 . . . . 3.96 109.505 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -126.15 171.61 10.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.883 2.473 . . . . 5.0700000000000003 107.596 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.8 p -154.78 142.75 12.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 125.596 1.558 . . . . 1.0 108.532 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -115.59 158.11 23.15 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.67 1.588 . . . . 3.48 109.524 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -111.22 117.01 32.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.076 1.35 . . . . 0.91000000000000003 109.099 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -120.14 149.86 41.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.206 1.402 . . . . 0.63 114.223 -174.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -93.3 161.12 14.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.265 1.826 . . . . 2.4199999999999999 111.134 160.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.6 m -129.4 146.14 51.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.52 1.928 . . . . 1.24 106.301 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -160.15 -179.05 7.41 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.727 1.01 . . . . 2.2400000000000002 113.727 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.7 mtm -116.46 148.28 40.91 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.792 1.637 . . . . 4.3200000000000003 111.882 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.62 154.34 45.34 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.444 1.497 . . . . 7.0499999999999998 111.977 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -91.54 137.43 32.37 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.738 -1.208 . . . . 3.1200000000000001 107.738 148.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -144.03 139.7 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.491 -1.67 . . . . 2.8300000000000001 106.491 160.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 64.18 19.92 11.97 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.141 1.376 . . . . 4.5700000000000003 113.931 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.76 17.12 72.88 Favored Glycine 0 CA--C 1.538 1.5 0 O-C-N 120.354 -1.466 . . . . 2.2599999999999998 113.354 -169.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -122.01 135.18 54.82 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.039 2.535 . . . . 3.02 109.526 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -74.49 118.7 17.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.861 2.064 . . . . 4.0499999999999998 108.564 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.44 -179.55 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.74 2.016 . . . . 2.8700000000000001 110.673 -174.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.97 174.31 6.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.507 1.123 . . . . 2.98 111.955 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.73 173.54 33.79 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.862 1.22 . . . . 0.89000000000000001 112.922 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -157.7 146.06 19.14 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.436 1.894 . . . . 1.26 107.841 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -150.39 157.74 36.58 Favored Pre-proline 0 N--CA 1.468 0.458 0 C-N-CA 125.255 1.422 . . . . 4.2800000000000002 109.6 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.82 153.87 43.01 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.724 1.616 . . . . 0.54000000000000004 111.07 164.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.5 m -134.6 152.18 77.29 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.531 1.532 . . . . 0.63 110.966 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -81.76 -21.61 5.87 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.301 2.667 . . . . 0.55000000000000004 113.208 -169.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.531 ' CD2' ' HD2' ' A' ' 31' ' ' ARG . 47.3 p90 -175.87 164.05 2.85 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.206 1.402 . . . . 2.0699999999999998 112.07 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.3 mt -109.98 156.64 20.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.877 1.671 . . . . 0.55000000000000004 110.145 163.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -114.35 146.6 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.182 0.593 . . . . 2.75 109.797 163.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.71 126.77 26.0 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.408 1.483 . . . . 1.3200000000000001 109.219 164.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -67.56 165.63 26.69 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.441 2.761 . . . . 1.3899999999999999 110.687 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.33 138.31 55.04 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.016 2.477 . . . . 1.1799999999999999 113.411 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.282 14.4 mtmt 60.14 29.75 19.28 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.684 1.594 . . . . 2.6499999999999999 114.89 168.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.77 -179.85 18.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.727 2.584 . . . . 1.5900000000000001 113.816 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.24 156.74 22.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.751 0.82 . . . . 4.4299999999999997 112.963 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.5 t -148.65 117.06 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.093 1.757 . . . . 3.3100000000000001 107.797 163.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.19 158.3 23.64 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.346 0.869 . . . . 2.8799999999999999 113.346 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -80.8 62.39 4.81 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.671 1.224 . . . . 2.04 109.704 151.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.477 ' H ' ' CD ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -56.54 126.69 70.8 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-O 118.066 -0.969 . . . . 3.6699999999999999 111.152 171.422 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -56.96 -39.17 93.43 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.256 3.304 . . . . 2.5499999999999998 114.018 -167.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.11 -3.21 51.52 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.025 -1.431 . . . . 1.96 115.051 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.59 -24.32 0.22 Allowed Glycine 0 N--CA 1.473 1.131 0 N-CA-C 118.155 2.022 . . . . 2.4100000000000001 118.155 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -148.89 143.47 26.26 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 120.67 2.235 . . . . 2.3500000000000001 112.796 175.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -160.48 154.61 23.13 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.745 1.218 . . . . 0.79000000000000004 110.961 174.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 82.2 m-85 -77.8 150.06 34.34 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.673 -0.862 . . . . 2.4199999999999999 108.673 161.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 tpt -106.71 115.18 29.75 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.34 1.856 . . . . 1.0 106.783 166.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.58 120.68 37.35 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.402 1.081 . . . . 1.3 108.741 -174.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.7 mp -116.82 138.15 51.7 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.008 0.923 . . . . 1.8400000000000001 112.611 -167.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.16 49.58 8.36 Favored Glycine 0 N--CA 1.473 1.158 0 O-C-N 121.928 -0.482 . . . . 1.5600000000000001 112.023 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -48.61 154.99 0.6 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 126.969 2.108 . . . . 0.94999999999999996 115.318 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -118.13 -31.38 5.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 113.511 -1.677 . . . . 2.1099999999999999 113.759 -173.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 -118.99 134.5 23.62 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 125.505 1.522 . . . . 4.9900000000000002 107.69 170.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -69.99 113.52 3.44 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 N-CA-C 107.144 -1.906 . . . . 1.75 107.144 163.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.61 153.72 12.71 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.969 1.308 . . . . 2.5299999999999998 113.262 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -131.49 147.05 52.51 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 123.512 1.625 . . . . 4.79 113.592 163.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.96 112.51 10.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.602 -1.636 . . . . 1.5900000000000001 110.237 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.67 -0.55 20.09 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 117.97 -1.461 . . . . 1.6399999999999999 115.376 -173.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -86.51 -176.32 5.8 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.48 1.64 . . . . 2.3500000000000001 110.372 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -142.76 146.15 33.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.641 2.376 . . . . 4.3399999999999999 108.084 171.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -145.22 142.15 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.64 1.576 . . . . 1.71 111.56 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -88.85 164.39 15.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.664 1.357 . . . . 2.5099999999999998 114.664 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 tt -154.97 134.1 12.36 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.347 1.459 . . . . 2.6000000000000001 110.872 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.37 153.34 29.83 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 127.479 2.312 . . . . 1.97 110.503 169.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.18 124.98 35.99 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.708 2.003 . . . . 1.1799999999999999 108.989 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.8 mt -106.21 116.32 31.74 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.725 1.21 . . . . 0.68000000000000005 109.754 -170.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -112.14 130.31 55.94 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.772 1.229 . . . . 2.0899999999999999 111.394 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.07 -19.13 62.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.982 1.313 . . . . 2.1800000000000002 113.367 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.64 32.63 1.01 Allowed Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.728 1.156 . . . . 4.8499999999999996 114.272 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.7 35.35 85.55 Favored Glycine 0 N--CA 1.471 1.003 0 C-N-CA 125.619 1.581 . . . . 2.71 114.342 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -142.06 145.39 34.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.942 1.371 . . . . 2.9399999999999999 114.026 -167.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -127.32 146.87 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.513 1.925 . . . . 2.29 109.326 167.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -156.7 147.78 22.05 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.045 2.138 . . . . 2.1600000000000001 107.932 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -122.73 155.91 35.5 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.591 1.541 . . . . 2.23 114.044 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.52 173.24 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.373 2.269 . . . . 1.75 108.886 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -136.1 136.81 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.443 1.497 . . . . 2.2200000000000002 110.618 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 mt -137.89 136.76 20.18 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.303 1.441 . . . . 2.29 111.127 -166.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.94 159.39 53.13 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.625 2.883 . . . . 0.95999999999999996 112.128 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.7 t -103.76 131.12 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.747 1.219 . . . . 1.5 109.761 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 CA--C 1.541 0.629 0 C-N-CA 126.227 1.811 . . . . 4.0599999999999996 110.838 -179.582 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 123.545 1.64 . . . . 4.4800000000000004 112.528 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.32 -178.66 15.72 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.188 1.851 . . . . 1.3500000000000001 111.935 175.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -148.95 149.0 30.45 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.071 1.138 . . . . 2.21 114.071 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -79.08 133.39 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 106.64 -1.615 . . . . 1.3400000000000001 106.64 163.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -68.05 -18.64 64.74 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.575 1.695 . . . . 4.2199999999999998 115.575 -158.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.4 t80 76.67 151.32 0.12 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.746 2.418 . . . . 3.0299999999999998 112.534 -174.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 t 174.88 161.31 0.38 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 129.667 3.187 . . . . 2.0899999999999999 108.639 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.63 -24.94 5.8 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.809 2.339 . . . . 1.25 112.761 159.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.47 -178.43 17.02 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.265 1.888 . . . . 1.0 112.447 -169.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.26 -0.49 21.9 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.023 1.412 . . . . 1.3600000000000001 113.273 -2.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -135.34 166.79 22.32 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.378 1.471 . . . . 2.1899999999999999 113.205 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.47 -174.12 4.8 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 129.191 2.996 . . . . 0.56000000000000005 111.413 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.26 175.6 9.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.401 1.88 . . . . 0.95999999999999996 108.83 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.59 17.81 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.339 -0.851 . . . . 0.58999999999999997 111.641 170.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.466 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 53.7 m-85 -109.21 69.64 0.71 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.386 1.874 . . . . 2.5099999999999998 109.268 176.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -79.28 158.65 27.51 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.617 0.767 . . . . 1.76 112.795 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.4 m -119.07 140.34 50.24 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.193 1.797 . . . . 2.1000000000000001 109.087 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.0 tp -155.33 178.95 9.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.037 1.735 . . . . 4.6299999999999999 108.811 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -158.27 149.61 21.09 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.222 1.809 . . . . 4.6399999999999997 107.889 -171.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -106.51 87.17 2.53 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 124.919 1.288 . . . . 1.6899999999999999 110.252 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.56 -11.55 28.28 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.512 2.142 . . . . 2.1800000000000002 114.136 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.28 174.45 53.48 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-O 123.075 1.375 . . . . 1.47 113.049 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.6 -1.76 32.07 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.205 2.202 . . . . 3.27 112.768 -167.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.27 156.87 57.13 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.698 1.999 . . . . 3.3300000000000001 109.683 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.12 170.4 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.908 2.406 . . . . 1.54 112.203 -162.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.21 146.55 44.15 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 122.851 1.31 . . . . 2.8700000000000001 111.354 167.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -135.53 110.94 9.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 111.73 -2.486 . . . . 2.1299999999999999 109.333 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.1 tp -94.37 112.14 23.92 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.945 1.698 . . . . 2.3900000000000001 110.042 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.64 -22.96 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.847 0.859 . . . . 0.54000000000000004 111.602 -170.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.57 -174.79 30.84 Favored Glycine 0 C--N 1.345 1.072 0 C-N-CA 125.117 1.341 . . . . 0.44 113.838 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.22 -178.44 6.39 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.401 1.881 . . . . 0.48999999999999999 110.913 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -156.58 175.36 14.14 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.41 2.284 . . . . 5.96 108.022 161.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -170.5 158.61 5.89 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 127.037 2.135 . . . . 0.73999999999999999 109.448 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.41 -5.94 9.16 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.452 2.101 . . . . 1.1399999999999999 114.861 169.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.88 16.45 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.017 1.488 . . . . 1.1399999999999999 115.017 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.77 159.47 24.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.945 2.098 . . . . 0.93000000000000005 109.181 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -108.33 -42.24 4.65 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.306 0.854 . . . . 3.8500000000000001 113.306 -170.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -113.98 147.82 37.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 122.48 1.133 . . . . 6.5599999999999996 108.442 164.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -135.47 134.31 52.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 125.186 1.395 . . . . 0.84999999999999998 107.582 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -130.92 125.86 34.6 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.508 1.523 . . . . 3.2999999999999998 109.525 -166.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.54 119.06 24.74 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.832 -0.543 . . . . 0.84999999999999998 111.925 -175.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 56.2 m170 -121.55 161.06 23.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.822 1.649 . . . . 0.51000000000000001 113.523 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.6 159.96 15.56 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.858 1.663 . . . . 2.1099999999999999 111.009 158.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.1 m -114.77 137.54 51.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 105.757 -1.942 . . . . 0.84999999999999998 105.757 161.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -133.75 174.57 10.31 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.667 1.222 . . . . 2.1000000000000001 113.203 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.4 mtm -119.24 141.03 49.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.244 1.417 . . . . 4.8600000000000003 110.554 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -133.99 144.77 48.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.317 1.047 . . . . 5.9400000000000004 110.738 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -78.86 114.53 17.87 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 106.479 -1.675 . . . . 2.29 106.479 137.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.9 t -94.03 97.86 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 104.449 -2.426 . . . . 2.9900000000000002 104.449 171.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.31 37.26 11.1 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.903 1.335 . . . . 8.8300000000000001 111.246 166.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.17 75.65 Favored Glycine 0 CA--C 1.527 0.824 0 O-C-N 121.018 -1.051 . . . . 2.2599999999999998 112.387 -175.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -120.93 108.96 14.52 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.725 1.61 . . . . 4.46 110.525 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.574 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -57.41 127.54 32.49 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.008 -1.683 . . . . 3.2599999999999998 111.706 171.818 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.3 p -158.33 174.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.398 1.879 . . . . 2.4300000000000002 110.711 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.9 mtt -105.97 172.38 6.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.572 1.149 . . . . 2.8799999999999999 112.414 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.87 -178.62 31.13 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.821 1.201 . . . . 0.69999999999999996 112.898 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.8 ttm -154.75 150.73 27.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.814 1.646 . . . . 1.1499999999999999 108.397 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -158.53 158.56 29.6 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 123.92 0.888 . . . . 4.7400000000000002 111.49 173.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.89 154.84 58.36 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.438 2.092 . . . . 0.58999999999999997 111.287 171.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.47 153.39 65.62 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.533 1.533 . . . . 0.65000000000000002 110.117 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.84 -26.7 4.38 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.27 2.647 . . . . 0.60999999999999999 113.116 -167.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -178.24 164.06 1.72 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.961 1.704 . . . . 2.0899999999999999 111.172 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.5 mt -109.44 154.39 22.69 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.696 1.198 . . . . 0.78000000000000003 109.762 166.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -124.93 137.01 54.28 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.052 1.341 . . . . 1.74 110.389 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.2 t -143.94 135.03 12.48 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 118.35 0.523 . . . . 1.4099999999999999 112.275 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.93 172.19 11.17 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.693 2.929 . . . . 0.93000000000000005 113.047 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -59.93 145.33 98.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.881 2.387 . . . . 1.1299999999999999 111.588 164.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt 67.58 -2.2 1.4 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.783 2.033 . . . . 1.78 114.059 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.85 159.8 46.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.673 1.606 . . . . 1.3899999999999999 114.247 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 134.7 34.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.99 1.316 . . . . 3.75 110.848 172.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 t -114.9 64.21 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 127.365 2.266 . . . . 5.0499999999999998 107.617 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -98.32 137.07 37.58 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.275 -0.891 . . . . 3.02 110.069 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.597 HD23 ' HA ' ' A' ' 83' ' ' HIS . 1.9 mp -73.62 -63.79 1.13 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 118.011 -0.995 . . . . 3.1899999999999999 111.034 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm 107.99 128.89 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 128.928 2.891 . . . . 3.6899999999999999 114.248 161.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.466 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 14.9 Cg_endo -53.48 -56.7 2.46 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 124.283 3.322 . . . . 2.1200000000000001 113.599 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.01 28.62 1.91 Allowed Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.555 -1.136 . . . . 1.8600000000000001 113.861 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.25 -128.88 0.99 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.709 1.147 . . . . 1.6299999999999999 115.554 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -74.76 144.21 43.7 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.052 -1.264 . . . . 1.8500000000000001 111.54 -165.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.597 ' HA ' HD23 ' A' ' 77' ' ' LEU . 47.3 p-80 -160.75 151.06 17.94 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.348 -0.845 . . . . 0.59999999999999998 112.246 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -78.06 128.5 33.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.738 -0.838 . . . . 2.1099999999999999 108.738 161.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.407 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 2.8 tpt -79.78 128.91 34.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.768 -1.197 . . . . 0.81000000000000005 107.768 160.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.48 115.36 29.5 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.3 1.04 . . . . 1.1399999999999999 108.303 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.05 149.78 42.19 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.666 1.186 . . . . 2.2200000000000002 111.137 -175.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.72 49.18 11.05 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.169 0.89 . . . . 1.8 111.277 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mt -52.03 153.28 2.72 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 123.479 1.609 . . . . 0.68999999999999995 114.395 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -121.13 -16.27 8.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 112.547 -2.115 . . . . 2.21 115.435 -168.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -134.3 144.59 51.84 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.816 1.246 . . . . 5.2400000000000002 111.084 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.6 91.98 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.458 2.105 . . . . 3.2999999999999998 107.55 161.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.689 ' H ' HD23 ' A' ' 93' ' ' LEU . 1.7 pt? -81.07 155.92 26.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.198 1.799 . . . . 2.7799999999999998 111.662 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -113.46 165.52 12.4 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 122.384 1.088 . . . . 3.5600000000000001 111.468 166.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.49 129.66 37.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.318 -1.31 . . . . 1.46 107.665 153.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.14 20.7 37.97 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.311 -1.272 . . . . 1.5 114.76 -172.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -100.31 179.09 4.57 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.56 1.68 . . . . 2.48 109.543 159.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -132.97 126.47 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.309 2.244 . . . . 3.6699999999999999 105.738 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.7 t -148.23 145.4 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 126.801 2.041 . . . . 1.76 108.194 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.3 151.49 22.65 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 123.407 1.575 . . . . 3.6499999999999999 114.079 -171.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.62 134.61 54.98 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.476 1.511 . . . . 1.8400000000000001 110.07 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.402 ' OD1' ' HE2' ' A' ' 112' ' ' LYS . 11.6 m-20 -81.65 130.67 35.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.003 1.721 . . . . 2.9500000000000002 108.273 164.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.64 135.58 48.84 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.035 1.289 . . . . 1.79 111.086 168.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -110.38 113.84 26.8 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.719 1.607 . . . . 0.59999999999999998 109.259 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.83 158.09 19.81 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.825 1.25 . . . . 2.3300000000000001 110.506 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.39 148.5 41.37 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.554 -0.716 . . . . 2.6800000000000002 112.079 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.7 23.14 43.68 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 119.056 -0.858 . . . . 4.1200000000000001 115.053 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.18 7.52 88.45 Favored Glycine 0 N--CA 1.474 1.225 0 CA-C-N 118.827 1.314 . . . . 1.8100000000000001 114.023 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -78.33 121.06 23.97 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.326 -1.103 . . . . 4.54 111.381 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.66 142.0 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.7 1.2 . . . . 1.8500000000000001 108.686 167.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.3 tt -151.19 112.58 4.38 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.934 0.893 . . . . 2.6499999999999999 109.997 -176.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HE2' ' OD1' ' A' ' 102' ' ' ASP . 23.7 ttmm -84.46 125.8 32.69 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.734 -0.604 . . . . 3.6600000000000001 111.881 175.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 m -98.0 145.98 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.277 1.431 . . . . 2.8599999999999999 110.329 170.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.19 135.37 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.082 1.753 . . . . 2.0699999999999998 107.726 168.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.409 ' N ' HD23 ' A' ' 115' ' ' LEU . 1.3 pt? -158.09 155.14 25.62 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.619 1.567 . . . . 1.9299999999999999 111.409 -171.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -65.91 145.74 80.94 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.774 2.316 . . . . 0.91000000000000003 112.227 169.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.9 t -82.35 124.24 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 105.896 -1.89 . . . . 1.1799999999999999 105.896 151.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 124.039 0.936 . . . . 3.9900000000000002 110.694 -172.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.448 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 10.0 tt0 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 110.096 -0.335 . . . . 9.3000000000000007 110.096 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.448 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -95.26 173.55 31.56 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.184 1.373 . . . . 2.3199999999999998 113.337 -174.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -154.87 167.67 29.5 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.458 1.103 . . . . 3.1200000000000001 112.3 173.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.94 148.6 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.73 1.212 . . . . 1.5 108.391 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -77.88 -135.96 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.105 -0.702 . . . . 5.7699999999999996 109.105 158.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -140.52 152.64 45.73 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.882 1.273 . . . . 2.8599999999999999 111.489 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 m -161.35 142.02 8.32 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 127.771 2.428 . . . . 2.5800000000000001 108.983 161.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.22 -23.74 20.73 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.424 2.083 . . . . 2.1200000000000001 112.261 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.04 171.81 13.69 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 127.145 2.307 . . . . 1.3200000000000001 110.8 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -79.55 4.14 33.51 Favored 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 119.667 1.733 . . . . 1.0900000000000001 112.403 -9.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.3 139.47 16.54 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.239 1.57 . . . . 2.6400000000000001 115.239 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.33 -176.78 3.17 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.024 2.53 . . . . 0.52000000000000002 111.282 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.77 135.08 18.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.807 1.643 . . . . 0.92000000000000004 108.805 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.7 137.32 54.8 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.758 1.223 . . . . 0.55000000000000004 111.237 -175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -105.62 86.34 2.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.242 1.817 . . . . 2.6400000000000001 109.068 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -90.41 158.08 17.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.403 0.681 . . . . 1.96 112.708 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 m -131.53 134.02 45.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.016 1.327 . . . . 1.9399999999999999 109.535 -172.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.35 169.95 23.58 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.003 1.721 . . . . 5.3200000000000003 108.865 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -142.86 145.52 33.22 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.287 1.435 . . . . 4.6500000000000004 108.4 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -93.58 108.15 31.97 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.772 1.229 . . . . 1.52 110.87 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.58 -10.27 12.05 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.949 2.433 . . . . 1.8700000000000001 114.91 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.44 169.62 54.05 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 120.085 1.311 . . . . 1.8799999999999999 113.616 -171.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.65 -6.47 58.24 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.414 2.286 . . . . 4.3099999999999996 111.537 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mp -124.5 162.11 44.32 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 127.057 2.143 . . . . 3.9300000000000002 109.587 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.34 155.66 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.854 2.369 . . . . 1.3300000000000001 111.478 -171.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.428 HD12 ' CD2' ' A' ' 105' ' ' PHE . 1.0 OUTLIER -117.79 162.11 18.62 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.625 1.97 . . . . 2.8399999999999999 111.016 177.301 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -155.12 120.66 5.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.193 -1.367 . . . . 2.3799999999999999 111.266 -173.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.5 tp -103.49 114.1 28.11 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.608 1.963 . . . . 2.1200000000000001 109.757 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.3 m -112.86 -20.28 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.749 0.819 . . . . 0.70999999999999996 112.634 -167.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.15 -174.71 29.22 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 124.674 1.13 . . . . 0.52000000000000002 112.251 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.64 -178.43 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.1 1.36 . . . . 0.54000000000000004 110.878 168.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 4.7 mtt180 -152.62 164.86 36.85 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.139 2.176 . . . . 5.0300000000000002 108.417 172.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -169.2 146.06 2.95 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 124.849 1.259 . . . . 0.70999999999999996 108.919 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -77.32 -10.22 17.58 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.381 2.054 . . . . 1.24 113.367 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.97 21.47 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.747 1.388 . . . . 1.4299999999999999 114.747 -174.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.3 38.97 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.172 -0.955 . . . . 0.88 113.067 167.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -72.98 -30.62 63.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.433 1.493 . . . . 3.5099999999999998 113.168 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -155.16 168.44 27.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.156 2.582 . . . . 4.7699999999999996 107.743 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.97 154.87 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.173 1.389 . . . . 0.93999999999999995 108.876 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.61 146.34 28.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.975 1.71 . . . . 4.0599999999999996 108.676 -166.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.8 tp -113.03 110.13 19.97 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.48 1.036 . . . . 0.89000000000000001 111.298 -164.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -116.71 150.04 38.85 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 122.663 1.221 . . . . 0.5 113.927 -173.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -91.94 -178.28 4.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.957 -1.474 . . . . 2.1499999999999999 111.136 158.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.1 m -149.24 127.41 12.06 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.085 -1.82 . . . . 1.03 106.085 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -128.41 170.17 13.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.967 0.889 . . . . 2.0899999999999999 113.267 -167.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.93 144.72 32.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.152 1.781 . . . . 5.5800000000000001 110.68 170.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.37 147.2 21.94 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.512 -0.742 . . . . 5.4299999999999997 112.849 -172.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -91.76 132.62 36.27 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.479 1.512 . . . . 2.2999999999999998 109.835 165.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.33 130.33 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.496 -1.668 . . . . 3.0299999999999998 106.496 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 62.88 28.05 16.22 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.761 0.824 . . . . 4.9500000000000002 112.254 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.21 16.05 79.85 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 120.967 -1.083 . . . . 2.4300000000000002 113.904 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -135.21 134.42 40.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.986 1.714 . . . . 3.71 109.883 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.07 126.31 34.68 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.466 1.506 . . . . 2.6400000000000001 111.976 -173.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.25 -178.97 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 129.558 3.143 . . . . 2.7400000000000002 109.603 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.3 mtm -110.76 170.01 8.38 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.817 0.847 . . . . 3.48 112.033 168.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.89 -176.55 27.24 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.047 1.784 . . . . 1.04 112.206 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ttm -154.67 149.53 26.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.611 1.565 . . . . 1.1799999999999999 108.596 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.9 ptt85 -158.57 156.8 27.93 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 124.891 1.276 . . . . 4.8200000000000003 110.314 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.2 158.06 45.54 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.0 1.8 . . . . 0.5 111.644 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.84 149.85 65.74 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.908 1.683 . . . . 0.67000000000000004 109.087 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.31 -20.28 11.25 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.256 2.637 . . . . 0.71999999999999997 113.02 -167.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 p90 178.96 167.62 0.93 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.666 2.386 . . . . 2.29 110.114 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.75 150.84 32.8 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.124 1.369 . . . . 0.85999999999999999 110.137 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -117.81 141.79 48.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.034 1.334 . . . . 2.3199999999999998 109.3 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 t -143.93 132.05 10.93 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 113.276 0.843 . . . . 1.6000000000000001 113.276 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.85 170.32 14.38 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.256 2.637 . . . . 1.7 112.488 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -56.63 139.82 88.89 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.699 2.266 . . . . 1.72 110.658 164.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt 69.13 1.84 3.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.489 1.516 . . . . 2.3900000000000001 113.743 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.77 158.09 36.58 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.676 1.608 . . . . 2.1299999999999999 113.449 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -79.92 145.63 32.55 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.926 0.89 . . . . 3.5699999999999998 111.925 173.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.57 61.29 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.015 2.126 . . . . 5.9100000000000001 107.92 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -116.57 136.21 53.17 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.845 0.831 . . . . 3.1299999999999999 111.192 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.97 85.55 7.47 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.099 -1.445 . . . . 1.9399999999999999 107.099 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -55.95 139.7 70.35 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 113.672 0.99 . . . . 4.8799999999999999 113.672 -167.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -56.54 130.02 37.82 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.08 1.853 . . . . 4.4699999999999998 109.289 165.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.64 28.98 66.29 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.655 -1.081 . . . . 2.1499999999999999 114.813 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.68 -17.56 0.02 OUTLIER Glycine 0 N--CA 1.472 1.087 0 N-CA-C 118.966 2.347 . . . . 2.3799999999999999 118.966 158.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -143.24 150.03 38.73 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.222 2.011 . . . . 1.79 112.406 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -162.44 153.69 17.83 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.287 1.035 . . . . 0.59999999999999998 111.192 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -86.47 127.68 34.88 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.193 -0.669 . . . . 2.46 109.193 165.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.4 tpt -82.64 119.41 24.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.394 2.278 . . . . 0.81000000000000005 109.396 170.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -100.33 120.82 40.52 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.345 -0.983 . . . . 1.23 108.345 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.56 146.02 30.18 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.626 1.17 . . . . 2.5699999999999998 112.415 -169.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.89 -48.77 3.04 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 126.919 2.199 . . . . 3.0099999999999998 114.126 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.0 mt 56.49 165.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.066 3.346 . . . . 0.67000000000000004 115.388 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -119.36 -7.41 10.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.385 1.874 . . . . 1.8700000000000001 113.292 174.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -127.96 131.51 23.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 128.366 2.666 . . . . 4.5999999999999996 109.385 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.35 76.28 3.97 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.755 2.303 . . . . 2.9500000000000002 106.454 153.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.404 ' H ' ' HG ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -68.34 140.3 55.89 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.585 1.154 . . . . 3.21 113.669 -156.505 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -93.31 156.92 16.51 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.381 1.086 . . . . 5.5599999999999996 111.65 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.62 118.15 7.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 113.847 -1.524 . . . . 1.5600000000000001 107.545 159.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.62 -2.36 36.54 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-O 117.853 -1.526 . . . . 1.77 115.869 -168.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.42 -178.6 5.28 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.586 1.693 . . . . 3.3199999999999998 111.467 160.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -152.62 141.77 21.38 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.753 2.821 . . . . 4.6100000000000003 106.636 -171.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 82.5 t -144.15 146.09 21.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 126.601 1.96 . . . . 1.4399999999999999 109.561 -168.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -97.76 136.29 38.31 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.953 0.901 . . . . 2.8399999999999999 110.094 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.63 140.12 50.42 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.262 1.025 . . . . 2.71 109.888 165.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 39.7 m-20 -94.44 134.12 37.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.149 2.579 . . . . 1.8700000000000001 108.351 160.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.44 130.18 42.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.634 1.574 . . . . 1.0800000000000001 108.848 164.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.4 111.43 23.33 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.049 0.939 . . . . 0.68999999999999995 110.678 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.428 ' CD2' HD12 ' A' ' 30' ' ' LEU . 85.6 m-85 -103.66 163.68 12.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.142 1.377 . . . . 2.1299999999999999 111.582 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.57 154.86 13.39 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.679 -0.691 . . . . 2.6000000000000001 112.122 166.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.36 24.95 62.22 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.138 -0.812 . . . . 3.9500000000000002 114.977 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.91 13.69 82.29 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 118.436 1.118 . . . . 1.8999999999999999 114.171 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -90.52 117.51 29.26 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.448 -1.03 . . . . 3.5800000000000001 112.128 -172.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.27 140.86 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.61 1.564 . . . . 2.3300000000000001 110.431 169.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 mt -140.01 129.2 23.78 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.035 1.334 . . . . 2.6200000000000001 110.846 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -106.21 143.41 34.39 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.797 0.666 . . . . 2.21 112.797 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.96 160.01 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 127.49 2.316 . . . . 2.27 111.704 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.47 137.23 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.542 1.937 . . . . 1.98 110.57 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.4 mp -134.76 114.57 12.08 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 126.525 1.93 . . . . 2.6400000000000001 110.741 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -75.5 150.02 35.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.265 2.644 . . . . 1.26 110.665 169.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.8 t -91.25 132.88 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.848 0.859 . . . . 1.3100000000000001 111.195 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 N--CA 1.477 0.882 0 C-N-CA 125.901 1.68 . . . . 4.5199999999999996 113.089 -176.26 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 122.925 1.345 . . . . 4.8499999999999996 110.359 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.31 172.35 20.38 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.883 1.23 . . . . 1.3 113.897 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -156.23 160.15 39.55 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.499 1.92 . . . . 2.3599999999999999 110.96 172.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -103.61 147.94 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.356 -1.35 . . . . 1.6599999999999999 107.356 170.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -72.08 -119.77 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 CA-C-O 121.542 0.687 . . . . 5.0899999999999999 109.432 164.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -151.41 143.03 23.64 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 119.383 -2.073 . . . . 3.0800000000000001 110.92 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.0 t -171.68 143.31 1.44 Allowed Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.703 1.601 . . . . 2.2599999999999998 110.572 167.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.9 -26.32 4.58 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.733 2.289 . . . . 1.4399999999999999 112.26 166.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.31 170.42 12.03 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.643 2.068 . . . . 1.0700000000000001 111.419 -171.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.69 -16.12 22.83 Favored 'Cis proline' 0 C--N 1.349 0.596 0 CA-C-N 119.328 1.564 . . . . 1.3200000000000001 112.761 0.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.09 160.43 40.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.805 1.288 . . . . 2.21 114.421 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.88 -179.06 4.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.433 2.693 . . . . 0.55000000000000004 110.486 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.06 133.39 26.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.162 1.385 . . . . 1.3 109.208 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.32 150.95 50.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.562 1.145 . . . . 0.88 113.481 -171.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.45 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 50.8 m-85 -131.55 127.15 36.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.19 2.196 . . . . 2.1000000000000001 109.548 -163.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.262 0.0 OUTLIER -162.5 161.7 27.13 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.822 1.415 . . . . 2.77 114.822 -172.334 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.5 m -93.26 127.75 38.96 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.896 1.678 . . . . 1.71 111.735 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.9 tp -112.34 122.0 46.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.809 1.243 . . . . 4.2400000000000002 110.302 166.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -122.07 142.29 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.577 1.151 . . . . 4.5099999999999998 109.211 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -105.87 97.73 16.06 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.561 0.744 . . . . 1.3700000000000001 111.322 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.31 -5.59 14.36 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.857 2.371 . . . . 1.21 114.044 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.93 163.65 34.95 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 119.624 1.102 . . . . 1.3400000000000001 111.347 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.9 4.29 50.42 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.848 2.059 . . . . 3.5099999999999998 112.374 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -118.79 152.81 52.01 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.248 2.219 . . . . 2.9199999999999999 110.346 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.35 142.36 21.12 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.216 1.944 . . . . 0.96999999999999997 110.7 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.1 mt -96.57 149.46 21.74 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 122.258 1.027 . . . . 1.8 110.841 172.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -135.98 100.14 4.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 113.866 -1.515 . . . . 2.3500000000000001 110.946 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.46 97.39 9.5 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.999 2.12 . . . . 1.8 108.066 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 m -94.13 -25.42 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.875 0.87 . . . . 0.48999999999999999 112.801 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.46 -177.09 32.23 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 123.974 0.797 . . . . 0.40000000000000002 113.208 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.3 178.94 6.33 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.462 0.705 . . . . 0.5 111.18 172.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.402 ' NH1' ' H ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -148.75 170.97 17.01 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.512 2.725 . . . . 5.4199999999999999 106.591 165.004 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.402 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 1.5 t -177.36 148.42 0.72 Allowed Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 127.187 2.195 . . . . 0.81000000000000005 108.703 -172.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -77.14 -24.73 9.32 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.031 1.821 . . . . 1.21 113.958 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.5 m -112.57 23.42 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 114.221 1.193 . . . . 1.1899999999999999 114.221 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.39 35.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.142 1.377 . . . . 1.4299999999999999 107.822 160.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -83.3 -54.41 5.02 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.237 1.015 . . . . 3.0 111.075 -171.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -115.97 166.75 11.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.582 2.753 . . . . 5.4900000000000002 106.392 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.95 134.36 2.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 125.533 1.533 . . . . 0.94999999999999996 108.267 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -113.97 135.99 53.39 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.21 1.404 . . . . 2.9399999999999999 109.455 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -83.48 124.45 30.73 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.542 -0.54 . . . . 1.22 109.542 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -122.61 158.33 30.19 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.19 1.796 . . . . 0.63 112.896 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -179.89 4.07 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.626 1.571 . . . . 3.3199999999999998 110.701 165.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.5 m -154.77 141.82 19.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.785 1.634 . . . . 0.83999999999999997 106.988 170.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -155.58 175.0 14.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.54 1.162 . . . . 2.04 113.387 -167.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.7 ttp -117.2 146.16 43.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.71 1.604 . . . . 3.4700000000000002 110.137 171.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -148.11 161.05 42.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.716 2.406 . . . . 7.6600000000000001 110.272 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -91.03 144.81 25.27 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.832 0.853 . . . . 2.46 109.5 166.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.7 t -137.22 115.48 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.095 -1.817 . . . . 2.4300000000000002 106.095 163.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 58.08 34.85 24.63 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.992 1.479 . . . . 5.4100000000000001 114.992 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.18 4.63 68.89 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.253 -1.529 . . . . 1.6200000000000001 113.553 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -103.52 115.31 30.29 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.122 1.769 . . . . 2.75 107.673 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 117.06 17.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.903 0.881 . . . . 3.0600000000000001 110.221 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 t -138.88 153.73 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 128.609 2.764 . . . . 2.21 107.705 -161.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.23 173.43 6.46 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.615 -1.303 . . . . 3.96 113.531 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.09 166.84 33.19 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.703 1.144 . . . . 0.57999999999999996 112.451 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 ttm -150.43 139.74 21.31 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.143 2.177 . . . . 1.4099999999999999 107.286 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -150.56 154.23 35.16 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.681 1.992 . . . . 4.3700000000000001 108.672 -171.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.71 159.71 31.52 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.323 2.016 . . . . 0.52000000000000002 111.194 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.76 155.99 52.21 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 125.767 1.627 . . . . 0.93999999999999995 110.931 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -84.88 -26.43 1.54 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.407 2.738 . . . . 0.46999999999999997 114.089 -164.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -174.8 164.81 3.58 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.991 1.716 . . . . 1.7 111.477 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 mt -111.7 160.57 17.15 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.924 1.29 . . . . 0.52000000000000002 109.296 157.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -138.0 148.79 45.51 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.61 1.164 . . . . 1.9399999999999999 110.11 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 t -139.82 129.09 13.69 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 123.836 0.71 . . . . 1.03 111.755 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -68.39 162.81 39.03 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.189 2.593 . . . . 1.21 110.967 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.05 138.66 79.83 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.097 2.532 . . . . 1.25 112.17 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.14 3.43 2.69 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 127.27 2.228 . . . . 2.1099999999999999 115.036 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.67 169.71 34.35 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.136 1.827 . . . . 1.47 113.263 169.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -132.17 157.21 44.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.334 1.054 . . . . 4.54 112.305 168.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.3 t -145.08 140.93 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 128.026 2.53 . . . . 3.3799999999999999 107.505 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -134.32 130.06 36.45 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.186 0.517 . . . . 3.9700000000000002 110.822 -170.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -75.69 80.51 2.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.224 1.41 . . . . 2.1099999999999999 109.709 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.84 155.58 91.31 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 126.604 1.962 . . . . 3.7599999999999998 114.323 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.45 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 55.9 Cg_endo -61.8 -44.46 21.0 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.126 2.551 . . . . 2.25 112.329 171.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.48 60.33 4.88 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.106 -0.83 . . . . 2.2200000000000002 112.426 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.25 -126.44 2.03 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 125.428 1.49 . . . . 1.51 114.191 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -72.63 136.62 45.74 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.674 -0.898 . . . . 1.8400000000000001 112.11 -167.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -160.09 163.88 33.49 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.61 1.164 . . . . 0.81999999999999995 111.439 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -97.18 132.68 42.71 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.914 -0.491 . . . . 1.8300000000000001 109.921 170.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -88.35 115.69 26.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.822 2.049 . . . . 0.91000000000000003 108.983 166.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.12 119.19 37.43 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.185 0.994 . . . . 1.45 109.013 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.56 141.04 52.11 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.263 1.208 . . . . 3.1800000000000002 114.263 -164.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.24 38.34 25.97 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.539 1.066 . . . . 1.8799999999999999 113.142 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mt -43.86 152.75 0.15 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 116.386 1.995 . . . . 0.70999999999999996 116.386 -174.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -112.84 -16.9 12.64 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.718 -1.583 . . . . 1.8300000000000001 114.939 -173.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -138.25 142.31 34.85 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.698 2.799 . . . . 6.5800000000000001 108.599 165.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.24 135.65 27.45 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.965 1.776 . . . . 1.3600000000000001 107.753 158.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.56 105.9 16.15 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.318 0.508 . . . . 3.2999999999999998 109.851 -176.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -86.91 20.54 2.58 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.587 2.069 . . . . 4.3399999999999999 116.587 -163.022 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 67.01 157.25 0.12 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 128.541 2.737 . . . . 1.5900000000000001 111.845 -161.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.25 0.26 85.89 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 118.95 -0.917 . . . . 1.28 114.536 -172.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.89 175.69 8.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.921 1.688 . . . . 2.6899999999999999 110.259 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -128.48 153.4 47.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.932 2.093 . . . . 4.0899999999999999 105.423 163.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.1 t -136.72 138.04 46.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 126.407 1.883 . . . . 1.53 109.077 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.415 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 38.9 tt0 -89.81 136.08 33.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.08 1.352 . . . . 3.0299999999999998 109.853 173.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.63 139.89 52.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.914 1.286 . . . . 2.6299999999999999 109.62 170.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -99.06 143.45 29.32 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.84 2.056 . . . . 2.6299999999999999 109.669 167.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -114.74 118.79 34.6 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.844 1.657 . . . . 1.1799999999999999 109.292 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.1 mt -92.39 112.31 24.21 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.883 1.273 . . . . 0.67000000000000004 109.408 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -104.66 106.5 17.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.567 1.147 . . . . 2.0899999999999999 110.564 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.8 21.8 2.08 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.766 1.626 . . . . 2.6400000000000001 114.78 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.68 -55.48 4.46 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.12 1.343 . . . . 4.2400000000000002 112.976 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.65 1.12 54.09 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 116.126 1.21 . . . . 2.0499999999999998 116.126 -172.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -140.68 149.15 41.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.077 1.439 . . . . 4.0800000000000001 112.326 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.71 153.14 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.407 1.483 . . . . 2.1400000000000001 110.919 170.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.0 tp -155.19 164.02 39.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.953 2.101 . . . . 2.1899999999999999 107.973 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.415 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 41.2 pttt -146.58 156.16 43.02 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.16 1.541 . . . . 1.9299999999999999 115.16 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.15 160.16 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.951 2.5 . . . . 2.6899999999999999 109.929 -167.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.0 142.97 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.959 0.904 . . . . 2.4900000000000002 110.028 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.21 144.57 15.21 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 124.631 1.172 . . . . 2.52 113.664 -168.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.49 158.86 25.65 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.984 3.79 . . . . 1.24 114.478 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.99 124.5 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.152 1.381 . . . . 1.2 110.227 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 N--CA 1.47 0.55 0 C-N-CA 124.345 1.058 . . . . 3.7200000000000002 111.149 174.956 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 113.362 0.875 . . . . 5.29 113.362 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.16 172.38 34.04 Favored Glycine 0 C--N 1.34 0.78 0 O-C-N 120.797 -1.189 . . . . 1.1899999999999999 114.809 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -157.35 159.55 37.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.198 1.399 . . . . 2.2999999999999998 113.358 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.1 t -107.99 143.31 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.905 1.282 . . . . 1.45 109.707 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -73.12 -15.77 61.47 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 117.263 2.32 . . . . 5.6900000000000004 117.263 -159.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 1.1 t80 71.83 115.76 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.863 2.065 . . . . 3.25 110.778 -174.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.5 m -162.06 145.4 9.14 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.887 1.675 . . . . 2.2599999999999998 108.806 169.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.12 -33.29 6.03 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.7 2.267 . . . . 1.8400000000000001 112.551 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.71 172.2 18.29 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.437 1.494 . . . . 1.24 111.503 -175.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.94 -1.26 25.14 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 CA-C-N 119.194 1.497 . . . . 1.1499999999999999 112.891 -1.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -144.0 169.38 17.93 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.256 1.023 . . . . 2.1899999999999999 113.45 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.26 178.27 9.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.966 2.506 . . . . 0.68999999999999995 110.941 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.64 166.3 22.93 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.989 2.116 . . . . 1.0800000000000001 108.823 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.24 154.4 34.58 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.863 0.865 . . . . 0.64000000000000001 111.863 174.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.25 131.86 28.84 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.537 1.535 . . . . 2.5600000000000001 109.818 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.26 162.47 39.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.083 0.856 . . . . 2.8199999999999998 112.841 175.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 39.4 m -89.03 127.08 35.67 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.346 1.458 . . . . 1.73 110.221 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.7 tp -104.47 127.47 52.18 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.115 1.366 . . . . 4.04 108.534 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -135.86 132.83 37.09 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.815 1.246 . . . . 4.6900000000000004 109.106 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -103.71 101.21 23.0 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.538 1.135 . . . . 1.53 110.41 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.82 -10.17 19.84 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.297 1.998 . . . . 1.1000000000000001 113.535 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 177.3 50.84 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-O 122.764 1.202 . . . . 1.1499999999999999 113.102 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -104.46 -5.25 21.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.496 2.318 . . . . 2.8799999999999999 112.368 -172.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -120.34 161.2 40.31 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 127.359 2.264 . . . . 3.6400000000000001 109.033 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.74 151.99 14.83 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.711 2.274 . . . . 1.0600000000000001 111.911 -167.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp -104.93 149.88 25.35 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.81 1.291 . . . . 2.1600000000000001 109.387 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -139.87 116.65 10.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.726 -1.579 . . . . 2.27 108.594 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -93.31 114.85 27.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.3 2.24 . . . . 2.2799999999999998 108.193 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.5 -25.34 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.708 0.803 . . . . 0.62 111.984 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.04 -175.8 33.45 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 123.808 0.718 . . . . 0.55000000000000004 114.573 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -123.51 178.29 5.25 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.64 1.176 . . . . 0.81000000000000005 112.1 166.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -157.06 147.66 21.41 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.708 1.603 . . . . 5.8200000000000003 107.094 162.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 t -159.59 151.6 17.1 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-O 117.538 -1.22 . . . . 0.68000000000000005 108.317 -169.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.93 0.59 9.1 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 121.805 1.67 . . . . 0.85999999999999999 114.047 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.07 28.3 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.809 2.044 . . . . 1.04 114.791 -171.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.26 143.14 16.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.786 1.175 . . . . 1.1499999999999999 111.013 168.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.96 -38.51 91.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.174 1.39 . . . . 3.02 111.697 173.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -149.95 144.39 25.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.085 1.754 . . . . 7.0300000000000002 107.856 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.66 132.67 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.329 1.452 . . . . 0.90000000000000002 109.394 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -97.63 167.98 10.63 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.714 1.206 . . . . 3.21 110.02 166.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -119.61 137.25 53.98 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.986 1.374 . . . . 2.4500000000000002 112.441 154.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -121.5 153.72 37.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.661 1.984 . . . . 0.73999999999999999 110.808 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -90.35 157.28 17.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.896 -1.047 . . . . 1.98 109.945 153.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.4 m -108.89 140.13 42.79 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 105.033 -2.21 . . . . 0.95999999999999996 105.033 157.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -136.15 167.99 20.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.869 1.318 . . . . 1.99 113.701 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.4 mtm -113.12 142.87 45.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.532 1.533 . . . . 4.71 110.843 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -134.88 143.27 46.87 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.129 1.372 . . . . 6.1799999999999997 110.047 170.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -91.25 142.31 27.85 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.214 -1.032 . . . . 3.3900000000000001 108.214 154.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.3 t -138.85 118.71 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 106.599 -1.63 . . . . 3.4399999999999999 106.599 164.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 64.59 19.89 11.97 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.411 1.484 . . . . 4.9199999999999999 114.264 -177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.54 4.81 87.41 Favored Glycine 0 N--CA 1.481 1.646 0 O-C-N 120.477 -1.39 . . . . 3.2799999999999998 113.64 -169.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -103.68 111.43 23.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.672 1.989 . . . . 3.54 107.87 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -87.64 117.71 26.64 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.336 1.454 . . . . 2.96 111.085 -173.436 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.17 139.85 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.396 1.878 . . . . 2.5499999999999998 109.329 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -101.13 166.98 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.902 1.281 . . . . 3.5800000000000001 112.77 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.1 -178.0 29.84 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.44 1.019 . . . . 0.58999999999999997 113.166 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.2 ttm -152.41 143.37 23.04 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.666 1.586 . . . . 1.29 108.759 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -162.96 153.75 14.23 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 123.569 0.748 . . . . 4.9400000000000004 112.065 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.33 146.22 35.33 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.644 2.229 . . . . 0.67000000000000004 112.852 -174.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.66 155.15 63.38 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 118.347 -0.835 . . . . 0.82999999999999996 110.905 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.38 -23.66 5.98 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.133 2.555 . . . . 0.59999999999999998 112.89 -171.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -178.37 167.41 1.88 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.089 1.756 . . . . 2.02 111.113 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.6 mt -115.08 155.13 27.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.191 1.796 . . . . 0.77000000000000002 109.952 163.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -116.13 145.81 42.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.387 1.475 . . . . 2.23 110.531 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.5 t -142.23 126.6 10.03 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 118.878 0.763 . . . . 0.92000000000000004 112.588 163.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.58 165.57 32.33 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.089 3.193 . . . . 1.02 112.39 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.99 137.63 80.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.342 2.694 . . . . 1.0700000000000001 112.218 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt 67.59 1.21 2.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.362 1.865 . . . . 1.6799999999999999 114.396 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.12 167.43 27.83 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 126.007 1.765 . . . . 1.1899999999999999 113.406 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -137.03 156.16 48.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.576 1.15 . . . . 5.6500000000000004 111.826 169.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.0 t -146.84 130.71 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.888 2.075 . . . . 3.4700000000000002 108.145 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -96.33 140.47 30.96 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.622 1.101 . . . . 3.1200000000000001 111.392 164.79 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -41.2 -52.37 3.36 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.364 1.865 . . . . 3.0600000000000001 111.959 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 104.11 127.89 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 128.575 2.75 . . . . 2.73 111.217 164.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.18 -11.27 30.53 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.238 2.625 . . . . 2.5 114.83 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.67 20.26 8.82 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.108 1.337 . . . . 1.8300000000000001 113.753 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -144.54 -119.32 1.3 Allowed Glycine 0 N--CA 1.471 1.0 0 CA-C-N 119.204 1.502 . . . . 1.8100000000000001 113.31 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -72.74 144.68 47.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.275 1.038 . . . . 2.1699999999999999 110.518 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -161.48 151.14 16.69 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.532 -0.73 . . . . 0.71999999999999997 110.728 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 59.0 m-85 -77.76 143.01 38.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.477 -0.935 . . . . 2.52 108.477 166.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 tpt -115.88 114.52 24.8 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.391 2.276 . . . . 1.1100000000000001 107.902 172.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -98.04 118.85 35.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.938 1.695 . . . . 1.5 108.73 -173.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.85 135.13 54.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.685 1.194 . . . . 2.2000000000000002 110.336 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.51 50.84 10.66 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.718 -0.614 . . . . 1.6299999999999999 112.689 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -47.76 156.38 0.33 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 115.932 1.827 . . . . 0.70999999999999996 115.932 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -112.08 -30.77 7.11 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 113.43 -1.714 . . . . 1.76 113.772 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -112.66 134.79 21.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.465 1.506 . . . . 4.3300000000000001 108.959 166.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.62 82.89 1.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.785 2.324 . . . . 1.46 107.265 160.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.3 pt? -87.6 124.75 33.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.562 0.745 . . . . 2.5299999999999998 112.952 -163.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 24.4 mtmm -110.38 167.23 10.36 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 115.268 1.581 . . . . 3.6200000000000001 115.268 -165.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.86 124.82 21.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.353 -1.294 . . . . 1.24 109.123 172.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.13 5.25 62.44 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 117.959 -1.467 . . . . 1.6899999999999999 115.639 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.01 178.26 6.71 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.193 1.997 . . . . 2.77 111.246 163.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -149.12 125.76 11.05 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 129.497 3.119 . . . . 3.4900000000000002 104.607 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.4 t -146.52 139.96 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.809 0.844 . . . . 1.76 110.783 -168.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -80.13 152.12 29.43 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.524 1.13 . . . . 3.1499999999999999 113.982 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.2 tt -144.47 130.74 19.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.426 1.49 . . . . 3.0600000000000001 110.639 168.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.8 117.88 21.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.644 2.778 . . . . 2.3500000000000001 109.095 165.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -87.87 121.08 29.85 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.124 -1.065 . . . . 1.03 108.124 171.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.1 mt -97.61 118.56 34.41 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.002 0.921 . . . . 0.83999999999999997 109.979 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -116.2 144.51 44.09 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.308 1.043 . . . . 2.2000000000000002 112.852 -171.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.58 137.0 57.94 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.279 -0.888 . . . . 2.1400000000000001 113.271 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.17 46.38 5.6 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.746 -1.03 . . . . 3.9199999999999999 113.627 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.3 32.79 46.54 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 123.959 0.79 . . . . 1.72 114.728 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -125.77 144.81 50.48 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.675 1.237 . . . . 3.7000000000000002 112.201 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.04 149.02 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.376 1.47 . . . . 2.02 110.644 176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -149.3 119.29 7.16 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.143 0.977 . . . . 2.2599999999999998 108.699 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -96.08 133.71 40.01 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.635 -0.665 . . . . 2.1699999999999999 111.757 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.28 170.47 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.934 1.693 . . . . 2.1600000000000001 108.469 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -124.75 136.77 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.752 1.621 . . . . 2.4100000000000001 108.726 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -127.73 139.12 34.4 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.305 1.442 . . . . 2.7799999999999998 109.131 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.26 150.41 76.5 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.231 2.621 . . . . 1.3400000000000001 111.311 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.1 t -99.39 137.73 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.491 1.116 . . . . 1.3500000000000001 108.384 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 126.525 1.93 . . . . 4.79 112.271 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 . . . . . 0 C--O 1.237 0.441 0 N-CA-C 107.602 -1.259 . . . . 5.4699999999999998 107.602 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.17 137.14 9.19 Favored Glycine 0 N--CA 1.467 0.701 0 N-CA-C 110.95 -0.86 . . . . 2.2000000000000002 110.95 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -96.87 173.12 7.46 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.521 1.304 . . . . 2.3300000000000001 114.521 -168.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.43 148.36 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.214 1.806 . . . . 1.25 108.6 168.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -69.46 -103.02 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.407 1.083 . . . . 4.5300000000000002 112.613 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.2 t80 169.96 126.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.705 2.402 . . . . 2.0 108.419 -166.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 m -173.34 145.47 1.22 Allowed Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 126.015 1.726 . . . . 2.0 109.389 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.78 -33.74 0.6 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.915 2.41 . . . . 1.6299999999999999 112.589 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.29 166.8 11.95 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.949 1.738 . . . . 1.54 111.314 -170.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.76 -2.04 25.17 Favored 'Cis proline' 0 CA--C 1.54 0.777 0 CA-C-N 119.192 1.496 . . . . 1.6000000000000001 113.092 -0.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -147.6 163.66 35.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.796 1.638 . . . . 1.9099999999999999 112.994 -172.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.58 -175.43 4.92 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.259 2.224 . . . . 0.70999999999999996 111.773 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.11 148.0 33.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.532 1.133 . . . . 0.68000000000000005 110.989 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.23 137.75 39.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 0.51000000000000001 113.096 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -105.93 23.36 14.09 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.252 2.621 . . . . 2.7200000000000002 113.818 -168.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -58.47 160.72 5.09 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 117.263 2.319 . . . . 2.25 117.263 -163.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -79.46 150.13 31.34 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.119 2.168 . . . . 1.8799999999999999 112.046 174.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.67 132.7 33.31 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.058 2.143 . . . . 3.4399999999999999 110.334 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -135.6 162.78 31.73 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.125 1.37 . . . . 4.6399999999999997 111.456 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -130.31 98.94 19.92 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.909 0.883 . . . . 1.76 109.662 168.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.16 -11.15 16.32 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.779 2.319 . . . . 1.24 113.007 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.85 -172.66 47.54 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.994 1.283 . . . . 1.26 113.155 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -113.73 -2.64 13.67 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.438 1.895 . . . . 3.3199999999999998 112.239 -165.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -124.54 153.86 69.65 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.363 2.265 . . . . 3.25 110.231 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.99 158.5 38.29 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.643 2.229 . . . . 1.3899999999999999 112.709 -168.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.3 mt -119.04 152.5 36.33 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.083 1.753 . . . . 2.02 110.196 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.3 ttp-105 -138.01 102.39 4.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.281 -1.781 . . . . 2.79 110.722 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.82 106.88 16.68 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.318 1.847 . . . . 1.8200000000000001 108.671 -174.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.25 -26.08 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.698 0.999 . . . . 0.54000000000000004 113.698 -170.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.09 -174.23 31.71 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 125.615 1.579 . . . . 0.48999999999999999 111.805 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.71 -175.14 4.54 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.643 0.735 . . . . 0.68999999999999995 112.443 173.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -145.23 178.1 8.32 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.808 2.843 . . . . 5.4199999999999999 107.598 160.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t 179.41 150.7 0.5 Allowed Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 127.089 2.156 . . . . 0.68000000000000005 109.115 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.77 -9.68 22.69 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.014 2.476 . . . . 1.05 113.746 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 30.1 m -114.04 23.34 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 115.248 1.573 . . . . 0.83999999999999997 115.248 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -151.75 173.24 14.97 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.408 1.483 . . . . 1.1699999999999999 109.252 166.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -101.21 -58.02 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.612 1.565 . . . . 4.5999999999999996 110.795 165.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -98.14 152.61 19.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.615 2.366 . . . . 5.8799999999999999 108.536 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.5 p -160.55 108.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 127.04 2.136 . . . . 1.74 110.224 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -127.58 140.94 51.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.16 -1.382 . . . . 5.4900000000000002 111.469 -168.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 tp -82.03 125.27 30.61 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.666 0.746 . . . . 1.53 111.59 -170.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -119.09 159.5 23.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.288 1.835 . . . . 0.56000000000000005 112.161 171.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -114.31 165.43 12.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.906 -1.497 . . . . 2.25 110.863 166.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -124.3 126.76 46.57 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.16 -1.793 . . . . 0.93000000000000005 106.16 169.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -127.14 171.35 11.49 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.23 0.826 . . . . 2.1000000000000001 113.23 -172.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 ttp -105.38 145.28 31.0 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.779 1.632 . . . . 3.8399999999999999 110.823 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -152.25 153.42 33.71 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.467 1.507 . . . . 8.2899999999999991 112.122 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -155.66 142.16 18.65 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.197 1.799 . . . . 2.79 108.802 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -164.78 145.41 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 129.54 3.136 . . . . 5.6299999999999999 105.797 171.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 61.64 9.18 2.66 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.767 1.627 . . . . 3.5899999999999999 115.063 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.48 8.52 73.99 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.416 1.008 . . . . 2.23 114.95 -168.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -85.55 66.66 9.78 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.948 -1.325 . . . . 2.77 111.938 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 111.93 1.7 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.331 -1.481 . . . . 2.75 111.315 171.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -155.23 159.81 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.203 1.401 . . . . 2.98 110.082 -170.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 65.1 mtm -91.84 172.69 8.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.71 1.004 . . . . 3.04 113.71 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.59 -179.17 24.3 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.472 1.987 . . . . 0.78000000000000003 111.211 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ttm -144.38 147.21 33.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.248 1.419 . . . . 1.26 107.856 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -158.97 155.44 24.47 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 4.8300000000000001 110.84 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.87 156.85 24.02 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.782 2.322 . . . . 0.68000000000000005 111.635 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.49 155.58 63.92 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.44 1.496 . . . . 1.0600000000000001 110.756 -176.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -84.81 -27.23 1.32 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.071 2.514 . . . . 0.62 113.493 -165.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -178.39 166.56 1.85 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.228 1.811 . . . . 1.71 112.003 -178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.2 mt -108.35 157.24 18.56 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.021 1.328 . . . . 0.69999999999999996 110.319 157.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -106.35 153.74 21.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.427 1.091 . . . . 1.8799999999999999 109.341 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.3 t -140.59 122.79 9.63 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 118.722 0.692 . . . . 1.4199999999999999 112.157 160.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.29 159.16 44.11 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.549 2.833 . . . . 1.26 111.296 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.6 140.89 89.22 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.423 2.748 . . . . 1.3200000000000001 112.586 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt 66.21 -2.07 1.06 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.877 2.071 . . . . 2.0 113.948 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.6 172.75 41.27 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.262 1.887 . . . . 1.26 113.577 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.51 144.0 23.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.137 1.375 . . . . 5.9400000000000004 111.348 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.9 t -149.48 137.35 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 126.814 2.046 . . . . 3.3599999999999999 107.16 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -133.45 127.33 33.09 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.446 -1.316 . . . . 4.3600000000000003 107.446 -162.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.6 -51.41 68.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.37 0.668 . . . . 2.6899999999999999 111.616 -162.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 82.74 158.63 0.12 Allowed Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 126.708 2.003 . . . . 5.4000000000000004 114.98 159.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -60.53 127.14 21.82 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.218 1.945 . . . . 2.8399999999999999 110.22 168.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.88 54.7 34.77 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.975 -0.557 . . . . 1.79 113.709 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.36 -44.74 0.03 OUTLIER Glycine 0 N--CA 1.473 1.117 0 N-CA-C 116.489 1.356 . . . . 1.9099999999999999 116.489 160.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -135.24 147.62 49.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.991 1.395 . . . . 2.1299999999999999 109.871 163.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -161.24 149.01 15.33 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.678 0.791 . . . . 0.62 109.693 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -79.07 136.43 37.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.426 -0.953 . . . . 2.1400000000000001 108.426 160.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.0 tpt -88.8 116.85 27.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.848 1.659 . . . . 0.79000000000000004 107.569 163.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -89.37 129.77 35.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.003 1.321 . . . . 1.1899999999999999 107.971 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.15 140.12 51.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.165 0.986 . . . . 2.0 111.073 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.57 48.88 7.64 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.923 0.773 . . . . 2.4100000000000001 111.259 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 14.0 mt -51.99 156.11 1.64 Allowed 'General case' 0 N--CA 1.46 0.046 0 N-CA-C 115.254 1.576 . . . . 0.94999999999999996 115.254 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 29.9 mmtp -120.92 -22.12 6.31 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 113.551 -1.659 . . . . 3.3199999999999998 113.513 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -132.89 142.83 46.16 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 128.436 2.695 . . . . 6.3899999999999997 109.122 165.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -68.93 137.57 38.26 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.369 2.046 . . . . 1.52 107.951 157.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.24 140.68 29.9 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.704 0.802 . . . . 2.1499999999999999 111.265 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.24 165.12 12.72 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 123.559 1.647 . . . . 4.0300000000000002 111.329 165.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.81 134.1 41.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 112.88 -1.963 . . . . 1.26 109.249 170.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.99 12.43 59.01 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.073 1.32 . . . . 1.97 115.051 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.07 -176.71 4.08 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.68 1.192 . . . . 2.6299999999999999 111.522 171.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.77 136.6 17.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 128.369 2.668 . . . . 3.04 106.183 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.3 t -147.86 146.2 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.979 1.312 . . . . 1.3899999999999999 110.738 -168.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.4 142.77 40.99 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.56 0.744 . . . . 2.5699999999999998 112.162 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mp -120.69 145.26 47.64 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.512 1.149 . . . . 1.8400000000000001 110.774 150.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -112.07 103.61 11.81 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.665 2.786 . . . . 2.4100000000000001 108.527 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.91 130.17 34.57 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.67 -1.268 . . . . 1.1899999999999999 110.762 -166.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.74 116.01 31.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.497 1.119 . . . . 0.93999999999999995 111.446 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -111.04 104.05 12.57 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.339 1.455 . . . . 2.0499999999999998 111.829 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 55.52 25.48 7.93 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.393 1.877 . . . . 3.2200000000000002 113.411 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.88 -58.22 4.27 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.229 1.395 . . . . 4.8099999999999996 112.697 -173.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.4 0.09 56.01 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.868 1.507 . . . . 2.1000000000000001 116.868 -167.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -137.04 143.09 42.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.535 1.668 . . . . 2.8300000000000001 111.649 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.35 148.82 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.121 1.768 . . . . 2.1600000000000001 110.711 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.5 tt -155.66 131.61 9.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.102 1.361 . . . . 1.8300000000000001 110.599 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -92.36 144.75 25.06 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.265 -0.897 . . . . 2.48 112.288 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.02 161.9 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.675 1.59 . . . . 1.96 108.381 167.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.62 130.64 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.18 0.992 . . . . 2.04 108.88 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.92 136.7 29.41 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.944 1.698 . . . . 3.1600000000000001 109.501 -165.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.47 160.2 41.99 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.385 2.723 . . . . 1.45 111.911 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 t -109.51 120.61 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.255 1.022 . . . . 1.1599999999999999 110.478 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 . . . . . 0 N--CA 1.466 0.374 0 C-N-CA 126.169 1.788 . . . . 3.77 108.732 173.071 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 120.69 0.281 . . . . 4.9299999999999997 111.162 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.15 167.75 21.7 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 121.212 -0.93 . . . . 1.24 112.889 -169.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -151.96 165.5 34.44 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.619 0.768 . . . . 2.27 112.893 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -105.88 139.58 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 106.471 -1.677 . . . . 1.4299999999999999 106.471 168.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ttt-85 -79.8 -126.63 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.102 0.865 . . . . 4.8399999999999999 109.001 170.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -154.45 154.43 33.19 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 119.695 -1.878 . . . . 2.9700000000000002 113.342 -173.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.7 t -176.36 140.36 0.52 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 129.757 3.223 . . . . 2.2000000000000002 107.037 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.2 -32.52 5.09 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.467 2.112 . . . . 1.3 112.067 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.88 171.95 23.58 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.807 1.194 . . . . 0.85999999999999999 112.657 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.95 1.21 19.5 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 119.026 1.413 . . . . 0.88 112.6 -6.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.86 144.83 24.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.463 1.653 . . . . 2.4900000000000002 115.463 -173.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.23 -176.11 3.14 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.898 2.479 . . . . 0.47999999999999998 112.58 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.5 133.25 25.45 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.089 1.356 . . . . 1.01 110.987 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.0 141.69 40.76 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.699 1.2 . . . . 0.55000000000000004 112.67 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -115.64 58.69 0.73 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.143 2.577 . . . . 2.4100000000000001 109.978 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -64.31 162.05 15.57 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.054 -1.029 . . . . 1.8100000000000001 111.836 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 m -108.32 139.76 42.57 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.403 0.681 . . . . 1.47 110.941 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -104.64 127.38 52.37 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.904 -1.044 . . . . 3.1299999999999999 110.242 -178.565 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.3 145.71 39.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.4 1.48 . . . . 5.5 110.178 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.46 60.42 48.13 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.614 0.766 . . . . 2.8100000000000001 111.897 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -60.66 -20.3 64.49 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.678 2.919 . . . . 1.49 114.573 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.41 -171.84 36.73 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 122.638 1.132 . . . . 1.3799999999999999 113.677 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -111.74 -3.02 15.11 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.17 1.788 . . . . 3.0899999999999999 112.45 -163.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.58 154.69 69.9 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 127.528 2.331 . . . . 3.0 110.021 175.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.66 138.59 19.32 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.731 2.287 . . . . 1.47 111.219 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.9 mt -94.89 137.84 33.44 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 123.602 1.667 . . . . 2.1699999999999999 112.341 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 ttp-105 -123.97 95.97 4.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.471 -2.149 . . . . 3.3999999999999999 111.508 -173.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.456 HD22 HD23 ' A' ' 22' ' ' LEU . 44.0 tp -79.62 107.71 12.6 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.413 1.885 . . . . 2.3799999999999999 109.909 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -98.01 -25.41 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 112.724 0.639 . . . . 0.53000000000000003 112.724 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.47 -173.96 27.56 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 124.657 1.122 . . . . 0.42999999999999999 112.388 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.23 174.19 10.06 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.667 -0.767 . . . . 0.51000000000000001 111.88 163.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.4 mtp-105 -138.97 170.95 15.05 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 128.992 2.917 . . . . 4.8600000000000003 107.056 158.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t 179.92 153.46 0.63 Allowed Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 125.459 1.504 . . . . 0.71999999999999997 110.022 -168.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.02 -1.7 9.45 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.8 2.333 . . . . 1.03 115.236 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -118.63 18.56 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 115.706 1.743 . . . . 1.02 115.706 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -166.04 162.63 18.04 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.194 2.197 . . . . 0.98999999999999999 109.105 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -120.84 -69.26 0.85 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.069 1.748 . . . . 4.0499999999999998 108.345 -172.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -84.1 75.05 10.2 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.528 -1.358 . . . . 5.6500000000000004 108.009 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.45 148.75 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.512 -0.767 . . . . 1.04 109.577 166.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.35 154.28 30.33 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.332 1.853 . . . . 4.0899999999999999 108.414 -164.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.9 tp -121.38 107.95 13.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.47 1.032 . . . . 0.82999999999999996 110.864 -167.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -115.94 150.13 37.63 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 114.99 1.478 . . . . 0.67000000000000004 114.99 -171.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -106.93 153.62 22.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.662 1.985 . . . . 2.1200000000000001 110.684 163.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.418 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 3.5 m -131.27 133.17 45.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.651 1.981 . . . . 0.93999999999999995 106.973 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -144.33 172.3 13.13 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.649 0.981 . . . . 1.99 113.649 -167.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.5 ttp -99.25 147.05 25.56 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.627 1.571 . . . . 3.77 109.889 167.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.91 158.35 43.05 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.876 1.67 . . . . 5.5499999999999998 109.822 -174.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -110.11 143.2 40.51 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.808 1.643 . . . . 2.8999999999999999 109.818 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.6 p -157.84 138.32 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.935 -1.135 . . . . 3.71 107.935 163.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 64.25 25.11 13.51 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.864 0.865 . . . . 4.0099999999999998 111.587 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.03 10.6 78.09 Favored Glycine 0 N--CA 1.48 1.584 0 O-C-N 120.428 -1.42 . . . . 2.3199999999999998 113.865 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -123.18 121.61 36.37 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.791 2.036 . . . . 2.6499999999999999 109.565 -166.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 mtmm -72.38 131.92 43.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.165 1.386 . . . . 3.7400000000000002 110.957 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.29 -179.5 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 129.095 2.958 . . . . 2.7000000000000002 109.367 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.73 162.39 22.11 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.787 0.835 . . . . 3.9300000000000002 112.289 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.57 31.12 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.54 1.067 . . . . 0.72999999999999998 113.319 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.0 ttm -154.75 144.3 21.4 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.226 1.41 . . . . 1.1000000000000001 110.567 -174.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -148.79 161.72 31.94 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 126.105 1.762 . . . . 4.4000000000000004 109.897 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.07 161.4 26.54 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.247 1.964 . . . . 0.53000000000000003 111.956 168.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.92 154.9 68.99 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 126.683 1.993 . . . . 1.02 110.612 175.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.91 -20.41 7.63 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.799 2.999 . . . . 0.46999999999999997 113.561 -165.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -178.33 163.69 1.65 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.431 1.892 . . . . 1.98 111.166 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -110.98 157.76 19.54 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.946 1.299 . . . . 0.63 109.822 159.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -133.17 152.33 51.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.519 0.728 . . . . 2.3199999999999998 111.359 172.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.2 t -136.15 141.09 34.95 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.536 1.934 . . . . 1.1000000000000001 112.398 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.83 156.13 13.57 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.282 3.321 . . . . 1.45 112.708 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -65.91 148.21 85.81 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.599 2.866 . . . . 1.3600000000000001 114.064 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 70.24 -13.4 0.44 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 129.133 2.973 . . . . 1.99 114.934 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.7 164.23 48.61 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.289 0.947 . . . . 1.96 113.454 173.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -98.41 159.06 15.19 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.519 -0.919 . . . . 4.2699999999999996 108.519 145.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.9 t -148.57 118.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.268 1.427 . . . . 3.54 107.48 163.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -78.85 156.26 28.76 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.719 -0.613 . . . . 2.9700000000000002 112.376 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.89 144.43 57.28 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.099 -1.074 . . . . 2.6000000000000001 108.099 155.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' H ' ' HB2' ' A' ' 82' ' ' TYR . 7.9 mptt -84.45 126.98 67.77 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 120.153 -1.592 . . . . 3.3599999999999999 109.751 -170.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -60.78 -14.82 34.07 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.814 3.009 . . . . 2.4700000000000002 115.071 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.56 -58.24 0.77 Allowed Glycine 0 CA--C 1.531 1.069 0 CA-C-N 118.752 0.706 . . . . 3.4700000000000002 111.867 155.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -75.15 -17.12 80.28 Favored Glycine 0 N--CA 1.476 1.338 0 N-CA-C 119.307 2.483 . . . . 2.0 119.307 -158.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.41 ' HB2' ' H ' ' A' ' 78' ' ' LYS . 80.5 m-85 -147.63 141.32 25.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.698 2.249 . . . . 2.25 111.643 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -158.2 150.32 21.88 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.606 0.763 . . . . 0.81000000000000005 111.392 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -79.71 117.03 20.24 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 108.912 -0.773 . . . . 1.8200000000000001 108.912 162.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 tpt -77.81 124.49 28.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.726 2.01 . . . . 1.0 108.278 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.5 mt -117.05 97.32 5.87 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.343 1.457 . . . . 1.99 108.946 -167.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.51 149.39 26.26 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.775 0.798 . . . . 2.3599999999999999 111.839 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.41 51.98 6.35 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 110.879 -0.888 . . . . 2.0800000000000001 110.879 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 10.5 mt -50.77 151.44 2.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.682 1.23 . . . . 0.97999999999999998 113.864 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -114.45 -20.49 10.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.031 -1.895 . . . . 3.0299999999999998 114.648 -173.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -126.51 154.55 75.2 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.294 2.238 . . . . 6.2199999999999998 108.184 166.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -64.7 139.92 65.56 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 N-CA-C 107.867 -1.628 . . . . 2.7599999999999998 107.867 151.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.26 163.34 29.52 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.192 1.397 . . . . 2.46 109.225 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.07 170.47 20.41 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.236 0.828 . . . . 4.1299999999999999 113.236 174.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.19 134.44 57.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.932 0.893 . . . . 1.3999999999999999 110.339 170.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.11 -7.52 35.32 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.683 1.611 . . . . 1.6899999999999999 115.323 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.69 -179.69 6.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.447 1.123 . . . . 3.7999999999999998 110.676 174.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 20.6 pt-20 -138.51 141.7 39.36 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.648 1.979 . . . . 3.3999999999999999 106.937 160.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.9 t -148.53 145.25 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.784 1.634 . . . . 1.3700000000000001 110.181 -165.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.51 145.62 26.72 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.263 1.579 . . . . 3.4700000000000002 115.263 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -118.31 144.29 45.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.79 1.636 . . . . 2.5099999999999998 109.526 161.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -95.62 113.24 24.87 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 128.568 2.747 . . . . 1.9399999999999999 108.171 167.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.9 mp -86.5 112.16 21.26 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.617 1.167 . . . . 1.6299999999999999 107.954 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.9 mt -95.61 106.33 18.41 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.79 0.805 . . . . 0.69999999999999996 110.705 -174.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -98.25 126.84 43.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.882 1.273 . . . . 1.97 111.929 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.81 41.27 4.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.088 2.155 . . . . 2.52 112.822 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.85 -93.17 1.73 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 125.338 1.447 . . . . 5.9900000000000002 111.458 -171.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.08 -6.68 61.55 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 116.969 1.548 . . . . 3.0800000000000001 116.969 -160.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -81.94 100.37 9.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.111 2.456 . . . . 4.21 110.632 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -94.91 137.0 24.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.235 1.014 . . . . 2.46 112.554 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.4 tp -133.71 113.97 12.92 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.711 1.604 . . . . 2.5299999999999998 109.703 170.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -89.73 125.59 35.34 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.616 -0.677 . . . . 2.4199999999999999 111.482 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.04 157.9 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.745 0.818 . . . . 2.5699999999999998 110.765 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.0 t -104.13 143.76 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.715 1.606 . . . . 1.8 108.706 -173.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.13 141.11 14.56 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.571 1.549 . . . . 1.97 109.399 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 55.6 Cg_endo -68.16 157.88 59.91 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.221 3.281 . . . . 0.92000000000000004 113.743 177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.7 t -110.23 139.59 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.852 2.061 . . . . 0.98999999999999999 108.928 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? . . . . . 0 N--CA 1.479 1.02 0 CA-C-N 119.741 1.155 . . . . 5.3499999999999996 114.025 -170.518 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 106.454 -1.684 . . . . 4.0800000000000001 106.454 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.93 164.69 32.38 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 127.159 2.314 . . . . 1.1599999999999999 111.091 -178.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -157.75 156.3 31.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.125 1.37 . . . . 2.1899999999999999 111.213 177.115 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.3 t -80.27 158.54 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.441 0.696 . . . . 1.52 109.42 175.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.72 -26.39 44.76 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.805 1.78 . . . . 5.3899999999999997 115.805 -176.144 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 85.0 t80 72.36 115.32 0.05 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.69 2.796 . . . . 2.48 111.756 -168.337 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.1 m -164.24 143.16 5.97 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 126.239 1.815 . . . . 2.3799999999999999 108.047 169.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.35 -25.77 11.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.828 2.352 . . . . 1.3 112.374 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.4 175.2 16.27 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 126.814 2.15 . . . . 0.80000000000000004 110.189 -172.166 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.42 -7.71 15.84 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 CA-C-N 119.473 1.637 . . . . 0.93000000000000005 112.747 -5.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -140.44 169.63 17.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.083 0.953 . . . . 1.8799999999999999 113.393 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.65 -177.62 5.39 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.644 2.378 . . . . 0.56999999999999995 109.966 175.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.59 170.35 14.86 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.76 1.224 . . . . 0.94999999999999996 110.071 169.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.98 144.22 21.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.727 1.211 . . . . 0.73999999999999999 111.254 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.94 152.52 40.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.681 1.992 . . . . 3.0299999999999998 109.315 -178.274 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -165.45 157.44 14.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.954 1.094 . . . . 2.0899999999999999 113.954 -177.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.8 m -84.4 124.15 30.99 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.789 1.635 . . . . 1.79 109.928 169.154 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.38 132.17 44.89 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.399 1.479 . . . . 3.3300000000000001 108.988 170.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -123.53 145.03 49.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.691 0.797 . . . . 3.5800000000000001 112.01 177.505 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.53 72.59 7.63 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.264 -0.88 . . . . 3.2200000000000002 110.47 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.31 -19.84 55.69 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.707 2.271 . . . . 1.22 113.607 -178.366 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.29 169.7 54.86 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-O 123.034 1.352 . . . . 1.3400000000000001 113.01 174.639 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 11.5 m-20 -95.82 -4.33 43.98 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 128.199 2.6 . . . . 3.1499999999999999 112.843 -170.245 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -122.24 160.31 48.33 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.353 2.261 . . . . 4.6600000000000001 108.717 172.537 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.97 143.25 14.29 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.859 2.373 . . . . 1.3700000000000001 110.844 -169.073 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.8 mt -94.3 153.49 17.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 122.72 1.247 . . . . 1.8300000000000001 112.435 172.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -136.41 113.12 10.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.131 -1.849 . . . . 1.73 110.65 178.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.87 112.02 24.36 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.78 2.032 . . . . 1.9099999999999999 108.539 -172.326 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.3 m -102.54 -29.07 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.886 0.875 . . . . 0.60999999999999999 113.011 -169.284 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.07 -174.44 30.94 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.969 1.271 . . . . 0.54000000000000004 113.047 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.76 -178.75 5.15 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.79 0.805 . . . . 0.56999999999999995 110.924 167.378 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -139.73 179.39 6.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.667 2.787 . . . . 5.8099999999999996 107.393 161.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t 176.6 151.19 0.35 Allowed Pre-proline 0 N--CA 1.469 0.484 0 C-N-CA 127.769 2.427 . . . . 0.78000000000000003 106.796 -170.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.68 -7.74 14.65 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.716 2.277 . . . . 0.76000000000000001 113.902 174.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.74 31.94 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.725 1.38 . . . . 0.96999999999999997 114.725 -170.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.92 138.28 13.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.662 1.585 . . . . 0.92000000000000004 110.977 168.284 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -61.2 -39.94 92.08 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.259 1.023 . . . . 2.8799999999999999 111.498 173.32 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -144.15 143.38 31.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 128.567 2.747 . . . . 6.1200000000000001 106.308 -168.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.07 137.02 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.018 -1.105 . . . . 1.0900000000000001 108.018 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -144.12 138.29 28.1 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.813 1.245 . . . . 2.98 109.638 -171.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.5 pt? -87.06 135.61 33.22 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 123.076 1.417 . . . . 1.8799999999999999 113.335 173.43 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -116.89 154.67 30.39 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 127.576 2.35 . . . . 0.94999999999999996 110.914 176.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.401 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 2.0 pp20? -103.31 155.93 18.1 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.388 1.875 . . . . 2.9100000000000001 110.453 161.142 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.406 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 24.6 m -127.73 132.44 49.59 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.007 -1.479 . . . . 0.92000000000000004 107.007 172.726 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -144.81 176.44 9.45 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.729 1.381 . . . . 2.0600000000000001 114.729 -166.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.6 ttp -113.36 142.47 45.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.823 2.049 . . . . 4.0599999999999996 111.399 176.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -128.29 163.28 25.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.227 1.811 . . . . 6.0099999999999998 111.753 166.745 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -94.6 145.32 24.91 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.008 -1.849 . . . . 3.52 106.008 152.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.8 p -153.09 124.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.324 0.65 . . . . 3.48 109.367 164.231 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 64.02 22.03 12.8 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.925 1.69 . . . . 4.54 113.163 -172.655 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.23 11.55 83.35 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 120.547 -1.346 . . . . 2.4300000000000002 113.622 -171.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -109.57 118.8 37.54 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.55 1.54 . . . . 4.2000000000000002 110.265 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.63 127.28 31.21 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.986 1.314 . . . . 3.98 109.251 164.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -145.52 176.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 128.294 2.637 . . . . 3.6299999999999999 109.759 -176.116 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -130.5 166.25 20.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.313 1.045 . . . . 3.7200000000000002 112.459 178.075 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.92 -179.84 31.29 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.395 1.474 . . . . 0.90000000000000002 112.954 177.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -153.91 137.38 15.89 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.006 1.322 . . . . 1.3 110.305 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -144.73 156.29 56.06 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.785 1.634 . . . . 9.6600000000000001 111.302 -174.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.95 154.71 53.22 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.705 2.27 . . . . 0.68999999999999995 110.488 172.581 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.83 158.39 73.87 Favored Pre-proline 0 N--CA 1.484 1.275 0 CA-C-O 118.299 -0.858 . . . . 0.72999999999999998 111.063 169.285 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -84.26 -18.78 4.88 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.313 2.675 . . . . 0.79000000000000004 113.969 -170.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -178.09 169.04 1.96 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.284 1.833 . . . . 1.77 111.771 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.8 mt -115.27 154.99 28.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.79 2.036 . . . . 0.56000000000000005 110.089 162.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.84 146.67 42.74 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.196 1.399 . . . . 1.6499999999999999 108.577 173.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.3 t -137.35 138.69 25.61 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.948 -0.548 . . . . 1.02 111.991 169.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -83.72 156.23 13.79 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 124.237 3.291 . . . . 1.24 112.479 178.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.57 140.31 80.73 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.765 2.977 . . . . 1.2 113.668 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.409 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 69.1 mmtt 69.55 -8.34 0.76 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.369 2.668 . . . . 1.53 114.345 -177.465 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.96 149.84 35.03 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.671 1.129 . . . . 1.3 112.266 175.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -108.71 132.03 54.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.924 1.689 . . . . 4.3600000000000003 106.88 163.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.8 122.93 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.075 1.35 . . . . 3.4199999999999999 107.916 177.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -101.95 135.56 43.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.87 1.268 . . . . 5.0599999999999996 110.116 -176.4 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 83' ' ' HIS . 1.0 OUTLIER -52.84 -48.5 66.98 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.877 1.671 . . . . 3.3199999999999998 113.216 -171.117 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 103.25 118.38 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 131.047 3.739 . . . . 3.1499999999999999 111.307 176.213 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.66 -1.01 6.8 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.513 2.808 . . . . 2.8100000000000001 115.036 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.13 2.31 12.99 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.434 1.492 . . . . 2.4900000000000002 114.774 170.171 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -132.9 -106.66 1.0 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.355 1.455 . . . . 1.8999999999999999 112.248 -174.521 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.401 ' CE2' ' HB3' ' A' ' 47' ' ' GLU . 86.7 m-85 -77.47 138.19 39.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.147 0.975 . . . . 2.1099999999999999 111.489 -175.686 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.559 ' HA ' HD23 ' A' ' 77' ' ' LEU . 54.7 p-80 -160.17 146.01 15.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.827 -0.624 . . . . 0.82999999999999996 111.057 -175.074 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.8 136.49 38.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.093 -1.077 . . . . 1.98 108.093 165.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.7 mtp -99.79 135.66 40.88 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 118.717 0.689 . . . . 1.96 110.001 157.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.8 109.03 20.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.691 -1.596 . . . . 1.4399999999999999 106.691 -179.211 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -102.61 130.9 49.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.88 1.672 . . . . 2.79 108.489 -173.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.81 53.51 8.12 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.824 0.726 . . . . 1.73 112.836 174.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.0 mt -48.23 156.54 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 115.938 1.829 . . . . 0.65000000000000002 115.938 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -110.96 -25.73 9.66 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 113.733 -1.576 . . . . 1.6799999999999999 113.973 178.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -124.53 142.07 39.48 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.412 2.285 . . . . 4.7400000000000002 109.068 169.062 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.27 156.18 55.3 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.7 2.267 . . . . 1.45 109.73 160.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.21 161.77 13.81 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.249 1.02 . . . . 2.5499999999999998 112.025 -169.527 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -132.74 -176.42 4.1 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.952 2.101 . . . . 4.6100000000000003 110.641 175.316 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.5 150.49 24.54 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.259 -1.015 . . . . 1.73 108.259 156.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.39 36.77 43.49 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.429 0.537 . . . . 1.77 114.386 176.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -122.63 -178.03 3.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.609 1.164 . . . . 3.3399999999999999 110.009 161.347 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -139.56 135.57 33.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.873 2.469 . . . . 3.6299999999999999 105.214 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.3 t -142.85 148.94 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.488 1.915 . . . . 1.6799999999999999 109.898 -171.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -100.83 148.67 24.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.165 1.386 . . . . 2.5499999999999998 114.071 -173.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mp -127.16 158.91 35.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.189 2.195 . . . . 1.6699999999999999 110.125 167.178 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -132.14 94.3 3.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.983 1.713 . . . . 2.79 110.762 -172.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.2 mp -78.48 135.93 37.48 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.375 1.07 . . . . 1.24 111.264 -168.152 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.2 mt -106.83 119.5 39.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.069 1.747 . . . . 0.68999999999999995 110.072 -176.597 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -118.58 145.44 45.39 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.235 1.414 . . . . 1.9199999999999999 111.016 -172.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.81 126.35 27.3 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.912 1.079 . . . . 2.1899999999999999 113.912 -169.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.82 68.47 1.49 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.907 1.241 . . . . 3.5899999999999999 112.502 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 20.44 79.83 Favored Glycine 0 N--CA 1.472 1.099 0 N-CA-C 116.278 1.271 . . . . 1.54 116.278 163.551 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -112.99 138.59 49.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.552 1.676 . . . . 3.6000000000000001 111.72 -173.477 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.4 t -139.82 145.87 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.347 1.059 . . . . 1.8500000000000001 109.675 178.404 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 tp -145.66 120.38 9.86 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.794 1.237 . . . . 2.1400000000000001 111.23 178.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -79.01 137.92 37.79 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.529 -0.732 . . . . 2.4700000000000002 111.155 173.523 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.05 161.58 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.946 2.098 . . . . 2.77 110.026 173.599 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.2 t -136.09 136.02 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.377 1.471 . . . . 1.8700000000000001 109.084 177.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.84 148.29 35.52 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.925 1.69 . . . . 2.3900000000000001 111.354 -173.365 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.81 151.97 81.39 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.403 2.735 . . . . 0.90000000000000002 113.243 175.24 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.0 t -95.32 118.86 42.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.839 -1.073 . . . . 1.5900000000000001 108.376 172.228 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 . . . . . 0 CA--C 1.535 0.382 0 C-N-CA 125.4 1.48 . . . . 5.5899999999999999 109.302 178.069 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.404 ' C ' ' HB ' ' A' ' 21' ' ' THR . 8.6 pm0 . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 114.769 1.396 . . . . 5.2999999999999998 114.769 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -79.8 179.41 53.18 Favored Glycine 0 N--CA 1.47 0.908 0 O-C-N 121.285 -0.884 . . . . 2.2999999999999998 114.078 173.706 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -153.01 146.07 24.62 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.999 1.319 . . . . 2.71 112.929 167.333 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.8 t -93.67 146.82 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.268 1.427 . . . . 1.3700000000000001 107.277 177.232 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 10' ' ' PHE 0.33 0.3 OUTLIER -74.88 -106.1 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.419 1.009 . . . . 4.79 113.528 176.117 . . . . . . . . 4 4 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.404 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 50.9 t80 -171.19 148.75 2.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.667 1.987 . . . . 2.1099999999999999 110.349 -178.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.8 t -179.6 143.43 0.38 Allowed Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 128.114 2.566 . . . . 2.1200000000000001 109.268 174.66 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.07 -23.75 10.25 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.843 2.362 . . . . 1.1699999999999999 112.12 169.085 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.81 176.81 14.56 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 126.676 2.084 . . . . 0.83999999999999997 111.573 -171.411 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.11 -6.37 16.7 Favored 'Cis proline' 0 CA--C 1.537 0.653 0 CA-C-N 118.571 1.185 . . . . 0.91000000000000003 112.337 -9.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -147.61 148.53 31.2 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.578 1.325 . . . . 2.3599999999999999 114.578 -177.131 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.08 -174.58 2.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.588 2.755 . . . . 0.41999999999999998 111.313 -179.029 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.81 164.33 30.52 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.066 1.746 . . . . 0.67000000000000004 108.825 170.046 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.96 153.16 32.4 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.323 0.965 . . . . 0.63 112.595 -177.408 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -122.6 87.71 2.8 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.631 1.972 . . . . 2.7400000000000002 110.802 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.419 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.6 pp -70.45 158.68 35.6 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 119.41 -2.056 . . . . 2.48 113.374 177.26 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.404 ' HB ' ' C ' ' A' ' 5' ' ' GLU . 20.8 m -135.47 141.27 45.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.459 1.904 . . . . 1.98 106.62 167.713 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.9 tp -162.46 156.27 20.88 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.9 2.48 . . . . 5.1200000000000001 109.556 177.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -102.04 154.35 19.06 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.224 -1.548 . . . . 4.0899999999999999 113.427 166.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -97.74 92.68 1.4 Allowed Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 121.036 -1.04 . . . . 1.52 109.13 162.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.05 -15.65 18.37 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.566 2.177 . . . . 1.4299999999999999 113.436 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.52 -173.75 47.06 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-O 122.421 1.011 . . . . 1.1399999999999999 112.882 -178.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -115.66 2.23 13.69 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.16 1.784 . . . . 3.2000000000000002 112.306 -167.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -112.41 155.58 43.49 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.985 2.114 . . . . 3.0899999999999999 111.017 173.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.55 158.83 25.44 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.615 2.21 . . . . 0.89000000000000001 110.979 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.6 mt -115.52 148.66 39.24 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.198 1.399 . . . . 2.02 110.469 174.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -131.61 110.63 11.07 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 112.608 -2.087 . . . . 2.3700000000000001 110.655 171.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -98.12 110.39 22.98 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.959 2.103 . . . . 2.1600000000000001 108.348 -170.517 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.78 -21.61 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.303 1.041 . . . . 0.58999999999999997 111.938 -165.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.85 -175.97 33.45 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 125.586 1.565 . . . . 0.40000000000000002 112.617 -178.042 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.42 -174.92 4.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.079 1.351 . . . . 0.57999999999999996 111.372 172.268 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -155.73 154.58 31.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.398 1.479 . . . . 4.3099999999999996 108.11 163.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -167.51 149.33 5.27 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 117.597 -1.192 . . . . 1.1200000000000001 109.215 -176.434 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.43 -19.1 10.49 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.884 1.723 . . . . 1.1499999999999999 113.207 -174.403 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -87.13 18.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 113.874 1.064 . . . . 1.55 113.874 -178.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.45 175.15 13.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.531 1.933 . . . . 1.25 109.599 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -111.56 -32.24 6.74 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.403 1.481 . . . . 2.73 113.155 177.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -139.59 159.59 41.81 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.014 2.926 . . . . 5.5599999999999996 106.11 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 p -157.05 106.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 125.219 1.408 . . . . 1.8799999999999999 111.005 -173.067 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.22 132.74 54.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.663 -1.608 . . . . 5.3899999999999997 111.622 -159.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.0 tp -84.69 124.08 31.09 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.012 -0.995 . . . . 0.96999999999999997 111.994 -163.256 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -121.39 161.97 21.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.355 1.462 . . . . 0.56000000000000005 113.088 179.081 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.88 -174.09 2.44 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.477 1.911 . . . . 3.29 110.73 163.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 m -146.03 138.78 25.64 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.056 -1.091 . . . . 0.81999999999999995 108.056 167.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -135.42 173.3 11.87 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 122.984 1.373 . . . . 2.4100000000000001 114.112 -172.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -122.06 142.17 50.62 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.709 2.004 . . . . 5.1100000000000003 111.897 170.648 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.15 158.84 41.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.627 1.971 . . . . 6.7400000000000002 110.739 172.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -129.01 133.29 47.69 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.955 2.102 . . . . 2.75 106.421 166.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -150.42 9.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.236 1.014 . . . . 3.48 113.532 -169.326 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -168.95 18.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.161 0.8 . . . . 4.2599999999999998 113.161 -156.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.28 13.44 58.03 Favored Glycine 0 N--CA 1.478 1.497 0 O-C-N 120.882 -1.136 . . . . 2.04 113.346 -168.263 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -143.96 145.76 32.47 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.461 2.704 . . . . 2.8999999999999999 107.661 -174.108 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -105.54 133.61 50.02 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.009 2.124 . . . . 2.98 109.331 -171.25 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -155.15 149.13 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.108 1.363 . . . . 2.3100000000000001 110.488 -171.254 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -102.42 167.01 10.23 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.546 0.943 . . . . 3.3799999999999999 113.546 -169.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.62 -179.19 30.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.996 1.76 . . . . 0.78000000000000003 112.851 178.05 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -151.56 141.79 22.32 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.104 1.762 . . . . 1.3200000000000001 108.082 -177.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -150.73 157.14 36.21 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.198 0.999 . . . . 4.9100000000000001 110.217 -177.48 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.06 158.01 34.13 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.6 2.2 . . . . 0.54000000000000004 111.497 -179.099 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.68 152.75 71.37 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.647 1.179 . . . . 0.53000000000000003 110.154 177.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.7 -24.12 6.41 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.14 2.56 . . . . 0.63 113.187 -167.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -178.3 166.72 1.9 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.444 1.898 . . . . 2.0800000000000001 111.15 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 mt -109.91 154.27 23.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.953 1.301 . . . . 0.62 110.091 163.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -114.24 143.06 45.46 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.581 1.152 . . . . 1.8 109.28 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.8 t -144.5 136.19 12.86 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.136 0.791 . . . . 1.05 113.136 172.12 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.24 167.34 26.03 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.648 2.898 . . . . 0.93000000000000005 113.061 177.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.54 145.67 97.62 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.742 2.961 . . . . 1.01 111.632 167.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt 66.94 -3.69 0.9 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.813 1.645 . . . . 1.6499999999999999 113.634 -178.005 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.48 174.73 55.05 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.748 1.642 . . . . 1.23 112.05 171.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 mtt85 -102.64 137.82 40.36 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.426 1.09 . . . . 4.8899999999999997 109.255 175.034 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.05 104.07 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.535 1.934 . . . . 6.0899999999999999 106.447 176.935 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.21 130.08 12.47 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.443 1.116 . . . . 3.2400000000000002 112.394 -163.173 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 83' ' ' HIS . 10.6 mp -94.32 131.13 40.25 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.156 1.382 . . . . 2.52 107.716 166.655 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.53 149.78 37.4 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.547 1.139 . . . . 3.3799999999999999 112.525 -166.281 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.26 -38.45 90.88 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.991 3.127 . . . . 2.1600000000000001 112.6 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.34 115.68 4.34 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.714 -1.354 . . . . 2.8700000000000001 109.714 164.13 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.51 -122.49 5.45 Favored Glycine 0 N--CA 1.467 0.704 0 C-N-CA 126.716 2.103 . . . . 1.55 110.896 176.727 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -71.34 134.56 46.81 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.709 0.755 . . . . 1.8300000000000001 112.313 -167.028 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.465 ' HA ' HD23 ' A' ' 77' ' ' LEU . 55.2 p-80 -157.81 151.86 24.31 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.536 1.134 . . . . 0.64000000000000001 110.893 -177.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -84.47 135.24 34.33 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.064 -1.022 . . . . 2.1400000000000001 108.414 168.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -86.31 127.16 34.75 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 126.207 1.803 . . . . 0.73999999999999999 108.285 162.155 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.73 112.16 25.12 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.839 1.255 . . . . 1.3200000000000001 108.387 -175.31 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.87 135.17 47.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.33 1.052 . . . . 2.6299999999999999 110.57 -169.287 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.62 48.51 7.91 Favored Glycine 0 N--CA 1.472 1.045 0 O-C-N 121.415 -0.803 . . . . 1.72 113.803 172.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.96 153.11 1.92 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 123.369 1.557 . . . . 0.92000000000000004 114.768 178.036 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -124.18 -23.49 4.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 112.174 -2.285 . . . . 1.55 114.472 -165.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -118.06 145.82 37.77 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 117.927 -1.035 . . . . 6.1699999999999999 108.727 152.296 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.11 98.08 0.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 106.675 -2.086 . . . . 1.8100000000000001 106.675 164.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.88 164.31 26.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.339 1.056 . . . . 2.6800000000000002 113.211 -169.675 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -139.4 150.22 45.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.362 1.865 . . . . 5.6399999999999997 113.412 -173.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.01 137.37 56.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 113.879 -1.509 . . . . 1.4199999999999999 108.159 171.03 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.02 -6.2 81.75 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.137 1.351 . . . . 1.5600000000000001 114.601 -173.146 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -76.61 -176.89 3.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.047 1.424 . . . . 2.6400000000000001 111.707 167.176 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -135.44 155.55 50.35 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 128.619 2.768 . . . . 3.9500000000000002 107.127 171.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.6 t -147.85 156.08 9.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 129.538 3.135 . . . . 1.3300000000000001 107.667 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -117.81 154.16 32.26 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.62 -0.675 . . . . 2.2799999999999998 111.26 167.556 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 tt -145.71 132.65 20.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.764 0.793 . . . . 3.0099999999999998 111.327 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -77.14 134.21 38.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 129.152 2.981 . . . . 2.1800000000000002 109.332 166.024 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -97.58 127.61 43.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.183 0.993 . . . . 1.22 108.763 162.328 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.21 115.75 30.6 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.01 0.924 . . . . 0.64000000000000001 109.337 175.073 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -111.2 151.86 27.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.579 1.552 . . . . 2.1299999999999999 111.414 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.59 151.74 32.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.126 0.571 . . . . 2.21 111.448 170.335 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.58 23.33 47.31 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 119.003 -0.887 . . . . 3.8700000000000001 114.364 -177.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.52 35.49 46.85 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.246 0.927 . . . . 1.54 113.376 173.263 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -120.6 122.08 39.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 117.871 0.836 . . . . 3.27 111.582 -167.022 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.23 142.86 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.801 1.64 . . . . 1.98 109.96 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.92 113.91 5.45 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.759 0.824 . . . . 1.99 110.829 -177.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -94.75 121.0 35.88 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.647 0.779 . . . . 2.0 112.397 -176.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.4 t -109.39 163.34 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.653 1.981 . . . . 1.8500000000000001 109.888 178.086 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.7 t -119.3 140.78 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.552 1.941 . . . . 2.25 109.616 178.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.24 142.65 13.21 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.867 1.267 . . . . 2.48 114.047 -165.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.32 163.84 36.77 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.438 2.759 . . . . 0.93999999999999995 112.582 172.08 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.26 131.18 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.996 1.318 . . . . 0.93999999999999995 109.107 165.398 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 126.874 2.07 . . . . 3.48 108.69 179.238 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.008 0.433 . . . . 4.6100000000000003 111.163 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.08 163.48 30.16 Favored Glycine 0 C--N 1.333 0.402 0 O-C-N 121.406 -0.809 . . . . 1.4199999999999999 111.207 170.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.0 p90 -140.4 177.91 7.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.737 0.643 . . . . 2.4300000000000002 112.737 178.303 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.9 t -111.72 143.75 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.707 1.203 . . . . 1.45 111.301 -178.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -27.06 64.38 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 129.328 3.051 . . . . 7.8700000000000001 116.445 -173.367 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.5 t80 66.73 129.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.611 2.765 . . . . 2.2200000000000002 113.634 -168.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -174.34 146.64 1.12 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.185 1.794 . . . . 2.0499999999999998 110.896 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.13 -20.21 11.57 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.961 2.441 . . . . 1.28 112.73 168.202 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.28 -174.49 19.23 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.781 1.658 . . . . 0.93999999999999995 111.663 -172.741 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.74 -10.64 9.77 Favored 'Cis proline' 0 CA--C 1.537 0.674 0 CA-C-N 119.133 1.467 . . . . 1.1200000000000001 112.493 -8.441 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -132.25 157.74 43.59 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 123.295 1.521 . . . . 2.4900000000000002 114.879 173.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.05 -176.39 4.05 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.448 2.699 . . . . 0.41999999999999998 109.781 171.391 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.9 152.58 36.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.153 1.781 . . . . 0.66000000000000003 107.617 176.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.01 140.1 41.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.32 0.964 . . . . 0.5 111.322 -177.214 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -114.18 34.22 4.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.51 1.524 . . . . 2.5499999999999998 112.763 -165.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 tt -48.43 143.82 4.56 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.737 2.015 . . . . 2.5699999999999998 112.862 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -82.74 149.75 27.09 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.457 0.91 . . . . 3.04 113.457 170.409 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.83 116.47 27.51 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.77 0.828 . . . . 3.5899999999999999 110.278 170.15 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -121.71 142.69 49.91 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.288 1.435 . . . . 4.5199999999999996 109.53 171.102 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -106.38 101.4 35.1 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.595 1.158 . . . . 1.3400000000000001 109.875 175.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.03 -10.95 15.13 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.951 2.434 . . . . 1.2 113.597 175.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.23 -177.61 50.75 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-O 122.502 1.057 . . . . 1.1100000000000001 112.86 -176.778 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -108.81 -1.71 19.05 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.383 2.273 . . . . 2.9100000000000001 111.774 -173.087 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.6 160.85 42.49 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 128.502 2.721 . . . . 2.73 109.67 173.597 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.63 146.69 21.54 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.674 2.249 . . . . 0.91000000000000003 111.525 -175.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mp -107.77 150.09 27.41 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.78 1.232 . . . . 2.3399999999999999 110.383 174.272 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -135.91 108.15 7.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.436 -2.165 . . . . 2.8999999999999999 110.257 178.5 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 tt -86.44 124.11 32.4 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.011 0.925 . . . . 2.2000000000000002 109.013 176.37 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.3 -23.61 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.53 0.732 . . . . 0.72999999999999998 111.531 -179.41 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.85 -173.16 27.99 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 124.73 1.157 . . . . 0.46000000000000002 114.299 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.93 -179.07 5.39 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.925 1.29 . . . . 0.56999999999999995 111.216 165.466 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -139.16 160.38 39.94 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.658 1.983 . . . . 5.6900000000000004 107.252 155.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -161.0 149.26 12.85 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 125.651 1.58 . . . . 0.80000000000000004 108.248 -178.498 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.02 -2.25 12.37 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.129 1.886 . . . . 1.0 114.25 -177.571 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.99 31.38 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.336 1.454 . . . . 0.95999999999999996 114.524 -170.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.39 159.51 44.41 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.835 1.654 . . . . 0.91000000000000003 110.419 165.435 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -83.4 -57.37 3.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.76 1.624 . . . . 2.77 110.094 169.371 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -106.68 130.47 54.41 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.47 1.508 . . . . 5.4500000000000002 107.351 166.558 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.78 144.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.137 -0.69 . . . . 1.01 109.137 152.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -138.6 152.49 48.19 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.966 1.707 . . . . 2.75 109.374 -173.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.2 tp -108.6 117.61 34.63 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.498 0.719 . . . . 0.98999999999999999 110.916 -173.554 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -121.73 152.76 39.06 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.569 1.548 . . . . 0.52000000000000002 113.283 -176.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -96.7 167.87 10.85 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.842 1.257 . . . . 2.1899999999999999 111.476 159.121 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.9 m -129.42 138.95 51.76 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.284 1.834 . . . . 0.80000000000000004 107.096 170.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -140.69 171.27 14.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.403 1.096 . . . . 2.0499999999999998 113.649 -173.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -115.31 142.51 46.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.543 1.937 . . . . 5.4500000000000002 111.407 173.445 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -137.59 139.45 40.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.155 0.982 . . . . 5.5 111.658 169.144 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -91.11 139.07 31.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.886 1.275 . . . . 2.9199999999999999 107.788 161.018 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.9 t -141.76 128.56 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 106.033 -1.839 . . . . 2.4399999999999999 106.033 168.2 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 58.68 24.42 12.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.11 1.364 . . . . 5.6699999999999999 114.408 -176.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.56 29.15 73.73 Favored Glycine 0 N--CA 1.472 1.095 0 O-C-N 120.488 -1.382 . . . . 1.98 112.453 -170.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mmtm -121.4 120.62 35.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.009 2.124 . . . . 4.7400000000000002 108.427 169.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 126.47 40.97 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.119 1.367 . . . . 2.9500000000000002 112.12 -176.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.3 t -144.33 144.98 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.976 2.11 . . . . 2.52 108.277 -171.196 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 73.4 mtm -90.63 172.9 8.35 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.361 0.874 . . . . 3.2400000000000002 113.361 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.4 30.99 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.748 1.166 . . . . 1.1299999999999999 111.783 166.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.07 162.32 35.23 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.484 0.713 . . . . 3.3399999999999999 110.771 161.735 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -157.19 154.47 26.04 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.871 1.268 . . . . 4.6299999999999999 110.062 -177.749 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.86 154.65 43.34 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.134 1.89 . . . . 0.56000000000000005 112.001 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.0 155.05 74.74 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.669 1.588 . . . . 0.68999999999999995 110.182 179.101 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.78 -26.34 2.53 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.096 2.531 . . . . 0.60999999999999999 113.333 -167.789 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -176.42 166.73 2.77 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.989 1.716 . . . . 2.27 111.231 -177.315 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.6 mt -114.63 151.76 33.0 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.002 1.721 . . . . 0.77000000000000002 110.517 166.472 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -120.79 138.94 53.77 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.767 1.227 . . . . 1.8100000000000001 109.024 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -140.81 126.67 11.41 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.192 0.442 . . . . 0.93000000000000005 112.192 170.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.53 161.71 41.65 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.392 3.394 . . . . 1.1599999999999999 111.958 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -59.9 140.37 92.65 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.673 2.916 . . . . 0.93999999999999995 113.051 -175.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 68.65 -3.02 1.49 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.179 2.192 . . . . 1.6599999999999999 114.484 178.725 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.4 169.15 28.74 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.565 1.555 . . . . 1.21 113.183 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -143.47 158.64 43.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.853 0.861 . . . . 5.2599999999999998 112.536 172.305 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.1 t -156.14 113.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 127.642 2.377 . . . . 3.9700000000000002 108.475 174.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.34 151.33 34.98 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.03 0.832 . . . . 3.5600000000000001 111.813 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.4 65.21 1.21 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.53 1.157 . . . . 2.1600000000000001 109.414 162.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -58.52 145.89 74.84 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.55 1.14 . . . . 4.1299999999999999 113.201 -174.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.85 81.39 0.84 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.342 2.695 . . . . 2.6699999999999999 109.391 169.177 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.64 34.0 0.1 OUTLIER Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.372 0.987 . . . . 2.3999999999999999 113.495 -162.383 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.04 -25.75 0.24 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 117.418 1.727 . . . . 2.4199999999999999 117.418 160.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -145.48 146.91 31.66 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.742 1.271 . . . . 1.8899999999999999 111.196 169.087 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -159.48 154.61 25.12 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.992 0.917 . . . . 0.54000000000000004 110.005 174.407 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -77.67 141.31 39.47 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.39 -0.967 . . . . 1.8300000000000001 108.39 159.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -94.25 131.96 39.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.218 1.407 . . . . 0.71999999999999997 108.354 164.15 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -109.2 109.92 21.0 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.012 -1.107 . . . . 1.3200000000000001 108.012 178.459 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.71 134.07 51.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.182 1.393 . . . . 2.3999999999999999 109.489 -175.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.18 53.49 14.0 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.854 -0.529 . . . . 1.6499999999999999 112.48 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.4 mt -44.66 155.41 0.1 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.088 1.755 . . . . 0.64000000000000001 115.067 178.132 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -108.6 -32.99 7.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 113.281 -1.782 . . . . 1.5800000000000001 112.847 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -120.99 137.57 26.75 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.55 1.54 . . . . 6.6900000000000004 108.634 163.442 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -66.88 130.95 24.29 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 N-CA-C 106.654 -2.094 . . . . 1.3300000000000001 106.654 160.028 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.16 171.61 14.21 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.245 0.545 . . . . 2.1699999999999999 111.166 -174.339 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.429 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 0.5 OUTLIER -116.83 157.91 24.83 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.267 -0.895 . . . . 4.0599999999999996 109.827 150.547 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.45 123.61 21.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.001 -1.481 . . . . 1.6899999999999999 107.001 159.046 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.76 53.96 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.166 -1.352 . . . . 2.0299999999999998 115.813 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 90.9 mt-10 -81.91 -174.39 5.02 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.816 1.808 . . . . 3.0099999999999998 111.12 165.001 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.29 135.7 48.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.829 2.452 . . . . 3.6800000000000002 106.284 166.341 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -119.24 144.78 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.829 2.052 . . . . 1.7 109.439 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -89.15 134.16 34.13 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.051 0.54 . . . . 2.6200000000000001 110.493 171.405 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp -116.51 132.4 56.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.301 1.048 . . . . 1.98 110.14 154.619 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -83.32 145.08 29.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.446 1.899 . . . . 2.1000000000000001 109.109 158.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.3 123.29 46.17 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.399 1.48 . . . . 1.52 109.943 -175.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.53 115.13 29.95 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.493 1.117 . . . . 2.3999999999999999 109.816 -176.168 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -112.66 145.89 39.64 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.263 1.425 . . . . 2.0499999999999998 111.76 -177.023 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.22 151.81 39.37 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.583 0.753 . . . . 2.2200000000000002 112.253 176.193 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.59 33.63 37.88 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.031 -0.872 . . . . 4.3399999999999999 113.56 177.22 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.66 47.49 15.24 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 124.618 1.104 . . . . 2.0699999999999998 113.852 171.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -133.88 131.82 39.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.195 0.998 . . . . 3.54 111.755 -171.308 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.1 t -140.87 150.56 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.594 1.158 . . . . 2.2599999999999998 109.121 178.789 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.4 tp -149.57 170.97 17.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.601 2.36 . . . . 2.1800000000000002 108.551 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -145.53 156.72 43.88 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.779 1.172 . . . . 2.23 113.072 162.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.1 160.98 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.309 1.443 . . . . 2.21 109.351 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.9 t -112.44 136.66 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.614 1.566 . . . . 1.8799999999999999 108.788 -179.378 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.61 142.44 41.0 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.63 1.572 . . . . 2.2599999999999998 110.145 -175.02 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.0 154.42 73.47 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.737 2.291 . . . . 1.21 112.143 175.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.4 t -93.47 139.49 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.704 -1.221 . . . . 1.3300000000000001 107.704 157.286 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 . . . . . 0 N--CA 1.468 0.465 0 C-N-CA 125.008 1.323 . . . . 4.29 109.937 174.822 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 121.704 0.764 . . . . 5.1200000000000001 111.138 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.06 172.33 23.21 Favored Glycine 0 N--CA 1.471 0.998 0 O-C-N 120.47 -1.394 . . . . 1.1100000000000001 115.546 -176.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -154.24 -179.34 7.83 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.33 1.452 . . . . 2.8300000000000001 112.475 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 t -121.24 144.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.226 1.011 . . . . 1.55 109.986 168.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -26.27 62.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.794 2.038 . . . . 5.8200000000000003 115.641 -175.389 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 73.2 t80 90.64 146.99 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 129.875 3.27 . . . . 2.9900000000000002 111.994 -168.509 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.8 m -176.77 144.79 0.63 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 130.159 3.383 . . . . 2.52 108.793 160.706 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.51 -36.32 0.93 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.678 2.252 . . . . 1.29 111.917 177.717 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.06 169.91 27.18 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.577 1.084 . . . . 0.90000000000000002 111.949 -179.538 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.7 -4.42 19.6 Favored 'Cis proline' 0 CA--C 1.539 0.748 0 CA-C-N 118.797 1.299 . . . . 1.1499999999999999 112.767 -5.126 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.1 153.72 34.49 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.99 1.107 . . . . 2.6899999999999999 113.99 -172.287 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.91 -178.99 3.88 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.524 1.93 . . . . 0.68999999999999995 111.837 174.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.25 140.78 48.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.794 1.237 . . . . 1.05 108.872 167.032 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.15 143.08 46.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.319 1.448 . . . . 0.67000000000000004 110.458 -178.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -131.11 105.66 7.85 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.866 2.066 . . . . 2.7999999999999998 108.994 -170.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.59 162.27 37.05 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.788 1.033 . . . . 2.1499999999999999 113.788 -168.366 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.462 HG21 ' HD2' ' A' ' 74' ' ' ARG . 2.9 m -79.86 155.6 27.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.031 -1.441 . . . . 1.9399999999999999 112.125 177.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.4 HD23 HD22 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -130.21 116.79 18.91 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 113.312 -1.767 . . . . 3.46 109.447 170.996 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.8 mp0 -101.26 133.85 45.21 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.666 1.986 . . . . 5.1600000000000001 110.923 175.042 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.27 76.67 1.09 Allowed Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 120.545 -1.347 . . . . 3.04 110.888 176.0 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.64 -19.3 42.11 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.667 2.245 . . . . 1.2 114.288 -176.277 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.43 176.6 54.2 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 122.733 1.185 . . . . 1.1599999999999999 112.956 176.403 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -100.52 -3.37 30.86 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.688 2.395 . . . . 2.8900000000000001 112.176 -170.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mp -126.01 160.35 57.39 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 128.122 2.569 . . . . 3.5899999999999999 108.534 174.401 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.55 139.51 11.39 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.462 2.108 . . . . 1.0700000000000001 111.455 -167.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.22 146.91 23.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 123.212 1.482 . . . . 2.2000000000000002 110.314 169.207 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.4 ttp-105 -134.53 102.78 5.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.536 -1.665 . . . . 3.3799999999999999 110.221 -176.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.4 HD22 HD23 ' A' ' 22' ' ' LEU . 52.7 tp -84.04 103.87 13.64 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.302 1.841 . . . . 2.5 110.249 -174.107 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 m -97.35 -24.46 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.611 0.764 . . . . 0.47999999999999998 112.565 -174.838 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.64 -174.42 29.37 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.839 1.209 . . . . 0.46999999999999997 113.052 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.69 -176.73 4.99 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.898 1.679 . . . . 0.54000000000000004 111.101 171.188 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -155.87 166.33 33.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 130.353 3.461 . . . . 4.6799999999999997 107.261 174.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t 179.75 153.19 0.6 Allowed Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 127.921 2.488 . . . . 0.72999999999999998 108.279 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.84 -27.69 10.13 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 CA-C-N 121.263 1.487 . . . . 0.87 113.014 176.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.72 22.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.193 1.553 . . . . 0.88 115.193 -170.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.18 162.16 34.97 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.206 1.803 . . . . 1.1299999999999999 108.075 164.307 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -77.32 -56.0 4.93 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.033 1.333 . . . . 4.2699999999999996 109.996 168.539 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -133.76 177.61 7.58 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.872 2.069 . . . . 5.4699999999999998 109.337 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.9 p -153.36 147.14 14.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.354 1.462 . . . . 0.83999999999999997 109.079 -174.095 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -133.17 147.74 52.06 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.783 1.633 . . . . 2.6699999999999999 110.381 -179.103 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.7 tp -96.76 121.06 38.2 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.322 0.649 . . . . 1.0 110.702 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -122.76 157.93 31.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 123.148 1.452 . . . . 0.59999999999999998 113.118 -175.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.32 154.37 21.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.873 -1.512 . . . . 2.0299999999999998 110.055 158.671 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -114.78 135.87 53.71 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.831 -1.915 . . . . 1.6499999999999999 105.831 159.072 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -126.12 165.46 18.82 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.41 1.084 . . . . 2.0699999999999998 112.398 -177.003 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.7 ttp -105.05 144.85 31.29 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.685 1.594 . . . . 3.2999999999999998 109.614 168.273 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.26 150.48 30.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.195 0.998 . . . . 6.1100000000000003 111.698 -175.847 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -95.42 142.83 27.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.786 1.634 . . . . 2.8399999999999999 110.131 169.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 t -116.0 -110.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.053 1.341 . . . . 3.6499999999999999 107.781 170.165 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.59 44.94 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 131.319 3.848 . . . . 4.3200000000000003 112.851 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.34 17.62 62.02 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 120.16 -1.587 . . . . 1.6399999999999999 112.746 -166.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -133.18 134.82 44.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.707 2.403 . . . . 2.46 107.605 -168.337 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -91.53 132.41 36.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.47 1.908 . . . . 2.98 110.819 -167.513 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -143.5 143.95 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.334 1.854 . . . . 2.2599999999999998 108.282 -176.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.4 mtm -88.49 165.42 14.89 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.633 0.605 . . . . 3.1400000000000001 112.633 173.493 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.76 -179.51 23.83 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.725 1.155 . . . . 0.89000000000000001 112.29 174.498 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.2 ttm -147.68 147.14 29.65 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.166 1.387 . . . . 1.1399999999999999 109.032 175.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -155.81 154.07 27.16 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.265 1.026 . . . . 4.6200000000000001 110.394 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.4 156.2 50.41 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.172 1.915 . . . . 0.59999999999999998 110.834 173.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.08 155.0 76.33 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.389 1.476 . . . . 0.55000000000000004 110.19 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.47 -23.79 3.97 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.781 2.32 . . . . 0.46999999999999997 113.468 -166.545 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -178.38 165.96 1.82 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.611 1.964 . . . . 1.6899999999999999 111.219 179.16 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 mt -110.13 159.1 17.64 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.863 1.265 . . . . 0.71999999999999997 109.785 157.418 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -127.09 152.62 47.05 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.949 0.9 . . . . 1.8999999999999999 110.12 169.058 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.4 t -136.7 141.65 36.07 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 123.894 0.877 . . . . 1.01 110.784 172.317 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.39 155.9 14.35 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.992 3.128 . . . . 1.1100000000000001 112.685 178.506 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.58 140.07 84.86 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.21 3.274 . . . . 0.98999999999999999 114.438 -174.222 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt 69.14 -8.53 0.68 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.719 2.408 . . . . 1.5900000000000001 113.792 -176.518 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.18 166.76 52.93 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.126 1.346 . . . . 1.21 112.636 174.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.462 ' HD2' HG21 ' A' ' 21' ' ' THR . 11.8 ttp-105 -136.29 136.26 39.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.172 2.189 . . . . 4.3399999999999999 106.994 172.065 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.6 t -149.65 139.27 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.231 1.412 . . . . 4.0199999999999996 108.782 177.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.32 149.48 24.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.325 1.059 . . . . 3.6000000000000001 113.383 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -59.78 108.02 0.69 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.197 -1.409 . . . . 1.95 107.197 158.233 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 139.38 90.92 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.902 -1.523 . . . . 2.3399999999999999 112.647 -160.783 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.51 -28.94 17.31 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.734 3.623 . . . . 2.79 115.791 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.59 4.11 13.35 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 117.559 -1.69 . . . . 2.8300000000000001 116.198 173.52 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.75 -98.58 1.42 Allowed Glycine 0 N--CA 1.472 1.057 0 CA-C-N 120.874 2.337 . . . . 1.8500000000000001 113.0 -176.424 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -71.86 140.87 49.53 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.158 -1.201 . . . . 2.1800000000000002 111.28 -176.397 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -161.57 153.71 19.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.624 1.17 . . . . 0.63 111.076 -174.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -88.01 129.78 35.16 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.556 -0.715 . . . . 1.76 109.305 166.254 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -82.83 119.52 24.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.836 1.654 . . . . 0.75 109.407 165.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -102.02 110.9 22.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.785 1.234 . . . . 1.27 109.296 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -104.24 139.87 38.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.071 1.348 . . . . 2.6299999999999999 111.079 -168.103 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.39 45.77 45.31 Favored Glycine 0 N--CA 1.473 1.156 0 O-C-N 121.328 -0.858 . . . . 1.8500000000000001 112.83 174.581 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.2 mt -47.8 155.19 0.43 Allowed 'General case' 0 CA--C 1.523 -0.09 0 CA-C-O 123.563 1.649 . . . . 0.94999999999999996 115.28 -177.596 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -116.09 -29.69 6.22 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 112.862 -1.972 . . . . 2.8999999999999999 112.55 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.8 mmt-85 -105.03 134.73 19.49 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.681 2.392 . . . . 4.5899999999999999 109.509 163.172 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.17 74.84 3.45 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 N-CA-C 106.572 -2.126 . . . . 1.8999999999999999 106.572 147.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.533 ' H ' HD23 ' A' ' 93' ' ' LEU . 1.4 pt? -63.5 127.34 30.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.887 0.851 . . . . 2.4300000000000002 112.717 -159.299 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -84.96 138.79 32.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.762 1.267 . . . . 5.9299999999999997 112.185 -170.273 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.64 118.91 5.74 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.928 -1.487 . . . . 1.29 108.194 167.719 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.16 -9.99 39.63 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 117.788 -1.562 . . . . 1.95 115.572 -169.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -78.59 173.27 12.59 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.13 1.965 . . . . 3.02 110.653 161.18 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 13.1 pt-20 -138.47 144.1 39.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.032 -1.84 . . . . 3.6400000000000001 106.032 160.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.0 148.69 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.824 1.249 . . . . 2.04 109.411 -171.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.88 149.44 21.54 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 123.401 1.572 . . . . 3.3300000000000001 114.578 -170.119 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.56 151.75 39.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.72 -1.582 . . . . 1.6799999999999999 110.083 170.671 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -118.02 103.51 9.98 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.78 2.432 . . . . 2.8599999999999999 109.483 174.419 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.7 mp -83.6 134.96 34.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.679 1.192 . . . . 1.1699999999999999 110.786 -172.801 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.98 110.56 23.0 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 122.341 1.067 . . . . 0.67000000000000004 110.406 -174.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -103.77 123.72 47.59 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.847 1.659 . . . . 1.97 111.309 -176.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 46.57 35.82 3.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.934 2.094 . . . . 2.4900000000000002 112.892 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.44 -102.54 2.73 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.989 1.281 . . . . 5.6200000000000001 111.05 -169.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.24 -6.76 83.96 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 117.026 1.57 . . . . 2.8599999999999999 117.026 -160.51 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -80.97 102.52 10.2 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.138 2.469 . . . . 3.0899999999999999 110.848 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.1 p -87.08 142.32 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 124.253 0.97 . . . . 2.3300000000000001 112.242 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.14 125.57 19.0 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.822 0.849 . . . . 2.6899999999999999 112.134 173.097 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.42 117.27 21.72 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.243 1.017 . . . . 2.5 111.472 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.13 166.76 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 126.31 1.844 . . . . 2.6899999999999999 110.66 169.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -144.6 117.76 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 119.171 0.896 . . . . 2.23 110.51 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -124.06 142.18 39.08 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.219 1.008 . . . . 3.3300000000000001 112.374 -172.116 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 70.6 Cg_endo -70.04 151.35 67.44 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.316 3.344 . . . . 0.90000000000000002 113.398 169.268 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.8 t -84.59 128.94 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.51 -0.768 . . . . 1.0900000000000001 109.702 168.676 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 127.118 2.167 . . . . 3.8700000000000001 107.88 172.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 108.958 -0.756 . . . . 7.2000000000000002 108.958 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.99 177.15 39.75 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 122.296 0.942 . . . . 1.3100000000000001 113.093 -177.084 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -157.23 155.12 30.3 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.492 0.717 . . . . 7.1399999999999997 111.1 168.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.0 t -128.96 137.02 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 106.68 -1.6 . . . . 1.6200000000000001 106.68 163.237 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -75.56 -62.4 1.59 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.484 0.584 . . . . 6.1600000000000001 110.362 -176.519 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -171.99 150.22 2.52 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.374 1.07 . . . . 2.9700000000000002 110.982 178.175 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 m -135.86 112.75 10.62 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.878 0.871 . . . . 4.7400000000000002 112.37 -178.234 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -82.92 -34.66 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.896 2.398 . . . . 2.2999999999999998 112.115 170.066 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.12 151.62 27.99 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 110.904 -0.878 . . . . 1.53 110.904 -158.844 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.94 0.65 32.86 Favored 'Cis proline' 0 CA--C 1.539 0.742 0 CA-C-N 119.636 1.718 . . . . 1.4399999999999999 113.297 1.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -144.75 172.58 12.81 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.514 1.302 . . . . 1.8100000000000001 114.514 -177.06 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.02 -175.65 5.4 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 129.786 3.234 . . . . 0.51000000000000001 112.335 -176.277 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.68 136.97 23.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.897 2.079 . . . . 0.75 108.72 174.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.89 144.15 50.48 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.841 1.657 . . . . 0.65000000000000002 112.543 -174.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -126.97 59.34 1.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.668 1.987 . . . . 2.5499999999999998 111.999 -163.158 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -73.18 152.04 41.26 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.963 1.468 . . . . 1.78 114.963 -173.404 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 m -84.97 144.16 28.5 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 121.34 -0.85 . . . . 1.72 110.443 161.711 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.2 129.63 25.66 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.281 1.832 . . . . 4.1100000000000003 111.318 -170.451 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -127.46 143.71 51.16 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.631 1.172 . . . . 3.8599999999999999 111.356 -176.702 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -105.73 95.22 10.05 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.815 0.846 . . . . 1.77 108.917 160.45 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.04 -4.99 15.85 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.097 2.532 . . . . 1.45 113.873 175.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.94 174.39 47.73 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 122.805 1.225 . . . . 1.27 113.099 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -99.85 -1.86 36.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.246 2.618 . . . . 3.4100000000000001 111.887 -174.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -122.21 157.95 56.89 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 128.473 2.709 . . . . 3.1400000000000001 110.021 176.057 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.33 143.44 22.16 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.587 2.191 . . . . 1.5700000000000001 111.302 -173.15 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.61 156.13 22.28 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.7 1.6 . . . . 3.02 109.839 173.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.1 ttp-105 -140.57 104.91 4.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.518 1.527 . . . . 2.7200000000000002 109.178 -177.179 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.8 113.72 21.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.453 1.501 . . . . 2.52 108.144 -176.277 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 m -103.88 -27.03 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.674 0.789 . . . . 0.51000000000000001 112.361 -174.233 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.25 -177.78 31.66 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 124.55 1.072 . . . . 0.40999999999999998 113.555 177.188 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.68 -174.72 3.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.947 1.299 . . . . 0.58999999999999997 109.642 168.469 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 4.5 mtt180 -155.59 168.75 26.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 128.029 2.532 . . . . 5.2599999999999998 106.82 173.349 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -173.51 151.08 1.89 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 125.504 1.522 . . . . 0.81999999999999995 108.431 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.72 -10.51 21.73 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.869 1.713 . . . . 1.21 113.832 176.432 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.13 18.94 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.96 1.467 . . . . 1.3999999999999999 114.96 -170.734 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.83 128.44 7.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.396 1.479 . . . . 1.49 111.683 172.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.69 -36.64 81.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.667 1.587 . . . . 3.4500000000000002 114.09 -176.645 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -140.66 88.02 2.16 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.515 1.526 . . . . 6.3899999999999997 108.683 -167.492 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 p -82.48 138.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.251 -0.886 . . . . 0.84999999999999998 110.905 169.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -124.06 152.43 42.67 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.203 2.201 . . . . 2.5499999999999998 110.026 177.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.7 tp -106.04 119.07 38.26 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.29 1.036 . . . . 0.94999999999999996 110.621 177.782 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -122.97 155.28 37.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.014 1.726 . . . . 0.57999999999999996 113.592 -175.151 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -100.89 159.88 14.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.876 -1.511 . . . . 2.3199999999999998 110.949 156.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.0 m -117.2 134.7 54.47 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 104.99 -2.226 . . . . 0.81999999999999995 104.99 158.814 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -122.42 166.98 13.87 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.944 1.298 . . . . 2.0 112.637 -174.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.7 ptm -91.1 149.56 21.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.464 0.706 . . . . 4.7000000000000002 111.707 169.193 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.29 151.04 27.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.596 1.158 . . . . 6.5 112.929 -177.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -109.19 139.85 43.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.906 1.682 . . . . 2.4100000000000001 106.474 161.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.6 m -138.17 126.67 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.168 -1.049 . . . . 3.3799999999999999 108.168 166.267 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.68 19.29 10.37 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.804 1.242 . . . . 4.2300000000000004 114.209 -178.171 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.96 14.74 76.69 Favored Glycine 0 N--CA 1.478 1.448 0 O-C-N 120.609 -1.307 . . . . 1.79 113.914 -170.477 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -112.24 118.62 35.8 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.796 2.438 . . . . 3.0499999999999998 108.575 -179.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.91 131.89 36.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.277 1.831 . . . . 2.7599999999999998 109.925 -176.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.3 p -155.83 175.72 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.497 1.519 . . . . 3.5800000000000001 111.132 -173.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.7 mtm -108.69 163.97 12.79 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.332 1.053 . . . . 3.77 112.021 164.194 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.1 -176.65 17.35 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.422 1.487 . . . . 1.0700000000000001 111.624 169.56 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.0 ttm -146.35 152.59 39.35 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.115 1.366 . . . . 1.1599999999999999 109.992 -173.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -162.18 156.17 18.34 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 124.796 1.238 . . . . 4.8499999999999996 111.328 173.876 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.09 153.68 57.34 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.331 2.021 . . . . 0.46999999999999997 111.423 171.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.86 154.82 73.15 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 125.777 1.631 . . . . 0.63 109.902 -177.764 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.61 -25.73 3.54 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.434 2.089 . . . . 0.5 113.178 -165.405 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -179.38 165.24 1.4 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.045 1.738 . . . . 1.73 111.797 -177.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.5 mt -111.7 153.41 26.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.958 1.703 . . . . 0.65000000000000002 109.651 163.268 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -107.1 149.38 27.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.175 0.99 . . . . 2.1200000000000001 108.934 175.46 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.48 121.28 9.93 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 118.253 0.479 . . . . 1.6499999999999999 111.273 164.437 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -67.49 164.66 30.04 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.966 2.444 . . . . 1.3799999999999999 110.58 175.299 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -58.4 138.79 87.72 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.594 2.196 . . . . 1.3600000000000001 112.04 177.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt 65.25 5.75 3.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.496 1.918 . . . . 2.23 113.675 -175.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.07 163.98 49.63 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.341 1.924 . . . . 1.8200000000000001 114.473 -174.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -127.75 142.23 51.37 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.51 2.324 . . . . 5.6200000000000001 109.877 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.3 t -143.27 135.7 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 107.166 -1.42 . . . . 3.2599999999999998 107.166 163.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -129.11 117.97 21.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.574 -0.899 . . . . 4.5999999999999996 108.574 -175.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -76.48 78.5 3.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.085 1.354 . . . . 2.3500000000000001 110.602 -168.431 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -66.96 151.01 97.54 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.083 1.353 . . . . 3.4700000000000002 114.058 -174.306 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.2 -31.09 64.57 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.563 2.176 . . . . 2.3100000000000001 113.32 173.714 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.15 53.85 4.48 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.177 0.899 . . . . 2.2400000000000002 111.929 168.014 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.09 -132.9 3.01 Favored Glycine 0 N--CA 1.471 1.024 0 C-N-CA 124.494 1.045 . . . . 1.6200000000000001 114.062 -179.528 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -72.49 140.42 48.21 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 122.866 0.467 . . . . 1.79 112.019 -170.024 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -162.64 160.56 25.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.625 1.17 . . . . 0.67000000000000004 111.351 -175.414 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -90.54 135.47 33.68 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.802 -0.561 . . . . 2.0600000000000001 109.877 167.574 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 tpt -86.55 127.52 34.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.14 -1.059 . . . . 0.78000000000000003 108.14 163.617 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.55 106.84 17.46 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.879 -1.156 . . . . 1.1399999999999999 107.879 177.732 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.88 151.28 26.49 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.756 0.788 . . . . 3.0 111.307 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.94 41.76 39.8 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.887 0.755 . . . . 2.1299999999999999 112.636 176.225 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.9 mt -50.2 154.02 1.3 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 123.401 1.572 . . . . 0.91000000000000003 114.229 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -99.83 -28.21 13.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 112.884 -1.962 . . . . 2.0600000000000001 112.501 173.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -146.39 148.52 34.63 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 127.409 2.283 . . . . 8.3300000000000001 111.171 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.7 146.87 55.57 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.939 2.426 . . . . 1.6699999999999999 109.866 165.323 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.1 mt -126.45 130.59 50.96 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.772 1.629 . . . . 3.29 109.43 -174.564 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.61 -178.84 4.64 Favored 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 126.52 1.928 . . . . 3.7999999999999998 111.984 -156.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.97 133.05 34.03 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.38 -0.825 . . . . 1.2 111.473 -175.098 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.82 46.81 8.22 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.834 1.207 . . . . 1.3200000000000001 112.06 -169.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -131.65 176.95 7.89 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.353 1.061 . . . . 2.3999999999999999 111.197 174.067 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -149.12 125.79 11.07 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.599 2.36 . . . . 3.4399999999999999 106.199 -165.195 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.0 t -140.77 140.25 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.329 1.052 . . . . 1.0700000000000001 111.282 -170.403 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -94.99 134.48 37.61 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.861 0.865 . . . . 3.54 112.881 177.585 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.8 mp -113.11 138.82 49.36 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.035 0.934 . . . . 1.74 110.678 158.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 11.4 m-20 -79.07 142.76 36.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.616 1.566 . . . . 2.48 108.447 159.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mp -110.7 123.82 50.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.782 2.433 . . . . 1.1399999999999999 109.659 176.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -106.45 115.12 29.67 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.343 1.057 . . . . 0.57999999999999996 110.73 -175.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.19 120.17 41.72 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.923 1.689 . . . . 1.95 111.538 -177.547 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.35 25.38 0.87 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.258 2.223 . . . . 3.0699999999999998 115.055 173.367 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.21 -60.75 3.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.23 1.395 . . . . 4.71 112.461 -168.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.49 -2.15 59.33 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 117.49 1.756 . . . . 1.8799999999999999 117.49 -164.816 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -135.45 130.66 35.09 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 120.057 1.929 . . . . 4.5999999999999996 113.248 173.029 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -96.96 151.75 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.41 1.484 . . . . 2.1099999999999999 110.563 161.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.9 tp -146.2 179.61 7.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.822 2.449 . . . . 2.2999999999999998 107.848 164.487 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -147.29 145.55 29.42 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.078 1.308 . . . . 2.4900000000000002 111.401 -177.565 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 t -142.86 157.24 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.561 1.145 . . . . 2.0 109.435 176.065 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.23 154.79 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.072 2.149 . . . . 2.1200000000000001 109.732 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.96 120.48 9.24 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.336 1.854 . . . . 3.1000000000000001 110.305 176.179 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.52 145.29 16.92 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 124.562 3.508 . . . . 1.55 113.549 156.382 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.57 127.95 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.828 -0.804 . . . . 1.02 108.828 161.592 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 . . . . . 0 N--CA 1.44 -0.974 0 C-N-CA 126.173 1.789 . . . . 4.2800000000000002 109.344 169.643 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.818 0 CA-C-O 121.064 0.459 . . . . 4.6399999999999997 111.483 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.02 156.44 27.2 Favored Glycine 0 N--CA 1.474 1.183 0 O-C-N 120.485 -1.384 . . . . 1.3700000000000001 115.604 -176.521 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -155.87 170.87 21.11 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.358 1.063 . . . . 2.1800000000000002 113.29 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -114.14 130.95 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.728 -1.212 . . . . 1.3500000000000001 107.728 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -78.69 -29.81 45.74 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.779 1.77 . . . . 5.4000000000000004 115.779 -157.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.9 t80 146.43 137.26 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 130.653 3.581 . . . . 2.25 109.721 174.483 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 t 179.54 133.78 0.25 Allowed Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 126.683 1.993 . . . . 1.8500000000000001 110.801 166.404 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.38 -25.66 15.2 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.419 2.079 . . . . 1.24 112.481 171.114 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.11 -176.96 17.07 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.82 1.676 . . . . 0.93000000000000005 112.256 -174.694 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.69 -11.43 20.54 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 118.445 1.122 . . . . 0.90000000000000002 113.449 3.444 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -128.02 155.79 43.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.586 1.954 . . . . 1.8100000000000001 112.87 179.239 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.43 173.42 11.62 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.07 2.148 . . . . 0.42999999999999999 110.867 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.09 125.09 30.53 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.056 1.343 . . . . 1.01 108.355 172.214 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.3 151.2 22.98 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.421 1.488 . . . . 0.62 110.751 177.327 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -141.79 70.39 1.34 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.593 1.557 . . . . 2.1499999999999999 110.053 -166.238 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -90.69 161.01 15.55 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.356 -0.84 . . . . 1.9399999999999999 112.941 175.105 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 23.1 m -79.59 157.61 27.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.125 -0.943 . . . . 1.7 109.985 160.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.68 136.44 54.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.227 1.011 . . . . 3.4300000000000002 110.156 175.882 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.84 131.35 47.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.698 1.199 . . . . 5.96 111.297 -173.234 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -107.05 111.17 63.7 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.387 -0.598 . . . . 1.46 109.387 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -86.83 -11.72 5.48 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.283 2.655 . . . . 1.8500000000000001 113.586 173.67 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.0 -179.84 47.19 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 124.992 1.282 . . . . 1.26 112.933 -175.074 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -104.21 -5.35 22.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.996 2.518 . . . . 3.3700000000000001 111.679 -171.268 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -121.18 159.61 48.91 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.817 2.447 . . . . 2.9300000000000002 109.702 175.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.03 137.5 19.57 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.124 1.882 . . . . 1.0600000000000001 110.463 -175.212 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.61 155.54 16.73 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.651 1.18 . . . . 2.4100000000000001 109.614 171.521 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 ttp-105 -143.93 102.96 3.97 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.423 1.489 . . . . 2.9100000000000001 110.567 -170.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -86.4 109.57 19.11 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.158 2.183 . . . . 2.1899999999999999 109.891 -173.159 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -103.14 -20.88 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.553 1.141 . . . . 0.53000000000000003 111.851 -172.385 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.85 -174.66 30.96 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 124.897 1.237 . . . . 0.44 113.507 177.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.99 -179.72 5.83 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.047 0.939 . . . . 0.48999999999999999 112.119 166.263 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.418 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -140.08 170.27 16.15 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.161 2.184 . . . . 4.9900000000000002 107.97 160.335 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -171.64 149.18 2.37 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 125.63 1.572 . . . . 0.71999999999999997 108.768 176.401 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.28 -14.47 16.47 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.405 2.07 . . . . 0.79000000000000004 113.706 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.46 26.76 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.045 1.338 . . . . 0.85999999999999999 113.615 -177.045 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.67 161.2 42.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.437 1.495 . . . . 0.85999999999999999 109.039 163.748 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -95.46 -36.51 11.29 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.348 1.059 . . . . 3.1000000000000001 112.858 177.235 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.7 160.86 33.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.024 1.729 . . . . 5.8700000000000001 107.38 170.448 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.81 155.06 17.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.387 1.475 . . . . 0.98999999999999999 109.014 173.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.59 152.57 34.27 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.636 1.974 . . . . 4.1900000000000004 108.324 -167.757 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.401 HD13 ' CE1' ' A' ' 84' ' ' PHE . 56.2 tp -121.07 107.44 12.63 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.224 -0.923 . . . . 0.81999999999999995 110.926 -162.076 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.6 m170 -117.64 145.05 44.62 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.473 1.286 . . . . 0.68000000000000005 114.473 -169.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -84.72 169.99 13.72 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.241 1.816 . . . . 2.1600000000000001 111.329 163.463 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.2 m -145.99 142.27 28.49 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.538 -1.352 . . . . 0.78000000000000003 107.444 174.06 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -162.21 178.84 8.39 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.743 1.386 . . . . 1.96 114.743 -167.261 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.8 ptm -118.36 150.99 38.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.048 1.739 . . . . 3.8100000000000001 112.541 176.491 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -156.07 146.37 21.6 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.834 1.254 . . . . 7.6100000000000003 112.64 -174.713 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -100.96 142.17 32.8 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.395 1.478 . . . . 2.6800000000000002 109.848 171.727 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.6 t -141.33 121.06 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.611 1.564 . . . . 2.6600000000000001 107.717 174.679 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 64.58 12.45 7.49 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.989 1.716 . . . . 4.6100000000000003 115.049 -179.129 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.24 22.99 53.19 Favored Glycine 0 N--CA 1.477 1.425 0 O-C-N 121.07 -1.019 . . . . 2.5600000000000001 113.243 -167.001 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -118.28 120.31 37.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.861 2.064 . . . . 4.6299999999999999 107.6 175.637 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.569 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -73.07 127.94 34.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.613 1.565 . . . . 3.9900000000000002 111.673 174.447 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -138.72 160.83 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 128.786 2.834 . . . . 2.6200000000000001 108.477 -173.084 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.9 mtt -111.5 170.12 8.34 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.823 -1.173 . . . . 2.5600000000000001 112.704 174.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.28 166.29 32.09 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.449 0.94 . . . . 0.70999999999999996 115.449 -167.965 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -161.05 146.19 14.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 128.439 2.696 . . . . 1.3 107.107 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -153.2 157.4 32.93 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.637 1.975 . . . . 4.4400000000000004 108.073 -177.763 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -78.27 159.93 29.55 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.631 1.554 . . . . 0.71999999999999997 110.692 167.84 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.26 152.86 74.26 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.126 1.371 . . . . 0.64000000000000001 110.532 177.754 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.26 -24.11 11.18 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.851 2.367 . . . . 0.65000000000000002 112.68 -170.951 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -176.95 166.91 2.5 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.569 1.948 . . . . 1.99 111.55 178.712 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -112.81 152.09 29.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.186 1.794 . . . . 0.66000000000000003 110.989 162.353 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -103.54 151.58 22.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.205 1.002 . . . . 1.8 109.874 176.655 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.57 126.68 13.83 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.154 0.582 . . . . 1.4199999999999999 111.71 161.601 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.21 158.85 44.78 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.984 3.122 . . . . 1.53 112.013 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.76 140.65 87.05 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 124.074 3.183 . . . . 1.4199999999999999 113.871 -174.286 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 66.72 -10.08 0.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.163 2.185 . . . . 2.46 114.358 -178.383 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.01 136.23 13.49 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.993 1.282 . . . . 1.72 113.209 -176.533 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.44 135.44 33.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.032 2.133 . . . . 3.73 109.783 159.082 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -149.2 124.15 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.718 1.607 . . . . 3.7599999999999998 108.807 178.12 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 2.2 mp0 -89.06 157.13 18.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.435 0.694 . . . . 3.25 111.637 -170.673 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mp -66.23 -32.87 74.55 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.218 0.917 . . . . 3.1899999999999999 113.372 174.051 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 93.5 140.95 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 130.518 3.527 . . . . 3.0499999999999998 110.426 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.71 -1.24 7.25 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.394 2.729 . . . . 2.5499999999999998 114.643 178.442 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.86 19.85 0.25 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-O 117.439 -1.756 . . . . 2.02 116.207 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.87 -27.46 0.86 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 120.243 2.022 . . . . 2.0699999999999998 116.987 172.129 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -137.87 151.54 48.15 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.3 2.05 . . . . 2.0600000000000001 111.435 160.269 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -156.84 148.46 22.49 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.333 0.653 . . . . 0.73999999999999999 110.65 175.673 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' CE1' HD13 ' A' ' 45' ' ' LEU . 45.7 m-85 -81.84 116.84 21.7 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.792 -0.818 . . . . 2.0600000000000001 108.792 165.472 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 tpt -78.25 107.8 11.11 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 126.705 2.002 . . . . 1.0900000000000001 108.609 170.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.3 mp -87.49 139.73 30.25 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.446 1.498 . . . . 1.3100000000000001 109.12 176.23 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.38 138.03 46.1 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.259 1.024 . . . . 2.1600000000000001 112.263 178.293 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.25 42.45 10.58 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 124.997 1.284 . . . . 1.5900000000000001 113.118 173.601 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.7 mt -47.36 151.28 0.77 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.938 1.829 . . . . 0.87 115.938 -172.47 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -111.42 -26.29 9.18 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 113.721 -1.581 . . . . 2.3100000000000001 113.85 -176.246 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -120.63 136.36 25.32 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.302 1.441 . . . . 4.6399999999999997 109.218 159.95 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.07 116.24 4.64 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.022 2.481 . . . . 1.45 107.767 170.14 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.357 4.1 pp -98.43 105.24 17.36 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 124.279 1.99 . . . . 3.0299999999999998 112.708 -162.506 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.26 171.01 7.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.03 2.132 . . . . 3.6499999999999999 112.256 176.68 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.31 129.46 41.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.106 0.962 . . . . 1.3700000000000001 110.804 175.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.66 31.78 48.62 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.702 -0.681 . . . . 2.9100000000000001 112.939 -173.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -100.02 179.38 4.52 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.382 -0.97 . . . . 2.6000000000000001 108.382 143.642 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.22 160.51 43.31 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.279 1.831 . . . . 3.2599999999999998 106.725 165.243 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.0 t -151.96 157.91 4.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 128.734 2.813 . . . . 1.49 107.73 -158.731 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -126.61 154.13 44.38 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.678 0.791 . . . . 2.4300000000000002 110.226 165.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.16 134.88 54.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.056 1.343 . . . . 1.99 109.96 166.351 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 67.9 m-20 -78.18 134.79 37.57 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.334 2.254 . . . . 2.5899999999999999 108.432 161.587 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.99 109.6 21.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.437 1.895 . . . . 1.21 108.815 178.461 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.5 mt -93.88 116.3 28.75 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.201 0.6 . . . . 0.68000000000000005 110.1 -176.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -109.23 148.71 30.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.614 1.166 . . . . 1.95 111.806 -177.825 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.75 150.18 33.26 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.775 -0.578 . . . . 2.1699999999999999 112.012 169.562 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.23 34.39 41.34 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.142 -0.81 . . . . 4.1399999999999997 114.029 177.166 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.72 44.3 39.64 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 118.048 0.924 . . . . 1.9399999999999999 114.235 166.47 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -134.07 140.96 46.99 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.241 1.02 . . . . 3.21 111.713 -177.882 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.2 t -142.67 134.39 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.83 1.252 . . . . 2.02 109.283 172.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -116.62 174.74 5.91 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.319 1.847 . . . . 3.0800000000000001 107.598 163.721 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -139.21 154.14 47.98 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.011 -1.056 . . . . 1.9099999999999999 112.373 161.177 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.0 t -132.3 160.86 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.197 1.399 . . . . 1.8799999999999999 109.734 -176.645 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.53 143.27 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 127.358 2.263 . . . . 3.0899999999999999 111.592 -173.288 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -143.76 105.2 4.93 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.742 1.617 . . . . 2.8199999999999998 109.84 -175.489 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -61.3 157.36 40.81 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.394 2.063 . . . . 1.4399999999999999 111.396 158.455 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.8 t -107.4 141.92 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.593 0.711 . . . . 1.23 110.139 173.155 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 128.577 2.751 . . . . 3.9199999999999999 110.496 -165.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 121.453 0.644 . . . . 4.5800000000000001 110.651 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.67 -177.79 32.09 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 125.581 1.563 . . . . 1.1799999999999999 113.642 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.1 p90 -152.96 143.21 22.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.558 1.543 . . . . 2.4399999999999999 110.567 170.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.3 156.61 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 121.048 -1.033 . . . . 1.6499999999999999 108.404 167.863 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.418 ' HB3' ' H ' ' A' ' 17' ' ' ALA . 27.8 ttt85 -86.3 149.75 24.83 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.865 1.317 . . . . 4.1900000000000004 112.974 -176.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -72.11 132.43 44.18 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 129.236 3.014 . . . . 2.6299999999999999 109.84 170.553 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.3 t 178.84 141.27 0.28 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 126.565 1.946 . . . . 2.25 111.229 176.307 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.74 -28.96 13.26 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.562 2.174 . . . . 1.4099999999999999 112.683 169.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.03 171.14 12.5 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.407 1.956 . . . . 0.94999999999999996 112.36 -172.946 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -82.98 -0.14 54.34 Favored 'Cis proline' 0 CA--C 1.539 0.74 0 CA-C-N 119.27 1.535 . . . . 1.1499999999999999 113.923 2.593 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -143.33 157.39 44.51 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.772 1.397 . . . . 2.5 114.772 174.331 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.13 -175.34 3.59 Favored 'General case' 0 CA--C 1.549 0.924 1 C-N-CA 131.838 4.055 . . . . 0.40999999999999998 108.804 175.349 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.418 ' H ' ' HB3' ' A' ' 9' ' ' ARG . . . -131.64 171.02 13.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.793 2.037 . . . . 1.1399999999999999 108.259 173.01 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.62 135.96 22.79 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.107 0.956 . . . . 0.64000000000000001 112.576 170.356 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -123.44 141.06 52.37 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.574 2.35 . . . . 2.3100000000000001 108.957 -174.541 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -174.05 143.16 0.9 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.869 1.433 . . . . 1.98 114.869 -171.379 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.0 m -79.52 120.86 24.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.594 1.157 . . . . 1.9299999999999999 110.98 178.512 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 135.23 39.72 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.329 1.852 . . . . 3.2400000000000002 109.361 175.036 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -139.12 146.89 41.22 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.066 1.747 . . . . 5.1500000000000004 109.137 -171.351 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -131.98 99.56 16.46 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.508 0.723 . . . . 1.6499999999999999 109.934 177.499 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -70.38 -14.37 34.05 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.368 2.045 . . . . 2.0299999999999998 113.069 176.231 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.35 140.69 11.58 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 128.188 2.804 . . . . 3.5099999999999998 112.666 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t0 174.23 -55.89 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.562 2.745 . . . . 8.3900000000000006 103.86 -158.236 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp 178.06 173.55 0.38 Allowed Pre-proline 0 CA--C 1.552 1.021 1 C-N-CA 132.898 4.479 . . . . 4.3700000000000001 110.848 -177.148 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.37 134.94 10.38 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.345 2.03 . . . . 1.3999999999999999 111.227 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.3 mt -93.84 145.23 24.76 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.646 1.178 . . . . 2.2200000000000002 111.108 -175.55 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 ttp-105 -137.31 91.88 2.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 112.62 -2.082 . . . . 2.96 111.628 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 98.02 7.37 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.098 1.759 . . . . 1.8300000000000001 108.418 -170.485 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.9 m -94.36 -30.65 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.25 1.42 . . . . 0.64000000000000001 112.21 -169.594 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.64 -176.78 32.09 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 123.87 0.747 . . . . 0.59999999999999998 113.765 178.699 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.26 177.45 8.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.322 1.049 . . . . 0.67000000000000004 112.253 172.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -153.36 157.64 40.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.051 2.54 . . . . 5.7699999999999996 108.236 168.444 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -167.32 152.45 6.98 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 123.798 0.839 . . . . 0.96999999999999997 111.894 -176.727 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.2 -8.75 23.35 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.794 2.329 . . . . 1.52 115.599 178.817 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.64 0.55 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 115.829 1.789 . . . . 1.48 115.829 178.166 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.04 164.13 37.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.135 1.374 . . . . 1.1899999999999999 112.186 -178.978 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -124.77 -65.04 1.06 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 123.103 1.43 . . . . 4.3899999999999997 111.399 -167.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -79.01 147.59 32.82 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.426 -2.065 . . . . 4.79 105.426 164.763 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -156.66 135.05 2.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 C-N-CA 125.141 1.376 . . . . 0.96999999999999997 108.034 -177.081 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -127.54 156.6 41.94 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.757 2.023 . . . . 2.8300000000000001 109.323 178.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.1 tp -105.46 126.58 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.799 0.84 . . . . 0.97999999999999998 109.231 169.032 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -124.24 160.63 27.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.0 2.12 . . . . 0.69999999999999996 113.984 -175.663 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -107.64 163.61 12.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.751 1.62 . . . . 2.0600000000000001 111.091 156.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.5 m -116.05 140.93 48.78 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.463 1.905 . . . . 1.04 106.602 165.189 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -145.31 -178.15 5.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.547 1.139 . . . . 2.0899999999999999 113.42 -177.114 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.1 mtm -126.79 144.28 51.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.364 1.466 . . . . 3.6400000000000001 112.749 -177.586 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.12 135.82 39.59 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.699 1.6 . . . . 6.0 111.764 178.795 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -104.49 127.69 52.26 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.844 1.658 . . . . 3.1600000000000001 111.34 168.35 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.9 t -134.82 123.97 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 107.651 -1.24 . . . . 2.6699999999999999 107.651 176.047 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 62.67 10.63 4.28 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.169 2.188 . . . . 3.98 115.146 -169.228 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.82 30.19 52.81 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 120.965 -1.085 . . . . 1.74 112.885 -164.488 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -118.52 129.28 55.27 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.955 1.702 . . . . 2.7400000000000002 108.261 169.08 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -86.84 126.61 34.75 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.029 1.732 . . . . 6.1399999999999997 112.294 -177.598 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.89 142.98 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.542 1.937 . . . . 2.9300000000000002 109.423 175.852 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 52.2 mtt -88.45 163.42 15.96 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.892 1.071 . . . . 2.6499999999999999 113.892 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.98 175.15 22.35 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.549 1.547 . . . . 0.59999999999999998 112.457 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.3 ttm -157.04 148.11 21.86 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.46 1.904 . . . . 1.51 108.245 -179.423 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -161.08 153.68 17.3 Favored Pre-proline 0 N--CA 1.476 0.862 0 CA-C-O 118.051 -0.976 . . . . 4.6799999999999997 111.639 -178.428 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.91 155.29 43.37 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.197 1.931 . . . . 0.56000000000000005 111.875 178.53 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.99 151.03 61.23 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.038 1.735 . . . . 0.58999999999999997 109.999 -177.668 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.8 -21.03 8.68 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.465 2.777 . . . . 0.52000000000000002 113.493 -164.638 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -178.09 165.83 1.94 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.568 1.947 . . . . 1.74 110.746 177.548 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 mt -106.95 146.26 31.26 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.082 0.953 . . . . 0.67000000000000004 110.529 158.347 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -105.86 140.2 39.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.391 1.076 . . . . 1.8700000000000001 108.929 175.078 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.9 t -141.01 113.14 6.88 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 122.902 0.481 . . . . 0.97999999999999998 110.725 165.314 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.9 162.44 37.32 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 124.095 3.197 . . . . 1.75 111.75 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.64 136.89 56.3 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.931 2.42 . . . . 1.52 111.784 -177.512 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt 74.68 -4.81 2.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 128.118 2.567 . . . . 3.5099999999999998 114.402 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.38 155.3 23.35 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.411 1.481 . . . . 1.8300000000000001 112.12 170.428 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -135.67 153.47 51.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.39 1.476 . . . . 4.2000000000000002 110.366 172.689 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.7 t -154.04 129.76 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.353 1.461 . . . . 3.6699999999999999 108.781 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.8 136.24 33.15 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.938 -1.101 . . . . 3.2200000000000002 112.265 176.52 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.82 84.17 0.66 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.077 -1.083 . . . . 2.2599999999999998 108.077 157.22 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -92.21 150.29 40.02 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.418 2.287 . . . . 2.54 113.377 -178.302 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -64.66 -39.69 26.03 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.004 2.469 . . . . 2.52 113.102 -174.541 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.33 45.84 2.66 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.689 1.137 . . . . 2.3300000000000001 112.511 170.963 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.08 -129.08 1.96 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 126.371 1.939 . . . . 1.48 111.65 177.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -73.57 138.33 44.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.714 1.257 . . . . 2.0 113.239 -166.364 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -161.32 161.5 30.56 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.59 1.156 . . . . 0.93000000000000005 111.503 -178.02 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -85.99 150.83 24.21 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.502 -0.749 . . . . 1.71 110.915 165.297 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -105.96 126.13 51.82 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.415 1.486 . . . . 1.1100000000000001 108.706 163.008 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.01 118.31 36.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.734 1.214 . . . . 1.1799999999999999 108.75 -175.23 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.08 155.26 31.82 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 123.409 1.576 . . . . 1.97 112.212 -170.48 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.09 -43.75 3.25 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 128.024 2.726 . . . . 2.4399999999999999 112.139 -178.057 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.2 mt 47.97 167.55 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.602 3.161 . . . . 1.1299999999999999 115.891 -168.474 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -135.33 -21.2 1.59 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.342 1.457 . . . . 2.75 113.781 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -122.27 149.86 55.71 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.148 2.179 . . . . 5.0099999999999998 107.619 161.033 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.71 112.37 2.63 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 106.23 -2.258 . . . . 1.49 106.23 153.209 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.35 108.16 5.33 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.048 -0.723 . . . . 2.0800000000000001 109.048 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -65.02 174.43 1.95 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.382 1.087 . . . . 4.0800000000000001 112.083 158.432 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.97 159.68 24.83 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.673 -1.149 . . . . 1.6200000000000001 108.439 149.285 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.16 49.74 75.31 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 121.575 -0.703 . . . . 2.1800000000000002 112.524 -172.317 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.53 -179.6 4.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.96 1.304 . . . . 2.25 108.483 163.23 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -148.04 151.48 35.79 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.154 1.781 . . . . 3.4199999999999999 107.346 169.167 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.7 t -154.35 145.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 128.006 2.522 . . . . 1.23 109.357 -160.496 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -101.11 154.37 18.79 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.276 0.63 . . . . 4.6900000000000004 111.385 171.79 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mt -139.56 134.14 31.75 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.594 1.557 . . . . 2.0499999999999998 110.26 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -83.69 131.41 34.94 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.709 2.004 . . . . 1.98 108.823 165.774 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.29 111.35 22.6 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.918 1.287 . . . . 0.91000000000000003 109.585 172.486 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.72 110.85 19.61 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.669 1.187 . . . . 0.91000000000000003 109.806 -178.191 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -106.28 105.3 15.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.923 1.289 . . . . 1.9299999999999999 110.751 -177.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 57.43 11.12 1.09 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.013 1.725 . . . . 2.5699999999999998 115.22 174.209 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.36 -43.08 2.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.498 1.523 . . . . 3.8300000000000001 113.186 -169.12 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.96 -11.11 78.56 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.339 0.971 . . . . 2.6200000000000001 115.514 -175.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -137.49 157.15 47.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.818 1.309 . . . . 4.2999999999999998 111.867 170.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.78 153.97 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 125.708 1.603 . . . . 2.0800000000000001 109.93 169.732 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.5 tp -144.44 121.78 11.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.593 1.157 . . . . 2.1200000000000001 109.654 174.373 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.77 114.33 28.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.53 0.732 . . . . 3.6499999999999999 110.587 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.55 167.72 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 126.748 2.019 . . . . 2.0800000000000001 110.548 -170.815 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.29 141.56 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.734 2.013 . . . . 2.6699999999999999 110.655 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.4 mt -150.85 149.1 24.6 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 126.279 1.832 . . . . 3.1299999999999999 111.625 -174.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -70.01 174.34 9.87 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.734 2.956 . . . . 1.1799999999999999 112.048 166.027 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.5 t -121.82 134.48 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.572 1.549 . . . . 1.3200000000000001 109.507 166.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 C--O 1.235 0.34 0 N-CA-C 114.377 1.251 . . . . 5.0199999999999996 114.377 177.073 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 121.897 0.856 . . . . 4.9500000000000002 110.916 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.33 -177.15 33.18 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.95 1.262 . . . . 1.3500000000000001 114.129 -175.393 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -153.81 160.02 42.08 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.606 1.562 . . . . 2.3900000000000001 111.381 167.754 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 t -97.04 146.78 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 106.897 -1.52 . . . . 1.3400000000000001 106.897 165.933 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -75.67 -102.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.367 0.985 . . . . 5.4000000000000004 112.032 -178.209 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -170.67 127.29 0.76 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.869 1.268 . . . . 2.75 108.198 -168.788 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 p 179.6 111.22 0.19 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.565 -0.731 . . . . 2.79 111.588 -167.586 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.29 -31.97 8.72 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.38 2.053 . . . . 1.1899999999999999 112.671 174.995 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.68 178.0 28.58 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.475 1.512 . . . . 1.0600000000000001 111.772 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.6 2.77 35.18 Favored 'Cis proline' 0 CA--C 1.539 0.77 0 CA-C-N 119.245 1.523 . . . . 1.4199999999999999 112.952 -3.545 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -151.9 167.45 28.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.109 0.963 . . . . 2.3199999999999998 112.085 176.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.48 173.73 12.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.537 2.335 . . . . 0.56000000000000005 110.842 -171.215 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.55 139.28 24.04 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.51 1.124 . . . . 0.90000000000000002 110.281 179.206 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.09 140.35 50.83 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.295 1.438 . . . . 0.75 111.549 -173.531 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -115.08 142.07 47.14 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.972 2.109 . . . . 3.3300000000000001 111.332 -176.176 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -162.94 147.43 11.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.869 1.433 . . . . 1.98 114.869 178.12 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.7 m -79.82 116.12 19.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.205 1.402 . . . . 1.8600000000000001 110.477 176.07 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.75 126.45 40.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.582 1.153 . . . . 3.3599999999999999 110.08 174.531 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -124.24 142.89 50.88 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.561 1.544 . . . . 4.1900000000000004 110.959 175.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -103.84 94.95 6.93 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.838 1.255 . . . . 1.4099999999999999 109.985 171.185 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.12 -8.24 18.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.717 2.278 . . . . 1.3200000000000001 113.796 177.354 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.72 177.96 51.27 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 122.425 1.014 . . . . 1.3300000000000001 112.36 -178.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -103.02 -2.44 27.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.17 2.188 . . . . 3.23 111.295 -176.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.61 162.12 21.92 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 129.333 3.053 . . . . 4.2400000000000002 108.873 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.29 146.86 20.03 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.453 2.102 . . . . 1.03 110.784 178.15 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mp -112.11 151.28 29.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.792 1.237 . . . . 2.3599999999999999 110.731 174.047 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -141.14 109.8 6.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.037 -1.892 . . . . 1.95 110.076 179.265 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.52 123.78 32.78 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 125.282 1.433 . . . . 1.98 108.607 178.124 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -106.57 -28.58 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.201 0.91 . . . . 0.69999999999999996 111.927 -175.862 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.24 -173.34 27.55 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 124.536 1.065 . . . . 0.47999999999999998 113.704 177.482 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -127.21 -176.77 3.82 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.339 1.056 . . . . 0.55000000000000004 111.014 161.785 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -144.98 156.33 43.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 131.357 3.863 . . . . 5.8700000000000001 105.178 166.336 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -167.18 137.24 2.37 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 124.256 1.022 . . . . 0.65000000000000002 109.991 171.807 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.57 -17.56 38.37 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.362 2.042 . . . . 0.93999999999999995 113.321 -171.694 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.2 m -93.8 17.5 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 114.747 1.388 . . . . 0.84999999999999998 114.747 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.12 164.15 28.3 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.582 1.083 . . . . 1.2 113.609 170.569 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -92.62 -35.86 13.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.546 1.138 . . . . 4.0700000000000003 111.149 175.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -135.36 156.72 48.47 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.179 2.192 . . . . 5.0 108.011 169.31 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.24 149.47 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.701 1.601 . . . . 0.97999999999999998 108.764 168.334 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -152.04 150.41 29.92 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.692 1.997 . . . . 2.8399999999999999 108.524 -172.373 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.435 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.5 pt? -105.83 134.15 49.41 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 123.068 1.414 . . . . 1.97 113.105 172.641 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -116.76 154.74 30.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.514 -1.676 . . . . 0.69999999999999996 111.321 177.377 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -175.48 5.32 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.566 1.546 . . . . 3.3500000000000001 110.889 159.112 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.0 m -151.15 147.7 27.37 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.585 1.154 . . . . 0.70999999999999996 108.489 164.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -159.2 177.01 11.51 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 123.467 1.604 . . . . 2.0499999999999998 113.724 -171.204 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.6 ttp -129.42 128.02 42.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.071 1.748 . . . . 3.2599999999999998 110.597 -179.433 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.49 148.76 22.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.343 1.457 . . . . 6.0899999999999999 110.623 164.655 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.65 138.05 33.51 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.468 -0.938 . . . . 2.6400000000000001 108.468 147.135 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.96 125.17 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 106.238 -1.764 . . . . 2.25 106.238 166.123 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 60.31 33.62 20.86 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.621 0.768 . . . . 4.3300000000000001 112.044 178.681 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.74 9.62 79.15 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.834 -1.166 . . . . 1.6200000000000001 114.454 -176.353 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -126.02 134.92 51.31 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.11 1.764 . . . . 2.29 109.241 -172.994 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -84.61 123.75 30.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.634 1.574 . . . . 3.1000000000000001 111.124 -171.815 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.1 t -141.36 131.0 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.657 1.983 . . . . 2.1800000000000002 108.403 -173.171 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.73 161.63 13.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.768 1.227 . . . . 3.2200000000000002 113.626 -171.56 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.27 -179.66 32.36 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.046 1.308 . . . . 1.0800000000000001 113.086 172.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.91 153.75 43.41 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.291 1.036 . . . . 3.6200000000000001 111.164 170.412 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -141.06 152.52 65.22 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.778 2.031 . . . . 4.3899999999999997 109.417 -174.408 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.69 153.61 59.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.119 1.879 . . . . 0.73999999999999999 111.273 172.399 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.53 154.92 77.53 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-O 118.452 -0.785 . . . . 0.96999999999999997 110.828 171.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.35 -22.9 10.58 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.114 2.543 . . . . 0.53000000000000003 112.602 -172.387 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -174.15 171.9 3.43 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.94 1.696 . . . . 2.0600000000000001 110.894 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.7 mt -117.54 158.27 24.86 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.225 1.81 . . . . 0.73999999999999999 109.915 160.318 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -137.34 146.34 44.45 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.69 0.796 . . . . 2.1899999999999999 110.673 178.06 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.9 t -144.04 130.12 9.99 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 123.961 0.788 . . . . 1.28 110.854 175.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.82 165.45 29.71 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.73 2.953 . . . . 1.23 111.316 175.664 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.61 141.66 97.7 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.281 2.654 . . . . 1.0600000000000001 113.16 -179.1 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt 69.62 -4.43 1.4 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 127.53 2.332 . . . . 1.5700000000000001 114.681 177.914 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.58 169.39 47.06 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.137 1.351 . . . . 1.28 113.974 179.22 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 -133.35 156.86 46.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.401 1.08 . . . . 4.54 111.691 164.419 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -149.0 133.53 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.92 2.088 . . . . 3.7400000000000002 106.922 171.523 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -98.03 133.71 42.12 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.947 -1.095 . . . . 2.8399999999999999 111.393 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mp -68.47 78.9 0.27 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.394 -0.965 . . . . 2.5 108.394 154.891 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -94.09 154.38 40.61 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.717 2.007 . . . . 2.54 112.051 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.43 -34.55 94.86 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.997 2.465 . . . . 2.3500000000000001 113.211 175.358 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.75 66.39 3.85 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.18 -0.768 . . . . 2.77 111.18 171.203 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.84 -123.59 3.72 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.178 1.371 . . . . 1.6200000000000001 112.966 -178.46 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -74.65 141.64 44.6 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.938 0.718 . . . . 2.2200000000000002 112.938 -162.533 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -159.97 154.97 24.69 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.587 -0.696 . . . . 0.77000000000000002 112.044 -176.855 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 43.4 m-85 -90.3 118.66 29.98 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.558 0.343 . . . . 2.6299999999999999 110.208 171.178 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -85.62 125.18 32.93 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.009 1.324 . . . . 0.93999999999999995 109.257 170.16 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.96 127.82 52.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.476 1.51 . . . . 1.4299999999999999 107.537 177.384 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.82 150.14 39.66 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.824 0.821 . . . . 2.04 112.237 -176.59 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.43 -41.26 1.83 Allowed Glycine 0 CA--C 1.531 1.094 0 C-N-CA 126.48 1.991 . . . . 2.8900000000000001 113.57 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.8 mt 57.04 170.52 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 129.916 3.286 . . . . 0.92000000000000004 114.29 -177.962 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -129.82 -28.51 2.21 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.002 2.121 . . . . 1.52 112.857 172.583 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -110.99 132.58 21.6 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.43 1.492 . . . . 4.7999999999999998 108.065 166.642 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.95 101.19 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 N-CA-C 106.362 -2.207 . . . . 1.9099999999999999 106.362 158.466 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.11 128.0 41.6 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.419 1.104 . . . . 2.8300000000000001 112.674 -159.703 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -132.87 172.31 12.76 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.259 1.823 . . . . 3.8500000000000001 113.335 -167.215 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.69 124.61 23.36 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.574 -0.739 . . . . 1.46 110.083 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.36 7.36 51.97 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.554 1.55 . . . . 1.8799999999999999 115.497 -176.952 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.28 -175.16 3.74 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.421 1.111 . . . . 2.9199999999999999 111.519 161.493 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -149.29 154.53 39.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.305 3.042 . . . . 3.1499999999999999 105.733 178.835 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.9 t -147.83 139.05 17.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 127.238 2.215 . . . . 1.3899999999999999 109.035 -176.233 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.15 149.76 25.63 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.795 1.238 . . . . 3.1600000000000001 110.998 176.852 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mp -132.16 134.24 45.17 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.192 1.397 . . . . 1.74 111.066 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -87.56 125.1 34.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.259 1.824 . . . . 2.1299999999999999 107.459 159.331 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 mp -98.29 131.51 44.55 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.102 1.361 . . . . 1.01 109.421 172.572 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.6 mt -107.19 120.04 41.03 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.0 1.32 . . . . 0.68000000000000005 109.589 -175.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -113.69 160.41 18.66 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.525 1.53 . . . . 1.9099999999999999 110.601 178.355 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.62 143.04 10.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.242 -0.89 . . . . 2.4900000000000002 111.605 170.19 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.88 -3.72 86.81 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 118.759 -1.023 . . . . 3.6299999999999999 114.37 -169.995 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.14 16.13 56.35 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.814 1.307 . . . . 2.8999999999999999 114.114 175.456 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -78.4 134.8 37.36 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.143 -1.21 . . . . 5.2999999999999998 112.557 -173.049 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.9 t -107.15 136.66 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.228 1.811 . . . . 2.1400000000000001 109.423 175.617 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.4 tp -141.17 133.62 28.37 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.115 0.966 . . . . 1.9099999999999999 111.502 174.873 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -79.93 126.41 30.98 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.669 0.618 . . . . 2.6499999999999999 112.669 177.763 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.3 t -114.74 164.48 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.334 1.854 . . . . 2.6800000000000002 108.355 157.438 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.6 t -146.61 140.36 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.893 1.677 . . . . 1.96 109.958 -176.027 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.3 mt -143.24 135.68 13.43 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 126.666 1.986 . . . . 2.4300000000000002 111.114 -167.584 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -73.97 159.1 45.3 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.113 2.542 . . . . 1.23 110.76 163.229 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.34 131.13 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.734 -0.839 . . . . 1.0900000000000001 108.734 167.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 124.461 1.105 . . . . 3.8100000000000001 113.359 -165.098 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 CA--C 1.545 0.763 0 CA-C-O 122.183 0.992 . . . . 4.96 112.718 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.18 179.69 19.21 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.331 1.443 . . . . 0.98999999999999999 113.09 176.969 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 23.2 p90 -155.46 169.58 23.92 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.845 1.424 . . . . 2.3900000000000001 114.845 -172.84 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.39 140.52 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 126.502 1.921 . . . . 1.3400000000000001 109.407 170.063 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -17.79 61.73 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.938 2.095 . . . . 6.1200000000000001 115.513 -174.203 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 4.3 t80 79.87 129.55 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.91 2.484 . . . . 2.4900000000000002 111.631 -177.405 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 t -175.77 142.85 0.65 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 129.378 3.071 . . . . 2.1099999999999999 107.774 174.358 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.08 -27.56 4.43 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.89 2.394 . . . . 1.4399999999999999 112.465 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.92 175.32 20.53 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.664 1.126 . . . . 0.82999999999999996 112.314 -174.545 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.57 -5.61 12.26 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 118.848 1.324 . . . . 0.93000000000000005 112.775 -4.35 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -147.26 160.98 41.86 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 123.435 1.588 . . . . 1.6499999999999999 114.358 -176.68 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.27 -176.93 4.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.74 2.816 . . . . 0.45000000000000001 110.454 -176.57 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.06 152.38 34.73 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.019 1.727 . . . . 0.76000000000000001 108.207 175.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.14 141.91 40.13 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.943 0.897 . . . . 0.64000000000000001 112.508 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 88.0 m-85 -105.87 74.33 1.05 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.129 2.172 . . . . 3.1200000000000001 108.776 174.026 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.425 HD13 HD11 ' A' ' 103' ' ' LEU . 2.3 pp -76.43 159.0 30.85 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.268 -0.895 . . . . 1.8799999999999999 111.43 -177.252 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 76' ' ' GLU . 28.5 m -140.25 147.25 39.7 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.431 1.092 . . . . 1.98 110.479 175.941 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.82 -178.11 5.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.346 2.258 . . . . 5.6299999999999999 108.69 169.907 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -140.45 123.93 16.97 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.807 -1.183 . . . . 4.5700000000000003 109.958 173.657 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -76.91 119.01 75.71 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.255 1.422 . . . . 1.5600000000000001 108.87 178.583 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.48 -17.99 33.9 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 121.974 1.783 . . . . 2.0 113.459 176.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.4 126.05 0.64 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 124.469 1.033 . . . . 2.8300000000000001 110.522 -163.847 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -178.66 -47.86 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.257 -2.497 . . . . 8.2699999999999996 104.257 -146.87 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -164.92 -171.21 0.25 Allowed Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 131.418 3.887 . . . . 4.6900000000000004 107.477 164.789 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.28 130.36 9.12 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 108.043 -1.56 . . . . 0.95999999999999996 108.043 159.592 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.486 HD12 ' CD1' ' A' ' 105' ' ' PHE . 2.8 mm? -91.86 156.52 17.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.691 1.234 . . . . 2.52 110.516 -175.835 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -153.47 107.04 2.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 113.736 -1.575 . . . . 1.77 111.571 -173.196 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.64 108.42 19.96 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.422 1.489 . . . . 2.4399999999999999 109.162 -171.395 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -106.66 -20.37 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 113.146 0.795 . . . . 0.68000000000000005 113.146 -169.829 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.49 -177.95 33.04 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 124.854 1.216 . . . . 0.41999999999999998 111.822 176.434 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.83 -179.51 5.44 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.819 0.848 . . . . 0.68999999999999995 111.18 171.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.42 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 1.9 mtt-85 -147.92 169.37 20.0 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.935 2.094 . . . . 3.8999999999999999 108.833 169.129 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.8 t 178.41 154.24 0.52 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.096 1.759 . . . . 0.85999999999999999 109.574 -171.105 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -89.39 -7.1 5.07 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.622 2.881 . . . . 0.72999999999999998 113.997 171.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.5 m -113.27 24.95 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 114.191 1.182 . . . . 0.88 114.191 -173.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.43 163.86 38.03 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.163 1.385 . . . . 0.81000000000000005 108.893 166.153 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -96.58 -30.84 13.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.141 1.776 . . . . 3.25 112.879 175.795 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 mtt85 -137.86 157.96 45.34 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.193 2.197 . . . . 5.2999999999999998 107.274 175.423 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 p -153.88 131.09 2.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 125.339 1.455 . . . . 1.1299999999999999 108.568 -176.145 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -140.16 133.14 29.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.199 0.999 . . . . 3.75 110.189 -160.066 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.3 tp -85.23 117.49 24.21 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.921 0.867 . . . . 1.3 111.436 -177.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.8 m170 -117.38 162.48 17.85 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.592 1.557 . . . . 0.62 112.859 176.758 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -113.11 -178.71 3.45 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.546 -1.661 . . . . 3.1800000000000002 110.801 163.885 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -148.67 135.65 20.0 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 106.594 -1.632 . . . . 1.27 106.594 172.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -131.71 169.03 16.75 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.275 1.43 . . . . 2.3300000000000001 113.138 -169.064 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.1 139.33 45.34 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.817 1.247 . . . . 5.7699999999999996 110.909 168.777 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -129.05 141.99 51.05 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.316 1.446 . . . . 5.4400000000000004 110.362 166.341 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -89.81 138.63 31.32 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.847 -1.168 . . . . 2.9399999999999999 107.847 154.317 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.0 t -133.94 116.14 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 106.43 -1.693 . . . . 2.4100000000000001 106.43 168.969 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.89 31.42 13.92 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.445 1.098 . . . . 5.0899999999999999 113.261 175.962 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.31 10.19 85.69 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 121.072 -1.018 . . . . 1.9399999999999999 114.112 -174.231 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -125.88 119.71 28.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.457 1.503 . . . . 3.0600000000000001 110.384 -173.312 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 135.16 35.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.265 1.426 . . . . 3.2799999999999998 111.472 -171.243 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.1 p -149.83 133.23 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 125.435 1.494 . . . . 2.9100000000000001 109.313 -178.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.7 mtp -83.8 165.43 18.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.532 0.682 . . . . 3.6200000000000001 111.657 177.33 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.59 178.65 27.89 Favored Glycine 0 C--O 1.224 -0.48 0 CA-C-N 115.357 -0.838 . . . . 0.87 111.717 170.086 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 ttm -147.07 143.15 28.13 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.833 1.653 . . . . 1.1299999999999999 107.4 -178.05 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -151.82 157.43 34.41 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.403 0.681 . . . . 4.8200000000000003 110.112 178.886 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.01 159.34 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.422 2.081 . . . . 0.56000000000000005 111.462 178.451 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.39 156.01 64.1 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.878 1.671 . . . . 0.58999999999999997 109.905 177.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.72 -24.83 2.14 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.855 2.37 . . . . 0.44 113.562 -167.029 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -176.34 169.87 2.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.497 1.919 . . . . 1.7 111.157 -178.667 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.99 154.37 26.57 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.068 1.347 . . . . 0.68999999999999995 110.554 159.583 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.19 142.09 46.2 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.614 1.565 . . . . 2.0800000000000001 108.003 173.762 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 t -143.65 128.9 9.78 Favored Pre-proline 0 N--CA 1.474 0.74 0 N-CA-C 112.458 0.54 . . . . 1.03 112.458 169.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.34 167.32 24.22 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.324 2.683 . . . . 0.91000000000000003 112.294 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.29 145.87 14.55 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.33 3.353 . . . . 1.1599999999999999 112.281 171.013 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt 73.49 -14.36 0.64 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.574 1.95 . . . . 3.1200000000000001 114.635 178.392 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.56 158.8 45.69 Favored Glycine 0 N--CA 1.472 1.088 0 CA-C-N 119.017 0.826 . . . . 1.3300000000000001 114.144 -168.149 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 mmt-85 -76.87 136.94 38.89 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.995 0.918 . . . . 4.0099999999999998 108.811 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.67 63.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.246 2.218 . . . . 5.6600000000000001 107.098 -174.158 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HB3' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -99.39 134.84 41.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.496 1.518 . . . . 3.6200000000000001 110.924 -177.756 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.32 94.15 8.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.185 -1.413 . . . . 1.8 107.185 164.416 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -46.12 115.83 3.2 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 117.638 -1.172 . . . . 2.5499999999999998 113.954 -168.964 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 30.0 Cg_endo -57.43 140.63 93.73 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.29 2.66 . . . . 3.71 112.536 176.734 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.56 -19.95 10.1 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.846 1.212 . . . . 2.73 114.343 -168.197 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.98 -98.7 1.73 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.003 1.402 . . . . 1.8300000000000001 113.331 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 77.6 m-85 -75.13 137.88 41.66 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 121.616 -0.932 . . . . 1.8300000000000001 111.756 -173.677 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -160.35 147.2 15.8 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.098 0.959 . . . . 0.59999999999999998 111.059 -174.262 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -82.39 127.24 33.06 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.089 -1.078 . . . . 2.1899999999999999 108.089 166.054 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -77.09 143.44 39.23 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.531 1.532 . . . . 0.92000000000000004 108.667 164.945 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.9 mt -128.3 112.14 14.14 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.983 1.313 . . . . 1.97 108.782 -173.45 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.5 132.21 56.37 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.494 1.117 . . . . 2.4300000000000002 109.954 -166.795 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.24 47.08 7.72 Favored Glycine 0 N--CA 1.472 1.095 0 C-N-CA 124.022 0.82 . . . . 1.8 113.965 173.191 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.5 mt -49.86 153.48 1.28 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 117.119 2.266 . . . . 0.66000000000000003 117.119 -173.596 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -117.3 -33.35 4.67 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.354 -1.748 . . . . 1.9399999999999999 113.399 -174.713 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -105.32 133.4 20.18 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 106.786 -1.561 . . . . 6.1100000000000003 106.786 156.404 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.15 135.01 28.48 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 N-CA-C 107.148 -1.904 . . . . 1.3899999999999999 107.148 156.623 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.23 157.99 16.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.347 0.594 . . . . 2.4399999999999999 111.05 -177.015 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.406 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -158.85 162.71 37.0 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.182 2.193 . . . . 4.4500000000000002 111.531 170.089 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.77 140.46 58.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.798 1.239 . . . . 1.1299999999999999 110.232 -175.772 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.79 48.41 28.14 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.416 -1.265 . . . . 1.9299999999999999 111.777 -170.158 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.26 176.49 7.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.762 1.225 . . . . 2.5600000000000001 108.524 153.911 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -137.38 162.1 34.51 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 127.657 2.383 . . . . 4.25 107.59 161.297 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 t -153.83 154.1 7.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 127.773 2.429 . . . . 1.51 110.088 -175.505 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -83.22 140.1 32.73 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 123.13 1.443 . . . . 3.6400000000000001 113.931 161.049 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mp -109.97 167.93 9.81 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.143 -1.39 . . . . 1.8899999999999999 108.526 148.95 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 62.3 m-20 -130.22 140.8 50.69 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.689 2.396 . . . . 2.5499999999999998 108.406 176.539 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.425 HD11 HD13 ' A' ' 20' ' ' LEU . 9.5 mp -103.26 127.37 50.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.252 1.421 . . . . 1.1699999999999999 109.735 175.528 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 mt -100.3 106.75 18.42 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.495 1.118 . . . . 0.68000000000000005 108.693 175.291 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.486 ' CD1' HD12 ' A' ' 30' ' ' LEU . 98.4 m-85 -97.86 125.23 42.63 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.036 0.934 . . . . 2.1600000000000001 111.629 177.933 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.56 15.06 0.45 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.894 2.077 . . . . 2.5099999999999998 115.36 176.701 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.59 -7.5 79.71 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.661 1.6 . . . . 4.9500000000000002 115.773 -178.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -134.53 -37.72 0.21 Allowed Glycine 0 N--CA 1.477 1.39 0 CA-C-N 119.438 1.619 . . . . 2.1400000000000001 116.483 -172.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -85.63 107.74 17.67 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.486 -1.596 . . . . 4.1799999999999997 110.851 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.0 t -99.73 132.86 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.94 0.896 . . . . 2.04 110.731 178.163 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.02 127.28 30.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 2.9500000000000002 111.868 172.383 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -79.88 141.67 35.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.711 1.604 . . . . 2.6800000000000002 114.174 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.61 164.18 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 127.989 2.516 . . . . 2.5800000000000001 109.91 170.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.4 t -135.16 132.66 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 106.647 -1.612 . . . . 1.6899999999999999 106.647 156.56 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.81 145.83 20.62 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.684 1.194 . . . . 2.2999999999999998 111.115 -167.822 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.61 161.69 39.23 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.552 2.835 . . . . 1.02 112.51 176.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.9 t -95.53 128.9 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.636 1.174 . . . . 1.04 110.025 164.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 128.283 2.633 . . . . 3.0499999999999998 109.031 -173.309 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 122.761 1.267 . . . . 4.6100000000000003 109.361 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.64 154.17 25.15 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.221 1.391 . . . . 1.45 113.612 171.031 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' TRP . . . . . 0.456 ' CD2' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -83.66 156.92 22.41 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.953 1.701 . . . . 7.9199999999999999 114.458 173.092 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -84.62 55.63 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 122.794 1.283 . . . . 3.02 110.19 165.431 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.456 ' HA ' ' CD2' ' A' ' 7' ' ' TRP 0.286 0.2 OUTLIER 27.58 -121.32 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 128.438 2.695 . . . . 5.25 115.043 -169.15 . . . . . . . . 4 4 . 1 . 030 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -166.35 131.3 2.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.346 1.458 . . . . 2.8100000000000001 109.182 -179.115 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -175.84 138.56 0.53 Allowed Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.96 1.304 . . . . 2.1600000000000001 110.306 -176.243 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.34 -38.85 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.666 2.244 . . . . 1.55 111.519 164.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.23 173.32 23.83 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.426 1.965 . . . . 1.1899999999999999 111.049 -173.544 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -77.76 2.44 25.93 Favored 'Cis proline' 0 CA--C 1.542 0.885 0 CA-C-N 119.559 1.679 . . . . 1.3400000000000001 112.722 -4.685 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -151.14 160.94 43.58 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 123.14 1.448 . . . . 2.0099999999999998 113.561 -175.158 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.69 -175.99 4.49 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.183 2.193 . . . . 0.41999999999999998 111.765 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.8 148.06 30.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.443 1.897 . . . . 0.72999999999999998 108.243 176.187 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.82 127.58 52.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.558 1.072 . . . . 0.81999999999999995 109.968 179.09 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.477 ' CE2' ' HA ' ' A' ' 79' ' ' PRO . 56.6 m-85 -116.2 78.93 1.24 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.054 1.341 . . . . 2.6400000000000001 109.59 -176.089 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -82.14 152.69 26.39 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.53 0.732 . . . . 2.4100000000000001 112.374 -179.387 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.1 m -84.1 130.71 34.84 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.675 -1.231 . . . . 1.8799999999999999 107.675 157.633 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.4 tp -96.7 133.3 41.41 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.071 -0.344 . . . . 4.3600000000000003 110.071 -179.533 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -124.69 129.29 50.24 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.629 1.172 . . . . 6.2000000000000002 112.215 -175.195 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -107.14 99.61 27.92 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.351 -0.843 . . . . 1.6399999999999999 110.506 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -81.16 -12.87 11.56 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.075 2.517 . . . . 1.6899999999999999 113.564 175.888 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.74 179.68 51.3 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.567 1.08 . . . . 1.6799999999999999 112.226 -175.963 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -105.05 0.45 27.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.115 2.166 . . . . 3.23 112.124 -174.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.12 161.08 51.6 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 128.363 2.665 . . . . 2.9300000000000002 109.665 176.377 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.32 143.29 27.91 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.168 1.912 . . . . 1.3899999999999999 110.995 -175.188 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.33 150.1 24.77 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.801 1.241 . . . . 2.46 109.558 171.142 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -136.56 97.18 3.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.316 -1.766 . . . . 2.3199999999999998 110.24 -174.718 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 tt -80.29 115.42 19.83 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.092 -1.077 . . . . 1.79 108.092 -175.626 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.81 -31.38 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.605 1.162 . . . . 0.75 112.58 -176.905 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.3 177.26 35.06 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 124.716 1.15 . . . . 0.67000000000000004 113.939 175.681 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.468 ' O ' HG11 ' A' ' 43' ' ' VAL . . . -124.38 160.13 28.83 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.821 -0.811 . . . . 1.25 110.549 169.147 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -130.52 157.36 42.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.458 1.903 . . . . 4.4699999999999998 108.432 167.314 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.5 t -165.71 148.31 6.56 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.152 1.781 . . . . 0.88 108.683 175.092 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -73.05 -19.71 22.65 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.521 1.481 . . . . 0.89000000000000001 113.609 -176.259 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 m -90.86 12.57 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 115.799 1.777 . . . . 0.84999999999999998 115.799 -176.058 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.28 155.39 38.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.518 1.303 . . . . 0.90000000000000002 114.518 173.382 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -92.1 -43.92 9.11 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.988 -1.005 . . . . 3.3799999999999999 113.695 -167.11 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -138.69 123.47 18.72 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.884 1.274 . . . . 6.0999999999999996 107.751 -167.362 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 35' ' ' ALA . 5.3 p -126.15 132.8 70.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.209 1.404 . . . . 1.29 109.479 -166.712 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -120.47 157.87 28.45 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.148 1.379 . . . . 3.1000000000000001 109.441 169.936 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.2 tp -105.58 117.69 34.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.798 1.239 . . . . 0.94999999999999996 108.686 169.972 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -118.89 147.61 43.8 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.122 1.369 . . . . 0.72999999999999998 113.533 -175.33 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.11 177.23 6.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.185 1.794 . . . . 2.3700000000000001 110.608 161.057 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -153.39 140.95 19.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.992 -1.855 . . . . 0.96999999999999997 105.992 174.434 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -153.43 173.18 16.01 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.243 1.201 . . . . 2.1000000000000001 114.243 -165.776 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.47 134.83 50.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.659 1.584 . . . . 5.5599999999999996 111.534 170.79 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.45 155.46 44.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.232 1.413 . . . . 6.1100000000000003 110.653 171.64 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -86.91 141.17 28.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.97 -0.752 . . . . 2.8700000000000001 108.97 157.864 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.9 t -135.69 115.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.165 1.786 . . . . 2.54 106.277 165.482 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 56.09 41.09 30.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.632 1.173 . . . . 4.7699999999999996 113.737 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.47 6.18 65.28 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.723 -1.236 . . . . 1.9299999999999999 114.281 -177.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -118.08 126.48 52.35 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.978 2.111 . . . . 2.7799999999999998 108.117 -178.017 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -76.86 121.93 24.1 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.921 1.289 . . . . 3.6000000000000001 109.533 -173.771 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.45 132.88 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.317 1.847 . . . . 2.4199999999999999 109.129 -174.295 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtt -80.55 166.66 20.94 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.154 0.798 . . . . 2.3599999999999999 113.154 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.97 177.07 32.43 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.1 0.857 . . . . 0.92000000000000004 113.426 179.246 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.5 ttm -155.93 140.56 16.96 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.524 1.529 . . . . 1.1200000000000001 109.707 -176.059 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -145.02 156.8 54.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.622 1.969 . . . . 8.8100000000000005 109.218 -176.597 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.46 151.97 15.44 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.761 2.308 . . . . 0.89000000000000001 110.629 170.677 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.25 155.51 79.84 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.477 1.511 . . . . 0.68999999999999995 110.449 -179.04 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.29 -27.59 3.47 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.945 2.43 . . . . 0.84999999999999998 113.094 -166.585 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -175.68 167.09 3.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.566 1.546 . . . . 2.2000000000000002 111.752 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.0 mt -113.27 153.31 28.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.469 1.908 . . . . 0.78000000000000003 110.355 166.166 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -117.14 142.77 46.59 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.879 1.272 . . . . 1.9099999999999999 109.434 176.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.3 t -140.97 128.49 12.09 Favored Pre-proline 0 N--CA 1.472 0.657 0 N-CA-C 112.436 0.532 . . . . 1.28 112.436 168.004 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.84 159.89 44.37 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.979 3.12 . . . . 1.4399999999999999 112.159 178.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.1 144.13 99.5 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.945 3.097 . . . . 1.6799999999999999 113.34 -176.198 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mptt 67.3 -9.56 0.39 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.589 2.356 . . . . 2.6200000000000001 114.483 -177.136 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.51 134.92 14.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.41 1.005 . . . . 1.6599999999999999 112.656 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.22 135.67 41.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.77 -0.826 . . . . 4.1699999999999999 108.77 155.948 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -147.07 129.53 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.031 1.732 . . . . 4.0199999999999996 107.65 -174.125 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -94.54 150.55 20.13 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.348 -0.845 . . . . 2.8599999999999999 112.565 -167.2 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.24 84.83 2.42 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.081 -1.451 . . . . 2.0099999999999998 107.081 156.867 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.428 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -64.08 145.5 97.94 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 120.949 -1.094 . . . . 2.71 113.261 -171.482 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.477 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 20.8 Cg_endo -55.36 -38.73 93.61 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.459 3.439 . . . . 2.1699999999999999 113.582 -174.421 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.14 24.3 19.54 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.199 -1.89 . . . . 2.2599999999999998 115.503 175.612 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.47 -15.11 0.02 OUTLIER Glycine 0 N--CA 1.476 1.315 0 N-CA-C 121.342 3.297 . . . . 2.2999999999999998 121.342 171.655 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -149.11 145.92 27.45 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 122.118 2.959 . . . . 2.1099999999999999 114.336 174.66 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -162.05 158.3 24.72 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.894 1.278 . . . . 0.68000000000000005 112.709 172.815 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -79.09 142.03 36.82 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.391 -0.818 . . . . 2.27 109.597 157.139 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 tpt -99.35 125.79 45.09 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.107 2.163 . . . . 1.1100000000000001 108.471 169.593 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mp -120.3 112.57 19.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.909 1.283 . . . . 1.4099999999999999 109.051 -173.08 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.15 155.33 18.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.242 1.417 . . . . 2.1299999999999999 110.928 -174.155 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.24 -48.82 3.99 Favored Glycine 0 N--CA 1.469 0.852 0 C-N-CA 126.822 2.153 . . . . 2.9900000000000002 113.05 173.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.9 mt 51.34 172.67 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.903 2.881 . . . . 0.82999999999999996 115.198 -172.105 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -137.9 -22.56 1.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.544 2.338 . . . . 2.5499999999999998 113.467 -176.75 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -137.63 143.99 42.91 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 128.566 2.747 . . . . 4.9400000000000004 109.178 175.892 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.43 145.38 37.96 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.31 2.007 . . . . 1.6000000000000001 108.351 155.062 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.64 119.6 39.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.851 0.86 . . . . 2.1699999999999999 111.203 -177.724 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -85.29 170.06 13.17 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.88 0.848 . . . . 3.8500000000000001 112.197 169.031 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.67 136.81 58.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.819 -0.628 . . . . 1.8100000000000001 109.32 157.715 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.79 9.51 87.01 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.291 -1.283 . . . . 1.75 114.954 174.247 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.63 173.06 10.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.982 1.391 . . . . 3.1400000000000001 108.792 160.359 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -145.47 151.68 38.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.64 2.376 . . . . 3.3599999999999999 106.869 169.726 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.4 t -153.08 139.87 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 127.105 2.162 . . . . 1.53 109.664 -176.166 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.21 144.29 34.53 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.489 0.922 . . . . 2.4700000000000002 113.489 173.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.1 mp -120.38 148.01 44.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.555 1.542 . . . . 1.8700000000000001 110.874 165.078 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.99 117.28 34.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.706 2.003 . . . . 2.8399999999999999 110.616 164.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -85.73 114.8 22.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.633 1.173 . . . . 1.3700000000000001 108.745 176.102 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.8 mt -90.91 114.03 26.39 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.646 1.178 . . . . 1.01 108.91 -175.665 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -113.07 117.22 31.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.613 1.565 . . . . 1.9399999999999999 112.495 -171.806 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 54.04 26.62 6.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.512 1.525 . . . . 2.1400000000000001 113.736 171.334 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.5 -68.93 2.64 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.144 1.354 . . . . 4.3799999999999999 112.351 -172.535 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.25 2.28 62.15 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 116.571 1.388 . . . . 1.8100000000000001 116.571 -166.267 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -129.44 139.04 51.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.445 1.623 . . . . 2.8500000000000001 111.078 173.529 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -137.74 142.47 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.425 1.49 . . . . 2.1699999999999999 108.196 176.73 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.3 tp -154.43 110.97 3.29 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.252 0.549 . . . . 2.27 112.279 -166.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -82.76 152.29 25.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.851 1.056 . . . . 2.1899999999999999 113.851 -170.7 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.14 167.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.128 1.771 . . . . 2.3999999999999999 110.291 178.3 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.26 138.58 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.307 1.043 . . . . 1.9299999999999999 109.744 -177.464 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.7 mp -130.17 134.16 25.78 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.038 1.735 . . . . 2.7000000000000002 110.744 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.63 177.71 7.68 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.298 2.665 . . . . 1.0 111.562 170.317 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 t -118.28 95.84 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.033 0.933 . . . . 1.1699999999999999 108.65 164.321 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.481 1.103 0 O-C-N 121.21 -0.931 . . . . 5.5999999999999996 113.282 -169.252 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 120.809 0.338 . . . . 9.2599999999999998 110.457 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.97 -171.98 13.6 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.087 2.28 . . . . 1.6499999999999999 110.78 177.358 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -121.81 178.27 4.93 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.004 1.483 . . . . 2.1699999999999999 115.004 -179.718 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.06 142.09 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.124 2.17 . . . . 1.47 107.106 172.217 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -79.36 -93.59 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.17 0.588 . . . . 7.2999999999999998 110.852 -178.697 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -161.59 150.56 15.94 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.92 -1.113 . . . . 3.3300000000000001 111.738 -170.941 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.16 127.73 25.8 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.523 1.129 . . . . 3.9900000000000002 111.444 176.215 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.49 -49.52 0.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 N-CA-C 109.126 -1.144 . . . . 4.0 109.126 154.143 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.04 141.3 9.33 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 108.872 -1.691 . . . . 1.4199999999999999 108.872 -155.171 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -86.91 14.93 44.17 Favored 'Cis proline' 0 CA--C 1.54 0.814 0 CA-C-N 120.308 2.054 . . . . 1.1899999999999999 112.63 5.166 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -144.22 171.54 14.15 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.343 1.238 . . . . 2.2599999999999998 114.343 -172.12 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.99 -177.03 6.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.03 2.532 . . . . 0.62 112.897 -176.443 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.0 141.46 22.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.657 1.583 . . . . 0.72999999999999998 110.122 177.537 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.24 153.61 36.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 0.66000000000000003 111.325 178.797 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -139.26 59.3 1.61 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.445 1.898 . . . . 2.1099999999999999 111.636 -168.368 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.86 167.37 17.46 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.612 1.338 . . . . 1.8100000000000001 114.612 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.3 m -101.41 146.46 27.58 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.84 1.656 . . . . 1.6599999999999999 110.628 -177.935 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.2 117.66 30.19 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.506 1.122 . . . . 4.0 110.012 172.783 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -123.23 128.35 49.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.961 -1.496 . . . . 4.2800000000000002 106.961 163.64 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -97.41 106.21 30.91 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.528 0.731 . . . . 1.3600000000000001 110.575 -179.473 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -84.58 -11.68 8.0 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.602 2.201 . . . . 1.0900000000000001 114.431 178.132 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.55 166.74 34.73 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 119.406 1.003 . . . . 1.2 111.422 -176.819 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.04 2.85 53.42 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.757 2.023 . . . . 3.3399999999999999 112.308 175.401 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -113.15 155.53 44.25 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.814 2.046 . . . . 3.3300000000000001 110.799 174.536 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -79.47 142.47 16.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.427 2.085 . . . . 0.92000000000000004 110.69 -178.08 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.91 142.61 30.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.903 0.859 . . . . 2.5899999999999999 109.575 172.513 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -138.02 106.15 5.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.608 1.963 . . . . 2.3500000000000001 108.724 178.135 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.47 106.16 18.2 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 128.31 2.644 . . . . 1.95 107.863 -170.27 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.3 m -104.35 -21.55 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.912 0.708 . . . . 0.69999999999999996 112.912 -167.434 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.41 -174.89 28.7 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.839 1.209 . . . . 0.62 112.395 175.398 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.36 179.7 6.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.639 0.733 . . . . 0.75 112.974 170.678 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -144.81 158.57 43.74 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.823 2.049 . . . . 4.96 107.873 161.905 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 t -164.6 145.2 6.34 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 125.717 1.607 . . . . 0.81999999999999995 108.542 175.324 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.24 -2.84 12.89 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.695 1.597 . . . . 1.1399999999999999 113.982 -175.914 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.6 m -107.03 11.98 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 116.174 1.916 . . . . 1.3300000000000001 116.174 -174.163 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.05 156.43 46.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.423 1.465 . . . . 1.22 113.283 177.377 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -86.41 -31.07 21.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.683 1.193 . . . . 3.1800000000000002 111.598 173.408 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -140.61 147.4 39.32 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.004 1.322 . . . . 4.6100000000000003 109.332 166.801 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.38 141.99 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.858 1.663 . . . . 0.98999999999999999 108.392 161.629 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -140.37 137.68 34.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.317 1.447 . . . . 2.9399999999999999 108.293 -171.449 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.3 tp -99.5 111.98 24.25 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.371 -0.831 . . . . 0.92000000000000004 111.922 -170.964 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -118.92 155.64 30.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.962 1.305 . . . . 0.76000000000000001 113.236 -176.614 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 9.4 pt-20 -100.25 176.51 5.35 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.579 1.552 . . . . 1.9099999999999999 112.187 159.951 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.3 m -143.64 136.27 27.26 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.1 -1.815 . . . . 1.2 106.1 165.085 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -138.77 164.65 29.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.97 1.308 . . . . 1.97 112.675 -165.672 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.5 ttp -99.42 142.64 30.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.929 1.292 . . . . 3.6899999999999999 109.943 170.931 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -142.75 145.16 33.04 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.903 1.681 . . . . 7.9800000000000004 111.278 173.22 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.93 141.39 34.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.466 1.106 . . . . 3.6699999999999999 109.903 158.768 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.3 t -138.44 121.19 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.159 1.783 . . . . 2.4500000000000002 106.4 170.699 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 62.39 15.98 8.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.506 1.522 . . . . 3.3700000000000001 114.011 -173.292 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.67 16.36 66.08 Favored Glycine 0 N--CA 1.477 1.402 0 O-C-N 120.979 -1.076 . . . . 2.1899999999999999 113.871 -170.356 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -121.37 121.11 36.91 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.686 2.395 . . . . 2.3300000000000001 108.394 -179.097 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.87 139.65 48.94 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.379 -1.45 . . . . 3.73 113.178 178.028 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.7 p -155.26 169.7 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 128.246 2.618 . . . . 2.52 108.347 176.762 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.0 mtm -100.29 172.1 7.37 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.787 -1.195 . . . . 3.8399999999999999 113.31 176.795 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.49 174.04 31.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.688 2.09 . . . . 0.60999999999999999 111.355 166.967 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ttm -136.43 153.73 50.99 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.33 1.852 . . . . 1.1599999999999999 108.08 175.948 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -159.13 156.06 25.41 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-O 118.076 -0.964 . . . . 4.6900000000000004 111.082 175.891 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.96 155.5 52.95 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.432 2.088 . . . . 0.56000000000000005 110.849 170.446 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -141.1 159.5 61.4 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 125.637 1.575 . . . . 0.84999999999999998 110.38 -175.199 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -82.19 -27.12 2.5 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.432 2.088 . . . . 0.67000000000000004 113.134 -168.412 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -177.59 164.82 2.08 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.378 1.471 . . . . 2.4199999999999999 112.171 -177.927 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.1 mt -107.94 160.21 15.94 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.93 1.292 . . . . 0.94999999999999996 110.376 160.272 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -145.15 147.58 32.65 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.235 -0.916 . . . . 2.04 111.521 -179.567 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.3 t -143.25 131.0 10.99 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.086 0.954 . . . . 1.1399999999999999 111.736 176.018 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.42 162.15 42.29 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 124.175 3.25 . . . . 0.90000000000000002 112.457 179.122 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -59.49 135.47 64.99 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.215 3.277 . . . . 0.97999999999999998 113.08 -177.419 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.55 -5.36 0.62 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.927 2.091 . . . . 1.8899999999999999 114.508 -179.51 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.84 167.92 51.86 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.917 1.722 . . . . 1.28 112.589 171.518 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.86 151.74 40.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.53 0.732 . . . . 5.8700000000000001 112.22 174.623 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 76' ' ' GLU . 29.7 t -146.83 -178.81 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 128.021 2.529 . . . . 3.5600000000000001 107.784 -178.498 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.48 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -146.83 154.52 41.44 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.347 1.859 . . . . 3.6200000000000001 108.206 171.191 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.7 mp -51.19 -38.88 54.81 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 123.048 0.539 . . . . 3.0600000000000001 111.899 175.788 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm 101.14 118.19 0.01 OUTLIER Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 127.773 2.429 . . . . 2.3300000000000001 109.906 161.605 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.24 -16.36 54.57 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.114 2.543 . . . . 2.7599999999999998 116.181 -161.06 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -115.34 7.16 20.89 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.655 1.121 . . . . 2.75 114.946 169.884 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.62 -110.09 1.93 Allowed Glycine 0 N--CA 1.47 0.915 0 C-N-CA 125.839 1.685 . . . . 2.1499999999999999 113.263 -171.123 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 60.2 m-85 -73.1 147.95 44.45 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 123.378 1.561 . . . . 2.1099999999999999 111.773 -175.873 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -159.68 142.39 13.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.579 -1.646 . . . . 0.97999999999999998 111.045 -178.24 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -79.88 111.24 16.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.972 -1.122 . . . . 2.0699999999999998 107.972 165.424 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.7 tpt -77.03 120.9 22.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.343 2.257 . . . . 1.0600000000000001 107.908 175.111 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.3 mt -109.74 122.22 47.0 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.272 1.429 . . . . 2.21 109.035 -173.206 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.98 143.76 46.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.691 1.196 . . . . 2.1899999999999999 111.415 -170.093 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.33 -43.22 2.85 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 127.248 2.356 . . . . 2.9300000000000002 113.955 175.519 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.8 mt 56.77 168.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 129.698 3.199 . . . . 1.05 115.637 -176.284 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -123.97 -30.83 3.46 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.97 1.708 . . . . 1.76 112.427 173.658 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -127.66 140.22 37.46 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 128.932 2.893 . . . . 5.7599999999999998 107.612 166.219 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.81 59.19 0.9 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.376 2.717 . . . . 2.79 112.717 -165.341 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -33.73 106.2 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 116.566 2.061 . . . . 3.0299999999999998 116.566 -157.704 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -100.95 168.63 9.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.265 1.826 . . . . 8.1300000000000008 111.043 169.047 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.69 134.2 50.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.93 0.892 . . . . 1.3400000000000001 110.724 -176.555 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.72 -6.33 52.05 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.26 1.886 . . . . 1.52 114.376 -175.331 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.59 -175.1 5.58 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.985 1.314 . . . . 2.9300000000000002 112.106 170.769 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.7 142.02 23.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 128.543 2.737 . . . . 6.5 107.247 -173.415 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 t -142.79 124.4 12.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 124.004 0.921 . . . . 1.74 110.68 -168.976 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -98.64 129.53 45.14 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.903 -1.044 . . . . 2.7400000000000002 110.707 -178.573 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.11 137.9 53.27 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.193 1.797 . . . . 2.52 110.3 179.091 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -97.92 124.2 42.25 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.324 2.25 . . . . 1.8 108.889 170.402 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.15 115.66 27.98 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.797 1.239 . . . . 0.98999999999999999 109.756 178.407 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.89 101.5 13.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.222 -0.658 . . . . 0.76000000000000001 109.222 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -94.29 136.9 34.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.161 0.984 . . . . 2.04 111.097 176.669 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.97 125.88 13.03 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.706 1.202 . . . . 2.04 113.449 -174.566 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.68 70.51 1.28 Allowed Glycine 0 N--CA 1.47 0.951 0 C-N-CA 124.259 0.933 . . . . 3.71 112.897 177.54 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.72 5.99 58.1 Favored Glycine 0 N--CA 1.474 1.224 0 N-CA-C 116.485 1.354 . . . . 1.6100000000000001 116.485 164.498 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -98.51 127.12 44.31 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.395 1.598 . . . . 3.52 109.878 -179.794 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.24 142.92 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.3 1.04 . . . . 2.2000000000000002 109.01 179.865 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.0 tt -152.5 135.98 15.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.336 1.455 . . . . 2.0 109.208 -177.841 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -102.1 140.42 36.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.354 0.662 . . . . 3.2400000000000002 112.433 -179.485 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.8 t -127.84 162.7 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 127.109 2.164 . . . . 1.76 108.311 175.575 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.9 t -128.33 141.25 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.397 1.479 . . . . 1.95 110.436 -178.662 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.3 mt -136.45 124.66 15.0 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.693 1.197 . . . . 2.2599999999999998 109.848 -164.957 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.67 149.36 48.72 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.048 1.832 . . . . 0.88 110.244 173.767 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.0 t -90.94 117.35 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.861 -0.792 . . . . 0.93000000000000005 108.861 167.792 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 108.12 -1.067 . . . . 4.04 108.12 175.25 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.088 0 N-CA-C 106.213 -2.755 . . . . 8.7200000000000006 106.213 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.68 147.35 3.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.109 0.455 . . . . 8.4299999999999997 111.662 127.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -161.33 138.9 9.06 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.132 2.173 . . . . 7.9500000000000002 109.659 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.8 p -80.08 57.06 2.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.353 1.061 . . . . 5.0700000000000003 111.123 167.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -85.56 123.79 31.38 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.699 1.199 . . . . 4.6500000000000004 112.038 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.68 179.32 35.33 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.65 1.119 . . . . 1.28 114.869 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -146.25 146.33 30.72 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.134 1.374 . . . . 2.4100000000000001 112.721 162.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -86.57 149.76 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.711 1.204 . . . . 1.4399999999999999 108.236 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -84.49 149.95 25.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.852 1.31 . . . . 3.8199999999999998 113.162 -176.035 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.416 ' H ' ' HD3' ' A' ' 9' ' ' ARG . 64.7 t80 -76.36 134.05 39.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.56 2.744 . . . . 2.1099999999999999 110.823 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.1 t 175.62 135.59 0.18 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.912 1.685 . . . . 2.3700000000000001 112.058 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.58 -24.85 21.61 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.441 2.094 . . . . 1.3899999999999999 112.506 170.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.2 171.59 12.27 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 127.074 2.273 . . . . 0.84999999999999998 111.375 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.65 -8.21 39.71 Favored 'Cis proline' 0 CA--C 1.538 0.692 0 CA-C-N 118.886 1.343 . . . . 0.92000000000000004 113.307 0.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -144.2 157.81 44.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.968 1.307 . . . . 1.8600000000000001 113.44 -172.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.02 -175.74 4.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.023 3.329 . . . . 0.42999999999999999 108.473 -176.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.34 176.81 8.37 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.155 1.382 . . . . 1.0600000000000001 109.173 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.8 138.17 19.49 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.685 1.13 . . . . 0.53000000000000003 112.327 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 17.7 m-85 -119.02 137.51 53.48 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.256 2.222 . . . . 2.0699999999999998 108.262 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -168.35 148.37 4.67 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.324 1.05 . . . . 1.6699999999999999 111.707 -172.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -89.53 122.21 32.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.923 0.889 . . . . 1.76 111.172 -176.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.401 HD11 ' CZ ' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -102.58 120.3 40.3 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.077 1.351 . . . . 3.1000000000000001 108.765 -177.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -122.13 141.75 51.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.527 1.131 . . . . 3.8999999999999999 111.3 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -117.05 108.94 43.31 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.393 1.077 . . . . 1.46 110.659 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.78 -10.99 10.4 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.939 2.426 . . . . 1.1599999999999999 113.848 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.25 175.88 49.93 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-O 122.787 1.215 . . . . 1.1699999999999999 113.224 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -99.41 -3.83 32.87 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.327 2.651 . . . . 3.0 111.43 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -122.37 157.27 59.23 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 128.336 2.654 . . . . 2.6699999999999999 109.883 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.0 145.8 31.86 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.788 2.325 . . . . 0.93000000000000005 111.137 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.1 mt -105.83 157.08 17.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 122.716 1.246 . . . . 1.9299999999999999 109.959 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -147.99 110.71 4.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.789 -2.005 . . . . 2.2400000000000002 112.724 -170.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.99 107.37 19.16 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.447 1.899 . . . . 1.8700000000000001 109.297 -173.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 m -103.71 -24.55 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.209 1.003 . . . . 0.67000000000000004 112.949 -168.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.34 -177.61 32.58 Favored Glycine 0 N--CA 1.466 0.686 0 C-N-CA 125.387 1.47 . . . . 0.48999999999999999 112.095 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.06 -178.84 5.27 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.057 -0.672 . . . . 0.56000000000000005 111.648 169.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.8 mtp-105 -144.32 177.07 8.89 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.237 1.815 . . . . 3.8199999999999998 108.273 158.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 t -172.92 152.31 2.36 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.158 1.783 . . . . 0.71999999999999997 109.517 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.39 -7.52 15.98 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.134 1.889 . . . . 0.81000000000000005 114.172 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.8 m -113.63 24.29 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 115.969 1.84 . . . . 0.78000000000000003 115.969 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.06 143.18 19.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.677 1.591 . . . . 0.88 110.977 169.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -68.87 -33.23 73.44 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.661 1.584 . . . . 3.1200000000000001 112.862 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -137.91 159.89 40.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.965 2.106 . . . . 4.4699999999999998 108.843 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.69 143.49 30.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.026 1.33 . . . . 0.93000000000000005 108.407 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -123.21 149.77 44.25 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.665 1.986 . . . . 2.6699999999999999 109.055 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.8 tp -102.3 121.75 42.89 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.573 0.749 . . . . 0.88 110.389 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -125.06 159.6 31.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 123.603 1.668 . . . . 0.48999999999999999 113.921 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -104.61 159.51 15.7 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.831 2.452 . . . . 2.1299999999999999 110.976 158.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.3 m -128.49 148.36 50.74 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 105.906 -1.887 . . . . 0.72999999999999998 105.906 165.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -159.97 175.89 12.49 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.992 0.917 . . . . 2.23 112.857 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.8 ttp -111.65 136.36 50.98 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.342 1.457 . . . . 3.2999999999999998 111.282 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -120.54 159.92 24.24 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.346 1.858 . . . . 4.75 110.611 171.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -90.68 147.99 22.91 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.451 0.7 . . . . 2.27 109.503 151.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.8 t -138.79 118.78 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.579 1.552 . . . . 2.2799999999999998 106.915 157.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 61.09 25.68 15.67 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.758 1.392 . . . . 3.3300000000000001 114.758 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.34 4.68 90.09 Favored Glycine 0 N--CA 1.481 1.647 0 O-C-N 120.044 -1.66 . . . . 1.79 113.984 -171.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -105.54 120.14 40.89 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.587 2.355 . . . . 2.5099999999999998 107.885 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -71.54 113.83 8.98 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.693 1.597 . . . . 2.6400000000000001 109.778 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.1 t -140.46 133.72 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.402 1.481 . . . . 2.1499999999999999 109.518 -172.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.7 mtt -79.5 171.88 14.56 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.347 1.24 . . . . 2.54 114.347 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.82 168.18 29.94 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.364 1.935 . . . . 0.79000000000000004 112.226 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.0 ttm -149.08 145.37 27.21 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.697 1.599 . . . . 1.0900000000000001 108.95 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -148.06 152.9 40.93 Favored Pre-proline 0 N--CA 1.467 0.4 0 C-N-CA 125.121 1.368 . . . . 4.4199999999999999 109.853 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.24 154.28 41.28 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.103 1.869 . . . . 0.5 110.742 163.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.05 157.95 70.45 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 125.768 1.627 . . . . 0.60999999999999999 110.309 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.22 -26.74 2.66 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.024 2.483 . . . . 0.58999999999999997 113.32 -167.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -177.43 164.54 2.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.662 1.585 . . . . 2.0499999999999998 111.763 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.2 mt -110.86 153.09 25.91 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.094 1.358 . . . . 0.72999999999999998 110.404 164.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -110.96 147.05 35.52 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.049 1.339 . . . . 2.0499999999999998 109.895 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.62 121.44 17.24 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 123.363 0.665 . . . . 1.4099999999999999 111.195 163.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.14 159.05 54.47 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.222 2.614 . . . . 1.1899999999999999 111.424 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.5 138.98 83.84 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.605 2.87 . . . . 0.93999999999999995 112.319 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt 65.63 -3.64 0.68 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.484 1.914 . . . . 1.7 114.032 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.08 -176.64 34.82 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 126.971 2.224 . . . . 1.1599999999999999 113.2 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -147.83 152.85 38.36 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.246 1.019 . . . . 3.5 112.406 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.81 134.24 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.805 1.642 . . . . 3.4900000000000002 107.735 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 143.82 31.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.305 1.042 . . . . 3.29 112.199 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -74.33 130.1 39.05 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.481 -1.303 . . . . 2.4399999999999999 107.481 151.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 155.2 73.92 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.445 1.498 . . . . 2.48 113.392 -170.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 38.4 Cg_endo -58.83 -36.72 96.53 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.507 2.805 . . . . 2.3199999999999998 113.731 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.26 12.89 36.03 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.592 -1.116 . . . . 1.79 115.001 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.35 -122.38 0.62 Allowed Glycine 0 C--N 1.343 0.937 0 CA-C-N 119.562 1.681 . . . . 1.76 114.778 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -71.34 140.9 50.4 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.049 -0.677 . . . . 1.8100000000000001 111.585 -168.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -161.88 153.97 19.35 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.288 1.035 . . . . 0.55000000000000004 112.137 -174.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -79.04 143.0 36.06 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.416 -0.587 . . . . 1.73 109.416 161.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -100.06 123.13 43.95 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.438 1.495 . . . . 0.70999999999999996 108.168 163.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -98.77 130.27 45.22 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.273 -1.01 . . . . 1.3300000000000001 108.273 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mp -129.32 139.05 51.88 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.672 0.789 . . . . 2.0099999999999998 111.326 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.33 47.03 8.49 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 123.588 0.613 . . . . 1.5800000000000001 112.223 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.413 HD13 HD23 ' A' ' 93' ' ' LEU . 10.5 mt -51.88 158.36 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 115.9 1.815 . . . . 0.87 115.9 -174.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -119.33 -32.83 4.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.035 -1.439 . . . . 1.6699999999999999 113.097 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -96.28 142.69 24.92 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.067 1.347 . . . . 4.8799999999999999 107.711 161.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 117.71 5.29 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 N-CA-C 106.33 -2.219 . . . . 1.4299999999999999 106.33 150.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.413 HD23 HD13 ' A' ' 89' ' ' LEU . 2.0 mm? -76.6 105.34 7.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.139 1.775 . . . . 1.9299999999999999 108.827 -175.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -98.56 171.91 7.84 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.746 1.219 . . . . 3.5699999999999998 111.452 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.9 131.77 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.216 -0.928 . . . . 1.0900000000000001 108.687 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.74 58.81 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.751 -1.027 . . . . 1.3400000000000001 114.576 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.83 -176.26 4.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.509 1.154 . . . . 2.3900000000000001 110.076 161.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -139.65 145.98 39.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 127.996 2.518 . . . . 2.79 105.851 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -146.42 149.28 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 127.537 2.335 . . . . 1.1299999999999999 108.871 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -111.87 150.13 30.85 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.066 0.946 . . . . 2.1400000000000001 113.091 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.4 mp -129.51 140.88 51.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.1 2.16 . . . . 1.6899999999999999 109.552 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -85.31 131.15 34.45 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.208 -1.034 . . . . 2.2000000000000002 108.208 160.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.88 109.8 21.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 121.239 1.836 . . . . 1.3 107.602 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.49 113.96 18.04 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.508 -0.923 . . . . 0.68999999999999995 108.508 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.401 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 9.2 m-30 -105.35 140.76 37.99 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.792 1.237 . . . . 2.1899999999999999 110.566 -175.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.03 126.73 28.67 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.49 -1.381 . . . . 2.3900000000000001 113.823 -173.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.34 75.84 0.85 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.785 1.183 . . . . 4.0099999999999998 112.739 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.8 72.62 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 115.473 0.949 . . . . 2.0 115.473 166.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -130.87 149.79 52.34 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.103 1.452 . . . . 3.46 112.236 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.8 t -149.01 147.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.175 1.39 . . . . 2.23 108.421 167.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.4 tp -126.2 113.74 17.4 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.869 1.267 . . . . 2.3999999999999999 108.985 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -83.3 133.44 34.97 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.731 -1.231 . . . . 2.0499999999999998 110.393 172.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -126.89 160.78 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.041 1.337 . . . . 1.72 109.167 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 t -133.15 137.71 52.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 127.125 2.17 . . . . 2.1000000000000001 107.591 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.22 150.85 20.33 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.752 1.221 . . . . 2.04 111.763 -169.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.36 163.88 30.46 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.258 2.639 . . . . 0.84999999999999998 112.387 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 t -100.48 124.37 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.393 -0.821 . . . . 0.92000000000000004 109.001 163.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -120.03 145.35 46.92 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.631 1.205 . . . . 3.7200000000000002 111.603 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.76 58.7 4.77 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.499 1.12 . . . . 2.0299999999999998 110.671 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.5 ttm-85 . . . . . 0 C--O 1.246 0.906 0 C-N-CA 125.757 1.623 . . . . 6.2699999999999996 110.144 177.218 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.309 0 N-CA-C 108.213 -1.955 . . . . 8.2200000000000006 108.213 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m 70.62 -162.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.116 -1.809 . . . . 7.4699999999999998 106.116 -114.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -135.04 101.25 4.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.965 1.711 . . . . 9.6699999999999999 110.402 167.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -139.07 -6.7 1.41 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.414 1.886 . . . . 4.5899999999999999 111.254 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -75.19 95.19 3.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.157 1.783 . . . . 4.6399999999999997 110.011 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.43 153.87 22.7 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 125.086 1.326 . . . . 1.1799999999999999 110.885 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -126.14 134.97 51.16 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.346 1.059 . . . . 2.52 111.367 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 t -84.26 56.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.065 1.346 . . . . 3.2000000000000002 109.166 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 32.08 -116.56 0.05 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.052 2.541 . . . . 4.4800000000000004 112.658 -171.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.0 t80 171.48 134.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.455 2.702 . . . . 2.5499999999999998 108.154 -173.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.5 t -178.31 144.54 0.49 Allowed Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.215 1.806 . . . . 1.97 110.745 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.76 -24.19 18.42 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.749 2.3 . . . . 1.24 112.513 164.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.22 -173.95 15.07 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.658 1.599 . . . . 0.84999999999999998 112.591 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.38 -12.66 19.68 Favored 'Cis proline' 0 CA--C 1.539 0.745 0 CA-C-N 118.55 1.175 . . . . 1.0700000000000001 113.475 1.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -125.05 169.83 11.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.803 1.641 . . . . 1.8500000000000001 111.718 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.67 -175.63 5.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.014 2.526 . . . . 0.62 110.96 -173.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.27 169.83 16.61 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.219 1.808 . . . . 1.1000000000000001 108.571 170.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.01 127.46 15.97 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.711 1.204 . . . . 0.75 110.99 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -107.27 66.58 0.67 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.861 2.064 . . . . 2.1299999999999999 110.122 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.27 153.06 42.69 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.183 -0.948 . . . . 1.74 111.942 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.439 HG23 ' HB3' ' A' ' 76' ' ' GLU . 88.5 m -130.83 132.33 45.15 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.737 1.215 . . . . 2.2200000000000002 108.785 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD21 HG21 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -154.26 178.02 10.47 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.998 2.119 . . . . 5.5499999999999998 109.382 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -139.67 160.24 40.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.385 1.474 . . . . 4.7999999999999998 110.772 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -103.66 96.78 9.42 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.367 1.867 . . . . 1.4399999999999999 109.335 171.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.8 -1.39 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.103 2.535 . . . . 1.3700000000000001 114.675 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.05 156.26 25.14 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.418 1.008 . . . . 1.3100000000000001 111.331 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.86 5.61 9.26 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.097 2.559 . . . . 4.0099999999999998 112.339 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.28 151.57 49.55 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 127.92 2.488 . . . . 3.2599999999999998 110.616 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.75 161.44 27.48 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.759 2.306 . . . . 1.02 111.58 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.1 mt -120.67 152.57 38.05 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 122.525 1.155 . . . . 1.96 110.985 169.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -132.64 118.22 18.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 112.558 -2.11 . . . . 2.1200000000000001 109.176 169.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.92 113.61 26.97 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.317 1.847 . . . . 1.77 107.724 -172.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 m -110.64 -24.6 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.54 0.736 . . . . 0.45000000000000001 112.83 -167.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.22 -174.85 28.45 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 125.053 1.311 . . . . 0.34999999999999998 112.884 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.4 -178.13 5.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.836 1.254 . . . . 0.45000000000000001 110.92 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.71 170.07 20.08 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.504 1.922 . . . . 5.9400000000000004 109.131 164.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -175.98 151.41 1.17 Allowed Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 127.12 2.168 . . . . 0.68999999999999995 109.117 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.0 -2.82 11.99 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.753 2.302 . . . . 0.88 114.111 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.05 28.72 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.578 1.551 . . . . 1.02 114.545 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.29 138.56 11.3 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.202 1.001 . . . . 1.0 111.76 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -65.55 -31.62 72.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.848 1.659 . . . . 2.8999999999999999 113.742 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -146.3 154.59 41.86 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.66 1.584 . . . . 4.6900000000000004 109.339 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -141.26 140.94 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.238 1.415 . . . . 0.83999999999999997 110.133 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -139.78 139.54 36.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.088 1.755 . . . . 2.8399999999999999 109.447 -166.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.6 tp -89.89 128.81 36.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.869 1.213 . . . . 1.4399999999999999 110.656 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -118.58 160.85 21.03 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.262 1.825 . . . . 0.93000000000000005 113.854 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -122.45 152.92 39.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.55 2.34 . . . . 2.27 109.991 167.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 m -129.84 135.47 48.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.524 1.53 . . . . 0.92000000000000004 107.7 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -150.5 171.24 17.38 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.542 1.163 . . . . 2.0600000000000001 113.673 -167.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.2 ttp -101.87 143.8 31.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.942 1.697 . . . . 3.8799999999999999 110.652 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -155.7 152.86 29.1 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.121 1.768 . . . . 8.2100000000000009 112.596 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 139.13 37.09 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.274 1.03 . . . . 2.6400000000000001 111.508 170.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.9 t -141.09 129.04 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 106.521 -1.659 . . . . 3.1299999999999999 106.521 164.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.59 29.99 17.0 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.195 0.998 . . . . 4.5300000000000002 112.392 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.37 16.56 78.79 Favored Glycine 0 N--CA 1.472 1.087 0 O-C-N 121.031 -1.043 . . . . 2.1400000000000001 114.167 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -133.48 133.6 42.45 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.405 1.482 . . . . 3.0600000000000001 110.758 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.32 122.86 22.7 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.078 1.351 . . . . 5.0499999999999998 110.493 -177.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -135.0 -175.78 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 129.492 3.117 . . . . 3.0 108.951 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -111.99 169.24 8.98 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.085 0.945 . . . . 2.79 113.401 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.24 171.93 33.45 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.636 2.065 . . . . 0.75 112.446 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.9 ttm -150.24 142.89 24.58 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.896 1.678 . . . . 1.76 109.364 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -144.01 155.58 58.76 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 125.483 1.513 . . . . 4.46 110.174 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -75.36 161.18 38.11 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.319 2.013 . . . . 0.73999999999999999 111.061 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.31 156.65 39.76 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.8 1.64 . . . . 1.1599999999999999 110.536 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.03 -25.68 1.71 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.366 2.711 . . . . 0.66000000000000003 113.813 -165.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -176.74 171.58 2.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.614 1.966 . . . . 2.4300000000000002 110.962 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.4 mt -116.07 153.04 32.42 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.346 1.858 . . . . 0.67000000000000004 109.942 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.1 145.02 42.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.803 1.241 . . . . 1.8700000000000001 108.029 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.9 133.96 12.66 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 118.664 0.665 . . . . 1.1299999999999999 112.759 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.41 170.83 12.74 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.56 2.84 . . . . 1.0600000000000001 112.704 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.36 147.32 87.31 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.105 2.537 . . . . 1.04 113.297 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.306 22.0 mtmt 54.75 44.95 27.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.636 1.574 . . . . 3.0 113.548 171.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.02 175.54 21.05 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.827 2.632 . . . . 1.1100000000000001 113.761 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -79.44 154.07 29.2 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.884 -0.774 . . . . 4.9400000000000004 112.406 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.47 66.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 127.259 2.224 . . . . 5.7599999999999998 107.253 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HB3' HG23 ' A' ' 21' ' ' THR . 2.1 pp20? -127.1 137.89 53.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.652 0.982 . . . . 2.7599999999999998 113.652 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.45 71.88 0.89 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.29 2.236 . . . . 2.1200000000000001 109.922 -170.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 140.02 17.46 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 125.754 1.622 . . . . 3.0499999999999998 113.674 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.01 -17.9 51.51 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.91 3.073 . . . . 1.99 114.826 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.14 10.14 61.68 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.086 -1.396 . . . . 1.8600000000000001 114.435 175.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.57 -111.2 0.26 Allowed Glycine 0 N--CA 1.473 1.13 0 CA-C-N 119.251 1.525 . . . . 1.4299999999999999 114.369 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -74.18 136.1 42.82 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.889 -0.771 . . . . 1.8799999999999999 112.318 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -160.79 164.96 31.09 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.793 1.237 . . . . 0.85999999999999999 111.796 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -92.84 140.7 29.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.544 0.611 . . . . 2.1400000000000001 111.141 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -93.98 135.96 34.77 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.902 1.681 . . . . 0.85999999999999999 109.478 163.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -114.54 135.71 53.83 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.863 1.665 . . . . 1.23 108.755 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.91 138.28 48.32 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.78 0.832 . . . . 2.1000000000000001 111.348 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.19 51.19 6.96 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.036 0.827 . . . . 1.6100000000000001 112.788 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.33 153.6 3.82 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 115.66 1.726 . . . . 0.81999999999999995 115.66 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -102.89 -16.13 15.98 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.939 1.459 . . . . 1.5700000000000001 114.939 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.2 mmt-85 -137.42 145.78 50.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 128.23 2.612 . . . . 6.5999999999999996 110.03 166.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.25 124.97 13.73 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 N-CA-C 106.649 -2.096 . . . . 1.4099999999999999 106.649 148.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.36 101.99 11.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.088 0.947 . . . . 2.3999999999999999 108.801 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.57 13.69 6.61 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.248 2.314 . . . . 4.8300000000000001 117.248 -152.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 74.92 151.0 0.12 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 129.493 3.117 . . . . 1.6899999999999999 112.498 -171.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.84 39.82 98.01 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.628 -0.989 . . . . 1.53 110.628 -165.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.58 171.27 7.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.96 1.704 . . . . 2.48 107.539 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -142.18 129.71 21.37 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.705 2.002 . . . . 3.7799999999999998 106.922 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.0 t -153.28 141.13 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.166 1.787 . . . . 1.6499999999999999 109.326 -162.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.41 ' OE1' ' HE2' ' A' ' 112' ' ' LYS . 9.6 pt-20 -86.42 147.47 26.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.657 1.354 . . . . 2.8900000000000001 114.657 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mp -121.29 146.48 46.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.832 1.653 . . . . 1.6499999999999999 110.5 164.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.58 134.67 38.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.04 2.536 . . . . 2.3100000000000001 108.245 161.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.84 130.96 46.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.849 1.26 . . . . 0.92000000000000004 108.072 164.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.4 mt -110.85 108.42 18.22 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.658 1.183 . . . . 0.66000000000000003 110.082 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -104.32 155.12 19.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.851 1.66 . . . . 2.1800000000000002 111.285 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.45 145.03 45.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.556 0.742 . . . . 2.6099999999999999 112.036 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.95 20.88 41.24 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.961 -0.911 . . . . 3.8199999999999998 114.598 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.46 9.22 86.98 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 118.521 1.16 . . . . 2.0499999999999998 113.901 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -79.32 106.83 11.63 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.357 -1.084 . . . . 3.0899999999999999 111.229 -174.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.5 p -115.89 115.84 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.199 1.4 . . . . 2.0800000000000001 110.848 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.9 mp -120.83 117.45 27.44 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.799 1.239 . . . . 3.1400000000000001 109.562 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.41 ' HE2' ' OE1' ' A' ' 100' ' ' GLU . 2.4 ttpm? -105.87 134.63 48.7 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.807 0.443 . . . . 2.6099999999999999 112.143 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.402 HG21 HD21 ' A' ' 22' ' ' LEU . 8.4 t -144.47 159.92 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.58 1.552 . . . . 2.8100000000000001 109.221 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -107.01 134.4 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.659 1.584 . . . . 2.6099999999999999 110.31 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.82 148.37 57.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.034 1.734 . . . . 3.1200000000000001 110.12 -169.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.05 170.33 19.22 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.516 2.811 . . . . 1.0700000000000001 113.374 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.68 121.19 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 127.291 2.236 . . . . 0.98999999999999999 109.589 169.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -158.85 150.78 21.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.788 1.28 . . . . 4.0999999999999996 114.1 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.53 53.65 2.74 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.58 1.326 . . . . 2.9300000000000002 114.58 -162.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? . . . . . 0 C--O 1.25 1.125 0 CA-C-O 116.871 -1.537 . . . . 7.8200000000000003 111.653 173.42 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.91 0 N-CA-C 107.868 -2.093 . . . . 11.83 107.868 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.9 150.12 18.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.467 0.634 . . . . 9.25 109.707 -148.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -68.57 130.17 42.07 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.375 -0.828 . . . . 9.4700000000000006 109.079 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 p 48.77 47.59 20.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.902 1.281 . . . . 9.1300000000000008 111.742 -171.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -77.86 164.81 24.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.061 0.944 . . . . 7.0599999999999996 110.325 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.47 -175.03 44.72 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.429 1.014 . . . . 1.51 111.633 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.2 p90 -142.59 -173.7 3.94 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.819 -0.812 . . . . 2.5800000000000001 112.988 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.4 t -122.61 129.23 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.029 -1.044 . . . . 1.9299999999999999 110.426 -169.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -48.88 -27.42 3.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.367 1.867 . . . . 6.6699999999999999 115.227 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 89.2 t80 69.42 116.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.452 2.701 . . . . 3.0899999999999999 111.437 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.1 m -170.12 150.48 3.62 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.13 1.372 . . . . 2.3799999999999999 110.231 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.17 -29.93 1.41 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.284 2.656 . . . . 1.3500000000000001 113.029 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.1 173.56 20.52 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.557 2.503 . . . . 1.01 110.538 -170.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -81.02 4.74 41.43 Favored 'Cis proline' 0 CA--C 1.541 0.827 0 CA-C-N 120.193 1.996 . . . . 1.6000000000000001 113.18 -3.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -148.26 164.86 32.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.159 0.98 . . . . 2.54 112.839 168.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.65 -178.14 4.93 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.049 2.139 . . . . 0.40999999999999998 109.771 165.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.49 154.82 49.82 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.949 2.1 . . . . 0.73999999999999999 107.183 168.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.82 142.67 49.09 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.073 0.949 . . . . 0.78000000000000003 110.434 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -124.03 19.98 9.14 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.608 1.336 . . . . 2.29 114.608 -160.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.402 ' HB3' HD22 ' A' ' 115' ' ' LEU . 2.4 pt? -51.48 161.46 0.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.753 1.76 . . . . 2.7200000000000002 115.753 -171.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -82.18 144.77 30.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.406 -0.815 . . . . 1.73 111.845 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.47 118.04 22.39 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.642 1.177 . . . . 3.8500000000000001 110.031 168.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -113.85 132.7 55.8 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.414 -1.328 . . . . 4.29 107.414 167.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -92.04 110.85 46.87 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.933 0.893 . . . . 1.3 109.321 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -85.07 -9.58 8.5 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.296 2.664 . . . . 1.3100000000000001 115.04 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.48 166.06 29.06 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 119.503 1.047 . . . . 1.3200000000000001 112.067 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.84 4.87 27.33 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.511 2.324 . . . . 3.5600000000000001 112.14 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.61 154.5 52.53 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 128.159 2.584 . . . . 2.9100000000000001 110.425 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.56 145.24 20.57 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.925 2.417 . . . . 0.89000000000000001 110.566 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 mt -105.04 148.55 26.65 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 122.319 1.057 . . . . 1.9099999999999999 111.649 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -130.22 112.08 13.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.283 -2.235 . . . . 1.8500000000000001 111.265 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.483 HD11 ' CZ ' ' A' ' 84' ' ' PHE . 2.4 tm? -100.16 111.12 23.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.242 2.217 . . . . 2.25 109.265 -172.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -104.11 -25.62 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.415 1.086 . . . . 0.51000000000000001 111.697 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.92 -175.89 32.43 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 125.022 1.296 . . . . 0.35999999999999999 113.432 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -140.94 -179.9 6.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.631 1.572 . . . . 0.45000000000000001 110.045 169.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -156.72 157.29 34.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.266 2.227 . . . . 4.4800000000000004 108.024 174.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -164.8 150.08 8.53 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.984 1.313 . . . . 0.81000000000000005 109.858 175.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.56 -12.14 33.7 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.96 2.44 . . . . 0.93999999999999995 115.061 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.7 m -109.64 16.56 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 116.732 2.123 . . . . 0.88 116.732 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.39 162.08 34.02 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.826 -1.171 . . . . 0.90000000000000002 114.144 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -100.07 -63.03 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.228 1.411 . . . . 2.6600000000000001 109.505 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -107.43 98.5 8.11 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.924 -1.11 . . . . 6.3700000000000001 110.382 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -79.01 141.62 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.223 -0.899 . . . . 1.54 110.189 164.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -153.26 138.37 17.34 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.5 1.52 . . . . 2.7799999999999998 109.4 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.0 tp -96.65 122.31 39.44 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.731 0.777 . . . . 1.01 112.023 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -121.97 161.56 22.69 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.911 1.685 . . . . 0.98999999999999999 113.779 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.13 -178.42 3.66 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.934 2.094 . . . . 3.1000000000000001 111.642 158.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.6 m -154.14 145.82 23.31 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.984 1.713 . . . . 0.97999999999999998 107.111 169.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -157.17 179.8 8.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.629 1.204 . . . . 2.4500000000000002 112.999 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.7 mtm -121.37 142.14 50.28 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.591 1.556 . . . . 5.2800000000000002 110.006 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -149.54 162.76 39.52 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.986 0.914 . . . . 5.2999999999999998 112.896 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.18 145.5 30.97 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.633 0.773 . . . . 3.0699999999999998 110.51 162.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.25 1.77 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 114.576 1.325 . . . . 3.3500000000000001 114.576 164.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -177.62 22.22 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.689 1.996 . . . . 4.6200000000000001 112.381 -168.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.41 -10.44 4.89 Favored Glycine 0 CA--C 1.543 1.798 0 O-C-N 119.148 -2.22 . . . . 2.1299999999999999 113.242 -160.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -95.13 130.49 41.82 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 129.346 3.059 . . . . 3.3900000000000001 108.213 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -77.1 117.37 18.59 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 128.04 2.536 . . . . 2.6899999999999999 109.149 -173.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -139.39 135.65 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.823 1.649 . . . . 2.2200000000000002 109.132 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.83 159.42 20.41 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 122.442 1.115 . . . . 3.2799999999999998 113.618 -175.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.02 164.98 24.99 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 125.103 1.335 . . . . 0.81000000000000005 112.451 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -149.38 132.96 16.74 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.271 1.428 . . . . 1.5 109.891 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -141.89 149.9 54.56 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.485 1.914 . . . . 9.1799999999999997 109.773 -170.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.43 153.66 39.94 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.228 1.952 . . . . 0.73999999999999999 110.012 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.18 148.95 64.48 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.157 0.983 . . . . 0.75 110.37 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.71 -23.08 13.0 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.525 2.816 . . . . 0.62 112.725 -170.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -173.93 172.51 3.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.296 1.838 . . . . 1.71 111.278 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -117.06 154.09 31.59 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.128 2.171 . . . . 0.59999999999999998 109.863 161.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -110.03 144.01 39.21 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.387 -0.968 . . . . 1.55 108.387 172.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.07 126.02 18.38 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.999 -0.524 . . . . 0.85999999999999999 111.285 163.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -68.2 164.22 33.09 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.788 2.992 . . . . 1.02 111.239 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.24 135.95 57.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.915 2.41 . . . . 0.98999999999999999 112.414 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.285 17.5 mtmt 59.27 40.18 21.66 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.018 1.39 . . . . 2.3300000000000001 113.193 171.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.37 164.72 26.9 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 127.926 2.679 . . . . 1.1299999999999999 113.699 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -113.82 146.52 39.83 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.18 1.792 . . . . 3.5899999999999999 111.732 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -139.82 116.45 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.5 1.12 . . . . 3.4199999999999999 108.481 152.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -79.92 148.31 31.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.961 0.905 . . . . 3.04 110.685 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mp -85.69 52.09 2.37 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.167 0.987 . . . . 2.52 112.707 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.94 146.21 8.2 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 115.424 1.638 . . . . 2.8900000000000001 115.424 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.24 -32.92 95.01 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.072 3.181 . . . . 3.0 114.076 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.32 31.24 1.38 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.475 1.036 . . . . 2.0299999999999998 113.433 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.72 -122.65 0.94 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.681 1.61 . . . . 1.6000000000000001 113.382 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -73.31 134.93 44.32 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 121.934 -0.745 . . . . 2.1699999999999999 112.761 -170.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -160.15 164.45 32.92 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.838 1.051 . . . . 1.01 113.838 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 73.8 m-85 -92.67 131.7 37.54 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 109.887 -0.412 . . . . 2.02 109.887 165.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 tpt -85.26 138.37 32.37 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.222 2.209 . . . . 0.81999999999999995 108.648 164.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.9 mt -132.24 91.39 2.94 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.44 1.496 . . . . 2.8300000000000001 109.221 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.0 mp -88.98 157.5 18.36 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.522 1.129 . . . . 2.5899999999999999 111.869 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.99 -52.67 4.77 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.322 1.915 . . . . 3.0499999999999998 112.577 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.5 mt 55.86 169.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 128.281 2.632 . . . . 1.0900000000000001 113.707 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -118.73 -25.88 6.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.937 -1.483 . . . . 1.6200000000000001 112.717 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -143.23 157.79 59.44 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 126.611 1.964 . . . . 6.2800000000000002 111.678 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.33 151.2 48.12 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.0 2.466 . . . . 1.5 110.467 158.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.93 148.0 22.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.83 1.252 . . . . 2.1299999999999999 111.524 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -95.73 -166.9 1.51 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.332 1.063 . . . . 4.75 111.122 164.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.49 152.05 24.17 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.737 1.215 . . . . 1.77 108.579 157.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.58 29.81 59.12 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.583 -0.565 . . . . 2.1499999999999999 114.287 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -109.63 -179.99 3.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.227 1.411 . . . . 2.5299999999999998 109.431 168.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -129.98 146.15 51.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 104.735 -2.32 . . . . 5.1500000000000004 104.735 164.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.3 t -138.76 139.49 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.861 1.665 . . . . 1.3799999999999999 109.628 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -92.1 144.96 24.91 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 122.831 1.3 . . . . 2.3399999999999999 112.787 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -135.98 140.71 44.14 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.71 2.404 . . . . 2.9300000000000002 109.207 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -88.74 140.58 29.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.218 1.807 . . . . 2.2000000000000002 109.064 164.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.5 mt -110.07 130.47 55.53 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.289 1.436 . . . . 2.1800000000000002 108.813 166.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.0 mt -110.06 125.15 52.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.097 1.359 . . . . 0.63 111.184 -174.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.06 153.28 37.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.457 1.503 . . . . 2.0299999999999998 112.549 -168.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.56 127.37 29.45 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.944 1.091 . . . . 1.95 113.944 -174.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.19 59.39 3.63 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.734 1.159 . . . . 3.6800000000000002 113.46 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.71 28.65 66.8 Favored Glycine 0 N--CA 1.474 1.17 0 CA-C-N 117.802 0.801 . . . . 1.72 115.074 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -113.7 145.01 41.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.937 1.369 . . . . 4.2999999999999998 112.242 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.1 150.63 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.212 1.405 . . . . 2.1600000000000001 111.969 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.4 tp -149.28 114.36 5.45 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.235 1.414 . . . . 2.3199999999999998 109.885 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -92.6 134.72 34.72 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.345 -0.847 . . . . 1.98 111.472 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 114' ' ' VAL . 40.4 t -133.7 173.94 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.839 2.056 . . . . 2.1600000000000001 108.322 -176.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.494 ' H ' HG12 ' A' ' 113' ' ' VAL . 11.0 p -149.98 127.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.919 1.288 . . . . 2.5299999999999998 110.431 -172.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -128.17 150.11 73.05 Favored Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 126.127 1.771 . . . . 2.5499999999999998 112.221 -171.241 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.36 148.3 43.12 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.772 2.981 . . . . 1.5 111.631 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 t -94.5 81.68 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.083 -1.08 . . . . 1.52 108.083 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -126.34 151.67 47.28 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.834 1.654 . . . . 4.3399999999999999 109.93 166.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.75 81.48 1.53 Allowed 'General case' 0 C--O 1.243 0.759 0 N-CA-C 113.777 1.029 . . . . 2.6400000000000001 113.777 -145.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.601 ' CZ ' ' HA ' ' A' ' 120' ' ' ARG 0.304 1.5 mmp_? . . . . . 0 C--O 1.252 1.211 0 CA-C-O 114.662 -2.59 . . . . 7.5 117.61 172.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.713 0 CA-C-O 118.047 -1.418 . . . . 12.109999999999999 110.519 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m -147.8 -16.0 0.37 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 117.045 2.239 . . . . 10.58 117.045 -161.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -175.0 37.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.602 2.761 . . . . 11.02 109.116 -176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 p -170.7 38.87 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.07 1.748 . . . . 4.71 109.363 -135.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -77.49 87.18 3.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.464 1.602 . . . . 4.7599999999999998 111.541 -167.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.78 -179.93 20.69 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.67 1.605 . . . . 1.27 110.195 168.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.3 p90 -142.13 160.36 40.39 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.339 1.055 . . . . 3.1099999999999999 112.035 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.28 136.39 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.514 -1.291 . . . . 1.22 107.514 164.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -51.82 -55.03 22.33 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.848 1.796 . . . . 4.2699999999999996 115.848 -155.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.4 t80 107.54 123.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 130.52 3.528 . . . . 2.5600000000000001 108.451 -154.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.4 m 175.52 131.33 0.15 Allowed Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 127.711 2.404 . . . . 2.5800000000000001 109.255 -176.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.71 -32.82 1.9 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.655 2.236 . . . . 1.29 112.577 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.13 176.14 22.15 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.77 1.652 . . . . 0.89000000000000001 111.678 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.05 -10.24 21.39 Favored 'Cis proline' 0 CA--C 1.537 0.647 0 CA-C-N 119.021 1.41 . . . . 0.98999999999999999 112.572 -3.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -143.52 162.87 34.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.497 1.519 . . . . 2.3900000000000001 112.315 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.14 -177.67 4.23 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.255 1.822 . . . . 0.62 111.623 -176.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -120.7 167.03 12.89 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.486 1.114 . . . . 0.92000000000000004 110.453 161.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.01 146.46 33.88 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.756 1.223 . . . . 0.71999999999999997 111.477 168.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -127.84 81.37 2.02 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.601 2.361 . . . . 3.3900000000000001 109.247 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.51 159.54 14.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.61 1.337 . . . . 1.71 114.61 -170.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.3 m -131.02 150.84 51.96 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.366 1.867 . . . . 1.79 109.311 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.602 HD21 HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -150.68 175.54 11.86 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.314 3.045 . . . . 5.0899999999999999 107.882 172.281 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -115.03 147.28 40.33 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 123.107 0.563 . . . . 4.6799999999999997 110.538 164.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -100.64 90.81 1.58 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.641 0.776 . . . . 1.3600000000000001 109.868 163.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.5 -5.07 16.39 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.756 2.304 . . . . 1.8500000000000001 113.96 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.25 178.55 53.89 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 122.831 1.24 . . . . 1.6399999999999999 113.793 -174.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -109.76 -1.28 18.04 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.405 2.282 . . . . 3.4900000000000002 112.132 -170.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -116.7 159.62 39.75 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 127.667 2.387 . . . . 2.9100000000000001 110.65 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.11 139.88 17.38 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.56 2.174 . . . . 1.04 111.004 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.44 HD12 ' CD1' ' A' ' 105' ' ' PHE . 1.4 mm? -104.37 159.29 15.84 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 125.829 1.652 . . . . 2.6099999999999999 110.965 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -155.27 111.0 3.09 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.724 -1.58 . . . . 1.73 111.155 -168.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.97 107.42 19.7 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.81 1.644 . . . . 2.5299999999999998 109.176 -171.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 m -104.59 -21.75 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.834 0.853 . . . . 0.64000000000000001 112.426 -169.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.38 -176.61 32.66 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 124.996 1.284 . . . . 0.47999999999999998 113.495 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.54 -178.74 6.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.55 1.54 . . . . 0.5 111.594 170.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -158.36 155.04 28.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.903 1.681 . . . . 3.9900000000000002 108.177 167.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.8 t -157.59 153.74 23.65 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.302 1.441 . . . . 0.77000000000000002 108.755 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.38 -12.19 14.17 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.127 1.885 . . . . 0.87 113.492 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.429 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 24.8 m -98.74 23.21 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.197 1.184 . . . . 0.97999999999999998 114.197 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -149.37 165.47 31.94 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.357 1.863 . . . . 1.1799999999999999 107.978 167.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.9 -35.76 9.29 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.687 1.195 . . . . 2.8199999999999998 112.617 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.54 177.68 7.43 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.673 1.589 . . . . 6.2599999999999998 107.71 171.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.62 150.67 10.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 125.468 1.507 . . . . 1.0800000000000001 108.254 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -131.11 156.88 44.49 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.166 2.186 . . . . 2.8100000000000001 109.11 174.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 tp -110.78 117.25 32.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.759 1.224 . . . . 0.83999999999999997 110.513 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -121.0 154.89 35.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.391 1.476 . . . . 0.75 113.192 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -95.23 154.32 17.24 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.335 -1.302 . . . . 1.95 110.267 155.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -103.48 146.0 29.17 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.642 -1.614 . . . . 0.98999999999999999 106.642 154.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -134.61 176.79 8.31 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.414 1.102 . . . . 2.0699999999999998 112.855 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.6 ttp -122.22 140.87 52.08 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.732 1.613 . . . . 3.23 109.823 170.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.74 145.89 48.89 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.878 1.271 . . . . 6.25 110.836 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -113.38 143.7 44.03 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.757 1.623 . . . . 2.8500000000000001 108.611 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.3 139.64 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.832 1.653 . . . . 4.3499999999999996 108.079 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 64.41 18.7 11.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.527 1.131 . . . . 5.5599999999999996 112.558 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.29 21.02 79.49 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.329 -1.482 . . . . 2.0299999999999998 113.057 -171.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -120.9 119.7 33.37 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.23 1.812 . . . . 4.0099999999999998 108.33 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.52 121.62 38.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.255 1.422 . . . . 2.8399999999999999 111.675 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.1 t -137.05 141.36 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.389 1.876 . . . . 2.2599999999999998 108.266 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.62 167.39 13.95 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.077 0.769 . . . . 3.5600000000000001 113.077 -176.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.92 -177.95 28.73 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 125.356 1.455 . . . . 0.80000000000000004 112.281 -172.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.3 ttm -158.76 149.68 20.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.903 1.281 . . . . 1.4299999999999999 109.552 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.7 ptt85 -160.89 151.96 15.66 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 123.921 0.888 . . . . 4.6799999999999997 111.707 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.48 150.98 52.68 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.156 1.904 . . . . 0.65000000000000002 111.204 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.58 150.8 73.12 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 125.246 1.418 . . . . 0.58999999999999997 109.827 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.85 -22.47 7.54 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.367 2.711 . . . . 0.57999999999999996 113.201 -166.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -177.99 166.59 2.03 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 2.1499999999999999 110.617 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.0 mt -109.44 154.45 22.6 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.478 1.111 . . . . 0.69999999999999996 110.077 161.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -113.65 144.69 42.5 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.346 1.458 . . . . 2.0600000000000001 109.289 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.0 130.58 10.23 Favored Pre-proline 0 N--CA 1.473 0.693 0 N-CA-C 112.541 0.571 . . . . 1.1200000000000001 112.541 169.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.86 168.46 18.62 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.286 2.658 . . . . 1.03 112.65 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.12 141.53 98.23 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.347 2.698 . . . . 1.26 111.598 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt 65.61 8.13 4.93 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.516 1.526 . . . . 1.95 113.053 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.58 150.66 24.6 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.714 2.102 . . . . 1.47 114.367 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -78.96 115.81 18.87 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.629 1.971 . . . . 3.71 111.141 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.47 55.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 122.484 1.135 . . . . 5.4500000000000002 108.946 -174.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.6 123.78 46.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.928 1.691 . . . . 2.9900000000000002 108.794 177.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mp -58.28 -56.19 25.31 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.469 1.107 . . . . 4.3099999999999996 112.439 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.595 ' HE3' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 139.59 140.94 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 131.618 3.967 . . . . 3.1600000000000001 111.176 178.578 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.21 131.94 26.42 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 N-CA-C 107.782 -1.661 . . . . 3.7999999999999998 107.782 159.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.89 -38.03 1.94 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.393 -1.226 . . . . 3.3399999999999999 114.794 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.8 -110.63 0.39 Allowed Glycine 0 N--CA 1.475 1.28 0 CA-C-N 119.165 1.483 . . . . 1.8200000000000001 113.692 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.76 141.3 49.74 Favored 'General case' 0 C--O 1.223 -0.319 0 O-C-N 121.617 -0.931 . . . . 1.97 111.007 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -158.3 143.19 16.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.716 -0.675 . . . . 0.76000000000000001 110.997 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -78.89 133.69 36.95 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.063 -0.717 . . . . 1.8700000000000001 109.063 167.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.2 tpt -92.74 119.44 32.12 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.697 1.599 . . . . 1.0600000000000001 108.086 168.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -103.88 105.69 15.97 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.475 1.51 . . . . 1.1499999999999999 110.161 -168.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.01 132.99 40.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.823 0.849 . . . . 2.4500000000000002 111.696 -166.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.08 47.47 7.56 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 123.954 0.788 . . . . 1.71 113.73 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 18.7 mt -49.02 154.89 0.69 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 116.345 1.98 . . . . 0.95999999999999996 116.345 -174.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 50.8 mmtt -119.22 -30.54 4.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 113.302 -1.772 . . . . 2.27 113.29 -176.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.455 HH21 ' CD ' ' A' ' 97' ' ' GLU . 9.9 mmm180 -106.74 144.89 29.96 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 126.444 1.897 . . . . 5.2699999999999996 108.173 160.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.92 128.06 13.65 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 N-CA-C 107.225 -1.875 . . . . 1.8799999999999999 107.225 153.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.29 115.72 22.62 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.741 -0.837 . . . . 2.2599999999999998 108.741 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.25 162.21 32.79 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.04 1.336 . . . . 4.7000000000000002 113.874 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 132.59 54.47 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.504 1.522 . . . . 1.3999999999999999 110.934 -172.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.23 44.86 16.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.023 -0.99 . . . . 1.3600000000000001 112.85 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.455 ' CD ' HH21 ' A' ' 91' ' ' ARG . 0.9 OUTLIER -103.67 167.06 10.03 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 117.787 0.793 . . . . 2.3999999999999999 109.044 148.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.43 128.34 46.85 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 102.625 -3.102 . . . . 4.9000000000000004 102.625 154.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.7 t -137.28 137.67 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.829 1.251 . . . . 1.55 109.999 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -84.54 155.97 21.87 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.061 1.504 . . . . 2.4100000000000001 115.061 -174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tt -155.31 140.3 17.34 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.127 2.171 . . . . 3.1000000000000001 110.902 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -84.38 127.87 34.25 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.899 2.08 . . . . 2.0699999999999998 109.29 165.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.16 127.0 35.15 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.563 -0.903 . . . . 1.22 108.563 161.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.5 mt -103.55 105.75 16.08 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 122.497 1.142 . . . . 0.73999999999999999 109.869 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.44 ' CD1' HD12 ' A' ' 30' ' ' LEU . 98.0 m-85 -96.16 152.76 18.26 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.146 1.379 . . . . 2.2799999999999998 111.354 174.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.45 127.51 20.18 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.55 1.14 . . . . 2.1299999999999999 113.643 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.22 66.1 2.25 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.573 1.082 . . . . 3.3700000000000001 112.793 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.5 11.81 80.18 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 115.792 1.077 . . . . 1.8300000000000001 115.792 167.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -96.15 104.14 16.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.779 1.79 . . . . 3.5600000000000001 110.983 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.82 143.23 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 123.863 0.865 . . . . 2.3799999999999999 110.685 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -145.07 108.02 4.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.209 1.004 . . . . 2.46 108.776 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -93.65 131.91 38.49 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.046 0.387 . . . . 2.1600000000000001 112.046 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.602 HG21 HD21 ' A' ' 22' ' ' LEU . 54.2 t -138.85 163.2 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.602 1.561 . . . . 2.3900000000000001 110.204 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.32 126.84 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.849 2.06 . . . . 2.0699999999999998 109.808 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.27 145.3 38.16 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 126.548 1.939 . . . . 3.1200000000000001 109.737 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.05 162.7 41.03 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.183 3.256 . . . . 1.1599999999999999 113.008 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.24 110.75 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 114.576 -1.193 . . . . 1.23 110.994 165.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -102.06 -175.64 2.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.19 2.196 . . . . 3.6800000000000002 109.324 156.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.12 94.38 4.86 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.476 -0.765 . . . . 2.3300000000000001 110.733 165.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.188 0 C-N-CA 126.411 1.885 . . . . 6.3600000000000003 110.313 -176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 108.883 -1.687 . . . . 9.7400000000000002 108.883 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m -142.26 161.04 39.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.661 1.184 . . . . 8.3000000000000007 109.316 -172.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -88.33 7.62 31.45 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.632 1.573 . . . . 11.470000000000001 112.549 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.1 t -165.48 148.06 7.75 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.261 1.424 . . . . 4.9400000000000004 110.317 -163.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' CG ' HG21 ' A' ' 21' ' ' THR . 10.3 pt-20 -159.75 59.06 0.38 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.419 2.288 . . . . 6.0 108.287 -155.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.83 167.58 29.92 Favored Glycine 0 N--CA 1.473 1.115 0 O-C-N 120.858 -1.151 . . . . 1.05 114.334 -167.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -152.76 169.27 23.18 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.852 1.427 . . . . 2.1800000000000002 114.852 -172.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.2 t -106.67 144.8 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.177 1.791 . . . . 1.23 107.13 168.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.26 0.6 OUTLIER -73.18 -100.11 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.388 0.884 . . . . 3.9100000000000001 113.388 175.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -161.21 143.46 12.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.242 1.817 . . . . 2.4900000000000002 109.5 -167.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t 171.81 136.17 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 126.93 2.092 . . . . 2.3100000000000001 111.676 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.08 -27.47 6.78 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.745 2.297 . . . . 1.6000000000000001 111.901 166.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.39 171.91 17.01 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 126.696 2.093 . . . . 1.05 111.195 -175.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -78.46 -9.0 35.88 Favored 'Cis proline' 0 CA--C 1.537 0.631 0 CA-C-N 118.508 1.154 . . . . 1.01 113.045 -0.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -151.36 167.89 26.5 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.734 1.214 . . . . 1.8899999999999999 113.374 -168.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.87 -177.51 6.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.485 2.314 . . . . 0.54000000000000004 111.72 -173.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.42 39.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.402 1.481 . . . . 0.96999999999999997 108.576 169.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.14 141.78 47.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.656 1.582 . . . . 0.59999999999999998 110.544 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.522 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 51.3 m-85 -121.42 70.78 0.94 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.724 2.01 . . . . 2.0499999999999998 110.835 -171.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -90.85 164.47 14.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.089 0.955 . . . . 1.98 113.21 -170.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.425 HG21 ' CG ' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -95.88 124.61 39.97 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.457 -0.777 . . . . 1.8899999999999999 110.299 175.046 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.2 tp -96.23 104.08 16.02 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.198 -1.038 . . . . 5.1699999999999999 108.198 167.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -82.46 171.24 14.36 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.663 0.744 . . . . 5.8700000000000001 111.929 165.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -134.58 101.12 12.07 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.566 0.747 . . . . 1.3400000000000001 109.417 155.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.78 -11.86 11.24 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.158 2.572 . . . . 1.55 112.992 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.23 178.92 49.45 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-O 122.749 1.194 . . . . 1.1899999999999999 112.55 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -104.29 -1.73 26.6 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.076 2.15 . . . . 3.1299999999999999 112.3 -173.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.9 mt -124.8 162.98 39.99 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 127.782 2.433 . . . . 3.6299999999999999 109.323 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.59 158.44 28.63 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.354 2.036 . . . . 1.0800000000000001 111.503 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mp -118.28 154.69 31.87 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.161 1.784 . . . . 2.1899999999999999 110.019 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -138.51 110.29 7.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 113.494 -1.685 . . . . 2.04 109.511 173.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.7 118.41 30.63 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.727 1.611 . . . . 1.8999999999999999 107.727 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 m -113.53 -22.43 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.181 0.993 . . . . 0.48999999999999999 112.691 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.32 -176.91 31.91 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 124.359 0.98 . . . . 0.42999999999999999 113.31 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.5 178.12 6.7 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.718 -0.872 . . . . 0.44 112.17 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -150.2 148.87 29.44 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.635 2.374 . . . . 7.5300000000000002 107.957 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 t -164.82 148.81 7.73 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 117.934 -1.031 . . . . 0.62 110.158 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.78 -12.11 21.97 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.174 1.916 . . . . 0.72999999999999998 114.78 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.63 20.82 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.125 1.528 . . . . 0.88 115.125 -170.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.36 150.25 25.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.486 1.514 . . . . 0.98999999999999999 109.075 169.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.85 -47.67 7.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.532 1.133 . . . . 3.3500000000000001 112.832 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -122.33 98.7 6.05 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.453 -1.314 . . . . 6.2599999999999998 107.453 -171.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.26 125.89 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.697 -0.683 . . . . 0.81999999999999995 109.802 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -116.82 150.46 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.71 2.004 . . . . 2.7000000000000002 109.069 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.4 tp -105.12 118.64 37.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.043 0.937 . . . . 0.88 110.356 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.1 m170 -124.64 155.29 39.41 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.046 1.338 . . . . 0.51000000000000001 114.123 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -100.43 162.54 12.87 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.867 1.667 . . . . 2.21 112.484 158.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.0 m -132.33 144.41 50.54 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.876 2.07 . . . . 0.73999999999999999 105.661 167.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -152.76 170.14 21.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.908 0.883 . . . . 2.02 112.491 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.9 ttp -98.83 140.1 33.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.92 1.288 . . . . 3.4500000000000002 110.812 173.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.3 148.18 32.15 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.018 1.727 . . . . 5.2800000000000002 111.314 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.92 144.49 26.15 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.298 1.039 . . . . 2.4199999999999999 108.572 166.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -141.83 138.05 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 107.806 -1.183 . . . . 2.79 107.806 155.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 59.11 22.85 11.02 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.847 1.425 . . . . 4.3200000000000003 114.847 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.31 17.83 79.75 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 120.717 -1.24 . . . . 1.6699999999999999 113.956 -170.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -109.45 122.57 47.69 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.626 1.971 . . . . 2.25 107.558 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -79.81 117.99 21.19 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.767 1.227 . . . . 3.0699999999999998 108.642 172.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 m -141.68 -175.76 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.709 2.404 . . . . 2.5 109.858 -171.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.76 175.74 5.39 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.807 0.843 . . . . 3.0 112.974 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.9 170.2 33.12 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.62 2.057 . . . . 0.80000000000000004 111.94 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -149.31 137.96 21.02 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.441 1.496 . . . . 1.1299999999999999 109.817 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -143.73 151.63 53.91 Favored Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 125.618 1.567 . . . . 8.8499999999999996 110.605 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.99 151.9 45.49 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.132 1.888 . . . . 0.57999999999999996 109.98 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.9 m -137.5 153.51 74.46 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.013 1.325 . . . . 0.56000000000000005 109.994 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.59 -28.12 2.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.719 2.279 . . . . 0.45000000000000001 112.805 -165.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -177.2 165.75 2.31 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.047 1.339 . . . . 2.0800000000000001 112.483 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.2 mt -109.91 152.0 26.37 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.673 1.589 . . . . 0.79000000000000004 111.051 162.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -121.89 136.76 54.94 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.584 1.553 . . . . 2.1600000000000001 108.407 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.8 t -143.69 129.4 9.97 Favored Pre-proline 0 N--CA 1.475 0.808 0 N-CA-C 113.665 0.987 . . . . 1.1599999999999999 113.665 174.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.81 161.66 43.18 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.161 3.241 . . . . 1.23 111.693 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.63 141.07 96.5 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.557 2.838 . . . . 1.1000000000000001 113.172 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 69.15 0.23 2.74 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.919 2.088 . . . . 2.1000000000000001 114.572 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.53 175.73 47.63 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.928 1.728 . . . . 1.0800000000000001 113.223 171.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.08 132.87 11.39 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.21 1.004 . . . . 5.6600000000000001 112.725 173.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.5 t -125.18 108.4 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.381 2.272 . . . . 3.5499999999999998 109.524 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.5 126.92 31.66 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 127.879 2.471 . . . . 3.6299999999999999 112.21 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -74.12 75.46 1.76 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.986 1.714 . . . . 2.1299999999999999 109.811 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -68.07 155.11 92.76 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 114.819 1.415 . . . . 2.4100000000000001 114.819 -173.354 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.522 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 37.0 Cg_endo -59.34 -15.81 31.46 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.323 3.349 . . . . 2.3700000000000001 116.628 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -97.92 -1.04 58.62 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.265 -1.297 . . . . 1.95 115.292 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.86 -115.66 0.9 Allowed Glycine 0 N--CA 1.473 1.136 0 CA-C-N 119.908 1.854 . . . . 1.54 113.958 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -70.79 141.55 51.4 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.17 -0.606 . . . . 1.8100000000000001 110.386 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -161.45 160.25 29.08 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.758 1.223 . . . . 0.64000000000000001 111.582 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -92.7 130.8 38.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.546 -0.539 . . . . 1.9099999999999999 109.546 166.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 tpt -84.96 128.8 34.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.072 1.349 . . . . 0.76000000000000001 108.89 166.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -114.74 107.53 15.58 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.36 1.064 . . . . 1.1000000000000001 108.614 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mp -107.45 148.91 28.54 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.045 0.839 . . . . 2.29 111.036 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.82 43.39 28.26 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.993 -0.893 . . . . 1.71 113.353 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 mt -46.62 150.88 0.63 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.999 1.481 . . . . 0.87 114.999 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -108.01 -21.31 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 112.986 -1.916 . . . . 2.0899999999999999 114.248 -172.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.92 145.83 58.75 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 126.699 1.999 . . . . 5.75 110.548 162.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -66.69 154.31 74.91 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.085 1.857 . . . . 1.47 108.777 162.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.85 159.76 43.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.466 1.127 . . . . 2.7200000000000002 112.547 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.55 173.9 6.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.923 2.089 . . . . 4.7400000000000002 111.301 -165.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.14 135.72 56.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.231 1.012 . . . . 1.45 112.857 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.69 40.37 31.88 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 114.828 -1.078 . . . . 1.5800000000000001 113.428 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -113.89 176.33 5.08 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.497 1.119 . . . . 2.7599999999999998 108.992 157.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -121.96 164.3 17.84 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.662 1.585 . . . . 2.9399999999999999 107.161 159.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.0 t -148.94 154.77 9.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 130.588 3.555 . . . . 1.6499999999999999 109.053 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.95 138.53 54.38 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.366 1.466 . . . . 2.9399999999999999 111.252 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.62 137.2 54.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.863 1.265 . . . . 1.8500000000000001 110.962 165.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.8 138.51 31.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.264 1.826 . . . . 2.4300000000000002 110.044 155.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.3 136.61 34.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.509 1.924 . . . . 1.27 109.45 167.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt -107.16 118.5 36.87 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.7 1.6 . . . . 0.64000000000000001 109.519 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -109.49 156.25 20.34 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.647 1.179 . . . . 1.99 111.041 -175.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.05 141.66 58.67 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.465 -0.772 . . . . 2.3500000000000001 110.748 164.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.54 35.68 11.55 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 119.066 -0.852 . . . . 4.1799999999999997 114.951 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.97 7.47 84.08 Favored Glycine 0 N--CA 1.476 1.317 0 CA-C-N 118.234 1.017 . . . . 1.8799999999999999 115.553 167.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -89.53 137.28 32.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.063 0.932 . . . . 3.2000000000000002 111.261 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.31 131.53 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.56 1.544 . . . . 1.8700000000000001 108.079 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.27 143.56 27.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.763 1.625 . . . . 3.52 109.189 -174.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -120.3 151.84 38.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.291 1.589 . . . . 2.3100000000000001 115.291 -172.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.0 m -122.98 153.04 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 128.062 2.545 . . . . 3.0299999999999998 110.825 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.2 138.72 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.106 1.762 . . . . 3.02 109.609 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -141.29 125.4 10.28 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.401 1.08 . . . . 2.6699999999999999 111.547 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.78 167.11 24.4 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.788 2.325 . . . . 1.1299999999999999 110.776 162.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.25 149.33 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.909 1.284 . . . . 1.0600000000000001 110.508 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -135.56 -172.49 3.1 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.514 1.925 . . . . 4.9299999999999997 112.817 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.11 66.97 1.28 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.258 1.823 . . . . 3.0899999999999999 112.156 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.183 0 C-N-CA 124.318 1.047 . . . . 8.8399999999999999 113.384 -172.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 CA-C-O 118.98 -0.9 . . . . 13.34 113.86 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 t -170.67 168.25 7.55 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.088 1.444 . . . . 11.109999999999999 109.469 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -75.06 78.07 2.24 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.404 1.002 . . . . 11.32 109.492 172.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 175.89 -42.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 1 C-N-CA 131.784 4.034 . . . . 7.1900000000000004 109.203 -160.634 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.33 134.93 5.75 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 123.482 1.61 . . . . 6.2199999999999998 112.161 177.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.54 157.54 15.78 Favored Glycine 0 C--N 1.329 0.155 0 CA-C-N 114.082 -1.417 . . . . 2.1299999999999999 110.039 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -92.42 162.55 14.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.611 1.196 . . . . 2.71 112.268 -160.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -80.34 132.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.49 -1.3 . . . . 1.1699999999999999 107.49 157.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -21.24 59.01 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.116 1.895 . . . . 6.2800000000000002 116.116 -163.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 t80 85.75 144.01 0.06 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.972 2.909 . . . . 2.77 111.201 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 t -171.28 150.9 2.93 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.672 1.189 . . . . 2.1499999999999999 112.233 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -81.37 -18.5 8.36 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.344 2.696 . . . . 1.5 112.109 158.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.81 -170.17 13.73 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 126.754 2.121 . . . . 1.28 111.631 -170.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.64 -3.54 22.15 Favored 'Cis proline' 0 CA--C 1.54 0.817 0 CA-C-N 119.196 1.498 . . . . 1.6499999999999999 112.477 -9.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -136.02 176.91 8.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.778 1.231 . . . . 4.3899999999999997 110.843 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.59 -174.54 4.98 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.611 2.365 . . . . 0.60999999999999999 112.133 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.47 149.25 28.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.957 2.503 . . . . 0.70999999999999996 108.452 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -135.52 136.5 41.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.857 1.208 . . . . 0.66000000000000003 113.417 -175.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 28.8 m-85 -106.5 41.12 1.49 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.715 1.606 . . . . 2.3199999999999998 114.09 -170.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.38 155.89 33.94 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.336 1.606 . . . . 1.75 115.336 -167.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 76' ' ' GLU . 54.8 m -99.71 143.29 30.11 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.438 1.095 . . . . 1.6000000000000001 112.128 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.47 123.62 47.93 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.83 2.452 . . . . 3.29 111.804 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -102.97 141.05 36.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.589 0.756 . . . . 3.7200000000000002 109.537 158.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -108.34 84.31 2.26 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.756 -0.59 . . . . 1.53 109.928 159.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.8 -10.05 24.46 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.424 2.083 . . . . 1.3999999999999999 113.181 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.73 176.43 47.75 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-O 122.861 1.256 . . . . 1.3899999999999999 113.1 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -102.02 -8.62 21.32 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.759 2.424 . . . . 3.3700000000000001 112.179 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.0 mt -132.01 152.56 80.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.523 1.929 . . . . 3.96 109.264 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.83 167.74 24.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.093 2.528 . . . . 1.5800000000000001 113.698 -152.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mp -115.05 147.98 39.47 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.29 1.836 . . . . 2.3700000000000001 108.683 168.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.23 98.92 3.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 112.855 -1.975 . . . . 2.52 108.737 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.3 tp -83.67 102.37 12.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.878 2.071 . . . . 2.1200000000000001 109.387 -168.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -94.7 -25.3 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.917 1.287 . . . . 1.21 111.711 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.06 -176.85 31.57 Favored Glycine 0 C--N 1.343 0.922 0 C-N-CA 123.792 0.711 . . . . 0.53000000000000003 114.092 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.24 -177.88 5.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.935 1.694 . . . . 0.56999999999999995 110.382 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -156.51 175.25 14.28 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 127.434 2.293 . . . . 5.8700000000000001 107.948 161.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t -162.7 152.2 13.12 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 128.755 2.822 . . . . 1.4099999999999999 106.796 166.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.07 -29.65 39.74 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 120.894 1.355 . . . . 1.9099999999999999 111.918 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.6 m -86.78 14.63 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 115.299 1.592 . . . . 1.9299999999999999 115.299 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.09 138.48 25.37 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.586 1.539 . . . . 1.1599999999999999 113.89 168.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.54 -26.84 41.35 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.837 1.421 . . . . 4.0099999999999998 114.837 -165.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -146.63 165.7 28.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.908 2.083 . . . . 5.0599999999999996 108.341 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.88 143.89 15.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 124.972 1.309 . . . . 1.1000000000000001 109.383 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -118.57 158.04 26.18 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.654 1.982 . . . . 3.2799999999999998 109.512 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 tp -106.88 117.56 34.39 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.538 0.735 . . . . 0.87 110.307 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -119.86 165.08 15.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 123.516 1.627 . . . . 0.68000000000000005 113.897 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -121.57 162.6 20.32 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.18 -1.827 . . . . 3.5899999999999999 111.501 156.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.4 m -118.01 139.56 51.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.19 2.196 . . . . 0.93000000000000005 106.158 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -136.48 169.31 17.9 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.578 1.18 . . . . 1.8999999999999999 113.736 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.2 ttp -111.55 147.27 35.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.281 1.833 . . . . 3.3599999999999999 109.102 170.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 153.53 38.3 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.802 1.241 . . . . 5.4400000000000004 110.505 -174.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -105.23 138.58 41.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.351 1.46 . . . . 3.4900000000000002 110.267 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.25 113.98 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.625 -1.25 . . . . 2.4700000000000002 107.625 169.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 66.66 14.25 9.69 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.238 1.815 . . . . 3.8599999999999999 114.33 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.5 20.43 58.5 Favored Glycine 0 N--CA 1.477 1.376 0 O-C-N 121.249 -0.907 . . . . 2.6499999999999999 113.467 -167.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -119.3 125.95 50.3 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.956 1.703 . . . . 2.4700000000000002 109.305 172.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -88.08 123.06 32.37 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.764 1.226 . . . . 4.8600000000000003 111.249 -170.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.0 t -141.68 141.06 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.2 1.8 . . . . 2.3100000000000001 109.601 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -93.56 168.45 11.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.339 1.056 . . . . 3.1699999999999999 113.051 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.04 -178.73 31.39 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.94 1.257 . . . . 0.68000000000000005 113.634 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ttm -152.66 150.1 29.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.963 1.705 . . . . 1.1499999999999999 108.816 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -158.22 154.26 23.56 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 118.23 -0.89 . . . . 4.8300000000000001 111.776 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.93 154.98 62.87 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.23 1.954 . . . . 0.52000000000000002 111.155 169.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.66 151.66 63.94 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.014 1.326 . . . . 0.56000000000000005 110.241 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.63 -27.85 8.68 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.382 2.721 . . . . 0.59999999999999998 112.573 -167.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -176.16 163.16 2.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.112 1.765 . . . . 1.7 111.472 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.8 mt -105.31 153.51 21.52 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.235 1.014 . . . . 0.56999999999999995 110.592 160.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.18 144.02 34.54 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.405 1.082 . . . . 1.8100000000000001 110.271 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.4 t -140.48 121.99 9.39 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 118.552 0.615 . . . . 1.0900000000000001 111.714 163.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -71.36 159.6 51.17 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.465 2.777 . . . . 1.1699999999999999 111.095 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.85 142.99 99.26 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.384 2.723 . . . . 1.46 111.816 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt 67.28 -5.48 0.72 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.178 2.191 . . . . 2.3300000000000001 114.374 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.12 165.31 48.79 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.016 1.293 . . . . 1.3200000000000001 112.118 172.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 145.53 35.87 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.701 1.201 . . . . 4.3099999999999996 109.298 171.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.0 t -148.96 158.86 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 126.562 1.945 . . . . 3.0600000000000001 107.809 -169.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 21' ' ' THR . 10.2 mt-10 -135.03 142.6 46.42 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.007 1.276 . . . . 4.46 111.706 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.21 79.05 1.79 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 122.121 0.962 . . . . 2.27 109.117 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -62.98 150.55 87.91 Favored Pre-proline 0 CA--C 1.558 1.281 0 N-CA-C 114.319 1.229 . . . . 3.2200000000000002 114.319 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.49 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 38.2 Cg_endo -58.32 -49.68 11.69 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.396 2.731 . . . . 2.27 113.055 174.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.53 58.3 4.45 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.869 0.747 . . . . 2.1200000000000001 111.474 171.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.32 -125.44 1.5 Allowed Glycine 0 N--CA 1.469 0.86 0 C-N-CA 124.819 1.2 . . . . 1.74 114.167 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -73.04 138.89 46.21 Favored 'General case' 0 C--O 1.219 -0.518 0 O-C-N 122.191 -0.593 . . . . 2.3399999999999999 112.279 -168.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -162.58 152.01 15.6 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.02 0.928 . . . . 0.65000000000000002 110.971 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.56 143.68 33.03 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.724 -0.473 . . . . 1.9299999999999999 109.724 162.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -96.33 123.99 40.17 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.726 1.61 . . . . 0.81999999999999995 108.428 166.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.17 120.37 42.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.397 0.999 . . . . 1.1799999999999999 108.906 -174.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -106.47 154.7 20.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.335 1.054 . . . . 2.4700000000000002 110.985 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.12 -51.4 3.21 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 127.269 2.366 . . . . 2.5600000000000001 114.747 174.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.7 mt 54.57 168.3 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.577 2.751 . . . . 1.1399999999999999 114.568 -171.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -116.82 -23.61 8.02 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.465 1.506 . . . . 2.5299999999999998 114.015 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.4 ptt-85 -137.31 149.85 67.01 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.569 1.548 . . . . 6.5199999999999996 111.414 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -68.19 142.65 56.27 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.982 1.788 . . . . 1.53 107.89 154.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.96 176.95 8.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.71 0.804 . . . . 3.0 110.479 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -120.66 176.28 5.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.194 1.798 . . . . 3.4700000000000002 108.618 155.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.18 126.96 33.62 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.399 -1.334 . . . . 1.49 107.399 154.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.69 6.24 54.76 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.195 -1.336 . . . . 1.99 116.155 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -77.54 -176.53 4.31 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.392 1.596 . . . . 2.8500000000000001 110.444 159.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.15 170.44 9.56 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 130.607 3.563 . . . . 4.8099999999999996 107.124 165.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.0 t -150.37 141.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 127.089 2.156 . . . . 1.3899999999999999 108.975 166.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.24 126.29 52.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.158 1.383 . . . . 3.9700000000000002 110.62 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.1 mp -115.33 140.78 48.82 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.15 0.98 . . . . 1.78 111.52 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.93 139.27 31.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 128.576 2.75 . . . . 2.9100000000000001 108.994 167.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -118.83 131.12 56.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.548 1.139 . . . . 1.1399999999999999 109.503 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.4 mt -112.44 116.9 31.03 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.48 1.512 . . . . 0.88 110.061 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -116.78 132.82 56.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.477 1.111 . . . . 2.1299999999999999 110.771 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.9 -24.05 66.71 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.976 0.732 . . . . 2.46 112.976 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.83 41.88 2.22 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.591 1.567 . . . . 5.5300000000000002 114.223 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.49 23.64 77.59 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.346 1.45 . . . . 3.4300000000000002 115.601 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -135.66 145.41 46.75 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.085 1.442 . . . . 3.9399999999999999 112.981 -166.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.19 141.89 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.591 1.556 . . . . 2.6499999999999999 107.496 162.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.45 172.1 13.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.841 1.656 . . . . 2.0899999999999999 109.658 -174.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.78 150.94 52.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.843 0.857 . . . . 4.3899999999999997 111.033 167.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.7 t -136.75 157.69 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.28 1.032 . . . . 2.1000000000000001 109.0 168.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.6 t -120.22 120.81 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.746 1.618 . . . . 2.3399999999999999 108.262 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -122.93 145.31 45.33 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 126.744 2.018 . . . . 2.9100000000000001 109.321 -170.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.48 164.08 33.12 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.192 2.595 . . . . 1.3100000000000001 110.807 171.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.6 t -100.89 119.66 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.465 -0.939 . . . . 0.93000000000000005 108.465 160.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -129.56 138.34 51.25 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.22 -1.77 . . . . 4.7400000000000002 106.22 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.51 68.74 9.7 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.851 -1.155 . . . . 1.97 110.903 -172.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.928 0 N-CA-C 115.927 1.825 . . . . 7.5 115.927 -171.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.905 0 N-CA-C 107.213 -2.355 . . . . 9.2200000000000006 107.213 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -153.29 -81.11 0.09 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.983 0.735 . . . . 7.0199999999999996 112.983 -142.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 171.88 -153.51 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.886 0.874 . . . . 10.43 109.431 -137.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.5 t -97.03 148.13 23.3 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.356 -0.979 . . . . 5.4900000000000002 108.356 147.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.22 57.59 0.89 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.375 1.083 . . . . 5.2300000000000004 109.834 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.78 -178.75 30.29 Favored Glycine 0 C--N 1.34 0.805 0 O-C-N 121.306 -0.871 . . . . 1.1399999999999999 111.634 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -131.77 160.38 35.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.024 1.12 . . . . 2.3500000000000001 114.024 -170.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.18 145.25 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.199 1.4 . . . . 1.55 108.552 159.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -93.3 150.05 20.77 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.75 0.82 . . . . 4.8399999999999999 111.908 -175.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -70.6 139.7 51.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.605 2.362 . . . . 2.6200000000000001 113.227 -172.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -179.99 142.4 0.35 Allowed Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.187 1.395 . . . . 2.1099999999999999 112.827 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.01 -20.88 18.88 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.727 2.285 . . . . 1.3600000000000001 112.492 162.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.58 175.67 13.96 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.809 2.147 . . . . 1.01 111.698 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.82 -15.6 29.07 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 118.893 1.346 . . . . 1.24 112.946 -3.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -128.44 159.89 33.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.031 0.919 . . . . 2.8100000000000001 113.125 174.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -131.22 -178.69 4.95 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.652 3.581 . . . . 0.58999999999999997 107.841 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.95 171.74 12.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.846 1.658 . . . . 1.1200000000000001 108.295 169.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.34 118.74 19.8 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.488 -0.757 . . . . 0.90000000000000002 109.894 164.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -102.32 63.05 0.87 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.55 1.54 . . . . 2.6699999999999999 108.583 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -89.68 160.02 16.81 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.975 -1.011 . . . . 1.6100000000000001 112.092 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -130.18 127.74 40.32 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.849 1.26 . . . . 2.21 108.443 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.498 HD21 HG11 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -119.74 179.72 4.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.03 1.332 . . . . 5.25 109.826 162.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -127.05 164.14 22.21 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.654 0.781 . . . . 4.8399999999999999 109.886 165.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.15 81.46 0.42 Allowed Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.585 1.954 . . . . 3.1600000000000001 109.314 -174.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.52 -17.41 34.15 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.78 2.32 . . . . 1.3300000000000001 114.809 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.7 157.95 51.0 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.367 0.985 . . . . 1.5 110.975 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.76 4.27 37.6 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 127.59 2.356 . . . . 3.77 112.408 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mp -122.88 158.0 58.48 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 127.291 2.236 . . . . 3.9100000000000001 108.72 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -83.01 141.63 10.62 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.72 2.28 . . . . 1.3999999999999999 111.381 -166.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -89.74 150.04 22.47 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 123.41 1.576 . . . . 2.25 112.626 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttm-85 -130.82 97.68 4.41 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.099 -1.864 . . . . 2.77 110.227 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.525 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 6.7 tt -78.79 110.66 14.17 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 125.236 1.414 . . . . 2.6000000000000001 107.695 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -100.12 -27.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 122.827 0.451 . . . . 0.5 111.697 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 -173.76 29.51 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.094 1.33 . . . . 0.42999999999999999 113.396 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -143.31 177.99 8.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.11 1.764 . . . . 0.42999999999999999 112.295 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -143.26 169.22 18.04 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.402 1.481 . . . . 5.5199999999999996 109.319 158.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -168.85 150.44 4.57 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.757 1.623 . . . . 0.62 108.313 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.07 -14.56 12.14 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.524 1.483 . . . . 0.85999999999999999 113.266 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 17.1 m -101.25 24.45 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.687 1.195 . . . . 0.81999999999999995 113.621 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.9 161.82 39.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.482 1.513 . . . . 0.87 109.46 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -93.58 -44.04 8.4 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.074 2.15 . . . . 3.96 112.363 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -131.83 159.56 38.19 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.07 0.948 . . . . 6.9100000000000001 109.013 160.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.84 143.6 30.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 125.277 1.431 . . . . 0.85999999999999999 108.887 166.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -117.47 149.25 40.89 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.858 1.663 . . . . 2.6400000000000001 109.272 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.5 tp -100.88 120.77 40.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.35 0.66 . . . . 0.90000000000000002 110.022 175.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -122.62 157.94 31.08 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.16 1.384 . . . . 0.65000000000000002 113.903 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -98.2 176.85 5.58 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.885 2.074 . . . . 2.4100000000000001 111.878 161.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.3 m -151.76 147.36 26.58 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.024 1.73 . . . . 1.02 106.762 166.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -161.71 -179.73 7.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.635 1.174 . . . . 2.4100000000000001 111.976 -164.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.0 ptt? -110.09 146.9 34.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.656 1.182 . . . . 4.3300000000000001 113.538 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -132.05 148.46 52.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.412 1.885 . . . . 5.7800000000000002 111.675 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.39 142.91 35.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.166 1.786 . . . . 3.5299999999999998 112.298 173.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.4 m -145.56 5.47 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 127.058 2.143 . . . . 3.8599999999999999 115.561 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -174.67 18.11 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.288 1.588 . . . . 3.8999999999999999 115.288 -161.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.27 -5.82 32.74 Favored Glycine 0 CA--C 1.54 1.606 0 O-C-N 119.914 -1.741 . . . . 2.2000000000000002 113.471 -163.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -97.39 69.93 2.27 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 129.12 2.968 . . . . 2.7400000000000002 109.64 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -55.33 120.08 6.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.884 1.274 . . . . 2.9500000000000002 109.953 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -145.37 144.56 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.32 1.848 . . . . 2.8300000000000001 109.122 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.5 mtp -82.28 169.13 16.89 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.293 1.22 . . . . 4.1500000000000004 114.293 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.2 176.83 32.72 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.911 1.719 . . . . 0.62 113.078 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.2 ttm -156.3 149.17 24.0 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.109 1.764 . . . . 1.26 109.916 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -150.94 155.43 35.2 Favored Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 125.835 1.654 . . . . 4.3499999999999996 109.361 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.5 155.89 50.13 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.941 1.76 . . . . 0.53000000000000003 110.847 165.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.43 153.89 66.3 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.731 1.613 . . . . 0.65000000000000002 110.09 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.27 -23.41 5.19 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.649 2.899 . . . . 0.57999999999999996 113.631 -167.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -176.54 160.47 2.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.05 1.74 . . . . 2.0099999999999998 111.011 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -106.28 159.04 16.42 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.486 1.115 . . . . 0.66000000000000003 109.182 159.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -132.95 149.97 52.2 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.256 1.022 . . . . 2.2799999999999998 110.157 173.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.65 138.62 15.46 Favored Pre-proline 0 CA--C 1.537 0.464 0 O-C-N 124.056 0.847 . . . . 1.1299999999999999 112.237 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.62 156.54 35.9 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.743 2.962 . . . . 1.3899999999999999 112.264 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.35 140.41 91.64 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.874 3.049 . . . . 1.52 112.995 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.45 2.78 1.67 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.25 2.22 . . . . 2.4100000000000001 113.96 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.52 179.7 51.92 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.227 2.346 . . . . 1.53 113.523 171.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.06 124.67 49.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.672 1.989 . . . . 4.5099999999999998 110.926 -173.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.8 t -94.67 72.92 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.807 2.043 . . . . 5.5700000000000003 108.27 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -117.52 115.27 24.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.806 1.288 . . . . 2.9700000000000002 111.794 -158.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -87.19 74.68 9.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.551 1.94 . . . . 2.0299999999999998 107.836 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 146.95 99.04 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 120.834 -1.166 . . . . 2.3100000000000001 113.514 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -61.02 147.13 96.63 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.335 2.023 . . . . 3.3500000000000001 109.485 164.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.07 -5.75 74.81 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.447 -1.196 . . . . 2.1499999999999999 113.703 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -147.33 -121.23 1.25 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 119.156 1.478 . . . . 1.48 113.674 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -73.94 138.47 44.26 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.482 -1.011 . . . . 2.0299999999999998 111.319 -167.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -160.24 153.09 21.36 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.824 0.849 . . . . 0.70999999999999996 111.453 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.528 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 43.8 m-85 -80.29 139.45 36.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.865 -0.791 . . . . 1.8 108.865 164.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 tpt -100.73 120.49 40.16 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.381 1.873 . . . . 1.1499999999999999 108.045 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -103.89 117.27 33.94 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.467 1.507 . . . . 1.21 108.152 -175.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.88 148.13 41.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.222 0.919 . . . . 2.0299999999999998 112.163 -174.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.61 36.78 36.85 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 124.154 0.883 . . . . 1.51 113.12 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.1 mt -46.0 151.93 0.43 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 117.194 2.294 . . . . 1.0700000000000001 117.194 -170.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 60.6 mmtt -114.27 -31.36 6.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 113.088 -1.869 . . . . 2.5699999999999998 113.423 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -100.47 125.54 38.87 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 117.109 -1.424 . . . . 4.8200000000000003 107.776 156.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.96 112.36 2.0 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 N-CA-C 105.501 -2.538 . . . . 1.3200000000000001 105.501 152.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.01 137.88 51.12 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.472 1.129 . . . . 2.4300000000000002 112.995 -159.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -132.99 164.78 26.23 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 126.058 1.743 . . . . 3.4500000000000002 113.67 -157.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.54 116.93 15.79 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.185 -0.916 . . . . 1.3400000000000001 109.778 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.2 15.13 36.63 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.736 -1.036 . . . . 1.26 114.527 -171.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -97.67 178.82 5.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.8 1.3 . . . . 2.21 110.411 159.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -137.32 150.83 48.03 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.391 2.276 . . . . 3.2799999999999998 105.873 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.1 t -145.06 144.83 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 127.177 2.191 . . . . 1.1399999999999999 109.329 -172.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -92.87 134.27 35.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.871 -0.604 . . . . 3.4900000000000002 111.429 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -114.3 146.01 41.02 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.271 1.828 . . . . 2.7200000000000002 109.774 164.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -101.35 139.82 36.5 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.473 1.509 . . . . 2.0099999999999998 108.757 157.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.82 122.6 46.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.248 1.419 . . . . 1.0900000000000001 108.932 167.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.8 mt -94.76 114.38 26.27 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.279 1.032 . . . . 0.63 110.232 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -109.93 112.92 25.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.039 1.336 . . . . 2.1099999999999999 111.326 -172.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 51.51 29.77 5.72 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.837 1.655 . . . . 2.3500000000000001 113.023 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.97 -71.21 1.71 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.182 1.373 . . . . 4.6600000000000001 111.98 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.9 13.45 18.71 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 116.999 1.56 . . . . 1.6799999999999999 116.999 -163.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -132.05 143.75 50.26 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.634 1.574 . . . . 3.29 110.048 168.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.63 144.79 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.39 1.076 . . . . 2.0600000000000001 109.106 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.9 tp -136.27 123.39 21.64 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.26 1.024 . . . . 2.2599999999999998 110.188 170.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -99.99 140.78 33.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.765 1.226 . . . . 3.0099999999999998 111.993 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.498 HG11 HD21 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -149.18 138.53 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.028 1.331 . . . . 2.0699999999999998 112.102 -173.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.3 p -83.07 136.53 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.814 0.846 . . . . 2.71 109.862 165.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 mt -134.96 142.37 41.88 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.338 2.255 . . . . 2.5 107.472 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 154.93 66.46 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.7 2.266 . . . . 0.79000000000000004 111.571 168.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 64.9 t -91.1 126.41 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.936 0.494 . . . . 0.93999999999999995 110.141 165.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -117.72 146.89 43.45 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.358 1.463 . . . . 4.6600000000000001 112.638 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.61 63.22 6.86 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.23 1.412 . . . . 2.1099999999999999 112.529 171.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 124.595 1.158 . . . . 7.0199999999999996 109.658 161.923 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.033 0 N-CA-C 107.24 -2.344 . . . . 10.06 107.24 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.4 p -71.53 -144.73 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 120.523 -0.471 . . . . 7.6699999999999999 110.487 137.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -162.15 173.93 13.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.081 1.352 . . . . 7.46 110.961 -166.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.6 m -64.5 128.29 35.16 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.719 -0.845 . . . . 5.5599999999999996 108.719 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -158.87 108.98 2.0 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 107.151 -1.426 . . . . 4.8799999999999999 107.151 -169.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.77 172.03 37.01 Favored Glycine 0 N--CA 1.464 0.536 0 O-C-N 121.341 -0.849 . . . . 1.3999999999999999 112.775 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.9 p90 -157.92 151.46 23.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.722 1.609 . . . . 2.3500000000000001 110.974 167.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.35 145.96 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 106.964 -1.495 . . . . 1.55 106.964 162.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -80.29 -88.98 0.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.056 1.298 . . . . 5.9100000000000001 111.786 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -164.09 141.55 6.95 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.723 0.809 . . . . 3.1099999999999999 112.118 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.1 t -176.43 140.2 0.51 Allowed Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.795 1.638 . . . . 2.25 111.489 165.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.32 -29.59 7.59 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.507 2.138 . . . . 1.46 112.53 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.64 171.91 12.35 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.309 1.909 . . . . 1.1100000000000001 111.629 -170.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.55 -6.02 31.53 Favored 'Cis proline' 0 CA--C 1.536 0.613 0 CA-C-N 119.305 1.552 . . . . 1.28 113.528 0.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -148.64 164.75 33.35 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.457 1.28 . . . . 2.0099999999999998 114.457 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.35 -179.02 5.64 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.975 2.51 . . . . 0.68999999999999995 110.443 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.39 138.97 33.38 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.148 1.379 . . . . 1.26 109.305 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.21 154.73 47.26 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.059 1.744 . . . . 0.88 112.597 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -136.89 143.91 43.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.51 2.324 . . . . 2.5099999999999998 110.187 -167.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -171.35 153.48 3.6 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.13 1.159 . . . . 2.2000000000000002 114.13 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.7 p -90.45 144.3 25.93 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.522 1.929 . . . . 2.96 110.456 173.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.5 142.86 51.28 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.733 1.613 . . . . 3.8900000000000001 107.929 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -127.9 140.59 51.91 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.949 -0.76 . . . . 4.3399999999999999 108.949 157.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -86.15 112.51 46.24 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.326 1.05 . . . . 1.3600000000000001 108.958 170.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.39 -12.89 11.29 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.615 2.21 . . . . 1.1699999999999999 113.788 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 171.74 46.85 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 122.964 1.313 . . . . 1.22 112.456 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.32 -5.38 36.72 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.346 2.659 . . . . 2.9300000000000002 112.274 -176.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.5 mt -121.16 162.62 34.61 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 127.896 2.478 . . . . 3.9300000000000002 109.3 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.72 150.51 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.359 2.04 . . . . 0.92000000000000004 111.849 -168.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.8 mt -103.45 148.83 25.45 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.26 1.024 . . . . 1.8500000000000001 109.951 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -134.0 101.92 5.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 112.886 -1.961 . . . . 1.6899999999999999 110.471 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.15 104.63 16.87 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.631 1.572 . . . . 1.77 108.318 -172.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -97.91 -30.3 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.616 0.766 . . . . 0.63 112.443 -168.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.33 -175.7 29.56 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.468 1.032 . . . . 0.44 112.423 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.01 174.21 10.42 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.658 0.742 . . . . 0.59999999999999998 111.98 166.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -127.65 164.03 22.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.481 1.912 . . . . 5.7800000000000002 107.8 156.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -171.8 151.02 2.69 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 127.186 2.195 . . . . 0.76000000000000001 108.801 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.13 -24.39 5.71 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.223 1.949 . . . . 1.02 114.013 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 25.5 m -103.97 22.58 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.502 1.121 . . . . 0.94999999999999996 113.817 -172.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.95 152.22 24.49 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 126.37 1.868 . . . . 1.03 108.221 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -90.93 -66.77 0.9 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 126.039 1.735 . . . . 3.5 109.394 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -86.79 140.7 29.45 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.951 -1.87 . . . . 6.4000000000000004 105.951 164.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.18 127.57 65.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 106.769 -1.567 . . . . 1.3400000000000001 106.769 162.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -124.75 125.79 44.63 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.563 1.145 . . . . 2.6299999999999999 109.275 -163.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.2 tp -79.89 122.78 27.1 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.053 -0.404 . . . . 0.97999999999999998 110.796 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -120.33 161.6 20.87 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.323 1.449 . . . . 0.54000000000000004 112.804 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.465 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 19.6 pt-20 -112.13 159.3 18.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.027 2.131 . . . . 2.8799999999999999 110.742 161.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.3 m -124.43 143.25 50.73 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.435 2.294 . . . . 0.77000000000000002 105.654 168.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -152.03 170.62 19.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.711 0.804 . . . . 2.1000000000000001 112.51 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.8 ptm -99.34 143.35 29.69 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.992 0.917 . . . . 4.3399999999999999 111.867 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -156.65 154.39 30.06 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.667 1.187 . . . . 8.1899999999999995 113.02 -177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.47 160.12 26.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.954 0.901 . . . . 5.1100000000000003 110.589 158.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.5 m -146.87 -12.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 117.083 2.253 . . . . 4.1699999999999999 117.083 170.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 178.38 32.35 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.493 2.035 . . . . 4.54 116.493 -158.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.56 15.45 70.79 Favored Glycine 0 N--CA 1.476 1.359 0 O-C-N 119.288 -2.133 . . . . 2.3799999999999999 112.685 -167.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -142.87 88.63 2.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.987 2.515 . . . . 2.8599999999999999 110.002 -166.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.13 122.63 12.87 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.023 -1.048 . . . . 3.7200000000000002 113.022 174.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.4 m -135.76 -176.08 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 129.376 3.071 . . . . 2.6400000000000001 110.043 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.5 mtp -98.51 166.21 11.46 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.803 1.287 . . . . 4.46 113.953 167.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.77 -179.91 17.51 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 127.142 2.306 . . . . 0.78000000000000003 111.079 170.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -149.47 145.69 27.03 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.366 1.866 . . . . 1.1599999999999999 108.344 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.35 147.47 33.96 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.646 1.578 . . . . 7.5800000000000001 109.533 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.82 150.01 23.57 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.522 2.148 . . . . 0.57999999999999996 110.254 167.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -139.09 156.2 72.4 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.802 1.241 . . . . 0.59999999999999998 111.185 -172.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -84.87 -23.22 2.63 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.128 2.552 . . . . 0.56000000000000005 113.712 -165.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -179.13 162.82 1.25 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.413 1.885 . . . . 1.77 111.415 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -107.71 150.39 27.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.573 1.149 . . . . 0.51000000000000001 110.244 162.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -109.5 142.76 40.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.018 -1.105 . . . . 2.1000000000000001 108.018 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.5 t -134.79 122.47 15.47 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.18 -0.438 . . . . 0.84999999999999998 111.131 165.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -69.23 161.5 45.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.539 2.826 . . . . 0.93999999999999995 111.153 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -58.99 138.5 86.03 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.412 2.742 . . . . 0.97999999999999998 112.41 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt 67.24 -7.68 0.5 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.134 1.774 . . . . 1.6799999999999999 114.092 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.55 142.97 25.32 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.751 1.167 . . . . 1.21 113.025 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -101.69 133.03 47.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.406 1.482 . . . . 3.8999999999999999 108.913 168.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -148.59 141.51 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.765 2.026 . . . . 3.3300000000000001 108.542 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.04 137.67 54.56 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.259 1.024 . . . . 3.5099999999999998 113.294 -168.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -70.63 74.03 0.56 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.126 1.77 . . . . 2.1000000000000001 109.372 158.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -68.65 138.92 91.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.244 2.218 . . . . 2.3999999999999999 111.99 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.65 -34.46 62.99 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.643 2.229 . . . . 2.2599999999999998 114.12 -173.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.89 6.78 46.49 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.26 -0.745 . . . . 1.8500000000000001 114.178 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.89 -121.07 1.27 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.307 1.908 . . . . 1.5600000000000001 111.907 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 96.8 m-85 -73.71 138.14 44.48 Favored 'General case' 0 C--O 1.223 -0.312 0 O-C-N 121.567 -0.961 . . . . 2.04 112.341 -171.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -159.89 150.67 19.11 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 124.209 1.003 . . . . 0.70999999999999996 111.1 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -87.8 128.01 35.33 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.755 -0.591 . . . . 1.95 109.481 171.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.2 tpt -85.57 110.87 19.54 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.752 1.621 . . . . 0.81999999999999995 109.655 168.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.7 mp -90.28 116.42 28.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.852 1.261 . . . . 1.48 108.574 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tt -127.17 143.36 51.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.995 0.902 . . . . 2.7799999999999998 112.54 -164.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.78 38.6 41.93 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 121.418 -0.801 . . . . 1.72 112.445 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt -45.52 153.88 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 117.865 2.543 . . . . 0.76000000000000001 117.865 -170.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 51.5 mmtt -119.26 -24.74 6.32 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.673 -1.603 . . . . 2.2400000000000002 113.759 -176.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -125.87 147.83 60.3 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.168 2.187 . . . . 6.1100000000000003 107.992 157.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -66.89 144.67 71.63 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.948 1.765 . . . . 2.0800000000000001 108.28 165.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.16 75.73 8.13 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.919 -1.141 . . . . 2.7400000000000002 107.919 170.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -88.8 165.1 14.91 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.609 1.164 . . . . 3.2999999999999998 111.662 170.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 119' ' ' ALA . . . -62.47 132.14 51.5 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.454 -0.779 . . . . 2.1000000000000001 111.372 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.6 1.41 58.94 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 117.231 -1.872 . . . . 1.8999999999999999 115.745 169.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -76.6 167.59 21.58 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.82 1.81 . . . . 2.3900000000000001 110.342 169.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.23 133.02 47.34 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 130.455 3.502 . . . . 3.8999999999999999 104.362 173.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.1 t -136.98 132.62 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.828 1.251 . . . . 1.3 111.196 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -79.37 142.78 35.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.279 -1.328 . . . . 2.3900000000000001 112.067 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -122.47 154.82 37.3 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.138 -0.937 . . . . 1.95 109.922 152.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -125.76 112.65 16.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.175 2.19 . . . . 2.6099999999999999 108.809 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mp -84.98 116.71 23.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.599 1.16 . . . . 0.91000000000000003 111.194 -171.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.9 mt -85.69 106.71 17.15 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.705 1.202 . . . . 0.60999999999999999 109.937 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -103.24 107.71 18.63 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.279 1.432 . . . . 2.04 111.74 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 55.17 27.43 9.59 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.975 1.71 . . . . 2.5099999999999998 112.906 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.85 -59.23 3.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.52 1.533 . . . . 4.6799999999999997 113.163 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.68 -1.23 70.96 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.58 1.392 . . . . 1.6100000000000001 116.58 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -133.32 146.74 51.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.218 1.509 . . . . 2.8300000000000001 111.372 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.89 149.75 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.352 1.461 . . . . 2.2400000000000002 110.779 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.7 tt -145.01 130.08 18.44 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.621 1.168 . . . . 2.1600000000000001 111.259 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 140.55 38.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.642 1.177 . . . . 2.2200000000000002 113.425 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.77 165.82 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.881 1.672 . . . . 2.71 110.749 163.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.24 151.3 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.813 1.245 . . . . 2.6699999999999999 109.493 168.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.38 137.77 9.6 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 126.188 1.795 . . . . 2.4500000000000002 112.796 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.45 163.62 31.89 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.264 3.309 . . . . 1.4199999999999999 113.364 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.6 t -103.87 109.58 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 122.326 1.06 . . . . 1.52 110.624 174.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -110.67 88.92 2.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.689 2.396 . . . . 4.1699999999999999 109.635 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . . . -78.75 82.12 5.0 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.378 -0.826 . . . . 3.6699999999999999 110.457 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 126.084 1.754 . . . . 9.5500000000000007 109.642 -174.064 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.254 0 N-CA-C 105.274 -3.13 . . . . 12.67 105.274 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.3 m -152.55 150.5 29.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.098 -1.041 . . . . 10.74 113.61 -123.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.68 67.34 0.96 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.094 1.758 . . . . 8.8800000000000008 110.232 -172.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.0 p -77.47 66.89 3.29 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.573 1.149 . . . . 5.2699999999999996 110.963 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -76.42 59.69 1.48 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.011 1.724 . . . . 4.8300000000000001 111.631 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.09 -178.42 15.5 Favored Glycine 0 N--CA 1.469 0.849 0 O-C-N 120.774 -1.204 . . . . 1.21 111.583 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -144.83 166.87 24.02 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.296 0.85 . . . . 2.4100000000000001 113.296 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.5 t -115.99 143.46 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.846 1.259 . . . . 1.24 109.185 176.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -26.29 60.9 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 117.268 2.322 . . . . 4.6500000000000004 117.268 -151.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER 79.78 114.79 0.06 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.232 2.213 . . . . 2.9399999999999999 108.159 -167.258 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.5 m -160.88 138.59 6.98 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.645 1.978 . . . . 2.29 108.286 166.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.03 -33.13 10.08 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.39 2.06 . . . . 1.46 111.76 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.57 179.87 22.14 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.18 1.372 . . . . 0.95999999999999996 112.331 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.22 -5.64 16.38 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 CA-C-N 118.48 1.14 . . . . 1.22 113.013 -2.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -135.74 175.14 9.87 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.759 1.623 . . . . 4.1399999999999997 111.903 -175.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.27 -175.46 5.42 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.947 2.899 . . . . 0.44 111.585 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.37 154.93 45.92 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.365 2.266 . . . . 0.73999999999999999 107.84 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.2 130.53 39.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.83 0.741 . . . . 0.52000000000000002 110.391 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -110.64 54.12 0.68 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.175 2.19 . . . . 2.3300000000000001 111.366 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.97 150.75 37.39 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.136 -0.978 . . . . 1.6299999999999999 113.309 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -91.79 134.67 34.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.304 0.642 . . . . 1.6299999999999999 109.78 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.56 134.54 51.79 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.143 2.177 . . . . 3.29 110.234 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -119.17 151.98 37.38 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.889 1.676 . . . . 5.3399999999999999 110.445 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -114.65 103.68 54.75 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.196 0.998 . . . . 1.3899999999999999 109.083 160.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -83.62 -8.54 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.244 2.629 . . . . 1.6699999999999999 114.455 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.57 175.9 30.73 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 119.441 1.019 . . . . 1.3500000000000001 112.066 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -92.18 1.21 57.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.069 2.148 . . . . 3.5099999999999998 112.984 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.0 pt? -112.16 157.21 40.5 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 127.425 2.29 . . . . 3.8799999999999999 110.402 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.25 158.01 41.42 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.802 2.335 . . . . 1.1499999999999999 111.067 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.3 mt -134.0 130.3 37.4 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 124.239 1.971 . . . . 1.8300000000000001 112.785 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -108.89 106.12 15.97 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 110.704 -2.953 . . . . 2.0 111.331 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.29 114.74 26.85 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.361 1.464 . . . . 2.3999999999999999 108.358 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.2 -25.56 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.646 0.778 . . . . 0.69999999999999996 112.685 -170.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.28 -174.55 27.13 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.319 0.961 . . . . 0.54000000000000004 112.9 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.94 -177.55 5.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.248 1.019 . . . . 0.67000000000000004 111.056 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.54 -175.58 5.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.849 2.459 . . . . 5.4500000000000002 109.441 164.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t 178.71 150.37 0.44 Allowed Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 129.528 3.131 . . . . 0.94999999999999996 106.192 -167.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.24 -12.82 14.11 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.925 1.75 . . . . 0.89000000000000001 113.472 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.93 23.54 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.717 1.377 . . . . 1.01 114.717 -170.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -150.78 134.15 16.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.874 1.67 . . . . 1.1200000000000001 109.764 168.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -59.51 -48.88 79.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.35 1.06 . . . . 2.7799999999999998 111.569 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.39 165.29 16.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.7 2.4 . . . . 5.4199999999999999 109.568 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -148.17 145.89 18.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 126.072 1.749 . . . . 0.90000000000000002 108.323 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -130.12 146.09 51.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.499 1.92 . . . . 2.6699999999999999 109.435 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -99.37 117.01 32.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.014 0.925 . . . . 0.89000000000000001 109.588 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -118.66 149.95 40.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 123.089 1.423 . . . . 0.56000000000000005 113.844 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -95.84 172.44 8.02 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.915 1.686 . . . . 2.3599999999999999 111.348 164.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.4 m -148.29 144.56 27.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.525 1.53 . . . . 0.94999999999999996 107.165 170.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -157.17 166.81 32.19 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.939 0.718 . . . . 2.0099999999999998 112.939 -166.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.2 mtp -93.73 144.36 25.48 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.068 0.947 . . . . 4.0199999999999996 111.473 170.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -157.88 163.0 38.36 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.708 1.603 . . . . 8.1899999999999995 111.906 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.27 152.65 32.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.904 1.282 . . . . 3.4100000000000001 110.534 165.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.65 120.46 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 106.714 -1.587 . . . . 3.8599999999999999 106.714 142.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 55.34 44.28 27.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.4 1.48 . . . . 5.7400000000000002 113.113 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.48 0.74 63.43 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.051 -1.031 . . . . 2.4700000000000002 114.128 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -109.35 114.78 28.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.077 1.351 . . . . 3.54 109.753 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -67.65 127.07 31.39 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.094 1.358 . . . . 4.25 111.171 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.65 -177.17 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 129.763 3.225 . . . . 2.3900000000000001 109.75 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 59.2 mtt -110.08 167.27 10.3 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.109 -0.994 . . . . 2.8799999999999999 113.602 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.53 172.15 29.56 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 126.034 1.778 . . . . 0.69999999999999996 112.262 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -149.68 147.5 28.15 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.294 1.838 . . . . 1.28 108.952 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -151.16 156.88 35.37 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 127.034 2.134 . . . . 4.6799999999999997 108.866 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.15 149.72 28.63 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.13 1.887 . . . . 0.45000000000000001 110.508 167.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.7 m -137.64 152.42 72.7 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 125.399 1.48 . . . . 0.88 110.362 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.59 -24.29 2.98 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.09 2.526 . . . . 0.57999999999999996 113.504 -160.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -177.11 160.85 1.81 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.255 1.422 . . . . 2.2000000000000002 112.25 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.63 154.77 20.43 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.704 1.601 . . . . 0.67000000000000004 109.89 162.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -115.77 149.86 37.83 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.7 1.2 . . . . 3.0699999999999998 108.71 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.19 127.86 10.64 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 112.776 0.658 . . . . 0.95999999999999996 112.776 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.62 155.42 44.77 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.416 2.744 . . . . 1.4399999999999999 112.098 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.33 139.59 83.69 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.228 3.285 . . . . 1.53 113.388 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.45 1.34 0.97 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.968 2.107 . . . . 2.54 114.347 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.84 167.13 51.14 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.201 1.858 . . . . 1.3999999999999999 113.037 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.21 150.73 45.88 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.541 1.536 . . . . 4.0499999999999998 109.174 169.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.3 t -149.79 135.97 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.866 1.667 . . . . 3.5 107.216 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.99 132.55 54.12 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 119.071 0.85 . . . . 2.6499999999999999 111.741 -177.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -71.25 80.7 0.73 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.933 1.349 . . . . 2.3700000000000001 109.694 168.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.53 146.85 66.52 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.529 1.532 . . . . 2.8799999999999999 112.838 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -53.56 -41.94 69.69 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.403 2.735 . . . . 2.9399999999999999 112.431 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.94 54.0 4.66 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 118.612 -1.104 . . . . 2.29 113.202 170.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.48 -29.64 0.51 Allowed Glycine 0 N--CA 1.472 1.084 0 N-CA-C 119.953 2.741 . . . . 2.46 119.953 155.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -147.26 137.12 23.05 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.924 2.362 . . . . 2.21 111.528 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -161.32 156.7 24.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.599 0.592 . . . . 0.66000000000000003 112.599 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -84.43 145.3 28.24 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.409 -0.589 . . . . 1.8200000000000001 109.409 163.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -99.23 132.19 44.72 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.073 1.749 . . . . 0.78000000000000003 108.838 161.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -110.21 115.38 29.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.17 1.388 . . . . 1.1499999999999999 108.257 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.62 142.22 42.78 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.96 0.904 . . . . 2.5 109.809 -171.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 64.03 55.83 21.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.413 1.006 . . . . 1.77 113.877 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 17.7 mt -48.56 154.26 0.68 Allowed 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 115.153 1.538 . . . . 0.72999999999999998 115.153 176.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -98.88 -26.69 14.2 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 113.016 -1.902 . . . . 1.75 113.276 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.83 152.0 29.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.734 2.414 . . . . 5.6200000000000001 110.741 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.39 135.4 24.43 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.422 2.748 . . . . 1.52 110.534 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -124.36 125.61 44.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.744 1.217 . . . . 2.2400000000000002 111.913 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 4.1 ptpp? -114.87 168.57 9.78 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.639 1.175 . . . . 3.1200000000000001 113.699 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.33 140.46 48.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.252 0.621 . . . . 1.9399999999999999 109.845 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.31 12.63 62.9 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.651 1.119 . . . . 1.8700000000000001 113.993 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -99.77 179.64 4.46 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.29 1.036 . . . . 2.3300000000000001 110.161 162.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 39.2 mt-10 -124.86 152.57 43.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.538 2.335 . . . . 3.3900000000000001 104.761 163.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.5 t -147.39 144.79 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.385 1.874 . . . . 1.2 109.809 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -94.12 142.26 27.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.115 0.966 . . . . 2.3799999999999999 113.3 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 54.2 mt -130.19 160.89 32.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.303 2.241 . . . . 2.73 110.596 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -121.29 126.13 48.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.65 2.38 . . . . 2.7999999999999998 109.05 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.95 123.56 45.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.233 1.413 . . . . 1.1499999999999999 110.653 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.8 mt -104.23 110.59 22.86 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.314 1.045 . . . . 0.79000000000000004 110.829 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.65 144.06 35.26 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.416 1.486 . . . . 1.95 111.044 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.51 134.39 56.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.569 0.748 . . . . 2.4199999999999999 112.152 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.67 42.2 5.81 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.865 -0.964 . . . . 3.6600000000000001 113.909 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.14 6.47 86.18 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 115.846 1.098 . . . . 1.8200000000000001 115.846 166.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -90.99 121.64 32.98 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.43 1.115 . . . . 3.2000000000000002 111.496 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.38 137.0 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.583 1.553 . . . . 2.0699999999999998 108.828 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.6 tp -137.15 113.58 10.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.049 0.94 . . . . 2.5800000000000001 110.329 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -83.43 141.53 31.63 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.936 -0.478 . . . . 2.5699999999999998 111.803 171.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.8 171.13 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 127.437 2.295 . . . . 2.6299999999999999 110.683 -171.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.87 138.22 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.484 1.113 . . . . 2.4300000000000002 110.394 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mp -142.94 153.2 60.39 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.106 1.762 . . . . 3.0600000000000001 109.951 -175.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 72.1 Cg_endo -69.46 154.32 69.09 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.016 3.144 . . . . 1.1699999999999999 112.999 171.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.5 t -93.98 125.75 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.237 -1.023 . . . . 1.29 108.237 165.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -144.27 141.94 30.14 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.195 1.398 . . . . 4.3200000000000003 108.421 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.24 53.88 2.62 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.411 -0.806 . . . . 2.9100000000000001 112.679 -171.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 . . . . . 0 C--O 1.251 1.169 0 N-CA-C 114.381 1.252 . . . . 7.8499999999999996 114.381 -167.917 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 108.764 -1.734 . . . . 15.779999999999999 108.764 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -145.95 167.56 23.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.526 1.13 . . . . 12.77 109.812 -173.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -69.85 156.15 39.49 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.411 0.685 . . . . 13.4 110.868 166.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.5 p -147.35 18.22 1.2 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.889 2.076 . . . . 8.6400000000000006 110.339 163.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -157.17 160.83 39.15 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.39 1.876 . . . . 6.1399999999999997 108.774 -166.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.25 169.33 13.76 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 114.927 0.731 . . . . 1.1699999999999999 114.927 -169.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -151.61 168.64 24.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.16 1.384 . . . . 2.3100000000000001 113.036 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.44 148.07 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.688 1.595 . . . . 1.26 107.784 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -70.98 -132.79 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.26 1.024 . . . . 6.6200000000000001 111.34 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -145.27 134.93 23.4 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.447 -1.408 . . . . 2.0099999999999998 109.831 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.1 p -176.53 117.13 0.28 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.883 1.068 . . . . 3.5600000000000001 113.883 -163.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.4 -28.01 10.72 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.432 2.088 . . . . 1.3899999999999999 112.263 169.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.24 -176.52 18.11 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.815 1.674 . . . . 0.96999999999999997 111.936 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.42 -8.26 21.81 Favored 'Cis proline' 0 CA--C 1.536 0.581 0 CA-C-N 118.924 1.362 . . . . 1.1399999999999999 113.43 1.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -128.23 165.01 21.31 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 126.41 1.884 . . . . 1.8700000000000001 112.552 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.57 -178.54 6.75 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.936 2.494 . . . . 0.71999999999999997 110.707 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.31 141.76 26.43 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.992 1.317 . . . . 0.67000000000000004 110.042 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.48 150.48 50.14 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.262 1.425 . . . . 0.81000000000000005 111.561 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -133.36 66.46 1.56 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.828 2.051 . . . . 2.29 109.564 -166.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -72.4 165.57 24.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.631 1.572 . . . . 2.0299999999999998 114.666 -173.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -93.63 151.45 19.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.321 1.048 . . . . 4.3799999999999999 110.4 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.9 tp -135.99 117.42 14.73 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.271 1.428 . . . . 4.3200000000000003 110.074 -167.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -114.11 135.18 54.31 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.306 1.442 . . . . 6.3499999999999996 111.001 -173.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.35 67.16 3.44 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.071 -1.018 . . . . 2.6299999999999999 110.965 171.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.75 -22.72 56.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.42 2.746 . . . . 1.7 114.64 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.56 -171.94 42.48 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-O 122.534 1.074 . . . . 1.54 113.338 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.85 -0.42 16.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.746 2.018 . . . . 2.98 112.929 -167.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.9 mt -122.29 160.25 48.73 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 127.001 2.12 . . . . 3.8999999999999999 109.243 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -81.96 144.29 13.46 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.711 2.274 . . . . 0.96999999999999997 111.349 -168.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 mp -101.55 154.61 18.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 123.031 1.396 . . . . 2.79 111.271 171.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -136.69 103.66 5.28 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 113.583 -1.644 . . . . 1.8100000000000001 109.627 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.15 108.07 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.571 1.549 . . . . 1.9099999999999999 108.263 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.5 m -102.57 -25.53 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.519 0.933 . . . . 0.60999999999999999 113.519 -169.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.23 -176.98 30.89 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 124.862 1.22 . . . . 0.53000000000000003 112.055 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.83 -179.72 5.47 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.555 0.693 . . . . 0.54000000000000004 112.582 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 172.91 14.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.371 2.269 . . . . 5.7199999999999998 108.862 161.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t 175.12 150.14 0.27 Allowed Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 129.509 3.123 . . . . 0.88 106.977 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.2 -15.73 25.42 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.128 1.885 . . . . 1.26 114.311 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.57 23.07 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 116.059 1.874 . . . . 1.1499999999999999 116.059 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.21 136.63 14.11 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.42 1.488 . . . . 1.1299999999999999 110.761 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.34 -46.55 89.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.251 1.02 . . . . 2.7599999999999998 112.338 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -127.52 160.22 32.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.894 2.078 . . . . 4.6600000000000001 108.993 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.0 152.96 24.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 126.851 2.06 . . . . 0.91000000000000003 108.545 170.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.5 147.41 26.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.232 1.813 . . . . 4.2599999999999998 108.313 -166.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.2 tp -111.05 110.12 20.51 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.445 1.02 . . . . 0.81999999999999995 110.711 -164.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -117.65 153.72 32.83 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 123.019 1.39 . . . . 0.57999999999999996 113.654 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -109.92 177.26 4.77 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 113.392 -1.731 . . . . 2.48 111.671 163.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.8 m -152.93 103.14 2.72 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.156 1.382 . . . . 1.2 107.342 -169.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -107.28 165.25 11.52 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.276 1.031 . . . . 2.27 113.59 -166.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.4 mtm -101.55 150.58 22.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.048 1.339 . . . . 4.8200000000000003 110.57 166.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.28 156.48 32.51 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.238 1.015 . . . . 5.2999999999999998 110.934 -169.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -108.89 145.7 34.93 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.606 1.563 . . . . 2.6400000000000001 108.665 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -153.13 136.62 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.545 -0.909 . . . . 2.9900000000000002 108.545 160.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 67.45 16.94 10.06 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.747 1.219 . . . . 3.8900000000000001 112.863 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.12 17.43 78.24 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.73 -1.231 . . . . 1.52 113.357 -169.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -120.82 126.72 50.81 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.985 2.114 . . . . 3.2200000000000002 109.109 -172.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -73.15 121.27 19.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.253 1.821 . . . . 3.04 108.974 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.26 179.8 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.418 1.887 . . . . 2.8500000000000001 110.543 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.7 mtt -130.31 170.27 14.35 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.178 1.391 . . . . 2.5699999999999998 111.091 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.49 -178.22 29.51 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.382 0.991 . . . . 0.56000000000000005 112.916 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.9 ttm -143.91 150.2 38.02 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.98 1.712 . . . . 1.1599999999999999 108.149 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -159.22 153.84 20.81 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.377 1.071 . . . . 4.9500000000000002 109.994 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.72 159.82 38.36 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.368 2.045 . . . . 0.55000000000000004 110.986 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.94 152.66 40.86 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 125.875 1.67 . . . . 1.0600000000000001 109.88 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -83.51 -26.53 2.09 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.992 2.461 . . . . 0.68999999999999995 113.557 -160.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -177.61 166.33 2.17 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.835 1.654 . . . . 2.1499999999999999 111.819 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.3 mt -109.83 153.35 24.53 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.405 1.482 . . . . 0.71999999999999997 110.277 161.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -117.97 147.55 43.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.888 1.675 . . . . 1.6899999999999999 108.504 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 t -140.41 139.06 19.74 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 112.606 0.595 . . . . 1.28 112.606 171.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.77 157.11 15.91 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.887 3.058 . . . . 1.1699999999999999 112.232 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.35 146.75 96.93 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.926 3.084 . . . . 1.3700000000000001 114.597 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm 70.37 -5.65 1.32 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.153 2.581 . . . . 2.2000000000000002 114.189 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.81 167.09 52.54 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.947 1.26 . . . . 2.0 113.987 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.18 135.19 20.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.223 2.609 . . . . 6.6600000000000001 106.457 168.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.2 t -152.87 96.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.715 1.206 . . . . 3.6600000000000001 111.848 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -74.04 160.39 31.35 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.31 -1.494 . . . . 4.2400000000000002 112.149 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mp -67.34 90.15 0.22 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.878 1.323 . . . . 2.3300000000000001 108.611 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.628 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -42.23 135.34 2.43 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 127.428 2.291 . . . . 4.0499999999999998 112.865 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.9 -31.79 91.92 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.389 2.06 . . . . 2.1499999999999999 112.513 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.65 96.37 1.72 Allowed Glycine 0 C--N 1.343 0.933 0 C-N-CA 123.97 0.795 . . . . 3.1099999999999999 111.374 166.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.56 -15.67 4.92 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 117.548 1.779 . . . . 1.8799999999999999 117.548 149.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -140.95 146.28 37.15 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.442 2.121 . . . . 2.1499999999999999 112.175 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -160.59 148.29 16.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.588 1.155 . . . . 0.78000000000000003 111.78 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -79.54 120.89 24.53 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.501 -0.925 . . . . 1.8500000000000001 108.501 161.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 tpt -78.88 127.6 32.23 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.061 2.545 . . . . 1.1599999999999999 108.756 167.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.1 mt -113.93 134.59 54.73 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.952 1.701 . . . . 2.3599999999999999 109.338 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.3 131.04 36.0 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.198 0.908 . . . . 2.1699999999999999 111.797 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.66 49.28 4.92 Favored Glycine 0 N--CA 1.468 0.819 0 C-N-CA 123.747 0.689 . . . . 1.8999999999999999 112.201 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.4 mt -52.66 155.83 2.11 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 115.078 1.51 . . . . 0.72999999999999998 115.078 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -110.01 -13.17 14.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.869 -1.514 . . . . 1.71 114.849 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.1 mmt-85 -140.38 138.11 18.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 130.136 3.374 . . . . 7.0499999999999998 108.697 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.52 137.89 18.91 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.34 2.027 . . . . 1.4099999999999999 108.583 161.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -91.65 143.64 26.35 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.785 0.802 . . . . 2.48 112.525 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -91.71 -162.96 0.97 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.911 1.338 . . . . 3.8100000000000001 109.203 163.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.11 142.96 37.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.132 -1.395 . . . . 1.0800000000000001 107.811 155.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.84 33.83 12.09 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.877 -0.957 . . . . 1.3200000000000001 114.309 -173.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -112.62 -176.38 2.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.162 1.385 . . . . 2.1699999999999999 110.473 168.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -146.51 134.99 22.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 128.274 2.63 . . . . 3.1000000000000001 105.153 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.4 t -143.72 144.51 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.118 1.367 . . . . 1.1899999999999999 107.929 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.79 146.21 28.1 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.514 0.673 . . . . 3.29 111.027 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.81 140.11 53.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.335 1.054 . . . . 1.75 109.894 169.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -79.78 135.17 36.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.595 2.758 . . . . 2.23 109.708 162.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.32 123.65 46.51 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.992 1.717 . . . . 1.29 106.946 170.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.67 104.67 16.68 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.926 -1.139 . . . . 0.84999999999999998 107.926 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -96.19 128.84 43.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.456 1.102 . . . . 2.1800000000000002 111.237 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 45.13 40.64 4.99 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.438 1.895 . . . . 2.9399999999999999 112.831 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.52 -94.38 1.97 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.539 1.066 . . . . 5.9000000000000004 111.506 -170.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.1 -6.78 62.91 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 117.121 1.609 . . . . 3.1200000000000001 117.121 -160.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -80.8 104.85 11.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.819 2.309 . . . . 2.6099999999999999 110.765 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.02 135.07 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.252 1.021 . . . . 2.46 111.402 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 tt -155.19 129.92 9.25 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.549 1.54 . . . . 2.2400000000000002 109.26 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.64 153.14 20.4 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.856 1.428 . . . . 3.7400000000000002 114.856 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 t -130.14 161.35 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.602 2.361 . . . . 2.1400000000000001 108.9 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.83 147.03 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.0 1.72 . . . . 2.0899999999999999 109.051 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.61 138.19 11.75 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.237 1.015 . . . . 2.0600000000000001 111.598 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.18 160.82 46.3 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.901 3.067 . . . . 0.98999999999999999 112.962 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.3 t -106.6 128.38 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.407 1.883 . . . . 0.94999999999999996 109.548 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -152.62 148.43 27.31 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.509 1.124 . . . . 3.46 110.956 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.38 91.96 3.32 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.965 0.888 . . . . 2.6600000000000001 111.208 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.4 mmp_? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 128.614 2.766 . . . . 6.5700000000000003 109.759 164.55 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.383 0 N-CA-C 108.765 -1.734 . . . . 12.41 108.765 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 m -150.5 158.52 44.24 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.614 1.207 . . . . 9.7599999999999998 109.941 -167.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -71.01 164.79 24.84 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.875 1.27 . . . . 8.8599999999999994 111.529 170.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.3 m -167.87 101.89 0.47 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.365 1.866 . . . . 8.0700000000000003 107.575 172.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -123.74 -178.33 4.01 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.27 1.028 . . . . 4.5800000000000001 111.952 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.04 177.35 39.79 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 116.079 1.192 . . . . 1.21 116.079 -163.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -150.24 149.46 30.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.337 1.855 . . . . 2.1800000000000002 110.483 166.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.0 t -93.22 148.61 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 121.004 -1.06 . . . . 1.1799999999999999 108.174 172.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -143.26 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.304 0.573 . . . . 5.2800000000000002 110.957 170.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -152.76 121.12 6.3 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 119.78 -1.825 . . . . 2.3100000000000001 111.044 -160.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -165.14 146.95 6.47 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 127.704 2.402 . . . . 1.95 109.796 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.46 -34.11 4.8 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.413 2.075 . . . . 1.6799999999999999 111.538 164.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.05 176.74 23.41 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.139 1.828 . . . . 1.0800000000000001 111.24 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.25 -4.62 33.85 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 CA-C-N 119.395 1.597 . . . . 1.0600000000000001 113.319 -1.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -138.27 164.04 30.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 122.265 1.031 . . . . 2.0299999999999998 113.337 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.31 -177.48 4.86 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.349 2.26 . . . . 0.56000000000000005 110.701 169.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.38 153.33 51.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.935 1.694 . . . . 0.87 109.227 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.21 153.07 42.46 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.991 0.916 . . . . 0.82999999999999996 113.025 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -126.82 134.94 50.44 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.568 1.947 . . . . 2.7599999999999998 108.811 -174.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.48 171.58 11.71 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.458 1.026 . . . . 3.0800000000000001 112.587 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.1 m -111.01 147.3 35.05 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.241 1.416 . . . . 1.97 111.128 -171.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.96 138.55 49.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.266 2.226 . . . . 4.2800000000000002 109.356 167.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.53 175.04 5.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.574 1.55 . . . . 6.9699999999999998 110.749 165.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -146.71 103.7 3.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 121.214 -0.929 . . . . 1.8300000000000001 109.728 166.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.03 -13.65 12.65 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.885 2.39 . . . . 2.0699999999999998 113.247 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.63 179.59 53.04 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 122.748 1.194 . . . . 1.5600000000000001 112.795 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.18 -2.49 24.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.866 2.466 . . . . 3.1099999999999999 111.87 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -123.07 159.36 54.47 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.391 2.676 . . . . 2.6800000000000002 109.866 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.73 151.29 28.19 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.439 2.093 . . . . 1.03 112.171 -171.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.8 mt -100.15 155.9 17.49 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 125.278 1.431 . . . . 2.1299999999999999 110.498 168.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -139.55 120.69 14.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 113.716 -1.584 . . . . 2.23 110.289 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.3 116.1 31.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.602 1.961 . . . . 1.8500000000000001 107.951 -171.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.32 -21.79 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.142 0.977 . . . . 0.51000000000000001 112.819 -166.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.4 -175.72 31.71 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 124.716 1.15 . . . . 0.55000000000000004 113.224 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.61 176.65 9.05 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.525 0.73 . . . . 0.69999999999999996 112.017 170.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.26 153.5 38.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.525 3.13 . . . . 5.5599999999999996 107.96 176.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -167.93 153.49 6.89 Favored Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 127.122 2.169 . . . . 0.67000000000000004 109.548 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -74.41 -18.54 20.25 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.834 2.356 . . . . 0.85999999999999999 114.246 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -108.72 20.15 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.739 1.385 . . . . 0.95999999999999996 114.739 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.07 150.61 31.97 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.469 1.907 . . . . 0.79000000000000004 107.813 166.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -79.79 -62.4 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.588 0.755 . . . . 3.6299999999999999 109.709 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.85 172.08 7.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.45 1.9 . . . . 4.8899999999999997 107.452 170.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.57 135.85 9.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 107.347 -1.353 . . . . 0.94999999999999996 107.347 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -105.97 149.84 26.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.476 1.51 . . . . 3.0299999999999998 109.496 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.3 tp -103.25 120.19 40.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.677 0.791 . . . . 0.88 109.62 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -123.65 149.61 45.21 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.239 1.416 . . . . 0.51000000000000001 113.966 -174.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -92.36 157.11 16.8 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.466 1.506 . . . . 2.0299999999999998 111.144 162.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.1 m -120.04 146.09 46.22 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 105.736 -1.949 . . . . 1.22 105.736 165.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -160.18 -171.87 3.37 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.202 0.91 . . . . 2.0899999999999999 112.796 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.2 mtt -127.78 148.0 50.43 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.25 1.42 . . . . 5.0999999999999996 113.131 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.28 146.86 52.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.882 1.673 . . . . 5.8499999999999996 112.992 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -87.51 140.0 29.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.652 1.181 . . . . 2.4399999999999999 109.103 151.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.4 t -142.82 122.59 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.275 1.83 . . . . 2.2599999999999998 106.974 168.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 63.76 12.76 6.92 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.155 1.782 . . . . 3.3300000000000001 114.777 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.31 24.23 59.51 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 120.918 -1.114 . . . . 1.5600000000000001 113.174 -167.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -127.65 137.42 52.52 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.059 2.144 . . . . 2.4700000000000002 108.296 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -98.31 123.98 42.7 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.678 1.191 . . . . 3.2400000000000002 111.92 -166.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.6 t -143.09 139.89 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.51 1.924 . . . . 2.2200000000000002 108.411 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.1 mtm -82.2 168.2 17.9 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.533 0.938 . . . . 3.7400000000000002 113.533 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.77 166.96 26.08 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.635 1.588 . . . . 0.78000000000000003 112.815 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.7 ttm -155.8 144.27 20.18 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.12 1.768 . . . . 1.1499999999999999 108.634 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 -146.36 155.75 49.88 Favored Pre-proline 0 N--CA 1.468 0.458 0 C-N-CA 125.244 1.418 . . . . 4.25 109.813 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.85 154.85 38.86 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.663 1.575 . . . . 0.53000000000000003 110.589 164.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.52 155.39 73.72 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 125.503 1.521 . . . . 0.56999999999999995 110.462 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.93 -28.41 3.26 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.738 2.292 . . . . 0.46999999999999997 112.867 -168.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -176.03 165.97 2.94 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.223 1.409 . . . . 1.77 112.294 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.7 153.21 24.61 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.694 1.598 . . . . 0.56999999999999995 110.284 164.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -110.76 146.45 36.33 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.937 1.295 . . . . 1.72 109.833 174.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.6 t -140.16 131.16 14.15 Favored Pre-proline 0 N--CA 1.477 0.891 0 N-CA-C 114.452 1.278 . . . . 1.3700000000000001 114.452 168.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.58 160.61 34.83 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.36 3.373 . . . . 1.1200000000000001 113.124 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.12 145.31 89.14 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.428 3.418 . . . . 1.1299999999999999 113.792 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt 67.93 -4.25 1.04 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.077 2.151 . . . . 2.2400000000000002 114.384 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.87 -179.98 47.35 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.694 1.616 . . . . 1.76 113.189 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.66 139.67 21.02 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.146 1.379 . . . . 3.9399999999999999 109.26 167.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -144.93 146.47 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.739 1.615 . . . . 3.1699999999999999 109.284 -168.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.33 150.97 46.66 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.882 1.068 . . . . 2.6299999999999999 113.882 -173.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -72.5 66.54 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.024 1.73 . . . . 2.0800000000000001 109.435 163.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.27 127.9 84.82 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.578 1.151 . . . . 3.0499999999999998 110.17 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -54.8 -38.61 91.98 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.338 3.359 . . . . 2.4900000000000002 113.916 -166.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.44 -1.08 56.84 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 117.53 -1.706 . . . . 1.8500000000000001 115.338 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -143.56 -23.15 0.17 Allowed Glycine 0 N--CA 1.474 1.199 0 CA-C-N 120.047 1.923 . . . . 2.2799999999999998 117.793 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -149.04 146.64 27.85 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.443 2.121 . . . . 2.2799999999999998 112.425 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -161.87 156.05 22.06 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.267 1.027 . . . . 0.66000000000000003 110.748 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -83.45 145.56 28.89 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.653 -0.499 . . . . 1.99 109.653 164.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -103.72 111.03 23.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.521 1.928 . . . . 0.79000000000000004 108.542 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.65 120.22 29.84 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.485 1.114 . . . . 1.28 108.697 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -121.12 144.39 48.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.458 1.123 . . . . 2.0600000000000001 112.881 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.01 38.42 40.66 Favored Glycine 0 N--CA 1.468 0.768 0 CA-C-N 115.163 -0.926 . . . . 1.75 111.867 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.4 mt -45.02 154.36 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 127.213 2.205 . . . . 0.71999999999999997 116.217 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -116.35 -21.98 9.02 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 113.544 -1.662 . . . . 2.1800000000000002 114.723 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -136.2 141.23 35.38 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 127.659 2.384 . . . . 7.1200000000000001 108.806 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.16 144.57 23.62 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.982 3.122 . . . . 1.3799999999999999 109.835 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.69 119.35 30.86 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.56 0.744 . . . . 2.0 110.369 -172.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -102.51 163.25 12.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.982 0.913 . . . . 3.5499999999999998 111.397 165.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.7 132.98 45.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.794 -0.817 . . . . 1.0800000000000001 108.794 166.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.6 1.09 71.67 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.16 -1.356 . . . . 1.3 115.641 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -75.0 179.87 4.71 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.571 1.686 . . . . 2.73 109.291 162.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -147.42 153.47 39.64 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.195 1.798 . . . . 3.04 108.03 165.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.9 t -142.79 143.3 25.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 127.718 2.407 . . . . 1.1499999999999999 109.589 -169.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.96 144.96 29.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.977 1.311 . . . . 3.5299999999999998 112.33 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 mp -130.5 138.72 50.37 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.124 1.77 . . . . 1.6799999999999999 109.861 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.407 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 28.5 m-20 -93.62 130.45 39.53 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.826 1.65 . . . . 2.3300000000000001 109.47 156.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.76 140.4 29.7 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.462 1.505 . . . . 1.02 108.93 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.3 mt -111.75 131.3 55.41 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.506 1.522 . . . . 0.73999999999999999 110.547 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -126.7 153.22 45.73 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.499 0.72 . . . . 2.71 112.675 -167.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.34 134.26 55.48 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.987 0.899 . . . . 2.1299999999999999 112.036 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.68 42.93 45.24 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.667 -1.074 . . . . 4.1399999999999997 113.703 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.65 46.2 6.48 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 116.235 1.254 . . . . 1.99 116.235 161.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -128.99 154.74 46.31 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.098 1.449 . . . . 3.46 112.182 167.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.5 t -143.69 144.71 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.593 1.957 . . . . 1.8899999999999999 107.034 171.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 tt -152.19 127.08 9.63 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.644 0.778 . . . . 2.6099999999999999 110.803 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.407 ' HE3' ' OD1' ' A' ' 102' ' ' ASP . 2.7 ttmt -93.89 134.57 36.13 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.172 0.804 . . . . 2.7599999999999998 113.172 -177.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.62 153.2 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.026 1.33 . . . . 1.8700000000000001 108.272 162.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 t -128.81 139.79 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.886 1.275 . . . . 2.0800000000000001 107.611 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.17 142.23 15.18 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 113.152 0.797 . . . . 2.3599999999999999 113.152 -165.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.84 170.39 14.21 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.282 3.321 . . . . 0.96999999999999997 112.863 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.34 145.74 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.982 1.313 . . . . 0.90000000000000002 110.632 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.48 144.77 32.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.015 1.326 . . . . 4.7300000000000004 112.805 -174.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.03 55.07 1.53 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.153 0.981 . . . . 2.9900000000000002 111.198 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 . . . . . 0 C--O 1.244 0.777 0 CA-C-O 115.783 -2.055 . . . . 7.3300000000000001 113.012 -152.633 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.082 0 N-CA-C 109.578 -1.409 . . . . 10.27 109.578 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.492 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -94.68 -173.87 3.14 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.205 1.402 . . . . 7.3799999999999999 109.709 146.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -80.82 150.17 29.28 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.578 -1.327 . . . . 10.6 112.04 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.297 20.0 p 61.06 24.85 14.92 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.196 2.199 . . . . 5.1299999999999999 114.798 168.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 2' ' ' SER . 62.5 mt-10 -78.32 61.86 2.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.444 1.498 . . . . 4.9400000000000004 110.54 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.16 159.95 15.39 Favored Glycine 0 N--CA 1.469 0.844 0 O-C-N 120.907 -1.121 . . . . 1.1599999999999999 111.575 175.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.2 p90 -156.66 157.55 35.4 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.947 0.899 . . . . 2.4100000000000001 112.187 166.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.45 145.47 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.589 1.156 . . . . 1.3500000000000001 108.446 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -69.75 -159.76 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.266 1.026 . . . . 5.79 110.668 164.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -128.63 150.61 50.15 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.328 1.451 . . . . 2.6099999999999999 110.684 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -170.72 145.22 2.03 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.958 1.703 . . . . 2.4199999999999999 109.294 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.03 -22.06 15.15 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.98 2.453 . . . . 1.97 112.683 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.09 173.21 13.26 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 126.158 1.837 . . . . 1.1499999999999999 111.745 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.98 -0.49 39.01 Favored 'Cis proline' 0 CA--C 1.541 0.834 0 CA-C-N 119.122 1.461 . . . . 1.0900000000000001 113.474 0.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -147.52 162.42 39.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.317 1.047 . . . . 1.8500000000000001 113.62 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.27 -179.05 5.33 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 129.606 3.163 . . . . 0.41999999999999998 109.634 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.81 146.78 49.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.399 1.48 . . . . 0.72999999999999998 108.728 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.23 148.67 45.01 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.327 1.051 . . . . 0.65000000000000002 112.333 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -115.66 136.17 53.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.932 2.093 . . . . 2.4300000000000002 111.197 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.93 145.65 43.48 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.757 0.823 . . . . 2.8399999999999999 110.807 173.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.0 m -124.96 113.65 18.1 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.827 0.851 . . . . 2.21 109.983 166.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.28 174.12 7.92 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.666 1.986 . . . . 5.4100000000000001 107.72 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.431 ' CD ' HH11 ' A' ' 74' ' ' ARG . 46.0 mt-10 -145.21 155.91 43.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.557 -1.275 . . . . 5.5499999999999998 107.557 173.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -101.16 100.26 12.86 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.167 0.587 . . . . 1.6100000000000001 111.036 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.81 -15.39 13.43 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.177 1.918 . . . . 2.2999999999999998 113.514 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.98 -178.07 52.22 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 119.137 0.88 . . . . 1.48 112.471 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 16.0 m-20 -114.86 3.27 14.56 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.43 1.892 . . . . 4.0 112.232 -167.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -106.36 154.01 40.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 127.096 2.158 . . . . 3.3100000000000001 110.254 166.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.21 147.08 20.38 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.869 2.379 . . . . 1.1399999999999999 110.877 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.7 mt -99.35 138.73 36.04 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 123.633 1.682 . . . . 2.3500000000000001 111.003 170.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 68' ' ' GLU . 14.6 tpp85 -134.68 105.85 6.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 111.716 -2.493 . . . . 2.0899999999999999 108.248 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.74 105.41 17.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.128 1.371 . . . . 2.3799999999999999 108.6 -171.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -101.78 -22.67 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.617 0.767 . . . . 0.47999999999999998 112.235 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.24 -177.07 30.99 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.199 1.381 . . . . 0.40999999999999998 112.553 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.0 -176.58 4.55 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.573 1.549 . . . . 0.51000000000000001 109.277 166.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.439 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -157.16 166.44 33.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.669 1.587 . . . . 4.2599999999999998 108.118 177.375 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 t -177.77 153.93 0.98 Allowed Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.865 1.266 . . . . 0.80000000000000004 110.382 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.31 -0.28 9.82 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.271 2.647 . . . . 0.93999999999999995 114.763 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.7 m -116.78 26.96 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 115.508 1.67 . . . . 0.85999999999999999 115.508 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.75 157.44 33.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.277 1.431 . . . . 0.85999999999999999 110.503 167.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.4 -26.99 41.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.021 1.728 . . . . 2.8900000000000001 112.087 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -155.56 149.35 25.31 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 127.498 2.319 . . . . 5.5599999999999996 108.621 -156.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.7 p -161.4 59.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 123.79 1.757 . . . . 2.2200000000000002 113.028 -158.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -91.4 134.86 34.26 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.096 -1.865 . . . . 5.46 112.236 -167.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.3 tp -83.06 122.9 28.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.496 1.518 . . . . 0.88 112.159 -167.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -121.91 150.29 42.19 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.843 1.657 . . . . 0.5 112.415 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -88.93 173.57 8.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.113 0.965 . . . . 2.02 111.067 162.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.7 m -139.99 129.99 24.86 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.589 -1.634 . . . . 0.97999999999999998 106.589 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -134.79 173.31 11.83 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.417 1.103 . . . . 2.23 112.951 -165.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.8 ttp -120.43 141.74 49.87 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.97 1.308 . . . . 3.3399999999999999 111.004 165.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -135.44 157.29 47.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.212 1.405 . . . . 5.4299999999999997 111.55 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -97.1 144.13 27.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.312 1.445 . . . . 2.3700000000000001 109.962 165.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 m -142.68 130.55 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.574 1.549 . . . . 2.77 108.584 163.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 62.21 11.2 4.26 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.599 2.074 . . . . 3.54 116.599 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.9 25.68 40.4 Favored Glycine 0 CA--C 1.539 1.533 0 O-C-N 120.909 -1.119 . . . . 1.74 113.537 -165.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -127.15 120.17 28.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.052 1.741 . . . . 2.4900000000000002 109.453 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.34 118.98 28.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.57 0.748 . . . . 7.0800000000000001 110.619 -175.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.52 139.85 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.024 1.73 . . . . 2.3300000000000001 109.5 -172.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 58.0 mtm -83.71 167.47 17.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.885 1.069 . . . . 3.25 113.885 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.5 -176.49 30.61 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.028 1.299 . . . . 0.91000000000000003 113.3 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ttm -155.85 150.06 25.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.783 2.033 . . . . 1.1200000000000001 107.65 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.96 158.49 30.17 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 124.495 1.118 . . . . 5.0 110.509 174.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.44 154.94 40.82 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.152 1.901 . . . . 0.54000000000000004 111.907 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -143.08 152.61 58.71 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.419 1.487 . . . . 0.54000000000000004 109.808 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -84.13 -23.44 3.0 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.187 2.592 . . . . 0.68000000000000005 113.547 -165.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' CD1' ' HD2' ' A' ' 31' ' ' ARG . 54.0 p90 -177.14 166.93 2.41 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.593 1.957 . . . . 2.02 110.678 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.2 mt -110.66 154.31 24.01 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.457 1.103 . . . . 0.56000000000000005 110.059 164.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 31' ' ' ARG . 3.9 tp10 -127.06 138.09 53.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.126 1.37 . . . . 1.74 109.612 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 t -143.48 136.79 14.02 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.998 0.919 . . . . 1.52 110.654 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.99 170.4 15.74 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.776 2.318 . . . . 1.3899999999999999 112.334 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.56 143.96 97.69 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.969 2.446 . . . . 1.6499999999999999 110.783 161.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.434 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 33.6 mmtm 67.47 0.13 2.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.403 1.481 . . . . 2.5299999999999998 114.157 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.56 162.77 41.89 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.753 1.644 . . . . 1.8999999999999999 113.635 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.431 HH11 ' CD ' ' A' ' 23' ' ' GLU . 59.5 mtt-85 -91.48 129.42 37.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.563 0.745 . . . . 5.5700000000000003 111.412 176.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -103.24 61.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.764 2.025 . . . . 5.4100000000000001 109.478 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.76 127.26 56.1 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.229 1.411 . . . . 3.1899999999999999 109.755 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 83' ' ' HIS . 3.3 mp -70.98 -38.59 72.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.604 1.562 . . . . 3.2000000000000002 114.003 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptt 91.13 138.07 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 129.416 3.086 . . . . 3.5499999999999998 109.93 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.7 11.74 0.47 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.589 2.86 . . . . 2.75 114.731 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.61 17.27 0.09 OUTLIER Glycine 0 CA--C 1.535 1.32 0 CA-C-O 116.621 -2.211 . . . . 1.8799999999999999 116.42 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.27 -29.31 0.45 Allowed Glycine 0 N--CA 1.487 2.044 0 CA-C-N 121.233 2.516 . . . . 2.1000000000000001 117.626 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.06 146.89 43.51 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.249 2.025 . . . . 2.1600000000000001 111.197 163.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.49 ' HA ' HD23 ' A' ' 77' ' ' LEU . 57.1 p-80 -158.46 149.02 20.19 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.572 0.582 . . . . 0.68000000000000005 112.572 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -79.96 131.8 35.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.345 -0.613 . . . . 1.97 109.345 161.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -91.81 103.42 15.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.038 1.735 . . . . 0.81000000000000005 108.459 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -85.73 116.88 24.26 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.659 -1.238 . . . . 1.25 107.659 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 tt -130.19 134.85 47.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.562 1.145 . . . . 3.1200000000000001 111.165 -162.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.53 48.69 7.83 Favored Glycine 0 N--CA 1.473 1.11 0 O-C-N 121.751 -0.593 . . . . 1.8500000000000001 111.969 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -48.26 154.34 0.61 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 126.253 1.821 . . . . 0.70999999999999996 114.99 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -119.34 -29.95 5.03 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.681 -1.6 . . . . 1.6899999999999999 114.585 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -107.38 147.5 35.37 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.902 1.681 . . . . 5.8300000000000001 109.552 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.39 162.68 37.84 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.66 2.24 . . . . 2.6600000000000001 109.132 157.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.8 155.87 35.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.48 1.512 . . . . 2.7799999999999998 109.759 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 24.24 1.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.326 1.973 . . . . 4.1399999999999997 116.326 -174.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 66.87 164.76 0.2 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.12 2.168 . . . . 1.49 110.943 -161.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.04 -5.99 30.02 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.947 -0.918 . . . . 1.3400000000000001 114.676 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -76.99 166.06 23.83 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.422 1.089 . . . . 2.9100000000000001 110.099 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -118.14 126.19 51.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 129.146 2.978 . . . . 3.8500000000000001 104.625 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.7 t -126.2 140.6 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.66 1.184 . . . . 1.3899999999999999 110.065 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -106.83 134.69 49.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.42 1.088 . . . . 3.7599999999999998 112.786 -170.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.5 133.57 43.96 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.25 1.42 . . . . 1.9099999999999999 111.887 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 27.4 m-20 -77.84 136.45 38.08 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.777 2.031 . . . . 1.8300000000000001 108.61 159.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.99 126.86 50.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.338 1.055 . . . . 0.97999999999999998 108.785 165.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.0 mt -104.19 106.54 17.08 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.353 1.061 . . . . 0.71999999999999997 110.069 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -105.8 151.81 24.02 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.612 1.565 . . . . 2.0699999999999998 112.35 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.83 131.39 46.79 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.87 1.063 . . . . 2.79 113.87 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 58.13 3.13 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.924 1.25 . . . . 3.8700000000000001 113.347 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.37 11.09 79.72 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 124.421 1.01 . . . . 2.1899999999999999 115.609 169.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -93.49 113.1 25.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.917 1.359 . . . . 2.8599999999999999 111.217 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.68 136.12 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.936 1.294 . . . . 1.8899999999999999 109.887 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.1 tt -143.12 112.61 6.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.471 0.708 . . . . 2.9700000000000002 111.544 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -87.73 98.35 11.4 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.961 0.726 . . . . 3.7000000000000002 112.961 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 114' ' ' VAL . 26.9 t -80.01 172.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 126.444 1.898 . . . . 2.1299999999999999 110.869 171.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.409 ' N ' HG12 ' A' ' 113' ' ' VAL . 10.7 p -139.34 143.01 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.057 2.143 . . . . 2.9199999999999999 108.378 166.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.48 144.55 15.01 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.883 1.673 . . . . 2.1800000000000002 111.677 -167.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.95 155.5 26.44 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.179 2.586 . . . . 0.96999999999999997 113.705 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.1 t -93.93 121.7 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.44 1.496 . . . . 1.04 109.472 173.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.0 159.49 15.29 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.317 1.847 . . . . 4.1299999999999999 110.582 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -93.03 55.66 2.4 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.216 -0.928 . . . . 2.8399999999999999 110.794 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 . . . . . 0 C--O 1.248 1.017 0 N-CA-C 115.107 1.521 . . . . 6.3099999999999996 115.107 -144.201 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.384 0 N-CA-C 108.952 -1.659 . . . . 10.98 108.952 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -77.27 -123.02 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 117.339 -1.315 . . . . 9.8499999999999996 107.959 132.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.01 167.34 30.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 121.108 1.776 . . . . 8.1600000000000001 112.083 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.4 p -128.13 61.63 1.44 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.744 1.618 . . . . 5.46 111.853 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -79.51 118.2 21.16 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.094 -1.004 . . . . 4.5999999999999996 111.59 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.49 168.75 33.77 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.02 -1.05 . . . . 1.1699999999999999 114.296 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -152.16 172.6 16.12 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.254 1.022 . . . . 2.1600000000000001 112.945 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 t -109.36 138.85 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.098 -1.001 . . . . 1.1399999999999999 109.03 172.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -51.68 -81.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.965 1.306 . . . . 5.0599999999999996 113.093 -173.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.1 t80 158.22 153.0 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 130.118 3.367 . . . . 3.0600000000000001 107.282 -157.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.0 t 150.22 128.8 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 129.34 3.056 . . . . 2.1400000000000001 110.879 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.88 -35.85 14.62 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.855 1.703 . . . . 1.29 111.793 173.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.25 173.13 21.52 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.483 1.992 . . . . 0.96999999999999997 112.035 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.75 5.16 56.05 Favored 'Cis proline' 0 CA--C 1.541 0.865 0 CA-C-N 119.33 1.565 . . . . 1.1200000000000001 113.654 3.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -154.68 160.24 41.25 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.412 1.085 . . . . 1.76 113.673 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.87 -177.44 5.33 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.935 2.094 . . . . 0.41999999999999998 111.623 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.27 147.92 28.24 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.791 1.236 . . . . 0.72999999999999998 110.756 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.03 145.52 48.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.092 1.757 . . . . 0.5 111.539 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' A' ' 79' ' ' PRO . 96.2 m-85 -144.19 121.52 11.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.884 2.073 . . . . 2.6899999999999999 109.961 -164.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -166.0 148.59 7.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.442 -1.411 . . . . 1.99 114.318 -155.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.5 m -81.99 135.17 35.39 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.759 0.79 . . . . 1.8899999999999999 110.434 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.51 137.0 47.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.881 2.072 . . . . 3.3500000000000001 108.791 170.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -114.67 166.41 11.76 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.129 0.572 . . . . 4.29 111.64 166.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -119.97 111.71 35.46 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 123.031 0.532 . . . . 1.48 110.246 164.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.21 -15.62 10.12 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.759 2.306 . . . . 1.1899999999999999 113.919 175.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.23 -175.27 49.76 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.496 1.046 . . . . 1.3 113.149 -173.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.91 -10.12 27.07 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.066 1.747 . . . . 3.3500000000000001 111.613 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -130.45 161.24 61.8 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 127.572 2.349 . . . . 3.8399999999999999 108.913 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.65 155.94 49.35 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.65 2.233 . . . . 1.4299999999999999 111.541 -170.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.9 mt -110.55 152.22 26.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 125.103 1.361 . . . . 1.8700000000000001 110.429 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -128.5 105.07 8.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.507 -1.679 . . . . 2.0099999999999998 111.264 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.54 104.57 16.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.133 1.373 . . . . 1.8400000000000001 108.118 -172.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.4 m -98.21 -28.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.401 0.681 . . . . 0.69999999999999996 112.182 -166.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.93 -178.61 33.1 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.521 1.534 . . . . 0.55000000000000004 111.336 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.55 ' O ' HG11 ' A' ' 43' ' ' VAL . . . -131.24 -178.48 4.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.868 0.867 . . . . 0.77000000000000002 109.375 161.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -144.75 169.73 17.46 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 129.539 3.136 . . . . 5.54 106.348 165.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -172.35 149.74 2.15 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 126.938 2.095 . . . . 0.56000000000000005 108.006 -172.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -71.51 -30.9 14.48 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.065 1.177 . . . . 1.01 112.478 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -89.16 19.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 115.856 1.799 . . . . 0.78000000000000003 115.856 -168.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.99 154.0 34.07 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.718 1.007 . . . . 0.79000000000000004 113.718 174.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -79.98 -65.17 1.04 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.611 1.564 . . . . 3.1000000000000001 109.819 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.3 mtp-105 -110.71 107.96 17.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.655 0.74 . . . . 6.1600000000000001 110.683 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 35' ' ' ALA . 7.4 p -77.58 146.9 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 126.054 1.741 . . . . 1.4299999999999999 108.689 162.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -155.5 146.62 22.57 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.852 1.261 . . . . 2.6400000000000001 109.417 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.0 tp -105.83 120.27 41.28 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.358 0.981 . . . . 0.92000000000000004 111.099 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -127.79 159.56 34.46 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.929 1.347 . . . . 0.76000000000000001 113.981 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.86 161.32 14.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.909 2.084 . . . . 2.1000000000000001 112.351 159.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.9 m -137.23 145.68 43.91 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.985 2.114 . . . . 1.3100000000000001 107.089 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.81 165.61 36.0 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.762 1.267 . . . . 2.1299999999999999 114.24 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.62 146.88 24.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.718 1.207 . . . . 5.8600000000000003 111.278 166.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.13 161.85 42.0 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.588 1.555 . . . . 5.4299999999999997 110.061 -171.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -112.79 142.36 45.52 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.347 1.059 . . . . 2.4300000000000002 112.296 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.8 t -136.28 115.96 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.264 1.425 . . . . 2.3500000000000001 108.433 164.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 66.37 7.48 4.99 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 127.291 2.236 . . . . 3.29 115.211 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.18 7.59 59.41 Favored Glycine 0 CA--C 1.54 1.624 0 O-C-N 121.123 -0.986 . . . . 1.6699999999999999 114.189 -165.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -109.09 129.43 55.47 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 127.416 2.286 . . . . 2.8100000000000001 108.292 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -79.7 120.54 24.15 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.938 -1.483 . . . . 2.75 109.251 -166.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.2 t -134.38 131.52 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.231 1.812 . . . . 2.5699999999999998 108.846 -173.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.1 mtt -83.35 165.3 19.4 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.506 -0.746 . . . . 2.79 112.632 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.24 173.88 32.73 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 124.25 0.929 . . . . 0.82999999999999996 112.943 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.5 ttm -157.09 137.39 12.86 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.889 1.676 . . . . 1.3300000000000001 109.395 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -143.01 149.28 48.63 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 125.529 1.532 . . . . 8.8499999999999996 110.643 -174.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.63 153.18 43.58 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.066 1.844 . . . . 0.57999999999999996 109.962 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.07 156.0 77.26 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.735 1.214 . . . . 0.68000000000000005 110.111 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.72 -27.82 2.44 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.851 2.367 . . . . 0.58999999999999997 113.242 -169.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -177.84 165.94 2.05 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.344 1.858 . . . . 2.2400000000000002 111.297 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.7 mt -110.7 155.85 21.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.031 1.332 . . . . 0.53000000000000003 109.884 163.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -113.24 146.77 38.77 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.725 1.21 . . . . 2.0800000000000001 109.105 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.88 128.0 14.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 113.647 0.98 . . . . 1.1100000000000001 113.647 168.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.59 156.57 28.26 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.332 3.355 . . . . 1.3700000000000001 113.05 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.11 141.89 78.34 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.758 3.639 . . . . 1.4199999999999999 114.005 -172.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 71.39 -15.95 0.4 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 129.122 2.969 . . . . 1.8799999999999999 114.161 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.83 -177.12 50.21 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.597 1.57 . . . . 1.71 113.561 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -146.72 150.7 35.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.086 0.954 . . . . 4.8799999999999999 111.389 163.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -149.67 139.44 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.965 2.106 . . . . 3.6400000000000001 107.079 -175.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.1 147.43 34.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.304 1.049 . . . . 3.5600000000000001 113.499 -174.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.07 74.94 0.49 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.668 1.587 . . . . 2.0600000000000001 107.438 157.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.47 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -57.87 142.48 78.91 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.625 1.17 . . . . 2.3199999999999998 114.08 -170.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.544 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 29.8 Cg_endo -58.86 -10.41 9.64 Favored 'Trans proline' 0 C--N 1.357 1.014 1 C-N-CA 125.606 4.204 . . . . 2.7400000000000002 117.736 -170.049 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.88 2.45 22.93 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.728 1.156 . . . . 2.7599999999999998 115.43 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.84 -112.07 1.46 Allowed Glycine 0 N--CA 1.472 1.084 0 CA-C-N 119.148 1.474 . . . . 1.97 113.136 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -72.5 143.09 48.5 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.988 -0.713 . . . . 1.8999999999999999 111.662 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 51.4 p-80 -160.39 157.17 27.35 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.568 1.147 . . . . 0.76000000000000001 111.843 -174.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.2 135.33 35.74 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.834 -0.802 . . . . 2.3500000000000001 108.834 155.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.1 126.09 47.77 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.272 2.229 . . . . 1.0600000000000001 108.444 169.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.14 113.09 23.53 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.16 0.984 . . . . 2.6099999999999999 109.847 -176.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.07 152.13 19.63 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.082 1.753 . . . . 2.0899999999999999 110.63 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.94 -50.65 4.44 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 127.799 2.619 . . . . 3.0299999999999998 113.551 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.1 mt 57.94 169.09 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.864 2.865 . . . . 1.0 115.675 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -128.48 -23.8 3.15 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.518 2.327 . . . . 1.7 114.256 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -130.61 150.76 77.26 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.512 2.325 . . . . 5.3200000000000003 109.903 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.21 123.94 8.13 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.585 2.19 . . . . 1.99 108.538 163.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.04 113.47 17.19 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.186 0.994 . . . . 2.5099999999999998 108.609 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.86 166.01 26.48 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.371 1.469 . . . . 3.6800000000000002 111.055 172.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.11 123.61 16.54 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.011 0.924 . . . . 1.4399999999999999 110.98 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.93 25.86 59.32 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.678 -0.692 . . . . 2.6400000000000001 113.82 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -86.69 172.71 9.99 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.893 1.347 . . . . 2.5299999999999998 108.757 133.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -144.37 158.56 43.68 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.045 2.938 . . . . 3.1299999999999999 105.257 171.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.7 t -150.56 146.59 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.385 1.874 . . . . 1.3100000000000001 110.112 -169.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.46 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 38.0 mt-10 -95.83 138.01 34.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.234 0.614 . . . . 2.6400000000000001 110.442 165.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.36 137.43 52.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.734 0.778 . . . . 1.71 110.262 159.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.62 113.17 26.58 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 128.316 2.646 . . . . 2.5600000000000001 108.92 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -94.75 132.9 39.01 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.513 -1.367 . . . . 1.0 111.339 -168.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.9 mt -104.65 106.24 16.66 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.392 1.477 . . . . 0.68999999999999995 109.994 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.0 115.27 30.14 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.76 1.224 . . . . 2.3700000000000001 110.76 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.11 23.74 2.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.863 2.065 . . . . 2.3199999999999998 113.845 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.0 -56.73 4.33 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.328 1.442 . . . . 4.4500000000000002 112.914 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.15 -6.68 69.48 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 117.054 1.582 . . . . 1.5700000000000001 117.054 -165.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -128.38 121.51 29.26 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.485 1.643 . . . . 4.5199999999999996 113.015 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -102.35 136.3 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.157 1.383 . . . . 1.96 109.429 166.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.9 tp -155.39 128.19 8.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.011 1.325 . . . . 2.8700000000000001 109.688 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 52.0 pttt -109.23 160.87 15.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.374 1.62 . . . . 2.1899999999999999 115.374 -174.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -140.07 161.6 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 126.838 2.055 . . . . 1.95 109.439 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.5 t -106.89 142.18 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.53 1.532 . . . . 1.8500000000000001 109.152 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -144.41 128.5 9.03 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.004 1.722 . . . . 2.77 110.2 -171.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.53 164.92 32.83 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.07 2.514 . . . . 1.1399999999999999 111.921 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.1 t -109.91 151.76 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.183 0.593 . . . . 0.82999999999999996 110.782 171.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -124.28 -171.09 2.26 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.756 2.022 . . . . 4.1600000000000001 112.54 -169.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.17 103.06 8.94 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.859 -1.15 . . . . 2.1000000000000001 109.359 167.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 . . . . . 0 N--CA 1.477 0.879 0 C-N-CA 128.127 2.571 . . . . 6.0 110.36 -167.237 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.783 0 N-CA-C 109.668 -1.373 . . . . 9.9199999999999999 109.668 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.3 t -132.01 104.99 7.13 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.22 1.408 . . . . 7.46 110.401 -175.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -159.39 171.6 19.48 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.573 2.349 . . . . 9.9199999999999999 109.578 -168.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.253 6.4 t 58.38 2.7 0.22 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 126.536 1.935 . . . . 5.29 115.372 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -73.37 90.21 1.66 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.369 -1.715 . . . . 4.79 106.369 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.2 -178.17 32.96 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.637 1.589 . . . . 1.24 113.426 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -156.18 157.71 36.38 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.422 1.889 . . . . 2.4700000000000002 112.345 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.9 132.7 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.283 1.433 . . . . 1.73 108.481 169.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -67.93 162.13 24.96 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.996 0.903 . . . . 4.3099999999999996 112.445 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -98.65 130.12 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.22 -1.4 . . . . 2.3199999999999998 107.22 171.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -167.73 147.43 4.38 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 127.057 2.143 . . . . 2.6000000000000001 107.083 174.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.99 -22.91 9.69 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.929 2.419 . . . . 1.9399999999999999 113.218 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.25 173.63 13.47 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 126.462 1.982 . . . . 1.6200000000000001 110.354 -166.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -70.67 -9.14 12.66 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 CA-C-N 119.681 1.741 . . . . 2.1899999999999999 112.412 -4.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -137.62 161.35 36.69 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.625 1.343 . . . . 2.3500000000000001 114.625 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.93 -173.87 3.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 131.654 3.981 . . . . 0.59999999999999998 107.492 174.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.9 166.75 23.27 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.635 -1.291 . . . . 1.1000000000000001 110.676 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.04 148.51 32.76 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 122.109 0.957 . . . . 0.56000000000000005 111.929 171.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -145.15 129.83 18.08 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.873 2.069 . . . . 2.6200000000000001 107.919 -165.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.11 150.79 9.68 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.571 1.078 . . . . 2.27 113.892 -174.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.2 m -79.87 112.73 17.44 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.62 1.568 . . . . 1.8400000000000001 110.74 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.77 127.69 36.01 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.214 1.005 . . . . 2.9199999999999999 108.571 169.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -116.63 134.42 54.85 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.905 1.282 . . . . 4.3700000000000001 108.801 168.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -99.46 117.68 63.45 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.506 1.122 . . . . 1.3700000000000001 109.882 173.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -88.4 -8.9 5.25 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.252 2.635 . . . . 1.3200000000000001 114.825 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.34 160.06 26.64 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 119.789 1.177 . . . . 1.4099999999999999 111.928 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.09 3.05 21.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.947 2.499 . . . . 3.75 112.127 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -123.87 152.12 65.75 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 128.333 2.653 . . . . 2.75 109.248 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.74 146.35 23.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.125 2.55 . . . . 1.1599999999999999 111.205 -171.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.4 mt -98.88 145.28 27.15 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.428 1.109 . . . . 1.8400000000000001 111.481 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.531 ' HD2' ' CD2' ' A' ' 66' ' ' PHE . 5.1 tpp180 -130.45 104.91 7.52 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.271 -1.786 . . . . 2.6400000000000001 109.796 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.407 HD13 ' C ' ' A' ' 32' ' ' LEU . 1.8 tm? -98.17 115.01 27.43 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.234 2.214 . . . . 2.0800000000000001 108.991 -169.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.98 -28.34 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.208 0.913 . . . . 0.88 112.363 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.01 -175.09 30.6 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 115.26 0.864 . . . . 0.41999999999999998 115.26 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -140.42 -176.85 4.78 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.977 1.711 . . . . 0.53000000000000003 112.049 171.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttt-85 -159.56 153.39 23.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.871 2.069 . . . . 5.1200000000000001 108.149 172.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -163.55 150.9 10.73 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-N 120.109 1.322 . . . . 0.91000000000000003 110.473 -170.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.29 -15.29 11.47 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.818 2.345 . . . . 1.1399999999999999 115.135 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -105.45 26.68 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.158 1.383 . . . . 1.2 113.634 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.38 174.03 10.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.242 1.417 . . . . 1.6000000000000001 109.215 162.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -99.91 -48.44 4.67 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.966 1.706 . . . . 3.96 109.505 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -126.15 171.61 10.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.883 2.473 . . . . 5.0700000000000003 107.596 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.8 p -154.78 142.75 12.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 125.596 1.558 . . . . 1.0 108.532 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -115.59 158.11 23.15 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.67 1.588 . . . . 3.48 109.524 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -111.22 117.01 32.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.076 1.35 . . . . 0.91000000000000003 109.099 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -120.14 149.86 41.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.206 1.402 . . . . 0.63 114.223 -174.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -93.3 161.12 14.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.265 1.826 . . . . 2.4199999999999999 111.134 160.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.6 m -129.4 146.14 51.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.52 1.928 . . . . 1.24 106.301 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -160.15 -179.05 7.41 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.727 1.01 . . . . 2.2400000000000002 113.727 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.7 mtm -116.46 148.28 40.91 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.792 1.637 . . . . 4.3200000000000003 111.882 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.62 154.34 45.34 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.444 1.497 . . . . 7.0499999999999998 111.977 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -91.54 137.43 32.37 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.738 -1.208 . . . . 3.1200000000000001 107.738 148.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -144.03 139.7 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.491 -1.67 . . . . 2.8300000000000001 106.491 160.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 64.18 19.92 11.97 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.141 1.376 . . . . 4.5700000000000003 113.931 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.76 17.12 72.88 Favored Glycine 0 CA--C 1.538 1.5 0 O-C-N 120.354 -1.466 . . . . 2.2599999999999998 113.354 -169.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -122.01 135.18 54.82 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.039 2.535 . . . . 3.02 109.526 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -74.49 118.7 17.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.861 2.064 . . . . 4.0499999999999998 108.564 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.44 -179.55 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.74 2.016 . . . . 2.8700000000000001 110.673 -174.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.97 174.31 6.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.507 1.123 . . . . 2.98 111.955 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.73 173.54 33.79 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.862 1.22 . . . . 0.89000000000000001 112.922 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -157.7 146.06 19.14 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.436 1.894 . . . . 1.26 107.841 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -150.39 157.74 36.58 Favored Pre-proline 0 N--CA 1.468 0.458 0 C-N-CA 125.255 1.422 . . . . 4.2800000000000002 109.6 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.82 153.87 43.01 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.724 1.616 . . . . 0.54000000000000004 111.07 164.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.5 m -134.6 152.18 77.29 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.531 1.532 . . . . 0.63 110.966 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -81.76 -21.61 5.87 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.301 2.667 . . . . 0.55000000000000004 113.208 -169.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.531 ' CD2' ' HD2' ' A' ' 31' ' ' ARG . 47.3 p90 -175.87 164.05 2.85 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.206 1.402 . . . . 2.0699999999999998 112.07 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.3 mt -109.98 156.64 20.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.877 1.671 . . . . 0.55000000000000004 110.145 163.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -114.35 146.6 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.182 0.593 . . . . 2.75 109.797 163.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.71 126.77 26.0 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.408 1.483 . . . . 1.3200000000000001 109.219 164.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -67.56 165.63 26.69 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.441 2.761 . . . . 1.3899999999999999 110.687 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.33 138.31 55.04 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.016 2.477 . . . . 1.1799999999999999 113.411 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.282 14.4 mtmt 60.14 29.75 19.28 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.684 1.594 . . . . 2.6499999999999999 114.89 168.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.77 -179.85 18.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.727 2.584 . . . . 1.5900000000000001 113.816 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.24 156.74 22.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.751 0.82 . . . . 4.4299999999999997 112.963 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.5 t -148.65 117.06 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.093 1.757 . . . . 3.3100000000000001 107.797 163.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.19 158.3 23.64 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.346 0.869 . . . . 2.8799999999999999 113.346 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -80.8 62.39 4.81 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.671 1.224 . . . . 2.04 109.704 151.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' H ' ' CD ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -56.54 126.69 70.8 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-O 118.066 -0.969 . . . . 3.6699999999999999 111.152 171.422 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -56.96 -39.17 93.43 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.256 3.304 . . . . 2.5499999999999998 114.018 -167.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.11 -3.21 51.52 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.025 -1.431 . . . . 1.96 115.051 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.59 -24.32 0.22 Allowed Glycine 0 N--CA 1.473 1.131 0 N-CA-C 118.155 2.022 . . . . 2.4100000000000001 118.155 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -148.89 143.47 26.26 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 120.67 2.235 . . . . 2.3500000000000001 112.796 175.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -160.48 154.61 23.13 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.745 1.218 . . . . 0.79000000000000004 110.961 174.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 82.2 m-85 -77.8 150.06 34.34 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.673 -0.862 . . . . 2.4199999999999999 108.673 161.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 tpt -106.71 115.18 29.75 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.34 1.856 . . . . 1.0 106.783 166.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.58 120.68 37.35 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.402 1.081 . . . . 1.3 108.741 -174.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.7 mp -116.82 138.15 51.7 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.008 0.923 . . . . 1.8400000000000001 112.611 -167.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.16 49.58 8.36 Favored Glycine 0 N--CA 1.473 1.158 0 O-C-N 121.928 -0.482 . . . . 1.5600000000000001 112.023 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -48.61 154.99 0.6 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 126.969 2.108 . . . . 0.94999999999999996 115.318 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -118.13 -31.38 5.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 113.511 -1.677 . . . . 2.1099999999999999 113.759 -173.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 -118.99 134.5 23.62 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 125.505 1.522 . . . . 4.9900000000000002 107.69 170.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -69.99 113.52 3.44 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 N-CA-C 107.144 -1.906 . . . . 1.75 107.144 163.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.61 153.72 12.71 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.969 1.308 . . . . 2.5299999999999998 113.262 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -131.49 147.05 52.51 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 123.512 1.625 . . . . 4.79 113.592 163.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.96 112.51 10.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.602 -1.636 . . . . 1.5900000000000001 110.237 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.67 -0.55 20.09 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 117.97 -1.461 . . . . 1.6399999999999999 115.376 -173.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -86.51 -176.32 5.8 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.48 1.64 . . . . 2.3500000000000001 110.372 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -142.76 146.15 33.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.641 2.376 . . . . 4.3399999999999999 108.084 171.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -145.22 142.15 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.64 1.576 . . . . 1.71 111.56 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -88.85 164.39 15.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.664 1.357 . . . . 2.5099999999999998 114.664 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 tt -154.97 134.1 12.36 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.347 1.459 . . . . 2.6000000000000001 110.872 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.37 153.34 29.83 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 127.479 2.312 . . . . 1.97 110.503 169.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.18 124.98 35.99 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.708 2.003 . . . . 1.1799999999999999 108.989 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.8 mt -106.21 116.32 31.74 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.725 1.21 . . . . 0.68000000000000005 109.754 -170.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -112.14 130.31 55.94 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.772 1.229 . . . . 2.0899999999999999 111.394 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.07 -19.13 62.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.982 1.313 . . . . 2.1800000000000002 113.367 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.64 32.63 1.01 Allowed Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.728 1.156 . . . . 4.8499999999999996 114.272 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.7 35.35 85.55 Favored Glycine 0 N--CA 1.471 1.003 0 C-N-CA 125.619 1.581 . . . . 2.71 114.342 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -142.06 145.39 34.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.942 1.371 . . . . 2.9399999999999999 114.026 -167.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -127.32 146.87 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.513 1.925 . . . . 2.29 109.326 167.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -156.7 147.78 22.05 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.045 2.138 . . . . 2.1600000000000001 107.932 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -122.73 155.91 35.5 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.591 1.541 . . . . 2.23 114.044 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.52 173.24 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.373 2.269 . . . . 1.75 108.886 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -136.1 136.81 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.443 1.497 . . . . 2.2200000000000002 110.618 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 mt -137.89 136.76 20.18 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.303 1.441 . . . . 2.29 111.127 -166.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.94 159.39 53.13 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.625 2.883 . . . . 0.95999999999999996 112.128 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.7 t -103.76 131.12 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.747 1.219 . . . . 1.5 109.761 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.54 170.56 16.18 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.227 1.811 . . . . 4.0599999999999996 110.838 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.32 118.1 31.82 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.218 1.007 . . . . 1.96 110.647 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 . . . . . 0 C--O 1.248 0.974 0 C-N-CA 126.422 1.889 . . . . 6.8700000000000001 109.086 -160.403 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.352 0 N-CA-C 107.835 -2.106 . . . . 10.550000000000001 107.835 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 p -56.8 -103.42 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 118.965 -1.094 . . . . 8.9100000000000001 108.804 114.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -67.69 157.01 35.59 Favored 'General case' 0 CA--C 1.552 1.051 0 O-C-N 120.423 -1.423 . . . . 8.2899999999999991 112.73 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.17 17.55 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.046 2.138 . . . . 4.9800000000000004 114.989 -167.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -76.43 73.81 3.18 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 123.545 1.64 . . . . 4.4800000000000004 112.528 -175.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.32 -178.66 15.72 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.188 1.851 . . . . 1.3500000000000001 111.935 175.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -148.95 149.0 30.45 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.071 1.138 . . . . 2.21 114.071 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -79.08 133.39 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 106.64 -1.615 . . . . 1.3400000000000001 106.64 163.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -68.05 -18.64 64.74 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.575 1.695 . . . . 4.2199999999999998 115.575 -158.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.4 t80 76.67 151.32 0.12 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.746 2.418 . . . . 3.0299999999999998 112.534 -174.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 t 174.88 161.31 0.38 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 129.667 3.187 . . . . 2.0899999999999999 108.639 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.63 -24.94 5.8 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.809 2.339 . . . . 1.25 112.761 159.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.47 -178.43 17.02 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.265 1.888 . . . . 1.0 112.447 -169.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.26 -0.49 21.9 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.023 1.412 . . . . 1.3600000000000001 113.273 -2.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -135.34 166.79 22.32 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.378 1.471 . . . . 2.1899999999999999 113.205 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.47 -174.12 4.8 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 129.191 2.996 . . . . 0.56000000000000005 111.413 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.26 175.6 9.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.401 1.88 . . . . 0.95999999999999996 108.83 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.59 17.81 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.339 -0.851 . . . . 0.58999999999999997 111.641 170.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.466 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 53.7 m-85 -109.21 69.64 0.71 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.386 1.874 . . . . 2.5099999999999998 109.268 176.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -79.28 158.65 27.51 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.617 0.767 . . . . 1.76 112.795 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.4 m -119.07 140.34 50.24 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.193 1.797 . . . . 2.1000000000000001 109.087 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.0 tp -155.33 178.95 9.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.037 1.735 . . . . 4.6299999999999999 108.811 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -158.27 149.61 21.09 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.222 1.809 . . . . 4.6399999999999997 107.889 -171.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -106.51 87.17 2.53 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 124.919 1.288 . . . . 1.6899999999999999 110.252 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.56 -11.55 28.28 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.512 2.142 . . . . 2.1800000000000002 114.136 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.28 174.45 53.48 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-O 123.075 1.375 . . . . 1.47 113.049 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.6 -1.76 32.07 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.205 2.202 . . . . 3.27 112.768 -167.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.27 156.87 57.13 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.698 1.999 . . . . 3.3300000000000001 109.683 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.12 170.4 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.908 2.406 . . . . 1.54 112.203 -162.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.21 146.55 44.15 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 122.851 1.31 . . . . 2.8700000000000001 111.354 167.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -135.53 110.94 9.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 111.73 -2.486 . . . . 2.1299999999999999 109.333 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.1 tp -94.37 112.14 23.92 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.945 1.698 . . . . 2.3900000000000001 110.042 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.64 -22.96 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.847 0.859 . . . . 0.54000000000000004 111.602 -170.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.57 -174.79 30.84 Favored Glycine 0 C--N 1.345 1.072 0 C-N-CA 125.117 1.341 . . . . 0.44 113.838 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.22 -178.44 6.39 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.401 1.881 . . . . 0.48999999999999999 110.913 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -156.58 175.36 14.14 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.41 2.284 . . . . 5.96 108.022 161.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -170.5 158.61 5.89 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 127.037 2.135 . . . . 0.73999999999999999 109.448 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.41 -5.94 9.16 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.452 2.101 . . . . 1.1399999999999999 114.861 169.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.88 16.45 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.017 1.488 . . . . 1.1399999999999999 115.017 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.77 159.47 24.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.945 2.098 . . . . 0.93000000000000005 109.181 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -108.33 -42.24 4.65 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.306 0.854 . . . . 3.8500000000000001 113.306 -170.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -113.98 147.82 37.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 122.48 1.133 . . . . 6.5599999999999996 108.442 164.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -135.47 134.31 52.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 125.186 1.395 . . . . 0.84999999999999998 107.582 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -130.92 125.86 34.6 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.508 1.523 . . . . 3.2999999999999998 109.525 -166.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.54 119.06 24.74 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.832 -0.543 . . . . 0.84999999999999998 111.925 -175.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 56.2 m170 -121.55 161.06 23.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.822 1.649 . . . . 0.51000000000000001 113.523 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.6 159.96 15.56 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.858 1.663 . . . . 2.1099999999999999 111.009 158.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.1 m -114.77 137.54 51.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 105.757 -1.942 . . . . 0.84999999999999998 105.757 161.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -133.75 174.57 10.31 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.667 1.222 . . . . 2.1000000000000001 113.203 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.4 mtm -119.24 141.03 49.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.244 1.417 . . . . 4.8600000000000003 110.554 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -133.99 144.77 48.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.317 1.047 . . . . 5.9400000000000004 110.738 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -78.86 114.53 17.87 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 106.479 -1.675 . . . . 2.29 106.479 137.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.9 t -94.03 97.86 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 104.449 -2.426 . . . . 2.9900000000000002 104.449 171.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.31 37.26 11.1 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.903 1.335 . . . . 8.8300000000000001 111.246 166.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.17 75.65 Favored Glycine 0 CA--C 1.527 0.824 0 O-C-N 121.018 -1.051 . . . . 2.2599999999999998 112.387 -175.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -120.93 108.96 14.52 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.725 1.61 . . . . 4.46 110.525 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.574 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -57.41 127.54 32.49 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.008 -1.683 . . . . 3.2599999999999998 111.706 171.818 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.3 p -158.33 174.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.398 1.879 . . . . 2.4300000000000002 110.711 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.9 mtt -105.97 172.38 6.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.572 1.149 . . . . 2.8799999999999999 112.414 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.87 -178.62 31.13 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.821 1.201 . . . . 0.69999999999999996 112.898 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.8 ttm -154.75 150.73 27.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.814 1.646 . . . . 1.1499999999999999 108.397 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -158.53 158.56 29.6 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 123.92 0.888 . . . . 4.7400000000000002 111.49 173.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.89 154.84 58.36 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.438 2.092 . . . . 0.58999999999999997 111.287 171.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.47 153.39 65.62 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.533 1.533 . . . . 0.65000000000000002 110.117 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.84 -26.7 4.38 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.27 2.647 . . . . 0.60999999999999999 113.116 -167.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -178.24 164.06 1.72 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.961 1.704 . . . . 2.0899999999999999 111.172 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.5 mt -109.44 154.39 22.69 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.696 1.198 . . . . 0.78000000000000003 109.762 166.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -124.93 137.01 54.28 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.052 1.341 . . . . 1.74 110.389 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.2 t -143.94 135.03 12.48 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 118.35 0.523 . . . . 1.4099999999999999 112.275 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.93 172.19 11.17 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.693 2.929 . . . . 0.93000000000000005 113.047 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -59.93 145.33 98.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.881 2.387 . . . . 1.1299999999999999 111.588 164.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt 67.58 -2.2 1.4 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.783 2.033 . . . . 1.78 114.059 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.85 159.8 46.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.673 1.606 . . . . 1.3899999999999999 114.247 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 134.7 34.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.99 1.316 . . . . 3.75 110.848 172.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 t -114.9 64.21 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 127.365 2.266 . . . . 5.0499999999999998 107.617 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -98.32 137.07 37.58 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.275 -0.891 . . . . 3.02 110.069 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.597 HD23 ' HA ' ' A' ' 83' ' ' HIS . 1.9 mp -73.62 -63.79 1.13 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 118.011 -0.995 . . . . 3.1899999999999999 111.034 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm 107.99 128.89 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 128.928 2.891 . . . . 3.6899999999999999 114.248 161.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.466 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 14.9 Cg_endo -53.48 -56.7 2.46 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 124.283 3.322 . . . . 2.1200000000000001 113.599 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.01 28.62 1.91 Allowed Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.555 -1.136 . . . . 1.8600000000000001 113.861 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.25 -128.88 0.99 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.709 1.147 . . . . 1.6299999999999999 115.554 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -74.76 144.21 43.7 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.052 -1.264 . . . . 1.8500000000000001 111.54 -165.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.597 ' HA ' HD23 ' A' ' 77' ' ' LEU . 47.3 p-80 -160.75 151.06 17.94 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.348 -0.845 . . . . 0.59999999999999998 112.246 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -78.06 128.5 33.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.738 -0.838 . . . . 2.1099999999999999 108.738 161.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.407 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 2.8 tpt -79.78 128.91 34.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.768 -1.197 . . . . 0.81000000000000005 107.768 160.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.48 115.36 29.5 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.3 1.04 . . . . 1.1399999999999999 108.303 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.05 149.78 42.19 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.666 1.186 . . . . 2.2200000000000002 111.137 -175.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.72 49.18 11.05 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.169 0.89 . . . . 1.8 111.277 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mt -52.03 153.28 2.72 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 123.479 1.609 . . . . 0.68999999999999995 114.395 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -121.13 -16.27 8.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 112.547 -2.115 . . . . 2.21 115.435 -168.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -134.3 144.59 51.84 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.816 1.246 . . . . 5.2400000000000002 111.084 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.6 91.98 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.458 2.105 . . . . 3.2999999999999998 107.55 161.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.689 ' H ' HD23 ' A' ' 93' ' ' LEU . 1.7 pt? -81.07 155.92 26.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.198 1.799 . . . . 2.7799999999999998 111.662 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -113.46 165.52 12.4 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 122.384 1.088 . . . . 3.5600000000000001 111.468 166.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.49 129.66 37.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.318 -1.31 . . . . 1.46 107.665 153.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.14 20.7 37.97 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.311 -1.272 . . . . 1.5 114.76 -172.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -100.31 179.09 4.57 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.56 1.68 . . . . 2.48 109.543 159.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -132.97 126.47 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.309 2.244 . . . . 3.6699999999999999 105.738 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.7 t -148.23 145.4 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 126.801 2.041 . . . . 1.76 108.194 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.3 151.49 22.65 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 123.407 1.575 . . . . 3.6499999999999999 114.079 -171.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.62 134.61 54.98 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.476 1.511 . . . . 1.8400000000000001 110.07 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.402 ' OD1' ' HE2' ' A' ' 112' ' ' LYS . 11.6 m-20 -81.65 130.67 35.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.003 1.721 . . . . 2.9500000000000002 108.273 164.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.64 135.58 48.84 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.035 1.289 . . . . 1.79 111.086 168.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -110.38 113.84 26.8 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.719 1.607 . . . . 0.59999999999999998 109.259 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.83 158.09 19.81 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.825 1.25 . . . . 2.3300000000000001 110.506 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.39 148.5 41.37 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.554 -0.716 . . . . 2.6800000000000002 112.079 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.7 23.14 43.68 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 119.056 -0.858 . . . . 4.1200000000000001 115.053 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.18 7.52 88.45 Favored Glycine 0 N--CA 1.474 1.225 0 CA-C-N 118.827 1.314 . . . . 1.8100000000000001 114.023 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -78.33 121.06 23.97 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.326 -1.103 . . . . 4.54 111.381 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.66 142.0 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.7 1.2 . . . . 1.8500000000000001 108.686 167.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.3 tt -151.19 112.58 4.38 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.934 0.893 . . . . 2.6499999999999999 109.997 -176.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HE2' ' OD1' ' A' ' 102' ' ' ASP . 23.7 ttmm -84.46 125.8 32.69 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.734 -0.604 . . . . 3.6600000000000001 111.881 175.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 m -98.0 145.98 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.277 1.431 . . . . 2.8599999999999999 110.329 170.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.19 135.37 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.082 1.753 . . . . 2.0699999999999998 107.726 168.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.409 ' N ' HD23 ' A' ' 115' ' ' LEU . 1.3 pt? -158.09 155.14 25.62 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.619 1.567 . . . . 1.9299999999999999 111.409 -171.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -65.91 145.74 80.94 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.774 2.316 . . . . 0.91000000000000003 112.227 169.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.9 t -82.35 124.24 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 105.896 -1.89 . . . . 1.1799999999999999 105.896 151.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.93 151.05 28.99 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.039 0.936 . . . . 3.9900000000000002 110.694 -172.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.3 73.85 5.33 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.544 0.737 . . . . 2.2999999999999998 112.758 -170.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 C-N-CA 124.876 1.27 . . . . 6.5300000000000002 108.684 156.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.403 0 N-CA-C 109.476 -1.45 . . . . 10.109999999999999 109.476 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -71.24 -29.18 64.8 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.258 1.577 . . . . 11.25 115.258 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -176.57 154.75 1.28 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.961 2.104 . . . . 10.51 109.727 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.0 p -149.62 55.13 0.96 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.409 1.484 . . . . 6.7699999999999996 110.473 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.448 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 10.0 tt0 -156.23 -179.99 8.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.444 1.098 . . . . 9.3000000000000007 110.096 -177.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.448 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -95.26 173.55 31.56 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.184 1.373 . . . . 2.3199999999999998 113.337 -174.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -154.87 167.67 29.5 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.458 1.103 . . . . 3.1200000000000001 112.3 173.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.94 148.6 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.73 1.212 . . . . 1.5 108.391 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -77.88 -135.96 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.105 -0.702 . . . . 5.7699999999999996 109.105 158.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -140.52 152.64 45.73 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.882 1.273 . . . . 2.8599999999999999 111.489 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 m -161.35 142.02 8.32 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 127.771 2.428 . . . . 2.5800000000000001 108.983 161.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.22 -23.74 20.73 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.424 2.083 . . . . 2.1200000000000001 112.261 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.04 171.81 13.69 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 127.145 2.307 . . . . 1.3200000000000001 110.8 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -79.55 4.14 33.51 Favored 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 119.667 1.733 . . . . 1.0900000000000001 112.403 -9.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.3 139.47 16.54 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.239 1.57 . . . . 2.6400000000000001 115.239 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.33 -176.78 3.17 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.024 2.53 . . . . 0.52000000000000002 111.282 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.77 135.08 18.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.807 1.643 . . . . 0.92000000000000004 108.805 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.7 137.32 54.8 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.758 1.223 . . . . 0.55000000000000004 111.237 -175.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -105.62 86.34 2.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.242 1.817 . . . . 2.6400000000000001 109.068 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -90.41 158.08 17.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.403 0.681 . . . . 1.96 112.708 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 m -131.53 134.02 45.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.016 1.327 . . . . 1.9399999999999999 109.535 -172.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.35 169.95 23.58 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.003 1.721 . . . . 5.3200000000000003 108.865 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -142.86 145.52 33.22 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.287 1.435 . . . . 4.6500000000000004 108.4 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -93.58 108.15 31.97 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.772 1.229 . . . . 1.52 110.87 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.58 -10.27 12.05 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.949 2.433 . . . . 1.8700000000000001 114.91 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.44 169.62 54.05 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 120.085 1.311 . . . . 1.8799999999999999 113.616 -171.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.65 -6.47 58.24 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.414 2.286 . . . . 4.3099999999999996 111.537 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mp -124.5 162.11 44.32 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 127.057 2.143 . . . . 3.9300000000000002 109.587 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.34 155.66 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.854 2.369 . . . . 1.3300000000000001 111.478 -171.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.428 HD12 ' CD2' ' A' ' 105' ' ' PHE . 1.0 OUTLIER -117.79 162.11 18.62 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.625 1.97 . . . . 2.8399999999999999 111.016 177.301 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -155.12 120.66 5.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.193 -1.367 . . . . 2.3799999999999999 111.266 -173.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.5 tp -103.49 114.1 28.11 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.608 1.963 . . . . 2.1200000000000001 109.757 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.3 m -112.86 -20.28 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.749 0.819 . . . . 0.70999999999999996 112.634 -167.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.15 -174.71 29.22 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 124.674 1.13 . . . . 0.52000000000000002 112.251 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.64 -178.43 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.1 1.36 . . . . 0.54000000000000004 110.878 168.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 4.7 mtt180 -152.62 164.86 36.85 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.139 2.176 . . . . 5.0300000000000002 108.417 172.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -169.2 146.06 2.95 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 124.849 1.259 . . . . 0.70999999999999996 108.919 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -77.32 -10.22 17.58 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.381 2.054 . . . . 1.24 113.367 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.97 21.47 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.747 1.388 . . . . 1.4299999999999999 114.747 -174.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.3 38.97 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.172 -0.955 . . . . 0.88 113.067 167.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -72.98 -30.62 63.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.433 1.493 . . . . 3.5099999999999998 113.168 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -155.16 168.44 27.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.156 2.582 . . . . 4.7699999999999996 107.743 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.97 154.87 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.173 1.389 . . . . 0.93999999999999995 108.876 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.61 146.34 28.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.975 1.71 . . . . 4.0599999999999996 108.676 -166.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.8 tp -113.03 110.13 19.97 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.48 1.036 . . . . 0.89000000000000001 111.298 -164.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -116.71 150.04 38.85 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 122.663 1.221 . . . . 0.5 113.927 -173.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -91.94 -178.28 4.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.957 -1.474 . . . . 2.1499999999999999 111.136 158.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.1 m -149.24 127.41 12.06 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.085 -1.82 . . . . 1.03 106.085 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -128.41 170.17 13.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.967 0.889 . . . . 2.0899999999999999 113.267 -167.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.93 144.72 32.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.152 1.781 . . . . 5.5800000000000001 110.68 170.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.37 147.2 21.94 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.512 -0.742 . . . . 5.4299999999999997 112.849 -172.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -91.76 132.62 36.27 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.479 1.512 . . . . 2.2999999999999998 109.835 165.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.33 130.33 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.496 -1.668 . . . . 3.0299999999999998 106.496 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 62.88 28.05 16.22 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.761 0.824 . . . . 4.9500000000000002 112.254 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.21 16.05 79.85 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 120.967 -1.083 . . . . 2.4300000000000002 113.904 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -135.21 134.42 40.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.986 1.714 . . . . 3.71 109.883 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.07 126.31 34.68 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.466 1.506 . . . . 2.6400000000000001 111.976 -173.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.25 -178.97 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 129.558 3.143 . . . . 2.7400000000000002 109.603 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.3 mtm -110.76 170.01 8.38 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.817 0.847 . . . . 3.48 112.033 168.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.89 -176.55 27.24 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.047 1.784 . . . . 1.04 112.206 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ttm -154.67 149.53 26.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.611 1.565 . . . . 1.1799999999999999 108.596 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.9 ptt85 -158.57 156.8 27.93 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 124.891 1.276 . . . . 4.8200000000000003 110.314 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.2 158.06 45.54 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.0 1.8 . . . . 0.5 111.644 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.84 149.85 65.74 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.908 1.683 . . . . 0.67000000000000004 109.087 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.31 -20.28 11.25 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.256 2.637 . . . . 0.71999999999999997 113.02 -167.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 p90 178.96 167.62 0.93 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.666 2.386 . . . . 2.29 110.114 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.75 150.84 32.8 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.124 1.369 . . . . 0.85999999999999999 110.137 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -117.81 141.79 48.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.034 1.334 . . . . 2.3199999999999998 109.3 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 t -143.93 132.05 10.93 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 113.276 0.843 . . . . 1.6000000000000001 113.276 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.85 170.32 14.38 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.256 2.637 . . . . 1.7 112.488 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -56.63 139.82 88.89 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.699 2.266 . . . . 1.72 110.658 164.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt 69.13 1.84 3.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.489 1.516 . . . . 2.3900000000000001 113.743 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.77 158.09 36.58 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.676 1.608 . . . . 2.1299999999999999 113.449 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -79.92 145.63 32.55 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.926 0.89 . . . . 3.5699999999999998 111.925 173.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.57 61.29 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.015 2.126 . . . . 5.9100000000000001 107.92 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -116.57 136.21 53.17 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.845 0.831 . . . . 3.1299999999999999 111.192 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.97 85.55 7.47 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.099 -1.445 . . . . 1.9399999999999999 107.099 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -55.95 139.7 70.35 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 113.672 0.99 . . . . 4.8799999999999999 113.672 -167.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -56.54 130.02 37.82 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.08 1.853 . . . . 4.4699999999999998 109.289 165.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.64 28.98 66.29 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.655 -1.081 . . . . 2.1499999999999999 114.813 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.68 -17.56 0.02 OUTLIER Glycine 0 N--CA 1.472 1.087 0 N-CA-C 118.966 2.347 . . . . 2.3799999999999999 118.966 158.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -143.24 150.03 38.73 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.222 2.011 . . . . 1.79 112.406 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -162.44 153.69 17.83 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.287 1.035 . . . . 0.59999999999999998 111.192 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -86.47 127.68 34.88 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.193 -0.669 . . . . 2.46 109.193 165.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.4 tpt -82.64 119.41 24.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.394 2.278 . . . . 0.81000000000000005 109.396 170.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -100.33 120.82 40.52 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.345 -0.983 . . . . 1.23 108.345 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.56 146.02 30.18 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.626 1.17 . . . . 2.5699999999999998 112.415 -169.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.89 -48.77 3.04 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 126.919 2.199 . . . . 3.0099999999999998 114.126 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.0 mt 56.49 165.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.066 3.346 . . . . 0.67000000000000004 115.388 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -119.36 -7.41 10.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.385 1.874 . . . . 1.8700000000000001 113.292 174.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -127.96 131.51 23.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 128.366 2.666 . . . . 4.5999999999999996 109.385 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.35 76.28 3.97 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.755 2.303 . . . . 2.9500000000000002 106.454 153.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.404 ' H ' ' HG ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -68.34 140.3 55.89 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.585 1.154 . . . . 3.21 113.669 -156.505 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -93.31 156.92 16.51 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.381 1.086 . . . . 5.5599999999999996 111.65 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.62 118.15 7.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 113.847 -1.524 . . . . 1.5600000000000001 107.545 159.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.62 -2.36 36.54 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-O 117.853 -1.526 . . . . 1.77 115.869 -168.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.42 -178.6 5.28 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.586 1.693 . . . . 3.3199999999999998 111.467 160.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -152.62 141.77 21.38 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.753 2.821 . . . . 4.6100000000000003 106.636 -171.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 82.5 t -144.15 146.09 21.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 126.601 1.96 . . . . 1.4399999999999999 109.561 -168.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -97.76 136.29 38.31 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.953 0.901 . . . . 2.8399999999999999 110.094 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.63 140.12 50.42 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.262 1.025 . . . . 2.71 109.888 165.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 39.7 m-20 -94.44 134.12 37.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.149 2.579 . . . . 1.8700000000000001 108.351 160.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.44 130.18 42.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.634 1.574 . . . . 1.0800000000000001 108.848 164.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.4 111.43 23.33 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.049 0.939 . . . . 0.68999999999999995 110.678 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.428 ' CD2' HD12 ' A' ' 30' ' ' LEU . 85.6 m-85 -103.66 163.68 12.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.142 1.377 . . . . 2.1299999999999999 111.582 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.57 154.86 13.39 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.679 -0.691 . . . . 2.6000000000000001 112.122 166.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.36 24.95 62.22 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.138 -0.812 . . . . 3.9500000000000002 114.977 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.91 13.69 82.29 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 118.436 1.118 . . . . 1.8999999999999999 114.171 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -90.52 117.51 29.26 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.448 -1.03 . . . . 3.5800000000000001 112.128 -172.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.27 140.86 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.61 1.564 . . . . 2.3300000000000001 110.431 169.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 mt -140.01 129.2 23.78 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.035 1.334 . . . . 2.6200000000000001 110.846 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -106.21 143.41 34.39 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.797 0.666 . . . . 2.21 112.797 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.96 160.01 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 127.49 2.316 . . . . 2.27 111.704 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.47 137.23 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.542 1.937 . . . . 1.98 110.57 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.4 mp -134.76 114.57 12.08 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 126.525 1.93 . . . . 2.6400000000000001 110.741 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -75.5 150.02 35.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.265 2.644 . . . . 1.26 110.665 169.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.8 t -91.25 132.88 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.848 0.859 . . . . 1.3100000000000001 111.195 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.9 149.31 44.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.901 1.68 . . . . 4.5199999999999996 113.089 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.63 96.13 5.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.675 0.79 . . . . 2.5299999999999998 109.645 159.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.241 0 C-N-CA 128.559 2.744 . . . . 6.1200000000000001 110.413 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 107.284 -2.327 . . . . 11.66 107.284 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -57.7 -176.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 117.194 0.497 . . . . 10.970000000000001 111.108 134.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -74.38 155.54 38.02 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.027 -0.421 . . . . 8.5 110.274 151.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.2 t 138.65 114.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 1 C-N-CA 132.301 4.24 . . . . 4.8899999999999997 104.371 -164.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.48 65.06 0.95 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.925 1.345 . . . . 4.8499999999999996 110.359 -160.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.31 172.35 20.38 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.883 1.23 . . . . 1.3 113.897 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -156.23 160.15 39.55 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.499 1.92 . . . . 2.3599999999999999 110.96 172.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -103.61 147.94 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.356 -1.35 . . . . 1.6599999999999999 107.356 170.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -72.08 -119.77 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 CA-C-O 121.542 0.687 . . . . 5.0899999999999999 109.432 164.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -151.41 143.03 23.64 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 119.383 -2.073 . . . . 3.0800000000000001 110.92 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.0 t -171.68 143.31 1.44 Allowed Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.703 1.601 . . . . 2.2599999999999998 110.572 167.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.9 -26.32 4.58 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.733 2.289 . . . . 1.4399999999999999 112.26 166.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.31 170.42 12.03 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.643 2.068 . . . . 1.0700000000000001 111.419 -171.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.69 -16.12 22.83 Favored 'Cis proline' 0 C--N 1.349 0.596 0 CA-C-N 119.328 1.564 . . . . 1.3200000000000001 112.761 0.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -142.09 160.43 40.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.805 1.288 . . . . 2.21 114.421 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.88 -179.06 4.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.433 2.693 . . . . 0.55000000000000004 110.486 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.06 133.39 26.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.162 1.385 . . . . 1.3 109.208 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.32 150.95 50.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.562 1.145 . . . . 0.88 113.481 -171.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.45 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 50.8 m-85 -131.55 127.15 36.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.19 2.196 . . . . 2.1000000000000001 109.548 -163.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.262 0.0 OUTLIER -162.5 161.7 27.13 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.822 1.415 . . . . 2.77 114.822 -172.334 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.5 m -93.26 127.75 38.96 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.896 1.678 . . . . 1.71 111.735 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.9 tp -112.34 122.0 46.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.809 1.243 . . . . 4.2400000000000002 110.302 166.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -122.07 142.29 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.577 1.151 . . . . 4.5099999999999998 109.211 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -105.87 97.73 16.06 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.561 0.744 . . . . 1.3700000000000001 111.322 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.31 -5.59 14.36 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.857 2.371 . . . . 1.21 114.044 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.93 163.65 34.95 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 119.624 1.102 . . . . 1.3400000000000001 111.347 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.9 4.29 50.42 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.848 2.059 . . . . 3.5099999999999998 112.374 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -118.79 152.81 52.01 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.248 2.219 . . . . 2.9199999999999999 110.346 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.35 142.36 21.12 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.216 1.944 . . . . 0.96999999999999997 110.7 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.1 mt -96.57 149.46 21.74 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 122.258 1.027 . . . . 1.8 110.841 172.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -135.98 100.14 4.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 113.866 -1.515 . . . . 2.3500000000000001 110.946 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.46 97.39 9.5 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.999 2.12 . . . . 1.8 108.066 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 m -94.13 -25.42 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.875 0.87 . . . . 0.48999999999999999 112.801 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.46 -177.09 32.23 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 123.974 0.797 . . . . 0.40000000000000002 113.208 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.3 178.94 6.33 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.462 0.705 . . . . 0.5 111.18 172.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.402 ' NH1' ' H ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -148.75 170.97 17.01 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.512 2.725 . . . . 5.4199999999999999 106.591 165.004 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.402 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 1.5 t -177.36 148.42 0.72 Allowed Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 127.187 2.195 . . . . 0.81000000000000005 108.703 -172.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -77.14 -24.73 9.32 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.031 1.821 . . . . 1.21 113.958 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.5 m -112.57 23.42 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 114.221 1.193 . . . . 1.1899999999999999 114.221 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.39 35.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.142 1.377 . . . . 1.4299999999999999 107.822 160.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -83.3 -54.41 5.02 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.237 1.015 . . . . 3.0 111.075 -171.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -115.97 166.75 11.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.582 2.753 . . . . 5.4900000000000002 106.392 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.95 134.36 2.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 125.533 1.533 . . . . 0.94999999999999996 108.267 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -113.97 135.99 53.39 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.21 1.404 . . . . 2.9399999999999999 109.455 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -83.48 124.45 30.73 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.542 -0.54 . . . . 1.22 109.542 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -122.61 158.33 30.19 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.19 1.796 . . . . 0.63 112.896 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -179.89 4.07 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.626 1.571 . . . . 3.3199999999999998 110.701 165.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.5 m -154.77 141.82 19.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.785 1.634 . . . . 0.83999999999999997 106.988 170.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -155.58 175.0 14.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.54 1.162 . . . . 2.04 113.387 -167.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.7 ttp -117.2 146.16 43.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.71 1.604 . . . . 3.4700000000000002 110.137 171.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -148.11 161.05 42.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.716 2.406 . . . . 7.6600000000000001 110.272 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -91.03 144.81 25.27 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.832 0.853 . . . . 2.46 109.5 166.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.7 t -137.22 115.48 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.095 -1.817 . . . . 2.4300000000000002 106.095 163.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 58.08 34.85 24.63 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.992 1.479 . . . . 5.4100000000000001 114.992 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.18 4.63 68.89 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.253 -1.529 . . . . 1.6200000000000001 113.553 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -103.52 115.31 30.29 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.122 1.769 . . . . 2.75 107.673 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 117.06 17.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.903 0.881 . . . . 3.0600000000000001 110.221 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 t -138.88 153.73 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 128.609 2.764 . . . . 2.21 107.705 -161.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.23 173.43 6.46 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.615 -1.303 . . . . 3.96 113.531 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.09 166.84 33.19 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.703 1.144 . . . . 0.57999999999999996 112.451 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 ttm -150.43 139.74 21.31 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.143 2.177 . . . . 1.4099999999999999 107.286 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -150.56 154.23 35.16 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.681 1.992 . . . . 4.3700000000000001 108.672 -171.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.71 159.71 31.52 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.323 2.016 . . . . 0.52000000000000002 111.194 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.76 155.99 52.21 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 125.767 1.627 . . . . 0.93999999999999995 110.931 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -84.88 -26.43 1.54 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.407 2.738 . . . . 0.46999999999999997 114.089 -164.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -174.8 164.81 3.58 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.991 1.716 . . . . 1.7 111.477 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 mt -111.7 160.57 17.15 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.924 1.29 . . . . 0.52000000000000002 109.296 157.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -138.0 148.79 45.51 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.61 1.164 . . . . 1.9399999999999999 110.11 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 t -139.82 129.09 13.69 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 123.836 0.71 . . . . 1.03 111.755 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -68.39 162.81 39.03 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.189 2.593 . . . . 1.21 110.967 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.05 138.66 79.83 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.097 2.532 . . . . 1.25 112.17 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.14 3.43 2.69 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 127.27 2.228 . . . . 2.1099999999999999 115.036 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.67 169.71 34.35 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.136 1.827 . . . . 1.47 113.263 169.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -132.17 157.21 44.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.334 1.054 . . . . 4.54 112.305 168.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.3 t -145.08 140.93 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 128.026 2.53 . . . . 3.3799999999999999 107.505 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -134.32 130.06 36.45 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.186 0.517 . . . . 3.9700000000000002 110.822 -170.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -75.69 80.51 2.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.224 1.41 . . . . 2.1099999999999999 109.709 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.84 155.58 91.31 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 126.604 1.962 . . . . 3.7599999999999998 114.323 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.45 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 55.9 Cg_endo -61.8 -44.46 21.0 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.126 2.551 . . . . 2.25 112.329 171.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.48 60.33 4.88 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.106 -0.83 . . . . 2.2200000000000002 112.426 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.25 -126.44 2.03 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 125.428 1.49 . . . . 1.51 114.191 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -72.63 136.62 45.74 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.674 -0.898 . . . . 1.8400000000000001 112.11 -167.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -160.09 163.88 33.49 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.61 1.164 . . . . 0.81999999999999995 111.439 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -97.18 132.68 42.71 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.914 -0.491 . . . . 1.8300000000000001 109.921 170.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -88.35 115.69 26.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.822 2.049 . . . . 0.91000000000000003 108.983 166.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.12 119.19 37.43 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.185 0.994 . . . . 1.45 109.013 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.56 141.04 52.11 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.263 1.208 . . . . 3.1800000000000002 114.263 -164.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.24 38.34 25.97 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.539 1.066 . . . . 1.8799999999999999 113.142 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mt -43.86 152.75 0.15 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 116.386 1.995 . . . . 0.70999999999999996 116.386 -174.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -112.84 -16.9 12.64 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.718 -1.583 . . . . 1.8300000000000001 114.939 -173.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -138.25 142.31 34.85 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.698 2.799 . . . . 6.5800000000000001 108.599 165.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.24 135.65 27.45 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.965 1.776 . . . . 1.3600000000000001 107.753 158.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.56 105.9 16.15 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.318 0.508 . . . . 3.2999999999999998 109.851 -176.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -86.91 20.54 2.58 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.587 2.069 . . . . 4.3399999999999999 116.587 -163.022 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 67.01 157.25 0.12 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 128.541 2.737 . . . . 1.5900000000000001 111.845 -161.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.25 0.26 85.89 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 118.95 -0.917 . . . . 1.28 114.536 -172.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.89 175.69 8.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.921 1.688 . . . . 2.6899999999999999 110.259 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -128.48 153.4 47.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.932 2.093 . . . . 4.0899999999999999 105.423 163.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.1 t -136.72 138.04 46.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 126.407 1.883 . . . . 1.53 109.077 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 38.9 tt0 -89.81 136.08 33.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.08 1.352 . . . . 3.0299999999999998 109.853 173.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.63 139.89 52.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.914 1.286 . . . . 2.6299999999999999 109.62 170.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -99.06 143.45 29.32 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.84 2.056 . . . . 2.6299999999999999 109.669 167.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -114.74 118.79 34.6 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.844 1.657 . . . . 1.1799999999999999 109.292 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.1 mt -92.39 112.31 24.21 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.883 1.273 . . . . 0.67000000000000004 109.408 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -104.66 106.5 17.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.567 1.147 . . . . 2.0899999999999999 110.564 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.8 21.8 2.08 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.766 1.626 . . . . 2.6400000000000001 114.78 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.68 -55.48 4.46 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.12 1.343 . . . . 4.2400000000000002 112.976 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.65 1.12 54.09 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 116.126 1.21 . . . . 2.0499999999999998 116.126 -172.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -140.68 149.15 41.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.077 1.439 . . . . 4.0800000000000001 112.326 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.71 153.14 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.407 1.483 . . . . 2.1400000000000001 110.919 170.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.0 tp -155.19 164.02 39.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.953 2.101 . . . . 2.1899999999999999 107.973 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.415 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 41.2 pttt -146.58 156.16 43.02 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.16 1.541 . . . . 1.9299999999999999 115.16 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.15 160.16 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.951 2.5 . . . . 2.6899999999999999 109.929 -167.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.0 142.97 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.959 0.904 . . . . 2.4900000000000002 110.028 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.21 144.57 15.21 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 124.631 1.172 . . . . 2.52 113.664 -168.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.49 158.86 25.65 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.984 3.79 . . . . 1.24 114.478 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.99 124.5 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.152 1.381 . . . . 1.2 110.227 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -135.57 143.48 45.68 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.345 1.058 . . . . 3.7200000000000002 111.149 174.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.48 59.42 4.62 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.104 -0.998 . . . . 2.6899999999999999 111.368 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.523 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 125.138 1.375 . . . . 6.2300000000000004 113.991 -173.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.353 0 N-CA-C 108.723 -1.751 . . . . 14.470000000000001 108.723 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p 176.94 159.84 0.37 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.981 1.712 . . . . 10.69 108.717 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.66 161.63 42.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.153 0.981 . . . . 11.109999999999999 112.211 -171.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.523 ' HA ' HG21 ' A' ' 21' ' ' THR . 29.2 m -135.58 70.57 1.43 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.128 1.771 . . . . 6.4699999999999998 108.172 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -144.43 169.98 16.9 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.337 1.055 . . . . 5.29 113.362 -162.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.16 172.38 34.04 Favored Glycine 0 C--N 1.34 0.78 0 O-C-N 120.797 -1.189 . . . . 1.1899999999999999 114.809 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -157.35 159.55 37.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.198 1.399 . . . . 2.2999999999999998 113.358 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.1 t -107.99 143.31 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.905 1.282 . . . . 1.45 109.707 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -73.12 -15.77 61.47 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 117.263 2.32 . . . . 5.6900000000000004 117.263 -159.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 1.1 t80 71.83 115.76 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.863 2.065 . . . . 3.25 110.778 -174.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.5 m -162.06 145.4 9.14 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.887 1.675 . . . . 2.2599999999999998 108.806 169.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.12 -33.29 6.03 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.7 2.267 . . . . 1.8400000000000001 112.551 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.71 172.2 18.29 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.437 1.494 . . . . 1.24 111.503 -175.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.94 -1.26 25.14 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 CA-C-N 119.194 1.497 . . . . 1.1499999999999999 112.891 -1.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -144.0 169.38 17.93 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.256 1.023 . . . . 2.1899999999999999 113.45 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.26 178.27 9.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.966 2.506 . . . . 0.68999999999999995 110.941 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.64 166.3 22.93 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.989 2.116 . . . . 1.0800000000000001 108.823 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.24 154.4 34.58 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.863 0.865 . . . . 0.64000000000000001 111.863 174.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.25 131.86 28.84 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.537 1.535 . . . . 2.5600000000000001 109.818 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.26 162.47 39.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.083 0.856 . . . . 2.8199999999999998 112.841 175.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.523 HG21 ' HA ' ' A' ' 4' ' ' THR . 39.4 m -89.03 127.08 35.67 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.346 1.458 . . . . 1.73 110.221 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.7 tp -104.47 127.47 52.18 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.115 1.366 . . . . 4.04 108.534 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -135.86 132.83 37.09 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.815 1.246 . . . . 4.6900000000000004 109.106 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -103.71 101.21 23.0 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.538 1.135 . . . . 1.53 110.41 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.82 -10.17 19.84 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.297 1.998 . . . . 1.1000000000000001 113.535 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 177.3 50.84 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-O 122.764 1.202 . . . . 1.1499999999999999 113.102 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -104.46 -5.25 21.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.496 2.318 . . . . 2.8799999999999999 112.368 -172.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -120.34 161.2 40.31 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 127.359 2.264 . . . . 3.6400000000000001 109.033 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.74 151.99 14.83 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.711 2.274 . . . . 1.0600000000000001 111.911 -167.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp -104.93 149.88 25.35 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.81 1.291 . . . . 2.1600000000000001 109.387 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -139.87 116.65 10.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.726 -1.579 . . . . 2.27 108.594 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -93.31 114.85 27.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.3 2.24 . . . . 2.2799999999999998 108.193 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.5 -25.34 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.708 0.803 . . . . 0.62 111.984 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.04 -175.8 33.45 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 123.808 0.718 . . . . 0.55000000000000004 114.573 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -123.51 178.29 5.25 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.64 1.176 . . . . 0.81000000000000005 112.1 166.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -157.06 147.66 21.41 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.708 1.603 . . . . 5.8200000000000003 107.094 162.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 t -159.59 151.6 17.1 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-O 117.538 -1.22 . . . . 0.68000000000000005 108.317 -169.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.93 0.59 9.1 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 121.805 1.67 . . . . 0.85999999999999999 114.047 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.07 28.3 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.809 2.044 . . . . 1.04 114.791 -171.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.26 143.14 16.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.786 1.175 . . . . 1.1499999999999999 111.013 168.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.96 -38.51 91.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.174 1.39 . . . . 3.02 111.697 173.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -149.95 144.39 25.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.085 1.754 . . . . 7.0300000000000002 107.856 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.66 132.67 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.329 1.452 . . . . 0.90000000000000002 109.394 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -97.63 167.98 10.63 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.714 1.206 . . . . 3.21 110.02 166.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -119.61 137.25 53.98 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.986 1.374 . . . . 2.4500000000000002 112.441 154.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -121.5 153.72 37.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.661 1.984 . . . . 0.73999999999999999 110.808 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -90.35 157.28 17.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.896 -1.047 . . . . 1.98 109.945 153.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.4 m -108.89 140.13 42.79 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 105.033 -2.21 . . . . 0.95999999999999996 105.033 157.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -136.15 167.99 20.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.869 1.318 . . . . 1.99 113.701 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.4 mtm -113.12 142.87 45.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.532 1.533 . . . . 4.71 110.843 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -134.88 143.27 46.87 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.129 1.372 . . . . 6.1799999999999997 110.047 170.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -91.25 142.31 27.85 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.214 -1.032 . . . . 3.3900000000000001 108.214 154.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.3 t -138.85 118.71 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 106.599 -1.63 . . . . 3.4399999999999999 106.599 164.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 64.59 19.89 11.97 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.411 1.484 . . . . 4.9199999999999999 114.264 -177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.54 4.81 87.41 Favored Glycine 0 N--CA 1.481 1.646 0 O-C-N 120.477 -1.39 . . . . 3.2799999999999998 113.64 -169.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -103.68 111.43 23.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.672 1.989 . . . . 3.54 107.87 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.417 ' HG2' ' H ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -87.64 117.71 26.64 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.336 1.454 . . . . 2.96 111.085 -173.436 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.17 139.85 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.396 1.878 . . . . 2.5499999999999998 109.329 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -101.13 166.98 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.902 1.281 . . . . 3.5800000000000001 112.77 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.1 -178.0 29.84 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.44 1.019 . . . . 0.58999999999999997 113.166 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.2 ttm -152.41 143.37 23.04 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.666 1.586 . . . . 1.29 108.759 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -162.96 153.75 14.23 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 123.569 0.748 . . . . 4.9400000000000004 112.065 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.33 146.22 35.33 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.644 2.229 . . . . 0.67000000000000004 112.852 -174.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.66 155.15 63.38 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 118.347 -0.835 . . . . 0.82999999999999996 110.905 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.38 -23.66 5.98 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.133 2.555 . . . . 0.59999999999999998 112.89 -171.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -178.37 167.41 1.88 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.089 1.756 . . . . 2.02 111.113 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.6 mt -115.08 155.13 27.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.191 1.796 . . . . 0.77000000000000002 109.952 163.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -116.13 145.81 42.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.387 1.475 . . . . 2.23 110.531 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.5 t -142.23 126.6 10.03 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 118.878 0.763 . . . . 0.92000000000000004 112.588 163.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.58 165.57 32.33 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.089 3.193 . . . . 1.02 112.39 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.99 137.63 80.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.342 2.694 . . . . 1.0700000000000001 112.218 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt 67.59 1.21 2.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.362 1.865 . . . . 1.6799999999999999 114.396 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.12 167.43 27.83 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 126.007 1.765 . . . . 1.1899999999999999 113.406 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -137.03 156.16 48.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.576 1.15 . . . . 5.6500000000000004 111.826 169.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.0 t -146.84 130.71 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.888 2.075 . . . . 3.4700000000000002 108.145 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -96.33 140.47 30.96 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.622 1.101 . . . . 3.1200000000000001 111.392 164.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -41.2 -52.37 3.36 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.364 1.865 . . . . 3.0600000000000001 111.959 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 104.11 127.89 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 128.575 2.75 . . . . 2.73 111.217 164.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.18 -11.27 30.53 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.238 2.625 . . . . 2.5 114.83 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.67 20.26 8.82 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.108 1.337 . . . . 1.8300000000000001 113.753 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -144.54 -119.32 1.3 Allowed Glycine 0 N--CA 1.471 1.0 0 CA-C-N 119.204 1.502 . . . . 1.8100000000000001 113.31 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -72.74 144.68 47.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.275 1.038 . . . . 2.1699999999999999 110.518 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -161.48 151.14 16.69 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.532 -0.73 . . . . 0.71999999999999997 110.728 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 59.0 m-85 -77.76 143.01 38.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.477 -0.935 . . . . 2.52 108.477 166.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 tpt -115.88 114.52 24.8 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.391 2.276 . . . . 1.1100000000000001 107.902 172.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -98.04 118.85 35.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.938 1.695 . . . . 1.5 108.73 -173.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.85 135.13 54.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.685 1.194 . . . . 2.2000000000000002 110.336 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.51 50.84 10.66 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.718 -0.614 . . . . 1.6299999999999999 112.689 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -47.76 156.38 0.33 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 115.932 1.827 . . . . 0.70999999999999996 115.932 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -112.08 -30.77 7.11 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 113.43 -1.714 . . . . 1.76 113.772 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -112.66 134.79 21.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.465 1.506 . . . . 4.3300000000000001 108.959 166.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.62 82.89 1.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.785 2.324 . . . . 1.46 107.265 160.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.3 pt? -87.6 124.75 33.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.562 0.745 . . . . 2.5299999999999998 112.952 -163.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 24.4 mtmm -110.38 167.23 10.36 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 115.268 1.581 . . . . 3.6200000000000001 115.268 -165.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.86 124.82 21.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.353 -1.294 . . . . 1.24 109.123 172.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.13 5.25 62.44 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 117.959 -1.467 . . . . 1.6899999999999999 115.639 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.01 178.26 6.71 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.193 1.997 . . . . 2.77 111.246 163.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -149.12 125.76 11.05 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 129.497 3.119 . . . . 3.4900000000000002 104.607 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.4 t -146.52 139.96 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.809 0.844 . . . . 1.76 110.783 -168.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -80.13 152.12 29.43 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.524 1.13 . . . . 3.1499999999999999 113.982 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.2 tt -144.47 130.74 19.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.426 1.49 . . . . 3.0600000000000001 110.639 168.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.8 117.88 21.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.644 2.778 . . . . 2.3500000000000001 109.095 165.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -87.87 121.08 29.85 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.124 -1.065 . . . . 1.03 108.124 171.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.1 mt -97.61 118.56 34.41 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.002 0.921 . . . . 0.83999999999999997 109.979 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -116.2 144.51 44.09 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.308 1.043 . . . . 2.2000000000000002 112.852 -171.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.58 137.0 57.94 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.279 -0.888 . . . . 2.1400000000000001 113.271 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.17 46.38 5.6 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.746 -1.03 . . . . 3.9199999999999999 113.627 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.3 32.79 46.54 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 123.959 0.79 . . . . 1.72 114.728 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -125.77 144.81 50.48 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.675 1.237 . . . . 3.7000000000000002 112.201 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.04 149.02 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.376 1.47 . . . . 2.02 110.644 176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -149.3 119.29 7.16 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.143 0.977 . . . . 2.2599999999999998 108.699 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -96.08 133.71 40.01 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.635 -0.665 . . . . 2.1699999999999999 111.757 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.28 170.47 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.934 1.693 . . . . 2.1600000000000001 108.469 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -124.75 136.77 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.752 1.621 . . . . 2.4100000000000001 108.726 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -127.73 139.12 34.4 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.305 1.442 . . . . 2.7799999999999998 109.131 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.26 150.41 76.5 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.231 2.621 . . . . 1.3400000000000001 111.311 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.1 t -99.39 137.73 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.491 1.116 . . . . 1.3500000000000001 108.384 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 160.21 42.33 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.525 1.93 . . . . 4.79 112.271 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.45 142.71 37.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.074 1.349 . . . . 2.6099999999999999 113.384 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.26 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 130.04 3.336 . . . . 9.2300000000000004 110.193 169.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.148 0 N-CA-C 107.427 -2.269 . . . . 11.5 107.427 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -61.66 159.11 13.95 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.359 1.08 . . . . 9.1899999999999995 110.21 146.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -82.57 41.02 0.69 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.273 -0.892 . . . . 12.51 112.27 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.4 p -149.05 29.62 0.8 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 129.71 3.204 . . . . 8.0299999999999994 108.835 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -157.06 139.99 15.27 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 128.559 2.743 . . . . 5.4699999999999998 107.602 -172.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.17 137.14 9.19 Favored Glycine 0 N--CA 1.467 0.701 0 N-CA-C 110.95 -0.86 . . . . 2.2000000000000002 110.95 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -96.87 173.12 7.46 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.521 1.304 . . . . 2.3300000000000001 114.521 -168.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.43 148.36 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.214 1.806 . . . . 1.25 108.6 168.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -69.46 -103.02 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.407 1.083 . . . . 4.5300000000000002 112.613 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.2 t80 169.96 126.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.705 2.402 . . . . 2.0 108.419 -166.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 m -173.34 145.47 1.22 Allowed Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 126.015 1.726 . . . . 2.0 109.389 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.78 -33.74 0.6 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.915 2.41 . . . . 1.6299999999999999 112.589 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.29 166.8 11.95 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.949 1.738 . . . . 1.54 111.314 -170.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.76 -2.04 25.17 Favored 'Cis proline' 0 CA--C 1.54 0.777 0 CA-C-N 119.192 1.496 . . . . 1.6000000000000001 113.092 -0.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -147.6 163.66 35.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.796 1.638 . . . . 1.9099999999999999 112.994 -172.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.58 -175.43 4.92 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.259 2.224 . . . . 0.70999999999999996 111.773 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.11 148.0 33.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.532 1.133 . . . . 0.68000000000000005 110.989 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.23 137.75 39.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 0.51000000000000001 113.096 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -105.93 23.36 14.09 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.252 2.621 . . . . 2.7200000000000002 113.818 -168.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -58.47 160.72 5.09 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 117.263 2.319 . . . . 2.25 117.263 -163.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -79.46 150.13 31.34 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.119 2.168 . . . . 1.8799999999999999 112.046 174.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.67 132.7 33.31 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.058 2.143 . . . . 3.4399999999999999 110.334 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -135.6 162.78 31.73 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.125 1.37 . . . . 4.6399999999999997 111.456 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -130.31 98.94 19.92 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.909 0.883 . . . . 1.76 109.662 168.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.16 -11.15 16.32 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.779 2.319 . . . . 1.24 113.007 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.85 -172.66 47.54 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.994 1.283 . . . . 1.26 113.155 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -113.73 -2.64 13.67 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.438 1.895 . . . . 3.3199999999999998 112.239 -165.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -124.54 153.86 69.65 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.363 2.265 . . . . 3.25 110.231 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.99 158.5 38.29 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.643 2.229 . . . . 1.3899999999999999 112.709 -168.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.3 mt -119.04 152.5 36.33 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.083 1.753 . . . . 2.02 110.196 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.3 ttp-105 -138.01 102.39 4.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.281 -1.781 . . . . 2.79 110.722 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.82 106.88 16.68 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.318 1.847 . . . . 1.8200000000000001 108.671 -174.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.25 -26.08 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.698 0.999 . . . . 0.54000000000000004 113.698 -170.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.09 -174.23 31.71 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 125.615 1.579 . . . . 0.48999999999999999 111.805 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.71 -175.14 4.54 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.643 0.735 . . . . 0.68999999999999995 112.443 173.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -145.23 178.1 8.32 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.808 2.843 . . . . 5.4199999999999999 107.598 160.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t 179.41 150.7 0.5 Allowed Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 127.089 2.156 . . . . 0.68000000000000005 109.115 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.77 -9.68 22.69 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.014 2.476 . . . . 1.05 113.746 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 30.1 m -114.04 23.34 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 115.248 1.573 . . . . 0.83999999999999997 115.248 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -151.75 173.24 14.97 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.408 1.483 . . . . 1.1699999999999999 109.252 166.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -101.21 -58.02 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.612 1.565 . . . . 4.5999999999999996 110.795 165.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -98.14 152.61 19.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.615 2.366 . . . . 5.8799999999999999 108.536 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.5 p -160.55 108.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 127.04 2.136 . . . . 1.74 110.224 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -127.58 140.94 51.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.16 -1.382 . . . . 5.4900000000000002 111.469 -168.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 tp -82.03 125.27 30.61 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.666 0.746 . . . . 1.53 111.59 -170.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -119.09 159.5 23.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.288 1.835 . . . . 0.56000000000000005 112.161 171.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -114.31 165.43 12.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.906 -1.497 . . . . 2.25 110.863 166.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -124.3 126.76 46.57 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.16 -1.793 . . . . 0.93000000000000005 106.16 169.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -127.14 171.35 11.49 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.23 0.826 . . . . 2.1000000000000001 113.23 -172.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 ttp -105.38 145.28 31.0 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.779 1.632 . . . . 3.8399999999999999 110.823 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -152.25 153.42 33.71 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.467 1.507 . . . . 8.2899999999999991 112.122 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -155.66 142.16 18.65 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.197 1.799 . . . . 2.79 108.802 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -164.78 145.41 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 129.54 3.136 . . . . 5.6299999999999999 105.797 171.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 61.64 9.18 2.66 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.767 1.627 . . . . 3.5899999999999999 115.063 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.48 8.52 73.99 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.416 1.008 . . . . 2.23 114.95 -168.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -85.55 66.66 9.78 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.948 -1.325 . . . . 2.77 111.938 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 111.93 1.7 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.331 -1.481 . . . . 2.75 111.315 171.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -155.23 159.81 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.203 1.401 . . . . 2.98 110.082 -170.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 65.1 mtm -91.84 172.69 8.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.71 1.004 . . . . 3.04 113.71 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.59 -179.17 24.3 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.472 1.987 . . . . 0.78000000000000003 111.211 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ttm -144.38 147.21 33.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.248 1.419 . . . . 1.26 107.856 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -158.97 155.44 24.47 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 4.8300000000000001 110.84 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.87 156.85 24.02 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.782 2.322 . . . . 0.68000000000000005 111.635 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.49 155.58 63.92 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.44 1.496 . . . . 1.0600000000000001 110.756 -176.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -84.81 -27.23 1.32 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.071 2.514 . . . . 0.62 113.493 -165.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -178.39 166.56 1.85 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.228 1.811 . . . . 1.71 112.003 -178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.2 mt -108.35 157.24 18.56 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.021 1.328 . . . . 0.69999999999999996 110.319 157.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -106.35 153.74 21.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.427 1.091 . . . . 1.8799999999999999 109.341 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.3 t -140.59 122.79 9.63 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 118.722 0.692 . . . . 1.4199999999999999 112.157 160.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.29 159.16 44.11 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.549 2.833 . . . . 1.26 111.296 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.6 140.89 89.22 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.423 2.748 . . . . 1.3200000000000001 112.586 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt 66.21 -2.07 1.06 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.877 2.071 . . . . 2.0 113.948 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.6 172.75 41.27 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.262 1.887 . . . . 1.26 113.577 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.51 144.0 23.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.137 1.375 . . . . 5.9400000000000004 111.348 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.9 t -149.48 137.35 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 126.814 2.046 . . . . 3.3599999999999999 107.16 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -133.45 127.33 33.09 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.446 -1.316 . . . . 4.3600000000000003 107.446 -162.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.6 -51.41 68.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.37 0.668 . . . . 2.6899999999999999 111.616 -162.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 82.74 158.63 0.12 Allowed Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 126.708 2.003 . . . . 5.4000000000000004 114.98 159.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -60.53 127.14 21.82 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.218 1.945 . . . . 2.8399999999999999 110.22 168.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.88 54.7 34.77 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.975 -0.557 . . . . 1.79 113.709 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.36 -44.74 0.03 OUTLIER Glycine 0 N--CA 1.473 1.117 0 N-CA-C 116.489 1.356 . . . . 1.9099999999999999 116.489 160.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -135.24 147.62 49.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.991 1.395 . . . . 2.1299999999999999 109.871 163.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -161.24 149.01 15.33 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.678 0.791 . . . . 0.62 109.693 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -79.07 136.43 37.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.426 -0.953 . . . . 2.1400000000000001 108.426 160.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.0 tpt -88.8 116.85 27.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.848 1.659 . . . . 0.79000000000000004 107.569 163.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -89.37 129.77 35.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.003 1.321 . . . . 1.1899999999999999 107.971 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.15 140.12 51.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.165 0.986 . . . . 2.0 111.073 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.57 48.88 7.64 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.923 0.773 . . . . 2.4100000000000001 111.259 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 14.0 mt -51.99 156.11 1.64 Allowed 'General case' 0 N--CA 1.46 0.046 0 N-CA-C 115.254 1.576 . . . . 0.94999999999999996 115.254 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 29.9 mmtp -120.92 -22.12 6.31 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 113.551 -1.659 . . . . 3.3199999999999998 113.513 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -132.89 142.83 46.16 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 128.436 2.695 . . . . 6.3899999999999997 109.122 165.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -68.93 137.57 38.26 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.369 2.046 . . . . 1.52 107.951 157.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.24 140.68 29.9 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.704 0.802 . . . . 2.1499999999999999 111.265 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.24 165.12 12.72 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 123.559 1.647 . . . . 4.0300000000000002 111.329 165.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.81 134.1 41.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 112.88 -1.963 . . . . 1.26 109.249 170.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.99 12.43 59.01 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.073 1.32 . . . . 1.97 115.051 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.07 -176.71 4.08 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.68 1.192 . . . . 2.6299999999999999 111.522 171.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.77 136.6 17.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 128.369 2.668 . . . . 3.04 106.183 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.3 t -147.86 146.2 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.979 1.312 . . . . 1.3899999999999999 110.738 -168.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.4 142.77 40.99 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.56 0.744 . . . . 2.5699999999999998 112.162 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mp -120.69 145.26 47.64 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.512 1.149 . . . . 1.8400000000000001 110.774 150.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -112.07 103.61 11.81 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.665 2.786 . . . . 2.4100000000000001 108.527 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.91 130.17 34.57 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.67 -1.268 . . . . 1.1899999999999999 110.762 -166.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.74 116.01 31.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.497 1.119 . . . . 0.93999999999999995 111.446 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -111.04 104.05 12.57 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.339 1.455 . . . . 2.0499999999999998 111.829 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 55.52 25.48 7.93 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.393 1.877 . . . . 3.2200000000000002 113.411 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.88 -58.22 4.27 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.229 1.395 . . . . 4.8099999999999996 112.697 -173.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.4 0.09 56.01 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.868 1.507 . . . . 2.1000000000000001 116.868 -167.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -137.04 143.09 42.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.535 1.668 . . . . 2.8300000000000001 111.649 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.35 148.82 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.121 1.768 . . . . 2.1600000000000001 110.711 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.5 tt -155.66 131.61 9.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.102 1.361 . . . . 1.8300000000000001 110.599 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -92.36 144.75 25.06 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.265 -0.897 . . . . 2.48 112.288 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.02 161.9 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.675 1.59 . . . . 1.96 108.381 167.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.62 130.64 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.18 0.992 . . . . 2.04 108.88 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.92 136.7 29.41 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.944 1.698 . . . . 3.1600000000000001 109.501 -165.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.47 160.2 41.99 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.385 2.723 . . . . 1.45 111.911 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 t -109.51 120.61 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.255 1.022 . . . . 1.1599999999999999 110.478 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -132.35 128.83 38.5 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.169 1.788 . . . . 3.77 108.732 173.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.89 55.04 1.99 Allowed 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.475 -0.766 . . . . 2.2599999999999998 113.0 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 . . . . . 0 C--O 1.248 1.025 0 C-N-CA 125.251 1.42 . . . . 6.0999999999999996 111.045 -173.379 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.407 0 N-CA-C 106.538 -2.625 . . . . 9.7300000000000004 106.538 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -62.27 158.87 16.2 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 116.853 -1.939 . . . . 10.279999999999999 109.645 125.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -136.73 36.06 2.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.971 1.708 . . . . 9.8499999999999996 111.011 -171.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.42 56.01 2.43 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.135 1.774 . . . . 5.4400000000000004 111.457 -175.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.22 60.59 1.96 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.491 2.317 . . . . 4.9299999999999997 111.162 -172.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.15 167.75 21.7 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 121.212 -0.93 . . . . 1.24 112.889 -169.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -151.96 165.5 34.44 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.619 0.768 . . . . 2.27 112.893 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -105.88 139.58 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 106.471 -1.677 . . . . 1.4299999999999999 106.471 168.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ttt-85 -79.8 -126.63 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.102 0.865 . . . . 4.8399999999999999 109.001 170.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -154.45 154.43 33.19 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 119.695 -1.878 . . . . 2.9700000000000002 113.342 -173.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.7 t -176.36 140.36 0.52 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 129.757 3.223 . . . . 2.2000000000000002 107.037 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.2 -32.52 5.09 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.467 2.112 . . . . 1.3 112.067 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.88 171.95 23.58 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.807 1.194 . . . . 0.85999999999999999 112.657 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.95 1.21 19.5 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 119.026 1.413 . . . . 0.88 112.6 -6.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.86 144.83 24.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.463 1.653 . . . . 2.4900000000000002 115.463 -173.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.23 -176.11 3.14 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.898 2.479 . . . . 0.47999999999999998 112.58 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.5 133.25 25.45 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.089 1.356 . . . . 1.01 110.987 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.0 141.69 40.76 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.699 1.2 . . . . 0.55000000000000004 112.67 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -115.64 58.69 0.73 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.143 2.577 . . . . 2.4100000000000001 109.978 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -64.31 162.05 15.57 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.054 -1.029 . . . . 1.8100000000000001 111.836 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 m -108.32 139.76 42.57 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.403 0.681 . . . . 1.47 110.941 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -104.64 127.38 52.37 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.904 -1.044 . . . . 3.1299999999999999 110.242 -178.565 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.3 145.71 39.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.4 1.48 . . . . 5.5 110.178 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.46 60.42 48.13 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.614 0.766 . . . . 2.8100000000000001 111.897 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -60.66 -20.3 64.49 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.678 2.919 . . . . 1.49 114.573 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.41 -171.84 36.73 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 122.638 1.132 . . . . 1.3799999999999999 113.677 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -111.74 -3.02 15.11 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.17 1.788 . . . . 3.0899999999999999 112.45 -163.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.58 154.69 69.9 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 127.528 2.331 . . . . 3.0 110.021 175.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.66 138.59 19.32 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.731 2.287 . . . . 1.47 111.219 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.9 mt -94.89 137.84 33.44 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 123.602 1.667 . . . . 2.1699999999999999 112.341 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 ttp-105 -123.97 95.97 4.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.471 -2.149 . . . . 3.3999999999999999 111.508 -173.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.456 HD22 HD23 ' A' ' 22' ' ' LEU . 44.0 tp -79.62 107.71 12.6 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.413 1.885 . . . . 2.3799999999999999 109.909 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -98.01 -25.41 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 112.724 0.639 . . . . 0.53000000000000003 112.724 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.47 -173.96 27.56 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 124.657 1.122 . . . . 0.42999999999999999 112.388 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.23 174.19 10.06 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.667 -0.767 . . . . 0.51000000000000001 111.88 163.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.4 mtp-105 -138.97 170.95 15.05 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 128.992 2.917 . . . . 4.8600000000000003 107.056 158.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t 179.92 153.46 0.63 Allowed Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 125.459 1.504 . . . . 0.71999999999999997 110.022 -168.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.02 -1.7 9.45 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.8 2.333 . . . . 1.03 115.236 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -118.63 18.56 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 115.706 1.743 . . . . 1.02 115.706 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -166.04 162.63 18.04 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.194 2.197 . . . . 0.98999999999999999 109.105 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -120.84 -69.26 0.85 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.069 1.748 . . . . 4.0499999999999998 108.345 -172.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -84.1 75.05 10.2 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.528 -1.358 . . . . 5.6500000000000004 108.009 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.45 148.75 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.512 -0.767 . . . . 1.04 109.577 166.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.35 154.28 30.33 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.332 1.853 . . . . 4.0899999999999999 108.414 -164.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.9 tp -121.38 107.95 13.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.47 1.032 . . . . 0.82999999999999996 110.864 -167.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -115.94 150.13 37.63 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 114.99 1.478 . . . . 0.67000000000000004 114.99 -171.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -106.93 153.62 22.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.662 1.985 . . . . 2.1200000000000001 110.684 163.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.418 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 3.5 m -131.27 133.17 45.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.651 1.981 . . . . 0.93999999999999995 106.973 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -144.33 172.3 13.13 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.649 0.981 . . . . 1.99 113.649 -167.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.5 ttp -99.25 147.05 25.56 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.627 1.571 . . . . 3.77 109.889 167.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.91 158.35 43.05 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.876 1.67 . . . . 5.5499999999999998 109.822 -174.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -110.11 143.2 40.51 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.808 1.643 . . . . 2.8999999999999999 109.818 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.6 p -157.84 138.32 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.935 -1.135 . . . . 3.71 107.935 163.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 64.25 25.11 13.51 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.864 0.865 . . . . 4.0099999999999998 111.587 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.03 10.6 78.09 Favored Glycine 0 N--CA 1.48 1.584 0 O-C-N 120.428 -1.42 . . . . 2.3199999999999998 113.865 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -123.18 121.61 36.37 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.791 2.036 . . . . 2.6499999999999999 109.565 -166.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 mtmm -72.38 131.92 43.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.165 1.386 . . . . 3.7400000000000002 110.957 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.29 -179.5 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 129.095 2.958 . . . . 2.7000000000000002 109.367 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.73 162.39 22.11 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.787 0.835 . . . . 3.9300000000000002 112.289 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.57 31.12 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.54 1.067 . . . . 0.72999999999999998 113.319 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.0 ttm -154.75 144.3 21.4 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.226 1.41 . . . . 1.1000000000000001 110.567 -174.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -148.79 161.72 31.94 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 126.105 1.762 . . . . 4.4000000000000004 109.897 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.07 161.4 26.54 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.247 1.964 . . . . 0.53000000000000003 111.956 168.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.92 154.9 68.99 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 126.683 1.993 . . . . 1.02 110.612 175.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.91 -20.41 7.63 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.799 2.999 . . . . 0.46999999999999997 113.561 -165.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -178.33 163.69 1.65 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.431 1.892 . . . . 1.98 111.166 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -110.98 157.76 19.54 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.946 1.299 . . . . 0.63 109.822 159.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -133.17 152.33 51.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.519 0.728 . . . . 2.3199999999999998 111.359 172.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.2 t -136.15 141.09 34.95 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.536 1.934 . . . . 1.1000000000000001 112.398 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.83 156.13 13.57 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.282 3.321 . . . . 1.45 112.708 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -65.91 148.21 85.81 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.599 2.866 . . . . 1.3600000000000001 114.064 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 70.24 -13.4 0.44 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 129.133 2.973 . . . . 1.99 114.934 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.7 164.23 48.61 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.289 0.947 . . . . 1.96 113.454 173.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -98.41 159.06 15.19 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.519 -0.919 . . . . 4.2699999999999996 108.519 145.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.9 t -148.57 118.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.268 1.427 . . . . 3.54 107.48 163.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -78.85 156.26 28.76 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.719 -0.613 . . . . 2.9700000000000002 112.376 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.89 144.43 57.28 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.099 -1.074 . . . . 2.6000000000000001 108.099 155.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' H ' ' HB2' ' A' ' 82' ' ' TYR . 7.9 mptt -84.45 126.98 67.77 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 120.153 -1.592 . . . . 3.3599999999999999 109.751 -170.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -60.78 -14.82 34.07 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.814 3.009 . . . . 2.4700000000000002 115.071 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.56 -58.24 0.77 Allowed Glycine 0 CA--C 1.531 1.069 0 CA-C-N 118.752 0.706 . . . . 3.4700000000000002 111.867 155.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -75.15 -17.12 80.28 Favored Glycine 0 N--CA 1.476 1.338 0 N-CA-C 119.307 2.483 . . . . 2.0 119.307 -158.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.41 ' HB2' ' H ' ' A' ' 78' ' ' LYS . 80.5 m-85 -147.63 141.32 25.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.698 2.249 . . . . 2.25 111.643 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -158.2 150.32 21.88 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.606 0.763 . . . . 0.81000000000000005 111.392 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -79.71 117.03 20.24 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 108.912 -0.773 . . . . 1.8200000000000001 108.912 162.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 tpt -77.81 124.49 28.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.726 2.01 . . . . 1.0 108.278 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.5 mt -117.05 97.32 5.87 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.343 1.457 . . . . 1.99 108.946 -167.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.51 149.39 26.26 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.775 0.798 . . . . 2.3599999999999999 111.839 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.41 51.98 6.35 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 110.879 -0.888 . . . . 2.0800000000000001 110.879 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 10.5 mt -50.77 151.44 2.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.682 1.23 . . . . 0.97999999999999998 113.864 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -114.45 -20.49 10.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.031 -1.895 . . . . 3.0299999999999998 114.648 -173.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -126.51 154.55 75.2 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.294 2.238 . . . . 6.2199999999999998 108.184 166.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -64.7 139.92 65.56 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 N-CA-C 107.867 -1.628 . . . . 2.7599999999999998 107.867 151.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.26 163.34 29.52 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.192 1.397 . . . . 2.46 109.225 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.07 170.47 20.41 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.236 0.828 . . . . 4.1299999999999999 113.236 174.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.19 134.44 57.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.932 0.893 . . . . 1.3999999999999999 110.339 170.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.11 -7.52 35.32 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.683 1.611 . . . . 1.6899999999999999 115.323 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.69 -179.69 6.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.447 1.123 . . . . 3.7999999999999998 110.676 174.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 20.6 pt-20 -138.51 141.7 39.36 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.648 1.979 . . . . 3.3999999999999999 106.937 160.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.9 t -148.53 145.25 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.784 1.634 . . . . 1.3700000000000001 110.181 -165.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.51 145.62 26.72 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.263 1.579 . . . . 3.4700000000000002 115.263 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -118.31 144.29 45.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.79 1.636 . . . . 2.5099999999999998 109.526 161.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -95.62 113.24 24.87 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 128.568 2.747 . . . . 1.9399999999999999 108.171 167.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.9 mp -86.5 112.16 21.26 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.617 1.167 . . . . 1.6299999999999999 107.954 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.9 mt -95.61 106.33 18.41 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.79 0.805 . . . . 0.69999999999999996 110.705 -174.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -98.25 126.84 43.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.882 1.273 . . . . 1.97 111.929 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.81 41.27 4.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.088 2.155 . . . . 2.52 112.822 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.85 -93.17 1.73 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 125.338 1.447 . . . . 5.9900000000000002 111.458 -171.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.08 -6.68 61.55 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 116.969 1.548 . . . . 3.0800000000000001 116.969 -160.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -81.94 100.37 9.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.111 2.456 . . . . 4.21 110.632 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -94.91 137.0 24.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.235 1.014 . . . . 2.46 112.554 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.4 tp -133.71 113.97 12.92 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.711 1.604 . . . . 2.5299999999999998 109.703 170.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -89.73 125.59 35.34 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.616 -0.677 . . . . 2.4199999999999999 111.482 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.04 157.9 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.745 0.818 . . . . 2.5699999999999998 110.765 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.0 t -104.13 143.76 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.715 1.606 . . . . 1.8 108.706 -173.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.13 141.11 14.56 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.571 1.549 . . . . 1.97 109.399 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 55.6 Cg_endo -68.16 157.88 59.91 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.221 3.281 . . . . 0.92000000000000004 113.743 177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.7 t -110.23 139.59 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.852 2.061 . . . . 0.98999999999999999 108.928 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -150.21 164.32 35.98 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.741 1.155 . . . . 5.3499999999999996 114.025 -170.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.18 151.78 36.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.339 -0.85 . . . . 2.8599999999999999 112.361 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 1 C-N-CA 132.769 4.428 . . . . 5.5300000000000002 105.36 -160.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.313 0 N-CA-C 106.024 -2.83 . . . . 11.01 106.024 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.6 p -59.38 166.86 2.1 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 117.971 -1.492 . . . . 9.8800000000000008 109.559 133.856 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -63.45 167.03 5.85 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.751 0.82 . . . . 8.2300000000000004 110.039 154.716 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -156.81 48.38 0.45 Allowed 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.105 -0.997 . . . . 5.54 109.752 -177.065 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.8 91.3 2.41 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.454 -1.684 . . . . 4.0800000000000001 106.454 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.93 164.69 32.38 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 127.159 2.314 . . . . 1.1599999999999999 111.091 -178.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -157.75 156.3 31.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.125 1.37 . . . . 2.1899999999999999 111.213 177.115 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.3 t -80.27 158.54 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.441 0.696 . . . . 1.52 109.42 175.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.72 -26.39 44.76 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.805 1.78 . . . . 5.3899999999999997 115.805 -176.144 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 85.0 t80 72.36 115.32 0.05 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.69 2.796 . . . . 2.48 111.756 -168.337 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.1 m -164.24 143.16 5.97 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 126.239 1.815 . . . . 2.3799999999999999 108.047 169.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.35 -25.77 11.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.828 2.352 . . . . 1.3 112.374 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.4 175.2 16.27 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 126.814 2.15 . . . . 0.80000000000000004 110.189 -172.166 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.42 -7.71 15.84 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 CA-C-N 119.473 1.637 . . . . 0.93000000000000005 112.747 -5.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -140.44 169.63 17.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.083 0.953 . . . . 1.8799999999999999 113.393 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.65 -177.62 5.39 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.644 2.378 . . . . 0.56999999999999995 109.966 175.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.59 170.35 14.86 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.76 1.224 . . . . 0.94999999999999996 110.071 169.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.98 144.22 21.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.727 1.211 . . . . 0.73999999999999999 111.254 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.94 152.52 40.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.681 1.992 . . . . 3.0299999999999998 109.315 -178.274 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -165.45 157.44 14.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.954 1.094 . . . . 2.0899999999999999 113.954 -177.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.8 m -84.4 124.15 30.99 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.789 1.635 . . . . 1.79 109.928 169.154 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.38 132.17 44.89 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.399 1.479 . . . . 3.3300000000000001 108.988 170.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -123.53 145.03 49.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.691 0.797 . . . . 3.5800000000000001 112.01 177.505 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.53 72.59 7.63 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.264 -0.88 . . . . 3.2200000000000002 110.47 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.31 -19.84 55.69 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.707 2.271 . . . . 1.22 113.607 -178.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.29 169.7 54.86 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-O 123.034 1.352 . . . . 1.3400000000000001 113.01 174.639 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 11.5 m-20 -95.82 -4.33 43.98 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 128.199 2.6 . . . . 3.1499999999999999 112.843 -170.245 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -122.24 160.31 48.33 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.353 2.261 . . . . 4.6600000000000001 108.717 172.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.97 143.25 14.29 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.859 2.373 . . . . 1.3700000000000001 110.844 -169.073 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.8 mt -94.3 153.49 17.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 122.72 1.247 . . . . 1.8300000000000001 112.435 172.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -136.41 113.12 10.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.131 -1.849 . . . . 1.73 110.65 178.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.87 112.02 24.36 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.78 2.032 . . . . 1.9099999999999999 108.539 -172.326 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.3 m -102.54 -29.07 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.886 0.875 . . . . 0.60999999999999999 113.011 -169.284 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.07 -174.44 30.94 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.969 1.271 . . . . 0.54000000000000004 113.047 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.76 -178.75 5.15 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.79 0.805 . . . . 0.56999999999999995 110.924 167.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -139.73 179.39 6.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.667 2.787 . . . . 5.8099999999999996 107.393 161.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t 176.6 151.19 0.35 Allowed Pre-proline 0 N--CA 1.469 0.484 0 C-N-CA 127.769 2.427 . . . . 0.78000000000000003 106.796 -170.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.68 -7.74 14.65 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.716 2.277 . . . . 0.76000000000000001 113.902 174.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.74 31.94 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.725 1.38 . . . . 0.96999999999999997 114.725 -170.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.92 138.28 13.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.662 1.585 . . . . 0.92000000000000004 110.977 168.284 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -61.2 -39.94 92.08 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.259 1.023 . . . . 2.8799999999999999 111.498 173.32 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -144.15 143.38 31.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 128.567 2.747 . . . . 6.1200000000000001 106.308 -168.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.07 137.02 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.018 -1.105 . . . . 1.0900000000000001 108.018 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -144.12 138.29 28.1 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.813 1.245 . . . . 2.98 109.638 -171.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.5 pt? -87.06 135.61 33.22 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 123.076 1.417 . . . . 1.8799999999999999 113.335 173.43 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -116.89 154.67 30.39 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 127.576 2.35 . . . . 0.94999999999999996 110.914 176.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.401 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 2.0 pp20? -103.31 155.93 18.1 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.388 1.875 . . . . 2.9100000000000001 110.453 161.142 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.406 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 24.6 m -127.73 132.44 49.59 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.007 -1.479 . . . . 0.92000000000000004 107.007 172.726 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -144.81 176.44 9.45 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.729 1.381 . . . . 2.0600000000000001 114.729 -166.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.6 ttp -113.36 142.47 45.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.823 2.049 . . . . 4.0599999999999996 111.399 176.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -128.29 163.28 25.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.227 1.811 . . . . 6.0099999999999998 111.753 166.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -94.6 145.32 24.91 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.008 -1.849 . . . . 3.52 106.008 152.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.8 p -153.09 124.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.324 0.65 . . . . 3.48 109.367 164.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 64.02 22.03 12.8 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.925 1.69 . . . . 4.54 113.163 -172.655 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.23 11.55 83.35 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 120.547 -1.346 . . . . 2.4300000000000002 113.622 -171.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -109.57 118.8 37.54 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.55 1.54 . . . . 4.2000000000000002 110.265 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.63 127.28 31.21 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.986 1.314 . . . . 3.98 109.251 164.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -145.52 176.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 128.294 2.637 . . . . 3.6299999999999999 109.759 -176.116 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -130.5 166.25 20.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.313 1.045 . . . . 3.7200000000000002 112.459 178.075 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.92 -179.84 31.29 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.395 1.474 . . . . 0.90000000000000002 112.954 177.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -153.91 137.38 15.89 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.006 1.322 . . . . 1.3 110.305 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -144.73 156.29 56.06 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.785 1.634 . . . . 9.6600000000000001 111.302 -174.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.95 154.71 53.22 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.705 2.27 . . . . 0.68999999999999995 110.488 172.581 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.83 158.39 73.87 Favored Pre-proline 0 N--CA 1.484 1.275 0 CA-C-O 118.299 -0.858 . . . . 0.72999999999999998 111.063 169.285 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -84.26 -18.78 4.88 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.313 2.675 . . . . 0.79000000000000004 113.969 -170.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -178.09 169.04 1.96 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.284 1.833 . . . . 1.77 111.771 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.8 mt -115.27 154.99 28.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.79 2.036 . . . . 0.56000000000000005 110.089 162.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.84 146.67 42.74 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.196 1.399 . . . . 1.6499999999999999 108.577 173.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.3 t -137.35 138.69 25.61 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.948 -0.548 . . . . 1.02 111.991 169.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -83.72 156.23 13.79 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 124.237 3.291 . . . . 1.24 112.479 178.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.57 140.31 80.73 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.765 2.977 . . . . 1.2 113.668 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.409 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 69.1 mmtt 69.55 -8.34 0.76 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.369 2.668 . . . . 1.53 114.345 -177.465 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.96 149.84 35.03 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.671 1.129 . . . . 1.3 112.266 175.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -108.71 132.03 54.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.924 1.689 . . . . 4.3600000000000003 106.88 163.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.8 122.93 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.075 1.35 . . . . 3.4199999999999999 107.916 177.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -101.95 135.56 43.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.87 1.268 . . . . 5.0599999999999996 110.116 -176.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 83' ' ' HIS . 1.0 OUTLIER -52.84 -48.5 66.98 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.877 1.671 . . . . 3.3199999999999998 113.216 -171.117 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 103.25 118.38 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 131.047 3.739 . . . . 3.1499999999999999 111.307 176.213 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.66 -1.01 6.8 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.513 2.808 . . . . 2.8100000000000001 115.036 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.13 2.31 12.99 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.434 1.492 . . . . 2.4900000000000002 114.774 170.171 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -132.9 -106.66 1.0 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.355 1.455 . . . . 1.8999999999999999 112.248 -174.521 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' CE2' ' HB3' ' A' ' 47' ' ' GLU . 86.7 m-85 -77.47 138.19 39.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.147 0.975 . . . . 2.1099999999999999 111.489 -175.686 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.559 ' HA ' HD23 ' A' ' 77' ' ' LEU . 54.7 p-80 -160.17 146.01 15.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.827 -0.624 . . . . 0.82999999999999996 111.057 -175.074 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.8 136.49 38.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.093 -1.077 . . . . 1.98 108.093 165.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.7 mtp -99.79 135.66 40.88 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 118.717 0.689 . . . . 1.96 110.001 157.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.8 109.03 20.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.691 -1.596 . . . . 1.4399999999999999 106.691 -179.211 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -102.61 130.9 49.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.88 1.672 . . . . 2.79 108.489 -173.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.81 53.51 8.12 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.824 0.726 . . . . 1.73 112.836 174.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.0 mt -48.23 156.54 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 115.938 1.829 . . . . 0.65000000000000002 115.938 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -110.96 -25.73 9.66 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 113.733 -1.576 . . . . 1.6799999999999999 113.973 178.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -124.53 142.07 39.48 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.412 2.285 . . . . 4.7400000000000002 109.068 169.062 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.27 156.18 55.3 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.7 2.267 . . . . 1.45 109.73 160.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.21 161.77 13.81 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.249 1.02 . . . . 2.5499999999999998 112.025 -169.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -132.74 -176.42 4.1 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.952 2.101 . . . . 4.6100000000000003 110.641 175.316 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.5 150.49 24.54 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.259 -1.015 . . . . 1.73 108.259 156.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.39 36.77 43.49 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.429 0.537 . . . . 1.77 114.386 176.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -122.63 -178.03 3.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.609 1.164 . . . . 3.3399999999999999 110.009 161.347 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -139.56 135.57 33.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.873 2.469 . . . . 3.6299999999999999 105.214 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.3 t -142.85 148.94 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.488 1.915 . . . . 1.6799999999999999 109.898 -171.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -100.83 148.67 24.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.165 1.386 . . . . 2.5499999999999998 114.071 -173.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mp -127.16 158.91 35.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.189 2.195 . . . . 1.6699999999999999 110.125 167.178 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -132.14 94.3 3.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.983 1.713 . . . . 2.79 110.762 -172.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.2 mp -78.48 135.93 37.48 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.375 1.07 . . . . 1.24 111.264 -168.152 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.2 mt -106.83 119.5 39.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.069 1.747 . . . . 0.68999999999999995 110.072 -176.597 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -118.58 145.44 45.39 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.235 1.414 . . . . 1.9199999999999999 111.016 -172.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.81 126.35 27.3 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.912 1.079 . . . . 2.1899999999999999 113.912 -169.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.82 68.47 1.49 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.907 1.241 . . . . 3.5899999999999999 112.502 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 20.44 79.83 Favored Glycine 0 N--CA 1.472 1.099 0 N-CA-C 116.278 1.271 . . . . 1.54 116.278 163.551 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -112.99 138.59 49.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.552 1.676 . . . . 3.6000000000000001 111.72 -173.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.4 t -139.82 145.87 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.347 1.059 . . . . 1.8500000000000001 109.675 178.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 tp -145.66 120.38 9.86 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.794 1.237 . . . . 2.1400000000000001 111.23 178.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -79.01 137.92 37.79 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.529 -0.732 . . . . 2.4700000000000002 111.155 173.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.05 161.58 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.946 2.098 . . . . 2.77 110.026 173.599 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.2 t -136.09 136.02 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.377 1.471 . . . . 1.8700000000000001 109.084 177.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.84 148.29 35.52 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.925 1.69 . . . . 2.3900000000000001 111.354 -173.365 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.81 151.97 81.39 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.403 2.735 . . . . 0.90000000000000002 113.243 175.24 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.0 t -95.32 118.86 42.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.839 -1.073 . . . . 1.5900000000000001 108.376 172.228 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -147.67 179.99 7.29 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.4 1.48 . . . . 5.5899999999999999 109.302 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.33 136.18 55.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.762 1.393 . . . . 2.1800000000000002 114.762 -168.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 127.872 2.469 . . . . 9.4900000000000002 109.809 166.046 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.982 0 N-CA-C 109.078 -1.609 . . . . 10.43 109.078 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.1 m -88.2 -23.92 23.44 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.635 1.346 . . . . 10.26 114.635 176.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -134.13 25.52 3.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.159 1.784 . . . . 9.6899999999999995 112.327 -161.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.94 22.22 7.17 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.523 2.329 . . . . 5.8799999999999999 113.82 -175.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.404 ' C ' ' HB ' ' A' ' 21' ' ' THR . 8.6 pm0 -91.04 146.64 23.68 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.741 2.016 . . . . 5.2999999999999998 114.769 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -79.8 179.41 53.18 Favored Glycine 0 N--CA 1.47 0.908 0 O-C-N 121.285 -0.884 . . . . 2.2999999999999998 114.078 173.706 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -153.01 146.07 24.62 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.999 1.319 . . . . 2.71 112.929 167.333 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.8 t -93.67 146.82 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.268 1.427 . . . . 1.3700000000000001 107.277 177.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 10' ' ' PHE 0.33 0.3 OUTLIER -74.88 -106.1 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.419 1.009 . . . . 4.79 113.528 176.117 . . . . . . . . 4 4 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.404 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 50.9 t80 -171.19 148.75 2.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.667 1.987 . . . . 2.1099999999999999 110.349 -178.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.8 t -179.6 143.43 0.38 Allowed Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 128.114 2.566 . . . . 2.1200000000000001 109.268 174.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.07 -23.75 10.25 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.843 2.362 . . . . 1.1699999999999999 112.12 169.085 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.81 176.81 14.56 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 126.676 2.084 . . . . 0.83999999999999997 111.573 -171.411 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.11 -6.37 16.7 Favored 'Cis proline' 0 CA--C 1.537 0.653 0 CA-C-N 118.571 1.185 . . . . 0.91000000000000003 112.337 -9.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -147.61 148.53 31.2 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.578 1.325 . . . . 2.3599999999999999 114.578 -177.131 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.08 -174.58 2.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.588 2.755 . . . . 0.41999999999999998 111.313 -179.029 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.81 164.33 30.52 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.066 1.746 . . . . 0.67000000000000004 108.825 170.046 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.96 153.16 32.4 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.323 0.965 . . . . 0.63 112.595 -177.408 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -122.6 87.71 2.8 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.631 1.972 . . . . 2.7400000000000002 110.802 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.419 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.6 pp -70.45 158.68 35.6 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 119.41 -2.056 . . . . 2.48 113.374 177.26 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.404 ' HB ' ' C ' ' A' ' 5' ' ' GLU . 20.8 m -135.47 141.27 45.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.459 1.904 . . . . 1.98 106.62 167.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.9 tp -162.46 156.27 20.88 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.9 2.48 . . . . 5.1200000000000001 109.556 177.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -102.04 154.35 19.06 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.224 -1.548 . . . . 4.0899999999999999 113.427 166.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -97.74 92.68 1.4 Allowed Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 121.036 -1.04 . . . . 1.52 109.13 162.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.05 -15.65 18.37 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.566 2.177 . . . . 1.4299999999999999 113.436 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.52 -173.75 47.06 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-O 122.421 1.011 . . . . 1.1399999999999999 112.882 -178.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -115.66 2.23 13.69 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.16 1.784 . . . . 3.2000000000000002 112.306 -167.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -112.41 155.58 43.49 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.985 2.114 . . . . 3.0899999999999999 111.017 173.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.55 158.83 25.44 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.615 2.21 . . . . 0.89000000000000001 110.979 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.6 mt -115.52 148.66 39.24 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.198 1.399 . . . . 2.02 110.469 174.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -131.61 110.63 11.07 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 112.608 -2.087 . . . . 2.3700000000000001 110.655 171.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -98.12 110.39 22.98 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.959 2.103 . . . . 2.1600000000000001 108.348 -170.517 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.78 -21.61 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.303 1.041 . . . . 0.58999999999999997 111.938 -165.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.85 -175.97 33.45 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 125.586 1.565 . . . . 0.40000000000000002 112.617 -178.042 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.42 -174.92 4.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.079 1.351 . . . . 0.57999999999999996 111.372 172.268 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -155.73 154.58 31.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.398 1.479 . . . . 4.3099999999999996 108.11 163.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -167.51 149.33 5.27 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 117.597 -1.192 . . . . 1.1200000000000001 109.215 -176.434 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.43 -19.1 10.49 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.884 1.723 . . . . 1.1499999999999999 113.207 -174.403 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -87.13 18.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 113.874 1.064 . . . . 1.55 113.874 -178.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.45 175.15 13.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.531 1.933 . . . . 1.25 109.599 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -111.56 -32.24 6.74 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.403 1.481 . . . . 2.73 113.155 177.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -139.59 159.59 41.81 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.014 2.926 . . . . 5.5599999999999996 106.11 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 p -157.05 106.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 125.219 1.408 . . . . 1.8799999999999999 111.005 -173.067 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.22 132.74 54.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.663 -1.608 . . . . 5.3899999999999997 111.622 -159.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.0 tp -84.69 124.08 31.09 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.012 -0.995 . . . . 0.96999999999999997 111.994 -163.256 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -121.39 161.97 21.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.355 1.462 . . . . 0.56000000000000005 113.088 179.081 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.88 -174.09 2.44 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.477 1.911 . . . . 3.29 110.73 163.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 m -146.03 138.78 25.64 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.056 -1.091 . . . . 0.81999999999999995 108.056 167.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -135.42 173.3 11.87 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 122.984 1.373 . . . . 2.4100000000000001 114.112 -172.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -122.06 142.17 50.62 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.709 2.004 . . . . 5.1100000000000003 111.897 170.648 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.15 158.84 41.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.627 1.971 . . . . 6.7400000000000002 110.739 172.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -129.01 133.29 47.69 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.955 2.102 . . . . 2.75 106.421 166.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -150.42 9.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.236 1.014 . . . . 3.48 113.532 -169.326 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -168.95 18.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.161 0.8 . . . . 4.2599999999999998 113.161 -156.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.28 13.44 58.03 Favored Glycine 0 N--CA 1.478 1.497 0 O-C-N 120.882 -1.136 . . . . 2.04 113.346 -168.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -143.96 145.76 32.47 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.461 2.704 . . . . 2.8999999999999999 107.661 -174.108 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -105.54 133.61 50.02 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.009 2.124 . . . . 2.98 109.331 -171.25 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -155.15 149.13 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.108 1.363 . . . . 2.3100000000000001 110.488 -171.254 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -102.42 167.01 10.23 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.546 0.943 . . . . 3.3799999999999999 113.546 -169.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.62 -179.19 30.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.996 1.76 . . . . 0.78000000000000003 112.851 178.05 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -151.56 141.79 22.32 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.104 1.762 . . . . 1.3200000000000001 108.082 -177.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -150.73 157.14 36.21 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.198 0.999 . . . . 4.9100000000000001 110.217 -177.48 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.06 158.01 34.13 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.6 2.2 . . . . 0.54000000000000004 111.497 -179.099 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.68 152.75 71.37 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.647 1.179 . . . . 0.53000000000000003 110.154 177.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.7 -24.12 6.41 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.14 2.56 . . . . 0.63 113.187 -167.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -178.3 166.72 1.9 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.444 1.898 . . . . 2.0800000000000001 111.15 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 mt -109.91 154.27 23.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.953 1.301 . . . . 0.62 110.091 163.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -114.24 143.06 45.46 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.581 1.152 . . . . 1.8 109.28 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.8 t -144.5 136.19 12.86 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.136 0.791 . . . . 1.05 113.136 172.12 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.24 167.34 26.03 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.648 2.898 . . . . 0.93000000000000005 113.061 177.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.54 145.67 97.62 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.742 2.961 . . . . 1.01 111.632 167.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt 66.94 -3.69 0.9 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.813 1.645 . . . . 1.6499999999999999 113.634 -178.005 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.48 174.73 55.05 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.748 1.642 . . . . 1.23 112.05 171.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 mtt85 -102.64 137.82 40.36 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.426 1.09 . . . . 4.8899999999999997 109.255 175.034 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.05 104.07 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.535 1.934 . . . . 6.0899999999999999 106.447 176.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.21 130.08 12.47 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.443 1.116 . . . . 3.2400000000000002 112.394 -163.173 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 83' ' ' HIS . 10.6 mp -94.32 131.13 40.25 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.156 1.382 . . . . 2.52 107.716 166.655 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.53 149.78 37.4 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.547 1.139 . . . . 3.3799999999999999 112.525 -166.281 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.43 ' HB2' HH11 ' A' ' 120' ' ' ARG . 22.5 Cg_endo -58.26 -38.45 90.88 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.991 3.127 . . . . 2.1600000000000001 112.6 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.34 115.68 4.34 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.714 -1.354 . . . . 2.8700000000000001 109.714 164.13 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.51 -122.49 5.45 Favored Glycine 0 N--CA 1.467 0.704 0 C-N-CA 126.716 2.103 . . . . 1.55 110.896 176.727 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -71.34 134.56 46.81 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.709 0.755 . . . . 1.8300000000000001 112.313 -167.028 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.465 ' HA ' HD23 ' A' ' 77' ' ' LEU . 55.2 p-80 -157.81 151.86 24.31 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.536 1.134 . . . . 0.64000000000000001 110.893 -177.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -84.47 135.24 34.33 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.064 -1.022 . . . . 2.1400000000000001 108.414 168.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -86.31 127.16 34.75 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 126.207 1.803 . . . . 0.73999999999999999 108.285 162.155 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.73 112.16 25.12 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.839 1.255 . . . . 1.3200000000000001 108.387 -175.31 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.87 135.17 47.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.33 1.052 . . . . 2.6299999999999999 110.57 -169.287 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.62 48.51 7.91 Favored Glycine 0 N--CA 1.472 1.045 0 O-C-N 121.415 -0.803 . . . . 1.72 113.803 172.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.96 153.11 1.92 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 123.369 1.557 . . . . 0.92000000000000004 114.768 178.036 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -124.18 -23.49 4.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 112.174 -2.285 . . . . 1.55 114.472 -165.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -118.06 145.82 37.77 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 117.927 -1.035 . . . . 6.1699999999999999 108.727 152.296 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.11 98.08 0.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 106.675 -2.086 . . . . 1.8100000000000001 106.675 164.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.88 164.31 26.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.339 1.056 . . . . 2.6800000000000002 113.211 -169.675 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -139.4 150.22 45.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.362 1.865 . . . . 5.6399999999999997 113.412 -173.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.01 137.37 56.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 113.879 -1.509 . . . . 1.4199999999999999 108.159 171.03 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.02 -6.2 81.75 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.137 1.351 . . . . 1.5600000000000001 114.601 -173.146 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -76.61 -176.89 3.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.047 1.424 . . . . 2.6400000000000001 111.707 167.176 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -135.44 155.55 50.35 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 128.619 2.768 . . . . 3.9500000000000002 107.127 171.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.6 t -147.85 156.08 9.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 129.538 3.135 . . . . 1.3300000000000001 107.667 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -117.81 154.16 32.26 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.62 -0.675 . . . . 2.2799999999999998 111.26 167.556 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 tt -145.71 132.65 20.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.764 0.793 . . . . 3.0099999999999998 111.327 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -77.14 134.21 38.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 129.152 2.981 . . . . 2.1800000000000002 109.332 166.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -97.58 127.61 43.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.183 0.993 . . . . 1.22 108.763 162.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.21 115.75 30.6 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.01 0.924 . . . . 0.64000000000000001 109.337 175.073 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -111.2 151.86 27.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.579 1.552 . . . . 2.1299999999999999 111.414 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.59 151.74 32.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.126 0.571 . . . . 2.21 111.448 170.335 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.58 23.33 47.31 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 119.003 -0.887 . . . . 3.8700000000000001 114.364 -177.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.52 35.49 46.85 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.246 0.927 . . . . 1.54 113.376 173.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -120.6 122.08 39.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 117.871 0.836 . . . . 3.27 111.582 -167.022 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.23 142.86 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.801 1.64 . . . . 1.98 109.96 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.92 113.91 5.45 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.759 0.824 . . . . 1.99 110.829 -177.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -94.75 121.0 35.88 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.647 0.779 . . . . 2.0 112.397 -176.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.4 t -109.39 163.34 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.653 1.981 . . . . 1.8500000000000001 109.888 178.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.7 t -119.3 140.78 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.552 1.941 . . . . 2.25 109.616 178.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.24 142.65 13.21 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.867 1.267 . . . . 2.48 114.047 -165.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.32 163.84 36.77 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.438 2.759 . . . . 0.93999999999999995 112.582 172.08 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.26 131.18 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.996 1.318 . . . . 0.93999999999999995 109.107 165.398 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.32 126.95 7.4 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.874 2.07 . . . . 3.48 108.69 179.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.67 57.53 1.64 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.552 2.056 . . . . 3.0099999999999998 116.552 -154.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.43 HH11 ' HB2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.299 0 C-N-CA 124.909 1.283 . . . . 8.9600000000000009 113.958 -172.284 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 N-CA-C 104.973 -3.251 . . . . 10.140000000000001 104.973 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -161.42 166.95 26.54 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.339 -0.615 . . . . 8.3699999999999992 109.339 -143.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -166.43 18.12 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.307 2.243 . . . . 10.32 111.506 -170.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.1 t -175.32 61.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.018 2.127 . . . . 5.6699999999999999 110.233 -159.117 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -80.17 58.83 3.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.342 1.457 . . . . 4.6100000000000003 111.163 -172.191 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.08 163.48 30.16 Favored Glycine 0 C--N 1.333 0.402 0 O-C-N 121.406 -0.809 . . . . 1.4199999999999999 111.207 170.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.0 p90 -140.4 177.91 7.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.737 0.643 . . . . 2.4300000000000002 112.737 178.303 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.9 t -111.72 143.75 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.707 1.203 . . . . 1.45 111.301 -178.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -27.06 64.38 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 129.328 3.051 . . . . 7.8700000000000001 116.445 -173.367 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.5 t80 66.73 129.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.611 2.765 . . . . 2.2200000000000002 113.634 -168.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -174.34 146.64 1.12 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.185 1.794 . . . . 2.0499999999999998 110.896 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.13 -20.21 11.57 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.961 2.441 . . . . 1.28 112.73 168.202 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.28 -174.49 19.23 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.781 1.658 . . . . 0.93999999999999995 111.663 -172.741 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.74 -10.64 9.77 Favored 'Cis proline' 0 CA--C 1.537 0.674 0 CA-C-N 119.133 1.467 . . . . 1.1200000000000001 112.493 -8.441 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -132.25 157.74 43.59 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 123.295 1.521 . . . . 2.4900000000000002 114.879 173.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.05 -176.39 4.05 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.448 2.699 . . . . 0.41999999999999998 109.781 171.391 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.9 152.58 36.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.153 1.781 . . . . 0.66000000000000003 107.617 176.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.01 140.1 41.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.32 0.964 . . . . 0.5 111.322 -177.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -114.18 34.22 4.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.51 1.524 . . . . 2.5499999999999998 112.763 -165.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 tt -48.43 143.82 4.56 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.737 2.015 . . . . 2.5699999999999998 112.862 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -82.74 149.75 27.09 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.457 0.91 . . . . 3.04 113.457 170.409 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.83 116.47 27.51 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.77 0.828 . . . . 3.5899999999999999 110.278 170.15 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -121.71 142.69 49.91 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.288 1.435 . . . . 4.5199999999999996 109.53 171.102 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -106.38 101.4 35.1 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.595 1.158 . . . . 1.3400000000000001 109.875 175.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.03 -10.95 15.13 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.951 2.434 . . . . 1.2 113.597 175.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.23 -177.61 50.75 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-O 122.502 1.057 . . . . 1.1100000000000001 112.86 -176.778 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -108.81 -1.71 19.05 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.383 2.273 . . . . 2.9100000000000001 111.774 -173.087 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.6 160.85 42.49 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 128.502 2.721 . . . . 2.73 109.67 173.597 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.63 146.69 21.54 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.674 2.249 . . . . 0.91000000000000003 111.525 -175.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mp -107.77 150.09 27.41 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.78 1.232 . . . . 2.3399999999999999 110.383 174.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -135.91 108.15 7.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.436 -2.165 . . . . 2.8999999999999999 110.257 178.5 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 tt -86.44 124.11 32.4 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.011 0.925 . . . . 2.2000000000000002 109.013 176.37 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.3 -23.61 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.53 0.732 . . . . 0.72999999999999998 111.531 -179.41 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.85 -173.16 27.99 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 124.73 1.157 . . . . 0.46000000000000002 114.299 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.93 -179.07 5.39 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.925 1.29 . . . . 0.56999999999999995 111.216 165.466 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -139.16 160.38 39.94 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.658 1.983 . . . . 5.6900000000000004 107.252 155.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -161.0 149.26 12.85 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 125.651 1.58 . . . . 0.80000000000000004 108.248 -178.498 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.02 -2.25 12.37 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.129 1.886 . . . . 1.0 114.25 -177.571 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.99 31.38 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.336 1.454 . . . . 0.95999999999999996 114.524 -170.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.39 159.51 44.41 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.835 1.654 . . . . 0.91000000000000003 110.419 165.435 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -83.4 -57.37 3.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.76 1.624 . . . . 2.77 110.094 169.371 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -106.68 130.47 54.41 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.47 1.508 . . . . 5.4500000000000002 107.351 166.558 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.78 144.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.137 -0.69 . . . . 1.01 109.137 152.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -138.6 152.49 48.19 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.966 1.707 . . . . 2.75 109.374 -173.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.2 tp -108.6 117.61 34.63 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.498 0.719 . . . . 0.98999999999999999 110.916 -173.554 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -121.73 152.76 39.06 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.569 1.548 . . . . 0.52000000000000002 113.283 -176.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -96.7 167.87 10.85 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.842 1.257 . . . . 2.1899999999999999 111.476 159.121 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.9 m -129.42 138.95 51.76 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.284 1.834 . . . . 0.80000000000000004 107.096 170.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -140.69 171.27 14.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.403 1.096 . . . . 2.0499999999999998 113.649 -173.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -115.31 142.51 46.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.543 1.937 . . . . 5.4500000000000002 111.407 173.445 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -137.59 139.45 40.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.155 0.982 . . . . 5.5 111.658 169.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -91.11 139.07 31.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.886 1.275 . . . . 2.9199999999999999 107.788 161.018 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.9 t -141.76 128.56 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 106.033 -1.839 . . . . 2.4399999999999999 106.033 168.2 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 58.68 24.42 12.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.11 1.364 . . . . 5.6699999999999999 114.408 -176.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.56 29.15 73.73 Favored Glycine 0 N--CA 1.472 1.095 0 O-C-N 120.488 -1.382 . . . . 1.98 112.453 -170.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mmtm -121.4 120.62 35.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.009 2.124 . . . . 4.7400000000000002 108.427 169.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 126.47 40.97 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.119 1.367 . . . . 2.9500000000000002 112.12 -176.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.3 t -144.33 144.98 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.976 2.11 . . . . 2.52 108.277 -171.196 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 73.4 mtm -90.63 172.9 8.35 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.361 0.874 . . . . 3.2400000000000002 113.361 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.4 30.99 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.748 1.166 . . . . 1.1299999999999999 111.783 166.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.07 162.32 35.23 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.484 0.713 . . . . 3.3399999999999999 110.771 161.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -157.19 154.47 26.04 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.871 1.268 . . . . 4.6299999999999999 110.062 -177.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.86 154.65 43.34 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.134 1.89 . . . . 0.56000000000000005 112.001 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.0 155.05 74.74 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.669 1.588 . . . . 0.68999999999999995 110.182 179.101 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.78 -26.34 2.53 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.096 2.531 . . . . 0.60999999999999999 113.333 -167.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -176.42 166.73 2.77 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.989 1.716 . . . . 2.27 111.231 -177.315 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.6 mt -114.63 151.76 33.0 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.002 1.721 . . . . 0.77000000000000002 110.517 166.472 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -120.79 138.94 53.77 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.767 1.227 . . . . 1.8100000000000001 109.024 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -140.81 126.67 11.41 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.192 0.442 . . . . 0.93000000000000005 112.192 170.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.53 161.71 41.65 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.392 3.394 . . . . 1.1599999999999999 111.958 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -59.9 140.37 92.65 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.673 2.916 . . . . 0.93999999999999995 113.051 -175.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 68.65 -3.02 1.49 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.179 2.192 . . . . 1.6599999999999999 114.484 178.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.4 169.15 28.74 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.565 1.555 . . . . 1.21 113.183 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -143.47 158.64 43.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.853 0.861 . . . . 5.2599999999999998 112.536 172.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.1 t -156.14 113.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 127.642 2.377 . . . . 3.9700000000000002 108.475 174.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.34 151.33 34.98 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.03 0.832 . . . . 3.5600000000000001 111.813 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.4 65.21 1.21 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.53 1.157 . . . . 2.1600000000000001 109.414 162.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -58.52 145.89 74.84 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.55 1.14 . . . . 4.1299999999999999 113.201 -174.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.85 81.39 0.84 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.342 2.695 . . . . 2.6699999999999999 109.391 169.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.64 34.0 0.1 OUTLIER Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.372 0.987 . . . . 2.3999999999999999 113.495 -162.383 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.04 -25.75 0.24 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 117.418 1.727 . . . . 2.4199999999999999 117.418 160.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -145.48 146.91 31.66 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.742 1.271 . . . . 1.8899999999999999 111.196 169.087 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -159.48 154.61 25.12 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.992 0.917 . . . . 0.54000000000000004 110.005 174.407 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -77.67 141.31 39.47 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.39 -0.967 . . . . 1.8300000000000001 108.39 159.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -94.25 131.96 39.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.218 1.407 . . . . 0.71999999999999997 108.354 164.15 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -109.2 109.92 21.0 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.012 -1.107 . . . . 1.3200000000000001 108.012 178.459 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.71 134.07 51.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.182 1.393 . . . . 2.3999999999999999 109.489 -175.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.18 53.49 14.0 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.854 -0.529 . . . . 1.6499999999999999 112.48 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.4 mt -44.66 155.41 0.1 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.088 1.755 . . . . 0.64000000000000001 115.067 178.132 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -108.6 -32.99 7.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 113.281 -1.782 . . . . 1.5800000000000001 112.847 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -120.99 137.57 26.75 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.55 1.54 . . . . 6.6900000000000004 108.634 163.442 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -66.88 130.95 24.29 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 N-CA-C 106.654 -2.094 . . . . 1.3300000000000001 106.654 160.028 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.16 171.61 14.21 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.245 0.545 . . . . 2.1699999999999999 111.166 -174.339 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.429 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 0.5 OUTLIER -116.83 157.91 24.83 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.267 -0.895 . . . . 4.0599999999999996 109.827 150.547 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.45 123.61 21.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.001 -1.481 . . . . 1.6899999999999999 107.001 159.046 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.76 53.96 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.166 -1.352 . . . . 2.0299999999999998 115.813 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 90.9 mt-10 -81.91 -174.39 5.02 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.816 1.808 . . . . 3.0099999999999998 111.12 165.001 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.29 135.7 48.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.829 2.452 . . . . 3.6800000000000002 106.284 166.341 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -119.24 144.78 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.829 2.052 . . . . 1.7 109.439 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -89.15 134.16 34.13 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.051 0.54 . . . . 2.6200000000000001 110.493 171.405 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp -116.51 132.4 56.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.301 1.048 . . . . 1.98 110.14 154.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -83.32 145.08 29.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.446 1.899 . . . . 2.1000000000000001 109.109 158.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.3 123.29 46.17 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.399 1.48 . . . . 1.52 109.943 -175.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.53 115.13 29.95 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.493 1.117 . . . . 2.3999999999999999 109.816 -176.168 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -112.66 145.89 39.64 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.263 1.425 . . . . 2.0499999999999998 111.76 -177.023 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.22 151.81 39.37 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.583 0.753 . . . . 2.2200000000000002 112.253 176.193 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.59 33.63 37.88 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.031 -0.872 . . . . 4.3399999999999999 113.56 177.22 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.66 47.49 15.24 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 124.618 1.104 . . . . 2.0699999999999998 113.852 171.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -133.88 131.82 39.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.195 0.998 . . . . 3.54 111.755 -171.308 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.1 t -140.87 150.56 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.594 1.158 . . . . 2.2599999999999998 109.121 178.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.4 tp -149.57 170.97 17.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.601 2.36 . . . . 2.1800000000000002 108.551 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -145.53 156.72 43.88 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.779 1.172 . . . . 2.23 113.072 162.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.1 160.98 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.309 1.443 . . . . 2.21 109.351 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.9 t -112.44 136.66 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.614 1.566 . . . . 1.8799999999999999 108.788 -179.378 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.61 142.44 41.0 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.63 1.572 . . . . 2.2599999999999998 110.145 -175.02 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.0 154.42 73.47 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.737 2.291 . . . . 1.21 112.143 175.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.4 t -93.47 139.49 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.704 -1.221 . . . . 1.3300000000000001 107.704 157.286 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -123.68 -179.71 4.47 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.008 1.323 . . . . 4.29 109.937 174.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.37 174.48 7.55 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.152 0.981 . . . . 2.6000000000000001 112.445 177.302 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 126.882 2.073 . . . . 10.85 109.75 166.956 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.985 0 N-CA-C 110.194 -1.163 . . . . 14.06 110.194 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.0 p -176.91 -152.43 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.677 1.991 . . . . 10.57 108.618 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -79.15 -11.47 59.98 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.521 1.129 . . . . 10.789999999999999 113.331 168.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.9 p -73.88 111.34 8.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.491 1.041 . . . . 5.1100000000000003 111.675 -162.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -78.49 65.7 3.85 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.616 1.566 . . . . 5.1200000000000001 111.138 -169.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.06 172.33 23.21 Favored Glycine 0 N--CA 1.471 0.998 0 O-C-N 120.47 -1.394 . . . . 1.1100000000000001 115.546 -176.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -154.24 -179.34 7.83 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.33 1.452 . . . . 2.8300000000000001 112.475 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 t -121.24 144.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.226 1.011 . . . . 1.55 109.986 168.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -26.27 62.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.794 2.038 . . . . 5.8200000000000003 115.641 -175.389 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 73.2 t80 90.64 146.99 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 129.875 3.27 . . . . 2.9900000000000002 111.994 -168.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.8 m -176.77 144.79 0.63 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 130.159 3.383 . . . . 2.52 108.793 160.706 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.51 -36.32 0.93 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.678 2.252 . . . . 1.29 111.917 177.717 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.06 169.91 27.18 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.577 1.084 . . . . 0.90000000000000002 111.949 -179.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.7 -4.42 19.6 Favored 'Cis proline' 0 CA--C 1.539 0.748 0 CA-C-N 118.797 1.299 . . . . 1.1499999999999999 112.767 -5.126 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.1 153.72 34.49 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.99 1.107 . . . . 2.6899999999999999 113.99 -172.287 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.91 -178.99 3.88 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.524 1.93 . . . . 0.68999999999999995 111.837 174.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.25 140.78 48.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.794 1.237 . . . . 1.05 108.872 167.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.15 143.08 46.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.319 1.448 . . . . 0.67000000000000004 110.458 -178.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -131.11 105.66 7.85 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.866 2.066 . . . . 2.7999999999999998 108.994 -170.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.59 162.27 37.05 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.788 1.033 . . . . 2.1499999999999999 113.788 -168.366 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.462 HG21 ' HD2' ' A' ' 74' ' ' ARG . 2.9 m -79.86 155.6 27.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.031 -1.441 . . . . 1.9399999999999999 112.125 177.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.4 HD23 HD22 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -130.21 116.79 18.91 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 113.312 -1.767 . . . . 3.46 109.447 170.996 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.8 mp0 -101.26 133.85 45.21 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.666 1.986 . . . . 5.1600000000000001 110.923 175.042 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.27 76.67 1.09 Allowed Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 120.545 -1.347 . . . . 3.04 110.888 176.0 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.64 -19.3 42.11 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.667 2.245 . . . . 1.2 114.288 -176.277 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.43 176.6 54.2 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 122.733 1.185 . . . . 1.1599999999999999 112.956 176.403 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -100.52 -3.37 30.86 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.688 2.395 . . . . 2.8900000000000001 112.176 -170.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mp -126.01 160.35 57.39 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 128.122 2.569 . . . . 3.5899999999999999 108.534 174.401 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.55 139.51 11.39 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.462 2.108 . . . . 1.0700000000000001 111.455 -167.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.22 146.91 23.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 123.212 1.482 . . . . 2.2000000000000002 110.314 169.207 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.4 ttp-105 -134.53 102.78 5.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.536 -1.665 . . . . 3.3799999999999999 110.221 -176.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.4 HD22 HD23 ' A' ' 22' ' ' LEU . 52.7 tp -84.04 103.87 13.64 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.302 1.841 . . . . 2.5 110.249 -174.107 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 m -97.35 -24.46 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.611 0.764 . . . . 0.47999999999999998 112.565 -174.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.64 -174.42 29.37 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.839 1.209 . . . . 0.46999999999999997 113.052 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.69 -176.73 4.99 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.898 1.679 . . . . 0.54000000000000004 111.101 171.188 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -155.87 166.33 33.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 130.353 3.461 . . . . 4.6799999999999997 107.261 174.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t 179.75 153.19 0.6 Allowed Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 127.921 2.488 . . . . 0.72999999999999998 108.279 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.84 -27.69 10.13 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 CA-C-N 121.263 1.487 . . . . 0.87 113.014 176.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.72 22.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.193 1.553 . . . . 0.88 115.193 -170.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.18 162.16 34.97 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.206 1.803 . . . . 1.1299999999999999 108.075 164.307 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -77.32 -56.0 4.93 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.033 1.333 . . . . 4.2699999999999996 109.996 168.539 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -133.76 177.61 7.58 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.872 2.069 . . . . 5.4699999999999998 109.337 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.9 p -153.36 147.14 14.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.354 1.462 . . . . 0.83999999999999997 109.079 -174.095 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -133.17 147.74 52.06 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.783 1.633 . . . . 2.6699999999999999 110.381 -179.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.7 tp -96.76 121.06 38.2 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.322 0.649 . . . . 1.0 110.702 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -122.76 157.93 31.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 123.148 1.452 . . . . 0.59999999999999998 113.118 -175.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.32 154.37 21.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.873 -1.512 . . . . 2.0299999999999998 110.055 158.671 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -114.78 135.87 53.71 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.831 -1.915 . . . . 1.6499999999999999 105.831 159.072 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -126.12 165.46 18.82 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.41 1.084 . . . . 2.0699999999999998 112.398 -177.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.7 ttp -105.05 144.85 31.29 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.685 1.594 . . . . 3.2999999999999998 109.614 168.273 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.26 150.48 30.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.195 0.998 . . . . 6.1100000000000003 111.698 -175.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -95.42 142.83 27.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.786 1.634 . . . . 2.8399999999999999 110.131 169.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 t -116.0 -110.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.053 1.341 . . . . 3.6499999999999999 107.781 170.165 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.59 44.94 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 131.319 3.848 . . . . 4.3200000000000003 112.851 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.34 17.62 62.02 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 120.16 -1.587 . . . . 1.6399999999999999 112.746 -166.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -133.18 134.82 44.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.707 2.403 . . . . 2.46 107.605 -168.337 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -91.53 132.41 36.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.47 1.908 . . . . 2.98 110.819 -167.513 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -143.5 143.95 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.334 1.854 . . . . 2.2599999999999998 108.282 -176.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.4 mtm -88.49 165.42 14.89 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.633 0.605 . . . . 3.1400000000000001 112.633 173.493 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.76 -179.51 23.83 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.725 1.155 . . . . 0.89000000000000001 112.29 174.498 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.2 ttm -147.68 147.14 29.65 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.166 1.387 . . . . 1.1399999999999999 109.032 175.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -155.81 154.07 27.16 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.265 1.026 . . . . 4.6200000000000001 110.394 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.4 156.2 50.41 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.172 1.915 . . . . 0.59999999999999998 110.834 173.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.08 155.0 76.33 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.389 1.476 . . . . 0.55000000000000004 110.19 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.47 -23.79 3.97 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.781 2.32 . . . . 0.46999999999999997 113.468 -166.545 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -178.38 165.96 1.82 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.611 1.964 . . . . 1.6899999999999999 111.219 179.16 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 mt -110.13 159.1 17.64 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.863 1.265 . . . . 0.71999999999999997 109.785 157.418 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -127.09 152.62 47.05 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.949 0.9 . . . . 1.8999999999999999 110.12 169.058 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.4 t -136.7 141.65 36.07 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 123.894 0.877 . . . . 1.01 110.784 172.317 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.39 155.9 14.35 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.992 3.128 . . . . 1.1100000000000001 112.685 178.506 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.58 140.07 84.86 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.21 3.274 . . . . 0.98999999999999999 114.438 -174.222 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt 69.14 -8.53 0.68 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.719 2.408 . . . . 1.5900000000000001 113.792 -176.518 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.18 166.76 52.93 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.126 1.346 . . . . 1.21 112.636 174.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' HD2' HG21 ' A' ' 21' ' ' THR . 11.8 ttp-105 -136.29 136.26 39.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.172 2.189 . . . . 4.3399999999999999 106.994 172.065 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.6 t -149.65 139.27 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.231 1.412 . . . . 4.0199999999999996 108.782 177.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.32 149.48 24.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.325 1.059 . . . . 3.6000000000000001 113.383 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -59.78 108.02 0.69 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.197 -1.409 . . . . 1.95 107.197 158.233 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 139.38 90.92 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.902 -1.523 . . . . 2.3399999999999999 112.647 -160.783 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.51 -28.94 17.31 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.734 3.623 . . . . 2.79 115.791 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.59 4.11 13.35 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 117.559 -1.69 . . . . 2.8300000000000001 116.198 173.52 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.75 -98.58 1.42 Allowed Glycine 0 N--CA 1.472 1.057 0 CA-C-N 120.874 2.337 . . . . 1.8500000000000001 113.0 -176.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -71.86 140.87 49.53 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.158 -1.201 . . . . 2.1800000000000002 111.28 -176.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -161.57 153.71 19.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.624 1.17 . . . . 0.63 111.076 -174.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -88.01 129.78 35.16 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.556 -0.715 . . . . 1.76 109.305 166.254 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -82.83 119.52 24.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.836 1.654 . . . . 0.75 109.407 165.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -102.02 110.9 22.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.785 1.234 . . . . 1.27 109.296 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -104.24 139.87 38.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.071 1.348 . . . . 2.6299999999999999 111.079 -168.103 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.39 45.77 45.31 Favored Glycine 0 N--CA 1.473 1.156 0 O-C-N 121.328 -0.858 . . . . 1.8500000000000001 112.83 174.581 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.2 mt -47.8 155.19 0.43 Allowed 'General case' 0 CA--C 1.523 -0.09 0 CA-C-O 123.563 1.649 . . . . 0.94999999999999996 115.28 -177.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -116.09 -29.69 6.22 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 112.862 -1.972 . . . . 2.8999999999999999 112.55 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.8 mmt-85 -105.03 134.73 19.49 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.681 2.392 . . . . 4.5899999999999999 109.509 163.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.17 74.84 3.45 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 N-CA-C 106.572 -2.126 . . . . 1.8999999999999999 106.572 147.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.533 ' H ' HD23 ' A' ' 93' ' ' LEU . 1.4 pt? -63.5 127.34 30.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.887 0.851 . . . . 2.4300000000000002 112.717 -159.299 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -84.96 138.79 32.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.762 1.267 . . . . 5.9299999999999997 112.185 -170.273 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.64 118.91 5.74 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.928 -1.487 . . . . 1.29 108.194 167.719 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.16 -9.99 39.63 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 117.788 -1.562 . . . . 1.95 115.572 -169.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -78.59 173.27 12.59 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.13 1.965 . . . . 3.02 110.653 161.18 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 13.1 pt-20 -138.47 144.1 39.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.032 -1.84 . . . . 3.6400000000000001 106.032 160.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.0 148.69 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.824 1.249 . . . . 2.04 109.411 -171.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.88 149.44 21.54 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 123.401 1.572 . . . . 3.3300000000000001 114.578 -170.119 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.56 151.75 39.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.72 -1.582 . . . . 1.6799999999999999 110.083 170.671 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -118.02 103.51 9.98 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.78 2.432 . . . . 2.8599999999999999 109.483 174.419 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.7 mp -83.6 134.96 34.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.679 1.192 . . . . 1.1699999999999999 110.786 -172.801 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.98 110.56 23.0 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 122.341 1.067 . . . . 0.67000000000000004 110.406 -174.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -103.77 123.72 47.59 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.847 1.659 . . . . 1.97 111.309 -176.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 46.57 35.82 3.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.934 2.094 . . . . 2.4900000000000002 112.892 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.44 -102.54 2.73 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.989 1.281 . . . . 5.6200000000000001 111.05 -169.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.24 -6.76 83.96 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 117.026 1.57 . . . . 2.8599999999999999 117.026 -160.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -80.97 102.52 10.2 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.138 2.469 . . . . 3.0899999999999999 110.848 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.1 p -87.08 142.32 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 124.253 0.97 . . . . 2.3300000000000001 112.242 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.14 125.57 19.0 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.822 0.849 . . . . 2.6899999999999999 112.134 173.097 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.42 117.27 21.72 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.243 1.017 . . . . 2.5 111.472 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.13 166.76 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 126.31 1.844 . . . . 2.6899999999999999 110.66 169.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -144.6 117.76 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 119.171 0.896 . . . . 2.23 110.51 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -124.06 142.18 39.08 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.219 1.008 . . . . 3.3300000000000001 112.374 -172.116 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 70.6 Cg_endo -70.04 151.35 67.44 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.316 3.344 . . . . 0.90000000000000002 113.398 169.268 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.8 t -84.59 128.94 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.51 -0.768 . . . . 1.0900000000000001 109.702 168.676 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.24 169.38 9.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.118 2.167 . . . . 3.8700000000000001 107.88 172.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.16 53.68 0.81 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.419 -0.8 . . . . 2.25 110.167 174.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.0 ttt-85 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 117.22 -1.371 . . . . 6.6500000000000004 114.348 -155.306 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.237 0 N-CA-C 108.591 -1.804 . . . . 12.43 108.591 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 p 172.11 -174.8 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.026 1.73 . . . . 10.890000000000001 107.79 -159.143 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -68.34 169.47 10.54 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.727 0.694 . . . . 13.99 109.835 151.002 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.9 t 149.09 -5.44 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 129.601 3.16 . . . . 7.1900000000000004 112.762 -164.468 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.11 -179.94 6.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.047 1.339 . . . . 7.2000000000000002 108.958 175.42 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.99 177.15 39.75 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 122.296 0.942 . . . . 1.3100000000000001 113.093 -177.084 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -157.23 155.12 30.3 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.492 0.717 . . . . 7.1399999999999997 111.1 168.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.0 t -128.96 137.02 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 106.68 -1.6 . . . . 1.6200000000000001 106.68 163.237 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -75.56 -62.4 1.59 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.484 0.584 . . . . 6.1600000000000001 110.362 -176.519 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -171.99 150.22 2.52 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.374 1.07 . . . . 2.9700000000000002 110.982 178.175 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 m -135.86 112.75 10.62 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.878 0.871 . . . . 4.7400000000000002 112.37 -178.234 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -82.92 -34.66 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.896 2.398 . . . . 2.2999999999999998 112.115 170.066 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.12 151.62 27.99 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 110.904 -0.878 . . . . 1.53 110.904 -158.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.94 0.65 32.86 Favored 'Cis proline' 0 CA--C 1.539 0.742 0 CA-C-N 119.636 1.718 . . . . 1.4399999999999999 113.297 1.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -144.75 172.58 12.81 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.514 1.302 . . . . 1.8100000000000001 114.514 -177.06 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.02 -175.65 5.4 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 129.786 3.234 . . . . 0.51000000000000001 112.335 -176.277 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.68 136.97 23.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.897 2.079 . . . . 0.75 108.72 174.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.89 144.15 50.48 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.841 1.657 . . . . 0.65000000000000002 112.543 -174.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -126.97 59.34 1.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.668 1.987 . . . . 2.5499999999999998 111.999 -163.158 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -73.18 152.04 41.26 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.963 1.468 . . . . 1.78 114.963 -173.404 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 m -84.97 144.16 28.5 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 121.34 -0.85 . . . . 1.72 110.443 161.711 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.2 129.63 25.66 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.281 1.832 . . . . 4.1100000000000003 111.318 -170.451 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -127.46 143.71 51.16 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.631 1.172 . . . . 3.8599999999999999 111.356 -176.702 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -105.73 95.22 10.05 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.815 0.846 . . . . 1.77 108.917 160.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.04 -4.99 15.85 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.097 2.532 . . . . 1.45 113.873 175.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.94 174.39 47.73 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 122.805 1.225 . . . . 1.27 113.099 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -99.85 -1.86 36.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.246 2.618 . . . . 3.4100000000000001 111.887 -174.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -122.21 157.95 56.89 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 128.473 2.709 . . . . 3.1400000000000001 110.021 176.057 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.33 143.44 22.16 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.587 2.191 . . . . 1.5700000000000001 111.302 -173.15 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.61 156.13 22.28 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.7 1.6 . . . . 3.02 109.839 173.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.1 ttp-105 -140.57 104.91 4.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.518 1.527 . . . . 2.7200000000000002 109.178 -177.179 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.8 113.72 21.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.453 1.501 . . . . 2.52 108.144 -176.277 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 m -103.88 -27.03 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.674 0.789 . . . . 0.51000000000000001 112.361 -174.233 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.25 -177.78 31.66 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 124.55 1.072 . . . . 0.40999999999999998 113.555 177.188 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.68 -174.72 3.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.947 1.299 . . . . 0.58999999999999997 109.642 168.469 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 4.5 mtt180 -155.59 168.75 26.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 128.029 2.532 . . . . 5.2599999999999998 106.82 173.349 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -173.51 151.08 1.89 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 125.504 1.522 . . . . 0.81999999999999995 108.431 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.72 -10.51 21.73 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.869 1.713 . . . . 1.21 113.832 176.432 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.13 18.94 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.96 1.467 . . . . 1.3999999999999999 114.96 -170.734 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.83 128.44 7.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.396 1.479 . . . . 1.49 111.683 172.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.69 -36.64 81.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.667 1.587 . . . . 3.4500000000000002 114.09 -176.645 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -140.66 88.02 2.16 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.515 1.526 . . . . 6.3899999999999997 108.683 -167.492 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 p -82.48 138.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.251 -0.886 . . . . 0.84999999999999998 110.905 169.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -124.06 152.43 42.67 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.203 2.201 . . . . 2.5499999999999998 110.026 177.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.7 tp -106.04 119.07 38.26 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.29 1.036 . . . . 0.94999999999999996 110.621 177.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -122.97 155.28 37.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.014 1.726 . . . . 0.57999999999999996 113.592 -175.151 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -100.89 159.88 14.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.876 -1.511 . . . . 2.3199999999999998 110.949 156.601 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.0 m -117.2 134.7 54.47 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 104.99 -2.226 . . . . 0.81999999999999995 104.99 158.814 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -122.42 166.98 13.87 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.944 1.298 . . . . 2.0 112.637 -174.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.7 ptm -91.1 149.56 21.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.464 0.706 . . . . 4.7000000000000002 111.707 169.193 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.29 151.04 27.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.596 1.158 . . . . 6.5 112.929 -177.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -109.19 139.85 43.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.906 1.682 . . . . 2.4100000000000001 106.474 161.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.6 m -138.17 126.67 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.168 -1.049 . . . . 3.3799999999999999 108.168 166.267 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.68 19.29 10.37 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.804 1.242 . . . . 4.2300000000000004 114.209 -178.171 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.96 14.74 76.69 Favored Glycine 0 N--CA 1.478 1.448 0 O-C-N 120.609 -1.307 . . . . 1.79 113.914 -170.477 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -112.24 118.62 35.8 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.796 2.438 . . . . 3.0499999999999998 108.575 -179.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.91 131.89 36.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.277 1.831 . . . . 2.7599999999999998 109.925 -176.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.3 p -155.83 175.72 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.497 1.519 . . . . 3.5800000000000001 111.132 -173.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.7 mtm -108.69 163.97 12.79 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.332 1.053 . . . . 3.77 112.021 164.194 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.1 -176.65 17.35 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.422 1.487 . . . . 1.0700000000000001 111.624 169.56 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.0 ttm -146.35 152.59 39.35 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.115 1.366 . . . . 1.1599999999999999 109.992 -173.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -162.18 156.17 18.34 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 124.796 1.238 . . . . 4.8499999999999996 111.328 173.876 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.09 153.68 57.34 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.331 2.021 . . . . 0.46999999999999997 111.423 171.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.86 154.82 73.15 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 125.777 1.631 . . . . 0.63 109.902 -177.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.61 -25.73 3.54 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.434 2.089 . . . . 0.5 113.178 -165.405 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -179.38 165.24 1.4 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.045 1.738 . . . . 1.73 111.797 -177.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.5 mt -111.7 153.41 26.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.958 1.703 . . . . 0.65000000000000002 109.651 163.268 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -107.1 149.38 27.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.175 0.99 . . . . 2.1200000000000001 108.934 175.46 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.48 121.28 9.93 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 118.253 0.479 . . . . 1.6499999999999999 111.273 164.437 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -67.49 164.66 30.04 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.966 2.444 . . . . 1.3799999999999999 110.58 175.299 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -58.4 138.79 87.72 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.594 2.196 . . . . 1.3600000000000001 112.04 177.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt 65.25 5.75 3.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.496 1.918 . . . . 2.23 113.675 -175.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.07 163.98 49.63 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.341 1.924 . . . . 1.8200000000000001 114.473 -174.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -127.75 142.23 51.37 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.51 2.324 . . . . 5.6200000000000001 109.877 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.3 t -143.27 135.7 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 107.166 -1.42 . . . . 3.2599999999999998 107.166 163.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -129.11 117.97 21.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.574 -0.899 . . . . 4.5999999999999996 108.574 -175.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -76.48 78.5 3.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.085 1.354 . . . . 2.3500000000000001 110.602 -168.431 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -66.96 151.01 97.54 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.083 1.353 . . . . 3.4700000000000002 114.058 -174.306 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.2 -31.09 64.57 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.563 2.176 . . . . 2.3100000000000001 113.32 173.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.15 53.85 4.48 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.177 0.899 . . . . 2.2400000000000002 111.929 168.014 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.09 -132.9 3.01 Favored Glycine 0 N--CA 1.471 1.024 0 C-N-CA 124.494 1.045 . . . . 1.6200000000000001 114.062 -179.528 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -72.49 140.42 48.21 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 122.866 0.467 . . . . 1.79 112.019 -170.024 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -162.64 160.56 25.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.625 1.17 . . . . 0.67000000000000004 111.351 -175.414 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -90.54 135.47 33.68 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.802 -0.561 . . . . 2.0600000000000001 109.877 167.574 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 tpt -86.55 127.52 34.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.14 -1.059 . . . . 0.78000000000000003 108.14 163.617 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.55 106.84 17.46 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.879 -1.156 . . . . 1.1399999999999999 107.879 177.732 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.88 151.28 26.49 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.756 0.788 . . . . 3.0 111.307 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.94 41.76 39.8 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.887 0.755 . . . . 2.1299999999999999 112.636 176.225 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.9 mt -50.2 154.02 1.3 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 123.401 1.572 . . . . 0.91000000000000003 114.229 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -99.83 -28.21 13.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 112.884 -1.962 . . . . 2.0600000000000001 112.501 173.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -146.39 148.52 34.63 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 127.409 2.283 . . . . 8.3300000000000001 111.171 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.7 146.87 55.57 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.939 2.426 . . . . 1.6699999999999999 109.866 165.323 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.1 mt -126.45 130.59 50.96 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.772 1.629 . . . . 3.29 109.43 -174.564 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.61 -178.84 4.64 Favored 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 126.52 1.928 . . . . 3.7999999999999998 111.984 -156.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.97 133.05 34.03 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.38 -0.825 . . . . 1.2 111.473 -175.098 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.82 46.81 8.22 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.834 1.207 . . . . 1.3200000000000001 112.06 -169.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -131.65 176.95 7.89 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.353 1.061 . . . . 2.3999999999999999 111.197 174.067 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -149.12 125.79 11.07 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.599 2.36 . . . . 3.4399999999999999 106.199 -165.195 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.0 t -140.77 140.25 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.329 1.052 . . . . 1.0700000000000001 111.282 -170.403 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -94.99 134.48 37.61 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.861 0.865 . . . . 3.54 112.881 177.585 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.8 mp -113.11 138.82 49.36 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.035 0.934 . . . . 1.74 110.678 158.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 11.4 m-20 -79.07 142.76 36.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.616 1.566 . . . . 2.48 108.447 159.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mp -110.7 123.82 50.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.782 2.433 . . . . 1.1399999999999999 109.659 176.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -106.45 115.12 29.67 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.343 1.057 . . . . 0.57999999999999996 110.73 -175.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.19 120.17 41.72 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.923 1.689 . . . . 1.95 111.538 -177.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.35 25.38 0.87 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.258 2.223 . . . . 3.0699999999999998 115.055 173.367 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.21 -60.75 3.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.23 1.395 . . . . 4.71 112.461 -168.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.49 -2.15 59.33 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 117.49 1.756 . . . . 1.8799999999999999 117.49 -164.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -135.45 130.66 35.09 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 120.057 1.929 . . . . 4.5999999999999996 113.248 173.029 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -96.96 151.75 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.41 1.484 . . . . 2.1099999999999999 110.563 161.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.9 tp -146.2 179.61 7.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.822 2.449 . . . . 2.2999999999999998 107.848 164.487 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -147.29 145.55 29.42 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.078 1.308 . . . . 2.4900000000000002 111.401 -177.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 t -142.86 157.24 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.561 1.145 . . . . 2.0 109.435 176.065 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.23 154.79 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.072 2.149 . . . . 2.1200000000000001 109.732 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.96 120.48 9.24 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.336 1.854 . . . . 3.1000000000000001 110.305 176.179 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.52 145.29 16.92 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 124.562 3.508 . . . . 1.55 113.549 156.382 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.57 127.95 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.828 -0.804 . . . . 1.02 108.828 161.592 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.42 ' CD ' HH21 ' A' ' 120' ' ' ARG . 12.1 tt0 -153.91 129.86 10.24 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.173 1.789 . . . . 4.2800000000000002 109.344 169.643 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.12 110.23 11.62 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.647 1.179 . . . . 3.1699999999999999 108.826 174.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.42 HH21 ' CD ' ' A' ' 118' ' ' GLU . 19.0 ttm180 . . . . . 0 C--O 1.25 1.107 0 C-N-CA 129.114 2.966 . . . . 7.9699999999999998 107.817 -172.206 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.364 0 N-CA-C 105.365 -3.094 . . . . 10.039999999999999 105.365 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 m -58.86 169.98 0.9 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 119.38 -0.928 . . . . 9.4399999999999995 110.959 135.038 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -177.75 -168.19 0.17 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 129.827 3.251 . . . . 7.8499999999999996 107.793 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.1 t -150.32 162.3 40.79 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.532 1.133 . . . . 4.4400000000000004 110.718 177.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.47 111.58 2.11 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.769 1.228 . . . . 4.6399999999999997 111.483 -156.662 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.02 156.44 27.2 Favored Glycine 0 N--CA 1.474 1.183 0 O-C-N 120.485 -1.384 . . . . 1.3700000000000001 115.604 -176.521 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -155.87 170.87 21.11 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.358 1.063 . . . . 2.1800000000000002 113.29 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -114.14 130.95 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.728 -1.212 . . . . 1.3500000000000001 107.728 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -78.69 -29.81 45.74 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.779 1.77 . . . . 5.4000000000000004 115.779 -157.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.9 t80 146.43 137.26 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 130.653 3.581 . . . . 2.25 109.721 174.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 t 179.54 133.78 0.25 Allowed Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 126.683 1.993 . . . . 1.8500000000000001 110.801 166.404 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.38 -25.66 15.2 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.419 2.079 . . . . 1.24 112.481 171.114 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.11 -176.96 17.07 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.82 1.676 . . . . 0.93000000000000005 112.256 -174.694 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.69 -11.43 20.54 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 118.445 1.122 . . . . 0.90000000000000002 113.449 3.444 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -128.02 155.79 43.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.586 1.954 . . . . 1.8100000000000001 112.87 179.239 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.43 173.42 11.62 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.07 2.148 . . . . 0.42999999999999999 110.867 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.09 125.09 30.53 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.056 1.343 . . . . 1.01 108.355 172.214 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.3 151.2 22.98 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.421 1.488 . . . . 0.62 110.751 177.327 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -141.79 70.39 1.34 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.593 1.557 . . . . 2.1499999999999999 110.053 -166.238 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -90.69 161.01 15.55 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.356 -0.84 . . . . 1.9399999999999999 112.941 175.105 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 23.1 m -79.59 157.61 27.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.125 -0.943 . . . . 1.7 109.985 160.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.68 136.44 54.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.227 1.011 . . . . 3.4300000000000002 110.156 175.882 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.84 131.35 47.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.698 1.199 . . . . 5.96 111.297 -173.234 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -107.05 111.17 63.7 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.387 -0.598 . . . . 1.46 109.387 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -86.83 -11.72 5.48 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.283 2.655 . . . . 1.8500000000000001 113.586 173.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.0 -179.84 47.19 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 124.992 1.282 . . . . 1.26 112.933 -175.074 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -104.21 -5.35 22.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.996 2.518 . . . . 3.3700000000000001 111.679 -171.268 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -121.18 159.61 48.91 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.817 2.447 . . . . 2.9300000000000002 109.702 175.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.03 137.5 19.57 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.124 1.882 . . . . 1.0600000000000001 110.463 -175.212 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.61 155.54 16.73 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.651 1.18 . . . . 2.4100000000000001 109.614 171.521 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 ttp-105 -143.93 102.96 3.97 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.423 1.489 . . . . 2.9100000000000001 110.567 -170.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -86.4 109.57 19.11 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.158 2.183 . . . . 2.1899999999999999 109.891 -173.159 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -103.14 -20.88 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.553 1.141 . . . . 0.53000000000000003 111.851 -172.385 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.85 -174.66 30.96 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 124.897 1.237 . . . . 0.44 113.507 177.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.99 -179.72 5.83 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.047 0.939 . . . . 0.48999999999999999 112.119 166.263 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.418 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -140.08 170.27 16.15 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.161 2.184 . . . . 4.9900000000000002 107.97 160.335 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -171.64 149.18 2.37 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 125.63 1.572 . . . . 0.71999999999999997 108.768 176.401 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.28 -14.47 16.47 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.405 2.07 . . . . 0.79000000000000004 113.706 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.46 26.76 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.045 1.338 . . . . 0.85999999999999999 113.615 -177.045 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.67 161.2 42.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.437 1.495 . . . . 0.85999999999999999 109.039 163.748 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -95.46 -36.51 11.29 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.348 1.059 . . . . 3.1000000000000001 112.858 177.235 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.7 160.86 33.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.024 1.729 . . . . 5.8700000000000001 107.38 170.448 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.81 155.06 17.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.387 1.475 . . . . 0.98999999999999999 109.014 173.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.59 152.57 34.27 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.636 1.974 . . . . 4.1900000000000004 108.324 -167.757 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.401 HD13 ' CE1' ' A' ' 84' ' ' PHE . 56.2 tp -121.07 107.44 12.63 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.224 -0.923 . . . . 0.81999999999999995 110.926 -162.076 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.6 m170 -117.64 145.05 44.62 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.473 1.286 . . . . 0.68000000000000005 114.473 -169.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -84.72 169.99 13.72 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.241 1.816 . . . . 2.1600000000000001 111.329 163.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.2 m -145.99 142.27 28.49 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.538 -1.352 . . . . 0.78000000000000003 107.444 174.06 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -162.21 178.84 8.39 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.743 1.386 . . . . 1.96 114.743 -167.261 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.8 ptm -118.36 150.99 38.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.048 1.739 . . . . 3.8100000000000001 112.541 176.491 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -156.07 146.37 21.6 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.834 1.254 . . . . 7.6100000000000003 112.64 -174.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -100.96 142.17 32.8 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.395 1.478 . . . . 2.6800000000000002 109.848 171.727 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.6 t -141.33 121.06 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.611 1.564 . . . . 2.6600000000000001 107.717 174.679 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 64.58 12.45 7.49 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.989 1.716 . . . . 4.6100000000000003 115.049 -179.129 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.24 22.99 53.19 Favored Glycine 0 N--CA 1.477 1.425 0 O-C-N 121.07 -1.019 . . . . 2.5600000000000001 113.243 -167.001 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -118.28 120.31 37.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.861 2.064 . . . . 4.6299999999999999 107.6 175.637 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.569 ' H ' ' HD2' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -73.07 127.94 34.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.613 1.565 . . . . 3.9900000000000002 111.673 174.447 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -138.72 160.83 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 128.786 2.834 . . . . 2.6200000000000001 108.477 -173.084 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.9 mtt -111.5 170.12 8.34 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.823 -1.173 . . . . 2.5600000000000001 112.704 174.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.28 166.29 32.09 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.449 0.94 . . . . 0.70999999999999996 115.449 -167.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -161.05 146.19 14.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 128.439 2.696 . . . . 1.3 107.107 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -153.2 157.4 32.93 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.637 1.975 . . . . 4.4400000000000004 108.073 -177.763 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -78.27 159.93 29.55 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.631 1.554 . . . . 0.71999999999999997 110.692 167.84 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.26 152.86 74.26 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.126 1.371 . . . . 0.64000000000000001 110.532 177.754 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.26 -24.11 11.18 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.851 2.367 . . . . 0.65000000000000002 112.68 -170.951 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -176.95 166.91 2.5 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.569 1.948 . . . . 1.99 111.55 178.712 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -112.81 152.09 29.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.186 1.794 . . . . 0.66000000000000003 110.989 162.353 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -103.54 151.58 22.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.205 1.002 . . . . 1.8 109.874 176.655 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.57 126.68 13.83 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.154 0.582 . . . . 1.4199999999999999 111.71 161.601 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.21 158.85 44.78 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.984 3.122 . . . . 1.53 112.013 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.76 140.65 87.05 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 124.074 3.183 . . . . 1.4199999999999999 113.871 -174.286 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 66.72 -10.08 0.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.163 2.185 . . . . 2.46 114.358 -178.383 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.01 136.23 13.49 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.993 1.282 . . . . 1.72 113.209 -176.533 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.44 135.44 33.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.032 2.133 . . . . 3.73 109.783 159.082 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -149.2 124.15 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.718 1.607 . . . . 3.7599999999999998 108.807 178.12 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 2.2 mp0 -89.06 157.13 18.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.435 0.694 . . . . 3.25 111.637 -170.673 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mp -66.23 -32.87 74.55 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.218 0.917 . . . . 3.1899999999999999 113.372 174.051 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 93.5 140.95 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 130.518 3.527 . . . . 3.0499999999999998 110.426 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.71 -1.24 7.25 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.394 2.729 . . . . 2.5499999999999998 114.643 178.442 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.86 19.85 0.25 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-O 117.439 -1.756 . . . . 2.02 116.207 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.87 -27.46 0.86 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 120.243 2.022 . . . . 2.0699999999999998 116.987 172.129 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -137.87 151.54 48.15 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.3 2.05 . . . . 2.0600000000000001 111.435 160.269 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -156.84 148.46 22.49 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.333 0.653 . . . . 0.73999999999999999 110.65 175.673 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' CE1' HD13 ' A' ' 45' ' ' LEU . 45.7 m-85 -81.84 116.84 21.7 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.792 -0.818 . . . . 2.0600000000000001 108.792 165.472 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 tpt -78.25 107.8 11.11 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 126.705 2.002 . . . . 1.0900000000000001 108.609 170.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.3 mp -87.49 139.73 30.25 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.446 1.498 . . . . 1.3100000000000001 109.12 176.23 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.38 138.03 46.1 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.259 1.024 . . . . 2.1600000000000001 112.263 178.293 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.25 42.45 10.58 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 124.997 1.284 . . . . 1.5900000000000001 113.118 173.601 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.7 mt -47.36 151.28 0.77 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.938 1.829 . . . . 0.87 115.938 -172.47 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -111.42 -26.29 9.18 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 113.721 -1.581 . . . . 2.3100000000000001 113.85 -176.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -120.63 136.36 25.32 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.302 1.441 . . . . 4.6399999999999997 109.218 159.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.07 116.24 4.64 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.022 2.481 . . . . 1.45 107.767 170.14 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.357 4.1 pp -98.43 105.24 17.36 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 124.279 1.99 . . . . 3.0299999999999998 112.708 -162.506 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.26 171.01 7.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.03 2.132 . . . . 3.6499999999999999 112.256 176.68 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.31 129.46 41.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.106 0.962 . . . . 1.3700000000000001 110.804 175.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.66 31.78 48.62 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.702 -0.681 . . . . 2.9100000000000001 112.939 -173.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -100.02 179.38 4.52 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.382 -0.97 . . . . 2.6000000000000001 108.382 143.642 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.22 160.51 43.31 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.279 1.831 . . . . 3.2599999999999998 106.725 165.243 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.0 t -151.96 157.91 4.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 128.734 2.813 . . . . 1.49 107.73 -158.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -126.61 154.13 44.38 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.678 0.791 . . . . 2.4300000000000002 110.226 165.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.16 134.88 54.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.056 1.343 . . . . 1.99 109.96 166.351 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 67.9 m-20 -78.18 134.79 37.57 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.334 2.254 . . . . 2.5899999999999999 108.432 161.587 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.99 109.6 21.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.437 1.895 . . . . 1.21 108.815 178.461 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.5 mt -93.88 116.3 28.75 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.201 0.6 . . . . 0.68000000000000005 110.1 -176.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -109.23 148.71 30.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.614 1.166 . . . . 1.95 111.806 -177.825 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.75 150.18 33.26 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.775 -0.578 . . . . 2.1699999999999999 112.012 169.562 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.23 34.39 41.34 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.142 -0.81 . . . . 4.1399999999999997 114.029 177.166 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.72 44.3 39.64 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 118.048 0.924 . . . . 1.9399999999999999 114.235 166.47 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -134.07 140.96 46.99 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.241 1.02 . . . . 3.21 111.713 -177.882 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.2 t -142.67 134.39 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.83 1.252 . . . . 2.02 109.283 172.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -116.62 174.74 5.91 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.319 1.847 . . . . 3.0800000000000001 107.598 163.721 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -139.21 154.14 47.98 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.011 -1.056 . . . . 1.9099999999999999 112.373 161.177 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.0 t -132.3 160.86 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.197 1.399 . . . . 1.8799999999999999 109.734 -176.645 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.53 143.27 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 127.358 2.263 . . . . 3.0899999999999999 111.592 -173.288 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -143.76 105.2 4.93 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.742 1.617 . . . . 2.8199999999999998 109.84 -175.489 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -61.3 157.36 40.81 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.394 2.063 . . . . 1.4399999999999999 111.396 158.455 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.8 t -107.4 141.92 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.593 0.711 . . . . 1.23 110.139 173.155 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -174.03 3.18 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.577 2.751 . . . . 3.9199999999999999 110.496 -165.389 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -131.56 93.73 3.39 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.414 1.086 . . . . 2.4300000000000002 110.855 162.271 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 . . . . . 0 N--CA 1.484 1.262 0 C-N-CA 125.996 1.718 . . . . 7.79 113.299 -170.922 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.179 0 N-CA-C 108.406 -1.878 . . . . 8.3300000000000001 108.406 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t 71.78 -176.37 0.19 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.059 -1.089 . . . . 7.8600000000000003 108.059 -126.365 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -107.85 -13.38 15.0 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.17 0.988 . . . . 10.720000000000001 111.846 158.367 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.6 p -78.58 52.9 1.24 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.993 2.117 . . . . 4.9800000000000004 112.517 -165.379 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -102.63 105.61 16.13 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.453 0.644 . . . . 4.5800000000000001 110.651 -163.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.67 -177.79 32.09 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 125.581 1.563 . . . . 1.1799999999999999 113.642 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.1 p90 -152.96 143.21 22.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.558 1.543 . . . . 2.4399999999999999 110.567 170.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.3 156.61 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 121.048 -1.033 . . . . 1.6499999999999999 108.404 167.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.418 ' HB3' ' H ' ' A' ' 17' ' ' ALA . 27.8 ttt85 -86.3 149.75 24.83 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.865 1.317 . . . . 4.1900000000000004 112.974 -176.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -72.11 132.43 44.18 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 129.236 3.014 . . . . 2.6299999999999999 109.84 170.553 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.3 t 178.84 141.27 0.28 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 126.565 1.946 . . . . 2.25 111.229 176.307 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.74 -28.96 13.26 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.562 2.174 . . . . 1.4099999999999999 112.683 169.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.03 171.14 12.5 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.407 1.956 . . . . 0.94999999999999996 112.36 -172.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -82.98 -0.14 54.34 Favored 'Cis proline' 0 CA--C 1.539 0.74 0 CA-C-N 119.27 1.535 . . . . 1.1499999999999999 113.923 2.593 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -143.33 157.39 44.51 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.772 1.397 . . . . 2.5 114.772 174.331 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.13 -175.34 3.59 Favored 'General case' 0 CA--C 1.549 0.924 1 C-N-CA 131.838 4.055 . . . . 0.40999999999999998 108.804 175.349 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.418 ' H ' ' HB3' ' A' ' 9' ' ' ARG . . . -131.64 171.02 13.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.793 2.037 . . . . 1.1399999999999999 108.259 173.01 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.62 135.96 22.79 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.107 0.956 . . . . 0.64000000000000001 112.576 170.356 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -123.44 141.06 52.37 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.574 2.35 . . . . 2.3100000000000001 108.957 -174.541 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -174.05 143.16 0.9 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.869 1.433 . . . . 1.98 114.869 -171.379 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.0 m -79.52 120.86 24.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.594 1.157 . . . . 1.9299999999999999 110.98 178.512 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 135.23 39.72 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.329 1.852 . . . . 3.2400000000000002 109.361 175.036 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -139.12 146.89 41.22 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.066 1.747 . . . . 5.1500000000000004 109.137 -171.351 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -131.98 99.56 16.46 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.508 0.723 . . . . 1.6499999999999999 109.934 177.499 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -70.38 -14.37 34.05 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.368 2.045 . . . . 2.0299999999999998 113.069 176.231 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.35 140.69 11.58 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 128.188 2.804 . . . . 3.5099999999999998 112.666 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t0 174.23 -55.89 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.562 2.745 . . . . 8.3900000000000006 103.86 -158.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp 178.06 173.55 0.38 Allowed Pre-proline 0 CA--C 1.552 1.021 1 C-N-CA 132.898 4.479 . . . . 4.3700000000000001 110.848 -177.148 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.37 134.94 10.38 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.345 2.03 . . . . 1.3999999999999999 111.227 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.3 mt -93.84 145.23 24.76 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.646 1.178 . . . . 2.2200000000000002 111.108 -175.55 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 ttp-105 -137.31 91.88 2.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 112.62 -2.082 . . . . 2.96 111.628 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 98.02 7.37 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.098 1.759 . . . . 1.8300000000000001 108.418 -170.485 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.9 m -94.36 -30.65 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.25 1.42 . . . . 0.64000000000000001 112.21 -169.594 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.64 -176.78 32.09 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 123.87 0.747 . . . . 0.59999999999999998 113.765 178.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.26 177.45 8.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.322 1.049 . . . . 0.67000000000000004 112.253 172.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -153.36 157.64 40.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.051 2.54 . . . . 5.7699999999999996 108.236 168.444 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -167.32 152.45 6.98 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 123.798 0.839 . . . . 0.96999999999999997 111.894 -176.727 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.2 -8.75 23.35 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.794 2.329 . . . . 1.52 115.599 178.817 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.64 0.55 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 115.829 1.789 . . . . 1.48 115.829 178.166 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.04 164.13 37.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.135 1.374 . . . . 1.1899999999999999 112.186 -178.978 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -124.77 -65.04 1.06 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 123.103 1.43 . . . . 4.3899999999999997 111.399 -167.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -79.01 147.59 32.82 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.426 -2.065 . . . . 4.79 105.426 164.763 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -156.66 135.05 2.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 C-N-CA 125.141 1.376 . . . . 0.96999999999999997 108.034 -177.081 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -127.54 156.6 41.94 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.757 2.023 . . . . 2.8300000000000001 109.323 178.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.1 tp -105.46 126.58 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.799 0.84 . . . . 0.97999999999999998 109.231 169.032 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -124.24 160.63 27.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.0 2.12 . . . . 0.69999999999999996 113.984 -175.663 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -107.64 163.61 12.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.751 1.62 . . . . 2.0600000000000001 111.091 156.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.5 m -116.05 140.93 48.78 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.463 1.905 . . . . 1.04 106.602 165.189 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -145.31 -178.15 5.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.547 1.139 . . . . 2.0899999999999999 113.42 -177.114 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.1 mtm -126.79 144.28 51.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.364 1.466 . . . . 3.6400000000000001 112.749 -177.586 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.12 135.82 39.59 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.699 1.6 . . . . 6.0 111.764 178.795 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -104.49 127.69 52.26 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.844 1.658 . . . . 3.1600000000000001 111.34 168.35 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.9 t -134.82 123.97 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 107.651 -1.24 . . . . 2.6699999999999999 107.651 176.047 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 62.67 10.63 4.28 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.169 2.188 . . . . 3.98 115.146 -169.228 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.82 30.19 52.81 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 120.965 -1.085 . . . . 1.74 112.885 -164.488 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -118.52 129.28 55.27 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.955 1.702 . . . . 2.7400000000000002 108.261 169.08 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -86.84 126.61 34.75 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.029 1.732 . . . . 6.1399999999999997 112.294 -177.598 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.89 142.98 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.542 1.937 . . . . 2.9300000000000002 109.423 175.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 52.2 mtt -88.45 163.42 15.96 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.892 1.071 . . . . 2.6499999999999999 113.892 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.98 175.15 22.35 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.549 1.547 . . . . 0.59999999999999998 112.457 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.3 ttm -157.04 148.11 21.86 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.46 1.904 . . . . 1.51 108.245 -179.423 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -161.08 153.68 17.3 Favored Pre-proline 0 N--CA 1.476 0.862 0 CA-C-O 118.051 -0.976 . . . . 4.6799999999999997 111.639 -178.428 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.91 155.29 43.37 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.197 1.931 . . . . 0.56000000000000005 111.875 178.53 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.99 151.03 61.23 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.038 1.735 . . . . 0.58999999999999997 109.999 -177.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.8 -21.03 8.68 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.465 2.777 . . . . 0.52000000000000002 113.493 -164.638 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -178.09 165.83 1.94 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.568 1.947 . . . . 1.74 110.746 177.548 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 mt -106.95 146.26 31.26 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.082 0.953 . . . . 0.67000000000000004 110.529 158.347 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -105.86 140.2 39.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.391 1.076 . . . . 1.8700000000000001 108.929 175.078 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.9 t -141.01 113.14 6.88 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 122.902 0.481 . . . . 0.97999999999999998 110.725 165.314 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.9 162.44 37.32 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 124.095 3.197 . . . . 1.75 111.75 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.64 136.89 56.3 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.931 2.42 . . . . 1.52 111.784 -177.512 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt 74.68 -4.81 2.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 128.118 2.567 . . . . 3.5099999999999998 114.402 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.38 155.3 23.35 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.411 1.481 . . . . 1.8300000000000001 112.12 170.428 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -135.67 153.47 51.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.39 1.476 . . . . 4.2000000000000002 110.366 172.689 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.7 t -154.04 129.76 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.353 1.461 . . . . 3.6699999999999999 108.781 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.8 136.24 33.15 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.938 -1.101 . . . . 3.2200000000000002 112.265 176.52 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.82 84.17 0.66 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.077 -1.083 . . . . 2.2599999999999998 108.077 157.22 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -92.21 150.29 40.02 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.418 2.287 . . . . 2.54 113.377 -178.302 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -64.66 -39.69 26.03 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.004 2.469 . . . . 2.52 113.102 -174.541 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.33 45.84 2.66 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.689 1.137 . . . . 2.3300000000000001 112.511 170.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.08 -129.08 1.96 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 126.371 1.939 . . . . 1.48 111.65 177.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -73.57 138.33 44.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.714 1.257 . . . . 2.0 113.239 -166.364 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -161.32 161.5 30.56 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.59 1.156 . . . . 0.93000000000000005 111.503 -178.02 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -85.99 150.83 24.21 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.502 -0.749 . . . . 1.71 110.915 165.297 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -105.96 126.13 51.82 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.415 1.486 . . . . 1.1100000000000001 108.706 163.008 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.01 118.31 36.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.734 1.214 . . . . 1.1799999999999999 108.75 -175.23 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.08 155.26 31.82 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 123.409 1.576 . . . . 1.97 112.212 -170.48 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.09 -43.75 3.25 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 128.024 2.726 . . . . 2.4399999999999999 112.139 -178.057 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.2 mt 47.97 167.55 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.602 3.161 . . . . 1.1299999999999999 115.891 -168.474 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -135.33 -21.2 1.59 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.342 1.457 . . . . 2.75 113.781 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -122.27 149.86 55.71 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.148 2.179 . . . . 5.0099999999999998 107.619 161.033 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.71 112.37 2.63 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 106.23 -2.258 . . . . 1.49 106.23 153.209 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.35 108.16 5.33 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.048 -0.723 . . . . 2.0800000000000001 109.048 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -65.02 174.43 1.95 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.382 1.087 . . . . 4.0800000000000001 112.083 158.432 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.97 159.68 24.83 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.673 -1.149 . . . . 1.6200000000000001 108.439 149.285 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.16 49.74 75.31 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 121.575 -0.703 . . . . 2.1800000000000002 112.524 -172.317 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.53 -179.6 4.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.96 1.304 . . . . 2.25 108.483 163.23 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -148.04 151.48 35.79 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.154 1.781 . . . . 3.4199999999999999 107.346 169.167 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.7 t -154.35 145.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 128.006 2.522 . . . . 1.23 109.357 -160.496 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -101.11 154.37 18.79 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.276 0.63 . . . . 4.6900000000000004 111.385 171.79 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mt -139.56 134.14 31.75 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.594 1.557 . . . . 2.0499999999999998 110.26 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -83.69 131.41 34.94 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.709 2.004 . . . . 1.98 108.823 165.774 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.29 111.35 22.6 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.918 1.287 . . . . 0.91000000000000003 109.585 172.486 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.72 110.85 19.61 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.669 1.187 . . . . 0.91000000000000003 109.806 -178.191 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -106.28 105.3 15.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.923 1.289 . . . . 1.9299999999999999 110.751 -177.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 57.43 11.12 1.09 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.013 1.725 . . . . 2.5699999999999998 115.22 174.209 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.36 -43.08 2.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.498 1.523 . . . . 3.8300000000000001 113.186 -169.12 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.96 -11.11 78.56 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.339 0.971 . . . . 2.6200000000000001 115.514 -175.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -137.49 157.15 47.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.818 1.309 . . . . 4.2999999999999998 111.867 170.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.78 153.97 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 125.708 1.603 . . . . 2.0800000000000001 109.93 169.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.5 tp -144.44 121.78 11.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.593 1.157 . . . . 2.1200000000000001 109.654 174.373 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.77 114.33 28.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.53 0.732 . . . . 3.6499999999999999 110.587 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.55 167.72 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 126.748 2.019 . . . . 2.0800000000000001 110.548 -170.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.29 141.56 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.734 2.013 . . . . 2.6699999999999999 110.655 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.4 mt -150.85 149.1 24.6 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 126.279 1.832 . . . . 3.1299999999999999 111.625 -174.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -70.01 174.34 9.87 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.734 2.956 . . . . 1.1799999999999999 112.048 166.027 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.5 t -121.82 134.48 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.572 1.549 . . . . 1.3200000000000001 109.507 166.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -150.0 159.25 44.54 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.377 1.251 . . . . 5.0199999999999996 114.377 177.073 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.08 50.72 2.0 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.347 -0.842 . . . . 2.5899999999999999 111.635 178.369 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? . . . . . 0 C--O 1.245 0.842 0 C-N-CA 124.31 1.044 . . . . 7.1100000000000003 110.477 175.19 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' HA3' ' OE2' ' A' ' 23' ' ' GLU . . . . . . . . 0 CA--C 1.503 -0.663 0 CA-C-O 119.678 -0.512 . . . . 9.6699999999999999 112.371 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -87.85 -38.01 16.03 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.997 1.319 . . . . 7.21 110.312 163.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 71.18 -42.77 0.54 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.02 2.528 . . . . 10.640000000000001 116.874 161.236 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.0 t -144.62 2.09 1.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.349 1.459 . . . . 5.4000000000000004 113.55 -163.717 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -77.31 104.23 7.7 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.847 0.859 . . . . 4.9500000000000002 110.916 -159.102 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.33 -177.15 33.18 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.95 1.262 . . . . 1.3500000000000001 114.129 -175.393 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -153.81 160.02 42.08 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.606 1.562 . . . . 2.3900000000000001 111.381 167.754 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 t -97.04 146.78 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 106.897 -1.52 . . . . 1.3400000000000001 106.897 165.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -75.67 -102.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.367 0.985 . . . . 5.4000000000000004 112.032 -178.209 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -170.67 127.29 0.76 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.869 1.268 . . . . 2.75 108.198 -168.788 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 p 179.6 111.22 0.19 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.565 -0.731 . . . . 2.79 111.588 -167.586 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.29 -31.97 8.72 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.38 2.053 . . . . 1.1899999999999999 112.671 174.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.68 178.0 28.58 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.475 1.512 . . . . 1.0600000000000001 111.772 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.6 2.77 35.18 Favored 'Cis proline' 0 CA--C 1.539 0.77 0 CA-C-N 119.245 1.523 . . . . 1.4199999999999999 112.952 -3.545 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -151.9 167.45 28.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.109 0.963 . . . . 2.3199999999999998 112.085 176.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.48 173.73 12.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.537 2.335 . . . . 0.56000000000000005 110.842 -171.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.55 139.28 24.04 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.51 1.124 . . . . 0.90000000000000002 110.281 179.206 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.09 140.35 50.83 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.295 1.438 . . . . 0.75 111.549 -173.531 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -115.08 142.07 47.14 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.972 2.109 . . . . 3.3300000000000001 111.332 -176.176 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -162.94 147.43 11.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.869 1.433 . . . . 1.98 114.869 178.12 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.7 m -79.82 116.12 19.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.205 1.402 . . . . 1.8600000000000001 110.477 176.07 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.75 126.45 40.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.582 1.153 . . . . 3.3599999999999999 110.08 174.531 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.466 ' OE2' ' HA3' ' A' ' 1' ' ' GLY . 47.5 tt0 -124.24 142.89 50.88 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.561 1.544 . . . . 4.1900000000000004 110.959 175.993 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -103.84 94.95 6.93 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.838 1.255 . . . . 1.4099999999999999 109.985 171.185 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.12 -8.24 18.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.717 2.278 . . . . 1.3200000000000001 113.796 177.354 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.72 177.96 51.27 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 122.425 1.014 . . . . 1.3300000000000001 112.36 -178.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -103.02 -2.44 27.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.17 2.188 . . . . 3.23 111.295 -176.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.61 162.12 21.92 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 129.333 3.053 . . . . 4.2400000000000002 108.873 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.29 146.86 20.03 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.453 2.102 . . . . 1.03 110.784 178.15 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mp -112.11 151.28 29.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.792 1.237 . . . . 2.3599999999999999 110.731 174.047 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -141.14 109.8 6.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.037 -1.892 . . . . 1.95 110.076 179.265 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.52 123.78 32.78 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 125.282 1.433 . . . . 1.98 108.607 178.124 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -106.57 -28.58 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.201 0.91 . . . . 0.69999999999999996 111.927 -175.862 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.24 -173.34 27.55 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 124.536 1.065 . . . . 0.47999999999999998 113.704 177.482 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -127.21 -176.77 3.82 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.339 1.056 . . . . 0.55000000000000004 111.014 161.785 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -144.98 156.33 43.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 131.357 3.863 . . . . 5.8700000000000001 105.178 166.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -167.18 137.24 2.37 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 124.256 1.022 . . . . 0.65000000000000002 109.991 171.807 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.57 -17.56 38.37 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.362 2.042 . . . . 0.93999999999999995 113.321 -171.694 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.2 m -93.8 17.5 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 114.747 1.388 . . . . 0.84999999999999998 114.747 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.12 164.15 28.3 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.582 1.083 . . . . 1.2 113.609 170.569 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -92.62 -35.86 13.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.546 1.138 . . . . 4.0700000000000003 111.149 175.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -135.36 156.72 48.47 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.179 2.192 . . . . 5.0 108.011 169.31 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.24 149.47 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.701 1.601 . . . . 0.97999999999999998 108.764 168.334 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -152.04 150.41 29.92 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.692 1.997 . . . . 2.8399999999999999 108.524 -172.373 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.435 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.5 pt? -105.83 134.15 49.41 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 123.068 1.414 . . . . 1.97 113.105 172.641 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -116.76 154.74 30.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.514 -1.676 . . . . 0.69999999999999996 111.321 177.377 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -175.48 5.32 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.566 1.546 . . . . 3.3500000000000001 110.889 159.112 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.0 m -151.15 147.7 27.37 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.585 1.154 . . . . 0.70999999999999996 108.489 164.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -159.2 177.01 11.51 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 123.467 1.604 . . . . 2.0499999999999998 113.724 -171.204 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.6 ttp -129.42 128.02 42.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.071 1.748 . . . . 3.2599999999999998 110.597 -179.433 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.49 148.76 22.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.343 1.457 . . . . 6.0899999999999999 110.623 164.655 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.65 138.05 33.51 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.468 -0.938 . . . . 2.6400000000000001 108.468 147.135 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.96 125.17 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 106.238 -1.764 . . . . 2.25 106.238 166.123 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 60.31 33.62 20.86 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.621 0.768 . . . . 4.3300000000000001 112.044 178.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.74 9.62 79.15 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.834 -1.166 . . . . 1.6200000000000001 114.454 -176.353 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -126.02 134.92 51.31 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.11 1.764 . . . . 2.29 109.241 -172.994 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -84.61 123.75 30.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.634 1.574 . . . . 3.1000000000000001 111.124 -171.815 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.1 t -141.36 131.0 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.657 1.983 . . . . 2.1800000000000002 108.403 -173.171 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.73 161.63 13.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.768 1.227 . . . . 3.2200000000000002 113.626 -171.56 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.27 -179.66 32.36 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.046 1.308 . . . . 1.0800000000000001 113.086 172.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.91 153.75 43.41 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.291 1.036 . . . . 3.6200000000000001 111.164 170.412 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -141.06 152.52 65.22 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.778 2.031 . . . . 4.3899999999999997 109.417 -174.408 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.69 153.61 59.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.119 1.879 . . . . 0.73999999999999999 111.273 172.399 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.53 154.92 77.53 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-O 118.452 -0.785 . . . . 0.96999999999999997 110.828 171.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.35 -22.9 10.58 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.114 2.543 . . . . 0.53000000000000003 112.602 -172.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -174.15 171.9 3.43 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.94 1.696 . . . . 2.0600000000000001 110.894 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.7 mt -117.54 158.27 24.86 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.225 1.81 . . . . 0.73999999999999999 109.915 160.318 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -137.34 146.34 44.45 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.69 0.796 . . . . 2.1899999999999999 110.673 178.06 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.9 t -144.04 130.12 9.99 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 123.961 0.788 . . . . 1.28 110.854 175.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.82 165.45 29.71 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.73 2.953 . . . . 1.23 111.316 175.664 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.61 141.66 97.7 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.281 2.654 . . . . 1.0600000000000001 113.16 -179.1 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt 69.62 -4.43 1.4 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 127.53 2.332 . . . . 1.5700000000000001 114.681 177.914 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.58 169.39 47.06 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.137 1.351 . . . . 1.28 113.974 179.22 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 -133.35 156.86 46.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.401 1.08 . . . . 4.54 111.691 164.419 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -149.0 133.53 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.92 2.088 . . . . 3.7400000000000002 106.922 171.523 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -98.03 133.71 42.12 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.947 -1.095 . . . . 2.8399999999999999 111.393 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mp -68.47 78.9 0.27 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.394 -0.965 . . . . 2.5 108.394 154.891 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -94.09 154.38 40.61 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.717 2.007 . . . . 2.54 112.051 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.43 -34.55 94.86 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.997 2.465 . . . . 2.3500000000000001 113.211 175.358 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.75 66.39 3.85 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.18 -0.768 . . . . 2.77 111.18 171.203 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.84 -123.59 3.72 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.178 1.371 . . . . 1.6200000000000001 112.966 -178.46 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -74.65 141.64 44.6 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.938 0.718 . . . . 2.2200000000000002 112.938 -162.533 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -159.97 154.97 24.69 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.587 -0.696 . . . . 0.77000000000000002 112.044 -176.855 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 43.4 m-85 -90.3 118.66 29.98 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.558 0.343 . . . . 2.6299999999999999 110.208 171.178 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -85.62 125.18 32.93 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.009 1.324 . . . . 0.93999999999999995 109.257 170.16 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.96 127.82 52.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.476 1.51 . . . . 1.4299999999999999 107.537 177.384 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.82 150.14 39.66 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.824 0.821 . . . . 2.04 112.237 -176.59 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.43 -41.26 1.83 Allowed Glycine 0 CA--C 1.531 1.094 0 C-N-CA 126.48 1.991 . . . . 2.8900000000000001 113.57 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.8 mt 57.04 170.52 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 129.916 3.286 . . . . 0.92000000000000004 114.29 -177.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -129.82 -28.51 2.21 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.002 2.121 . . . . 1.52 112.857 172.583 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -110.99 132.58 21.6 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.43 1.492 . . . . 4.7999999999999998 108.065 166.642 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.95 101.19 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 N-CA-C 106.362 -2.207 . . . . 1.9099999999999999 106.362 158.466 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.11 128.0 41.6 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.419 1.104 . . . . 2.8300000000000001 112.674 -159.703 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -132.87 172.31 12.76 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.259 1.823 . . . . 3.8500000000000001 113.335 -167.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.69 124.61 23.36 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.574 -0.739 . . . . 1.46 110.083 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.36 7.36 51.97 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.554 1.55 . . . . 1.8799999999999999 115.497 -176.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.28 -175.16 3.74 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.421 1.111 . . . . 2.9199999999999999 111.519 161.493 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -149.29 154.53 39.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.305 3.042 . . . . 3.1499999999999999 105.733 178.835 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.9 t -147.83 139.05 17.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 127.238 2.215 . . . . 1.3899999999999999 109.035 -176.233 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.15 149.76 25.63 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.795 1.238 . . . . 3.1600000000000001 110.998 176.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mp -132.16 134.24 45.17 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.192 1.397 . . . . 1.74 111.066 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -87.56 125.1 34.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.259 1.824 . . . . 2.1299999999999999 107.459 159.331 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 mp -98.29 131.51 44.55 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.102 1.361 . . . . 1.01 109.421 172.572 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.6 mt -107.19 120.04 41.03 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.0 1.32 . . . . 0.68000000000000005 109.589 -175.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -113.69 160.41 18.66 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.525 1.53 . . . . 1.9099999999999999 110.601 178.355 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.62 143.04 10.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.242 -0.89 . . . . 2.4900000000000002 111.605 170.19 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.88 -3.72 86.81 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 118.759 -1.023 . . . . 3.6299999999999999 114.37 -169.995 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.14 16.13 56.35 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.814 1.307 . . . . 2.8999999999999999 114.114 175.456 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -78.4 134.8 37.36 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.143 -1.21 . . . . 5.2999999999999998 112.557 -173.049 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.9 t -107.15 136.66 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.228 1.811 . . . . 2.1400000000000001 109.423 175.617 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.4 tp -141.17 133.62 28.37 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.115 0.966 . . . . 1.9099999999999999 111.502 174.873 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -79.93 126.41 30.98 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.669 0.618 . . . . 2.6499999999999999 112.669 177.763 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.3 t -114.74 164.48 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.334 1.854 . . . . 2.6800000000000002 108.355 157.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.6 t -146.61 140.36 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.893 1.677 . . . . 1.96 109.958 -176.027 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.3 mt -143.24 135.68 13.43 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 126.666 1.986 . . . . 2.4300000000000002 111.114 -167.584 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -73.97 159.1 45.3 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.113 2.542 . . . . 1.23 110.76 163.229 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.34 131.13 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.734 -0.839 . . . . 1.0900000000000001 108.734 167.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -153.12 146.94 25.25 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.461 1.105 . . . . 3.8100000000000001 113.359 -165.098 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.04 59.87 2.8 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 120.621 -1.299 . . . . 2.6099999999999999 111.697 171.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.8 mtm105 . . . . . 0 N--CA 1.478 0.959 0 C-N-CA 125.754 1.621 . . . . 7.8099999999999996 113.704 -179.963 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.992 0 N-CA-C 108.156 -1.978 . . . . 10.35 108.156 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m 52.74 -129.11 2.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 117.967 -1.016 . . . . 7.3799999999999999 111.452 -179.223 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -148.6 -173.96 4.48 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.409 1.459 . . . . 8.1099999999999994 112.329 167.529 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.3 p -78.45 62.95 3.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.074 1.35 . . . . 5.4299999999999997 110.353 175.628 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -78.99 60.54 2.94 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.353 1.861 . . . . 4.96 112.718 -172.044 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.18 179.69 19.21 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.331 1.443 . . . . 0.98999999999999999 113.09 176.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 23.2 p90 -155.46 169.58 23.92 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.845 1.424 . . . . 2.3900000000000001 114.845 -172.84 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.39 140.52 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 126.502 1.921 . . . . 1.3400000000000001 109.407 170.063 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -17.79 61.73 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.938 2.095 . . . . 6.1200000000000001 115.513 -174.203 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 4.3 t80 79.87 129.55 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.91 2.484 . . . . 2.4900000000000002 111.631 -177.405 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 t -175.77 142.85 0.65 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 129.378 3.071 . . . . 2.1099999999999999 107.774 174.358 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.08 -27.56 4.43 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.89 2.394 . . . . 1.4399999999999999 112.465 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.92 175.32 20.53 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.664 1.126 . . . . 0.82999999999999996 112.314 -174.545 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.57 -5.61 12.26 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 118.848 1.324 . . . . 0.93000000000000005 112.775 -4.35 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -147.26 160.98 41.86 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 123.435 1.588 . . . . 1.6499999999999999 114.358 -176.68 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.27 -176.93 4.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.74 2.816 . . . . 0.45000000000000001 110.454 -176.57 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.06 152.38 34.73 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.019 1.727 . . . . 0.76000000000000001 108.207 175.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.14 141.91 40.13 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.943 0.897 . . . . 0.64000000000000001 112.508 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 88.0 m-85 -105.87 74.33 1.05 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.129 2.172 . . . . 3.1200000000000001 108.776 174.026 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.425 HD13 HD11 ' A' ' 103' ' ' LEU . 2.3 pp -76.43 159.0 30.85 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.268 -0.895 . . . . 1.8799999999999999 111.43 -177.252 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 76' ' ' GLU . 28.5 m -140.25 147.25 39.7 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.431 1.092 . . . . 1.98 110.479 175.941 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.82 -178.11 5.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.346 2.258 . . . . 5.6299999999999999 108.69 169.907 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -140.45 123.93 16.97 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.807 -1.183 . . . . 4.5700000000000003 109.958 173.657 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -76.91 119.01 75.71 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.255 1.422 . . . . 1.5600000000000001 108.87 178.583 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.48 -17.99 33.9 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 121.974 1.783 . . . . 2.0 113.459 176.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.4 126.05 0.64 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 124.469 1.033 . . . . 2.8300000000000001 110.522 -163.847 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -178.66 -47.86 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.257 -2.497 . . . . 8.2699999999999996 104.257 -146.87 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -164.92 -171.21 0.25 Allowed Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 131.418 3.887 . . . . 4.6900000000000004 107.477 164.789 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.28 130.36 9.12 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 108.043 -1.56 . . . . 0.95999999999999996 108.043 159.592 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.486 HD12 ' CD1' ' A' ' 105' ' ' PHE . 2.8 mm? -91.86 156.52 17.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.691 1.234 . . . . 2.52 110.516 -175.835 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -153.47 107.04 2.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 113.736 -1.575 . . . . 1.77 111.571 -173.196 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.64 108.42 19.96 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.422 1.489 . . . . 2.4399999999999999 109.162 -171.395 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -106.66 -20.37 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 113.146 0.795 . . . . 0.68000000000000005 113.146 -169.829 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.49 -177.95 33.04 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 124.854 1.216 . . . . 0.41999999999999998 111.822 176.434 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.83 -179.51 5.44 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.819 0.848 . . . . 0.68999999999999995 111.18 171.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.42 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 1.9 mtt-85 -147.92 169.37 20.0 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.935 2.094 . . . . 3.8999999999999999 108.833 169.129 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.8 t 178.41 154.24 0.52 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.096 1.759 . . . . 0.85999999999999999 109.574 -171.105 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -89.39 -7.1 5.07 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.622 2.881 . . . . 0.72999999999999998 113.997 171.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.5 m -113.27 24.95 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 114.191 1.182 . . . . 0.88 114.191 -173.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.43 163.86 38.03 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.163 1.385 . . . . 0.81000000000000005 108.893 166.153 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -96.58 -30.84 13.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.141 1.776 . . . . 3.25 112.879 175.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 mtt85 -137.86 157.96 45.34 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.193 2.197 . . . . 5.2999999999999998 107.274 175.423 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 p -153.88 131.09 2.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 125.339 1.455 . . . . 1.1299999999999999 108.568 -176.145 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -140.16 133.14 29.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.199 0.999 . . . . 3.75 110.189 -160.066 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.3 tp -85.23 117.49 24.21 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.921 0.867 . . . . 1.3 111.436 -177.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.8 m170 -117.38 162.48 17.85 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.592 1.557 . . . . 0.62 112.859 176.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -113.11 -178.71 3.45 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.546 -1.661 . . . . 3.1800000000000002 110.801 163.885 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -148.67 135.65 20.0 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 106.594 -1.632 . . . . 1.27 106.594 172.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -131.71 169.03 16.75 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.275 1.43 . . . . 2.3300000000000001 113.138 -169.064 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.1 139.33 45.34 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.817 1.247 . . . . 5.7699999999999996 110.909 168.777 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -129.05 141.99 51.05 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.316 1.446 . . . . 5.4400000000000004 110.362 166.341 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -89.81 138.63 31.32 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.847 -1.168 . . . . 2.9399999999999999 107.847 154.317 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.0 t -133.94 116.14 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 106.43 -1.693 . . . . 2.4100000000000001 106.43 168.969 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.89 31.42 13.92 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.445 1.098 . . . . 5.0899999999999999 113.261 175.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.31 10.19 85.69 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 121.072 -1.018 . . . . 1.9399999999999999 114.112 -174.231 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -125.88 119.71 28.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.457 1.503 . . . . 3.0600000000000001 110.384 -173.312 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 135.16 35.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.265 1.426 . . . . 3.2799999999999998 111.472 -171.243 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.1 p -149.83 133.23 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 125.435 1.494 . . . . 2.9100000000000001 109.313 -178.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.7 mtp -83.8 165.43 18.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.532 0.682 . . . . 3.6200000000000001 111.657 177.33 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.59 178.65 27.89 Favored Glycine 0 C--O 1.224 -0.48 0 CA-C-N 115.357 -0.838 . . . . 0.87 111.717 170.086 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 ttm -147.07 143.15 28.13 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.833 1.653 . . . . 1.1299999999999999 107.4 -178.05 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -151.82 157.43 34.41 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.403 0.681 . . . . 4.8200000000000003 110.112 178.886 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.01 159.34 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.422 2.081 . . . . 0.56000000000000005 111.462 178.451 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.39 156.01 64.1 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.878 1.671 . . . . 0.58999999999999997 109.905 177.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.72 -24.83 2.14 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.855 2.37 . . . . 0.44 113.562 -167.029 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -176.34 169.87 2.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.497 1.919 . . . . 1.7 111.157 -178.667 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.99 154.37 26.57 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.068 1.347 . . . . 0.68999999999999995 110.554 159.583 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.19 142.09 46.2 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.614 1.565 . . . . 2.0800000000000001 108.003 173.762 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 t -143.65 128.9 9.78 Favored Pre-proline 0 N--CA 1.474 0.74 0 N-CA-C 112.458 0.54 . . . . 1.03 112.458 169.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.34 167.32 24.22 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.324 2.683 . . . . 0.91000000000000003 112.294 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.29 145.87 14.55 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.33 3.353 . . . . 1.1599999999999999 112.281 171.013 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt 73.49 -14.36 0.64 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.574 1.95 . . . . 3.1200000000000001 114.635 178.392 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.56 158.8 45.69 Favored Glycine 0 N--CA 1.472 1.088 0 CA-C-N 119.017 0.826 . . . . 1.3300000000000001 114.144 -168.149 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 mmt-85 -76.87 136.94 38.89 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.995 0.918 . . . . 4.0099999999999998 108.811 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.67 63.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.246 2.218 . . . . 5.6600000000000001 107.098 -174.158 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HB3' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -99.39 134.84 41.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.496 1.518 . . . . 3.6200000000000001 110.924 -177.756 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.32 94.15 8.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.185 -1.413 . . . . 1.8 107.185 164.416 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -46.12 115.83 3.2 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 117.638 -1.172 . . . . 2.5499999999999998 113.954 -168.964 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 30.0 Cg_endo -57.43 140.63 93.73 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.29 2.66 . . . . 3.71 112.536 176.734 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.56 -19.95 10.1 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.846 1.212 . . . . 2.73 114.343 -168.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.98 -98.7 1.73 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.003 1.402 . . . . 1.8300000000000001 113.331 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 77.6 m-85 -75.13 137.88 41.66 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 121.616 -0.932 . . . . 1.8300000000000001 111.756 -173.677 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -160.35 147.2 15.8 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.098 0.959 . . . . 0.59999999999999998 111.059 -174.262 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -82.39 127.24 33.06 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.089 -1.078 . . . . 2.1899999999999999 108.089 166.054 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -77.09 143.44 39.23 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.531 1.532 . . . . 0.92000000000000004 108.667 164.945 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.9 mt -128.3 112.14 14.14 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.983 1.313 . . . . 1.97 108.782 -173.45 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.5 132.21 56.37 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.494 1.117 . . . . 2.4300000000000002 109.954 -166.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.24 47.08 7.72 Favored Glycine 0 N--CA 1.472 1.095 0 C-N-CA 124.022 0.82 . . . . 1.8 113.965 173.191 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.5 mt -49.86 153.48 1.28 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 117.119 2.266 . . . . 0.66000000000000003 117.119 -173.596 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -117.3 -33.35 4.67 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.354 -1.748 . . . . 1.9399999999999999 113.399 -174.713 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -105.32 133.4 20.18 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 106.786 -1.561 . . . . 6.1100000000000003 106.786 156.404 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.15 135.01 28.48 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 N-CA-C 107.148 -1.904 . . . . 1.3899999999999999 107.148 156.623 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.23 157.99 16.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.347 0.594 . . . . 2.4399999999999999 111.05 -177.015 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.406 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -158.85 162.71 37.0 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.182 2.193 . . . . 4.4500000000000002 111.531 170.089 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.77 140.46 58.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.798 1.239 . . . . 1.1299999999999999 110.232 -175.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.79 48.41 28.14 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.416 -1.265 . . . . 1.9299999999999999 111.777 -170.158 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.26 176.49 7.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.762 1.225 . . . . 2.5600000000000001 108.524 153.911 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -137.38 162.1 34.51 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 127.657 2.383 . . . . 4.25 107.59 161.297 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 t -153.83 154.1 7.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 127.773 2.429 . . . . 1.51 110.088 -175.505 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -83.22 140.1 32.73 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 123.13 1.443 . . . . 3.6400000000000001 113.931 161.049 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mp -109.97 167.93 9.81 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.143 -1.39 . . . . 1.8899999999999999 108.526 148.95 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 62.3 m-20 -130.22 140.8 50.69 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.689 2.396 . . . . 2.5499999999999998 108.406 176.539 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.425 HD11 HD13 ' A' ' 20' ' ' LEU . 9.5 mp -103.26 127.37 50.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.252 1.421 . . . . 1.1699999999999999 109.735 175.528 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 mt -100.3 106.75 18.42 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.495 1.118 . . . . 0.68000000000000005 108.693 175.291 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.486 ' CD1' HD12 ' A' ' 30' ' ' LEU . 98.4 m-85 -97.86 125.23 42.63 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.036 0.934 . . . . 2.1600000000000001 111.629 177.933 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.56 15.06 0.45 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.894 2.077 . . . . 2.5099999999999998 115.36 176.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.59 -7.5 79.71 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.661 1.6 . . . . 4.9500000000000002 115.773 -178.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -134.53 -37.72 0.21 Allowed Glycine 0 N--CA 1.477 1.39 0 CA-C-N 119.438 1.619 . . . . 2.1400000000000001 116.483 -172.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -85.63 107.74 17.67 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.486 -1.596 . . . . 4.1799999999999997 110.851 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.0 t -99.73 132.86 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.94 0.896 . . . . 2.04 110.731 178.163 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.02 127.28 30.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 2.9500000000000002 111.868 172.383 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -79.88 141.67 35.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.711 1.604 . . . . 2.6800000000000002 114.174 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.61 164.18 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 127.989 2.516 . . . . 2.5800000000000001 109.91 170.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.4 t -135.16 132.66 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 106.647 -1.612 . . . . 1.6899999999999999 106.647 156.56 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.81 145.83 20.62 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.684 1.194 . . . . 2.2999999999999998 111.115 -167.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.61 161.69 39.23 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.552 2.835 . . . . 1.02 112.51 176.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.9 t -95.53 128.9 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.636 1.174 . . . . 1.04 110.025 164.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -142.79 -179.05 6.1 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.283 2.633 . . . . 3.0499999999999998 109.031 -173.309 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.22 109.58 12.48 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.041 -1.037 . . . . 3.27 109.953 162.843 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 129.165 2.986 . . . . 7.0800000000000001 108.519 -161.413 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.872 0 N-CA-C 107.9 -2.08 . . . . 13.789999999999999 107.9 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.3 p -159.46 -15.87 0.06 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.119 2.168 . . . . 10.130000000000001 113.413 174.66 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.88 33.84 0.3 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.705 1.139 . . . . 7.5 113.71 -159.106 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.9 p -71.37 70.03 0.59 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.761 1.224 . . . . 6.21 112.076 170.639 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -76.4 76.79 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.047 1.339 . . . . 4.6100000000000003 109.361 173.408 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.64 154.17 25.15 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.221 1.391 . . . . 1.45 113.612 171.031 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.456 ' CD2' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -83.66 156.92 22.41 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.953 1.701 . . . . 7.9199999999999999 114.458 173.092 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -84.62 55.63 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 122.794 1.283 . . . . 3.02 110.19 165.431 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.456 ' HA ' ' CD2' ' A' ' 7' ' ' TRP 0.286 0.2 OUTLIER 27.58 -121.32 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 128.438 2.695 . . . . 5.25 115.043 -169.15 . . . . . . . . 4 4 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -166.35 131.3 2.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.346 1.458 . . . . 2.8100000000000001 109.182 -179.115 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -175.84 138.56 0.53 Allowed Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.96 1.304 . . . . 2.1600000000000001 110.306 -176.243 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.34 -38.85 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.666 2.244 . . . . 1.55 111.519 164.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.23 173.32 23.83 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.426 1.965 . . . . 1.1899999999999999 111.049 -173.544 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -77.76 2.44 25.93 Favored 'Cis proline' 0 CA--C 1.542 0.885 0 CA-C-N 119.559 1.679 . . . . 1.3400000000000001 112.722 -4.685 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -151.14 160.94 43.58 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 123.14 1.448 . . . . 2.0099999999999998 113.561 -175.158 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.69 -175.99 4.49 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.183 2.193 . . . . 0.41999999999999998 111.765 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.8 148.06 30.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.443 1.897 . . . . 0.72999999999999998 108.243 176.187 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.82 127.58 52.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.558 1.072 . . . . 0.81999999999999995 109.968 179.09 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.477 ' CE2' ' HA ' ' A' ' 79' ' ' PRO . 56.6 m-85 -116.2 78.93 1.24 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.054 1.341 . . . . 2.6400000000000001 109.59 -176.089 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -82.14 152.69 26.39 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.53 0.732 . . . . 2.4100000000000001 112.374 -179.387 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.1 m -84.1 130.71 34.84 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.675 -1.231 . . . . 1.8799999999999999 107.675 157.633 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.4 tp -96.7 133.3 41.41 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.071 -0.344 . . . . 4.3600000000000003 110.071 -179.533 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -124.69 129.29 50.24 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.629 1.172 . . . . 6.2000000000000002 112.215 -175.195 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -107.14 99.61 27.92 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.351 -0.843 . . . . 1.6399999999999999 110.506 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -81.16 -12.87 11.56 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.075 2.517 . . . . 1.6899999999999999 113.564 175.888 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.74 179.68 51.3 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.567 1.08 . . . . 1.6799999999999999 112.226 -175.963 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -105.05 0.45 27.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.115 2.166 . . . . 3.23 112.124 -174.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.12 161.08 51.6 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 128.363 2.665 . . . . 2.9300000000000002 109.665 176.377 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.32 143.29 27.91 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.168 1.912 . . . . 1.3899999999999999 110.995 -175.188 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.33 150.1 24.77 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.801 1.241 . . . . 2.46 109.558 171.142 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -136.56 97.18 3.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.316 -1.766 . . . . 2.3199999999999998 110.24 -174.718 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 tt -80.29 115.42 19.83 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.092 -1.077 . . . . 1.79 108.092 -175.626 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.81 -31.38 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.605 1.162 . . . . 0.75 112.58 -176.905 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.3 177.26 35.06 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 124.716 1.15 . . . . 0.67000000000000004 113.939 175.681 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.468 ' O ' HG11 ' A' ' 43' ' ' VAL . . . -124.38 160.13 28.83 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.821 -0.811 . . . . 1.25 110.549 169.147 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -130.52 157.36 42.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.458 1.903 . . . . 4.4699999999999998 108.432 167.314 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.5 t -165.71 148.31 6.56 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.152 1.781 . . . . 0.88 108.683 175.092 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -73.05 -19.71 22.65 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.521 1.481 . . . . 0.89000000000000001 113.609 -176.259 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 m -90.86 12.57 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 115.799 1.777 . . . . 0.84999999999999998 115.799 -176.058 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.28 155.39 38.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.518 1.303 . . . . 0.90000000000000002 114.518 173.382 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -92.1 -43.92 9.11 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.988 -1.005 . . . . 3.3799999999999999 113.695 -167.11 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -138.69 123.47 18.72 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.884 1.274 . . . . 6.0999999999999996 107.751 -167.362 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 35' ' ' ALA . 5.3 p -126.15 132.8 70.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.209 1.404 . . . . 1.29 109.479 -166.712 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -120.47 157.87 28.45 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.148 1.379 . . . . 3.1000000000000001 109.441 169.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.2 tp -105.58 117.69 34.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.798 1.239 . . . . 0.94999999999999996 108.686 169.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -118.89 147.61 43.8 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.122 1.369 . . . . 0.72999999999999998 113.533 -175.33 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.11 177.23 6.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.185 1.794 . . . . 2.3700000000000001 110.608 161.057 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -153.39 140.95 19.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.992 -1.855 . . . . 0.96999999999999997 105.992 174.434 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -153.43 173.18 16.01 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.243 1.201 . . . . 2.1000000000000001 114.243 -165.776 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.47 134.83 50.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.659 1.584 . . . . 5.5599999999999996 111.534 170.79 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.45 155.46 44.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.232 1.413 . . . . 6.1100000000000003 110.653 171.64 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -86.91 141.17 28.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.97 -0.752 . . . . 2.8700000000000001 108.97 157.864 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.9 t -135.69 115.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.165 1.786 . . . . 2.54 106.277 165.482 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 56.09 41.09 30.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.632 1.173 . . . . 4.7699999999999996 113.737 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.47 6.18 65.28 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.723 -1.236 . . . . 1.9299999999999999 114.281 -177.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -118.08 126.48 52.35 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.978 2.111 . . . . 2.7799999999999998 108.117 -178.017 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -76.86 121.93 24.1 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.921 1.289 . . . . 3.6000000000000001 109.533 -173.771 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.45 132.88 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.317 1.847 . . . . 2.4199999999999999 109.129 -174.295 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtt -80.55 166.66 20.94 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.154 0.798 . . . . 2.3599999999999999 113.154 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.97 177.07 32.43 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.1 0.857 . . . . 0.92000000000000004 113.426 179.246 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.5 ttm -155.93 140.56 16.96 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.524 1.529 . . . . 1.1200000000000001 109.707 -176.059 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -145.02 156.8 54.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.622 1.969 . . . . 8.8100000000000005 109.218 -176.597 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.46 151.97 15.44 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.761 2.308 . . . . 0.89000000000000001 110.629 170.677 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.25 155.51 79.84 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.477 1.511 . . . . 0.68999999999999995 110.449 -179.04 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.29 -27.59 3.47 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.945 2.43 . . . . 0.84999999999999998 113.094 -166.585 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -175.68 167.09 3.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.566 1.546 . . . . 2.2000000000000002 111.752 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.0 mt -113.27 153.31 28.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.469 1.908 . . . . 0.78000000000000003 110.355 166.166 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -117.14 142.77 46.59 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.879 1.272 . . . . 1.9099999999999999 109.434 176.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.3 t -140.97 128.49 12.09 Favored Pre-proline 0 N--CA 1.472 0.657 0 N-CA-C 112.436 0.532 . . . . 1.28 112.436 168.004 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.84 159.89 44.37 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.979 3.12 . . . . 1.4399999999999999 112.159 178.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.1 144.13 99.5 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.945 3.097 . . . . 1.6799999999999999 113.34 -176.198 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mptt 67.3 -9.56 0.39 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.589 2.356 . . . . 2.6200000000000001 114.483 -177.136 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.51 134.92 14.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.41 1.005 . . . . 1.6599999999999999 112.656 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.22 135.67 41.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.77 -0.826 . . . . 4.1699999999999999 108.77 155.948 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -147.07 129.53 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.031 1.732 . . . . 4.0199999999999996 107.65 -174.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -94.54 150.55 20.13 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.348 -0.845 . . . . 2.8599999999999999 112.565 -167.2 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.24 84.83 2.42 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.081 -1.451 . . . . 2.0099999999999998 107.081 156.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.428 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -64.08 145.5 97.94 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 120.949 -1.094 . . . . 2.71 113.261 -171.482 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.477 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 20.8 Cg_endo -55.36 -38.73 93.61 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.459 3.439 . . . . 2.1699999999999999 113.582 -174.421 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.14 24.3 19.54 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.199 -1.89 . . . . 2.2599999999999998 115.503 175.612 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.47 -15.11 0.02 OUTLIER Glycine 0 N--CA 1.476 1.315 0 N-CA-C 121.342 3.297 . . . . 2.2999999999999998 121.342 171.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -149.11 145.92 27.45 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 122.118 2.959 . . . . 2.1099999999999999 114.336 174.66 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -162.05 158.3 24.72 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.894 1.278 . . . . 0.68000000000000005 112.709 172.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -79.09 142.03 36.82 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.391 -0.818 . . . . 2.27 109.597 157.139 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 tpt -99.35 125.79 45.09 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.107 2.163 . . . . 1.1100000000000001 108.471 169.593 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mp -120.3 112.57 19.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.909 1.283 . . . . 1.4099999999999999 109.051 -173.08 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.15 155.33 18.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.242 1.417 . . . . 2.1299999999999999 110.928 -174.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.24 -48.82 3.99 Favored Glycine 0 N--CA 1.469 0.852 0 C-N-CA 126.822 2.153 . . . . 2.9900000000000002 113.05 173.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.9 mt 51.34 172.67 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.903 2.881 . . . . 0.82999999999999996 115.198 -172.105 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -137.9 -22.56 1.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.544 2.338 . . . . 2.5499999999999998 113.467 -176.75 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -137.63 143.99 42.91 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 128.566 2.747 . . . . 4.9400000000000004 109.178 175.892 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.43 145.38 37.96 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.31 2.007 . . . . 1.6000000000000001 108.351 155.062 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.64 119.6 39.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.851 0.86 . . . . 2.1699999999999999 111.203 -177.724 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -85.29 170.06 13.17 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.88 0.848 . . . . 3.8500000000000001 112.197 169.031 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.67 136.81 58.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.819 -0.628 . . . . 1.8100000000000001 109.32 157.715 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.79 9.51 87.01 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.291 -1.283 . . . . 1.75 114.954 174.247 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.63 173.06 10.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.982 1.391 . . . . 3.1400000000000001 108.792 160.359 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -145.47 151.68 38.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.64 2.376 . . . . 3.3599999999999999 106.869 169.726 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.4 t -153.08 139.87 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 127.105 2.162 . . . . 1.53 109.664 -176.166 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.21 144.29 34.53 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.489 0.922 . . . . 2.4700000000000002 113.489 173.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.1 mp -120.38 148.01 44.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.555 1.542 . . . . 1.8700000000000001 110.874 165.078 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.99 117.28 34.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.706 2.003 . . . . 2.8399999999999999 110.616 164.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -85.73 114.8 22.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.633 1.173 . . . . 1.3700000000000001 108.745 176.102 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.8 mt -90.91 114.03 26.39 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.646 1.178 . . . . 1.01 108.91 -175.665 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -113.07 117.22 31.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.613 1.565 . . . . 1.9399999999999999 112.495 -171.806 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 54.04 26.62 6.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.512 1.525 . . . . 2.1400000000000001 113.736 171.334 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.5 -68.93 2.64 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.144 1.354 . . . . 4.3799999999999999 112.351 -172.535 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.25 2.28 62.15 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 116.571 1.388 . . . . 1.8100000000000001 116.571 -166.267 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -129.44 139.04 51.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.445 1.623 . . . . 2.8500000000000001 111.078 173.529 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -137.74 142.47 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.425 1.49 . . . . 2.1699999999999999 108.196 176.73 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.3 tp -154.43 110.97 3.29 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.252 0.549 . . . . 2.27 112.279 -166.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -82.76 152.29 25.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.851 1.056 . . . . 2.1899999999999999 113.851 -170.7 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.14 167.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.128 1.771 . . . . 2.3999999999999999 110.291 178.3 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.26 138.58 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.307 1.043 . . . . 1.9299999999999999 109.744 -177.464 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.7 mp -130.17 134.16 25.78 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.038 1.735 . . . . 2.7000000000000002 110.744 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.63 177.71 7.68 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.298 2.665 . . . . 1.0 111.562 170.317 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 t -118.28 95.84 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.033 0.933 . . . . 1.1699999999999999 108.65 164.321 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.44 60.21 2.22 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 121.21 -0.931 . . . . 5.5999999999999996 113.282 -169.252 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.43 117.32 19.53 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.659 -0.651 . . . . 4.9199999999999999 112.3 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 126.591 1.956 . . . . 8.3300000000000001 111.028 -173.034 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.779 0 N-CA-C 107.715 -2.154 . . . . 8.4100000000000001 107.715 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 m -65.45 103.18 0.79 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.94 -1.133 . . . . 9.2400000000000002 107.94 157.91 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 70.46 123.95 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.089 2.156 . . . . 10.18 110.6 -154.577 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -119.68 -29.96 4.92 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.363 1.865 . . . . 5.4900000000000002 110.307 168.283 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -95.92 174.84 6.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.326 1.45 . . . . 9.2599999999999998 110.457 164.706 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.97 -171.98 13.6 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.087 2.28 . . . . 1.6499999999999999 110.78 177.358 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -121.81 178.27 4.93 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.004 1.483 . . . . 2.1699999999999999 115.004 -179.718 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.06 142.09 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.124 2.17 . . . . 1.47 107.106 172.217 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -79.36 -93.59 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.17 0.588 . . . . 7.2999999999999998 110.852 -178.697 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -161.59 150.56 15.94 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.92 -1.113 . . . . 3.3300000000000001 111.738 -170.941 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.16 127.73 25.8 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.523 1.129 . . . . 3.9900000000000002 111.444 176.215 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.49 -49.52 0.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 N-CA-C 109.126 -1.144 . . . . 4.0 109.126 154.143 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.04 141.3 9.33 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 108.872 -1.691 . . . . 1.4199999999999999 108.872 -155.171 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -86.91 14.93 44.17 Favored 'Cis proline' 0 CA--C 1.54 0.814 0 CA-C-N 120.308 2.054 . . . . 1.1899999999999999 112.63 5.166 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -144.22 171.54 14.15 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.343 1.238 . . . . 2.2599999999999998 114.343 -172.12 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.99 -177.03 6.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.03 2.532 . . . . 0.62 112.897 -176.443 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.0 141.46 22.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.657 1.583 . . . . 0.72999999999999998 110.122 177.537 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.24 153.61 36.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 0.66000000000000003 111.325 178.797 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -139.26 59.3 1.61 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.445 1.898 . . . . 2.1099999999999999 111.636 -168.368 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.86 167.37 17.46 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.612 1.338 . . . . 1.8100000000000001 114.612 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.3 m -101.41 146.46 27.58 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.84 1.656 . . . . 1.6599999999999999 110.628 -177.935 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.2 117.66 30.19 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.506 1.122 . . . . 4.0 110.012 172.783 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -123.23 128.35 49.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.961 -1.496 . . . . 4.2800000000000002 106.961 163.64 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -97.41 106.21 30.91 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.528 0.731 . . . . 1.3600000000000001 110.575 -179.473 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -84.58 -11.68 8.0 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.602 2.201 . . . . 1.0900000000000001 114.431 178.132 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.55 166.74 34.73 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 119.406 1.003 . . . . 1.2 111.422 -176.819 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.04 2.85 53.42 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.757 2.023 . . . . 3.3399999999999999 112.308 175.401 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -113.15 155.53 44.25 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.814 2.046 . . . . 3.3300000000000001 110.799 174.536 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -79.47 142.47 16.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.427 2.085 . . . . 0.92000000000000004 110.69 -178.08 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.91 142.61 30.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.903 0.859 . . . . 2.5899999999999999 109.575 172.513 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -138.02 106.15 5.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.608 1.963 . . . . 2.3500000000000001 108.724 178.135 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.47 106.16 18.2 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 128.31 2.644 . . . . 1.95 107.863 -170.27 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.3 m -104.35 -21.55 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.912 0.708 . . . . 0.69999999999999996 112.912 -167.434 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.41 -174.89 28.7 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.839 1.209 . . . . 0.62 112.395 175.398 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.36 179.7 6.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.639 0.733 . . . . 0.75 112.974 170.678 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -144.81 158.57 43.74 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.823 2.049 . . . . 4.96 107.873 161.905 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 t -164.6 145.2 6.34 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 125.717 1.607 . . . . 0.81999999999999995 108.542 175.324 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.24 -2.84 12.89 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.695 1.597 . . . . 1.1399999999999999 113.982 -175.914 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.6 m -107.03 11.98 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 116.174 1.916 . . . . 1.3300000000000001 116.174 -174.163 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.05 156.43 46.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.423 1.465 . . . . 1.22 113.283 177.377 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -86.41 -31.07 21.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.683 1.193 . . . . 3.1800000000000002 111.598 173.408 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -140.61 147.4 39.32 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.004 1.322 . . . . 4.6100000000000003 109.332 166.801 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.38 141.99 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.858 1.663 . . . . 0.98999999999999999 108.392 161.629 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -140.37 137.68 34.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.317 1.447 . . . . 2.9399999999999999 108.293 -171.449 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.3 tp -99.5 111.98 24.25 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.371 -0.831 . . . . 0.92000000000000004 111.922 -170.964 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -118.92 155.64 30.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.962 1.305 . . . . 0.76000000000000001 113.236 -176.614 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 9.4 pt-20 -100.25 176.51 5.35 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.579 1.552 . . . . 1.9099999999999999 112.187 159.951 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.3 m -143.64 136.27 27.26 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.1 -1.815 . . . . 1.2 106.1 165.085 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -138.77 164.65 29.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.97 1.308 . . . . 1.97 112.675 -165.672 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.5 ttp -99.42 142.64 30.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.929 1.292 . . . . 3.6899999999999999 109.943 170.931 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -142.75 145.16 33.04 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.903 1.681 . . . . 7.9800000000000004 111.278 173.22 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.93 141.39 34.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.466 1.106 . . . . 3.6699999999999999 109.903 158.768 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.3 t -138.44 121.19 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.159 1.783 . . . . 2.4500000000000002 106.4 170.699 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 62.39 15.98 8.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.506 1.522 . . . . 3.3700000000000001 114.011 -173.292 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.67 16.36 66.08 Favored Glycine 0 N--CA 1.477 1.402 0 O-C-N 120.979 -1.076 . . . . 2.1899999999999999 113.871 -170.356 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -121.37 121.11 36.91 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.686 2.395 . . . . 2.3300000000000001 108.394 -179.097 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.87 139.65 48.94 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.379 -1.45 . . . . 3.73 113.178 178.028 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.7 p -155.26 169.7 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 128.246 2.618 . . . . 2.52 108.347 176.762 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.0 mtm -100.29 172.1 7.37 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.787 -1.195 . . . . 3.8399999999999999 113.31 176.795 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.49 174.04 31.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.688 2.09 . . . . 0.60999999999999999 111.355 166.967 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ttm -136.43 153.73 50.99 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.33 1.852 . . . . 1.1599999999999999 108.08 175.948 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -159.13 156.06 25.41 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-O 118.076 -0.964 . . . . 4.6900000000000004 111.082 175.891 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.96 155.5 52.95 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.432 2.088 . . . . 0.56000000000000005 110.849 170.446 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -141.1 159.5 61.4 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 125.637 1.575 . . . . 0.84999999999999998 110.38 -175.199 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -82.19 -27.12 2.5 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.432 2.088 . . . . 0.67000000000000004 113.134 -168.412 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -177.59 164.82 2.08 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.378 1.471 . . . . 2.4199999999999999 112.171 -177.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.1 mt -107.94 160.21 15.94 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.93 1.292 . . . . 0.94999999999999996 110.376 160.272 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -145.15 147.58 32.65 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.235 -0.916 . . . . 2.04 111.521 -179.567 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.3 t -143.25 131.0 10.99 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.086 0.954 . . . . 1.1399999999999999 111.736 176.018 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.42 162.15 42.29 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 124.175 3.25 . . . . 0.90000000000000002 112.457 179.122 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -59.49 135.47 64.99 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.215 3.277 . . . . 0.97999999999999998 113.08 -177.419 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.55 -5.36 0.62 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.927 2.091 . . . . 1.8899999999999999 114.508 -179.51 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.84 167.92 51.86 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.917 1.722 . . . . 1.28 112.589 171.518 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.86 151.74 40.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.53 0.732 . . . . 5.8700000000000001 112.22 174.623 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 76' ' ' GLU . 29.7 t -146.83 -178.81 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 128.021 2.529 . . . . 3.5600000000000001 107.784 -178.498 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.48 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -146.83 154.52 41.44 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.347 1.859 . . . . 3.6200000000000001 108.206 171.191 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.7 mp -51.19 -38.88 54.81 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 123.048 0.539 . . . . 3.0600000000000001 111.899 175.788 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm 101.14 118.19 0.01 OUTLIER Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 127.773 2.429 . . . . 2.3300000000000001 109.906 161.605 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.24 -16.36 54.57 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.114 2.543 . . . . 2.7599999999999998 116.181 -161.06 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -115.34 7.16 20.89 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.655 1.121 . . . . 2.75 114.946 169.884 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.62 -110.09 1.93 Allowed Glycine 0 N--CA 1.47 0.915 0 C-N-CA 125.839 1.685 . . . . 2.1499999999999999 113.263 -171.123 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 60.2 m-85 -73.1 147.95 44.45 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 123.378 1.561 . . . . 2.1099999999999999 111.773 -175.873 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -159.68 142.39 13.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.579 -1.646 . . . . 0.97999999999999998 111.045 -178.24 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -79.88 111.24 16.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.972 -1.122 . . . . 2.0699999999999998 107.972 165.424 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.7 tpt -77.03 120.9 22.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.343 2.257 . . . . 1.0600000000000001 107.908 175.111 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.3 mt -109.74 122.22 47.0 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.272 1.429 . . . . 2.21 109.035 -173.206 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.98 143.76 46.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.691 1.196 . . . . 2.1899999999999999 111.415 -170.093 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.33 -43.22 2.85 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 127.248 2.356 . . . . 2.9300000000000002 113.955 175.519 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.8 mt 56.77 168.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 129.698 3.199 . . . . 1.05 115.637 -176.284 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -123.97 -30.83 3.46 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.97 1.708 . . . . 1.76 112.427 173.658 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -127.66 140.22 37.46 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 128.932 2.893 . . . . 5.7599999999999998 107.612 166.219 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.81 59.19 0.9 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.376 2.717 . . . . 2.79 112.717 -165.341 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -33.73 106.2 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 116.566 2.061 . . . . 3.0299999999999998 116.566 -157.704 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -100.95 168.63 9.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.265 1.826 . . . . 8.1300000000000008 111.043 169.047 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.69 134.2 50.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.93 0.892 . . . . 1.3400000000000001 110.724 -176.555 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.72 -6.33 52.05 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.26 1.886 . . . . 1.52 114.376 -175.331 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.59 -175.1 5.58 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.985 1.314 . . . . 2.9300000000000002 112.106 170.769 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.7 142.02 23.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 128.543 2.737 . . . . 6.5 107.247 -173.415 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 t -142.79 124.4 12.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 124.004 0.921 . . . . 1.74 110.68 -168.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -98.64 129.53 45.14 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.903 -1.044 . . . . 2.7400000000000002 110.707 -178.573 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.11 137.9 53.27 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.193 1.797 . . . . 2.52 110.3 179.091 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -97.92 124.2 42.25 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.324 2.25 . . . . 1.8 108.889 170.402 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.15 115.66 27.98 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.797 1.239 . . . . 0.98999999999999999 109.756 178.407 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.89 101.5 13.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.222 -0.658 . . . . 0.76000000000000001 109.222 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -94.29 136.9 34.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.161 0.984 . . . . 2.04 111.097 176.669 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.97 125.88 13.03 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.706 1.202 . . . . 2.04 113.449 -174.566 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.68 70.51 1.28 Allowed Glycine 0 N--CA 1.47 0.951 0 C-N-CA 124.259 0.933 . . . . 3.71 112.897 177.54 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.72 5.99 58.1 Favored Glycine 0 N--CA 1.474 1.224 0 N-CA-C 116.485 1.354 . . . . 1.6100000000000001 116.485 164.498 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -98.51 127.12 44.31 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.395 1.598 . . . . 3.52 109.878 -179.794 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.24 142.92 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.3 1.04 . . . . 2.2000000000000002 109.01 179.865 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.0 tt -152.5 135.98 15.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.336 1.455 . . . . 2.0 109.208 -177.841 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -102.1 140.42 36.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.354 0.662 . . . . 3.2400000000000002 112.433 -179.485 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.8 t -127.84 162.7 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 127.109 2.164 . . . . 1.76 108.311 175.575 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.9 t -128.33 141.25 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.397 1.479 . . . . 1.95 110.436 -178.662 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.3 mt -136.45 124.66 15.0 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.693 1.197 . . . . 2.2599999999999998 109.848 -164.957 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.67 149.36 48.72 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.048 1.832 . . . . 0.88 110.244 173.767 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.0 t -90.94 117.35 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.861 -0.792 . . . . 0.93000000000000005 108.861 167.792 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -137.8 123.71 20.11 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.12 -1.067 . . . . 4.04 108.12 175.25 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.18 58.23 2.46 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.093 0.557 . . . . 2.1000000000000001 111.781 -179.278 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.907 0 C-N-CA 126.263 1.825 . . . . 8.2100000000000009 112.107 -179.224 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 . . . . . 0 CA--C 1.544 0.729 0 CA-C-O 121.237 0.541 . . . . 4.65 112.038 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.68 179.32 35.33 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.65 1.119 . . . . 1.28 114.869 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -146.25 146.33 30.72 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.134 1.374 . . . . 2.41 112.721 162.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -86.57 149.76 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.711 1.204 . . . . 1.44 108.236 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -84.49 149.95 25.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.852 1.31 . . . . 3.82 113.162 -176.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.416 ' H ' ' HD3' ' A' ' 9' ' ' ARG . 64.7 t80 -76.36 134.05 39.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.56 2.744 . . . . 2.11 110.823 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.1 t 175.62 135.59 0.18 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.912 1.685 . . . . 2.37 112.058 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.58 -24.85 21.61 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.441 2.094 . . . . 1.39 112.506 170.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.2 171.59 12.27 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 127.074 2.273 . . . . 0.85 111.375 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.65 -8.21 39.71 Favored 'Cis proline' 0 CA--C 1.538 0.692 0 CA-C-N 118.886 1.343 . . . . 0.92 113.307 0.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -144.2 157.81 44.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.968 1.307 . . . . 1.86 113.44 -172.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.02 -175.74 4.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.023 3.329 . . . . 0.43 108.473 -176.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.34 176.81 8.37 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.155 1.382 . . . . 1.06 109.173 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.8 138.17 19.49 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.685 1.13 . . . . 0.53 112.327 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 17.7 m-85 -119.02 137.51 53.48 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.256 2.222 . . . . 2.07 108.262 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -168.35 148.37 4.67 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.324 1.05 . . . . 1.67 111.707 -172.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -89.53 122.21 32.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.923 0.889 . . . . 1.76 111.172 -176.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.401 HD11 ' CZ ' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -102.58 120.3 40.3 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.077 1.351 . . . . 3.1 108.765 -177.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -122.13 141.75 51.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.527 1.131 . . . . 3.9 111.3 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -117.05 108.94 43.31 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.393 1.077 . . . . 1.46 110.659 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.78 -10.99 10.4 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.939 2.426 . . . . 1.16 113.848 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.25 175.88 49.93 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-O 122.787 1.215 . . . . 1.17 113.224 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -99.41 -3.83 32.87 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.327 2.651 . . . . 3.0 111.43 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -122.37 157.27 59.23 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 128.336 2.654 . . . . 2.67 109.883 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.0 145.8 31.86 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.788 2.325 . . . . 0.93 111.137 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.1 mt -105.83 157.08 17.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 122.716 1.246 . . . . 1.93 109.959 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -147.99 110.71 4.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.789 -2.005 . . . . 2.24 112.724 -170.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.99 107.37 19.16 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.447 1.899 . . . . 1.87 109.297 -173.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 m -103.71 -24.55 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.209 1.003 . . . . 0.67 112.949 -168.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.34 -177.61 32.58 Favored Glycine 0 N--CA 1.466 0.686 0 C-N-CA 125.387 1.47 . . . . 0.49 112.095 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.06 -178.84 5.27 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.057 -0.672 . . . . 0.56 111.648 169.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.8 mtp-105 -144.32 177.07 8.89 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.237 1.815 . . . . 3.82 108.273 158.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 t -172.92 152.31 2.36 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.158 1.783 . . . . 0.72 109.517 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.39 -7.52 15.98 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.134 1.889 . . . . 0.81 114.172 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.8 m -113.63 24.29 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 115.969 1.84 . . . . 0.78 115.969 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.06 143.18 19.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.677 1.591 . . . . 0.88 110.977 169.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -68.87 -33.23 73.44 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.661 1.584 . . . . 3.12 112.862 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -137.91 159.89 40.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.965 2.106 . . . . 4.47 108.843 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.69 143.49 30.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.026 1.33 . . . . 0.93 108.407 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -123.21 149.77 44.25 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.665 1.986 . . . . 2.67 109.055 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.8 tp -102.3 121.75 42.89 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.573 0.749 . . . . 0.88 110.389 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -125.06 159.6 31.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 123.603 1.668 . . . . 0.49 113.921 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -104.61 159.51 15.7 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.831 2.452 . . . . 2.13 110.976 158.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.3 m -128.49 148.36 50.74 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 105.906 -1.887 . . . . 0.73 105.906 165.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -159.97 175.89 12.49 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.992 0.917 . . . . 2.23 112.857 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.8 ttp -111.65 136.36 50.98 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.342 1.457 . . . . 3.3 111.282 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -120.54 159.92 24.24 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.346 1.858 . . . . 4.75 110.611 171.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -90.68 147.99 22.91 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.451 0.7 . . . . 2.27 109.503 151.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.8 t -138.79 118.78 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.579 1.552 . . . . 2.28 106.915 157.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 61.09 25.68 15.67 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.758 1.392 . . . . 3.33 114.758 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.34 4.68 90.09 Favored Glycine 0 N--CA 1.481 1.647 0 O-C-N 120.044 -1.66 . . . . 1.79 113.984 -171.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -105.54 120.14 40.89 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.587 2.355 . . . . 2.51 107.885 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -71.54 113.83 8.98 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.693 1.597 . . . . 2.64 109.778 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.1 t -140.46 133.72 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.402 1.481 . . . . 2.15 109.518 -172.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.7 mtt -79.5 171.88 14.56 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.347 1.24 . . . . 2.54 114.347 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.82 168.18 29.94 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.364 1.935 . . . . 0.79 112.226 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.0 ttm -149.08 145.37 27.21 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.697 1.599 . . . . 1.09 108.95 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -148.06 152.9 40.93 Favored Pre-proline 0 N--CA 1.467 0.4 0 C-N-CA 125.121 1.368 . . . . 4.42 109.853 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.24 154.28 41.28 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.103 1.869 . . . . 0.5 110.742 163.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.05 157.95 70.45 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 125.768 1.627 . . . . 0.61 110.309 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.22 -26.74 2.66 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.024 2.483 . . . . 0.59 113.32 -167.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -177.43 164.54 2.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.662 1.585 . . . . 2.05 111.763 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.2 mt -110.86 153.09 25.91 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.094 1.358 . . . . 0.73 110.404 164.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -110.96 147.05 35.52 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.049 1.339 . . . . 2.05 109.895 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.62 121.44 17.24 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 123.363 0.665 . . . . 1.41 111.195 163.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.14 159.05 54.47 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.222 2.614 . . . . 1.19 111.424 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.5 138.98 83.84 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.605 2.87 . . . . 0.94 112.319 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt 65.63 -3.64 0.68 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.484 1.914 . . . . 1.7 114.032 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.08 -176.64 34.82 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 126.971 2.224 . . . . 1.16 113.2 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -147.83 152.85 38.36 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.246 1.019 . . . . 3.5 112.406 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.81 134.24 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.805 1.642 . . . . 3.49 107.735 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 143.82 31.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.305 1.042 . . . . 3.29 112.199 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -74.33 130.1 39.05 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.481 -1.303 . . . . 2.44 107.481 151.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 155.2 73.92 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.445 1.498 . . . . 2.48 113.392 -170.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 38.4 Cg_endo -58.83 -36.72 96.53 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.507 2.805 . . . . 2.32 113.731 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.26 12.89 36.03 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.592 -1.116 . . . . 1.79 115.001 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.35 -122.38 0.62 Allowed Glycine 0 C--N 1.343 0.937 0 CA-C-N 119.562 1.681 . . . . 1.76 114.778 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -71.34 140.9 50.4 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.049 -0.677 . . . . 1.81 111.585 -168.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -161.88 153.97 19.35 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.288 1.035 . . . . 0.55 112.137 -174.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -79.04 143.0 36.06 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.416 -0.587 . . . . 1.73 109.416 161.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -100.06 123.13 43.95 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.438 1.495 . . . . 0.71 108.168 163.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -98.77 130.27 45.22 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.273 -1.01 . . . . 1.33 108.273 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mp -129.32 139.05 51.88 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.672 0.789 . . . . 2.01 111.326 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.33 47.03 8.49 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 123.588 0.613 . . . . 1.58 112.223 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.413 HD13 HD23 ' A' ' 93' ' ' LEU . 10.5 mt -51.88 158.36 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 115.9 1.815 . . . . 0.87 115.9 -174.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -119.33 -32.83 4.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.035 -1.439 . . . . 1.67 113.097 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -96.28 142.69 24.92 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.067 1.347 . . . . 4.88 107.711 161.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 117.71 5.29 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 N-CA-C 106.33 -2.219 . . . . 1.43 106.33 150.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.413 HD23 HD13 ' A' ' 89' ' ' LEU . 2.0 mm? -76.6 105.34 7.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.139 1.775 . . . . 1.93 108.827 -175.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -98.56 171.91 7.84 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.746 1.219 . . . . 3.57 111.452 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.9 131.77 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.216 -0.928 . . . . 1.09 108.687 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.74 58.81 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.751 -1.027 . . . . 1.34 114.576 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.83 -176.26 4.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.509 1.154 . . . . 2.39 110.076 161.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -139.65 145.98 39.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 127.996 2.518 . . . . 2.79 105.851 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -146.42 149.28 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 127.537 2.335 . . . . 1.13 108.871 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -111.87 150.13 30.85 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.066 0.946 . . . . 2.14 113.091 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.4 mp -129.51 140.88 51.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.1 2.16 . . . . 1.69 109.552 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -85.31 131.15 34.45 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.208 -1.034 . . . . 2.2 108.208 160.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.88 109.8 21.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 121.239 1.836 . . . . 1.3 107.602 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.49 113.96 18.04 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.508 -0.923 . . . . 0.69 108.508 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.401 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 9.2 m-30 -105.35 140.76 37.99 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.792 1.237 . . . . 2.19 110.566 -175.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.03 126.73 28.67 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.49 -1.381 . . . . 2.39 113.823 -173.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.34 75.84 0.85 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.785 1.183 . . . . 4.01 112.739 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.8 72.62 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 115.473 0.949 . . . . 2.0 115.473 166.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -130.87 149.79 52.34 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.103 1.452 . . . . 3.46 112.236 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.8 t -149.01 147.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.175 1.39 . . . . 2.23 108.421 167.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.4 tp -126.2 113.74 17.4 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.869 1.267 . . . . 2.4 108.985 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -83.3 133.44 34.97 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.731 -1.231 . . . . 2.05 110.393 172.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -126.89 160.78 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.041 1.337 . . . . 1.72 109.167 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 t -133.15 137.71 52.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 127.125 2.17 . . . . 2.1 107.591 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.22 150.85 20.33 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.752 1.221 . . . . 2.04 111.763 -169.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.36 163.88 30.46 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.258 2.639 . . . . 0.85 112.387 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 t -100.48 124.37 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.393 -0.821 . . . . 0.92 109.001 163.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 122.631 1.205 . . . . 3.72 111.603 172.48 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 . . . . . 0 CA--C 1.537 0.45 0 CA-C-O 121.798 0.809 . . . . 4.64 110.011 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.43 153.87 22.7 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 125.086 1.326 . . . . 1.18 110.885 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -126.14 134.97 51.16 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.346 1.059 . . . . 2.52 111.367 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 t -84.26 56.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.065 1.346 . . . . 3.2 109.166 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 32.08 -116.56 0.05 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.052 2.541 . . . . 4.48 112.658 -171.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.0 t80 171.48 134.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.455 2.702 . . . . 2.55 108.154 -173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.5 t -178.31 144.54 0.49 Allowed Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.215 1.806 . . . . 1.97 110.745 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.76 -24.19 18.42 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.749 2.3 . . . . 1.24 112.513 164.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.22 -173.95 15.07 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.658 1.599 . . . . 0.85 112.591 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.38 -12.66 19.68 Favored 'Cis proline' 0 CA--C 1.539 0.745 0 CA-C-N 118.55 1.175 . . . . 1.07 113.475 1.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -125.05 169.83 11.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.803 1.641 . . . . 1.85 111.718 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.67 -175.63 5.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.014 2.526 . . . . 0.62 110.96 -173.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.27 169.83 16.61 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.219 1.808 . . . . 1.1 108.571 170.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.01 127.46 15.97 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.711 1.204 . . . . 0.75 110.99 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -107.27 66.58 0.67 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.861 2.064 . . . . 2.13 110.122 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.27 153.06 42.69 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.183 -0.948 . . . . 1.74 111.942 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.439 HG23 ' HB3' ' A' ' 76' ' ' GLU . 88.5 m -130.83 132.33 45.15 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.737 1.215 . . . . 2.22 108.785 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD21 HG21 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -154.26 178.02 10.47 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.998 2.119 . . . . 5.55 109.382 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -139.67 160.24 40.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.385 1.474 . . . . 4.8 110.772 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -103.66 96.78 9.42 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.367 1.867 . . . . 1.44 109.335 171.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.8 -1.39 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.103 2.535 . . . . 1.37 114.675 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.05 156.26 25.14 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.418 1.008 . . . . 1.31 111.331 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.86 5.61 9.26 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.097 2.559 . . . . 4.01 112.339 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.28 151.57 49.55 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 127.92 2.488 . . . . 3.26 110.616 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.75 161.44 27.48 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.759 2.306 . . . . 1.02 111.58 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.1 mt -120.67 152.57 38.05 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 122.525 1.155 . . . . 1.96 110.985 169.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -132.64 118.22 18.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 112.558 -2.11 . . . . 2.12 109.176 169.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.92 113.61 26.97 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.317 1.847 . . . . 1.77 107.724 -172.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 m -110.64 -24.6 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.54 0.736 . . . . 0.45 112.83 -167.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.22 -174.85 28.45 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 125.053 1.311 . . . . 0.35 112.884 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.4 -178.13 5.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.836 1.254 . . . . 0.45 110.92 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.71 170.07 20.08 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.504 1.922 . . . . 5.94 109.131 164.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -175.98 151.41 1.17 Allowed Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 127.12 2.168 . . . . 0.69 109.117 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.0 -2.82 11.99 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.753 2.302 . . . . 0.88 114.111 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.05 28.72 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.578 1.551 . . . . 1.02 114.545 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.29 138.56 11.3 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.202 1.001 . . . . 1.0 111.76 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -65.55 -31.62 72.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.848 1.659 . . . . 2.9 113.742 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -146.3 154.59 41.86 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.66 1.584 . . . . 4.69 109.339 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -141.26 140.94 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.238 1.415 . . . . 0.84 110.133 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -139.78 139.54 36.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.088 1.755 . . . . 2.84 109.447 -166.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.6 tp -89.89 128.81 36.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.869 1.213 . . . . 1.44 110.656 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -118.58 160.85 21.03 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.262 1.825 . . . . 0.93 113.854 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -122.45 152.92 39.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.55 2.34 . . . . 2.27 109.991 167.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 m -129.84 135.47 48.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.524 1.53 . . . . 0.92 107.7 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -150.5 171.24 17.38 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.542 1.163 . . . . 2.06 113.673 -167.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.2 ttp -101.87 143.8 31.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.942 1.697 . . . . 3.88 110.652 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -155.7 152.86 29.1 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.121 1.768 . . . . 8.21 112.596 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 139.13 37.09 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.274 1.03 . . . . 2.64 111.508 170.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.9 t -141.09 129.04 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 106.521 -1.659 . . . . 3.13 106.521 164.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.59 29.99 17.0 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.195 0.998 . . . . 4.53 112.392 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.37 16.56 78.79 Favored Glycine 0 N--CA 1.472 1.087 0 O-C-N 121.031 -1.043 . . . . 2.14 114.167 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -133.48 133.6 42.45 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.405 1.482 . . . . 3.06 110.758 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.32 122.86 22.7 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.078 1.351 . . . . 5.05 110.493 -177.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -135.0 -175.78 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 129.492 3.117 . . . . 3.0 108.951 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -111.99 169.24 8.98 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.085 0.945 . . . . 2.79 113.401 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.24 171.93 33.45 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.636 2.065 . . . . 0.75 112.446 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.9 ttm -150.24 142.89 24.58 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.896 1.678 . . . . 1.76 109.364 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -144.01 155.58 58.76 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 125.483 1.513 . . . . 4.46 110.174 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -75.36 161.18 38.11 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.319 2.013 . . . . 0.74 111.061 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.31 156.65 39.76 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.8 1.64 . . . . 1.16 110.536 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.03 -25.68 1.71 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.366 2.711 . . . . 0.66 113.813 -165.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -176.74 171.58 2.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.614 1.966 . . . . 2.43 110.962 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.4 mt -116.07 153.04 32.42 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.346 1.858 . . . . 0.67 109.942 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.1 145.02 42.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.803 1.241 . . . . 1.87 108.029 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.9 133.96 12.66 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 118.664 0.665 . . . . 1.13 112.759 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.41 170.83 12.74 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.56 2.84 . . . . 1.06 112.704 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.36 147.32 87.31 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.105 2.537 . . . . 1.04 113.297 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.306 22.0 mtmt 54.75 44.95 27.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.636 1.574 . . . . 3.0 113.548 171.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.02 175.54 21.05 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.827 2.632 . . . . 1.11 113.761 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -79.44 154.07 29.2 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.884 -0.774 . . . . 4.94 112.406 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.47 66.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 127.259 2.224 . . . . 5.76 107.253 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HB3' HG23 ' A' ' 21' ' ' THR . 2.1 pp20? -127.1 137.89 53.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.652 0.982 . . . . 2.76 113.652 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.45 71.88 0.89 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.29 2.236 . . . . 2.12 109.922 -170.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 140.02 17.46 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 125.754 1.622 . . . . 3.05 113.674 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.01 -17.9 51.51 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.91 3.073 . . . . 1.99 114.826 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.14 10.14 61.68 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.086 -1.396 . . . . 1.86 114.435 175.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.57 -111.2 0.26 Allowed Glycine 0 N--CA 1.473 1.13 0 CA-C-N 119.251 1.525 . . . . 1.43 114.369 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -74.18 136.1 42.82 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.889 -0.771 . . . . 1.88 112.318 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -160.79 164.96 31.09 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.793 1.237 . . . . 0.86 111.796 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -92.84 140.7 29.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.544 0.611 . . . . 2.14 111.141 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -93.98 135.96 34.77 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.902 1.681 . . . . 0.86 109.478 163.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -114.54 135.71 53.83 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.863 1.665 . . . . 1.23 108.755 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.91 138.28 48.32 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.78 0.832 . . . . 2.1 111.348 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.19 51.19 6.96 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.036 0.827 . . . . 1.61 112.788 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.33 153.6 3.82 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 115.66 1.726 . . . . 0.82 115.66 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -102.89 -16.13 15.98 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.939 1.459 . . . . 1.57 114.939 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.2 mmt-85 -137.42 145.78 50.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 128.23 2.612 . . . . 6.6 110.03 166.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.25 124.97 13.73 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 N-CA-C 106.649 -2.096 . . . . 1.41 106.649 148.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.36 101.99 11.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.088 0.947 . . . . 2.4 108.801 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.57 13.69 6.61 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.248 2.314 . . . . 4.83 117.248 -152.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 74.92 151.0 0.12 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 129.493 3.117 . . . . 1.69 112.498 -171.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.84 39.82 98.01 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.628 -0.989 . . . . 1.53 110.628 -165.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.58 171.27 7.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.96 1.704 . . . . 2.48 107.539 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -142.18 129.71 21.37 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.705 2.002 . . . . 3.78 106.922 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.0 t -153.28 141.13 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.166 1.787 . . . . 1.65 109.326 -162.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.41 ' OE1' ' HE2' ' A' ' 112' ' ' LYS . 9.6 pt-20 -86.42 147.47 26.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.657 1.354 . . . . 2.89 114.657 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mp -121.29 146.48 46.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.832 1.653 . . . . 1.65 110.5 164.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.58 134.67 38.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.04 2.536 . . . . 2.31 108.245 161.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.84 130.96 46.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.849 1.26 . . . . 0.92 108.072 164.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.4 mt -110.85 108.42 18.22 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.658 1.183 . . . . 0.66 110.082 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -104.32 155.12 19.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.851 1.66 . . . . 2.18 111.285 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.45 145.03 45.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.556 0.742 . . . . 2.61 112.036 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.95 20.88 41.24 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.961 -0.911 . . . . 3.82 114.598 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.46 9.22 86.98 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 118.521 1.16 . . . . 2.05 113.901 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -79.32 106.83 11.63 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.357 -1.084 . . . . 3.09 111.229 -174.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.5 p -115.89 115.84 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.199 1.4 . . . . 2.08 110.848 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.9 mp -120.83 117.45 27.44 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.799 1.239 . . . . 3.14 109.562 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.41 ' HE2' ' OE1' ' A' ' 100' ' ' GLU . 2.4 ttpm? -105.87 134.63 48.7 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.807 0.443 . . . . 2.61 112.143 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.402 HG21 HD21 ' A' ' 22' ' ' LEU . 8.4 t -144.47 159.92 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.58 1.552 . . . . 2.81 109.221 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -107.01 134.4 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.659 1.584 . . . . 2.61 110.31 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.82 148.37 57.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.034 1.734 . . . . 3.12 110.12 -169.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.05 170.33 19.22 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.516 2.811 . . . . 1.07 113.374 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.68 121.19 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 127.291 2.236 . . . . 0.99 109.589 169.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 122.788 1.28 . . . . 4.1 114.1 176.198 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 CA--C 1.538 0.508 0 CA-C-O 120.987 0.422 . . . . 7.06 110.325 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.47 -175.03 44.72 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.429 1.014 . . . . 1.51 111.633 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.2 p90 -142.59 -173.7 3.94 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.819 -0.812 . . . . 2.58 112.988 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.4 t -122.61 129.23 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.029 -1.044 . . . . 1.93 110.426 -169.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -48.88 -27.42 3.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.367 1.867 . . . . 6.67 115.227 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 89.2 t80 69.42 116.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.452 2.701 . . . . 3.09 111.437 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.1 m -170.12 150.48 3.62 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.13 1.372 . . . . 2.38 110.231 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.17 -29.93 1.41 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.284 2.656 . . . . 1.35 113.029 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.1 173.56 20.52 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.557 2.503 . . . . 1.01 110.538 -170.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -81.02 4.74 41.43 Favored 'Cis proline' 0 CA--C 1.541 0.827 0 CA-C-N 120.193 1.996 . . . . 1.6 113.18 -3.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -148.26 164.86 32.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.159 0.98 . . . . 2.54 112.839 168.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.65 -178.14 4.93 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.049 2.139 . . . . 0.41 109.771 165.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.49 154.82 49.82 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.949 2.1 . . . . 0.74 107.183 168.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.82 142.67 49.09 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.073 0.949 . . . . 0.78 110.434 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -124.03 19.98 9.14 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.608 1.336 . . . . 2.29 114.608 -160.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.402 ' HB3' HD22 ' A' ' 115' ' ' LEU . 2.4 pt? -51.48 161.46 0.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.753 1.76 . . . . 2.72 115.753 -171.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -82.18 144.77 30.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.406 -0.815 . . . . 1.73 111.845 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.47 118.04 22.39 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.642 1.177 . . . . 3.85 110.031 168.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -113.85 132.7 55.8 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.414 -1.328 . . . . 4.29 107.414 167.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -92.04 110.85 46.87 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.933 0.893 . . . . 1.3 109.321 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -85.07 -9.58 8.5 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.296 2.664 . . . . 1.31 115.04 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.48 166.06 29.06 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 119.503 1.047 . . . . 1.32 112.067 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.84 4.87 27.33 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.511 2.324 . . . . 3.56 112.14 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.61 154.5 52.53 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 128.159 2.584 . . . . 2.91 110.425 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.56 145.24 20.57 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.925 2.417 . . . . 0.89 110.566 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 mt -105.04 148.55 26.65 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 122.319 1.057 . . . . 1.91 111.649 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -130.22 112.08 13.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.283 -2.235 . . . . 1.85 111.265 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.483 HD11 ' CZ ' ' A' ' 84' ' ' PHE . 2.4 tm? -100.16 111.12 23.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.242 2.217 . . . . 2.25 109.265 -172.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -104.11 -25.62 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.415 1.086 . . . . 0.51 111.697 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.92 -175.89 32.43 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 125.022 1.296 . . . . 0.36 113.432 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -140.94 -179.9 6.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.631 1.572 . . . . 0.45 110.045 169.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -156.72 157.29 34.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.266 2.227 . . . . 4.48 108.024 174.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -164.8 150.08 8.53 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.984 1.313 . . . . 0.81 109.858 175.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.56 -12.14 33.7 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.96 2.44 . . . . 0.94 115.061 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.7 m -109.64 16.56 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 116.732 2.123 . . . . 0.88 116.732 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.39 162.08 34.02 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.826 -1.171 . . . . 0.9 114.144 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -100.07 -63.03 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.228 1.411 . . . . 2.66 109.505 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -107.43 98.5 8.11 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.924 -1.11 . . . . 6.37 110.382 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -79.01 141.62 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.223 -0.899 . . . . 1.54 110.189 164.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -153.26 138.37 17.34 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.5 1.52 . . . . 2.78 109.4 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.0 tp -96.65 122.31 39.44 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.731 0.777 . . . . 1.01 112.023 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -121.97 161.56 22.69 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.911 1.685 . . . . 0.99 113.779 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.13 -178.42 3.66 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.934 2.094 . . . . 3.1 111.642 158.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.6 m -154.14 145.82 23.31 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.984 1.713 . . . . 0.98 107.111 169.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -157.17 179.8 8.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.629 1.204 . . . . 2.45 112.999 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.7 mtm -121.37 142.14 50.28 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.591 1.556 . . . . 5.28 110.006 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -149.54 162.76 39.52 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.986 0.914 . . . . 5.3 112.896 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.18 145.5 30.97 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.633 0.773 . . . . 3.07 110.51 162.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.25 1.77 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 114.576 1.325 . . . . 3.35 114.576 164.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -177.62 22.22 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.689 1.996 . . . . 4.62 112.381 -168.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.41 -10.44 4.89 Favored Glycine 0 CA--C 1.543 1.798 0 O-C-N 119.148 -2.22 . . . . 2.13 113.242 -160.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -95.13 130.49 41.82 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 129.346 3.059 . . . . 3.39 108.213 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -77.1 117.37 18.59 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 128.04 2.536 . . . . 2.69 109.149 -173.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -139.39 135.65 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.823 1.649 . . . . 2.22 109.132 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.83 159.42 20.41 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 122.442 1.115 . . . . 3.28 113.618 -175.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.02 164.98 24.99 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 125.103 1.335 . . . . 0.81 112.451 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -149.38 132.96 16.74 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.271 1.428 . . . . 1.5 109.891 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -141.89 149.9 54.56 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.485 1.914 . . . . 9.18 109.773 -170.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.43 153.66 39.94 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.228 1.952 . . . . 0.74 110.012 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.18 148.95 64.48 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.157 0.983 . . . . 0.75 110.37 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.71 -23.08 13.0 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.525 2.816 . . . . 0.62 112.725 -170.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -173.93 172.51 3.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.296 1.838 . . . . 1.71 111.278 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -117.06 154.09 31.59 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.128 2.171 . . . . 0.6 109.863 161.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -110.03 144.01 39.21 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.387 -0.968 . . . . 1.55 108.387 172.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.07 126.02 18.38 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.999 -0.524 . . . . 0.86 111.285 163.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -68.2 164.22 33.09 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.788 2.992 . . . . 1.02 111.239 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.24 135.95 57.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.915 2.41 . . . . 0.99 112.414 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.285 17.5 mtmt 59.27 40.18 21.66 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.018 1.39 . . . . 2.33 113.193 171.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.37 164.72 26.9 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 127.926 2.679 . . . . 1.13 113.699 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -113.82 146.52 39.83 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.18 1.792 . . . . 3.59 111.732 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -139.82 116.45 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.5 1.12 . . . . 3.42 108.481 152.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -79.92 148.31 31.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.961 0.905 . . . . 3.04 110.685 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mp -85.69 52.09 2.37 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.167 0.987 . . . . 2.52 112.707 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.94 146.21 8.2 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 115.424 1.638 . . . . 2.89 115.424 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.24 -32.92 95.01 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.072 3.181 . . . . 3.0 114.076 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.32 31.24 1.38 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.475 1.036 . . . . 2.03 113.433 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.72 -122.65 0.94 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.681 1.61 . . . . 1.6 113.382 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -73.31 134.93 44.32 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 121.934 -0.745 . . . . 2.17 112.761 -170.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -160.15 164.45 32.92 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.838 1.051 . . . . 1.01 113.838 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 73.8 m-85 -92.67 131.7 37.54 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 109.887 -0.412 . . . . 2.02 109.887 165.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 tpt -85.26 138.37 32.37 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.222 2.209 . . . . 0.82 108.648 164.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.9 mt -132.24 91.39 2.94 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.44 1.496 . . . . 2.83 109.221 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.0 mp -88.98 157.5 18.36 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.522 1.129 . . . . 2.59 111.869 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.99 -52.67 4.77 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.322 1.915 . . . . 3.05 112.577 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.5 mt 55.86 169.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 128.281 2.632 . . . . 1.09 113.707 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -118.73 -25.88 6.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.937 -1.483 . . . . 1.62 112.717 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -143.23 157.79 59.44 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 126.611 1.964 . . . . 6.28 111.678 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.33 151.2 48.12 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.0 2.466 . . . . 1.5 110.467 158.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.93 148.0 22.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.83 1.252 . . . . 2.13 111.524 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -95.73 -166.9 1.51 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.332 1.063 . . . . 4.75 111.122 164.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.49 152.05 24.17 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.737 1.215 . . . . 1.77 108.579 157.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.58 29.81 59.12 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.583 -0.565 . . . . 2.15 114.287 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -109.63 -179.99 3.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.227 1.411 . . . . 2.53 109.431 168.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -129.98 146.15 51.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 104.735 -2.32 . . . . 5.15 104.735 164.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.3 t -138.76 139.49 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.861 1.665 . . . . 1.38 109.628 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -92.1 144.96 24.91 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 122.831 1.3 . . . . 2.34 112.787 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -135.98 140.71 44.14 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.71 2.404 . . . . 2.93 109.207 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -88.74 140.58 29.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.218 1.807 . . . . 2.2 109.064 164.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.5 mt -110.07 130.47 55.53 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.289 1.436 . . . . 2.18 108.813 166.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.0 mt -110.06 125.15 52.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.097 1.359 . . . . 0.63 111.184 -174.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.06 153.28 37.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.457 1.503 . . . . 2.03 112.549 -168.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.56 127.37 29.45 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.944 1.091 . . . . 1.95 113.944 -174.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.19 59.39 3.63 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.734 1.159 . . . . 3.68 113.46 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.71 28.65 66.8 Favored Glycine 0 N--CA 1.474 1.17 0 CA-C-N 117.802 0.801 . . . . 1.72 115.074 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -113.7 145.01 41.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.937 1.369 . . . . 4.3 112.242 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.1 150.63 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.212 1.405 . . . . 2.16 111.969 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.4 tp -149.28 114.36 5.45 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.235 1.414 . . . . 2.32 109.885 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -92.6 134.72 34.72 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.345 -0.847 . . . . 1.98 111.472 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 114' ' ' VAL . 40.4 t -133.7 173.94 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.839 2.056 . . . . 2.16 108.322 -176.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.494 ' H ' HG12 ' A' ' 113' ' ' VAL . 11.0 p -149.98 127.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.919 1.288 . . . . 2.53 110.431 -172.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -128.17 150.11 73.05 Favored Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 126.127 1.771 . . . . 2.55 112.221 -171.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.36 148.3 43.12 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.772 2.981 . . . . 1.5 111.631 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 t -94.5 81.68 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.083 -1.08 . . . . 1.52 108.083 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 . . . . . 0 CA--C 1.538 0.486 0 C-N-CA 125.834 1.654 . . . . 4.34 109.93 166.586 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 . . . . . 0 CA--C 1.535 0.376 0 CA-C-O 123.464 1.602 . . . . 4.76 111.541 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.78 -179.93 20.69 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.67 1.605 . . . . 1.27 110.195 168.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.3 p90 -142.13 160.36 40.39 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.339 1.055 . . . . 3.11 112.035 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.28 136.39 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.514 -1.291 . . . . 1.22 107.514 164.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -51.82 -55.03 22.33 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.848 1.796 . . . . 4.27 115.848 -155.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.4 t80 107.54 123.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 130.52 3.528 . . . . 2.56 108.451 -154.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.4 m 175.52 131.33 0.15 Allowed Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 127.711 2.404 . . . . 2.58 109.255 -176.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.71 -32.82 1.9 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.655 2.236 . . . . 1.29 112.577 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.13 176.14 22.15 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.77 1.652 . . . . 0.89 111.678 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.05 -10.24 21.39 Favored 'Cis proline' 0 CA--C 1.537 0.647 0 CA-C-N 119.021 1.41 . . . . 0.99 112.572 -3.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -143.52 162.87 34.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.497 1.519 . . . . 2.39 112.315 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.14 -177.67 4.23 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.255 1.822 . . . . 0.62 111.623 -176.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -120.7 167.03 12.89 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.486 1.114 . . . . 0.92 110.453 161.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.01 146.46 33.88 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.756 1.223 . . . . 0.72 111.477 168.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -127.84 81.37 2.02 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.601 2.361 . . . . 3.39 109.247 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.51 159.54 14.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.61 1.337 . . . . 1.71 114.61 -170.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.3 m -131.02 150.84 51.96 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.366 1.867 . . . . 1.79 109.311 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.602 HD21 HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -150.68 175.54 11.86 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.314 3.045 . . . . 5.09 107.882 172.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -115.03 147.28 40.33 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 123.107 0.563 . . . . 4.68 110.538 164.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -100.64 90.81 1.58 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.641 0.776 . . . . 1.36 109.868 163.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.5 -5.07 16.39 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.756 2.304 . . . . 1.85 113.96 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.25 178.55 53.89 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 122.831 1.24 . . . . 1.64 113.793 -174.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -109.76 -1.28 18.04 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.405 2.282 . . . . 3.49 112.132 -170.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -116.7 159.62 39.75 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 127.667 2.387 . . . . 2.91 110.65 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.11 139.88 17.38 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.56 2.174 . . . . 1.04 111.004 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.44 HD12 ' CD1' ' A' ' 105' ' ' PHE . 1.4 mm? -104.37 159.29 15.84 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 125.829 1.652 . . . . 2.61 110.965 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -155.27 111.0 3.09 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.724 -1.58 . . . . 1.73 111.155 -168.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.97 107.42 19.7 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.81 1.644 . . . . 2.53 109.176 -171.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 m -104.59 -21.75 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.834 0.853 . . . . 0.64 112.426 -169.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.38 -176.61 32.66 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 124.996 1.284 . . . . 0.48 113.495 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.54 -178.74 6.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.55 1.54 . . . . 0.5 111.594 170.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -158.36 155.04 28.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.903 1.681 . . . . 3.99 108.177 167.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.8 t -157.59 153.74 23.65 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.302 1.441 . . . . 0.77 108.755 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.38 -12.19 14.17 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.127 1.885 . . . . 0.87 113.492 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.429 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 24.8 m -98.74 23.21 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.197 1.184 . . . . 0.98 114.197 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -149.37 165.47 31.94 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.357 1.863 . . . . 1.18 107.978 167.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.9 -35.76 9.29 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.687 1.195 . . . . 2.82 112.617 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.54 177.68 7.43 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.673 1.589 . . . . 6.26 107.71 171.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.62 150.67 10.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 125.468 1.507 . . . . 1.08 108.254 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -131.11 156.88 44.49 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.166 2.186 . . . . 2.81 109.11 174.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 tp -110.78 117.25 32.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.759 1.224 . . . . 0.84 110.513 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -121.0 154.89 35.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.391 1.476 . . . . 0.75 113.192 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -95.23 154.32 17.24 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.335 -1.302 . . . . 1.95 110.267 155.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -103.48 146.0 29.17 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.642 -1.614 . . . . 0.99 106.642 154.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -134.61 176.79 8.31 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.414 1.102 . . . . 2.07 112.855 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.6 ttp -122.22 140.87 52.08 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.732 1.613 . . . . 3.23 109.823 170.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.74 145.89 48.89 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.878 1.271 . . . . 6.25 110.836 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -113.38 143.7 44.03 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.757 1.623 . . . . 2.85 108.611 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.3 139.64 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.832 1.653 . . . . 4.35 108.079 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 64.41 18.7 11.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.527 1.131 . . . . 5.56 112.558 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.29 21.02 79.49 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.329 -1.482 . . . . 2.03 113.057 -171.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -120.9 119.7 33.37 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.23 1.812 . . . . 4.01 108.33 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.52 121.62 38.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.255 1.422 . . . . 2.84 111.675 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.1 t -137.05 141.36 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.389 1.876 . . . . 2.26 108.266 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.62 167.39 13.95 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.077 0.769 . . . . 3.56 113.077 -176.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.92 -177.95 28.73 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 125.356 1.455 . . . . 0.8 112.281 -172.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.3 ttm -158.76 149.68 20.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.903 1.281 . . . . 1.43 109.552 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.7 ptt85 -160.89 151.96 15.66 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 123.921 0.888 . . . . 4.68 111.707 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.48 150.98 52.68 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.156 1.904 . . . . 0.65 111.204 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.58 150.8 73.12 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 125.246 1.418 . . . . 0.59 109.827 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.85 -22.47 7.54 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.367 2.711 . . . . 0.58 113.201 -166.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -177.99 166.59 2.03 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 2.15 110.617 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.0 mt -109.44 154.45 22.6 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.478 1.111 . . . . 0.7 110.077 161.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -113.65 144.69 42.5 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.346 1.458 . . . . 2.06 109.289 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.0 130.58 10.23 Favored Pre-proline 0 N--CA 1.473 0.693 0 N-CA-C 112.541 0.571 . . . . 1.12 112.541 169.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.86 168.46 18.62 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.286 2.658 . . . . 1.03 112.65 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.12 141.53 98.23 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.347 2.698 . . . . 1.26 111.598 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt 65.61 8.13 4.93 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.516 1.526 . . . . 1.95 113.053 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.58 150.66 24.6 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.714 2.102 . . . . 1.47 114.367 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -78.96 115.81 18.87 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.629 1.971 . . . . 3.71 111.141 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.47 55.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 122.484 1.135 . . . . 5.45 108.946 -174.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.6 123.78 46.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.928 1.691 . . . . 2.99 108.794 177.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mp -58.28 -56.19 25.31 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.469 1.107 . . . . 4.31 112.439 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.595 ' HE3' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 139.59 140.94 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 131.618 3.967 . . . . 3.16 111.176 178.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.21 131.94 26.42 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 N-CA-C 107.782 -1.661 . . . . 3.8 107.782 159.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.89 -38.03 1.94 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.393 -1.226 . . . . 3.34 114.794 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.8 -110.63 0.39 Allowed Glycine 0 N--CA 1.475 1.28 0 CA-C-N 119.165 1.483 . . . . 1.82 113.692 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.76 141.3 49.74 Favored 'General case' 0 C--O 1.223 -0.319 0 O-C-N 121.617 -0.931 . . . . 1.97 111.007 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -158.3 143.19 16.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.716 -0.675 . . . . 0.76 110.997 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -78.89 133.69 36.95 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.063 -0.717 . . . . 1.87 109.063 167.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.2 tpt -92.74 119.44 32.12 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.697 1.599 . . . . 1.06 108.086 168.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -103.88 105.69 15.97 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.475 1.51 . . . . 1.15 110.161 -168.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.01 132.99 40.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.823 0.849 . . . . 2.45 111.696 -166.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.08 47.47 7.56 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 123.954 0.788 . . . . 1.71 113.73 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 18.7 mt -49.02 154.89 0.69 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 116.345 1.98 . . . . 0.96 116.345 -174.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 50.8 mmtt -119.22 -30.54 4.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 113.302 -1.772 . . . . 2.27 113.29 -176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.455 HH21 ' CD ' ' A' ' 97' ' ' GLU . 9.9 mmm180 -106.74 144.89 29.96 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 126.444 1.897 . . . . 5.27 108.173 160.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.92 128.06 13.65 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 N-CA-C 107.225 -1.875 . . . . 1.88 107.225 153.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.29 115.72 22.62 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.741 -0.837 . . . . 2.26 108.741 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.25 162.21 32.79 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.04 1.336 . . . . 4.7 113.874 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 132.59 54.47 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.504 1.522 . . . . 1.4 110.934 -172.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.23 44.86 16.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.023 -0.99 . . . . 1.36 112.85 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.455 ' CD ' HH21 ' A' ' 91' ' ' ARG . 0.9 OUTLIER -103.67 167.06 10.03 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 117.787 0.793 . . . . 2.4 109.044 148.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.43 128.34 46.85 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 102.625 -3.102 . . . . 4.9 102.625 154.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.7 t -137.28 137.67 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.829 1.251 . . . . 1.55 109.999 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -84.54 155.97 21.87 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.061 1.504 . . . . 2.41 115.061 -174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tt -155.31 140.3 17.34 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.127 2.171 . . . . 3.1 110.902 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -84.38 127.87 34.25 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.899 2.08 . . . . 2.07 109.29 165.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.16 127.0 35.15 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.563 -0.903 . . . . 1.22 108.563 161.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.5 mt -103.55 105.75 16.08 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 122.497 1.142 . . . . 0.74 109.869 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.44 ' CD1' HD12 ' A' ' 30' ' ' LEU . 98.0 m-85 -96.16 152.76 18.26 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.146 1.379 . . . . 2.28 111.354 174.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.45 127.51 20.18 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.55 1.14 . . . . 2.13 113.643 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.22 66.1 2.25 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.573 1.082 . . . . 3.37 112.793 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.5 11.81 80.18 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 115.792 1.077 . . . . 1.83 115.792 167.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -96.15 104.14 16.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.779 1.79 . . . . 3.56 110.983 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.82 143.23 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 123.863 0.865 . . . . 2.38 110.685 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -145.07 108.02 4.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.209 1.004 . . . . 2.46 108.776 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -93.65 131.91 38.49 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.046 0.387 . . . . 2.16 112.046 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.602 HG21 HD21 ' A' ' 22' ' ' LEU . 54.2 t -138.85 163.2 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.602 1.561 . . . . 2.39 110.204 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.32 126.84 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.849 2.06 . . . . 2.07 109.808 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.27 145.3 38.16 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 126.548 1.939 . . . . 3.12 109.737 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.05 162.7 41.03 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.183 3.256 . . . . 1.16 113.008 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.24 110.75 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 114.576 -1.193 . . . . 1.23 110.994 165.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 CA--C 1.544 0.718 0 C-N-CA 127.19 2.196 . . . . 3.68 109.324 156.768 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.59 ' N ' ' HG1' ' A' ' 21' ' ' THR . 10.3 pt-20 . . . . . 0 CA--C 1.545 0.784 0 N-CA-C 108.287 -1.005 . . . . 6.0 108.287 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.83 167.58 29.92 Favored Glycine 0 N--CA 1.473 1.115 0 O-C-N 120.858 -1.151 . . . . 1.05 114.334 -167.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -152.76 169.27 23.18 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.852 1.427 . . . . 2.18 114.852 -172.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.2 t -106.67 144.8 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.177 1.791 . . . . 1.23 107.13 168.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.26 0.6 OUTLIER -73.18 -100.11 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.388 0.884 . . . . 3.91 113.388 175.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -161.21 143.46 12.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.242 1.817 . . . . 2.49 109.5 -167.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t 171.81 136.17 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 126.93 2.092 . . . . 2.31 111.676 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.08 -27.47 6.78 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.745 2.297 . . . . 1.6 111.901 166.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.39 171.91 17.01 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 126.696 2.093 . . . . 1.05 111.195 -175.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -78.46 -9.0 35.88 Favored 'Cis proline' 0 CA--C 1.537 0.631 0 CA-C-N 118.508 1.154 . . . . 1.01 113.045 -0.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -151.36 167.89 26.5 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.734 1.214 . . . . 1.89 113.374 -168.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.87 -177.51 6.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.485 2.314 . . . . 0.54 111.72 -173.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.42 39.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.402 1.481 . . . . 0.97 108.576 169.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.14 141.78 47.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.656 1.582 . . . . 0.6 110.544 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.522 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 51.3 m-85 -121.42 70.78 0.94 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.724 2.01 . . . . 2.05 110.835 -171.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -90.85 164.47 14.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.089 0.955 . . . . 1.98 113.21 -170.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.59 ' HG1' ' N ' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -95.88 124.61 39.97 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.457 -0.777 . . . . 1.89 110.299 175.046 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.2 tp -96.23 104.08 16.02 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.198 -1.038 . . . . 5.17 108.198 167.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -82.46 171.24 14.36 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.663 0.744 . . . . 5.87 111.929 165.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -134.58 101.12 12.07 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.566 0.747 . . . . 1.34 109.417 155.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.78 -11.86 11.24 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.158 2.572 . . . . 1.55 112.992 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.23 178.92 49.45 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-O 122.749 1.194 . . . . 1.19 112.55 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -104.29 -1.73 26.6 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.076 2.15 . . . . 3.13 112.3 -173.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.9 mt -124.8 162.98 39.99 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 127.782 2.433 . . . . 3.63 109.323 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.59 158.44 28.63 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.354 2.036 . . . . 1.08 111.503 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mp -118.28 154.69 31.87 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.161 1.784 . . . . 2.19 110.019 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -138.51 110.29 7.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 113.494 -1.685 . . . . 2.04 109.511 173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.7 118.41 30.63 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.727 1.611 . . . . 1.9 107.727 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 m -113.53 -22.43 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.181 0.993 . . . . 0.49 112.691 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.32 -176.91 31.91 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 124.359 0.98 . . . . 0.43 113.31 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.5 178.12 6.7 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.718 -0.872 . . . . 0.44 112.17 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -150.2 148.87 29.44 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.635 2.374 . . . . 7.53 107.957 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 t -164.82 148.81 7.73 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 117.934 -1.031 . . . . 0.62 110.158 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.78 -12.11 21.97 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.174 1.916 . . . . 0.73 114.78 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.63 20.82 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.125 1.528 . . . . 0.88 115.125 -170.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.36 150.25 25.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.486 1.514 . . . . 0.99 109.075 169.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.85 -47.67 7.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.532 1.133 . . . . 3.35 112.832 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -122.33 98.7 6.05 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.453 -1.314 . . . . 6.26 107.453 -171.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.26 125.89 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.697 -0.683 . . . . 0.82 109.802 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -116.82 150.46 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.71 2.004 . . . . 2.7 109.069 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.4 tp -105.12 118.64 37.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.043 0.937 . . . . 0.88 110.356 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.1 m170 -124.64 155.29 39.41 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.046 1.338 . . . . 0.51 114.123 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -100.43 162.54 12.87 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.867 1.667 . . . . 2.21 112.484 158.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.0 m -132.33 144.41 50.54 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.876 2.07 . . . . 0.74 105.661 167.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -152.76 170.14 21.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.908 0.883 . . . . 2.02 112.491 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.9 ttp -98.83 140.1 33.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.92 1.288 . . . . 3.45 110.812 173.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.3 148.18 32.15 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.018 1.727 . . . . 5.28 111.314 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.92 144.49 26.15 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.298 1.039 . . . . 2.42 108.572 166.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -141.83 138.05 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 107.806 -1.183 . . . . 2.79 107.806 155.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 59.11 22.85 11.02 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.847 1.425 . . . . 4.32 114.847 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.31 17.83 79.75 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 120.717 -1.24 . . . . 1.67 113.956 -170.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -109.45 122.57 47.69 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.626 1.971 . . . . 2.25 107.558 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -79.81 117.99 21.19 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.767 1.227 . . . . 3.07 108.642 172.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 m -141.68 -175.76 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.709 2.404 . . . . 2.5 109.858 -171.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.76 175.74 5.39 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.807 0.843 . . . . 3.0 112.974 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.9 170.2 33.12 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.62 2.057 . . . . 0.8 111.94 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -149.31 137.96 21.02 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.441 1.496 . . . . 1.13 109.817 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -143.73 151.63 53.91 Favored Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 125.618 1.567 . . . . 8.85 110.605 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.99 151.9 45.49 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.132 1.888 . . . . 0.58 109.98 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.9 m -137.5 153.51 74.46 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.013 1.325 . . . . 0.56 109.994 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.59 -28.12 2.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.719 2.279 . . . . 0.45 112.805 -165.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -177.2 165.75 2.31 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.047 1.339 . . . . 2.08 112.483 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.2 mt -109.91 152.0 26.37 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.673 1.589 . . . . 0.79 111.051 162.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -121.89 136.76 54.94 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.584 1.553 . . . . 2.16 108.407 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.8 t -143.69 129.4 9.97 Favored Pre-proline 0 N--CA 1.475 0.808 0 N-CA-C 113.665 0.987 . . . . 1.16 113.665 174.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.81 161.66 43.18 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.161 3.241 . . . . 1.23 111.693 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.63 141.07 96.5 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.557 2.838 . . . . 1.1 113.172 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 69.15 0.23 2.74 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.919 2.088 . . . . 2.1 114.572 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.53 175.73 47.63 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.928 1.728 . . . . 1.08 113.223 171.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.08 132.87 11.39 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.21 1.004 . . . . 5.66 112.725 173.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.5 t -125.18 108.4 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.381 2.272 . . . . 3.55 109.524 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.5 126.92 31.66 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 127.879 2.471 . . . . 3.63 112.21 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -74.12 75.46 1.76 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.986 1.714 . . . . 2.13 109.811 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -68.07 155.11 92.76 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 114.819 1.415 . . . . 2.41 114.819 -173.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.522 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 37.0 Cg_endo -59.34 -15.81 31.46 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.323 3.349 . . . . 2.37 116.628 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -97.92 -1.04 58.62 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.265 -1.297 . . . . 1.95 115.292 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.86 -115.66 0.9 Allowed Glycine 0 N--CA 1.473 1.136 0 CA-C-N 119.908 1.854 . . . . 1.54 113.958 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -70.79 141.55 51.4 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.17 -0.606 . . . . 1.81 110.386 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -161.45 160.25 29.08 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.758 1.223 . . . . 0.64 111.582 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -92.7 130.8 38.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.546 -0.539 . . . . 1.91 109.546 166.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 tpt -84.96 128.8 34.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.072 1.349 . . . . 0.76 108.89 166.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -114.74 107.53 15.58 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.36 1.064 . . . . 1.1 108.614 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mp -107.45 148.91 28.54 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.045 0.839 . . . . 2.29 111.036 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.82 43.39 28.26 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.993 -0.893 . . . . 1.71 113.353 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 mt -46.62 150.88 0.63 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.999 1.481 . . . . 0.87 114.999 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -108.01 -21.31 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 112.986 -1.916 . . . . 2.09 114.248 -172.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.92 145.83 58.75 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 126.699 1.999 . . . . 5.75 110.548 162.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -66.69 154.31 74.91 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.085 1.857 . . . . 1.47 108.777 162.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.85 159.76 43.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.466 1.127 . . . . 2.72 112.547 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.55 173.9 6.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.923 2.089 . . . . 4.74 111.301 -165.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.14 135.72 56.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.231 1.012 . . . . 1.45 112.857 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.69 40.37 31.88 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 114.828 -1.078 . . . . 1.58 113.428 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -113.89 176.33 5.08 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.497 1.119 . . . . 2.76 108.992 157.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -121.96 164.3 17.84 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.662 1.585 . . . . 2.94 107.161 159.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.0 t -148.94 154.77 9.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 130.588 3.555 . . . . 1.65 109.053 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.95 138.53 54.38 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.366 1.466 . . . . 2.94 111.252 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.62 137.2 54.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.863 1.265 . . . . 1.85 110.962 165.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.8 138.51 31.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.264 1.826 . . . . 2.43 110.044 155.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.3 136.61 34.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.509 1.924 . . . . 1.27 109.45 167.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt -107.16 118.5 36.87 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.7 1.6 . . . . 0.64 109.519 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -109.49 156.25 20.34 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.647 1.179 . . . . 1.99 111.041 -175.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.05 141.66 58.67 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.465 -0.772 . . . . 2.35 110.748 164.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.54 35.68 11.55 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 119.066 -0.852 . . . . 4.18 114.951 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.97 7.47 84.08 Favored Glycine 0 N--CA 1.476 1.317 0 CA-C-N 118.234 1.017 . . . . 1.88 115.553 167.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -89.53 137.28 32.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.063 0.932 . . . . 3.2 111.261 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.31 131.53 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.56 1.544 . . . . 1.87 108.079 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.27 143.56 27.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.763 1.625 . . . . 3.52 109.189 -174.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -120.3 151.84 38.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.291 1.589 . . . . 2.31 115.291 -172.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.0 m -122.98 153.04 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 128.062 2.545 . . . . 3.03 110.825 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.2 138.72 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.106 1.762 . . . . 3.02 109.609 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -141.29 125.4 10.28 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.401 1.08 . . . . 2.67 111.547 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.78 167.11 24.4 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.788 2.325 . . . . 1.13 110.776 162.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.25 149.33 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.909 1.284 . . . . 1.06 110.508 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 126.514 1.925 . . . . 4.93 112.817 -176.593 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.52 0 CA-C-O 123.482 1.61 . . . . 6.22 112.161 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.54 157.54 15.78 Favored Glycine 0 C--N 1.329 0.155 0 CA-C-N 114.082 -1.417 . . . . 2.13 110.039 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -92.42 162.55 14.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.611 1.196 . . . . 2.71 112.268 -160.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -80.34 132.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.49 -1.3 . . . . 1.17 107.49 157.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -21.24 59.01 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.116 1.895 . . . . 6.28 116.116 -163.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 t80 85.75 144.01 0.06 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.972 2.909 . . . . 2.77 111.201 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 t -171.28 150.9 2.93 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.672 1.189 . . . . 2.15 112.233 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -81.37 -18.5 8.36 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.344 2.696 . . . . 1.5 112.109 158.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.81 -170.17 13.73 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 126.754 2.121 . . . . 1.28 111.631 -170.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.64 -3.54 22.15 Favored 'Cis proline' 0 CA--C 1.54 0.817 0 CA-C-N 119.196 1.498 . . . . 1.65 112.477 -9.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.426 HD22 ' H ' ' A' ' 88' ' ' GLY . 2.4 m120 -136.02 176.91 8.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.778 1.231 . . . . 4.39 110.843 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.59 -174.54 4.98 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.611 2.365 . . . . 0.61 112.133 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.47 149.25 28.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.957 2.503 . . . . 0.71 108.452 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -135.52 136.5 41.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.857 1.208 . . . . 0.66 113.417 -175.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 28.8 m-85 -106.5 41.12 1.49 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.715 1.606 . . . . 2.32 114.09 -170.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.38 155.89 33.94 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.336 1.606 . . . . 1.75 115.336 -167.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 76' ' ' GLU . 54.8 m -99.71 143.29 30.11 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.438 1.095 . . . . 1.6 112.128 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.47 123.62 47.93 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.83 2.452 . . . . 3.29 111.804 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -102.97 141.05 36.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.589 0.756 . . . . 3.72 109.537 158.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -108.34 84.31 2.26 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.756 -0.59 . . . . 1.53 109.928 159.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.8 -10.05 24.46 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.424 2.083 . . . . 1.4 113.181 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.73 176.43 47.75 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-O 122.861 1.256 . . . . 1.39 113.1 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -102.02 -8.62 21.32 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.759 2.424 . . . . 3.37 112.179 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.0 mt -132.01 152.56 80.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.523 1.929 . . . . 3.96 109.264 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.83 167.74 24.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.093 2.528 . . . . 1.58 113.698 -152.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mp -115.05 147.98 39.47 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.29 1.836 . . . . 2.37 108.683 168.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.23 98.92 3.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 112.855 -1.975 . . . . 2.52 108.737 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.3 tp -83.67 102.37 12.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.878 2.071 . . . . 2.12 109.387 -168.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -94.7 -25.3 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.917 1.287 . . . . 1.21 111.711 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.06 -176.85 31.57 Favored Glycine 0 C--N 1.343 0.922 0 C-N-CA 123.792 0.711 . . . . 0.53 114.092 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.24 -177.88 5.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.935 1.694 . . . . 0.57 110.382 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -156.51 175.25 14.28 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 127.434 2.293 . . . . 5.87 107.948 161.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t -162.7 152.2 13.12 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 128.755 2.822 . . . . 1.41 106.796 166.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.07 -29.65 39.74 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 120.894 1.355 . . . . 1.91 111.918 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.6 m -86.78 14.63 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 115.299 1.592 . . . . 1.93 115.299 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.09 138.48 25.37 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.586 1.539 . . . . 1.16 113.89 168.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.54 -26.84 41.35 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.837 1.421 . . . . 4.01 114.837 -165.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -146.63 165.7 28.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.908 2.083 . . . . 5.06 108.341 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.88 143.89 15.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 124.972 1.309 . . . . 1.1 109.383 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -118.57 158.04 26.18 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.654 1.982 . . . . 3.28 109.512 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 tp -106.88 117.56 34.39 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.538 0.735 . . . . 0.87 110.307 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -119.86 165.08 15.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 123.516 1.627 . . . . 0.68 113.897 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -121.57 162.6 20.32 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.18 -1.827 . . . . 3.59 111.501 156.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.4 m -118.01 139.56 51.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.19 2.196 . . . . 0.93 106.158 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -136.48 169.31 17.9 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.578 1.18 . . . . 1.9 113.736 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.2 ttp -111.55 147.27 35.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.281 1.833 . . . . 3.36 109.102 170.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 153.53 38.3 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.802 1.241 . . . . 5.44 110.505 -174.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -105.23 138.58 41.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.351 1.46 . . . . 3.49 110.267 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.25 113.98 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.625 -1.25 . . . . 2.47 107.625 169.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 66.66 14.25 9.69 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.238 1.815 . . . . 3.86 114.33 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.5 20.43 58.5 Favored Glycine 0 N--CA 1.477 1.376 0 O-C-N 121.249 -0.907 . . . . 2.65 113.467 -167.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -119.3 125.95 50.3 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.956 1.703 . . . . 2.47 109.305 172.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -88.08 123.06 32.37 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.764 1.226 . . . . 4.86 111.249 -170.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.0 t -141.68 141.06 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.2 1.8 . . . . 2.31 109.601 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -93.56 168.45 11.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.339 1.056 . . . . 3.17 113.051 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.04 -178.73 31.39 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.94 1.257 . . . . 0.68 113.634 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ttm -152.66 150.1 29.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.963 1.705 . . . . 1.15 108.816 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -158.22 154.26 23.56 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 118.23 -0.89 . . . . 4.83 111.776 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.93 154.98 62.87 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.23 1.954 . . . . 0.52 111.155 169.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.66 151.66 63.94 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.014 1.326 . . . . 0.56 110.241 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.63 -27.85 8.68 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.382 2.721 . . . . 0.6 112.573 -167.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -176.16 163.16 2.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.112 1.765 . . . . 1.7 111.472 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.8 mt -105.31 153.51 21.52 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.235 1.014 . . . . 0.57 110.592 160.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.18 144.02 34.54 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.405 1.082 . . . . 1.81 110.271 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.4 t -140.48 121.99 9.39 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 118.552 0.615 . . . . 1.09 111.714 163.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -71.36 159.6 51.17 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.465 2.777 . . . . 1.17 111.095 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.85 142.99 99.26 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.384 2.723 . . . . 1.46 111.816 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt 67.28 -5.48 0.72 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.178 2.191 . . . . 2.33 114.374 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.12 165.31 48.79 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.016 1.293 . . . . 1.32 112.118 172.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 145.53 35.87 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.701 1.201 . . . . 4.31 109.298 171.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.0 t -148.96 158.86 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 126.562 1.945 . . . . 3.06 107.809 -169.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 21' ' ' THR . 10.2 mt-10 -135.03 142.6 46.42 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.007 1.276 . . . . 4.46 111.706 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.21 79.05 1.79 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 122.121 0.962 . . . . 2.27 109.117 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -62.98 150.55 87.91 Favored Pre-proline 0 CA--C 1.558 1.281 0 N-CA-C 114.319 1.229 . . . . 3.22 114.319 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.49 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 38.2 Cg_endo -58.32 -49.68 11.69 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.396 2.731 . . . . 2.27 113.055 174.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.53 58.3 4.45 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.869 0.747 . . . . 2.12 111.474 171.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.32 -125.44 1.5 Allowed Glycine 0 N--CA 1.469 0.86 0 C-N-CA 124.819 1.2 . . . . 1.74 114.167 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -73.04 138.89 46.21 Favored 'General case' 0 C--O 1.219 -0.518 0 O-C-N 122.191 -0.593 . . . . 2.34 112.279 -168.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -162.58 152.01 15.6 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.02 0.928 . . . . 0.65 110.971 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.56 143.68 33.03 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.724 -0.473 . . . . 1.93 109.724 162.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -96.33 123.99 40.17 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.726 1.61 . . . . 0.82 108.428 166.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.17 120.37 42.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.397 0.999 . . . . 1.18 108.906 -174.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -106.47 154.7 20.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.335 1.054 . . . . 2.47 110.985 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.426 ' H ' HD22 ' A' ' 15' ' ' ASN . . . 77.12 -51.4 3.21 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 127.269 2.366 . . . . 2.56 114.747 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.7 mt 54.57 168.3 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.577 2.751 . . . . 1.14 114.568 -171.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -116.82 -23.61 8.02 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.465 1.506 . . . . 2.53 114.015 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.4 ptt-85 -137.31 149.85 67.01 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.569 1.548 . . . . 6.52 111.414 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -68.19 142.65 56.27 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.982 1.788 . . . . 1.53 107.89 154.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.96 176.95 8.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.71 0.804 . . . . 3.0 110.479 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -120.66 176.28 5.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.194 1.798 . . . . 3.47 108.618 155.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.18 126.96 33.62 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.399 -1.334 . . . . 1.49 107.399 154.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.69 6.24 54.76 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.195 -1.336 . . . . 1.99 116.155 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -77.54 -176.53 4.31 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.392 1.596 . . . . 2.85 110.444 159.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.15 170.44 9.56 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 130.607 3.563 . . . . 4.81 107.124 165.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.0 t -150.37 141.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 127.089 2.156 . . . . 1.39 108.975 166.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.24 126.29 52.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.158 1.383 . . . . 3.97 110.62 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.1 mp -115.33 140.78 48.82 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.15 0.98 . . . . 1.78 111.52 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.93 139.27 31.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 128.576 2.75 . . . . 2.91 108.994 167.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -118.83 131.12 56.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.548 1.139 . . . . 1.14 109.503 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.4 mt -112.44 116.9 31.03 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.48 1.512 . . . . 0.88 110.061 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -116.78 132.82 56.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.477 1.111 . . . . 2.13 110.771 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.9 -24.05 66.71 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.976 0.732 . . . . 2.46 112.976 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.83 41.88 2.22 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.591 1.567 . . . . 5.53 114.223 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.49 23.64 77.59 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.346 1.45 . . . . 3.43 115.601 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -135.66 145.41 46.75 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.085 1.442 . . . . 3.94 112.981 -166.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.19 141.89 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.591 1.556 . . . . 2.65 107.496 162.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.45 172.1 13.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.841 1.656 . . . . 2.09 109.658 -174.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.78 150.94 52.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.843 0.857 . . . . 4.39 111.033 167.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.7 t -136.75 157.69 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.28 1.032 . . . . 2.1 109.0 168.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.6 t -120.22 120.81 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.746 1.618 . . . . 2.34 108.262 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -122.93 145.31 45.33 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 126.744 2.018 . . . . 2.91 109.321 -170.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.48 164.08 33.12 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.192 2.595 . . . . 1.31 110.807 171.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.6 t -100.89 119.66 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.465 -0.939 . . . . 0.93 108.465 160.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 . . . . . 0 CA--C 1.537 0.471 0 N-CA-C 106.22 -1.77 . . . . 4.74 106.22 178.698 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 122.375 1.083 . . . . 5.23 109.834 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.78 -178.75 30.29 Favored Glycine 0 C--N 1.34 0.805 0 O-C-N 121.306 -0.871 . . . . 1.14 111.634 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -131.77 160.38 35.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.024 1.12 . . . . 2.35 114.024 -170.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.18 145.25 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.199 1.4 . . . . 1.55 108.552 159.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -93.3 150.05 20.77 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.75 0.82 . . . . 4.84 111.908 -175.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -70.6 139.7 51.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.605 2.362 . . . . 2.62 113.227 -172.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -179.99 142.4 0.35 Allowed Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.187 1.395 . . . . 2.11 112.827 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.01 -20.88 18.88 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.727 2.285 . . . . 1.36 112.492 162.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.58 175.67 13.96 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.809 2.147 . . . . 1.01 111.698 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.82 -15.6 29.07 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 118.893 1.346 . . . . 1.24 112.946 -3.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -128.44 159.89 33.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.031 0.919 . . . . 2.81 113.125 174.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -131.22 -178.69 4.95 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.652 3.581 . . . . 0.59 107.841 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.95 171.74 12.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.846 1.658 . . . . 1.12 108.295 169.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.34 118.74 19.8 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.488 -0.757 . . . . 0.9 109.894 164.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -102.32 63.05 0.87 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.55 1.54 . . . . 2.67 108.583 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -89.68 160.02 16.81 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.975 -1.011 . . . . 1.61 112.092 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -130.18 127.74 40.32 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.849 1.26 . . . . 2.21 108.443 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.498 HD21 HG11 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -119.74 179.72 4.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.03 1.332 . . . . 5.25 109.826 162.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -127.05 164.14 22.21 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.654 0.781 . . . . 4.84 109.886 165.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.15 81.46 0.42 Allowed Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.585 1.954 . . . . 3.16 109.314 -174.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.52 -17.41 34.15 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.78 2.32 . . . . 1.33 114.809 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.7 157.95 51.0 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.367 0.985 . . . . 1.5 110.975 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.76 4.27 37.6 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 127.59 2.356 . . . . 3.77 112.408 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mp -122.88 158.0 58.48 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 127.291 2.236 . . . . 3.91 108.72 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -83.01 141.63 10.62 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.72 2.28 . . . . 1.4 111.381 -166.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -89.74 150.04 22.47 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 123.41 1.576 . . . . 2.25 112.626 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttm-85 -130.82 97.68 4.41 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.099 -1.864 . . . . 2.77 110.227 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.525 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 6.7 tt -78.79 110.66 14.17 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 125.236 1.414 . . . . 2.6 107.695 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -100.12 -27.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 122.827 0.451 . . . . 0.5 111.697 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 -173.76 29.51 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.094 1.33 . . . . 0.43 113.396 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -143.31 177.99 8.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.11 1.764 . . . . 0.43 112.295 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -143.26 169.22 18.04 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.402 1.481 . . . . 5.52 109.319 158.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -168.85 150.44 4.57 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.757 1.623 . . . . 0.62 108.313 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.07 -14.56 12.14 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.524 1.483 . . . . 0.86 113.266 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 17.1 m -101.25 24.45 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.687 1.195 . . . . 0.82 113.621 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.9 161.82 39.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.482 1.513 . . . . 0.87 109.46 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -93.58 -44.04 8.4 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.074 2.15 . . . . 3.96 112.363 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -131.83 159.56 38.19 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.07 0.948 . . . . 6.91 109.013 160.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.84 143.6 30.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 125.277 1.431 . . . . 0.86 108.887 166.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -117.47 149.25 40.89 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.858 1.663 . . . . 2.64 109.272 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.5 tp -100.88 120.77 40.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.35 0.66 . . . . 0.9 110.022 175.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -122.62 157.94 31.08 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.16 1.384 . . . . 0.65 113.903 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -98.2 176.85 5.58 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.885 2.074 . . . . 2.41 111.878 161.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.3 m -151.76 147.36 26.58 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.024 1.73 . . . . 1.02 106.762 166.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -161.71 -179.73 7.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.635 1.174 . . . . 2.41 111.976 -164.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.0 ptt? -110.09 146.9 34.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.656 1.182 . . . . 4.33 113.538 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -132.05 148.46 52.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.412 1.885 . . . . 5.78 111.675 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.39 142.91 35.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.166 1.786 . . . . 3.53 112.298 173.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.4 m -145.56 5.47 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 127.058 2.143 . . . . 3.86 115.561 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -174.67 18.11 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.288 1.588 . . . . 3.9 115.288 -161.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.27 -5.82 32.74 Favored Glycine 0 CA--C 1.54 1.606 0 O-C-N 119.914 -1.741 . . . . 2.2 113.471 -163.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -97.39 69.93 2.27 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 129.12 2.968 . . . . 2.74 109.64 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -55.33 120.08 6.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.884 1.274 . . . . 2.95 109.953 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -145.37 144.56 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.32 1.848 . . . . 2.83 109.122 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.5 mtp -82.28 169.13 16.89 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.293 1.22 . . . . 4.15 114.293 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.2 176.83 32.72 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.911 1.719 . . . . 0.62 113.078 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.2 ttm -156.3 149.17 24.0 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.109 1.764 . . . . 1.26 109.916 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -150.94 155.43 35.2 Favored Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 125.835 1.654 . . . . 4.35 109.361 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.5 155.89 50.13 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.941 1.76 . . . . 0.53 110.847 165.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.43 153.89 66.3 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.731 1.613 . . . . 0.65 110.09 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.27 -23.41 5.19 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.649 2.899 . . . . 0.58 113.631 -167.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -176.54 160.47 2.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.05 1.74 . . . . 2.01 111.011 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -106.28 159.04 16.42 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.486 1.115 . . . . 0.66 109.182 159.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -132.95 149.97 52.2 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.256 1.022 . . . . 2.28 110.157 173.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.65 138.62 15.46 Favored Pre-proline 0 CA--C 1.537 0.464 0 O-C-N 124.056 0.847 . . . . 1.13 112.237 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.62 156.54 35.9 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.743 2.962 . . . . 1.39 112.264 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.35 140.41 91.64 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.874 3.049 . . . . 1.52 112.995 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.45 2.78 1.67 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.25 2.22 . . . . 2.41 113.96 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.52 179.7 51.92 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.227 2.346 . . . . 1.53 113.523 171.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.06 124.67 49.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.672 1.989 . . . . 4.51 110.926 -173.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.8 t -94.67 72.92 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.807 2.043 . . . . 5.57 108.27 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -117.52 115.27 24.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.806 1.288 . . . . 2.97 111.794 -158.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -87.19 74.68 9.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.551 1.94 . . . . 2.03 107.836 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 146.95 99.04 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 120.834 -1.166 . . . . 2.31 113.514 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -61.02 147.13 96.63 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.335 2.023 . . . . 3.35 109.485 164.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.07 -5.75 74.81 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.447 -1.196 . . . . 2.15 113.703 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -147.33 -121.23 1.25 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 119.156 1.478 . . . . 1.48 113.674 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -73.94 138.47 44.26 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.482 -1.011 . . . . 2.03 111.319 -167.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -160.24 153.09 21.36 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.824 0.849 . . . . 0.71 111.453 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.528 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 43.8 m-85 -80.29 139.45 36.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.865 -0.791 . . . . 1.8 108.865 164.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 tpt -100.73 120.49 40.16 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.381 1.873 . . . . 1.15 108.045 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -103.89 117.27 33.94 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.467 1.507 . . . . 1.21 108.152 -175.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.88 148.13 41.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.222 0.919 . . . . 2.03 112.163 -174.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.61 36.78 36.85 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 124.154 0.883 . . . . 1.51 113.12 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.1 mt -46.0 151.93 0.43 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 117.194 2.294 . . . . 1.07 117.194 -170.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 60.6 mmtt -114.27 -31.36 6.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 113.088 -1.869 . . . . 2.57 113.423 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -100.47 125.54 38.87 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 117.109 -1.424 . . . . 4.82 107.776 156.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.96 112.36 2.0 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 N-CA-C 105.501 -2.538 . . . . 1.32 105.501 152.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.01 137.88 51.12 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.472 1.129 . . . . 2.43 112.995 -159.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -132.99 164.78 26.23 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 126.058 1.743 . . . . 3.45 113.67 -157.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.54 116.93 15.79 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.185 -0.916 . . . . 1.34 109.778 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.2 15.13 36.63 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.736 -1.036 . . . . 1.26 114.527 -171.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -97.67 178.82 5.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.8 1.3 . . . . 2.21 110.411 159.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -137.32 150.83 48.03 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.391 2.276 . . . . 3.28 105.873 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.1 t -145.06 144.83 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 127.177 2.191 . . . . 1.14 109.329 -172.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -92.87 134.27 35.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.871 -0.604 . . . . 3.49 111.429 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -114.3 146.01 41.02 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.271 1.828 . . . . 2.72 109.774 164.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -101.35 139.82 36.5 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.473 1.509 . . . . 2.01 108.757 157.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.82 122.6 46.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.248 1.419 . . . . 1.09 108.932 167.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.8 mt -94.76 114.38 26.27 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.279 1.032 . . . . 0.63 110.232 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -109.93 112.92 25.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.039 1.336 . . . . 2.11 111.326 -172.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 51.51 29.77 5.72 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.837 1.655 . . . . 2.35 113.023 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.97 -71.21 1.71 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.182 1.373 . . . . 4.66 111.98 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.9 13.45 18.71 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 116.999 1.56 . . . . 1.68 116.999 -163.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -132.05 143.75 50.26 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.634 1.574 . . . . 3.29 110.048 168.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.63 144.79 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.39 1.076 . . . . 2.06 109.106 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.9 tp -136.27 123.39 21.64 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.26 1.024 . . . . 2.26 110.188 170.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -99.99 140.78 33.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.765 1.226 . . . . 3.01 111.993 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.498 HG11 HD21 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -149.18 138.53 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.028 1.331 . . . . 2.07 112.102 -173.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.3 p -83.07 136.53 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.814 0.846 . . . . 2.71 109.862 165.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 mt -134.96 142.37 41.88 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.338 2.255 . . . . 2.5 107.472 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 154.93 66.46 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.7 2.266 . . . . 0.79 111.571 168.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 64.9 t -91.1 126.41 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.936 0.494 . . . . 0.94 110.141 165.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 . . . . . 0 N--CA 1.469 0.516 0 C-N-CA 125.358 1.463 . . . . 4.66 112.638 175.307 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 107.151 -1.426 . . . . 4.88 107.151 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.77 172.03 37.01 Favored Glycine 0 N--CA 1.464 0.536 0 O-C-N 121.341 -0.849 . . . . 1.4 112.775 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.9 p90 -157.92 151.46 23.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.722 1.609 . . . . 2.35 110.974 167.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.35 145.96 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 106.964 -1.495 . . . . 1.55 106.964 162.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -80.29 -88.98 0.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.056 1.298 . . . . 5.91 111.786 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -164.09 141.55 6.95 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.723 0.809 . . . . 3.11 112.118 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.1 t -176.43 140.2 0.51 Allowed Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.795 1.638 . . . . 2.25 111.489 165.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.32 -29.59 7.59 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.507 2.138 . . . . 1.46 112.53 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.64 171.91 12.35 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.309 1.909 . . . . 1.11 111.629 -170.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.55 -6.02 31.53 Favored 'Cis proline' 0 CA--C 1.536 0.613 0 CA-C-N 119.305 1.552 . . . . 1.28 113.528 0.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -148.64 164.75 33.35 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.457 1.28 . . . . 2.01 114.457 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.35 -179.02 5.64 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.975 2.51 . . . . 0.69 110.443 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.39 138.97 33.38 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.148 1.379 . . . . 1.26 109.305 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.21 154.73 47.26 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.059 1.744 . . . . 0.88 112.597 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -136.89 143.91 43.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.51 2.324 . . . . 2.51 110.187 -167.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -171.35 153.48 3.6 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.13 1.159 . . . . 2.2 114.13 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.7 p -90.45 144.3 25.93 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.522 1.929 . . . . 2.96 110.456 173.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.5 142.86 51.28 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.733 1.613 . . . . 3.89 107.929 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -127.9 140.59 51.91 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.949 -0.76 . . . . 4.34 108.949 157.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -86.15 112.51 46.24 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.326 1.05 . . . . 1.36 108.958 170.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.39 -12.89 11.29 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.615 2.21 . . . . 1.17 113.788 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 171.74 46.85 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 122.964 1.313 . . . . 1.22 112.456 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.32 -5.38 36.72 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.346 2.659 . . . . 2.93 112.274 -176.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.5 mt -121.16 162.62 34.61 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 127.896 2.478 . . . . 3.93 109.3 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.72 150.51 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.359 2.04 . . . . 0.92 111.849 -168.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.8 mt -103.45 148.83 25.45 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.26 1.024 . . . . 1.85 109.951 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -134.0 101.92 5.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 112.886 -1.961 . . . . 1.69 110.471 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.15 104.63 16.87 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.631 1.572 . . . . 1.77 108.318 -172.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -97.91 -30.3 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.616 0.766 . . . . 0.63 112.443 -168.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.33 -175.7 29.56 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.468 1.032 . . . . 0.44 112.423 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.01 174.21 10.42 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.658 0.742 . . . . 0.6 111.98 166.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -127.65 164.03 22.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.481 1.912 . . . . 5.78 107.8 156.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -171.8 151.02 2.69 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 127.186 2.195 . . . . 0.76 108.801 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.13 -24.39 5.71 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.223 1.949 . . . . 1.02 114.013 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 25.5 m -103.97 22.58 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.502 1.121 . . . . 0.95 113.817 -172.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.95 152.22 24.49 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 126.37 1.868 . . . . 1.03 108.221 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -90.93 -66.77 0.9 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 126.039 1.735 . . . . 3.5 109.394 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -86.79 140.7 29.45 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.951 -1.87 . . . . 6.4 105.951 164.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.18 127.57 65.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 106.769 -1.567 . . . . 1.34 106.769 162.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -124.75 125.79 44.63 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.563 1.145 . . . . 2.63 109.275 -163.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.2 tp -79.89 122.78 27.1 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.053 -0.404 . . . . 0.98 110.796 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -120.33 161.6 20.87 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.323 1.449 . . . . 0.54 112.804 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.465 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 19.6 pt-20 -112.13 159.3 18.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.027 2.131 . . . . 2.88 110.742 161.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.3 m -124.43 143.25 50.73 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.435 2.294 . . . . 0.77 105.654 168.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -152.03 170.62 19.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.711 0.804 . . . . 2.1 112.51 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.8 ptm -99.34 143.35 29.69 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.992 0.917 . . . . 4.34 111.867 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -156.65 154.39 30.06 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.667 1.187 . . . . 8.19 113.02 -177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.47 160.12 26.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.954 0.901 . . . . 5.11 110.589 158.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.5 m -146.87 -12.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 117.083 2.253 . . . . 4.17 117.083 170.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 178.38 32.35 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.493 2.035 . . . . 4.54 116.493 -158.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.56 15.45 70.79 Favored Glycine 0 N--CA 1.476 1.359 0 O-C-N 119.288 -2.133 . . . . 2.38 112.685 -167.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -142.87 88.63 2.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.987 2.515 . . . . 2.86 110.002 -166.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.13 122.63 12.87 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.023 -1.048 . . . . 3.72 113.022 174.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.4 m -135.76 -176.08 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 129.376 3.071 . . . . 2.64 110.043 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.5 mtp -98.51 166.21 11.46 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.803 1.287 . . . . 4.46 113.953 167.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.77 -179.91 17.51 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 127.142 2.306 . . . . 0.78 111.079 170.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -149.47 145.69 27.03 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.366 1.866 . . . . 1.16 108.344 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.35 147.47 33.96 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.646 1.578 . . . . 7.58 109.533 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.82 150.01 23.57 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.522 2.148 . . . . 0.58 110.254 167.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -139.09 156.2 72.4 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.802 1.241 . . . . 0.6 111.185 -172.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -84.87 -23.22 2.63 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.128 2.552 . . . . 0.56 113.712 -165.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -179.13 162.82 1.25 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.413 1.885 . . . . 1.77 111.415 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -107.71 150.39 27.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.573 1.149 . . . . 0.51 110.244 162.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -109.5 142.76 40.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.018 -1.105 . . . . 2.1 108.018 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.5 t -134.79 122.47 15.47 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.18 -0.438 . . . . 0.85 111.131 165.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -69.23 161.5 45.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.539 2.826 . . . . 0.94 111.153 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -58.99 138.5 86.03 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.412 2.742 . . . . 0.98 112.41 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt 67.24 -7.68 0.5 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.134 1.774 . . . . 1.68 114.092 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.55 142.97 25.32 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.751 1.167 . . . . 1.21 113.025 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -101.69 133.03 47.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.406 1.482 . . . . 3.9 108.913 168.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -148.59 141.51 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.765 2.026 . . . . 3.33 108.542 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.04 137.67 54.56 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.259 1.024 . . . . 3.51 113.294 -168.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -70.63 74.03 0.56 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.126 1.77 . . . . 2.1 109.372 158.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -68.65 138.92 91.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.244 2.218 . . . . 2.4 111.99 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.65 -34.46 62.99 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.643 2.229 . . . . 2.26 114.12 -173.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.89 6.78 46.49 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.26 -0.745 . . . . 1.85 114.178 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.89 -121.07 1.27 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.307 1.908 . . . . 1.56 111.907 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 96.8 m-85 -73.71 138.14 44.48 Favored 'General case' 0 C--O 1.223 -0.312 0 O-C-N 121.567 -0.961 . . . . 2.04 112.341 -171.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -159.89 150.67 19.11 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 124.209 1.003 . . . . 0.71 111.1 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -87.8 128.01 35.33 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.755 -0.591 . . . . 1.95 109.481 171.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.2 tpt -85.57 110.87 19.54 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.752 1.621 . . . . 0.82 109.655 168.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.7 mp -90.28 116.42 28.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.852 1.261 . . . . 1.48 108.574 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tt -127.17 143.36 51.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.995 0.902 . . . . 2.78 112.54 -164.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.78 38.6 41.93 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 121.418 -0.801 . . . . 1.72 112.445 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt -45.52 153.88 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 117.865 2.543 . . . . 0.76 117.865 -170.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 51.5 mmtt -119.26 -24.74 6.32 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.673 -1.603 . . . . 2.24 113.759 -176.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -125.87 147.83 60.3 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.168 2.187 . . . . 6.11 107.992 157.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -66.89 144.67 71.63 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.948 1.765 . . . . 2.08 108.28 165.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.16 75.73 8.13 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.919 -1.141 . . . . 2.74 107.919 170.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -88.8 165.1 14.91 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.609 1.164 . . . . 3.3 111.662 170.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.47 132.14 51.5 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.454 -0.779 . . . . 2.1 111.372 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.6 1.41 58.94 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 117.231 -1.872 . . . . 1.9 115.745 169.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -76.6 167.59 21.58 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.82 1.81 . . . . 2.39 110.342 169.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.23 133.02 47.34 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 130.455 3.502 . . . . 3.9 104.362 173.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.1 t -136.98 132.62 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.828 1.251 . . . . 1.3 111.196 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -79.37 142.78 35.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.279 -1.328 . . . . 2.39 112.067 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -122.47 154.82 37.3 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.138 -0.937 . . . . 1.95 109.922 152.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -125.76 112.65 16.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.175 2.19 . . . . 2.61 108.809 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mp -84.98 116.71 23.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.599 1.16 . . . . 0.91 111.194 -171.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.9 mt -85.69 106.71 17.15 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.705 1.202 . . . . 0.61 109.937 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -103.24 107.71 18.63 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.279 1.432 . . . . 2.04 111.74 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 55.17 27.43 9.59 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.975 1.71 . . . . 2.51 112.906 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.85 -59.23 3.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.52 1.533 . . . . 4.68 113.163 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.68 -1.23 70.96 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.58 1.392 . . . . 1.61 116.58 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -133.32 146.74 51.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.218 1.509 . . . . 2.83 111.372 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.89 149.75 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.352 1.461 . . . . 2.24 110.779 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.7 tt -145.01 130.08 18.44 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.621 1.168 . . . . 2.16 111.259 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 140.55 38.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.642 1.177 . . . . 2.22 113.425 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.77 165.82 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.881 1.672 . . . . 2.71 110.749 163.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.24 151.3 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.813 1.245 . . . . 2.67 109.493 168.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.38 137.77 9.6 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 126.188 1.795 . . . . 2.45 112.796 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.45 163.62 31.89 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.264 3.309 . . . . 1.42 113.364 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.6 t -103.87 109.58 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 122.326 1.06 . . . . 1.52 110.624 174.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 . . . . . 0 CA--C 1.534 0.334 0 C-N-CA 127.689 2.396 . . . . 4.17 109.635 -170.383 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 . . . . . 0 N--CA 1.474 0.761 0 CA-C-O 121.457 0.646 . . . . 4.83 111.631 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.09 -178.42 15.5 Favored Glycine 0 N--CA 1.469 0.849 0 O-C-N 120.774 -1.204 . . . . 1.21 111.583 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -144.83 166.87 24.02 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.296 0.85 . . . . 2.41 113.296 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.5 t -115.99 143.46 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.846 1.259 . . . . 1.24 109.185 176.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -26.29 60.9 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 117.268 2.322 . . . . 4.65 117.268 -151.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER 79.78 114.79 0.06 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.232 2.213 . . . . 2.94 108.159 -167.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.5 m -160.88 138.59 6.98 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.645 1.978 . . . . 2.29 108.286 166.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.03 -33.13 10.08 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.39 2.06 . . . . 1.46 111.76 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.57 179.87 22.14 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.18 1.372 . . . . 0.96 112.331 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.22 -5.64 16.38 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 CA-C-N 118.48 1.14 . . . . 1.22 113.013 -2.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.56 HD22 ' H ' ' A' ' 88' ' ' GLY . 2.8 m120 -135.74 175.14 9.87 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.759 1.623 . . . . 4.14 111.903 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.27 -175.46 5.42 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.947 2.899 . . . . 0.44 111.585 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.37 154.93 45.92 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.365 2.266 . . . . 0.74 107.84 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.2 130.53 39.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.83 0.741 . . . . 0.52 110.391 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -110.64 54.12 0.68 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.175 2.19 . . . . 2.33 111.366 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.97 150.75 37.39 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.136 -0.978 . . . . 1.63 113.309 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -91.79 134.67 34.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.304 0.642 . . . . 1.63 109.78 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.56 134.54 51.79 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.143 2.177 . . . . 3.29 110.234 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -119.17 151.98 37.38 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.889 1.676 . . . . 5.34 110.445 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -114.65 103.68 54.75 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.196 0.998 . . . . 1.39 109.083 160.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -83.62 -8.54 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.244 2.629 . . . . 1.67 114.455 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.57 175.9 30.73 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 119.441 1.019 . . . . 1.35 112.066 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -92.18 1.21 57.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.069 2.148 . . . . 3.51 112.984 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.0 pt? -112.16 157.21 40.5 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 127.425 2.29 . . . . 3.88 110.402 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.25 158.01 41.42 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.802 2.335 . . . . 1.15 111.067 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.3 mt -134.0 130.3 37.4 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 124.239 1.971 . . . . 1.83 112.785 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -108.89 106.12 15.97 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 110.704 -2.953 . . . . 2.0 111.331 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.29 114.74 26.85 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.361 1.464 . . . . 2.4 108.358 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.2 -25.56 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.646 0.778 . . . . 0.7 112.685 -170.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.28 -174.55 27.13 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.319 0.961 . . . . 0.54 112.9 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.94 -177.55 5.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.248 1.019 . . . . 0.67 111.056 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.54 -175.58 5.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.849 2.459 . . . . 5.45 109.441 164.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t 178.71 150.37 0.44 Allowed Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 129.528 3.131 . . . . 0.95 106.192 -167.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.24 -12.82 14.11 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.925 1.75 . . . . 0.89 113.472 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.93 23.54 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.717 1.377 . . . . 1.01 114.717 -170.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -150.78 134.15 16.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.874 1.67 . . . . 1.12 109.764 168.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -59.51 -48.88 79.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.35 1.06 . . . . 2.78 111.569 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.39 165.29 16.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.7 2.4 . . . . 5.42 109.568 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -148.17 145.89 18.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 126.072 1.749 . . . . 0.9 108.323 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -130.12 146.09 51.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.499 1.92 . . . . 2.67 109.435 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -99.37 117.01 32.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.014 0.925 . . . . 0.89 109.588 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -118.66 149.95 40.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 123.089 1.423 . . . . 0.56 113.844 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -95.84 172.44 8.02 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.915 1.686 . . . . 2.36 111.348 164.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.4 m -148.29 144.56 27.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.525 1.53 . . . . 0.95 107.165 170.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -157.17 166.81 32.19 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.939 0.718 . . . . 2.01 112.939 -166.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.2 mtp -93.73 144.36 25.48 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.068 0.947 . . . . 4.02 111.473 170.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -157.88 163.0 38.36 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.708 1.603 . . . . 8.19 111.906 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.27 152.65 32.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.904 1.282 . . . . 3.41 110.534 165.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.65 120.46 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 106.714 -1.587 . . . . 3.86 106.714 142.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 55.34 44.28 27.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.4 1.48 . . . . 5.74 113.113 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.48 0.74 63.43 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.051 -1.031 . . . . 2.47 114.128 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -109.35 114.78 28.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.077 1.351 . . . . 3.54 109.753 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -67.65 127.07 31.39 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.094 1.358 . . . . 4.25 111.171 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.65 -177.17 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 129.763 3.225 . . . . 2.39 109.75 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 59.2 mtt -110.08 167.27 10.3 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.109 -0.994 . . . . 2.88 113.602 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.53 172.15 29.56 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 126.034 1.778 . . . . 0.7 112.262 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -149.68 147.5 28.15 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.294 1.838 . . . . 1.28 108.952 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -151.16 156.88 35.37 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 127.034 2.134 . . . . 4.68 108.866 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.15 149.72 28.63 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.13 1.887 . . . . 0.45 110.508 167.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.7 m -137.64 152.42 72.7 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 125.399 1.48 . . . . 0.88 110.362 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.59 -24.29 2.98 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.09 2.526 . . . . 0.58 113.504 -160.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -177.11 160.85 1.81 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.255 1.422 . . . . 2.2 112.25 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.63 154.77 20.43 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.704 1.601 . . . . 0.67 109.89 162.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -115.77 149.86 37.83 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.7 1.2 . . . . 3.07 108.71 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.19 127.86 10.64 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 112.776 0.658 . . . . 0.96 112.776 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.62 155.42 44.77 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.416 2.744 . . . . 1.44 112.098 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.33 139.59 83.69 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.228 3.285 . . . . 1.53 113.388 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.45 1.34 0.97 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.968 2.107 . . . . 2.54 114.347 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.84 167.13 51.14 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.201 1.858 . . . . 1.4 113.037 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.21 150.73 45.88 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.541 1.536 . . . . 4.05 109.174 169.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.3 t -149.79 135.97 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.866 1.667 . . . . 3.5 107.216 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.99 132.55 54.12 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 119.071 0.85 . . . . 2.65 111.741 -177.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -71.25 80.7 0.73 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.933 1.349 . . . . 2.37 109.694 168.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.53 146.85 66.52 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.529 1.532 . . . . 2.88 112.838 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -53.56 -41.94 69.69 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.403 2.735 . . . . 2.94 112.431 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.94 54.0 4.66 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 118.612 -1.104 . . . . 2.29 113.202 170.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.48 -29.64 0.51 Allowed Glycine 0 N--CA 1.472 1.084 0 N-CA-C 119.953 2.741 . . . . 2.46 119.953 155.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -147.26 137.12 23.05 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.924 2.362 . . . . 2.21 111.528 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -161.32 156.7 24.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.599 0.592 . . . . 0.66 112.599 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -84.43 145.3 28.24 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.409 -0.589 . . . . 1.82 109.409 163.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -99.23 132.19 44.72 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.073 1.749 . . . . 0.78 108.838 161.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -110.21 115.38 29.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.17 1.388 . . . . 1.15 108.257 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.62 142.22 42.78 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.96 0.904 . . . . 2.5 109.809 -171.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.56 ' H ' HD22 ' A' ' 15' ' ' ASN . . . 64.03 55.83 21.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.413 1.006 . . . . 1.77 113.877 174.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 17.7 mt -48.56 154.26 0.68 Allowed 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 115.153 1.538 . . . . 0.73 115.153 176.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -98.88 -26.69 14.2 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 113.016 -1.902 . . . . 1.75 113.276 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.83 152.0 29.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.734 2.414 . . . . 5.62 110.741 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.39 135.4 24.43 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.422 2.748 . . . . 1.52 110.534 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -124.36 125.61 44.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.744 1.217 . . . . 2.24 111.913 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.5 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 4.1 ptpp? -114.87 168.57 9.78 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.639 1.175 . . . . 3.12 113.699 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.33 140.46 48.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.252 0.621 . . . . 1.94 109.845 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.31 12.63 62.9 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.651 1.119 . . . . 1.87 113.993 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -99.77 179.64 4.46 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.29 1.036 . . . . 2.33 110.161 162.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 39.2 mt-10 -124.86 152.57 43.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.538 2.335 . . . . 3.39 104.761 163.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.5 t -147.39 144.79 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.385 1.874 . . . . 1.2 109.809 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -94.12 142.26 27.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.115 0.966 . . . . 2.38 113.3 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 54.2 mt -130.19 160.89 32.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.303 2.241 . . . . 2.73 110.596 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -121.29 126.13 48.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.65 2.38 . . . . 2.8 109.05 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.95 123.56 45.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.233 1.413 . . . . 1.15 110.653 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.8 mt -104.23 110.59 22.86 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.314 1.045 . . . . 0.79 110.829 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.65 144.06 35.26 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.416 1.486 . . . . 1.95 111.044 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.51 134.39 56.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.569 0.748 . . . . 2.42 112.152 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.67 42.2 5.81 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.865 -0.964 . . . . 3.66 113.909 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.14 6.47 86.18 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 115.846 1.098 . . . . 1.82 115.846 166.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -90.99 121.64 32.98 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.43 1.115 . . . . 3.2 111.496 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.38 137.0 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.583 1.553 . . . . 2.07 108.828 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.6 tp -137.15 113.58 10.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.049 0.94 . . . . 2.58 110.329 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -83.43 141.53 31.63 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.936 -0.478 . . . . 2.57 111.803 171.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.8 171.13 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 127.437 2.295 . . . . 2.63 110.683 -171.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.87 138.22 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.484 1.113 . . . . 2.43 110.394 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mp -142.94 153.2 60.39 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.106 1.762 . . . . 3.06 109.951 -175.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 72.1 Cg_endo -69.46 154.32 69.09 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.016 3.144 . . . . 1.17 112.999 171.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.5 t -93.98 125.75 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.237 -1.023 . . . . 1.29 108.237 165.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 N--CA 1.466 0.345 0 C-N-CA 125.195 1.398 . . . . 4.32 108.421 179.159 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 108.774 -0.825 . . . . 6.14 108.774 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.25 169.33 13.76 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 114.927 0.731 . . . . 1.17 114.927 -169.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -151.61 168.64 24.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.16 1.384 . . . . 2.31 113.036 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.44 148.07 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.688 1.595 . . . . 1.26 107.784 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -70.98 -132.79 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.26 1.024 . . . . 6.62 111.34 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -145.27 134.93 23.4 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.447 -1.408 . . . . 2.01 109.831 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.1 p -176.53 117.13 0.28 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.883 1.068 . . . . 3.56 113.883 -163.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.4 -28.01 10.72 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.432 2.088 . . . . 1.39 112.263 169.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.24 -176.52 18.11 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.815 1.674 . . . . 0.97 111.936 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.42 -8.26 21.81 Favored 'Cis proline' 0 CA--C 1.536 0.581 0 CA-C-N 118.924 1.362 . . . . 1.14 113.43 1.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -128.23 165.01 21.31 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 126.41 1.884 . . . . 1.87 112.552 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.57 -178.54 6.75 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.936 2.494 . . . . 0.72 110.707 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.31 141.76 26.43 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.992 1.317 . . . . 0.67 110.042 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.48 150.48 50.14 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.262 1.425 . . . . 0.81 111.561 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -133.36 66.46 1.56 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.828 2.051 . . . . 2.29 109.564 -166.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -72.4 165.57 24.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.631 1.572 . . . . 2.03 114.666 -173.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -93.63 151.45 19.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.321 1.048 . . . . 4.38 110.4 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.9 tp -135.99 117.42 14.73 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.271 1.428 . . . . 4.32 110.074 -167.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -114.11 135.18 54.31 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.306 1.442 . . . . 6.35 111.001 -173.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.35 67.16 3.44 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.071 -1.018 . . . . 2.63 110.965 171.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.75 -22.72 56.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.42 2.746 . . . . 1.7 114.64 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.56 -171.94 42.48 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-O 122.534 1.074 . . . . 1.54 113.338 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.85 -0.42 16.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.746 2.018 . . . . 2.98 112.929 -167.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.9 mt -122.29 160.25 48.73 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 127.001 2.12 . . . . 3.9 109.243 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -81.96 144.29 13.46 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.711 2.274 . . . . 0.97 111.349 -168.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 mp -101.55 154.61 18.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 123.031 1.396 . . . . 2.79 111.271 171.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -136.69 103.66 5.28 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 113.583 -1.644 . . . . 1.81 109.627 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.15 108.07 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.571 1.549 . . . . 1.91 108.263 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.5 m -102.57 -25.53 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.519 0.933 . . . . 0.61 113.519 -169.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.23 -176.98 30.89 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 124.862 1.22 . . . . 0.53 112.055 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.83 -179.72 5.47 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.555 0.693 . . . . 0.54 112.582 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 172.91 14.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.371 2.269 . . . . 5.72 108.862 161.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t 175.12 150.14 0.27 Allowed Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 129.509 3.123 . . . . 0.88 106.977 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.2 -15.73 25.42 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.128 1.885 . . . . 1.26 114.311 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.57 23.07 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 116.059 1.874 . . . . 1.15 116.059 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.21 136.63 14.11 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.42 1.488 . . . . 1.13 110.761 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.34 -46.55 89.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.251 1.02 . . . . 2.76 112.338 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -127.52 160.22 32.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.894 2.078 . . . . 4.66 108.993 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.0 152.96 24.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 126.851 2.06 . . . . 0.91 108.545 170.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.5 147.41 26.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.232 1.813 . . . . 4.26 108.313 -166.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.2 tp -111.05 110.12 20.51 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.445 1.02 . . . . 0.82 110.711 -164.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -117.65 153.72 32.83 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 123.019 1.39 . . . . 0.58 113.654 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -109.92 177.26 4.77 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 113.392 -1.731 . . . . 2.48 111.671 163.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.8 m -152.93 103.14 2.72 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.156 1.382 . . . . 1.2 107.342 -169.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -107.28 165.25 11.52 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.276 1.031 . . . . 2.27 113.59 -166.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.4 mtm -101.55 150.58 22.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.048 1.339 . . . . 4.82 110.57 166.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.28 156.48 32.51 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.238 1.015 . . . . 5.3 110.934 -169.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -108.89 145.7 34.93 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.606 1.563 . . . . 2.64 108.665 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -153.13 136.62 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.545 -0.909 . . . . 2.99 108.545 160.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 67.45 16.94 10.06 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.747 1.219 . . . . 3.89 112.863 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.12 17.43 78.24 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.73 -1.231 . . . . 1.52 113.357 -169.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -120.82 126.72 50.81 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.985 2.114 . . . . 3.22 109.109 -172.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -73.15 121.27 19.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.253 1.821 . . . . 3.04 108.974 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.26 179.8 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.418 1.887 . . . . 2.85 110.543 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.7 mtt -130.31 170.27 14.35 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.178 1.391 . . . . 2.57 111.091 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.49 -178.22 29.51 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.382 0.991 . . . . 0.56 112.916 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.9 ttm -143.91 150.2 38.02 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.98 1.712 . . . . 1.16 108.149 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -159.22 153.84 20.81 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.377 1.071 . . . . 4.95 109.994 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.72 159.82 38.36 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.368 2.045 . . . . 0.55 110.986 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.94 152.66 40.86 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 125.875 1.67 . . . . 1.06 109.88 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -83.51 -26.53 2.09 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.992 2.461 . . . . 0.69 113.557 -160.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -177.61 166.33 2.17 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.835 1.654 . . . . 2.15 111.819 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.3 mt -109.83 153.35 24.53 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.405 1.482 . . . . 0.72 110.277 161.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -117.97 147.55 43.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.888 1.675 . . . . 1.69 108.504 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 t -140.41 139.06 19.74 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 112.606 0.595 . . . . 1.28 112.606 171.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.77 157.11 15.91 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.887 3.058 . . . . 1.17 112.232 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.35 146.75 96.93 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.926 3.084 . . . . 1.37 114.597 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm 70.37 -5.65 1.32 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.153 2.581 . . . . 2.2 114.189 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.81 167.09 52.54 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.947 1.26 . . . . 2.0 113.987 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.18 135.19 20.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.223 2.609 . . . . 6.66 106.457 168.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.2 t -152.87 96.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.715 1.206 . . . . 3.66 111.848 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -74.04 160.39 31.35 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.31 -1.494 . . . . 4.24 112.149 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mp -67.34 90.15 0.22 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.878 1.323 . . . . 2.33 108.611 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.628 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -42.23 135.34 2.43 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 127.428 2.291 . . . . 4.05 112.865 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.9 -31.79 91.92 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.389 2.06 . . . . 2.15 112.513 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.65 96.37 1.72 Allowed Glycine 0 C--N 1.343 0.933 0 C-N-CA 123.97 0.795 . . . . 3.11 111.374 166.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.56 -15.67 4.92 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 117.548 1.779 . . . . 1.88 117.548 149.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -140.95 146.28 37.15 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.442 2.121 . . . . 2.15 112.175 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -160.59 148.29 16.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.588 1.155 . . . . 0.78 111.78 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -79.54 120.89 24.53 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.501 -0.925 . . . . 1.85 108.501 161.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 tpt -78.88 127.6 32.23 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.061 2.545 . . . . 1.16 108.756 167.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.1 mt -113.93 134.59 54.73 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.952 1.701 . . . . 2.36 109.338 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.3 131.04 36.0 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.198 0.908 . . . . 2.17 111.797 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.66 49.28 4.92 Favored Glycine 0 N--CA 1.468 0.819 0 C-N-CA 123.747 0.689 . . . . 1.9 112.201 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.4 mt -52.66 155.83 2.11 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 115.078 1.51 . . . . 0.73 115.078 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -110.01 -13.17 14.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.869 -1.514 . . . . 1.71 114.849 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.1 mmt-85 -140.38 138.11 18.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 130.136 3.374 . . . . 7.05 108.697 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.52 137.89 18.91 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.34 2.027 . . . . 1.41 108.583 161.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -91.65 143.64 26.35 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.785 0.802 . . . . 2.48 112.525 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -91.71 -162.96 0.97 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.911 1.338 . . . . 3.81 109.203 163.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.11 142.96 37.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.132 -1.395 . . . . 1.08 107.811 155.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.84 33.83 12.09 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.877 -0.957 . . . . 1.32 114.309 -173.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -112.62 -176.38 2.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.162 1.385 . . . . 2.17 110.473 168.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -146.51 134.99 22.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 128.274 2.63 . . . . 3.1 105.153 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.4 t -143.72 144.51 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.118 1.367 . . . . 1.19 107.929 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.79 146.21 28.1 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.514 0.673 . . . . 3.29 111.027 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.81 140.11 53.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.335 1.054 . . . . 1.75 109.894 169.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -79.78 135.17 36.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.595 2.758 . . . . 2.23 109.708 162.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.32 123.65 46.51 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.992 1.717 . . . . 1.29 106.946 170.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.67 104.67 16.68 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.926 -1.139 . . . . 0.85 107.926 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -96.19 128.84 43.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.456 1.102 . . . . 2.18 111.237 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 45.13 40.64 4.99 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.438 1.895 . . . . 2.94 112.831 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.52 -94.38 1.97 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.539 1.066 . . . . 5.9 111.506 -170.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.1 -6.78 62.91 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 117.121 1.609 . . . . 3.12 117.121 -160.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -80.8 104.85 11.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.819 2.309 . . . . 2.61 110.765 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.02 135.07 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.252 1.021 . . . . 2.46 111.402 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 tt -155.19 129.92 9.25 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.549 1.54 . . . . 2.24 109.26 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.64 153.14 20.4 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.856 1.428 . . . . 3.74 114.856 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 t -130.14 161.35 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.602 2.361 . . . . 2.14 108.9 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.83 147.03 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.0 1.72 . . . . 2.09 109.051 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.61 138.19 11.75 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.237 1.015 . . . . 2.06 111.598 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.18 160.82 46.3 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.901 3.067 . . . . 0.99 112.962 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.3 t -106.6 128.38 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.407 1.883 . . . . 0.95 109.548 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 . . . . . 0 CA--C 1.542 0.666 0 C-N-CA 124.509 1.124 . . . . 3.46 110.956 -174.385 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 . . . . . 0 CA--C 1.543 0.677 0 CA-C-O 121.515 0.674 . . . . 4.58 111.952 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.04 177.35 39.79 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 116.079 1.192 . . . . 1.21 116.079 -163.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -150.24 149.46 30.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.337 1.855 . . . . 2.18 110.483 166.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.0 t -93.22 148.61 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 121.004 -1.06 . . . . 1.18 108.174 172.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -143.26 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.304 0.573 . . . . 5.28 110.957 170.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -152.76 121.12 6.3 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 119.78 -1.825 . . . . 2.31 111.044 -160.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -165.14 146.95 6.47 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 127.704 2.402 . . . . 1.95 109.796 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.46 -34.11 4.8 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.413 2.075 . . . . 1.68 111.538 164.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.05 176.74 23.41 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.139 1.828 . . . . 1.08 111.24 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.25 -4.62 33.85 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 CA-C-N 119.395 1.597 . . . . 1.06 113.319 -1.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -138.27 164.04 30.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 122.265 1.031 . . . . 2.03 113.337 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.31 -177.48 4.86 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.349 2.26 . . . . 0.56 110.701 169.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.38 153.33 51.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.935 1.694 . . . . 0.87 109.227 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.21 153.07 42.46 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.991 0.916 . . . . 0.83 113.025 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -126.82 134.94 50.44 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.568 1.947 . . . . 2.76 108.811 -174.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.48 171.58 11.71 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.458 1.026 . . . . 3.08 112.587 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.1 m -111.01 147.3 35.05 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.241 1.416 . . . . 1.97 111.128 -171.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.96 138.55 49.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.266 2.226 . . . . 4.28 109.356 167.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.53 175.04 5.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.574 1.55 . . . . 6.97 110.749 165.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -146.71 103.7 3.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 121.214 -0.929 . . . . 1.83 109.728 166.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.03 -13.65 12.65 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.885 2.39 . . . . 2.07 113.247 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.63 179.59 53.04 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 122.748 1.194 . . . . 1.56 112.795 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.18 -2.49 24.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.866 2.466 . . . . 3.11 111.87 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -123.07 159.36 54.47 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.391 2.676 . . . . 2.68 109.866 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.73 151.29 28.19 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.439 2.093 . . . . 1.03 112.171 -171.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.8 mt -100.15 155.9 17.49 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 125.278 1.431 . . . . 2.13 110.498 168.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -139.55 120.69 14.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 113.716 -1.584 . . . . 2.23 110.289 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.3 116.1 31.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.602 1.961 . . . . 1.85 107.951 -171.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.32 -21.79 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.142 0.977 . . . . 0.51 112.819 -166.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.4 -175.72 31.71 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 124.716 1.15 . . . . 0.55 113.224 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.61 176.65 9.05 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.525 0.73 . . . . 0.7 112.017 170.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.26 153.5 38.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.525 3.13 . . . . 5.56 107.96 176.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -167.93 153.49 6.89 Favored Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 127.122 2.169 . . . . 0.67 109.548 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -74.41 -18.54 20.25 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.834 2.356 . . . . 0.86 114.246 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -108.72 20.15 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.739 1.385 . . . . 0.96 114.739 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.07 150.61 31.97 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.469 1.907 . . . . 0.79 107.813 166.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -79.79 -62.4 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.588 0.755 . . . . 3.63 109.709 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.85 172.08 7.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.45 1.9 . . . . 4.89 107.452 170.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.57 135.85 9.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 107.347 -1.353 . . . . 0.95 107.347 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -105.97 149.84 26.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.476 1.51 . . . . 3.03 109.496 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.3 tp -103.25 120.19 40.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.677 0.791 . . . . 0.88 109.62 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -123.65 149.61 45.21 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.239 1.416 . . . . 0.51 113.966 -174.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -92.36 157.11 16.8 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.466 1.506 . . . . 2.03 111.144 162.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.1 m -120.04 146.09 46.22 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 105.736 -1.949 . . . . 1.22 105.736 165.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -160.18 -171.87 3.37 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.202 0.91 . . . . 2.09 112.796 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.2 mtt -127.78 148.0 50.43 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.25 1.42 . . . . 5.1 113.131 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.28 146.86 52.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.882 1.673 . . . . 5.85 112.992 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -87.51 140.0 29.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.652 1.181 . . . . 2.44 109.103 151.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.4 t -142.82 122.59 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.275 1.83 . . . . 2.26 106.974 168.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 63.76 12.76 6.92 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.155 1.782 . . . . 3.33 114.777 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.31 24.23 59.51 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 120.918 -1.114 . . . . 1.56 113.174 -167.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -127.65 137.42 52.52 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.059 2.144 . . . . 2.47 108.296 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -98.31 123.98 42.7 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.678 1.191 . . . . 3.24 111.92 -166.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.6 t -143.09 139.89 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.51 1.924 . . . . 2.22 108.411 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.1 mtm -82.2 168.2 17.9 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.533 0.938 . . . . 3.74 113.533 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.77 166.96 26.08 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.635 1.588 . . . . 0.78 112.815 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.7 ttm -155.8 144.27 20.18 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.12 1.768 . . . . 1.15 108.634 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 -146.36 155.75 49.88 Favored Pre-proline 0 N--CA 1.468 0.458 0 C-N-CA 125.244 1.418 . . . . 4.25 109.813 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.85 154.85 38.86 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.663 1.575 . . . . 0.53 110.589 164.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.52 155.39 73.72 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 125.503 1.521 . . . . 0.57 110.462 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.93 -28.41 3.26 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.738 2.292 . . . . 0.47 112.867 -168.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -176.03 165.97 2.94 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.223 1.409 . . . . 1.77 112.294 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.7 153.21 24.61 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.694 1.598 . . . . 0.57 110.284 164.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -110.76 146.45 36.33 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.937 1.295 . . . . 1.72 109.833 174.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.6 t -140.16 131.16 14.15 Favored Pre-proline 0 N--CA 1.477 0.891 0 N-CA-C 114.452 1.278 . . . . 1.37 114.452 168.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.58 160.61 34.83 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.36 3.373 . . . . 1.12 113.124 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.12 145.31 89.14 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.428 3.418 . . . . 1.13 113.792 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt 67.93 -4.25 1.04 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.077 2.151 . . . . 2.24 114.384 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.87 -179.98 47.35 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.694 1.616 . . . . 1.76 113.189 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.66 139.67 21.02 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.146 1.379 . . . . 3.94 109.26 167.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -144.93 146.47 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.739 1.615 . . . . 3.17 109.284 -168.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.33 150.97 46.66 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.882 1.068 . . . . 2.63 113.882 -173.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -72.5 66.54 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.024 1.73 . . . . 2.08 109.435 163.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.27 127.9 84.82 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.578 1.151 . . . . 3.05 110.17 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -54.8 -38.61 91.98 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.338 3.359 . . . . 2.49 113.916 -166.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.44 -1.08 56.84 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 117.53 -1.706 . . . . 1.85 115.338 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -143.56 -23.15 0.17 Allowed Glycine 0 N--CA 1.474 1.199 0 CA-C-N 120.047 1.923 . . . . 2.28 117.793 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -149.04 146.64 27.85 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.443 2.121 . . . . 2.28 112.425 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -161.87 156.05 22.06 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.267 1.027 . . . . 0.66 110.748 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -83.45 145.56 28.89 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.653 -0.499 . . . . 1.99 109.653 164.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -103.72 111.03 23.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.521 1.928 . . . . 0.79 108.542 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.65 120.22 29.84 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.485 1.114 . . . . 1.28 108.697 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -121.12 144.39 48.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.458 1.123 . . . . 2.06 112.881 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.01 38.42 40.66 Favored Glycine 0 N--CA 1.468 0.768 0 CA-C-N 115.163 -0.926 . . . . 1.75 111.867 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.4 mt -45.02 154.36 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 127.213 2.205 . . . . 0.72 116.217 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -116.35 -21.98 9.02 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 113.544 -1.662 . . . . 2.18 114.723 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -136.2 141.23 35.38 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 127.659 2.384 . . . . 7.12 108.806 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.16 144.57 23.62 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.982 3.122 . . . . 1.38 109.835 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.69 119.35 30.86 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.56 0.744 . . . . 2.0 110.369 -172.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -102.51 163.25 12.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.982 0.913 . . . . 3.55 111.397 165.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.7 132.98 45.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.794 -0.817 . . . . 1.08 108.794 166.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.6 1.09 71.67 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.16 -1.356 . . . . 1.3 115.641 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -75.0 179.87 4.71 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.571 1.686 . . . . 2.73 109.291 162.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -147.42 153.47 39.64 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.195 1.798 . . . . 3.04 108.03 165.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.9 t -142.79 143.3 25.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 127.718 2.407 . . . . 1.15 109.589 -169.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.96 144.96 29.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.977 1.311 . . . . 3.53 112.33 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 mp -130.5 138.72 50.37 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.124 1.77 . . . . 1.68 109.861 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.407 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 28.5 m-20 -93.62 130.45 39.53 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.826 1.65 . . . . 2.33 109.47 156.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.76 140.4 29.7 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.462 1.505 . . . . 1.02 108.93 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.3 mt -111.75 131.3 55.41 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.506 1.522 . . . . 0.74 110.547 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -126.7 153.22 45.73 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.499 0.72 . . . . 2.71 112.675 -167.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.34 134.26 55.48 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.987 0.899 . . . . 2.13 112.036 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.68 42.93 45.24 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.667 -1.074 . . . . 4.14 113.703 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.65 46.2 6.48 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 116.235 1.254 . . . . 1.99 116.235 161.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -128.99 154.74 46.31 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.098 1.449 . . . . 3.46 112.182 167.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.5 t -143.69 144.71 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.593 1.957 . . . . 1.89 107.034 171.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 tt -152.19 127.08 9.63 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.644 0.778 . . . . 2.61 110.803 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.407 ' HE3' ' OD1' ' A' ' 102' ' ' ASP . 2.7 ttmt -93.89 134.57 36.13 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.172 0.804 . . . . 2.76 113.172 -177.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.62 153.2 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.026 1.33 . . . . 1.87 108.272 162.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 t -128.81 139.79 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.886 1.275 . . . . 2.08 107.611 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.17 142.23 15.18 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 113.152 0.797 . . . . 2.36 113.152 -165.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.84 170.39 14.21 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.282 3.321 . . . . 0.97 112.863 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.34 145.74 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.982 1.313 . . . . 0.9 110.632 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.599 0 C-N-CA 125.015 1.326 . . . . 4.73 112.805 -174.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 62.5 mt-10 . . . . . 0 CA--C 1.545 0.787 0 CA-C-O 121.078 0.466 . . . . 4.94 110.54 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.16 159.95 15.39 Favored Glycine 0 N--CA 1.469 0.844 0 O-C-N 120.907 -1.121 . . . . 1.16 111.575 175.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.2 p90 -156.66 157.55 35.4 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.947 0.899 . . . . 2.41 112.187 166.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.45 145.47 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.589 1.156 . . . . 1.35 108.446 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -69.75 -159.76 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.266 1.026 . . . . 5.79 110.668 164.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -128.63 150.61 50.15 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.328 1.451 . . . . 2.61 110.684 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -170.72 145.22 2.03 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.958 1.703 . . . . 2.42 109.294 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.03 -22.06 15.15 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.98 2.453 . . . . 1.97 112.683 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.09 173.21 13.26 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 126.158 1.837 . . . . 1.15 111.745 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.98 -0.49 39.01 Favored 'Cis proline' 0 CA--C 1.541 0.834 0 CA-C-N 119.122 1.461 . . . . 1.09 113.474 0.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -147.52 162.42 39.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.317 1.047 . . . . 1.85 113.62 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.27 -179.05 5.33 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 129.606 3.163 . . . . 0.42 109.634 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.81 146.78 49.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.399 1.48 . . . . 0.73 108.728 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.23 148.67 45.01 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.327 1.051 . . . . 0.65 112.333 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -115.66 136.17 53.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.932 2.093 . . . . 2.43 111.197 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.93 145.65 43.48 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.757 0.823 . . . . 2.84 110.807 173.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.0 m -124.96 113.65 18.1 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.827 0.851 . . . . 2.21 109.983 166.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.28 174.12 7.92 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.666 1.986 . . . . 5.41 107.72 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.431 ' CD ' HH11 ' A' ' 74' ' ' ARG . 46.0 mt-10 -145.21 155.91 43.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.557 -1.275 . . . . 5.55 107.557 173.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -101.16 100.26 12.86 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.167 0.587 . . . . 1.61 111.036 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.81 -15.39 13.43 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.177 1.918 . . . . 2.3 113.514 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.98 -178.07 52.22 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 119.137 0.88 . . . . 1.48 112.471 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 16.0 m-20 -114.86 3.27 14.56 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.43 1.892 . . . . 4.0 112.232 -167.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -106.36 154.01 40.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 127.096 2.158 . . . . 3.31 110.254 166.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.21 147.08 20.38 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.869 2.379 . . . . 1.14 110.877 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.7 mt -99.35 138.73 36.04 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 123.633 1.682 . . . . 2.35 111.003 170.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 68' ' ' GLU . 14.6 tpp85 -134.68 105.85 6.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 111.716 -2.493 . . . . 2.09 108.248 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.74 105.41 17.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.128 1.371 . . . . 2.38 108.6 -171.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -101.78 -22.67 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.617 0.767 . . . . 0.48 112.235 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.24 -177.07 30.99 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.199 1.381 . . . . 0.41 112.553 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.0 -176.58 4.55 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.573 1.549 . . . . 0.51 109.277 166.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.439 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -157.16 166.44 33.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.669 1.587 . . . . 4.26 108.118 177.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 t -177.77 153.93 0.98 Allowed Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.865 1.266 . . . . 0.8 110.382 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.31 -0.28 9.82 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.271 2.647 . . . . 0.94 114.763 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.7 m -116.78 26.96 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 115.508 1.67 . . . . 0.86 115.508 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.75 157.44 33.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.277 1.431 . . . . 0.86 110.503 167.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.4 -26.99 41.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.021 1.728 . . . . 2.89 112.087 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -155.56 149.35 25.31 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 127.498 2.319 . . . . 5.56 108.621 -156.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.7 p -161.4 59.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 123.79 1.757 . . . . 2.22 113.028 -158.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -91.4 134.86 34.26 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.096 -1.865 . . . . 5.46 112.236 -167.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.3 tp -83.06 122.9 28.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.496 1.518 . . . . 0.88 112.159 -167.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -121.91 150.29 42.19 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.843 1.657 . . . . 0.5 112.415 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -88.93 173.57 8.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.113 0.965 . . . . 2.02 111.067 162.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.7 m -139.99 129.99 24.86 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.589 -1.634 . . . . 0.98 106.589 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -134.79 173.31 11.83 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.417 1.103 . . . . 2.23 112.951 -165.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.8 ttp -120.43 141.74 49.87 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.97 1.308 . . . . 3.34 111.004 165.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -135.44 157.29 47.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.212 1.405 . . . . 5.43 111.55 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -97.1 144.13 27.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.312 1.445 . . . . 2.37 109.962 165.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 m -142.68 130.55 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.574 1.549 . . . . 2.77 108.584 163.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 62.21 11.2 4.26 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.599 2.074 . . . . 3.54 116.599 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.9 25.68 40.4 Favored Glycine 0 CA--C 1.539 1.533 0 O-C-N 120.909 -1.119 . . . . 1.74 113.537 -165.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -127.15 120.17 28.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.052 1.741 . . . . 2.49 109.453 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.34 118.98 28.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.57 0.748 . . . . 7.08 110.619 -175.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.52 139.85 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.024 1.73 . . . . 2.33 109.5 -172.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 58.0 mtm -83.71 167.47 17.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.885 1.069 . . . . 3.25 113.885 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.5 -176.49 30.61 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.028 1.299 . . . . 0.91 113.3 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ttm -155.85 150.06 25.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.783 2.033 . . . . 1.12 107.65 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.96 158.49 30.17 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 124.495 1.118 . . . . 5.0 110.509 174.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.44 154.94 40.82 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.152 1.901 . . . . 0.54 111.907 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -143.08 152.61 58.71 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.419 1.487 . . . . 0.54 109.808 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -84.13 -23.44 3.0 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.187 2.592 . . . . 0.68 113.547 -165.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.443 ' CD1' ' HD2' ' A' ' 31' ' ' ARG . 54.0 p90 -177.14 166.93 2.41 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.593 1.957 . . . . 2.02 110.678 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.2 mt -110.66 154.31 24.01 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.457 1.103 . . . . 0.56 110.059 164.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 31' ' ' ARG . 3.9 tp10 -127.06 138.09 53.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.126 1.37 . . . . 1.74 109.612 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 t -143.48 136.79 14.02 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.998 0.919 . . . . 1.52 110.654 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.99 170.4 15.74 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.776 2.318 . . . . 1.39 112.334 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.56 143.96 97.69 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.969 2.446 . . . . 1.65 110.783 161.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.434 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 33.6 mmtm 67.47 0.13 2.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.403 1.481 . . . . 2.53 114.157 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.56 162.77 41.89 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.753 1.644 . . . . 1.9 113.635 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.431 HH11 ' CD ' ' A' ' 23' ' ' GLU . 59.5 mtt-85 -91.48 129.42 37.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.563 0.745 . . . . 5.57 111.412 176.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -103.24 61.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.764 2.025 . . . . 5.41 109.478 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.76 127.26 56.1 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.229 1.411 . . . . 3.19 109.755 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 83' ' ' HIS . 3.3 mp -70.98 -38.59 72.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.604 1.562 . . . . 3.2 114.003 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptt 91.13 138.07 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 129.416 3.086 . . . . 3.55 109.93 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.7 11.74 0.47 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.589 2.86 . . . . 2.75 114.731 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.61 17.27 0.09 OUTLIER Glycine 0 CA--C 1.535 1.32 0 CA-C-O 116.621 -2.211 . . . . 1.88 116.42 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.27 -29.31 0.45 Allowed Glycine 0 N--CA 1.487 2.044 0 CA-C-N 121.233 2.516 . . . . 2.1 117.626 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.06 146.89 43.51 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.249 2.025 . . . . 2.16 111.197 163.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.49 ' HA ' HD23 ' A' ' 77' ' ' LEU . 57.1 p-80 -158.46 149.02 20.19 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.572 0.582 . . . . 0.68 112.572 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -79.96 131.8 35.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.345 -0.613 . . . . 1.97 109.345 161.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -91.81 103.42 15.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.038 1.735 . . . . 0.81 108.459 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -85.73 116.88 24.26 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.659 -1.238 . . . . 1.25 107.659 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 tt -130.19 134.85 47.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.562 1.145 . . . . 3.12 111.165 -162.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.53 48.69 7.83 Favored Glycine 0 N--CA 1.473 1.11 0 O-C-N 121.751 -0.593 . . . . 1.85 111.969 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -48.26 154.34 0.61 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 126.253 1.821 . . . . 0.71 114.99 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -119.34 -29.95 5.03 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.681 -1.6 . . . . 1.69 114.585 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -107.38 147.5 35.37 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.902 1.681 . . . . 5.83 109.552 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.39 162.68 37.84 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.66 2.24 . . . . 2.66 109.132 157.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.8 155.87 35.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.48 1.512 . . . . 2.78 109.759 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 24.24 1.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.326 1.973 . . . . 4.14 116.326 -174.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 66.87 164.76 0.2 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.12 2.168 . . . . 1.49 110.943 -161.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.04 -5.99 30.02 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.947 -0.918 . . . . 1.34 114.676 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -76.99 166.06 23.83 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.422 1.089 . . . . 2.91 110.099 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -118.14 126.19 51.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 129.146 2.978 . . . . 3.85 104.625 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.7 t -126.2 140.6 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.66 1.184 . . . . 1.39 110.065 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -106.83 134.69 49.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.42 1.088 . . . . 3.76 112.786 -170.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.5 133.57 43.96 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.25 1.42 . . . . 1.91 111.887 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 27.4 m-20 -77.84 136.45 38.08 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.777 2.031 . . . . 1.83 108.61 159.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.99 126.86 50.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.338 1.055 . . . . 0.98 108.785 165.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.0 mt -104.19 106.54 17.08 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.353 1.061 . . . . 0.72 110.069 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -105.8 151.81 24.02 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.612 1.565 . . . . 2.07 112.35 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.83 131.39 46.79 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.87 1.063 . . . . 2.79 113.87 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 58.13 3.13 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.924 1.25 . . . . 3.87 113.347 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.37 11.09 79.72 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 124.421 1.01 . . . . 2.19 115.609 169.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -93.49 113.1 25.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.917 1.359 . . . . 2.86 111.217 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.68 136.12 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.936 1.294 . . . . 1.89 109.887 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.1 tt -143.12 112.61 6.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.471 0.708 . . . . 2.97 111.544 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -87.73 98.35 11.4 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.961 0.726 . . . . 3.7 112.961 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 114' ' ' VAL . 26.9 t -80.01 172.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 126.444 1.898 . . . . 2.13 110.869 171.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.409 ' N ' HG12 ' A' ' 113' ' ' VAL . 10.7 p -139.34 143.01 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.057 2.143 . . . . 2.92 108.378 166.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.48 144.55 15.01 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.883 1.673 . . . . 2.18 111.677 -167.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.95 155.5 26.44 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.179 2.586 . . . . 0.97 113.705 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.1 t -93.93 121.7 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.44 1.496 . . . . 1.04 109.472 173.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 126.317 1.847 . . . . 4.13 110.582 176.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 . . . . . 0 CA--C 1.542 0.652 0 CA-C-O 121.584 0.707 . . . . 4.6 111.59 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.49 168.75 33.77 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.02 -1.05 . . . . 1.17 114.296 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -152.16 172.6 16.12 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.254 1.022 . . . . 2.16 112.945 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 t -109.36 138.85 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.098 -1.001 . . . . 1.14 109.03 172.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -51.68 -81.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.965 1.306 . . . . 5.06 113.093 -173.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.1 t80 158.22 153.0 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 130.118 3.367 . . . . 3.06 107.282 -157.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.0 t 150.22 128.8 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 129.34 3.056 . . . . 2.14 110.879 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.88 -35.85 14.62 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.855 1.703 . . . . 1.29 111.793 173.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.25 173.13 21.52 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.483 1.992 . . . . 0.97 112.035 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.75 5.16 56.05 Favored 'Cis proline' 0 CA--C 1.541 0.865 0 CA-C-N 119.33 1.565 . . . . 1.12 113.654 3.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -154.68 160.24 41.25 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.412 1.085 . . . . 1.76 113.673 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.87 -177.44 5.33 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.935 2.094 . . . . 0.42 111.623 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.27 147.92 28.24 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.791 1.236 . . . . 0.73 110.756 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.03 145.52 48.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.092 1.757 . . . . 0.5 111.539 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' A' ' 79' ' ' PRO . 96.2 m-85 -144.19 121.52 11.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.884 2.073 . . . . 2.69 109.961 -164.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -166.0 148.59 7.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.442 -1.411 . . . . 1.99 114.318 -155.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.5 m -81.99 135.17 35.39 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.759 0.79 . . . . 1.89 110.434 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.51 137.0 47.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.881 2.072 . . . . 3.35 108.791 170.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -114.67 166.41 11.76 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.129 0.572 . . . . 4.29 111.64 166.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -119.97 111.71 35.46 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 123.031 0.532 . . . . 1.48 110.246 164.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.21 -15.62 10.12 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.759 2.306 . . . . 1.19 113.919 175.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.23 -175.27 49.76 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.496 1.046 . . . . 1.3 113.149 -173.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.91 -10.12 27.07 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.066 1.747 . . . . 3.35 111.613 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -130.45 161.24 61.8 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 127.572 2.349 . . . . 3.84 108.913 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.65 155.94 49.35 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.65 2.233 . . . . 1.43 111.541 -170.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.9 mt -110.55 152.22 26.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 125.103 1.361 . . . . 1.87 110.429 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -128.5 105.07 8.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.507 -1.679 . . . . 2.01 111.264 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.54 104.57 16.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.133 1.373 . . . . 1.84 108.118 -172.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.4 m -98.21 -28.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.401 0.681 . . . . 0.7 112.182 -166.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.93 -178.61 33.1 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.521 1.534 . . . . 0.55 111.336 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.55 ' O ' HG11 ' A' ' 43' ' ' VAL . . . -131.24 -178.48 4.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.868 0.867 . . . . 0.77 109.375 161.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -144.75 169.73 17.46 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 129.539 3.136 . . . . 5.54 106.348 165.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -172.35 149.74 2.15 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 126.938 2.095 . . . . 0.56 108.006 -172.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -71.51 -30.9 14.48 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.065 1.177 . . . . 1.01 112.478 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -89.16 19.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 115.856 1.799 . . . . 0.78 115.856 -168.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.99 154.0 34.07 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.718 1.007 . . . . 0.79 113.718 174.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -79.98 -65.17 1.04 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.611 1.564 . . . . 3.1 109.819 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.3 mtp-105 -110.71 107.96 17.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.655 0.74 . . . . 6.16 110.683 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 35' ' ' ALA . 7.4 p -77.58 146.9 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 126.054 1.741 . . . . 1.43 108.689 162.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -155.5 146.62 22.57 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.852 1.261 . . . . 2.64 109.417 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.0 tp -105.83 120.27 41.28 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.358 0.981 . . . . 0.92 111.099 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -127.79 159.56 34.46 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.929 1.347 . . . . 0.76 113.981 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.86 161.32 14.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.909 2.084 . . . . 2.1 112.351 159.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.9 m -137.23 145.68 43.91 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.985 2.114 . . . . 1.31 107.089 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.81 165.61 36.0 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.762 1.267 . . . . 2.13 114.24 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.62 146.88 24.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.718 1.207 . . . . 5.86 111.278 166.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.13 161.85 42.0 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.588 1.555 . . . . 5.43 110.061 -171.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -112.79 142.36 45.52 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.347 1.059 . . . . 2.43 112.296 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.8 t -136.28 115.96 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.264 1.425 . . . . 2.35 108.433 164.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 66.37 7.48 4.99 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 127.291 2.236 . . . . 3.29 115.211 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.18 7.59 59.41 Favored Glycine 0 CA--C 1.54 1.624 0 O-C-N 121.123 -0.986 . . . . 1.67 114.189 -165.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -109.09 129.43 55.47 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 127.416 2.286 . . . . 2.81 108.292 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -79.7 120.54 24.15 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.938 -1.483 . . . . 2.75 109.251 -166.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.2 t -134.38 131.52 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.231 1.812 . . . . 2.57 108.846 -173.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.1 mtt -83.35 165.3 19.4 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.506 -0.746 . . . . 2.79 112.632 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.24 173.88 32.73 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 124.25 0.929 . . . . 0.83 112.943 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.5 ttm -157.09 137.39 12.86 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.889 1.676 . . . . 1.33 109.395 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -143.01 149.28 48.63 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 125.529 1.532 . . . . 8.85 110.643 -174.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.63 153.18 43.58 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.066 1.844 . . . . 0.58 109.962 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.07 156.0 77.26 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.735 1.214 . . . . 0.68 110.111 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.72 -27.82 2.44 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.851 2.367 . . . . 0.59 113.242 -169.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -177.84 165.94 2.05 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.344 1.858 . . . . 2.24 111.297 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.7 mt -110.7 155.85 21.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.031 1.332 . . . . 0.53 109.884 163.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -113.24 146.77 38.77 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.725 1.21 . . . . 2.08 109.105 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.88 128.0 14.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 113.647 0.98 . . . . 1.11 113.647 168.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.59 156.57 28.26 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.332 3.355 . . . . 1.37 113.05 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.11 141.89 78.34 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.758 3.639 . . . . 1.42 114.005 -172.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 71.39 -15.95 0.4 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 129.122 2.969 . . . . 1.88 114.161 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.83 -177.12 50.21 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.597 1.57 . . . . 1.71 113.561 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -146.72 150.7 35.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.086 0.954 . . . . 4.88 111.389 163.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -149.67 139.44 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.965 2.106 . . . . 3.64 107.079 -175.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.1 147.43 34.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.304 1.049 . . . . 3.56 113.499 -174.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.07 74.94 0.49 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.668 1.587 . . . . 2.06 107.438 157.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.47 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -57.87 142.48 78.91 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.625 1.17 . . . . 2.32 114.08 -170.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.544 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 29.8 Cg_endo -58.86 -10.41 9.64 Favored 'Trans proline' 0 C--N 1.357 1.014 1 C-N-CA 125.606 4.204 . . . . 2.74 117.736 -170.049 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.88 2.45 22.93 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.728 1.156 . . . . 2.76 115.43 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.84 -112.07 1.46 Allowed Glycine 0 N--CA 1.472 1.084 0 CA-C-N 119.148 1.474 . . . . 1.97 113.136 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -72.5 143.09 48.5 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.988 -0.713 . . . . 1.9 111.662 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 51.4 p-80 -160.39 157.17 27.35 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.568 1.147 . . . . 0.76 111.843 -174.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.2 135.33 35.74 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.834 -0.802 . . . . 2.35 108.834 155.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.1 126.09 47.77 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.272 2.229 . . . . 1.06 108.444 169.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.14 113.09 23.53 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.16 0.984 . . . . 2.61 109.847 -176.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.07 152.13 19.63 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.082 1.753 . . . . 2.09 110.63 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.94 -50.65 4.44 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 127.799 2.619 . . . . 3.03 113.551 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.1 mt 57.94 169.09 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.864 2.865 . . . . 1.0 115.675 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -128.48 -23.8 3.15 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.518 2.327 . . . . 1.7 114.256 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -130.61 150.76 77.26 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.512 2.325 . . . . 5.32 109.903 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.21 123.94 8.13 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.585 2.19 . . . . 1.99 108.538 163.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.04 113.47 17.19 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.186 0.994 . . . . 2.51 108.609 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.86 166.01 26.48 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.371 1.469 . . . . 3.68 111.055 172.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.11 123.61 16.54 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.011 0.924 . . . . 1.44 110.98 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.93 25.86 59.32 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.678 -0.692 . . . . 2.64 113.82 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -86.69 172.71 9.99 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.893 1.347 . . . . 2.53 108.757 133.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -144.37 158.56 43.68 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.045 2.938 . . . . 3.13 105.257 171.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.7 t -150.56 146.59 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.385 1.874 . . . . 1.31 110.112 -169.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.46 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 38.0 mt-10 -95.83 138.01 34.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.234 0.614 . . . . 2.64 110.442 165.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.36 137.43 52.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.734 0.778 . . . . 1.71 110.262 159.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.62 113.17 26.58 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 128.316 2.646 . . . . 2.56 108.92 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -94.75 132.9 39.01 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.513 -1.367 . . . . 1.0 111.339 -168.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.9 mt -104.65 106.24 16.66 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.392 1.477 . . . . 0.69 109.994 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.0 115.27 30.14 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.76 1.224 . . . . 2.37 110.76 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.11 23.74 2.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.863 2.065 . . . . 2.32 113.845 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.0 -56.73 4.33 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.328 1.442 . . . . 4.45 112.914 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.15 -6.68 69.48 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 117.054 1.582 . . . . 1.57 117.054 -165.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -128.38 121.51 29.26 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.485 1.643 . . . . 4.52 113.015 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -102.35 136.3 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.157 1.383 . . . . 1.96 109.429 166.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.9 tp -155.39 128.19 8.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.011 1.325 . . . . 2.87 109.688 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 52.0 pttt -109.23 160.87 15.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.374 1.62 . . . . 2.19 115.374 -174.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -140.07 161.6 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 126.838 2.055 . . . . 1.95 109.439 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.5 t -106.89 142.18 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.53 1.532 . . . . 1.85 109.152 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -144.41 128.5 9.03 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.004 1.722 . . . . 2.77 110.2 -171.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.53 164.92 32.83 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.07 2.514 . . . . 1.14 111.921 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.1 t -109.91 151.76 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.183 0.593 . . . . 0.83 110.782 171.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 . . . . . 0 CA--C 1.547 0.847 0 C-N-CA 126.756 2.022 . . . . 4.16 112.54 -169.474 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 CA--C 1.539 0.52 0 N-CA-C 106.369 -1.715 . . . . 4.79 106.369 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.2 -178.17 32.96 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.637 1.589 . . . . 1.24 113.426 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -156.18 157.71 36.38 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.422 1.889 . . . . 2.47 112.345 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.9 132.7 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.283 1.433 . . . . 1.73 108.481 169.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -67.93 162.13 24.96 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.996 0.903 . . . . 4.31 112.445 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -98.65 130.12 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.22 -1.4 . . . . 2.32 107.22 171.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -167.73 147.43 4.38 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 127.057 2.143 . . . . 2.6 107.083 174.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.99 -22.91 9.69 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.929 2.419 . . . . 1.94 113.218 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.25 173.63 13.47 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 126.462 1.982 . . . . 1.62 110.354 -166.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -70.67 -9.14 12.66 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 CA-C-N 119.681 1.741 . . . . 2.19 112.412 -4.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -137.62 161.35 36.69 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.625 1.343 . . . . 2.35 114.625 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.93 -173.87 3.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 131.654 3.981 . . . . 0.6 107.492 174.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.9 166.75 23.27 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.635 -1.291 . . . . 1.1 110.676 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.04 148.51 32.76 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 122.109 0.957 . . . . 0.56 111.929 171.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -145.15 129.83 18.08 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.873 2.069 . . . . 2.62 107.919 -165.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.11 150.79 9.68 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.571 1.078 . . . . 2.27 113.892 -174.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.2 m -79.87 112.73 17.44 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.62 1.568 . . . . 1.84 110.74 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.77 127.69 36.01 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.214 1.005 . . . . 2.92 108.571 169.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -116.63 134.42 54.85 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.905 1.282 . . . . 4.37 108.801 168.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -99.46 117.68 63.45 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.506 1.122 . . . . 1.37 109.882 173.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -88.4 -8.9 5.25 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.252 2.635 . . . . 1.32 114.825 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.34 160.06 26.64 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 119.789 1.177 . . . . 1.41 111.928 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.09 3.05 21.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.947 2.499 . . . . 3.75 112.127 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -123.87 152.12 65.75 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 128.333 2.653 . . . . 2.75 109.248 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.74 146.35 23.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.125 2.55 . . . . 1.16 111.205 -171.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.4 mt -98.88 145.28 27.15 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.428 1.109 . . . . 1.84 111.481 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.531 ' HD2' ' CD2' ' A' ' 66' ' ' PHE . 5.1 tpp180 -130.45 104.91 7.52 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.271 -1.786 . . . . 2.64 109.796 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.407 HD13 ' C ' ' A' ' 32' ' ' LEU . 1.8 tm? -98.17 115.01 27.43 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.234 2.214 . . . . 2.08 108.991 -169.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.98 -28.34 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.208 0.913 . . . . 0.88 112.363 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.01 -175.09 30.6 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 115.26 0.864 . . . . 0.42 115.26 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -140.42 -176.85 4.78 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.977 1.711 . . . . 0.53 112.049 171.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttt-85 -159.56 153.39 23.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.871 2.069 . . . . 5.12 108.149 172.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -163.55 150.9 10.73 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-N 120.109 1.322 . . . . 0.91 110.473 -170.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.29 -15.29 11.47 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.818 2.345 . . . . 1.14 115.135 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -105.45 26.68 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.158 1.383 . . . . 1.2 113.634 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.38 174.03 10.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.242 1.417 . . . . 1.6 109.215 162.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -99.91 -48.44 4.67 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.966 1.706 . . . . 3.96 109.505 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -126.15 171.61 10.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.883 2.473 . . . . 5.07 107.596 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.8 p -154.78 142.75 12.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 125.596 1.558 . . . . 1.0 108.532 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -115.59 158.11 23.15 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.67 1.588 . . . . 3.48 109.524 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -111.22 117.01 32.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.076 1.35 . . . . 0.91 109.099 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -120.14 149.86 41.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.206 1.402 . . . . 0.63 114.223 -174.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -93.3 161.12 14.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.265 1.826 . . . . 2.42 111.134 160.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.6 m -129.4 146.14 51.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.52 1.928 . . . . 1.24 106.301 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -160.15 -179.05 7.41 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.727 1.01 . . . . 2.24 113.727 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.7 mtm -116.46 148.28 40.91 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.792 1.637 . . . . 4.32 111.882 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.62 154.34 45.34 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.444 1.497 . . . . 7.05 111.977 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -91.54 137.43 32.37 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.738 -1.208 . . . . 3.12 107.738 148.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -144.03 139.7 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.491 -1.67 . . . . 2.83 106.491 160.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 64.18 19.92 11.97 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.141 1.376 . . . . 4.57 113.931 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.76 17.12 72.88 Favored Glycine 0 CA--C 1.538 1.5 0 O-C-N 120.354 -1.466 . . . . 2.26 113.354 -169.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -122.01 135.18 54.82 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.039 2.535 . . . . 3.02 109.526 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -74.49 118.7 17.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.861 2.064 . . . . 4.05 108.564 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.44 -179.55 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.74 2.016 . . . . 2.87 110.673 -174.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.97 174.31 6.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.507 1.123 . . . . 2.98 111.955 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.73 173.54 33.79 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.862 1.22 . . . . 0.89 112.922 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -157.7 146.06 19.14 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.436 1.894 . . . . 1.26 107.841 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -150.39 157.74 36.58 Favored Pre-proline 0 N--CA 1.468 0.458 0 C-N-CA 125.255 1.422 . . . . 4.28 109.6 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.82 153.87 43.01 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.724 1.616 . . . . 0.54 111.07 164.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.5 m -134.6 152.18 77.29 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.531 1.532 . . . . 0.63 110.966 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -81.76 -21.61 5.87 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.301 2.667 . . . . 0.55 113.208 -169.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.531 ' CD2' ' HD2' ' A' ' 31' ' ' ARG . 47.3 p90 -175.87 164.05 2.85 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.206 1.402 . . . . 2.07 112.07 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.3 mt -109.98 156.64 20.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.877 1.671 . . . . 0.55 110.145 163.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -114.35 146.6 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.182 0.593 . . . . 2.75 109.797 163.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.71 126.77 26.0 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.408 1.483 . . . . 1.32 109.219 164.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -67.56 165.63 26.69 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.441 2.761 . . . . 1.39 110.687 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.33 138.31 55.04 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.016 2.477 . . . . 1.18 113.411 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.282 14.4 mtmt 60.14 29.75 19.28 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.684 1.594 . . . . 2.65 114.89 168.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.77 -179.85 18.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.727 2.584 . . . . 1.59 113.816 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.24 156.74 22.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.751 0.82 . . . . 4.43 112.963 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.5 t -148.65 117.06 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.093 1.757 . . . . 3.31 107.797 163.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.19 158.3 23.64 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.346 0.869 . . . . 2.88 113.346 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -80.8 62.39 4.81 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.671 1.224 . . . . 2.04 109.704 151.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.477 ' CD ' ' H ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -56.54 126.69 70.8 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-O 118.066 -0.969 . . . . 3.67 111.152 171.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -56.96 -39.17 93.43 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.256 3.304 . . . . 2.55 114.018 -167.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.11 -3.21 51.52 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.025 -1.431 . . . . 1.96 115.051 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.59 -24.32 0.22 Allowed Glycine 0 N--CA 1.473 1.131 0 N-CA-C 118.155 2.022 . . . . 2.41 118.155 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -148.89 143.47 26.26 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 120.67 2.235 . . . . 2.35 112.796 175.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -160.48 154.61 23.13 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.745 1.218 . . . . 0.79 110.961 174.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 82.2 m-85 -77.8 150.06 34.34 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.673 -0.862 . . . . 2.42 108.673 161.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 tpt -106.71 115.18 29.75 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.34 1.856 . . . . 1.0 106.783 166.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.58 120.68 37.35 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.402 1.081 . . . . 1.3 108.741 -174.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.7 mp -116.82 138.15 51.7 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.008 0.923 . . . . 1.84 112.611 -167.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.16 49.58 8.36 Favored Glycine 0 N--CA 1.473 1.158 0 O-C-N 121.928 -0.482 . . . . 1.56 112.023 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -48.61 154.99 0.6 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 126.969 2.108 . . . . 0.95 115.318 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -118.13 -31.38 5.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 113.511 -1.677 . . . . 2.11 113.759 -173.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 -118.99 134.5 23.62 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 125.505 1.522 . . . . 4.99 107.69 170.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -69.99 113.52 3.44 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 N-CA-C 107.144 -1.906 . . . . 1.75 107.144 163.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.61 153.72 12.71 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.969 1.308 . . . . 2.53 113.262 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -131.49 147.05 52.51 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 123.512 1.625 . . . . 4.79 113.592 163.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.96 112.51 10.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.602 -1.636 . . . . 1.59 110.237 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.67 -0.55 20.09 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 117.97 -1.461 . . . . 1.64 115.376 -173.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -86.51 -176.32 5.8 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.48 1.64 . . . . 2.35 110.372 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -142.76 146.15 33.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.641 2.376 . . . . 4.34 108.084 171.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -145.22 142.15 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.64 1.576 . . . . 1.71 111.56 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -88.85 164.39 15.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.664 1.357 . . . . 2.51 114.664 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 tt -154.97 134.1 12.36 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.347 1.459 . . . . 2.6 110.872 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.37 153.34 29.83 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 127.479 2.312 . . . . 1.97 110.503 169.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.18 124.98 35.99 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.708 2.003 . . . . 1.18 108.989 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.8 mt -106.21 116.32 31.74 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.725 1.21 . . . . 0.68 109.754 -170.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -112.14 130.31 55.94 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.772 1.229 . . . . 2.09 111.394 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.07 -19.13 62.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.982 1.313 . . . . 2.18 113.367 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.64 32.63 1.01 Allowed Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.728 1.156 . . . . 4.85 114.272 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.7 35.35 85.55 Favored Glycine 0 N--CA 1.471 1.003 0 C-N-CA 125.619 1.581 . . . . 2.71 114.342 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -142.06 145.39 34.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.942 1.371 . . . . 2.94 114.026 -167.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -127.32 146.87 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.513 1.925 . . . . 2.29 109.326 167.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -156.7 147.78 22.05 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.045 2.138 . . . . 2.16 107.932 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -122.73 155.91 35.5 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.591 1.541 . . . . 2.23 114.044 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.52 173.24 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.373 2.269 . . . . 1.75 108.886 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -136.1 136.81 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.443 1.497 . . . . 2.22 110.618 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 mt -137.89 136.76 20.18 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.303 1.441 . . . . 2.29 111.127 -166.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.94 159.39 53.13 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.625 2.883 . . . . 0.96 112.128 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.7 t -103.76 131.12 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.747 1.219 . . . . 1.5 109.761 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 CA--C 1.541 0.629 0 C-N-CA 126.227 1.811 . . . . 4.06 110.838 -179.582 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 123.545 1.64 . . . . 4.48 112.528 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.32 -178.66 15.72 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.188 1.851 . . . . 1.35 111.935 175.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -148.95 149.0 30.45 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.071 1.138 . . . . 2.21 114.071 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -79.08 133.39 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 106.64 -1.615 . . . . 1.34 106.64 163.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -68.05 -18.64 64.74 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.575 1.695 . . . . 4.22 115.575 -158.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.4 t80 76.67 151.32 0.12 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.746 2.418 . . . . 3.03 112.534 -174.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 t 174.88 161.31 0.38 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 129.667 3.187 . . . . 2.09 108.639 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.63 -24.94 5.8 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.809 2.339 . . . . 1.25 112.761 159.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.47 -178.43 17.02 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.265 1.888 . . . . 1.0 112.447 -169.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.26 -0.49 21.9 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.023 1.412 . . . . 1.36 113.273 -2.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -135.34 166.79 22.32 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.378 1.471 . . . . 2.19 113.205 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.47 -174.12 4.8 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 129.191 2.996 . . . . 0.56 111.413 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.26 175.6 9.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.401 1.88 . . . . 0.96 108.83 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.59 17.81 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.339 -0.851 . . . . 0.59 111.641 170.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.466 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 53.7 m-85 -109.21 69.64 0.71 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.386 1.874 . . . . 2.51 109.268 176.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -79.28 158.65 27.51 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.617 0.767 . . . . 1.76 112.795 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.4 m -119.07 140.34 50.24 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.193 1.797 . . . . 2.1 109.087 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.0 tp -155.33 178.95 9.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.037 1.735 . . . . 4.63 108.811 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -158.27 149.61 21.09 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.222 1.809 . . . . 4.64 107.889 -171.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -106.51 87.17 2.53 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 124.919 1.288 . . . . 1.69 110.252 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.56 -11.55 28.28 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.512 2.142 . . . . 2.18 114.136 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.28 174.45 53.48 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-O 123.075 1.375 . . . . 1.47 113.049 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.6 -1.76 32.07 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.205 2.202 . . . . 3.27 112.768 -167.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.27 156.87 57.13 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.698 1.999 . . . . 3.33 109.683 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.12 170.4 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.908 2.406 . . . . 1.54 112.203 -162.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.21 146.55 44.15 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 122.851 1.31 . . . . 2.87 111.354 167.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -135.53 110.94 9.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 111.73 -2.486 . . . . 2.13 109.333 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.1 tp -94.37 112.14 23.92 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.945 1.698 . . . . 2.39 110.042 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.64 -22.96 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.847 0.859 . . . . 0.54 111.602 -170.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.57 -174.79 30.84 Favored Glycine 0 C--N 1.345 1.072 0 C-N-CA 125.117 1.341 . . . . 0.44 113.838 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.22 -178.44 6.39 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.401 1.881 . . . . 0.49 110.913 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -156.58 175.36 14.14 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.41 2.284 . . . . 5.96 108.022 161.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -170.5 158.61 5.89 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 127.037 2.135 . . . . 0.74 109.448 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.41 -5.94 9.16 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.452 2.101 . . . . 1.14 114.861 169.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.88 16.45 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.017 1.488 . . . . 1.14 115.017 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.77 159.47 24.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.945 2.098 . . . . 0.93 109.181 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -108.33 -42.24 4.65 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.306 0.854 . . . . 3.85 113.306 -170.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -113.98 147.82 37.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 122.48 1.133 . . . . 6.56 108.442 164.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -135.47 134.31 52.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 125.186 1.395 . . . . 0.85 107.582 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -130.92 125.86 34.6 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.508 1.523 . . . . 3.3 109.525 -166.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.54 119.06 24.74 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.832 -0.543 . . . . 0.85 111.925 -175.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . 0.407 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 56.2 m170 -121.55 161.06 23.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.822 1.649 . . . . 0.51 113.523 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.6 159.96 15.56 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.858 1.663 . . . . 2.11 111.009 158.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.1 m -114.77 137.54 51.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 105.757 -1.942 . . . . 0.85 105.757 161.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -133.75 174.57 10.31 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.667 1.222 . . . . 2.1 113.203 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.4 mtm -119.24 141.03 49.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.244 1.417 . . . . 4.86 110.554 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -133.99 144.77 48.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.317 1.047 . . . . 5.94 110.738 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -78.86 114.53 17.87 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 106.479 -1.675 . . . . 2.29 106.479 137.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.9 t -94.03 97.86 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 104.449 -2.426 . . . . 2.99 104.449 171.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.31 37.26 11.1 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.903 1.335 . . . . 8.83 111.246 166.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.17 75.65 Favored Glycine 0 CA--C 1.527 0.824 0 O-C-N 121.018 -1.051 . . . . 2.26 112.387 -175.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -120.93 108.96 14.52 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.725 1.61 . . . . 4.46 110.525 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.574 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -57.41 127.54 32.49 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.008 -1.683 . . . . 3.26 111.706 171.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.3 p -158.33 174.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.398 1.879 . . . . 2.43 110.711 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.9 mtt -105.97 172.38 6.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.572 1.149 . . . . 2.88 112.414 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.87 -178.62 31.13 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.821 1.201 . . . . 0.7 112.898 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.8 ttm -154.75 150.73 27.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.814 1.646 . . . . 1.15 108.397 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -158.53 158.56 29.6 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 123.92 0.888 . . . . 4.74 111.49 173.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.89 154.84 58.36 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.438 2.092 . . . . 0.59 111.287 171.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.47 153.39 65.62 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.533 1.533 . . . . 0.65 110.117 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.84 -26.7 4.38 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.27 2.647 . . . . 0.61 113.116 -167.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -178.24 164.06 1.72 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.961 1.704 . . . . 2.09 111.172 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.5 mt -109.44 154.39 22.69 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.696 1.198 . . . . 0.78 109.762 166.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -124.93 137.01 54.28 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.052 1.341 . . . . 1.74 110.389 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.2 t -143.94 135.03 12.48 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 118.35 0.523 . . . . 1.41 112.275 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.93 172.19 11.17 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.693 2.929 . . . . 0.93 113.047 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -59.93 145.33 98.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.881 2.387 . . . . 1.13 111.588 164.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt 67.58 -2.2 1.4 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.783 2.033 . . . . 1.78 114.059 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.85 159.8 46.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.673 1.606 . . . . 1.39 114.247 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 134.7 34.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.99 1.316 . . . . 3.75 110.848 172.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 t -114.9 64.21 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 127.365 2.266 . . . . 5.05 107.617 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -98.32 137.07 37.58 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.275 -0.891 . . . . 3.02 110.069 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.597 HD23 ' HA ' ' A' ' 83' ' ' HIS . 1.9 mp -73.62 -63.79 1.13 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 118.011 -0.995 . . . . 3.19 111.034 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm 107.99 128.89 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 128.928 2.891 . . . . 3.69 114.248 161.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.466 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 14.9 Cg_endo -53.48 -56.7 2.46 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 124.283 3.322 . . . . 2.12 113.599 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.01 28.62 1.91 Allowed Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.555 -1.136 . . . . 1.86 113.861 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.25 -128.88 0.99 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.709 1.147 . . . . 1.63 115.554 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -74.76 144.21 43.7 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.052 -1.264 . . . . 1.85 111.54 -165.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.597 ' HA ' HD23 ' A' ' 77' ' ' LEU . 47.3 p-80 -160.75 151.06 17.94 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.348 -0.845 . . . . 0.6 112.246 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -78.06 128.5 33.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.738 -0.838 . . . . 2.11 108.738 161.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.407 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 2.8 tpt -79.78 128.91 34.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.768 -1.197 . . . . 0.81 107.768 160.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.48 115.36 29.5 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.3 1.04 . . . . 1.14 108.303 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.05 149.78 42.19 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.666 1.186 . . . . 2.22 111.137 -175.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.72 49.18 11.05 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.169 0.89 . . . . 1.8 111.277 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mt -52.03 153.28 2.72 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 123.479 1.609 . . . . 0.69 114.395 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -121.13 -16.27 8.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 112.547 -2.115 . . . . 2.21 115.435 -168.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -134.3 144.59 51.84 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.816 1.246 . . . . 5.24 111.084 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.6 91.98 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.458 2.105 . . . . 3.3 107.55 161.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.689 ' H ' HD23 ' A' ' 93' ' ' LEU . 1.7 pt? -81.07 155.92 26.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.198 1.799 . . . . 2.78 111.662 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -113.46 165.52 12.4 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 122.384 1.088 . . . . 3.56 111.468 166.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.49 129.66 37.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.318 -1.31 . . . . 1.46 107.665 153.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.14 20.7 37.97 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.311 -1.272 . . . . 1.5 114.76 -172.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -100.31 179.09 4.57 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.56 1.68 . . . . 2.48 109.543 159.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -132.97 126.47 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.309 2.244 . . . . 3.67 105.738 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.7 t -148.23 145.4 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 126.801 2.041 . . . . 1.76 108.194 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.3 151.49 22.65 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 123.407 1.575 . . . . 3.65 114.079 -171.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.62 134.61 54.98 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.476 1.511 . . . . 1.84 110.07 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.402 ' OD1' ' HE2' ' A' ' 112' ' ' LYS . 11.6 m-20 -81.65 130.67 35.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.003 1.721 . . . . 2.95 108.273 164.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.64 135.58 48.84 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.035 1.289 . . . . 1.79 111.086 168.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -110.38 113.84 26.8 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.719 1.607 . . . . 0.6 109.259 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.83 158.09 19.81 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.825 1.25 . . . . 2.33 110.506 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.39 148.5 41.37 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.554 -0.716 . . . . 2.68 112.079 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.7 23.14 43.68 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 119.056 -0.858 . . . . 4.12 115.053 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.18 7.52 88.45 Favored Glycine 0 N--CA 1.474 1.225 0 CA-C-N 118.827 1.314 . . . . 1.81 114.023 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -78.33 121.06 23.97 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.326 -1.103 . . . . 4.54 111.381 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.66 142.0 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.7 1.2 . . . . 1.85 108.686 167.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.3 tt -151.19 112.58 4.38 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.934 0.893 . . . . 2.65 109.997 -176.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HE2' ' OD1' ' A' ' 102' ' ' ASP . 23.7 ttmm -84.46 125.8 32.69 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.734 -0.604 . . . . 3.66 111.881 175.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 m -98.0 145.98 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.277 1.431 . . . . 2.86 110.329 170.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.19 135.37 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.082 1.753 . . . . 2.07 107.726 168.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.409 ' N ' HD23 ' A' ' 115' ' ' LEU . 1.3 pt? -158.09 155.14 25.62 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.619 1.567 . . . . 1.93 111.409 -171.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -65.91 145.74 80.94 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.774 2.316 . . . . 0.91 112.227 169.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.9 t -82.35 124.24 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 105.896 -1.89 . . . . 1.18 105.896 151.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 C-N-CA 124.039 0.936 . . . . 3.99 110.694 -172.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.448 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 10.0 tt0 . . . . . 0 CA--C 1.539 0.553 0 N-CA-C 110.096 -0.335 . . . . 9.3 110.096 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.448 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -95.26 173.55 31.56 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.184 1.373 . . . . 2.32 113.337 -174.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -154.87 167.67 29.5 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.458 1.103 . . . . 3.12 112.3 173.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.94 148.6 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.73 1.212 . . . . 1.5 108.391 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -77.88 -135.96 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.105 -0.702 . . . . 5.77 109.105 158.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -140.52 152.64 45.73 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.882 1.273 . . . . 2.86 111.489 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 m -161.35 142.02 8.32 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 127.771 2.428 . . . . 2.58 108.983 161.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.22 -23.74 20.73 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.424 2.083 . . . . 2.12 112.261 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.04 171.81 13.69 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 127.145 2.307 . . . . 1.32 110.8 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -79.55 4.14 33.51 Favored 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 119.667 1.733 . . . . 1.09 112.403 -9.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.3 139.47 16.54 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.239 1.57 . . . . 2.64 115.239 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.33 -176.78 3.17 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.024 2.53 . . . . 0.52 111.282 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.77 135.08 18.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.807 1.643 . . . . 0.92 108.805 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.7 137.32 54.8 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.758 1.223 . . . . 0.55 111.237 -175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -105.62 86.34 2.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.242 1.817 . . . . 2.64 109.068 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -90.41 158.08 17.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.403 0.681 . . . . 1.96 112.708 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 m -131.53 134.02 45.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.016 1.327 . . . . 1.94 109.535 -172.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.35 169.95 23.58 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.003 1.721 . . . . 5.32 108.865 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -142.86 145.52 33.22 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.287 1.435 . . . . 4.65 108.4 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -93.58 108.15 31.97 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.772 1.229 . . . . 1.52 110.87 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.58 -10.27 12.05 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.949 2.433 . . . . 1.87 114.91 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.44 169.62 54.05 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 120.085 1.311 . . . . 1.88 113.616 -171.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.65 -6.47 58.24 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.414 2.286 . . . . 4.31 111.537 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mp -124.5 162.11 44.32 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 127.057 2.143 . . . . 3.93 109.587 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.34 155.66 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.854 2.369 . . . . 1.33 111.478 -171.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.428 HD12 ' CD2' ' A' ' 105' ' ' PHE . 1.0 OUTLIER -117.79 162.11 18.62 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.625 1.97 . . . . 2.84 111.016 177.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -155.12 120.66 5.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.193 -1.367 . . . . 2.38 111.266 -173.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.5 tp -103.49 114.1 28.11 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.608 1.963 . . . . 2.12 109.757 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.3 m -112.86 -20.28 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.749 0.819 . . . . 0.71 112.634 -167.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.15 -174.71 29.22 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 124.674 1.13 . . . . 0.52 112.251 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.64 -178.43 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.1 1.36 . . . . 0.54 110.878 168.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.409 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 4.7 mtt180 -152.62 164.86 36.85 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.139 2.176 . . . . 5.03 108.417 172.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -169.2 146.06 2.95 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 124.849 1.259 . . . . 0.71 108.919 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -77.32 -10.22 17.58 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.381 2.054 . . . . 1.24 113.367 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.97 21.47 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.747 1.388 . . . . 1.43 114.747 -174.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.3 38.97 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.172 -0.955 . . . . 0.88 113.067 167.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -72.98 -30.62 63.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.433 1.493 . . . . 3.51 113.168 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -155.16 168.44 27.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.156 2.582 . . . . 4.77 107.743 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.97 154.87 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.173 1.389 . . . . 0.94 108.876 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.61 146.34 28.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.975 1.71 . . . . 4.06 108.676 -166.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.8 tp -113.03 110.13 19.97 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.48 1.036 . . . . 0.89 111.298 -164.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -116.71 150.04 38.85 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 122.663 1.221 . . . . 0.5 113.927 -173.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -91.94 -178.28 4.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.957 -1.474 . . . . 2.15 111.136 158.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.1 m -149.24 127.41 12.06 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.085 -1.82 . . . . 1.03 106.085 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -128.41 170.17 13.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.967 0.889 . . . . 2.09 113.267 -167.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.93 144.72 32.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.152 1.781 . . . . 5.58 110.68 170.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.37 147.2 21.94 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.512 -0.742 . . . . 5.43 112.849 -172.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -91.76 132.62 36.27 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.479 1.512 . . . . 2.3 109.835 165.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.33 130.33 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.496 -1.668 . . . . 3.03 106.496 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 62.88 28.05 16.22 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.761 0.824 . . . . 4.95 112.254 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.21 16.05 79.85 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 120.967 -1.083 . . . . 2.43 113.904 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -135.21 134.42 40.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.986 1.714 . . . . 3.71 109.883 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.07 126.31 34.68 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.466 1.506 . . . . 2.64 111.976 -173.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.25 -178.97 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 129.558 3.143 . . . . 2.74 109.603 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.3 mtm -110.76 170.01 8.38 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.817 0.847 . . . . 3.48 112.033 168.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.89 -176.55 27.24 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.047 1.784 . . . . 1.04 112.206 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ttm -154.67 149.53 26.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.611 1.565 . . . . 1.18 108.596 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.9 ptt85 -158.57 156.8 27.93 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 124.891 1.276 . . . . 4.82 110.314 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.2 158.06 45.54 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.0 1.8 . . . . 0.5 111.644 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.84 149.85 65.74 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.908 1.683 . . . . 0.67 109.087 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.31 -20.28 11.25 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.256 2.637 . . . . 0.72 113.02 -167.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 p90 178.96 167.62 0.93 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.666 2.386 . . . . 2.29 110.114 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.75 150.84 32.8 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.124 1.369 . . . . 0.86 110.137 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -117.81 141.79 48.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.034 1.334 . . . . 2.32 109.3 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 t -143.93 132.05 10.93 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 113.276 0.843 . . . . 1.6 113.276 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.85 170.32 14.38 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.256 2.637 . . . . 1.7 112.488 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -56.63 139.82 88.89 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.699 2.266 . . . . 1.72 110.658 164.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt 69.13 1.84 3.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.489 1.516 . . . . 2.39 113.743 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.77 158.09 36.58 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.676 1.608 . . . . 2.13 113.449 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -79.92 145.63 32.55 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.926 0.89 . . . . 3.57 111.925 173.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.57 61.29 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.015 2.126 . . . . 5.91 107.92 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -116.57 136.21 53.17 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.845 0.831 . . . . 3.13 111.192 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.97 85.55 7.47 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.099 -1.445 . . . . 1.94 107.099 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -55.95 139.7 70.35 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 113.672 0.99 . . . . 4.88 113.672 -167.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -56.54 130.02 37.82 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.08 1.853 . . . . 4.47 109.289 165.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.64 28.98 66.29 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.655 -1.081 . . . . 2.15 114.813 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.68 -17.56 0.02 OUTLIER Glycine 0 N--CA 1.472 1.087 0 N-CA-C 118.966 2.347 . . . . 2.38 118.966 158.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -143.24 150.03 38.73 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.222 2.011 . . . . 1.79 112.406 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -162.44 153.69 17.83 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.287 1.035 . . . . 0.6 111.192 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -86.47 127.68 34.88 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.193 -0.669 . . . . 2.46 109.193 165.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.4 tpt -82.64 119.41 24.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.394 2.278 . . . . 0.81 109.396 170.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -100.33 120.82 40.52 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.345 -0.983 . . . . 1.23 108.345 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.56 146.02 30.18 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.626 1.17 . . . . 2.57 112.415 -169.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.89 -48.77 3.04 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 126.919 2.199 . . . . 3.01 114.126 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.0 mt 56.49 165.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.066 3.346 . . . . 0.67 115.388 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -119.36 -7.41 10.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.385 1.874 . . . . 1.87 113.292 174.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -127.96 131.51 23.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 128.366 2.666 . . . . 4.6 109.385 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.35 76.28 3.97 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.755 2.303 . . . . 2.95 106.454 153.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.404 ' H ' ' HG ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -68.34 140.3 55.89 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.585 1.154 . . . . 3.21 113.669 -156.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -93.31 156.92 16.51 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.381 1.086 . . . . 5.56 111.65 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.62 118.15 7.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 113.847 -1.524 . . . . 1.56 107.545 159.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.62 -2.36 36.54 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-O 117.853 -1.526 . . . . 1.77 115.869 -168.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.42 -178.6 5.28 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.586 1.693 . . . . 3.32 111.467 160.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -152.62 141.77 21.38 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.753 2.821 . . . . 4.61 106.636 -171.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 82.5 t -144.15 146.09 21.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 126.601 1.96 . . . . 1.44 109.561 -168.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -97.76 136.29 38.31 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.953 0.901 . . . . 2.84 110.094 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.63 140.12 50.42 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.262 1.025 . . . . 2.71 109.888 165.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 39.7 m-20 -94.44 134.12 37.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.149 2.579 . . . . 1.87 108.351 160.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.44 130.18 42.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.634 1.574 . . . . 1.08 108.848 164.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.4 111.43 23.33 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.049 0.939 . . . . 0.69 110.678 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.428 ' CD2' HD12 ' A' ' 30' ' ' LEU . 85.6 m-85 -103.66 163.68 12.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.142 1.377 . . . . 2.13 111.582 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.57 154.86 13.39 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.679 -0.691 . . . . 2.6 112.122 166.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.36 24.95 62.22 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.138 -0.812 . . . . 3.95 114.977 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.91 13.69 82.29 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 118.436 1.118 . . . . 1.9 114.171 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -90.52 117.51 29.26 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.448 -1.03 . . . . 3.58 112.128 -172.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.27 140.86 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.61 1.564 . . . . 2.33 110.431 169.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 mt -140.01 129.2 23.78 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.035 1.334 . . . . 2.62 110.846 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -106.21 143.41 34.39 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.797 0.666 . . . . 2.21 112.797 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.96 160.01 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 127.49 2.316 . . . . 2.27 111.704 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.47 137.23 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.542 1.937 . . . . 1.98 110.57 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.4 mp -134.76 114.57 12.08 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 126.525 1.93 . . . . 2.64 110.741 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -75.5 150.02 35.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.265 2.644 . . . . 1.26 110.665 169.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.8 t -91.25 132.88 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.848 0.859 . . . . 1.31 111.195 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 . . . . . 0 N--CA 1.477 0.882 0 C-N-CA 125.901 1.68 . . . . 4.52 113.089 -176.26 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 122.925 1.345 . . . . 4.85 110.359 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.31 172.35 20.38 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.883 1.23 . . . . 1.3 113.897 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -156.23 160.15 39.55 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.499 1.92 . . . . 2.36 110.96 172.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -103.61 147.94 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.356 -1.35 . . . . 1.66 107.356 170.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -72.08 -119.77 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 CA-C-O 121.542 0.687 . . . . 5.09 109.432 164.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -151.41 143.03 23.64 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 119.383 -2.073 . . . . 3.08 110.92 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.0 t -171.68 143.31 1.44 Allowed Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.703 1.601 . . . . 2.26 110.572 167.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.9 -26.32 4.58 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.733 2.289 . . . . 1.44 112.26 166.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.31 170.42 12.03 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.643 2.068 . . . . 1.07 111.419 -171.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.69 -16.12 22.83 Favored 'Cis proline' 0 C--N 1.349 0.596 0 CA-C-N 119.328 1.564 . . . . 1.32 112.761 0.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.53 HD22 HD12 ' A' ' 87' ' ' LEU . 51.6 p30 -142.09 160.43 40.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.805 1.288 . . . . 2.21 114.421 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.88 -179.06 4.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.433 2.693 . . . . 0.55 110.486 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.06 133.39 26.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.162 1.385 . . . . 1.3 109.208 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.32 150.95 50.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.562 1.145 . . . . 0.88 113.481 -171.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.45 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 50.8 m-85 -131.55 127.15 36.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.19 2.196 . . . . 2.1 109.548 -163.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.262 0.0 OUTLIER -162.5 161.7 27.13 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.822 1.415 . . . . 2.77 114.822 -172.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.5 m -93.26 127.75 38.96 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.896 1.678 . . . . 1.71 111.735 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.9 tp -112.34 122.0 46.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.809 1.243 . . . . 4.24 110.302 166.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -122.07 142.29 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.577 1.151 . . . . 4.51 109.211 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -105.87 97.73 16.06 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.561 0.744 . . . . 1.37 111.322 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.31 -5.59 14.36 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.857 2.371 . . . . 1.21 114.044 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.93 163.65 34.95 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 119.624 1.102 . . . . 1.34 111.347 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.9 4.29 50.42 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.848 2.059 . . . . 3.51 112.374 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -118.79 152.81 52.01 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.248 2.219 . . . . 2.92 110.346 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.35 142.36 21.12 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.216 1.944 . . . . 0.97 110.7 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.1 mt -96.57 149.46 21.74 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 122.258 1.027 . . . . 1.8 110.841 172.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -135.98 100.14 4.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 113.866 -1.515 . . . . 2.35 110.946 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.46 97.39 9.5 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.999 2.12 . . . . 1.8 108.066 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 m -94.13 -25.42 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.875 0.87 . . . . 0.49 112.801 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.46 -177.09 32.23 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 123.974 0.797 . . . . 0.4 113.208 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.3 178.94 6.33 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.462 0.705 . . . . 0.5 111.18 172.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.402 ' NH1' ' H ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -148.75 170.97 17.01 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.512 2.725 . . . . 5.42 106.591 165.004 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.402 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 1.5 t -177.36 148.42 0.72 Allowed Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 127.187 2.195 . . . . 0.81 108.703 -172.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -77.14 -24.73 9.32 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.031 1.821 . . . . 1.21 113.958 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.5 m -112.57 23.42 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 114.221 1.193 . . . . 1.19 114.221 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.39 35.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.142 1.377 . . . . 1.43 107.822 160.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -83.3 -54.41 5.02 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.237 1.015 . . . . 3.0 111.075 -171.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -115.97 166.75 11.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.582 2.753 . . . . 5.49 106.392 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.95 134.36 2.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 125.533 1.533 . . . . 0.95 108.267 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -113.97 135.99 53.39 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.21 1.404 . . . . 2.94 109.455 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -83.48 124.45 30.73 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.542 -0.54 . . . . 1.22 109.542 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -122.61 158.33 30.19 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.19 1.796 . . . . 0.63 112.896 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -179.89 4.07 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.626 1.571 . . . . 3.32 110.701 165.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.5 m -154.77 141.82 19.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.785 1.634 . . . . 0.84 106.988 170.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -155.58 175.0 14.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.54 1.162 . . . . 2.04 113.387 -167.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.7 ttp -117.2 146.16 43.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.71 1.604 . . . . 3.47 110.137 171.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -148.11 161.05 42.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.716 2.406 . . . . 7.66 110.272 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -91.03 144.81 25.27 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.832 0.853 . . . . 2.46 109.5 166.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.7 t -137.22 115.48 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.095 -1.817 . . . . 2.43 106.095 163.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 58.08 34.85 24.63 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.992 1.479 . . . . 5.41 114.992 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.18 4.63 68.89 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.253 -1.529 . . . . 1.62 113.553 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -103.52 115.31 30.29 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.122 1.769 . . . . 2.75 107.673 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 117.06 17.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.903 0.881 . . . . 3.06 110.221 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 t -138.88 153.73 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 128.609 2.764 . . . . 2.21 107.705 -161.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.23 173.43 6.46 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.615 -1.303 . . . . 3.96 113.531 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.09 166.84 33.19 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.703 1.144 . . . . 0.58 112.451 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 ttm -150.43 139.74 21.31 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.143 2.177 . . . . 1.41 107.286 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -150.56 154.23 35.16 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.681 1.992 . . . . 4.37 108.672 -171.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.71 159.71 31.52 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.323 2.016 . . . . 0.52 111.194 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.76 155.99 52.21 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 125.767 1.627 . . . . 0.94 110.931 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -84.88 -26.43 1.54 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.407 2.738 . . . . 0.47 114.089 -164.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -174.8 164.81 3.58 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.991 1.716 . . . . 1.7 111.477 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 mt -111.7 160.57 17.15 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.924 1.29 . . . . 0.52 109.296 157.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -138.0 148.79 45.51 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.61 1.164 . . . . 1.94 110.11 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 t -139.82 129.09 13.69 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 123.836 0.71 . . . . 1.03 111.755 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -68.39 162.81 39.03 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.189 2.593 . . . . 1.21 110.967 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.05 138.66 79.83 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.097 2.532 . . . . 1.25 112.17 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.14 3.43 2.69 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 127.27 2.228 . . . . 2.11 115.036 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.67 169.71 34.35 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.136 1.827 . . . . 1.47 113.263 169.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -132.17 157.21 44.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.334 1.054 . . . . 4.54 112.305 168.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.3 t -145.08 140.93 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 128.026 2.53 . . . . 3.38 107.505 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -134.32 130.06 36.45 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.186 0.517 . . . . 3.97 110.822 -170.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -75.69 80.51 2.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.224 1.41 . . . . 2.11 109.709 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.84 155.58 91.31 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 126.604 1.962 . . . . 3.76 114.323 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.45 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 55.9 Cg_endo -61.8 -44.46 21.0 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.126 2.551 . . . . 2.25 112.329 171.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.48 60.33 4.88 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.106 -0.83 . . . . 2.22 112.426 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.25 -126.44 2.03 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 125.428 1.49 . . . . 1.51 114.191 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -72.63 136.62 45.74 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.674 -0.898 . . . . 1.84 112.11 -167.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -160.09 163.88 33.49 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.61 1.164 . . . . 0.82 111.439 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -97.18 132.68 42.71 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.914 -0.491 . . . . 1.83 109.921 170.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -88.35 115.69 26.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.822 2.049 . . . . 0.91 108.983 166.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.12 119.19 37.43 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.185 0.994 . . . . 1.45 109.013 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.53 HD12 HD22 ' A' ' 15' ' ' ASN . 0.4 OUTLIER -122.56 141.04 52.11 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.263 1.208 . . . . 3.18 114.263 -164.288 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.24 38.34 25.97 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.539 1.066 . . . . 1.88 113.142 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mt -43.86 152.75 0.15 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 116.386 1.995 . . . . 0.71 116.386 -174.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -112.84 -16.9 12.64 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.718 -1.583 . . . . 1.83 114.939 -173.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -138.25 142.31 34.85 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.698 2.799 . . . . 6.58 108.599 165.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.24 135.65 27.45 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.965 1.776 . . . . 1.36 107.753 158.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.56 105.9 16.15 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.318 0.508 . . . . 3.3 109.851 -176.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -86.91 20.54 2.58 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.587 2.069 . . . . 4.34 116.587 -163.022 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 67.01 157.25 0.12 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 128.541 2.737 . . . . 1.59 111.845 -161.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.25 0.26 85.89 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 118.95 -0.917 . . . . 1.28 114.536 -172.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.89 175.69 8.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.921 1.688 . . . . 2.69 110.259 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -128.48 153.4 47.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.932 2.093 . . . . 4.09 105.423 163.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.1 t -136.72 138.04 46.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 126.407 1.883 . . . . 1.53 109.077 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.415 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 38.9 tt0 -89.81 136.08 33.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.08 1.352 . . . . 3.03 109.853 173.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.63 139.89 52.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.914 1.286 . . . . 2.63 109.62 170.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -99.06 143.45 29.32 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.84 2.056 . . . . 2.63 109.669 167.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -114.74 118.79 34.6 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.844 1.657 . . . . 1.18 109.292 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.1 mt -92.39 112.31 24.21 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.883 1.273 . . . . 0.67 109.408 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -104.66 106.5 17.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.567 1.147 . . . . 2.09 110.564 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.8 21.8 2.08 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.766 1.626 . . . . 2.64 114.78 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.68 -55.48 4.46 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.12 1.343 . . . . 4.24 112.976 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.65 1.12 54.09 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 116.126 1.21 . . . . 2.05 116.126 -172.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -140.68 149.15 41.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.077 1.439 . . . . 4.08 112.326 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.71 153.14 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.407 1.483 . . . . 2.14 110.919 170.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.0 tp -155.19 164.02 39.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.953 2.101 . . . . 2.19 107.973 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.415 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 41.2 pttt -146.58 156.16 43.02 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.16 1.541 . . . . 1.93 115.16 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.15 160.16 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.951 2.5 . . . . 2.69 109.929 -167.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.0 142.97 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.959 0.904 . . . . 2.49 110.028 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.21 144.57 15.21 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 124.631 1.172 . . . . 2.52 113.664 -168.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.49 158.86 25.65 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.984 3.79 . . . . 1.24 114.478 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.99 124.5 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.152 1.381 . . . . 1.2 110.227 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 . . . . . 0 N--CA 1.47 0.55 0 C-N-CA 124.345 1.058 . . . . 3.72 111.149 174.956 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 113.362 0.875 . . . . 5.29 113.362 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.16 172.38 34.04 Favored Glycine 0 C--N 1.34 0.78 0 O-C-N 120.797 -1.189 . . . . 1.19 114.809 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -157.35 159.55 37.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.198 1.399 . . . . 2.3 113.358 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.1 t -107.99 143.31 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.905 1.282 . . . . 1.45 109.707 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -73.12 -15.77 61.47 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 117.263 2.32 . . . . 5.69 117.263 -159.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 1.1 t80 71.83 115.76 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.863 2.065 . . . . 3.25 110.778 -174.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.5 m -162.06 145.4 9.14 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.887 1.675 . . . . 2.26 108.806 169.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.12 -33.29 6.03 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.7 2.267 . . . . 1.84 112.551 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.71 172.2 18.29 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.437 1.494 . . . . 1.24 111.503 -175.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.94 -1.26 25.14 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 CA-C-N 119.194 1.497 . . . . 1.15 112.891 -1.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -144.0 169.38 17.93 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.256 1.023 . . . . 2.19 113.45 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.26 178.27 9.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.966 2.506 . . . . 0.69 110.941 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.64 166.3 22.93 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.989 2.116 . . . . 1.08 108.823 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.24 154.4 34.58 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.863 0.865 . . . . 0.64 111.863 174.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.25 131.86 28.84 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.537 1.535 . . . . 2.56 109.818 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.26 162.47 39.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.083 0.856 . . . . 2.82 112.841 175.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 39.4 m -89.03 127.08 35.67 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.346 1.458 . . . . 1.73 110.221 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.7 tp -104.47 127.47 52.18 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.115 1.366 . . . . 4.04 108.534 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -135.86 132.83 37.09 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.815 1.246 . . . . 4.69 109.106 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -103.71 101.21 23.0 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.538 1.135 . . . . 1.53 110.41 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.82 -10.17 19.84 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.297 1.998 . . . . 1.1 113.535 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 177.3 50.84 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-O 122.764 1.202 . . . . 1.15 113.102 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -104.46 -5.25 21.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.496 2.318 . . . . 2.88 112.368 -172.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -120.34 161.2 40.31 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 127.359 2.264 . . . . 3.64 109.033 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.74 151.99 14.83 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.711 2.274 . . . . 1.06 111.911 -167.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp -104.93 149.88 25.35 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.81 1.291 . . . . 2.16 109.387 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -139.87 116.65 10.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.726 -1.579 . . . . 2.27 108.594 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -93.31 114.85 27.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.3 2.24 . . . . 2.28 108.193 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.5 -25.34 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.708 0.803 . . . . 0.62 111.984 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.04 -175.8 33.45 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 123.808 0.718 . . . . 0.55 114.573 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -123.51 178.29 5.25 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.64 1.176 . . . . 0.81 112.1 166.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -157.06 147.66 21.41 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.708 1.603 . . . . 5.82 107.094 162.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 t -159.59 151.6 17.1 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-O 117.538 -1.22 . . . . 0.68 108.317 -169.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.93 0.59 9.1 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 121.805 1.67 . . . . 0.86 114.047 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.07 28.3 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.809 2.044 . . . . 1.04 114.791 -171.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.26 143.14 16.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.786 1.175 . . . . 1.15 111.013 168.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.96 -38.51 91.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.174 1.39 . . . . 3.02 111.697 173.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -149.95 144.39 25.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.085 1.754 . . . . 7.03 107.856 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.66 132.67 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.329 1.452 . . . . 0.9 109.394 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -97.63 167.98 10.63 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.714 1.206 . . . . 3.21 110.02 166.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -119.61 137.25 53.98 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.986 1.374 . . . . 2.45 112.441 154.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -121.5 153.72 37.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.661 1.984 . . . . 0.74 110.808 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -90.35 157.28 17.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.896 -1.047 . . . . 1.98 109.945 153.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.4 m -108.89 140.13 42.79 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 105.033 -2.21 . . . . 0.96 105.033 157.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -136.15 167.99 20.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.869 1.318 . . . . 1.99 113.701 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.4 mtm -113.12 142.87 45.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.532 1.533 . . . . 4.71 110.843 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -134.88 143.27 46.87 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.129 1.372 . . . . 6.18 110.047 170.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -91.25 142.31 27.85 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.214 -1.032 . . . . 3.39 108.214 154.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.3 t -138.85 118.71 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 106.599 -1.63 . . . . 3.44 106.599 164.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 64.59 19.89 11.97 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.411 1.484 . . . . 4.92 114.264 -177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.54 4.81 87.41 Favored Glycine 0 N--CA 1.481 1.646 0 O-C-N 120.477 -1.39 . . . . 3.28 113.64 -169.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -103.68 111.43 23.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.672 1.989 . . . . 3.54 107.87 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -87.64 117.71 26.64 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.336 1.454 . . . . 2.96 111.085 -173.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.17 139.85 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.396 1.878 . . . . 2.55 109.329 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -101.13 166.98 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.902 1.281 . . . . 3.58 112.77 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.1 -178.0 29.84 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.44 1.019 . . . . 0.59 113.166 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.2 ttm -152.41 143.37 23.04 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.666 1.586 . . . . 1.29 108.759 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -162.96 153.75 14.23 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 123.569 0.748 . . . . 4.94 112.065 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.33 146.22 35.33 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.644 2.229 . . . . 0.67 112.852 -174.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.66 155.15 63.38 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 118.347 -0.835 . . . . 0.83 110.905 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.38 -23.66 5.98 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.133 2.555 . . . . 0.6 112.89 -171.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -178.37 167.41 1.88 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.089 1.756 . . . . 2.02 111.113 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.6 mt -115.08 155.13 27.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.191 1.796 . . . . 0.77 109.952 163.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -116.13 145.81 42.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.387 1.475 . . . . 2.23 110.531 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.5 t -142.23 126.6 10.03 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 118.878 0.763 . . . . 0.92 112.588 163.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.58 165.57 32.33 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.089 3.193 . . . . 1.02 112.39 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.99 137.63 80.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.342 2.694 . . . . 1.07 112.218 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt 67.59 1.21 2.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.362 1.865 . . . . 1.68 114.396 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.12 167.43 27.83 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 126.007 1.765 . . . . 1.19 113.406 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -137.03 156.16 48.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.576 1.15 . . . . 5.65 111.826 169.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.0 t -146.84 130.71 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.888 2.075 . . . . 3.47 108.145 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -96.33 140.47 30.96 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.622 1.101 . . . . 3.12 111.392 164.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -41.2 -52.37 3.36 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.364 1.865 . . . . 3.06 111.959 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 104.11 127.89 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 128.575 2.75 . . . . 2.73 111.217 164.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.18 -11.27 30.53 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.238 2.625 . . . . 2.5 114.83 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.67 20.26 8.82 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.108 1.337 . . . . 1.83 113.753 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -144.54 -119.32 1.3 Allowed Glycine 0 N--CA 1.471 1.0 0 CA-C-N 119.204 1.502 . . . . 1.81 113.31 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -72.74 144.68 47.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.275 1.038 . . . . 2.17 110.518 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -161.48 151.14 16.69 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.532 -0.73 . . . . 0.72 110.728 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 59.0 m-85 -77.76 143.01 38.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.477 -0.935 . . . . 2.52 108.477 166.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 tpt -115.88 114.52 24.8 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.391 2.276 . . . . 1.11 107.902 172.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -98.04 118.85 35.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.938 1.695 . . . . 1.5 108.73 -173.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.85 135.13 54.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.685 1.194 . . . . 2.2 110.336 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.51 50.84 10.66 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.718 -0.614 . . . . 1.63 112.689 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -47.76 156.38 0.33 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 115.932 1.827 . . . . 0.71 115.932 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -112.08 -30.77 7.11 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 113.43 -1.714 . . . . 1.76 113.772 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -112.66 134.79 21.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.465 1.506 . . . . 4.33 108.959 166.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.62 82.89 1.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.785 2.324 . . . . 1.46 107.265 160.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.3 pt? -87.6 124.75 33.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.562 0.745 . . . . 2.53 112.952 -163.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 24.4 mtmm -110.38 167.23 10.36 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 115.268 1.581 . . . . 3.62 115.268 -165.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.86 124.82 21.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.353 -1.294 . . . . 1.24 109.123 172.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.13 5.25 62.44 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 117.959 -1.467 . . . . 1.69 115.639 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.01 178.26 6.71 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.193 1.997 . . . . 2.77 111.246 163.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -149.12 125.76 11.05 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 129.497 3.119 . . . . 3.49 104.607 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.4 t -146.52 139.96 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.809 0.844 . . . . 1.76 110.783 -168.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -80.13 152.12 29.43 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.524 1.13 . . . . 3.15 113.982 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.2 tt -144.47 130.74 19.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.426 1.49 . . . . 3.06 110.639 168.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.8 117.88 21.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.644 2.778 . . . . 2.35 109.095 165.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -87.87 121.08 29.85 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.124 -1.065 . . . . 1.03 108.124 171.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.1 mt -97.61 118.56 34.41 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.002 0.921 . . . . 0.84 109.979 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -116.2 144.51 44.09 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.308 1.043 . . . . 2.2 112.852 -171.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.58 137.0 57.94 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.279 -0.888 . . . . 2.14 113.271 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.17 46.38 5.6 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.746 -1.03 . . . . 3.92 113.627 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.3 32.79 46.54 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 123.959 0.79 . . . . 1.72 114.728 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -125.77 144.81 50.48 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.675 1.237 . . . . 3.7 112.201 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.04 149.02 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.376 1.47 . . . . 2.02 110.644 176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -149.3 119.29 7.16 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.143 0.977 . . . . 2.26 108.699 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -96.08 133.71 40.01 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.635 -0.665 . . . . 2.17 111.757 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.28 170.47 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.934 1.693 . . . . 2.16 108.469 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -124.75 136.77 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.752 1.621 . . . . 2.41 108.726 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -127.73 139.12 34.4 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.305 1.442 . . . . 2.78 109.131 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.26 150.41 76.5 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.231 2.621 . . . . 1.34 111.311 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.1 t -99.39 137.73 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.491 1.116 . . . . 1.35 108.384 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.444 0 C-N-CA 126.525 1.93 . . . . 4.79 112.271 -174.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 . . . . . 0 C--O 1.237 0.441 0 N-CA-C 107.602 -1.259 . . . . 5.47 107.602 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.17 137.14 9.19 Favored Glycine 0 N--CA 1.467 0.701 0 N-CA-C 110.95 -0.86 . . . . 2.2 110.95 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -96.87 173.12 7.46 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.521 1.304 . . . . 2.33 114.521 -168.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.43 148.36 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.214 1.806 . . . . 1.25 108.6 168.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -69.46 -103.02 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.407 1.083 . . . . 4.53 112.613 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.2 t80 169.96 126.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.705 2.402 . . . . 2.0 108.419 -166.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 m -173.34 145.47 1.22 Allowed Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 126.015 1.726 . . . . 2.0 109.389 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.78 -33.74 0.6 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.915 2.41 . . . . 1.63 112.589 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.29 166.8 11.95 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.949 1.738 . . . . 1.54 111.314 -170.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.76 -2.04 25.17 Favored 'Cis proline' 0 CA--C 1.54 0.777 0 CA-C-N 119.192 1.496 . . . . 1.6 113.092 -0.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -147.6 163.66 35.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.796 1.638 . . . . 1.91 112.994 -172.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.58 -175.43 4.92 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.259 2.224 . . . . 0.71 111.773 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.11 148.0 33.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.532 1.133 . . . . 0.68 110.989 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.23 137.75 39.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 0.51 113.096 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -105.93 23.36 14.09 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.252 2.621 . . . . 2.72 113.818 -168.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -58.47 160.72 5.09 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 117.263 2.319 . . . . 2.25 117.263 -163.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -79.46 150.13 31.34 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.119 2.168 . . . . 1.88 112.046 174.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.67 132.7 33.31 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.058 2.143 . . . . 3.44 110.334 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -135.6 162.78 31.73 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.125 1.37 . . . . 4.64 111.456 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -130.31 98.94 19.92 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.909 0.883 . . . . 1.76 109.662 168.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.16 -11.15 16.32 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.779 2.319 . . . . 1.24 113.007 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.85 -172.66 47.54 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.994 1.283 . . . . 1.26 113.155 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -113.73 -2.64 13.67 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.438 1.895 . . . . 3.32 112.239 -165.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -124.54 153.86 69.65 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.363 2.265 . . . . 3.25 110.231 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.99 158.5 38.29 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.643 2.229 . . . . 1.39 112.709 -168.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.3 mt -119.04 152.5 36.33 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.083 1.753 . . . . 2.02 110.196 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.3 ttp-105 -138.01 102.39 4.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.281 -1.781 . . . . 2.79 110.722 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.82 106.88 16.68 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.318 1.847 . . . . 1.82 108.671 -174.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.25 -26.08 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.698 0.999 . . . . 0.54 113.698 -170.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.09 -174.23 31.71 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 125.615 1.579 . . . . 0.49 111.805 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.71 -175.14 4.54 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.643 0.735 . . . . 0.69 112.443 173.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -145.23 178.1 8.32 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.808 2.843 . . . . 5.42 107.598 160.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t 179.41 150.7 0.5 Allowed Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 127.089 2.156 . . . . 0.68 109.115 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.77 -9.68 22.69 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.014 2.476 . . . . 1.05 113.746 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 30.1 m -114.04 23.34 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 115.248 1.573 . . . . 0.84 115.248 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -151.75 173.24 14.97 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.408 1.483 . . . . 1.17 109.252 166.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -101.21 -58.02 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.612 1.565 . . . . 4.6 110.795 165.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -98.14 152.61 19.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.615 2.366 . . . . 5.88 108.536 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.5 p -160.55 108.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 127.04 2.136 . . . . 1.74 110.224 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -127.58 140.94 51.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.16 -1.382 . . . . 5.49 111.469 -168.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 tp -82.03 125.27 30.61 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.666 0.746 . . . . 1.53 111.59 -170.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -119.09 159.5 23.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.288 1.835 . . . . 0.56 112.161 171.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -114.31 165.43 12.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.906 -1.497 . . . . 2.25 110.863 166.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -124.3 126.76 46.57 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.16 -1.793 . . . . 0.93 106.16 169.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -127.14 171.35 11.49 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.23 0.826 . . . . 2.1 113.23 -172.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 ttp -105.38 145.28 31.0 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.779 1.632 . . . . 3.84 110.823 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -152.25 153.42 33.71 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.467 1.507 . . . . 8.29 112.122 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -155.66 142.16 18.65 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.197 1.799 . . . . 2.79 108.802 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -164.78 145.41 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 129.54 3.136 . . . . 5.63 105.797 171.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 61.64 9.18 2.66 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.767 1.627 . . . . 3.59 115.063 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.48 8.52 73.99 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.416 1.008 . . . . 2.23 114.95 -168.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -85.55 66.66 9.78 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.948 -1.325 . . . . 2.77 111.938 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 111.93 1.7 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.331 -1.481 . . . . 2.75 111.315 171.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -155.23 159.81 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.203 1.401 . . . . 2.98 110.082 -170.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 65.1 mtm -91.84 172.69 8.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.71 1.004 . . . . 3.04 113.71 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.59 -179.17 24.3 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.472 1.987 . . . . 0.78 111.211 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ttm -144.38 147.21 33.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.248 1.419 . . . . 1.26 107.856 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -158.97 155.44 24.47 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 4.83 110.84 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.87 156.85 24.02 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.782 2.322 . . . . 0.68 111.635 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.49 155.58 63.92 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.44 1.496 . . . . 1.06 110.756 -176.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -84.81 -27.23 1.32 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.071 2.514 . . . . 0.62 113.493 -165.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -178.39 166.56 1.85 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.228 1.811 . . . . 1.71 112.003 -178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.2 mt -108.35 157.24 18.56 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.021 1.328 . . . . 0.7 110.319 157.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -106.35 153.74 21.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.427 1.091 . . . . 1.88 109.341 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.3 t -140.59 122.79 9.63 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 118.722 0.692 . . . . 1.42 112.157 160.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.29 159.16 44.11 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.549 2.833 . . . . 1.26 111.296 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.6 140.89 89.22 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.423 2.748 . . . . 1.32 112.586 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt 66.21 -2.07 1.06 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.877 2.071 . . . . 2.0 113.948 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.6 172.75 41.27 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.262 1.887 . . . . 1.26 113.577 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.51 144.0 23.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.137 1.375 . . . . 5.94 111.348 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.9 t -149.48 137.35 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 126.814 2.046 . . . . 3.36 107.16 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -133.45 127.33 33.09 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.446 -1.316 . . . . 4.36 107.446 -162.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.6 -51.41 68.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.37 0.668 . . . . 2.69 111.616 -162.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 82.74 158.63 0.12 Allowed Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 126.708 2.003 . . . . 5.4 114.98 159.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -60.53 127.14 21.82 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.218 1.945 . . . . 2.84 110.22 168.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.88 54.7 34.77 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.975 -0.557 . . . . 1.79 113.709 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.36 -44.74 0.03 OUTLIER Glycine 0 N--CA 1.473 1.117 0 N-CA-C 116.489 1.356 . . . . 1.91 116.489 160.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -135.24 147.62 49.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.991 1.395 . . . . 2.13 109.871 163.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -161.24 149.01 15.33 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.678 0.791 . . . . 0.62 109.693 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -79.07 136.43 37.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.426 -0.953 . . . . 2.14 108.426 160.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.0 tpt -88.8 116.85 27.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.848 1.659 . . . . 0.79 107.569 163.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -89.37 129.77 35.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.003 1.321 . . . . 1.19 107.971 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.15 140.12 51.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.165 0.986 . . . . 2.0 111.073 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.57 48.88 7.64 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.923 0.773 . . . . 2.41 111.259 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 14.0 mt -51.99 156.11 1.64 Allowed 'General case' 0 N--CA 1.46 0.046 0 N-CA-C 115.254 1.576 . . . . 0.95 115.254 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 29.9 mmtp -120.92 -22.12 6.31 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 113.551 -1.659 . . . . 3.32 113.513 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -132.89 142.83 46.16 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 128.436 2.695 . . . . 6.39 109.122 165.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -68.93 137.57 38.26 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.369 2.046 . . . . 1.52 107.951 157.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.24 140.68 29.9 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.704 0.802 . . . . 2.15 111.265 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.24 165.12 12.72 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 123.559 1.647 . . . . 4.03 111.329 165.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.81 134.1 41.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 112.88 -1.963 . . . . 1.26 109.249 170.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.99 12.43 59.01 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.073 1.32 . . . . 1.97 115.051 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.07 -176.71 4.08 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.68 1.192 . . . . 2.63 111.522 171.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.77 136.6 17.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 128.369 2.668 . . . . 3.04 106.183 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.3 t -147.86 146.2 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.979 1.312 . . . . 1.39 110.738 -168.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.4 142.77 40.99 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.56 0.744 . . . . 2.57 112.162 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mp -120.69 145.26 47.64 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.512 1.149 . . . . 1.84 110.774 150.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -112.07 103.61 11.81 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.665 2.786 . . . . 2.41 108.527 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.91 130.17 34.57 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.67 -1.268 . . . . 1.19 110.762 -166.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.74 116.01 31.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.497 1.119 . . . . 0.94 111.446 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -111.04 104.05 12.57 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.339 1.455 . . . . 2.05 111.829 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 55.52 25.48 7.93 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.393 1.877 . . . . 3.22 113.411 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.88 -58.22 4.27 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.229 1.395 . . . . 4.81 112.697 -173.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.4 0.09 56.01 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.868 1.507 . . . . 2.1 116.868 -167.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -137.04 143.09 42.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.535 1.668 . . . . 2.83 111.649 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.35 148.82 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.121 1.768 . . . . 2.16 110.711 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.5 tt -155.66 131.61 9.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.102 1.361 . . . . 1.83 110.599 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -92.36 144.75 25.06 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.265 -0.897 . . . . 2.48 112.288 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.02 161.9 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.675 1.59 . . . . 1.96 108.381 167.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.62 130.64 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.18 0.992 . . . . 2.04 108.88 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.92 136.7 29.41 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.944 1.698 . . . . 3.16 109.501 -165.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.47 160.2 41.99 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.385 2.723 . . . . 1.45 111.911 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 t -109.51 120.61 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.255 1.022 . . . . 1.16 110.478 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 . . . . . 0 N--CA 1.466 0.374 0 C-N-CA 126.169 1.788 . . . . 3.77 108.732 173.071 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 120.69 0.281 . . . . 4.93 111.162 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.15 167.75 21.7 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 121.212 -0.93 . . . . 1.24 112.889 -169.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -151.96 165.5 34.44 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.619 0.768 . . . . 2.27 112.893 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -105.88 139.58 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 106.471 -1.677 . . . . 1.43 106.471 168.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ttt-85 -79.8 -126.63 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.102 0.865 . . . . 4.84 109.001 170.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -154.45 154.43 33.19 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 119.695 -1.878 . . . . 2.97 113.342 -173.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.7 t -176.36 140.36 0.52 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 129.757 3.223 . . . . 2.2 107.037 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.2 -32.52 5.09 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.467 2.112 . . . . 1.3 112.067 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.88 171.95 23.58 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.807 1.194 . . . . 0.86 112.657 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.95 1.21 19.5 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 119.026 1.413 . . . . 0.88 112.6 -6.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.86 144.83 24.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.463 1.653 . . . . 2.49 115.463 -173.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.23 -176.11 3.14 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.898 2.479 . . . . 0.48 112.58 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.5 133.25 25.45 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.089 1.356 . . . . 1.01 110.987 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.0 141.69 40.76 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.699 1.2 . . . . 0.55 112.67 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -115.64 58.69 0.73 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.143 2.577 . . . . 2.41 109.978 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -64.31 162.05 15.57 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.054 -1.029 . . . . 1.81 111.836 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 m -108.32 139.76 42.57 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.403 0.681 . . . . 1.47 110.941 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -104.64 127.38 52.37 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.904 -1.044 . . . . 3.13 110.242 -178.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.3 145.71 39.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.4 1.48 . . . . 5.5 110.178 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.46 60.42 48.13 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.614 0.766 . . . . 2.81 111.897 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -60.66 -20.3 64.49 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.678 2.919 . . . . 1.49 114.573 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.41 -171.84 36.73 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 122.638 1.132 . . . . 1.38 113.677 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -111.74 -3.02 15.11 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.17 1.788 . . . . 3.09 112.45 -163.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.58 154.69 69.9 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 127.528 2.331 . . . . 3.0 110.021 175.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.66 138.59 19.32 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.731 2.287 . . . . 1.47 111.219 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.9 mt -94.89 137.84 33.44 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 123.602 1.667 . . . . 2.17 112.341 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 ttp-105 -123.97 95.97 4.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.471 -2.149 . . . . 3.4 111.508 -173.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.456 HD22 HD23 ' A' ' 22' ' ' LEU . 44.0 tp -79.62 107.71 12.6 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.413 1.885 . . . . 2.38 109.909 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -98.01 -25.41 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 112.724 0.639 . . . . 0.53 112.724 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.47 -173.96 27.56 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 124.657 1.122 . . . . 0.43 112.388 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.23 174.19 10.06 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.667 -0.767 . . . . 0.51 111.88 163.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.4 mtp-105 -138.97 170.95 15.05 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 128.992 2.917 . . . . 4.86 107.056 158.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t 179.92 153.46 0.63 Allowed Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 125.459 1.504 . . . . 0.72 110.022 -168.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.02 -1.7 9.45 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.8 2.333 . . . . 1.03 115.236 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -118.63 18.56 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 115.706 1.743 . . . . 1.02 115.706 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -166.04 162.63 18.04 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.194 2.197 . . . . 0.99 109.105 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -120.84 -69.26 0.85 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.069 1.748 . . . . 4.05 108.345 -172.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -84.1 75.05 10.2 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.528 -1.358 . . . . 5.65 108.009 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.45 148.75 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.512 -0.767 . . . . 1.04 109.577 166.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.35 154.28 30.33 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.332 1.853 . . . . 4.09 108.414 -164.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.9 tp -121.38 107.95 13.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.47 1.032 . . . . 0.83 110.864 -167.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -115.94 150.13 37.63 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 114.99 1.478 . . . . 0.67 114.99 -171.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -106.93 153.62 22.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.662 1.985 . . . . 2.12 110.684 163.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.418 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 3.5 m -131.27 133.17 45.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.651 1.981 . . . . 0.94 106.973 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -144.33 172.3 13.13 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.649 0.981 . . . . 1.99 113.649 -167.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.5 ttp -99.25 147.05 25.56 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.627 1.571 . . . . 3.77 109.889 167.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.91 158.35 43.05 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.876 1.67 . . . . 5.55 109.822 -174.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -110.11 143.2 40.51 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.808 1.643 . . . . 2.9 109.818 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.6 p -157.84 138.32 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.935 -1.135 . . . . 3.71 107.935 163.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 64.25 25.11 13.51 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.864 0.865 . . . . 4.01 111.587 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.03 10.6 78.09 Favored Glycine 0 N--CA 1.48 1.584 0 O-C-N 120.428 -1.42 . . . . 2.32 113.865 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -123.18 121.61 36.37 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.791 2.036 . . . . 2.65 109.565 -166.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 mtmm -72.38 131.92 43.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.165 1.386 . . . . 3.74 110.957 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.29 -179.5 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 129.095 2.958 . . . . 2.7 109.367 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.73 162.39 22.11 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.787 0.835 . . . . 3.93 112.289 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.57 31.12 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.54 1.067 . . . . 0.73 113.319 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.0 ttm -154.75 144.3 21.4 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.226 1.41 . . . . 1.1 110.567 -174.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -148.79 161.72 31.94 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 126.105 1.762 . . . . 4.4 109.897 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.07 161.4 26.54 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.247 1.964 . . . . 0.53 111.956 168.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.92 154.9 68.99 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 126.683 1.993 . . . . 1.02 110.612 175.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.91 -20.41 7.63 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.799 2.999 . . . . 0.47 113.561 -165.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -178.33 163.69 1.65 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.431 1.892 . . . . 1.98 111.166 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -110.98 157.76 19.54 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.946 1.299 . . . . 0.63 109.822 159.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -133.17 152.33 51.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.519 0.728 . . . . 2.32 111.359 172.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.2 t -136.15 141.09 34.95 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.536 1.934 . . . . 1.1 112.398 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.83 156.13 13.57 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.282 3.321 . . . . 1.45 112.708 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -65.91 148.21 85.81 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.599 2.866 . . . . 1.36 114.064 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 70.24 -13.4 0.44 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 129.133 2.973 . . . . 1.99 114.934 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.7 164.23 48.61 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.289 0.947 . . . . 1.96 113.454 173.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -98.41 159.06 15.19 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.519 -0.919 . . . . 4.27 108.519 145.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.9 t -148.57 118.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.268 1.427 . . . . 3.54 107.48 163.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -78.85 156.26 28.76 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.719 -0.613 . . . . 2.97 112.376 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.89 144.43 57.28 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.099 -1.074 . . . . 2.6 108.099 155.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' H ' ' HB2' ' A' ' 82' ' ' TYR . 7.9 mptt -84.45 126.98 67.77 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 120.153 -1.592 . . . . 3.36 109.751 -170.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -60.78 -14.82 34.07 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.814 3.009 . . . . 2.47 115.071 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.56 -58.24 0.77 Allowed Glycine 0 CA--C 1.531 1.069 0 CA-C-N 118.752 0.706 . . . . 3.47 111.867 155.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -75.15 -17.12 80.28 Favored Glycine 0 N--CA 1.476 1.338 0 N-CA-C 119.307 2.483 . . . . 2.0 119.307 -158.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.41 ' HB2' ' H ' ' A' ' 78' ' ' LYS . 80.5 m-85 -147.63 141.32 25.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.698 2.249 . . . . 2.25 111.643 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -158.2 150.32 21.88 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.606 0.763 . . . . 0.81 111.392 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -79.71 117.03 20.24 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 108.912 -0.773 . . . . 1.82 108.912 162.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 tpt -77.81 124.49 28.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.726 2.01 . . . . 1.0 108.278 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.5 mt -117.05 97.32 5.87 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.343 1.457 . . . . 1.99 108.946 -167.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.51 149.39 26.26 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.775 0.798 . . . . 2.36 111.839 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.41 51.98 6.35 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 110.879 -0.888 . . . . 2.08 110.879 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 10.5 mt -50.77 151.44 2.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.682 1.23 . . . . 0.98 113.864 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -114.45 -20.49 10.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.031 -1.895 . . . . 3.03 114.648 -173.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -126.51 154.55 75.2 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.294 2.238 . . . . 6.22 108.184 166.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -64.7 139.92 65.56 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 N-CA-C 107.867 -1.628 . . . . 2.76 107.867 151.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.26 163.34 29.52 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.192 1.397 . . . . 2.46 109.225 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.07 170.47 20.41 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.236 0.828 . . . . 4.13 113.236 174.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.19 134.44 57.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.932 0.893 . . . . 1.4 110.339 170.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.11 -7.52 35.32 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.683 1.611 . . . . 1.69 115.323 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.69 -179.69 6.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.447 1.123 . . . . 3.8 110.676 174.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 20.6 pt-20 -138.51 141.7 39.36 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.648 1.979 . . . . 3.4 106.937 160.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.9 t -148.53 145.25 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.784 1.634 . . . . 1.37 110.181 -165.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.51 145.62 26.72 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.263 1.579 . . . . 3.47 115.263 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -118.31 144.29 45.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.79 1.636 . . . . 2.51 109.526 161.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -95.62 113.24 24.87 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 128.568 2.747 . . . . 1.94 108.171 167.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.9 mp -86.5 112.16 21.26 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.617 1.167 . . . . 1.63 107.954 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.9 mt -95.61 106.33 18.41 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.79 0.805 . . . . 0.7 110.705 -174.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -98.25 126.84 43.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.882 1.273 . . . . 1.97 111.929 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.81 41.27 4.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.088 2.155 . . . . 2.52 112.822 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.85 -93.17 1.73 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 125.338 1.447 . . . . 5.99 111.458 -171.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.08 -6.68 61.55 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 116.969 1.548 . . . . 3.08 116.969 -160.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -81.94 100.37 9.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.111 2.456 . . . . 4.21 110.632 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -94.91 137.0 24.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.235 1.014 . . . . 2.46 112.554 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.4 tp -133.71 113.97 12.92 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.711 1.604 . . . . 2.53 109.703 170.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -89.73 125.59 35.34 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.616 -0.677 . . . . 2.42 111.482 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.04 157.9 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.745 0.818 . . . . 2.57 110.765 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.0 t -104.13 143.76 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.715 1.606 . . . . 1.8 108.706 -173.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.13 141.11 14.56 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.571 1.549 . . . . 1.97 109.399 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 55.6 Cg_endo -68.16 157.88 59.91 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.221 3.281 . . . . 0.92 113.743 177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.7 t -110.23 139.59 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.852 2.061 . . . . 0.99 108.928 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? . . . . . 0 N--CA 1.479 1.02 0 CA-C-N 119.741 1.155 . . . . 5.35 114.025 -170.518 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 106.454 -1.684 . . . . 4.08 106.454 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.93 164.69 32.38 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 127.159 2.314 . . . . 1.16 111.091 -178.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -157.75 156.3 31.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.125 1.37 . . . . 2.19 111.213 177.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.3 t -80.27 158.54 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.441 0.696 . . . . 1.52 109.42 175.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.72 -26.39 44.76 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.805 1.78 . . . . 5.39 115.805 -176.144 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 85.0 t80 72.36 115.32 0.05 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.69 2.796 . . . . 2.48 111.756 -168.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.1 m -164.24 143.16 5.97 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 126.239 1.815 . . . . 2.38 108.047 169.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.35 -25.77 11.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.828 2.352 . . . . 1.3 112.374 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.4 175.2 16.27 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 126.814 2.15 . . . . 0.8 110.189 -172.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.42 -7.71 15.84 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 CA-C-N 119.473 1.637 . . . . 0.93 112.747 -5.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -140.44 169.63 17.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.083 0.953 . . . . 1.88 113.393 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.65 -177.62 5.39 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.644 2.378 . . . . 0.57 109.966 175.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.59 170.35 14.86 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.76 1.224 . . . . 0.95 110.071 169.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.98 144.22 21.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.727 1.211 . . . . 0.74 111.254 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.94 152.52 40.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.681 1.992 . . . . 3.03 109.315 -178.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -165.45 157.44 14.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.954 1.094 . . . . 2.09 113.954 -177.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.8 m -84.4 124.15 30.99 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.789 1.635 . . . . 1.79 109.928 169.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.38 132.17 44.89 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.399 1.479 . . . . 3.33 108.988 170.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -123.53 145.03 49.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.691 0.797 . . . . 3.58 112.01 177.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.53 72.59 7.63 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.264 -0.88 . . . . 3.22 110.47 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.31 -19.84 55.69 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.707 2.271 . . . . 1.22 113.607 -178.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.29 169.7 54.86 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-O 123.034 1.352 . . . . 1.34 113.01 174.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 11.5 m-20 -95.82 -4.33 43.98 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 128.199 2.6 . . . . 3.15 112.843 -170.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -122.24 160.31 48.33 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.353 2.261 . . . . 4.66 108.717 172.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.97 143.25 14.29 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.859 2.373 . . . . 1.37 110.844 -169.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.8 mt -94.3 153.49 17.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 122.72 1.247 . . . . 1.83 112.435 172.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -136.41 113.12 10.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.131 -1.849 . . . . 1.73 110.65 178.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.87 112.02 24.36 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.78 2.032 . . . . 1.91 108.539 -172.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.3 m -102.54 -29.07 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.886 0.875 . . . . 0.61 113.011 -169.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.07 -174.44 30.94 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.969 1.271 . . . . 0.54 113.047 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.76 -178.75 5.15 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.79 0.805 . . . . 0.57 110.924 167.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -139.73 179.39 6.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.667 2.787 . . . . 5.81 107.393 161.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t 176.6 151.19 0.35 Allowed Pre-proline 0 N--CA 1.469 0.484 0 C-N-CA 127.769 2.427 . . . . 0.78 106.796 -170.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.68 -7.74 14.65 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.716 2.277 . . . . 0.76 113.902 174.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.74 31.94 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.725 1.38 . . . . 0.97 114.725 -170.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.92 138.28 13.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.662 1.585 . . . . 0.92 110.977 168.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -61.2 -39.94 92.08 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.259 1.023 . . . . 2.88 111.498 173.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -144.15 143.38 31.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 128.567 2.747 . . . . 6.12 106.308 -168.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.07 137.02 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.018 -1.105 . . . . 1.09 108.018 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -144.12 138.29 28.1 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.813 1.245 . . . . 2.98 109.638 -171.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.5 pt? -87.06 135.61 33.22 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 123.076 1.417 . . . . 1.88 113.335 173.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -116.89 154.67 30.39 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 127.576 2.35 . . . . 0.95 110.914 176.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.401 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 2.0 pp20? -103.31 155.93 18.1 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.388 1.875 . . . . 2.91 110.453 161.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.406 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 24.6 m -127.73 132.44 49.59 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.007 -1.479 . . . . 0.92 107.007 172.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -144.81 176.44 9.45 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.729 1.381 . . . . 2.06 114.729 -166.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.6 ttp -113.36 142.47 45.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.823 2.049 . . . . 4.06 111.399 176.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -128.29 163.28 25.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.227 1.811 . . . . 6.01 111.753 166.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -94.6 145.32 24.91 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.008 -1.849 . . . . 3.52 106.008 152.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.8 p -153.09 124.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.324 0.65 . . . . 3.48 109.367 164.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 64.02 22.03 12.8 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.925 1.69 . . . . 4.54 113.163 -172.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.23 11.55 83.35 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 120.547 -1.346 . . . . 2.43 113.622 -171.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -109.57 118.8 37.54 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.55 1.54 . . . . 4.2 110.265 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.63 127.28 31.21 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.986 1.314 . . . . 3.98 109.251 164.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -145.52 176.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 128.294 2.637 . . . . 3.63 109.759 -176.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -130.5 166.25 20.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.313 1.045 . . . . 3.72 112.459 178.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.92 -179.84 31.29 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.395 1.474 . . . . 0.9 112.954 177.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -153.91 137.38 15.89 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.006 1.322 . . . . 1.3 110.305 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -144.73 156.29 56.06 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.785 1.634 . . . . 9.66 111.302 -174.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.95 154.71 53.22 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.705 2.27 . . . . 0.69 110.488 172.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.83 158.39 73.87 Favored Pre-proline 0 N--CA 1.484 1.275 0 CA-C-O 118.299 -0.858 . . . . 0.73 111.063 169.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -84.26 -18.78 4.88 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.313 2.675 . . . . 0.79 113.969 -170.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -178.09 169.04 1.96 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.284 1.833 . . . . 1.77 111.771 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.8 mt -115.27 154.99 28.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.79 2.036 . . . . 0.56 110.089 162.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.84 146.67 42.74 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.196 1.399 . . . . 1.65 108.577 173.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.3 t -137.35 138.69 25.61 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.948 -0.548 . . . . 1.02 111.991 169.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -83.72 156.23 13.79 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 124.237 3.291 . . . . 1.24 112.479 178.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.57 140.31 80.73 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.765 2.977 . . . . 1.2 113.668 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.409 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 69.1 mmtt 69.55 -8.34 0.76 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.369 2.668 . . . . 1.53 114.345 -177.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.96 149.84 35.03 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.671 1.129 . . . . 1.3 112.266 175.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -108.71 132.03 54.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.924 1.689 . . . . 4.36 106.88 163.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.8 122.93 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.075 1.35 . . . . 3.42 107.916 177.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -101.95 135.56 43.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.87 1.268 . . . . 5.06 110.116 -176.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 83' ' ' HIS . 1.0 OUTLIER -52.84 -48.5 66.98 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.877 1.671 . . . . 3.32 113.216 -171.117 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 103.25 118.38 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 131.047 3.739 . . . . 3.15 111.307 176.213 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.66 -1.01 6.8 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.513 2.808 . . . . 2.81 115.036 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.13 2.31 12.99 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.434 1.492 . . . . 2.49 114.774 170.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -132.9 -106.66 1.0 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.355 1.455 . . . . 1.9 112.248 -174.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.401 ' CE2' ' HB3' ' A' ' 47' ' ' GLU . 86.7 m-85 -77.47 138.19 39.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.147 0.975 . . . . 2.11 111.489 -175.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.559 ' HA ' HD23 ' A' ' 77' ' ' LEU . 54.7 p-80 -160.17 146.01 15.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.827 -0.624 . . . . 0.83 111.057 -175.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.8 136.49 38.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.093 -1.077 . . . . 1.98 108.093 165.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.7 mtp -99.79 135.66 40.88 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 118.717 0.689 . . . . 1.96 110.001 157.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.8 109.03 20.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.691 -1.596 . . . . 1.44 106.691 -179.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -102.61 130.9 49.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.88 1.672 . . . . 2.79 108.489 -173.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.81 53.51 8.12 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.824 0.726 . . . . 1.73 112.836 174.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.0 mt -48.23 156.54 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 115.938 1.829 . . . . 0.65 115.938 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -110.96 -25.73 9.66 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 113.733 -1.576 . . . . 1.68 113.973 178.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -124.53 142.07 39.48 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.412 2.285 . . . . 4.74 109.068 169.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.27 156.18 55.3 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.7 2.267 . . . . 1.45 109.73 160.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.21 161.77 13.81 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.249 1.02 . . . . 2.55 112.025 -169.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -132.74 -176.42 4.1 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.952 2.101 . . . . 4.61 110.641 175.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.5 150.49 24.54 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.259 -1.015 . . . . 1.73 108.259 156.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.39 36.77 43.49 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.429 0.537 . . . . 1.77 114.386 176.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -122.63 -178.03 3.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.609 1.164 . . . . 3.34 110.009 161.347 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -139.56 135.57 33.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.873 2.469 . . . . 3.63 105.214 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.3 t -142.85 148.94 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.488 1.915 . . . . 1.68 109.898 -171.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -100.83 148.67 24.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.165 1.386 . . . . 2.55 114.071 -173.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mp -127.16 158.91 35.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.189 2.195 . . . . 1.67 110.125 167.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -132.14 94.3 3.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.983 1.713 . . . . 2.79 110.762 -172.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.2 mp -78.48 135.93 37.48 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.375 1.07 . . . . 1.24 111.264 -168.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.2 mt -106.83 119.5 39.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.069 1.747 . . . . 0.69 110.072 -176.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -118.58 145.44 45.39 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.235 1.414 . . . . 1.92 111.016 -172.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.81 126.35 27.3 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.912 1.079 . . . . 2.19 113.912 -169.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.82 68.47 1.49 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.907 1.241 . . . . 3.59 112.502 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 20.44 79.83 Favored Glycine 0 N--CA 1.472 1.099 0 N-CA-C 116.278 1.271 . . . . 1.54 116.278 163.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -112.99 138.59 49.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.552 1.676 . . . . 3.6 111.72 -173.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.4 t -139.82 145.87 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.347 1.059 . . . . 1.85 109.675 178.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 tp -145.66 120.38 9.86 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.794 1.237 . . . . 2.14 111.23 178.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -79.01 137.92 37.79 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.529 -0.732 . . . . 2.47 111.155 173.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.05 161.58 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.946 2.098 . . . . 2.77 110.026 173.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.2 t -136.09 136.02 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.377 1.471 . . . . 1.87 109.084 177.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.84 148.29 35.52 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.925 1.69 . . . . 2.39 111.354 -173.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.81 151.97 81.39 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.403 2.735 . . . . 0.9 113.243 175.24 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.0 t -95.32 118.86 42.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.839 -1.073 . . . . 1.59 108.376 172.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 . . . . . 0 CA--C 1.535 0.382 0 C-N-CA 125.4 1.48 . . . . 5.59 109.302 178.069 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.404 ' C ' ' HB ' ' A' ' 21' ' ' THR . 8.6 pm0 . . . . . 0 CA--C 1.54 0.564 0 N-CA-C 114.769 1.396 . . . . 5.3 114.769 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -79.8 179.41 53.18 Favored Glycine 0 N--CA 1.47 0.908 0 O-C-N 121.285 -0.884 . . . . 2.3 114.078 173.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -153.01 146.07 24.62 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.999 1.319 . . . . 2.71 112.929 167.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.8 t -93.67 146.82 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.268 1.427 . . . . 1.37 107.277 177.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 10' ' ' PHE 0.33 0.3 OUTLIER -74.88 -106.1 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.419 1.009 . . . . 4.79 113.528 176.117 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.404 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 50.9 t80 -171.19 148.75 2.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.667 1.987 . . . . 2.11 110.349 -178.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.8 t -179.6 143.43 0.38 Allowed Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 128.114 2.566 . . . . 2.12 109.268 174.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.07 -23.75 10.25 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.843 2.362 . . . . 1.17 112.12 169.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.81 176.81 14.56 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 126.676 2.084 . . . . 0.84 111.573 -171.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.11 -6.37 16.7 Favored 'Cis proline' 0 CA--C 1.537 0.653 0 CA-C-N 118.571 1.185 . . . . 0.91 112.337 -9.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -147.61 148.53 31.2 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.578 1.325 . . . . 2.36 114.578 -177.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.08 -174.58 2.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.588 2.755 . . . . 0.42 111.313 -179.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.81 164.33 30.52 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.066 1.746 . . . . 0.67 108.825 170.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.96 153.16 32.4 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.323 0.965 . . . . 0.63 112.595 -177.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -122.6 87.71 2.8 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.631 1.972 . . . . 2.74 110.802 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.419 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.6 pp -70.45 158.68 35.6 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 119.41 -2.056 . . . . 2.48 113.374 177.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.404 ' HB ' ' C ' ' A' ' 5' ' ' GLU . 20.8 m -135.47 141.27 45.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.459 1.904 . . . . 1.98 106.62 167.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.9 tp -162.46 156.27 20.88 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.9 2.48 . . . . 5.12 109.556 177.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -102.04 154.35 19.06 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.224 -1.548 . . . . 4.09 113.427 166.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -97.74 92.68 1.4 Allowed Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 121.036 -1.04 . . . . 1.52 109.13 162.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.05 -15.65 18.37 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.566 2.177 . . . . 1.43 113.436 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.52 -173.75 47.06 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-O 122.421 1.011 . . . . 1.14 112.882 -178.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -115.66 2.23 13.69 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.16 1.784 . . . . 3.2 112.306 -167.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -112.41 155.58 43.49 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.985 2.114 . . . . 3.09 111.017 173.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.55 158.83 25.44 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.615 2.21 . . . . 0.89 110.979 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.6 mt -115.52 148.66 39.24 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.198 1.399 . . . . 2.02 110.469 174.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -131.61 110.63 11.07 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 112.608 -2.087 . . . . 2.37 110.655 171.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -98.12 110.39 22.98 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.959 2.103 . . . . 2.16 108.348 -170.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.78 -21.61 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.303 1.041 . . . . 0.59 111.938 -165.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.85 -175.97 33.45 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 125.586 1.565 . . . . 0.4 112.617 -178.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.42 -174.92 4.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.079 1.351 . . . . 0.58 111.372 172.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -155.73 154.58 31.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.398 1.479 . . . . 4.31 108.11 163.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -167.51 149.33 5.27 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 117.597 -1.192 . . . . 1.12 109.215 -176.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.43 -19.1 10.49 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.884 1.723 . . . . 1.15 113.207 -174.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -87.13 18.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 113.874 1.064 . . . . 1.55 113.874 -178.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.45 175.15 13.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.531 1.933 . . . . 1.25 109.599 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -111.56 -32.24 6.74 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.403 1.481 . . . . 2.73 113.155 177.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -139.59 159.59 41.81 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.014 2.926 . . . . 5.56 106.11 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 p -157.05 106.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 125.219 1.408 . . . . 1.88 111.005 -173.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.22 132.74 54.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.663 -1.608 . . . . 5.39 111.622 -159.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.0 tp -84.69 124.08 31.09 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.012 -0.995 . . . . 0.97 111.994 -163.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -121.39 161.97 21.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.355 1.462 . . . . 0.56 113.088 179.081 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.88 -174.09 2.44 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.477 1.911 . . . . 3.29 110.73 163.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 m -146.03 138.78 25.64 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.056 -1.091 . . . . 0.82 108.056 167.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -135.42 173.3 11.87 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 122.984 1.373 . . . . 2.41 114.112 -172.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -122.06 142.17 50.62 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.709 2.004 . . . . 5.11 111.897 170.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.15 158.84 41.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.627 1.971 . . . . 6.74 110.739 172.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -129.01 133.29 47.69 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.955 2.102 . . . . 2.75 106.421 166.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -150.42 9.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.236 1.014 . . . . 3.48 113.532 -169.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -168.95 18.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.161 0.8 . . . . 4.26 113.161 -156.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.28 13.44 58.03 Favored Glycine 0 N--CA 1.478 1.497 0 O-C-N 120.882 -1.136 . . . . 2.04 113.346 -168.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -143.96 145.76 32.47 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.461 2.704 . . . . 2.9 107.661 -174.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -105.54 133.61 50.02 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.009 2.124 . . . . 2.98 109.331 -171.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -155.15 149.13 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.108 1.363 . . . . 2.31 110.488 -171.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -102.42 167.01 10.23 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.546 0.943 . . . . 3.38 113.546 -169.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.62 -179.19 30.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.996 1.76 . . . . 0.78 112.851 178.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -151.56 141.79 22.32 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.104 1.762 . . . . 1.32 108.082 -177.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -150.73 157.14 36.21 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.198 0.999 . . . . 4.91 110.217 -177.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.06 158.01 34.13 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.6 2.2 . . . . 0.54 111.497 -179.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.68 152.75 71.37 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.647 1.179 . . . . 0.53 110.154 177.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.7 -24.12 6.41 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.14 2.56 . . . . 0.63 113.187 -167.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -178.3 166.72 1.9 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.444 1.898 . . . . 2.08 111.15 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 mt -109.91 154.27 23.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.953 1.301 . . . . 0.62 110.091 163.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -114.24 143.06 45.46 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.581 1.152 . . . . 1.8 109.28 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.8 t -144.5 136.19 12.86 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.136 0.791 . . . . 1.05 113.136 172.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.24 167.34 26.03 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.648 2.898 . . . . 0.93 113.061 177.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.54 145.67 97.62 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.742 2.961 . . . . 1.01 111.632 167.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt 66.94 -3.69 0.9 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.813 1.645 . . . . 1.65 113.634 -178.005 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.48 174.73 55.05 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.748 1.642 . . . . 1.23 112.05 171.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 mtt85 -102.64 137.82 40.36 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.426 1.09 . . . . 4.89 109.255 175.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.05 104.07 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.535 1.934 . . . . 6.09 106.447 176.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.21 130.08 12.47 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.443 1.116 . . . . 3.24 112.394 -163.173 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 83' ' ' HIS . 10.6 mp -94.32 131.13 40.25 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.156 1.382 . . . . 2.52 107.716 166.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.53 149.78 37.4 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.547 1.139 . . . . 3.38 112.525 -166.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -58.26 -38.45 90.88 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.991 3.127 . . . . 2.16 112.6 -179.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.34 115.68 4.34 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.714 -1.354 . . . . 2.87 109.714 164.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.51 -122.49 5.45 Favored Glycine 0 N--CA 1.467 0.704 0 C-N-CA 126.716 2.103 . . . . 1.55 110.896 176.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -71.34 134.56 46.81 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.709 0.755 . . . . 1.83 112.313 -167.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.465 ' HA ' HD23 ' A' ' 77' ' ' LEU . 55.2 p-80 -157.81 151.86 24.31 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.536 1.134 . . . . 0.64 110.893 -177.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -84.47 135.24 34.33 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.064 -1.022 . . . . 2.14 108.414 168.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -86.31 127.16 34.75 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 126.207 1.803 . . . . 0.74 108.285 162.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.73 112.16 25.12 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.839 1.255 . . . . 1.32 108.387 -175.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.87 135.17 47.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.33 1.052 . . . . 2.63 110.57 -169.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.62 48.51 7.91 Favored Glycine 0 N--CA 1.472 1.045 0 O-C-N 121.415 -0.803 . . . . 1.72 113.803 172.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.96 153.11 1.92 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 123.369 1.557 . . . . 0.92 114.768 178.036 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -124.18 -23.49 4.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 112.174 -2.285 . . . . 1.55 114.472 -165.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -118.06 145.82 37.77 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 117.927 -1.035 . . . . 6.17 108.727 152.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.11 98.08 0.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 106.675 -2.086 . . . . 1.81 106.675 164.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.88 164.31 26.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.339 1.056 . . . . 2.68 113.211 -169.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -139.4 150.22 45.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.362 1.865 . . . . 5.64 113.412 -173.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.01 137.37 56.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 113.879 -1.509 . . . . 1.42 108.159 171.03 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.02 -6.2 81.75 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.137 1.351 . . . . 1.56 114.601 -173.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -76.61 -176.89 3.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.047 1.424 . . . . 2.64 111.707 167.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -135.44 155.55 50.35 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 128.619 2.768 . . . . 3.95 107.127 171.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.6 t -147.85 156.08 9.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 129.538 3.135 . . . . 1.33 107.667 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -117.81 154.16 32.26 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.62 -0.675 . . . . 2.28 111.26 167.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 tt -145.71 132.65 20.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.764 0.793 . . . . 3.01 111.327 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -77.14 134.21 38.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 129.152 2.981 . . . . 2.18 109.332 166.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -97.58 127.61 43.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.183 0.993 . . . . 1.22 108.763 162.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.21 115.75 30.6 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.01 0.924 . . . . 0.64 109.337 175.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -111.2 151.86 27.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.579 1.552 . . . . 2.13 111.414 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.59 151.74 32.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.126 0.571 . . . . 2.21 111.448 170.335 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.58 23.33 47.31 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 119.003 -0.887 . . . . 3.87 114.364 -177.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.52 35.49 46.85 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.246 0.927 . . . . 1.54 113.376 173.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -120.6 122.08 39.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 117.871 0.836 . . . . 3.27 111.582 -167.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.23 142.86 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.801 1.64 . . . . 1.98 109.96 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.92 113.91 5.45 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.759 0.824 . . . . 1.99 110.829 -177.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -94.75 121.0 35.88 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.647 0.779 . . . . 2.0 112.397 -176.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.4 t -109.39 163.34 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.653 1.981 . . . . 1.85 109.888 178.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.7 t -119.3 140.78 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.552 1.941 . . . . 2.25 109.616 178.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.24 142.65 13.21 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.867 1.267 . . . . 2.48 114.047 -165.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.32 163.84 36.77 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.438 2.759 . . . . 0.94 112.582 172.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.26 131.18 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.996 1.318 . . . . 0.94 109.107 165.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 126.874 2.07 . . . . 3.48 108.69 179.238 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.008 0.433 . . . . 4.61 111.163 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.08 163.48 30.16 Favored Glycine 0 C--N 1.333 0.402 0 O-C-N 121.406 -0.809 . . . . 1.42 111.207 170.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.0 p90 -140.4 177.91 7.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.737 0.643 . . . . 2.43 112.737 178.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.9 t -111.72 143.75 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.707 1.203 . . . . 1.45 111.301 -178.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -27.06 64.38 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 129.328 3.051 . . . . 7.87 116.445 -173.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.5 t80 66.73 129.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.611 2.765 . . . . 2.22 113.634 -168.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -174.34 146.64 1.12 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.185 1.794 . . . . 2.05 110.896 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.13 -20.21 11.57 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.961 2.441 . . . . 1.28 112.73 168.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.28 -174.49 19.23 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.781 1.658 . . . . 0.94 111.663 -172.741 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.74 -10.64 9.77 Favored 'Cis proline' 0 CA--C 1.537 0.674 0 CA-C-N 119.133 1.467 . . . . 1.12 112.493 -8.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -132.25 157.74 43.59 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 123.295 1.521 . . . . 2.49 114.879 173.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.05 -176.39 4.05 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.448 2.699 . . . . 0.42 109.781 171.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.9 152.58 36.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.153 1.781 . . . . 0.66 107.617 176.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.01 140.1 41.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.32 0.964 . . . . 0.5 111.322 -177.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -114.18 34.22 4.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.51 1.524 . . . . 2.55 112.763 -165.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 tt -48.43 143.82 4.56 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.737 2.015 . . . . 2.57 112.862 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -82.74 149.75 27.09 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.457 0.91 . . . . 3.04 113.457 170.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.83 116.47 27.51 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.77 0.828 . . . . 3.59 110.278 170.15 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -121.71 142.69 49.91 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.288 1.435 . . . . 4.52 109.53 171.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -106.38 101.4 35.1 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.595 1.158 . . . . 1.34 109.875 175.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.03 -10.95 15.13 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.951 2.434 . . . . 1.2 113.597 175.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.23 -177.61 50.75 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-O 122.502 1.057 . . . . 1.11 112.86 -176.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -108.81 -1.71 19.05 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.383 2.273 . . . . 2.91 111.774 -173.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.6 160.85 42.49 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 128.502 2.721 . . . . 2.73 109.67 173.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.63 146.69 21.54 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.674 2.249 . . . . 0.91 111.525 -175.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mp -107.77 150.09 27.41 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.78 1.232 . . . . 2.34 110.383 174.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -135.91 108.15 7.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.436 -2.165 . . . . 2.9 110.257 178.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 tt -86.44 124.11 32.4 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.011 0.925 . . . . 2.2 109.013 176.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.3 -23.61 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.53 0.732 . . . . 0.73 111.531 -179.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.85 -173.16 27.99 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 124.73 1.157 . . . . 0.46 114.299 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.93 -179.07 5.39 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.925 1.29 . . . . 0.57 111.216 165.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -139.16 160.38 39.94 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.658 1.983 . . . . 5.69 107.252 155.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -161.0 149.26 12.85 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 125.651 1.58 . . . . 0.8 108.248 -178.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.02 -2.25 12.37 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.129 1.886 . . . . 1.0 114.25 -177.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.99 31.38 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.336 1.454 . . . . 0.96 114.524 -170.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.39 159.51 44.41 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.835 1.654 . . . . 0.91 110.419 165.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -83.4 -57.37 3.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.76 1.624 . . . . 2.77 110.094 169.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -106.68 130.47 54.41 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.47 1.508 . . . . 5.45 107.351 166.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.78 144.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.137 -0.69 . . . . 1.01 109.137 152.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -138.6 152.49 48.19 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.966 1.707 . . . . 2.75 109.374 -173.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.2 tp -108.6 117.61 34.63 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.498 0.719 . . . . 0.99 110.916 -173.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -121.73 152.76 39.06 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.569 1.548 . . . . 0.52 113.283 -176.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -96.7 167.87 10.85 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.842 1.257 . . . . 2.19 111.476 159.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.9 m -129.42 138.95 51.76 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.284 1.834 . . . . 0.8 107.096 170.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -140.69 171.27 14.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.403 1.096 . . . . 2.05 113.649 -173.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -115.31 142.51 46.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.543 1.937 . . . . 5.45 111.407 173.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -137.59 139.45 40.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.155 0.982 . . . . 5.5 111.658 169.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -91.11 139.07 31.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.886 1.275 . . . . 2.92 107.788 161.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.9 t -141.76 128.56 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 106.033 -1.839 . . . . 2.44 106.033 168.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 58.68 24.42 12.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.11 1.364 . . . . 5.67 114.408 -176.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.56 29.15 73.73 Favored Glycine 0 N--CA 1.472 1.095 0 O-C-N 120.488 -1.382 . . . . 1.98 112.453 -170.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mmtm -121.4 120.62 35.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.009 2.124 . . . . 4.74 108.427 169.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 126.47 40.97 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.119 1.367 . . . . 2.95 112.12 -176.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.3 t -144.33 144.98 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.976 2.11 . . . . 2.52 108.277 -171.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 73.4 mtm -90.63 172.9 8.35 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.361 0.874 . . . . 3.24 113.361 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.4 30.99 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.748 1.166 . . . . 1.13 111.783 166.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.07 162.32 35.23 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.484 0.713 . . . . 3.34 110.771 161.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -157.19 154.47 26.04 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.871 1.268 . . . . 4.63 110.062 -177.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.86 154.65 43.34 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.134 1.89 . . . . 0.56 112.001 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.0 155.05 74.74 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.669 1.588 . . . . 0.69 110.182 179.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.78 -26.34 2.53 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.096 2.531 . . . . 0.61 113.333 -167.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -176.42 166.73 2.77 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.989 1.716 . . . . 2.27 111.231 -177.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.6 mt -114.63 151.76 33.0 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.002 1.721 . . . . 0.77 110.517 166.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -120.79 138.94 53.77 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.767 1.227 . . . . 1.81 109.024 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -140.81 126.67 11.41 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.192 0.442 . . . . 0.93 112.192 170.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.53 161.71 41.65 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.392 3.394 . . . . 1.16 111.958 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -59.9 140.37 92.65 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.673 2.916 . . . . 0.94 113.051 -175.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 68.65 -3.02 1.49 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.179 2.192 . . . . 1.66 114.484 178.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.4 169.15 28.74 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.565 1.555 . . . . 1.21 113.183 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -143.47 158.64 43.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.853 0.861 . . . . 5.26 112.536 172.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.1 t -156.14 113.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 127.642 2.377 . . . . 3.97 108.475 174.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.34 151.33 34.98 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.03 0.832 . . . . 3.56 111.813 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.4 65.21 1.21 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.53 1.157 . . . . 2.16 109.414 162.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -58.52 145.89 74.84 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.55 1.14 . . . . 4.13 113.201 -174.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.85 81.39 0.84 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.342 2.695 . . . . 2.67 109.391 169.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.64 34.0 0.1 OUTLIER Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.372 0.987 . . . . 2.4 113.495 -162.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.04 -25.75 0.24 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 117.418 1.727 . . . . 2.42 117.418 160.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -145.48 146.91 31.66 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.742 1.271 . . . . 1.89 111.196 169.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -159.48 154.61 25.12 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.992 0.917 . . . . 0.54 110.005 174.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -77.67 141.31 39.47 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.39 -0.967 . . . . 1.83 108.39 159.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -94.25 131.96 39.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.218 1.407 . . . . 0.72 108.354 164.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -109.2 109.92 21.0 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.012 -1.107 . . . . 1.32 108.012 178.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.71 134.07 51.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.182 1.393 . . . . 2.4 109.489 -175.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.18 53.49 14.0 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.854 -0.529 . . . . 1.65 112.48 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.4 mt -44.66 155.41 0.1 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.088 1.755 . . . . 0.64 115.067 178.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -108.6 -32.99 7.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 113.281 -1.782 . . . . 1.58 112.847 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -120.99 137.57 26.75 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.55 1.54 . . . . 6.69 108.634 163.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -66.88 130.95 24.29 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 N-CA-C 106.654 -2.094 . . . . 1.33 106.654 160.028 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.16 171.61 14.21 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.245 0.545 . . . . 2.17 111.166 -174.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.429 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 0.5 OUTLIER -116.83 157.91 24.83 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.267 -0.895 . . . . 4.06 109.827 150.547 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.45 123.61 21.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.001 -1.481 . . . . 1.69 107.001 159.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.76 53.96 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.166 -1.352 . . . . 2.03 115.813 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 90.9 mt-10 -81.91 -174.39 5.02 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.816 1.808 . . . . 3.01 111.12 165.001 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.29 135.7 48.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.829 2.452 . . . . 3.68 106.284 166.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -119.24 144.78 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.829 2.052 . . . . 1.7 109.439 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -89.15 134.16 34.13 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.051 0.54 . . . . 2.62 110.493 171.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp -116.51 132.4 56.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.301 1.048 . . . . 1.98 110.14 154.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -83.32 145.08 29.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.446 1.899 . . . . 2.1 109.109 158.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.3 123.29 46.17 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.399 1.48 . . . . 1.52 109.943 -175.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.53 115.13 29.95 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.493 1.117 . . . . 2.4 109.816 -176.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -112.66 145.89 39.64 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.263 1.425 . . . . 2.05 111.76 -177.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.22 151.81 39.37 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.583 0.753 . . . . 2.22 112.253 176.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.59 33.63 37.88 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.031 -0.872 . . . . 4.34 113.56 177.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.66 47.49 15.24 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 124.618 1.104 . . . . 2.07 113.852 171.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -133.88 131.82 39.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.195 0.998 . . . . 3.54 111.755 -171.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.1 t -140.87 150.56 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.594 1.158 . . . . 2.26 109.121 178.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.4 tp -149.57 170.97 17.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.601 2.36 . . . . 2.18 108.551 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -145.53 156.72 43.88 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.779 1.172 . . . . 2.23 113.072 162.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.1 160.98 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.309 1.443 . . . . 2.21 109.351 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.9 t -112.44 136.66 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.614 1.566 . . . . 1.88 108.788 -179.378 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.61 142.44 41.0 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.63 1.572 . . . . 2.26 110.145 -175.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.0 154.42 73.47 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.737 2.291 . . . . 1.21 112.143 175.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.4 t -93.47 139.49 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.704 -1.221 . . . . 1.33 107.704 157.286 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 . . . . . 0 N--CA 1.468 0.465 0 C-N-CA 125.008 1.323 . . . . 4.29 109.937 174.822 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 . . . . . 0 CA--C 1.545 0.764 0 CA-C-O 121.704 0.764 . . . . 5.12 111.138 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.06 172.33 23.21 Favored Glycine 0 N--CA 1.471 0.998 0 O-C-N 120.47 -1.394 . . . . 1.11 115.546 -176.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -154.24 -179.34 7.83 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.33 1.452 . . . . 2.83 112.475 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 t -121.24 144.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.226 1.011 . . . . 1.55 109.986 168.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -26.27 62.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.794 2.038 . . . . 5.82 115.641 -175.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 73.2 t80 90.64 146.99 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 129.875 3.27 . . . . 2.99 111.994 -168.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.8 m -176.77 144.79 0.63 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 130.159 3.383 . . . . 2.52 108.793 160.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.51 -36.32 0.93 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.678 2.252 . . . . 1.29 111.917 177.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.06 169.91 27.18 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.577 1.084 . . . . 0.9 111.949 -179.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.7 -4.42 19.6 Favored 'Cis proline' 0 CA--C 1.539 0.748 0 CA-C-N 118.797 1.299 . . . . 1.15 112.767 -5.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.1 153.72 34.49 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.99 1.107 . . . . 2.69 113.99 -172.287 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.91 -178.99 3.88 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.524 1.93 . . . . 0.69 111.837 174.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.25 140.78 48.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.794 1.237 . . . . 1.05 108.872 167.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.15 143.08 46.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.319 1.448 . . . . 0.67 110.458 -178.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -131.11 105.66 7.85 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.866 2.066 . . . . 2.8 108.994 -170.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.59 162.27 37.05 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.788 1.033 . . . . 2.15 113.788 -168.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.462 HG21 ' HD2' ' A' ' 74' ' ' ARG . 2.9 m -79.86 155.6 27.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.031 -1.441 . . . . 1.94 112.125 177.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.4 HD23 HD22 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -130.21 116.79 18.91 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 113.312 -1.767 . . . . 3.46 109.447 170.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.8 mp0 -101.26 133.85 45.21 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.666 1.986 . . . . 5.16 110.923 175.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.27 76.67 1.09 Allowed Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 120.545 -1.347 . . . . 3.04 110.888 176.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.64 -19.3 42.11 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.667 2.245 . . . . 1.2 114.288 -176.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.43 176.6 54.2 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 122.733 1.185 . . . . 1.16 112.956 176.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -100.52 -3.37 30.86 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.688 2.395 . . . . 2.89 112.176 -170.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mp -126.01 160.35 57.39 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 128.122 2.569 . . . . 3.59 108.534 174.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.55 139.51 11.39 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.462 2.108 . . . . 1.07 111.455 -167.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.22 146.91 23.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 123.212 1.482 . . . . 2.2 110.314 169.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.4 ttp-105 -134.53 102.78 5.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.536 -1.665 . . . . 3.38 110.221 -176.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.4 HD22 HD23 ' A' ' 22' ' ' LEU . 52.7 tp -84.04 103.87 13.64 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.302 1.841 . . . . 2.5 110.249 -174.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 m -97.35 -24.46 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.611 0.764 . . . . 0.48 112.565 -174.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.64 -174.42 29.37 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.839 1.209 . . . . 0.47 113.052 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.69 -176.73 4.99 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.898 1.679 . . . . 0.54 111.101 171.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -155.87 166.33 33.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 130.353 3.461 . . . . 4.68 107.261 174.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t 179.75 153.19 0.6 Allowed Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 127.921 2.488 . . . . 0.73 108.279 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.84 -27.69 10.13 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 CA-C-N 121.263 1.487 . . . . 0.87 113.014 176.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.72 22.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.193 1.553 . . . . 0.88 115.193 -170.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.18 162.16 34.97 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.206 1.803 . . . . 1.13 108.075 164.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -77.32 -56.0 4.93 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.033 1.333 . . . . 4.27 109.996 168.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -133.76 177.61 7.58 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.872 2.069 . . . . 5.47 109.337 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.9 p -153.36 147.14 14.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.354 1.462 . . . . 0.84 109.079 -174.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -133.17 147.74 52.06 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.783 1.633 . . . . 2.67 110.381 -179.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.7 tp -96.76 121.06 38.2 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.322 0.649 . . . . 1.0 110.702 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -122.76 157.93 31.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 123.148 1.452 . . . . 0.6 113.118 -175.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.32 154.37 21.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.873 -1.512 . . . . 2.03 110.055 158.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -114.78 135.87 53.71 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.831 -1.915 . . . . 1.65 105.831 159.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -126.12 165.46 18.82 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.41 1.084 . . . . 2.07 112.398 -177.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.7 ttp -105.05 144.85 31.29 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.685 1.594 . . . . 3.3 109.614 168.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.26 150.48 30.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.195 0.998 . . . . 6.11 111.698 -175.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -95.42 142.83 27.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.786 1.634 . . . . 2.84 110.131 169.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 t -116.0 -110.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.053 1.341 . . . . 3.65 107.781 170.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.59 44.94 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 131.319 3.848 . . . . 4.32 112.851 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.34 17.62 62.02 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 120.16 -1.587 . . . . 1.64 112.746 -166.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -133.18 134.82 44.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.707 2.403 . . . . 2.46 107.605 -168.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -91.53 132.41 36.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.47 1.908 . . . . 2.98 110.819 -167.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -143.5 143.95 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.334 1.854 . . . . 2.26 108.282 -176.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.4 mtm -88.49 165.42 14.89 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.633 0.605 . . . . 3.14 112.633 173.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.76 -179.51 23.83 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.725 1.155 . . . . 0.89 112.29 174.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.2 ttm -147.68 147.14 29.65 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.166 1.387 . . . . 1.14 109.032 175.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -155.81 154.07 27.16 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.265 1.026 . . . . 4.62 110.394 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.4 156.2 50.41 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.172 1.915 . . . . 0.6 110.834 173.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.08 155.0 76.33 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.389 1.476 . . . . 0.55 110.19 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.47 -23.79 3.97 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.781 2.32 . . . . 0.47 113.468 -166.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -178.38 165.96 1.82 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.611 1.964 . . . . 1.69 111.219 179.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 mt -110.13 159.1 17.64 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.863 1.265 . . . . 0.72 109.785 157.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -127.09 152.62 47.05 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.949 0.9 . . . . 1.9 110.12 169.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.4 t -136.7 141.65 36.07 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 123.894 0.877 . . . . 1.01 110.784 172.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.39 155.9 14.35 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.992 3.128 . . . . 1.11 112.685 178.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.58 140.07 84.86 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.21 3.274 . . . . 0.99 114.438 -174.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt 69.14 -8.53 0.68 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.719 2.408 . . . . 1.59 113.792 -176.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.18 166.76 52.93 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.126 1.346 . . . . 1.21 112.636 174.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.462 ' HD2' HG21 ' A' ' 21' ' ' THR . 11.8 ttp-105 -136.29 136.26 39.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.172 2.189 . . . . 4.34 106.994 172.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.6 t -149.65 139.27 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.231 1.412 . . . . 4.02 108.782 177.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.32 149.48 24.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.325 1.059 . . . . 3.6 113.383 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -59.78 108.02 0.69 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.197 -1.409 . . . . 1.95 107.197 158.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 139.38 90.92 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.902 -1.523 . . . . 2.34 112.647 -160.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.51 -28.94 17.31 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.734 3.623 . . . . 2.79 115.791 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.59 4.11 13.35 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 117.559 -1.69 . . . . 2.83 116.198 173.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.75 -98.58 1.42 Allowed Glycine 0 N--CA 1.472 1.057 0 CA-C-N 120.874 2.337 . . . . 1.85 113.0 -176.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -71.86 140.87 49.53 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.158 -1.201 . . . . 2.18 111.28 -176.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -161.57 153.71 19.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.624 1.17 . . . . 0.63 111.076 -174.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -88.01 129.78 35.16 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.556 -0.715 . . . . 1.76 109.305 166.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -82.83 119.52 24.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.836 1.654 . . . . 0.75 109.407 165.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -102.02 110.9 22.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.785 1.234 . . . . 1.27 109.296 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -104.24 139.87 38.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.071 1.348 . . . . 2.63 111.079 -168.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.39 45.77 45.31 Favored Glycine 0 N--CA 1.473 1.156 0 O-C-N 121.328 -0.858 . . . . 1.85 112.83 174.581 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.2 mt -47.8 155.19 0.43 Allowed 'General case' 0 CA--C 1.523 -0.09 0 CA-C-O 123.563 1.649 . . . . 0.95 115.28 -177.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -116.09 -29.69 6.22 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 112.862 -1.972 . . . . 2.9 112.55 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.8 mmt-85 -105.03 134.73 19.49 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.681 2.392 . . . . 4.59 109.509 163.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.17 74.84 3.45 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 N-CA-C 106.572 -2.126 . . . . 1.9 106.572 147.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.533 ' H ' HD23 ' A' ' 93' ' ' LEU . 1.4 pt? -63.5 127.34 30.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.887 0.851 . . . . 2.43 112.717 -159.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -84.96 138.79 32.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.762 1.267 . . . . 5.93 112.185 -170.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.64 118.91 5.74 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.928 -1.487 . . . . 1.29 108.194 167.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.16 -9.99 39.63 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 117.788 -1.562 . . . . 1.95 115.572 -169.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -78.59 173.27 12.59 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.13 1.965 . . . . 3.02 110.653 161.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 13.1 pt-20 -138.47 144.1 39.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.032 -1.84 . . . . 3.64 106.032 160.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.0 148.69 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.824 1.249 . . . . 2.04 109.411 -171.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.88 149.44 21.54 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 123.401 1.572 . . . . 3.33 114.578 -170.119 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.56 151.75 39.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.72 -1.582 . . . . 1.68 110.083 170.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -118.02 103.51 9.98 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.78 2.432 . . . . 2.86 109.483 174.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.7 mp -83.6 134.96 34.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.679 1.192 . . . . 1.17 110.786 -172.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.98 110.56 23.0 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 122.341 1.067 . . . . 0.67 110.406 -174.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -103.77 123.72 47.59 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.847 1.659 . . . . 1.97 111.309 -176.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 46.57 35.82 3.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.934 2.094 . . . . 2.49 112.892 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.44 -102.54 2.73 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.989 1.281 . . . . 5.62 111.05 -169.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.24 -6.76 83.96 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 117.026 1.57 . . . . 2.86 117.026 -160.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -80.97 102.52 10.2 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.138 2.469 . . . . 3.09 110.848 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.1 p -87.08 142.32 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 124.253 0.97 . . . . 2.33 112.242 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.14 125.57 19.0 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.822 0.849 . . . . 2.69 112.134 173.097 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.42 117.27 21.72 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.243 1.017 . . . . 2.5 111.472 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.13 166.76 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 126.31 1.844 . . . . 2.69 110.66 169.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -144.6 117.76 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 119.171 0.896 . . . . 2.23 110.51 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -124.06 142.18 39.08 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.219 1.008 . . . . 3.33 112.374 -172.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 70.6 Cg_endo -70.04 151.35 67.44 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.316 3.344 . . . . 0.9 113.398 169.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.8 t -84.59 128.94 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.51 -0.768 . . . . 1.09 109.702 168.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.539 0.522 0 C-N-CA 127.118 2.167 . . . . 3.87 107.88 172.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 108.958 -0.756 . . . . 7.2 108.958 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.99 177.15 39.75 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 122.296 0.942 . . . . 1.31 113.093 -177.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -157.23 155.12 30.3 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.492 0.717 . . . . 7.14 111.1 168.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.0 t -128.96 137.02 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 106.68 -1.6 . . . . 1.62 106.68 163.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -75.56 -62.4 1.59 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.484 0.584 . . . . 6.16 110.362 -176.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -171.99 150.22 2.52 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.374 1.07 . . . . 2.97 110.982 178.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 m -135.86 112.75 10.62 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.878 0.871 . . . . 4.74 112.37 -178.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -82.92 -34.66 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.896 2.398 . . . . 2.3 112.115 170.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.12 151.62 27.99 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 110.904 -0.878 . . . . 1.53 110.904 -158.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.94 0.65 32.86 Favored 'Cis proline' 0 CA--C 1.539 0.742 0 CA-C-N 119.636 1.718 . . . . 1.44 113.297 1.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -144.75 172.58 12.81 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.514 1.302 . . . . 1.81 114.514 -177.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.02 -175.65 5.4 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 129.786 3.234 . . . . 0.51 112.335 -176.277 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.68 136.97 23.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.897 2.079 . . . . 0.75 108.72 174.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.89 144.15 50.48 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.841 1.657 . . . . 0.65 112.543 -174.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -126.97 59.34 1.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.668 1.987 . . . . 2.55 111.999 -163.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -73.18 152.04 41.26 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.963 1.468 . . . . 1.78 114.963 -173.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 m -84.97 144.16 28.5 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 121.34 -0.85 . . . . 1.72 110.443 161.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.2 129.63 25.66 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.281 1.832 . . . . 4.11 111.318 -170.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -127.46 143.71 51.16 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.631 1.172 . . . . 3.86 111.356 -176.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -105.73 95.22 10.05 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.815 0.846 . . . . 1.77 108.917 160.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.04 -4.99 15.85 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.097 2.532 . . . . 1.45 113.873 175.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.94 174.39 47.73 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 122.805 1.225 . . . . 1.27 113.099 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -99.85 -1.86 36.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.246 2.618 . . . . 3.41 111.887 -174.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -122.21 157.95 56.89 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 128.473 2.709 . . . . 3.14 110.021 176.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.33 143.44 22.16 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.587 2.191 . . . . 1.57 111.302 -173.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.61 156.13 22.28 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.7 1.6 . . . . 3.02 109.839 173.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.1 ttp-105 -140.57 104.91 4.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.518 1.527 . . . . 2.72 109.178 -177.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.8 113.72 21.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.453 1.501 . . . . 2.52 108.144 -176.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 m -103.88 -27.03 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.674 0.789 . . . . 0.51 112.361 -174.233 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.25 -177.78 31.66 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 124.55 1.072 . . . . 0.41 113.555 177.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.68 -174.72 3.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.947 1.299 . . . . 0.59 109.642 168.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 4.5 mtt180 -155.59 168.75 26.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 128.029 2.532 . . . . 5.26 106.82 173.349 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -173.51 151.08 1.89 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 125.504 1.522 . . . . 0.82 108.431 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.72 -10.51 21.73 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.869 1.713 . . . . 1.21 113.832 176.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.13 18.94 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.96 1.467 . . . . 1.4 114.96 -170.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.83 128.44 7.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.396 1.479 . . . . 1.49 111.683 172.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.69 -36.64 81.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.667 1.587 . . . . 3.45 114.09 -176.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -140.66 88.02 2.16 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.515 1.526 . . . . 6.39 108.683 -167.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 p -82.48 138.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.251 -0.886 . . . . 0.85 110.905 169.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -124.06 152.43 42.67 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.203 2.201 . . . . 2.55 110.026 177.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.7 tp -106.04 119.07 38.26 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.29 1.036 . . . . 0.95 110.621 177.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -122.97 155.28 37.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.014 1.726 . . . . 0.58 113.592 -175.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -100.89 159.88 14.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.876 -1.511 . . . . 2.32 110.949 156.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.0 m -117.2 134.7 54.47 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 104.99 -2.226 . . . . 0.82 104.99 158.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -122.42 166.98 13.87 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.944 1.298 . . . . 2.0 112.637 -174.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.7 ptm -91.1 149.56 21.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.464 0.706 . . . . 4.7 111.707 169.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.29 151.04 27.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.596 1.158 . . . . 6.5 112.929 -177.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -109.19 139.85 43.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.906 1.682 . . . . 2.41 106.474 161.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.6 m -138.17 126.67 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.168 -1.049 . . . . 3.38 108.168 166.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.68 19.29 10.37 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.804 1.242 . . . . 4.23 114.209 -178.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.96 14.74 76.69 Favored Glycine 0 N--CA 1.478 1.448 0 O-C-N 120.609 -1.307 . . . . 1.79 113.914 -170.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -112.24 118.62 35.8 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.796 2.438 . . . . 3.05 108.575 -179.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.91 131.89 36.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.277 1.831 . . . . 2.76 109.925 -176.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.3 p -155.83 175.72 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.497 1.519 . . . . 3.58 111.132 -173.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.7 mtm -108.69 163.97 12.79 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.332 1.053 . . . . 3.77 112.021 164.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.1 -176.65 17.35 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.422 1.487 . . . . 1.07 111.624 169.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.0 ttm -146.35 152.59 39.35 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.115 1.366 . . . . 1.16 109.992 -173.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -162.18 156.17 18.34 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 124.796 1.238 . . . . 4.85 111.328 173.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.09 153.68 57.34 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.331 2.021 . . . . 0.47 111.423 171.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.86 154.82 73.15 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 125.777 1.631 . . . . 0.63 109.902 -177.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.61 -25.73 3.54 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.434 2.089 . . . . 0.5 113.178 -165.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -179.38 165.24 1.4 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.045 1.738 . . . . 1.73 111.797 -177.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.5 mt -111.7 153.41 26.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.958 1.703 . . . . 0.65 109.651 163.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -107.1 149.38 27.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.175 0.99 . . . . 2.12 108.934 175.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.48 121.28 9.93 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 118.253 0.479 . . . . 1.65 111.273 164.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -67.49 164.66 30.04 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.966 2.444 . . . . 1.38 110.58 175.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -58.4 138.79 87.72 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.594 2.196 . . . . 1.36 112.04 177.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt 65.25 5.75 3.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.496 1.918 . . . . 2.23 113.675 -175.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.07 163.98 49.63 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.341 1.924 . . . . 1.82 114.473 -174.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -127.75 142.23 51.37 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.51 2.324 . . . . 5.62 109.877 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.3 t -143.27 135.7 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 107.166 -1.42 . . . . 3.26 107.166 163.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -129.11 117.97 21.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.574 -0.899 . . . . 4.6 108.574 -175.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -76.48 78.5 3.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.085 1.354 . . . . 2.35 110.602 -168.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -66.96 151.01 97.54 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.083 1.353 . . . . 3.47 114.058 -174.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.2 -31.09 64.57 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.563 2.176 . . . . 2.31 113.32 173.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.15 53.85 4.48 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.177 0.899 . . . . 2.24 111.929 168.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.09 -132.9 3.01 Favored Glycine 0 N--CA 1.471 1.024 0 C-N-CA 124.494 1.045 . . . . 1.62 114.062 -179.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -72.49 140.42 48.21 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 122.866 0.467 . . . . 1.79 112.019 -170.024 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -162.64 160.56 25.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.625 1.17 . . . . 0.67 111.351 -175.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -90.54 135.47 33.68 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.802 -0.561 . . . . 2.06 109.877 167.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 tpt -86.55 127.52 34.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.14 -1.059 . . . . 0.78 108.14 163.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.55 106.84 17.46 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.879 -1.156 . . . . 1.14 107.879 177.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.88 151.28 26.49 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.756 0.788 . . . . 3.0 111.307 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.94 41.76 39.8 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.887 0.755 . . . . 2.13 112.636 176.225 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.9 mt -50.2 154.02 1.3 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 123.401 1.572 . . . . 0.91 114.229 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -99.83 -28.21 13.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 112.884 -1.962 . . . . 2.06 112.501 173.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -146.39 148.52 34.63 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 127.409 2.283 . . . . 8.33 111.171 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.7 146.87 55.57 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.939 2.426 . . . . 1.67 109.866 165.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.1 mt -126.45 130.59 50.96 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.772 1.629 . . . . 3.29 109.43 -174.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.61 -178.84 4.64 Favored 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 126.52 1.928 . . . . 3.8 111.984 -156.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.97 133.05 34.03 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.38 -0.825 . . . . 1.2 111.473 -175.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.82 46.81 8.22 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.834 1.207 . . . . 1.32 112.06 -169.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -131.65 176.95 7.89 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.353 1.061 . . . . 2.4 111.197 174.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -149.12 125.79 11.07 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.599 2.36 . . . . 3.44 106.199 -165.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.0 t -140.77 140.25 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.329 1.052 . . . . 1.07 111.282 -170.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -94.99 134.48 37.61 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.861 0.865 . . . . 3.54 112.881 177.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.8 mp -113.11 138.82 49.36 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.035 0.934 . . . . 1.74 110.678 158.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 11.4 m-20 -79.07 142.76 36.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.616 1.566 . . . . 2.48 108.447 159.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mp -110.7 123.82 50.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.782 2.433 . . . . 1.14 109.659 176.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -106.45 115.12 29.67 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.343 1.057 . . . . 0.58 110.73 -175.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.19 120.17 41.72 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.923 1.689 . . . . 1.95 111.538 -177.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.35 25.38 0.87 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.258 2.223 . . . . 3.07 115.055 173.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.21 -60.75 3.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.23 1.395 . . . . 4.71 112.461 -168.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.49 -2.15 59.33 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 117.49 1.756 . . . . 1.88 117.49 -164.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -135.45 130.66 35.09 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 120.057 1.929 . . . . 4.6 113.248 173.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -96.96 151.75 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.41 1.484 . . . . 2.11 110.563 161.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.9 tp -146.2 179.61 7.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.822 2.449 . . . . 2.3 107.848 164.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -147.29 145.55 29.42 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.078 1.308 . . . . 2.49 111.401 -177.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 t -142.86 157.24 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.561 1.145 . . . . 2.0 109.435 176.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.23 154.79 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.072 2.149 . . . . 2.12 109.732 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.96 120.48 9.24 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.336 1.854 . . . . 3.1 110.305 176.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.52 145.29 16.92 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 124.562 3.508 . . . . 1.55 113.549 156.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.57 127.95 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.828 -0.804 . . . . 1.02 108.828 161.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 . . . . . 0 N--CA 1.44 -0.974 0 C-N-CA 126.173 1.789 . . . . 4.28 109.344 169.643 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.546 0.818 0 CA-C-O 121.064 0.459 . . . . 4.64 111.483 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.02 156.44 27.2 Favored Glycine 0 N--CA 1.474 1.183 0 O-C-N 120.485 -1.384 . . . . 1.37 115.604 -176.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -155.87 170.87 21.11 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.358 1.063 . . . . 2.18 113.29 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -114.14 130.95 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.728 -1.212 . . . . 1.35 107.728 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -78.69 -29.81 45.74 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.779 1.77 . . . . 5.4 115.779 -157.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.9 t80 146.43 137.26 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 130.653 3.581 . . . . 2.25 109.721 174.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 t 179.54 133.78 0.25 Allowed Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 126.683 1.993 . . . . 1.85 110.801 166.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.38 -25.66 15.2 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.419 2.079 . . . . 1.24 112.481 171.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.11 -176.96 17.07 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.82 1.676 . . . . 0.93 112.256 -174.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.69 -11.43 20.54 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 118.445 1.122 . . . . 0.9 113.449 3.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -128.02 155.79 43.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.586 1.954 . . . . 1.81 112.87 179.239 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.43 173.42 11.62 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.07 2.148 . . . . 0.43 110.867 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.09 125.09 30.53 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.056 1.343 . . . . 1.01 108.355 172.214 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.3 151.2 22.98 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.421 1.488 . . . . 0.62 110.751 177.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -141.79 70.39 1.34 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.593 1.557 . . . . 2.15 110.053 -166.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -90.69 161.01 15.55 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.356 -0.84 . . . . 1.94 112.941 175.105 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 23.1 m -79.59 157.61 27.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.125 -0.943 . . . . 1.7 109.985 160.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.68 136.44 54.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.227 1.011 . . . . 3.43 110.156 175.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.84 131.35 47.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.698 1.199 . . . . 5.96 111.297 -173.234 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -107.05 111.17 63.7 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.387 -0.598 . . . . 1.46 109.387 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -86.83 -11.72 5.48 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.283 2.655 . . . . 1.85 113.586 173.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.0 -179.84 47.19 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 124.992 1.282 . . . . 1.26 112.933 -175.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -104.21 -5.35 22.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.996 2.518 . . . . 3.37 111.679 -171.268 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -121.18 159.61 48.91 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.817 2.447 . . . . 2.93 109.702 175.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.03 137.5 19.57 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.124 1.882 . . . . 1.06 110.463 -175.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.61 155.54 16.73 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.651 1.18 . . . . 2.41 109.614 171.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 ttp-105 -143.93 102.96 3.97 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.423 1.489 . . . . 2.91 110.567 -170.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -86.4 109.57 19.11 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.158 2.183 . . . . 2.19 109.891 -173.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -103.14 -20.88 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.553 1.141 . . . . 0.53 111.851 -172.385 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.85 -174.66 30.96 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 124.897 1.237 . . . . 0.44 113.507 177.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.99 -179.72 5.83 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.047 0.939 . . . . 0.49 112.119 166.263 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.418 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -140.08 170.27 16.15 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.161 2.184 . . . . 4.99 107.97 160.335 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -171.64 149.18 2.37 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 125.63 1.572 . . . . 0.72 108.768 176.401 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.28 -14.47 16.47 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.405 2.07 . . . . 0.79 113.706 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.46 26.76 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.045 1.338 . . . . 0.86 113.615 -177.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.67 161.2 42.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.437 1.495 . . . . 0.86 109.039 163.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -95.46 -36.51 11.29 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.348 1.059 . . . . 3.1 112.858 177.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.7 160.86 33.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.024 1.729 . . . . 5.87 107.38 170.448 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.81 155.06 17.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.387 1.475 . . . . 0.99 109.014 173.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.59 152.57 34.27 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.636 1.974 . . . . 4.19 108.324 -167.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.401 HD13 ' CE1' ' A' ' 84' ' ' PHE . 56.2 tp -121.07 107.44 12.63 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.224 -0.923 . . . . 0.82 110.926 -162.076 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.6 m170 -117.64 145.05 44.62 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.473 1.286 . . . . 0.68 114.473 -169.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -84.72 169.99 13.72 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.241 1.816 . . . . 2.16 111.329 163.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.2 m -145.99 142.27 28.49 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.538 -1.352 . . . . 0.78 107.444 174.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -162.21 178.84 8.39 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.743 1.386 . . . . 1.96 114.743 -167.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.8 ptm -118.36 150.99 38.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.048 1.739 . . . . 3.81 112.541 176.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -156.07 146.37 21.6 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.834 1.254 . . . . 7.61 112.64 -174.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -100.96 142.17 32.8 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.395 1.478 . . . . 2.68 109.848 171.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.6 t -141.33 121.06 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.611 1.564 . . . . 2.66 107.717 174.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 64.58 12.45 7.49 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.989 1.716 . . . . 4.61 115.049 -179.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.24 22.99 53.19 Favored Glycine 0 N--CA 1.477 1.425 0 O-C-N 121.07 -1.019 . . . . 2.56 113.243 -167.001 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -118.28 120.31 37.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.861 2.064 . . . . 4.63 107.6 175.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.569 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -73.07 127.94 34.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.613 1.565 . . . . 3.99 111.673 174.447 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -138.72 160.83 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 128.786 2.834 . . . . 2.62 108.477 -173.084 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.9 mtt -111.5 170.12 8.34 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.823 -1.173 . . . . 2.56 112.704 174.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.28 166.29 32.09 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.449 0.94 . . . . 0.71 115.449 -167.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -161.05 146.19 14.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 128.439 2.696 . . . . 1.3 107.107 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -153.2 157.4 32.93 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.637 1.975 . . . . 4.44 108.073 -177.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -78.27 159.93 29.55 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.631 1.554 . . . . 0.72 110.692 167.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.26 152.86 74.26 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.126 1.371 . . . . 0.64 110.532 177.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.26 -24.11 11.18 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.851 2.367 . . . . 0.65 112.68 -170.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -176.95 166.91 2.5 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.569 1.948 . . . . 1.99 111.55 178.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -112.81 152.09 29.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.186 1.794 . . . . 0.66 110.989 162.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -103.54 151.58 22.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.205 1.002 . . . . 1.8 109.874 176.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.57 126.68 13.83 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.154 0.582 . . . . 1.42 111.71 161.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.21 158.85 44.78 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.984 3.122 . . . . 1.53 112.013 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.76 140.65 87.05 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 124.074 3.183 . . . . 1.42 113.871 -174.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 66.72 -10.08 0.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.163 2.185 . . . . 2.46 114.358 -178.383 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.01 136.23 13.49 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.993 1.282 . . . . 1.72 113.209 -176.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.44 135.44 33.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.032 2.133 . . . . 3.73 109.783 159.082 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -149.2 124.15 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.718 1.607 . . . . 3.76 108.807 178.12 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 2.2 mp0 -89.06 157.13 18.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.435 0.694 . . . . 3.25 111.637 -170.673 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mp -66.23 -32.87 74.55 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.218 0.917 . . . . 3.19 113.372 174.051 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 93.5 140.95 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 130.518 3.527 . . . . 3.05 110.426 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.71 -1.24 7.25 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.394 2.729 . . . . 2.55 114.643 178.442 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.86 19.85 0.25 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-O 117.439 -1.756 . . . . 2.02 116.207 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.87 -27.46 0.86 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 120.243 2.022 . . . . 2.07 116.987 172.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -137.87 151.54 48.15 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.3 2.05 . . . . 2.06 111.435 160.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -156.84 148.46 22.49 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.333 0.653 . . . . 0.74 110.65 175.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' CE1' HD13 ' A' ' 45' ' ' LEU . 45.7 m-85 -81.84 116.84 21.7 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.792 -0.818 . . . . 2.06 108.792 165.472 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 tpt -78.25 107.8 11.11 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 126.705 2.002 . . . . 1.09 108.609 170.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.3 mp -87.49 139.73 30.25 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.446 1.498 . . . . 1.31 109.12 176.23 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.38 138.03 46.1 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.259 1.024 . . . . 2.16 112.263 178.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.25 42.45 10.58 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 124.997 1.284 . . . . 1.59 113.118 173.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.7 mt -47.36 151.28 0.77 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.938 1.829 . . . . 0.87 115.938 -172.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -111.42 -26.29 9.18 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 113.721 -1.581 . . . . 2.31 113.85 -176.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -120.63 136.36 25.32 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.302 1.441 . . . . 4.64 109.218 159.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.07 116.24 4.64 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.022 2.481 . . . . 1.45 107.767 170.14 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.357 4.1 pp -98.43 105.24 17.36 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 124.279 1.99 . . . . 3.03 112.708 -162.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.26 171.01 7.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.03 2.132 . . . . 3.65 112.256 176.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.31 129.46 41.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.106 0.962 . . . . 1.37 110.804 175.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.66 31.78 48.62 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.702 -0.681 . . . . 2.91 112.939 -173.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -100.02 179.38 4.52 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.382 -0.97 . . . . 2.6 108.382 143.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.22 160.51 43.31 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.279 1.831 . . . . 3.26 106.725 165.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.0 t -151.96 157.91 4.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 128.734 2.813 . . . . 1.49 107.73 -158.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -126.61 154.13 44.38 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.678 0.791 . . . . 2.43 110.226 165.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.16 134.88 54.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.056 1.343 . . . . 1.99 109.96 166.351 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 67.9 m-20 -78.18 134.79 37.57 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.334 2.254 . . . . 2.59 108.432 161.587 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.99 109.6 21.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.437 1.895 . . . . 1.21 108.815 178.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.5 mt -93.88 116.3 28.75 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.201 0.6 . . . . 0.68 110.1 -176.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -109.23 148.71 30.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.614 1.166 . . . . 1.95 111.806 -177.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.75 150.18 33.26 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.775 -0.578 . . . . 2.17 112.012 169.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.23 34.39 41.34 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.142 -0.81 . . . . 4.14 114.029 177.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.72 44.3 39.64 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 118.048 0.924 . . . . 1.94 114.235 166.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -134.07 140.96 46.99 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.241 1.02 . . . . 3.21 111.713 -177.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.2 t -142.67 134.39 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.83 1.252 . . . . 2.02 109.283 172.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -116.62 174.74 5.91 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.319 1.847 . . . . 3.08 107.598 163.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -139.21 154.14 47.98 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.011 -1.056 . . . . 1.91 112.373 161.177 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.0 t -132.3 160.86 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.197 1.399 . . . . 1.88 109.734 -176.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.53 143.27 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 127.358 2.263 . . . . 3.09 111.592 -173.288 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -143.76 105.2 4.93 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.742 1.617 . . . . 2.82 109.84 -175.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -61.3 157.36 40.81 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.394 2.063 . . . . 1.44 111.396 158.455 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.8 t -107.4 141.92 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.593 0.711 . . . . 1.23 110.139 173.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.546 0.79 0 C-N-CA 128.577 2.751 . . . . 3.92 110.496 -165.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 121.453 0.644 . . . . 4.58 110.651 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.67 -177.79 32.09 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 125.581 1.563 . . . . 1.18 113.642 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.1 p90 -152.96 143.21 22.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.558 1.543 . . . . 2.44 110.567 170.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.3 156.61 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 121.048 -1.033 . . . . 1.65 108.404 167.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.418 ' HB3' ' H ' ' A' ' 17' ' ' ALA . 27.8 ttt85 -86.3 149.75 24.83 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.865 1.317 . . . . 4.19 112.974 -176.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -72.11 132.43 44.18 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 129.236 3.014 . . . . 2.63 109.84 170.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.3 t 178.84 141.27 0.28 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 126.565 1.946 . . . . 2.25 111.229 176.307 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.74 -28.96 13.26 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.562 2.174 . . . . 1.41 112.683 169.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.03 171.14 12.5 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.407 1.956 . . . . 0.95 112.36 -172.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -82.98 -0.14 54.34 Favored 'Cis proline' 0 CA--C 1.539 0.74 0 CA-C-N 119.27 1.535 . . . . 1.15 113.923 2.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -143.33 157.39 44.51 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.772 1.397 . . . . 2.5 114.772 174.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.13 -175.34 3.59 Favored 'General case' 0 CA--C 1.549 0.924 1 C-N-CA 131.838 4.055 . . . . 0.41 108.804 175.349 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.418 ' H ' ' HB3' ' A' ' 9' ' ' ARG . . . -131.64 171.02 13.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.793 2.037 . . . . 1.14 108.259 173.01 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.62 135.96 22.79 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.107 0.956 . . . . 0.64 112.576 170.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -123.44 141.06 52.37 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.574 2.35 . . . . 2.31 108.957 -174.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -174.05 143.16 0.9 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.869 1.433 . . . . 1.98 114.869 -171.379 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.0 m -79.52 120.86 24.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.594 1.157 . . . . 1.93 110.98 178.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 135.23 39.72 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.329 1.852 . . . . 3.24 109.361 175.036 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -139.12 146.89 41.22 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.066 1.747 . . . . 5.15 109.137 -171.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -131.98 99.56 16.46 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.508 0.723 . . . . 1.65 109.934 177.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -70.38 -14.37 34.05 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.368 2.045 . . . . 2.03 113.069 176.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.35 140.69 11.58 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 128.188 2.804 . . . . 3.51 112.666 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t0 174.23 -55.89 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.562 2.745 . . . . 8.39 103.86 -158.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp 178.06 173.55 0.38 Allowed Pre-proline 0 CA--C 1.552 1.021 1 C-N-CA 132.898 4.479 . . . . 4.37 110.848 -177.148 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.37 134.94 10.38 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.345 2.03 . . . . 1.4 111.227 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.3 mt -93.84 145.23 24.76 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.646 1.178 . . . . 2.22 111.108 -175.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 ttp-105 -137.31 91.88 2.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 112.62 -2.082 . . . . 2.96 111.628 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 98.02 7.37 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.098 1.759 . . . . 1.83 108.418 -170.485 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.9 m -94.36 -30.65 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.25 1.42 . . . . 0.64 112.21 -169.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.64 -176.78 32.09 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 123.87 0.747 . . . . 0.6 113.765 178.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.26 177.45 8.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.322 1.049 . . . . 0.67 112.253 172.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -153.36 157.64 40.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.051 2.54 . . . . 5.77 108.236 168.444 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -167.32 152.45 6.98 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 123.798 0.839 . . . . 0.97 111.894 -176.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.2 -8.75 23.35 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.794 2.329 . . . . 1.52 115.599 178.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.64 0.55 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 115.829 1.789 . . . . 1.48 115.829 178.166 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.04 164.13 37.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.135 1.374 . . . . 1.19 112.186 -178.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -124.77 -65.04 1.06 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 123.103 1.43 . . . . 4.39 111.399 -167.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -79.01 147.59 32.82 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.426 -2.065 . . . . 4.79 105.426 164.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -156.66 135.05 2.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 C-N-CA 125.141 1.376 . . . . 0.97 108.034 -177.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -127.54 156.6 41.94 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.757 2.023 . . . . 2.83 109.323 178.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.1 tp -105.46 126.58 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.799 0.84 . . . . 0.98 109.231 169.032 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -124.24 160.63 27.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.0 2.12 . . . . 0.7 113.984 -175.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -107.64 163.61 12.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.751 1.62 . . . . 2.06 111.091 156.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.5 m -116.05 140.93 48.78 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.463 1.905 . . . . 1.04 106.602 165.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -145.31 -178.15 5.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.547 1.139 . . . . 2.09 113.42 -177.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.1 mtm -126.79 144.28 51.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.364 1.466 . . . . 3.64 112.749 -177.586 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.12 135.82 39.59 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.699 1.6 . . . . 6.0 111.764 178.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -104.49 127.69 52.26 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.844 1.658 . . . . 3.16 111.34 168.35 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.9 t -134.82 123.97 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 107.651 -1.24 . . . . 2.67 107.651 176.047 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 62.67 10.63 4.28 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.169 2.188 . . . . 3.98 115.146 -169.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.82 30.19 52.81 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 120.965 -1.085 . . . . 1.74 112.885 -164.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -118.52 129.28 55.27 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.955 1.702 . . . . 2.74 108.261 169.08 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -86.84 126.61 34.75 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.029 1.732 . . . . 6.14 112.294 -177.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.89 142.98 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.542 1.937 . . . . 2.93 109.423 175.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 52.2 mtt -88.45 163.42 15.96 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.892 1.071 . . . . 2.65 113.892 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.98 175.15 22.35 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.549 1.547 . . . . 0.6 112.457 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.3 ttm -157.04 148.11 21.86 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.46 1.904 . . . . 1.51 108.245 -179.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -161.08 153.68 17.3 Favored Pre-proline 0 N--CA 1.476 0.862 0 CA-C-O 118.051 -0.976 . . . . 4.68 111.639 -178.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.91 155.29 43.37 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.197 1.931 . . . . 0.56 111.875 178.53 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.99 151.03 61.23 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.038 1.735 . . . . 0.59 109.999 -177.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.8 -21.03 8.68 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.465 2.777 . . . . 0.52 113.493 -164.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -178.09 165.83 1.94 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.568 1.947 . . . . 1.74 110.746 177.548 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 mt -106.95 146.26 31.26 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.082 0.953 . . . . 0.67 110.529 158.347 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -105.86 140.2 39.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.391 1.076 . . . . 1.87 108.929 175.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.9 t -141.01 113.14 6.88 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 122.902 0.481 . . . . 0.98 110.725 165.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.9 162.44 37.32 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 124.095 3.197 . . . . 1.75 111.75 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.64 136.89 56.3 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.931 2.42 . . . . 1.52 111.784 -177.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt 74.68 -4.81 2.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 128.118 2.567 . . . . 3.51 114.402 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.38 155.3 23.35 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.411 1.481 . . . . 1.83 112.12 170.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -135.67 153.47 51.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.39 1.476 . . . . 4.2 110.366 172.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.7 t -154.04 129.76 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.353 1.461 . . . . 3.67 108.781 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.8 136.24 33.15 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.938 -1.101 . . . . 3.22 112.265 176.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.82 84.17 0.66 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.077 -1.083 . . . . 2.26 108.077 157.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -92.21 150.29 40.02 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.418 2.287 . . . . 2.54 113.377 -178.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -64.66 -39.69 26.03 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.004 2.469 . . . . 2.52 113.102 -174.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.33 45.84 2.66 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.689 1.137 . . . . 2.33 112.511 170.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.08 -129.08 1.96 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 126.371 1.939 . . . . 1.48 111.65 177.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -73.57 138.33 44.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.714 1.257 . . . . 2.0 113.239 -166.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -161.32 161.5 30.56 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.59 1.156 . . . . 0.93 111.503 -178.02 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -85.99 150.83 24.21 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.502 -0.749 . . . . 1.71 110.915 165.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -105.96 126.13 51.82 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.415 1.486 . . . . 1.11 108.706 163.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.01 118.31 36.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.734 1.214 . . . . 1.18 108.75 -175.23 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.08 155.26 31.82 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 123.409 1.576 . . . . 1.97 112.212 -170.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.09 -43.75 3.25 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 128.024 2.726 . . . . 2.44 112.139 -178.057 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.2 mt 47.97 167.55 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.602 3.161 . . . . 1.13 115.891 -168.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -135.33 -21.2 1.59 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.342 1.457 . . . . 2.75 113.781 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -122.27 149.86 55.71 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.148 2.179 . . . . 5.01 107.619 161.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.71 112.37 2.63 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 106.23 -2.258 . . . . 1.49 106.23 153.209 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.35 108.16 5.33 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.048 -0.723 . . . . 2.08 109.048 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -65.02 174.43 1.95 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.382 1.087 . . . . 4.08 112.083 158.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.97 159.68 24.83 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.673 -1.149 . . . . 1.62 108.439 149.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.16 49.74 75.31 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 121.575 -0.703 . . . . 2.18 112.524 -172.317 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.53 -179.6 4.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.96 1.304 . . . . 2.25 108.483 163.23 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -148.04 151.48 35.79 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.154 1.781 . . . . 3.42 107.346 169.167 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.7 t -154.35 145.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 128.006 2.522 . . . . 1.23 109.357 -160.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -101.11 154.37 18.79 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.276 0.63 . . . . 4.69 111.385 171.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mt -139.56 134.14 31.75 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.594 1.557 . . . . 2.05 110.26 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -83.69 131.41 34.94 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.709 2.004 . . . . 1.98 108.823 165.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.29 111.35 22.6 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.918 1.287 . . . . 0.91 109.585 172.486 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.72 110.85 19.61 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.669 1.187 . . . . 0.91 109.806 -178.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -106.28 105.3 15.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.923 1.289 . . . . 1.93 110.751 -177.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 57.43 11.12 1.09 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.013 1.725 . . . . 2.57 115.22 174.209 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.36 -43.08 2.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.498 1.523 . . . . 3.83 113.186 -169.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.96 -11.11 78.56 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.339 0.971 . . . . 2.62 115.514 -175.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -137.49 157.15 47.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.818 1.309 . . . . 4.3 111.867 170.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.78 153.97 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 125.708 1.603 . . . . 2.08 109.93 169.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.5 tp -144.44 121.78 11.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.593 1.157 . . . . 2.12 109.654 174.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.77 114.33 28.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.53 0.732 . . . . 3.65 110.587 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.55 167.72 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 126.748 2.019 . . . . 2.08 110.548 -170.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.29 141.56 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.734 2.013 . . . . 2.67 110.655 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.4 mt -150.85 149.1 24.6 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 126.279 1.832 . . . . 3.13 111.625 -174.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -70.01 174.34 9.87 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.734 2.956 . . . . 1.18 112.048 166.027 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.5 t -121.82 134.48 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.572 1.549 . . . . 1.32 109.507 166.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 C--O 1.235 0.34 0 N-CA-C 114.377 1.251 . . . . 5.02 114.377 177.073 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 121.897 0.856 . . . . 4.95 110.916 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.33 -177.15 33.18 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.95 1.262 . . . . 1.35 114.129 -175.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -153.81 160.02 42.08 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.606 1.562 . . . . 2.39 111.381 167.754 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 t -97.04 146.78 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 106.897 -1.52 . . . . 1.34 106.897 165.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -75.67 -102.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.367 0.985 . . . . 5.4 112.032 -178.209 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -170.67 127.29 0.76 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.869 1.268 . . . . 2.75 108.198 -168.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 p 179.6 111.22 0.19 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.565 -0.731 . . . . 2.79 111.588 -167.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.29 -31.97 8.72 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.38 2.053 . . . . 1.19 112.671 174.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.68 178.0 28.58 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.475 1.512 . . . . 1.06 111.772 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.6 2.77 35.18 Favored 'Cis proline' 0 CA--C 1.539 0.77 0 CA-C-N 119.245 1.523 . . . . 1.42 112.952 -3.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -151.9 167.45 28.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.109 0.963 . . . . 2.32 112.085 176.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.48 173.73 12.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.537 2.335 . . . . 0.56 110.842 -171.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.55 139.28 24.04 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.51 1.124 . . . . 0.9 110.281 179.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.09 140.35 50.83 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.295 1.438 . . . . 0.75 111.549 -173.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -115.08 142.07 47.14 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.972 2.109 . . . . 3.33 111.332 -176.176 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -162.94 147.43 11.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.869 1.433 . . . . 1.98 114.869 178.12 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.7 m -79.82 116.12 19.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.205 1.402 . . . . 1.86 110.477 176.07 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.75 126.45 40.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.582 1.153 . . . . 3.36 110.08 174.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -124.24 142.89 50.88 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.561 1.544 . . . . 4.19 110.959 175.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -103.84 94.95 6.93 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.838 1.255 . . . . 1.41 109.985 171.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.12 -8.24 18.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.717 2.278 . . . . 1.32 113.796 177.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.72 177.96 51.27 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 122.425 1.014 . . . . 1.33 112.36 -178.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -103.02 -2.44 27.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.17 2.188 . . . . 3.23 111.295 -176.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.61 162.12 21.92 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 129.333 3.053 . . . . 4.24 108.873 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.29 146.86 20.03 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.453 2.102 . . . . 1.03 110.784 178.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mp -112.11 151.28 29.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.792 1.237 . . . . 2.36 110.731 174.047 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -141.14 109.8 6.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.037 -1.892 . . . . 1.95 110.076 179.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.52 123.78 32.78 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 125.282 1.433 . . . . 1.98 108.607 178.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -106.57 -28.58 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.201 0.91 . . . . 0.7 111.927 -175.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.24 -173.34 27.55 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 124.536 1.065 . . . . 0.48 113.704 177.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -127.21 -176.77 3.82 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.339 1.056 . . . . 0.55 111.014 161.785 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -144.98 156.33 43.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 131.357 3.863 . . . . 5.87 105.178 166.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -167.18 137.24 2.37 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 124.256 1.022 . . . . 0.65 109.991 171.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.57 -17.56 38.37 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.362 2.042 . . . . 0.94 113.321 -171.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.2 m -93.8 17.5 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 114.747 1.388 . . . . 0.85 114.747 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.12 164.15 28.3 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.582 1.083 . . . . 1.2 113.609 170.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -92.62 -35.86 13.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.546 1.138 . . . . 4.07 111.149 175.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -135.36 156.72 48.47 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.179 2.192 . . . . 5.0 108.011 169.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.24 149.47 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.701 1.601 . . . . 0.98 108.764 168.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -152.04 150.41 29.92 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.692 1.997 . . . . 2.84 108.524 -172.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.435 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.5 pt? -105.83 134.15 49.41 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 123.068 1.414 . . . . 1.97 113.105 172.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -116.76 154.74 30.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.514 -1.676 . . . . 0.7 111.321 177.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -175.48 5.32 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.566 1.546 . . . . 3.35 110.889 159.112 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.0 m -151.15 147.7 27.37 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.585 1.154 . . . . 0.71 108.489 164.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -159.2 177.01 11.51 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 123.467 1.604 . . . . 2.05 113.724 -171.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.6 ttp -129.42 128.02 42.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.071 1.748 . . . . 3.26 110.597 -179.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.49 148.76 22.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.343 1.457 . . . . 6.09 110.623 164.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.65 138.05 33.51 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.468 -0.938 . . . . 2.64 108.468 147.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.96 125.17 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 106.238 -1.764 . . . . 2.25 106.238 166.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 60.31 33.62 20.86 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.621 0.768 . . . . 4.33 112.044 178.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.74 9.62 79.15 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.834 -1.166 . . . . 1.62 114.454 -176.353 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -126.02 134.92 51.31 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.11 1.764 . . . . 2.29 109.241 -172.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -84.61 123.75 30.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.634 1.574 . . . . 3.1 111.124 -171.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.1 t -141.36 131.0 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.657 1.983 . . . . 2.18 108.403 -173.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.73 161.63 13.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.768 1.227 . . . . 3.22 113.626 -171.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.27 -179.66 32.36 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.046 1.308 . . . . 1.08 113.086 172.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.91 153.75 43.41 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.291 1.036 . . . . 3.62 111.164 170.412 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -141.06 152.52 65.22 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.778 2.031 . . . . 4.39 109.417 -174.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.69 153.61 59.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.119 1.879 . . . . 0.74 111.273 172.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.53 154.92 77.53 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-O 118.452 -0.785 . . . . 0.97 110.828 171.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.35 -22.9 10.58 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.114 2.543 . . . . 0.53 112.602 -172.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -174.15 171.9 3.43 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.94 1.696 . . . . 2.06 110.894 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.7 mt -117.54 158.27 24.86 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.225 1.81 . . . . 0.74 109.915 160.318 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -137.34 146.34 44.45 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.69 0.796 . . . . 2.19 110.673 178.06 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.9 t -144.04 130.12 9.99 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 123.961 0.788 . . . . 1.28 110.854 175.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.82 165.45 29.71 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.73 2.953 . . . . 1.23 111.316 175.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.61 141.66 97.7 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.281 2.654 . . . . 1.06 113.16 -179.1 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt 69.62 -4.43 1.4 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 127.53 2.332 . . . . 1.57 114.681 177.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.58 169.39 47.06 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.137 1.351 . . . . 1.28 113.974 179.22 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 -133.35 156.86 46.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.401 1.08 . . . . 4.54 111.691 164.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -149.0 133.53 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.92 2.088 . . . . 3.74 106.922 171.523 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -98.03 133.71 42.12 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.947 -1.095 . . . . 2.84 111.393 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mp -68.47 78.9 0.27 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.394 -0.965 . . . . 2.5 108.394 154.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -94.09 154.38 40.61 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.717 2.007 . . . . 2.54 112.051 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.43 -34.55 94.86 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.997 2.465 . . . . 2.35 113.211 175.358 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.75 66.39 3.85 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.18 -0.768 . . . . 2.77 111.18 171.203 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.84 -123.59 3.72 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.178 1.371 . . . . 1.62 112.966 -178.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -74.65 141.64 44.6 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.938 0.718 . . . . 2.22 112.938 -162.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -159.97 154.97 24.69 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.587 -0.696 . . . . 0.77 112.044 -176.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 43.4 m-85 -90.3 118.66 29.98 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.558 0.343 . . . . 2.63 110.208 171.178 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -85.62 125.18 32.93 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.009 1.324 . . . . 0.94 109.257 170.16 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.96 127.82 52.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.476 1.51 . . . . 1.43 107.537 177.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.82 150.14 39.66 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.824 0.821 . . . . 2.04 112.237 -176.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.43 -41.26 1.83 Allowed Glycine 0 CA--C 1.531 1.094 0 C-N-CA 126.48 1.991 . . . . 2.89 113.57 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.8 mt 57.04 170.52 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 129.916 3.286 . . . . 0.92 114.29 -177.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -129.82 -28.51 2.21 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.002 2.121 . . . . 1.52 112.857 172.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -110.99 132.58 21.6 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.43 1.492 . . . . 4.8 108.065 166.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.95 101.19 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 N-CA-C 106.362 -2.207 . . . . 1.91 106.362 158.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.11 128.0 41.6 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.419 1.104 . . . . 2.83 112.674 -159.703 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -132.87 172.31 12.76 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.259 1.823 . . . . 3.85 113.335 -167.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.69 124.61 23.36 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.574 -0.739 . . . . 1.46 110.083 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.36 7.36 51.97 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.554 1.55 . . . . 1.88 115.497 -176.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.28 -175.16 3.74 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.421 1.111 . . . . 2.92 111.519 161.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -149.29 154.53 39.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.305 3.042 . . . . 3.15 105.733 178.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.9 t -147.83 139.05 17.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 127.238 2.215 . . . . 1.39 109.035 -176.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.15 149.76 25.63 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.795 1.238 . . . . 3.16 110.998 176.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mp -132.16 134.24 45.17 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.192 1.397 . . . . 1.74 111.066 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -87.56 125.1 34.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.259 1.824 . . . . 2.13 107.459 159.331 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 mp -98.29 131.51 44.55 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.102 1.361 . . . . 1.01 109.421 172.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.6 mt -107.19 120.04 41.03 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.0 1.32 . . . . 0.68 109.589 -175.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -113.69 160.41 18.66 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.525 1.53 . . . . 1.91 110.601 178.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.62 143.04 10.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.242 -0.89 . . . . 2.49 111.605 170.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.88 -3.72 86.81 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 118.759 -1.023 . . . . 3.63 114.37 -169.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.14 16.13 56.35 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.814 1.307 . . . . 2.9 114.114 175.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -78.4 134.8 37.36 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.143 -1.21 . . . . 5.3 112.557 -173.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.9 t -107.15 136.66 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.228 1.811 . . . . 2.14 109.423 175.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.4 tp -141.17 133.62 28.37 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.115 0.966 . . . . 1.91 111.502 174.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -79.93 126.41 30.98 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.669 0.618 . . . . 2.65 112.669 177.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.3 t -114.74 164.48 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.334 1.854 . . . . 2.68 108.355 157.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.6 t -146.61 140.36 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.893 1.677 . . . . 1.96 109.958 -176.027 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.3 mt -143.24 135.68 13.43 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 126.666 1.986 . . . . 2.43 111.114 -167.584 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -73.97 159.1 45.3 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.113 2.542 . . . . 1.23 110.76 163.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.34 131.13 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.734 -0.839 . . . . 1.09 108.734 167.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 124.461 1.105 . . . . 3.81 113.359 -165.098 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 . . . . . 0 CA--C 1.545 0.763 0 CA-C-O 122.183 0.992 . . . . 4.96 112.718 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.18 179.69 19.21 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.331 1.443 . . . . 0.99 113.09 176.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 23.2 p90 -155.46 169.58 23.92 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.845 1.424 . . . . 2.39 114.845 -172.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.39 140.52 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 126.502 1.921 . . . . 1.34 109.407 170.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -17.79 61.73 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.938 2.095 . . . . 6.12 115.513 -174.203 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 4.3 t80 79.87 129.55 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.91 2.484 . . . . 2.49 111.631 -177.405 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 t -175.77 142.85 0.65 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 129.378 3.071 . . . . 2.11 107.774 174.358 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.08 -27.56 4.43 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.89 2.394 . . . . 1.44 112.465 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.92 175.32 20.53 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.664 1.126 . . . . 0.83 112.314 -174.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.57 -5.61 12.26 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 118.848 1.324 . . . . 0.93 112.775 -4.35 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -147.26 160.98 41.86 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 123.435 1.588 . . . . 1.65 114.358 -176.68 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.27 -176.93 4.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.74 2.816 . . . . 0.45 110.454 -176.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.06 152.38 34.73 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.019 1.727 . . . . 0.76 108.207 175.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.14 141.91 40.13 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.943 0.897 . . . . 0.64 112.508 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 88.0 m-85 -105.87 74.33 1.05 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.129 2.172 . . . . 3.12 108.776 174.026 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.425 HD13 HD11 ' A' ' 103' ' ' LEU . 2.3 pp -76.43 159.0 30.85 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.268 -0.895 . . . . 1.88 111.43 -177.252 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 76' ' ' GLU . 28.5 m -140.25 147.25 39.7 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.431 1.092 . . . . 1.98 110.479 175.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.82 -178.11 5.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.346 2.258 . . . . 5.63 108.69 169.907 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -140.45 123.93 16.97 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.807 -1.183 . . . . 4.57 109.958 173.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -76.91 119.01 75.71 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.255 1.422 . . . . 1.56 108.87 178.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.48 -17.99 33.9 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 121.974 1.783 . . . . 2.0 113.459 176.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.4 126.05 0.64 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 124.469 1.033 . . . . 2.83 110.522 -163.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -178.66 -47.86 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.257 -2.497 . . . . 8.27 104.257 -146.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -164.92 -171.21 0.25 Allowed Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 131.418 3.887 . . . . 4.69 107.477 164.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.28 130.36 9.12 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 108.043 -1.56 . . . . 0.96 108.043 159.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.486 HD12 ' CD1' ' A' ' 105' ' ' PHE . 2.8 mm? -91.86 156.52 17.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.691 1.234 . . . . 2.52 110.516 -175.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -153.47 107.04 2.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 113.736 -1.575 . . . . 1.77 111.571 -173.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.64 108.42 19.96 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.422 1.489 . . . . 2.44 109.162 -171.395 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -106.66 -20.37 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 113.146 0.795 . . . . 0.68 113.146 -169.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.49 -177.95 33.04 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 124.854 1.216 . . . . 0.42 111.822 176.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.83 -179.51 5.44 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.819 0.848 . . . . 0.69 111.18 171.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.42 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 1.9 mtt-85 -147.92 169.37 20.0 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.935 2.094 . . . . 3.9 108.833 169.129 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.8 t 178.41 154.24 0.52 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.096 1.759 . . . . 0.86 109.574 -171.105 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -89.39 -7.1 5.07 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.622 2.881 . . . . 0.73 113.997 171.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.5 m -113.27 24.95 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 114.191 1.182 . . . . 0.88 114.191 -173.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.43 163.86 38.03 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.163 1.385 . . . . 0.81 108.893 166.153 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -96.58 -30.84 13.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.141 1.776 . . . . 3.25 112.879 175.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 mtt85 -137.86 157.96 45.34 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.193 2.197 . . . . 5.3 107.274 175.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 p -153.88 131.09 2.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 125.339 1.455 . . . . 1.13 108.568 -176.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -140.16 133.14 29.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.199 0.999 . . . . 3.75 110.189 -160.066 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.3 tp -85.23 117.49 24.21 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.921 0.867 . . . . 1.3 111.436 -177.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.8 m170 -117.38 162.48 17.85 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.592 1.557 . . . . 0.62 112.859 176.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -113.11 -178.71 3.45 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.546 -1.661 . . . . 3.18 110.801 163.885 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -148.67 135.65 20.0 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 106.594 -1.632 . . . . 1.27 106.594 172.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -131.71 169.03 16.75 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.275 1.43 . . . . 2.33 113.138 -169.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.1 139.33 45.34 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.817 1.247 . . . . 5.77 110.909 168.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -129.05 141.99 51.05 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.316 1.446 . . . . 5.44 110.362 166.341 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -89.81 138.63 31.32 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.847 -1.168 . . . . 2.94 107.847 154.317 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.0 t -133.94 116.14 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 106.43 -1.693 . . . . 2.41 106.43 168.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.89 31.42 13.92 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.445 1.098 . . . . 5.09 113.261 175.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.31 10.19 85.69 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 121.072 -1.018 . . . . 1.94 114.112 -174.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -125.88 119.71 28.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.457 1.503 . . . . 3.06 110.384 -173.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 135.16 35.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.265 1.426 . . . . 3.28 111.472 -171.243 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.1 p -149.83 133.23 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 125.435 1.494 . . . . 2.91 109.313 -178.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.7 mtp -83.8 165.43 18.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.532 0.682 . . . . 3.62 111.657 177.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.59 178.65 27.89 Favored Glycine 0 C--O 1.224 -0.48 0 CA-C-N 115.357 -0.838 . . . . 0.87 111.717 170.086 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 ttm -147.07 143.15 28.13 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.833 1.653 . . . . 1.13 107.4 -178.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -151.82 157.43 34.41 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.403 0.681 . . . . 4.82 110.112 178.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.01 159.34 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.422 2.081 . . . . 0.56 111.462 178.451 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.39 156.01 64.1 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.878 1.671 . . . . 0.59 109.905 177.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.72 -24.83 2.14 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.855 2.37 . . . . 0.44 113.562 -167.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -176.34 169.87 2.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.497 1.919 . . . . 1.7 111.157 -178.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.99 154.37 26.57 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.068 1.347 . . . . 0.69 110.554 159.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.19 142.09 46.2 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.614 1.565 . . . . 2.08 108.003 173.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 t -143.65 128.9 9.78 Favored Pre-proline 0 N--CA 1.474 0.74 0 N-CA-C 112.458 0.54 . . . . 1.03 112.458 169.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.34 167.32 24.22 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.324 2.683 . . . . 0.91 112.294 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.29 145.87 14.55 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.33 3.353 . . . . 1.16 112.281 171.013 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt 73.49 -14.36 0.64 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.574 1.95 . . . . 3.12 114.635 178.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.56 158.8 45.69 Favored Glycine 0 N--CA 1.472 1.088 0 CA-C-N 119.017 0.826 . . . . 1.33 114.144 -168.149 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 mmt-85 -76.87 136.94 38.89 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.995 0.918 . . . . 4.01 108.811 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.67 63.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.246 2.218 . . . . 5.66 107.098 -174.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HB3' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -99.39 134.84 41.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.496 1.518 . . . . 3.62 110.924 -177.756 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.32 94.15 8.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.185 -1.413 . . . . 1.8 107.185 164.416 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -46.12 115.83 3.2 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 117.638 -1.172 . . . . 2.55 113.954 -168.964 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 30.0 Cg_endo -57.43 140.63 93.73 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.29 2.66 . . . . 3.71 112.536 176.734 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.56 -19.95 10.1 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.846 1.212 . . . . 2.73 114.343 -168.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.98 -98.7 1.73 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.003 1.402 . . . . 1.83 113.331 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 77.6 m-85 -75.13 137.88 41.66 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 121.616 -0.932 . . . . 1.83 111.756 -173.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -160.35 147.2 15.8 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.098 0.959 . . . . 0.6 111.059 -174.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -82.39 127.24 33.06 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.089 -1.078 . . . . 2.19 108.089 166.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -77.09 143.44 39.23 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.531 1.532 . . . . 0.92 108.667 164.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.9 mt -128.3 112.14 14.14 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.983 1.313 . . . . 1.97 108.782 -173.45 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.5 132.21 56.37 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.494 1.117 . . . . 2.43 109.954 -166.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.24 47.08 7.72 Favored Glycine 0 N--CA 1.472 1.095 0 C-N-CA 124.022 0.82 . . . . 1.8 113.965 173.191 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.5 mt -49.86 153.48 1.28 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 117.119 2.266 . . . . 0.66 117.119 -173.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -117.3 -33.35 4.67 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.354 -1.748 . . . . 1.94 113.399 -174.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -105.32 133.4 20.18 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 106.786 -1.561 . . . . 6.11 106.786 156.404 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.15 135.01 28.48 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 N-CA-C 107.148 -1.904 . . . . 1.39 107.148 156.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.23 157.99 16.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.347 0.594 . . . . 2.44 111.05 -177.015 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.406 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -158.85 162.71 37.0 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.182 2.193 . . . . 4.45 111.531 170.089 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.77 140.46 58.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.798 1.239 . . . . 1.13 110.232 -175.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.79 48.41 28.14 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.416 -1.265 . . . . 1.93 111.777 -170.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.26 176.49 7.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.762 1.225 . . . . 2.56 108.524 153.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -137.38 162.1 34.51 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 127.657 2.383 . . . . 4.25 107.59 161.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 t -153.83 154.1 7.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 127.773 2.429 . . . . 1.51 110.088 -175.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -83.22 140.1 32.73 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 123.13 1.443 . . . . 3.64 113.931 161.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mp -109.97 167.93 9.81 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.143 -1.39 . . . . 1.89 108.526 148.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 62.3 m-20 -130.22 140.8 50.69 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.689 2.396 . . . . 2.55 108.406 176.539 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.425 HD11 HD13 ' A' ' 20' ' ' LEU . 9.5 mp -103.26 127.37 50.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.252 1.421 . . . . 1.17 109.735 175.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 mt -100.3 106.75 18.42 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.495 1.118 . . . . 0.68 108.693 175.291 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.486 ' CD1' HD12 ' A' ' 30' ' ' LEU . 98.4 m-85 -97.86 125.23 42.63 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.036 0.934 . . . . 2.16 111.629 177.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.56 15.06 0.45 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.894 2.077 . . . . 2.51 115.36 176.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.59 -7.5 79.71 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.661 1.6 . . . . 4.95 115.773 -178.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -134.53 -37.72 0.21 Allowed Glycine 0 N--CA 1.477 1.39 0 CA-C-N 119.438 1.619 . . . . 2.14 116.483 -172.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -85.63 107.74 17.67 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.486 -1.596 . . . . 4.18 110.851 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.0 t -99.73 132.86 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.94 0.896 . . . . 2.04 110.731 178.163 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.02 127.28 30.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 2.95 111.868 172.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -79.88 141.67 35.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.711 1.604 . . . . 2.68 114.174 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.61 164.18 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 127.989 2.516 . . . . 2.58 109.91 170.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.4 t -135.16 132.66 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 106.647 -1.612 . . . . 1.69 106.647 156.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.81 145.83 20.62 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.684 1.194 . . . . 2.3 111.115 -167.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.61 161.69 39.23 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.552 2.835 . . . . 1.02 112.51 176.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.9 t -95.53 128.9 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.636 1.174 . . . . 1.04 110.025 164.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 . . . . . 0 CA--C 1.545 0.784 0 C-N-CA 128.283 2.633 . . . . 3.05 109.031 -173.309 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 . . . . . 0 CA--C 1.546 0.824 0 CA-C-O 122.761 1.267 . . . . 4.61 109.361 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.64 154.17 25.15 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.221 1.391 . . . . 1.45 113.612 171.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . 0.456 ' CD2' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -83.66 156.92 22.41 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.953 1.701 . . . . 7.92 114.458 173.092 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -84.62 55.63 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 122.794 1.283 . . . . 3.02 110.19 165.431 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.456 ' HA ' ' CD2' ' A' ' 7' ' ' TRP 0.286 0.2 OUTLIER 27.58 -121.32 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 128.438 2.695 . . . . 5.25 115.043 -169.15 . . . . . . . . 4 4 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -166.35 131.3 2.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.346 1.458 . . . . 2.81 109.182 -179.115 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -175.84 138.56 0.53 Allowed Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.96 1.304 . . . . 2.16 110.306 -176.243 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.34 -38.85 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.666 2.244 . . . . 1.55 111.519 164.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.23 173.32 23.83 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.426 1.965 . . . . 1.19 111.049 -173.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -77.76 2.44 25.93 Favored 'Cis proline' 0 CA--C 1.542 0.885 0 CA-C-N 119.559 1.679 . . . . 1.34 112.722 -4.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -151.14 160.94 43.58 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 123.14 1.448 . . . . 2.01 113.561 -175.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.69 -175.99 4.49 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.183 2.193 . . . . 0.42 111.765 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.8 148.06 30.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.443 1.897 . . . . 0.73 108.243 176.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.82 127.58 52.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.558 1.072 . . . . 0.82 109.968 179.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.477 ' CE2' ' HA ' ' A' ' 79' ' ' PRO . 56.6 m-85 -116.2 78.93 1.24 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.054 1.341 . . . . 2.64 109.59 -176.089 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -82.14 152.69 26.39 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.53 0.732 . . . . 2.41 112.374 -179.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.1 m -84.1 130.71 34.84 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.675 -1.231 . . . . 1.88 107.675 157.633 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.4 tp -96.7 133.3 41.41 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.071 -0.344 . . . . 4.36 110.071 -179.533 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -124.69 129.29 50.24 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.629 1.172 . . . . 6.2 112.215 -175.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -107.14 99.61 27.92 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.351 -0.843 . . . . 1.64 110.506 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -81.16 -12.87 11.56 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.075 2.517 . . . . 1.69 113.564 175.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.74 179.68 51.3 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.567 1.08 . . . . 1.68 112.226 -175.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -105.05 0.45 27.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.115 2.166 . . . . 3.23 112.124 -174.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.12 161.08 51.6 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 128.363 2.665 . . . . 2.93 109.665 176.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.32 143.29 27.91 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.168 1.912 . . . . 1.39 110.995 -175.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.33 150.1 24.77 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.801 1.241 . . . . 2.46 109.558 171.142 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -136.56 97.18 3.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.316 -1.766 . . . . 2.32 110.24 -174.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 tt -80.29 115.42 19.83 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.092 -1.077 . . . . 1.79 108.092 -175.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.81 -31.38 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.605 1.162 . . . . 0.75 112.58 -176.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.3 177.26 35.06 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 124.716 1.15 . . . . 0.67 113.939 175.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.468 ' O ' HG11 ' A' ' 43' ' ' VAL . . . -124.38 160.13 28.83 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.821 -0.811 . . . . 1.25 110.549 169.147 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -130.52 157.36 42.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.458 1.903 . . . . 4.47 108.432 167.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.5 t -165.71 148.31 6.56 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.152 1.781 . . . . 0.88 108.683 175.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -73.05 -19.71 22.65 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.521 1.481 . . . . 0.89 113.609 -176.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 m -90.86 12.57 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 115.799 1.777 . . . . 0.85 115.799 -176.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.28 155.39 38.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.518 1.303 . . . . 0.9 114.518 173.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -92.1 -43.92 9.11 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.988 -1.005 . . . . 3.38 113.695 -167.11 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -138.69 123.47 18.72 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.884 1.274 . . . . 6.1 107.751 -167.362 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 35' ' ' ALA . 5.3 p -126.15 132.8 70.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.209 1.404 . . . . 1.29 109.479 -166.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -120.47 157.87 28.45 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.148 1.379 . . . . 3.1 109.441 169.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.2 tp -105.58 117.69 34.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.798 1.239 . . . . 0.95 108.686 169.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -118.89 147.61 43.8 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.122 1.369 . . . . 0.73 113.533 -175.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.11 177.23 6.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.185 1.794 . . . . 2.37 110.608 161.057 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -153.39 140.95 19.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.992 -1.855 . . . . 0.97 105.992 174.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -153.43 173.18 16.01 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.243 1.201 . . . . 2.1 114.243 -165.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.47 134.83 50.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.659 1.584 . . . . 5.56 111.534 170.79 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.45 155.46 44.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.232 1.413 . . . . 6.11 110.653 171.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -86.91 141.17 28.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.97 -0.752 . . . . 2.87 108.97 157.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.9 t -135.69 115.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.165 1.786 . . . . 2.54 106.277 165.482 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 56.09 41.09 30.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.632 1.173 . . . . 4.77 113.737 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.47 6.18 65.28 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.723 -1.236 . . . . 1.93 114.281 -177.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -118.08 126.48 52.35 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.978 2.111 . . . . 2.78 108.117 -178.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -76.86 121.93 24.1 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.921 1.289 . . . . 3.6 109.533 -173.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.45 132.88 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.317 1.847 . . . . 2.42 109.129 -174.295 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtt -80.55 166.66 20.94 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.154 0.798 . . . . 2.36 113.154 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.97 177.07 32.43 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.1 0.857 . . . . 0.92 113.426 179.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.5 ttm -155.93 140.56 16.96 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.524 1.529 . . . . 1.12 109.707 -176.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -145.02 156.8 54.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.622 1.969 . . . . 8.81 109.218 -176.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.46 151.97 15.44 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.761 2.308 . . . . 0.89 110.629 170.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.25 155.51 79.84 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.477 1.511 . . . . 0.69 110.449 -179.04 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.29 -27.59 3.47 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.945 2.43 . . . . 0.85 113.094 -166.585 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -175.68 167.09 3.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.566 1.546 . . . . 2.2 111.752 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.0 mt -113.27 153.31 28.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.469 1.908 . . . . 0.78 110.355 166.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -117.14 142.77 46.59 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.879 1.272 . . . . 1.91 109.434 176.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.3 t -140.97 128.49 12.09 Favored Pre-proline 0 N--CA 1.472 0.657 0 N-CA-C 112.436 0.532 . . . . 1.28 112.436 168.004 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.84 159.89 44.37 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.979 3.12 . . . . 1.44 112.159 178.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.1 144.13 99.5 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.945 3.097 . . . . 1.68 113.34 -176.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mptt 67.3 -9.56 0.39 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.589 2.356 . . . . 2.62 114.483 -177.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.51 134.92 14.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.41 1.005 . . . . 1.66 112.656 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.22 135.67 41.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.77 -0.826 . . . . 4.17 108.77 155.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -147.07 129.53 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.031 1.732 . . . . 4.02 107.65 -174.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -94.54 150.55 20.13 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.348 -0.845 . . . . 2.86 112.565 -167.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.24 84.83 2.42 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.081 -1.451 . . . . 2.01 107.081 156.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.428 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -64.08 145.5 97.94 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 120.949 -1.094 . . . . 2.71 113.261 -171.482 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.477 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 20.8 Cg_endo -55.36 -38.73 93.61 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.459 3.439 . . . . 2.17 113.582 -174.421 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.14 24.3 19.54 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.199 -1.89 . . . . 2.26 115.503 175.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.47 -15.11 0.02 OUTLIER Glycine 0 N--CA 1.476 1.315 0 N-CA-C 121.342 3.297 . . . . 2.3 121.342 171.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -149.11 145.92 27.45 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 122.118 2.959 . . . . 2.11 114.336 174.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -162.05 158.3 24.72 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.894 1.278 . . . . 0.68 112.709 172.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -79.09 142.03 36.82 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.391 -0.818 . . . . 2.27 109.597 157.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 tpt -99.35 125.79 45.09 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.107 2.163 . . . . 1.11 108.471 169.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mp -120.3 112.57 19.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.909 1.283 . . . . 1.41 109.051 -173.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.15 155.33 18.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.242 1.417 . . . . 2.13 110.928 -174.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.24 -48.82 3.99 Favored Glycine 0 N--CA 1.469 0.852 0 C-N-CA 126.822 2.153 . . . . 2.99 113.05 173.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.9 mt 51.34 172.67 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.903 2.881 . . . . 0.83 115.198 -172.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -137.9 -22.56 1.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.544 2.338 . . . . 2.55 113.467 -176.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -137.63 143.99 42.91 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 128.566 2.747 . . . . 4.94 109.178 175.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.43 145.38 37.96 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.31 2.007 . . . . 1.6 108.351 155.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.64 119.6 39.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.851 0.86 . . . . 2.17 111.203 -177.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -85.29 170.06 13.17 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.88 0.848 . . . . 3.85 112.197 169.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.67 136.81 58.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.819 -0.628 . . . . 1.81 109.32 157.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.79 9.51 87.01 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.291 -1.283 . . . . 1.75 114.954 174.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.63 173.06 10.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.982 1.391 . . . . 3.14 108.792 160.359 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -145.47 151.68 38.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.64 2.376 . . . . 3.36 106.869 169.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.4 t -153.08 139.87 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 127.105 2.162 . . . . 1.53 109.664 -176.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.21 144.29 34.53 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.489 0.922 . . . . 2.47 113.489 173.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.1 mp -120.38 148.01 44.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.555 1.542 . . . . 1.87 110.874 165.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.99 117.28 34.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.706 2.003 . . . . 2.84 110.616 164.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -85.73 114.8 22.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.633 1.173 . . . . 1.37 108.745 176.102 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.8 mt -90.91 114.03 26.39 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.646 1.178 . . . . 1.01 108.91 -175.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -113.07 117.22 31.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.613 1.565 . . . . 1.94 112.495 -171.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 54.04 26.62 6.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.512 1.525 . . . . 2.14 113.736 171.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.5 -68.93 2.64 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.144 1.354 . . . . 4.38 112.351 -172.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.25 2.28 62.15 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 116.571 1.388 . . . . 1.81 116.571 -166.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -129.44 139.04 51.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.445 1.623 . . . . 2.85 111.078 173.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -137.74 142.47 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.425 1.49 . . . . 2.17 108.196 176.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.3 tp -154.43 110.97 3.29 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.252 0.549 . . . . 2.27 112.279 -166.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -82.76 152.29 25.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.851 1.056 . . . . 2.19 113.851 -170.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.14 167.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.128 1.771 . . . . 2.4 110.291 178.3 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.26 138.58 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.307 1.043 . . . . 1.93 109.744 -177.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.7 mp -130.17 134.16 25.78 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.038 1.735 . . . . 2.7 110.744 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.63 177.71 7.68 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.298 2.665 . . . . 1.0 111.562 170.317 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 t -118.28 95.84 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.033 0.933 . . . . 1.17 108.65 164.321 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.481 1.103 0 O-C-N 121.21 -0.931 . . . . 5.6 113.282 -169.252 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 . . . . . 0 CA--C 1.539 0.526 0 CA-C-O 120.809 0.338 . . . . 9.26 110.457 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.97 -171.98 13.6 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.087 2.28 . . . . 1.65 110.78 177.358 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -121.81 178.27 4.93 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.004 1.483 . . . . 2.17 115.004 -179.718 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.06 142.09 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.124 2.17 . . . . 1.47 107.106 172.217 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -79.36 -93.59 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.17 0.588 . . . . 7.3 110.852 -178.697 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -161.59 150.56 15.94 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.92 -1.113 . . . . 3.33 111.738 -170.941 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.16 127.73 25.8 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.523 1.129 . . . . 3.99 111.444 176.215 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.49 -49.52 0.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 N-CA-C 109.126 -1.144 . . . . 4.0 109.126 154.143 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.04 141.3 9.33 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 108.872 -1.691 . . . . 1.42 108.872 -155.171 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -86.91 14.93 44.17 Favored 'Cis proline' 0 CA--C 1.54 0.814 0 CA-C-N 120.308 2.054 . . . . 1.19 112.63 5.166 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -144.22 171.54 14.15 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.343 1.238 . . . . 2.26 114.343 -172.12 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.99 -177.03 6.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.03 2.532 . . . . 0.62 112.897 -176.443 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.0 141.46 22.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.657 1.583 . . . . 0.73 110.122 177.537 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.24 153.61 36.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 0.66 111.325 178.797 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -139.26 59.3 1.61 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.445 1.898 . . . . 2.11 111.636 -168.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.86 167.37 17.46 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.612 1.338 . . . . 1.81 114.612 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.3 m -101.41 146.46 27.58 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.84 1.656 . . . . 1.66 110.628 -177.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.2 117.66 30.19 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.506 1.122 . . . . 4.0 110.012 172.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -123.23 128.35 49.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.961 -1.496 . . . . 4.28 106.961 163.64 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -97.41 106.21 30.91 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.528 0.731 . . . . 1.36 110.575 -179.473 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -84.58 -11.68 8.0 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.602 2.201 . . . . 1.09 114.431 178.132 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.55 166.74 34.73 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 119.406 1.003 . . . . 1.2 111.422 -176.819 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.04 2.85 53.42 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.757 2.023 . . . . 3.34 112.308 175.401 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -113.15 155.53 44.25 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.814 2.046 . . . . 3.33 110.799 174.536 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -79.47 142.47 16.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.427 2.085 . . . . 0.92 110.69 -178.08 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.91 142.61 30.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.903 0.859 . . . . 2.59 109.575 172.513 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -138.02 106.15 5.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.608 1.963 . . . . 2.35 108.724 178.135 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.47 106.16 18.2 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 128.31 2.644 . . . . 1.95 107.863 -170.27 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.3 m -104.35 -21.55 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.912 0.708 . . . . 0.7 112.912 -167.434 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.41 -174.89 28.7 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.839 1.209 . . . . 0.62 112.395 175.398 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.36 179.7 6.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.639 0.733 . . . . 0.75 112.974 170.678 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -144.81 158.57 43.74 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.823 2.049 . . . . 4.96 107.873 161.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 t -164.6 145.2 6.34 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 125.717 1.607 . . . . 0.82 108.542 175.324 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.24 -2.84 12.89 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.695 1.597 . . . . 1.14 113.982 -175.914 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.6 m -107.03 11.98 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 116.174 1.916 . . . . 1.33 116.174 -174.163 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.05 156.43 46.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.423 1.465 . . . . 1.22 113.283 177.377 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -86.41 -31.07 21.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.683 1.193 . . . . 3.18 111.598 173.408 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -140.61 147.4 39.32 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.004 1.322 . . . . 4.61 109.332 166.801 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.38 141.99 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.858 1.663 . . . . 0.99 108.392 161.629 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -140.37 137.68 34.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.317 1.447 . . . . 2.94 108.293 -171.449 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.3 tp -99.5 111.98 24.25 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.371 -0.831 . . . . 0.92 111.922 -170.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -118.92 155.64 30.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.962 1.305 . . . . 0.76 113.236 -176.614 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 9.4 pt-20 -100.25 176.51 5.35 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.579 1.552 . . . . 1.91 112.187 159.951 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.3 m -143.64 136.27 27.26 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.1 -1.815 . . . . 1.2 106.1 165.085 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -138.77 164.65 29.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.97 1.308 . . . . 1.97 112.675 -165.672 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.5 ttp -99.42 142.64 30.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.929 1.292 . . . . 3.69 109.943 170.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -142.75 145.16 33.04 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.903 1.681 . . . . 7.98 111.278 173.22 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.93 141.39 34.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.466 1.106 . . . . 3.67 109.903 158.768 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.3 t -138.44 121.19 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.159 1.783 . . . . 2.45 106.4 170.699 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 62.39 15.98 8.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.506 1.522 . . . . 3.37 114.011 -173.292 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.67 16.36 66.08 Favored Glycine 0 N--CA 1.477 1.402 0 O-C-N 120.979 -1.076 . . . . 2.19 113.871 -170.356 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -121.37 121.11 36.91 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.686 2.395 . . . . 2.33 108.394 -179.097 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.87 139.65 48.94 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.379 -1.45 . . . . 3.73 113.178 178.028 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.7 p -155.26 169.7 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 128.246 2.618 . . . . 2.52 108.347 176.762 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.0 mtm -100.29 172.1 7.37 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.787 -1.195 . . . . 3.84 113.31 176.795 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.49 174.04 31.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.688 2.09 . . . . 0.61 111.355 166.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ttm -136.43 153.73 50.99 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.33 1.852 . . . . 1.16 108.08 175.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -159.13 156.06 25.41 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-O 118.076 -0.964 . . . . 4.69 111.082 175.891 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.96 155.5 52.95 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.432 2.088 . . . . 0.56 110.849 170.446 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -141.1 159.5 61.4 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 125.637 1.575 . . . . 0.85 110.38 -175.199 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -82.19 -27.12 2.5 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.432 2.088 . . . . 0.67 113.134 -168.412 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -177.59 164.82 2.08 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.378 1.471 . . . . 2.42 112.171 -177.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.1 mt -107.94 160.21 15.94 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.93 1.292 . . . . 0.95 110.376 160.272 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -145.15 147.58 32.65 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.235 -0.916 . . . . 2.04 111.521 -179.567 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.3 t -143.25 131.0 10.99 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.086 0.954 . . . . 1.14 111.736 176.018 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.42 162.15 42.29 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 124.175 3.25 . . . . 0.9 112.457 179.122 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -59.49 135.47 64.99 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.215 3.277 . . . . 0.98 113.08 -177.419 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.55 -5.36 0.62 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.927 2.091 . . . . 1.89 114.508 -179.51 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.84 167.92 51.86 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.917 1.722 . . . . 1.28 112.589 171.518 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.86 151.74 40.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.53 0.732 . . . . 5.87 112.22 174.623 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 76' ' ' GLU . 29.7 t -146.83 -178.81 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 128.021 2.529 . . . . 3.56 107.784 -178.498 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.48 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -146.83 154.52 41.44 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.347 1.859 . . . . 3.62 108.206 171.191 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.7 mp -51.19 -38.88 54.81 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 123.048 0.539 . . . . 3.06 111.899 175.788 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm 101.14 118.19 0.01 OUTLIER Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 127.773 2.429 . . . . 2.33 109.906 161.605 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.24 -16.36 54.57 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.114 2.543 . . . . 2.76 116.181 -161.06 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -115.34 7.16 20.89 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.655 1.121 . . . . 2.75 114.946 169.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.62 -110.09 1.93 Allowed Glycine 0 N--CA 1.47 0.915 0 C-N-CA 125.839 1.685 . . . . 2.15 113.263 -171.123 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 60.2 m-85 -73.1 147.95 44.45 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 123.378 1.561 . . . . 2.11 111.773 -175.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -159.68 142.39 13.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.579 -1.646 . . . . 0.98 111.045 -178.24 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -79.88 111.24 16.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.972 -1.122 . . . . 2.07 107.972 165.424 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.7 tpt -77.03 120.9 22.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.343 2.257 . . . . 1.06 107.908 175.111 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.3 mt -109.74 122.22 47.0 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.272 1.429 . . . . 2.21 109.035 -173.206 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.98 143.76 46.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.691 1.196 . . . . 2.19 111.415 -170.093 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.33 -43.22 2.85 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 127.248 2.356 . . . . 2.93 113.955 175.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.8 mt 56.77 168.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 129.698 3.199 . . . . 1.05 115.637 -176.284 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -123.97 -30.83 3.46 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.97 1.708 . . . . 1.76 112.427 173.658 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -127.66 140.22 37.46 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 128.932 2.893 . . . . 5.76 107.612 166.219 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.81 59.19 0.9 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.376 2.717 . . . . 2.79 112.717 -165.341 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -33.73 106.2 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 116.566 2.061 . . . . 3.03 116.566 -157.704 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -100.95 168.63 9.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.265 1.826 . . . . 8.13 111.043 169.047 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.69 134.2 50.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.93 0.892 . . . . 1.34 110.724 -176.555 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.72 -6.33 52.05 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.26 1.886 . . . . 1.52 114.376 -175.331 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.59 -175.1 5.58 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.985 1.314 . . . . 2.93 112.106 170.769 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.7 142.02 23.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 128.543 2.737 . . . . 6.5 107.247 -173.415 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 t -142.79 124.4 12.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 124.004 0.921 . . . . 1.74 110.68 -168.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -98.64 129.53 45.14 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.903 -1.044 . . . . 2.74 110.707 -178.573 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.11 137.9 53.27 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.193 1.797 . . . . 2.52 110.3 179.091 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -97.92 124.2 42.25 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.324 2.25 . . . . 1.8 108.889 170.402 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.15 115.66 27.98 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.797 1.239 . . . . 0.99 109.756 178.407 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.89 101.5 13.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.222 -0.658 . . . . 0.76 109.222 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -94.29 136.9 34.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.161 0.984 . . . . 2.04 111.097 176.669 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.97 125.88 13.03 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.706 1.202 . . . . 2.04 113.449 -174.566 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.68 70.51 1.28 Allowed Glycine 0 N--CA 1.47 0.951 0 C-N-CA 124.259 0.933 . . . . 3.71 112.897 177.54 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.72 5.99 58.1 Favored Glycine 0 N--CA 1.474 1.224 0 N-CA-C 116.485 1.354 . . . . 1.61 116.485 164.498 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -98.51 127.12 44.31 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.395 1.598 . . . . 3.52 109.878 -179.794 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.24 142.92 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.3 1.04 . . . . 2.2 109.01 179.865 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.0 tt -152.5 135.98 15.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.336 1.455 . . . . 2.0 109.208 -177.841 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -102.1 140.42 36.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.354 0.662 . . . . 3.24 112.433 -179.485 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.8 t -127.84 162.7 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 127.109 2.164 . . . . 1.76 108.311 175.575 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.9 t -128.33 141.25 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.397 1.479 . . . . 1.95 110.436 -178.662 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.3 mt -136.45 124.66 15.0 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.693 1.197 . . . . 2.26 109.848 -164.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.67 149.36 48.72 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.048 1.832 . . . . 0.88 110.244 173.767 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.0 t -90.94 117.35 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.861 -0.792 . . . . 0.93 108.861 167.792 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 108.12 -1.067 . . . . 4.04 108.12 175.25 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.088 0 N-CA-C 106.213 -2.755 . . . . 8.72 106.213 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.68 147.35 3.65 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 117.109 0.455 . . . . 8.43 111.662 127.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -161.33 138.9 9.06 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 127.132 2.173 . . . . 7.95 109.659 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.8 p -80.08 57.06 2.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.353 1.061 . . . . 5.07 111.123 167.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -85.56 123.79 31.38 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.699 1.199 . . . . 4.65 112.038 -171.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.68 179.32 35.33 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.65 1.119 . . . . 1.28 114.869 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -146.25 146.33 30.72 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.134 1.374 . . . . 2.41 112.721 162.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -86.57 149.76 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.711 1.204 . . . . 1.44 108.236 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.416 ' HD3' ' H ' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -84.49 149.95 25.6 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 122.852 1.31 . . . . 3.82 113.162 -176.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.416 ' H ' ' HD3' ' A' ' 9' ' ' ARG . 64.7 t80 -76.36 134.05 39.79 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 128.56 2.744 . . . . 2.11 110.823 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 35.1 t 175.62 135.59 0.18 Allowed Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 125.912 1.685 . . . . 2.37 112.058 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.58 -24.85 21.61 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.441 2.094 . . . . 1.39 112.506 170.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 139.2 171.59 12.27 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 127.074 2.273 . . . . 0.85 111.375 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -79.65 -8.21 39.71 Favored 'Cis proline' 0 CA--C 1.538 0.692 0 CA-C-N 118.886 1.343 . . . . 0.92 113.307 0.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -144.2 157.81 44.08 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.968 1.307 . . . . 1.86 113.44 -172.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -143.02 -175.74 4.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 130.023 3.329 . . . . 0.43 108.473 -176.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.34 176.81 8.37 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.155 1.382 . . . . 1.06 109.173 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -150.8 138.17 19.49 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 119.685 1.13 . . . . 0.53 112.327 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 17.7 m-85 -119.02 137.51 53.48 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 127.256 2.222 . . . . 2.07 108.262 175.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.3 pp -168.35 148.37 4.67 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.324 1.05 . . . . 1.67 111.707 -172.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 90.5 m -89.53 122.21 32.48 Favored 'General case' 0 CA--C 1.519 -0.224 0 C-N-CA 123.923 0.889 . . . . 1.76 111.172 -176.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.401 HD11 ' CZ ' ' A' ' 105' ' ' PHE . 0.1 OUTLIER -102.58 120.3 40.3 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 125.077 1.351 . . . . 3.1 108.765 -177.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -122.13 141.75 51.11 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.527 1.131 . . . . 3.9 111.3 -173.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -117.05 108.94 43.31 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 124.393 1.077 . . . . 1.46 110.659 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -82.78 -10.99 10.4 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.939 2.426 . . . . 1.16 113.848 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.25 175.88 49.93 Favored Glycine 0 C--N 1.339 0.735 0 CA-C-O 122.787 1.215 . . . . 1.17 113.224 -175.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -99.41 -3.83 32.87 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.327 2.651 . . . . 3.0 111.43 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -122.37 157.27 59.23 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 128.336 2.654 . . . . 2.67 109.883 174.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.0 145.8 31.86 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.788 2.325 . . . . 0.93 111.137 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.1 mt -105.83 157.08 17.72 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-O 122.716 1.246 . . . . 1.93 109.959 169.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -147.99 110.71 4.74 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 112.789 -2.005 . . . . 2.24 112.724 -170.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.99 107.37 19.16 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.447 1.899 . . . . 1.87 109.297 -173.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.8 m -103.71 -24.55 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 C-N-CA 124.209 1.003 . . . . 0.67 112.949 -168.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.34 -177.61 32.58 Favored Glycine 0 N--CA 1.466 0.686 0 C-N-CA 125.387 1.47 . . . . 0.49 112.095 175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.06 -178.84 5.27 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 122.057 -0.672 . . . . 0.56 111.648 169.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.8 mtp-105 -144.32 177.07 8.89 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 126.237 1.815 . . . . 3.82 108.273 158.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 t -172.92 152.31 2.36 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 126.158 1.783 . . . . 0.72 109.517 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.39 -7.52 15.98 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.134 1.889 . . . . 0.81 114.172 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.8 m -113.63 24.29 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 N-CA-C 115.969 1.84 . . . . 0.78 115.969 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.06 143.18 19.07 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.677 1.591 . . . . 0.88 110.977 169.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -68.87 -33.23 73.44 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.661 1.584 . . . . 3.12 112.862 177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -137.91 159.89 40.77 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 126.965 2.106 . . . . 4.47 108.843 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -139.69 143.49 30.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.026 1.33 . . . . 0.93 108.407 166.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.0 mt-10 -123.21 149.77 44.25 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.665 1.986 . . . . 2.67 109.055 174.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.8 tp -102.3 121.75 42.89 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.573 0.749 . . . . 0.88 110.389 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -125.06 159.6 31.0 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 123.603 1.668 . . . . 0.49 113.921 -173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -104.61 159.51 15.7 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.831 2.452 . . . . 2.13 110.976 158.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 20.3 m -128.49 148.36 50.74 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 105.906 -1.887 . . . . 0.73 105.906 165.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -159.97 175.89 12.49 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.992 0.917 . . . . 2.23 112.857 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 55.8 ttp -111.65 136.36 50.98 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.342 1.457 . . . . 3.3 111.282 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 9.1 mtp-105 -120.54 159.92 24.24 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.346 1.858 . . . . 4.75 110.611 171.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -90.68 147.99 22.91 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 123.451 0.7 . . . . 2.27 109.503 151.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.8 t -138.79 118.78 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.579 1.552 . . . . 2.28 106.915 157.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 61.09 25.68 15.67 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 114.758 1.392 . . . . 3.33 114.758 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 82.34 4.68 90.09 Favored Glycine 0 N--CA 1.481 1.647 0 O-C-N 120.044 -1.66 . . . . 1.79 113.984 -171.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 58.7 mttt -105.54 120.14 40.89 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.587 2.355 . . . . 2.51 107.885 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.1 mmtm -71.54 113.83 8.98 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.693 1.597 . . . . 2.64 109.778 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 72.1 t -140.46 133.72 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.402 1.481 . . . . 2.15 109.518 -172.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 66.7 mtt -79.5 171.88 14.56 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.347 1.24 . . . . 2.54 114.347 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.82 168.18 29.94 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 126.364 1.935 . . . . 0.79 112.226 174.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.0 ttm -149.08 145.37 27.21 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.697 1.599 . . . . 1.09 108.95 178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.8 mtm180 -148.06 152.9 40.93 Favored Pre-proline 0 N--CA 1.467 0.4 0 C-N-CA 125.121 1.368 . . . . 4.42 109.853 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -75.24 154.28 41.28 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.103 1.869 . . . . 0.5 110.742 163.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -139.05 157.95 70.45 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 125.768 1.627 . . . . 0.61 110.309 -177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.22 -26.74 2.66 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 123.024 2.483 . . . . 0.59 113.32 -167.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -177.43 164.54 2.11 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.662 1.585 . . . . 2.05 111.763 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.2 mt -110.86 153.09 25.91 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 125.094 1.358 . . . . 0.73 110.404 164.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -110.96 147.05 35.52 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 125.049 1.339 . . . . 2.05 109.895 178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -132.62 121.44 17.24 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 123.363 0.665 . . . . 1.41 111.195 163.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.14 159.05 54.47 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.222 2.614 . . . . 1.19 111.424 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -60.5 138.98 83.84 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.605 2.87 . . . . 0.94 112.319 -178.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt 65.63 -3.64 0.68 Allowed 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 126.484 1.914 . . . . 1.7 114.032 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.08 -176.64 34.82 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 126.971 2.224 . . . . 1.16 113.2 -176.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -147.83 152.85 38.36 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.246 1.019 . . . . 3.5 112.406 171.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 48.1 t -142.81 134.24 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.805 1.642 . . . . 3.49 107.735 172.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.68 143.82 31.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.305 1.042 . . . . 3.29 112.199 -176.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.0 mp -74.33 130.1 39.05 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 107.481 -1.303 . . . . 2.44 107.481 151.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.45 155.2 73.92 Favored Pre-proline 0 N--CA 1.477 0.919 0 C-N-CA 125.445 1.498 . . . . 2.48 113.392 -170.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.447 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 38.4 Cg_endo -58.83 -36.72 96.53 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.507 2.805 . . . . 2.32 113.731 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.26 12.89 36.03 Favored Glycine 0 CA--C 1.534 1.236 0 CA-C-O 118.592 -1.116 . . . . 1.79 115.001 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -169.35 -122.38 0.62 Allowed Glycine 0 C--N 1.343 0.937 0 CA-C-N 119.562 1.681 . . . . 1.76 114.778 -174.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -71.34 140.9 50.4 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 122.049 -0.677 . . . . 1.81 111.585 -168.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -161.88 153.97 19.35 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.288 1.035 . . . . 0.55 112.137 -174.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -79.04 143.0 36.06 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 109.416 -0.587 . . . . 1.73 109.416 161.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -100.06 123.13 43.95 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.438 1.495 . . . . 0.71 108.168 163.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -98.77 130.27 45.22 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 108.273 -1.01 . . . . 1.33 108.273 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.9 mp -129.32 139.05 51.88 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.672 0.789 . . . . 2.01 111.326 -177.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.33 47.03 8.49 Favored Glycine 0 N--CA 1.471 0.999 0 C-N-CA 123.588 0.613 . . . . 1.58 112.223 176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.413 HD13 HD23 ' A' ' 93' ' ' LEU . 10.5 mt -51.88 158.36 1.04 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 115.9 1.815 . . . . 0.87 115.9 -174.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -119.33 -32.83 4.27 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.035 -1.439 . . . . 1.67 113.097 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -96.28 142.69 24.92 Favored Pre-proline 0 CA--C 1.538 0.509 0 C-N-CA 125.067 1.347 . . . . 4.88 107.711 161.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.68 117.71 5.29 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 N-CA-C 106.33 -2.219 . . . . 1.43 106.33 150.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.413 HD23 HD13 ' A' ' 89' ' ' LEU . 2.0 mm? -76.6 105.34 7.61 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 126.139 1.775 . . . . 1.93 108.827 -175.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -98.56 171.91 7.84 Favored 'General case' 0 C--O 1.221 -0.418 0 C-N-CA 124.746 1.219 . . . . 3.57 111.452 177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -82.9 131.77 35.18 Favored 'General case' 0 C--N 1.329 -0.315 0 O-C-N 121.216 -0.928 . . . . 1.09 108.687 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.1 18.74 58.81 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.751 -1.027 . . . . 1.34 114.576 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -89.83 -176.26 4.89 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.509 1.154 . . . . 2.39 110.076 161.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -139.65 145.98 39.13 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 127.996 2.518 . . . . 2.79 105.851 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -146.42 149.28 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 C-N-CA 127.537 2.335 . . . . 1.13 108.871 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -111.87 150.13 30.85 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 124.066 0.946 . . . . 2.14 113.091 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.4 mp -129.51 140.88 51.13 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.1 2.16 . . . . 1.69 109.552 175.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -85.31 131.15 34.45 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.208 -1.034 . . . . 2.2 108.208 160.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.88 109.8 21.68 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 121.239 1.836 . . . . 1.3 107.602 174.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 60.5 mt -79.49 113.96 18.04 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.508 -0.923 . . . . 0.69 108.508 -176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.401 ' CZ ' HD11 ' A' ' 22' ' ' LEU . 9.2 m-30 -105.35 140.76 37.99 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.792 1.237 . . . . 2.19 110.566 -175.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.03 126.73 28.67 Favored 'General case' 0 CA--C 1.544 0.712 0 O-C-N 120.49 -1.381 . . . . 2.39 113.823 -173.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.34 75.84 0.85 Allowed Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.785 1.183 . . . . 4.01 112.739 173.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.8 72.62 Favored Glycine 0 N--CA 1.472 1.036 0 N-CA-C 115.473 0.949 . . . . 2.0 115.473 166.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -130.87 149.79 52.34 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.103 1.452 . . . . 3.46 112.236 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 92.8 t -149.01 147.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.175 1.39 . . . . 2.23 108.421 167.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.4 tp -126.2 113.74 17.4 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.869 1.267 . . . . 2.4 108.985 168.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 32.0 ttpt -83.3 133.44 34.97 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.731 -1.231 . . . . 2.05 110.393 172.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.7 t -126.89 160.78 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.041 1.337 . . . . 1.72 109.167 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.9 t -133.15 137.71 52.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 127.125 2.17 . . . . 2.1 107.591 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -156.22 150.85 20.33 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 124.752 1.221 . . . . 2.04 111.763 -169.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.36 163.88 30.46 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 123.258 2.639 . . . . 0.85 112.387 174.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.5 t -100.48 124.37 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.393 -0.821 . . . . 0.92 109.001 163.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -120.03 145.35 46.92 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 122.631 1.205 . . . . 3.72 111.603 172.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -83.76 58.7 4.77 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.499 1.12 . . . . 2.03 110.671 165.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.5 ttm-85 . . . . . 0 C--O 1.246 0.906 0 C-N-CA 125.757 1.623 . . . . 6.27 110.144 177.218 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.309 0 N-CA-C 108.213 -1.955 . . . . 8.22 108.213 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m 70.62 -162.73 0.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.116 -1.809 . . . . 7.47 106.116 -114.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -135.04 101.25 4.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 120.965 1.711 . . . . 9.67 110.402 167.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -139.07 -6.7 1.41 Allowed 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.414 1.886 . . . . 4.59 111.254 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -75.19 95.19 3.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.157 1.783 . . . . 4.64 110.011 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.43 153.87 22.7 Favored Glycine 0 N--CA 1.467 0.722 0 C-N-CA 125.086 1.326 . . . . 1.18 110.885 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.9 p90 -126.14 134.97 51.16 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.346 1.059 . . . . 2.52 111.367 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.5 t -84.26 56.91 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.065 1.346 . . . . 3.2 109.166 -177.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 32.08 -116.56 0.05 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 128.052 2.541 . . . . 4.48 112.658 -171.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.0 t80 171.48 134.18 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.455 2.702 . . . . 2.55 108.154 -173.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.5 t -178.31 144.54 0.49 Allowed Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.215 1.806 . . . . 1.97 110.745 176.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.76 -24.19 18.42 Favored 'Trans proline' 0 CA--C 1.536 0.608 0 C-N-CA 122.749 2.3 . . . . 1.24 112.513 164.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.22 -173.95 15.07 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.658 1.599 . . . . 0.85 112.591 -174.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.38 -12.66 19.68 Favored 'Cis proline' 0 CA--C 1.539 0.745 0 CA-C-N 118.55 1.175 . . . . 1.07 113.475 1.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -125.05 169.83 11.76 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.803 1.641 . . . . 1.85 111.718 177.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.67 -175.63 5.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 128.014 2.526 . . . . 0.62 110.96 -173.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.27 169.83 16.61 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.219 1.808 . . . . 1.1 108.571 170.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -145.01 127.46 15.97 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.711 1.204 . . . . 0.75 110.99 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -107.27 66.58 0.67 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.861 2.064 . . . . 2.13 110.122 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.27 153.06 42.69 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.183 -0.948 . . . . 1.74 111.942 -177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.439 HG23 ' HB3' ' A' ' 76' ' ' GLU . 88.5 m -130.83 132.33 45.15 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.737 1.215 . . . . 2.22 108.785 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD21 HG21 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -154.26 178.02 10.47 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 126.998 2.119 . . . . 5.55 109.382 -178.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -139.67 160.24 40.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.385 1.474 . . . . 4.8 110.772 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -103.66 96.78 9.42 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 126.367 1.867 . . . . 1.44 109.335 171.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -81.8 -1.39 10.87 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.103 2.535 . . . . 1.37 114.675 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -90.05 156.26 25.14 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.418 1.008 . . . . 1.31 111.331 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -77.86 5.61 9.26 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.097 2.559 . . . . 4.01 112.339 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -118.28 151.57 49.55 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 127.92 2.488 . . . . 3.26 110.616 177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -78.75 161.44 27.48 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.759 2.306 . . . . 1.02 111.58 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.1 mt -120.67 152.57 38.05 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 122.525 1.155 . . . . 1.96 110.985 169.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.6 ttm180 -132.64 118.22 18.88 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 112.558 -2.11 . . . . 2.12 109.176 169.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -101.92 113.61 26.97 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 126.317 1.847 . . . . 1.77 107.724 -172.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.9 m -110.64 -24.6 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.54 0.736 . . . . 0.45 112.83 -167.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.22 -174.85 28.45 Favored Glycine 0 C--N 1.341 0.832 0 C-N-CA 125.053 1.311 . . . . 0.35 112.884 -178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.4 -178.13 5.82 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.836 1.254 . . . . 0.45 110.92 176.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.71 170.07 20.08 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.504 1.922 . . . . 5.94 109.131 164.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 t -175.98 151.41 1.17 Allowed Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 127.12 2.168 . . . . 0.69 109.117 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -81.0 -2.82 11.99 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.753 2.302 . . . . 0.88 114.111 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.0 m -114.05 28.72 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.578 1.551 . . . . 1.02 114.545 -177.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.29 138.56 11.3 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.202 1.001 . . . . 1.0 111.76 168.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -65.55 -31.62 72.78 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.848 1.659 . . . . 2.9 113.742 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -146.3 154.59 41.86 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.66 1.584 . . . . 4.69 109.339 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -141.26 140.94 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.238 1.415 . . . . 0.84 110.133 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -139.78 139.54 36.47 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.088 1.755 . . . . 2.84 109.447 -166.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.6 tp -89.89 128.81 36.27 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.869 1.213 . . . . 1.44 110.656 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -118.58 160.85 21.03 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.262 1.825 . . . . 0.93 113.854 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -122.45 152.92 39.77 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.55 2.34 . . . . 2.27 109.991 167.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 m -129.84 135.47 48.44 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.524 1.53 . . . . 0.92 107.7 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -150.5 171.24 17.38 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 122.542 1.163 . . . . 2.06 113.673 -167.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.2 ttp -101.87 143.8 31.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.942 1.697 . . . . 3.88 110.652 171.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.6 ptt180 -155.7 152.86 29.1 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.121 1.768 . . . . 8.21 112.596 -177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.02 139.13 37.09 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 124.274 1.03 . . . . 2.64 111.508 170.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 88.9 t -141.09 129.04 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 N-CA-C 106.521 -1.659 . . . . 3.13 106.521 164.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 62.59 29.99 17.0 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.195 0.998 . . . . 4.53 112.392 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.37 16.56 78.79 Favored Glycine 0 N--CA 1.472 1.087 0 O-C-N 121.031 -1.043 . . . . 2.14 114.167 -176.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -133.48 133.6 42.45 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.405 1.482 . . . . 3.06 110.758 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.32 122.86 22.7 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.078 1.351 . . . . 5.05 110.493 -177.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 m -135.0 -175.78 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 129.492 3.117 . . . . 3.0 108.951 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mpp? -111.99 169.24 8.98 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 122.085 0.945 . . . . 2.79 113.401 179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.24 171.93 33.45 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.636 2.065 . . . . 0.75 112.446 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.9 ttm -150.24 142.89 24.58 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.896 1.678 . . . . 1.76 109.364 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 75.2 mtm180 -144.01 155.58 58.76 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 125.483 1.513 . . . . 4.46 110.174 -175.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -75.36 161.18 38.11 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 122.319 2.013 . . . . 0.74 111.061 169.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -149.31 156.65 39.76 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 125.8 1.64 . . . . 1.16 110.536 -178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.03 -25.68 1.71 Allowed 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.366 2.711 . . . . 0.66 113.813 -165.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -176.74 171.58 2.22 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.614 1.966 . . . . 2.43 110.962 -178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.4 mt -116.07 153.04 32.42 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.346 1.858 . . . . 0.67 109.942 163.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -115.1 145.02 42.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.803 1.241 . . . . 1.87 108.029 173.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.9 133.96 12.66 Favored Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 118.664 0.665 . . . . 1.13 112.759 171.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.41 170.83 12.74 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 123.56 2.84 . . . . 1.06 112.704 175.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -65.36 147.32 87.31 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.105 2.537 . . . . 1.04 113.297 171.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.306 22.0 mtmt 54.75 44.95 27.69 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.636 1.574 . . . . 3.0 113.548 171.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -137.02 175.54 21.05 Favored Glycine 0 CA--C 1.534 1.278 0 C-N-CA 127.827 2.632 . . . . 1.11 113.761 175.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -79.44 154.07 29.2 Favored 'General case' 0 N--CA 1.47 0.573 0 O-C-N 121.884 -0.774 . . . . 4.94 112.406 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.47 66.98 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 127.259 2.224 . . . . 5.76 107.253 178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HB3' HG23 ' A' ' 21' ' ' THR . 2.1 pp20? -127.1 137.89 53.09 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.652 0.982 . . . . 2.76 113.652 -172.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.45 71.88 0.89 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 127.29 2.236 . . . . 2.12 109.922 -170.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.14 140.02 17.46 Favored Pre-proline 0 CA--C 1.555 1.156 0 C-N-CA 125.754 1.622 . . . . 3.05 113.674 177.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.01 -17.9 51.51 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 123.91 3.073 . . . . 1.99 114.826 -175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.14 10.14 61.68 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 118.086 -1.396 . . . . 1.86 114.435 175.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -162.57 -111.2 0.26 Allowed Glycine 0 N--CA 1.473 1.13 0 CA-C-N 119.251 1.525 . . . . 1.43 114.369 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -74.18 136.1 42.82 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.889 -0.771 . . . . 1.88 112.318 -174.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.6 p-80 -160.79 164.96 31.09 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 124.793 1.237 . . . . 0.86 111.796 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -92.84 140.7 29.23 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 118.544 0.611 . . . . 2.14 111.141 166.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -93.98 135.96 34.77 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.902 1.681 . . . . 0.86 109.478 163.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -114.54 135.71 53.83 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.863 1.665 . . . . 1.23 108.755 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.91 138.28 48.32 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.78 0.832 . . . . 2.1 111.348 -177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.19 51.19 6.96 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.036 0.827 . . . . 1.61 112.788 175.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.0 mt -53.33 153.6 3.82 Favored 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 115.66 1.726 . . . . 0.82 115.66 -177.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.5 mmtt -102.89 -16.13 15.98 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.939 1.459 . . . . 1.57 114.939 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.2 mmt-85 -137.42 145.78 50.92 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 128.23 2.612 . . . . 6.6 110.03 166.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -65.25 124.97 13.73 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 N-CA-C 106.649 -2.096 . . . . 1.41 106.649 148.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.36 101.99 11.31 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 122.088 0.947 . . . . 2.4 108.801 -174.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.57 13.69 6.61 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 117.248 2.314 . . . . 4.83 117.248 -152.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 74.92 151.0 0.12 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 129.493 3.117 . . . . 1.69 112.498 -171.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 61.84 39.82 98.01 Favored Glycine 0 CA--C 1.531 1.065 0 N-CA-C 110.628 -0.989 . . . . 1.53 110.628 -165.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -108.58 171.27 7.52 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.96 1.704 . . . . 2.48 107.539 168.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -142.18 129.71 21.37 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.705 2.002 . . . . 3.78 106.922 174.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.0 t -153.28 141.13 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.166 1.787 . . . . 1.65 109.326 -162.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.41 ' OE1' ' HE2' ' A' ' 112' ' ' LYS . 9.6 pt-20 -86.42 147.47 26.0 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.657 1.354 . . . . 2.89 114.657 -178.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.9 mp -121.29 146.48 46.79 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.832 1.653 . . . . 1.65 110.5 164.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -95.58 134.67 38.18 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 128.04 2.536 . . . . 2.31 108.245 161.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.5 mp -100.84 130.96 46.93 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.849 1.26 . . . . 0.92 108.072 164.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.4 mt -110.85 108.42 18.22 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.658 1.183 . . . . 0.66 110.082 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -104.32 155.12 19.02 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.851 1.66 . . . . 2.18 111.285 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -59.45 145.03 45.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.556 0.742 . . . . 2.61 112.036 173.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 89.95 20.88 41.24 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-O 118.961 -0.911 . . . . 3.82 114.598 -175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.46 9.22 86.98 Favored Glycine 0 N--CA 1.477 1.369 0 CA-C-N 118.521 1.16 . . . . 2.05 113.901 178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -79.32 106.83 11.63 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.357 -1.084 . . . . 3.09 111.229 -174.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.5 p -115.89 115.84 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 125.199 1.4 . . . . 2.08 110.848 177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.9 mp -120.83 117.45 27.44 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.799 1.239 . . . . 3.14 109.562 -176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.41 ' HE2' ' OE1' ' A' ' 100' ' ' GLU . 2.4 ttpm? -105.87 134.63 48.7 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 122.807 0.443 . . . . 2.61 112.143 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.402 HG21 HD21 ' A' ' 22' ' ' LEU . 8.4 t -144.47 159.92 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.58 1.552 . . . . 2.81 109.221 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -107.01 134.4 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.659 1.584 . . . . 2.61 110.31 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.82 148.37 57.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.034 1.734 . . . . 3.12 110.12 -169.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.05 170.33 19.22 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.516 2.811 . . . . 1.07 113.374 173.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 91.1 t -118.68 121.19 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 127.291 2.236 . . . . 0.99 109.589 169.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -158.85 150.78 21.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 122.788 1.28 . . . . 4.1 114.1 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -84.53 53.65 2.74 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 114.58 1.326 . . . . 2.93 114.58 -162.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? . . . . . 0 C--O 1.25 1.125 0 CA-C-O 116.871 -1.537 . . . . 7.82 111.653 173.42 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.91 0 N-CA-C 107.868 -2.093 . . . . 11.83 107.868 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.9 150.12 18.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.467 0.634 . . . . 9.25 109.707 -148.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -68.57 130.17 42.07 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.375 -0.828 . . . . 9.47 109.079 174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.8 p 48.77 47.59 20.95 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 124.902 1.281 . . . . 9.13 111.742 -171.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -77.86 164.81 24.84 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.061 0.944 . . . . 7.06 110.325 169.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.47 -175.03 44.72 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.429 1.014 . . . . 1.51 111.633 171.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.2 p90 -142.59 -173.7 3.94 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.819 -0.812 . . . . 2.58 112.988 -176.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 78.4 t -122.61 129.23 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.029 -1.044 . . . . 1.93 110.426 -169.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -48.88 -27.42 3.05 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.367 1.867 . . . . 6.67 115.227 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 89.2 t80 69.42 116.67 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 128.452 2.701 . . . . 3.09 111.437 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 53.1 m -170.12 150.48 3.62 Favored Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 125.13 1.372 . . . . 2.38 110.231 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.17 -29.93 1.41 Allowed 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.284 2.656 . . . . 1.35 113.029 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.1 173.56 20.52 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.557 2.503 . . . . 1.01 110.538 -170.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -81.02 4.74 41.43 Favored 'Cis proline' 0 CA--C 1.541 0.827 0 CA-C-N 120.193 1.996 . . . . 1.6 113.18 -3.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -148.26 164.86 32.71 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.159 0.98 . . . . 2.54 112.839 168.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.65 -178.14 4.93 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.049 2.139 . . . . 0.41 109.771 165.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.49 154.82 49.82 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.949 2.1 . . . . 0.74 107.183 168.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.82 142.67 49.09 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.073 0.949 . . . . 0.78 110.434 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -124.03 19.98 9.14 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 114.608 1.336 . . . . 2.29 114.608 -160.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.402 ' HB3' HD22 ' A' ' 115' ' ' LEU . 2.4 pt? -51.48 161.46 0.47 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 115.753 1.76 . . . . 2.72 115.753 -171.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -82.18 144.77 30.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.406 -0.815 . . . . 1.73 111.845 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.47 118.04 22.39 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.642 1.177 . . . . 3.85 110.031 168.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -113.85 132.7 55.8 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.414 -1.328 . . . . 4.29 107.414 167.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -92.04 110.85 46.87 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 123.933 0.893 . . . . 1.3 109.321 172.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -85.07 -9.58 8.5 Favored 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 123.296 2.664 . . . . 1.31 115.04 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -92.48 166.06 29.06 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 119.503 1.047 . . . . 1.32 112.067 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -83.84 4.87 27.33 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 127.511 2.324 . . . . 3.56 112.14 176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -118.61 154.5 52.53 Favored Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 128.159 2.584 . . . . 2.91 110.425 176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.56 145.24 20.57 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.925 2.417 . . . . 0.89 110.566 -177.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 44.0 mt -105.04 148.55 26.65 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 122.319 1.057 . . . . 1.91 111.649 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.6 ttm180 -130.22 112.08 13.02 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 112.283 -2.235 . . . . 1.85 111.265 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.483 HD11 ' CZ ' ' A' ' 84' ' ' PHE . 2.4 tm? -100.16 111.12 23.4 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 127.242 2.217 . . . . 2.25 109.265 -172.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.1 m -104.11 -25.62 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 124.415 1.086 . . . . 0.51 111.697 -168.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.92 -175.89 32.43 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 125.022 1.296 . . . . 0.36 113.432 -177.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -140.94 -179.9 6.34 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.631 1.572 . . . . 0.45 110.045 169.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -156.72 157.29 34.86 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.266 2.227 . . . . 4.48 108.024 174.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -164.8 150.08 8.53 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 124.984 1.313 . . . . 0.81 109.858 175.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -65.56 -12.14 33.7 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.96 2.44 . . . . 0.94 115.061 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.7 m -109.64 16.56 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 116.732 2.123 . . . . 0.88 116.732 -175.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.39 162.08 34.02 Favored 'General case' 0 N--CA 1.475 0.803 0 O-C-N 120.826 -1.171 . . . . 0.9 114.144 172.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -100.07 -63.03 1.16 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.228 1.411 . . . . 2.66 109.505 176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -107.43 98.5 8.11 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 120.924 -1.11 . . . . 6.37 110.382 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -79.01 141.62 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 115.223 -0.899 . . . . 1.54 110.189 164.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -153.26 138.37 17.34 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.5 1.52 . . . . 2.78 109.4 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.0 tp -96.65 122.31 39.44 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.731 0.777 . . . . 1.01 112.023 -176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 50.7 m170 -121.97 161.56 22.69 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.911 1.685 . . . . 0.99 113.779 -175.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.13 -178.42 3.66 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.934 2.094 . . . . 3.1 111.642 158.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.6 m -154.14 145.82 23.31 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.984 1.713 . . . . 0.98 107.111 169.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -157.17 179.8 8.93 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 122.629 1.204 . . . . 2.45 112.999 -170.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 21.7 mtm -121.37 142.14 50.28 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 125.591 1.556 . . . . 5.28 110.006 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.3 ptp180 -149.54 162.76 39.52 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.986 0.914 . . . . 5.3 112.896 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.18 145.5 30.97 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 123.633 0.773 . . . . 3.07 110.51 162.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.25 1.77 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 N-CA-C 114.576 1.325 . . . . 3.35 114.576 164.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -177.62 22.22 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 126.689 1.996 . . . . 4.62 112.381 -168.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.41 -10.44 4.89 Favored Glycine 0 CA--C 1.543 1.798 0 O-C-N 119.148 -2.22 . . . . 2.13 113.242 -160.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -95.13 130.49 41.82 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 129.346 3.059 . . . . 3.39 108.213 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 29.6 mmtt -77.1 117.37 18.59 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 128.04 2.536 . . . . 2.69 109.149 -173.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.4 t -139.39 135.65 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.823 1.649 . . . . 2.22 109.132 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.83 159.42 20.41 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 122.442 1.115 . . . . 3.28 113.618 -175.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -136.02 164.98 24.99 Favored Glycine 0 C--O 1.226 -0.401 0 C-N-CA 125.103 1.335 . . . . 0.81 112.451 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -149.38 132.96 16.74 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.271 1.428 . . . . 1.5 109.891 174.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -141.89 149.9 54.56 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.485 1.914 . . . . 9.18 109.773 -170.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.43 153.66 39.94 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.228 1.952 . . . . 0.74 110.012 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -137.18 148.95 64.48 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 124.157 0.983 . . . . 0.75 110.37 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -75.71 -23.08 13.0 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 123.525 2.816 . . . . 0.62 112.725 -170.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -173.93 172.51 3.42 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.296 1.838 . . . . 1.71 111.278 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.6 mt -117.06 154.09 31.59 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.128 2.171 . . . . 0.6 109.863 161.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -110.03 144.01 39.21 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.387 -0.968 . . . . 1.55 108.387 172.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 39.6 t -134.07 126.02 18.38 Favored Pre-proline 0 CA--C 1.538 0.498 0 CA-C-O 118.999 -0.524 . . . . 0.86 111.285 163.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -68.2 164.22 33.09 Favored 'Trans proline' 0 CA--C 1.538 0.705 0 C-N-CA 123.788 2.992 . . . . 1.02 111.239 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -62.24 135.95 57.26 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.915 2.41 . . . . 0.99 112.414 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.285 17.5 mtmt 59.27 40.18 21.66 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 123.018 1.39 . . . . 2.33 113.193 171.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.37 164.72 26.9 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 127.926 2.679 . . . . 1.13 113.699 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 9.0 ttp85 -113.82 146.52 39.83 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 126.18 1.792 . . . . 3.59 111.732 -177.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.4 t -139.82 116.45 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.5 1.12 . . . . 3.42 108.481 152.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -79.92 148.31 31.31 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.961 0.905 . . . . 3.04 110.685 170.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mp -85.69 52.09 2.37 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 124.167 0.987 . . . . 2.52 112.707 177.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.94 146.21 8.2 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 115.424 1.638 . . . . 2.89 115.424 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.24 -32.92 95.01 Favored 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 124.072 3.181 . . . . 3.0 114.076 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -76.32 31.24 1.38 Allowed Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.475 1.036 . . . . 2.03 113.433 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.72 -122.65 0.94 Allowed Glycine 0 C--N 1.337 0.63 0 C-N-CA 125.681 1.61 . . . . 1.6 113.382 175.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -73.31 134.93 44.32 Favored 'General case' 0 C--O 1.217 -0.606 0 O-C-N 121.934 -0.745 . . . . 2.17 112.761 -170.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -160.15 164.45 32.92 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.838 1.051 . . . . 1.01 113.838 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 73.8 m-85 -92.67 131.7 37.54 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 109.887 -0.412 . . . . 2.02 109.887 165.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 tpt -85.26 138.37 32.37 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.222 2.209 . . . . 0.82 108.648 164.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.9 mt -132.24 91.39 2.94 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 125.44 1.496 . . . . 2.83 109.221 -174.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.0 mp -88.98 157.5 18.36 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.522 1.129 . . . . 2.59 111.869 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.99 -52.67 4.77 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.322 1.915 . . . . 3.05 112.577 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 45.5 mt 55.86 169.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 128.281 2.632 . . . . 1.09 113.707 -169.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -118.73 -25.88 6.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.937 -1.483 . . . . 1.62 112.717 173.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.6 ptt85 -143.23 157.79 59.44 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 126.611 1.964 . . . . 6.28 111.678 174.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -73.33 151.2 48.12 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 123.0 2.466 . . . . 1.5 110.467 158.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.93 148.0 22.56 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.83 1.252 . . . . 2.13 111.524 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -95.73 -166.9 1.51 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.332 1.063 . . . . 4.75 111.122 164.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.49 152.05 24.17 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.737 1.215 . . . . 1.77 108.579 157.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.58 29.81 59.12 Favored Glycine 0 CA--C 1.531 1.087 0 CA-C-O 119.583 -0.565 . . . . 2.15 114.287 176.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -109.63 -179.99 3.97 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 125.227 1.411 . . . . 2.53 109.431 168.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -129.98 146.15 51.66 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 104.735 -2.32 . . . . 5.15 104.735 164.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.3 t -138.76 139.49 40.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.861 1.665 . . . . 1.38 109.628 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -92.1 144.96 24.91 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 122.831 1.3 . . . . 2.34 112.787 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -135.98 140.71 44.14 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 127.71 2.404 . . . . 2.93 109.207 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -88.74 140.58 29.3 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.218 1.807 . . . . 2.2 109.064 164.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.5 mt -110.07 130.47 55.53 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.289 1.436 . . . . 2.18 108.813 166.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.0 mt -110.06 125.15 52.64 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.097 1.359 . . . . 0.63 111.184 -174.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.06 153.28 37.62 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.457 1.503 . . . . 2.03 112.549 -168.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.56 127.37 29.45 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.944 1.091 . . . . 1.95 113.944 -174.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 75.19 59.39 3.63 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 124.734 1.159 . . . . 3.68 113.46 174.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.71 28.65 66.8 Favored Glycine 0 N--CA 1.474 1.17 0 CA-C-N 117.802 0.801 . . . . 1.72 115.074 169.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -113.7 145.01 41.99 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 118.937 1.369 . . . . 4.3 112.242 -177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.5 p -145.1 150.63 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.212 1.405 . . . . 2.16 111.969 -178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.4 tp -149.28 114.36 5.45 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.235 1.414 . . . . 2.32 109.885 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -92.6 134.72 34.72 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.345 -0.847 . . . . 1.98 111.472 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 114' ' ' VAL . 40.4 t -133.7 173.94 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.839 2.056 . . . . 2.16 108.322 -176.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.494 ' H ' HG12 ' A' ' 113' ' ' VAL . 11.0 p -149.98 127.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.919 1.288 . . . . 2.53 110.431 -172.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.402 HD22 ' HB3' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -128.17 150.11 73.05 Favored Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 126.127 1.771 . . . . 2.55 112.221 -171.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.36 148.3 43.12 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.772 2.981 . . . . 1.5 111.631 177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.1 t -94.5 81.68 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.083 -1.08 . . . . 1.52 108.083 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -126.34 151.67 47.28 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.834 1.654 . . . . 4.34 109.93 166.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.75 81.48 1.53 Allowed 'General case' 0 C--O 1.243 0.759 0 N-CA-C 113.777 1.029 . . . . 2.64 113.777 -145.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.601 ' HA ' ' CZ ' ' A' ' 120' ' ' ARG 0.304 1.5 mmp_? . . . . . 0 C--O 1.252 1.211 0 CA-C-O 114.662 -2.59 . . . . 7.5 117.61 172.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.713 0 CA-C-O 118.047 -1.418 . . . . 12.11 110.519 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 m -147.8 -16.0 0.37 Allowed 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 117.045 2.239 . . . . 10.58 117.045 -161.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -175.0 37.5 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 128.602 2.761 . . . . 11.02 109.116 -176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.4 p -170.7 38.87 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.07 1.748 . . . . 4.71 109.363 -135.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -77.49 87.18 3.83 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 123.464 1.602 . . . . 4.76 111.541 -167.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.78 -179.93 20.69 Favored Glycine 0 CA--C 1.525 0.678 0 C-N-CA 125.67 1.605 . . . . 1.27 110.195 168.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 8.3 p90 -142.13 160.36 40.39 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.339 1.055 . . . . 3.11 112.035 -175.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.28 136.39 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.514 -1.291 . . . . 1.22 107.514 164.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -51.82 -55.03 22.33 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 115.848 1.796 . . . . 4.27 115.848 -155.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.4 t80 107.54 123.34 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 130.52 3.528 . . . . 2.56 108.451 -154.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.4 m 175.52 131.33 0.15 Allowed Pre-proline 0 N--CA 1.48 1.058 0 C-N-CA 127.711 2.404 . . . . 2.58 109.255 -176.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.71 -32.82 1.9 Allowed 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.655 2.236 . . . . 1.29 112.577 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 149.13 176.14 22.15 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 125.77 1.652 . . . . 0.89 111.678 -175.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.05 -10.24 21.39 Favored 'Cis proline' 0 CA--C 1.537 0.647 0 CA-C-N 119.021 1.41 . . . . 0.99 112.572 -3.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -143.52 162.87 34.72 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.497 1.519 . . . . 2.39 112.315 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -128.14 -177.67 4.23 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.255 1.822 . . . . 0.62 111.623 -176.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -120.7 167.03 12.89 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.486 1.114 . . . . 0.92 110.453 161.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.01 146.46 33.88 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.756 1.223 . . . . 0.72 111.477 168.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -127.84 81.37 2.02 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.601 2.361 . . . . 3.39 109.247 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.51 159.54 14.88 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 114.61 1.337 . . . . 1.71 114.61 -170.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.3 m -131.02 150.84 51.96 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.366 1.867 . . . . 1.79 109.311 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.602 HD21 HG21 ' A' ' 113' ' ' VAL . 0.3 OUTLIER -150.68 175.54 11.86 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.314 3.045 . . . . 5.09 107.882 172.281 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -115.03 147.28 40.33 Favored 'General case' 0 N--CA 1.462 0.173 0 C-N-CA 123.107 0.563 . . . . 4.68 110.538 164.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 42.3 t30 -100.64 90.81 1.58 Allowed Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 123.641 0.776 . . . . 1.36 109.868 163.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.5 -5.07 16.39 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.756 2.304 . . . . 1.85 113.96 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.25 178.55 53.89 Favored Glycine 0 C--N 1.341 0.857 0 CA-C-O 122.831 1.24 . . . . 1.64 113.793 -174.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -109.76 -1.28 18.04 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.405 2.282 . . . . 3.49 112.132 -170.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -116.7 159.62 39.75 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 127.667 2.387 . . . . 2.91 110.65 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -78.11 139.88 17.38 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.56 2.174 . . . . 1.04 111.004 -176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.44 HD12 ' CD1' ' A' ' 105' ' ' PHE . 1.4 mm? -104.37 159.29 15.84 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 125.829 1.652 . . . . 2.61 110.965 176.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -155.27 111.0 3.09 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.724 -1.58 . . . . 1.73 111.155 -168.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.0 tp -95.97 107.42 19.7 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.81 1.644 . . . . 2.53 109.176 -171.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.1 m -104.59 -21.75 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.834 0.853 . . . . 0.64 112.426 -169.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.38 -176.61 32.66 Favored Glycine 0 C--N 1.342 0.864 0 C-N-CA 124.996 1.284 . . . . 0.48 113.495 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -145.54 -178.74 6.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.55 1.54 . . . . 0.5 111.594 170.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -158.36 155.04 28.01 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.903 1.681 . . . . 3.99 108.177 167.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.8 t -157.59 153.74 23.65 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 125.302 1.441 . . . . 0.77 108.755 177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -79.38 -12.19 14.17 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.127 1.885 . . . . 0.87 113.492 178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.429 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 24.8 m -98.74 23.21 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 N-CA-C 114.197 1.184 . . . . 0.98 114.197 178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -149.37 165.47 31.94 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.357 1.863 . . . . 1.18 107.978 167.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -100.9 -35.76 9.29 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.687 1.195 . . . . 2.82 112.617 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -132.54 177.68 7.43 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.673 1.589 . . . . 6.26 107.71 171.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -155.62 150.67 10.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 125.468 1.507 . . . . 1.08 108.254 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -131.11 156.88 44.49 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.166 2.186 . . . . 2.81 109.11 174.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 tp -110.78 117.25 32.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.759 1.224 . . . . 0.84 110.513 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -121.0 154.89 35.43 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.391 1.476 . . . . 0.75 113.192 -175.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -95.23 154.32 17.24 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.335 -1.302 . . . . 1.95 110.267 155.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.0 m -103.48 146.0 29.17 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 106.642 -1.614 . . . . 0.99 106.642 154.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -134.61 176.79 8.31 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 122.414 1.102 . . . . 2.07 112.855 175.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 38.6 ttp -122.22 140.87 52.08 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.732 1.613 . . . . 3.23 109.823 170.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.74 145.89 48.89 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.878 1.271 . . . . 6.25 110.836 173.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -113.38 143.7 44.03 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.757 1.623 . . . . 2.85 108.611 172.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.3 p -158.3 139.64 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 125.832 1.653 . . . . 4.35 108.079 169.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 64.41 18.7 11.48 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.527 1.131 . . . . 5.56 112.558 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.29 21.02 79.49 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.329 -1.482 . . . . 2.03 113.057 -171.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -120.9 119.7 33.37 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.23 1.812 . . . . 4.01 108.33 -179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.52 121.62 38.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.255 1.422 . . . . 2.84 111.675 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.1 t -137.05 141.36 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 126.389 1.876 . . . . 2.26 108.266 -174.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -87.62 167.39 13.95 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.077 0.769 . . . . 3.56 113.077 -176.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.92 -177.95 28.73 Favored Glycine 0 CA--C 1.52 0.392 0 C-N-CA 125.356 1.455 . . . . 0.8 112.281 -172.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.3 ttm -158.76 149.68 20.25 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.903 1.281 . . . . 1.43 109.552 -173.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.7 ptt85 -160.89 151.96 15.66 Favored Pre-proline 0 N--CA 1.473 0.687 0 C-N-CA 123.921 0.888 . . . . 4.68 111.707 174.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.48 150.98 52.68 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.156 1.904 . . . . 0.65 111.204 177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.58 150.8 73.12 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 125.246 1.418 . . . . 0.59 109.827 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.85 -22.47 7.54 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.367 2.711 . . . . 0.58 113.201 -166.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -177.99 166.59 2.03 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.977 2.111 . . . . 2.15 110.617 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.0 mt -109.44 154.45 22.6 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.478 1.111 . . . . 0.7 110.077 161.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -113.65 144.69 42.5 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.346 1.458 . . . . 2.06 109.289 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.0 130.58 10.23 Favored Pre-proline 0 N--CA 1.473 0.693 0 N-CA-C 112.541 0.571 . . . . 1.12 112.541 169.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -67.86 168.46 18.62 Favored 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 123.286 2.658 . . . . 1.03 112.65 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.12 141.53 98.23 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.347 2.698 . . . . 1.26 111.598 169.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.4 mmtt 65.61 8.13 4.93 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 125.516 1.526 . . . . 1.95 113.053 -175.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.58 150.66 24.6 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 126.714 2.102 . . . . 1.47 114.367 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -78.96 115.81 18.87 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 126.629 1.971 . . . . 3.71 111.141 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.9 t -95.47 55.07 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 122.484 1.135 . . . . 5.45 108.946 -174.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.6 123.78 46.17 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 125.928 1.691 . . . . 2.99 108.794 177.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.4 mp -58.28 -56.19 25.31 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.469 1.107 . . . . 4.31 112.439 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.595 ' HE3' ' HA ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER 139.59 140.94 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.432 0 C-N-CA 131.618 3.967 . . . . 3.16 111.176 178.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -67.21 131.94 26.42 Favored 'Trans proline' 0 N--CA 1.452 -0.946 0 N-CA-C 107.782 -1.661 . . . . 3.8 107.782 159.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.89 -38.03 1.94 Allowed Glycine 0 CA--C 1.532 1.115 0 CA-C-O 118.393 -1.226 . . . . 3.34 114.794 178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -81.8 -110.63 0.39 Allowed Glycine 0 N--CA 1.475 1.28 0 CA-C-N 119.165 1.483 . . . . 1.82 113.692 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -71.76 141.3 49.74 Favored 'General case' 0 C--O 1.223 -0.319 0 O-C-N 121.617 -0.931 . . . . 1.97 111.007 -169.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.1 p-80 -158.3 143.19 16.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.716 -0.675 . . . . 0.76 110.997 -173.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -78.89 133.69 36.95 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.063 -0.717 . . . . 1.87 109.063 167.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.2 tpt -92.74 119.44 32.12 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.697 1.599 . . . . 1.06 108.086 168.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -103.88 105.69 15.97 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.475 1.51 . . . . 1.15 110.161 -168.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.01 132.99 40.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.823 0.849 . . . . 2.45 111.696 -166.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.08 47.47 7.56 Favored Glycine 0 N--CA 1.472 1.079 0 C-N-CA 123.954 0.788 . . . . 1.71 113.73 169.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 18.7 mt -49.02 154.89 0.69 Allowed 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 116.345 1.98 . . . . 0.96 116.345 -174.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.429 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 50.8 mmtt -119.22 -30.54 4.92 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 113.302 -1.772 . . . . 2.27 113.29 -176.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.455 HH21 ' CD ' ' A' ' 97' ' ' GLU . 9.9 mmm180 -106.74 144.89 29.96 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 126.444 1.897 . . . . 5.27 108.173 160.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -71.92 128.06 13.65 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 N-CA-C 107.225 -1.875 . . . . 1.88 107.225 153.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.29 115.72 22.62 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 108.741 -0.837 . . . . 2.26 108.741 -174.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.25 162.21 32.79 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.04 1.336 . . . . 4.7 113.874 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 132.59 54.47 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.504 1.522 . . . . 1.4 110.934 -172.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.23 44.86 16.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-N 115.023 -0.99 . . . . 1.36 112.85 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.455 ' CD ' HH21 ' A' ' 91' ' ' ARG . 0.9 OUTLIER -103.67 167.06 10.03 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 117.787 0.793 . . . . 2.4 109.044 148.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.43 128.34 46.85 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 102.625 -3.102 . . . . 4.9 102.625 154.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.7 t -137.28 137.67 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.829 1.251 . . . . 1.55 109.999 -169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -84.54 155.97 21.87 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 115.061 1.504 . . . . 2.41 115.061 -174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.8 tt -155.31 140.3 17.34 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.127 2.171 . . . . 3.1 110.902 177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -84.38 127.87 34.25 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 126.899 2.08 . . . . 2.07 109.29 165.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.2 mp -87.16 127.0 35.15 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.563 -0.903 . . . . 1.22 108.563 161.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 66.5 mt -103.55 105.75 16.08 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 122.497 1.142 . . . . 0.74 109.869 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.44 ' CD1' HD12 ' A' ' 30' ' ' LEU . 98.0 m-85 -96.16 152.76 18.26 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.146 1.379 . . . . 2.28 111.354 174.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -51.45 127.51 20.18 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.55 1.14 . . . . 2.13 113.643 -173.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 71.22 66.1 2.25 Favored Glycine 0 CA--C 1.527 0.808 0 C-N-CA 124.573 1.082 . . . . 3.37 112.793 174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.5 11.81 80.18 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 115.792 1.077 . . . . 1.83 115.792 167.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -96.15 104.14 16.08 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.779 1.79 . . . . 3.56 110.983 -178.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.0 p -105.82 143.23 17.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 123.863 0.865 . . . . 2.38 110.685 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 tt -145.07 108.02 4.51 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.209 1.004 . . . . 2.46 108.776 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.7 ttpt -93.65 131.91 38.49 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 112.046 0.387 . . . . 2.16 112.046 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.602 HG21 HD21 ' A' ' 22' ' ' LEU . 54.2 t -138.85 163.2 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.602 1.561 . . . . 2.39 110.204 -177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.2 t -114.32 126.84 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.849 2.06 . . . . 2.07 109.808 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.27 145.3 38.16 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 126.548 1.939 . . . . 3.12 109.737 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.05 162.7 41.03 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 124.183 3.256 . . . . 1.16 113.008 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.7 t -113.24 110.75 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 114.576 -1.193 . . . . 1.23 110.994 165.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -102.06 -175.64 2.9 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.19 2.196 . . . . 3.68 109.324 156.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -113.12 94.38 4.86 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.476 -0.765 . . . . 2.33 110.733 165.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.188 0 C-N-CA 126.411 1.885 . . . . 6.36 110.313 -176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.306 0 N-CA-C 108.883 -1.687 . . . . 9.74 108.883 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 m -142.26 161.04 39.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.661 1.184 . . . . 8.3 109.316 -172.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -88.33 7.62 31.45 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.632 1.573 . . . . 11.47 112.549 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.1 t -165.48 148.06 7.75 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.261 1.424 . . . . 4.94 110.317 -163.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.425 ' CG ' HG21 ' A' ' 21' ' ' THR . 10.3 pt-20 -159.75 59.06 0.38 Allowed 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 127.419 2.288 . . . . 6.0 108.287 -155.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.83 167.58 29.92 Favored Glycine 0 N--CA 1.473 1.115 0 O-C-N 120.858 -1.151 . . . . 1.05 114.334 -167.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -152.76 169.27 23.18 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 114.852 1.427 . . . . 2.18 114.852 -172.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 81.2 t -106.67 144.8 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.177 1.791 . . . . 1.23 107.13 168.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . 0.26 0.6 OUTLIER -73.18 -100.11 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.388 0.884 . . . . 3.91 113.388 175.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 73.1 t80 -161.21 143.46 12.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.242 1.817 . . . . 2.49 109.5 -167.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.8 t 171.81 136.17 0.09 OUTLIER Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 126.93 2.092 . . . . 2.31 111.676 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -77.08 -27.47 6.78 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 122.745 2.297 . . . . 1.6 111.901 166.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.39 171.91 17.01 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 126.696 2.093 . . . . 1.05 111.195 -175.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -78.46 -9.0 35.88 Favored 'Cis proline' 0 CA--C 1.537 0.631 0 CA-C-N 118.508 1.154 . . . . 1.01 113.045 -0.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 44.7 p-10 -151.36 167.89 26.5 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.734 1.214 . . . . 1.89 113.374 -168.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.87 -177.51 6.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.485 2.314 . . . . 0.54 111.72 -173.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.96 139.42 39.72 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.402 1.481 . . . . 0.97 108.576 169.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -114.14 141.78 47.06 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.656 1.582 . . . . 0.6 110.544 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.522 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 51.3 m-85 -121.42 70.78 0.94 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.724 2.01 . . . . 2.05 110.835 -171.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -90.85 164.47 14.04 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.089 0.955 . . . . 1.98 113.21 -170.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.425 HG21 ' CG ' ' A' ' 5' ' ' GLU . 0.5 OUTLIER -95.88 124.61 39.97 Favored 'General case' 0 N--CA 1.471 0.624 0 O-C-N 121.457 -0.777 . . . . 1.89 110.299 175.046 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.2 tp -96.23 104.08 16.02 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 108.198 -1.038 . . . . 5.17 108.198 167.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -82.46 171.24 14.36 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.663 0.744 . . . . 5.87 111.929 165.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -134.58 101.12 12.07 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 123.566 0.747 . . . . 1.34 109.417 155.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.78 -11.86 11.24 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.158 2.572 . . . . 1.55 112.992 179.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.23 178.92 49.45 Favored Glycine 0 C--N 1.34 0.766 0 CA-C-O 122.749 1.194 . . . . 1.19 112.55 -177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -104.29 -1.73 26.6 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.076 2.15 . . . . 3.13 112.3 -173.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.9 mt -124.8 162.98 39.99 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 127.782 2.433 . . . . 3.63 109.323 172.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -78.59 158.44 28.63 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.354 2.036 . . . . 1.08 111.503 -170.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.9 mp -118.28 154.69 31.87 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 126.161 1.784 . . . . 2.19 110.019 174.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.3 ttm180 -138.51 110.29 7.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 113.494 -1.685 . . . . 2.04 109.511 173.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.7 118.41 30.63 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 125.727 1.611 . . . . 1.9 107.727 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.6 m -113.53 -22.43 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.181 0.993 . . . . 0.49 112.691 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.32 -176.91 31.91 Favored Glycine 0 C--N 1.344 0.998 0 C-N-CA 124.359 0.98 . . . . 0.43 113.31 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.5 178.12 6.7 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.718 -0.872 . . . . 0.44 112.17 170.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 32.6 ttp180 -150.2 148.87 29.44 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 127.635 2.374 . . . . 7.53 107.957 173.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.8 t -164.82 148.81 7.73 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 117.934 -1.031 . . . . 0.62 110.158 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.78 -12.11 21.97 Favored 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.174 1.916 . . . . 0.73 114.78 177.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.6 m -114.63 20.82 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 115.125 1.528 . . . . 0.88 115.125 -170.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.36 150.25 25.03 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.486 1.514 . . . . 0.99 109.075 169.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -91.85 -47.67 7.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.532 1.133 . . . . 3.35 112.832 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -122.33 98.7 6.05 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 107.453 -1.314 . . . . 6.26 107.453 -171.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 p -98.26 125.89 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-N 115.697 -0.683 . . . . 0.82 109.802 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.5 mt-10 -116.82 150.46 38.32 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 126.71 2.004 . . . . 2.7 109.069 -178.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.4 tp -105.12 118.64 37.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.043 0.937 . . . . 0.88 110.356 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.1 m170 -124.64 155.29 39.41 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.046 1.338 . . . . 0.51 114.123 -174.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -100.43 162.54 12.87 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.867 1.667 . . . . 2.21 112.484 158.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 14.0 m -132.33 144.41 50.54 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 126.876 2.07 . . . . 0.74 105.661 167.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -152.76 170.14 21.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.908 0.883 . . . . 2.02 112.491 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.9 ttp -98.83 140.1 33.52 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.92 1.288 . . . . 3.45 110.812 173.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.3 148.18 32.15 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 126.018 1.727 . . . . 5.28 111.314 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.92 144.49 26.15 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.298 1.039 . . . . 2.42 108.572 166.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -141.83 138.05 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 107.806 -1.183 . . . . 2.79 107.806 155.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 59.11 22.85 11.02 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 114.847 1.425 . . . . 4.32 114.847 175.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.31 17.83 79.75 Favored Glycine 0 CA--C 1.537 1.42 0 O-C-N 120.717 -1.24 . . . . 1.67 113.956 -170.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -109.45 122.57 47.69 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 126.626 1.971 . . . . 2.25 107.558 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -79.81 117.99 21.19 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.767 1.227 . . . . 3.07 108.642 172.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.0 m -141.68 -175.76 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 C-N-CA 127.709 2.404 . . . . 2.5 109.858 -171.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.76 175.74 5.39 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.807 0.843 . . . . 3.0 112.974 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.9 170.2 33.12 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 126.62 2.057 . . . . 0.8 111.94 173.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.6 ttm -149.31 137.96 21.02 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 125.441 1.496 . . . . 1.13 109.817 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -143.73 151.63 53.91 Favored Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 125.618 1.567 . . . . 8.85 110.605 -176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -73.99 151.9 45.49 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.132 1.888 . . . . 0.58 109.98 170.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.9 m -137.5 153.51 74.46 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.013 1.325 . . . . 0.56 109.994 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.59 -28.12 2.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.719 2.279 . . . . 0.45 112.805 -165.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -177.2 165.75 2.31 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.047 1.339 . . . . 2.08 112.483 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 36.2 mt -109.91 152.0 26.37 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 125.673 1.589 . . . . 0.79 111.051 162.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -121.89 136.76 54.94 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 125.584 1.553 . . . . 2.16 108.407 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.8 t -143.69 129.4 9.97 Favored Pre-proline 0 N--CA 1.475 0.808 0 N-CA-C 113.665 0.987 . . . . 1.16 113.665 174.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -72.81 161.66 43.18 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.161 3.241 . . . . 1.23 111.693 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -59.63 141.07 96.5 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 123.557 2.838 . . . . 1.1 113.172 -177.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 69.15 0.23 2.74 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.919 2.088 . . . . 2.1 114.572 177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -86.53 175.73 47.63 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.928 1.728 . . . . 1.08 113.223 171.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.08 132.87 11.39 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.21 1.004 . . . . 5.66 112.725 173.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 98.5 t -125.18 108.4 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 127.381 2.272 . . . . 3.55 109.524 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.5 126.92 31.66 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 127.879 2.471 . . . . 3.63 112.21 175.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -74.12 75.46 1.76 Allowed 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.986 1.714 . . . . 2.13 109.811 168.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.446 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -68.07 155.11 92.76 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 114.819 1.415 . . . . 2.41 114.819 -173.354 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.522 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 37.0 Cg_endo -59.34 -15.81 31.46 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.323 3.349 . . . . 2.37 116.628 176.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -97.92 -1.04 58.62 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 118.265 -1.297 . . . . 1.95 115.292 174.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.86 -115.66 0.9 Allowed Glycine 0 N--CA 1.473 1.136 0 CA-C-N 119.908 1.854 . . . . 1.54 113.958 -175.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -70.79 141.55 51.4 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.17 -0.606 . . . . 1.81 110.386 -174.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -161.45 160.25 29.08 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 124.758 1.223 . . . . 0.64 111.582 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -92.7 130.8 38.22 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 109.546 -0.539 . . . . 1.91 109.546 166.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 tpt -84.96 128.8 34.79 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.072 1.349 . . . . 0.76 108.89 166.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -114.74 107.53 15.58 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.36 1.064 . . . . 1.1 108.614 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.5 mp -107.45 148.91 28.54 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.045 0.839 . . . . 2.29 111.036 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.82 43.39 28.26 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 118.993 -0.893 . . . . 1.71 113.353 175.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.4 mt -46.62 150.88 0.63 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.999 1.481 . . . . 0.87 114.999 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -108.01 -21.31 12.86 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 112.986 -1.916 . . . . 2.09 114.248 -172.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.92 145.83 58.75 Favored Pre-proline 0 N--CA 1.447 -0.608 0 C-N-CA 126.699 1.999 . . . . 5.75 110.548 162.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -66.69 154.31 74.91 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.085 1.857 . . . . 1.47 108.777 162.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 pp -147.85 159.76 43.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 122.466 1.127 . . . . 2.72 112.547 -173.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.55 173.9 6.17 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 126.923 2.089 . . . . 4.74 111.301 -165.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.14 135.72 56.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.231 1.012 . . . . 1.45 112.857 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.69 40.37 31.88 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-N 114.828 -1.078 . . . . 1.58 113.428 -177.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -113.89 176.33 5.08 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.497 1.119 . . . . 2.76 108.992 157.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -121.96 164.3 17.84 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.662 1.585 . . . . 2.94 107.161 159.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 52.0 t -148.94 154.77 9.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 130.588 3.555 . . . . 1.65 109.053 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -121.95 138.53 54.38 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.366 1.466 . . . . 2.94 111.252 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.62 137.2 54.39 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.863 1.265 . . . . 1.85 110.962 165.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -87.8 138.51 31.4 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.264 1.826 . . . . 2.43 110.044 155.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.2 mp -94.3 136.61 34.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.509 1.924 . . . . 1.27 109.45 167.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.8 mt -107.16 118.5 36.87 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.7 1.6 . . . . 0.64 109.519 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -109.49 156.25 20.34 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.647 1.179 . . . . 1.99 111.041 -175.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -65.05 141.66 58.67 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 121.465 -0.772 . . . . 2.35 110.748 164.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.54 35.68 11.55 Favored Glycine 0 CA--C 1.532 1.129 0 CA-C-O 119.066 -0.852 . . . . 4.18 114.951 176.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.97 7.47 84.08 Favored Glycine 0 N--CA 1.476 1.317 0 CA-C-N 118.234 1.017 . . . . 1.88 115.553 167.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -89.53 137.28 32.47 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 118.063 0.932 . . . . 3.2 111.261 179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 87.8 t -140.31 131.53 30.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 125.56 1.544 . . . . 1.87 108.079 170.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.27 143.56 27.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.763 1.625 . . . . 3.52 109.189 -174.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -120.3 151.84 38.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.291 1.589 . . . . 2.31 115.291 -172.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.0 m -122.98 153.04 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 128.062 2.545 . . . . 3.03 110.825 -173.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 98.8 t -106.2 138.72 30.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.106 1.762 . . . . 3.02 109.609 -176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.0 mp -141.29 125.4 10.28 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.401 1.08 . . . . 2.67 111.547 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -77.78 167.11 24.4 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.788 2.325 . . . . 1.13 110.776 162.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.9 t -116.25 149.33 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.909 1.284 . . . . 1.06 110.508 174.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -135.56 -172.49 3.1 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.514 1.925 . . . . 4.93 112.817 -176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -127.11 66.97 1.28 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 126.258 1.823 . . . . 3.09 112.156 176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.183 0 C-N-CA 124.318 1.047 . . . . 8.84 113.384 -172.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.053 0 CA-C-O 118.98 -0.9 . . . . 13.34 113.86 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 t -170.67 168.25 7.55 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 119.088 1.444 . . . . 11.11 109.469 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -75.06 78.07 2.24 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 119.404 1.002 . . . . 11.32 109.492 172.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 175.89 -42.26 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.989 1 C-N-CA 131.784 4.034 . . . . 7.19 109.203 -160.634 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.33 134.93 5.75 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 123.482 1.61 . . . . 6.22 112.161 177.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -120.54 157.54 15.78 Favored Glycine 0 C--N 1.329 0.155 0 CA-C-N 114.082 -1.417 . . . . 2.13 110.039 -176.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 31.3 p90 -92.42 162.55 14.2 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-O 122.611 1.196 . . . . 2.71 112.268 -160.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.4 t -80.34 132.32 32.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.49 -1.3 . . . . 1.17 107.49 157.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.14 -21.24 59.01 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 116.116 1.895 . . . . 6.28 116.116 -163.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.4 t80 85.75 144.01 0.06 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 128.972 2.909 . . . . 2.77 111.201 -172.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 t -171.28 150.9 2.93 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 124.672 1.189 . . . . 2.15 112.233 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -81.37 -18.5 8.36 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.344 2.696 . . . . 1.5 112.109 158.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 118.81 -170.17 13.73 Favored Glycine 0 CA--C 1.535 1.342 0 C-N-CA 126.754 2.121 . . . . 1.28 111.631 -170.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -75.64 -3.54 22.15 Favored 'Cis proline' 0 CA--C 1.54 0.817 0 CA-C-N 119.196 1.498 . . . . 1.65 112.477 -9.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.426 HD22 ' H ' ' A' ' 88' ' ' GLY . 2.4 m120 -136.02 176.91 8.25 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.778 1.231 . . . . 4.39 110.843 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.59 -174.54 4.98 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.611 2.365 . . . . 0.61 112.133 -175.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -152.47 149.25 28.35 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.957 2.503 . . . . 0.71 108.452 178.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -135.52 136.5 41.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 119.857 1.208 . . . . 0.66 113.417 -175.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 28.8 m-85 -106.5 41.12 1.49 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.715 1.606 . . . . 2.32 114.09 -170.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.0 pp -65.38 155.89 33.94 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 115.336 1.606 . . . . 1.75 115.336 -167.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.411 HG23 ' HG2' ' A' ' 76' ' ' GLU . 54.8 m -99.71 143.29 30.11 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.438 1.095 . . . . 1.6 112.128 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -116.47 123.62 47.93 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.83 2.452 . . . . 3.29 111.804 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -102.97 141.05 36.43 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 123.589 0.756 . . . . 3.72 109.537 158.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -108.34 84.31 2.26 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 121.756 -0.59 . . . . 1.53 109.928 159.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -72.8 -10.05 24.46 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.424 2.083 . . . . 1.4 113.181 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.73 176.43 47.75 Favored Glycine 0 C--N 1.341 0.844 0 CA-C-O 122.861 1.256 . . . . 1.39 113.1 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -102.02 -8.62 21.32 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.759 2.424 . . . . 3.37 112.179 -170.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 99.0 mt -132.01 152.56 80.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.523 1.929 . . . . 3.96 109.264 174.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.83 167.74 24.76 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.093 2.528 . . . . 1.58 113.698 -152.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.7 mp -115.05 147.98 39.47 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.29 1.836 . . . . 2.37 108.683 168.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -144.23 98.92 3.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 112.855 -1.975 . . . . 2.52 108.737 174.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.3 tp -83.67 102.37 12.18 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 126.878 2.071 . . . . 2.12 109.387 -168.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -94.7 -25.3 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.917 1.287 . . . . 1.21 111.711 -175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.06 -176.85 31.57 Favored Glycine 0 C--N 1.343 0.922 0 C-N-CA 123.792 0.711 . . . . 0.53 114.092 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.24 -177.88 5.68 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.935 1.694 . . . . 0.57 110.382 173.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -156.51 175.25 14.28 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 127.434 2.293 . . . . 5.87 107.948 161.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t -162.7 152.2 13.12 Favored Pre-proline 0 N--CA 1.475 0.806 0 C-N-CA 128.755 2.822 . . . . 1.41 106.796 166.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -67.07 -29.65 39.74 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 120.894 1.355 . . . . 1.91 111.918 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 30.6 m -86.78 14.63 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 N-CA-C 115.299 1.592 . . . . 1.93 115.299 -176.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.09 138.48 25.37 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 120.586 1.539 . . . . 1.16 113.89 168.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -79.54 -26.84 41.35 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 114.837 1.421 . . . . 4.01 114.837 -165.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -146.63 165.7 28.75 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 126.908 2.083 . . . . 5.06 108.341 174.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -151.88 143.89 15.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 C-N-CA 124.972 1.309 . . . . 1.1 109.383 -178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -118.57 158.04 26.18 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 126.654 1.982 . . . . 3.28 109.512 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.0 tp -106.88 117.56 34.39 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.538 0.735 . . . . 0.87 110.307 170.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -119.86 165.08 15.07 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 123.516 1.627 . . . . 0.68 113.897 -178.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -121.57 162.6 20.32 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 113.18 -1.827 . . . . 3.59 111.501 156.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.4 m -118.01 139.56 51.02 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 127.19 2.196 . . . . 0.93 106.158 173.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -136.48 169.31 17.9 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 122.578 1.18 . . . . 1.9 113.736 -174.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 63.2 ttp -111.55 147.27 35.76 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.281 1.833 . . . . 3.36 109.102 170.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.76 153.53 38.3 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.802 1.241 . . . . 5.44 110.505 -174.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -105.23 138.58 41.21 Favored 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 125.351 1.46 . . . . 3.49 110.267 174.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 57.5 t -137.25 113.98 12.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.625 -1.25 . . . . 2.47 107.625 169.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 66.66 14.25 9.69 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 126.238 1.815 . . . . 3.86 114.33 -178.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.5 20.43 58.5 Favored Glycine 0 N--CA 1.477 1.376 0 O-C-N 121.249 -0.907 . . . . 2.65 113.467 -167.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt -119.3 125.95 50.3 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.956 1.703 . . . . 2.47 109.305 172.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -88.08 123.06 32.37 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.764 1.226 . . . . 4.86 111.249 -170.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 52.0 t -141.68 141.06 30.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 126.2 1.8 . . . . 2.31 109.601 -176.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -93.56 168.45 11.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.339 1.056 . . . . 3.17 113.051 -172.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.04 -178.73 31.39 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 124.94 1.257 . . . . 0.68 113.634 -176.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 9.1 ttm -152.66 150.1 29.12 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 125.963 1.705 . . . . 1.15 108.816 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -158.22 154.26 23.56 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-O 118.23 -0.89 . . . . 4.83 111.776 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -70.93 154.98 62.87 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.23 1.954 . . . . 0.52 111.155 169.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -140.66 151.66 63.94 Favored Pre-proline 0 N--CA 1.475 0.798 0 C-N-CA 125.014 1.326 . . . . 0.56 110.241 -176.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -75.63 -27.85 8.68 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.382 2.721 . . . . 0.6 112.573 -167.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -176.16 163.16 2.58 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 126.112 1.765 . . . . 1.7 111.472 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.8 mt -105.31 153.51 21.52 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 124.235 1.014 . . . . 0.57 110.592 160.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -107.18 144.02 34.54 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.405 1.082 . . . . 1.81 110.271 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.4 t -140.48 121.99 9.39 Favored Pre-proline 0 N--CA 1.475 0.811 0 CA-C-N 118.552 0.615 . . . . 1.09 111.714 163.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -71.36 159.6 51.17 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.465 2.777 . . . . 1.17 111.095 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.85 142.99 99.26 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.384 2.723 . . . . 1.46 111.816 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt 67.28 -5.48 0.72 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 127.178 2.191 . . . . 2.33 114.374 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.12 165.31 48.79 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.016 1.293 . . . . 1.32 112.118 172.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 145.53 35.87 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 124.701 1.201 . . . . 4.31 109.298 171.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 84.0 t -148.96 158.86 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 126.562 1.945 . . . . 3.06 107.809 -169.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HG2' HG23 ' A' ' 21' ' ' THR . 10.2 mt-10 -135.03 142.6 46.42 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 120.007 1.276 . . . . 4.46 111.706 -178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.4 mp -74.21 79.05 1.79 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 122.121 0.962 . . . . 2.27 109.117 169.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -62.98 150.55 87.91 Favored Pre-proline 0 CA--C 1.558 1.281 0 N-CA-C 114.319 1.229 . . . . 3.22 114.319 -175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.49 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 38.2 Cg_endo -58.32 -49.68 11.69 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 123.396 2.731 . . . . 2.27 113.055 174.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.53 58.3 4.45 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 123.869 0.747 . . . . 2.12 111.474 171.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.32 -125.44 1.5 Allowed Glycine 0 N--CA 1.469 0.86 0 C-N-CA 124.819 1.2 . . . . 1.74 114.167 -178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -73.04 138.89 46.21 Favored 'General case' 0 C--O 1.219 -0.518 0 O-C-N 122.191 -0.593 . . . . 2.34 112.279 -168.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -162.58 152.01 15.6 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 124.02 0.928 . . . . 0.65 110.971 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -80.56 143.68 33.03 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.724 -0.473 . . . . 1.93 109.724 162.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -96.33 123.99 40.17 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.726 1.61 . . . . 0.82 108.428 166.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.17 120.37 42.32 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.397 0.999 . . . . 1.18 108.906 -174.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -106.47 154.7 20.47 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.335 1.054 . . . . 2.47 110.985 -171.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.426 ' H ' HD22 ' A' ' 15' ' ' ASN . . . 77.12 -51.4 3.21 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 127.269 2.366 . . . . 2.56 114.747 174.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.7 mt 54.57 168.3 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 128.577 2.751 . . . . 1.14 114.568 -171.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -116.82 -23.61 8.02 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.465 1.506 . . . . 2.53 114.015 173.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 12.4 ptt-85 -137.31 149.85 67.01 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 125.569 1.548 . . . . 6.52 111.414 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -68.19 142.65 56.27 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 121.982 1.788 . . . . 1.53 107.89 154.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -84.96 176.95 8.13 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.71 0.804 . . . . 3.0 110.479 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -120.66 176.28 5.6 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 126.194 1.798 . . . . 3.47 108.618 155.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -84.18 126.96 33.62 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 107.399 -1.334 . . . . 1.49 107.399 154.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.69 6.24 54.76 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 118.195 -1.336 . . . . 1.99 116.155 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -77.54 -176.53 4.31 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.392 1.596 . . . . 2.85 110.444 159.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.15 170.44 9.56 Favored 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 130.607 3.563 . . . . 4.81 107.124 165.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.0 t -150.37 141.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 127.089 2.156 . . . . 1.39 108.975 166.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.24 126.29 52.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.158 1.383 . . . . 3.97 110.62 178.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.1 mp -115.33 140.78 48.82 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.15 0.98 . . . . 1.78 111.52 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.93 139.27 31.36 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 128.576 2.75 . . . . 2.91 108.994 167.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -118.83 131.12 56.07 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.548 1.139 . . . . 1.14 109.503 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.4 mt -112.44 116.9 31.03 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 125.48 1.512 . . . . 0.88 110.061 -174.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -116.78 132.82 56.59 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.477 1.111 . . . . 2.13 110.771 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.9 -24.05 66.71 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.976 0.732 . . . . 2.46 112.976 175.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -78.83 41.88 2.22 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.591 1.567 . . . . 5.53 114.223 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.49 23.64 77.59 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.346 1.45 . . . . 3.43 115.601 170.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -135.66 145.41 46.75 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 119.085 1.442 . . . . 3.94 112.981 -166.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.5 t -129.19 141.89 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.591 1.556 . . . . 2.65 107.496 162.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.45 172.1 13.19 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.841 1.656 . . . . 2.09 109.658 -174.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.78 150.94 52.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.843 0.857 . . . . 4.39 111.033 167.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.7 t -136.75 157.69 36.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.28 1.032 . . . . 2.1 109.0 168.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.6 t -120.22 120.81 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.746 1.618 . . . . 2.34 108.262 -174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -122.93 145.31 45.33 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 126.744 2.018 . . . . 2.91 109.321 -170.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.48 164.08 33.12 Favored 'Trans proline' 0 CA--C 1.536 0.618 0 C-N-CA 123.192 2.595 . . . . 1.31 110.807 171.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 5.6 t -100.89 119.66 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.465 -0.939 . . . . 0.93 108.465 160.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -129.56 138.34 51.25 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 106.22 -1.77 . . . . 4.74 106.22 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -87.51 68.74 9.7 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 120.851 -1.155 . . . . 1.97 110.903 -172.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.928 0 N-CA-C 115.927 1.825 . . . . 7.5 115.927 -171.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.905 0 N-CA-C 107.213 -2.355 . . . . 9.22 107.213 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -153.29 -81.11 0.09 Allowed 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.983 0.735 . . . . 7.02 112.983 -142.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 171.88 -153.51 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 123.886 0.874 . . . . 10.43 109.431 -137.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.5 t -97.03 148.13 23.3 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.356 -0.979 . . . . 5.49 108.356 147.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -151.22 57.59 0.89 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 122.375 1.083 . . . . 5.23 109.834 -174.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.78 -178.75 30.29 Favored Glycine 0 C--N 1.34 0.805 0 O-C-N 121.306 -0.871 . . . . 1.14 111.634 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 29.5 p90 -131.77 160.38 35.74 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 114.024 1.12 . . . . 2.35 114.024 -170.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.18 145.25 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.199 1.4 . . . . 1.55 108.552 159.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 tmt_? -93.3 150.05 20.77 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.75 0.82 . . . . 4.84 111.908 -175.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -70.6 139.7 51.48 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 127.605 2.362 . . . . 2.62 113.227 -172.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -179.99 142.4 0.35 Allowed Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 125.187 1.395 . . . . 2.11 112.827 169.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -74.01 -20.88 18.88 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.727 2.285 . . . . 1.36 112.492 162.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 135.58 175.67 13.96 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 126.809 2.147 . . . . 1.01 111.698 -173.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.82 -15.6 29.07 Favored 'Cis proline' 0 CA--C 1.536 0.615 0 CA-C-N 118.893 1.346 . . . . 1.24 112.946 -3.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -128.44 159.89 33.98 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.031 0.919 . . . . 2.81 113.125 174.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -131.22 -178.69 4.95 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 130.652 3.581 . . . . 0.59 107.841 169.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.95 171.74 12.04 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.846 1.658 . . . . 1.12 108.295 169.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -132.34 118.74 19.8 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.488 -0.757 . . . . 0.9 109.894 164.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -102.32 63.05 0.87 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 125.55 1.54 . . . . 2.67 108.583 175.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 pp -89.68 160.02 16.81 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 114.975 -1.011 . . . . 1.61 112.092 -170.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 m -130.18 127.74 40.32 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 124.849 1.26 . . . . 2.21 108.443 177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.498 HD21 HG11 ' A' ' 113' ' ' VAL . 0.6 OUTLIER -119.74 179.72 4.15 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.03 1.332 . . . . 5.25 109.826 162.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -127.05 164.14 22.21 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 123.654 0.781 . . . . 4.84 109.886 165.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -103.15 81.46 0.42 Allowed Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 126.585 1.954 . . . . 3.16 109.314 -174.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.52 -17.41 34.15 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.78 2.32 . . . . 1.33 114.809 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.7 157.95 51.0 Favored Glycine 0 C--N 1.339 0.736 0 CA-C-N 119.367 0.985 . . . . 1.5 110.975 173.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -85.76 4.27 37.6 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 127.59 2.356 . . . . 3.77 112.408 176.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mp -122.88 158.0 58.48 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 127.291 2.236 . . . . 3.91 108.72 174.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -83.01 141.63 10.62 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.72 2.28 . . . . 1.4 111.381 -166.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 55.6 mt -89.74 150.04 22.47 Favored 'General case' 0 C--O 1.227 -0.12 0 CA-C-O 123.41 1.576 . . . . 2.25 112.626 172.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttm-85 -130.82 97.68 4.41 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.099 -1.864 . . . . 2.77 110.227 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.525 HD21 ' CZ ' ' A' ' 84' ' ' PHE . 6.7 tt -78.79 110.66 14.17 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 125.236 1.414 . . . . 2.6 107.695 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -100.12 -27.61 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 122.827 0.451 . . . . 0.5 111.697 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.54 -173.76 29.51 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 125.094 1.33 . . . . 0.43 113.396 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.528 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -143.31 177.99 8.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.11 1.764 . . . . 0.43 112.295 171.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.0 mtm180 -143.26 169.22 18.04 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.402 1.481 . . . . 5.52 109.319 158.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.0 t -168.85 150.44 4.57 Favored Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 125.757 1.623 . . . . 0.62 108.313 175.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -80.07 -14.56 12.14 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 121.524 1.483 . . . . 0.86 113.266 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 17.1 m -101.25 24.45 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.687 1.195 . . . . 0.82 113.621 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.9 161.82 39.96 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.482 1.513 . . . . 0.87 109.46 166.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -93.58 -44.04 8.4 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 127.074 2.15 . . . . 3.96 112.363 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 27.0 ptt-85 -131.83 159.56 38.19 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.07 0.948 . . . . 6.91 109.013 160.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.5 p -119.84 143.6 30.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 C-N-CA 125.277 1.431 . . . . 0.86 108.887 166.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -117.47 149.25 40.89 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.858 1.663 . . . . 2.64 109.272 170.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.5 tp -100.88 120.77 40.63 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.35 0.66 . . . . 0.9 110.022 175.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 55.0 m170 -122.62 157.94 31.08 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.16 1.384 . . . . 0.65 113.903 -174.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -98.2 176.85 5.58 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.885 2.074 . . . . 2.41 111.878 161.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.3 m -151.76 147.36 26.58 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.024 1.73 . . . . 1.02 106.762 166.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -161.71 -179.73 7.48 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.635 1.174 . . . . 2.41 111.976 -164.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 17.0 ptt? -110.09 146.9 34.63 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.656 1.182 . . . . 4.33 113.538 173.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -132.05 148.46 52.5 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.412 1.885 . . . . 5.78 111.675 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.39 142.91 35.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.166 1.786 . . . . 3.53 112.298 173.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.4 m -145.56 5.47 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 127.058 2.143 . . . . 3.86 115.561 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -174.67 18.11 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 115.288 1.588 . . . . 3.9 115.288 -161.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.27 -5.82 32.74 Favored Glycine 0 CA--C 1.54 1.606 0 O-C-N 119.914 -1.741 . . . . 2.2 113.471 -163.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -97.39 69.93 2.27 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 129.12 2.968 . . . . 2.74 109.64 -169.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 26.8 mtmm -55.33 120.08 6.55 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.884 1.274 . . . . 2.95 109.953 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.4 p -145.37 144.56 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.32 1.848 . . . . 2.83 109.122 -177.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 61.5 mtp -82.28 169.13 16.89 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.293 1.22 . . . . 4.15 114.293 -177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.2 176.83 32.72 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.911 1.719 . . . . 0.62 113.078 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.2 ttm -156.3 149.17 24.0 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 126.109 1.764 . . . . 1.26 109.916 -172.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 49.6 mtm180 -150.94 155.43 35.2 Favored Pre-proline 0 N--CA 1.468 0.456 0 C-N-CA 125.835 1.654 . . . . 4.35 109.361 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -73.5 155.89 50.13 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 121.941 1.76 . . . . 0.53 110.847 165.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -141.43 153.89 66.3 Favored Pre-proline 0 N--CA 1.478 0.956 0 C-N-CA 125.731 1.613 . . . . 0.65 110.09 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -81.27 -23.41 5.19 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.649 2.899 . . . . 0.58 113.631 -167.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -176.54 160.47 2.03 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 126.05 1.74 . . . . 2.01 111.011 177.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -106.28 159.04 16.42 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.486 1.115 . . . . 0.66 109.182 159.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -132.95 149.97 52.2 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 124.256 1.022 . . . . 2.28 110.157 173.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.8 t -143.65 138.62 15.46 Favored Pre-proline 0 CA--C 1.537 0.464 0 O-C-N 124.056 0.847 . . . . 1.13 112.237 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -76.62 156.54 35.9 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.743 2.962 . . . . 1.39 112.264 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -60.35 140.41 91.64 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.874 3.049 . . . . 1.52 112.995 -178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 64.45 2.78 1.67 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 127.25 2.22 . . . . 2.41 113.96 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.52 179.7 51.92 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 127.227 2.346 . . . . 1.53 113.523 171.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.06 124.67 49.94 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.672 1.989 . . . . 4.51 110.926 -173.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 37.8 t -94.67 72.92 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 126.807 2.043 . . . . 5.57 108.27 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -117.52 115.27 24.81 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 122.806 1.288 . . . . 2.97 111.794 -158.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.9 mp -87.19 74.68 9.52 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.551 1.94 . . . . 2.03 107.836 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 146.95 99.04 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 120.834 -1.166 . . . . 2.31 113.514 -177.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -61.02 147.13 96.63 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.335 2.023 . . . . 3.35 109.485 164.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 83.07 -5.75 74.81 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-O 118.447 -1.196 . . . . 2.15 113.703 -172.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -147.33 -121.23 1.25 Allowed Glycine 0 C--N 1.342 0.913 0 CA-C-N 119.156 1.478 . . . . 1.48 113.674 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -73.94 138.47 44.26 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.482 -1.011 . . . . 2.03 111.319 -167.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -160.24 153.09 21.36 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 123.824 0.849 . . . . 0.71 111.453 -176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.528 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 43.8 m-85 -80.29 139.45 36.63 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.865 -0.791 . . . . 1.8 108.865 164.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.5 tpt -100.73 120.49 40.16 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.381 1.873 . . . . 1.15 108.045 166.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.9 mp -103.89 117.27 33.94 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.467 1.507 . . . . 1.21 108.152 -175.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.88 148.13 41.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 119.222 0.919 . . . . 2.03 112.163 -174.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.61 36.78 36.85 Favored Glycine 0 N--CA 1.471 0.981 0 C-N-CA 124.154 0.883 . . . . 1.51 113.12 172.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.1 mt -46.0 151.93 0.43 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 117.194 2.294 . . . . 1.07 117.194 -170.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 60.6 mmtt -114.27 -31.36 6.32 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 113.088 -1.869 . . . . 2.57 113.423 -174.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -100.47 125.54 38.87 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 117.109 -1.424 . . . . 4.82 107.776 156.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -64.96 112.36 2.0 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 N-CA-C 105.501 -2.538 . . . . 1.32 105.501 152.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.4 pp -114.01 137.88 51.12 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 122.472 1.129 . . . . 2.43 112.995 -159.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.0 mtmp? -132.99 164.78 26.23 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 126.058 1.743 . . . . 3.45 113.67 -157.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.54 116.93 15.79 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.185 -0.916 . . . . 1.34 109.778 -175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.2 15.13 36.63 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.736 -1.036 . . . . 1.26 114.527 -171.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -97.67 178.82 5.04 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.8 1.3 . . . . 2.21 110.411 159.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -137.32 150.83 48.03 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 127.391 2.276 . . . . 3.28 105.873 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 51.1 t -145.06 144.83 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 127.177 2.191 . . . . 1.14 109.329 -172.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -92.87 134.27 35.25 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.871 -0.604 . . . . 3.49 111.429 175.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -114.3 146.01 41.02 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.271 1.828 . . . . 2.72 109.774 164.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 -101.35 139.82 36.5 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.473 1.509 . . . . 2.01 108.757 157.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.0 mp -104.82 122.6 46.09 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.248 1.419 . . . . 1.09 108.932 167.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 74.8 mt -94.76 114.38 26.27 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.279 1.032 . . . . 0.63 110.232 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -109.93 112.92 25.23 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.039 1.336 . . . . 2.11 111.326 -172.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 51.51 29.77 5.72 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.837 1.655 . . . . 2.35 113.023 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 74.97 -71.21 1.71 Allowed Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.182 1.373 . . . . 4.66 111.98 -169.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -78.9 13.45 18.71 Favored Glycine 0 CA--C 1.533 1.218 0 N-CA-C 116.999 1.56 . . . . 1.68 116.999 -163.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -132.05 143.75 50.26 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.634 1.574 . . . . 3.29 110.048 168.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.6 t -134.63 144.79 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.39 1.076 . . . . 2.06 109.106 178.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 48.9 tp -136.27 123.39 21.64 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.26 1.024 . . . . 2.26 110.188 170.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 ptmm? -99.99 140.78 33.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.765 1.226 . . . . 3.01 111.993 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.498 HG11 HD21 ' A' ' 22' ' ' LEU . 0.8 OUTLIER -149.18 138.53 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.028 1.331 . . . . 2.07 112.102 -173.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.3 p -83.07 136.53 22.64 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 123.814 0.846 . . . . 2.71 109.862 165.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.4 mt -134.96 142.37 41.88 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 127.338 2.255 . . . . 2.5 107.472 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 154.93 66.46 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.7 2.266 . . . . 0.79 111.571 168.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 64.9 t -91.1 126.41 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.936 0.494 . . . . 0.94 110.141 165.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -117.72 146.89 43.45 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.358 1.463 . . . . 4.66 112.638 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -88.61 63.22 6.86 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.23 1.412 . . . . 2.11 112.529 171.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 35.8 mtt180 . . . . . 0 C--O 1.249 1.049 0 C-N-CA 124.595 1.158 . . . . 7.02 109.658 161.923 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.033 0 N-CA-C 107.24 -2.344 . . . . 10.06 107.24 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 86.4 p -71.53 -144.73 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 120.523 -0.471 . . . . 7.67 110.487 137.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -162.15 173.93 13.62 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.081 1.352 . . . . 7.46 110.961 -166.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.6 m -64.5 128.29 35.16 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.719 -0.845 . . . . 5.56 108.719 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -158.87 108.98 2.0 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 107.151 -1.426 . . . . 4.88 107.151 -169.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.77 172.03 37.01 Favored Glycine 0 N--CA 1.464 0.536 0 O-C-N 121.341 -0.849 . . . . 1.4 112.775 -178.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.9 p90 -157.92 151.46 23.61 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.722 1.609 . . . . 2.35 110.974 167.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 t -99.35 145.96 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 106.964 -1.495 . . . . 1.55 106.964 162.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.9 ttt-85 -80.29 -88.98 0.07 Allowed 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 120.056 1.298 . . . . 5.91 111.786 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -164.09 141.55 6.95 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.723 0.809 . . . . 3.11 112.118 -174.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.1 t -176.43 140.2 0.51 Allowed Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 125.795 1.638 . . . . 2.25 111.489 165.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.32 -29.59 7.59 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.507 2.138 . . . . 1.46 112.53 170.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 137.64 171.91 12.35 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 126.309 1.909 . . . . 1.11 111.629 -170.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -77.55 -6.02 31.53 Favored 'Cis proline' 0 CA--C 1.536 0.613 0 CA-C-N 119.305 1.552 . . . . 1.28 113.528 0.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -148.64 164.75 33.35 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.457 1.28 . . . . 2.01 114.457 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -139.35 -179.02 5.64 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.975 2.51 . . . . 0.69 110.443 -175.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.39 138.97 33.38 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.148 1.379 . . . . 1.26 109.305 177.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.21 154.73 47.26 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 126.059 1.744 . . . . 0.88 112.597 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -136.89 143.91 43.25 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.51 2.324 . . . . 2.51 110.187 -167.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -171.35 153.48 3.6 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.13 1.159 . . . . 2.2 114.13 -176.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.7 p -90.45 144.3 25.93 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.522 1.929 . . . . 2.96 110.456 173.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.5 142.86 51.28 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.733 1.613 . . . . 3.89 107.929 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -127.9 140.59 51.91 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 108.949 -0.76 . . . . 4.34 108.949 157.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 63.5 t-20 -86.15 112.51 46.24 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 124.326 1.05 . . . . 1.36 108.958 170.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -81.39 -12.89 11.29 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 122.615 2.21 . . . . 1.17 113.788 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 171.74 46.85 Favored Glycine 0 C--N 1.337 0.619 0 CA-C-O 122.964 1.313 . . . . 1.22 112.456 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -97.32 -5.38 36.72 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.346 2.659 . . . . 2.93 112.274 -176.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.5 mt -121.16 162.62 34.61 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 127.896 2.478 . . . . 3.93 109.3 171.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.72 150.51 21.44 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.359 2.04 . . . . 0.92 111.849 -168.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.8 mt -103.45 148.83 25.45 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 124.26 1.024 . . . . 1.85 109.951 169.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -134.0 101.92 5.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 112.886 -1.961 . . . . 1.69 110.471 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.15 104.63 16.87 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 125.631 1.572 . . . . 1.77 108.318 -172.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.7 m -97.91 -30.3 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 123.616 0.766 . . . . 0.63 112.443 -168.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.33 -175.7 29.56 Favored Glycine 0 C--N 1.338 0.65 0 C-N-CA 124.468 1.032 . . . . 0.44 112.423 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -132.01 174.21 10.42 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.658 0.742 . . . . 0.6 111.98 166.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -127.65 164.03 22.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.481 1.912 . . . . 5.78 107.8 156.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -171.8 151.02 2.69 Favored Pre-proline 0 N--CA 1.479 1.002 0 C-N-CA 127.186 2.195 . . . . 0.76 108.801 -174.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -80.13 -24.39 5.71 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.223 1.949 . . . . 1.02 114.013 -178.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.411 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 25.5 m -103.97 22.58 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.502 1.121 . . . . 0.95 113.817 -172.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.95 152.22 24.49 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 126.37 1.868 . . . . 1.03 108.221 170.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -90.93 -66.77 0.9 Allowed 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 126.039 1.735 . . . . 3.5 109.394 -175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.4 mtp-105 -86.79 140.7 29.45 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 105.951 -1.87 . . . . 6.4 105.951 164.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.18 127.57 65.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 106.769 -1.567 . . . . 1.34 106.769 162.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -124.75 125.79 44.63 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.563 1.145 . . . . 2.63 109.275 -163.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 43.2 tp -79.89 122.78 27.1 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 122.053 -0.404 . . . . 0.98 110.796 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -120.33 161.6 20.87 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.323 1.449 . . . . 0.54 112.804 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.465 ' HB3' ' CE1' ' A' ' 82' ' ' TYR . 19.6 pt-20 -112.13 159.3 18.66 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.027 2.131 . . . . 2.88 110.742 161.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.3 m -124.43 143.25 50.73 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.435 2.294 . . . . 0.77 105.654 168.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -152.03 170.62 19.46 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.711 0.804 . . . . 2.1 112.51 -173.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 6.8 ptm -99.34 143.35 29.69 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.992 0.917 . . . . 4.34 111.867 174.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -156.65 154.39 30.06 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.667 1.187 . . . . 8.19 113.02 -177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.47 160.12 26.71 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.954 0.901 . . . . 5.11 110.589 158.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.5 m -146.87 -12.61 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 N-CA-C 117.083 2.253 . . . . 4.17 117.083 170.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 178.38 32.35 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 116.493 2.035 . . . . 4.54 116.493 -158.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.56 15.45 70.79 Favored Glycine 0 N--CA 1.476 1.359 0 O-C-N 119.288 -2.133 . . . . 2.38 112.685 -167.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -142.87 88.63 2.06 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.987 2.515 . . . . 2.86 110.002 -166.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.13 122.63 12.87 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 121.023 -1.048 . . . . 3.72 113.022 174.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.4 m -135.76 -176.08 1.49 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 129.376 3.071 . . . . 2.64 110.043 -176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 17.5 mtp -98.51 166.21 11.46 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.803 1.287 . . . . 4.46 113.953 167.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -137.77 -179.91 17.51 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 127.142 2.306 . . . . 0.78 111.079 170.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -149.47 145.69 27.03 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.366 1.866 . . . . 1.16 108.344 178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -145.35 147.47 33.96 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.646 1.578 . . . . 7.58 109.533 -177.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -78.82 150.01 23.57 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.522 2.148 . . . . 0.58 110.254 167.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.5 m -139.09 156.2 72.4 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.802 1.241 . . . . 0.6 111.185 -172.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -84.87 -23.22 2.63 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 123.128 2.552 . . . . 0.56 113.712 -165.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -179.13 162.82 1.25 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 126.413 1.885 . . . . 1.77 111.415 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.6 mt -107.71 150.39 27.01 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.573 1.149 . . . . 0.51 110.244 162.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -109.5 142.76 40.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.018 -1.105 . . . . 2.1 108.018 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.5 t -134.79 122.47 15.47 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 119.18 -0.438 . . . . 0.85 111.131 165.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -69.23 161.5 45.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.539 2.826 . . . . 0.94 111.153 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -58.99 138.5 86.03 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.412 2.742 . . . . 0.98 112.41 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt 67.24 -7.68 0.5 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.134 1.774 . . . . 1.68 114.092 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.55 142.97 25.32 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.751 1.167 . . . . 1.21 113.025 -177.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.1 ttt180 -101.69 133.03 47.04 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.406 1.482 . . . . 3.9 108.913 168.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -148.59 141.51 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 126.765 2.026 . . . . 3.33 108.542 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.04 137.67 54.56 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.259 1.024 . . . . 3.51 113.294 -168.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.0 mp -70.63 74.03 0.56 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.126 1.77 . . . . 2.1 109.372 158.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.6 ptpp? -68.65 138.92 91.07 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 127.244 2.218 . . . . 2.4 111.99 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.65 -34.46 62.99 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.643 2.229 . . . . 2.26 114.12 -173.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.89 6.78 46.49 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-O 119.26 -0.745 . . . . 1.85 114.178 173.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -146.89 -121.07 1.27 Allowed Glycine 0 C--N 1.337 0.598 0 C-N-CA 126.307 1.908 . . . . 1.56 111.907 179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 47' ' ' GLU . 96.8 m-85 -73.71 138.14 44.48 Favored 'General case' 0 C--O 1.223 -0.312 0 O-C-N 121.567 -0.961 . . . . 2.04 112.341 -171.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -159.89 150.67 19.11 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 124.209 1.003 . . . . 0.71 111.1 -172.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -87.8 128.01 35.33 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 121.755 -0.591 . . . . 1.95 109.481 171.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.2 tpt -85.57 110.87 19.54 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.752 1.621 . . . . 0.82 109.655 168.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.7 mp -90.28 116.42 28.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.852 1.261 . . . . 1.48 108.574 -178.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 tt -127.17 143.36 51.28 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 121.995 0.902 . . . . 2.78 112.54 -164.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.78 38.6 41.93 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 121.418 -0.801 . . . . 1.72 112.445 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.5 mt -45.52 153.88 0.22 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 117.865 2.543 . . . . 0.76 117.865 -170.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 51.5 mmtt -119.26 -24.74 6.32 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 113.673 -1.603 . . . . 2.24 113.759 -176.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 89.0 mmt-85 -125.87 147.83 60.3 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 127.168 2.187 . . . . 6.11 107.992 157.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -66.89 144.67 71.63 Favored 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 121.948 1.765 . . . . 2.08 108.28 165.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.16 75.73 8.13 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 107.919 -1.141 . . . . 2.74 107.919 170.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -88.8 165.1 14.91 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.609 1.164 . . . . 3.3 111.662 170.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 119' ' ' ALA . . . -62.47 132.14 51.5 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.454 -0.779 . . . . 2.1 111.372 176.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 97.6 1.41 58.94 Favored Glycine 0 CA--C 1.527 0.807 0 CA-C-O 117.231 -1.872 . . . . 1.9 115.745 169.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -76.6 167.59 21.58 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.82 1.81 . . . . 2.39 110.342 169.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.23 133.02 47.34 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 130.455 3.502 . . . . 3.9 104.362 173.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 93.1 t -136.98 132.62 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.828 1.251 . . . . 1.3 111.196 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -79.37 142.78 35.71 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.279 -1.328 . . . . 2.39 112.067 173.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -122.47 154.82 37.3 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 115.138 -0.937 . . . . 1.95 109.922 152.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -125.76 112.65 16.31 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 127.175 2.19 . . . . 2.61 108.809 172.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mp -84.98 116.71 23.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.599 1.16 . . . . 0.91 111.194 -171.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.9 mt -85.69 106.71 17.15 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.705 1.202 . . . . 0.61 109.937 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -103.24 107.71 18.63 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.279 1.432 . . . . 2.04 111.74 -175.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 55.17 27.43 9.59 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.975 1.71 . . . . 2.51 112.906 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.85 -59.23 3.85 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.52 1.533 . . . . 4.68 113.163 -175.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -76.68 -1.23 70.96 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.58 1.392 . . . . 1.61 116.58 -167.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 32.0 mtmt -133.32 146.74 51.62 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.218 1.509 . . . . 2.83 111.372 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.89 149.75 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.352 1.461 . . . . 2.24 110.779 175.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.7 tt -145.01 130.08 18.44 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.621 1.168 . . . . 2.16 111.259 -176.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.61 140.55 38.43 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.642 1.177 . . . . 2.22 113.425 -177.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.0 m -137.77 165.82 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 125.881 1.672 . . . . 2.71 110.749 163.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.24 151.3 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.813 1.245 . . . . 2.67 109.493 168.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -156.38 137.77 9.6 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 126.188 1.795 . . . . 2.45 112.796 -175.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.45 163.62 31.89 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 124.264 3.309 . . . . 1.42 113.364 -178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.6 t -103.87 109.58 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 CA-C-O 122.326 1.06 . . . . 1.52 110.624 174.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -110.67 88.92 2.89 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.689 2.396 . . . . 4.17 109.635 -170.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' A' ' 95' ' ' ALA . . . -78.75 82.12 5.0 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.378 -0.826 . . . . 3.67 110.457 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 . . . . . 0 C--O 1.247 0.964 0 C-N-CA 126.084 1.754 . . . . 9.55 109.642 -174.064 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.254 0 N-CA-C 105.274 -3.13 . . . . 12.67 105.274 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.3 m -152.55 150.5 29.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 119.098 -1.041 . . . . 10.74 113.61 -123.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -122.68 67.34 0.96 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.094 1.758 . . . . 8.88 110.232 -172.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 24.0 p -77.47 66.89 3.29 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.573 1.149 . . . . 5.27 110.963 178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -76.42 59.69 1.48 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.011 1.724 . . . . 4.83 111.631 -177.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.09 -178.42 15.5 Favored Glycine 0 N--CA 1.469 0.849 0 O-C-N 120.774 -1.204 . . . . 1.21 111.583 -177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -144.83 166.87 24.02 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.296 0.85 . . . . 2.41 113.296 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.5 t -115.99 143.46 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.846 1.259 . . . . 1.24 109.185 176.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -26.29 60.9 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 117.268 2.322 . . . . 4.65 117.268 -151.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 0.8 OUTLIER 79.78 114.79 0.06 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 127.232 2.213 . . . . 2.94 108.159 -167.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.5 m -160.88 138.59 6.98 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 126.645 1.978 . . . . 2.29 108.286 166.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.03 -33.13 10.08 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.39 2.06 . . . . 1.46 111.76 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.57 179.87 22.14 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 125.18 1.372 . . . . 0.96 112.331 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.22 -5.64 16.38 Favored 'Cis proline' 0 CA--C 1.537 0.626 0 CA-C-N 118.48 1.14 . . . . 1.22 113.013 -2.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.56 HD22 ' H ' ' A' ' 88' ' ' GLY . 2.8 m120 -135.74 175.14 9.87 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 125.759 1.623 . . . . 4.14 111.903 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -157.27 -175.46 5.42 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 128.947 2.899 . . . . 0.44 111.585 -175.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.37 154.93 45.92 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 127.365 2.266 . . . . 0.74 107.84 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.2 130.53 39.22 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 118.83 0.741 . . . . 0.52 110.391 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -110.64 54.12 0.68 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.175 2.19 . . . . 2.33 111.366 -176.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -75.97 150.75 37.39 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.136 -0.978 . . . . 1.63 113.309 -172.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.1 m -91.79 134.67 34.54 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.304 0.642 . . . . 1.63 109.78 172.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.56 134.54 51.79 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.143 2.177 . . . . 3.29 110.234 -176.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -119.17 151.98 37.38 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 125.889 1.676 . . . . 5.34 110.445 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -114.65 103.68 54.75 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.196 0.998 . . . . 1.39 109.083 160.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -83.62 -8.54 10.35 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.244 2.629 . . . . 1.67 114.455 -177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -97.57 175.9 30.73 Favored Glycine 0 C--N 1.342 0.874 0 CA-C-N 119.441 1.019 . . . . 1.35 112.066 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -92.18 1.21 57.35 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.069 2.148 . . . . 3.51 112.984 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 28' ' ' LEU . 2.0 pt? -112.16 157.21 40.5 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 127.425 2.29 . . . . 3.88 110.402 175.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.25 158.01 41.42 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.802 2.335 . . . . 1.15 111.067 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 69.3 mt -134.0 130.3 37.4 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-O 124.239 1.971 . . . . 1.83 112.785 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -108.89 106.12 15.97 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 110.704 -2.953 . . . . 2.0 111.331 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.29 114.74 26.85 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 125.361 1.464 . . . . 2.4 108.358 -178.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 12.7 m -110.2 -25.56 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.646 0.778 . . . . 0.7 112.685 -170.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.28 -174.55 27.13 Favored Glycine 0 C--N 1.343 0.935 0 C-N-CA 124.319 0.961 . . . . 0.54 112.9 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.94 -177.55 5.14 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 124.248 1.019 . . . . 0.67 111.056 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.54 -175.58 5.51 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.849 2.459 . . . . 5.45 109.441 164.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 t 178.71 150.37 0.44 Allowed Pre-proline 0 C--N 1.327 -0.397 0 C-N-CA 129.528 3.131 . . . . 0.95 106.192 -167.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.24 -12.82 14.11 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 121.925 1.75 . . . . 0.89 113.472 172.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -112.93 23.54 4.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.717 1.377 . . . . 1.01 114.717 -170.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -150.78 134.15 16.26 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.874 1.67 . . . . 1.12 109.764 168.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -59.51 -48.88 79.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.35 1.06 . . . . 2.78 111.569 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -122.39 165.29 16.53 Favored 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 127.7 2.4 . . . . 5.42 109.568 177.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.6 p -148.17 145.89 18.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 C-N-CA 126.072 1.749 . . . . 0.9 108.323 172.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -130.12 146.09 51.74 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 126.499 1.92 . . . . 2.67 109.435 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.2 tp -99.37 117.01 32.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.014 0.925 . . . . 0.89 109.588 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -118.66 149.95 40.54 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 123.089 1.423 . . . . 0.56 113.844 -176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -95.84 172.44 8.02 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.915 1.686 . . . . 2.36 111.348 164.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.4 m -148.29 144.56 27.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.525 1.53 . . . . 0.95 107.165 170.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -157.17 166.81 32.19 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 112.939 0.718 . . . . 2.01 112.939 -166.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.2 mtp -93.73 144.36 25.48 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.068 0.947 . . . . 4.02 111.473 170.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -157.88 163.0 38.36 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.708 1.603 . . . . 8.19 111.906 -176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -78.27 152.65 32.4 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.904 1.282 . . . . 3.41 110.534 165.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.65 120.46 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 N-CA-C 106.714 -1.587 . . . . 3.86 106.714 142.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 55.34 44.28 27.56 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.4 1.48 . . . . 5.74 113.113 174.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.48 0.74 63.43 Favored Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.051 -1.031 . . . . 2.47 114.128 -178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.9 mtmp? -109.35 114.78 28.74 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.077 1.351 . . . . 3.54 109.753 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -67.65 127.07 31.39 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.094 1.358 . . . . 4.25 111.171 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.65 -177.17 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 129.763 3.225 . . . . 2.39 109.75 -176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 59.2 mtt -110.08 167.27 10.3 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.109 -0.994 . . . . 2.88 113.602 171.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -149.53 172.15 29.56 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 126.034 1.778 . . . . 0.7 112.262 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -149.68 147.5 28.15 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 126.294 1.838 . . . . 1.28 108.952 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.0 mtm180 -151.16 156.88 35.37 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 127.034 2.134 . . . . 4.68 108.866 -176.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -77.15 149.72 28.63 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.13 1.887 . . . . 0.45 110.508 167.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.7 m -137.64 152.42 72.7 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 125.399 1.48 . . . . 0.88 110.362 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -83.59 -24.29 2.98 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.09 2.526 . . . . 0.58 113.504 -160.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -177.11 160.85 1.81 Allowed 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.255 1.422 . . . . 2.2 112.25 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -106.63 154.77 20.43 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.704 1.601 . . . . 0.67 109.89 162.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -115.77 149.86 37.83 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 124.7 1.2 . . . . 3.07 108.71 170.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.2 t -142.19 127.86 10.64 Favored Pre-proline 0 CA--C 1.542 0.642 0 N-CA-C 112.776 0.658 . . . . 0.96 112.776 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -74.62 155.42 44.77 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.416 2.744 . . . . 1.44 112.098 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.33 139.59 83.69 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 124.228 3.285 . . . . 1.53 113.388 -175.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 63.45 1.34 0.97 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 126.968 2.107 . . . . 2.54 114.347 -176.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.84 167.13 51.14 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 126.201 1.858 . . . . 1.4 113.037 174.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.21 150.73 45.88 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 125.541 1.536 . . . . 4.05 109.174 169.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.3 t -149.79 135.97 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 125.866 1.667 . . . . 3.5 107.216 -178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.99 132.55 54.12 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 119.071 0.85 . . . . 2.65 111.741 -177.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -71.25 80.7 0.73 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 122.933 1.349 . . . . 2.37 109.694 168.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.53 146.85 66.52 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 125.529 1.532 . . . . 2.88 112.838 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -53.56 -41.94 69.69 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.403 2.735 . . . . 2.94 112.431 176.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.94 54.0 4.66 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 118.612 -1.104 . . . . 2.29 113.202 170.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 157.48 -29.64 0.51 Allowed Glycine 0 N--CA 1.472 1.084 0 N-CA-C 119.953 2.741 . . . . 2.46 119.953 155.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -147.26 137.12 23.05 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 120.924 2.362 . . . . 2.21 111.528 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -161.32 156.7 24.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.599 0.592 . . . . 0.66 112.599 -178.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -84.43 145.3 28.24 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.409 -0.589 . . . . 1.82 109.409 163.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -99.23 132.19 44.72 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.073 1.749 . . . . 0.78 108.838 161.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -110.21 115.38 29.62 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.17 1.388 . . . . 1.15 108.257 -178.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -110.62 142.22 42.78 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.96 0.904 . . . . 2.5 109.809 -171.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.56 ' H ' HD22 ' A' ' 15' ' ' ASN . . . 64.03 55.83 21.94 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.413 1.006 . . . . 1.77 113.877 174.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 17.7 mt -48.56 154.26 0.68 Allowed 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 115.153 1.538 . . . . 0.73 115.153 176.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -98.88 -26.69 14.2 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 113.016 -1.902 . . . . 1.75 113.276 176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.83 152.0 29.29 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 127.734 2.414 . . . . 5.62 110.741 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.39 135.4 24.43 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.422 2.748 . . . . 1.52 110.534 172.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -124.36 125.61 44.6 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.744 1.217 . . . . 2.24 111.913 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.5 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 4.1 ptpp? -114.87 168.57 9.78 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.639 1.175 . . . . 3.12 113.699 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.33 140.46 48.51 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.252 0.621 . . . . 1.94 109.845 -178.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.31 12.63 62.9 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.651 1.119 . . . . 1.87 113.993 -172.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -99.77 179.64 4.46 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.29 1.036 . . . . 2.33 110.161 162.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 39.2 mt-10 -124.86 152.57 43.81 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 127.538 2.335 . . . . 3.39 104.761 163.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 92.5 t -147.39 144.79 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.385 1.874 . . . . 1.2 109.809 -177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -94.12 142.26 27.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.115 0.966 . . . . 2.38 113.3 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 54.2 mt -130.19 160.89 32.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.303 2.241 . . . . 2.73 110.596 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -121.29 126.13 48.76 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.65 2.38 . . . . 2.8 109.05 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.95 123.56 45.33 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.233 1.413 . . . . 1.15 110.653 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.8 mt -104.23 110.59 22.86 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.314 1.045 . . . . 0.79 110.829 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.65 144.06 35.26 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.416 1.486 . . . . 1.95 111.044 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -57.51 134.39 56.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.569 0.748 . . . . 2.42 112.152 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 88.67 42.2 5.81 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-O 118.865 -0.964 . . . . 3.66 113.909 -177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.14 6.47 86.18 Favored Glycine 0 N--CA 1.477 1.374 0 N-CA-C 115.846 1.098 . . . . 1.82 115.846 166.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.8 mtmt -90.99 121.64 32.98 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.43 1.115 . . . . 3.2 111.496 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.38 137.0 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 125.583 1.553 . . . . 2.07 108.828 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 59.6 tp -137.15 113.58 10.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.049 0.94 . . . . 2.58 110.329 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -83.43 141.53 31.63 Favored 'General case' 0 CA--C 1.547 0.837 0 O-C-N 121.936 -0.478 . . . . 2.57 111.803 171.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.2 m -139.8 171.13 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 127.437 2.295 . . . . 2.63 110.683 -171.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.87 138.22 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 124.484 1.113 . . . . 2.43 110.394 174.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.4 mp -142.94 153.2 60.39 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 126.106 1.762 . . . . 3.06 109.951 -175.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 72.1 Cg_endo -69.46 154.32 69.09 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 124.016 3.144 . . . . 1.17 112.999 171.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.5 t -93.98 125.75 46.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 108.237 -1.023 . . . . 1.29 108.237 165.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -144.27 141.94 30.14 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.195 1.398 . . . . 4.32 108.421 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.24 53.88 2.62 Favored 'General case' 0 CA--C 1.539 0.537 0 O-C-N 121.411 -0.806 . . . . 2.91 112.679 -171.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 51.0 ptt85 . . . . . 0 C--O 1.251 1.169 0 N-CA-C 114.381 1.252 . . . . 7.85 114.381 -167.917 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.393 0 N-CA-C 108.764 -1.734 . . . . 15.78 108.764 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -145.95 167.56 23.01 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.526 1.13 . . . . 12.77 109.812 -173.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -69.85 156.15 39.49 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.411 0.685 . . . . 13.4 110.868 166.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.5 p -147.35 18.22 1.2 Allowed 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 126.889 2.076 . . . . 8.64 110.339 163.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -157.17 160.83 39.15 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.39 1.876 . . . . 6.14 108.774 -166.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -109.25 169.33 13.76 Favored Glycine 0 N--CA 1.47 0.942 0 N-CA-C 114.927 0.731 . . . . 1.17 114.927 -169.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.6 p90 -151.61 168.64 24.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.16 1.384 . . . . 2.31 113.036 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.0 t -107.44 148.07 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.688 1.595 . . . . 1.26 107.784 172.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -70.98 -132.79 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.26 1.024 . . . . 6.62 111.34 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -145.27 134.93 23.4 Favored 'General case' 0 N--CA 1.464 0.27 0 O-C-N 120.447 -1.408 . . . . 2.01 109.831 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.1 p -176.53 117.13 0.28 Allowed Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.883 1.068 . . . . 3.56 113.883 -163.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -74.4 -28.01 10.72 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.432 2.088 . . . . 1.39 112.263 169.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 128.24 -176.52 18.11 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 125.815 1.674 . . . . 0.97 111.936 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -74.42 -8.26 21.81 Favored 'Cis proline' 0 CA--C 1.536 0.581 0 CA-C-N 118.924 1.362 . . . . 1.14 113.43 1.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -128.23 165.01 21.31 Favored 'General case' 0 CA--C 1.546 0.788 0 C-N-CA 126.41 1.884 . . . . 1.87 112.552 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -151.57 -178.54 6.75 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.936 2.494 . . . . 0.72 110.707 -176.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.31 141.76 26.43 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.992 1.317 . . . . 0.67 110.042 173.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -128.48 150.48 50.14 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 125.262 1.425 . . . . 0.81 111.561 -177.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -133.36 66.46 1.56 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.828 2.051 . . . . 2.29 109.564 -166.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 pp -72.4 165.57 24.28 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.631 1.572 . . . . 2.03 114.666 -173.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.4 t -93.63 151.45 19.66 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.321 1.048 . . . . 4.38 110.4 169.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.9 tp -135.99 117.42 14.73 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.271 1.428 . . . . 4.32 110.074 -167.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.0 mp0 -114.11 135.18 54.31 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 125.306 1.442 . . . . 6.35 111.001 -173.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.35 67.16 3.44 Favored Pre-proline 0 CA--C 1.548 0.87 0 O-C-N 121.071 -1.018 . . . . 2.63 110.965 171.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.75 -22.72 56.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.42 2.746 . . . . 1.7 114.64 -172.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -79.56 -171.94 42.48 Favored Glycine 0 C--N 1.34 0.782 0 CA-C-O 122.534 1.074 . . . . 1.54 113.338 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -110.85 -0.42 16.9 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.746 2.018 . . . . 2.98 112.929 -167.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 86.9 mt -122.29 160.25 48.73 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 127.001 2.12 . . . . 3.9 109.243 169.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -81.96 144.29 13.46 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 122.711 2.274 . . . . 0.97 111.349 -168.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.2 mp -101.55 154.61 18.69 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 123.031 1.396 . . . . 2.79 111.271 171.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -136.69 103.66 5.28 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 113.583 -1.644 . . . . 1.81 109.627 -177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -86.15 108.07 18.15 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.571 1.549 . . . . 1.91 108.263 -174.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.5 m -102.57 -25.53 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.519 0.933 . . . . 0.61 113.519 -169.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.23 -176.98 30.89 Favored Glycine 0 N--CA 1.468 0.796 0 C-N-CA 124.862 1.22 . . . . 0.53 112.055 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.83 -179.72 5.47 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.555 0.693 . . . . 0.54 112.582 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.86 172.91 14.9 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.371 2.269 . . . . 5.72 108.862 161.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.3 t 175.12 150.14 0.27 Allowed Pre-proline 0 N--CA 1.475 0.808 0 C-N-CA 129.509 3.123 . . . . 0.88 106.977 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -73.2 -15.73 25.42 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.128 1.885 . . . . 1.26 114.311 -176.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.57 23.07 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 116.059 1.874 . . . . 1.15 116.059 -168.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.21 136.63 14.11 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.42 1.488 . . . . 1.13 110.761 171.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -60.34 -46.55 89.52 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.251 1.02 . . . . 2.76 112.338 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -127.52 160.22 32.2 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 126.894 2.078 . . . . 4.66 108.993 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -139.0 152.96 24.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 C-N-CA 126.851 2.06 . . . . 0.91 108.545 170.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.5 147.41 26.8 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.232 1.813 . . . . 4.26 108.313 -166.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 62.2 tp -111.05 110.12 20.51 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.445 1.02 . . . . 0.82 110.711 -164.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.3 m170 -117.65 153.72 32.83 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 123.019 1.39 . . . . 0.58 113.654 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -109.92 177.26 4.77 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 113.392 -1.731 . . . . 2.48 111.671 163.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.8 m -152.93 103.14 2.72 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.156 1.382 . . . . 1.2 107.342 -169.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -107.28 165.25 11.52 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.276 1.031 . . . . 2.27 113.59 -166.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.4 mtm -101.55 150.58 22.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.048 1.339 . . . . 4.82 110.57 166.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.28 156.48 32.51 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.238 1.015 . . . . 5.3 110.934 -169.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -108.89 145.7 34.93 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.606 1.563 . . . . 2.64 108.665 169.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.9 p -153.13 136.62 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 108.545 -0.909 . . . . 2.99 108.545 160.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 67.45 16.94 10.06 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.747 1.219 . . . . 3.89 112.863 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.12 17.43 78.24 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.73 -1.231 . . . . 1.52 113.357 -169.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 20.4 mmtp -120.82 126.72 50.81 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.985 2.114 . . . . 3.22 109.109 -172.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -73.15 121.27 19.98 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.253 1.821 . . . . 3.04 108.974 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 35.9 m -132.26 179.8 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.418 1.887 . . . . 2.85 110.543 178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 53.7 mtt -130.31 170.27 14.35 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.178 1.391 . . . . 2.57 111.091 172.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.49 -178.22 29.51 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.382 0.991 . . . . 0.56 112.916 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.9 ttm -143.91 150.2 38.02 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 125.98 1.712 . . . . 1.16 108.149 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -159.22 153.84 20.81 Favored Pre-proline 0 N--CA 1.47 0.567 0 C-N-CA 124.377 1.071 . . . . 4.95 109.994 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -75.72 159.82 38.36 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.368 2.045 . . . . 0.55 110.986 174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -147.94 152.66 40.86 Favored Pre-proline 0 N--CA 1.471 0.609 0 C-N-CA 125.875 1.67 . . . . 1.06 109.88 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -83.51 -26.53 2.09 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.992 2.461 . . . . 0.69 113.557 -160.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -177.61 166.33 2.17 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.835 1.654 . . . . 2.15 111.819 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.3 mt -109.83 153.35 24.53 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.405 1.482 . . . . 0.72 110.277 161.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -117.97 147.55 43.07 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.888 1.675 . . . . 1.69 108.504 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.2 t -140.41 139.06 19.74 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 112.606 0.595 . . . . 1.28 112.606 171.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -82.77 157.11 15.91 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.887 3.058 . . . . 1.17 112.232 173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.35 146.75 96.93 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.926 3.084 . . . . 1.37 114.597 -176.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm 70.37 -5.65 1.32 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 128.153 2.581 . . . . 2.2 114.189 -177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.81 167.09 52.54 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.947 1.26 . . . . 2.0 113.987 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.18 135.19 20.19 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 128.223 2.609 . . . . 6.66 106.457 168.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.2 t -152.87 96.19 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 124.715 1.206 . . . . 3.66 111.848 -168.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -74.04 160.39 31.35 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 120.31 -1.494 . . . . 4.24 112.149 -172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.1 mp -67.34 90.15 0.22 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.878 1.323 . . . . 2.33 108.611 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.628 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -42.23 135.34 2.43 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 127.428 2.291 . . . . 4.05 112.865 -179.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -60.9 -31.79 91.92 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.389 2.06 . . . . 2.15 112.513 177.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -98.65 96.37 1.72 Allowed Glycine 0 C--N 1.343 0.933 0 C-N-CA 123.97 0.795 . . . . 3.11 111.374 166.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 132.56 -15.67 4.92 Favored Glycine 0 N--CA 1.466 0.667 0 N-CA-C 117.548 1.779 . . . . 1.88 117.548 149.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -140.95 146.28 37.15 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 120.442 2.121 . . . . 2.15 112.175 174.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -160.59 148.29 16.04 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.588 1.155 . . . . 0.78 111.78 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -79.54 120.89 24.53 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 108.501 -0.925 . . . . 1.85 108.501 161.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.3 tpt -78.88 127.6 32.23 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 128.061 2.545 . . . . 1.16 108.756 167.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 38.1 mt -113.93 134.59 54.73 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.952 1.701 . . . . 2.36 109.338 -174.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.3 131.04 36.0 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 119.198 0.908 . . . . 2.17 111.797 -172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.66 49.28 4.92 Favored Glycine 0 N--CA 1.468 0.819 0 C-N-CA 123.747 0.689 . . . . 1.9 112.201 175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.4 mt -52.66 155.83 2.11 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 115.078 1.51 . . . . 0.73 115.078 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -110.01 -13.17 14.45 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 113.869 -1.514 . . . . 1.71 114.849 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 67.1 mmt-85 -140.38 138.11 18.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 130.136 3.374 . . . . 7.05 108.697 176.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -76.52 137.89 18.91 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.34 2.027 . . . . 1.41 108.583 161.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -91.65 143.64 26.35 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.785 0.802 . . . . 2.48 112.525 -176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -91.71 -162.96 0.97 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 122.911 1.338 . . . . 3.81 109.203 163.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -108.11 142.96 37.52 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.132 -1.395 . . . . 1.08 107.811 155.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.84 33.83 12.09 Favored Glycine 0 CA--C 1.531 1.085 0 CA-C-O 118.877 -0.957 . . . . 1.32 114.309 -173.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -112.62 -176.38 2.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.162 1.385 . . . . 2.17 110.473 168.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -146.51 134.99 22.01 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 128.274 2.63 . . . . 3.1 105.153 -174.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.4 t -143.72 144.51 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.118 1.367 . . . . 1.19 107.929 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -101.79 146.21 28.1 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 121.514 0.673 . . . . 3.29 111.027 176.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.81 140.11 53.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.335 1.054 . . . . 1.75 109.894 169.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -79.78 135.17 36.43 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 128.595 2.758 . . . . 2.23 109.708 162.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -102.32 123.65 46.51 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 125.992 1.717 . . . . 1.29 106.946 170.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.1 mt -96.67 104.67 16.68 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.926 -1.139 . . . . 0.85 107.926 177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -96.19 128.84 43.46 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.456 1.102 . . . . 2.18 111.237 -178.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 45.13 40.64 4.99 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.438 1.895 . . . . 2.94 112.831 176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 90.52 -94.38 1.97 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.539 1.066 . . . . 5.9 111.506 -170.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -93.1 -6.78 62.91 Favored Glycine 0 N--CA 1.473 1.126 0 N-CA-C 117.121 1.609 . . . . 3.12 117.121 -160.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 46.3 mtpt -80.8 104.85 11.59 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 120.819 2.309 . . . . 2.61 110.765 177.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.02 135.07 37.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.252 1.021 . . . . 2.46 111.402 -176.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 tt -155.19 129.92 9.25 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.549 1.54 . . . . 2.24 109.26 174.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.64 153.14 20.4 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 114.856 1.428 . . . . 3.74 114.856 178.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.1 t -130.14 161.35 40.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 127.602 2.361 . . . . 2.14 108.9 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 48.7 t -109.83 147.03 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 126.0 1.72 . . . . 2.09 109.051 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.61 138.19 11.75 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.237 1.015 . . . . 2.06 111.598 -176.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.18 160.82 46.3 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.901 3.067 . . . . 0.99 112.962 175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.3 t -106.6 128.38 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 126.407 1.883 . . . . 0.95 109.548 172.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -152.62 148.43 27.31 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.509 1.124 . . . . 3.46 110.956 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -76.38 91.96 3.32 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 121.965 0.888 . . . . 2.66 111.208 171.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.4 mmp_? . . . . . 0 C--O 1.249 1.072 0 C-N-CA 128.614 2.766 . . . . 6.57 109.759 164.55 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.383 0 N-CA-C 108.765 -1.734 . . . . 12.41 108.765 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 m -150.5 158.52 44.24 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 118.614 1.207 . . . . 9.76 109.941 -167.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -71.01 164.79 24.84 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.875 1.27 . . . . 8.86 111.529 170.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.3 m -167.87 101.89 0.47 Allowed 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 126.365 1.866 . . . . 8.07 107.575 172.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.4 mp0 -123.74 -178.33 4.01 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.27 1.028 . . . . 4.58 111.952 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.04 177.35 39.79 Favored Glycine 0 C--N 1.337 0.621 0 N-CA-C 116.079 1.192 . . . . 1.21 116.079 -163.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 18.9 p90 -150.24 149.46 30.2 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.337 1.855 . . . . 2.18 110.483 166.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.0 t -93.22 148.61 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 O-C-N 121.004 -1.06 . . . . 1.18 108.174 172.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -143.26 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 121.304 0.573 . . . . 5.28 110.957 170.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -152.76 121.12 6.3 Favored 'General case' 0 CA--C 1.528 0.12 0 O-C-N 119.78 -1.825 . . . . 2.31 111.044 -160.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -165.14 146.95 6.47 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 127.704 2.402 . . . . 1.95 109.796 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.46 -34.11 4.8 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.413 2.075 . . . . 1.68 111.538 164.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 150.05 176.74 23.41 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 126.139 1.828 . . . . 1.08 111.24 -175.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.25 -4.62 33.85 Favored 'Cis proline' 0 CA--C 1.538 0.724 0 CA-C-N 119.395 1.597 . . . . 1.06 113.319 -1.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -138.27 164.04 30.24 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 122.265 1.031 . . . . 2.03 113.337 177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.31 -177.48 4.86 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.349 2.26 . . . . 0.56 110.701 169.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.38 153.33 51.96 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.935 1.694 . . . . 0.87 109.227 171.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.21 153.07 42.46 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.991 0.916 . . . . 0.83 113.025 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -126.82 134.94 50.44 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.568 1.947 . . . . 2.76 108.811 -174.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -166.48 171.58 11.71 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.458 1.026 . . . . 3.08 112.587 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.1 m -111.01 147.3 35.05 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 125.241 1.416 . . . . 1.97 111.128 -171.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 20.3 tp -112.96 138.55 49.66 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 127.266 2.226 . . . . 4.28 109.356 167.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.53 175.04 5.63 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.574 1.55 . . . . 6.97 110.749 165.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.0 t-20 -146.71 103.7 3.93 Favored Pre-proline 0 CA--C 1.538 0.487 0 O-C-N 121.214 -0.929 . . . . 1.83 109.728 166.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.03 -13.65 12.65 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 122.885 2.39 . . . . 2.07 113.247 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.63 179.59 53.04 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-O 122.748 1.194 . . . . 1.56 112.795 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -105.18 -2.49 24.12 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 127.866 2.466 . . . . 3.11 111.87 -173.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -123.07 159.36 54.47 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 128.391 2.676 . . . . 2.68 109.866 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -77.73 151.29 28.19 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 122.439 2.093 . . . . 1.03 112.171 -171.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.8 mt -100.15 155.9 17.49 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 125.278 1.431 . . . . 2.13 110.498 168.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 31.3 ttm180 -139.55 120.69 14.73 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 113.716 -1.584 . . . . 2.23 110.289 175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.3 116.1 31.38 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 126.602 1.961 . . . . 1.85 107.951 -171.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.32 -21.79 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.142 0.977 . . . . 0.51 112.819 -166.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.4 -175.72 31.71 Favored Glycine 0 N--CA 1.472 1.078 0 C-N-CA 124.716 1.15 . . . . 0.55 113.224 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -143.61 176.65 9.05 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.525 0.73 . . . . 0.7 112.017 170.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.26 153.5 38.79 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 129.525 3.13 . . . . 5.56 107.96 176.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -167.93 153.49 6.89 Favored Pre-proline 0 N--CA 1.481 1.081 0 C-N-CA 127.122 2.169 . . . . 0.67 109.548 -179.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -74.41 -18.54 20.25 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.834 2.356 . . . . 0.86 114.246 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -108.72 20.15 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 114.739 1.385 . . . . 0.96 114.739 -172.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.07 150.61 31.97 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.469 1.907 . . . . 0.79 107.813 166.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -79.79 -62.4 1.7 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 123.588 0.755 . . . . 3.63 109.709 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -105.85 172.08 7.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 126.45 1.9 . . . . 4.89 107.452 170.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -151.57 135.85 9.12 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 107.347 -1.353 . . . . 0.95 107.347 171.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -105.97 149.84 26.25 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.476 1.51 . . . . 3.03 109.496 177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.3 tp -103.25 120.19 40.29 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.677 0.791 . . . . 0.88 109.62 175.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.4 m170 -123.65 149.61 45.21 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.239 1.416 . . . . 0.51 113.966 -174.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -92.36 157.11 16.8 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.466 1.506 . . . . 2.03 111.144 162.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.1 m -120.04 146.09 46.22 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 105.736 -1.949 . . . . 1.22 105.736 165.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -160.18 -171.87 3.37 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 119.202 0.91 . . . . 2.09 112.796 -178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.2 mtt -127.78 148.0 50.43 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.25 1.42 . . . . 5.1 113.131 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -132.28 146.86 52.29 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.882 1.673 . . . . 5.85 112.992 173.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -87.51 140.0 29.97 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.652 1.181 . . . . 2.44 109.103 151.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 65.4 t -142.82 122.59 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 126.275 1.83 . . . . 2.26 106.974 168.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 63.76 12.76 6.92 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 126.155 1.782 . . . . 3.33 114.777 -175.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.31 24.23 59.51 Favored Glycine 0 CA--C 1.537 1.421 0 O-C-N 120.918 -1.114 . . . . 1.56 113.174 -167.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -127.65 137.42 52.52 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.059 2.144 . . . . 2.47 108.296 176.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -98.31 123.98 42.7 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.678 1.191 . . . . 3.24 111.92 -166.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.6 t -143.09 139.89 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.51 1.924 . . . . 2.22 108.411 -173.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 12.1 mtm -82.2 168.2 17.9 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.533 0.938 . . . . 3.74 113.533 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -141.77 166.96 26.08 Favored Glycine 0 CA--C 1.526 0.735 0 C-N-CA 125.635 1.588 . . . . 0.78 112.815 -178.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.7 ttm -155.8 144.27 20.18 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 126.12 1.768 . . . . 1.15 108.634 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 32.7 mtm180 -146.36 155.75 49.88 Favored Pre-proline 0 N--CA 1.468 0.458 0 C-N-CA 125.244 1.418 . . . . 4.25 109.813 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.85 154.85 38.86 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.663 1.575 . . . . 0.53 110.589 164.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.52 155.39 73.72 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 125.503 1.521 . . . . 0.57 110.462 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.93 -28.41 3.26 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.738 2.292 . . . . 0.47 112.867 -168.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -176.03 165.97 2.94 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.223 1.409 . . . . 1.77 112.294 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.8 mt -109.7 153.21 24.61 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.694 1.598 . . . . 0.57 110.284 164.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -110.76 146.45 36.33 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.937 1.295 . . . . 1.72 109.833 174.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 65.6 t -140.16 131.16 14.15 Favored Pre-proline 0 N--CA 1.477 0.891 0 N-CA-C 114.452 1.278 . . . . 1.37 114.452 168.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -76.58 160.61 34.83 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 124.36 3.373 . . . . 1.12 113.124 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.12 145.31 89.14 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.428 3.418 . . . . 1.13 113.792 -178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt 67.93 -4.25 1.04 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 127.077 2.151 . . . . 2.24 114.384 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -87.87 -179.98 47.35 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.694 1.616 . . . . 1.76 113.189 178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.66 139.67 21.02 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.146 1.379 . . . . 3.94 109.26 167.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 53.4 t -144.93 146.47 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 125.739 1.615 . . . . 3.17 109.284 -168.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.33 150.97 46.66 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.882 1.068 . . . . 2.63 113.882 -173.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -72.5 66.54 0.7 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.024 1.73 . . . . 2.08 109.435 163.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -59.27 127.9 84.82 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 124.578 1.151 . . . . 3.05 110.17 175.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -54.8 -38.61 91.98 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 124.338 3.359 . . . . 2.49 113.916 -166.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.44 -1.08 56.84 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 117.53 -1.706 . . . . 1.85 115.338 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -143.56 -23.15 0.17 Allowed Glycine 0 N--CA 1.474 1.199 0 CA-C-N 120.047 1.923 . . . . 2.28 117.793 172.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -149.04 146.64 27.85 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 120.443 2.121 . . . . 2.28 112.425 174.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -161.87 156.05 22.06 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.267 1.027 . . . . 0.66 110.748 174.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -83.45 145.56 28.89 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 109.653 -0.499 . . . . 1.99 109.653 164.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.1 tpt -103.72 111.03 23.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.521 1.928 . . . . 0.79 108.542 168.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -88.65 120.22 29.84 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 124.485 1.114 . . . . 1.28 108.697 -177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -121.12 144.39 48.59 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 122.458 1.123 . . . . 2.06 112.881 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.01 38.42 40.66 Favored Glycine 0 N--CA 1.468 0.768 0 CA-C-N 115.163 -0.926 . . . . 1.75 111.867 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.4 mt -45.02 154.36 0.15 Allowed 'General case' 0 N--CA 1.464 0.268 0 C-N-CA 127.213 2.205 . . . . 0.72 116.217 -176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -116.35 -21.98 9.02 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 113.544 -1.662 . . . . 2.18 114.723 -175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 79.8 mmt-85 -136.2 141.23 35.38 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 127.659 2.384 . . . . 7.12 108.806 170.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.16 144.57 23.62 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 123.982 3.122 . . . . 1.38 109.835 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -90.69 119.35 30.86 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.56 0.744 . . . . 2.0 110.369 -172.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -102.51 163.25 12.33 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.982 0.913 . . . . 3.55 111.397 165.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.7 132.98 45.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.794 -0.817 . . . . 1.08 108.794 166.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.6 1.09 71.67 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.16 -1.356 . . . . 1.3 115.641 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -75.0 179.87 4.71 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 119.571 1.686 . . . . 2.73 109.291 162.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -147.42 153.47 39.64 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 126.195 1.798 . . . . 3.04 108.03 165.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.9 t -142.79 143.3 25.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 127.718 2.407 . . . . 1.15 109.589 -169.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.96 144.96 29.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.977 1.311 . . . . 3.53 112.33 176.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.2 mp -130.5 138.72 50.37 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.124 1.77 . . . . 1.68 109.861 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.407 ' OD1' ' HE3' ' A' ' 112' ' ' LYS . 28.5 m-20 -93.62 130.45 39.53 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.826 1.65 . . . . 2.33 109.47 156.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.4 mp -93.76 140.4 29.7 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.462 1.505 . . . . 1.02 108.93 171.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.3 mt -111.75 131.3 55.41 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.506 1.522 . . . . 0.74 110.547 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -126.7 153.22 45.73 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.499 0.72 . . . . 2.71 112.675 -167.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.34 134.26 55.48 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-O 121.987 0.899 . . . . 2.13 112.036 174.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.68 42.93 45.24 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.667 -1.074 . . . . 4.14 113.703 173.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 82.65 46.2 6.48 Favored Glycine 0 N--CA 1.472 1.047 0 N-CA-C 116.235 1.254 . . . . 1.99 116.235 161.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -128.99 154.74 46.31 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.098 1.449 . . . . 3.46 112.182 167.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.5 t -143.69 144.71 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 C-N-CA 126.593 1.957 . . . . 1.89 107.034 171.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.5 tt -152.19 127.08 9.63 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.644 0.778 . . . . 2.61 110.803 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.407 ' HE3' ' OD1' ' A' ' 102' ' ' ASP . 2.7 ttmt -93.89 134.57 36.13 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.172 0.804 . . . . 2.76 113.172 -177.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.6 t -124.62 153.2 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.026 1.33 . . . . 1.87 108.272 162.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 25.8 t -128.81 139.79 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.886 1.275 . . . . 2.08 107.611 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -151.17 142.23 15.18 Favored Pre-proline 0 CA--C 1.543 0.686 0 N-CA-C 113.152 0.797 . . . . 2.36 113.152 -165.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.84 170.39 14.21 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 124.282 3.321 . . . . 0.97 112.863 174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 22.0 t -118.34 145.74 23.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.982 1.313 . . . . 0.9 110.632 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.48 144.77 32.13 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.015 1.326 . . . . 4.73 112.805 -174.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.03 55.07 1.53 Allowed 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.153 0.981 . . . . 2.99 111.198 -178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 . . . . . 0 C--O 1.244 0.777 0 CA-C-O 115.783 -2.055 . . . . 7.33 113.012 -152.633 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.082 0 N-CA-C 109.578 -1.409 . . . . 10.27 109.578 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.492 ' H ' ' CD ' ' A' ' 5' ' ' GLU . 0.7 OUTLIER -94.68 -173.87 3.14 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.205 1.402 . . . . 7.38 109.709 146.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -80.82 150.17 29.28 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 120.578 -1.327 . . . . 10.6 112.04 169.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.297 20.0 p 61.06 24.85 14.92 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.196 2.199 . . . . 5.13 114.798 168.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 2' ' ' SER . 62.5 mt-10 -78.32 61.86 2.86 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.444 1.498 . . . . 4.94 110.54 172.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.16 159.95 15.39 Favored Glycine 0 N--CA 1.469 0.844 0 O-C-N 120.907 -1.121 . . . . 1.16 111.575 175.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 32.2 p90 -156.66 157.55 35.4 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.947 0.899 . . . . 2.41 112.187 166.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.45 145.47 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 124.589 1.156 . . . . 1.35 108.446 175.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -69.75 -159.76 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.266 1.026 . . . . 5.79 110.668 164.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -128.63 150.61 50.15 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 125.328 1.451 . . . . 2.61 110.684 177.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.7 t -170.72 145.22 2.03 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 125.958 1.703 . . . . 2.42 109.294 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.03 -22.06 15.15 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.98 2.453 . . . . 1.97 112.683 170.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.09 173.21 13.26 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 126.158 1.837 . . . . 1.15 111.745 -174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -79.98 -0.49 39.01 Favored 'Cis proline' 0 CA--C 1.541 0.834 0 CA-C-N 119.122 1.461 . . . . 1.09 113.474 0.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.6 p30 -147.52 162.42 39.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.317 1.047 . . . . 1.85 113.62 -177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -134.27 -179.05 5.33 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 129.606 3.163 . . . . 0.42 109.634 -178.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.81 146.78 49.63 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.399 1.48 . . . . 0.73 108.728 170.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.23 148.67 45.01 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.327 1.051 . . . . 0.65 112.333 -178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -115.66 136.17 53.33 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 126.932 2.093 . . . . 2.43 111.197 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.93 145.65 43.48 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.757 0.823 . . . . 2.84 110.807 173.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.0 m -124.96 113.65 18.1 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.827 0.851 . . . . 2.21 109.983 166.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -124.28 174.12 7.92 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.666 1.986 . . . . 5.41 107.72 165.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.431 ' CD ' HH11 ' A' ' 74' ' ' ARG . 46.0 mt-10 -145.21 155.91 43.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 107.557 -1.275 . . . . 5.55 107.557 173.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.6 t-20 -101.16 100.26 12.86 Favored Pre-proline 0 CA--C 1.542 0.668 0 C-N-CA 123.167 0.587 . . . . 1.61 111.036 -171.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.81 -15.39 13.43 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 122.177 1.918 . . . . 2.3 113.514 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.98 -178.07 52.22 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 119.137 0.88 . . . . 1.48 112.471 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 16.0 m-20 -114.86 3.27 14.56 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.43 1.892 . . . . 4.0 112.232 -167.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -106.36 154.01 40.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 127.096 2.158 . . . . 3.31 110.254 166.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -79.21 147.08 20.38 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.869 2.379 . . . . 1.14 110.877 -175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.7 mt -99.35 138.73 36.04 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 123.633 1.682 . . . . 2.35 111.003 170.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.482 ' HE ' ' CD ' ' A' ' 68' ' ' GLU . 14.6 tpp85 -134.68 105.85 6.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 111.716 -2.493 . . . . 2.09 108.248 -173.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.74 105.41 17.55 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 125.128 1.371 . . . . 2.38 108.6 -171.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.7 m -101.78 -22.67 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 123.617 0.767 . . . . 0.48 112.235 -169.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.24 -177.07 30.99 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 125.199 1.381 . . . . 0.41 112.553 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.0 -176.58 4.55 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.573 1.549 . . . . 0.51 109.277 166.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.439 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -157.16 166.44 33.21 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.669 1.587 . . . . 4.26 108.118 177.375 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.0 t -177.77 153.93 0.98 Allowed Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 124.865 1.266 . . . . 0.8 110.382 -174.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.31 -0.28 9.82 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 123.271 2.647 . . . . 0.94 114.763 172.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.7 m -116.78 26.96 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 N-CA-C 115.508 1.67 . . . . 0.86 115.508 -177.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.75 157.44 33.42 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.277 1.431 . . . . 0.86 110.503 167.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.4 -26.99 41.81 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.021 1.728 . . . . 2.89 112.087 169.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.2 mmt-85 -155.56 149.35 25.31 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 127.498 2.319 . . . . 5.56 108.621 -156.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.7 p -161.4 59.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-O 123.79 1.757 . . . . 2.22 113.028 -158.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -91.4 134.86 34.26 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.096 -1.865 . . . . 5.46 112.236 -167.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.3 tp -83.06 122.9 28.94 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.496 1.518 . . . . 0.88 112.159 -167.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.1 m170 -121.91 150.29 42.19 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.843 1.657 . . . . 0.5 112.415 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -88.93 173.57 8.42 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.113 0.965 . . . . 2.02 111.067 162.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 99.7 m -139.99 129.99 24.86 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 106.589 -1.634 . . . . 0.98 106.589 170.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.7 p90 -134.79 173.31 11.83 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 122.417 1.103 . . . . 2.23 112.951 -165.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 42.8 ttp -120.43 141.74 49.87 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.97 1.308 . . . . 3.34 111.004 165.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -135.44 157.29 47.28 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.212 1.405 . . . . 5.43 111.55 172.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -97.1 144.13 27.26 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.312 1.445 . . . . 2.37 109.962 165.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.1 m -142.68 130.55 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.574 1.549 . . . . 2.77 108.584 163.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 62.21 11.2 4.26 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.599 2.074 . . . . 3.54 116.599 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.9 25.68 40.4 Favored Glycine 0 CA--C 1.539 1.533 0 O-C-N 120.909 -1.119 . . . . 1.74 113.537 -165.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -127.15 120.17 28.2 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.052 1.741 . . . . 2.49 109.453 177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.34 118.98 28.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.57 0.748 . . . . 7.08 110.619 -175.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.52 139.85 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 126.024 1.73 . . . . 2.33 109.5 -172.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 58.0 mtm -83.71 167.47 17.16 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.885 1.069 . . . . 3.25 113.885 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -158.5 -176.49 30.61 Favored Glycine 0 CA--C 1.523 0.58 0 C-N-CA 125.028 1.299 . . . . 0.91 113.3 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.2 ttm -155.85 150.06 25.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 126.783 2.033 . . . . 1.12 107.65 -177.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -157.96 158.49 30.17 Favored Pre-proline 0 N--CA 1.471 0.582 0 C-N-CA 124.495 1.118 . . . . 5.0 110.509 174.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -75.44 154.94 40.82 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.152 1.901 . . . . 0.54 111.907 177.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.7 m -143.08 152.61 58.71 Favored Pre-proline 0 N--CA 1.476 0.844 0 C-N-CA 125.419 1.487 . . . . 0.54 109.808 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -84.13 -23.44 3.0 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 123.187 2.592 . . . . 0.68 113.547 -165.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.443 ' CD1' ' HD2' ' A' ' 31' ' ' ARG . 54.0 p90 -177.14 166.93 2.41 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 126.593 1.957 . . . . 2.02 110.678 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 26.2 mt -110.66 154.31 24.01 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 124.457 1.103 . . . . 0.56 110.059 164.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.482 ' CD ' ' HE ' ' A' ' 31' ' ' ARG . 3.9 tp10 -127.06 138.09 53.15 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.126 1.37 . . . . 1.74 109.612 179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.3 t -143.48 136.79 14.02 Favored Pre-proline 0 CA--C 1.539 0.522 0 C-N-CA 123.998 0.919 . . . . 1.52 110.654 175.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.99 170.4 15.74 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.776 2.318 . . . . 1.39 112.334 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.56 143.96 97.69 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.969 2.446 . . . . 1.65 110.783 161.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.434 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 33.6 mmtm 67.47 0.13 2.06 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.403 1.481 . . . . 2.53 114.157 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.56 162.77 41.89 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 125.753 1.644 . . . . 1.9 113.635 173.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.431 HH11 ' CD ' ' A' ' 23' ' ' GLU . 59.5 mtt-85 -91.48 129.42 37.47 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.563 0.745 . . . . 5.57 111.412 176.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.1 t -103.24 61.14 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 126.764 2.025 . . . . 5.41 109.478 -175.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.76 127.26 56.1 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.229 1.411 . . . . 3.19 109.755 -174.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 83' ' ' HIS . 3.3 mp -70.98 -38.59 72.75 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 125.604 1.562 . . . . 3.2 114.003 -176.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 2.3 mptt 91.13 138.07 0.04 OUTLIER Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 129.416 3.086 . . . . 3.55 109.93 -177.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -70.7 11.74 0.47 Allowed 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.589 2.86 . . . . 2.75 114.731 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -165.61 17.27 0.09 OUTLIER Glycine 0 CA--C 1.535 1.32 0 CA-C-O 116.621 -2.211 . . . . 1.88 116.42 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.27 -29.31 0.45 Allowed Glycine 0 N--CA 1.487 2.044 0 CA-C-N 121.233 2.516 . . . . 2.1 117.626 173.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -138.06 146.89 43.51 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 120.249 2.025 . . . . 2.16 111.197 163.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.49 ' HA ' HD23 ' A' ' 77' ' ' LEU . 57.1 p-80 -158.46 149.02 20.19 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.572 0.582 . . . . 0.68 112.572 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -79.96 131.8 35.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.345 -0.613 . . . . 1.97 109.345 161.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -91.81 103.42 15.98 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.038 1.735 . . . . 0.81 108.459 171.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -85.73 116.88 24.26 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.659 -1.238 . . . . 1.25 107.659 -174.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 tt -130.19 134.85 47.58 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.562 1.145 . . . . 3.12 111.165 -162.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.53 48.69 7.83 Favored Glycine 0 N--CA 1.473 1.11 0 O-C-N 121.751 -0.593 . . . . 1.85 111.969 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.8 mt -48.26 154.34 0.61 Allowed 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 126.253 1.821 . . . . 0.71 114.99 -177.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -119.34 -29.95 5.03 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 113.681 -1.6 . . . . 1.69 114.585 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -107.38 147.5 35.37 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.902 1.681 . . . . 5.83 109.552 173.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -74.39 162.68 37.84 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.66 2.24 . . . . 2.66 109.132 157.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -154.8 155.87 35.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.48 1.512 . . . . 2.78 109.759 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.81 24.24 1.21 Allowed 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 116.326 1.973 . . . . 4.14 116.326 -174.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 66.87 164.76 0.2 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.12 2.168 . . . . 1.49 110.943 -161.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.04 -5.99 30.02 Favored Glycine 0 CA--C 1.535 1.325 0 CA-C-O 118.947 -0.918 . . . . 1.34 114.676 -176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -76.99 166.06 23.83 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.422 1.089 . . . . 2.91 110.099 173.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -118.14 126.19 51.73 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 129.146 2.978 . . . . 3.85 104.625 171.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 69.7 t -126.2 140.6 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.66 1.184 . . . . 1.39 110.065 -178.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -106.83 134.69 49.59 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.42 1.088 . . . . 3.76 112.786 -170.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.6 mp -132.5 133.57 43.96 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.25 1.42 . . . . 1.91 111.887 -179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.439 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 27.4 m-20 -77.84 136.45 38.08 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 126.777 2.031 . . . . 1.83 108.61 159.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 mp -102.99 126.86 50.35 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.338 1.055 . . . . 0.98 108.785 165.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 67.0 mt -104.19 106.54 17.08 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.353 1.061 . . . . 0.72 110.069 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -105.8 151.81 24.02 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.612 1.565 . . . . 2.07 112.35 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -55.83 131.39 46.79 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 113.87 1.063 . . . . 2.79 113.87 -178.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.67 58.13 3.13 Favored Glycine 0 CA--C 1.529 0.935 0 C-N-CA 124.924 1.25 . . . . 3.87 113.347 176.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.37 11.09 79.72 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 124.421 1.01 . . . . 2.19 115.609 169.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 15.7 mttp -93.49 113.1 25.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 118.917 1.359 . . . . 2.86 111.217 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.8 t -126.68 136.12 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.936 1.294 . . . . 1.89 109.887 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.1 tt -143.12 112.61 6.84 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.471 0.708 . . . . 2.97 111.544 -176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -87.73 98.35 11.4 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.961 0.726 . . . . 3.7 112.961 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 114' ' ' VAL . 26.9 t -80.01 172.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 126.444 1.898 . . . . 2.13 110.869 171.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.409 ' N ' HG12 ' A' ' 113' ' ' VAL . 10.7 p -139.34 143.01 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 127.057 2.143 . . . . 2.92 108.378 166.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.48 144.55 15.01 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 125.883 1.673 . . . . 2.18 111.677 -167.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.95 155.5 26.44 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.179 2.586 . . . . 0.97 113.705 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 46.1 t -93.93 121.7 44.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 125.44 1.496 . . . . 1.04 109.472 173.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.0 159.49 15.29 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.317 1.847 . . . . 4.13 110.582 176.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -93.03 55.66 2.4 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.216 -0.928 . . . . 2.84 110.794 -178.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 . . . . . 0 C--O 1.248 1.017 0 N-CA-C 115.107 1.521 . . . . 6.31 115.107 -144.201 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.384 0 N-CA-C 108.952 -1.659 . . . . 10.98 108.952 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -77.27 -123.02 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 117.339 -1.315 . . . . 9.85 107.959 132.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -156.01 167.34 30.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 121.108 1.776 . . . . 8.16 112.083 174.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 81.4 p -128.13 61.63 1.44 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.744 1.618 . . . . 5.46 111.853 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -79.51 118.2 21.16 Favored 'General case' 0 CA--C 1.542 0.652 0 O-C-N 121.094 -1.004 . . . . 4.6 111.59 174.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.49 168.75 33.77 Favored Glycine 0 C--N 1.341 0.838 0 O-C-N 121.02 -1.05 . . . . 1.17 114.296 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 7.2 p90 -152.16 172.6 16.12 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.254 1.022 . . . . 2.16 112.945 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.5 t -109.36 138.85 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 121.098 -1.001 . . . . 1.14 109.03 172.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.1 mmt85 -51.68 -81.61 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.965 1.306 . . . . 5.06 113.093 -173.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 75.1 t80 158.22 153.0 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 130.118 3.367 . . . . 3.06 107.282 -157.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.0 t 150.22 128.8 0.0 OUTLIER Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 129.34 3.056 . . . . 2.14 110.879 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -68.88 -35.85 14.62 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 121.855 1.703 . . . . 1.29 111.793 173.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 152.25 173.13 21.52 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 126.483 1.992 . . . . 0.97 112.035 -176.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -83.75 5.16 56.05 Favored 'Cis proline' 0 CA--C 1.541 0.865 0 CA-C-N 119.33 1.565 . . . . 1.12 113.654 3.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -154.68 160.24 41.25 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.412 1.085 . . . . 1.76 113.673 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.87 -177.44 5.33 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.935 2.094 . . . . 0.42 111.623 -177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.27 147.92 28.24 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.791 1.236 . . . . 0.73 110.756 175.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -122.03 145.52 48.06 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.092 1.757 . . . . 0.5 111.539 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' A' ' 79' ' ' PRO . 96.2 m-85 -144.19 121.52 11.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.884 2.073 . . . . 2.69 109.961 -164.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pp -166.0 148.59 7.27 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 120.442 -1.411 . . . . 1.99 114.318 -155.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.5 m -81.99 135.17 35.39 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.759 0.79 . . . . 1.89 110.434 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.51 137.0 47.18 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.881 2.072 . . . . 3.35 108.791 170.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -114.67 166.41 11.76 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.129 0.572 . . . . 4.29 111.64 166.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -119.97 111.71 35.46 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 123.031 0.532 . . . . 1.48 110.246 164.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -81.21 -15.62 10.12 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 122.759 2.306 . . . . 1.19 113.919 175.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.23 -175.27 49.76 Favored Glycine 0 C--N 1.342 0.898 0 C-N-CA 124.496 1.046 . . . . 1.3 113.149 -173.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.91 -10.12 27.07 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.066 1.747 . . . . 3.35 111.613 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.2 mp -130.45 161.24 61.8 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 127.572 2.349 . . . . 3.84 108.913 -175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.65 155.94 49.35 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.65 2.233 . . . . 1.43 111.541 -170.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.9 mt -110.55 152.22 26.67 Favored 'General case' 0 CA--C 1.517 -0.297 0 C-N-CA 125.103 1.361 . . . . 1.87 110.429 172.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -128.5 105.07 8.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.507 -1.679 . . . . 2.01 111.264 -179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -92.54 104.57 16.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 125.133 1.373 . . . . 1.84 108.118 -172.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.4 m -98.21 -28.59 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.401 0.681 . . . . 0.7 112.182 -166.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.93 -178.61 33.1 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 125.521 1.534 . . . . 0.55 111.336 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.55 ' O ' HG11 ' A' ' 43' ' ' VAL . . . -131.24 -178.48 4.85 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.868 0.867 . . . . 0.77 109.375 161.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 25.3 tpt180 -144.75 169.73 17.46 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 129.539 3.136 . . . . 5.54 106.348 165.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -172.35 149.74 2.15 Favored Pre-proline 0 N--CA 1.469 0.506 0 C-N-CA 126.938 2.095 . . . . 0.56 108.006 -172.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -71.51 -30.9 14.48 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.065 1.177 . . . . 1.01 112.478 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -89.16 19.24 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 115.856 1.799 . . . . 0.78 115.856 -168.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.99 154.0 34.07 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.718 1.007 . . . . 0.79 113.718 174.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -79.98 -65.17 1.04 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.611 1.564 . . . . 3.1 109.819 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 18.3 mtp-105 -110.71 107.96 17.68 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.655 0.74 . . . . 6.16 110.683 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.55 HG11 ' O ' ' A' ' 35' ' ' ALA . 7.4 p -77.58 146.9 7.71 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 126.054 1.741 . . . . 1.43 108.689 162.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -155.5 146.62 22.57 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.852 1.261 . . . . 2.64 109.417 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.0 tp -105.83 120.27 41.28 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.358 0.981 . . . . 0.92 111.099 -174.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -127.79 159.56 34.46 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-O 122.929 1.347 . . . . 0.76 113.981 -174.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -104.86 161.32 14.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.909 2.084 . . . . 2.1 112.351 159.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.9 m -137.23 145.68 43.91 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.985 2.114 . . . . 1.31 107.089 172.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -155.81 165.61 36.0 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 122.762 1.267 . . . . 2.13 114.24 -169.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.62 146.88 24.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.718 1.207 . . . . 5.86 111.278 166.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -152.13 161.85 42.0 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.588 1.555 . . . . 5.43 110.061 -171.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -112.79 142.36 45.52 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.347 1.059 . . . . 2.43 112.296 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.8 t -136.28 115.96 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.264 1.425 . . . . 2.35 108.433 164.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 66.37 7.48 4.99 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 127.291 2.236 . . . . 3.29 115.211 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.18 7.59 59.41 Favored Glycine 0 CA--C 1.54 1.624 0 O-C-N 121.123 -0.986 . . . . 1.67 114.189 -165.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.1 mtpt -109.09 129.43 55.47 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 127.416 2.286 . . . . 2.81 108.292 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -79.7 120.54 24.15 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.938 -1.483 . . . . 2.75 109.251 -166.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 74.2 t -134.38 131.52 54.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 126.231 1.812 . . . . 2.57 108.846 -173.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.1 mtt -83.35 165.3 19.4 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 121.506 -0.746 . . . . 2.79 112.632 177.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.24 173.88 32.73 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 124.25 0.929 . . . . 0.83 112.943 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 12.5 ttm -157.09 137.39 12.86 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.889 1.676 . . . . 1.33 109.395 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -143.01 149.28 48.63 Favored Pre-proline 0 N--CA 1.469 0.503 0 C-N-CA 125.529 1.532 . . . . 8.85 110.643 -174.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.63 153.18 43.58 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.066 1.844 . . . . 0.58 109.962 169.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.07 156.0 77.26 Favored Pre-proline 0 N--CA 1.478 0.959 0 C-N-CA 124.735 1.214 . . . . 0.68 110.111 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.72 -27.82 2.44 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.851 2.367 . . . . 0.59 113.242 -169.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -177.84 165.94 2.05 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 126.344 1.858 . . . . 2.24 111.297 -178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.7 mt -110.7 155.85 21.86 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.031 1.332 . . . . 0.53 109.884 163.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -113.24 146.77 38.77 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.725 1.21 . . . . 2.08 109.105 172.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.88 128.0 14.21 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 113.647 0.98 . . . . 1.11 113.647 168.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -78.59 156.57 28.26 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.332 3.355 . . . . 1.37 113.05 -177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -64.11 141.89 78.34 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 124.758 3.639 . . . . 1.42 114.005 -172.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.7 mmtt 71.39 -15.95 0.4 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 129.122 2.969 . . . . 1.88 114.161 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.83 -177.12 50.21 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 125.597 1.57 . . . . 1.71 113.561 -176.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -146.72 150.7 35.89 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.086 0.954 . . . . 4.88 111.389 163.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.6 t -149.67 139.44 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.965 2.106 . . . . 3.64 107.079 -175.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.1 147.43 34.86 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 122.304 1.049 . . . . 3.56 113.499 -174.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.07 74.94 0.49 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.668 1.587 . . . . 2.06 107.438 157.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.47 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -57.87 142.48 78.91 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.625 1.17 . . . . 2.32 114.08 -170.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.544 ' HA ' ' CD2' ' A' ' 19' ' ' TYR . 29.8 Cg_endo -58.86 -10.41 9.64 Favored 'Trans proline' 0 C--N 1.357 1.014 1 C-N-CA 125.606 4.204 . . . . 2.74 117.736 -170.049 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -114.88 2.45 22.93 Favored Glycine 0 CA--C 1.538 1.48 0 C-N-CA 124.728 1.156 . . . . 2.76 115.43 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -130.84 -112.07 1.46 Allowed Glycine 0 N--CA 1.472 1.084 0 CA-C-N 119.148 1.474 . . . . 1.97 113.136 -172.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -72.5 143.09 48.5 Favored 'General case' 0 N--CA 1.466 0.327 0 O-C-N 121.988 -0.713 . . . . 1.9 111.662 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 19' ' ' TYR . 51.4 p-80 -160.39 157.17 27.35 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 124.568 1.147 . . . . 0.76 111.843 -174.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -81.2 135.33 35.74 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.834 -0.802 . . . . 2.35 108.834 155.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.1 126.09 47.77 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.272 2.229 . . . . 1.06 108.444 169.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -115.14 113.09 23.53 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 124.16 0.984 . . . . 2.61 109.847 -176.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.07 152.13 19.63 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.082 1.753 . . . . 2.09 110.63 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.94 -50.65 4.44 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 127.799 2.619 . . . . 3.03 113.551 175.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.1 mt 57.94 169.09 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 128.864 2.865 . . . . 1.0 115.675 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -128.48 -23.8 3.15 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.518 2.327 . . . . 1.7 114.256 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -130.61 150.76 77.26 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 127.512 2.325 . . . . 5.32 109.903 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.21 123.94 8.13 Favored 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 122.585 2.19 . . . . 1.99 108.538 163.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.04 113.47 17.19 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.186 0.994 . . . . 2.51 108.609 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.86 166.01 26.48 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 125.371 1.469 . . . . 3.68 111.055 172.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.11 123.61 16.54 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.011 0.924 . . . . 1.44 110.98 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.93 25.86 59.32 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-N 115.678 -0.692 . . . . 2.64 113.82 -174.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -86.69 172.71 9.99 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 118.893 1.347 . . . . 2.53 108.757 133.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -144.37 158.56 43.68 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 129.045 2.938 . . . . 3.13 105.257 171.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 98.7 t -150.56 146.59 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 126.385 1.874 . . . . 1.31 110.112 -169.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.46 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 38.0 mt-10 -95.83 138.01 34.09 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.234 0.614 . . . . 2.64 110.442 165.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 mp -115.36 137.43 52.05 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.734 0.778 . . . . 1.71 110.262 159.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.62 113.17 26.58 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 128.316 2.646 . . . . 2.56 108.92 177.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.1 mp -94.75 132.9 39.01 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.513 -1.367 . . . . 1.0 111.339 -168.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 55.9 mt -104.65 106.24 16.66 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.392 1.477 . . . . 0.69 109.994 -174.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -104.0 115.27 30.14 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.76 1.224 . . . . 2.37 110.76 -176.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.11 23.74 2.41 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 126.863 2.065 . . . . 2.32 113.845 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.0 -56.73 4.33 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.328 1.442 . . . . 4.45 112.914 -169.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.15 -6.68 69.48 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 117.054 1.582 . . . . 1.57 117.054 -165.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -128.38 121.51 29.26 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 119.485 1.643 . . . . 4.52 113.015 177.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.0 t -102.35 136.3 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.157 1.383 . . . . 1.96 109.429 166.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 68.9 tp -155.39 128.19 8.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.011 1.325 . . . . 2.87 109.688 174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.46 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 52.0 pttt -109.23 160.87 15.76 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.374 1.62 . . . . 2.19 115.374 -174.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.4 t -140.07 161.6 25.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 126.838 2.055 . . . . 1.95 109.439 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 40.5 t -106.89 142.18 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.53 1.532 . . . . 1.85 109.152 178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.7 mp -144.41 128.5 9.03 Favored Pre-proline 0 CA--C 1.551 1.002 0 C-N-CA 126.004 1.722 . . . . 2.77 110.2 -171.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.53 164.92 32.83 Favored 'Trans proline' 0 CA--C 1.535 0.536 0 C-N-CA 123.07 2.514 . . . . 1.14 111.921 172.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 16.1 t -109.91 151.76 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 123.183 0.593 . . . . 0.83 110.782 171.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -124.28 -171.09 2.26 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 126.756 2.022 . . . . 4.16 112.54 -169.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -120.17 103.06 8.94 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 120.859 -1.15 . . . . 2.1 109.359 167.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 . . . . . 0 N--CA 1.477 0.879 0 C-N-CA 128.127 2.571 . . . . 6.0 110.36 -167.237 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.783 0 N-CA-C 109.668 -1.373 . . . . 9.92 109.668 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.3 t -132.01 104.99 7.13 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.22 1.408 . . . . 7.46 110.401 -175.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -159.39 171.6 19.48 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 127.573 2.349 . . . . 9.92 109.578 -168.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . 0.253 6.4 t 58.38 2.7 0.22 Allowed 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 126.536 1.935 . . . . 5.29 115.372 178.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -73.37 90.21 1.66 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 106.369 -1.715 . . . . 4.79 106.369 170.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.2 -178.17 32.96 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.637 1.589 . . . . 1.24 113.426 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 33.1 p90 -156.18 157.71 36.38 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.422 1.889 . . . . 2.47 112.345 179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.9 132.7 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 C-N-CA 125.283 1.433 . . . . 1.73 108.481 169.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -67.93 162.13 24.96 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.996 0.903 . . . . 4.31 112.445 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -98.65 130.12 45.16 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.22 -1.4 . . . . 2.32 107.22 171.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 68.5 m -167.73 147.43 4.38 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 127.057 2.143 . . . . 2.6 107.083 174.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.99 -22.91 9.69 Favored 'Trans proline' 0 CA--C 1.535 0.543 0 C-N-CA 122.929 2.419 . . . . 1.94 113.218 178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.25 173.63 13.47 Favored Glycine 0 CA--C 1.541 1.694 0 C-N-CA 126.462 1.982 . . . . 1.62 110.354 -166.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -70.67 -9.14 12.66 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 CA-C-N 119.681 1.741 . . . . 2.19 112.412 -4.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -137.62 161.35 36.69 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.625 1.343 . . . . 2.35 114.625 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.93 -173.87 3.21 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 131.654 3.981 . . . . 0.6 107.492 174.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -137.9 166.75 23.27 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 120.635 -1.291 . . . . 1.1 110.676 176.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.04 148.51 32.76 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 122.109 0.957 . . . . 0.56 111.929 171.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -145.15 129.83 18.08 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.873 2.069 . . . . 2.62 107.919 -165.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -165.11 150.79 9.68 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.571 1.078 . . . . 2.27 113.892 -174.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 97.2 m -79.87 112.73 17.44 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 125.62 1.568 . . . . 1.84 110.74 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.77 127.69 36.01 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 124.214 1.005 . . . . 2.92 108.571 169.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -116.63 134.42 54.85 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.905 1.282 . . . . 4.37 108.801 168.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 58.6 t-20 -99.46 117.68 63.45 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.506 1.122 . . . . 1.37 109.882 173.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -88.4 -8.9 5.25 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.252 2.635 . . . . 1.32 114.825 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -91.34 160.06 26.64 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-N 119.789 1.177 . . . . 1.41 111.928 -177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -80.09 3.05 21.64 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 127.947 2.499 . . . . 3.75 112.127 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -123.87 152.12 65.75 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 128.333 2.653 . . . . 2.75 109.248 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.74 146.35 23.68 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 123.125 2.55 . . . . 1.16 111.205 -171.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 48.4 mt -98.88 145.28 27.15 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 122.428 1.109 . . . . 1.84 111.481 171.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.531 ' HD2' ' CD2' ' A' ' 66' ' ' PHE . 5.1 tpp180 -130.45 104.91 7.52 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.271 -1.786 . . . . 2.64 109.796 -174.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.407 HD13 ' C ' ' A' ' 32' ' ' LEU . 1.8 tm? -98.17 115.01 27.43 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 127.234 2.214 . . . . 2.08 108.991 -169.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.9 m -101.98 -28.34 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.208 0.913 . . . . 0.88 112.363 -175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.01 -175.09 30.6 Favored Glycine 0 C--N 1.344 0.974 0 N-CA-C 115.26 0.864 . . . . 0.42 115.26 -176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -140.42 -176.85 4.78 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.977 1.711 . . . . 0.53 112.049 171.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.8 ttt-85 -159.56 153.39 23.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.871 2.069 . . . . 5.12 108.149 172.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -163.55 150.9 10.73 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-N 120.109 1.322 . . . . 0.91 110.473 -170.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -80.29 -15.29 11.47 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.818 2.345 . . . . 1.14 115.135 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -105.45 26.68 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.158 1.383 . . . . 1.2 113.634 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.38 174.03 10.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.242 1.417 . . . . 1.6 109.215 162.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -99.91 -48.44 4.67 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.966 1.706 . . . . 3.96 109.505 169.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -126.15 171.61 10.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 127.883 2.473 . . . . 5.07 107.596 -179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.8 p -154.78 142.75 12.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 125.596 1.558 . . . . 1.0 108.532 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -115.59 158.11 23.15 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 125.67 1.588 . . . . 3.48 109.524 172.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.6 tp -111.22 117.01 32.02 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.076 1.35 . . . . 0.91 109.099 173.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -120.14 149.86 41.55 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.206 1.402 . . . . 0.63 114.223 -174.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -93.3 161.12 14.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.265 1.826 . . . . 2.42 111.134 160.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.6 m -129.4 146.14 51.31 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.52 1.928 . . . . 1.24 106.301 170.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -160.15 -179.05 7.41 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.727 1.01 . . . . 2.24 113.727 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 44.7 mtm -116.46 148.28 40.91 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.792 1.637 . . . . 4.32 111.882 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.62 154.34 45.34 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.444 1.497 . . . . 7.05 111.977 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -91.54 137.43 32.37 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 107.738 -1.208 . . . . 3.12 107.738 148.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.4 t -144.03 139.7 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 N-CA-C 106.491 -1.67 . . . . 2.83 106.491 160.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 64.18 19.92 11.97 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.141 1.376 . . . . 4.57 113.931 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.76 17.12 72.88 Favored Glycine 0 CA--C 1.538 1.5 0 O-C-N 120.354 -1.466 . . . . 2.26 113.354 -169.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -122.01 135.18 54.82 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 128.039 2.535 . . . . 3.02 109.526 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.2 mmtt -74.49 118.7 17.75 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.861 2.064 . . . . 4.05 108.564 -176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.44 -179.55 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 126.74 2.016 . . . . 2.87 110.673 -174.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.97 174.31 6.54 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.507 1.123 . . . . 2.98 111.955 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.73 173.54 33.79 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.862 1.22 . . . . 0.89 112.922 176.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.5 ttm -157.7 146.06 19.14 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 126.436 1.894 . . . . 1.26 107.841 -178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -150.39 157.74 36.58 Favored Pre-proline 0 N--CA 1.468 0.458 0 C-N-CA 125.255 1.422 . . . . 4.28 109.6 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -74.82 153.87 43.01 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.724 1.616 . . . . 0.54 111.07 164.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 23.5 m -134.6 152.18 77.29 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.531 1.532 . . . . 0.63 110.966 177.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -81.76 -21.61 5.87 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.301 2.667 . . . . 0.55 113.208 -169.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.531 ' CD2' ' HD2' ' A' ' 31' ' ' ARG . 47.3 p90 -175.87 164.05 2.85 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.206 1.402 . . . . 2.07 112.07 178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 32.3 mt -109.98 156.64 20.21 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.877 1.671 . . . . 0.55 110.145 163.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -114.35 146.6 40.33 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 123.182 0.593 . . . . 2.75 109.797 163.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 10.5 t -122.71 126.77 26.0 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 125.408 1.483 . . . . 1.32 109.219 164.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -67.56 165.63 26.69 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.441 2.761 . . . . 1.39 110.687 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.33 138.31 55.04 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 123.016 2.477 . . . . 1.18 113.411 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . 0.282 14.4 mtmt 60.14 29.75 19.28 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.684 1.594 . . . . 2.65 114.89 168.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.77 -179.85 18.14 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 127.727 2.584 . . . . 1.59 113.816 176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -113.24 156.74 22.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.751 0.82 . . . . 4.43 112.963 174.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.5 t -148.65 117.06 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 126.093 1.757 . . . . 3.31 107.797 163.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.19 158.3 23.64 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.346 0.869 . . . . 2.88 113.346 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.3 mp -80.8 62.39 4.81 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 122.671 1.224 . . . . 2.04 109.704 151.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' CD ' ' H ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -56.54 126.69 70.8 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-O 118.066 -0.969 . . . . 3.67 111.152 171.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -56.96 -39.17 93.43 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.256 3.304 . . . . 2.55 114.018 -167.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.11 -3.21 51.52 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 118.025 -1.431 . . . . 1.96 115.051 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -141.59 -24.32 0.22 Allowed Glycine 0 N--CA 1.473 1.131 0 N-CA-C 118.155 2.022 . . . . 2.41 118.155 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -148.89 143.47 26.26 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 120.67 2.235 . . . . 2.35 112.796 175.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -160.48 154.61 23.13 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 124.745 1.218 . . . . 0.79 110.961 174.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.461 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 82.2 m-85 -77.8 150.06 34.34 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 108.673 -0.862 . . . . 2.42 108.673 161.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.8 tpt -106.71 115.18 29.75 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.34 1.856 . . . . 1.0 106.783 166.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.58 120.68 37.35 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.402 1.081 . . . . 1.3 108.741 -174.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.7 mp -116.82 138.15 51.7 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.008 0.923 . . . . 1.84 112.611 -167.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.16 49.58 8.36 Favored Glycine 0 N--CA 1.473 1.158 0 O-C-N 121.928 -0.482 . . . . 1.56 112.023 172.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 10.5 mt -48.61 154.99 0.6 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 126.969 2.108 . . . . 0.95 115.318 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -118.13 -31.38 5.04 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 113.511 -1.677 . . . . 2.11 113.759 -173.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.4 mtp-105 -118.99 134.5 23.62 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 125.505 1.522 . . . . 4.99 107.69 170.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -69.99 113.52 3.44 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 N-CA-C 107.144 -1.906 . . . . 1.75 107.144 163.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -57.61 153.72 12.71 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.969 1.308 . . . . 2.53 113.262 -174.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -131.49 147.05 52.51 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 123.512 1.625 . . . . 4.79 113.592 163.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.96 112.51 10.15 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.602 -1.636 . . . . 1.59 110.237 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 116.67 -0.55 20.09 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-O 117.97 -1.461 . . . . 1.64 115.376 -173.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -86.51 -176.32 5.8 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.48 1.64 . . . . 2.35 110.372 170.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -142.76 146.15 33.99 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.641 2.376 . . . . 4.34 108.084 171.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -145.22 142.15 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.64 1.576 . . . . 1.71 111.56 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -88.85 164.39 15.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.664 1.357 . . . . 2.51 114.664 179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.5 tt -154.97 134.1 12.36 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.347 1.459 . . . . 2.6 110.872 177.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -79.37 153.34 29.83 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 127.479 2.312 . . . . 1.97 110.503 169.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.18 124.98 35.99 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.708 2.003 . . . . 1.18 108.989 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.8 mt -106.21 116.32 31.74 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.725 1.21 . . . . 0.68 109.754 -170.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -112.14 130.31 55.94 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.772 1.229 . . . . 2.09 111.394 -176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -62.07 -19.13 62.61 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.982 1.313 . . . . 2.18 113.367 174.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -74.64 32.63 1.01 Allowed Glycine 0 CA--C 1.538 1.503 0 C-N-CA 124.728 1.156 . . . . 4.85 114.272 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 67.7 35.35 85.55 Favored Glycine 0 N--CA 1.471 1.003 0 C-N-CA 125.619 1.581 . . . . 2.71 114.342 175.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.6 mttp -142.06 145.39 34.29 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.942 1.371 . . . . 2.94 114.026 -167.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 13.7 p -127.32 146.87 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 126.513 1.925 . . . . 2.29 109.326 167.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -156.7 147.78 22.05 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 127.045 2.138 . . . . 2.16 107.932 -178.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -122.73 155.91 35.5 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 120.591 1.541 . . . . 2.23 114.044 172.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.52 173.24 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.373 2.269 . . . . 1.75 108.886 -179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -136.1 136.81 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.443 1.497 . . . . 2.22 110.618 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.9 mt -137.89 136.76 20.18 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.303 1.441 . . . . 2.29 111.127 -166.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.94 159.39 53.13 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.625 2.883 . . . . 0.96 112.128 171.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 47.7 t -103.76 131.12 53.11 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.747 1.219 . . . . 1.5 109.761 174.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -145.54 170.56 16.18 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.227 1.811 . . . . 4.06 110.838 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -116.32 118.1 31.82 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.218 1.007 . . . . 1.96 110.647 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 . . . . . 0 C--O 1.248 0.974 0 C-N-CA 126.422 1.889 . . . . 6.87 109.086 -160.403 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.352 0 N-CA-C 107.835 -2.106 . . . . 10.55 107.835 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 p -56.8 -103.42 0.0 OUTLIER 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 118.965 -1.094 . . . . 8.91 108.804 114.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -67.69 157.01 35.59 Favored 'General case' 0 CA--C 1.552 1.051 0 O-C-N 120.423 -1.423 . . . . 8.29 112.73 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.17 17.55 0.18 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 127.046 2.138 . . . . 4.98 114.989 -167.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -76.43 73.81 3.18 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-O 123.545 1.64 . . . . 4.48 112.528 -175.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.32 -178.66 15.72 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 126.188 1.851 . . . . 1.35 111.935 175.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -148.95 149.0 30.45 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.071 1.138 . . . . 2.21 114.071 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 91.1 t -79.08 133.39 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 106.64 -1.615 . . . . 1.34 106.64 163.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -68.05 -18.64 64.74 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 115.575 1.695 . . . . 4.22 115.575 -158.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.4 t80 76.67 151.32 0.12 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 127.746 2.418 . . . . 3.03 112.534 -174.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.5 t 174.88 161.31 0.38 Allowed Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 129.667 3.187 . . . . 2.09 108.639 -175.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -79.63 -24.94 5.8 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.809 2.339 . . . . 1.25 112.761 159.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 117.47 -178.43 17.02 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 126.265 1.888 . . . . 1.0 112.447 -169.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -76.26 -0.49 21.9 Favored 'Cis proline' 0 CA--C 1.54 0.823 0 CA-C-N 119.023 1.412 . . . . 1.36 113.273 -2.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -135.34 166.79 22.32 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.378 1.471 . . . . 2.19 113.205 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -156.47 -174.12 4.8 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 129.191 2.996 . . . . 0.56 111.413 -175.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -138.26 175.6 9.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.401 1.88 . . . . 0.96 108.83 169.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -144.3 128.59 17.81 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.339 -0.851 . . . . 0.59 111.641 170.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.466 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 53.7 m-85 -109.21 69.64 0.71 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.386 1.874 . . . . 2.51 109.268 176.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.9 pp -79.28 158.65 27.51 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.617 0.767 . . . . 1.76 112.795 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.4 m -119.07 140.34 50.24 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.193 1.797 . . . . 2.1 109.087 172.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 37.0 tp -155.33 178.95 9.64 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.037 1.735 . . . . 4.63 108.811 174.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -158.27 149.61 21.09 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.222 1.809 . . . . 4.64 107.889 -171.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -106.51 87.17 2.53 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 124.919 1.288 . . . . 1.69 110.252 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -71.56 -11.55 28.28 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.512 2.142 . . . . 2.18 114.136 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.28 174.45 53.48 Favored Glycine 0 C--N 1.339 0.719 0 CA-C-O 123.075 1.375 . . . . 1.47 113.049 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -101.6 -1.76 32.07 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 127.205 2.202 . . . . 3.27 112.768 -167.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.27 156.87 57.13 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 126.698 1.999 . . . . 3.33 109.683 172.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.12 170.4 16.44 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.908 2.406 . . . . 1.54 112.203 -162.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 76.9 mt -118.21 146.55 44.15 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 122.851 1.31 . . . . 2.87 111.354 167.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 34.9 ttm180 -135.53 110.94 9.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 111.73 -2.486 . . . . 2.13 109.333 169.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 45.1 tp -94.37 112.14 23.92 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.945 1.698 . . . . 2.39 110.042 -173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.7 m -107.64 -22.96 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.847 0.859 . . . . 0.54 111.602 -170.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.57 -174.79 30.84 Favored Glycine 0 C--N 1.345 1.072 0 C-N-CA 125.117 1.341 . . . . 0.44 113.838 -177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -149.22 -178.44 6.39 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.401 1.881 . . . . 0.49 110.913 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -156.58 175.36 14.14 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.41 2.284 . . . . 5.96 108.022 161.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.8 t -170.5 158.61 5.89 Favored Pre-proline 0 N--CA 1.473 0.705 0 C-N-CA 127.037 2.135 . . . . 0.74 109.448 -174.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -85.41 -5.94 9.16 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.452 2.101 . . . . 1.14 114.861 169.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -107.88 16.45 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 115.017 1.488 . . . . 1.14 115.017 -178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -162.77 159.47 24.15 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.945 2.098 . . . . 0.93 109.181 176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -108.33 -42.24 4.65 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.306 0.854 . . . . 3.85 113.306 -170.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -113.98 147.82 37.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 122.48 1.133 . . . . 6.56 108.442 164.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -135.47 134.31 52.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 125.186 1.395 . . . . 0.85 107.582 178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -130.92 125.86 34.6 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 125.508 1.523 . . . . 3.3 109.525 -166.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.54 119.06 24.74 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.832 -0.543 . . . . 0.85 111.925 -175.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . 0.407 ' CE1' ' HB2' ' A' ' 85' ' ' MET . 56.2 m170 -121.55 161.06 23.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.822 1.649 . . . . 0.51 113.523 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.6 159.96 15.56 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.858 1.663 . . . . 2.11 111.009 158.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.1 m -114.77 137.54 51.82 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 105.757 -1.942 . . . . 0.85 105.757 161.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -133.75 174.57 10.31 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 122.667 1.222 . . . . 2.1 113.203 -176.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 29.4 mtm -119.24 141.03 49.28 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.244 1.417 . . . . 4.86 110.554 174.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 11.6 mtp180 -133.99 144.77 48.95 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.317 1.047 . . . . 5.94 110.738 172.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -78.86 114.53 17.87 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 106.479 -1.675 . . . . 2.29 106.479 137.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 42.9 t -94.03 97.86 7.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.601 0 N-CA-C 104.449 -2.426 . . . . 2.99 104.449 171.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.31 37.26 11.1 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 122.903 1.335 . . . . 8.83 111.246 166.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.87 18.17 75.65 Favored Glycine 0 CA--C 1.527 0.824 0 O-C-N 121.018 -1.051 . . . . 2.26 112.387 -175.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.9 mmtm -120.93 108.96 14.52 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.725 1.61 . . . . 4.46 110.525 168.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.574 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -57.41 127.54 32.49 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 120.008 -1.683 . . . . 3.26 111.706 171.818 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 9.3 p -158.33 174.0 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.398 1.879 . . . . 2.43 110.711 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.9 mtt -105.97 172.38 6.84 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.572 1.149 . . . . 2.88 112.414 171.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.87 -178.62 31.13 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 124.821 1.201 . . . . 0.7 112.898 178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 6.8 ttm -154.75 150.73 27.89 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.814 1.646 . . . . 1.15 108.397 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -158.53 158.56 29.6 Favored Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 123.92 0.888 . . . . 4.74 111.49 173.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -71.89 154.84 58.36 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.438 2.092 . . . . 0.59 111.287 171.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.47 153.39 65.62 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 125.533 1.533 . . . . 0.65 110.117 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -79.84 -26.7 4.38 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.27 2.647 . . . . 0.61 113.116 -167.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -178.24 164.06 1.72 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.961 1.704 . . . . 2.09 111.172 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.5 mt -109.44 154.39 22.69 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.696 1.198 . . . . 0.78 109.762 166.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -124.93 137.01 54.28 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.052 1.341 . . . . 1.74 110.389 -178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 27.2 t -143.94 135.03 12.48 Favored Pre-proline 0 N--CA 1.475 0.819 0 CA-C-N 118.35 0.523 . . . . 1.41 112.275 172.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.93 172.19 11.17 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.693 2.929 . . . . 0.93 113.047 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -59.93 145.33 98.58 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.881 2.387 . . . . 1.13 111.588 164.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt 67.58 -2.2 1.4 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.783 2.033 . . . . 1.78 114.059 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.85 159.8 46.16 Favored Glycine 0 CA--C 1.535 1.301 0 C-N-CA 125.673 1.606 . . . . 1.39 114.247 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.24 134.7 34.53 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.99 1.316 . . . . 3.75 110.848 172.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.8 t -114.9 64.21 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 127.365 2.266 . . . . 5.05 107.617 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -98.32 137.07 37.58 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.275 -0.891 . . . . 3.02 110.069 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.597 HD23 ' HA ' ' A' ' 83' ' ' HIS . 1.9 mp -73.62 -63.79 1.13 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 118.011 -0.995 . . . . 3.19 111.034 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm 107.99 128.89 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 128.928 2.891 . . . . 3.69 114.248 161.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.466 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 14.9 Cg_endo -53.48 -56.7 2.46 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 124.283 3.322 . . . . 2.12 113.599 -179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.01 28.62 1.91 Allowed Glycine 0 CA--C 1.534 1.239 0 CA-C-O 118.555 -1.136 . . . . 1.86 113.861 175.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.25 -128.88 0.99 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 124.709 1.147 . . . . 1.63 115.554 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -74.76 144.21 43.7 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 121.052 -1.264 . . . . 1.85 111.54 -165.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.597 ' HA ' HD23 ' A' ' 77' ' ' LEU . 47.3 p-80 -160.75 151.06 17.94 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.348 -0.845 . . . . 0.6 112.246 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -78.06 128.5 33.94 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.738 -0.838 . . . . 2.11 108.738 161.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.407 ' HB2' ' CE1' ' A' ' 46' ' ' HIS . 2.8 tpt -79.78 128.91 34.0 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 107.768 -1.197 . . . . 0.81 107.768 160.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.48 115.36 29.5 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 124.3 1.04 . . . . 1.14 108.303 -178.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.8 mp -121.05 149.78 42.19 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.666 1.186 . . . . 2.22 111.137 -175.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.72 49.18 11.05 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 124.169 0.89 . . . . 1.8 111.277 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mt -52.03 153.28 2.72 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 123.479 1.609 . . . . 0.69 114.395 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -121.13 -16.27 8.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 112.547 -2.115 . . . . 2.21 115.435 -168.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.9 mmm180 -134.3 144.59 51.84 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 124.816 1.246 . . . . 5.24 111.084 -173.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -72.6 91.98 0.78 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 122.458 2.105 . . . . 3.3 107.55 161.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.689 ' H ' HD23 ' A' ' 93' ' ' LEU . 1.7 pt? -81.07 155.92 26.08 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.198 1.799 . . . . 2.78 111.662 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -113.46 165.52 12.4 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 122.384 1.088 . . . . 3.56 111.468 166.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -75.49 129.66 37.62 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 114.318 -1.31 . . . . 1.46 107.665 153.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.14 20.7 37.97 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.311 -1.272 . . . . 1.5 114.76 -172.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -100.31 179.09 4.57 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.56 1.68 . . . . 2.48 109.543 159.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -132.97 126.47 32.07 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 127.309 2.244 . . . . 3.67 105.738 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 88.7 t -148.23 145.4 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 126.801 2.041 . . . . 1.76 108.194 -170.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.3 151.49 22.65 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 123.407 1.575 . . . . 3.65 114.079 -171.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.3 mp -118.62 134.61 54.98 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 125.476 1.511 . . . . 1.84 110.07 171.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.402 ' OD1' ' HE2' ' A' ' 112' ' ' LYS . 11.6 m-20 -81.65 130.67 35.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.003 1.721 . . . . 2.95 108.273 164.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.9 mp -107.64 135.58 48.84 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 120.035 1.289 . . . . 1.79 111.086 168.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -110.38 113.84 26.8 Favored 'General case' 0 C--O 1.239 0.538 0 C-N-CA 125.719 1.607 . . . . 0.6 109.259 -177.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -111.83 158.09 19.81 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.825 1.25 . . . . 2.33 110.506 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.39 148.5 41.37 Favored 'General case' 0 CA--C 1.547 0.838 0 O-C-N 121.554 -0.716 . . . . 2.68 112.079 172.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.7 23.14 43.68 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 119.056 -0.858 . . . . 4.12 115.053 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 80.18 7.52 88.45 Favored Glycine 0 N--CA 1.474 1.225 0 CA-C-N 118.827 1.314 . . . . 1.81 114.023 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 73.2 mttt -78.33 121.06 23.97 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.326 -1.103 . . . . 4.54 111.381 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.66 142.0 41.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.7 1.2 . . . . 1.85 108.686 167.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.3 tt -151.19 112.58 4.38 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 123.934 0.893 . . . . 2.65 109.997 -176.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HE2' ' OD1' ' A' ' 102' ' ' ASP . 23.7 ttmm -84.46 125.8 32.69 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.734 -0.604 . . . . 3.66 111.881 175.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.3 m -98.0 145.98 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.277 1.431 . . . . 2.86 110.329 170.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 95.5 t -107.19 135.37 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 126.082 1.753 . . . . 2.07 107.726 168.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.409 ' N ' HD23 ' A' ' 115' ' ' LEU . 1.3 pt? -158.09 155.14 25.62 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.619 1.567 . . . . 1.93 111.409 -171.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -65.91 145.74 80.94 Favored 'Trans proline' 0 N--CA 1.454 -0.834 0 C-N-CA 122.774 2.316 . . . . 0.91 112.227 169.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.9 t -82.35 124.24 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 N-CA-C 105.896 -1.89 . . . . 1.18 105.896 151.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.93 151.05 28.99 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.039 0.936 . . . . 3.99 110.694 -172.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -92.3 73.85 5.33 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.544 0.737 . . . . 2.3 112.758 -170.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 C-N-CA 124.876 1.27 . . . . 6.53 108.684 156.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.403 0 N-CA-C 109.476 -1.45 . . . . 10.11 109.476 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.0 m -71.24 -29.18 64.8 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 115.258 1.577 . . . . 11.25 115.258 -171.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -176.57 154.75 1.28 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.961 2.104 . . . . 10.51 109.727 -171.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.0 p -149.62 55.13 0.96 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.409 1.484 . . . . 6.77 110.473 -173.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.448 ' HG2' ' H ' ' A' ' 6' ' ' GLY . 10.0 tt0 -156.23 -179.99 8.69 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.444 1.098 . . . . 9.3 110.096 -177.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.448 ' H ' ' HG2' ' A' ' 5' ' ' GLU . . . -95.26 173.55 31.56 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 125.184 1.373 . . . . 2.32 113.337 -174.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 12.0 p90 -154.87 167.67 29.5 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.458 1.103 . . . . 3.12 112.3 173.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -107.94 148.6 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.73 1.212 . . . . 1.5 108.391 175.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.3 ptm180 -77.88 -135.96 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 109.105 -0.702 . . . . 5.77 109.105 158.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -140.52 152.64 45.73 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 124.882 1.273 . . . . 2.86 111.489 -172.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 m -161.35 142.02 8.32 Favored Pre-proline 0 CA--C 1.543 0.694 0 C-N-CA 127.771 2.428 . . . . 2.58 108.983 161.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.22 -23.74 20.73 Favored 'Trans proline' 0 CA--C 1.539 0.734 0 C-N-CA 122.424 2.083 . . . . 2.12 112.261 170.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.04 171.81 13.69 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 127.145 2.307 . . . . 1.32 110.8 -175.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -79.55 4.14 33.51 Favored 'Cis proline' 0 CA--C 1.542 0.877 0 CA-C-N 119.667 1.733 . . . . 1.09 112.403 -9.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -155.3 139.47 16.54 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 115.239 1.57 . . . . 2.64 115.239 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.33 -176.78 3.17 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 128.024 2.53 . . . . 0.52 111.282 -177.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.77 135.08 18.19 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.807 1.643 . . . . 0.92 108.805 178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -121.7 137.32 54.8 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.758 1.223 . . . . 0.55 111.237 -175.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -105.62 86.34 2.39 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.242 1.817 . . . . 2.64 109.068 174.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 pp -90.41 158.08 17.27 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.403 0.681 . . . . 1.96 112.708 -174.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.5 m -131.53 134.02 45.68 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.016 1.327 . . . . 1.94 109.535 -172.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.35 169.95 23.58 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.003 1.721 . . . . 5.32 108.865 173.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -142.86 145.52 33.22 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.287 1.435 . . . . 4.65 108.4 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 41.6 t30 -93.58 108.15 31.97 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 124.772 1.229 . . . . 1.52 110.87 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -81.58 -10.27 12.05 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.949 2.433 . . . . 1.87 114.91 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -74.44 169.62 54.05 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 120.085 1.311 . . . . 1.88 113.616 -171.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.65 -6.47 58.24 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.414 2.286 . . . . 4.31 111.537 175.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.9 mp -124.5 162.11 44.32 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 127.057 2.143 . . . . 3.93 109.587 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.34 155.66 19.11 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.854 2.369 . . . . 1.33 111.478 -171.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.428 HD12 ' CD2' ' A' ' 105' ' ' PHE . 1.0 OUTLIER -117.79 162.11 18.62 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 126.625 1.97 . . . . 2.84 111.016 177.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -155.12 120.66 5.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.193 -1.367 . . . . 2.38 111.266 -173.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.5 tp -103.49 114.1 28.11 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.608 1.963 . . . . 2.12 109.757 -173.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.3 m -112.86 -20.28 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.749 0.819 . . . . 0.71 112.634 -167.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.15 -174.71 29.22 Favored Glycine 0 C--N 1.342 0.902 0 C-N-CA 124.674 1.13 . . . . 0.52 112.251 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.64 -178.43 5.3 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.1 1.36 . . . . 0.54 110.878 168.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.409 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 4.7 mtt180 -152.62 164.86 36.85 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.139 2.176 . . . . 5.03 108.417 172.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.3 t -169.2 146.06 2.95 Favored Pre-proline 0 N--CA 1.477 0.909 0 C-N-CA 124.849 1.259 . . . . 0.71 108.919 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -77.32 -10.22 17.58 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.381 2.054 . . . . 1.24 113.367 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.97 21.47 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 114.747 1.388 . . . . 1.43 114.747 -174.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.34 150.3 38.97 Favored 'General case' 0 N--CA 1.472 0.63 0 O-C-N 121.172 -0.955 . . . . 0.88 113.067 167.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -72.98 -30.62 63.95 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.433 1.493 . . . . 3.51 113.168 -175.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -155.16 168.44 27.02 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.156 2.582 . . . . 4.77 107.743 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.97 154.87 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 C-N-CA 125.173 1.389 . . . . 0.94 108.876 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.61 146.34 28.18 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.975 1.71 . . . . 4.06 108.676 -166.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.8 tp -113.03 110.13 19.97 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.48 1.036 . . . . 0.89 111.298 -164.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 59.0 m170 -116.71 150.04 38.85 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 122.663 1.221 . . . . 0.5 113.927 -173.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -91.94 -178.28 4.97 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 113.957 -1.474 . . . . 2.15 111.136 158.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 87.1 m -149.24 127.41 12.06 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.085 -1.82 . . . . 1.03 106.085 174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -128.41 170.17 13.43 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.967 0.889 . . . . 2.09 113.267 -167.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.93 144.72 32.26 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.152 1.781 . . . . 5.58 110.68 170.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.37 147.2 21.94 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 121.512 -0.742 . . . . 5.43 112.849 -172.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -91.76 132.62 36.27 Favored 'General case' 0 N--CA 1.445 -0.707 0 C-N-CA 125.479 1.512 . . . . 2.3 109.835 165.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.6 t -143.33 130.33 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 106.496 -1.668 . . . . 3.03 106.496 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 62.88 28.05 16.22 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 123.761 0.824 . . . . 4.95 112.254 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.21 16.05 79.85 Favored Glycine 0 CA--C 1.534 1.255 0 O-C-N 120.967 -1.083 . . . . 2.43 113.904 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.7 mtmt -135.21 134.42 40.05 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.986 1.714 . . . . 3.71 109.883 -173.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.07 126.31 34.68 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.466 1.506 . . . . 2.64 111.976 -173.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 m -136.25 -178.97 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 129.558 3.143 . . . . 2.74 109.603 -174.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.3 mtm -110.76 170.01 8.38 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.817 0.847 . . . . 3.48 112.033 168.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.89 -176.55 27.24 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 126.047 1.784 . . . . 1.04 112.206 178.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ttm -154.67 149.53 26.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.611 1.565 . . . . 1.18 108.596 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.9 ptt85 -158.57 156.8 27.93 Favored Pre-proline 0 N--CA 1.47 0.532 0 C-N-CA 124.891 1.276 . . . . 4.82 110.314 175.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -74.2 158.06 45.54 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 122.0 1.8 . . . . 0.5 111.644 174.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.84 149.85 65.74 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 125.908 1.683 . . . . 0.67 109.087 176.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -78.31 -20.28 11.25 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 123.256 2.637 . . . . 0.72 113.02 -167.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.9 p90 178.96 167.62 0.93 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 127.666 2.386 . . . . 2.29 110.114 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.7 mt -113.75 150.84 32.8 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 125.124 1.369 . . . . 0.86 110.137 165.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -117.81 141.79 48.03 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.034 1.334 . . . . 2.32 109.3 -177.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.2 t -143.93 132.05 10.93 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 113.276 0.843 . . . . 1.6 113.276 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.85 170.32 14.38 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.256 2.637 . . . . 1.7 112.488 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -56.63 139.82 88.89 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.699 2.266 . . . . 1.72 110.658 164.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt 69.13 1.84 3.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 125.489 1.516 . . . . 2.39 113.743 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.77 158.09 36.58 Favored Glycine 0 N--CA 1.474 1.178 0 C-N-CA 125.676 1.608 . . . . 2.13 113.449 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -79.92 145.63 32.55 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 123.926 0.89 . . . . 3.57 111.925 173.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.8 t -124.57 61.29 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 127.015 2.126 . . . . 5.91 107.92 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -116.57 136.21 53.17 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.845 0.831 . . . . 3.13 111.192 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 mp -84.97 85.55 7.47 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 107.099 -1.445 . . . . 1.94 107.099 175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.7 ptmt -55.95 139.7 70.35 Favored Pre-proline 0 CA--C 1.548 0.882 0 N-CA-C 113.672 0.99 . . . . 4.88 113.672 -167.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -56.54 130.02 37.82 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.08 1.853 . . . . 4.47 109.289 165.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.64 28.98 66.29 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-O 118.655 -1.081 . . . . 2.15 114.813 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -167.68 -17.56 0.02 OUTLIER Glycine 0 N--CA 1.472 1.087 0 N-CA-C 118.966 2.347 . . . . 2.38 118.966 158.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -143.24 150.03 38.73 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 120.222 2.011 . . . . 1.79 112.406 169.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.0 p-80 -162.44 153.69 17.83 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.287 1.035 . . . . 0.6 111.192 172.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -86.47 127.68 34.88 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.193 -0.669 . . . . 2.46 109.193 165.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.4 tpt -82.64 119.41 24.25 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.394 2.278 . . . . 0.81 109.396 170.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.1 mp -100.33 120.82 40.52 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 108.345 -0.983 . . . . 1.23 108.345 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.56 146.02 30.18 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.626 1.17 . . . . 2.57 112.415 -169.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.89 -48.77 3.04 Favored Glycine 0 N--CA 1.475 1.235 0 C-N-CA 126.919 2.199 . . . . 3.01 114.126 177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 26.0 mt 56.49 165.88 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 130.066 3.346 . . . . 0.67 115.388 -174.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -119.36 -7.41 10.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.385 1.874 . . . . 1.87 113.292 174.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -127.96 131.51 23.84 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 128.366 2.666 . . . . 4.6 109.385 172.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.35 76.28 3.97 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.755 2.303 . . . . 2.95 106.454 153.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.404 ' H ' ' HG ' ' A' ' 93' ' ' LEU . 0.9 OUTLIER -68.34 140.3 55.89 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.585 1.154 . . . . 3.21 113.669 -156.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.7 mmtt -93.31 156.92 16.51 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 122.381 1.086 . . . . 5.56 111.65 174.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.62 118.15 7.23 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 113.847 -1.524 . . . . 1.56 107.545 159.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 106.62 -2.36 36.54 Favored Glycine 0 CA--C 1.538 1.513 0 CA-C-O 117.853 -1.526 . . . . 1.77 115.869 -168.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -77.42 -178.6 5.28 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.586 1.693 . . . . 3.32 111.467 160.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -152.62 141.77 21.38 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.753 2.821 . . . . 4.61 106.636 -171.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 82.5 t -144.15 146.09 21.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 126.601 1.96 . . . . 1.44 109.561 -168.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -97.76 136.29 38.31 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.953 0.901 . . . . 2.84 110.094 168.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -118.63 140.12 50.42 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.262 1.025 . . . . 2.71 109.888 165.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.409 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 39.7 m-20 -94.44 134.12 37.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 128.149 2.579 . . . . 1.87 108.351 160.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.44 130.18 42.35 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.634 1.574 . . . . 1.08 108.848 164.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.4 111.43 23.33 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.049 0.939 . . . . 0.69 110.678 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.428 ' CD2' HD12 ' A' ' 30' ' ' LEU . 85.6 m-85 -103.66 163.68 12.16 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.142 1.377 . . . . 2.13 111.582 178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.57 154.86 13.39 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 115.679 -0.691 . . . . 2.6 112.122 166.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.36 24.95 62.22 Favored Glycine 0 CA--C 1.535 1.314 0 CA-C-O 119.138 -0.812 . . . . 3.95 114.977 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.91 13.69 82.29 Favored Glycine 0 N--CA 1.474 1.177 0 CA-C-N 118.436 1.118 . . . . 1.9 114.171 176.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 45.1 mttm -90.52 117.51 29.26 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.448 -1.03 . . . . 3.58 112.128 -172.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.2 p -114.27 140.86 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.61 1.564 . . . . 2.33 110.431 169.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 16.4 mt -140.01 129.2 23.78 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.035 1.334 . . . . 2.62 110.846 174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -106.21 143.41 34.39 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 112.797 0.666 . . . . 2.21 112.797 -175.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.96 160.01 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 127.49 2.316 . . . . 2.27 111.704 -177.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.47 137.23 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 126.542 1.937 . . . . 1.98 110.57 176.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.4 mp -134.76 114.57 12.08 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 126.525 1.93 . . . . 2.64 110.741 -174.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -75.5 150.02 35.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.265 2.644 . . . . 1.26 110.665 169.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.8 t -91.25 132.88 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 123.848 0.859 . . . . 1.31 111.195 175.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -122.9 149.31 44.39 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.901 1.68 . . . . 4.52 113.089 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -119.63 96.13 5.07 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.675 0.79 . . . . 2.53 109.645 159.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.241 0 C-N-CA 128.559 2.744 . . . . 6.12 110.413 -175.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.436 0 N-CA-C 107.284 -2.327 . . . . 11.66 107.284 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -57.7 -176.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 117.194 0.497 . . . . 10.97 111.108 134.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -74.38 155.54 38.02 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 122.027 -0.421 . . . . 8.5 110.274 151.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.2 t 138.65 114.13 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.86 1 C-N-CA 132.301 4.24 . . . . 4.89 104.371 -164.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.48 65.06 0.95 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.925 1.345 . . . . 4.85 110.359 -160.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -104.31 172.35 20.38 Favored Glycine 0 C--N 1.34 0.765 0 C-N-CA 124.883 1.23 . . . . 1.3 113.897 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 22.0 p90 -156.23 160.15 39.55 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.499 1.92 . . . . 2.36 110.96 172.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 t -103.61 147.94 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.356 -1.35 . . . . 1.66 107.356 170.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.7 ttm180 -72.08 -119.77 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 CA-C-O 121.542 0.687 . . . . 5.09 109.432 164.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -151.41 143.03 23.64 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 119.383 -2.073 . . . . 3.08 110.92 -172.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.0 t -171.68 143.31 1.44 Allowed Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 125.703 1.601 . . . . 2.26 110.572 167.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -79.9 -26.32 4.58 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.733 2.289 . . . . 1.44 112.26 166.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 140.31 170.42 12.03 Favored Glycine 0 CA--C 1.539 1.579 0 C-N-CA 126.643 2.068 . . . . 1.07 111.419 -171.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.69 -16.12 22.83 Favored 'Cis proline' 0 C--N 1.349 0.596 0 CA-C-N 119.328 1.564 . . . . 1.32 112.761 0.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.53 HD22 HD12 ' A' ' 87' ' ' LEU . 51.6 p30 -142.09 160.43 40.24 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 122.805 1.288 . . . . 2.21 114.421 178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -129.88 -179.06 4.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.433 2.693 . . . . 0.55 110.486 -178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.06 133.39 26.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.162 1.385 . . . . 1.3 109.208 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -134.32 150.95 50.99 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.562 1.145 . . . . 0.88 113.481 -171.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.45 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 50.8 m-85 -131.55 127.15 36.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 127.19 2.196 . . . . 2.1 109.548 -163.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.262 0.0 OUTLIER -162.5 161.7 27.13 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.822 1.415 . . . . 2.77 114.822 -172.334 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.5 m -93.26 127.75 38.96 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.896 1.678 . . . . 1.71 111.735 -170.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 31.9 tp -112.34 122.0 46.47 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.809 1.243 . . . . 4.24 110.302 166.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -122.07 142.29 50.5 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.577 1.151 . . . . 4.51 109.211 169.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -105.87 97.73 16.06 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 123.561 0.744 . . . . 1.37 111.322 -176.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -79.31 -5.59 14.36 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.857 2.371 . . . . 1.21 114.044 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -86.93 163.65 34.95 Favored Glycine 0 C--N 1.341 0.832 0 CA-C-N 119.624 1.102 . . . . 1.34 111.347 178.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.9 4.29 50.42 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.848 2.059 . . . . 3.51 112.374 176.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 pp -118.79 152.81 52.01 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 127.248 2.219 . . . . 2.92 110.346 175.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.35 142.36 21.12 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.216 1.944 . . . . 0.97 110.7 -173.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 52.1 mt -96.57 149.46 21.74 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 122.258 1.027 . . . . 1.8 110.841 172.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -135.98 100.14 4.35 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 113.866 -1.515 . . . . 2.35 110.946 176.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.46 97.39 9.5 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.999 2.12 . . . . 1.8 108.066 -174.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.8 m -94.13 -25.42 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.875 0.87 . . . . 0.49 112.801 -170.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.46 -177.09 32.23 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 123.974 0.797 . . . . 0.4 113.208 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.3 178.94 6.33 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.462 0.705 . . . . 0.5 111.18 172.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.402 ' NH1' ' H ' ' A' ' 37' ' ' THR . 0.1 OUTLIER -148.75 170.97 17.01 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.512 2.725 . . . . 5.42 106.591 165.004 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.402 ' H ' ' NH1' ' A' ' 36' ' ' ARG . 1.5 t -177.36 148.42 0.72 Allowed Pre-proline 0 N--CA 1.484 1.241 0 C-N-CA 127.187 2.195 . . . . 0.81 108.703 -172.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -77.14 -24.73 9.32 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.031 1.821 . . . . 1.21 113.958 -176.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.5 m -112.57 23.42 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 N-CA-C 114.221 1.193 . . . . 1.19 114.221 -173.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.91 149.39 35.2 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.142 1.377 . . . . 1.43 107.822 160.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -83.3 -54.41 5.02 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.237 1.015 . . . . 3.0 111.075 -171.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -115.97 166.75 11.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 128.582 2.753 . . . . 5.49 106.392 177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.95 134.36 2.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 125.533 1.533 . . . . 0.95 108.267 -177.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -113.97 135.99 53.39 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.21 1.404 . . . . 2.94 109.455 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -83.48 124.45 30.73 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 109.542 -0.54 . . . . 1.22 109.542 169.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -122.61 158.33 30.19 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.19 1.796 . . . . 0.63 112.896 -179.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.22 -179.89 4.07 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.626 1.571 . . . . 3.32 110.701 165.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 17.5 m -154.77 141.82 19.3 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.785 1.634 . . . . 0.84 106.988 170.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -155.58 175.0 14.47 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.54 1.162 . . . . 2.04 113.387 -167.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 51.7 ttp -117.2 146.16 43.41 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.71 1.604 . . . . 3.47 110.137 171.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -148.11 161.05 42.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 127.716 2.406 . . . . 7.66 110.272 -178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -91.03 144.81 25.27 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 123.832 0.853 . . . . 2.46 109.5 166.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.7 t -137.22 115.48 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 106.095 -1.817 . . . . 2.43 106.095 163.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 58.08 34.85 24.63 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.992 1.479 . . . . 5.41 114.992 -178.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.18 4.63 68.89 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.253 -1.529 . . . . 1.62 113.553 -172.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -103.52 115.31 30.29 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 126.122 1.769 . . . . 2.75 107.673 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.65 117.06 17.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.903 0.881 . . . . 3.06 110.221 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 t -138.88 153.73 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 128.609 2.764 . . . . 2.21 107.705 -161.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.23 173.43 6.46 Favored 'General case' 0 N--CA 1.471 0.584 0 O-C-N 120.615 -1.303 . . . . 3.96 113.531 -176.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.09 166.84 33.19 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.703 1.144 . . . . 0.58 112.451 177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.7 ttm -150.43 139.74 21.31 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 127.143 2.177 . . . . 1.41 107.286 174.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -150.56 154.23 35.16 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 126.681 1.992 . . . . 4.37 108.672 -171.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -77.71 159.71 31.52 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.323 2.016 . . . . 0.52 111.194 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.76 155.99 52.21 Favored Pre-proline 0 N--CA 1.479 1.017 0 C-N-CA 125.767 1.627 . . . . 0.94 110.931 -176.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -84.88 -26.43 1.54 Allowed 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.407 2.738 . . . . 0.47 114.089 -164.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -174.8 164.81 3.58 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.991 1.716 . . . . 1.7 111.477 -179.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.3 mt -111.7 160.57 17.15 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.924 1.29 . . . . 0.52 109.296 157.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -138.0 148.79 45.51 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.61 1.164 . . . . 1.94 110.11 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.3 t -139.82 129.09 13.69 Favored Pre-proline 0 CA--C 1.534 0.364 0 O-C-N 123.836 0.71 . . . . 1.03 111.755 177.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -68.39 162.81 39.03 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.189 2.593 . . . . 1.21 110.967 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.05 138.66 79.83 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.097 2.532 . . . . 1.25 112.17 177.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.14 3.43 2.69 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 127.27 2.228 . . . . 2.11 115.036 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.67 169.71 34.35 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 126.136 1.827 . . . . 1.47 113.263 169.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -132.17 157.21 44.87 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.334 1.054 . . . . 4.54 112.305 168.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.3 t -145.08 140.93 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 128.026 2.53 . . . . 3.38 107.505 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -134.32 130.06 36.45 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 121.186 0.517 . . . . 3.97 110.822 -170.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.6 mp -75.69 80.51 2.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.224 1.41 . . . . 2.11 109.709 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.1 ptpt -67.84 155.58 91.31 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 126.604 1.962 . . . . 3.76 114.323 -176.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.45 ' HA ' ' CE1' ' A' ' 19' ' ' TYR . 55.9 Cg_endo -61.8 -44.46 21.0 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.126 2.551 . . . . 2.25 112.329 171.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.48 60.33 4.88 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 119.106 -0.83 . . . . 2.22 112.426 174.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.25 -126.44 2.03 Favored Glycine 0 N--CA 1.468 0.791 0 C-N-CA 125.428 1.49 . . . . 1.51 114.191 177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -72.63 136.62 45.74 Favored 'General case' 0 N--CA 1.467 0.415 0 O-C-N 121.674 -0.898 . . . . 1.84 112.11 -167.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -160.09 163.88 33.49 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 124.61 1.164 . . . . 0.82 111.439 -176.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -97.18 132.68 42.71 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.914 -0.491 . . . . 1.83 109.921 170.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -88.35 115.69 26.03 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.822 2.049 . . . . 0.91 108.983 166.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.9 mp -99.12 119.19 37.43 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.185 0.994 . . . . 1.45 109.013 -173.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.53 HD12 HD22 ' A' ' 15' ' ' ASN . 0.4 OUTLIER -122.56 141.04 52.11 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.263 1.208 . . . . 3.18 114.263 -164.288 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.24 38.34 25.97 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.539 1.066 . . . . 1.88 113.142 178.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 11.0 mt -43.86 152.75 0.15 Allowed 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 116.386 1.995 . . . . 0.71 116.386 -174.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -112.84 -16.9 12.64 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.718 -1.583 . . . . 1.83 114.939 -173.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 86.6 mmt-85 -138.25 142.31 34.85 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 128.698 2.799 . . . . 6.58 108.599 165.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -71.24 135.65 27.45 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 121.965 1.776 . . . . 1.36 107.753 158.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -105.56 105.9 16.15 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.318 0.508 . . . . 3.3 109.851 -176.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . 0.259 0.0 OUTLIER -86.91 20.54 2.58 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.587 2.069 . . . . 4.34 116.587 -163.022 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 67.01 157.25 0.12 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 128.541 2.737 . . . . 1.59 111.845 -161.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.25 0.26 85.89 Favored Glycine 0 CA--C 1.536 1.381 0 CA-C-O 118.95 -0.917 . . . . 1.28 114.536 -172.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -84.89 175.69 8.94 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.921 1.688 . . . . 2.69 110.259 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -128.48 153.4 47.18 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 126.932 2.093 . . . . 4.09 105.423 163.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.1 t -136.72 138.04 46.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 C-N-CA 126.407 1.883 . . . . 1.53 109.077 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' CD ' ' HZ2' ' A' ' 112' ' ' LYS . 38.9 tt0 -89.81 136.08 33.25 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.08 1.352 . . . . 3.03 109.853 173.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.63 139.89 52.34 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.914 1.286 . . . . 2.63 109.62 170.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -99.06 143.45 29.32 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 126.84 2.056 . . . . 2.63 109.669 167.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 6.8 mp -114.74 118.79 34.6 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.844 1.657 . . . . 1.18 109.292 175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.1 mt -92.39 112.31 24.21 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 124.883 1.273 . . . . 0.67 109.408 -178.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -104.66 106.5 17.02 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.567 1.147 . . . . 2.09 110.564 -174.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.8 21.8 2.08 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.766 1.626 . . . . 2.64 114.78 174.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.68 -55.48 4.46 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.12 1.343 . . . . 4.24 112.976 -173.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.65 1.12 54.09 Favored Glycine 0 CA--C 1.534 1.265 0 N-CA-C 116.126 1.21 . . . . 2.05 116.126 -172.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -140.68 149.15 41.87 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 119.077 1.439 . . . . 4.08 112.326 176.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 10.9 p -138.71 153.14 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.407 1.483 . . . . 2.14 110.919 170.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.0 tp -155.19 164.02 39.39 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.953 2.101 . . . . 2.19 107.973 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.415 ' HZ2' ' CD ' ' A' ' 100' ' ' GLU . 41.2 pttt -146.58 156.16 43.02 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 115.16 1.541 . . . . 1.93 115.16 -176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.15 160.16 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 127.951 2.5 . . . . 2.69 109.929 -167.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.0 142.97 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.959 0.904 . . . . 2.49 110.028 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.21 144.57 15.21 Favored Pre-proline 0 CA--C 1.556 1.175 0 C-N-CA 124.631 1.172 . . . . 2.52 113.664 -168.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.49 158.86 25.65 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.984 3.79 . . . . 1.24 114.478 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 39.4 t -105.99 124.5 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.152 1.381 . . . . 1.2 110.227 175.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -135.57 143.48 45.68 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.345 1.058 . . . . 3.72 111.149 174.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -82.48 59.42 4.62 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.104 -0.998 . . . . 2.69 111.368 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.523 ' HG3' HH11 ' A' ' 120' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.853 0 C-N-CA 125.138 1.375 . . . . 6.23 113.991 -173.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.353 0 N-CA-C 108.723 -1.751 . . . . 14.47 108.723 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 p 176.94 159.84 0.37 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.981 1.712 . . . . 10.69 108.717 -168.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -150.66 161.63 42.22 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.153 0.981 . . . . 11.11 112.211 -171.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.523 ' HA ' HG21 ' A' ' 21' ' ' THR . 29.2 m -135.58 70.57 1.43 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.128 1.771 . . . . 6.47 108.172 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -144.43 169.98 16.9 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.337 1.055 . . . . 5.29 113.362 -162.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.16 172.38 34.04 Favored Glycine 0 C--N 1.34 0.78 0 O-C-N 120.797 -1.189 . . . . 1.19 114.809 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 6.6 p90 -157.35 159.55 37.57 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.198 1.399 . . . . 2.3 113.358 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.1 t -107.99 143.31 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.025 0 C-N-CA 124.905 1.282 . . . . 1.45 109.707 -178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -73.12 -15.77 61.47 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 117.263 2.32 . . . . 5.69 117.263 -159.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.483 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 1.1 t80 71.83 115.76 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.863 2.065 . . . . 3.25 110.778 -174.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.5 m -162.06 145.4 9.14 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 125.887 1.675 . . . . 2.26 108.806 169.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.12 -33.29 6.03 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.7 2.267 . . . . 1.84 112.551 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 148.71 172.2 18.29 Favored Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.437 1.494 . . . . 1.24 111.503 -175.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -76.94 -1.26 25.14 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 CA-C-N 119.194 1.497 . . . . 1.15 112.891 -1.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 p30 -144.0 169.38 17.93 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.256 1.023 . . . . 2.19 113.45 -175.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -152.26 178.27 9.68 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.966 2.506 . . . . 0.69 110.941 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -133.64 166.3 22.93 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.989 2.116 . . . . 1.08 108.823 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -153.24 154.4 34.58 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.863 0.865 . . . . 0.64 111.863 174.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.25 131.86 28.84 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.537 1.535 . . . . 2.56 109.818 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.26 162.47 39.97 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.083 0.856 . . . . 2.82 112.841 175.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.523 HG21 ' HA ' ' A' ' 4' ' ' THR . 39.4 m -89.03 127.08 35.67 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 125.346 1.458 . . . . 1.73 110.221 178.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 22.7 tp -104.47 127.47 52.18 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.115 1.366 . . . . 4.04 108.534 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -135.86 132.83 37.09 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 124.815 1.246 . . . . 4.69 109.106 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -103.71 101.21 23.0 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 124.538 1.135 . . . . 1.53 110.41 -175.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -75.82 -10.17 19.84 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.297 1.998 . . . . 1.1 113.535 176.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.03 177.3 50.84 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-O 122.764 1.202 . . . . 1.15 113.102 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -104.46 -5.25 21.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.496 2.318 . . . . 2.88 112.368 -172.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 81.9 mt -120.34 161.2 40.31 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 127.359 2.264 . . . . 3.64 109.033 170.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -82.74 151.99 14.83 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.711 2.274 . . . . 1.06 111.911 -167.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.6 mp -104.93 149.88 25.35 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.81 1.291 . . . . 2.16 109.387 169.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.6 ttm180 -139.87 116.65 10.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 113.726 -1.579 . . . . 2.27 108.594 176.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -93.31 114.85 27.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 127.3 2.24 . . . . 2.28 108.193 -176.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -103.5 -25.34 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.708 0.803 . . . . 0.62 111.984 -174.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.04 -175.8 33.45 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 123.808 0.718 . . . . 0.55 114.573 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -123.51 178.29 5.25 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.64 1.176 . . . . 0.81 112.1 166.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.8 ttp180 -157.06 147.66 21.41 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 125.708 1.603 . . . . 5.82 107.094 162.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.7 t -159.59 151.6 17.1 Favored Pre-proline 0 N--CA 1.471 0.611 0 CA-C-O 117.538 -1.22 . . . . 0.68 108.317 -169.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.93 0.59 9.1 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 121.805 1.67 . . . . 0.86 114.047 -175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.9 m -120.07 28.3 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 126.809 2.044 . . . . 1.04 114.791 -171.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -158.26 143.14 16.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 119.786 1.175 . . . . 1.15 111.013 168.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -64.96 -38.51 91.22 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.174 1.39 . . . . 3.02 111.697 173.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 16.3 ttt180 -149.95 144.39 25.84 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 126.085 1.754 . . . . 7.03 107.856 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.6 p -119.66 132.67 68.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.329 1.452 . . . . 0.9 109.394 174.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.9 mm-40 -97.63 167.98 10.63 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.714 1.206 . . . . 3.21 110.02 166.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -119.61 137.25 53.98 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 122.986 1.374 . . . . 2.45 112.441 154.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 65.0 m170 -121.5 153.72 37.57 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 126.661 1.984 . . . . 0.74 110.808 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -90.35 157.28 17.71 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.896 -1.047 . . . . 1.98 109.945 153.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.4 m -108.89 140.13 42.79 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 105.033 -2.21 . . . . 0.96 105.033 157.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -136.15 167.99 20.24 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 122.869 1.318 . . . . 1.99 113.701 -175.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.4 mtm -113.12 142.87 45.25 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.532 1.533 . . . . 4.71 110.843 172.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 -134.88 143.27 46.87 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.129 1.372 . . . . 6.18 110.047 170.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -91.25 142.31 27.85 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.214 -1.032 . . . . 3.39 108.214 154.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.3 t -138.85 118.71 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 106.599 -1.63 . . . . 3.44 106.599 164.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 64.59 19.89 11.97 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 125.411 1.484 . . . . 4.92 114.264 -177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.54 4.81 87.41 Favored Glycine 0 N--CA 1.481 1.646 0 O-C-N 120.477 -1.39 . . . . 3.28 113.64 -169.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.9 mttt -103.68 111.43 23.91 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 126.672 1.989 . . . . 3.54 107.87 -178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.417 ' H ' ' HG2' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -87.64 117.71 26.64 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.336 1.454 . . . . 2.96 111.085 -173.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.7 t -145.17 139.85 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 126.396 1.878 . . . . 2.55 109.329 -170.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -101.13 166.98 10.51 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 124.902 1.281 . . . . 3.58 112.77 -170.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -156.1 -178.0 29.84 Favored Glycine 0 CA--C 1.524 0.649 0 C-N-CA 124.44 1.019 . . . . 0.59 113.166 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.2 ttm -152.41 143.37 23.04 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 125.666 1.586 . . . . 1.29 108.759 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -162.96 153.75 14.23 Favored Pre-proline 0 N--CA 1.476 0.866 0 C-N-CA 123.569 0.748 . . . . 4.94 112.065 -178.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.33 146.22 35.33 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.644 2.229 . . . . 0.67 112.852 -174.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.5 m -122.66 155.15 63.38 Favored Pre-proline 0 N--CA 1.478 0.961 0 CA-C-O 118.347 -0.835 . . . . 0.83 110.905 178.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -80.38 -23.66 5.98 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 123.133 2.555 . . . . 0.6 112.89 -171.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.5 p90 -178.37 167.41 1.88 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.089 1.756 . . . . 2.02 111.113 -179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.6 mt -115.08 155.13 27.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 126.191 1.796 . . . . 0.77 109.952 163.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -116.13 145.81 42.75 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.387 1.475 . . . . 2.23 110.531 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.5 t -142.23 126.6 10.03 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-N 118.878 0.763 . . . . 0.92 112.588 163.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -72.58 165.57 32.33 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 124.089 3.193 . . . . 1.02 112.39 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -58.99 137.63 80.87 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.342 2.694 . . . . 1.07 112.218 176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt 67.59 1.21 2.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.362 1.865 . . . . 1.68 114.396 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.12 167.43 27.83 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 126.007 1.765 . . . . 1.19 113.406 177.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 ptp85 -137.03 156.16 48.77 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.576 1.15 . . . . 5.65 111.826 169.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 85.0 t -146.84 130.71 9.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 126.888 2.075 . . . . 3.47 108.145 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -96.33 140.47 30.96 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 119.622 1.101 . . . . 3.12 111.392 164.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -41.2 -52.37 3.36 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.364 1.865 . . . . 3.06 111.959 178.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 104.11 127.89 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 128.575 2.75 . . . . 2.73 111.217 164.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.18 -11.27 30.53 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.238 2.625 . . . . 2.5 114.83 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.67 20.26 8.82 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.108 1.337 . . . . 1.83 113.753 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -144.54 -119.32 1.3 Allowed Glycine 0 N--CA 1.471 1.0 0 CA-C-N 119.204 1.502 . . . . 1.81 113.31 -175.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -72.74 144.68 47.54 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 118.275 1.038 . . . . 2.17 110.518 -175.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -161.48 151.14 16.69 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.532 -0.73 . . . . 0.72 110.728 -178.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.428 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 59.0 m-85 -77.76 143.01 38.33 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.477 -0.935 . . . . 2.52 108.477 166.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.3 tpt -115.88 114.52 24.8 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 127.391 2.276 . . . . 1.11 107.902 172.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.2 mp -98.04 118.85 35.56 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 125.938 1.695 . . . . 1.5 108.73 -173.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.85 135.13 54.31 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.685 1.194 . . . . 2.2 110.336 -177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.51 50.84 10.66 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 121.718 -0.614 . . . . 1.63 112.689 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 12.7 mt -47.76 156.38 0.33 Allowed 'General case' 0 N--CA 1.462 0.133 0 N-CA-C 115.932 1.827 . . . . 0.71 115.932 -177.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.6 mmtt -112.08 -30.77 7.11 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 113.43 -1.714 . . . . 1.76 113.772 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 59.3 mtp85 -112.66 134.79 21.59 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 125.465 1.506 . . . . 4.33 108.959 166.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -72.62 82.89 1.38 Allowed 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.785 2.324 . . . . 1.46 107.265 160.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.485 ' H ' HD23 ' A' ' 93' ' ' LEU . 2.3 pt? -87.6 124.75 33.84 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.562 0.745 . . . . 2.53 112.952 -163.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 24.4 mtmm -110.38 167.23 10.36 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 115.268 1.581 . . . . 3.62 115.268 -165.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.86 124.82 21.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.353 -1.294 . . . . 1.24 109.123 172.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.13 5.25 62.44 Favored Glycine 0 CA--C 1.534 1.273 0 CA-C-O 117.959 -1.467 . . . . 1.69 115.639 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -88.01 178.26 6.71 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.193 1.997 . . . . 2.77 111.246 163.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -149.12 125.76 11.05 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 129.497 3.119 . . . . 3.49 104.607 -173.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.4 t -146.52 139.96 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 123.809 0.844 . . . . 1.76 110.783 -168.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -80.13 152.12 29.43 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.524 1.13 . . . . 3.15 113.982 -177.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.2 tt -144.47 130.74 19.67 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.426 1.49 . . . . 3.06 110.639 168.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.8 117.88 21.08 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.644 2.778 . . . . 2.35 109.095 165.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -87.87 121.08 29.85 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.124 -1.065 . . . . 1.03 108.124 171.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.1 mt -97.61 118.56 34.41 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.002 0.921 . . . . 0.84 109.979 -173.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -116.2 144.51 44.09 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.308 1.043 . . . . 2.2 112.852 -171.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.58 137.0 57.94 Favored 'General case' 0 CA--C 1.547 0.833 0 O-C-N 121.279 -0.888 . . . . 2.14 113.271 -179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.17 46.38 5.6 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.746 -1.03 . . . . 3.92 113.627 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 77.3 32.79 46.54 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 123.959 0.79 . . . . 1.72 114.728 169.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.5 mttt -125.77 144.81 50.48 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.675 1.237 . . . . 3.7 112.201 -170.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.04 149.02 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 125.376 1.47 . . . . 2.02 110.644 176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 tt -149.3 119.29 7.16 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.143 0.977 . . . . 2.26 108.699 178.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -96.08 133.71 40.01 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.635 -0.665 . . . . 2.17 111.757 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.28 170.47 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.934 1.693 . . . . 2.16 108.469 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 p -124.75 136.77 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.752 1.621 . . . . 2.41 108.726 174.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -127.73 139.12 34.4 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 125.305 1.442 . . . . 2.78 109.131 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.26 150.41 76.5 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 123.231 2.621 . . . . 1.34 111.311 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 20.1 t -99.39 137.73 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.491 1.116 . . . . 1.35 108.384 172.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.63 160.21 42.33 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.525 1.93 . . . . 4.79 112.271 -174.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.45 142.71 37.31 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.074 1.349 . . . . 2.61 113.384 -176.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . 0.26 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 C-N-CA 130.04 3.336 . . . . 9.23 110.193 169.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.148 0 N-CA-C 107.427 -2.269 . . . . 11.5 107.427 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -61.66 159.11 13.95 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.359 1.08 . . . . 9.19 110.21 146.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -82.57 41.02 0.69 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.273 -0.892 . . . . 12.51 112.27 177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 82.4 p -149.05 29.62 0.8 Allowed 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 129.71 3.204 . . . . 8.03 108.835 -177.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -157.06 139.99 15.27 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 128.559 2.743 . . . . 5.47 107.602 -172.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -132.17 137.14 9.19 Favored Glycine 0 N--CA 1.467 0.701 0 N-CA-C 110.95 -0.86 . . . . 2.2 110.95 -171.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -96.87 173.12 7.46 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.521 1.304 . . . . 2.33 114.521 -168.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.9 t -102.43 148.36 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 126.214 1.806 . . . . 1.25 108.6 168.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 -69.46 -103.02 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.407 1.083 . . . . 4.53 112.613 177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.2 t80 169.96 126.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.705 2.402 . . . . 2.0 108.419 -166.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 m -173.34 145.47 1.22 Allowed Pre-proline 0 N--CA 1.474 0.771 0 C-N-CA 126.015 1.726 . . . . 2.0 109.389 175.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.78 -33.74 0.6 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 122.915 2.41 . . . . 1.63 112.589 179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 145.29 166.8 11.95 Favored Glycine 0 CA--C 1.538 1.499 0 C-N-CA 125.949 1.738 . . . . 1.54 111.314 -170.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.76 -2.04 25.17 Favored 'Cis proline' 0 CA--C 1.54 0.777 0 CA-C-N 119.192 1.496 . . . . 1.6 113.092 -0.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.6 p-10 -147.6 163.66 35.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.796 1.638 . . . . 1.91 112.994 -172.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.58 -175.43 4.92 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.259 2.224 . . . . 0.71 111.773 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -145.11 148.0 33.15 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 124.532 1.133 . . . . 0.68 110.989 175.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.23 137.75 39.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 0.51 113.096 -177.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 -105.93 23.36 14.09 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.252 2.621 . . . . 2.72 113.818 -168.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -58.47 160.72 5.09 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 117.263 2.319 . . . . 2.25 117.263 -163.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.6 m -79.46 150.13 31.34 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 127.119 2.168 . . . . 1.88 112.046 174.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -137.67 132.7 33.31 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.058 2.143 . . . . 3.44 110.334 176.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -135.6 162.78 31.73 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.125 1.37 . . . . 4.64 111.456 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 54.5 t-20 -130.31 98.94 19.92 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 123.909 0.883 . . . . 1.76 109.662 168.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -78.16 -11.15 16.32 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 122.779 2.319 . . . . 1.24 113.007 174.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -87.85 -172.66 47.54 Favored Glycine 0 C--N 1.341 0.81 0 C-N-CA 124.994 1.283 . . . . 1.26 113.155 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -113.73 -2.64 13.67 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.438 1.895 . . . . 3.32 112.239 -165.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -124.54 153.86 69.65 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 127.363 2.265 . . . . 3.25 110.231 176.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.99 158.5 38.29 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.643 2.229 . . . . 1.39 112.709 -168.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 46.3 mt -119.04 152.5 36.33 Favored 'General case' 0 CA--C 1.52 -0.201 0 C-N-CA 126.083 1.753 . . . . 2.02 110.196 175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.3 ttp-105 -138.01 102.39 4.68 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 113.281 -1.781 . . . . 2.79 110.722 175.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.82 106.88 16.68 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 126.318 1.847 . . . . 1.82 108.671 -174.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -104.25 -26.08 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 N-CA-C 113.698 0.999 . . . . 0.54 113.698 -170.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -162.09 -174.23 31.71 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 125.615 1.579 . . . . 0.49 111.805 -175.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -144.71 -175.14 4.54 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-O 121.643 0.735 . . . . 0.69 112.443 173.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.4 mmt180 -145.23 178.1 8.32 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 128.808 2.843 . . . . 5.42 107.598 160.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t 179.41 150.7 0.5 Allowed Pre-proline 0 N--CA 1.473 0.715 0 C-N-CA 127.089 2.156 . . . . 0.68 109.115 -176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -73.77 -9.68 22.69 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.014 2.476 . . . . 1.05 113.746 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HA ' ' HB2' ' A' ' 90' ' ' LYS . 30.1 m -114.04 23.34 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 N-CA-C 115.248 1.573 . . . . 0.84 115.248 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -151.75 173.24 14.97 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.408 1.483 . . . . 1.17 109.252 166.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -101.21 -58.02 1.97 Allowed 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 125.612 1.565 . . . . 4.6 110.795 165.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 46.3 mtp85 -98.14 152.61 19.16 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 127.615 2.366 . . . . 5.88 108.536 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.5 p -160.55 108.97 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 127.04 2.136 . . . . 1.74 110.224 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -127.58 140.94 51.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.16 -1.382 . . . . 5.49 111.469 -168.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 tp -82.03 125.27 30.61 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.666 0.746 . . . . 1.53 111.59 -170.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.8 m170 -119.09 159.5 23.82 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.288 1.835 . . . . 0.56 112.161 171.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -114.31 165.43 12.71 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 113.906 -1.497 . . . . 2.25 110.863 166.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 98.8 m -124.3 126.76 46.57 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 106.16 -1.793 . . . . 0.93 106.16 169.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -127.14 171.35 11.49 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.23 0.826 . . . . 2.1 113.23 -172.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 26.6 ttp -105.38 145.28 31.0 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.779 1.632 . . . . 3.84 110.823 176.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 ptt180 -152.25 153.42 33.71 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.467 1.507 . . . . 8.29 112.122 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -155.66 142.16 18.65 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 126.197 1.799 . . . . 2.79 108.802 178.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.4 p -164.78 145.41 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 C-N-CA 129.54 3.136 . . . . 5.63 105.797 171.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 61.64 9.18 2.66 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.767 1.627 . . . . 3.59 115.063 -173.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.48 8.52 73.99 Favored Glycine 0 CA--C 1.539 1.576 0 C-N-CA 124.416 1.008 . . . . 2.23 114.95 -168.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.8 mmtp -85.55 66.66 9.78 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.948 -1.325 . . . . 2.77 111.938 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.08 111.93 1.7 Allowed 'General case' 0 CA--C 1.542 0.641 0 O-C-N 120.331 -1.481 . . . . 2.75 111.315 171.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -155.23 159.81 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 125.203 1.401 . . . . 2.98 110.082 -170.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 65.1 mtm -91.84 172.69 8.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.71 1.004 . . . . 3.04 113.71 175.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -148.59 -179.17 24.3 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.472 1.987 . . . . 0.78 111.211 172.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.7 ttm -144.38 147.21 33.12 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 125.248 1.419 . . . . 1.26 107.856 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -158.97 155.44 24.47 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 4.83 110.84 -178.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.87 156.85 24.02 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.782 2.322 . . . . 0.68 111.635 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.49 155.58 63.92 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 125.44 1.496 . . . . 1.06 110.756 -176.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -84.81 -27.23 1.32 Allowed 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 123.071 2.514 . . . . 0.62 113.493 -165.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -178.39 166.56 1.85 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.228 1.811 . . . . 1.71 112.003 -178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.2 mt -108.35 157.24 18.56 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.021 1.328 . . . . 0.7 110.319 157.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 -106.35 153.74 21.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.427 1.091 . . . . 1.88 109.341 169.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.3 t -140.59 122.79 9.63 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-N 118.722 0.692 . . . . 1.42 112.157 160.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -74.29 159.16 44.11 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.549 2.833 . . . . 1.26 111.296 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.6 140.89 89.22 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 123.423 2.748 . . . . 1.32 112.586 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt 66.21 -2.07 1.06 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 126.877 2.071 . . . . 2.0 113.948 -175.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -88.6 172.75 41.27 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.262 1.887 . . . . 1.26 113.577 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.51 144.0 23.39 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.137 1.375 . . . . 5.94 111.348 176.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 58.9 t -149.48 137.35 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 126.814 2.046 . . . . 3.36 107.16 -177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -133.45 127.33 33.09 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.446 -1.316 . . . . 4.36 107.446 -162.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.1 mp -61.6 -51.41 68.64 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.37 0.668 . . . . 2.69 111.616 -162.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 82.74 158.63 0.12 Allowed Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 126.708 2.003 . . . . 5.4 114.98 159.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -60.53 127.14 21.82 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.218 1.945 . . . . 2.84 110.22 168.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.88 54.7 34.77 Favored Glycine 0 CA--C 1.526 0.766 0 CA-C-N 115.975 -0.557 . . . . 1.79 113.709 174.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -168.36 -44.74 0.03 OUTLIER Glycine 0 N--CA 1.473 1.117 0 N-CA-C 116.489 1.356 . . . . 1.91 116.489 160.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -135.24 147.62 49.35 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 118.991 1.395 . . . . 2.13 109.871 163.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -161.24 149.01 15.33 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 123.678 0.791 . . . . 0.62 109.693 174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -79.07 136.43 37.16 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.426 -0.953 . . . . 2.14 108.426 160.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.0 tpt -88.8 116.85 27.37 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.848 1.659 . . . . 0.79 107.569 163.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.4 mp -89.37 129.77 35.84 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.003 1.321 . . . . 1.19 107.971 178.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.6 mp -129.15 140.12 51.66 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.165 0.986 . . . . 2.0 111.073 -177.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.57 48.88 7.64 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.923 0.773 . . . . 2.41 111.259 178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 14.0 mt -51.99 156.11 1.64 Allowed 'General case' 0 N--CA 1.46 0.046 0 N-CA-C 115.254 1.576 . . . . 0.95 115.254 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . 29.9 mmtp -120.92 -22.12 6.31 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 113.551 -1.659 . . . . 3.32 113.513 -174.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 84.8 mmt-85 -132.89 142.83 46.16 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 128.436 2.695 . . . . 6.39 109.122 165.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -68.93 137.57 38.26 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.369 2.046 . . . . 1.52 107.951 157.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -86.24 140.68 29.9 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.704 0.802 . . . . 2.15 111.265 -177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.24 165.12 12.72 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 123.559 1.647 . . . . 4.03 111.329 165.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -74.81 134.1 41.82 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 112.88 -1.963 . . . . 1.26 109.249 170.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.99 12.43 59.01 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 125.073 1.32 . . . . 1.97 115.051 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -94.07 -176.71 4.08 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.68 1.192 . . . . 2.63 111.522 171.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -151.77 136.6 17.18 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 128.369 2.668 . . . . 3.04 106.183 176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.3 t -147.86 146.2 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.979 1.312 . . . . 1.39 110.738 -168.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -76.4 142.77 40.99 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.56 0.744 . . . . 2.57 112.162 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.3 mp -120.69 145.26 47.64 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 122.512 1.149 . . . . 1.84 110.774 150.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -112.07 103.61 11.81 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 128.665 2.786 . . . . 2.41 108.527 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.91 130.17 34.57 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 120.67 -1.268 . . . . 1.19 110.762 -166.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.7 mt -100.74 116.01 31.63 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.497 1.119 . . . . 0.94 111.446 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -111.04 104.05 12.57 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.339 1.455 . . . . 2.05 111.829 -173.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 55.52 25.48 7.93 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.393 1.877 . . . . 3.22 113.411 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.88 -58.22 4.27 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.229 1.395 . . . . 4.81 112.697 -173.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -74.4 0.09 56.01 Favored Glycine 0 CA--C 1.534 1.237 0 N-CA-C 116.868 1.507 . . . . 2.1 116.868 -167.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -137.04 143.09 42.49 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.535 1.668 . . . . 2.83 111.649 175.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.7 p -131.35 148.82 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.121 1.768 . . . . 2.16 110.711 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.5 tt -155.66 131.61 9.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.102 1.361 . . . . 1.83 110.599 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -92.36 144.75 25.06 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.265 -0.897 . . . . 2.48 112.288 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.9 t -133.02 161.9 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 125.675 1.59 . . . . 1.96 108.381 167.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 47.7 t -120.62 130.64 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 C-N-CA 124.18 0.992 . . . . 2.04 108.88 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -127.92 136.7 29.41 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.944 1.698 . . . . 3.16 109.501 -165.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.47 160.2 41.99 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 123.385 2.723 . . . . 1.45 111.911 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.0 t -109.51 120.61 61.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 C-N-CA 124.255 1.022 . . . . 1.16 110.478 174.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -132.35 128.83 38.5 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 126.169 1.788 . . . . 3.77 108.732 173.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.89 55.04 1.99 Allowed 'General case' 0 CA--C 1.546 0.81 0 O-C-N 121.475 -0.766 . . . . 2.26 113.0 -176.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 . . . . . 0 C--O 1.248 1.025 0 C-N-CA 125.251 1.42 . . . . 6.1 111.045 -173.379 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.407 0 N-CA-C 106.538 -2.625 . . . . 9.73 106.538 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 m -62.27 158.87 16.2 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 116.853 -1.939 . . . . 10.28 109.645 125.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -136.73 36.06 2.64 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.971 1.708 . . . . 9.85 111.011 -171.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -80.42 56.01 2.43 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.135 1.774 . . . . 5.44 111.457 -175.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -77.22 60.59 1.96 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.491 2.317 . . . . 4.93 111.162 -172.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.15 167.75 21.7 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 121.212 -0.93 . . . . 1.24 112.889 -169.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 16.5 p90 -151.96 165.5 34.44 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.619 0.768 . . . . 2.27 112.893 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -105.88 139.58 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 106.471 -1.677 . . . . 1.43 106.471 168.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.3 ttt-85 -79.8 -126.63 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 119.102 0.865 . . . . 4.84 109.001 170.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -154.45 154.43 33.19 Favored 'General case' 0 N--CA 1.465 0.32 0 O-C-N 119.695 -1.878 . . . . 2.97 113.342 -173.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.7 t -176.36 140.36 0.52 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 129.757 3.223 . . . . 2.2 107.037 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -75.2 -32.52 5.09 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.467 2.112 . . . . 1.3 112.067 176.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 156.88 171.95 23.58 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.807 1.194 . . . . 0.86 112.657 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.95 1.21 19.5 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 119.026 1.413 . . . . 0.88 112.6 -6.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.86 144.83 24.48 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.463 1.653 . . . . 2.49 115.463 -173.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.23 -176.11 3.14 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 127.898 2.479 . . . . 0.48 112.58 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.5 133.25 25.45 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.089 1.356 . . . . 1.01 110.987 173.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.0 141.69 40.76 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.699 1.2 . . . . 0.55 112.67 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -115.64 58.69 0.73 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.143 2.577 . . . . 2.41 109.978 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.1 pp -64.31 162.05 15.57 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 121.054 -1.029 . . . . 1.81 111.836 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.1 m -108.32 139.76 42.57 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.403 0.681 . . . . 1.47 110.941 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.456 HD23 HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -104.64 127.38 52.37 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 114.904 -1.044 . . . . 3.13 110.242 -178.565 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -112.3 145.71 39.52 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.4 1.48 . . . . 5.5 110.178 175.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.46 60.42 48.13 Favored Pre-proline 0 CA--C 1.543 0.689 0 C-N-CA 123.614 0.766 . . . . 2.81 111.897 -177.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -60.66 -20.3 64.49 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.678 2.919 . . . . 1.49 114.573 -175.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -77.41 -171.84 36.73 Favored Glycine 0 CA--C 1.531 1.036 0 CA-C-O 122.638 1.132 . . . . 1.38 113.677 175.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -111.74 -3.02 15.11 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 126.17 1.788 . . . . 3.09 112.45 -163.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.58 154.69 69.9 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 127.528 2.331 . . . . 3.0 110.021 175.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.66 138.59 19.32 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.731 2.287 . . . . 1.47 111.219 -170.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.9 mt -94.89 137.84 33.44 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 123.602 1.667 . . . . 2.17 112.341 175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.9 ttp-105 -123.97 95.97 4.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 112.471 -2.149 . . . . 3.4 111.508 -173.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.456 HD22 HD23 ' A' ' 22' ' ' LEU . 44.0 tp -79.62 107.71 12.6 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.413 1.885 . . . . 2.38 109.909 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.7 m -98.01 -25.41 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 N-CA-C 112.724 0.639 . . . . 0.53 112.724 -175.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.47 -173.96 27.56 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 124.657 1.122 . . . . 0.43 112.388 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.23 174.19 10.06 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 114.667 -0.767 . . . . 0.51 111.88 163.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 15.4 mtp-105 -138.97 170.95 15.05 Favored 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 128.992 2.917 . . . . 4.86 107.056 158.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 t 179.92 153.46 0.63 Allowed Pre-proline 0 N--CA 1.486 1.346 0 C-N-CA 125.459 1.504 . . . . 0.72 110.022 -168.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -85.02 -1.7 9.45 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.8 2.333 . . . . 1.03 115.236 178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.8 m -118.63 18.56 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 115.706 1.743 . . . . 1.02 115.706 -175.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . . . -166.04 162.63 18.04 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 127.194 2.197 . . . . 0.99 109.105 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -120.84 -69.26 0.85 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.069 1.748 . . . . 4.05 108.345 -172.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -84.1 75.05 10.2 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 120.528 -1.358 . . . . 5.65 108.009 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.6 p -76.45 148.75 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 115.512 -0.767 . . . . 1.04 109.577 166.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.35 154.28 30.33 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.332 1.853 . . . . 4.09 108.414 -164.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 57.9 tp -121.38 107.95 13.1 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.47 1.032 . . . . 0.83 110.864 -167.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.1 m170 -115.94 150.13 37.63 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 114.99 1.478 . . . . 0.67 114.99 -171.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -106.93 153.62 22.27 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.662 1.985 . . . . 2.12 110.684 163.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.418 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 3.5 m -131.27 133.17 45.15 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.651 1.981 . . . . 0.94 106.973 -176.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -144.33 172.3 13.13 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.649 0.981 . . . . 1.99 113.649 -167.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 57.5 ttp -99.25 147.05 25.56 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.627 1.571 . . . . 3.77 109.889 167.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -151.91 158.35 43.05 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.876 1.67 . . . . 5.55 109.822 -174.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -110.11 143.2 40.51 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.808 1.643 . . . . 2.9 109.818 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.6 p -157.84 138.32 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 107.935 -1.135 . . . . 3.71 107.935 163.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.3 tt0 64.25 25.11 13.51 Favored 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 123.864 0.865 . . . . 4.01 111.587 -175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.03 10.6 78.09 Favored Glycine 0 N--CA 1.48 1.584 0 O-C-N 120.428 -1.42 . . . . 2.32 113.865 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -123.18 121.61 36.37 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 126.791 2.036 . . . . 2.65 109.565 -166.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.0 mtmm -72.38 131.92 43.26 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.165 1.386 . . . . 3.74 110.957 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.29 -179.5 2.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 C-N-CA 129.095 2.958 . . . . 2.7 109.367 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.73 162.39 22.11 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.787 0.835 . . . . 3.93 112.289 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.57 31.12 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 124.54 1.067 . . . . 0.73 113.319 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 7.0 ttm -154.75 144.3 21.4 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.226 1.41 . . . . 1.1 110.567 -174.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 -148.79 161.72 31.94 Favored Pre-proline 0 N--CA 1.47 0.56 0 C-N-CA 126.105 1.762 . . . . 4.4 109.897 179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.07 161.4 26.54 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.247 1.964 . . . . 0.53 111.956 168.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.92 154.9 68.99 Favored Pre-proline 0 N--CA 1.475 0.791 0 C-N-CA 126.683 1.993 . . . . 1.02 110.612 175.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.91 -20.41 7.63 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.799 2.999 . . . . 0.47 113.561 -165.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -178.33 163.69 1.65 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.431 1.892 . . . . 1.98 111.166 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.2 mt -110.98 157.76 19.54 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.946 1.299 . . . . 0.63 109.822 159.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -133.17 152.33 51.95 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.519 0.728 . . . . 2.32 111.359 172.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 56.2 t -136.15 141.09 34.95 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 126.536 1.934 . . . . 1.1 112.398 179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -83.83 156.13 13.57 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 124.282 3.321 . . . . 1.45 112.708 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -65.91 148.21 85.81 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.599 2.866 . . . . 1.36 114.064 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 70.24 -13.4 0.44 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 129.133 2.973 . . . . 1.99 114.934 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.7 164.23 48.61 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.289 0.947 . . . . 1.96 113.454 173.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -98.41 159.06 15.19 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.519 -0.919 . . . . 4.27 108.519 145.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.9 t -148.57 118.86 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.268 1.427 . . . . 3.54 107.48 163.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -78.85 156.26 28.76 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.719 -0.613 . . . . 2.97 112.376 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.89 144.43 57.28 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.099 -1.074 . . . . 2.6 108.099 155.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' H ' ' HB2' ' A' ' 82' ' ' TYR . 7.9 mptt -84.45 126.98 67.77 Favored Pre-proline 0 CA--C 1.539 0.55 0 O-C-N 120.153 -1.592 . . . . 3.36 109.751 -170.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -60.78 -14.82 34.07 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.814 3.009 . . . . 2.47 115.071 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.56 -58.24 0.77 Allowed Glycine 0 CA--C 1.531 1.069 0 CA-C-N 118.752 0.706 . . . . 3.47 111.867 155.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -75.15 -17.12 80.28 Favored Glycine 0 N--CA 1.476 1.338 0 N-CA-C 119.307 2.483 . . . . 2.0 119.307 -158.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.41 ' HB2' ' H ' ' A' ' 78' ' ' LYS . 80.5 m-85 -147.63 141.32 25.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 120.698 2.249 . . . . 2.25 111.643 176.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -158.2 150.32 21.88 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.606 0.763 . . . . 0.81 111.392 178.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -79.71 117.03 20.24 Favored 'General case' 0 C--O 1.225 -0.185 0 N-CA-C 108.912 -0.773 . . . . 1.82 108.912 162.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.2 tpt -77.81 124.49 28.04 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 126.726 2.01 . . . . 1.0 108.278 171.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.5 mt -117.05 97.32 5.87 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 125.343 1.457 . . . . 1.99 108.946 -167.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.0 mp -105.51 149.39 26.26 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.775 0.798 . . . . 2.36 111.839 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.41 51.98 6.35 Favored Glycine 0 N--CA 1.465 0.584 0 N-CA-C 110.879 -0.888 . . . . 2.08 110.879 173.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 40' ' ' ALA . 10.5 mt -50.77 151.44 2.43 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.682 1.23 . . . . 0.98 113.864 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -114.45 -20.49 10.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.031 -1.895 . . . . 3.03 114.648 -173.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 90.2 mtt-85 -126.51 154.55 75.2 Favored Pre-proline 0 CA--C 1.536 0.442 0 C-N-CA 127.294 2.238 . . . . 6.22 108.184 166.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -64.7 139.92 65.56 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 N-CA-C 107.867 -1.628 . . . . 2.76 107.867 151.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 pp -133.26 163.34 29.52 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.192 1.397 . . . . 2.46 109.225 -178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.07 170.47 20.41 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.236 0.828 . . . . 4.13 113.236 174.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.19 134.44 57.0 Favored 'General case' 0 N--CA 1.446 -0.669 0 C-N-CA 123.932 0.893 . . . . 1.4 110.339 170.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 108.11 -7.52 35.32 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.683 1.611 . . . . 1.69 115.323 179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -88.69 -179.69 6.07 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 118.447 1.123 . . . . 3.8 110.676 174.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 20.6 pt-20 -138.51 141.7 39.36 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 126.648 1.979 . . . . 3.4 106.937 160.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 45.9 t -148.53 145.25 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.784 1.634 . . . . 1.37 110.181 -165.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -86.51 145.62 26.72 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 115.263 1.579 . . . . 3.47 115.263 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -118.31 144.29 45.95 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.79 1.636 . . . . 2.51 109.526 161.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -95.62 113.24 24.87 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 128.568 2.747 . . . . 1.94 108.171 167.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.9 mp -86.5 112.16 21.26 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.617 1.167 . . . . 1.63 107.954 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.9 mt -95.61 106.33 18.41 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.79 0.805 . . . . 0.7 110.705 -174.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -98.25 126.84 43.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.882 1.273 . . . . 1.97 111.929 -176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 44.81 41.27 4.96 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.088 2.155 . . . . 2.52 112.822 178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 92.85 -93.17 1.73 Allowed Glycine 0 C--N 1.341 0.826 0 C-N-CA 125.338 1.447 . . . . 5.99 111.458 -171.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -94.08 -6.68 61.55 Favored Glycine 0 N--CA 1.469 0.877 0 N-CA-C 116.969 1.548 . . . . 3.08 116.969 -160.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -81.94 100.37 9.62 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 121.111 2.456 . . . . 4.21 110.632 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 p -94.91 137.0 24.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 C-N-CA 124.235 1.014 . . . . 2.46 112.554 -178.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.4 tp -133.71 113.97 12.92 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.711 1.604 . . . . 2.53 109.703 170.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt -89.73 125.59 35.34 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 121.616 -0.677 . . . . 2.42 111.482 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.1 t -135.04 157.9 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.745 0.818 . . . . 2.57 110.765 178.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.0 t -104.13 143.76 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 125.715 1.606 . . . . 1.8 108.706 -173.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.13 141.11 14.56 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 125.571 1.549 . . . . 1.97 109.399 -176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 55.6 Cg_endo -68.16 157.88 59.91 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 124.221 3.281 . . . . 0.92 113.743 177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.7 t -110.23 139.59 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 126.852 2.061 . . . . 0.99 108.928 173.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -150.21 164.32 35.98 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 119.741 1.155 . . . . 5.35 114.025 -170.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -148.18 151.78 36.12 Favored 'General case' 0 CA--C 1.537 0.454 0 O-C-N 121.339 -0.85 . . . . 2.86 112.361 177.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.997 1 C-N-CA 132.769 4.428 . . . . 5.53 105.36 -160.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.313 0 N-CA-C 106.024 -2.83 . . . . 11.01 106.024 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 76.6 p -59.38 166.86 2.1 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 117.971 -1.492 . . . . 9.88 109.559 133.856 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -63.45 167.03 5.85 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.751 0.82 . . . . 8.23 110.039 154.716 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.5 m -156.81 48.38 0.45 Allowed 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.105 -0.997 . . . . 5.54 109.752 -177.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.8 91.3 2.41 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 106.454 -1.684 . . . . 4.08 106.454 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -155.93 164.69 32.38 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 127.159 2.314 . . . . 1.16 111.091 -178.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -157.75 156.3 31.36 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.125 1.37 . . . . 2.19 111.213 177.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.3 t -80.27 158.54 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 123.441 0.696 . . . . 1.52 109.42 175.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.72 -26.39 44.76 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.805 1.78 . . . . 5.39 115.805 -176.144 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 85.0 t80 72.36 115.32 0.05 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 128.69 2.796 . . . . 2.48 111.756 -168.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.1 m -164.24 143.16 5.97 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 126.239 1.815 . . . . 2.38 108.047 169.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.35 -25.77 11.02 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.828 2.352 . . . . 1.3 112.374 -178.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.4 175.2 16.27 Favored Glycine 0 CA--C 1.539 1.537 0 C-N-CA 126.814 2.15 . . . . 0.8 110.189 -172.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.42 -7.71 15.84 Favored 'Cis proline' 0 CA--C 1.537 0.648 0 CA-C-N 119.473 1.637 . . . . 0.93 112.747 -5.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -140.44 169.63 17.31 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.083 0.953 . . . . 1.88 113.393 175.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -142.65 -177.62 5.39 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 127.644 2.378 . . . . 0.57 109.966 175.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.59 170.35 14.86 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.76 1.224 . . . . 0.95 110.071 169.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -154.98 144.22 21.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.727 1.211 . . . . 0.74 111.254 178.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -122.94 152.52 40.76 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.681 1.992 . . . . 3.03 109.315 -178.274 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -165.45 157.44 14.96 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 113.954 1.094 . . . . 2.09 113.954 -177.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.8 m -84.4 124.15 30.99 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.789 1.635 . . . . 1.79 109.928 169.154 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.38 132.17 44.89 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 125.399 1.479 . . . . 3.33 108.988 170.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -123.53 145.03 49.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.691 0.797 . . . . 3.58 112.01 177.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.53 72.59 7.63 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.264 -0.88 . . . . 3.22 110.47 -179.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.31 -19.84 55.69 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.707 2.271 . . . . 1.22 113.607 -178.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.29 169.7 54.86 Favored Glycine 0 C--N 1.34 0.771 0 CA-C-O 123.034 1.352 . . . . 1.34 113.01 174.639 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 11.5 m-20 -95.82 -4.33 43.98 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 128.199 2.6 . . . . 3.15 112.843 -170.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.5 mt -122.24 160.31 48.33 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.353 2.261 . . . . 4.66 108.717 172.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.97 143.25 14.29 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.859 2.373 . . . . 1.37 110.844 -169.073 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.8 mt -94.3 153.49 17.99 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 122.72 1.247 . . . . 1.83 112.435 172.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -136.41 113.12 10.19 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 113.131 -1.849 . . . . 1.73 110.65 178.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.87 112.02 24.36 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.78 2.032 . . . . 1.91 108.539 -172.326 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.3 m -102.54 -29.07 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 123.886 0.875 . . . . 0.61 113.011 -169.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.07 -174.44 30.94 Favored Glycine 0 C--N 1.34 0.792 0 C-N-CA 124.969 1.271 . . . . 0.54 113.047 179.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.76 -178.75 5.15 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 121.79 0.805 . . . . 0.57 110.924 167.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.2 mmt180 -139.73 179.39 6.61 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 128.667 2.787 . . . . 5.81 107.393 161.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 t 176.6 151.19 0.35 Allowed Pre-proline 0 N--CA 1.469 0.484 0 C-N-CA 127.769 2.427 . . . . 0.78 106.796 -170.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.68 -7.74 14.65 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.716 2.277 . . . . 0.76 113.902 174.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.4 m -119.74 31.94 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 N-CA-C 114.725 1.38 . . . . 0.97 114.725 -170.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.92 138.28 13.85 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.662 1.585 . . . . 0.92 110.977 168.284 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -61.2 -39.94 92.08 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.259 1.023 . . . . 2.88 111.498 173.32 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -144.15 143.38 31.07 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 128.567 2.747 . . . . 6.12 106.308 -168.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.0 p -142.07 137.02 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 108.018 -1.105 . . . . 1.09 108.018 178.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -144.12 138.29 28.1 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.813 1.245 . . . . 2.98 109.638 -171.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.5 pt? -87.06 135.61 33.22 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 123.076 1.417 . . . . 1.88 113.335 173.43 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -116.89 154.67 30.39 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 127.576 2.35 . . . . 0.95 110.914 176.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.401 ' HB3' ' CE2' ' A' ' 82' ' ' TYR . 2.0 pp20? -103.31 155.93 18.1 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 126.388 1.875 . . . . 2.91 110.453 161.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.406 ' HB ' ' HA2' ' A' ' 81' ' ' GLY . 24.6 m -127.73 132.44 49.59 Favored 'General case' 0 N--CA 1.473 0.675 0 N-CA-C 107.007 -1.479 . . . . 0.92 107.007 172.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -144.81 176.44 9.45 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 114.729 1.381 . . . . 2.06 114.729 -166.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 53.6 ttp -113.36 142.47 45.83 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.823 2.049 . . . . 4.06 111.399 176.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -128.29 163.28 25.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.227 1.811 . . . . 6.01 111.753 166.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -94.6 145.32 24.91 Favored 'General case' 0 N--CA 1.441 -0.908 0 N-CA-C 106.008 -1.849 . . . . 3.52 106.008 152.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.8 p -153.09 124.84 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.324 0.65 . . . . 3.48 109.367 164.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 64.02 22.03 12.8 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 125.925 1.69 . . . . 4.54 113.163 -172.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.23 11.55 83.35 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 120.547 -1.346 . . . . 2.43 113.622 -171.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.8 mtmp? -109.57 118.8 37.54 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.55 1.54 . . . . 4.2 110.265 177.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.63 127.28 31.21 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.986 1.314 . . . . 3.98 109.251 164.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.3 m -145.52 176.01 2.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 C-N-CA 128.294 2.637 . . . . 3.63 109.759 -176.116 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -130.5 166.25 20.94 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.313 1.045 . . . . 3.72 112.459 178.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.92 -179.84 31.29 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.395 1.474 . . . . 0.9 112.954 177.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.8 ttm -153.91 137.38 15.89 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 125.006 1.322 . . . . 1.3 110.305 179.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -144.73 156.29 56.06 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.785 1.634 . . . . 9.66 111.302 -174.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -72.95 154.71 53.22 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.705 2.27 . . . . 0.69 110.488 172.581 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.2 m -129.83 158.39 73.87 Favored Pre-proline 0 N--CA 1.484 1.275 0 CA-C-O 118.299 -0.858 . . . . 0.73 111.063 169.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -84.26 -18.78 4.88 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 123.313 2.675 . . . . 0.79 113.969 -170.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -178.09 169.04 1.96 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.284 1.833 . . . . 1.77 111.771 179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.8 mt -115.27 154.99 28.08 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 126.79 2.036 . . . . 0.56 110.089 162.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -116.84 146.67 42.74 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.196 1.399 . . . . 1.65 108.577 173.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.3 t -137.35 138.69 25.61 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 118.948 -0.548 . . . . 1.02 111.991 169.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -83.72 156.23 13.79 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 124.237 3.291 . . . . 1.24 112.479 178.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -62.57 140.31 80.73 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.765 2.977 . . . . 1.2 113.668 -174.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.409 ' HZ1' ' CG ' ' A' ' 27' ' ' ASP . 69.1 mmtt 69.55 -8.34 0.76 Allowed 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 128.369 2.668 . . . . 1.53 114.345 -177.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.96 149.84 35.03 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.671 1.129 . . . . 1.3 112.266 175.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -108.71 132.03 54.34 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.924 1.689 . . . . 4.36 106.88 163.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 59.7 t -131.8 122.93 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.075 1.35 . . . . 3.42 107.916 177.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -101.95 135.56 43.3 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.87 1.268 . . . . 5.06 110.116 -176.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 83' ' ' HIS . 1.0 OUTLIER -52.84 -48.5 66.98 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.877 1.671 . . . . 3.32 113.216 -171.117 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 103.25 118.38 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 131.047 3.739 . . . . 3.15 111.307 176.213 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -68.66 -1.01 6.8 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.513 2.808 . . . . 2.81 115.036 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -120.13 2.31 12.99 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 125.434 1.492 . . . . 2.49 114.774 170.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.406 ' HA2' ' HB ' ' A' ' 48' ' ' THR . . . -132.9 -106.66 1.0 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 125.355 1.455 . . . . 1.9 112.248 -174.521 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' CE2' ' HB3' ' A' ' 47' ' ' GLU . 86.7 m-85 -77.47 138.19 39.09 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 122.147 0.975 . . . . 2.11 111.489 -175.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.559 ' HA ' HD23 ' A' ' 77' ' ' LEU . 54.7 p-80 -160.17 146.01 15.38 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.827 -0.624 . . . . 0.83 111.057 -175.074 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -76.8 136.49 38.97 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.093 -1.077 . . . . 1.98 108.093 165.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 16.7 mtp -99.79 135.66 40.88 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 118.717 0.689 . . . . 1.96 110.001 157.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -102.8 109.03 20.47 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.691 -1.596 . . . . 1.44 106.691 -179.211 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -102.61 130.9 49.63 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.88 1.672 . . . . 2.79 108.489 -173.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.81 53.51 8.12 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.824 0.726 . . . . 1.73 112.836 174.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.0 mt -48.23 156.54 0.39 Allowed 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 115.938 1.829 . . . . 0.65 115.938 179.574 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -110.96 -25.73 9.66 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 113.733 -1.576 . . . . 1.68 113.973 178.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.8 mtp180 -124.53 142.07 39.48 Favored Pre-proline 0 CA--C 1.54 0.559 0 C-N-CA 127.412 2.285 . . . . 4.74 109.068 169.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.27 156.18 55.3 Favored 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 122.7 2.267 . . . . 1.45 109.73 160.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.21 161.77 13.81 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.249 1.02 . . . . 2.55 112.025 -169.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -132.74 -176.42 4.1 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.952 2.101 . . . . 4.61 110.641 175.316 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.5 150.49 24.54 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.259 -1.015 . . . . 1.73 108.259 156.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.39 36.77 43.49 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.429 0.537 . . . . 1.77 114.386 176.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -122.63 -178.03 3.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.609 1.164 . . . . 3.34 110.009 161.347 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -139.56 135.57 33.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 127.873 2.469 . . . . 3.63 105.214 179.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 74.3 t -142.85 148.94 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 126.488 1.915 . . . . 1.68 109.898 -171.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -100.83 148.67 24.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.165 1.386 . . . . 2.55 114.071 -173.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mp -127.16 158.91 35.81 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 127.189 2.195 . . . . 1.67 110.125 167.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -132.14 94.3 3.44 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.983 1.713 . . . . 2.79 110.762 -172.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.2 mp -78.48 135.93 37.48 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.375 1.07 . . . . 1.24 111.264 -168.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.2 mt -106.83 119.5 39.5 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.069 1.747 . . . . 0.69 110.072 -176.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -118.58 145.44 45.39 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.235 1.414 . . . . 1.92 111.016 -172.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -58.81 126.35 27.3 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.912 1.079 . . . . 2.19 113.912 -169.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.82 68.47 1.49 Allowed Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.907 1.241 . . . . 3.59 112.502 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 73.57 20.44 79.83 Favored Glycine 0 N--CA 1.472 1.099 0 N-CA-C 116.278 1.271 . . . . 1.54 116.278 163.551 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -112.99 138.59 49.64 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 119.552 1.676 . . . . 3.6 111.72 -173.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 54.4 t -139.82 145.87 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.347 1.059 . . . . 1.85 109.675 178.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 64.2 tp -145.66 120.38 9.86 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.794 1.237 . . . . 2.14 111.23 178.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -79.01 137.92 37.79 Favored 'General case' 0 CA--C 1.541 0.622 0 O-C-N 121.529 -0.732 . . . . 2.47 111.155 173.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.05 161.58 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 126.946 2.098 . . . . 2.77 110.026 173.599 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 26.2 t -136.09 136.02 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.377 1.471 . . . . 1.87 109.084 177.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.84 148.29 35.52 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.925 1.69 . . . . 2.39 111.354 -173.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.81 151.97 81.39 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.403 2.735 . . . . 0.9 113.243 175.24 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.0 t -95.32 118.86 42.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.839 -1.073 . . . . 1.59 108.376 172.228 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -147.67 179.99 7.29 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.4 1.48 . . . . 5.59 109.302 178.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -121.33 136.18 55.0 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.762 1.393 . . . . 2.18 114.762 -168.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 127.872 2.469 . . . . 9.49 109.809 166.046 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.982 0 N-CA-C 109.078 -1.609 . . . . 10.43 109.078 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.1 m -88.2 -23.92 23.44 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.635 1.346 . . . . 10.26 114.635 176.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -134.13 25.52 3.88 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.159 1.784 . . . . 9.69 112.327 -161.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 68.94 22.22 7.17 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.523 2.329 . . . . 5.88 113.82 -175.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.404 ' C ' ' HB ' ' A' ' 21' ' ' THR . 8.6 pm0 -91.04 146.64 23.68 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.741 2.016 . . . . 5.3 114.769 179.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 20' ' ' LEU . . . -79.8 179.41 53.18 Favored Glycine 0 N--CA 1.47 0.908 0 O-C-N 121.285 -0.884 . . . . 2.3 114.078 173.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -153.01 146.07 24.62 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.999 1.319 . . . . 2.71 112.929 167.333 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.8 t -93.67 146.82 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 125.268 1.427 . . . . 1.37 107.277 177.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 10' ' ' PHE 0.33 0.3 OUTLIER -74.88 -106.1 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.419 1.009 . . . . 4.79 113.528 176.117 . . . . . . . . 4 4 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.404 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 50.9 t80 -171.19 148.75 2.73 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.667 1.987 . . . . 2.11 110.349 -178.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.8 t -179.6 143.43 0.38 Allowed Pre-proline 0 CA--C 1.543 0.701 0 C-N-CA 128.114 2.566 . . . . 2.12 109.268 174.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.07 -23.75 10.25 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.843 2.362 . . . . 1.17 112.12 169.085 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 136.81 176.81 14.56 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 126.676 2.084 . . . . 0.84 111.573 -171.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.11 -6.37 16.7 Favored 'Cis proline' 0 CA--C 1.537 0.653 0 CA-C-N 118.571 1.185 . . . . 0.91 112.337 -9.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -147.61 148.53 31.2 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 114.578 1.325 . . . . 2.36 114.578 -177.131 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.08 -174.58 2.8 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 128.588 2.755 . . . . 0.42 111.313 -179.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.81 164.33 30.52 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 126.066 1.746 . . . . 0.67 108.825 170.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -152.96 153.16 32.4 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.323 0.965 . . . . 0.63 112.595 -177.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -122.6 87.71 2.8 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.631 1.972 . . . . 2.74 110.802 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.419 ' HA ' ' HA3' ' A' ' 6' ' ' GLY . 3.6 pp -70.45 158.68 35.6 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 119.41 -2.056 . . . . 2.48 113.374 177.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.404 ' HB ' ' C ' ' A' ' 5' ' ' GLU . 20.8 m -135.47 141.27 45.32 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.459 1.904 . . . . 1.98 106.62 167.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 50.9 tp -162.46 156.27 20.88 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 127.9 2.48 . . . . 5.12 109.556 177.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -102.04 154.35 19.06 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.224 -1.548 . . . . 4.09 113.427 166.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 61.2 t-20 -97.74 92.68 1.4 Allowed Pre-proline 0 CA--C 1.546 0.805 0 O-C-N 121.036 -1.04 . . . . 1.52 109.13 162.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -76.05 -15.65 18.37 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 122.566 2.177 . . . . 1.43 113.436 179.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -80.52 -173.75 47.06 Favored Glycine 0 C--N 1.339 0.701 0 CA-C-O 122.421 1.011 . . . . 1.14 112.882 -178.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -115.66 2.23 13.69 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.16 1.784 . . . . 3.2 112.306 -167.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -112.41 155.58 43.49 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 126.985 2.114 . . . . 3.09 111.017 173.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -79.55 158.83 25.44 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.615 2.21 . . . . 0.89 110.979 -178.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.6 mt -115.52 148.66 39.24 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 125.198 1.399 . . . . 2.02 110.469 174.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -131.61 110.63 11.07 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 112.608 -2.087 . . . . 2.37 110.655 171.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -98.12 110.39 22.98 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 126.959 2.103 . . . . 2.16 108.348 -170.517 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.6 m -109.78 -21.61 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.303 1.041 . . . . 0.59 111.938 -165.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -161.85 -175.97 33.45 Favored Glycine 0 C--N 1.341 0.844 0 C-N-CA 125.586 1.565 . . . . 0.4 112.617 -178.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -139.42 -174.92 4.01 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.079 1.351 . . . . 0.58 111.372 172.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -155.73 154.58 31.69 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.398 1.479 . . . . 4.31 108.11 163.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -167.51 149.33 5.27 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 117.597 -1.192 . . . . 1.12 109.215 -176.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.43 -19.1 10.49 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 121.884 1.723 . . . . 1.15 113.207 -174.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 33.4 m -87.13 18.12 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 N-CA-C 113.874 1.064 . . . . 1.55 113.874 -178.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -153.45 175.15 13.48 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.531 1.933 . . . . 1.25 109.599 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -111.56 -32.24 6.74 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 125.403 1.481 . . . . 2.73 113.155 177.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 mtt85 -139.59 159.59 41.81 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.014 2.926 . . . . 5.56 106.11 179.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.2 p -157.05 106.85 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 125.219 1.408 . . . . 1.88 111.005 -173.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -122.22 132.74 54.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 113.663 -1.608 . . . . 5.39 111.622 -159.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.0 tp -84.69 124.08 31.09 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 115.012 -0.995 . . . . 0.97 111.994 -163.256 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -121.39 161.97 21.21 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.355 1.462 . . . . 0.56 113.088 179.081 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.88 -174.09 2.44 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.477 1.911 . . . . 3.29 110.73 163.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.7 m -146.03 138.78 25.64 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 108.056 -1.091 . . . . 0.82 108.056 167.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -135.42 173.3 11.87 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 122.984 1.373 . . . . 2.41 114.112 -172.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -122.06 142.17 50.62 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.709 2.004 . . . . 5.11 111.897 170.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.15 158.84 41.81 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.627 1.971 . . . . 6.74 110.739 172.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -129.01 133.29 47.69 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 126.955 2.102 . . . . 2.75 106.421 166.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -150.42 9.6 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.236 1.014 . . . . 3.48 113.532 -169.326 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -168.95 18.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.161 0.8 . . . . 4.26 113.161 -156.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.28 13.44 58.03 Favored Glycine 0 N--CA 1.478 1.497 0 O-C-N 120.882 -1.136 . . . . 2.04 113.346 -168.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mtmt -143.96 145.76 32.47 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 128.461 2.704 . . . . 2.9 107.661 -174.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.0 mttm -105.54 133.61 50.02 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 127.009 2.124 . . . . 2.98 109.331 -171.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.9 p -155.15 149.13 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.108 1.363 . . . . 2.31 110.488 -171.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -102.42 167.01 10.23 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.546 0.943 . . . . 3.38 113.546 -169.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.62 -179.19 30.53 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.996 1.76 . . . . 0.78 112.851 178.05 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.4 ttm -151.56 141.79 22.32 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.104 1.762 . . . . 1.32 108.082 -177.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -150.73 157.14 36.21 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 124.198 0.999 . . . . 4.91 110.217 -177.48 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -77.06 158.01 34.13 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.6 2.2 . . . . 0.54 111.497 -179.099 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -138.68 152.75 71.37 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.647 1.179 . . . . 0.53 110.154 177.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -79.7 -24.12 6.41 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.14 2.56 . . . . 0.63 113.187 -167.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -178.3 166.72 1.9 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.444 1.898 . . . . 2.08 111.15 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 21.7 mt -109.91 154.27 23.32 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 124.953 1.301 . . . . 0.62 110.091 163.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -114.24 143.06 45.46 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.581 1.152 . . . . 1.8 109.28 175.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.8 t -144.5 136.19 12.86 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 113.136 0.791 . . . . 1.05 113.136 172.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -76.24 167.34 26.03 Favored 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 123.648 2.898 . . . . 0.93 113.061 177.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.54 145.67 97.62 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.742 2.961 . . . . 1.01 111.632 167.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt 66.94 -3.69 0.9 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.813 1.645 . . . . 1.65 113.634 -178.005 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.48 174.73 55.05 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.748 1.642 . . . . 1.23 112.05 171.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.0 mtt85 -102.64 137.82 40.36 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.426 1.09 . . . . 4.89 109.255 175.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.6 t -100.05 104.07 15.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 C-N-CA 126.535 1.934 . . . . 6.09 106.447 176.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -151.21 130.08 12.47 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 122.443 1.116 . . . . 3.24 112.394 -163.173 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 83' ' ' HIS . 10.6 mp -94.32 131.13 40.25 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.156 1.382 . . . . 2.52 107.716 166.655 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.53 149.78 37.4 Favored Pre-proline 0 CA--C 1.541 0.626 0 C-N-CA 124.547 1.139 . . . . 3.38 112.525 -166.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.43 ' HB2' HH11 ' A' ' 120' ' ' ARG . 22.5 Cg_endo -58.26 -38.45 90.88 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.991 3.127 . . . . 2.16 112.6 -179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -109.34 115.68 4.34 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 109.714 -1.354 . . . . 2.87 109.714 164.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 117.51 -122.49 5.45 Favored Glycine 0 N--CA 1.467 0.704 0 C-N-CA 126.716 2.103 . . . . 1.55 110.896 176.727 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -71.34 134.56 46.81 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 117.709 0.755 . . . . 1.83 112.313 -167.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.465 ' HA ' HD23 ' A' ' 77' ' ' LEU . 55.2 p-80 -157.81 151.86 24.31 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 124.536 1.134 . . . . 0.64 110.893 -177.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -84.47 135.24 34.33 Favored 'General case' 0 N--CA 1.463 0.203 0 O-C-N 121.064 -1.022 . . . . 2.14 108.414 168.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -86.31 127.16 34.75 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 126.207 1.803 . . . . 0.74 108.285 162.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.73 112.16 25.12 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.839 1.255 . . . . 1.32 108.387 -175.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -105.87 135.17 47.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.33 1.052 . . . . 2.63 110.57 -169.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.62 48.51 7.91 Favored Glycine 0 N--CA 1.472 1.045 0 O-C-N 121.415 -0.803 . . . . 1.72 113.803 172.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.9 mt -50.96 153.11 1.92 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 123.369 1.557 . . . . 0.92 114.768 178.036 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -124.18 -23.49 4.53 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 112.174 -2.285 . . . . 1.55 114.472 -165.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -118.06 145.82 37.77 Favored Pre-proline 0 N--CA 1.447 -0.621 0 CA-C-O 117.927 -1.035 . . . . 6.17 108.727 152.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.11 98.08 0.79 Allowed 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 106.675 -2.086 . . . . 1.81 106.675 164.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.88 164.31 26.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.339 1.056 . . . . 2.68 113.211 -169.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -139.4 150.22 45.02 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.362 1.865 . . . . 5.64 113.412 -173.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.01 137.37 56.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 113.879 -1.509 . . . . 1.42 108.159 171.03 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 91.02 -6.2 81.75 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.137 1.351 . . . . 1.56 114.601 -173.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -76.61 -176.89 3.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 119.047 1.424 . . . . 2.64 111.707 167.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -135.44 155.55 50.35 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 128.619 2.768 . . . . 3.95 107.127 171.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 60.6 t -147.85 156.08 9.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 C-N-CA 129.538 3.135 . . . . 1.33 107.667 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -117.81 154.16 32.26 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 121.62 -0.675 . . . . 2.28 111.26 167.556 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.7 tt -145.71 132.65 20.2 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 121.764 0.793 . . . . 3.01 111.327 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -77.14 134.21 38.75 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 129.152 2.981 . . . . 2.18 109.332 166.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -97.58 127.61 43.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 124.183 0.993 . . . . 1.22 108.763 162.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.6 mt -100.21 115.75 30.6 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 124.01 0.924 . . . . 0.64 109.337 175.073 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -111.2 151.86 27.75 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.579 1.552 . . . . 2.13 111.414 178.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -61.59 151.74 32.43 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.126 0.571 . . . . 2.21 111.448 170.335 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 85.58 23.33 47.31 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 119.003 -0.887 . . . . 3.87 114.364 -177.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 75.52 35.49 46.85 Favored Glycine 0 N--CA 1.473 1.107 0 C-N-CA 124.246 0.927 . . . . 1.54 113.376 173.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 35.2 mttm -120.6 122.08 39.74 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 117.871 0.836 . . . . 3.27 111.582 -167.022 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.23 142.86 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 C-N-CA 125.801 1.64 . . . . 1.98 109.96 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 tt -148.92 113.91 5.45 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.759 0.824 . . . . 1.99 110.829 -177.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.4 ttpp -94.75 121.0 35.88 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.647 0.779 . . . . 2.0 112.397 -176.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.4 t -109.39 163.34 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 126.653 1.981 . . . . 1.85 109.888 178.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.7 t -119.3 140.78 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 126.552 1.941 . . . . 2.25 109.616 178.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -156.24 142.65 13.21 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 124.867 1.267 . . . . 2.48 114.047 -165.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -73.32 163.84 36.77 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.438 2.759 . . . . 0.94 112.582 172.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.26 131.18 50.85 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.996 1.318 . . . . 0.94 109.107 165.398 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -155.32 126.95 7.4 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.874 2.07 . . . . 3.48 108.69 179.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.67 57.53 1.64 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.552 2.056 . . . . 3.01 116.552 -154.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.43 HH11 ' HB2' ' A' ' 79' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.299 0 C-N-CA 124.909 1.283 . . . . 8.96 113.958 -172.284 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.146 0 N-CA-C 104.973 -3.251 . . . . 10.14 104.973 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -161.42 166.95 26.54 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 109.339 -0.615 . . . . 8.37 109.339 -143.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -166.43 18.12 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.307 2.243 . . . . 10.32 111.506 -170.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.1 t -175.32 61.16 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 127.018 2.127 . . . . 5.67 110.233 -159.117 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -80.17 58.83 3.13 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.342 1.457 . . . . 4.61 111.163 -172.191 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -152.08 163.48 30.16 Favored Glycine 0 C--N 1.333 0.402 0 O-C-N 121.406 -0.809 . . . . 1.42 111.207 170.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 42.0 p90 -140.4 177.91 7.68 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.737 0.643 . . . . 2.43 112.737 178.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 88.9 t -111.72 143.75 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.707 1.203 . . . . 1.45 111.301 -178.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -27.06 64.38 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 129.328 3.051 . . . . 7.87 116.445 -173.367 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.5 t80 66.73 129.87 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 128.611 2.765 . . . . 2.22 113.634 -168.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.5 t -174.34 146.64 1.12 Allowed Pre-proline 0 CA--C 1.542 0.662 0 C-N-CA 126.185 1.794 . . . . 2.05 110.896 -179.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -78.13 -20.21 11.57 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.961 2.441 . . . . 1.28 112.73 168.202 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 129.28 -174.49 19.23 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.781 1.658 . . . . 0.94 111.663 -172.741 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.74 -10.64 9.77 Favored 'Cis proline' 0 CA--C 1.537 0.674 0 CA-C-N 119.133 1.467 . . . . 1.12 112.493 -8.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -132.25 157.74 43.59 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-O 123.295 1.521 . . . . 2.49 114.879 173.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -132.05 -176.39 4.05 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 128.448 2.699 . . . . 0.42 109.781 171.391 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -148.9 152.58 36.65 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.153 1.781 . . . . 0.66 107.617 176.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -137.01 140.1 41.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 119.32 0.964 . . . . 0.5 111.322 -177.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.7 m-85 -114.18 34.22 4.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.51 1.524 . . . . 2.55 112.763 -165.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 tt -48.43 143.82 4.56 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.737 2.015 . . . . 2.57 112.862 -179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -82.74 149.75 27.09 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.457 0.91 . . . . 3.04 113.457 170.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.83 116.47 27.51 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.77 0.828 . . . . 3.59 110.278 170.15 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -121.71 142.69 49.91 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 125.288 1.435 . . . . 4.52 109.53 171.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.1 t-20 -106.38 101.4 35.1 Favored Pre-proline 0 CA--C 1.544 0.724 0 C-N-CA 124.595 1.158 . . . . 1.34 109.875 175.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -79.03 -10.95 15.13 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 122.951 2.434 . . . . 1.2 113.597 175.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.23 -177.61 50.75 Favored Glycine 0 C--N 1.34 0.769 0 CA-C-O 122.502 1.057 . . . . 1.11 112.86 -176.778 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -108.81 -1.71 19.05 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.383 2.273 . . . . 2.91 111.774 -173.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -120.6 160.85 42.49 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 128.502 2.721 . . . . 2.73 109.67 173.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -78.63 146.69 21.54 Favored 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 122.674 2.249 . . . . 0.91 111.525 -175.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 2.5 mp -107.77 150.09 27.41 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 124.78 1.232 . . . . 2.34 110.383 174.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 9.6 ttp-105 -135.91 108.15 7.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 112.436 -2.165 . . . . 2.9 110.257 178.5 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 tt -86.44 124.11 32.4 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.011 0.925 . . . . 2.2 109.013 176.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -109.3 -23.61 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 123.53 0.732 . . . . 0.73 111.531 -179.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.85 -173.16 27.99 Favored Glycine 0 C--N 1.345 1.05 0 C-N-CA 124.73 1.157 . . . . 0.46 114.299 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.93 -179.07 5.39 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.925 1.29 . . . . 0.57 111.216 165.466 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.9 ttt-85 -139.16 160.38 39.94 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.658 1.983 . . . . 5.69 107.252 155.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 t -161.0 149.26 12.85 Favored Pre-proline 0 N--CA 1.473 0.713 0 C-N-CA 125.651 1.58 . . . . 0.8 108.248 -178.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -78.02 -2.25 12.37 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.129 1.886 . . . . 1.0 114.25 -177.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 27.4 m -124.99 31.38 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 125.336 1.454 . . . . 0.96 114.524 -170.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.39 159.51 44.41 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.835 1.654 . . . . 0.91 110.419 165.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -83.4 -57.37 3.28 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.76 1.624 . . . . 2.77 110.094 169.371 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -106.68 130.47 54.41 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.47 1.508 . . . . 5.45 107.351 166.558 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.7 p -98.78 144.88 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.137 -0.69 . . . . 1.01 109.137 152.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -138.6 152.49 48.19 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.966 1.707 . . . . 2.75 109.374 -173.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.2 tp -108.6 117.61 34.63 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.498 0.719 . . . . 0.99 110.916 -173.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -121.73 152.76 39.06 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.569 1.548 . . . . 0.52 113.283 -176.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -96.7 167.87 10.85 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.842 1.257 . . . . 2.19 111.476 159.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 50.9 m -129.42 138.95 51.76 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 126.284 1.834 . . . . 0.8 107.096 170.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -140.69 171.27 14.34 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.403 1.096 . . . . 2.05 113.649 -173.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -115.31 142.51 46.59 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.543 1.937 . . . . 5.45 111.407 173.445 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 6.6 ptp85 -137.59 139.45 40.38 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.155 0.982 . . . . 5.5 111.658 169.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -91.11 139.07 31.1 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 124.886 1.275 . . . . 2.92 107.788 161.018 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.9 t -141.76 128.56 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 106.033 -1.839 . . . . 2.44 106.033 168.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 58.68 24.42 12.14 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 125.11 1.364 . . . . 5.67 114.408 -176.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.56 29.15 73.73 Favored Glycine 0 N--CA 1.472 1.095 0 O-C-N 120.488 -1.382 . . . . 1.98 112.453 -170.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 25.7 mmtm -121.4 120.62 35.51 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 127.009 2.124 . . . . 4.74 108.427 169.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.68 126.47 40.97 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.119 1.367 . . . . 2.95 112.12 -176.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 36.3 t -144.33 144.98 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 126.976 2.11 . . . . 2.52 108.277 -171.196 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 73.4 mtm -90.63 172.9 8.35 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.361 0.874 . . . . 3.24 113.361 -179.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -155.95 -179.4 30.99 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 124.748 1.166 . . . . 1.13 111.783 166.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.07 162.32 35.23 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.484 0.713 . . . . 3.34 110.771 161.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.2 ptt85 -157.19 154.47 26.04 Favored Pre-proline 0 N--CA 1.473 0.698 0 C-N-CA 124.871 1.268 . . . . 4.63 110.062 -177.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.86 154.65 43.34 Favored 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 122.134 1.89 . . . . 0.56 112.001 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.2 m -138.0 155.05 74.74 Favored Pre-proline 0 N--CA 1.474 0.741 0 C-N-CA 125.669 1.588 . . . . 0.69 110.182 179.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -82.78 -26.34 2.53 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.096 2.531 . . . . 0.61 113.333 -167.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -176.42 166.73 2.77 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.989 1.716 . . . . 2.27 111.231 -177.315 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.6 mt -114.63 151.76 33.0 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 126.002 1.721 . . . . 0.77 110.517 166.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -120.79 138.94 53.77 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.767 1.227 . . . . 1.81 109.024 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 44.4 t -140.81 126.67 11.41 Favored Pre-proline 0 CA--C 1.543 0.681 0 N-CA-C 112.192 0.442 . . . . 0.93 112.192 170.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -73.53 161.71 41.65 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 124.392 3.394 . . . . 1.16 111.958 179.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -59.9 140.37 92.65 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 123.673 2.916 . . . . 0.94 113.051 -175.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt 68.65 -3.02 1.49 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 127.179 2.192 . . . . 1.66 114.484 178.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -94.4 169.15 28.74 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.565 1.555 . . . . 1.21 113.183 176.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -143.47 158.64 43.49 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.853 0.861 . . . . 5.26 112.536 172.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 47.1 t -156.14 113.53 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 127.642 2.377 . . . . 3.97 108.475 174.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.34 151.33 34.98 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 119.03 0.832 . . . . 3.56 111.813 -179.693 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.6 mp -74.4 65.21 1.21 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 122.53 1.157 . . . . 2.16 109.414 162.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -58.52 145.89 74.84 Favored Pre-proline 0 CA--C 1.55 0.949 0 C-N-CA 124.55 1.14 . . . . 4.13 113.201 -174.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.85 81.39 0.84 Allowed 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 123.342 2.695 . . . . 2.67 109.391 169.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.64 34.0 0.1 OUTLIER Glycine 0 CA--C 1.527 0.798 0 C-N-CA 124.372 0.987 . . . . 2.4 113.495 -162.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.04 -25.75 0.24 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 117.418 1.727 . . . . 2.42 117.418 160.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -145.48 146.91 31.66 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 118.742 1.271 . . . . 1.89 111.196 169.087 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.2 p-80 -159.48 154.61 25.12 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.992 0.917 . . . . 0.54 110.005 174.407 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -77.67 141.31 39.47 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.39 -0.967 . . . . 1.83 108.39 159.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -94.25 131.96 39.31 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.218 1.407 . . . . 0.72 108.354 164.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.0 mp -109.2 109.92 21.0 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 108.012 -1.107 . . . . 1.32 108.012 178.459 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -107.71 134.07 51.21 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.182 1.393 . . . . 2.4 109.489 -175.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.18 53.49 14.0 Favored Glycine 0 CA--C 1.528 0.874 0 O-C-N 121.854 -0.529 . . . . 1.65 112.48 174.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.4 mt -44.66 155.41 0.1 Allowed 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.088 1.755 . . . . 0.64 115.067 178.132 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -108.6 -32.99 7.15 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 113.281 -1.782 . . . . 1.58 112.847 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 ptt180 -120.99 137.57 26.75 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.55 1.54 . . . . 6.69 108.634 163.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -66.88 130.95 24.29 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 N-CA-C 106.654 -2.094 . . . . 1.33 106.654 160.028 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -76.16 171.61 14.21 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.245 0.545 . . . . 2.17 111.166 -174.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.429 ' H ' ' CD ' ' A' ' 97' ' ' GLU . 0.5 OUTLIER -116.83 157.91 24.83 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.267 -0.895 . . . . 4.06 109.827 150.547 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.45 123.61 21.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 107.001 -1.481 . . . . 1.69 107.001 159.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 99.32 7.76 53.96 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-O 118.166 -1.352 . . . . 2.03 115.813 -175.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.429 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 90.9 mt-10 -81.91 -174.39 5.02 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-N 119.816 1.808 . . . . 3.01 111.12 165.001 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -130.29 135.7 48.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.829 2.452 . . . . 3.68 106.284 166.341 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 58.0 t -119.24 144.78 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 126.829 2.052 . . . . 1.7 109.439 179.24 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -89.15 134.16 34.13 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.051 0.54 . . . . 2.62 110.493 171.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.6 mp -116.51 132.4 56.69 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 122.301 1.048 . . . . 1.98 110.14 154.619 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -83.32 145.08 29.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.446 1.899 . . . . 2.1 109.109 158.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.4 mp -117.3 123.29 46.17 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 125.399 1.48 . . . . 1.52 109.943 -175.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -103.53 115.13 29.95 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.493 1.117 . . . . 2.4 109.816 -176.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -112.66 145.89 39.64 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.263 1.425 . . . . 2.05 111.76 -177.023 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.22 151.81 39.37 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.583 0.753 . . . . 2.22 112.253 176.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.59 33.63 37.88 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-O 119.031 -0.872 . . . . 4.34 113.56 177.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 74.66 47.49 15.24 Favored Glycine 0 N--CA 1.471 1.014 0 C-N-CA 124.618 1.104 . . . . 2.07 113.852 171.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -133.88 131.82 39.59 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 118.195 0.998 . . . . 3.54 111.755 -171.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.1 t -140.87 150.56 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.594 1.158 . . . . 2.26 109.121 178.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.4 tp -149.57 170.97 17.4 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 127.601 2.36 . . . . 2.18 108.551 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -145.53 156.72 43.88 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 119.779 1.172 . . . . 2.23 113.072 162.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.5 t -146.1 160.98 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 125.309 1.443 . . . . 2.21 109.351 176.736 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 18.9 t -112.44 136.66 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.614 1.566 . . . . 1.88 108.788 -179.378 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -135.61 142.44 41.0 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 125.63 1.572 . . . . 2.26 110.145 -175.02 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -65.0 154.42 73.47 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.737 2.291 . . . . 1.21 112.143 175.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.4 t -93.47 139.49 18.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.704 -1.221 . . . . 1.33 107.704 157.286 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -123.68 -179.71 4.47 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 125.008 1.323 . . . . 4.29 109.937 174.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -90.37 174.48 7.55 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.152 0.981 . . . . 2.6 112.445 177.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.6 mtp-105 . . . . . 0 C--O 1.25 1.129 0 C-N-CA 126.882 2.073 . . . . 10.85 109.75 166.956 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.985 0 N-CA-C 110.194 -1.163 . . . . 14.06 110.194 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.0 p -176.91 -152.43 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.677 1.991 . . . . 10.57 108.618 179.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.0 p90 -79.15 -11.47 59.98 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.521 1.129 . . . . 10.79 113.331 168.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 53.9 p -73.88 111.34 8.94 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.491 1.041 . . . . 5.11 111.675 -162.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -78.49 65.7 3.85 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.616 1.566 . . . . 5.12 111.138 -169.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.06 172.33 23.21 Favored Glycine 0 N--CA 1.471 0.998 0 O-C-N 120.47 -1.394 . . . . 1.11 115.546 -176.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.6 p90 -154.24 -179.34 7.83 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.33 1.452 . . . . 2.83 112.475 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.6 t -121.24 144.85 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.226 1.011 . . . . 1.55 109.986 168.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -26.27 62.92 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 126.794 2.038 . . . . 5.82 115.641 -175.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 73.2 t80 90.64 146.99 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 129.875 3.27 . . . . 2.99 111.994 -168.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.8 m -176.77 144.79 0.63 Allowed Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 130.159 3.383 . . . . 2.52 108.793 160.706 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.51 -36.32 0.93 Allowed 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.678 2.252 . . . . 1.29 111.917 177.717 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 163.06 169.91 27.18 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.577 1.084 . . . . 0.9 111.949 -179.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.7 -4.42 19.6 Favored 'Cis proline' 0 CA--C 1.539 0.748 0 CA-C-N 118.797 1.299 . . . . 1.15 112.767 -5.126 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.1 153.72 34.49 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.99 1.107 . . . . 2.69 113.99 -172.287 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -120.91 -178.99 3.88 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.524 1.93 . . . . 0.69 111.837 174.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.25 140.78 48.78 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.794 1.237 . . . . 1.05 108.872 167.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -118.15 143.08 46.78 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.319 1.448 . . . . 0.67 110.458 -178.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -131.11 105.66 7.85 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.866 2.066 . . . . 2.8 108.994 -170.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -144.59 162.27 37.05 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 113.788 1.033 . . . . 2.15 113.788 -168.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.462 HG21 ' HD2' ' A' ' 74' ' ' ARG . 2.9 m -79.86 155.6 27.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 114.031 -1.441 . . . . 1.94 112.125 177.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.4 HD23 HD22 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -130.21 116.79 18.91 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 113.312 -1.767 . . . . 3.46 109.447 170.996 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 35.8 mp0 -101.26 133.85 45.21 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.666 1.986 . . . . 5.16 110.923 175.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.27 76.67 1.09 Allowed Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 120.545 -1.347 . . . . 3.04 110.888 176.0 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.64 -19.3 42.11 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.667 2.245 . . . . 1.2 114.288 -176.277 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -78.43 176.6 54.2 Favored Glycine 0 C--N 1.34 0.751 0 CA-C-O 122.733 1.185 . . . . 1.16 112.956 176.403 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -100.52 -3.37 30.86 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 127.688 2.395 . . . . 2.89 112.176 -170.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mp -126.01 160.35 57.39 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 128.122 2.569 . . . . 3.59 108.534 174.401 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -81.55 139.51 11.39 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.462 2.108 . . . . 1.07 111.455 -167.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.22 146.91 23.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 123.212 1.482 . . . . 2.2 110.314 169.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.4 ttp-105 -134.53 102.78 5.43 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 113.536 -1.665 . . . . 3.38 110.221 -176.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.4 HD22 HD23 ' A' ' 22' ' ' LEU . 52.7 tp -84.04 103.87 13.64 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 126.302 1.841 . . . . 2.5 110.249 -174.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 17.6 m -97.35 -24.46 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 123.611 0.764 . . . . 0.48 112.565 -174.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.64 -174.42 29.37 Favored Glycine 0 C--N 1.34 0.79 0 C-N-CA 124.839 1.209 . . . . 0.47 113.052 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.69 -176.73 4.99 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.898 1.679 . . . . 0.54 111.101 171.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 8.9 mtt180 -155.87 166.33 33.81 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 130.353 3.461 . . . . 4.68 107.261 174.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 t 179.75 153.19 0.6 Allowed Pre-proline 0 N--CA 1.485 1.312 0 C-N-CA 127.921 2.488 . . . . 0.73 108.279 -178.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.84 -27.69 10.13 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 CA-C-N 121.263 1.487 . . . . 0.87 113.014 176.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.5 m -93.72 22.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 N-CA-C 115.193 1.553 . . . . 0.88 115.193 -170.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -138.18 162.16 34.97 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.206 1.803 . . . . 1.13 108.075 164.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -77.32 -56.0 4.93 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.033 1.333 . . . . 4.27 109.996 168.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -133.76 177.61 7.58 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 126.872 2.069 . . . . 5.47 109.337 176.589 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.9 p -153.36 147.14 14.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.354 1.462 . . . . 0.84 109.079 -174.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -133.17 147.74 52.06 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.783 1.633 . . . . 2.67 110.381 -179.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.7 tp -96.76 121.06 38.2 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.322 0.649 . . . . 1.0 110.702 177.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.1 m170 -122.76 157.93 31.28 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 123.148 1.452 . . . . 0.6 113.118 -175.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -107.32 154.37 21.38 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 113.873 -1.512 . . . . 2.03 110.055 158.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.9 m -114.78 135.87 53.71 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 105.831 -1.915 . . . . 1.65 105.831 159.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -126.12 165.46 18.82 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.41 1.084 . . . . 2.07 112.398 -177.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 40.7 ttp -105.05 144.85 31.29 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.685 1.594 . . . . 3.3 109.614 168.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.26 150.48 30.61 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.195 0.998 . . . . 6.11 111.698 -175.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -95.42 142.83 27.33 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 125.786 1.634 . . . . 2.84 110.131 169.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.3 t -116.0 -110.58 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.053 1.341 . . . . 3.65 107.781 170.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -68.59 44.94 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 131.319 3.848 . . . . 4.32 112.851 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.34 17.62 62.02 Favored Glycine 0 CA--C 1.536 1.365 0 O-C-N 120.16 -1.587 . . . . 1.64 112.746 -166.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.6 mtpt -133.18 134.82 44.61 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 127.707 2.403 . . . . 2.46 107.605 -168.337 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 34.4 mttm -91.53 132.41 36.3 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 126.47 1.908 . . . . 2.98 110.819 -167.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 t -143.5 143.95 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 126.334 1.854 . . . . 2.26 108.282 -176.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 49.4 mtm -88.49 165.42 14.89 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.633 0.605 . . . . 3.14 112.633 173.493 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.76 -179.51 23.83 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 124.725 1.155 . . . . 0.89 112.29 174.498 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 8.2 ttm -147.68 147.14 29.65 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.166 1.387 . . . . 1.14 109.032 175.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -155.81 154.07 27.16 Favored Pre-proline 0 CA--C 1.54 0.578 0 C-N-CA 124.265 1.026 . . . . 4.62 110.394 176.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.4 156.2 50.41 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.172 1.915 . . . . 0.6 110.834 173.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.08 155.0 76.33 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.389 1.476 . . . . 0.55 110.19 -179.587 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.47 -23.79 3.97 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.781 2.32 . . . . 0.47 113.468 -166.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -178.38 165.96 1.82 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.611 1.964 . . . . 1.69 111.219 179.16 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.0 mt -110.13 159.1 17.64 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.863 1.265 . . . . 0.72 109.785 157.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -127.09 152.62 47.05 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 123.949 0.9 . . . . 1.9 110.12 169.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 52.4 t -136.7 141.65 36.07 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 123.894 0.877 . . . . 1.01 110.784 172.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -83.39 155.9 14.35 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.992 3.128 . . . . 1.11 112.685 178.506 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -61.58 140.07 84.86 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.21 3.274 . . . . 0.99 114.438 -174.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt 69.14 -8.53 0.68 Allowed 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 127.719 2.408 . . . . 1.59 113.792 -176.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.18 166.76 52.93 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.126 1.346 . . . . 1.21 112.636 174.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.462 ' HD2' HG21 ' A' ' 21' ' ' THR . 11.8 ttp-105 -136.29 136.26 39.63 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.172 2.189 . . . . 4.34 106.994 172.065 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.6 t -149.65 139.27 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.231 1.412 . . . . 4.02 108.782 177.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.32 149.48 24.69 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 122.325 1.059 . . . . 3.6 113.383 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -59.78 108.02 0.69 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.197 -1.409 . . . . 1.95 107.197 158.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.04 139.38 90.92 Favored Pre-proline 0 CA--C 1.546 0.819 0 CA-C-O 116.902 -1.523 . . . . 2.34 112.647 -160.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -49.51 -28.94 17.31 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 124.734 3.623 . . . . 2.79 115.791 -179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -119.59 4.11 13.35 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 117.559 -1.69 . . . . 2.83 116.198 173.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -122.75 -98.58 1.42 Allowed Glycine 0 N--CA 1.472 1.057 0 CA-C-N 120.874 2.337 . . . . 1.85 113.0 -176.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -71.86 140.87 49.53 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.158 -1.201 . . . . 2.18 111.28 -176.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -161.57 153.71 19.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.624 1.17 . . . . 0.63 111.076 -174.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -88.01 129.78 35.16 Favored 'General case' 0 N--CA 1.467 0.394 0 O-C-N 121.556 -0.715 . . . . 1.76 109.305 166.254 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.5 tpt -82.83 119.52 24.48 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.836 1.654 . . . . 0.75 109.407 165.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.6 mp -102.02 110.9 22.99 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.785 1.234 . . . . 1.27 109.296 -179.088 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -104.24 139.87 38.64 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.071 1.348 . . . . 2.63 111.079 -168.103 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 71.39 45.77 45.31 Favored Glycine 0 N--CA 1.473 1.156 0 O-C-N 121.328 -0.858 . . . . 1.85 112.83 174.581 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.2 mt -47.8 155.19 0.43 Allowed 'General case' 0 CA--C 1.523 -0.09 0 CA-C-O 123.563 1.649 . . . . 0.95 115.28 -177.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 25.3 mmtp -116.09 -29.69 6.22 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 112.862 -1.972 . . . . 2.9 112.55 -178.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 7.8 mmt-85 -105.03 134.73 19.49 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.681 2.392 . . . . 4.59 109.509 163.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.17 74.84 3.45 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 N-CA-C 106.572 -2.126 . . . . 1.9 106.572 147.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.533 ' H ' HD23 ' A' ' 93' ' ' LEU . 1.4 pt? -63.5 127.34 30.89 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.887 0.851 . . . . 2.43 112.717 -159.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 29.1 mmmt -84.96 138.79 32.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 122.762 1.267 . . . . 5.93 112.185 -170.273 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.64 118.91 5.74 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 113.928 -1.487 . . . . 1.29 108.194 167.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 107.16 -9.99 39.63 Favored Glycine 0 CA--C 1.537 1.438 0 CA-C-O 117.788 -1.562 . . . . 1.95 115.572 -169.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -78.59 173.27 12.59 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 120.13 1.965 . . . . 3.02 110.653 161.18 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 116' ' ' PRO . 13.1 pt-20 -138.47 144.1 39.91 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 106.032 -1.84 . . . . 3.64 106.032 160.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.9 t -145.0 148.69 17.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 124.824 1.249 . . . . 2.04 109.411 -171.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.88 149.44 21.54 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 123.401 1.572 . . . . 3.33 114.578 -170.119 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.6 mp -120.56 151.75 39.0 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 113.72 -1.582 . . . . 1.68 110.083 170.671 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -118.02 103.51 9.98 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.78 2.432 . . . . 2.86 109.483 174.419 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.7 mp -83.6 134.96 34.78 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 124.679 1.192 . . . . 1.17 110.786 -172.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.2 mt -104.98 110.56 23.0 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 122.341 1.067 . . . . 0.67 110.406 -174.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -103.77 123.72 47.59 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.847 1.659 . . . . 1.97 111.309 -176.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 46.57 35.82 3.2 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.934 2.094 . . . . 2.49 112.892 -179.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.44 -102.54 2.73 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 124.989 1.281 . . . . 5.62 111.05 -169.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -85.24 -6.76 83.96 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 117.026 1.57 . . . . 2.86 117.026 -160.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -80.97 102.52 10.2 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 121.138 2.469 . . . . 3.09 110.848 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.1 p -87.08 142.32 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 124.253 0.97 . . . . 2.33 112.242 178.738 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.14 125.57 19.0 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 123.822 0.849 . . . . 2.69 112.134 173.097 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.42 117.27 21.72 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.243 1.017 . . . . 2.5 111.472 179.418 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.9 m -112.13 166.76 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 126.31 1.844 . . . . 2.69 110.66 169.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.3 t -144.6 117.76 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 CA-C-N 119.171 0.896 . . . . 2.23 110.51 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -124.06 142.18 39.08 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.219 1.008 . . . . 3.33 112.374 -172.116 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 98' ' ' GLU . 70.6 Cg_endo -70.04 151.35 67.44 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.316 3.344 . . . . 0.9 113.398 169.268 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 40.8 t -84.59 128.94 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 115.51 -0.768 . . . . 1.09 109.702 168.676 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.24 169.38 9.76 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.118 2.167 . . . . 3.87 107.88 172.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -115.16 53.68 0.81 Allowed 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.419 -0.8 . . . . 2.25 110.167 174.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.0 ttt-85 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 117.22 -1.371 . . . . 6.65 114.348 -155.306 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.237 0 N-CA-C 108.591 -1.804 . . . . 12.43 108.591 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 p 172.11 -174.8 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.026 1.73 . . . . 10.89 107.79 -159.143 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -68.34 169.47 10.54 Favored 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 118.727 0.694 . . . . 13.99 109.835 151.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.9 t 149.09 -5.44 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 129.601 3.16 . . . . 7.19 112.762 -164.468 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.11 -179.94 6.27 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.047 1.339 . . . . 7.2 108.958 175.42 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.99 177.15 39.75 Favored Glycine 0 CA--C 1.523 0.575 0 CA-C-O 122.296 0.942 . . . . 1.31 113.093 -177.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -157.23 155.12 30.3 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.492 0.717 . . . . 7.14 111.1 168.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 96.0 t -128.96 137.02 58.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 N-CA-C 106.68 -1.6 . . . . 1.62 106.68 163.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.5 mmm-85 -75.56 -62.4 1.59 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.484 0.584 . . . . 6.16 110.362 -176.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -171.99 150.22 2.52 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.374 1.07 . . . . 2.97 110.982 178.175 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.9 m -135.86 112.75 10.62 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.878 0.871 . . . . 4.74 112.37 -178.234 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -82.92 -34.66 0.33 Allowed 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.896 2.398 . . . . 2.3 112.115 170.066 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 97.12 151.62 27.99 Favored Glycine 0 CA--C 1.539 1.55 0 N-CA-C 110.904 -0.878 . . . . 1.53 110.904 -158.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.94 0.65 32.86 Favored 'Cis proline' 0 CA--C 1.539 0.742 0 CA-C-N 119.636 1.718 . . . . 1.44 113.297 1.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -144.75 172.58 12.81 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 114.514 1.302 . . . . 1.81 114.514 -177.06 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -159.02 -175.65 5.4 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 129.786 3.234 . . . . 0.51 112.335 -176.277 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -146.68 136.97 23.68 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.897 2.079 . . . . 0.75 108.72 174.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -124.89 144.15 50.48 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.841 1.657 . . . . 0.65 112.543 -174.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -126.97 59.34 1.4 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.668 1.987 . . . . 2.55 111.999 -163.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 pp -73.18 152.04 41.26 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 114.963 1.468 . . . . 1.78 114.963 -173.404 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 m -84.97 144.16 28.5 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 121.34 -0.85 . . . . 1.72 110.443 161.711 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -139.2 129.63 25.66 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.281 1.832 . . . . 4.11 111.318 -170.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -127.46 143.71 51.16 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.631 1.172 . . . . 3.86 111.356 -176.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -105.73 95.22 10.05 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 123.815 0.846 . . . . 1.77 108.917 160.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.04 -4.99 15.85 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.097 2.532 . . . . 1.45 113.873 175.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -85.94 174.39 47.73 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 122.805 1.225 . . . . 1.27 113.099 -177.373 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -99.85 -1.86 36.41 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 128.246 2.618 . . . . 3.41 111.887 -174.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -122.21 157.95 56.89 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 128.473 2.709 . . . . 3.14 110.021 176.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -77.33 143.44 22.16 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.587 2.191 . . . . 1.57 111.302 -173.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -111.61 156.13 22.28 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.7 1.6 . . . . 3.02 109.839 173.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.1 ttp-105 -140.57 104.91 4.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.518 1.527 . . . . 2.72 109.178 -177.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.8 113.72 21.55 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.453 1.501 . . . . 2.52 108.144 -176.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 m -103.88 -27.03 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.674 0.789 . . . . 0.51 112.361 -174.233 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.25 -177.78 31.66 Favored Glycine 0 C--N 1.342 0.889 0 C-N-CA 124.55 1.072 . . . . 0.41 113.555 177.188 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -125.68 -174.72 3.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.947 1.299 . . . . 0.59 109.642 168.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 4.5 mtt180 -155.59 168.75 26.12 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 128.029 2.532 . . . . 5.26 106.82 173.349 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.9 t -173.51 151.08 1.89 Allowed Pre-proline 0 N--CA 1.471 0.579 0 C-N-CA 125.504 1.522 . . . . 0.82 108.431 179.284 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.72 -10.51 21.73 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 121.869 1.713 . . . . 1.21 113.832 176.432 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.13 18.94 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 114.96 1.467 . . . . 1.4 114.96 -170.734 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.83 128.44 7.84 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 125.396 1.479 . . . . 1.49 111.683 172.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -67.69 -36.64 81.05 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.667 1.587 . . . . 3.45 114.09 -176.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? -140.66 88.02 2.16 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.515 1.526 . . . . 6.39 108.683 -167.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.7 p -82.48 138.26 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.251 -0.886 . . . . 0.85 110.905 169.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -124.06 152.43 42.67 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 127.203 2.201 . . . . 2.55 110.026 177.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.7 tp -106.04 119.07 38.26 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.29 1.036 . . . . 0.95 110.621 177.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -122.97 155.28 37.1 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.014 1.726 . . . . 0.58 113.592 -175.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -100.89 159.88 14.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 113.876 -1.511 . . . . 2.32 110.949 156.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 31.0 m -117.2 134.7 54.47 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 104.99 -2.226 . . . . 0.82 104.99 158.814 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -122.42 166.98 13.87 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 124.944 1.298 . . . . 2.0 112.637 -174.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 19.7 ptm -91.1 149.56 21.76 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.464 0.706 . . . . 4.7 111.707 169.193 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -155.29 151.04 27.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.596 1.158 . . . . 6.5 112.929 -177.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -109.19 139.85 43.56 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.906 1.682 . . . . 2.41 106.474 161.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.6 m -138.17 126.67 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 N-CA-C 108.168 -1.049 . . . . 3.38 108.168 166.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 61.68 19.29 10.37 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.804 1.242 . . . . 4.23 114.209 -178.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 81.96 14.74 76.69 Favored Glycine 0 N--CA 1.478 1.448 0 O-C-N 120.609 -1.307 . . . . 1.79 113.914 -170.477 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 66.9 mttt -112.24 118.62 35.8 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.796 2.438 . . . . 3.05 108.575 -179.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -78.91 131.89 36.55 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.277 1.831 . . . . 2.76 109.925 -176.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.3 p -155.83 175.72 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.497 1.519 . . . . 3.58 111.132 -173.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.7 mtm -108.69 163.97 12.79 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.332 1.053 . . . . 3.77 112.021 164.194 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -143.1 -176.65 17.35 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.422 1.487 . . . . 1.07 111.624 169.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 10.0 ttm -146.35 152.59 39.35 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.115 1.366 . . . . 1.16 109.992 -173.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -162.18 156.17 18.34 Favored Pre-proline 0 N--CA 1.475 0.81 0 C-N-CA 124.796 1.238 . . . . 4.85 111.328 173.876 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -72.09 153.68 57.34 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.331 2.021 . . . . 0.47 111.423 171.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.1 m -138.86 154.82 73.15 Favored Pre-proline 0 N--CA 1.476 0.847 0 C-N-CA 125.777 1.631 . . . . 0.63 109.902 -177.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -81.61 -25.73 3.54 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.434 2.089 . . . . 0.5 113.178 -165.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -179.38 165.24 1.4 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.045 1.738 . . . . 1.73 111.797 -177.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 23.5 mt -111.7 153.41 26.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 125.958 1.703 . . . . 0.65 109.651 163.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -107.1 149.38 27.69 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 124.175 0.99 . . . . 2.12 108.934 175.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.48 121.28 9.93 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 118.253 0.479 . . . . 1.65 111.273 164.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -67.49 164.66 30.04 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.966 2.444 . . . . 1.38 110.58 175.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -58.4 138.79 87.72 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.594 2.196 . . . . 1.36 112.04 177.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt 65.25 5.75 3.24 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.496 1.918 . . . . 2.23 113.675 -175.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.07 163.98 49.63 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 126.341 1.924 . . . . 1.82 114.473 -174.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.0 mmt180 -127.75 142.23 51.37 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 127.51 2.324 . . . . 5.62 109.877 179.703 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.3 t -143.27 135.7 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 N-CA-C 107.166 -1.42 . . . . 3.26 107.166 163.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -129.11 117.97 21.71 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.574 -0.899 . . . . 4.6 108.574 -175.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.0 mp -76.48 78.5 3.19 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.085 1.354 . . . . 2.35 110.602 -168.431 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -66.96 151.01 97.54 Favored Pre-proline 0 CA--C 1.552 1.027 0 C-N-CA 125.083 1.353 . . . . 3.47 114.058 -174.306 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -64.2 -31.09 64.57 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.563 2.176 . . . . 2.31 113.32 173.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -87.15 53.85 4.48 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-N 119.177 0.899 . . . . 2.24 111.929 168.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 161.09 -132.9 3.01 Favored Glycine 0 N--CA 1.471 1.024 0 C-N-CA 124.494 1.045 . . . . 1.62 114.062 -179.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -72.49 140.42 48.21 Favored 'General case' 0 C--O 1.221 -0.406 0 C-N-CA 122.866 0.467 . . . . 1.79 112.019 -170.024 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -162.64 160.56 25.87 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.625 1.17 . . . . 0.67 111.351 -175.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -90.54 135.47 33.68 Favored 'General case' 0 C--N 1.33 -0.24 0 O-C-N 121.802 -0.561 . . . . 2.06 109.877 167.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.7 tpt -86.55 127.52 34.9 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.14 -1.059 . . . . 0.78 108.14 163.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.1 mp -103.55 106.84 17.46 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.879 -1.156 . . . . 1.14 107.879 177.732 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -108.88 151.28 26.49 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.756 0.788 . . . . 3.0 111.307 177.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.94 41.76 39.8 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.887 0.755 . . . . 2.13 112.636 176.225 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.9 mt -50.2 154.02 1.3 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 123.401 1.572 . . . . 0.91 114.229 -179.204 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.3 mmtt -99.83 -28.21 13.24 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 112.884 -1.962 . . . . 2.06 112.501 173.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.9 mmt-85 -146.39 148.52 34.63 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 127.409 2.283 . . . . 8.33 111.171 -178.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -70.7 146.87 55.57 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.939 2.426 . . . . 1.67 109.866 165.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 37.1 mt -126.45 130.59 50.96 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.772 1.629 . . . . 3.29 109.43 -174.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.61 -178.84 4.64 Favored 'General case' 0 C--O 1.218 -0.559 0 C-N-CA 126.52 1.928 . . . . 3.8 111.984 -156.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -87.97 133.05 34.03 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.38 -0.825 . . . . 1.2 111.473 -175.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.82 46.81 8.22 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.834 1.207 . . . . 1.32 112.06 -169.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -131.65 176.95 7.89 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.353 1.061 . . . . 2.4 111.197 174.067 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -149.12 125.79 11.07 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 127.599 2.36 . . . . 3.44 106.199 -165.195 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.0 t -140.77 140.25 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 124.329 1.052 . . . . 1.07 111.282 -170.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -94.99 134.48 37.61 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.861 0.865 . . . . 3.54 112.881 177.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.8 mp -113.11 138.82 49.36 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.035 0.934 . . . . 1.74 110.678 158.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.429 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 11.4 m-20 -79.07 142.76 36.22 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.616 1.566 . . . . 2.48 108.447 159.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.0 mp -110.7 123.82 50.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.782 2.433 . . . . 1.14 109.659 176.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.7 mt -106.45 115.12 29.67 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 124.343 1.057 . . . . 0.58 110.73 -175.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.19 120.17 41.72 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.923 1.689 . . . . 1.95 111.538 -177.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 48.35 25.38 0.87 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.258 2.223 . . . . 3.07 115.055 173.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.21 -60.75 3.89 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.23 1.395 . . . . 4.71 112.461 -168.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -73.49 -2.15 59.33 Favored Glycine 0 CA--C 1.537 1.448 0 N-CA-C 117.49 1.756 . . . . 1.88 117.49 -164.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -135.45 130.66 35.09 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 120.057 1.929 . . . . 4.6 113.248 173.029 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -96.96 151.75 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.41 1.484 . . . . 2.11 110.563 161.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.9 tp -146.2 179.61 7.39 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 127.822 2.449 . . . . 2.3 107.848 164.487 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -147.29 145.55 29.42 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 120.078 1.308 . . . . 2.49 111.401 -177.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.5 t -142.86 157.24 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.561 1.145 . . . . 2.0 109.435 176.065 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 42.9 t -93.23 154.79 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 127.072 2.149 . . . . 2.12 109.732 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 mp -139.96 120.48 9.24 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.336 1.854 . . . . 3.1 110.305 176.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -49.52 145.29 16.92 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 124.562 3.508 . . . . 1.55 113.549 156.382 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.57 127.95 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.828 -0.804 . . . . 1.02 108.828 161.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.42 ' CD ' HH21 ' A' ' 120' ' ' ARG . 12.1 tt0 -153.91 129.86 10.24 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 126.173 1.789 . . . . 4.28 109.344 169.643 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -77.12 110.23 11.62 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.647 1.179 . . . . 3.17 108.826 174.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.42 HH21 ' CD ' ' A' ' 118' ' ' GLU . 19.0 ttm180 . . . . . 0 C--O 1.25 1.107 0 C-N-CA 129.114 2.966 . . . . 7.97 107.817 -172.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.364 0 N-CA-C 105.365 -3.094 . . . . 10.04 105.365 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 m -58.86 169.98 0.9 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 119.38 -0.928 . . . . 9.44 110.959 135.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -177.75 -168.19 0.17 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 129.827 3.251 . . . . 7.85 107.793 179.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.1 t -150.32 162.3 40.79 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.532 1.133 . . . . 4.44 110.718 177.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -159.47 111.58 2.11 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.769 1.228 . . . . 4.64 111.483 -156.662 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -157.02 156.44 27.2 Favored Glycine 0 N--CA 1.474 1.183 0 O-C-N 120.485 -1.384 . . . . 1.37 115.604 -176.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 9.7 p90 -155.87 170.87 21.11 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.358 1.063 . . . . 2.18 113.29 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.9 t -114.14 130.95 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 N-CA-C 107.728 -1.212 . . . . 1.35 107.728 169.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -78.69 -29.81 45.74 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.779 1.77 . . . . 5.4 115.779 -157.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 42.9 t80 146.43 137.26 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 130.653 3.581 . . . . 2.25 109.721 174.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.2 t 179.54 133.78 0.25 Allowed Pre-proline 0 N--CA 1.473 0.721 0 C-N-CA 126.683 1.993 . . . . 1.85 110.801 166.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -73.38 -25.66 15.2 Favored 'Trans proline' 0 CA--C 1.537 0.637 0 C-N-CA 122.419 2.079 . . . . 1.24 112.481 171.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 125.11 -176.96 17.07 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.82 1.676 . . . . 0.93 112.256 -174.694 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -73.69 -11.43 20.54 Favored 'Cis proline' 0 CA--C 1.538 0.679 0 CA-C-N 118.445 1.122 . . . . 0.9 113.449 3.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -128.02 155.79 43.76 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 126.586 1.954 . . . . 1.81 112.87 179.239 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.43 173.42 11.62 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.07 2.148 . . . . 0.43 110.867 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.09 125.09 30.53 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 125.056 1.343 . . . . 1.01 108.355 172.214 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.3 151.2 22.98 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.421 1.488 . . . . 0.62 110.751 177.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -141.79 70.39 1.34 Allowed 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 125.593 1.557 . . . . 2.15 110.053 -166.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -90.69 161.01 15.55 Favored 'General case' 0 C--O 1.236 0.366 0 O-C-N 121.356 -0.84 . . . . 1.94 112.941 175.105 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' GLU . 23.1 m -79.59 157.61 27.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.125 -0.943 . . . . 1.7 109.985 160.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.68 136.44 54.47 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.227 1.011 . . . . 3.43 110.156 175.882 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.84 131.35 47.7 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.698 1.199 . . . . 5.96 111.297 -173.234 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -107.05 111.17 63.7 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 109.387 -0.598 . . . . 1.46 109.387 169.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -86.83 -11.72 5.48 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.283 2.655 . . . . 1.85 113.586 173.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.0 -179.84 47.19 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 124.992 1.282 . . . . 1.26 112.933 -175.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -104.21 -5.35 22.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.996 2.518 . . . . 3.37 111.679 -171.268 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.6 pp -121.18 159.61 48.91 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 127.817 2.447 . . . . 2.93 109.702 175.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.03 137.5 19.57 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 122.124 1.882 . . . . 1.06 110.463 -175.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mp -96.61 155.54 16.73 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 124.651 1.18 . . . . 2.41 109.614 171.521 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 ttp-105 -143.93 102.96 3.97 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 125.423 1.489 . . . . 2.91 110.567 -170.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.8 tp -86.4 109.57 19.11 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 127.158 2.183 . . . . 2.19 109.891 -173.159 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.4 m -103.14 -20.88 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.553 1.141 . . . . 0.53 111.851 -172.385 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -160.85 -174.66 30.96 Favored Glycine 0 C--N 1.343 0.937 0 C-N-CA 124.897 1.237 . . . . 0.44 113.507 177.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.99 -179.72 5.83 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.047 0.939 . . . . 0.49 112.119 166.263 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.418 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 0.0 OUTLIER -140.08 170.27 16.15 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.161 2.184 . . . . 4.99 107.97 160.335 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 t -171.64 149.18 2.37 Favored Pre-proline 0 N--CA 1.478 0.973 0 C-N-CA 125.63 1.572 . . . . 0.72 108.768 176.401 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -77.28 -14.47 16.47 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 122.405 2.07 . . . . 0.79 113.706 179.907 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -107.46 26.76 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 125.045 1.338 . . . . 0.86 113.615 -177.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.67 161.2 42.2 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.437 1.495 . . . . 0.86 109.039 163.748 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -95.46 -36.51 11.29 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.348 1.059 . . . . 3.1 112.858 177.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -130.7 160.86 33.04 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 126.024 1.729 . . . . 5.87 107.38 170.448 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.3 p -142.81 155.06 17.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.387 1.475 . . . . 0.99 109.014 173.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.59 152.57 34.27 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.636 1.974 . . . . 4.19 108.324 -167.757 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.401 HD13 ' CE1' ' A' ' 84' ' ' PHE . 56.2 tp -121.07 107.44 12.63 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 121.224 -0.923 . . . . 0.82 110.926 -162.076 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 61.6 m170 -117.64 145.05 44.62 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 114.473 1.286 . . . . 0.68 114.473 -169.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -84.72 169.99 13.72 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 126.241 1.816 . . . . 2.16 111.329 163.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 88.2 m -145.99 142.27 28.49 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 120.538 -1.352 . . . . 0.78 107.444 174.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 47.3 p90 -162.21 178.84 8.39 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.743 1.386 . . . . 1.96 114.743 -167.261 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 9.8 ptm -118.36 150.99 38.59 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.048 1.739 . . . . 3.81 112.541 176.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -156.07 146.37 21.6 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.834 1.254 . . . . 7.61 112.64 -174.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.2 tp10 -100.96 142.17 32.8 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 125.395 1.478 . . . . 2.68 109.848 171.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.6 t -141.33 121.06 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.611 1.564 . . . . 2.66 107.717 174.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 64.58 12.45 7.49 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 125.989 1.716 . . . . 4.61 115.049 -179.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.24 22.99 53.19 Favored Glycine 0 N--CA 1.477 1.425 0 O-C-N 121.07 -1.019 . . . . 2.56 113.243 -167.001 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -118.28 120.31 37.26 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.861 2.064 . . . . 4.63 107.6 175.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.569 ' HD2' ' H ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -73.07 127.94 34.02 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.613 1.565 . . . . 3.99 111.673 174.447 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 78.3 t -138.72 160.83 30.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 C-N-CA 128.786 2.834 . . . . 2.62 108.477 -173.084 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 35.9 mtt -111.5 170.12 8.34 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 120.823 -1.173 . . . . 2.56 112.704 174.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.28 166.29 32.09 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 115.449 0.94 . . . . 0.71 115.449 -167.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -161.05 146.19 14.07 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 128.439 2.696 . . . . 1.3 107.107 179.568 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.6 mtm180 -153.2 157.4 32.93 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 126.637 1.975 . . . . 4.44 108.073 -177.763 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -78.27 159.93 29.55 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.631 1.554 . . . . 0.72 110.692 167.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.26 152.86 74.26 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.126 1.371 . . . . 0.64 110.532 177.754 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.26 -24.11 11.18 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.851 2.367 . . . . 0.65 112.68 -170.951 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -176.95 166.91 2.5 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.569 1.948 . . . . 1.99 111.55 178.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.3 mt -112.81 152.09 29.59 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.186 1.794 . . . . 0.66 110.989 162.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -103.54 151.58 22.7 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.205 1.002 . . . . 1.8 109.874 176.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.57 126.68 13.83 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 123.154 0.582 . . . . 1.42 111.71 161.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.21 158.85 44.78 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.984 3.122 . . . . 1.53 112.013 -179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.76 140.65 87.05 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 124.074 3.183 . . . . 1.42 113.871 -174.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt 66.72 -10.08 0.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 127.163 2.185 . . . . 2.46 114.358 -178.383 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -89.01 136.23 13.49 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 124.993 1.282 . . . . 1.72 113.209 -176.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.44 135.44 33.48 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 127.032 2.133 . . . . 3.73 109.783 159.082 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.6 t -149.2 124.15 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.718 1.607 . . . . 3.76 108.807 178.12 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 76' ' ' GLU . 2.2 mp0 -89.06 157.13 18.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.435 0.694 . . . . 3.25 111.637 -170.673 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.8 mp -66.23 -32.87 74.55 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.218 0.917 . . . . 3.19 113.372 174.051 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 93.5 140.95 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.743 0 C-N-CA 130.518 3.527 . . . . 3.05 110.426 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -68.71 -1.24 7.25 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.394 2.729 . . . . 2.55 114.643 178.442 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -159.86 19.85 0.25 Allowed Glycine 0 CA--C 1.535 1.302 0 CA-C-O 117.439 -1.756 . . . . 2.02 116.207 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -128.87 -27.46 0.86 Allowed Glycine 0 N--CA 1.484 1.875 0 CA-C-N 120.243 2.022 . . . . 2.07 116.987 172.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -137.87 151.54 48.15 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 120.3 2.05 . . . . 2.06 111.435 160.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -156.84 148.46 22.49 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 123.333 0.653 . . . . 0.74 110.65 175.673 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' CE1' HD13 ' A' ' 45' ' ' LEU . 45.7 m-85 -81.84 116.84 21.7 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 108.792 -0.818 . . . . 2.06 108.792 165.472 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.3 tpt -78.25 107.8 11.11 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 126.705 2.002 . . . . 1.09 108.609 170.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.3 mp -87.49 139.73 30.25 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.446 1.498 . . . . 1.31 109.12 176.23 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.9 mp -133.38 138.03 46.1 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.259 1.024 . . . . 2.16 112.263 178.293 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.25 42.45 10.58 Favored Glycine 0 N--CA 1.468 0.795 0 C-N-CA 124.997 1.284 . . . . 1.59 113.118 173.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.7 mt -47.36 151.28 0.77 Allowed 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 115.938 1.829 . . . . 0.87 115.938 -172.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 61.3 mmtt -111.42 -26.29 9.18 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 113.721 -1.581 . . . . 2.31 113.85 -176.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 75.7 mtp85 -120.63 136.36 25.32 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 125.302 1.441 . . . . 4.64 109.218 159.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.07 116.24 4.64 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.022 2.481 . . . . 1.45 107.767 170.14 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . 0.357 4.1 pp -98.43 105.24 17.36 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 124.279 1.99 . . . . 3.03 112.708 -162.506 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.26 171.01 7.81 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 127.03 2.132 . . . . 3.65 112.256 176.68 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.31 129.46 41.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.106 0.962 . . . . 1.37 110.804 175.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.66 31.78 48.62 Favored Glycine 0 CA--C 1.529 0.967 0 CA-C-N 115.702 -0.681 . . . . 2.91 112.939 -173.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -100.02 179.38 4.52 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.382 -0.97 . . . . 2.6 108.382 143.642 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -149.22 160.51 43.31 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 126.279 1.831 . . . . 3.26 106.725 165.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 50.0 t -151.96 157.91 4.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 C-N-CA 128.734 2.813 . . . . 1.49 107.73 -158.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -126.61 154.13 44.38 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.678 0.791 . . . . 2.43 110.226 165.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.8 mp -122.16 134.88 54.73 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.056 1.343 . . . . 1.99 109.96 166.351 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 67.9 m-20 -78.18 134.79 37.57 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 127.334 2.254 . . . . 2.59 108.432 161.587 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.7 mp -104.99 109.6 21.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.437 1.895 . . . . 1.21 108.815 178.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.5 mt -93.88 116.3 28.75 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 123.201 0.6 . . . . 0.68 110.1 -176.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -109.23 148.71 30.52 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.614 1.166 . . . . 1.95 111.806 -177.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -60.75 150.18 33.26 Favored 'General case' 0 CA--C 1.545 0.772 0 O-C-N 121.775 -0.578 . . . . 2.17 112.012 169.562 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.23 34.39 41.34 Favored Glycine 0 CA--C 1.532 1.096 0 CA-C-O 119.142 -0.81 . . . . 4.14 114.029 177.166 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 72.72 44.3 39.64 Favored Glycine 0 CA--C 1.528 0.867 0 CA-C-N 118.048 0.924 . . . . 1.94 114.235 166.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 39.5 mttp -134.07 140.96 46.99 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 118.241 1.02 . . . . 3.21 111.713 -177.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.2 t -142.67 134.39 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.83 1.252 . . . . 2.02 109.283 172.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.0 mp -116.62 174.74 5.91 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.319 1.847 . . . . 3.08 107.598 163.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -139.21 154.14 47.98 Favored 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.011 -1.056 . . . . 1.91 112.373 161.177 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 24.0 t -132.3 160.86 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.197 1.399 . . . . 1.88 109.734 -176.645 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.6 p -101.53 143.27 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 127.358 2.263 . . . . 3.09 111.592 -173.288 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.0 mp -143.76 105.2 4.93 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.742 1.617 . . . . 2.82 109.84 -175.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -61.3 157.36 40.81 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.394 2.063 . . . . 1.44 111.396 158.455 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.8 t -107.4 141.92 21.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.593 0.711 . . . . 1.23 110.139 173.155 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.6 -174.03 3.18 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 128.577 2.751 . . . . 3.92 110.496 -165.389 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -131.56 93.73 3.39 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.414 1.086 . . . . 2.43 110.855 162.271 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 . . . . . 0 N--CA 1.484 1.262 0 C-N-CA 125.996 1.718 . . . . 7.79 113.299 -170.922 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.179 0 N-CA-C 108.406 -1.878 . . . . 8.33 108.406 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t 71.78 -176.37 0.19 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 108.059 -1.089 . . . . 7.86 108.059 -126.365 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -107.85 -13.38 15.0 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.17 0.988 . . . . 10.72 111.846 158.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.6 p -78.58 52.9 1.24 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.993 2.117 . . . . 4.98 112.517 -165.379 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -102.63 105.61 16.13 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.453 0.644 . . . . 4.58 110.651 -163.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -158.67 -177.79 32.09 Favored Glycine 0 N--CA 1.467 0.726 0 C-N-CA 125.581 1.563 . . . . 1.18 113.642 -176.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 20.1 p90 -152.96 143.21 22.46 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.558 1.543 . . . . 2.44 110.567 170.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.3 156.61 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 O-C-N 121.048 -1.033 . . . . 1.65 108.404 167.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.418 ' HB3' ' H ' ' A' ' 17' ' ' ALA . 27.8 ttt85 -86.3 149.75 24.83 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 122.865 1.317 . . . . 4.19 112.974 -176.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -72.11 132.43 44.18 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 129.236 3.014 . . . . 2.63 109.84 170.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.3 t 178.84 141.27 0.28 Allowed Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 126.565 1.946 . . . . 2.25 111.229 176.307 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -72.74 -28.96 13.26 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.562 2.174 . . . . 1.41 112.683 169.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 134.03 171.14 12.5 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.407 1.956 . . . . 0.95 112.36 -172.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -82.98 -0.14 54.34 Favored 'Cis proline' 0 CA--C 1.539 0.74 0 CA-C-N 119.27 1.535 . . . . 1.15 113.923 2.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -143.33 157.39 44.51 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.772 1.397 . . . . 2.5 114.772 174.331 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -130.13 -175.34 3.59 Favored 'General case' 0 CA--C 1.549 0.924 1 C-N-CA 131.838 4.055 . . . . 0.41 108.804 175.349 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.418 ' H ' ' HB3' ' A' ' 9' ' ' ARG . . . -131.64 171.02 13.96 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.793 2.037 . . . . 1.14 108.259 173.01 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -146.62 135.96 22.79 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.107 0.956 . . . . 0.64 112.576 170.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -123.44 141.06 52.37 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.574 2.35 . . . . 2.31 108.957 -174.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -174.05 143.16 0.9 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.869 1.433 . . . . 1.98 114.869 -171.379 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.0 m -79.52 120.86 24.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.594 1.157 . . . . 1.93 110.98 178.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 135.23 39.72 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 126.329 1.852 . . . . 3.24 109.361 175.036 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -139.12 146.89 41.22 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.066 1.747 . . . . 5.15 109.137 -171.351 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.8 t-20 -131.98 99.56 16.46 Favored Pre-proline 0 CA--C 1.542 0.671 0 C-N-CA 123.508 0.723 . . . . 1.65 109.934 177.499 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -70.38 -14.37 34.05 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 122.368 2.045 . . . . 2.03 113.069 176.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.35 140.69 11.58 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 128.188 2.804 . . . . 3.51 112.666 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 20.3 t0 174.23 -55.89 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 128.562 2.745 . . . . 8.39 103.86 -158.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 pp 178.06 173.55 0.38 Allowed Pre-proline 0 CA--C 1.552 1.021 1 C-N-CA 132.898 4.479 . . . . 4.37 110.848 -177.148 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -80.37 134.94 10.38 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.345 2.03 . . . . 1.4 111.227 176.804 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 19.3 mt -93.84 145.23 24.76 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.646 1.178 . . . . 2.22 111.108 -175.55 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.8 ttp-105 -137.31 91.88 2.65 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 112.62 -2.082 . . . . 2.96 111.628 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.47 98.02 7.37 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 126.098 1.759 . . . . 1.83 108.418 -170.485 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.9 m -94.36 -30.65 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.25 1.42 . . . . 0.64 112.21 -169.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.64 -176.78 32.09 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 123.87 0.747 . . . . 0.6 113.765 178.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -141.26 177.45 8.09 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.322 1.049 . . . . 0.67 112.253 172.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.2 mmm180 -153.36 157.64 40.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.051 2.54 . . . . 5.77 108.236 168.444 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.9 t -167.32 152.45 6.98 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 123.798 0.839 . . . . 0.97 111.894 -176.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.2 -8.75 23.35 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.794 2.329 . . . . 1.52 115.599 178.817 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 32.7 m -102.64 0.55 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 115.829 1.789 . . . . 1.48 115.829 178.166 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -152.04 164.13 37.87 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.135 1.374 . . . . 1.19 112.186 -178.978 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -124.77 -65.04 1.06 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 123.103 1.43 . . . . 4.39 111.399 -167.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 15.4 mmt180 -79.01 147.59 32.82 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 105.426 -2.065 . . . . 4.79 105.426 164.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 9.8 p -156.66 135.05 2.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 C-N-CA 125.141 1.376 . . . . 0.97 108.034 -177.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.5 mt-10 -127.54 156.6 41.94 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.757 2.023 . . . . 2.83 109.323 178.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 38.1 tp -105.46 126.58 52.28 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 123.799 0.84 . . . . 0.98 109.231 169.032 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -124.24 160.63 27.53 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.0 2.12 . . . . 0.7 113.984 -175.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -107.64 163.61 12.94 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.751 1.62 . . . . 2.06 111.091 156.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 93.5 m -116.05 140.93 48.78 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.463 1.905 . . . . 1.04 106.602 165.189 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -145.31 -178.15 5.92 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.547 1.139 . . . . 2.09 113.42 -177.114 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 77.1 mtm -126.79 144.28 51.0 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.364 1.466 . . . . 3.64 112.749 -177.586 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -136.12 135.82 39.59 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.699 1.6 . . . . 6.0 111.764 178.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -104.49 127.69 52.26 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.844 1.658 . . . . 3.16 111.34 168.35 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 44.9 t -134.82 123.97 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 N-CA-C 107.651 -1.24 . . . . 2.67 107.651 176.047 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 62.67 10.63 4.28 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.169 2.188 . . . . 3.98 115.146 -169.228 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.82 30.19 52.81 Favored Glycine 0 CA--C 1.535 1.305 0 O-C-N 120.965 -1.085 . . . . 1.74 112.885 -164.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -118.52 129.28 55.27 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 125.955 1.702 . . . . 2.74 108.261 169.08 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -86.84 126.61 34.75 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.029 1.732 . . . . 6.14 112.294 -177.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.9 p -140.89 142.98 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 126.542 1.937 . . . . 2.93 109.423 175.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 52.2 mtt -88.45 163.42 15.96 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.892 1.071 . . . . 2.65 113.892 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -140.98 175.15 22.35 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 125.549 1.547 . . . . 0.6 112.457 178.647 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 21.3 ttm -157.04 148.11 21.86 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 126.46 1.904 . . . . 1.51 108.245 -179.423 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -161.08 153.68 17.3 Favored Pre-proline 0 N--CA 1.476 0.862 0 CA-C-O 118.051 -0.976 . . . . 4.68 111.639 -178.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.91 155.29 43.37 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.197 1.931 . . . . 0.56 111.875 178.53 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.99 151.03 61.23 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 126.038 1.735 . . . . 0.59 109.999 -177.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.8 -21.03 8.68 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.465 2.777 . . . . 0.52 113.493 -164.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -178.09 165.83 1.94 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.568 1.947 . . . . 1.74 110.746 177.548 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 mt -106.95 146.26 31.26 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.082 0.953 . . . . 0.67 110.529 158.347 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.0 tp10 -105.86 140.2 39.25 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.391 1.076 . . . . 1.87 108.929 175.078 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 35.9 t -141.01 113.14 6.88 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 122.902 0.481 . . . . 0.98 110.725 165.314 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.9 162.44 37.32 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 124.095 3.197 . . . . 1.75 111.75 -179.656 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -63.64 136.89 56.3 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.931 2.42 . . . . 1.52 111.784 -177.512 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 22.5 mmmt 74.68 -4.81 2.26 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 128.118 2.567 . . . . 3.51 114.402 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -91.38 155.3 23.35 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.411 1.481 . . . . 1.83 112.12 170.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 19.6 ptt180 -135.67 153.47 51.6 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.39 1.476 . . . . 4.2 110.366 172.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.7 t -154.04 129.76 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 125.353 1.461 . . . . 3.67 108.781 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -89.8 136.24 33.15 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.938 -1.101 . . . . 3.22 112.265 176.52 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -70.82 84.17 0.66 Allowed 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.077 -1.083 . . . . 2.26 108.077 157.22 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 5.7 ptpt -92.21 150.29 40.02 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 127.418 2.287 . . . . 2.54 113.377 -178.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -64.66 -39.69 26.03 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.004 2.469 . . . . 2.52 113.102 -174.541 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.33 45.84 2.66 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.689 1.137 . . . . 2.33 112.511 170.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.08 -129.08 1.96 Allowed Glycine 0 CA--C 1.523 0.593 0 C-N-CA 126.371 1.939 . . . . 1.48 111.65 177.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -73.57 138.33 44.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 118.714 1.257 . . . . 2.0 113.239 -166.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.8 p-80 -161.32 161.5 30.56 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.59 1.156 . . . . 0.93 111.503 -178.02 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -85.99 150.83 24.21 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.502 -0.749 . . . . 1.71 110.915 165.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.0 tpt -105.96 126.13 51.82 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.415 1.486 . . . . 1.11 108.706 163.008 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.01 118.31 36.09 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.734 1.214 . . . . 1.18 108.75 -175.23 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.08 155.26 31.82 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 123.409 1.576 . . . . 1.97 112.212 -170.48 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.09 -43.75 3.25 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 128.024 2.726 . . . . 2.44 112.139 -178.057 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 18.2 mt 47.97 167.55 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 129.602 3.161 . . . . 1.13 115.891 -168.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -135.33 -21.2 1.59 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.342 1.457 . . . . 2.75 113.781 179.931 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 71.0 mtp85 -122.27 149.86 55.71 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.148 2.179 . . . . 5.01 107.619 161.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.71 112.37 2.63 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 N-CA-C 106.23 -2.258 . . . . 1.49 106.23 153.209 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -72.35 108.16 5.33 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.048 -0.723 . . . . 2.08 109.048 -179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? -65.02 174.43 1.95 Allowed 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.382 1.087 . . . . 4.08 112.083 158.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -80.97 159.68 24.83 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.673 -1.149 . . . . 1.62 108.439 149.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.16 49.74 75.31 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 121.575 -0.703 . . . . 2.18 112.524 -172.317 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.53 -179.6 4.03 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.96 1.304 . . . . 2.25 108.483 163.23 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -148.04 151.48 35.79 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 126.154 1.781 . . . . 3.42 107.346 169.167 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 53.7 t -154.35 145.09 13.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 C-N-CA 128.006 2.522 . . . . 1.23 109.357 -160.496 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.7 mt-10 -101.11 154.37 18.79 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.276 0.63 . . . . 4.69 111.385 171.79 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mt -139.56 134.14 31.75 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.594 1.557 . . . . 2.05 110.26 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 -83.69 131.41 34.94 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 126.709 2.004 . . . . 1.98 108.823 165.774 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.2 mp -110.29 111.35 22.6 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.918 1.287 . . . . 0.91 109.585 172.486 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.7 mt -85.72 110.85 19.61 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.669 1.187 . . . . 0.91 109.806 -178.191 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -106.28 105.3 15.27 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.923 1.289 . . . . 1.93 110.751 -177.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 57.43 11.12 1.09 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 126.013 1.725 . . . . 2.57 115.22 174.209 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 78.36 -43.08 2.24 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.498 1.523 . . . . 3.83 113.186 -169.12 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -72.96 -11.11 78.56 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 124.339 0.971 . . . . 2.62 115.514 -175.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -137.49 157.15 47.17 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.818 1.309 . . . . 4.3 111.867 170.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.78 153.97 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 125.708 1.603 . . . . 2.08 109.93 169.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 47.5 tp -144.44 121.78 11.62 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.593 1.157 . . . . 2.12 109.654 174.373 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.77 114.33 28.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.53 0.732 . . . . 3.65 110.587 179.671 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.3 t -115.55 167.72 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 126.748 2.019 . . . . 2.08 110.548 -170.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.29 141.56 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 126.734 2.013 . . . . 2.67 110.655 179.31 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 95.4 mt -150.85 149.1 24.6 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 126.279 1.832 . . . . 3.13 111.625 -174.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -70.01 174.34 9.87 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.734 2.956 . . . . 1.18 112.048 166.027 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.5 t -121.82 134.48 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.572 1.549 . . . . 1.32 109.507 166.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -150.0 159.25 44.54 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 114.377 1.251 . . . . 5.02 114.377 177.073 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -89.08 50.72 2.0 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.347 -0.842 . . . . 2.59 111.635 178.369 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.7 tpm_? . . . . . 0 C--O 1.245 0.842 0 C-N-CA 124.31 1.044 . . . . 7.11 110.477 175.19 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' HA3' ' OE2' ' A' ' 23' ' ' GLU . . . . . . . . 0 CA--C 1.503 -0.663 0 CA-C-O 119.678 -0.512 . . . . 9.67 112.371 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -87.85 -38.01 16.03 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.997 1.319 . . . . 7.21 110.312 163.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 71.18 -42.77 0.54 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.02 2.528 . . . . 10.64 116.874 161.236 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.0 t -144.62 2.09 1.06 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.349 1.459 . . . . 5.4 113.55 -163.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 73.9 tt0 -77.31 104.23 7.7 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.847 0.859 . . . . 4.95 110.916 -159.102 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.33 -177.15 33.18 Favored Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.95 1.262 . . . . 1.35 114.129 -175.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 28.4 p90 -153.81 160.02 42.08 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.606 1.562 . . . . 2.39 111.381 167.754 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.6 t -97.04 146.78 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 N-CA-C 106.897 -1.52 . . . . 1.34 106.897 165.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 27.4 ttm180 -75.67 -102.68 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 119.367 0.985 . . . . 5.4 112.032 -178.209 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -170.67 127.29 0.76 Allowed 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.869 1.268 . . . . 2.75 108.198 -168.788 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.3 p 179.6 111.22 0.19 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.565 -0.731 . . . . 2.79 111.588 -167.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.29 -31.97 8.72 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.38 2.053 . . . . 1.19 112.671 174.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 154.68 178.0 28.58 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.475 1.512 . . . . 1.06 111.772 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -79.6 2.77 35.18 Favored 'Cis proline' 0 CA--C 1.539 0.77 0 CA-C-N 119.245 1.523 . . . . 1.42 112.952 -3.545 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -151.9 167.45 28.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.109 0.963 . . . . 2.32 112.085 176.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -146.48 173.73 12.04 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.537 2.335 . . . . 0.56 110.842 -171.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.55 139.28 24.04 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.51 1.124 . . . . 0.9 110.281 179.206 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -130.09 140.35 50.83 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.295 1.438 . . . . 0.75 111.549 -173.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -115.08 142.07 47.14 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.972 2.109 . . . . 3.33 111.332 -176.176 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.2 pp -162.94 147.43 11.45 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.869 1.433 . . . . 1.98 114.869 178.12 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.7 m -79.82 116.12 19.8 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.205 1.402 . . . . 1.86 110.477 176.07 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.75 126.45 40.06 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.582 1.153 . . . . 3.36 110.08 174.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.466 ' OE2' ' HA3' ' A' ' 1' ' ' GLY . 47.5 tt0 -124.24 142.89 50.88 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.561 1.544 . . . . 4.19 110.959 175.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -103.84 94.95 6.93 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.838 1.255 . . . . 1.41 109.985 171.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.12 -8.24 18.63 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.717 2.278 . . . . 1.32 113.796 177.354 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.72 177.96 51.27 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-O 122.425 1.014 . . . . 1.33 112.36 -178.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -103.02 -2.44 27.57 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.17 2.188 . . . . 3.23 111.295 -176.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.61 162.12 21.92 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 129.333 3.053 . . . . 4.24 108.873 177.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -79.29 146.86 20.03 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.453 2.102 . . . . 1.03 110.784 178.15 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.1 mp -112.11 151.28 29.61 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.792 1.237 . . . . 2.36 110.731 174.047 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -141.14 109.8 6.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 113.037 -1.892 . . . . 1.95 110.076 179.265 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.3 tt -87.52 123.78 32.78 Favored 'General case' 0 C--O 1.218 -0.553 0 C-N-CA 125.282 1.433 . . . . 1.98 108.607 178.124 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.5 m -106.57 -28.58 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-N 119.201 0.91 . . . . 0.7 111.927 -175.862 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.24 -173.34 27.55 Favored Glycine 0 C--N 1.344 1.024 0 C-N-CA 124.536 1.065 . . . . 0.48 113.704 177.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 84' ' ' PHE . . . -127.21 -176.77 3.82 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.339 1.056 . . . . 0.55 111.014 161.785 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.6 mtt180 -144.98 156.33 43.9 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 131.357 3.863 . . . . 5.87 105.178 166.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 t -167.18 137.24 2.37 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 124.256 1.022 . . . . 0.65 109.991 171.807 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.57 -17.56 38.37 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.362 2.042 . . . . 0.94 113.321 -171.694 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 31.2 m -93.8 17.5 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 114.747 1.388 . . . . 0.85 114.747 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -135.12 164.15 28.3 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.582 1.083 . . . . 1.2 113.609 170.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 11.0 tm-20 -92.62 -35.86 13.31 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.546 1.138 . . . . 4.07 111.149 175.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.2 mtt-85 -135.36 156.72 48.47 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 127.179 2.192 . . . . 5.0 108.011 169.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.4 p -138.24 149.47 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.701 1.601 . . . . 0.98 108.764 168.334 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -152.04 150.41 29.92 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.692 1.997 . . . . 2.84 108.524 -172.373 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.435 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.5 pt? -105.83 134.15 49.41 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 123.068 1.414 . . . . 1.97 113.105 172.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 56.2 m170 -116.76 154.74 30.13 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 113.514 -1.676 . . . . 0.7 111.321 177.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -175.48 5.32 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.566 1.546 . . . . 3.35 110.889 159.112 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.0 m -151.15 147.7 27.37 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.585 1.154 . . . . 0.71 108.489 164.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -159.2 177.01 11.51 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 123.467 1.604 . . . . 2.05 113.724 -171.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 60.6 ttp -129.42 128.02 42.13 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.071 1.748 . . . . 3.26 110.597 -179.433 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.49 148.76 22.48 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.343 1.457 . . . . 6.09 110.623 164.655 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -83.65 138.05 33.51 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.468 -0.938 . . . . 2.64 108.468 147.135 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.5 t -139.96 125.17 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 106.238 -1.764 . . . . 2.25 106.238 166.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 60.31 33.62 20.86 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 123.621 0.768 . . . . 4.33 112.044 178.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.74 9.62 79.15 Favored Glycine 0 CA--C 1.535 1.289 0 O-C-N 120.834 -1.166 . . . . 1.62 114.454 -176.353 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -126.02 134.92 51.31 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 126.11 1.764 . . . . 2.29 109.241 -172.994 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -84.61 123.75 30.67 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 125.634 1.574 . . . . 3.1 111.124 -171.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 82.1 t -141.36 131.0 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.657 1.983 . . . . 2.18 108.403 -173.171 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -101.73 161.63 13.51 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.768 1.227 . . . . 3.22 113.626 -171.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -157.27 -179.66 32.36 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.046 1.308 . . . . 1.08 113.086 172.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.91 153.75 43.41 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.291 1.036 . . . . 3.62 111.164 170.412 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -141.06 152.52 65.22 Favored Pre-proline 0 CA--C 1.541 0.61 0 C-N-CA 126.778 2.031 . . . . 4.39 109.417 -174.408 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -71.69 153.61 59.47 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.119 1.879 . . . . 0.74 111.273 172.399 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.53 154.92 77.53 Favored Pre-proline 0 N--CA 1.483 1.179 0 CA-C-O 118.452 -0.785 . . . . 0.97 110.828 171.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.35 -22.9 10.58 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.114 2.543 . . . . 0.53 112.602 -172.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -174.15 171.9 3.43 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.94 1.696 . . . . 2.06 110.894 -179.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 50.7 mt -117.54 158.27 24.86 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.225 1.81 . . . . 0.74 109.915 160.318 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -137.34 146.34 44.45 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 123.69 0.796 . . . . 2.19 110.673 178.06 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 18.9 t -144.04 130.12 9.99 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 123.961 0.788 . . . . 1.28 110.854 175.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -68.82 165.45 29.71 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.73 2.953 . . . . 1.23 111.316 175.664 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.61 141.66 97.7 Favored 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 123.281 2.654 . . . . 1.06 113.16 -179.1 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt 69.62 -4.43 1.4 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 127.53 2.332 . . . . 1.57 114.681 177.914 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -83.58 169.39 47.06 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.137 1.351 . . . . 1.28 113.974 179.22 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.4 ptt85 -133.35 156.86 46.87 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.401 1.08 . . . . 4.54 111.691 164.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.3 t -149.0 133.53 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 126.92 2.088 . . . . 3.74 106.922 171.523 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -98.03 133.71 42.12 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 120.947 -1.095 . . . . 2.84 111.393 -176.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 mp -68.47 78.9 0.27 Allowed 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.394 -0.965 . . . . 2.5 108.394 154.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 ptpt -94.09 154.38 40.61 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 126.717 2.007 . . . . 2.54 112.051 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -56.43 -34.55 94.86 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.997 2.465 . . . . 2.35 113.211 175.358 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.75 66.39 3.85 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.18 -0.768 . . . . 2.77 111.18 171.203 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 131.84 -123.59 3.72 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.178 1.371 . . . . 1.62 112.966 -178.46 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -74.65 141.64 44.6 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 112.938 0.718 . . . . 2.22 112.938 -162.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -159.97 154.97 24.69 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.587 -0.696 . . . . 0.77 112.044 -176.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 35' ' ' ALA . 43.4 m-85 -90.3 118.66 29.98 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 122.558 0.343 . . . . 2.63 110.208 171.178 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 2.9 tpt -85.62 125.18 32.93 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.009 1.324 . . . . 0.94 109.257 170.16 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 10.8 mp -104.96 127.82 52.97 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.476 1.51 . . . . 1.43 107.537 177.384 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.82 150.14 39.66 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.824 0.821 . . . . 2.04 112.237 -176.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.43 -41.26 1.83 Allowed Glycine 0 CA--C 1.531 1.094 0 C-N-CA 126.48 1.991 . . . . 2.89 113.57 179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.8 mt 57.04 170.52 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 129.916 3.286 . . . . 0.92 114.29 -177.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -129.82 -28.51 2.21 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 127.002 2.121 . . . . 1.52 112.857 172.583 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.0 mmm180 -110.99 132.58 21.6 Favored Pre-proline 0 CA--C 1.536 0.44 0 C-N-CA 125.43 1.492 . . . . 4.8 108.065 166.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.95 101.19 1.04 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 N-CA-C 106.362 -2.207 . . . . 1.91 106.362 158.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.5 pp -95.11 128.0 41.6 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 122.419 1.104 . . . . 2.83 112.674 -159.703 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.8 mtmp? -132.87 172.31 12.76 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 126.259 1.823 . . . . 3.85 113.335 -167.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.69 124.61 23.36 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.574 -0.739 . . . . 1.46 110.083 179.749 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.36 7.36 51.97 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.554 1.55 . . . . 1.88 115.497 -176.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -93.28 -175.16 3.74 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.421 1.111 . . . . 2.92 111.519 161.493 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -149.29 154.53 39.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 129.305 3.042 . . . . 3.15 105.733 178.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 68.9 t -147.83 139.05 17.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 C-N-CA 127.238 2.215 . . . . 1.39 109.035 -176.233 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.15 149.76 25.63 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 124.795 1.238 . . . . 3.16 110.998 176.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 mp -132.16 134.24 45.17 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.192 1.397 . . . . 1.74 111.066 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -87.56 125.1 34.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.259 1.824 . . . . 2.13 107.459 159.331 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.1 mp -98.29 131.51 44.55 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.102 1.361 . . . . 1.01 109.421 172.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 62.6 mt -107.19 120.04 41.03 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 125.0 1.32 . . . . 0.68 109.589 -175.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -113.69 160.41 18.66 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.525 1.53 . . . . 1.91 110.601 178.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -50.62 143.04 10.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.242 -0.89 . . . . 2.49 111.605 170.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 86.88 -3.72 86.81 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-O 118.759 -1.023 . . . . 3.63 114.37 -169.995 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 90.14 16.13 56.35 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.814 1.307 . . . . 2.9 114.114 175.456 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -78.4 134.8 37.36 Favored 'General case' 0 CA--C 1.538 0.495 0 O-C-N 121.143 -1.21 . . . . 5.3 112.557 -173.049 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 82.9 t -107.15 136.66 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 126.228 1.811 . . . . 2.14 109.423 175.617 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 65.4 tp -141.17 133.62 28.37 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.115 0.966 . . . . 1.91 111.502 174.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 tpmt? -79.93 126.41 30.98 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 112.669 0.618 . . . . 2.65 112.669 177.763 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 99.3 t -114.74 164.48 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 126.334 1.854 . . . . 2.68 108.355 157.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 39.6 t -146.61 140.36 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.893 1.677 . . . . 1.96 109.958 -176.027 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.3 mt -143.24 135.68 13.43 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 126.666 1.986 . . . . 2.43 111.114 -167.584 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -73.97 159.1 45.3 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.113 2.542 . . . . 1.23 110.76 163.229 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.34 131.13 48.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 108.734 -0.839 . . . . 1.09 108.734 167.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -153.12 146.94 25.25 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.461 1.105 . . . . 3.81 113.359 -165.098 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.04 59.87 2.8 Favored 'General case' 0 CA--C 1.549 0.918 0 O-C-N 120.621 -1.299 . . . . 2.61 111.697 171.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 36.8 mtm105 . . . . . 0 N--CA 1.478 0.959 0 C-N-CA 125.754 1.621 . . . . 7.81 113.704 -179.963 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.992 0 N-CA-C 108.156 -1.978 . . . . 10.35 108.156 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m 52.74 -129.11 2.37 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-O 117.967 -1.016 . . . . 7.38 111.452 -179.223 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -148.6 -173.96 4.48 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.409 1.459 . . . . 8.11 112.329 167.529 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 42.3 p -78.45 62.95 3.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.074 1.35 . . . . 5.43 110.353 175.628 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -78.99 60.54 2.94 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.353 1.861 . . . . 4.96 112.718 -172.044 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -141.18 179.69 19.21 Favored Glycine 0 CA--C 1.53 1.014 0 C-N-CA 125.331 1.443 . . . . 0.99 113.09 176.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 23.2 p90 -155.46 169.58 23.92 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 114.845 1.424 . . . . 2.39 114.845 -172.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.39 140.52 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 126.502 1.921 . . . . 1.34 109.407 170.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -17.79 61.73 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.938 2.095 . . . . 6.12 115.513 -174.203 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 94' ' ' LYS . 4.3 t80 79.87 129.55 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 127.91 2.484 . . . . 2.49 111.631 -177.405 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.2 t -175.77 142.85 0.65 Allowed Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 129.378 3.071 . . . . 2.11 107.774 174.358 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -79.08 -27.56 4.43 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.89 2.394 . . . . 1.44 112.465 175.364 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 147.92 175.32 20.53 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.664 1.126 . . . . 0.83 112.314 -174.545 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.57 -5.61 12.26 Favored 'Cis proline' 0 CA--C 1.54 0.787 0 CA-C-N 118.848 1.324 . . . . 0.93 112.775 -4.35 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 51.5 p-10 -147.26 160.98 41.86 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 123.435 1.588 . . . . 1.65 114.358 -176.68 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.27 -176.93 4.79 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.74 2.816 . . . . 0.45 110.454 -176.57 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -150.06 152.38 34.73 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 126.019 1.727 . . . . 0.76 108.207 175.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.14 141.91 40.13 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.943 0.897 . . . . 0.64 112.508 -179.195 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 79' ' ' PRO . 88.0 m-85 -105.87 74.33 1.05 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.129 2.172 . . . . 3.12 108.776 174.026 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.425 HD13 HD11 ' A' ' 103' ' ' LEU . 2.3 pp -76.43 159.0 30.85 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.268 -0.895 . . . . 1.88 111.43 -177.252 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 76' ' ' GLU . 28.5 m -140.25 147.25 39.7 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 124.431 1.092 . . . . 1.98 110.479 175.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.82 -178.11 5.86 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.346 2.258 . . . . 5.63 108.69 169.907 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -140.45 123.93 16.97 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 120.807 -1.183 . . . . 4.57 109.958 173.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.0 t-20 -76.91 119.01 75.71 Favored Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 125.255 1.422 . . . . 1.56 108.87 178.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.48 -17.99 33.9 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 121.974 1.783 . . . . 2.0 113.459 176.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.4 126.05 0.64 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 124.469 1.033 . . . . 2.83 110.522 -163.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -178.66 -47.86 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 104.257 -2.497 . . . . 8.27 104.257 -146.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -164.92 -171.21 0.25 Allowed Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 131.418 3.887 . . . . 4.69 107.477 164.789 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.28 130.36 9.12 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 N-CA-C 108.043 -1.56 . . . . 0.96 108.043 159.592 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.486 HD12 ' CD1' ' A' ' 105' ' ' PHE . 2.8 mm? -91.86 156.52 17.44 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 122.691 1.234 . . . . 2.52 110.516 -175.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -153.47 107.04 2.99 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 113.736 -1.575 . . . . 1.77 111.571 -173.196 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.7 tp -92.64 108.42 19.96 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.422 1.489 . . . . 2.44 109.162 -171.395 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.2 m -106.66 -20.37 6.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 113.146 0.795 . . . . 0.68 113.146 -169.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.49 -177.95 33.04 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 124.854 1.216 . . . . 0.42 111.822 176.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -131.83 -179.51 5.44 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.819 0.848 . . . . 0.69 111.18 171.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.42 ' CB ' ' HB2' ' A' ' 102' ' ' ASP . 1.9 mtt-85 -147.92 169.37 20.0 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.935 2.094 . . . . 3.9 108.833 169.129 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.8 t 178.41 154.24 0.52 Allowed Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 126.096 1.759 . . . . 0.86 109.574 -171.105 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -89.39 -7.1 5.07 Favored 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.622 2.881 . . . . 0.73 113.997 171.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 23.5 m -113.27 24.95 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 N-CA-C 114.191 1.182 . . . . 0.88 114.191 -173.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.43 163.86 38.03 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.163 1.385 . . . . 0.81 108.893 166.153 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -96.58 -30.84 13.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.141 1.776 . . . . 3.25 112.879 175.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 31.8 mtt85 -137.86 157.96 45.34 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 127.193 2.197 . . . . 5.3 107.274 175.423 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 13.5 p -153.88 131.09 2.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 C-N-CA 125.339 1.455 . . . . 1.13 108.568 -176.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -140.16 133.14 29.36 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.199 0.999 . . . . 3.75 110.189 -160.066 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.3 tp -85.23 117.49 24.21 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.921 0.867 . . . . 1.3 111.436 -177.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 57.8 m170 -117.38 162.48 17.85 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.592 1.557 . . . . 0.62 112.859 176.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 0.0 OUTLIER -113.11 -178.71 3.45 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 113.546 -1.661 . . . . 3.18 110.801 163.885 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.1 m -148.67 135.65 20.0 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 106.594 -1.632 . . . . 1.27 106.594 172.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -131.71 169.03 16.75 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.275 1.43 . . . . 2.33 113.138 -169.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.1 139.33 45.34 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.817 1.247 . . . . 5.77 110.909 168.777 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 82.9 mtt-85 -129.05 141.99 51.05 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.316 1.446 . . . . 5.44 110.362 166.341 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -89.81 138.63 31.32 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.847 -1.168 . . . . 2.94 107.847 154.317 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 79.0 t -133.94 116.14 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 106.43 -1.693 . . . . 2.41 106.43 168.969 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 63.89 31.42 13.92 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.445 1.098 . . . . 5.09 113.261 175.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.31 10.19 85.69 Favored Glycine 0 CA--C 1.537 1.412 0 O-C-N 121.072 -1.018 . . . . 1.94 114.112 -174.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -125.88 119.71 28.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.457 1.503 . . . . 3.06 110.384 -173.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.38 135.16 35.65 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.265 1.426 . . . . 3.28 111.472 -171.243 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.1 p -149.83 133.23 7.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 125.435 1.494 . . . . 2.91 109.313 -178.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 75.7 mtp -83.8 165.43 18.82 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.532 0.682 . . . . 3.62 111.657 177.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.59 178.65 27.89 Favored Glycine 0 C--O 1.224 -0.48 0 CA-C-N 115.357 -0.838 . . . . 0.87 111.717 170.086 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 ttm -147.07 143.15 28.13 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.833 1.653 . . . . 1.13 107.4 -178.05 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.6 ptt180 -151.82 157.43 34.41 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 123.403 0.681 . . . . 4.82 110.112 178.886 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.01 159.34 34.07 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.422 2.081 . . . . 0.56 111.462 178.451 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.5 m -142.39 156.01 64.1 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.878 1.671 . . . . 0.59 109.905 177.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.72 -24.83 2.14 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.855 2.37 . . . . 0.44 113.562 -167.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.6 p90 -176.34 169.87 2.64 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.497 1.919 . . . . 1.7 111.157 -178.667 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.9 mt -112.99 154.37 26.57 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.068 1.347 . . . . 0.69 110.554 159.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -113.19 142.09 46.2 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 125.614 1.565 . . . . 2.08 108.003 173.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.5 t -143.65 128.9 9.78 Favored Pre-proline 0 N--CA 1.474 0.74 0 N-CA-C 112.458 0.54 . . . . 1.03 112.458 169.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.34 167.32 24.22 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 123.324 2.683 . . . . 0.91 112.294 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.29 145.87 14.55 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 124.33 3.353 . . . . 1.16 112.281 171.013 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 mmmt 73.49 -14.36 0.64 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 126.574 1.95 . . . . 3.12 114.635 178.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.56 158.8 45.69 Favored Glycine 0 N--CA 1.472 1.088 0 CA-C-N 119.017 0.826 . . . . 1.33 114.144 -168.149 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.7 mmt-85 -76.87 136.94 38.89 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.995 0.918 . . . . 4.01 108.811 170.671 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.1 t -109.67 63.4 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.246 2.218 . . . . 5.66 107.098 -174.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.446 ' HB3' HG23 ' A' ' 21' ' ' THR . 0.0 OUTLIER -99.39 134.84 41.68 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 125.496 1.518 . . . . 3.62 110.924 -177.756 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -85.32 94.15 8.88 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.185 -1.413 . . . . 1.8 107.185 164.416 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 79' ' ' PRO . 0.2 OUTLIER -46.12 115.83 3.2 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 117.638 -1.172 . . . . 2.55 113.954 -168.964 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' A' ' 19' ' ' TYR . 30.0 Cg_endo -57.43 140.63 93.73 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.29 2.66 . . . . 3.71 112.536 176.734 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 82.56 -19.95 10.1 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 124.846 1.212 . . . . 2.73 114.343 -168.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -119.98 -98.7 1.73 Allowed Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.003 1.402 . . . . 1.83 113.331 -179.271 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 77.6 m-85 -75.13 137.88 41.66 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 121.616 -0.932 . . . . 1.83 111.756 -173.677 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -160.35 147.2 15.8 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 124.098 0.959 . . . . 0.6 111.059 -174.262 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -82.39 127.24 33.06 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.089 -1.078 . . . . 2.19 108.089 166.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.5 tpt -77.09 143.44 39.23 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.531 1.532 . . . . 0.92 108.667 164.945 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.9 mt -128.3 112.14 14.14 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 124.983 1.313 . . . . 1.97 108.782 -173.45 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.5 132.21 56.37 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.494 1.117 . . . . 2.43 109.954 -166.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.24 47.08 7.72 Favored Glycine 0 N--CA 1.472 1.095 0 C-N-CA 124.022 0.82 . . . . 1.8 113.965 173.191 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.5 mt -49.86 153.48 1.28 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 117.119 2.266 . . . . 0.66 117.119 -173.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -117.3 -33.35 4.67 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 113.354 -1.748 . . . . 1.94 113.399 -174.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 70.2 mtp180 -105.32 133.4 20.18 Favored Pre-proline 0 CA--C 1.535 0.401 0 N-CA-C 106.786 -1.561 . . . . 6.11 106.786 156.404 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.15 135.01 28.48 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 N-CA-C 107.148 -1.904 . . . . 1.39 107.148 156.623 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -99.23 157.99 16.0 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.347 0.594 . . . . 2.44 111.05 -177.015 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.406 ' HA ' ' CD1' ' A' ' 10' ' ' PHE . 0.0 OUTLIER -158.85 162.71 37.0 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 127.182 2.193 . . . . 4.45 111.531 170.089 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.77 140.46 58.23 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.798 1.239 . . . . 1.13 110.232 -175.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.79 48.41 28.14 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 114.416 -1.265 . . . . 1.93 111.777 -170.158 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -126.26 176.49 7.05 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.762 1.225 . . . . 2.56 108.524 153.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -137.38 162.1 34.51 Favored 'General case' 0 N--CA 1.433 -1.288 0 C-N-CA 127.657 2.383 . . . . 4.25 107.59 161.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 t -153.83 154.1 7.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 127.773 2.429 . . . . 1.51 110.088 -175.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -83.22 140.1 32.73 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 123.13 1.443 . . . . 3.64 113.931 161.049 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.7 mp -109.97 167.93 9.81 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 114.143 -1.39 . . . . 1.89 108.526 148.95 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.42 ' HB2' ' CB ' ' A' ' 36' ' ' ARG . 62.3 m-20 -130.22 140.8 50.69 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 127.689 2.396 . . . . 2.55 108.406 176.539 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.425 HD11 HD13 ' A' ' 20' ' ' LEU . 9.5 mp -103.26 127.37 50.6 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.252 1.421 . . . . 1.17 109.735 175.528 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.6 mt -100.3 106.75 18.42 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.495 1.118 . . . . 0.68 108.693 175.291 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.486 ' CD1' HD12 ' A' ' 30' ' ' LEU . 98.4 m-85 -97.86 125.23 42.63 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.036 0.934 . . . . 2.16 111.629 177.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 52.56 15.06 0.45 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.894 2.077 . . . . 2.51 115.36 176.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 91.59 -7.5 79.71 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.661 1.6 . . . . 4.95 115.773 -178.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -134.53 -37.72 0.21 Allowed Glycine 0 N--CA 1.477 1.39 0 CA-C-N 119.438 1.619 . . . . 2.14 116.483 -172.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -85.63 107.74 17.67 Favored 'General case' 0 N--CA 1.469 0.517 0 O-C-N 120.486 -1.596 . . . . 4.18 110.851 178.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.0 t -99.73 132.86 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 123.94 0.896 . . . . 2.04 110.731 178.163 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.1 mp -135.02 127.28 30.16 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 2.95 111.868 172.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -79.88 141.67 35.92 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.711 1.604 . . . . 2.68 114.174 179.131 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.0 t -107.61 164.18 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 127.989 2.516 . . . . 2.58 109.91 170.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 57.4 t -135.16 132.66 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 N-CA-C 106.647 -1.612 . . . . 1.69 106.647 156.56 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -148.81 145.83 20.62 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.684 1.194 . . . . 2.3 111.115 -167.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -74.61 161.69 39.23 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 123.552 2.835 . . . . 1.02 112.51 176.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 65.9 t -95.53 128.9 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.636 1.174 . . . . 1.04 110.025 164.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -142.79 -179.05 6.1 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.283 2.633 . . . . 3.05 109.031 -173.309 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -126.22 109.58 12.48 Favored 'General case' 0 N--CA 1.468 0.463 0 O-C-N 121.041 -1.037 . . . . 3.27 109.953 162.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 129.165 2.986 . . . . 7.08 108.519 -161.413 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.872 0 N-CA-C 107.9 -2.08 . . . . 13.79 107.9 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.3 p -159.46 -15.87 0.06 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 127.119 2.168 . . . . 10.13 113.413 174.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.88 33.84 0.3 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.705 1.139 . . . . 7.5 113.71 -159.106 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 32.9 p -71.37 70.03 0.59 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.761 1.224 . . . . 6.21 112.076 170.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -76.4 76.79 3.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.047 1.339 . . . . 4.61 109.361 173.408 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.64 154.17 25.15 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.221 1.391 . . . . 1.45 113.612 171.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.456 ' CD2' ' HA ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -83.66 156.92 22.41 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.953 1.701 . . . . 7.92 114.458 173.092 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.7 t -84.62 55.63 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 CA-C-O 122.794 1.283 . . . . 3.02 110.19 165.431 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.456 ' HA ' ' CD2' ' A' ' 7' ' ' TRP 0.286 0.2 OUTLIER 27.58 -121.32 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 128.438 2.695 . . . . 5.25 115.043 -169.15 . . . . . . . . 4 4 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -166.35 131.3 2.24 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.346 1.458 . . . . 2.81 109.182 -179.115 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 m -175.84 138.56 0.53 Allowed Pre-proline 0 N--CA 1.47 0.571 0 C-N-CA 124.96 1.304 . . . . 2.16 110.306 -176.243 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -82.34 -38.85 0.17 Allowed 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 122.666 2.244 . . . . 1.55 111.519 164.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 155.23 173.32 23.83 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 126.426 1.965 . . . . 1.19 111.049 -173.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -77.76 2.44 25.93 Favored 'Cis proline' 0 CA--C 1.542 0.885 0 CA-C-N 119.559 1.679 . . . . 1.34 112.722 -4.685 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -151.14 160.94 43.58 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 123.14 1.448 . . . . 2.01 113.561 -175.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -140.69 -175.99 4.49 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.183 2.193 . . . . 0.42 111.765 -179.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -147.8 148.06 30.52 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.443 1.897 . . . . 0.73 108.243 176.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -119.82 127.58 52.9 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.558 1.072 . . . . 0.82 109.968 179.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.477 ' CE2' ' HA ' ' A' ' 79' ' ' PRO . 56.6 m-85 -116.2 78.93 1.24 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.054 1.341 . . . . 2.64 109.59 -176.089 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.9 pp -82.14 152.69 26.39 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.53 0.732 . . . . 2.41 112.374 -179.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.1 m -84.1 130.71 34.84 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 107.675 -1.231 . . . . 1.88 107.675 157.633 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 11.4 tp -96.7 133.3 41.41 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 110.071 -0.344 . . . . 4.36 110.071 -179.533 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -124.69 129.29 50.24 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.629 1.172 . . . . 6.2 112.215 -175.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -107.14 99.61 27.92 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.351 -0.843 . . . . 1.64 110.506 172.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -81.16 -12.87 11.56 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.075 2.517 . . . . 1.69 113.564 175.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -84.74 179.68 51.3 Favored Glycine 0 C--N 1.341 0.821 0 C-N-CA 124.567 1.08 . . . . 1.68 112.226 -175.963 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -105.05 0.45 27.59 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.115 2.166 . . . . 3.23 112.124 -174.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -125.12 161.08 51.6 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 128.363 2.665 . . . . 2.93 109.665 176.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.32 143.29 27.91 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.168 1.912 . . . . 1.39 110.995 -175.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.2 mp -104.33 150.1 24.77 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.801 1.241 . . . . 2.46 109.558 171.142 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.7 ttm180 -136.56 97.18 3.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.316 -1.766 . . . . 2.32 110.24 -174.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 tt -80.29 115.42 19.83 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.092 -1.077 . . . . 1.79 108.092 -175.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.3 m -98.81 -31.38 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 124.605 1.162 . . . . 0.75 112.58 -176.905 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.3 177.26 35.06 Favored Glycine 0 C--N 1.345 1.052 0 C-N-CA 124.716 1.15 . . . . 0.67 113.939 175.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.468 ' O ' HG11 ' A' ' 43' ' ' VAL . . . -124.38 160.13 28.83 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 121.821 -0.811 . . . . 1.25 110.549 169.147 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.7 mmt180 -130.52 157.36 42.89 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 126.458 1.903 . . . . 4.47 108.432 167.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.5 t -165.71 148.31 6.56 Favored Pre-proline 0 N--CA 1.475 0.804 0 C-N-CA 126.152 1.781 . . . . 0.88 108.683 175.092 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -73.05 -19.71 22.65 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 121.521 1.481 . . . . 0.89 113.609 -176.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.1 m -90.86 12.57 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 N-CA-C 115.799 1.777 . . . . 0.85 115.799 -176.058 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -151.28 155.39 38.66 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.518 1.303 . . . . 0.9 114.518 173.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -92.1 -43.92 9.11 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 114.988 -1.005 . . . . 3.38 113.695 -167.11 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -138.69 123.47 18.72 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.884 1.274 . . . . 6.1 107.751 -167.362 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 35' ' ' ALA . 5.3 p -126.15 132.8 70.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 125.209 1.404 . . . . 1.29 109.479 -166.712 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -120.47 157.87 28.45 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 125.148 1.379 . . . . 3.1 109.441 169.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.2 tp -105.58 117.69 34.67 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.798 1.239 . . . . 0.95 108.686 169.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 54.3 m170 -118.89 147.61 43.8 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.122 1.369 . . . . 0.73 113.533 -175.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -89.11 177.23 6.69 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.185 1.794 . . . . 2.37 110.608 161.057 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 86.5 m -153.39 140.95 19.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 105.992 -1.855 . . . . 0.97 105.992 174.434 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -153.43 173.18 16.01 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 114.243 1.201 . . . . 2.1 114.243 -165.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.47 134.83 50.72 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 125.659 1.584 . . . . 5.56 111.534 170.79 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.45 155.46 44.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.232 1.413 . . . . 6.11 110.653 171.64 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -86.91 141.17 28.94 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 108.97 -0.752 . . . . 2.87 108.97 157.864 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.9 t -135.69 115.31 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.165 1.786 . . . . 2.54 106.277 165.482 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 56.09 41.09 30.0 Favored 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 124.632 1.173 . . . . 4.77 113.737 179.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.47 6.18 65.28 Favored Glycine 0 CA--C 1.537 1.468 0 O-C-N 120.723 -1.236 . . . . 1.93 114.281 -177.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -118.08 126.48 52.35 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 126.978 2.111 . . . . 2.78 108.117 -178.017 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -76.86 121.93 24.1 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.921 1.289 . . . . 3.6 109.533 -173.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 91.5 t -137.45 132.88 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 126.317 1.847 . . . . 2.42 109.129 -174.295 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 63.9 mtt -80.55 166.66 20.94 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 113.154 0.798 . . . . 2.36 113.154 179.787 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -154.97 177.07 32.43 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.1 0.857 . . . . 0.92 113.426 179.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.5 ttm -155.93 140.56 16.96 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.524 1.529 . . . . 1.12 109.707 -176.059 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -145.02 156.8 54.9 Favored Pre-proline 0 CA--C 1.539 0.55 0 C-N-CA 126.622 1.969 . . . . 8.81 109.218 -176.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -82.46 151.97 15.44 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 122.761 2.308 . . . . 0.89 110.629 170.677 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.4 m -134.25 155.51 79.84 Favored Pre-proline 0 N--CA 1.477 0.915 0 C-N-CA 125.477 1.511 . . . . 0.69 110.449 -179.04 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -80.29 -27.59 3.47 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.945 2.43 . . . . 0.85 113.094 -166.585 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -175.68 167.09 3.19 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.566 1.546 . . . . 2.2 111.752 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.0 mt -113.27 153.31 28.63 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 126.469 1.908 . . . . 0.78 110.355 166.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -117.14 142.77 46.59 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.879 1.272 . . . . 1.91 109.434 176.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 49.3 t -140.97 128.49 12.09 Favored Pre-proline 0 N--CA 1.472 0.657 0 N-CA-C 112.436 0.532 . . . . 1.28 112.436 168.004 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.84 159.89 44.37 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 123.979 3.12 . . . . 1.44 112.159 178.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -60.1 144.13 99.5 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.945 3.097 . . . . 1.68 113.34 -176.198 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 7.7 mptt 67.3 -9.56 0.39 Allowed 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 127.589 2.356 . . . . 2.62 114.483 -177.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.51 134.92 14.34 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.41 1.005 . . . . 1.66 112.656 177.397 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.22 135.67 41.3 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 108.77 -0.826 . . . . 4.17 108.77 155.948 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 60.5 t -147.07 129.53 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.031 1.732 . . . . 4.02 107.65 -174.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -94.54 150.55 20.13 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.348 -0.845 . . . . 2.86 112.565 -167.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.24 84.83 2.42 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 107.081 -1.451 . . . . 2.01 107.081 156.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.428 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -64.08 145.5 97.94 Favored Pre-proline 0 CA--C 1.55 0.952 0 O-C-N 120.949 -1.094 . . . . 2.71 113.261 -171.482 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.477 ' HA ' ' CE2' ' A' ' 19' ' ' TYR . 20.8 Cg_endo -55.36 -38.73 93.61 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 124.459 3.439 . . . . 2.17 113.582 -174.421 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -91.14 24.3 19.54 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 117.199 -1.89 . . . . 2.26 115.503 175.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -164.47 -15.11 0.02 OUTLIER Glycine 0 N--CA 1.476 1.315 0 N-CA-C 121.342 3.297 . . . . 2.3 121.342 171.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -149.11 145.92 27.45 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 122.118 2.959 . . . . 2.11 114.336 174.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -162.05 158.3 24.72 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.894 1.278 . . . . 0.68 112.709 172.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -79.09 142.03 36.82 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.391 -0.818 . . . . 2.27 109.597 157.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 tpt -99.35 125.79 45.09 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 127.107 2.163 . . . . 1.11 108.471 169.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 9.5 mp -120.3 112.57 19.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.909 1.283 . . . . 1.41 109.051 -173.08 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -104.15 155.33 18.8 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.242 1.417 . . . . 2.13 110.928 -174.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.24 -48.82 3.99 Favored Glycine 0 N--CA 1.469 0.852 0 C-N-CA 126.822 2.153 . . . . 2.99 113.05 173.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.9 mt 51.34 172.67 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.903 2.881 . . . . 0.83 115.198 -172.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -137.9 -22.56 1.07 Allowed 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 127.544 2.338 . . . . 2.55 113.467 -176.75 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -137.63 143.99 42.91 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 128.566 2.747 . . . . 4.94 109.178 175.892 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -73.43 145.38 37.96 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.31 2.007 . . . . 1.6 108.351 155.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -105.64 119.6 39.54 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.851 0.86 . . . . 2.17 111.203 -177.724 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 20.6 mttp -85.29 170.06 13.17 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.88 0.848 . . . . 3.85 112.197 169.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.67 136.81 58.07 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.819 -0.628 . . . . 1.81 109.32 157.715 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 78.79 9.51 87.01 Favored Glycine 0 CA--C 1.529 0.919 0 CA-C-O 118.291 -1.283 . . . . 1.75 114.954 174.247 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -73.63 173.06 10.29 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 118.982 1.391 . . . . 3.14 108.792 160.359 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -145.47 151.68 38.58 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.64 2.376 . . . . 3.36 106.869 169.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 8.4 t -153.08 139.87 12.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 127.105 2.162 . . . . 1.53 109.664 -176.166 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -79.21 144.29 34.53 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.489 0.922 . . . . 2.47 113.489 173.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.1 mp -120.38 148.01 44.32 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.555 1.542 . . . . 1.87 110.874 165.078 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.99 117.28 34.24 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 126.706 2.003 . . . . 2.84 110.616 164.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 5.8 mp -85.73 114.8 22.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.633 1.173 . . . . 1.37 108.745 176.102 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.8 mt -90.91 114.03 26.39 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.646 1.178 . . . . 1.01 108.91 -175.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -113.07 117.22 31.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.613 1.565 . . . . 1.94 112.495 -171.806 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . 54.04 26.62 6.63 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.512 1.525 . . . . 2.14 113.736 171.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.5 -68.93 2.64 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.144 1.354 . . . . 4.38 112.351 -172.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . -77.25 2.28 62.15 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 116.571 1.388 . . . . 1.81 116.571 -166.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 38.9 mtmt -129.44 139.04 51.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.445 1.623 . . . . 2.85 111.078 173.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.8 t -137.74 142.47 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 125.425 1.49 . . . . 2.17 108.196 176.73 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 50.3 tp -154.43 110.97 3.29 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.252 0.549 . . . . 2.27 112.279 -166.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.7 ttpt -82.76 152.29 25.78 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.851 1.056 . . . . 2.19 113.851 -170.7 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.14 167.52 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 126.128 1.771 . . . . 2.4 110.291 178.3 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 59.2 t -114.26 138.58 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.307 1.043 . . . . 1.93 109.744 -177.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 6.7 mp -130.17 134.16 25.78 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 126.038 1.735 . . . . 2.7 110.744 -177.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -73.63 177.71 7.68 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.298 2.665 . . . . 1.0 111.562 170.317 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 t -118.28 95.84 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.033 0.933 . . . . 1.17 108.65 164.321 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.44 60.21 2.22 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 121.21 -0.931 . . . . 5.6 113.282 -169.252 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -78.43 117.32 19.53 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.659 -0.651 . . . . 4.92 112.3 179.765 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.782 0 C-N-CA 126.591 1.956 . . . . 8.33 111.028 -173.034 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.779 0 N-CA-C 107.715 -2.154 . . . . 8.41 107.715 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.0 m -65.45 103.18 0.79 Allowed 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.94 -1.133 . . . . 9.24 107.94 157.91 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 70.46 123.95 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 127.089 2.156 . . . . 10.18 110.6 -154.577 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.0 m -119.68 -29.96 4.92 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.363 1.865 . . . . 5.49 110.307 168.283 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -95.92 174.84 6.74 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.326 1.45 . . . . 9.26 110.457 164.706 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.97 -171.98 13.6 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 127.087 2.28 . . . . 1.65 110.78 177.358 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 1.3 p90 -121.81 178.27 4.93 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 115.004 1.483 . . . . 2.17 115.004 -179.718 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 55.9 t -120.06 142.09 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 127.124 2.17 . . . . 1.47 107.106 172.217 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -79.36 -93.59 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.17 0.588 . . . . 7.3 110.852 -178.697 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -161.59 150.56 15.94 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.92 -1.113 . . . . 3.33 111.738 -170.941 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -122.16 127.73 25.8 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 124.523 1.129 . . . . 3.99 111.444 176.215 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.49 -49.52 0.45 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 N-CA-C 109.126 -1.144 . . . . 4.0 109.126 154.143 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.04 141.3 9.33 Favored Glycine 0 CA--C 1.542 1.723 0 N-CA-C 108.872 -1.691 . . . . 1.42 108.872 -155.171 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -86.91 14.93 44.17 Favored 'Cis proline' 0 CA--C 1.54 0.814 0 CA-C-N 120.308 2.054 . . . . 1.19 112.63 5.166 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -144.22 171.54 14.15 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 114.343 1.238 . . . . 2.26 114.343 -172.12 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -155.99 -177.03 6.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.03 2.532 . . . . 0.62 112.897 -176.443 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -151.0 141.46 22.5 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.657 1.583 . . . . 0.73 110.122 177.537 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -120.24 153.61 36.08 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 0.66 111.325 178.797 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -139.26 59.3 1.61 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.445 1.898 . . . . 2.11 111.636 -168.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.86 167.37 17.46 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.612 1.338 . . . . 1.81 114.612 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.3 m -101.41 146.46 27.58 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.84 1.656 . . . . 1.66 110.628 -177.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.2 117.66 30.19 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.506 1.122 . . . . 4.0 110.012 172.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -123.23 128.35 49.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.961 -1.496 . . . . 4.28 106.961 163.64 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.7 t-20 -97.41 106.21 30.91 Favored Pre-proline 0 CA--C 1.542 0.659 0 C-N-CA 123.528 0.731 . . . . 1.36 110.575 -179.473 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -84.58 -11.68 8.0 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.602 2.201 . . . . 1.09 114.431 178.132 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -88.55 166.74 34.73 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 119.406 1.003 . . . . 1.2 111.422 -176.819 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.04 2.85 53.42 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.757 2.023 . . . . 3.34 112.308 175.401 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.5 pp -113.15 155.53 44.25 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.814 2.046 . . . . 3.33 110.799 174.536 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -79.47 142.47 16.5 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.427 2.085 . . . . 0.92 110.69 -178.08 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.91 142.61 30.2 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.903 0.859 . . . . 2.59 109.575 172.513 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 7.6 ttp180 -138.02 106.15 5.73 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.608 1.963 . . . . 2.35 108.724 178.135 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.47 106.16 18.2 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 128.31 2.644 . . . . 1.95 107.863 -170.27 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.3 m -104.35 -21.55 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 N-CA-C 112.912 0.708 . . . . 0.7 112.912 -167.434 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -158.41 -174.89 28.7 Favored Glycine 0 N--CA 1.467 0.758 0 C-N-CA 124.839 1.209 . . . . 0.62 112.395 175.398 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.36 179.7 6.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.639 0.733 . . . . 0.75 112.974 170.678 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -144.81 158.57 43.74 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.823 2.049 . . . . 4.96 107.873 161.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.6 t -164.6 145.2 6.34 Favored Pre-proline 0 N--CA 1.465 0.316 0 C-N-CA 125.717 1.607 . . . . 0.82 108.542 175.324 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.24 -2.84 12.89 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.695 1.597 . . . . 1.14 113.982 -175.914 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.6 m -107.03 11.98 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 116.174 1.916 . . . . 1.33 116.174 -174.163 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.05 156.43 46.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.423 1.465 . . . . 1.22 113.283 177.377 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -86.41 -31.07 21.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.683 1.193 . . . . 3.18 111.598 173.408 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -140.61 147.4 39.32 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.004 1.322 . . . . 4.61 109.332 166.801 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.5 p -118.38 141.99 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.858 1.663 . . . . 0.99 108.392 161.629 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -140.37 137.68 34.25 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.317 1.447 . . . . 2.94 108.293 -171.449 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.3 tp -99.5 111.98 24.25 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 121.371 -0.831 . . . . 0.92 111.922 -170.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' HIS . . . . . . . . . . . . . 58.3 m170 -118.92 155.64 30.94 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.962 1.305 . . . . 0.76 113.236 -176.614 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 9.4 pt-20 -100.25 176.51 5.35 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.579 1.552 . . . . 1.91 112.187 159.951 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.3 m -143.64 136.27 27.26 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 106.1 -1.815 . . . . 1.2 106.1 165.085 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -138.77 164.65 29.04 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 124.97 1.308 . . . . 1.97 112.675 -165.672 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 7.5 ttp -99.42 142.64 30.64 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.929 1.292 . . . . 3.69 109.943 170.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -142.75 145.16 33.04 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 125.903 1.681 . . . . 7.98 111.278 173.22 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -80.93 141.39 34.56 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 124.466 1.106 . . . . 3.67 109.903 158.768 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 67.3 t -138.44 121.19 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 126.159 1.783 . . . . 2.45 106.4 170.699 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 62.39 15.98 8.18 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 125.506 1.522 . . . . 3.37 114.011 -173.292 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.67 16.36 66.08 Favored Glycine 0 N--CA 1.477 1.402 0 O-C-N 120.979 -1.076 . . . . 2.19 113.871 -170.356 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 52.8 mttt -121.37 121.11 36.91 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.686 2.395 . . . . 2.33 108.394 -179.097 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.87 139.65 48.94 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 120.379 -1.45 . . . . 3.73 113.178 178.028 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.7 p -155.26 169.7 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 128.246 2.618 . . . . 2.52 108.347 176.762 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.0 mtm -100.29 172.1 7.37 Favored 'General case' 0 N--CA 1.47 0.541 0 O-C-N 120.787 -1.195 . . . . 3.84 113.31 176.795 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -152.49 174.04 31.44 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.688 2.09 . . . . 0.61 111.355 166.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 4.1 ttm -136.43 153.73 50.99 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.33 1.852 . . . . 1.16 108.08 175.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -159.13 156.06 25.41 Favored Pre-proline 0 N--CA 1.47 0.559 0 CA-C-O 118.076 -0.964 . . . . 4.69 111.082 175.891 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.96 155.5 52.95 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.432 2.088 . . . . 0.56 110.849 170.446 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.9 m -141.1 159.5 61.4 Favored Pre-proline 0 N--CA 1.479 1.01 0 C-N-CA 125.637 1.575 . . . . 0.85 110.38 -175.199 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -82.19 -27.12 2.5 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.432 2.088 . . . . 0.67 113.134 -168.412 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -177.59 164.82 2.08 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.378 1.471 . . . . 2.42 112.171 -177.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.1 mt -107.94 160.21 15.94 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.93 1.292 . . . . 0.95 110.376 160.272 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -145.15 147.58 32.65 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.235 -0.916 . . . . 2.04 111.521 -179.567 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 48.3 t -143.25 131.0 10.99 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.086 0.954 . . . . 1.14 111.736 176.018 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -72.42 162.15 42.29 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 124.175 3.25 . . . . 0.9 112.457 179.122 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -59.49 135.47 64.99 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 124.215 3.277 . . . . 0.98 113.08 -177.419 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 66.55 -5.36 0.62 Allowed 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.927 2.091 . . . . 1.89 114.508 -179.51 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.84 167.92 51.86 Favored Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.917 1.722 . . . . 1.28 112.589 171.518 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.86 151.74 40.26 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.53 0.732 . . . . 5.87 112.22 174.623 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.48 HG12 ' H ' ' A' ' 76' ' ' GLU . 29.7 t -146.83 -178.81 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.016 0 C-N-CA 128.021 2.529 . . . . 3.56 107.784 -178.498 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.48 ' H ' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -146.83 154.52 41.44 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.347 1.859 . . . . 3.62 108.206 171.191 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.7 mp -51.19 -38.88 54.81 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 123.048 0.539 . . . . 3.06 111.899 175.788 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 18.0 ttmm 101.14 118.19 0.01 OUTLIER Pre-proline 0 N--CA 1.478 0.972 0 C-N-CA 127.773 2.429 . . . . 2.33 109.906 161.605 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -64.24 -16.36 54.57 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.114 2.543 . . . . 2.76 116.181 -161.06 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -115.34 7.16 20.89 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 124.655 1.121 . . . . 2.75 114.946 169.884 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.62 -110.09 1.93 Allowed Glycine 0 N--CA 1.47 0.915 0 C-N-CA 125.839 1.685 . . . . 2.15 113.263 -171.123 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 47' ' ' GLU . 60.2 m-85 -73.1 147.95 44.45 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 123.378 1.561 . . . . 2.11 111.773 -175.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -159.68 142.39 13.81 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.579 -1.646 . . . . 0.98 111.045 -178.24 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -79.88 111.24 16.01 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.972 -1.122 . . . . 2.07 107.972 165.424 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 1.7 tpt -77.03 120.9 22.77 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 127.343 2.257 . . . . 1.06 107.908 175.111 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.3 mt -109.74 122.22 47.0 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 125.272 1.429 . . . . 2.21 109.035 -173.206 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -117.98 143.76 46.1 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.691 1.196 . . . . 2.19 111.415 -170.093 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.33 -43.22 2.85 Favored Glycine 0 N--CA 1.476 1.305 0 C-N-CA 127.248 2.356 . . . . 2.93 113.955 175.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.8 mt 56.77 168.44 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 129.698 3.199 . . . . 1.05 115.637 -176.284 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -123.97 -30.83 3.46 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.97 1.708 . . . . 1.76 112.427 173.658 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -127.66 140.22 37.46 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 128.932 2.893 . . . . 5.76 107.612 166.219 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.81 59.19 0.9 Allowed 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.376 2.717 . . . . 2.79 112.717 -165.341 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -33.73 106.2 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 116.566 2.061 . . . . 3.03 116.566 -157.704 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.1 mmtt -100.95 168.63 9.5 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 126.265 1.826 . . . . 8.13 111.043 169.047 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.69 134.2 50.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.93 0.892 . . . . 1.34 110.724 -176.555 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.72 -6.33 52.05 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 126.26 1.886 . . . . 1.52 114.376 -175.331 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -82.59 -175.1 5.58 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.985 1.314 . . . . 2.93 112.106 170.769 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.7 142.02 23.31 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 128.543 2.737 . . . . 6.5 107.247 -173.415 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.2 t -142.79 124.4 12.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 C-N-CA 124.004 0.921 . . . . 1.74 110.68 -168.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -98.64 129.53 45.14 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 114.903 -1.044 . . . . 2.74 110.707 -178.573 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -119.11 137.9 53.27 Favored 'General case' 0 N--CA 1.462 0.174 0 C-N-CA 126.193 1.797 . . . . 2.52 110.3 179.091 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -97.92 124.2 42.25 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 127.324 2.25 . . . . 1.8 108.889 170.402 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.15 115.66 27.98 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.797 1.239 . . . . 0.99 109.756 178.407 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 78.5 mt -87.89 101.5 13.79 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 109.222 -0.658 . . . . 0.76 109.222 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -94.29 136.9 34.07 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.161 0.984 . . . . 2.04 111.097 176.669 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -49.97 125.88 13.03 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.706 1.202 . . . . 2.04 113.449 -174.566 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 76.68 70.51 1.28 Allowed Glycine 0 N--CA 1.47 0.951 0 C-N-CA 124.259 0.933 . . . . 3.71 112.897 177.54 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' GLY . . . . . . . . . . . . . . . 70.72 5.99 58.1 Favored Glycine 0 N--CA 1.474 1.224 0 N-CA-C 116.485 1.354 . . . . 1.61 116.485 164.498 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm -98.51 127.12 44.31 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.395 1.598 . . . . 3.52 109.878 -179.794 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.24 142.92 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.3 1.04 . . . . 2.2 109.01 179.865 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 9.0 tt -152.5 135.98 15.99 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.336 1.455 . . . . 2.0 109.208 -177.841 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -102.1 140.42 36.4 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.354 0.662 . . . . 3.24 112.433 -179.485 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.8 t -127.84 162.7 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 C-N-CA 127.109 2.164 . . . . 1.76 108.311 175.575 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.9 t -128.33 141.25 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.397 1.479 . . . . 1.95 110.436 -178.662 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 16.3 mt -136.45 124.66 15.0 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.693 1.197 . . . . 2.26 109.848 -164.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.67 149.36 48.72 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.048 1.832 . . . . 0.88 110.244 173.767 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.0 t -90.94 117.35 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 N-CA-C 108.861 -0.792 . . . . 0.93 108.861 167.792 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -137.8 123.71 20.11 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.12 -1.067 . . . . 4.04 108.12 175.25 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -79.18 58.23 2.46 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.093 0.557 . . . . 2.1 111.781 -179.278 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.246 0.907 0 C-N-CA 126.263 1.825 . . . . 8.21 112.107 -179.224 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_